data_1zrr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zrr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.471 ' O ' ' CG2' ' A' ' 19' ' ' THR . 3.7 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.92 169.52 9.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.043 -1.036 . . . . 0.0 108.991 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.5 tp -158.0 115.02 2.91 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.0 134.08 52.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.34 -0.85 . . . . 0.0 110.06 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.483 ' CD1' ' OE1' ' A' ' 27' ' ' GLN . 38.4 mt -129.74 132.12 66.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 96.6 m-85 -124.05 167.45 14.18 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -86.31 174.57 8.96 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.269 -0.895 . . . . 0.0 108.948 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.76 -31.32 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.898 -1.126 . . . . 0.0 109.492 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -73.03 -37.34 66.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.947 . . . . 0.0 110.303 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -136.52 124.71 14.96 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 109.519 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.427 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 56.3 Cg_endo -81.09 -35.53 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 122.068 1.845 . . . . 0.0 112.317 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.63 4.99 1.58 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.442 -0.787 . . . . 0.0 110.258 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 11' ' ' PRO . 84.6 m-20 -114.52 118.99 35.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.401 -0.812 . . . . 0.0 109.007 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.4 p -98.65 123.16 42.68 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.277 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 pp -91.0 -7.72 51.18 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.633 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.588 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 31.9 t90 -157.43 105.27 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.338 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -120.6 115.99 24.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.57 -0.706 . . . . 0.0 109.876 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.445 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -162.34 165.01 27.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.33 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' A' ' 1' ' ' SER . 52.1 m -131.37 90.2 2.83 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.573 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 84.0 m-20 -127.04 151.24 48.87 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.288 -0.882 . . . . 0.0 110.491 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.91 -45.02 13.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.037 -1.664 . . . . 0.0 108.279 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 23' ' ' GLU . 10.6 pt-20 -82.89 -46.12 13.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.704 . . . . 0.0 110.18 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.514 ' N ' ' CG ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -62.84 -23.69 67.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.52 -1.362 . . . . 0.0 108.705 -178.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.573 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 4.6 mt -70.42 -58.68 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.522 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 6.6 pt20 -56.36 -44.17 79.88 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.303 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.522 ' N ' ' CG ' ' A' ' 25' ' ' GLN . 74.5 mt-30 -57.73 -33.27 68.27 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.317 -0.865 . . . . 0.0 109.906 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.588 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 5.7 tt0 -70.34 -61.36 1.8 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.024 -1.048 . . . . 0.0 109.41 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -66.98 -55.36 14.8 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.776 -1.202 . . . . 0.0 109.794 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 18.1 t-20 -49.9 -31.95 13.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.886 -1.134 . . . . 0.0 109.333 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.59 -24.61 67.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.021 -1.049 . . . . 0.0 108.44 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.526 ' NZ ' ' OE1' ' A' ' 120' ' ' GLU . 30.0 mttt -92.48 14.12 17.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.54 24.44 26.01 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.714 -1.232 . . . . 0.0 110.089 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.599 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 39.6 t -96.36 146.3 7.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.386 -1.067 . . . . 0.0 109.704 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -85.83 155.85 20.81 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 120.927 -1.108 . . . . 0.0 109.136 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.454 ' CD1' ' CB ' ' A' ' 25' ' ' GLN . 1.2 t80 -154.62 149.44 26.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.912 -1.117 . . . . 0.0 108.912 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 1.3 mt-10 -175.04 172.92 2.74 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.903 -1.123 . . . . 0.0 109.878 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -150.81 114.83 5.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 108.839 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.41 ' CH2' HD21 ' A' ' 131' ' ' LEU . 19.0 m0 -110.67 152.59 26.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.62 -0.675 . . . . 0.0 109.235 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -143.12 167.43 22.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 109.964 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.52 158.66 15.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 108.86 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -102.97 -17.43 15.46 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.204 -0.935 . . . . 0.0 108.534 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -93.38 171.47 8.89 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.591 0.71 . . . . 0.0 109.185 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -94.34 116.88 29.33 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.556 -0.715 . . . . 0.0 109.501 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mt -91.17 163.68 14.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.429 -0.795 . . . . 0.0 109.137 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.62 -101.08 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.68 93.07 4.83 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.108 -1.23 . . . . 0.0 109.48 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.55 91.61 34.56 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -77.02 -26.94 7.32 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.412 2.074 . . . . 0.0 112.701 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.6 p -119.92 141.16 49.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 0.0 109.581 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.93 -20.85 41.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.405 -0.809 . . . . 0.0 109.475 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 50' ' ' ALA . 84.8 tt0 -44.83 -37.89 4.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.005 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.7 p -79.73 -31.95 41.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.275 -0.891 . . . . 0.0 109.42 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ALA . 79.7 t -67.74 -47.67 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 109.777 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 58' ' ' GLN . 9.9 mm -60.26 -37.26 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.957 . . . . 0.0 108.859 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.32 -29.87 70.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.418 -0.802 . . . . 0.0 109.45 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.23 -18.68 60.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 110.317 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -118.42 -7.5 10.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.389 -0.82 . . . . 0.0 109.181 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.686 HE21 ' CG1' ' A' ' 61' ' ' ILE . 28.9 tp60 -50.53 -39.4 48.83 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.313 -0.867 . . . . 0.0 108.774 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.741 ' CD2' ' N ' ' A' ' 60' ' ' ALA . 10.7 p-80 -53.04 -42.99 66.27 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.853 -1.154 . . . . 0.0 109.24 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.741 ' N ' ' CD2' ' A' ' 59' ' ' HIS . . . -61.88 -58.69 6.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.075 -1.015 . . . . 0.0 109.464 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.686 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.5 OUTLIER -64.24 -28.52 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.763 -1.211 . . . . 0.0 109.15 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 58' ' ' GLN . 27.0 t70 -55.29 -25.4 33.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.145 -0.972 . . . . 0.0 109.395 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HG2' ' N ' ' A' ' 64' ' ' LEU . 8.8 ptmt -83.71 -37.26 22.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.08 -1.012 . . . . 0.0 109.493 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.457 ' N ' ' HG2' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -68.86 -45.56 70.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.206 -0.934 . . . . 0.0 109.895 -179.415 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 69' ' ' GLY . 3.3 p -68.56 -32.64 56.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.431 -0.793 . . . . 0.0 109.479 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.1 67.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.209 -0.932 . . . . 0.0 109.538 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -79.44 -50.03 11.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.123 -0.985 . . . . 0.0 109.897 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.659 ' O ' ' C ' ' A' ' 69' ' ' GLY . 20.5 mmtt -85.83 14.12 6.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.464 -0.772 . . . . 0.0 110.14 -177.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.659 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -7.53 85.64 0.0 OUTLIER Glycine 0 N--CA 1.501 2.984 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.467 ' N ' ' O ' ' A' ' 68' ' ' LYS . 11.7 m-85 -75.96 166.84 22.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.463 -1.022 . . . . 0.0 108.977 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -57.53 -40.58 79.12 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.441 -0.787 . . . . 0.0 109.805 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.29 167.53 30.15 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.631 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.559 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 13.2 t-105 -134.24 137.64 44.48 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.269 -0.895 . . . . 0.0 109.126 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.69 179.02 8.9 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.061 -1.025 . . . . 0.0 108.343 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 m -124.17 149.38 28.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.422 -0.799 . . . . 0.0 109.438 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.4 mt -100.86 117.04 45.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.489 ' O ' ' OG ' ' A' ' 77' ' ' SER . 27.8 p -170.13 101.69 0.29 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.453 -0.78 . . . . 0.0 109.399 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.587 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -110.95 179.84 3.94 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.95 1.705 . . . . 0.0 107.864 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.587 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -89.71 144.75 25.72 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.688 -1.258 . . . . 0.0 109.062 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.66 2.21 0.11 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.749 -0.594 . . . . 0.0 109.593 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.568 ' H ' ' C ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -85.63 -28.28 24.88 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.469 -1.292 . . . . 0.0 108.888 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -64.51 123.84 84.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.905 -1.122 . . . . 0.0 109.45 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -79.19 -8.97 15.32 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.134 1.889 . . . . 0.0 112.349 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -90.21 3.13 54.42 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.96 -1.087 . . . . 0.0 109.596 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.547 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 44.6 pttt -60.96 -47.4 86.6 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.211 -0.93 . . . . 0.0 108.96 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.547 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 96.5 mt-10 -64.56 -42.88 95.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.64 76.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.029 -1.044 . . . . 0.0 109.432 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.53 -50.17 72.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 0.0 110.129 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.567 HH12 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -65.06 -24.66 67.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.229 -0.92 . . . . 0.0 109.701 -179.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.567 ' CD ' HH12 ' A' ' 89' ' ' ARG . 58.0 mm-40 -65.41 -60.03 3.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.37 -0.831 . . . . 0.0 109.6 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.405 ' HZ3' ' CB ' ' A' ' 91' ' ' LYS . 8.8 mtmp? -53.32 -27.81 25.23 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.072 -1.018 . . . . 0.0 109.038 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -18.4 33.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.017 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.9 -36.72 70.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.199 -0.938 . . . . 0.0 109.848 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -46.64 137.18 7.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.057 . . . . 0.0 109.337 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -70.93 164.6 25.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 0.0 109.555 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -175.9 -167.26 0.22 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.442 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.8 t -163.88 134.31 4.31 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.619 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -103.73 154.86 19.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 0.0 109.786 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.42 -6.58 86.66 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -123.97 170.06 11.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.443 -1.033 . . . . 0.0 109.38 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -73.84 143.19 46.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.217 -0.927 . . . . 0.0 109.778 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.559 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 4.6 tt0 -104.47 94.45 5.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.214 -0.929 . . . . 0.0 109.053 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.3 t -81.65 131.11 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.199 -0.938 . . . . 0.0 110.161 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.99 109.64 11.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.451 -0.78 . . . . 0.0 109.854 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.624 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 14.7 t80 -104.8 131.52 52.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.335 -0.853 . . . . 0.0 109.071 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.567 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -90.06 132.27 35.49 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.408 0.623 . . . . 0.0 109.861 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.4 t -113.48 -31.01 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.743 -0.598 . . . . 0.0 109.784 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -167.65 156.02 9.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.1 -1.0 . . . . 0.0 109.358 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.29 155.76 8.42 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.69 148.75 37.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -1.072 . . . . 0.0 109.365 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.23 -136.69 3.47 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 26.5 tp -138.24 154.08 49.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.397 -1.06 . . . . 0.0 109.493 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -122.23 145.43 48.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.582 -0.699 . . . . 0.0 109.39 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.67 108.71 4.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.578 -0.701 . . . . 0.0 109.713 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.92 112.87 20.18 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.555 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.1 t-160 -105.25 113.22 26.68 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.204 -0.935 . . . . 0.0 109.601 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.68 119.24 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.25 -0.906 . . . . 0.0 110.203 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.37 -143.16 33.83 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 105.998 -2.841 . . . . 0.0 105.998 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 7.0 p-10 -105.36 79.26 1.45 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 115.185 -2.606 . . . . 0.0 109.61 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.555 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 78.8 tt0 -165.19 166.19 19.13 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.7 t -129.91 152.19 36.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.038 -1.038 . . . . 0.0 109.683 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.28 131.32 46.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.63 -0.669 . . . . 0.0 109.286 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -128.24 115.04 17.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 109.11 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.3 t -108.22 138.08 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 125' ' ' LEU . 0.3 OUTLIER -134.56 90.3 2.64 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.213 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 126' ' ' CYS . 31.2 p -166.35 135.35 3.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.388 -1.445 . . . . 0.0 107.546 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -107.05 94.91 5.35 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 116.195 -2.202 . . . . 0.0 110.642 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.542 ' C ' ' H ' ' A' ' 130' ' ' ASP . 29.8 mtmm -114.55 157.69 22.67 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.655 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.624 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 1.7 m120 -58.68 -4.0 0.38 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.421 -1.424 . . . . 0.0 108.096 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 128' ' ' LYS . 56.2 p30 -72.23 152.72 42.01 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.39 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.508 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 2.3 pp -126.27 162.03 26.4 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.051 0.929 . . . . 0.0 110.944 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 9.7 mt -129.95 130.8 66.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.6 t -106.81 136.92 45.81 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.477 -0.765 . . . . 0.0 109.011 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.98 133.63 20.58 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.743 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.09 151.33 81.81 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.835 1.69 . . . . 0.0 112.484 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.612 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.23 135.05 48.64 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.612 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.0 t-80 91.94 10.4 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.39 125.84 33.08 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.087 -1.008 . . . . 0.0 108.785 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.1 130.57 27.7 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.573 1.516 . . . . 0.0 111.573 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -166.94 165.42 15.97 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.229 -178.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.489 ' CE3' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -136.14 -149.76 0.34 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 109.646 -178.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.409 ' H ' ' HB2' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -175.08 125.0 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 109.167 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.488 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 16.3 p-10 -141.6 132.12 25.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.627 ' O ' ' C ' ' A' ' 145' ' ' GLY . 49.7 mtt -112.73 17.77 18.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.597 -0.69 . . . . 0.0 110.692 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.627 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 8.97 -90.08 0.0 OUTLIER Glycine 0 N--CA 1.502 3.098 0 CA-C-N 119.206 0.912 . . . . 0.0 111.685 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.492 ' H ' ' HB2' ' A' ' 178' ' ' LEU . 70.9 m -86.56 116.13 24.48 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 117.763 -1.575 . . . . 0.0 109.127 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.16 113.44 37.33 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.985 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.558 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.7 Cg_endo -103.36 40.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 122.935 2.423 . . . . 0.0 111.684 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 81.75 72.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.998 -177.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 5.5 p90 -94.53 138.23 32.68 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.215 -0.928 . . . . 0.0 110.476 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.9 m -103.57 118.73 37.4 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.723 -0.61 . . . . 0.0 109.625 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.8 163.34 33.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.454 -0.779 . . . . 0.0 109.283 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.559 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 61.4 mt -109.35 127.04 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.272 -0.893 . . . . 0.0 110.062 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -129.9 157.28 42.7 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.55 0.69 . . . . 0.0 109.514 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.49 ' CD1' ' N ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -102.89 149.26 7.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -96.22 120.86 37.27 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 0.0 110.319 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -133.71 162.99 30.46 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -94.52 161.98 27.32 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.143 -0.973 . . . . 0.0 109.23 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.633 ' O ' ' N ' ' A' ' 161' ' ' GLY . 40.1 Cg_endo -65.21 -57.37 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.014 1.809 . . . . 0.0 111.54 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 159' ' ' PRO . 50.6 mt-10 -43.98 -13.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.793 . . . . 0.0 109.126 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -76.77 -33.05 47.94 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 177.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.52 ' N ' ' O ' ' A' ' 159' ' ' PRO . 4.3 p90 -118.3 159.12 23.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.274 -1.133 . . . . 0.0 110.279 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 26.6 mm -100.99 147.3 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.428 -0.795 . . . . 0.0 109.392 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.464 ' C ' ' NE2' ' A' ' 165' ' ' GLN . . . -57.36 -72.67 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.464 ' NE2' ' C ' ' A' ' 164' ' ' ALA . 11.7 mp0 -141.4 165.29 27.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.14 -0.975 . . . . 0.0 109.646 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -100.03 -41.45 7.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.467 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 59.4 m -105.3 -30.54 9.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.166 -0.958 . . . . 0.0 109.128 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.57 -6.35 52.45 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -81.88 149.33 28.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.78 -1.424 . . . . 0.0 108.522 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 44.2 p30 -107.82 87.54 2.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.116 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.1 tt -78.31 -26.92 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.59 -1.319 . . . . 0.0 109.313 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.583 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -58.22 -42.6 86.63 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.572 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 28.6 p -54.54 -2.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 109.924 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.583 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.03 -39.8 33.03 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.097 -1.002 . . . . 0.0 111.473 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.629 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.3 m-85 -111.38 23.92 0.08 OUTLIER Pre-proline 0 N--CA 1.512 2.64 0 O-C-N 120.603 -1.31 . . . . 0.0 113.039 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 49.9 Cg_endo -65.07 -20.1 63.51 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 123.466 2.777 . . . . 0.0 113.581 -173.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -89.31 126.71 35.63 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.217 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.502 ' O ' ' C ' ' A' ' 179' ' ' ALA . 7.9 mp -86.08 147.75 26.03 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.837 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.589 ' O ' ' OG1' ' A' ' 19' ' ' THR . 89.6 p . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.39 173.39 7.22 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.102 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.517 ' CD2' ' CZ3' ' A' ' 16' ' ' TRP . 18.0 tp -160.06 114.43 2.26 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.51 131.54 55.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.022 -1.049 . . . . 0.0 110.227 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.405 ' CD1' ' CE2' ' A' ' 122' ' ' PHE . 60.5 mt -126.76 133.64 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 11' ' ' PRO . 98.4 m-85 -128.37 165.5 20.47 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.46 0.648 . . . . 0.0 109.72 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.456 ' OG ' ' CD1' ' A' ' 15' ' ' LEU . 64.2 m -89.66 176.29 6.92 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.78 -25.82 5.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 120.732 -1.23 . . . . 0.0 109.428 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -72.56 -40.72 66.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.969 -1.082 . . . . 0.0 110.16 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -137.44 124.57 13.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.018 . . . . 0.0 109.324 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 56.4 Cg_endo -81.86 -29.92 1.54 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.876 1.717 . . . . 0.0 112.35 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -68.37 -27.36 66.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.505 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -94.56 120.87 35.47 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.798 -1.189 . . . . 0.0 108.985 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 p -95.31 132.86 39.86 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.391 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.456 ' CD1' ' OG ' ' A' ' 7' ' ' SER . 11.1 mp -89.34 -10.27 47.31 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.991 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.517 ' CZ3' ' CD2' ' A' ' 3' ' ' LEU . 37.6 t90 -158.45 105.99 1.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.291 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -120.01 116.39 25.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 0.0 109.759 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.73 166.86 25.99 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.476 -0.765 . . . . 0.0 109.776 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.589 ' OG1' ' O ' ' A' ' 1' ' ' SER . 9.0 t -130.33 88.19 2.61 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.524 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 15.0 m-20 -126.04 139.23 53.58 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.52 -35.58 27.18 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.095 -1.628 . . . . 0.0 108.919 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.534 ' CG ' ' N ' ' A' ' 23' ' ' GLU . 19.8 pt-20 -82.49 -49.92 9.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.12 -0.988 . . . . 0.0 108.981 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.534 ' N ' ' CG ' ' A' ' 22' ' ' GLU . 1.6 tm-20 -63.11 -18.97 64.0 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.893 -1.13 . . . . 0.0 108.57 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 1.8 mt -71.32 -56.77 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.246 -0.909 . . . . 0.0 109.504 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.56 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 7.2 pt20 -53.25 -47.6 68.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 109.654 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.56 ' N ' ' CG ' ' A' ' 25' ' ' GLN . 49.3 tt0 -63.1 -26.77 68.98 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.444 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.516 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -69.74 -66.05 0.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.137 0.97 . . . . 0.0 110.871 -178.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.424 HD11 ' H ' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -71.35 -46.79 59.64 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.682 -1.261 . . . . 0.0 109.636 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.573 HD21 ' C ' ' A' ' 33' ' ' VAL . 10.8 m120 -54.8 -27.43 41.65 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.602 -1.311 . . . . 0.0 109.062 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -25.75 68.54 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.483 ' CD ' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -92.6 8.67 37.99 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.367 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.06 25.47 11.26 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.742 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.573 ' C ' HD21 ' A' ' 29' ' ' ASN . 69.5 t -94.08 145.46 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.633 -1.51 . . . . 0.0 109.084 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.592 HH12 ' NZ ' ' A' ' 68' ' ' LYS . 23.9 ttm180 -84.32 156.1 22.07 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.487 ' O ' ' OE1' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -153.43 147.09 25.12 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.1 tp10 -174.24 171.42 3.49 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.79 -1.194 . . . . 0.0 109.381 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -148.06 112.3 5.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.036 -1.04 . . . . 0.0 108.368 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.508 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 22.7 m0 -111.19 155.28 23.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.432 -0.793 . . . . 0.0 108.988 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.32 161.64 37.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.928 . . . . 0.0 109.969 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.86 158.14 16.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 108.931 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -102.64 -14.76 16.59 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.63 163.63 13.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.605 0.717 . . . . 0.0 109.155 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 46.3 p-10 -96.74 120.68 37.51 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.459 -0.775 . . . . 0.0 109.735 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.06 164.69 13.86 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.282 -0.886 . . . . 0.0 109.07 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.4 -105.8 0.22 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.73 90.97 5.24 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.052 -1.263 . . . . 0.0 109.104 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.44 92.17 42.9 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.93 -20.83 19.16 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.151 1.901 . . . . 0.0 112.501 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.8 p -124.27 141.67 51.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.563 -0.71 . . . . 0.0 109.622 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' GLU . . . -80.23 -20.58 44.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.538 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' ALA . 84.6 tt0 -43.12 -37.83 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.063 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.2 p -79.36 -36.35 39.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.149 -0.969 . . . . 0.0 109.144 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 50' ' ' ALA . 60.1 t -67.33 -46.34 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -0.846 . . . . 0.0 109.747 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 58' ' ' GLN . 7.8 mm -60.92 -34.24 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 108.889 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.63 -29.27 70.49 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.449 -0.782 . . . . 0.0 109.627 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.56 -21.89 48.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.988 . . . . 0.0 110.136 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -110.56 -10.31 14.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.48 -0.762 . . . . 0.0 109.769 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 54' ' ' ILE . 5.5 mm-40 -47.59 -36.75 11.19 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.054 -1.029 . . . . 0.0 109.128 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.677 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 5.4 p80 -53.22 -48.01 68.5 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.979 -1.088 . . . . 0.0 109.57 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.677 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.15 -58.1 9.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.941 -1.099 . . . . 0.0 110.054 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.45 HG12 HE21 ' A' ' 58' ' ' GLN . 0.9 OUTLIER -65.19 -26.25 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.924 -1.11 . . . . 0.0 109.462 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 58' ' ' GLN . 21.0 t70 -58.57 -25.19 62.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 109.32 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -83.99 -44.23 14.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.416 -0.803 . . . . 0.0 109.859 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.64 -46.46 79.12 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.422 -0.799 . . . . 0.0 109.761 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' GLY . 5.9 p -66.63 -29.61 47.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.85 -44.53 74.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.907 -1.121 . . . . 0.0 109.425 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -80.39 -51.46 8.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.934 -1.104 . . . . 0.0 110.182 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.599 ' O ' ' C ' ' A' ' 69' ' ' GLY . 33.1 mttt -85.01 13.62 5.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 110.732 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.599 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -5.22 84.16 0.0 OUTLIER Glycine 0 N--CA 1.5 2.932 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 68' ' ' LYS . 32.4 m-85 -77.5 165.08 24.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.663 -0.904 . . . . 0.0 108.703 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -57.21 -89.55 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.164 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.605 ' OG ' ' CG ' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -102.38 163.06 12.44 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.668 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.4 ' CE3' HG22 ' A' ' 155' ' ' ILE . 5.7 t-105 -136.98 141.23 42.58 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.46 -0.775 . . . . 0.0 109.187 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -174.7 -167.42 0.3 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.462 ' CB ' ' O ' ' A' ' 152' ' ' ALA . 4.7 m -124.21 168.21 17.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.492 -0.755 . . . . 0.0 109.488 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.9 mt -94.49 132.95 37.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.5 p -93.0 166.79 12.19 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.857 1.313 . . . . 0.0 112.135 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.607 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 1.0 OUTLIER -169.13 160.49 9.8 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.209 176.295 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -132.4 141.52 48.91 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.47 -0.72 6.95 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.837 -1.164 . . . . 0.0 109.684 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -118.47 -12.44 9.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.086 -1.009 . . . . 0.0 109.196 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.454 ' C ' ' ND2' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -62.72 123.9 81.17 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.938 . . . . 0.0 110.453 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.04 -1.6 11.5 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.758 2.306 . . . . 0.0 112.542 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.439 ' N ' ' ND2' ' A' ' 82' ' ' ASN . 72.9 mt-30 -83.25 16.19 2.58 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.76 -1.212 . . . . 0.0 109.161 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.419 ' HG3' ' H ' ' A' ' 86' ' ' GLU . 6.2 pttt -61.36 -59.88 4.59 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.5 -0.75 . . . . 0.0 109.507 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.419 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 20.1 pt-20 -64.56 -31.74 73.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.312 -0.868 . . . . 0.0 109.666 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.89 -59.27 5.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 110.077 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 72.4 mt -61.95 -42.81 99.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 110.185 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.413 ' HG2' ' H ' ' A' ' 144' ' ' MET . 49.6 mtm180 -59.52 -28.98 67.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.886 . . . . 0.0 110.079 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.96 -59.58 4.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 0.0 109.497 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -51.22 -34.34 31.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.376 -0.827 . . . . 0.0 109.404 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -88.14 -17.74 30.31 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.043 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.603 ' CD2' ' HG ' ' A' ' 173' ' ' SER . 8.6 tp -55.79 -34.39 65.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 109.822 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.477 HD21 HE22 ' A' ' 165' ' ' GLN . 6.1 m120 -63.28 135.29 56.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.121 -0.987 . . . . 0.0 110.22 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -70.71 164.45 25.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.527 -0.733 . . . . 0.0 109.418 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -174.92 -165.6 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.82 -1.175 . . . . 0.0 111.272 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 t -164.56 135.33 4.16 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.607 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -105.93 154.58 20.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.466 -0.771 . . . . 0.0 110.207 -178.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.39 -6.35 86.42 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -124.24 169.93 11.27 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.487 -1.008 . . . . 0.0 109.61 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -74.91 143.62 43.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 0.0 109.827 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.484 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 6.7 tt0 -107.54 93.25 4.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.261 -0.899 . . . . 0.0 108.592 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.5 p -94.67 131.98 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.738 -1.226 . . . . 0.0 111.025 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.692 ' HE ' HH21 ' A' ' 154' ' ' ARG . 78.0 mtt180 -130.2 126.93 38.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.735 -0.603 . . . . 0.0 109.402 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.605 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 13.3 t80 -109.05 132.0 54.53 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.533 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -85.21 126.25 33.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.941 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.4 ' O ' ' CG ' ' A' ' 108' ' ' GLU . 5.0 t -107.15 -41.18 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.369 -0.832 . . . . 0.0 110.692 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 91.1 mt-10 -154.8 141.07 18.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.883 -1.136 . . . . 0.0 109.815 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.97 159.89 36.07 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.92 151.03 32.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -1.223 . . . . 0.0 109.737 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.57 -126.83 1.95 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.9 tp -147.95 163.22 37.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -1.015 . . . . 0.0 109.074 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -134.8 90.81 2.69 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.046 -1.034 . . . . 0.0 109.098 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.589 ' SG ' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -78.13 146.25 35.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.982 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.419 HD23 ' HZ3' ' A' ' 31' ' ' LYS . 1.9 mt -148.53 101.53 3.23 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -102.13 113.4 26.63 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.825 -1.172 . . . . 0.0 109.562 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 118' ' ' GLY . 0.1 OUTLIER -134.97 124.79 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.095 -1.003 . . . . 0.0 110.506 -178.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.401 ' N ' HD13 ' A' ' 117' ' ' ILE . . . 70.22 -142.67 36.24 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 105.636 -2.986 . . . . 0.0 105.636 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.32 79.11 1.18 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 115.157 -2.617 . . . . 0.0 108.303 176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -165.07 166.62 19.05 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.4 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 51.0 t -125.99 140.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.087 -1.008 . . . . 0.0 110.404 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.405 ' CE2' ' CD1' ' A' ' 5' ' ' ILE . 16.0 m-85 -123.83 131.02 53.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.442 0.639 . . . . 0.0 109.791 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -141.94 118.62 11.05 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.169 -0.957 . . . . 0.0 109.785 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -101.79 147.23 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.612 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tp -127.58 81.62 2.03 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.46 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.447 ' SG ' ' CB ' ' A' ' 1' ' ' SER . 35.9 t -166.56 122.65 1.22 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.584 ' H ' ' CD ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -109.3 105.82 15.38 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 116.705 -1.998 . . . . 0.0 112.338 -178.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.58 ' C ' ' H ' ' A' ' 130' ' ' ASP . 42.1 mmtt -113.77 171.04 7.82 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.02 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.605 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 12.5 m120 -58.76 -3.03 0.27 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.832 -1.168 . . . . 0.0 107.895 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.58 ' H ' ' C ' ' A' ' 128' ' ' LYS . 40.2 p30 -73.43 153.99 40.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.793 0.806 . . . . 0.0 109.888 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.54 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 2.3 pp -122.89 161.31 24.37 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.073 0.939 . . . . 0.0 110.366 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.3 mp -131.54 127.83 60.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.664 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.9 t -123.71 135.93 54.15 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.75 148.63 36.1 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.278 -0.889 . . . . 0.0 108.799 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.22 157.95 57.87 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.554 2.169 . . . . 0.0 113.052 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.621 ' O ' ' CD2' ' A' ' 137' ' ' HIS . . . -73.38 135.62 44.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.237 -0.914 . . . . 0.0 108.997 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.703 ' O ' ' ND1' ' A' ' 137' ' ' HIS . 0.1 OUTLIER 95.43 3.92 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.352 0.596 . . . . 0.0 109.732 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.78 125.47 42.19 Favored Pre-proline 0 N--CA 1.487 1.42 0 O-C-N 120.84 -1.162 . . . . 0.0 108.816 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.14 132.9 33.38 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.433 1.422 . . . . 0.0 111.6 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.512 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.42 164.28 15.05 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.189 -0.944 . . . . 0.0 110.161 -178.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.589 ' CD1' ' SG ' ' A' ' 114' ' ' CYS . 14.6 p90 -130.06 -153.78 0.59 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.469 -0.77 . . . . 0.0 109.752 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.616 ' CD1' ' NH1' ' A' ' 104' ' ' ARG . 2.8 t80 -170.78 125.01 0.68 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.303 -0.873 . . . . 0.0 108.999 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.501 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 49.0 p-10 -148.19 130.97 16.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.944 -1.097 . . . . 0.0 109.374 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.615 ' O ' ' C ' ' A' ' 145' ' ' GLY . 8.6 mmt -107.18 18.91 21.1 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 111.334 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 11.56 -99.39 0.01 OUTLIER Glycine 0 N--CA 1.501 3.008 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.433 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 31.6 t -84.16 120.56 26.33 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.897 -1.354 . . . . 0.0 109.351 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 147' ' ' GLU . 1.0 OUTLIER -115.51 117.6 40.32 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 57.2 Cg_endo -100.03 31.2 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.258 1.972 . . . . 0.0 112.209 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER 81.79 63.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.688 -179.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.51 ' C ' ' CD2' ' A' ' 150' ' ' PHE . 15.0 p90 -101.41 169.85 8.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.519 -0.738 . . . . 0.0 109.222 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 53.3 m -130.28 106.53 8.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.57 -0.706 . . . . 0.0 109.489 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' A' ' 75' ' ' VAL . . . -105.91 161.94 14.01 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.987 -1.07 . . . . 0.0 109.827 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 153' ' ' ILE . 23.5 mt -105.45 123.26 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.869 -1.145 . . . . 0.0 110.291 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.692 HH21 ' HE ' ' A' ' 104' ' ' ARG . 1.9 mtt-85 -130.62 159.85 35.97 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.485 ' CD1' ' N ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.98 155.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.605 ' CG ' ' OG ' ' A' ' 72' ' ' SER . 5.8 m-85 -96.19 121.87 38.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 110.224 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 49.2 p30 -132.04 163.28 28.78 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -92.79 161.86 30.65 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.979 -1.076 . . . . 0.0 108.865 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.598 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.0 Cg_endo -62.52 -60.4 0.19 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.747 1.631 . . . . 0.0 112.288 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.7 tt0 -45.92 -13.53 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -72.7 -43.87 41.43 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.563 ' CE3' ' O ' ' A' ' 163' ' ' ILE . 9.9 p-90 -110.13 161.02 15.96 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.518 -0.989 . . . . 0.0 110.348 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.563 ' O ' ' CE3' ' A' ' 162' ' ' TRP . 4.0 tp -99.92 154.44 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.249 -0.907 . . . . 0.0 109.194 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.78 -75.54 0.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.97 . . . . 0.0 110.435 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.477 HE22 HD21 ' A' ' 94' ' ' ASN . 31.1 mt-30 -142.3 164.61 29.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.103 -0.998 . . . . 0.0 110.156 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -101.21 -40.18 7.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.89 . . . . 0.0 109.326 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 22.0 m -114.68 -32.36 5.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.937 . . . . 0.0 108.568 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.61 -1.34 58.38 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.505 ' O ' ' OD2' ' A' ' 169' ' ' ASP . 39.1 p30 -80.29 145.82 31.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.3 -1.706 . . . . 0.0 108.726 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.416 ' OD2' ' ND2' ' A' ' 94' ' ' ASN . 90.4 m-20 -113.21 89.7 3.15 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.113 -1.435 . . . . 0.0 110.263 175.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.71 -17.89 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.241 -1.537 . . . . 0.0 108.854 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.582 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -58.67 -41.59 86.51 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.362 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.603 ' HG ' ' CD2' ' A' ' 93' ' ' LEU . 1.2 m -52.46 -3.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.538 -0.726 . . . . 0.0 109.873 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.71 -39.57 26.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.909 -1.119 . . . . 0.0 111.371 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.639 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -114.57 25.58 0.09 OUTLIER Pre-proline 0 N--CA 1.516 2.842 0 O-C-N 120.668 -1.27 . . . . 0.0 112.089 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 39.1 Cg_endo -59.25 -18.18 43.44 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.333 2.689 . . . . 0.0 114.177 -171.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -89.44 125.57 35.22 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.619 -1.233 . . . . 0.0 108.107 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.433 ' HB3' ' H ' ' A' ' 146' ' ' SER . 3.9 tt -86.68 125.45 33.87 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.092 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.593 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.623 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.492 ' H3 ' ' HG ' ' A' ' 1' ' ' SER . 2.8 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.49 169.32 9.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.066 . . . . 0.0 109.074 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 16.3 tp -157.65 114.99 3.01 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.7 OUTLIER -109.02 138.59 45.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.216 -0.928 . . . . 0.0 110.119 -179.16 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.55 ' CD1' ' OE1' ' A' ' 27' ' ' GLN . 52.9 mt -132.87 131.45 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -125.6 164.29 20.88 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m -85.91 175.0 8.87 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.144 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -26.87 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.023 -1.048 . . . . 0.0 109.677 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -74.11 -38.43 63.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.05 -1.031 . . . . 0.0 110.181 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.33 125.91 14.77 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 109.679 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 13' ' ' ASN . 56.1 Cg_endo -80.42 -36.9 0.43 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 121.974 1.783 . . . . 0.0 112.202 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 7.86 0.77 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.768 . . . . 0.0 110.113 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 11' ' ' PRO . 80.6 m-20 -116.96 119.77 36.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.196 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -98.96 123.65 43.39 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.579 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 3.9 mm? -89.93 -9.84 47.36 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.585 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.528 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 33.1 t90 -157.48 106.87 2.15 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.629 -1.228 . . . . 0.0 110.133 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -121.87 119.92 33.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.512 -0.742 . . . . 0.0 109.729 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.409 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -162.85 164.56 25.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.218 -0.926 . . . . 0.0 110.132 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' A' ' 1' ' ' SER . 76.1 m -130.14 89.11 2.75 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.017 -1.052 . . . . 0.0 108.188 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.534 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 29.9 m120 -127.73 144.26 51.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.458 -0.776 . . . . 0.0 110.422 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.73 -38.74 21.0 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.235 -1.541 . . . . 0.0 108.312 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -82.9 -48.36 10.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.516 -0.74 . . . . 0.0 109.749 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.477 ' OE1' ' OD1' ' A' ' 20' ' ' ASN . 1.2 tt0 -62.83 -19.56 64.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.722 -1.236 . . . . 0.0 108.608 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 4.0 mt -74.47 -56.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.871 . . . . 0.0 109.326 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.418 ' CB ' ' CD1' ' A' ' 35' ' ' PHE . 3.0 pp0? -55.41 -34.9 64.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.309 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -68.09 -47.5 68.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.276 -0.89 . . . . 0.0 109.447 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.55 ' OE1' ' CD1' ' A' ' 5' ' ' ILE . 7.6 tt0 -68.16 -40.46 82.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.167 -0.958 . . . . 0.0 109.082 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.18 -62.42 1.41 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.172 -0.955 . . . . 0.0 109.286 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 15.1 t-20 -58.13 -17.98 22.21 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.298 -0.876 . . . . 0.0 109.907 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.1 -32.52 73.73 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.847 -1.158 . . . . 0.0 109.387 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -90.51 9.34 29.72 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.98 24.56 16.82 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.283 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 33.7 t -96.96 147.82 6.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.279 -1.13 . . . . 0.0 109.554 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.415 ' HB3' ' H ' ' A' ' 133' ' ' SER . 19.5 ttt180 -84.02 154.01 23.51 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 120.511 -1.368 . . . . 0.0 108.368 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.538 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 1.1 t80 -154.39 149.97 27.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.023 -1.048 . . . . 0.0 108.276 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 2.9 mt-10 -177.24 177.08 1.26 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.045 -1.034 . . . . 0.0 109.481 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -148.61 112.44 5.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.534 ' NE1' ' OE2' ' A' ' 36' ' ' GLU . 31.4 m0 -111.02 157.4 19.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.271 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -142.72 156.24 44.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 0.0 109.927 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.35 152.75 20.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.205 -0.934 . . . . 0.0 108.997 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -104.03 -6.39 21.22 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -93.34 159.15 15.39 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.781 0.801 . . . . 0.0 109.093 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -94.51 115.31 27.45 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.66 -0.65 . . . . 0.0 109.537 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.7 mt -94.86 164.96 12.7 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.43 -0.794 . . . . 0.0 109.505 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.29 -103.76 0.2 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.6 92.97 4.76 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.989 -1.301 . . . . 0.0 109.187 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.16 92.12 44.88 Favored Pre-proline 0 C--N 1.306 -1.293 0 C-N-CA 119.8 -0.76 . . . . 0.0 108.965 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.54 -21.91 14.41 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.297 1.998 . . . . 0.0 112.763 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 p -122.93 142.12 51.16 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.584 -0.698 . . . . 0.0 109.705 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.34 -16.91 53.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.43 -0.794 . . . . 0.0 109.419 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -46.92 -39.03 11.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.344 -0.847 . . . . 0.0 108.725 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.3 m -79.2 -39.68 32.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.617 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.71 -46.53 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.291 -0.881 . . . . 0.0 109.669 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 58' ' ' GLN . 15.6 mt -60.48 -36.02 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.073 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.06 -28.65 69.75 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.411 -0.806 . . . . 0.0 109.407 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.76 -20.29 50.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.038 -1.039 . . . . 0.0 110.331 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 58' ' ' GLN . 61.7 m-85 -112.02 -12.27 13.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.298 -0.876 . . . . 0.0 109.552 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.702 HE21 ' CG1' ' A' ' 61' ' ' ILE . 30.1 tp60 -45.52 -35.9 4.19 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.567 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.6 -47.64 63.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 109.546 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.567 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.34 -60.08 4.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 109.755 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.702 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.6 OUTLIER -63.17 -29.51 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 120.608 -1.308 . . . . 0.0 109.127 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 58' ' ' GLN . 21.3 t70 -55.9 -26.41 47.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.706 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -78.28 -36.1 47.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.985 -1.072 . . . . 0.0 109.543 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 8.4 mp -63.19 -40.79 98.53 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.545 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -70.13 -29.01 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.173 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.53 -56.66 12.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.431 -1.418 . . . . 0.0 109.191 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -83.53 -48.81 9.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.035 -1.04 . . . . 0.0 110.608 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.627 ' O ' ' C ' ' A' ' 69' ' ' GLY . 7.5 mtpm? -87.79 14.7 8.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.878 . . . . 0.0 110.788 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.627 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -11.68 89.33 0.0 OUTLIER Glycine 0 N--CA 1.501 3.028 0 CA-C-O 121.959 0.755 . . . . 0.0 111.227 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 68' ' ' LYS . 84.3 m-85 -76.86 164.42 25.83 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.586 ' NE2' ' OG ' ' A' ' 72' ' ' SER . 0.6 OUTLIER -63.2 -87.48 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.43 -0.794 . . . . 0.0 109.78 -178.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.586 ' OG ' ' NE2' ' A' ' 71' ' ' GLN . 14.7 m -102.74 160.24 14.76 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 109.595 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 74' ' ' ASP . 7.6 t-105 -140.79 145.75 36.74 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.454 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.2 OUTLIER -165.36 -176.6 4.1 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 152' ' ' ALA . 9.9 p -119.8 142.73 33.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 tp -101.33 115.71 43.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.507 ' O ' ' OG ' ' A' ' 77' ' ' SER . 4.7 p -169.56 102.99 0.33 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.381 -0.825 . . . . 0.0 108.845 177.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.605 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -117.98 179.77 3.99 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.094 1.77 . . . . 0.0 108.12 -179.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.605 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 3.2 tpt180 -89.88 143.85 26.44 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.667 -1.27 . . . . 0.0 109.412 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.42 1.38 0.35 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.568 -0.707 . . . . 0.0 109.593 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 79' ' ' ARG . 84.6 m-20 -78.87 -29.09 44.28 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.213 -1.395 . . . . 0.0 108.872 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.716 HD22 ' CD ' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -64.27 124.85 86.9 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.044 -1.035 . . . . 0.0 109.085 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -78.55 -8.56 16.01 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.171 1.914 . . . . 0.0 112.401 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -89.59 4.14 50.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.006 -1.059 . . . . 0.0 109.482 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.716 ' CD ' HD22 ' A' ' 82' ' ' ASN . 3.5 tptp -60.0 -49.82 76.18 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.194 -0.941 . . . . 0.0 108.919 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -62.82 -41.99 99.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 109.57 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.16 -38.27 76.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.612 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -60.3 -42.75 96.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.345 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.572 ' NH2' ' O ' ' A' ' 85' ' ' LYS . 1.0 OUTLIER -60.49 -30.65 69.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.845 . . . . 0.0 109.873 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.22 -60.22 3.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 109.671 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.403 ' O ' ' ND2' ' A' ' 94' ' ' ASN . 50.4 mttp -57.17 -32.18 66.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.504 -0.747 . . . . 0.0 109.278 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -85.6 -18.25 33.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.415 -0.803 . . . . 0.0 110.243 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -40.17 91.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.125 -0.984 . . . . 0.0 109.85 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 94' ' ' ASN . 21.5 p30 -46.89 125.48 7.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.121 -0.987 . . . . 0.0 109.452 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.53 166.32 1.32 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.504 -0.748 . . . . 0.0 109.366 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -173.17 -169.26 0.52 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.899 -1.12 . . . . 0.0 111.433 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.2 t -164.1 135.58 4.6 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.676 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -107.55 156.2 19.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.443 -0.785 . . . . 0.0 109.735 -178.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.18 -6.94 86.7 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -123.51 170.67 10.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.316 -1.108 . . . . 0.0 109.288 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -76.26 142.99 41.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.972 -1.08 . . . . 0.0 110.161 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -100.24 94.6 6.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.194 -0.942 . . . . 0.0 109.058 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.662 ' CA ' ' HG ' ' A' ' 133' ' ' SER . 1.0 OUTLIER -91.46 130.67 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.507 -0.745 . . . . 0.0 109.878 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.487 HH21 ' CB ' ' A' ' 152' ' ' ALA . 51.2 ttt180 -132.01 123.77 27.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.398 -0.814 . . . . 0.0 109.346 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 27.2 t80 -104.78 131.89 51.7 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.09 128.42 35.42 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.608 -0.682 . . . . 0.0 110.228 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.0 t -112.63 -29.67 2.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.683 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -169.04 158.04 8.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.027 . . . . 0.0 109.031 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.488 ' O ' ' OE1' ' A' ' 127' ' ' GLU . . . 78.49 150.0 4.69 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.9 156.05 31.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.421 -1.046 . . . . 0.0 109.512 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -151.49 -125.99 1.24 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 mt -148.95 164.32 34.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -1.08 . . . . 0.0 109.659 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.47 91.59 2.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.569 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.643 ' SG ' ' NE2' ' A' ' 123' ' ' GLN . 0.8 OUTLIER -77.97 117.04 18.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 109.476 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.34 106.16 12.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.116 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.5 t-160 -101.33 109.56 21.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.972 . . . . 0.0 109.462 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mm -125.57 111.82 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.005 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.99 -142.12 28.11 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 106.537 -2.625 . . . . 0.0 106.537 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.494 ' CG ' ' O ' ' A' ' 119' ' ' ASP . 48.2 p-10 -103.8 79.2 1.63 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 115.103 -2.639 . . . . 0.0 109.369 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.479 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 75.8 tt0 -165.92 167.34 16.78 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.485 ' CG1' HE22 ' A' ' 123' ' ' GLN . 86.7 t -130.43 151.91 36.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.089 -1.007 . . . . 0.0 109.924 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.439 ' C ' ' OE1' ' A' ' 123' ' ' GLN . 32.7 m-85 -130.87 133.27 45.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.691 -0.631 . . . . 0.0 109.986 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.643 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 4.2 mp0 -122.35 110.07 15.2 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.412 -0.805 . . . . 0.0 109.088 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.84 133.9 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.647 ' CD1' ' N ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.55 90.54 2.62 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.341 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' A' ' 126' ' ' CYS . 30.1 p -166.36 128.8 1.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.393 -1.442 . . . . 0.0 107.329 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 7.0 tt0 -107.39 96.35 6.34 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 116.096 -2.242 . . . . 0.0 110.569 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' A' ' 130' ' ' ASP . 17.1 mtpp -112.73 159.78 18.6 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.66 176.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.586 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 14.6 m120 -57.12 -4.27 0.18 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.442 -1.411 . . . . 0.0 107.761 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.592 ' H ' ' C ' ' A' ' 128' ' ' LYS . 67.3 m-20 -66.73 143.14 57.12 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.705 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.576 ' CD1' ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -110.79 142.67 42.45 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.614 0.721 . . . . 0.0 110.706 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.576 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 47.6 pt -132.64 147.66 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.662 ' HG ' ' CA ' ' A' ' 103' ' ' VAL . 8.9 t -137.03 153.78 50.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.349 -0.844 . . . . 0.0 109.581 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -106.11 143.01 26.06 Favored Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.49 152.65 80.38 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.283 1.989 . . . . 0.0 112.274 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.609 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.59 134.61 47.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.275 -0.891 . . . . 0.0 109.223 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.609 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.1 t-80 91.31 11.21 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.121 0.486 . . . . 0.0 109.742 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.13 126.5 31.48 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 0.0 108.739 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.98 131.49 29.0 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.581 1.52 . . . . 0.0 111.474 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.488 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.9 163.79 9.62 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.223 -179.186 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.45 ' CG ' ' CB ' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -134.53 -146.94 0.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.239 -0.913 . . . . 0.0 109.713 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -177.9 126.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.926 -1.109 . . . . 0.0 109.037 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 143' ' ' ASP . 10.9 p-10 -144.25 134.14 23.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.31 -0.869 . . . . 0.0 109.895 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.618 ' O ' ' C ' ' A' ' 145' ' ' GLY . 84.1 mmm -112.94 20.48 16.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.584 -0.697 . . . . 0.0 111.202 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.61 -92.68 0.01 OUTLIER Glycine 0 N--CA 1.506 3.363 0 CA-C-N 119.265 0.939 . . . . 0.0 111.534 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.472 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 74.5 m -85.85 117.51 24.76 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.92 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.557 ' CD ' ' H ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -117.3 113.18 39.12 Favored Pre-proline 0 C--N 1.299 -1.609 0 C-N-CA 119.764 -0.775 . . . . 0.0 109.804 178.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.3 Cg_endo -103.12 40.95 0.04 OUTLIER 'Trans proline' 0 C--O 1.213 -0.767 0 C-N-CA 122.717 2.278 . . . . 0.0 111.349 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 81.79 71.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.124 -177.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.536 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 8.9 p90 -95.53 144.31 26.11 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.388 -0.82 . . . . 0.0 109.895 -177.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.8 m -113.17 122.96 49.09 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.536 -0.728 . . . . 0.0 109.754 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.487 ' CB ' HH21 ' A' ' 104' ' ' ARG . . . -142.83 162.58 35.1 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 57.6 mt -107.49 126.92 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.076 -1.015 . . . . 0.0 109.374 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -136.51 164.13 28.9 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.113 -0.992 . . . . 0.0 109.803 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 4.7 mp -102.5 145.12 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.579 -0.701 . . . . 0.0 109.562 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.454 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.2 m-85 -95.54 118.81 32.94 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.291 -0.881 . . . . 0.0 109.361 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 0.9 OUTLIER -134.93 164.13 28.29 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.3 OUTLIER -93.65 160.26 33.16 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.167 -0.958 . . . . 0.0 109.052 -179.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.3 Cg_endo -61.76 -55.65 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.198 1.932 . . . . 0.0 112.199 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.4 tt0 -44.09 -15.49 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.336 -0.853 . . . . 0.0 108.986 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -72.72 -46.68 29.68 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 178.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.464 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 6.5 p90 -107.38 165.03 11.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.341 -1.094 . . . . 0.0 110.05 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 163' ' ' ILE . 72.6 mt -100.59 149.58 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.35 -71.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.088 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.583 ' NE2' ' OD1' ' A' ' 170' ' ' ASP . 43.1 mt-30 -140.39 159.01 43.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 109.632 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -101.21 -41.12 6.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 109.564 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.7 p -102.44 -30.43 11.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.085 -1.009 . . . . 0.0 108.856 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.49 -6.49 52.81 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -82.13 148.55 28.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.704 -1.468 . . . . 0.0 108.688 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.583 ' OD1' ' NE2' ' A' ' 165' ' ' GLN . 88.5 m-20 -109.08 88.35 2.71 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 117.568 -1.653 . . . . 0.0 111.096 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.5 tt -77.75 -23.69 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.609 -1.307 . . . . 0.0 109.348 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.554 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -60.41 -41.44 93.92 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.592 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 93.4 p -54.62 -2.95 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.481 -0.762 . . . . 0.0 109.994 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.31 -39.84 31.83 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.942 -1.099 . . . . 0.0 111.298 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.627 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 9.9 m-85 -111.64 24.4 0.08 OUTLIER Pre-proline 0 N--CA 1.514 2.754 0 O-C-N 120.85 -1.156 . . . . 0.0 112.808 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 45.3 Cg_endo -63.59 -19.3 67.32 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.68 2.92 . . . . 0.0 113.348 -173.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.08 125.51 35.05 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.99 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.472 ' HB3' ' H ' ' A' ' 146' ' ' SER . 1.8 tp -88.03 120.41 29.34 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.525 -0.734 . . . . 0.0 109.135 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.786 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.34 -179.858 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.608 ' O ' ' OG1' ' A' ' 19' ' ' THR . 1.6 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.96 171.55 8.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 108.925 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.2 tp -158.85 113.1 2.44 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.74 130.32 54.96 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.166 -0.959 . . . . 0.0 110.365 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' CD1' ' OE1' ' A' ' 27' ' ' GLN . 63.9 mt -124.59 133.61 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 97.2 m-85 -126.63 165.36 19.34 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -91.73 176.33 6.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 108.715 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -25.68 5.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.888 -1.133 . . . . 0.0 109.418 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -73.13 -40.68 64.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 110.086 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -136.81 124.01 14.16 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.093 -1.004 . . . . 0.0 109.437 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.565 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 56.4 Cg_endo -82.18 -33.13 0.6 Allowed 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.925 1.75 . . . . 0.0 112.319 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.482 ' O ' ' OE1' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -68.43 -25.99 65.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 110.347 -178.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -95.41 120.79 36.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.959 -1.088 . . . . 0.0 108.977 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.412 ' H ' ' HG ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -95.38 131.99 40.91 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.297 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 pp -90.37 -8.96 49.38 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.209 -0.996 . . . . 0.0 108.822 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.488 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 45.1 t90 -157.54 106.79 2.13 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.506 -1.278 . . . . 0.0 109.943 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -120.77 119.82 33.85 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.535 -0.728 . . . . 0.0 109.801 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.47 161.84 30.24 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.198 -0.939 . . . . 0.0 109.82 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.608 ' OG1' ' O ' ' A' ' 1' ' ' SER . 8.9 t -131.36 89.08 2.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 118.773 -1.171 . . . . 0.0 108.507 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.541 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 1.9 m-20 -126.27 142.37 51.55 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.372 -0.83 . . . . 0.0 110.24 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.85 -37.05 27.57 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.463 -1.398 . . . . 0.0 109.137 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.68 -50.15 9.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.167 -0.958 . . . . 0.0 109.862 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -63.32 -18.53 63.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.036 -1.04 . . . . 0.0 108.719 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 3.1 mt -73.56 -56.07 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 108.912 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.4 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 9.2 pt20 -57.61 -40.77 79.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.211 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -62.04 -43.03 99.7 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.142 -0.974 . . . . 0.0 109.114 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.488 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 7.5 tt0 -72.47 -44.85 61.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.204 -0.935 . . . . 0.0 108.899 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -64.19 -62.56 1.54 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.054 -1.029 . . . . 0.0 109.371 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.618 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -61.23 -17.56 53.93 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.165 -178.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.52 -28.82 70.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.529 -1.357 . . . . 0.0 108.439 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.403 ' CD ' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -94.19 6.81 47.46 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.855 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.81 25.64 12.92 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.046 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.29 145.98 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.149 -1.206 . . . . 0.0 109.191 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -83.59 153.47 24.3 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 121.058 -1.026 . . . . 0.0 108.555 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.593 ' CD2' ' OD2' ' A' ' 130' ' ' ASP . 2.2 t80 -154.21 146.47 23.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.159 -0.963 . . . . 0.0 108.729 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.535 ' O ' ' OD2' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -177.9 178.07 1.0 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.006 -1.059 . . . . 0.0 110.251 178.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 119.3 6.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 108.886 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 23.1 m0 -111.99 156.83 21.51 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -143.05 160.98 39.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.867 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.44 158.17 16.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 108.946 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -101.45 -14.1 17.67 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -92.9 158.79 15.65 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.535 0.684 . . . . 0.0 109.161 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -93.71 123.63 37.16 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 109.46 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 mt -94.39 165.67 12.45 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 109.368 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.7 -105.14 0.22 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.01 93.06 5.04 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.999 -1.295 . . . . 0.0 109.327 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.9 91.65 43.37 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -75.88 -22.04 13.7 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.155 1.903 . . . . 0.0 112.421 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.1 p -120.58 141.19 50.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.618 -0.677 . . . . 0.0 109.679 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.86 -17.86 49.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.478 -0.764 . . . . 0.0 109.535 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.69 -39.22 16.86 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.223 -0.923 . . . . 0.0 108.862 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.8 m -78.92 -34.89 44.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 109.587 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.76 -57.12 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.342 -0.849 . . . . 0.0 110.33 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.458 ' N ' ' CD1' ' A' ' 54' ' ' ILE . 1.7 mp -58.8 -34.99 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.968 -1.083 . . . . 0.0 108.9 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.68 -35.18 72.18 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.413 -0.804 . . . . 0.0 109.365 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.51 -13.7 60.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.21 -0.931 . . . . 0.0 109.632 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.4 m-85 -111.42 -8.39 14.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.489 -0.757 . . . . 0.0 109.762 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 62' ' ' ASP . 10.3 mm-40 -47.06 -36.05 7.63 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.159 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.713 ' CD2' ' N ' ' A' ' 60' ' ' ALA . 11.9 p-80 -53.36 -44.18 68.36 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.74 -1.225 . . . . 0.0 109.516 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.713 ' N ' ' CD2' ' A' ' 59' ' ' HIS . . . -63.6 -61.1 2.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.0 -1.063 . . . . 0.0 110.071 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.419 ' HB ' ' CZ2' ' A' ' 73' ' ' TRP . 1.3 pp -62.36 -27.72 43.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.75 -1.219 . . . . 0.0 108.983 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' A' ' 62' ' ' ASP . 36.8 t0 -58.41 -27.69 64.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.96 . . . . 0.0 109.567 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -74.19 -40.93 62.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.959 . . . . 0.0 109.121 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 7.6 mp -64.42 -34.85 79.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 109.295 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.464 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 11.5 t -68.13 -29.93 46.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.035 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.75 72.82 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.658 -1.276 . . . . 0.0 109.524 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -87.74 -53.86 4.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.083 -1.011 . . . . 0.0 110.5 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.604 ' O ' ' C ' ' A' ' 69' ' ' GLY . 8.2 mmtp -85.96 14.51 6.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.355 -0.84 . . . . 0.0 110.489 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -16.41 87.58 0.0 OUTLIER Glycine 0 N--CA 1.499 2.885 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 68' ' ' LYS . 81.1 m-85 -76.58 164.01 26.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.429 HE21 ' HA ' ' A' ' 157' ' ' ASP . 32.8 mt-30 -57.74 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.312 -0.868 . . . . 0.0 109.673 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.58 163.0 12.58 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.598 0.713 . . . . 0.0 110.058 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.487 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 5.6 t-105 -131.84 135.76 46.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.86 166.81 25.57 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.9 -1.125 . . . . 0.0 108.142 178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -119.55 141.28 40.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 7.6 tp -102.7 115.01 43.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.235 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.497 ' OG ' ' OG1' ' A' ' 151' ' ' THR . 2.0 t -167.63 100.06 0.49 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.34 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.599 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -125.01 -179.26 4.48 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.34 -1.475 . . . . 0.0 107.658 -179.52 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.599 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 23.2 tpt180 -88.91 153.07 21.34 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.671 -1.268 . . . . 0.0 109.075 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.97 0.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.583 ' H ' ' C ' ' A' ' 79' ' ' ARG . 83.8 m-20 -103.43 30.54 4.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.552 ' OD1' ' N ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -82.26 135.08 47.76 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.52 -0.737 . . . . 0.0 110.201 178.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.446 ' C ' ' OE1' ' A' ' 84' ' ' GLN . 55.7 Cg_endo -77.41 -25.75 7.97 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.173 1.915 . . . . 0.0 112.198 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.487 ' N ' ' OE1' ' A' ' 84' ' ' GLN . 0.9 OUTLIER -92.5 8.13 40.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.895 -1.128 . . . . 0.0 109.493 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.576 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 18.0 pttt -58.73 -51.7 68.86 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.214 -0.929 . . . . 0.0 108.774 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.576 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 84.2 tt0 -67.6 -54.24 21.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.146 -0.972 . . . . 0.0 109.504 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.83 -47.02 83.85 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.311 -0.955 . . . . 0.0 109.727 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 84' ' ' GLN . 13.3 tp -63.07 -46.13 88.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.768 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -60.83 -36.96 80.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 109.602 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.7 -58.84 4.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -0.878 . . . . 0.0 109.625 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -50.5 -37.89 41.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.278 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.03 -19.46 51.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.117 -0.99 . . . . 0.0 109.134 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.3 -34.86 75.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 109.758 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -64.26 150.44 45.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.107 -0.995 . . . . 0.0 110.188 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.639 ' CD ' ' H ' ' A' ' 95' ' ' GLU . 7.7 pm0 -80.91 166.31 20.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 0.0 109.567 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -173.96 -169.24 0.47 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.044 -1.062 . . . . 0.0 111.195 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.2 t -163.48 132.97 4.09 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.635 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -104.3 156.74 17.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.516 -0.74 . . . . 0.0 110.125 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.433 ' N ' ' HB3' ' A' ' 162' ' ' TRP . . . -78.78 -6.56 88.49 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -124.36 171.15 10.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.395 -1.062 . . . . 0.0 109.429 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 102' ' ' GLU . 48.3 t0 -75.19 139.91 42.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.109 -0.994 . . . . 0.0 110.248 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.594 ' N ' ' OD2' ' A' ' 101' ' ' ASP . 14.9 tt0 -97.13 95.17 7.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.344 -0.848 . . . . 0.0 108.931 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.426 ' CG1' ' OG ' ' A' ' 133' ' ' SER . 29.5 t -95.29 123.17 47.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.65 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 34.0 ttm105 -127.28 126.3 42.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.46 -0.775 . . . . 0.0 109.018 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.622 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 15.2 t80 -102.36 131.18 49.15 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.825 0.822 . . . . 0.0 109.201 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.405 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -85.9 126.46 34.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.49 0.662 . . . . 0.0 110.154 -178.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.9 t -108.5 -30.24 2.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.73 -0.606 . . . . 0.0 109.476 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -165.94 153.8 10.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 109.27 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.76 157.09 32.8 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.17 162.38 32.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -1.171 . . . . 0.0 109.089 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.63 155.16 13.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.429 ' CG ' ' O ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -103.14 98.93 8.79 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.133 -1.216 . . . . 0.0 110.638 -178.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -80.5 126.41 31.18 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.66 -1.275 . . . . 0.0 110.054 -178.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.652 ' HG ' ' NE2' ' A' ' 123' ' ' GLN . 0.9 OUTLIER -78.5 125.84 29.93 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.312 0.577 . . . . 0.0 109.984 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -113.62 125.53 54.27 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.48 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 8.2 t-160 -107.91 110.37 22.1 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.2 pt -124.64 114.25 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 O-C-N 121.45 -0.781 . . . . 0.0 110.513 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.63 -143.81 33.15 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 104.845 -3.302 . . . . 0.0 104.845 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -106.19 79.93 1.45 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 115.048 -2.661 . . . . 0.0 108.636 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.48 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 12.2 pt-20 -166.35 170.16 13.33 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 88.9 t -125.27 137.56 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.006 -1.059 . . . . 0.0 109.853 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 115' ' ' LEU . 7.2 m-85 -122.09 129.54 52.46 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.652 ' NE2' ' HG ' ' A' ' 114' ' ' CYS . 7.5 mt-30 -128.39 115.24 17.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 108.984 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 11.5 t -101.76 133.54 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.7 tt -134.42 91.0 2.73 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.746 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.402 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 30.7 p -164.77 134.75 3.82 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -106.33 94.64 5.26 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 115.55 -2.46 . . . . 0.0 110.538 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.571 ' C ' ' H ' ' A' ' 130' ' ' ASP . 20.1 tptm -114.2 156.8 23.62 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.088 176.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.622 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 83.3 m-20 -58.35 -3.32 0.26 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.487 -1.383 . . . . 0.0 107.891 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.593 ' OD2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.89 153.03 43.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.199 -178.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 130' ' ' ASP . 2.1 pp -117.56 160.57 21.03 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.893 0.854 . . . . 0.0 110.095 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.6 mm -131.65 128.77 60.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.805 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.426 ' OG ' ' CG1' ' A' ' 103' ' ' VAL . 14.5 m -123.0 142.09 51.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.401 -0.812 . . . . 0.0 109.373 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.499 ' O ' ' OD2' ' A' ' 101' ' ' ASP . 8.3 m -109.31 148.96 39.08 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.407 -0.808 . . . . 0.0 108.98 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -66.81 154.76 73.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.378 2.052 . . . . 0.0 112.966 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.618 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -73.32 136.53 44.49 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.459 -0.776 . . . . 0.0 109.329 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.618 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 4.1 t-80 92.95 10.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.37 126.17 32.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 108.556 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.79 132.2 31.83 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.54 1.493 . . . . 0.0 111.534 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.45 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.86 162.83 9.54 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.219 -0.926 . . . . 0.0 110.18 -178.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.451 ' HB2' ' H ' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -133.71 -147.16 0.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.65 ' CE1' ' NH1' ' A' ' 104' ' ' ARG . 0.2 OUTLIER -178.74 127.7 0.11 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.864 -1.148 . . . . 0.0 109.077 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 143' ' ' ASP . 54.7 p-10 -147.23 139.55 24.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.808 . . . . 0.0 109.852 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.604 ' O ' ' C ' ' A' ' 145' ' ' GLY . 2.6 ptt? -113.7 22.9 13.6 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.579 -0.7 . . . . 0.0 110.72 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 7.11 -90.61 0.0 OUTLIER Glycine 0 N--CA 1.502 3.053 0 CA-C-N 119.517 1.053 . . . . 0.0 112.465 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.494 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 23.0 t -86.05 116.78 24.48 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 117.886 -1.525 . . . . 0.0 108.834 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.56 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -116.74 114.36 39.75 Favored Pre-proline 0 C--N 1.296 -1.719 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.748 178.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.0 Cg_endo -101.41 38.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.885 0 C-N-CA 122.873 2.382 . . . . 0.0 110.705 176.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER 82.56 70.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -176.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 20.2 p90 -95.25 163.35 13.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.747 -0.595 . . . . 0.0 109.635 -177.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.497 ' OG1' ' OG ' ' A' ' 77' ' ' SER . 34.5 m -134.42 126.9 30.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 0.0 109.931 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.65 163.48 33.13 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.539 -0.726 . . . . 0.0 109.14 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.487 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 24.8 mt -110.59 130.04 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.192 -0.943 . . . . 0.0 109.681 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 155' ' ' ILE . 6.5 ptm180 -131.26 159.02 39.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.42 -0.8 . . . . 0.0 110.494 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.512 ' O ' ' NH1' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -108.12 149.63 11.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.501 0.667 . . . . 0.0 109.446 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -97.33 120.62 38.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.866 0.841 . . . . 0.0 110.77 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.582 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 52.0 t0 -133.93 158.93 42.23 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.594 ' O ' ' NE1' ' A' ' 162' ' ' TRP . 80.9 m-20 -96.96 150.8 37.26 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.901 -1.124 . . . . 0.0 109.513 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.625 ' O ' ' N ' ' A' ' 161' ' ' GLY . 45.9 Cg_endo -70.65 -53.23 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.363 2.042 . . . . 0.0 112.121 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.5 tt0 -42.4 -15.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.672 -0.643 . . . . 0.0 109.514 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.27 -41.4 13.74 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 177.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.594 ' NE1' ' O ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -114.4 175.66 5.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.596 -0.944 . . . . 0.0 110.952 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 19.2 pt -96.32 155.44 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.535 -0.728 . . . . 0.0 109.339 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -93.56 -70.84 0.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 110.663 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -107.06 143.07 35.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.07 -1.019 . . . . 0.0 110.197 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -102.07 -40.48 6.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 109.619 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -116.92 -30.12 5.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.323 -0.861 . . . . 0.0 108.688 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.83 -7.41 53.02 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -80.9 149.2 29.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.661 -1.494 . . . . 0.0 108.176 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.484 ' OD2' ' OG ' ' A' ' 173' ' ' SER . 1.7 p30 -107.98 88.42 2.73 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 117.425 -1.71 . . . . 0.0 111.152 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -25.62 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.832 -1.168 . . . . 0.0 109.328 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -60.56 -40.37 91.41 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.567 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 52.8 p -55.45 -4.22 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.577 -0.702 . . . . 0.0 110.22 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -81.58 -37.84 27.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.04 -1.037 . . . . 0.0 111.281 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.624 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.3 m-85 -112.13 23.84 0.08 OUTLIER Pre-proline 0 N--CA 1.509 2.522 0 O-C-N 120.538 -1.351 . . . . 0.0 112.777 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 45.3 Cg_endo -64.0 -18.84 65.26 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 123.153 2.569 . . . . 0.0 113.911 -173.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -88.36 125.07 34.52 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.849 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 0.8 OUTLIER -87.97 120.84 29.71 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.367 -0.833 . . . . 0.0 109.194 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.571 ' CB ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.432 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.597 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.426 ' N ' ' HG ' ' A' ' 126' ' ' CYS . . . -97.35 171.93 8.1 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.097 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.451 ' CD2' ' CZ3' ' A' ' 16' ' ' TRP . 18.3 tp -157.58 115.02 3.03 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.439 ' OG1' ' CD1' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -111.76 131.99 54.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.023 -1.048 . . . . 0.0 110.062 -178.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 53.8 mt -127.11 131.55 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 71.4 m-85 -129.79 164.37 24.19 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.6 m -89.02 174.96 7.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.21 -0.931 . . . . 0.0 108.906 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -23.92 6.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 120.902 -1.124 . . . . 0.0 109.532 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -41.05 62.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.059 -1.026 . . . . 0.0 110.334 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.25 123.08 11.0 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.991 -1.068 . . . . 0.0 109.52 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.588 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 55.6 Cg_endo -82.58 -27.29 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.885 1.724 . . . . 0.0 112.214 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.519 ' O ' ' NE2' ' A' ' 12' ' ' GLN . 1.4 pp0? -70.45 0.55 6.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 110.546 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.578 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -123.12 118.63 28.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 108.923 179.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.32 129.41 41.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.03 -1.044 . . . . 0.0 109.095 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.546 ' CD1' HD22 ' A' ' 13' ' ' ASN . 9.4 mp -88.46 -12.25 43.59 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.046 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.564 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 40.8 t90 -158.44 107.33 1.98 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.747 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -120.03 117.69 28.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.367 -0.833 . . . . 0.0 109.76 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.71 163.43 29.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.532 -0.73 . . . . 0.0 109.753 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.597 ' OG1' ' O ' ' A' ' 1' ' ' SER . 8.9 t -130.63 89.25 2.74 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.039 -1.038 . . . . 0.0 108.297 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.495 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 23.1 m120 -125.17 138.6 54.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.32 -0.862 . . . . 0.0 110.535 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.93 -34.08 30.03 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 119.874 -1.766 . . . . 0.0 108.555 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -82.65 -53.55 5.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.096 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -58.56 -20.22 44.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.134 -0.979 . . . . 0.0 108.666 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.495 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 5.5 mt -75.85 -57.09 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.053 -1.03 . . . . 0.0 108.748 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.499 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 61.5 tt0 -53.47 -41.08 65.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.409 -0.807 . . . . 0.0 109.077 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -71.84 -49.08 41.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.124 -0.985 . . . . 0.0 110.652 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.564 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 27.0 mt-30 -72.23 -47.33 51.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.977 -1.077 . . . . 0.0 110.998 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.22 -54.66 41.36 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.017 -1.052 . . . . 0.0 109.467 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 15.0 m120 -62.78 -16.2 56.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.978 -1.076 . . . . 0.0 109.636 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.86 -28.96 70.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.616 -1.302 . . . . 0.0 108.507 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 12.51 11.82 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.792 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.44 24.65 28.04 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.139 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.564 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 99.9 t -95.64 143.82 11.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.39 -1.065 . . . . 0.0 109.513 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -84.04 158.87 21.31 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.476 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -150.45 146.04 26.4 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 36.7 mt-10 -162.96 162.87 26.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.116 -0.99 . . . . 0.0 108.932 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.2 mtm-85 -148.41 111.59 4.91 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.615 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 18.0 m0 -112.71 155.99 23.57 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -142.65 162.32 35.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 0.0 109.846 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.23 159.59 15.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 108.905 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -100.59 -17.1 17.22 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -92.88 159.68 15.25 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.51 123.36 35.75 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.569 -0.707 . . . . 0.0 109.379 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.3 mt -90.53 166.15 13.38 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.299 -0.876 . . . . 0.0 109.342 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.69 -105.13 0.21 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.26 91.24 4.99 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.133 -1.216 . . . . 0.0 109.388 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.2 92.4 22.07 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.78 -27.43 8.81 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.206 1.937 . . . . 0.0 112.461 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 p -121.24 141.87 50.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.633 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.48 -21.2 42.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 109.532 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 50' ' ' ALA . 83.7 tt0 -43.54 -38.78 3.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -0.825 . . . . 0.0 109.096 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.479 ' HG1' ' N ' ' A' ' 53' ' ' VAL . 62.7 p -78.52 -34.77 47.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 109.244 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.479 ' N ' ' HG1' ' A' ' 52' ' ' THR . 59.1 t -68.28 -46.35 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.349 -0.844 . . . . 0.0 109.916 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 58' ' ' GLN . 6.5 mm -61.62 -35.62 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.957 . . . . 0.0 108.881 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.17 -30.34 71.51 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.52 -0.738 . . . . 0.0 109.653 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.55 -20.47 56.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 110.086 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.404 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.5 m-85 -110.74 -6.76 14.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.454 -0.779 . . . . 0.0 109.479 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.441 HE21 HG12 ' A' ' 61' ' ' ILE . 5.1 mm-40 -47.62 -37.9 13.57 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.068 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.702 ' CD2' ' N ' ' A' ' 60' ' ' ALA . 13.3 p-80 -52.59 -45.0 66.33 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.865 -1.147 . . . . 0.0 109.633 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.702 ' N ' ' CD2' ' A' ' 59' ' ' HIS . . . -63.66 -59.83 4.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.73 -1.232 . . . . 0.0 110.403 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.451 ' CD1' ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -61.83 -28.06 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.763 -1.211 . . . . 0.0 108.826 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 58' ' ' GLN . 25.9 t70 -57.62 -28.91 64.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.239 -0.913 . . . . 0.0 109.441 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.406 ' CD ' ' O ' ' A' ' 59' ' ' HIS . 4.7 mptp? -73.74 -41.31 62.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.108 -0.995 . . . . 0.0 109.185 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 9.4 mp -64.09 -35.27 80.21 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.387 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 3.7 t -69.1 -28.9 41.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.227 -0.92 . . . . 0.0 109.321 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.77 -53.84 53.82 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.546 -1.346 . . . . 0.0 109.57 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -85.57 -53.69 5.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.024 -1.048 . . . . 0.0 110.704 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.583 ' O ' ' C ' ' A' ' 69' ' ' GLY . 11.2 mmtp -84.96 14.45 4.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.443 -0.786 . . . . 0.0 110.646 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -18.23 87.93 0.0 OUTLIER Glycine 0 N--CA 1.498 2.805 0 CA-C-O 122.041 0.8 . . . . 0.0 111.332 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 68' ' ' LYS . 58.7 m-85 -76.12 165.07 25.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.71 HE22 ' ND2' ' A' ' 158' ' ' ASN . 81.4 mt-30 -57.14 -88.83 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.431 -0.793 . . . . 0.0 109.522 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.76 163.1 12.56 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.641 0.734 . . . . 0.0 109.999 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.499 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 5.2 t-105 -135.23 139.24 44.31 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -155.48 173.5 16.6 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.98 141.39 39.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.451 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 16.2 tt -102.78 117.09 47.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.517 ' O ' ' OG ' ' A' ' 77' ' ' SER . 8.8 p -168.24 101.78 0.44 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.585 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 9.6 tp -116.01 179.43 3.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 119.31 -2.119 . . . . 0.0 107.781 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.556 ' C ' ' H ' ' A' ' 81' ' ' ASP . 0.8 OUTLIER -89.51 150.01 22.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.032 -1.042 . . . . 0.0 109.173 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.458 ' CA ' ' HZ3' ' A' ' 85' ' ' LYS . . . -60.2 2.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -0.881 . . . . 0.0 109.675 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 79' ' ' ARG . 32.3 t0 -78.77 -28.1 44.7 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.566 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -63.69 123.66 82.13 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.872 -1.143 . . . . 0.0 109.91 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.59 -4.77 12.36 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.048 1.832 . . . . 0.0 111.97 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -87.98 6.26 36.8 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.044 -1.035 . . . . 0.0 109.761 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.532 ' HG3' ' H ' ' A' ' 86' ' ' GLU . 11.9 ptpt -57.27 -50.89 71.48 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.162 -0.961 . . . . 0.0 108.975 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.532 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 84.4 tt0 -66.33 -42.57 87.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.282 -0.886 . . . . 0.0 109.899 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.72 -59.42 4.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.13 -0.981 . . . . 0.0 110.136 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.418 HD13 ' H ' ' A' ' 88' ' ' LEU . 6.1 mp -62.8 -44.53 95.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.953 -1.092 . . . . 0.0 109.49 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 145' ' ' GLY . 47.7 ttp180 -59.54 -30.33 68.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.845 . . . . 0.0 109.627 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.82 -61.66 2.34 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.616 -0.833 . . . . 0.0 109.638 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -54.98 -32.66 61.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.462 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -63.69 -31.34 72.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.902 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 73.6 mt -50.87 -41.37 58.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.001 -1.062 . . . . 0.0 110.014 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.727 HD21 ' H ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -49.22 141.01 8.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.762 -1.211 . . . . 0.0 109.583 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.727 ' H ' HD21 ' A' ' 94' ' ' ASN . 0.7 OUTLIER -81.63 171.65 14.37 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.5 p-80 -177.71 -165.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 110.537 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.1 t -163.32 137.74 6.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.625 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -109.33 155.57 21.04 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 109.87 -178.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.87 -7.03 87.49 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -123.51 170.64 10.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.54 -0.977 . . . . 0.0 109.356 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 101' ' ' ASP . 48.3 p30 -75.98 143.9 41.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.056 -1.027 . . . . 0.0 110.07 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.415 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 1.8 mt-10 -104.11 94.28 5.3 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.06 -1.025 . . . . 0.0 108.446 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.1 t -97.55 127.02 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.023 -1.048 . . . . 0.0 110.313 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 129.73 43.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.342 -0.849 . . . . 0.0 109.244 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.641 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 14.2 t80 -106.44 131.92 53.07 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.161 -0.962 . . . . 0.0 109.33 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.54 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -87.86 130.82 34.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 110.279 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.63 -34.17 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.66 -0.65 . . . . 0.0 110.065 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 109' ' ' GLY . 1.4 tm-20 -164.01 151.68 12.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.477 ' N ' ' OE1' ' A' ' 108' ' ' GLU . . . 87.42 148.76 14.63 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.71 155.39 27.83 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.32 -1.106 . . . . 0.0 108.933 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -150.87 -119.61 0.9 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.2 tp -146.71 162.23 38.95 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.368 -1.078 . . . . 0.0 109.097 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -131.31 90.43 2.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.282 -0.886 . . . . 0.0 109.234 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.67 ' SG ' ' CD1' ' A' ' 141' ' ' TRP . 5.1 p -79.47 131.96 36.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 110.107 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.67 104.26 5.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.358 -0.839 . . . . 0.0 108.772 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.52 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 1.7 t-160 -98.41 108.93 21.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.928 -1.108 . . . . 0.0 109.582 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.12 113.19 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.004 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.85 -141.47 27.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 104.968 -3.253 . . . . 0.0 104.968 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.495 ' OD2' ' O ' ' A' ' 119' ' ' ASP . 39.9 p30 -108.25 80.92 1.41 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 115.488 -2.485 . . . . 0.0 108.956 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.52 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 23.2 pt-20 -166.41 168.88 14.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.5 t -129.19 150.8 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.984 . . . . 0.0 109.83 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -125.39 129.8 50.61 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.213 0.53 . . . . 0.0 109.575 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 4' ' ' THR . 28.6 mt-30 -129.23 110.74 12.22 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.2 138.2 27.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.551 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 5.6 mp -122.39 79.51 1.62 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 117.685 -1.606 . . . . 0.0 109.226 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.551 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -165.86 118.42 1.11 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 178.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 7.3 tm-20 -113.9 104.19 11.92 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 116.618 -2.033 . . . . 0.0 110.916 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.535 ' C ' ' H ' ' A' ' 130' ' ' ASP . 44.6 mtmt -110.15 178.01 4.53 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.688 177.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.641 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.3 OUTLIER -59.42 -3.57 0.46 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.592 ' N ' HD21 ' A' ' 129' ' ' ASN . 26.7 p30 -72.28 151.88 42.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.835 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.498 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 1.9 pp -114.9 160.77 19.13 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.023 0.916 . . . . 0.0 110.57 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 6.2 mm -128.07 125.96 65.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.586 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.0 m -123.35 141.26 52.17 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.46 148.58 39.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.852 . . . . 0.0 108.716 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -70.24 156.68 61.55 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.269 1.979 . . . . 0.0 112.926 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.605 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.15 133.51 46.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.438 -0.789 . . . . 0.0 109.036 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.605 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 11.1 t60 92.24 11.75 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.168 0.509 . . . . 0.0 110.012 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.24 126.26 32.07 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.99 133.86 40.47 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.442 1.428 . . . . 0.0 111.699 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.511 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.41 163.49 8.59 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.084 -1.047 . . . . 0.0 110.313 -179.263 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.67 ' CD1' ' SG ' ' A' ' 114' ' ' CYS . 10.7 p90 -130.95 -153.49 0.57 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.365 -0.835 . . . . 0.0 110.031 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.534 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -168.41 125.06 1.03 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.476 -0.765 . . . . 0.0 109.169 179.112 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 143' ' ' ASP . 46.2 p-10 -146.04 129.48 16.86 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.053 -1.029 . . . . 0.0 109.749 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.586 ' O ' ' C ' ' A' ' 145' ' ' GLY . 29.8 mtt -102.95 16.51 26.42 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.369 -0.832 . . . . 0.0 111.198 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 20.86 -113.85 0.01 OUTLIER Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' A' ' 178' ' ' LEU . 67.2 m -81.3 120.77 25.35 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.064 -1.454 . . . . 0.0 109.159 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.04 114.46 46.21 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 120.181 -0.607 . . . . 0.0 109.386 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 59.6 Cg_endo -104.14 44.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 122.614 2.209 . . . . 0.0 111.485 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER 81.68 70.35 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.177 -177.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 23.8 p90 -96.44 159.06 15.14 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.414 -0.804 . . . . 0.0 110.225 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.3 m -125.37 125.39 43.37 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.582 0.706 . . . . 0.0 110.716 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.22 162.76 34.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.37 -0.831 . . . . 0.0 109.295 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.499 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 94.9 mt -110.9 129.87 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.256 -0.902 . . . . 0.0 109.942 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -129.87 158.03 40.63 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.578 -0.701 . . . . 0.0 109.596 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.428 ' CD1' ' N ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.68 154.41 8.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -95.81 120.15 35.57 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.093 -1.004 . . . . 0.0 110.196 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.562 ' CG ' ' CE2' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -134.82 161.89 33.91 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.71 ' ND2' HE22 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -95.92 160.61 29.71 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 120.92 -1.113 . . . . 0.0 109.268 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 161' ' ' GLY . 43.0 Cg_endo -67.9 -54.83 0.3 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.367 2.044 . . . . 0.0 112.088 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 159' ' ' PRO . 16.5 pt-20 -43.98 -14.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.243 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -89.04 -36.7 7.54 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CE2' ' CG ' ' A' ' 157' ' ' ASP . 47.6 m0 -102.26 163.35 12.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.601 -0.941 . . . . 0.0 110.675 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -99.25 139.33 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.362 -0.836 . . . . 0.0 109.238 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.36 -73.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.5 -0.75 . . . . 0.0 110.736 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -142.25 159.69 41.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.941 -1.099 . . . . 0.0 110.062 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.6 -41.45 6.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.753 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.9 -31.74 5.0 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.26 -1.27 64.48 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.467 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 94.6 m-20 -80.71 149.51 29.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.761 -1.435 . . . . 0.0 108.291 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.462 ' OD2' ' OG ' ' A' ' 173' ' ' SER . 5.8 p-10 -109.5 88.07 2.65 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.624 -1.63 . . . . 0.0 110.682 176.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.16 -20.76 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.336 -1.477 . . . . 0.0 109.594 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.567 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -61.51 -39.82 92.4 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.972 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.535 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 38.2 p -52.9 -3.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.711 -0.618 . . . . 0.0 110.193 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.567 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.98 -39.66 29.6 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.957 -1.09 . . . . 0.0 111.491 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.636 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.7 m-85 -113.48 24.27 0.08 OUTLIER Pre-proline 0 N--CA 1.516 2.864 0 O-C-N 120.534 -1.353 . . . . 0.0 112.73 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 43.9 Cg_endo -61.56 -19.59 65.36 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.653 2.902 . . . . 0.0 114.486 -172.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -89.36 127.05 35.77 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.879 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 1.0 OUTLIER -85.5 118.81 25.25 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.085 -1.009 . . . . 0.0 108.698 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.594 ' CB ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.624 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.556 ' O ' ' OG1' ' A' ' 19' ' ' THR . 1.3 p . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.77 171.08 8.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.237 -0.914 . . . . 0.0 109.437 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.9 tp -158.9 112.53 2.36 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.29 128.97 54.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.829 -1.169 . . . . 0.0 110.091 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.464 ' CD1' ' CE2' ' A' ' 122' ' ' PHE . 60.4 mt -123.7 130.07 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -125.9 165.55 18.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.535 ' OG ' ' CD1' ' A' ' 15' ' ' LEU . 14.3 m -84.35 172.77 11.49 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.32 -0.863 . . . . 0.0 109.019 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.43 -30.45 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.121 . . . . 0.0 109.955 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -73.73 -38.33 64.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 0.0 110.043 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.71 123.93 13.12 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.34 -30.43 1.55 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.234 1.956 . . . . 0.0 112.312 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.708 HE21 ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -69.67 2.27 3.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.466 -0.771 . . . . 0.0 109.928 -179.102 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.708 ' ND2' HE21 ' A' ' 12' ' ' GLN . 0.9 OUTLIER -117.79 119.45 34.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.5 p -96.12 124.38 40.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.292 -0.88 . . . . 0.0 109.334 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.535 ' CD1' ' OG ' ' A' ' 7' ' ' SER . 72.0 mt -87.62 -15.4 37.42 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.607 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 46.2 t90 -158.93 108.59 1.96 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.649 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -120.5 122.08 39.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.136 -0.977 . . . . 0.0 109.275 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.07 164.02 20.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.969 -1.082 . . . . 0.0 109.961 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.57 ' O ' ' CG2' ' A' ' 19' ' ' THR . 10.3 t -131.47 89.89 2.78 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.566 175.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.558 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 29.8 m120 -125.59 145.54 50.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.964 -1.085 . . . . 0.0 110.688 177.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.58 -41.67 19.27 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.34 -1.475 . . . . 0.0 109.072 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -82.77 -48.81 10.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.349 -0.844 . . . . 0.0 109.6 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.486 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.1 tt0 -61.31 -19.95 62.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.974 -1.079 . . . . 0.0 108.533 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.558 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 2.3 mt -73.27 -58.59 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.183 -0.948 . . . . 0.0 109.316 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.516 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 6.2 pt20 -61.28 -42.22 98.27 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.035 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.516 ' N ' ' CG ' ' A' ' 25' ' ' GLN . 62.7 tt0 -61.77 -47.46 85.08 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.347 -0.846 . . . . 0.0 109.48 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.607 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 4.7 tt0 -76.06 -45.44 34.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.062 -1.024 . . . . 0.0 109.332 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.9 tp -64.54 -56.74 12.08 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.02 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.579 HD22 ' CB ' ' A' ' 35' ' ' PHE . 1.2 m-20 -57.26 -17.92 13.95 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.928 -1.108 . . . . 0.0 109.469 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.93 -27.8 69.39 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.916 -1.115 . . . . 0.0 109.084 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -89.75 10.53 23.09 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.721 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.0 23.49 25.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.1 t -93.69 143.35 11.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.249 -1.148 . . . . 0.0 109.672 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 ttt85 -85.08 155.7 21.39 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.385 -0.822 . . . . 0.0 109.055 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.579 ' CB ' HD22 ' A' ' 29' ' ' ASN . 1.5 t80 -155.81 153.59 30.02 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.711 -1.243 . . . . 0.0 109.059 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' OE1' ' O ' ' A' ' 35' ' ' PHE . 13.1 tp10 -175.71 173.34 2.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.763 -1.211 . . . . 0.0 109.576 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.46 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 37.5 mtm180 -148.38 117.56 6.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.813 -1.18 . . . . 0.0 108.665 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.527 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 26.8 m0 -110.2 154.07 23.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 109.283 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.574 HE22 ' ND2' ' A' ' 129' ' ' ASN . 99.5 mm-40 -141.12 155.88 46.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.481 -0.762 . . . . 0.0 109.92 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.99 156.64 17.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.328 -0.857 . . . . 0.0 109.004 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.499 ' OD2' ' N ' ' A' ' 42' ' ' ARG . 53.2 p30 -101.11 -11.81 19.3 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.125 -0.985 . . . . 0.0 108.7 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.499 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -93.38 156.38 16.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.33 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -92.12 119.03 31.4 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.688 -0.632 . . . . 0.0 109.566 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.36 163.65 14.12 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.696 0.76 . . . . 0.0 109.3 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.37 -102.81 0.19 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.18 92.82 4.49 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.928 -1.336 . . . . 0.0 109.23 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.54 91.47 44.61 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -75.58 -22.67 13.6 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.461 2.107 . . . . 0.0 112.756 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 p -121.96 141.97 50.78 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.542 -0.723 . . . . 0.0 109.59 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 51' ' ' GLU . . . -80.29 -18.24 49.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.333 -0.854 . . . . 0.0 109.405 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 50' ' ' ALA . 79.8 mm-40 -45.34 -38.32 5.69 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.911 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.4 m -77.84 -33.3 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.41 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 50' ' ' ALA . 65.3 t -68.22 -47.0 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 109.961 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.513 ' O ' ' N ' ' A' ' 58' ' ' GLN . 14.4 mm -60.61 -39.16 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 109.261 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.26 70.62 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.571 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.34 -19.55 58.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 0.0 110.507 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -116.33 -8.53 11.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.435 -0.791 . . . . 0.0 109.267 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.673 HE21 ' CG1' ' A' ' 61' ' ' ILE . 33.5 tp60 -48.36 -38.03 18.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 108.737 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.599 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.22 -47.95 62.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.01 -1.056 . . . . 0.0 109.885 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.599 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.37 -58.93 6.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.968 -1.082 . . . . 0.0 109.819 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.673 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.5 OUTLIER -62.72 -29.42 46.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.953 -1.092 . . . . 0.0 108.883 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 58' ' ' GLN . 47.4 t0 -57.31 -25.37 59.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.86 . . . . 0.0 109.713 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -78.47 -38.09 41.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 110.126 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -62.99 -39.52 94.97 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.266 -0.973 . . . . 0.0 109.695 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -69.25 -30.38 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.026 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.62 61.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.216 -1.552 . . . . 0.0 109.462 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -83.7 -52.48 6.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.022 -1.049 . . . . 0.0 110.799 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.629 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -86.7 14.88 6.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.544 -0.723 . . . . 0.0 110.666 -177.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -14.7 89.38 0.01 OUTLIER Glycine 0 N--CA 1.5 2.944 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.492 ' N ' ' O ' ' A' ' 68' ' ' LYS . 97.2 m-85 -76.03 160.07 30.19 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -58.93 -40.86 85.88 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.315 -0.866 . . . . 0.0 109.754 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.1 t -144.49 155.22 43.6 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.212 -0.93 . . . . 0.0 109.104 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.537 ' CD1' ' N ' ' A' ' 74' ' ' ASP . 9.8 t-105 -141.68 146.3 35.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.303 -0.873 . . . . 0.0 108.658 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.537 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.3 OUTLIER -176.55 -165.87 0.15 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.57 165.57 27.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.446 -0.784 . . . . 0.0 109.625 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.647 ' CD1' ' HE ' ' A' ' 154' ' ' ARG . 1.4 mp -95.52 136.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.0 p -91.95 165.6 13.14 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.423 1.106 . . . . 0.0 111.412 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.526 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -161.5 137.63 8.07 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.884 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.441 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -123.64 137.78 54.66 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.414 ' H ' ' HD3' ' A' ' 79' ' ' ARG . . . -70.56 -7.03 40.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 0.0 109.709 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.424 ' H ' ' HD2' ' A' ' 79' ' ' ARG . 45.8 t0 -110.64 -18.24 13.21 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.519 -0.738 . . . . 0.0 109.396 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.821 HD22 ' N ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -63.34 116.67 27.16 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.239 -178.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -90.07 -16.53 1.79 Allowed 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.964 2.443 . . . . 0.0 113.032 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.402 ' CG ' ' OD1' ' A' ' 82' ' ' ASN . 16.5 pt20 -80.26 1.18 29.56 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.008 -1.058 . . . . 0.0 109.165 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.821 ' N ' HD22 ' A' ' 82' ' ' ASN . 0.8 OUTLIER -65.84 -42.16 90.87 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.21 178.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -51.45 -47.04 63.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.013 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.87 -43.93 77.62 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.672 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 91.4 mt -61.75 -38.38 87.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.887 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.671 ' NH2' ' HZ2' ' A' ' 85' ' ' LYS . 1.6 mmt-85 -58.78 -25.53 63.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.885 . . . . 0.0 108.865 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -58.57 3.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.465 -0.772 . . . . 0.0 110.248 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -54.81 -45.69 74.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.342 -0.849 . . . . 0.0 109.736 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -67.81 -18.67 64.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.48 -34.38 76.72 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 109.705 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 94' ' ' ASN . 45.9 p-10 -47.58 140.28 6.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 109.944 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' A' ' 96' ' ' HIS . 23.1 tt0 -77.79 163.08 26.43 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.293 -0.88 . . . . 0.0 109.476 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.523 ' N ' ' CG ' ' A' ' 95' ' ' GLU . 50.7 p-80 -174.64 -167.13 0.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.349 -1.341 . . . . 0.0 112.07 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.99 134.39 2.47 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -106.1 156.07 18.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.86 -178.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.6 -6.19 86.63 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -123.04 170.04 10.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.456 -1.026 . . . . 0.0 109.431 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -75.85 142.89 42.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 109.887 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.416 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 1.8 mt-10 -102.79 92.67 4.7 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.405 ' CG2' ' OG ' ' A' ' 133' ' ' SER . 35.1 t -89.65 128.15 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.484 -0.76 . . . . 0.0 109.636 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.2 tmm_? -130.27 122.6 28.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -0.784 . . . . 0.0 109.904 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.632 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 11.0 t80 -100.87 130.92 46.95 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.477 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -87.78 130.25 34.91 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.544 -0.722 . . . . 0.0 110.196 -178.507 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.8 -30.93 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.687 -0.633 . . . . 0.0 109.423 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -162.01 151.48 16.08 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.18 -0.95 . . . . 0.0 109.374 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.81 164.8 39.71 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -147.72 171.53 15.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.478 -1.013 . . . . 0.0 109.281 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.7 154.52 10.74 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.401 ' O ' ' CG ' ' A' ' 112' ' ' LEU . 0.7 OUTLIER -93.65 96.78 10.04 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.744 -1.445 . . . . 0.0 110.08 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.503 ' CE1' ' O ' ' A' ' 114' ' ' CYS . 3.5 t80 -87.75 127.95 35.31 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.767 -1.208 . . . . 0.0 109.332 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.664 ' SG ' ' NE2' ' A' ' 123' ' ' GLN . 1.8 m -78.93 129.96 35.07 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.711 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 122' ' ' PHE . 3.0 tm? -114.62 129.47 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 4.9 t-160 -114.68 112.84 23.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.417 -0.802 . . . . 0.0 109.558 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.3 112.2 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.441 -0.787 . . . . 0.0 109.597 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.42 -127.76 10.08 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 106.437 -2.665 . . . . 0.0 106.437 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.559 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 46.4 p30 -116.23 75.51 0.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 115.374 -2.53 . . . . 0.0 110.342 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.581 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 22.3 pt-20 -166.2 168.25 15.44 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.4 138.96 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.46 -0.775 . . . . 0.0 109.986 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 115' ' ' LEU . 7.6 m-85 -127.61 131.25 49.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 0.0 109.353 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.664 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 11.7 mt-30 -126.45 118.54 25.16 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.031 -1.043 . . . . 0.0 108.983 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.409 ' C ' ' CD2' ' A' ' 125' ' ' LEU . 21.7 t -110.14 135.54 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.557 ' N ' ' CD2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -133.64 90.96 2.78 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.594 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 126' ' ' CYS . 1.7 p -164.64 134.11 3.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 119.685 -1.884 . . . . 0.0 106.827 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -106.34 93.72 4.75 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 115.71 -2.396 . . . . 0.0 110.185 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.595 ' C ' ' H ' ' A' ' 130' ' ' ASP . 51.7 mttm -115.52 158.95 21.85 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.108 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.632 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 23.1 m-80 -58.37 -3.02 0.23 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.345 -1.472 . . . . 0.0 107.622 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.595 ' H ' ' C ' ' A' ' 128' ' ' LYS . 56.1 p30 -72.81 152.78 41.39 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.139 -0.976 . . . . 0.0 109.28 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.516 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 3.0 pp -117.23 161.43 19.49 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.686 0.755 . . . . 0.0 110.052 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 17.3 tt -133.11 126.36 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.281 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.405 ' OG ' ' CG2' ' A' ' 103' ' ' VAL . 19.1 t -122.1 138.53 54.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.452 -0.78 . . . . 0.0 109.605 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.16 147.87 35.02 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.387 -0.821 . . . . 0.0 109.145 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.411 ' O ' ' CG2' ' A' ' 138' ' ' THR . 39.1 Cg_endo -66.81 156.51 65.69 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.269 1.979 . . . . 0.0 112.795 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.644 ' O ' ' ND1' ' A' ' 137' ' ' HIS . . . -71.84 139.74 49.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.311 -0.868 . . . . 0.0 108.675 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.644 ' ND1' ' O ' ' A' ' 136' ' ' ALA . 7.4 m80 88.62 13.46 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.852 -0.53 . . . . 0.0 109.719 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 135' ' ' PRO . 14.9 t -106.7 126.4 30.4 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.288 -0.883 . . . . 0.0 108.864 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 116' ' ' HIS . 39.6 Cg_endo -63.66 134.06 42.39 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.597 1.531 . . . . 0.0 111.452 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.51 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -172.29 162.08 5.45 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.959 -1.088 . . . . 0.0 109.982 -179.088 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.501 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -133.19 -149.01 0.35 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.159 -0.963 . . . . 0.0 109.413 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.417 ' H ' ' HB2' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -176.38 127.99 0.2 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.925 -1.109 . . . . 0.0 108.938 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.76 138.68 18.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 109.143 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.623 ' SD ' ' CZ ' ' A' ' 89' ' ' ARG . 1.4 mpt? -113.17 21.69 15.06 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.395 -0.816 . . . . 0.0 110.574 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.599 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.67 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.501 2.971 0 CA-C-N 119.417 1.008 . . . . 0.0 111.835 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.457 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 74.9 m -86.74 117.24 25.36 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 117.94 -1.504 . . . . 0.0 109.562 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.45 ' N ' ' OE1' ' A' ' 147' ' ' GLU . 22.3 mp0 -115.2 116.92 41.81 Favored Pre-proline 0 C--N 1.294 -1.835 0 O-C-N 121.805 -0.56 . . . . 0.0 109.778 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.616 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 51.1 Cg_endo -103.39 31.96 0.07 OUTLIER 'Trans proline' 0 C--O 1.207 -1.064 0 C-N-CA 123.395 2.73 . . . . 0.0 111.791 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.721 ' CG ' ' O ' ' A' ' 149' ' ' ASN . 0.1 OUTLIER 82.54 63.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 123.102 1.43 . . . . 0.0 109.807 -178.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.526 ' CZ ' ' CD2' ' A' ' 78' ' ' LEU . 11.2 p90 -99.84 -178.86 3.99 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 119.805 -1.809 . . . . 0.0 110.16 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 59.7 m -135.69 131.7 36.0 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.701 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -134.98 153.94 51.91 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.065 -1.022 . . . . 0.0 108.972 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.9 mt -110.21 129.58 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.159 -0.963 . . . . 0.0 109.805 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.647 ' HE ' ' CD1' ' A' ' 76' ' ' ILE . 25.9 mtm-85 -143.97 170.08 16.6 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.192 -0.943 . . . . 0.0 109.481 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.455 ' CG2' ' CG ' ' A' ' 70' ' ' TYR . 4.6 mp -101.33 145.81 10.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.471 -0.768 . . . . 0.0 109.034 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.521 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 5.2 m-85 -96.38 118.73 33.52 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.489 -0.757 . . . . 0.0 109.408 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.563 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 55.3 p30 -134.89 161.57 34.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.848 -0.533 . . . . 0.0 109.607 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.605 ' O ' ' NE1' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -96.08 156.99 36.47 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.096 . . . . 0.0 108.981 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.5 Cg_endo -66.93 -54.06 0.45 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.667 2.245 . . . . 0.0 112.249 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.6 ' N ' ' OD1' ' A' ' 158' ' ' ASN . 95.5 mt-10 -44.4 -17.53 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.312 -0.867 . . . . 0.0 108.856 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.48 -50.84 5.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.605 ' NE1' ' O ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -104.07 169.33 8.56 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.474 -1.016 . . . . 0.0 109.95 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 74.9 mt -96.99 149.81 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 0.0 109.341 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 96' ' ' HIS . . . -83.31 -71.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 0.0 110.349 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -117.6 146.3 43.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.161 -0.962 . . . . 0.0 109.699 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -101.56 -41.71 6.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.436 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 69.4 p -106.44 -31.18 8.67 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.22 -0.925 . . . . 0.0 109.049 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.23 -9.1 56.01 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -82.78 145.98 29.23 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.253 -1.734 . . . . 0.0 108.722 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -112.33 90.6 3.38 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.527 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.07 -16.78 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.036 -1.665 . . . . 0.0 108.758 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.579 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -57.94 -38.05 75.22 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.614 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 22.7 t -51.61 -3.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.232 -0.917 . . . . 0.0 110.191 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.579 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -76.64 -42.05 43.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.784 -1.197 . . . . 0.0 111.701 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.629 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.1 OUTLIER -113.95 26.7 0.1 OUTLIER Pre-proline 0 N--CA 1.511 2.606 0 O-C-N 120.574 -1.328 . . . . 0.0 111.966 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 46.4 Cg_endo -60.95 -24.24 79.03 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 124.146 3.231 . . . . 0.0 113.038 -172.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.11 126.18 35.35 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.895 -1.122 . . . . 0.0 109.186 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.512 ' O ' ' C ' ' A' ' 179' ' ' ALA . 1.3 tp -87.59 122.69 31.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.633 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.633 ' O ' ' OG1' ' A' ' 19' ' ' THR . 11.3 p . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.68 170.76 8.78 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.301 -0.874 . . . . 0.0 109.325 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 tp -159.01 115.92 2.72 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.83 140.78 41.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.1 mt -134.18 134.65 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -126.65 166.89 16.51 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.9 m -86.04 173.92 9.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.051 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.3 -28.09 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.982 -1.074 . . . . 0.0 109.399 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -75.83 -36.59 59.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 110.381 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -137.89 123.75 12.81 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.476 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -81.69 -32.11 0.94 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.066 1.844 . . . . 0.0 112.353 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.577 ' O ' ' NE2' ' A' ' 12' ' ' GLN . 23.5 tp60 -69.81 2.78 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.448 -0.782 . . . . 0.0 110.011 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -114.73 120.11 38.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.912 . . . . 0.0 109.474 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.85 122.15 40.62 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.251 -0.906 . . . . 0.0 109.248 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.43 -6.18 55.21 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.022 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.703 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 39.1 t90 -156.22 105.13 2.29 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.43 -1.308 . . . . 0.0 110.276 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -119.13 110.97 17.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.642 -0.661 . . . . 0.0 109.544 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.448 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -163.01 163.45 26.03 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.002 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.633 ' OG1' ' O ' ' A' ' 1' ' ' SER . 11.7 t -131.47 90.77 2.91 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 120.786 -1.196 . . . . 0.0 108.416 176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.595 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 29.9 m120 -124.66 152.29 43.84 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.851 -1.156 . . . . 0.0 110.613 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.32 -47.54 11.38 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.343 -1.473 . . . . 0.0 108.758 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -82.49 -43.35 17.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.347 -0.846 . . . . 0.0 110.242 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.498 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.2 tt0 -66.07 -24.73 66.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.749 -1.219 . . . . 0.0 108.908 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.595 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 3.3 mt -68.26 -58.45 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.165 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 29' ' ' ASN . 14.2 pt20 -58.39 -43.77 88.69 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.127 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -53.89 -35.11 61.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.463 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.703 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -66.97 -63.55 1.04 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.0 -1.062 . . . . 0.0 109.314 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -69.18 -54.94 12.24 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.822 -1.174 . . . . 0.0 109.834 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 17.1 t-20 -47.52 -33.06 5.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.681 -1.262 . . . . 0.0 109.068 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.68 -25.33 68.16 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.064 -1.022 . . . . 0.0 108.531 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 28' ' ' LEU . 29.0 mttm -91.39 10.53 27.17 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.273 -0.892 . . . . 0.0 110.498 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.92 25.88 12.4 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.048 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.6 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 48.4 t -96.36 146.2 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.449 -1.03 . . . . 0.0 109.347 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.77 155.24 21.93 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.135 -0.978 . . . . 0.0 109.243 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.483 ' O ' ' OE1' ' A' ' 36' ' ' GLU . 2.1 t80 -155.37 154.26 31.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.043 -1.036 . . . . 0.0 109.006 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 35' ' ' PHE . 11.5 tp10 -176.12 173.05 2.27 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.975 -1.078 . . . . 0.0 109.519 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.465 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 65.4 mtm-85 -148.54 118.45 7.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.039 -1.038 . . . . 0.0 108.603 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.44 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 30.2 m0 -110.93 148.37 32.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.324 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.667 HE21 ' ND2' ' A' ' 129' ' ' ASN . 49.6 mm-40 -137.08 159.98 40.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.437 -0.789 . . . . 0.0 109.664 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.27 160.45 14.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 109.044 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -98.45 -18.46 18.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.236 -0.915 . . . . 0.0 108.687 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -93.54 167.85 11.42 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -94.39 121.15 35.63 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.727 . . . . 0.0 109.386 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.33 167.14 11.52 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.05 -121.7 0.59 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.44 78.83 9.63 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.068 -1.254 . . . . 0.0 108.653 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.15 95.62 30.99 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 121.375 -0.828 . . . . 0.0 109.309 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.479 ' O ' ' CG2' ' A' ' 49' ' ' THR . 46.8 Cg_endo -70.61 79.17 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.22 1.947 . . . . 0.0 111.736 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 48' ' ' PRO . 6.0 p -162.99 118.03 1.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.061 -1.024 . . . . 0.0 109.364 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.81 -43.98 17.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.062 -1.024 . . . . 0.0 109.96 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -65.11 -17.17 64.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.392 -0.817 . . . . 0.0 109.728 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.6 m -77.05 -41.78 41.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.229 -0.919 . . . . 0.0 110.373 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.6 t -63.93 -47.87 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.051 -1.031 . . . . 0.0 109.537 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 58' ' ' GLN . 11.7 mm -61.21 -42.25 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 108.722 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.38 -30.3 71.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.332 -0.855 . . . . 0.0 109.83 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.77 -19.38 59.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 110.405 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.0 m-85 -113.75 -6.67 13.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.373 -0.829 . . . . 0.0 109.462 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.649 HE21 ' CG1' ' A' ' 61' ' ' ILE . 26.3 tp60 -47.74 -39.72 18.56 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -50.43 -44.22 55.25 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.619 -1.3 . . . . 0.0 109.369 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.87 -59.42 4.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.869 -1.144 . . . . 0.0 110.452 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.649 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.8 OUTLIER -61.41 -30.39 47.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 120.912 -1.117 . . . . 0.0 108.968 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -55.04 -28.85 55.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.01 -1.056 . . . . 0.0 109.68 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -74.94 -38.94 61.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.034 -1.041 . . . . 0.0 109.4 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 9.8 mp -65.28 -35.34 80.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.069 -1.019 . . . . 0.0 109.739 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.488 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 2.6 t -70.11 -31.18 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.72 64.02 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.639 -1.288 . . . . 0.0 109.386 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -87.33 -52.52 5.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 110.612 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.581 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -85.81 14.85 5.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.843 . . . . 0.0 110.44 -177.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.581 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -19.54 89.08 0.01 OUTLIER Glycine 0 N--CA 1.495 2.572 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 68' ' ' LYS . 48.8 m-85 -76.75 167.71 21.36 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -57.19 -88.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.431 -0.793 . . . . 0.0 109.452 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -104.74 166.13 10.59 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.399 0.619 . . . . 0.0 109.69 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.438 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 5.5 t-105 -137.58 141.61 41.31 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.448 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -158.47 176.64 12.17 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.4 p -122.89 144.58 31.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.1 mt -105.53 116.84 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.484 ' O ' ' OG ' ' A' ' 77' ' ' SER . 11.2 p -168.66 103.05 0.41 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.261 -0.9 . . . . 0.0 109.216 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.461 ' HG ' ' H ' ' A' ' 79' ' ' ARG . 1.0 OUTLIER -115.27 -177.22 3.09 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 120.7 1.591 . . . . 0.0 108.645 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.59 ' C ' ' H ' ' A' ' 81' ' ' ASP . 2.3 ttt180 -92.82 152.61 19.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.375 -1.453 . . . . 0.0 109.129 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.15 -6.87 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.062 -1.024 . . . . 0.0 110.4 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.59 ' H ' ' C ' ' A' ' 79' ' ' ARG . 95.3 m-20 -92.52 33.78 1.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.651 ' ND2' ' N ' ' A' ' 85' ' ' LYS . 23.7 t30 -76.12 124.8 88.42 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.914 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.16 -27.86 3.42 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.645 2.23 . . . . 0.0 112.271 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 88' ' ' LEU . 24.7 mt-30 -90.79 10.66 25.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.917 -1.115 . . . . 0.0 109.194 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.651 ' N ' ' ND2' ' A' ' 82' ' ' ASN . 0.4 OUTLIER -53.34 -58.52 6.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.146 -0.972 . . . . 0.0 108.815 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.38 -51.4 52.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.116 -0.99 . . . . 0.0 109.324 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.99 -42.06 72.0 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.343 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 5.7 tp -59.75 -42.92 94.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.179 -0.95 . . . . 0.0 109.199 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -56.77 -37.67 71.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.568 -1.332 . . . . 0.0 110.174 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -66.06 -22.35 66.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.538 ' CG ' ' N ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -65.64 -45.47 82.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.617 -0.677 . . . . 0.0 110.121 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.668 ' CD2' ' O ' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -88.14 -13.57 40.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 0.0 110.477 -178.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 92' ' ' PHE . 65.5 tp -42.18 -18.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.152 -0.967 . . . . 0.0 109.883 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 92' ' ' PHE . 9.4 p30 -99.8 114.61 27.89 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.055 -1.028 . . . . 0.0 109.235 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.504 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 3.0 pp20? -52.02 173.91 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.504 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 50.2 p-80 -176.5 -166.78 0.17 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.295 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.06 135.47 3.83 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.607 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -103.61 154.8 19.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 109.741 -178.567 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.73 -6.59 87.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -123.97 171.18 9.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.333 -1.099 . . . . 0.0 109.424 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -74.31 141.79 45.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.975 . . . . 0.0 110.068 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.607 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 3.7 tt0 -102.83 89.9 3.62 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.8 p -88.43 130.43 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.082 -1.011 . . . . 0.0 110.521 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.519 ' NH1' ' HE ' ' A' ' 154' ' ' ARG . 52.5 mtt-85 -129.68 121.79 27.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.594 -0.691 . . . . 0.0 109.439 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.615 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 21.7 t80 -101.76 132.97 47.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 108.593 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.542 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.33 129.53 35.36 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.677 -0.639 . . . . 0.0 109.747 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.3 t -112.42 -30.41 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.697 -0.627 . . . . 0.0 109.749 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -168.59 158.69 9.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.04 -1.038 . . . . 0.0 109.108 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.05 156.83 5.61 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.33 -168.79 1.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -1.126 . . . . 0.0 109.35 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.31 -135.75 3.5 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.9 mt -144.74 162.91 35.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -1.138 . . . . 0.0 109.602 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -136.83 89.6 2.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 109.455 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.48 108.68 13.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.428 -0.795 . . . . 0.0 109.904 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.2 mp -115.71 114.13 24.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.289 -0.882 . . . . 0.0 109.118 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.442 ' NE2' ' O ' ' A' ' 118' ' ' GLY . 11.1 t-160 -102.89 109.9 21.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.046 -1.034 . . . . 0.0 109.476 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.2 mt -125.59 111.79 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.281 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.442 ' O ' ' NE2' ' A' ' 116' ' ' HIS . . . 75.45 -142.92 29.78 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 106.427 -2.669 . . . . 0.0 106.427 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.49 ' CG ' ' O ' ' A' ' 119' ' ' ASP . 48.2 p-10 -103.48 79.09 1.66 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 114.909 -2.716 . . . . 0.0 109.167 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.438 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 24.0 tp10 -166.29 167.28 16.13 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.474 -1.391 . . . . 0.0 107.781 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.427 ' H ' ' HG3' ' A' ' 120' ' ' GLU . 57.3 t -128.52 147.06 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.809 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -123.94 131.4 53.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.771 -0.581 . . . . 0.0 109.714 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -126.65 106.66 9.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -0.949 . . . . 0.0 108.905 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.01 136.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.2 tt -136.53 91.57 2.67 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.937 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 20.0 p -166.16 136.37 3.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.598 -1.314 . . . . 0.0 108.468 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.507 ' CD ' ' O ' ' A' ' 127' ' ' GLU . 3.4 tm-20 -107.23 93.95 4.83 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 115.819 -2.352 . . . . 0.0 110.884 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.574 ' C ' ' H ' ' A' ' 130' ' ' ASP . 30.4 mttp -114.5 155.55 26.21 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.755 176.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.667 ' ND2' HE21 ' A' ' 39' ' ' GLN . 12.6 p30 -55.71 -5.15 0.13 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.229 -1.544 . . . . 0.0 107.928 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 128' ' ' LYS . 43.4 p-10 -72.21 150.3 43.82 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.881 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.527 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 3.0 pp -119.03 161.58 20.0 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.753 0.787 . . . . 0.0 110.547 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 17.0 tt -134.84 125.57 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.2 t -120.21 135.84 54.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 0.0 109.444 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.7 m -95.99 148.02 33.88 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.303 -0.873 . . . . 0.0 108.821 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.04 154.9 71.49 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.239 1.96 . . . . 0.0 112.621 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.613 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.93 136.34 46.82 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.613 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 5.7 t-80 91.67 11.12 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.92 126.61 30.67 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.32 131.63 30.82 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.621 1.547 . . . . 0.0 111.449 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.566 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.94 167.66 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.132 -0.98 . . . . 0.0 110.064 -179.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.501 ' CE3' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -138.41 -150.07 0.32 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.269 -0.895 . . . . 0.0 109.52 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.668 ' O ' ' CD2' ' A' ' 92' ' ' PHE . 76.9 t80 -174.95 122.93 0.24 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.893 -1.129 . . . . 0.0 109.034 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.594 ' OD2' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -139.29 134.06 32.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.321 -0.862 . . . . 0.0 110.186 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.622 ' O ' ' C ' ' A' ' 145' ' ' GLY . 4.0 mtp -113.42 20.65 15.9 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.667 -0.646 . . . . 0.0 110.569 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.622 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 5.17 -83.83 0.0 OUTLIER Glycine 0 N--CA 1.503 3.13 0 CA-C-N 119.155 0.889 . . . . 0.0 111.62 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.525 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 22.2 p -87.81 118.8 27.58 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.001 -1.48 . . . . 0.0 109.019 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -112.85 109.68 52.52 Favored Pre-proline 0 C--N 1.292 -1.911 0 C-N-CA 119.514 -0.875 . . . . 0.0 109.054 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.809 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 58.3 Cg_endo -100.06 20.44 0.27 Allowed 'Trans proline' 0 C--O 1.195 -1.629 0 C-N-CA 123.147 2.565 . . . . 0.0 112.129 176.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.888 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 0.0 OUTLIER 90.39 69.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 123.533 1.635 . . . . 0.0 110.14 -176.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 14.2 p90 -89.21 167.44 13.09 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 118.986 -2.322 . . . . 0.0 110.278 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.6 m -131.41 118.69 20.61 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.734 -177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.75 163.71 33.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.505 -0.747 . . . . 0.0 109.041 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.438 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 36.8 mt -110.81 131.18 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.335 -0.853 . . . . 0.0 109.914 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.569 ' NH1' ' O ' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -133.51 161.1 35.5 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.118 -0.988 . . . . 0.0 108.885 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.569 ' O ' ' NH1' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -104.1 146.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.544 -0.722 . . . . 0.0 109.087 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.448 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.7 m-30 -95.97 119.67 34.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.025 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.414 ' HB3' ' CZ2' ' A' ' 162' ' ' TRP . 24.3 t70 -134.65 160.8 36.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.845 -0.535 . . . . 0.0 109.654 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.575 ' N ' ' ND2' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -96.21 161.0 28.56 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 109.172 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.4 Cg_endo -67.89 -54.03 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.564 2.176 . . . . 0.0 111.859 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 159' ' ' PRO . 98.1 mt-10 -42.91 -20.21 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.86 -36.64 7.68 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.558 ' N ' ' O ' ' A' ' 159' ' ' PRO . 45.9 m0 -97.06 165.28 12.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.36 -1.082 . . . . 0.0 110.266 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 21.0 mm -99.1 153.5 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.306 -0.871 . . . . 0.0 109.386 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.76 -72.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.163 -0.96 . . . . 0.0 110.404 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -141.07 153.43 45.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -0.919 . . . . 0.0 109.796 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.32 -41.65 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.249 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.61 -31.29 8.54 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.42 -8.17 62.15 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -80.79 148.24 30.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.686 -1.479 . . . . 0.0 108.591 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.53 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 47.4 p30 -111.02 87.82 2.63 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 117.536 -1.666 . . . . 0.0 111.514 175.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.6 tt -78.37 -17.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 119.968 -1.707 . . . . 0.0 109.352 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.569 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -61.68 -40.45 95.03 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.71 -0.619 . . . . 0.0 109.338 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.596 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 53.9 p -53.43 -3.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.569 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.09 -39.9 28.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.947 -1.096 . . . . 0.0 111.362 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.622 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 7.0 m-85 -111.47 24.8 0.08 OUTLIER Pre-proline 0 N--CA 1.514 2.749 0 O-C-N 120.791 -1.193 . . . . 0.0 112.482 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 53.8 Cg_endo -65.26 -19.62 62.23 Favored 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 123.399 2.732 . . . . 0.0 113.129 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -89.03 125.54 35.04 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.043 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.561 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 1.5 tp -88.44 118.93 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.42 -0.8 . . . . 0.0 109.236 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.566 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.624 ' O ' ' OG1' ' A' ' 19' ' ' THR . 10.5 p . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.16 171.24 8.58 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.191 -0.943 . . . . 0.0 109.142 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 tp -158.97 115.84 2.72 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -109.14 139.23 44.32 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.151 -0.968 . . . . 0.0 110.149 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.404 ' CG2' ' O ' ' A' ' 121' ' ' VAL . 45.0 mt -132.99 132.26 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.06 165.03 20.26 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 p -84.99 174.04 10.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.149 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.62 -31.23 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.096 -1.003 . . . . 0.0 109.362 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 tttp -74.13 -37.94 63.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.184 -0.948 . . . . 0.0 110.532 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.85 124.11 14.18 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.005 -1.059 . . . . 0.0 109.537 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.78 -30.06 1.52 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.922 1.748 . . . . 0.0 112.308 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.657 ' NE2' HD21 ' A' ' 13' ' ' ASN . 5.4 pp0? -69.85 4.69 1.86 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.461 -0.774 . . . . 0.0 110.358 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.657 HD21 ' NE2' ' A' ' 12' ' ' GLN . 0.5 OUTLIER -117.83 119.12 33.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.052 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -97.67 126.17 42.85 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.135 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.83 -8.35 46.85 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.94 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.715 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 33.2 t90 -157.47 103.91 1.98 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.276 -1.37 . . . . 0.0 110.587 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -117.47 109.24 16.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.536 -0.727 . . . . 0.0 109.413 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.452 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -163.89 163.95 23.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.261 -0.9 . . . . 0.0 109.724 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.624 ' OG1' ' O ' ' A' ' 1' ' ' SER . 9.9 t -131.47 90.69 2.89 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.508 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.547 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.6 OUTLIER -124.5 146.94 48.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.221 -0.925 . . . . 0.0 110.479 177.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.99 -39.49 23.53 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.266 -1.521 . . . . 0.0 108.423 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -82.86 -48.57 10.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.624 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -59.94 -25.07 64.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.086 -1.009 . . . . 0.0 108.42 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.547 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 13.0 mt -72.38 -50.81 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.025 -1.047 . . . . 0.0 108.999 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 29' ' ' ASN . 23.1 tm0? -62.06 -51.92 66.02 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.287 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -61.21 -40.3 93.47 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.235 -0.916 . . . . 0.0 109.732 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.715 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 5.2 tt0 -75.07 -50.8 15.27 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.062 -1.024 . . . . 0.0 109.478 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.3 tp -70.45 -56.18 7.23 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.847 -1.158 . . . . 0.0 109.832 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 11.5 t-20 -57.1 -19.9 22.34 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.776 -1.202 . . . . 0.0 109.286 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.5 -27.99 67.46 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.796 -1.19 . . . . 0.0 108.637 177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -86.42 12.54 10.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.141 -0.974 . . . . 0.0 109.604 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.24 21.58 32.16 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.185 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.55 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 47.9 t -92.71 146.54 6.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.384 -1.068 . . . . 0.0 109.348 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.1 ttt85 -82.49 156.87 23.82 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -155.21 155.46 33.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.815 -1.178 . . . . 0.0 108.354 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.476 ' OE2' ' N ' ' A' ' 37' ' ' ARG . 1.3 mm-40 -175.42 174.73 2.27 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.051 -1.031 . . . . 0.0 109.3 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.476 ' N ' ' OE2' ' A' ' 36' ' ' GLU . 74.4 mtm-85 -151.93 112.95 4.24 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.529 ' H ' HD21 ' A' ' 129' ' ' ASN . 34.2 m0 -110.73 151.52 27.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.124 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.574 ' NE2' ' OD1' ' A' ' 129' ' ' ASN . 82.0 mm-40 -138.49 154.35 48.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.908 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.93 158.34 16.06 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -101.28 -9.09 21.53 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.2 mtp85 -92.91 155.0 17.86 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.792 0.806 . . . . 0.0 109.216 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -93.25 118.98 31.89 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.569 -0.707 . . . . 0.0 109.524 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.12 161.89 14.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.774 0.797 . . . . 0.0 109.488 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.32 -99.26 0.15 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.98 92.63 4.97 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.134 -1.215 . . . . 0.0 109.483 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.27 92.02 30.33 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.434 -0.791 . . . . 0.0 109.008 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.42 -28.27 7.07 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.314 2.01 . . . . 0.0 112.613 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.6 p -119.57 141.86 48.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.619 -0.675 . . . . 0.0 109.594 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.34 -16.71 53.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.471 -0.768 . . . . 0.0 109.432 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -50.56 -37.49 39.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 109.06 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.5 m -78.64 -33.39 47.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 109.484 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.66 -52.41 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.352 -0.843 . . . . 0.0 110.273 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 58' ' ' GLN . 6.4 mt -59.21 -40.01 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.046 -1.034 . . . . 0.0 108.836 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.34 -32.13 69.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.367 -0.833 . . . . 0.0 109.479 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.416 ' O ' ' CD2' ' A' ' 59' ' ' HIS . . . -74.67 -14.59 60.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.937 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -117.14 -9.4 11.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.0 109.588 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 62' ' ' ASP . 5.8 mm-40 -50.86 -39.75 54.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.102 -0.998 . . . . 0.0 109.07 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.453 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 20.0 p80 -51.71 -46.1 63.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.453 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -60.39 -59.24 5.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.988 -1.07 . . . . 0.0 109.703 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.484 ' CD1' ' C ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -64.48 -28.54 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.717 -1.239 . . . . 0.0 109.364 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 58' ' ' GLN . 24.7 t70 -55.56 -25.09 36.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.372 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -84.36 -37.22 21.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 109.556 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -46.73 74.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.31 -0.869 . . . . 0.0 109.497 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 69' ' ' GLY . 1.1 p -70.03 -30.45 44.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.394 -0.816 . . . . 0.0 109.633 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.54 -46.29 66.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.152 -0.967 . . . . 0.0 109.484 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -77.6 -48.92 15.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.103 -0.998 . . . . 0.0 109.647 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.653 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -85.22 13.75 6.01 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.448 -0.782 . . . . 0.0 110.16 -177.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.653 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -1.46 84.08 0.0 OUTLIER Glycine 0 N--CA 1.502 3.053 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.468 ' CG ' ' CG2' ' A' ' 155' ' ' ILE . 20.3 m-85 -77.06 164.53 25.64 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.21 -1.171 . . . . 0.0 109.446 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -59.85 -43.11 94.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.57 -0.706 . . . . 0.0 110.222 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.27 165.65 36.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.991 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.708 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 6.6 t-105 -135.6 139.4 43.81 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.388 -0.82 . . . . 0.0 109.165 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.461 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -160.08 178.4 9.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.3 t -117.91 141.69 35.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 pt -100.42 116.97 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -174.59 106.7 0.11 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.113 -0.992 . . . . 0.0 109.69 177.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.552 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -101.38 179.99 4.2 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 120.9 1.682 . . . . 0.0 109.052 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' ASP . 9.4 tpt180 -88.81 146.25 25.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.968 -1.083 . . . . 0.0 109.386 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.9 0.38 0.15 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 109.489 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ARG . 23.9 t70 -91.58 -27.13 18.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.175 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.717 HD22 ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -63.52 122.14 74.43 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 120.911 -1.118 . . . . 0.0 109.437 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -83.78 -5.07 10.69 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.159 1.906 . . . . 0.0 112.385 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -86.39 3.02 45.46 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.653 -1.28 . . . . 0.0 109.428 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.717 ' N ' HD22 ' A' ' 82' ' ' ASN . 29.3 tptt -61.08 -46.61 89.94 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.176 -0.952 . . . . 0.0 109.134 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.601 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 15.9 mm-40 -59.85 -50.04 75.33 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.758 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.53 -41.49 88.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.889 . . . . 0.0 109.475 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.08 -55.09 32.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.96 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.601 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 7.4 ptt-85 -64.26 -20.14 65.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.97 -60.57 2.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.863 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -56.28 -37.44 69.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.107 -0.996 . . . . 0.0 109.538 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -72.45 -18.7 61.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 109.719 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.498 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 0.4 OUTLIER -62.33 -26.3 68.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.666 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -48.74 145.9 3.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.918 . . . . 0.0 109.928 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 96' ' ' HIS . 55.1 tt0 -76.54 157.27 32.2 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.5 -0.75 . . . . 0.0 110.095 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.423 ' N ' ' CG ' ' A' ' 95' ' ' GLU . 46.0 p-80 -172.17 -170.6 0.75 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.736 -1.185 . . . . 0.0 111.978 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.8 t -163.01 137.69 6.42 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.689 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.85 155.4 20.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.545 -178.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.66 -5.56 86.3 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 101' ' ' ASP . 23.8 tp10 -124.52 168.49 13.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.378 -1.072 . . . . 0.0 109.221 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 88.5 m-20 -74.52 143.43 44.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.117 . . . . 0.0 110.106 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.424 ' HG3' ' CE1' ' A' ' 98' ' ' HIS . 2.2 mt-10 -101.08 90.37 4.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.12 -0.987 . . . . 0.0 108.491 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.41 ' CG1' ' OG ' ' A' ' 133' ' ' SER . 15.7 m -85.86 130.26 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.693 -0.629 . . . . 0.0 110.138 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.696 ' NE ' HH21 ' A' ' 154' ' ' ARG . 41.0 ttm105 -131.03 128.29 40.02 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.458 -0.777 . . . . 0.0 109.598 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.498 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 36.9 t80 -106.1 129.15 54.24 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.65 129.9 36.02 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.488 -0.757 . . . . 0.0 110.395 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.4 t -115.2 -27.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.651 -0.656 . . . . 0.0 109.672 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -166.29 153.06 9.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.395 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.96 154.25 25.64 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -137.45 165.83 25.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.191 -1.182 . . . . 0.0 108.944 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.34 152.97 10.09 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.423 ' O ' ' CD1' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -99.72 98.61 9.43 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.047 -1.267 . . . . 0.0 110.256 -179.135 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 114' ' ' CYS . 2.3 t80 -84.4 135.02 34.44 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.873 -1.142 . . . . 0.0 109.715 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.568 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -77.77 117.68 19.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.431 0.634 . . . . 0.0 109.815 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 122' ' ' PHE . 2.2 mt -106.71 123.11 47.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 7.0 t-160 -105.53 106.97 17.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.156 -0.965 . . . . 0.0 109.602 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.95 109.34 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.956 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.34 -144.37 31.76 Favored Glycine 0 N--CA 1.502 3.092 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -100.5 78.27 2.0 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 114.891 -2.724 . . . . 0.0 109.521 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 1.6 mt-10 -167.04 171.94 10.6 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.404 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 78.6 t -125.14 140.76 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.076 -1.015 . . . . 0.0 109.907 177.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 115' ' ' LEU . 26.4 m-85 -122.72 128.51 50.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.7 -0.625 . . . . 0.0 110.364 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' THR . 32.6 mm-40 -119.97 104.62 10.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -100.58 133.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tt -133.34 87.57 2.4 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.107 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.616 ' SG ' ' O ' ' A' ' 126' ' ' CYS . 16.8 p -167.88 122.42 0.97 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.47 100.0 9.58 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 116.384 -2.127 . . . . 0.0 110.352 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.62 ' C ' ' H ' ' A' ' 130' ' ' ASP . 1.5 mmmt -117.24 166.02 12.76 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.19 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.574 ' OD1' ' NE2' ' A' ' 39' ' ' GLN . 0.7 OUTLIER -58.62 -0.31 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 128' ' ' LYS . 53.6 p-10 -69.52 139.14 53.8 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.862 -1.149 . . . . 0.0 109.819 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.45 HD13 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -91.28 123.18 34.52 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.884 0.849 . . . . 0.0 109.586 -178.112 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.45 ' N ' HD13 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -115.11 112.18 38.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.41 ' OG ' ' CG1' ' A' ' 103' ' ' VAL . 9.4 t -120.74 151.68 39.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.391 -0.818 . . . . 0.0 109.168 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.72 137.79 20.88 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.564 ' O ' ' OG1' ' A' ' 138' ' ' THR . 36.6 Cg_endo -61.99 154.95 58.41 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.977 1.785 . . . . 0.0 113.46 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -74.85 136.35 41.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.347 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.619 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 24.4 t60 94.77 9.21 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.564 ' OG1' ' O ' ' A' ' 135' ' ' PRO . 0.2 OUTLIER -104.48 127.39 29.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.164 179.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.7 132.03 31.45 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.64 1.56 . . . . 0.0 111.678 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.529 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.0 163.9 9.43 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.142 -179.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.566 ' O ' ' CZ ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -135.3 -148.15 0.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.122 -0.986 . . . . 0.0 109.567 -178.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.68 ' CD1' ' NH2' ' A' ' 154' ' ' ARG . 90.1 t80 -176.42 127.54 0.2 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.962 -1.087 . . . . 0.0 109.281 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.499 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 43.3 p30 -148.2 137.52 22.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -0.871 . . . . 0.0 109.785 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.593 ' O ' ' C ' ' A' ' 145' ' ' GLY . 4.2 mmt -112.59 19.09 17.82 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.451 -0.781 . . . . 0.0 111.122 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.593 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 9.78 -88.12 0.0 OUTLIER Glycine 0 N--CA 1.507 3.395 0 CA-C-N 119.155 0.889 . . . . 0.0 111.922 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.471 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 22.9 p -89.0 119.62 29.68 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.253 -1.379 . . . . 0.0 109.6 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.559 ' CG ' ' O ' ' A' ' 147' ' ' GLU . 8.4 pt-20 -109.14 117.13 54.16 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.621 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 57.2 Cg_endo -102.42 25.48 0.12 Allowed 'Trans proline' 0 N--CA 1.48 0.731 0 C-N-CA 122.361 2.041 . . . . 0.0 111.363 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 80.73 69.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.96 -177.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.479 ' O ' ' CB ' ' A' ' 77' ' ' SER . 20.9 p90 -94.68 -178.21 4.46 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.488 -0.758 . . . . 0.0 109.084 -177.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 86.1 m -148.3 95.9 2.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.543 -0.723 . . . . 0.0 109.988 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -110.47 163.5 13.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.988 -1.07 . . . . 0.0 108.787 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.708 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 25.6 mt -111.57 129.7 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.696 HH21 ' NE ' ' A' ' 104' ' ' ARG . 63.0 mtt180 -138.91 168.32 20.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 110.063 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.468 ' CG2' ' CG ' ' A' ' 70' ' ' TYR . 4.2 mp -105.41 147.87 10.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.642 -0.661 . . . . 0.0 109.667 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.461 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.6 m-30 -95.79 117.75 31.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.545 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.602 ' OD2' ' NE1' ' A' ' 162' ' ' TRP . 17.9 t0 -136.46 160.75 37.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.842 -0.536 . . . . 0.0 109.771 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.52 160.65 29.06 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.176 -0.953 . . . . 0.0 109.106 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.4 Cg_endo -66.56 -50.86 1.14 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.883 2.388 . . . . 0.0 112.306 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 159' ' ' PRO . 96.1 mt-10 -43.34 -20.77 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.481 -0.762 . . . . 0.0 109.073 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -87.75 -42.15 6.15 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.602 ' NE1' ' OD2' ' A' ' 157' ' ' ASP . 45.8 m0 -96.17 166.49 11.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.293 -1.122 . . . . 0.0 109.888 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.3 mm -98.23 148.39 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 109.666 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 96' ' ' HIS . . . -79.09 -71.57 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.096 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -135.42 155.89 49.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.244 -0.91 . . . . 0.0 109.659 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -101.3 -41.1 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.635 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.452 ' HG1' ' N ' ' A' ' 168' ' ' GLY . 60.2 p -108.09 -30.43 8.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.21 -0.931 . . . . 0.0 109.198 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.452 ' N ' ' HG1' ' A' ' 167' ' ' THR . . . 101.75 -8.28 56.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -80.65 148.04 30.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.887 -1.36 . . . . 0.0 108.451 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.503 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 34.6 p30 -111.03 87.55 2.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.966 -1.493 . . . . 0.0 111.122 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.7 tt -78.09 -17.39 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.261 -1.524 . . . . 0.0 109.486 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.558 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -60.2 -41.43 92.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.591 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 59.6 p -53.51 -3.72 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 110.283 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.25 -40.21 31.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.004 . . . . 0.0 111.279 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.612 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 5.8 m-85 -112.63 24.96 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.623 0 O-C-N 120.575 -1.328 . . . . 0.0 112.471 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 44.3 Cg_endo -62.16 -18.82 64.14 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 123.71 2.94 . . . . 0.0 113.75 -172.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.0 ttm-85 -89.11 125.85 35.2 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.363 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.471 ' HB3' ' H ' ' A' ' 146' ' ' SER . 4.5 tt -88.38 123.44 32.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.213 -0.929 . . . . 0.0 109.194 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.656 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.395 -179.829 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.473 ' O ' ' CG2' ' A' ' 19' ' ' THR . 6.4 p . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.96 171.06 8.52 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.881 -1.137 . . . . 0.0 109.053 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 tp -158.99 116.94 2.85 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.83 133.47 53.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.64 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.7 mt -128.16 134.83 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -126.59 168.02 14.86 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m -85.23 174.24 9.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.234 -0.916 . . . . 0.0 108.981 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -28.3 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.954 -1.091 . . . . 0.0 109.415 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -76.69 -34.7 58.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.55 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.39 124.08 14.69 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.202 -0.936 . . . . 0.0 109.429 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.55 -36.85 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.119 1.879 . . . . 0.0 112.347 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.53 3.99 2.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 110.235 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -111.9 119.05 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.418 -0.801 . . . . 0.0 109.211 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -99.41 120.97 40.46 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.379 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -91.32 -4.01 56.25 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.171 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.657 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 41.8 t90 -156.8 104.44 2.13 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 118.433 -1.307 . . . . 0.0 110.542 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -119.07 112.18 19.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.541 -0.725 . . . . 0.0 109.57 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.568 ' OG ' ' CH2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -161.45 163.7 30.26 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.262 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 1' ' ' SER . 45.4 m -131.38 89.56 2.74 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.938 -1.102 . . . . 0.0 108.35 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.55 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 31.0 m120 -127.83 142.23 51.35 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.425 -0.797 . . . . 0.0 110.37 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.13 -37.86 23.17 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.303 -1.498 . . . . 0.0 108.337 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -83.67 -50.64 7.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.855 . . . . 0.0 109.751 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.46 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.2 tt0 -59.13 -21.73 59.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.107 -0.996 . . . . 0.0 108.754 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.55 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 11.2 mt -76.09 -49.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.13 -0.981 . . . . 0.0 109.207 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.717 HE21 ' ND2' ' A' ' 29' ' ' ASN . 24.4 tm0? -59.68 -44.8 93.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.777 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -38.58 73.42 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.243 -0.91 . . . . 0.0 109.344 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.657 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 6.5 tt0 -77.0 -49.81 14.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 110.252 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 24' ' ' ILE . 12.2 tp -62.07 -54.52 40.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.015 -1.053 . . . . 0.0 108.857 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.717 ' ND2' HE21 ' A' ' 25' ' ' GLN . 1.1 m-20 -61.95 -16.45 51.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.905 -1.122 . . . . 0.0 109.856 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.77 -30.07 71.17 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.63 -1.294 . . . . 0.0 108.845 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.96 11.09 12.23 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.009 -1.076 . . . . 0.0 109.558 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.46 25.01 31.84 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.2 t -95.47 145.99 7.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 122.018 0.913 . . . . 0.0 109.471 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -84.32 156.87 21.7 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 121.346 -0.846 . . . . 0.0 108.855 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.558 ' CB ' HD22 ' A' ' 29' ' ' ASN . 1.8 t80 -154.12 149.63 27.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.913 -1.117 . . . . 0.0 109.041 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -169.79 167.78 9.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.006 -1.059 . . . . 0.0 109.866 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.474 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 18.8 ptt-85 -151.82 115.91 4.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.425 -0.797 . . . . 0.0 109.139 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.507 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 11.7 m0 -113.22 157.31 21.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.17 166.39 25.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.678 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.93 162.19 13.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.366 -0.834 . . . . 0.0 108.932 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -94.49 -26.02 16.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.123 -0.986 . . . . 0.0 108.695 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -94.85 172.98 7.83 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -89.86 131.59 35.71 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.368 -0.833 . . . . 0.0 108.993 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.4 mt -92.97 167.95 11.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.239 -0.913 . . . . 0.0 109.812 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.78 -94.28 0.11 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.45 107.47 7.6 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.33 -1.1 . . . . 0.0 108.166 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.4 90.44 45.31 Favored Pre-proline 0 C--N 1.302 -1.494 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.677 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -83.71 40.92 0.96 Allowed 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.795 2.33 . . . . 0.0 111.221 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.1 m -166.24 138.11 3.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.61 -1.306 . . . . 0.0 109.457 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.443 ' C ' ' H ' ' A' ' 52' ' ' THR . . . -82.64 -51.78 7.42 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.905 -1.122 . . . . 0.0 110.262 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.15 -0.68 1.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.422 -0.799 . . . . 0.0 109.75 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.443 ' H ' ' C ' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -77.08 -56.82 4.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 109.806 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.19 -45.53 96.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 O-C-N 121.137 -0.977 . . . . 0.0 109.579 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.4 mt -59.82 -41.07 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.274 -0.97 . . . . 0.0 108.807 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.87 -24.16 67.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.351 -0.843 . . . . 0.0 109.788 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.04 -21.48 56.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.047 -1.033 . . . . 0.0 110.323 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 58' ' ' GLN . 57.0 m-85 -112.28 -6.54 14.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.384 -0.822 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 62' ' ' ASP . 5.5 mm-40 -45.85 -39.05 8.02 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.743 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -50.81 -48.04 59.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.909 -1.116 . . . . 0.0 109.634 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.607 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.37 -60.77 3.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.01 -1.056 . . . . 0.0 110.309 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.459 ' CD1' ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -62.6 -29.71 47.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 120.751 -1.218 . . . . 0.0 109.184 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 58' ' ' GLN . 45.5 t0 -54.85 -27.62 43.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.805 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -77.82 -37.41 48.68 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.018 -1.051 . . . . 0.0 109.812 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 9.6 mp -63.98 -39.22 93.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.126 -0.984 . . . . 0.0 109.865 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.51 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -69.24 -29.06 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 0.0 108.924 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.02 -54.12 47.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.474 -1.391 . . . . 0.0 109.297 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.42 -52.47 5.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.254 -0.904 . . . . 0.0 110.954 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.624 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -86.86 14.53 7.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 110.596 -177.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -15.54 89.31 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.49 ' N ' ' O ' ' A' ' 68' ' ' LYS . 87.4 m-85 -77.58 164.78 25.05 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -58.56 -88.01 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 109.949 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.52 ' OG ' ' CG ' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -101.26 159.72 15.01 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.568 -0.707 . . . . 0.0 109.618 -179.064 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -136.29 140.04 43.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.496 -0.753 . . . . 0.0 109.139 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.1 -173.47 2.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 108.775 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.9 m -122.99 148.45 26.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.513 -0.742 . . . . 0.0 109.587 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.8 tt -100.89 118.09 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 150' ' ' PHE . 91.8 p -171.83 103.79 0.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.604 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.567 ' CD1' ' H ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -105.39 -178.38 3.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 121.078 1.763 . . . . 0.0 108.209 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.609 ' C ' ' H ' ' A' ' 81' ' ' ASP . 8.2 tpt180 -89.45 148.77 23.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.891 -1.131 . . . . 0.0 109.528 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.41 3.91 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.615 -0.678 . . . . 0.0 109.641 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.609 ' H ' ' C ' ' A' ' 79' ' ' ARG . 80.5 m-20 -92.16 -24.11 19.19 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.922 -1.111 . . . . 0.0 109.34 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.728 HD22 ' HZ2' ' A' ' 85' ' ' LYS . 27.7 p-10 -60.63 118.07 31.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.83 -1.169 . . . . 0.0 109.586 -178.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -88.57 -23.77 0.98 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.241 1.96 . . . . 0.0 112.501 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -91.93 -14.8 28.97 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.919 -1.113 . . . . 0.0 109.945 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.728 ' HZ2' HD22 ' A' ' 82' ' ' ASN . 0.0 OUTLIER -60.89 -35.75 77.44 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.794 178.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 96.9 mt-10 -57.17 -40.57 77.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.133 -0.979 . . . . 0.0 108.491 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.41 -27.29 68.43 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.792 -1.193 . . . . 0.0 109.154 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.6 tp -60.67 -47.61 85.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -0.948 . . . . 0.0 109.989 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -64.58 -27.66 69.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.108 -0.995 . . . . 0.0 109.285 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.07 -60.74 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.394 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -58.33 -35.07 71.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.08 -1.013 . . . . 0.0 109.19 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -79.77 -18.35 51.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.414 -0.803 . . . . 0.0 109.956 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 94' ' ' ASN . 0.3 OUTLIER -60.75 -26.49 67.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.49 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 94' ' ' ASN . 32.5 p-10 -46.27 135.22 8.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.293 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.68 159.33 13.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 0.0 109.871 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -171.9 -169.73 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.763 -1.175 . . . . 0.0 111.965 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.81 130.98 4.47 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.549 0.69 . . . . 0.0 109.364 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.621 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -100.67 154.37 18.65 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.625 -0.672 . . . . 0.0 109.716 -179.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.11 -7.98 87.52 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -123.4 170.98 9.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -1.112 . . . . 0.0 109.286 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -74.07 143.06 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.973 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.599 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 5.0 tt0 -103.49 90.02 3.55 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.405 ' CG2' ' OG ' ' A' ' 133' ' ' SER . 26.1 t -85.7 127.06 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.286 -0.884 . . . . 0.0 109.714 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 115.49 17.29 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.501 -0.749 . . . . 0.0 109.617 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.65 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 10.9 t80 -99.94 132.19 45.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 108.612 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.566 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.8 OUTLIER -91.08 135.47 33.74 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.364 0.602 . . . . 0.0 109.939 -179.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.0 t -116.84 -26.97 2.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.371 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 109' ' ' GLY . 73.7 tt0 -169.12 158.02 8.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.155 -0.965 . . . . 0.0 108.949 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 108' ' ' GLU . . . 48.37 107.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.416 ' CB ' ' CE2' ' A' ' 106' ' ' PHE . . . -151.8 112.33 4.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.649 -1.501 . . . . 0.0 109.574 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.93 -141.97 4.36 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 124' ' ' VAL . 0.5 OUTLIER -108.9 100.42 9.63 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.329 -1.101 . . . . 0.0 110.851 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.659 ' CD2' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.47 132.12 36.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.934 -1.104 . . . . 0.0 110.043 -178.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 9.8 m -78.46 154.7 30.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.554 -0.716 . . . . 0.0 110.148 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 122' ' ' PHE . 1.1 tp -145.28 121.0 10.51 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.5 t-160 -111.48 111.15 21.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.224 -0.923 . . . . 0.0 109.677 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.46 113.85 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.744 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.49 -145.14 35.3 Favored Glycine 0 N--CA 1.503 3.15 0 N-CA-C 106.146 -2.782 . . . . 0.0 106.146 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -100.73 77.74 1.91 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 114.581 -2.848 . . . . 0.0 109.688 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.59 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 1.5 mt-10 -166.6 170.0 13.09 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 120.949 -1.095 . . . . 0.0 108.064 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 50.7 t -126.56 140.34 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.573 ' O ' ' N ' ' A' ' 115' ' ' LEU . 2.3 m-85 -126.95 130.71 50.61 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.601 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -131.23 110.14 10.91 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.444 -0.785 . . . . 0.0 109.134 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -98.52 138.22 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.496 ' CD1' ' N ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.8 88.13 2.68 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.425 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.522 ' SG ' ' O ' ' A' ' 126' ' ' CYS . 5.2 p -167.89 136.11 2.37 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.291 -1.506 . . . . 0.0 107.216 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -104.42 96.8 6.86 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 115.292 -2.563 . . . . 0.0 110.05 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.586 ' C ' ' H ' ' A' ' 130' ' ' ASP . 24.5 mmtt -116.75 157.48 25.43 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.324 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.65 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 40.3 m-80 -58.38 -2.11 0.18 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.586 ' H ' ' C ' ' A' ' 128' ' ' LYS . 17.2 m-20 -70.47 147.32 49.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.108 -0.995 . . . . 0.0 109.303 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.533 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 0.8 OUTLIER -111.31 154.66 24.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.605 0.717 . . . . 0.0 110.448 -179.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 29.1 mm -116.65 118.73 59.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.405 ' OG ' ' CG2' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -111.03 129.82 55.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.545 -0.722 . . . . 0.0 109.285 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.48 141.75 23.19 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.06 153.66 71.79 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.058 1.839 . . . . 0.0 112.347 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.623 ' O ' ' CG ' ' A' ' 137' ' ' HIS . . . -71.06 135.45 47.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -0.85 . . . . 0.0 108.895 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.623 ' CG ' ' O ' ' A' ' 136' ' ' ALA . 2.6 m170 89.83 14.95 0.05 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.094 0.473 . . . . 0.0 110.004 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.39 127.21 28.66 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.53 131.65 32.53 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.924 1.749 . . . . 0.0 111.513 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.08 163.09 9.19 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.245 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.449 ' CE3' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -134.52 -148.7 0.32 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.933 . . . . 0.0 109.542 -178.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.42 ' H ' ' HB2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -176.78 126.45 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.937 -1.102 . . . . 0.0 109.196 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.479 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 37.2 p-10 -144.58 134.28 23.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.429 -0.794 . . . . 0.0 109.686 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.671 ' N ' ' SD ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -112.96 19.13 17.55 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.614 -0.679 . . . . 0.0 110.44 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 13.18 -93.13 0.01 OUTLIER Glycine 0 N--CA 1.501 3.02 0 CA-C-N 119.216 0.916 . . . . 0.0 111.663 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.442 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 19.4 p -84.53 119.56 25.32 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.259 -1.376 . . . . 0.0 108.924 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -113.71 112.23 48.27 Favored Pre-proline 0 C--N 1.294 -1.847 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.093 178.447 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.8 Cg_endo -103.52 34.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 123.326 2.684 . . . . 0.0 111.542 176.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 81.56 69.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.529 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 9.0 p90 -95.67 135.89 36.78 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.064 -1.023 . . . . 0.0 109.944 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.7 m -97.73 119.72 36.82 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.779 -0.575 . . . . 0.0 109.686 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.45 159.96 41.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 109.266 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.1 mt -108.69 125.97 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.513 -0.742 . . . . 0.0 110.086 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -132.5 160.72 35.69 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.575 -0.703 . . . . 0.0 109.713 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -108.39 156.91 8.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.416 0.627 . . . . 0.0 109.478 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.52 ' CG ' ' OG ' ' A' ' 72' ' ' SER . 4.5 m-85 -100.51 119.75 38.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.053 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 12.2 p30 -134.55 159.22 41.85 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -98.32 146.76 32.1 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.985 -1.072 . . . . 0.0 109.494 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.618 ' O ' ' N ' ' A' ' 161' ' ' GLY . 47.3 Cg_endo -71.37 -52.61 0.21 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.355 2.037 . . . . 0.0 112.048 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -43.54 -14.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.605 -0.685 . . . . 0.0 109.403 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.49 -32.17 38.87 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.634 ' CD1' ' N ' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -118.71 176.09 5.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.599 -0.942 . . . . 0.0 110.469 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 70.8 mt -94.2 145.75 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.306 -0.871 . . . . 0.0 109.277 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.27 -73.14 0.31 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.372 -0.83 . . . . 0.0 110.643 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -120.91 151.15 40.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.367 -0.833 . . . . 0.0 109.854 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.467 ' CD2' ' N ' ' A' ' 166' ' ' PHE . 2.7 p90 -101.54 -40.43 7.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.564 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 m -110.2 -31.15 7.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.315 -0.866 . . . . 0.0 108.977 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.68 -4.94 53.9 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.421 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -82.76 148.67 27.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.749 -1.442 . . . . 0.0 108.926 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.482 ' OD1' ' OG ' ' A' ' 173' ' ' SER . 60.9 t0 -109.83 89.13 2.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 117.925 -1.51 . . . . 0.0 111.058 176.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.09 -22.38 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.489 -1.382 . . . . 0.0 109.366 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.582 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -60.36 -40.55 91.19 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.619 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 24.1 m -51.17 -3.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 110.19 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -77.4 -41.52 39.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.789 -1.194 . . . . 0.0 111.629 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.631 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 1.0 OUTLIER -112.83 25.24 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.607 0 O-C-N 120.772 -1.205 . . . . 0.0 112.27 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 49.6 Cg_endo -62.41 -22.66 74.36 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.722 2.948 . . . . 0.0 113.522 -172.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 177' ' ' ARG . 28.3 ptt85 -89.42 126.45 35.56 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.003 -1.079 . . . . 0.0 108.885 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.56 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 0.6 OUTLIER -87.78 118.68 27.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.262 -0.899 . . . . 0.0 109.022 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.534 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.508 ' O ' ' CG2' ' A' ' 19' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.119 0.485 . . . . 0.0 109.703 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.412 ' HA ' ' HG1' ' A' ' 19' ' ' THR . . . -95.89 171.09 8.85 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.959 -1.097 . . . . 0.0 109.288 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.567 ' CD2' ' CZ3' ' A' ' 16' ' ' TRP . 18.7 tp -157.83 109.36 2.28 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.79 127.09 53.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.51 -0.744 . . . . 0.0 110.523 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.2 mt -120.87 135.62 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.27 169.75 15.02 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.8 p -87.47 173.05 9.34 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.0 -33.37 6.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.084 -1.01 . . . . 0.0 108.874 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -71.72 -37.47 70.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.53 -0.731 . . . . 0.0 110.384 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.14 125.25 14.58 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.98 -1.075 . . . . 0.0 109.634 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -82.26 -30.21 1.28 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.892 1.728 . . . . 0.0 112.266 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -70.22 0.74 5.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.41 -0.806 . . . . 0.0 110.662 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -114.7 118.69 34.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.024 -1.047 . . . . 0.0 108.497 179.168 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -97.13 125.42 41.62 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.846 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.412 ' CD1' HD22 ' A' ' 13' ' ' ASN . 2.6 mp -90.46 -12.25 37.91 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.497 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.687 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 34.7 t90 -159.73 107.41 1.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.222 -1.391 . . . . 0.0 109.939 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -121.09 119.43 32.42 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.09 -1.006 . . . . 0.0 110.332 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.481 ' OG ' ' CH2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -161.02 166.68 27.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.266 -0.897 . . . . 0.0 110.155 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.508 ' CG2' ' O ' ' A' ' 1' ' ' SER . 45.8 m -129.21 86.42 2.43 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.459 ' O ' ' CG1' ' A' ' 24' ' ' ILE . 0.4 OUTLIER -129.45 138.96 51.73 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.794 -0.566 . . . . 0.0 110.369 177.22 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.75 -28.59 30.31 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.592 -1.942 . . . . 0.0 108.905 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -82.95 -53.3 5.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -62.28 -18.76 62.16 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.66 -1.275 . . . . 0.0 107.984 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.459 ' CG1' ' O ' ' A' ' 20' ' ' ASN . 3.0 mt -73.28 -59.14 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.344 -0.847 . . . . 0.0 109.375 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.413 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 21.2 pt20 -58.34 -39.16 78.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.4 ' N ' ' HG3' ' A' ' 25' ' ' GLN . 44.1 tt0 -66.99 -42.64 84.69 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.332 -0.855 . . . . 0.0 109.47 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.687 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -67.2 -46.83 72.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.101 -1.0 . . . . 0.0 109.524 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.95 -53.56 37.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.327 -0.858 . . . . 0.0 109.447 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 17.9 t-20 -64.16 -19.0 65.0 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.58 -0.7 . . . . 0.0 110.573 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.15 71.17 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.535 -1.353 . . . . 0.0 108.164 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -89.38 14.81 10.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.598 -0.689 . . . . 0.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.68 20.38 58.28 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.434 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 21.9 t -93.3 147.09 5.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.277 -1.131 . . . . 0.0 109.078 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.669 ' HE ' ' H ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -83.09 155.59 23.77 Favored 'General case' 0 C--N 1.281 -2.378 0 O-C-N 120.644 -1.285 . . . . 0.0 107.833 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.669 ' H ' ' HE ' ' A' ' 34' ' ' ARG . 2.3 t80 -152.87 147.09 25.59 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 17.0 tp10 -174.35 172.65 3.16 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.592 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.483 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 30.7 ptt-85 -151.95 121.86 7.06 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.115 -0.991 . . . . 0.0 108.732 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.465 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 33.7 m0 -112.75 156.43 22.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.512 -0.742 . . . . 0.0 109.141 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -142.64 157.64 44.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.293 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.71 159.06 15.34 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -98.66 -13.6 20.23 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -93.74 156.97 16.39 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.495 ' O ' ' OD2' ' A' ' 43' ' ' ASP . 46.4 p-10 -95.52 122.23 38.05 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.473 -0.767 . . . . 0.0 109.384 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.8 mt -91.8 165.83 13.07 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.176 -0.952 . . . . 0.0 108.95 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.95 -121.92 0.58 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.13 79.45 9.12 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.086 -1.244 . . . . 0.0 108.497 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.62 93.89 46.65 Favored Pre-proline 0 C--N 1.306 -1.317 0 O-C-N 121.462 -0.773 . . . . 0.0 109.56 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.456 ' O ' ' CG2' ' A' ' 49' ' ' THR . 46.9 Cg_endo -70.2 85.61 0.67 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.084 1.856 . . . . 0.0 111.505 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.525 ' OG1' ' OG1' ' A' ' 52' ' ' THR . 1.5 p -165.05 117.93 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -0.863 . . . . 0.0 109.019 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.43 -36.84 28.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.836 -1.165 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -69.3 -14.92 63.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.943 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.525 ' OG1' ' OG1' ' A' ' 49' ' ' THR . 4.2 p -78.25 -43.67 27.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.051 -1.031 . . . . 0.0 110.89 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 t -67.13 -46.44 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.938 -1.101 . . . . 0.0 109.564 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 58' ' ' GLN . 55.7 mt -61.2 -39.58 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.282 -0.886 . . . . 0.0 108.888 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.22 70.66 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.678 -0.639 . . . . 0.0 109.905 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.85 -21.61 54.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.067 -1.021 . . . . 0.0 110.376 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -114.44 -7.09 12.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.489 -0.757 . . . . 0.0 109.13 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.64 HE21 ' CG1' ' A' ' 61' ' ' ILE . 38.1 tp60 -48.59 -36.93 16.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.242 -0.911 . . . . 0.0 108.546 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.685 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -53.25 -48.84 67.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.043 -1.035 . . . . 0.0 109.941 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.685 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.06 -55.43 32.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.728 -1.232 . . . . 0.0 109.669 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.64 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.5 OUTLIER -65.71 -26.91 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.083 -1.01 . . . . 0.0 109.543 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 58' ' ' GLN . 20.7 t70 -59.2 -25.2 63.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.461 -0.774 . . . . 0.0 109.224 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.7 -43.29 14.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 110.016 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 tt -65.6 -48.46 72.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.307 -0.87 . . . . 0.0 109.819 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' GLY . 3.4 p -66.91 -28.25 42.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.43 -44.21 76.06 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.791 -1.193 . . . . 0.0 109.279 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -80.02 -52.86 7.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.999 -1.063 . . . . 0.0 109.714 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.623 ' O ' ' C ' ' A' ' 69' ' ' GLY . 54.0 mttm -83.08 12.67 4.79 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.401 -0.812 . . . . 0.0 110.685 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -5.63 83.21 0.0 OUTLIER Glycine 0 N--CA 1.506 3.304 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 68' ' ' LYS . 69.6 m-85 -75.66 156.6 34.66 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.433 -1.039 . . . . 0.0 109.88 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -64.82 -49.59 70.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.486 -0.759 . . . . 0.0 110.574 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.9 m -125.27 135.49 52.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.356 -0.84 . . . . 0.0 109.729 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 7.4 t-105 -133.57 138.98 46.29 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.4 -168.87 0.56 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.155 -0.965 . . . . 0.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 t -125.99 155.91 35.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.3 mt -93.88 131.82 39.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.5 p -93.55 167.77 11.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 122.769 1.271 . . . . 0.0 111.839 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.428 HD22 ' H ' ' A' ' 149' ' ' ASN . 10.1 tp -167.78 157.6 10.25 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.497 176.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.99 142.18 51.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.35 -4.79 11.9 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.216 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.426 ' OD2' ' C ' ' A' ' 81' ' ' ASP . 8.5 p-10 -116.64 -8.02 11.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.197 -0.939 . . . . 0.0 109.087 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.468 ' CG ' ' O ' ' A' ' 82' ' ' ASN . 1.6 p30 -62.88 124.72 84.56 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 109.801 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.36 -2.37 12.25 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.291 1.994 . . . . 0.0 111.954 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -90.19 3.75 52.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.976 . . . . 0.0 109.832 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 19.4 pttp -60.31 -51.25 70.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.159 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.579 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 46.1 tp10 -65.45 -43.16 91.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.882 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.99 -43.48 98.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.855 . . . . 0.0 109.981 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.2 tp -59.46 -45.61 91.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 109.171 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.579 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 17.1 ttp-105 -63.0 -28.59 70.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.555 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.93 -60.55 2.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.806 . . . . 0.0 109.377 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -55.88 -31.57 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 109.461 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.06 -18.18 50.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.16 -0.963 . . . . 0.0 110.037 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.478 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -64.67 -27.54 68.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -1.0 . . . . 0.0 110.031 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -60.45 136.97 58.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.07 -1.019 . . . . 0.0 110.233 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 169' ' ' ASP . 20.7 pt-20 -73.95 164.07 27.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.394 -0.816 . . . . 0.0 109.186 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -172.54 -167.52 0.46 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.008 -1.058 . . . . 0.0 110.463 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.96 133.17 5.95 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.6 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -103.63 153.47 20.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 109.804 -179.181 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.22 -7.07 86.8 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -125.28 170.93 10.81 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.285 -1.126 . . . . 0.0 109.53 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -71.64 143.02 49.92 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.117 -0.989 . . . . 0.0 109.821 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.6 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 3.3 tt0 -104.16 97.91 7.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 110.034 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.4 t -97.41 124.71 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.18 126.56 43.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.47 -0.769 . . . . 0.0 109.236 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 33.4 t80 -108.31 129.3 55.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.835 0.826 . . . . 0.0 109.008 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.439 ' CE2' ' HB1' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -80.85 117.05 21.16 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.566 -0.709 . . . . 0.0 110.353 -178.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.5 t -85.14 -47.54 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -0.822 . . . . 0.0 110.346 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -169.27 158.1 7.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.915 -1.116 . . . . 0.0 110.545 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.61 61.56 4.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' HB1' ' CE2' ' A' ' 106' ' ' PHE . . . -119.58 129.9 54.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.877 -1.367 . . . . 0.0 108.446 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -118.57 -29.92 1.79 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -141.66 160.13 40.79 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.387 -1.066 . . . . 0.0 109.748 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.533 ' N ' ' CD1' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -139.35 95.51 2.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.413 ' HG ' HE21 ' A' ' 123' ' ' GLN . 1.8 m -77.78 136.43 38.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.42 -0.8 . . . . 0.0 110.318 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.64 114.19 6.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.409 -0.807 . . . . 0.0 109.734 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 6.8 t-160 -106.73 110.55 22.76 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.901 -1.124 . . . . 0.0 109.342 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.3 mm -128.61 121.53 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.469 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.15 -143.82 36.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 103.682 -3.767 . . . . 0.0 103.682 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.492 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 44.7 p30 -111.0 82.67 1.63 Allowed 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 115.417 -2.513 . . . . 0.0 108.369 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.506 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 60.0 tt0 -164.76 167.69 18.67 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.0 t -128.5 140.25 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.986 -1.071 . . . . 0.0 110.085 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -125.57 132.25 52.58 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.928 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.413 HE21 ' HG ' ' A' ' 114' ' ' CYS . 73.8 mt-30 -142.05 122.13 13.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.069 -1.02 . . . . 0.0 109.029 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -106.74 147.09 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.241 -0.912 . . . . 0.0 109.191 179.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.9 mt -118.44 78.33 1.25 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 117.848 -1.541 . . . . 0.0 111.586 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.446 ' SG ' ' N ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -166.79 163.65 16.46 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 103.3 -2.852 . . . . 0.0 103.3 177.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.619 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -117.78 110.74 18.18 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 122.59 2.45 . . . . 0.0 106.312 176.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.611 ' C ' ' H ' ' A' ' 130' ' ' ASP . 13.0 mmtt -113.61 148.51 36.08 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.603 -0.686 . . . . 0.0 111.114 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.579 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 93.5 m-20 -61.12 -0.19 0.31 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.611 ' H ' ' C ' ' A' ' 128' ' ' LYS . 49.2 p30 -70.28 153.06 43.48 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.222 1.011 . . . . 0.0 110.903 -176.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.532 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 0.9 OUTLIER -125.76 161.87 26.37 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.856 0.836 . . . . 0.0 110.972 -178.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 mp -128.43 145.41 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.669 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.6 t -119.12 138.08 53.15 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.308 -0.87 . . . . 0.0 109.789 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -112.14 140.06 23.13 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.33 150.83 59.33 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.099 1.866 . . . . 0.0 112.328 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -72.48 132.57 44.04 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.815 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 12.5 t60 94.53 9.86 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.39 126.94 30.12 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 108.46 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.41 132.59 31.82 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.541 1.494 . . . . 0.0 111.463 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.516 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -166.61 162.84 16.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.315 -0.866 . . . . 0.0 110.177 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.672 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 21.6 p90 -127.22 -154.37 0.63 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.505 -0.747 . . . . 0.0 109.818 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.672 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 47.4 t80 -169.71 119.79 0.65 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 143' ' ' ASP . 34.3 p30 -139.52 119.64 13.63 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.28 -0.887 . . . . 0.0 108.692 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.566 ' SD ' ' CZ ' ' A' ' 150' ' ' PHE . 25.9 mtm -93.31 16.59 12.91 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 111.491 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 50.24 -144.3 10.93 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.404 ' H ' ' CD2' ' A' ' 178' ' ' LEU . 31.6 t -83.29 121.04 26.6 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.0 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -116.27 120.42 35.05 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.88 -0.512 . . . . 0.0 110.536 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 59.3 Cg_endo -102.87 59.41 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.807 0 C-N-CA 122.378 2.052 . . . . 0.0 110.65 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.2 OUTLIER 82.48 64.26 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.304 -0.873 . . . . 0.0 109.691 -177.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.566 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 1.0 OUTLIER -101.42 168.19 9.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.7 m -127.1 133.19 50.46 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.43 -0.794 . . . . 0.0 109.281 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.16 157.35 46.48 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.031 -1.043 . . . . 0.0 109.591 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.3 mt -108.32 124.91 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.062 -1.024 . . . . 0.0 108.985 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.16 164.49 27.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.414 -0.804 . . . . 0.0 109.346 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.43 ' CG2' ' CG ' ' A' ' 70' ' ' TYR . 2.9 mt -119.24 124.46 73.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 156' ' ' PHE . 26.5 m-85 -93.87 133.39 37.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.983 -1.073 . . . . 0.0 110.241 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.62 ' OD2' ' N ' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -129.84 165.57 21.72 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.644 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -91.2 160.63 36.98 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.935 -1.103 . . . . 0.0 108.625 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 161' ' ' GLY . 36.1 Cg_endo -57.02 -54.28 3.88 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.678 2.252 . . . . 0.0 113.12 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 159' ' ' PRO . 11.8 pt-20 -42.27 -23.17 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.506 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.27 -56.07 2.1 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.644 ' CD1' ' O ' ' A' ' 158' ' ' ASN . 39.0 p-90 -98.86 155.97 17.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.121 -1.223 . . . . 0.0 110.633 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 14.8 tt -103.88 159.08 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.497 -0.752 . . . . 0.0 109.184 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.97 -71.73 0.24 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.37 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -139.82 158.63 43.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.014 -1.054 . . . . 0.0 110.242 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -101.09 -41.87 6.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.162 -0.961 . . . . 0.0 109.704 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.6 m -115.92 -34.21 4.84 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.93 -3.95 57.38 Favored Glycine 0 N--CA 1.484 1.863 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.812 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.422 ' O ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -81.7 148.11 29.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.08 -1.835 . . . . 0.0 107.957 178.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -112.35 91.16 3.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.089 -1.444 . . . . 0.0 111.104 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.404 HD13 ' HD1' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -75.3 -20.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.113 -1.617 . . . . 0.0 108.799 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -61.34 -39.91 92.3 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.503 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -51.4 -3.85 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.827 -0.546 . . . . 0.0 110.698 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.547 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.36 -36.34 34.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.915 -1.116 . . . . 0.0 111.053 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.612 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.5 OUTLIER -111.49 20.09 0.07 OUTLIER Pre-proline 0 N--CA 1.511 2.595 0 O-C-N 120.708 -1.245 . . . . 0.0 113.993 -178.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 51.8 Cg_endo -65.48 -23.62 57.6 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.961 2.441 . . . . 0.0 114.636 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -87.81 126.54 35.07 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.268 -1.373 . . . . 0.0 108.41 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.597 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 9.4 tp -85.41 145.2 27.58 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 108.779 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.597 ' CB ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.168 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.619 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.29 168.22 10.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.071 -1.018 . . . . 0.0 109.313 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 4' ' ' THR . 2.6 tp -156.48 125.49 6.01 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.7 OUTLIER -121.73 126.62 49.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.205 -0.935 . . . . 0.0 109.633 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.1 mt -117.43 140.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.794 ' CZ ' ' O ' ' A' ' 7' ' ' SER . 1.2 t80 -144.41 156.19 44.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.794 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 50.7 p -89.57 179.76 5.97 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.984 -1.073 . . . . 0.0 108.132 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.19 3.21 5.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 119.975 -1.703 . . . . 0.0 110.149 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.406 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 1.4 mmmt -76.81 -49.57 15.53 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 120.509 -1.369 . . . . 0.0 114.13 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.787 ' O ' ' CE1' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -145.26 123.7 6.59 Favored Pre-proline 0 N--CA 1.507 2.404 0 O-C-N 119.96 -1.712 . . . . 0.0 109.546 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.43 ' HA ' ' CE2' ' A' ' 6' ' ' PHE . 43.4 Cg_endo -67.71 -33.96 26.21 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.324 1.349 . . . . 0.0 113.413 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.586 ' C ' HD21 ' A' ' 13' ' ' ASN . 0.2 OUTLIER -70.43 6.15 1.5 Allowed 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.281 -0.887 . . . . 0.0 110.127 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.586 HD21 ' C ' ' A' ' 12' ' ' GLN . 4.2 m120 -125.74 124.64 41.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.152 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.6 p -113.44 133.44 55.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.46 -0.775 . . . . 0.0 108.931 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.592 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 6.3 mp -94.19 5.41 51.81 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.105 -0.997 . . . . 0.0 109.881 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.483 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 23.8 t90 -153.91 102.08 2.48 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.788 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -117.99 107.43 14.03 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.197 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.421 ' OG ' ' CZ3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -161.68 161.71 29.57 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.511 179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.619 ' OG1' ' O ' ' A' ' 1' ' ' SER . 8.8 t -132.57 90.54 2.79 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 120.881 -1.137 . . . . 0.0 107.996 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.561 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 12.6 t-20 -123.76 141.96 51.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.254 -0.904 . . . . 0.0 110.037 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.83 -35.53 29.31 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.035 -1.666 . . . . 0.0 108.779 176.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -83.13 -52.27 6.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.168 -0.957 . . . . 0.0 109.548 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.495 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 1.4 tm-20 -60.17 -20.48 58.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.96 . . . . 0.0 108.667 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.586 ' CD1' ' HG ' ' A' ' 1' ' ' SER . 4.6 mt -73.04 -54.76 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.198 -0.939 . . . . 0.0 108.766 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -58.72 -43.0 90.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.488 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -62.08 -40.72 96.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.207 -0.933 . . . . 0.0 108.967 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.483 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 8.9 tt0 -73.25 -45.74 54.16 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.01 -61.16 2.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.031 -1.043 . . . . 0.0 110.089 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.2 t-20 -59.48 -18.88 43.58 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.321 -0.862 . . . . 0.0 110.262 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.04 -31.25 72.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.81 -1.181 . . . . 0.0 108.966 177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.685 ' NZ ' ' CD2' ' A' ' 122' ' ' PHE . 13.6 mtmt -91.47 12.3 21.17 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.296 -0.877 . . . . 0.0 109.963 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.25 24.76 30.58 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.159 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 28.8 t -95.3 147.41 5.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.385 -1.068 . . . . 0.0 109.194 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -82.82 153.23 25.29 Favored 'General case' 0 C--N 1.285 -2.208 0 O-C-N 120.82 -1.175 . . . . 0.0 108.097 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -154.81 149.45 26.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.063 -1.023 . . . . 0.0 108.564 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.533 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 5.5 pt-20 -178.78 179.54 0.7 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.019 -1.051 . . . . 0.0 110.561 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.8 ptt85 -152.97 122.35 6.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.319 -0.863 . . . . 0.0 109.353 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.612 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 33.4 m0 -111.78 153.38 26.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.49 -0.756 . . . . 0.0 109.108 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -140.01 155.01 47.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.901 . . . . 0.0 109.658 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.27 157.55 15.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 108.783 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -102.73 -8.75 20.6 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.61 162.16 14.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.683 0.754 . . . . 0.0 109.184 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 39.8 p-10 -96.41 123.72 40.16 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.425 0.631 . . . . 0.0 109.694 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.94 160.88 14.24 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.369 -0.832 . . . . 0.0 109.43 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.1 -105.3 0.22 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.87 88.62 4.68 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.057 -1.261 . . . . 0.0 109.078 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.99 91.89 40.77 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.145 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.91 -23.7 13.74 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.179 1.919 . . . . 0.0 112.477 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.0 p -119.65 141.93 48.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.782 -0.574 . . . . 0.0 109.494 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.42 -17.68 51.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.804 . . . . 0.0 109.428 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' ALA . 97.8 mt-10 -44.69 -38.2 4.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.476 -0.765 . . . . 0.0 109.094 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 m -76.36 -33.11 58.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.194 -0.941 . . . . 0.0 109.412 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 50' ' ' ALA . 70.1 t -65.84 -45.07 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.385 -0.822 . . . . 0.0 110.042 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.609 ' O ' ' N ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -61.47 -38.54 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.098 -1.001 . . . . 0.0 109.006 -179.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.21 -31.28 70.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.425 -0.797 . . . . 0.0 109.686 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.86 -21.78 50.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.084 -1.01 . . . . 0.0 110.443 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -112.53 -10.22 13.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.332 -0.855 . . . . 0.0 109.526 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.677 HE21 ' CG1' ' A' ' 61' ' ' ILE . 28.2 tp60 -52.64 -43.05 65.2 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.421 -0.911 . . . . 0.0 108.86 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.547 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 6.3 p80 -49.71 -48.52 49.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.017 -1.052 . . . . 0.0 109.653 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.547 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.08 -60.76 3.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.948 -1.095 . . . . 0.0 109.853 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.677 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.6 OUTLIER -62.13 -30.01 47.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.773 -1.204 . . . . 0.0 109.304 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.4 t70 -55.22 -25.85 35.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.069 -1.019 . . . . 0.0 109.624 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -80.3 -35.23 36.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 109.298 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.97 -42.66 94.36 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.42 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -72.04 -28.97 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 109.532 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.66 -52.91 53.67 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.937 -1.102 . . . . 0.0 109.502 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.64 -46.27 17.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.023 -1.048 . . . . 0.0 109.988 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.626 ' O ' ' C ' ' A' ' 69' ' ' GLY . 23.2 mttm -83.59 13.36 4.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.835 . . . . 0.0 110.631 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.626 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -6.11 82.21 0.0 OUTLIER Glycine 0 N--CA 1.504 3.187 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.476 ' N ' ' O ' ' A' ' 68' ' ' LYS . 43.2 m-85 -76.36 161.82 28.39 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.709 -0.877 . . . . 0.0 109.138 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -58.93 -42.85 90.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 0.0 109.974 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.501 ' HG ' ' N ' ' A' ' 73' ' ' TRP . 2.8 t -151.29 161.21 43.12 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.154 -0.967 . . . . 0.0 109.895 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.519 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 12.3 t-105 -137.74 143.0 40.96 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.454 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -160.87 179.13 8.74 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.9 142.04 40.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.47 -0.769 . . . . 0.0 109.264 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.5 mm -100.0 116.25 42.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.515 ' O ' ' OG ' ' A' ' 77' ' ' SER . 5.8 p -168.71 102.07 0.4 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.512 -0.743 . . . . 0.0 109.047 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.622 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 10.3 tp -121.47 179.88 4.3 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 119.581 -1.95 . . . . 0.0 107.712 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.548 ' HE ' ' CG ' ' A' ' 81' ' ' ASP . 4.0 ttp85 -87.94 160.39 17.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.649 -1.282 . . . . 0.0 109.118 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.421 ' CB ' HH21 ' A' ' 79' ' ' ARG . . . -58.52 -2.74 0.23 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.895 0.855 . . . . 0.0 109.849 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.548 ' CG ' ' HE ' ' A' ' 79' ' ' ARG . 89.1 m-20 -97.95 31.98 2.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.618 ' ND2' ' CA ' ' A' ' 85' ' ' LYS . 1.5 t30 -80.19 125.13 82.12 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.7 -0.625 . . . . 0.0 110.771 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -78.73 -23.03 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.042 1.828 . . . . 0.0 112.405 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.493 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 88.8 mm-40 -91.9 10.73 27.52 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.917 -1.114 . . . . 0.0 109.365 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.618 ' CA ' ' ND2' ' A' ' 82' ' ' ASN . 47.1 pttt -57.98 -53.68 55.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.585 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 84.8 tt0 -68.7 -52.06 34.98 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.197 -0.94 . . . . 0.0 109.606 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.68 -45.92 84.99 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.71 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 84' ' ' GLN . 7.3 tt -62.3 -43.98 97.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.718 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -59.0 -36.41 74.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.1 -1.0 . . . . 0.0 109.696 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -66.97 -56.27 10.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 109.803 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -51.03 -36.21 38.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.479 -0.763 . . . . 0.0 109.232 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -87.88 -18.97 28.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.544 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.51 -36.09 81.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 109.889 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -61.36 133.41 55.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 110.017 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.74 151.5 38.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.444 -0.785 . . . . 0.0 109.376 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -163.39 -172.88 3.12 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.5 t -163.0 137.69 6.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.688 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -110.46 154.51 23.52 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.395 -0.815 . . . . 0.0 109.663 -178.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.26 -5.75 82.05 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.458 ' OE2' ' OH ' ' A' ' 70' ' ' TYR . 79.9 tt0 -125.11 168.2 13.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.191 -1.181 . . . . 0.0 109.168 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -73.13 142.99 47.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.893 -1.129 . . . . 0.0 110.315 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.84 95.87 7.49 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.298 -0.876 . . . . 0.0 109.317 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.28 131.5 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.467 0.651 . . . . 0.0 109.302 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.672 ' NH2' ' CE2' ' A' ' 142' ' ' PHE . 20.0 mmm180 -129.26 114.23 16.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.654 -0.654 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.631 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 16.1 t80 -109.75 129.9 55.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.506 ' CD2' ' OE2' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -93.05 137.5 32.35 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 110.396 -179.086 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t -111.92 -30.25 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.686 -0.634 . . . . 0.0 109.817 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -168.57 158.27 9.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.067 -1.021 . . . . 0.0 109.426 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.21 162.18 15.56 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.57 -176.62 2.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -1.137 . . . . 0.0 109.317 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.25 -144.36 5.12 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.6 tt -142.37 160.06 41.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -1.168 . . . . 0.0 109.663 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -137.55 87.68 2.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 109.833 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.592 ' SG ' ' NE1' ' A' ' 141' ' ' TRP . 42.2 t -81.01 114.13 19.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.446 -0.784 . . . . 0.0 109.428 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.8 mt -119.41 117.23 27.92 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.148 -0.97 . . . . 0.0 108.819 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.586 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 4.0 t-160 -106.85 113.56 27.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.053 -1.029 . . . . 0.0 109.635 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.79 117.68 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.678 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.74 -143.1 31.98 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 105.85 -2.9 . . . . 0.0 105.85 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -106.71 79.36 1.34 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 115.739 -2.385 . . . . 0.0 108.538 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.586 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 74.9 tt0 -165.61 167.94 16.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.421 ' H ' ' HG2' ' A' ' 120' ' ' GLU . 3.9 t -130.7 149.18 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.139 -0.976 . . . . 0.0 110.066 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.685 ' CD2' ' NZ ' ' A' ' 31' ' ' LYS . 51.1 m-85 -129.32 133.8 47.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.803 -0.561 . . . . 0.0 109.771 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 4' ' ' THR . 83.7 mm-40 -128.39 108.95 10.99 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.74 138.11 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.686 ' N ' ' CD2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -130.98 83.17 2.09 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.452 178.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.538 ' SG ' ' O ' ' A' ' 126' ' ' CYS . 25.9 p -170.19 116.89 0.53 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.506 ' OE2' ' CD2' ' A' ' 106' ' ' PHE . 79.3 mm-40 -114.82 103.44 10.95 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 116.126 -2.229 . . . . 0.0 111.245 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.598 ' C ' ' H ' ' A' ' 130' ' ' ASP . 93.6 mttt -109.34 177.26 4.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.333 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.631 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 22.5 p30 -55.7 -5.96 0.18 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.598 ' H ' ' C ' ' A' ' 128' ' ' LYS . 29.7 p30 -72.22 144.55 48.44 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.918 0.866 . . . . 0.0 109.362 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.551 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -109.24 148.47 30.92 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.885 0.85 . . . . 0.0 109.974 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.465 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 37.3 mm -122.35 121.11 62.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.4 t -111.74 142.4 44.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.67 143.55 26.92 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.0 108.894 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.17 150.19 85.12 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.317 2.011 . . . . 0.0 112.53 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.58 134.7 46.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.38 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.7 t60 92.71 10.17 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.65 125.46 34.71 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.075 -1.016 . . . . 0.0 108.685 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.57 132.05 31.77 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.482 1.455 . . . . 0.0 111.629 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.477 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.71 163.54 9.96 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.235 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.592 ' NE1' ' SG ' ' A' ' 114' ' ' CYS . 0.6 OUTLIER -133.36 -147.33 0.29 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.312 -0.868 . . . . 0.0 109.851 -178.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.672 ' CE2' ' NH2' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -178.71 126.26 0.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.887 -1.133 . . . . 0.0 109.289 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 176' ' ' PRO . 53.0 t0 -146.57 137.48 24.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.264 -0.898 . . . . 0.0 109.626 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.588 ' O ' ' C ' ' A' ' 145' ' ' GLY . 5.5 ptt? -109.81 21.1 17.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.515 -0.741 . . . . 0.0 111.295 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.588 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.12 -90.46 0.01 OUTLIER Glycine 0 N--CA 1.503 3.117 0 CA-C-N 119.336 0.971 . . . . 0.0 112.073 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.511 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 39.7 t -86.88 120.41 28.13 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.035 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -113.42 111.74 49.39 Favored Pre-proline 0 C--N 1.294 -1.805 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.742 178.335 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.584 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.4 Cg_endo -102.07 28.21 0.1 Allowed 'Trans proline' 0 C--O 1.212 -0.822 0 C-N-CA 123.068 2.512 . . . . 0.0 111.432 176.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.622 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER 84.06 71.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.747 0.784 . . . . 0.0 109.632 -177.229 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 25.6 p90 -94.89 159.55 14.99 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.64 -0.662 . . . . 0.0 109.528 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.7 m -130.26 125.52 35.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.223 -0.923 . . . . 0.0 110.012 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.62 164.16 31.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 109.44 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.519 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 29.1 mt -110.61 129.93 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.075 -1.016 . . . . 0.0 109.346 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.419 ' HE ' ' HD3' ' A' ' 104' ' ' ARG . 4.3 ttt180 -138.6 167.42 21.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.422 -0.799 . . . . 0.0 109.69 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.467 ' CG2' ' CG ' ' A' ' 70' ' ' TYR . 4.1 mp -104.36 146.68 11.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.501 -0.75 . . . . 0.0 109.444 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.454 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.3 m-30 -95.35 118.56 32.32 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.008 0.909 . . . . 0.0 109.732 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.61 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 11.8 p30 -135.89 161.92 34.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.891 -0.505 . . . . 0.0 109.829 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 2.3 m-20 -96.03 160.23 30.46 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.059 -1.025 . . . . 0.0 109.484 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 161' ' ' GLY . 43.8 Cg_endo -69.02 -54.26 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.56 2.173 . . . . 0.0 112.042 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 159' ' ' PRO . 77.4 tt0 -43.45 -16.84 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 109.219 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.61 -25.67 29.55 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.61 ' HE1' ' CG ' ' A' ' 157' ' ' ASP . 32.6 m95 -107.27 169.08 8.78 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.387 -1.067 . . . . 0.0 109.964 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 77.3 mt -97.21 150.55 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.24 -0.912 . . . . 0.0 109.282 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -76.77 -71.63 0.39 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.31 -0.869 . . . . 0.0 110.449 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -133.95 158.71 42.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.215 -0.928 . . . . 0.0 109.819 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -101.08 -39.67 7.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.873 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.18 -30.26 5.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.328 -0.857 . . . . 0.0 108.957 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.66 -9.92 55.75 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.91 148.56 31.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.838 -1.389 . . . . 0.0 108.074 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -111.22 87.55 2.57 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 117.614 -1.635 . . . . 0.0 110.94 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.2 tt -77.79 -16.99 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.602 -1.311 . . . . 0.0 109.147 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -56.25 -38.91 71.75 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.574 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 68.0 m -52.82 -4.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.434 -0.791 . . . . 0.0 109.961 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -76.23 -41.37 49.42 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.68 -1.262 . . . . 0.0 111.894 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.629 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.6 m-85 -113.29 25.04 0.08 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 O-C-N 120.457 -1.402 . . . . 0.0 112.416 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 41.0 Cg_endo -60.66 -25.97 81.97 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 123.898 3.065 . . . . 0.0 113.892 -172.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -89.57 125.5 35.24 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 118.719 -1.192 . . . . 0.0 108.408 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.577 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 0.5 OUTLIER -87.34 120.9 29.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.2 -0.937 . . . . 0.0 109.084 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.491 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.641 ' O ' ' OG1' ' A' ' 19' ' ' THR . 6.0 p . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.31 170.48 9.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.208 -0.932 . . . . 0.0 108.699 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 tp -156.93 119.23 3.91 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.74 134.01 52.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.164 -0.96 . . . . 0.0 109.761 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.2 mt -127.97 137.51 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -130.65 166.59 20.36 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.406 ' OG ' ' CD2' ' A' ' 15' ' ' LEU . 51.0 m -87.41 173.9 8.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.048 -1.033 . . . . 0.0 108.579 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.86 -29.53 5.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.913 -1.117 . . . . 0.0 109.413 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -73.02 -38.12 66.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.783 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -139.22 123.93 11.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.996 -1.065 . . . . 0.0 109.743 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -84.1 -21.91 3.65 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.754 1.636 . . . . 0.0 112.471 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.48 -1.87 12.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.484 -0.76 . . . . 0.0 111.579 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.544 ' OD1' ' O ' ' A' ' 13' ' ' ASN . 47.4 p-10 -124.89 122.79 38.37 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.16 -0.962 . . . . 0.0 108.886 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.2 p -93.22 129.76 39.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.874 -1.141 . . . . 0.0 108.53 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.406 ' CD2' ' OG ' ' A' ' 7' ' ' SER . 11.0 mp -90.38 -7.28 53.62 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.166 -1.013 . . . . 0.0 109.068 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.703 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 39.0 t90 -157.58 105.63 2.05 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.253 -1.379 . . . . 0.0 110.055 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -119.0 111.13 17.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.378 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.425 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -161.37 162.71 30.83 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.369 -0.832 . . . . 0.0 109.872 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.641 ' OG1' ' O ' ' A' ' 1' ' ' SER . 10.2 t -131.72 89.18 2.66 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.005 -1.059 . . . . 0.0 108.153 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.574 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.6 OUTLIER -125.52 151.45 46.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.014 -1.054 . . . . 0.0 110.06 177.423 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.26 -41.32 20.36 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.21 -1.557 . . . . 0.0 108.827 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -82.81 -47.35 12.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 110.737 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -64.52 -23.44 67.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.757 -1.215 . . . . 0.0 108.984 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.574 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 7.2 mt -70.73 -51.36 37.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.228 -0.92 . . . . 0.0 108.537 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.429 ' NE2' ' CB ' ' A' ' 29' ' ' ASN . 13.2 tm0? -57.08 -50.1 73.83 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.525 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.416 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 44.6 tt0 -58.42 -35.03 71.46 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.525 -0.735 . . . . 0.0 110.229 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.703 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -64.3 -63.48 1.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.933 -1.105 . . . . 0.0 109.587 -179.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -55.09 14.15 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.114 -0.991 . . . . 0.0 109.76 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 19.8 t-20 -52.46 -27.63 16.91 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.972 -1.08 . . . . 0.0 109.73 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' GLN . . . -64.5 -27.05 68.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.677 -1.264 . . . . 0.0 108.263 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -90.71 11.29 22.7 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.26 -0.9 . . . . 0.0 110.54 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.26 25.69 15.87 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.088 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.615 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 43.3 t -96.8 145.75 8.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.348 -1.089 . . . . 0.0 109.929 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -84.17 157.04 21.8 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -153.1 149.82 28.48 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 37' ' ' ARG . 36.2 tp10 -174.89 166.41 3.61 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.95 -1.094 . . . . 0.0 108.619 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.4 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 11.7 ptt180 -153.77 131.06 11.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -117.38 151.58 36.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.583 -0.698 . . . . 0.0 109.945 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -135.96 158.75 43.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.372 -0.83 . . . . 0.0 109.439 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.38 160.46 14.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.917 . . . . 0.0 109.179 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -98.64 -17.64 18.5 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.222 -0.924 . . . . 0.0 108.544 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -93.61 164.83 13.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.687 0.756 . . . . 0.0 109.161 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.17 119.39 32.93 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.645 -0.659 . . . . 0.0 109.599 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.98 166.05 12.9 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.4 -121.87 0.59 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.46 79.4 8.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.069 -1.254 . . . . 0.0 108.98 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.92 94.93 26.76 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.448 -0.783 . . . . 0.0 109.205 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.467 ' O ' ' CG2' ' A' ' 49' ' ' THR . 50.6 Cg_endo -70.86 79.46 1.29 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.002 1.801 . . . . 0.0 111.854 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.467 ' CG2' ' O ' ' A' ' 48' ' ' PRO . 3.8 p -163.55 119.56 1.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.129 -0.982 . . . . 0.0 109.273 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.95 -43.54 17.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.858 -1.151 . . . . 0.0 110.044 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -66.61 -17.89 65.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.488 -0.757 . . . . 0.0 110.148 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 m -77.11 -40.77 44.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 110.228 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.9 t -66.87 -48.11 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.117 -0.989 . . . . 0.0 109.953 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 58' ' ' GLN . 8.5 mm -61.31 -41.94 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 108.619 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.81 -29.87 70.44 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.435 -0.79 . . . . 0.0 109.691 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.16 -17.85 59.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.98 . . . . 0.0 110.12 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 58' ' ' GLN . 57.4 m-85 -114.34 -7.47 12.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 109.121 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' A' ' 62' ' ' ASP . 5.1 mm-40 -46.52 -39.84 11.54 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.759 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.32 -46.6 62.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.54 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -63.67 -59.63 4.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.804 -1.185 . . . . 0.0 110.341 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.48 ' CD1' ' C ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -62.32 -31.85 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.996 -1.065 . . . . 0.0 109.352 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.7 t70 -59.04 -25.05 63.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.594 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.54 -39.08 47.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.949 . . . . 0.0 109.411 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.19 -38.07 89.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.365 -0.834 . . . . 0.0 108.936 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 69' ' ' GLY . 2.8 t -71.02 -29.68 38.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.368 -0.832 . . . . 0.0 109.458 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.38 -52.36 63.8 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.514 -1.366 . . . . 0.0 109.597 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.05 -49.8 9.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.955 -1.091 . . . . 0.0 110.366 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.602 ' O ' ' C ' ' A' ' 69' ' ' GLY . 20.2 mmtt -83.99 13.0 5.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -0.868 . . . . 0.0 111.37 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.602 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -3.01 80.83 0.0 OUTLIER Glycine 0 N--CA 1.506 3.336 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.433 ' N ' ' O ' ' A' ' 68' ' ' LYS . 69.1 m-85 -77.35 158.94 29.86 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.658 -0.907 . . . . 0.0 108.791 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -57.65 -88.53 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.479 -0.763 . . . . 0.0 109.3 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -103.44 159.58 15.46 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.719 0.771 . . . . 0.0 110.161 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.41 ' CD1' ' N ' ' A' ' 74' ' ' ASP . 7.9 t-105 -139.51 144.7 38.03 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -163.05 -178.6 6.15 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.13 143.87 32.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.521 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 19.8 tt -101.72 115.45 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.502 ' HG ' ' C ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -167.94 101.06 0.46 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.816 -0.753 . . . . 0.0 109.194 177.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.521 ' HG ' ' H ' ' A' ' 79' ' ' ARG . 11.5 tp -106.59 178.34 4.59 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 121.08 1.764 . . . . 0.0 107.939 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.564 ' C ' ' H ' ' A' ' 81' ' ' ASP . 0.7 OUTLIER -89.88 143.84 26.45 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.693 -1.254 . . . . 0.0 109.664 -178.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.03 0.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.594 -0.691 . . . . 0.0 109.588 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.564 ' H ' ' C ' ' A' ' 79' ' ' ARG . 58.5 t0 -83.57 -27.54 29.2 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.471 -1.292 . . . . 0.0 109.444 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.681 HD22 ' CB ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -67.41 122.42 83.03 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.054 -1.029 . . . . 0.0 109.507 179.481 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -85.83 -3.78 8.99 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.021 1.814 . . . . 0.0 112.234 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -88.39 -3.44 58.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.944 -1.097 . . . . 0.0 110.513 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.681 ' CB ' HD22 ' A' ' 82' ' ' ASN . 2.3 mmtt -62.8 -40.57 97.75 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.036 -1.04 . . . . 0.0 109.283 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -54.49 44.1 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.322 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.04 -35.0 75.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.06 -1.025 . . . . 0.0 109.644 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.37 -43.51 98.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.73 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.6 ptt-85 -63.76 -25.78 68.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 109.934 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.72 -59.66 3.69 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.408 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -54.25 -29.39 46.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.962 . . . . 0.0 109.27 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.39 -18.37 36.3 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.306 -0.871 . . . . 0.0 109.661 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.466 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -58.44 -25.88 62.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 109.936 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -55.25 142.37 31.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.108 -0.995 . . . . 0.0 110.211 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.511 ' OE2' ' O ' ' A' ' 169' ' ' ASP . 19.8 pt-20 -72.59 164.24 26.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.395 -0.816 . . . . 0.0 109.663 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -174.24 -170.92 0.56 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.492 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.2 t -160.48 132.28 5.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.65 0.738 . . . . 0.0 109.36 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.665 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -103.4 154.64 19.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.712 -0.617 . . . . 0.0 110.01 -179.037 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.439 ' H ' ' HB3' ' A' ' 162' ' ' TRP . . . -78.83 -6.05 88.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -124.77 170.11 11.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -1.027 . . . . 0.0 109.382 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -74.68 143.54 44.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.956 -1.09 . . . . 0.0 110.103 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' A' ' 98' ' ' HIS . 2.0 mt-10 -101.1 93.64 5.58 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.114 -0.992 . . . . 0.0 108.901 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.1 m -89.11 130.65 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.767 -0.583 . . . . 0.0 109.495 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.693 ' NH1' ' CD1' ' A' ' 142' ' ' PHE . 21.4 mtp180 -129.59 116.94 19.63 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.561 -0.712 . . . . 0.0 109.437 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.457 ' CE2' ' O ' ' A' ' 106' ' ' PHE . 25.4 t80 -101.08 134.08 44.62 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.457 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.88 129.26 35.63 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.422 -0.799 . . . . 0.0 110.388 -178.492 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.9 t -107.96 -33.54 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.577 -0.702 . . . . 0.0 109.711 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -167.97 157.81 10.07 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.094 -1.004 . . . . 0.0 108.88 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.19 161.4 9.14 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.12 -177.51 3.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -1.061 . . . . 0.0 109.107 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.88 -142.51 4.09 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 113' ' ' PHE . 5.8 tp -142.62 159.7 41.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.23 -1.159 . . . . 0.0 109.026 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.41 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 55.7 m-85 -136.83 88.09 2.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.06 -1.025 . . . . 0.0 109.258 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.75 108.87 14.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.473 -0.767 . . . . 0.0 110.026 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 mp -116.43 121.18 41.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -0.924 . . . . 0.0 108.82 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 4.7 t-160 -107.29 113.37 26.72 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.097 -1.002 . . . . 0.0 109.277 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.5 mt -128.34 118.72 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.852 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.17 -142.49 33.05 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 105.429 -3.068 . . . . 0.0 105.429 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -107.8 80.64 1.41 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 121.517 2.658 . . . . 0.0 108.182 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 77.5 tt0 -165.11 166.81 18.82 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.0 t -126.61 142.12 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.244 -0.91 . . . . 0.0 110.037 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -124.19 130.85 53.24 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.038 0.447 . . . . 0.0 109.922 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -132.32 118.08 18.97 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 109.35 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.43 137.89 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.456 ' N ' ' CD2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -135.91 91.07 2.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.061 -1.025 . . . . 0.0 110.634 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 126' ' ' CYS . 20.3 p -166.95 137.47 3.11 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.505 -1.372 . . . . 0.0 108.603 178.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.509 ' CD ' ' O ' ' A' ' 127' ' ' GLU . 2.8 tm-20 -106.99 92.92 4.28 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 115.367 -2.533 . . . . 0.0 110.012 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.664 ' C ' ' H ' ' A' ' 130' ' ' ASP . 39.7 tttp -118.26 157.71 26.53 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.439 175.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -56.12 0.83 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.106 -1.621 . . . . 0.0 108.406 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.664 ' H ' ' C ' ' A' ' 128' ' ' LYS . 49.5 p-10 -66.84 131.36 45.75 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.157 0.979 . . . . 0.0 109.566 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -100.97 132.86 46.18 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.862 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 8.2 tt -125.43 129.96 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.582 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.3 m -125.77 151.59 46.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.48 149.59 39.01 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.41 151.52 75.91 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.569 2.179 . . . . 0.0 112.904 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.609 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -73.31 133.47 43.88 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.182 -0.949 . . . . 0.0 109.186 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.609 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.1 t-80 94.89 9.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.166 0.508 . . . . 0.0 109.705 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.09 126.96 30.26 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 108.579 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.84 132.1 31.37 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.57 1.513 . . . . 0.0 111.548 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -168.95 164.06 11.51 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.999 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.435 ' HB2' ' H ' ' A' ' 142' ' ' PHE . 0.7 OUTLIER -134.46 -148.8 0.33 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 109.348 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.693 ' CD1' ' NH1' ' A' ' 104' ' ' ARG . 83.5 t80 -176.03 126.38 0.21 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.052 -1.03 . . . . 0.0 109.048 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 143' ' ' ASP . 31.9 p-10 -144.69 132.86 21.62 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.368 -0.833 . . . . 0.0 109.361 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.612 ' O ' ' C ' ' A' ' 145' ' ' GLY . 11.3 ptp -110.9 21.36 16.56 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.657 -0.652 . . . . 0.0 111.093 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.612 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 7.52 -86.21 0.0 OUTLIER Glycine 0 N--CA 1.499 2.893 0 CA-C-N 119.061 0.846 . . . . 0.0 111.94 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.47 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 51.2 m -88.07 116.74 26.47 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 117.688 -1.605 . . . . 0.0 108.75 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.28 115.11 36.28 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.517 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 59.1 Cg_endo -105.04 36.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.437 2.091 . . . . 0.0 111.395 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.62 ' CG ' ' O ' ' A' ' 149' ' ' ASN . 0.0 OUTLIER 81.85 69.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 123.246 1.498 . . . . 0.0 108.682 -177.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.435 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 26.7 p90 -95.75 161.68 13.92 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.489 -1.382 . . . . 0.0 109.766 -177.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.7 m -130.54 125.87 35.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.953 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.26 164.55 30.42 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.8 mt -109.73 128.77 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.954 -1.091 . . . . 0.0 109.342 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -134.51 163.18 30.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 36.2 mt -102.64 144.14 14.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.467 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.3 m-85 -96.46 118.55 33.22 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.415 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.579 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -135.73 161.56 35.21 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.04 158.61 33.84 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 120.699 -1.251 . . . . 0.0 109.483 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.584 ' O ' ' N ' ' A' ' 161' ' ' GLY . 46.4 Cg_endo -71.31 -53.86 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.326 2.017 . . . . 0.0 112.737 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 159' ' ' PRO . 83.7 tt0 -43.3 -16.7 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -69.38 -38.76 80.98 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.439 ' HB3' ' H ' ' A' ' 99' ' ' GLY . 4.3 p90 -119.14 175.74 5.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.695 -0.885 . . . . 0.0 111.03 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.404 HD11 HG21 ' A' ' 163' ' ' ILE . 76.2 mt -96.26 147.6 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.597 0.713 . . . . 0.0 109.315 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.92 -73.61 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.425 -0.797 . . . . 0.0 110.525 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -126.76 156.6 40.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.149 -0.969 . . . . 0.0 109.872 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.1 -40.6 7.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 0.0 109.754 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 86.1 m -101.54 -32.23 10.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.043 . . . . 0.0 108.976 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.24 -6.93 58.2 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.518 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 44.4 p30 -80.92 148.35 29.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.568 -1.548 . . . . 0.0 108.545 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -112.17 88.68 2.87 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 117.737 -1.585 . . . . 0.0 110.368 175.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.27 -16.83 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.008 -1.682 . . . . 0.0 109.24 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -55.98 -37.96 69.78 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.521 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 7.3 m -56.09 -3.97 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.824 -0.547 . . . . 0.0 110.161 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.504 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.78 -37.87 29.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.022 -1.049 . . . . 0.0 111.755 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.627 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.5 m-85 -112.83 23.09 0.08 OUTLIER Pre-proline 0 N--CA 1.513 2.717 0 O-C-N 120.558 -1.339 . . . . 0.0 113.037 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 46.1 Cg_endo -63.31 -19.56 68.58 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 123.443 2.762 . . . . 0.0 114.262 -173.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -88.93 126.47 35.41 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.765 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.47 ' HB3' ' H ' ' A' ' 146' ' ' SER . 5.7 tt -87.8 122.25 31.22 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.926 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.691 0 O-C-N 121.138 -0.976 . . . . 0.0 109.367 -179.855 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.462 ' O ' ' CG2' ' A' ' 19' ' ' THR . 5.1 p . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.11 169.03 9.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.004 -1.06 . . . . 0.0 109.08 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.8 tp -157.79 117.3 3.29 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.44 135.97 53.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.432 -0.792 . . . . 0.0 109.973 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.7 mt -130.44 133.6 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -127.4 168.26 15.09 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.39 174.81 7.6 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.216 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.73 -23.77 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.066 . . . . 0.0 109.575 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -75.1 -37.93 61.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.051 -1.031 . . . . 0.0 110.413 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -136.93 126.49 15.58 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.655 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 13' ' ' ASN . 56.2 Cg_endo -79.87 -39.16 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.002 1.801 . . . . 0.0 112.156 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 9.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.729 . . . . 0.0 110.041 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -114.69 119.1 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.176 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.9 p -102.29 122.9 45.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.249 -0.907 . . . . 0.0 109.493 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.445 ' CD1' ' OD1' ' A' ' 13' ' ' ASN . 3.6 mp -90.2 -3.86 57.59 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.671 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.734 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 35.4 t90 -156.04 104.25 2.26 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.667 -1.213 . . . . 0.0 110.256 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -118.8 110.36 17.14 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.736 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.464 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -162.58 163.62 27.16 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.079 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.462 ' CG2' ' O ' ' A' ' 1' ' ' SER . 54.6 m -130.93 89.46 2.75 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.15 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.55 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.7 OUTLIER -128.16 148.46 50.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.429 -0.794 . . . . 0.0 110.401 177.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.38 -38.27 22.2 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.311 -1.493 . . . . 0.0 108.107 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -83.69 -48.8 9.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.472 -0.767 . . . . 0.0 109.855 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 27' ' ' GLN . 43.9 tt0 -60.99 -24.02 65.81 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.831 -1.168 . . . . 0.0 108.604 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.55 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 10.4 mt -73.04 -62.75 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.174 -0.953 . . . . 0.0 109.497 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.514 ' CD ' ' N ' ' A' ' 26' ' ' GLN . 3.8 pp0? -61.41 -43.34 99.04 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.879 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 25' ' ' GLN . 11.0 tm0? -61.49 -43.99 97.88 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.129 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.734 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -77.67 -47.23 19.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.977 . . . . 0.0 109.229 179.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 24' ' ' ILE . 23.9 tp -66.45 -54.41 24.47 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.999 -1.063 . . . . 0.0 109.149 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 25' ' ' GLN . 40.7 t-20 -57.9 -20.08 34.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.0 109.411 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.25 -27.63 68.78 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.06 -1.025 . . . . 0.0 108.796 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.78 13.39 10.73 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.217 -0.927 . . . . 0.0 109.867 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.13 22.95 30.97 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.179 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.479 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 56.3 t -94.13 145.43 7.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.424 -1.044 . . . . 0.0 109.344 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.442 ' NE ' ' OG ' ' A' ' 133' ' ' SER . 2.4 ttm-85 -84.0 158.4 21.51 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.24 -0.912 . . . . 0.0 108.724 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.541 ' CE1' ' OD2' ' A' ' 130' ' ' ASP . 1.2 t80 -153.38 145.67 23.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.943 -1.098 . . . . 0.0 108.682 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.554 ' O ' ' OD1' ' A' ' 130' ' ' ASP . 43.8 mt-10 -165.81 168.64 15.78 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.188 -0.945 . . . . 0.0 109.961 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -148.53 113.91 5.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.587 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 22.1 m0 -109.98 153.81 24.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.273 -0.892 . . . . 0.0 109.308 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -142.79 159.09 42.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.902 . . . . 0.0 109.685 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.19 159.05 15.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.263 -0.898 . . . . 0.0 109.08 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -101.98 -13.64 17.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.152 -0.967 . . . . 0.0 108.535 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -93.05 161.55 14.39 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.234 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -95.08 118.94 32.74 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.734 -0.604 . . . . 0.0 109.666 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.0 mt -90.26 163.11 14.9 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.732 0.777 . . . . 0.0 109.292 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.08 -99.8 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.36 91.95 5.13 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.044 -1.269 . . . . 0.0 109.187 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.16 91.88 37.99 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.416 -0.802 . . . . 0.0 109.008 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -76.21 -26.41 9.07 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.316 2.011 . . . . 0.0 112.588 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.7 p -122.61 141.74 51.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.645 -0.66 . . . . 0.0 109.504 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.69 -16.5 53.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.426 -0.796 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -47.63 -38.96 15.77 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.796 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.1 m -79.43 -35.31 40.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.573 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.92 -48.78 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.887 . . . . 0.0 109.802 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 58' ' ' GLN . 17.7 mt -59.91 -36.77 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 108.796 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.51 -30.44 70.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.815 . . . . 0.0 109.527 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.59 -17.4 60.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.139 -0.975 . . . . 0.0 110.158 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -114.41 -8.59 12.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.393 -0.817 . . . . 0.0 109.507 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.708 HE21 ' CG1' ' A' ' 61' ' ' ILE . 26.9 tp60 -48.95 -38.57 23.35 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 108.86 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.624 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 20.2 p80 -50.62 -46.81 58.32 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.54 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.624 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.39 -60.51 3.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.065 -1.022 . . . . 0.0 109.977 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.708 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.7 OUTLIER -61.71 -30.16 47.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.85 -1.156 . . . . 0.0 109.024 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 58' ' ' GLN . 40.3 t0 -57.44 -26.43 61.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 0.0 109.645 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.75 -40.53 61.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.078 -1.013 . . . . 0.0 109.261 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.66 -34.65 78.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.064 -1.023 . . . . 0.0 109.653 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.0 t -71.47 -33.95 51.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.245 -0.909 . . . . 0.0 109.442 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.37 -51.76 57.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.534 -1.354 . . . . 0.0 109.489 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -83.23 -50.07 8.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.013 -1.054 . . . . 0.0 110.472 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.605 ' O ' ' C ' ' A' ' 69' ' ' GLY . 15.7 mttm -86.65 15.79 5.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.608 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -12.01 85.52 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.497 ' N ' ' O ' ' A' ' 68' ' ' LYS . 53.9 m-85 -78.5 165.57 23.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.532 ' CD ' ' H ' ' A' ' 71' ' ' GLN . 25.4 mp0 -63.98 -83.99 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.372 -0.83 . . . . 0.0 109.401 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.23 157.3 17.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.597 -0.689 . . . . 0.0 109.566 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.401 ' HE1' HG23 ' A' ' 153' ' ' ILE . 6.7 t-105 -136.15 139.36 42.83 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -167.38 -174.42 2.55 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.341 -0.849 . . . . 0.0 108.734 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.409 ' CB ' ' O ' ' A' ' 152' ' ' ALA . 3.2 m -118.92 146.76 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.0 109.45 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.24 116.53 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.542 ' OG ' ' O ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -174.42 108.84 0.13 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.828 -1.17 . . . . 0.0 109.563 177.464 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.432 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -100.39 -178.83 3.93 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 121.403 1.91 . . . . 0.0 109.331 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.495 ' C ' ' H ' ' A' ' 81' ' ' ASP . 7.8 tpt180 -88.88 143.81 26.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.856 -1.152 . . . . 0.0 109.207 -178.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.46 0.83 0.63 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.56 -0.712 . . . . 0.0 109.788 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 79' ' ' ARG . 57.5 t0 -94.08 -27.16 16.42 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.348 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -64.29 127.95 92.68 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.924 -1.11 . . . . 0.0 109.996 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.75 -1.79 11.96 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.323 2.015 . . . . 0.0 112.003 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -84.41 15.04 3.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.902 -1.124 . . . . 0.0 109.547 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.642 ' HZ1' ' CB ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -57.55 -58.54 7.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.305 -0.872 . . . . 0.0 108.809 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.01 -33.91 77.16 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.304 -0.873 . . . . 0.0 109.164 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.88 -58.2 8.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.0 110.023 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.0 tp -61.0 -43.98 98.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.639 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.445 ' NE ' ' N ' ' A' ' 145' ' ' GLY . 23.2 mtp-105 -60.71 -31.34 70.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.646 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -66.99 -58.28 5.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.454 -0.779 . . . . 0.0 110.322 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -53.98 -35.04 61.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 109.268 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -87.57 -18.21 30.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.274 -0.891 . . . . 0.0 109.629 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 89' ' ' ARG . 39.0 tp -56.9 -37.06 70.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.155 -0.966 . . . . 0.0 109.912 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -54.15 134.1 44.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.143 -0.973 . . . . 0.0 109.441 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.553 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 0.9 OUTLIER -64.77 164.7 11.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.418 -0.801 . . . . 0.0 109.537 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.553 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 42.8 p-80 -170.38 -171.44 1.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.066 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.7 p -159.04 131.97 7.02 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.626 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -100.39 155.84 17.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' A' ' 162' ' ' TRP . . . -79.53 -7.22 88.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.56 171.83 10.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.33 -1.1 . . . . 0.0 109.515 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -72.2 142.97 49.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.345 -0.847 . . . . 0.0 110.141 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.606 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 2.6 tt0 -101.7 93.33 5.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.5 m -92.38 127.88 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.41 0.624 . . . . 0.0 109.786 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -127.41 126.64 42.79 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.632 -0.667 . . . . 0.0 109.318 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.629 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 18.7 t80 -108.51 133.23 52.93 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.785 0.802 . . . . 0.0 109.153 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.49 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.05 127.59 35.4 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.476 0.655 . . . . 0.0 110.022 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.8 t -108.83 -35.17 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.644 -0.66 . . . . 0.0 109.624 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -160.31 146.6 15.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 0.0 109.339 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.3 165.92 35.41 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.41 154.02 39.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.501 -0.999 . . . . 0.0 109.591 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.59 -132.08 2.65 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.1 tp -147.08 161.93 39.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.333 -1.098 . . . . 0.0 109.32 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -134.58 88.9 2.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.88 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.54 110.16 15.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.536 -0.727 . . . . 0.0 109.642 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.4 mp -117.31 114.77 24.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.195 -0.94 . . . . 0.0 109.38 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.6 t-160 -105.05 112.86 26.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.067 -1.021 . . . . 0.0 109.483 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.4 pt -129.57 115.51 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.238 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.99 -143.34 30.83 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 106.424 -2.671 . . . . 0.0 106.424 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -104.04 78.69 1.55 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 115.116 -2.634 . . . . 0.0 108.895 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.564 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 15.3 pt-20 -166.85 168.58 13.98 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.6 t -128.84 151.46 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.257 -0.902 . . . . 0.0 109.949 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -129.12 131.99 47.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.612 . . . . 0.0 109.823 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -131.87 111.07 11.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 0.0 109.277 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.7 t -102.55 139.41 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.624 ' CD1' ' N ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.0 91.18 2.72 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.078 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 31.6 p -165.47 138.34 4.36 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.176 -1.577 . . . . 0.0 107.783 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -106.37 93.39 4.58 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 115.836 -2.345 . . . . 0.0 110.387 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.571 ' C ' ' H ' ' A' ' 130' ' ' ASP . 46.3 mtpt -114.7 154.57 28.22 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.917 176.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.629 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 89.7 m-20 -58.99 -3.03 0.29 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.479 -1.388 . . . . 0.0 107.778 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' A' ' 131' ' ' LEU . 7.3 t0 -70.58 148.57 48.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.066 -1.021 . . . . 0.0 109.314 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.633 ' N ' ' OD1' ' A' ' 130' ' ' ASP . 0.3 OUTLIER -111.08 149.83 30.24 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.512 0.672 . . . . 0.0 110.545 -179.681 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.426 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 29.5 mm -115.31 138.59 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.442 ' OG ' ' NE ' ' A' ' 34' ' ' ARG . 5.0 m -121.25 145.64 47.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.486 -0.759 . . . . 0.0 110.193 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.5 t -116.12 135.47 22.8 Favored Pre-proline 0 N--CA 1.485 1.308 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.55 147.96 94.04 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.147 1.898 . . . . 0.0 113.126 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.617 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -72.31 134.61 45.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.136 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.617 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 8.8 t-80 92.28 11.13 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.1 126.51 30.85 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.015 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.21 130.3 28.33 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.959 1.773 . . . . 0.0 111.648 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.551 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.37 165.86 14.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.197 -0.94 . . . . 0.0 110.196 -179.189 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.471 ' CG ' ' CB ' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -137.03 -149.58 0.32 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -178.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.4 ' CZ ' ' HG2' ' A' ' 144' ' ' MET . 11.5 t80 -175.61 125.27 0.23 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.934 -1.104 . . . . 0.0 109.018 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -143.81 135.17 25.89 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.373 -0.829 . . . . 0.0 109.942 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.642 ' O ' ' C ' ' A' ' 145' ' ' GLY . 52.1 mmm -113.38 21.29 15.34 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.886 -0.509 . . . . 0.0 110.852 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.642 ' C ' ' O ' ' A' ' 144' ' ' MET . . . -1.32 -74.21 0.0 OUTLIER Glycine 0 N--CA 1.503 3.151 0 CA-C-N 119.279 0.945 . . . . 0.0 111.407 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 144' ' ' MET . 22.9 t -91.4 115.49 28.08 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 117.671 -1.612 . . . . 0.0 109.171 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -119.23 116.81 33.64 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.41 -0.806 . . . . 0.0 110.164 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.2 Cg_endo -100.18 33.37 0.09 OUTLIER 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 122.56 2.173 . . . . 0.0 111.628 176.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 79.8 68.39 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.521 -0.872 . . . . 0.0 108.721 -178.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.542 ' O ' ' OG ' ' A' ' 77' ' ' SER . 14.2 p90 -96.41 -179.5 4.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.307 -0.871 . . . . 0.0 109.37 -177.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 87.1 m -149.15 100.35 3.04 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.629 -0.669 . . . . 0.0 109.574 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 75' ' ' VAL . . . -110.69 163.77 13.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.918 -1.114 . . . . 0.0 109.19 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.401 HG23 ' HE1' ' A' ' 73' ' ' TRP . 94.7 mt -107.25 127.29 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.13 -0.981 . . . . 0.0 110.222 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.87 162.49 32.25 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.419 0.628 . . . . 0.0 109.427 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.453 ' CG2' ' CG ' ' A' ' 70' ' ' TYR . 4.0 mp -106.78 149.46 10.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.522 -0.736 . . . . 0.0 109.369 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -96.87 118.95 34.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.583 ' OD2' ' N ' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -135.72 162.19 33.44 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.695 -0.628 . . . . 0.0 109.569 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -95.87 157.42 35.92 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.97 -1.081 . . . . 0.0 109.33 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 161' ' ' GLY . 47.4 Cg_endo -71.77 -52.58 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.614 2.209 . . . . 0.0 112.395 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 159' ' ' PRO . 95.1 mt-10 -43.83 -16.53 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.475 -0.765 . . . . 0.0 109.381 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -70.26 -39.88 70.91 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.461 ' HB3' ' H ' ' A' ' 99' ' ' GLY . 2.7 p90 -119.05 177.26 4.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.761 -0.847 . . . . 0.0 110.617 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.9 mm -95.37 152.05 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.417 -0.802 . . . . 0.0 109.219 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.34 -74.0 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 110.575 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -131.11 157.01 44.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -101.1 -41.54 6.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.707 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 60.0 p -105.86 -32.35 8.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.931 . . . . 0.0 109.235 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.29 -4.15 60.21 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.545 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -80.46 145.81 31.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.773 -1.428 . . . . 0.0 108.957 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -110.32 89.22 2.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.776 -1.569 . . . . 0.0 111.402 176.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.5 tt -78.63 -17.92 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.525 -1.359 . . . . 0.0 109.167 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.524 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -57.59 -42.7 83.7 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.596 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 45.8 m -54.17 -4.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.391 -0.818 . . . . 0.0 109.985 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.04 -40.5 31.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.958 -1.089 . . . . 0.0 111.549 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.618 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 9.3 m-85 -112.23 25.59 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.619 0 O-C-N 120.707 -1.246 . . . . 0.0 112.495 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 43.6 Cg_endo -62.42 -21.03 72.19 Favored 'Trans proline' 0 N--CA 1.503 2.088 0 C-N-CA 123.588 2.859 . . . . 0.0 113.168 -172.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -89.45 127.07 35.8 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.157 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' C ' ' A' ' 179' ' ' ALA . 0.7 OUTLIER -85.91 145.68 27.05 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.403 ' CA ' ' SG ' ' A' ' 126' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.538 ' N ' ' SG ' ' A' ' 126' ' ' CYS . . . -99.2 172.04 7.62 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.147 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.485 ' CD2' ' CZ3' ' A' ' 16' ' ' TRP . 25.2 tp -157.05 114.26 3.09 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.26 130.69 55.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 110.72 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.9 mt -124.76 134.0 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.2 168.93 14.75 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t -92.18 175.75 6.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.058 -1.026 . . . . 0.0 108.306 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.95 -26.7 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.728 -1.232 . . . . 0.0 109.396 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -72.35 -38.54 68.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.175 -0.953 . . . . 0.0 110.57 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.489 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 9.1 m-20 -139.41 123.38 11.02 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 109.766 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.3 -27.84 1.33 Allowed 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.021 1.814 . . . . 0.0 112.52 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -69.79 -0.49 7.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.455 -0.778 . . . . 0.0 111.178 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 6.7 p-10 -123.08 126.13 46.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.079 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 p -97.84 128.49 44.49 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 108.748 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pp -90.13 -9.93 46.47 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.801 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.702 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 31.1 t90 -158.01 108.79 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.052 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -122.37 124.58 44.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.334 -0.854 . . . . 0.0 110.241 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.61 168.62 21.47 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.053 -1.029 . . . . 0.0 110.594 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.526 ' O ' ' CG2' ' A' ' 19' ' ' THR . 1.0 OUTLIER -127.99 88.35 2.75 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 176.377 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.515 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 19.5 m120 -127.37 139.37 52.91 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.538 -0.726 . . . . 0.0 109.984 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.4 -36.13 24.52 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 119.676 -1.89 . . . . 0.0 108.675 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.35 -49.39 10.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.719 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.09 -22.94 67.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.875 -1.141 . . . . 0.0 108.128 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.515 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 1.7 mt -66.8 -50.32 66.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 29' ' ' ASN . 53.3 tt0 -56.2 -55.12 37.11 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.432 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.428 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 62.1 tt0 -56.66 -34.28 67.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 0.0 110.45 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.702 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -62.36 -65.13 0.73 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.912 -1.117 . . . . 0.0 109.656 -179.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.27 -46.97 63.29 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.662 -1.274 . . . . 0.0 109.677 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.626 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 20.4 t-20 -57.0 -25.71 59.0 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.045 -1.035 . . . . 0.0 109.427 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 26' ' ' GLN . . . -65.78 -28.08 68.76 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.76 -1.213 . . . . 0.0 107.762 177.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -87.58 14.6 8.03 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.975 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.91 23.38 35.63 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.434 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.626 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 56.7 t -94.53 144.73 9.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.226 -1.161 . . . . 0.0 109.89 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.7 ttt-85 -84.62 157.73 21.08 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.501 ' CZ ' ' OD2' ' A' ' 130' ' ' ASP . 1.3 t80 -155.22 153.68 31.04 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.3 pt-20 -175.81 176.45 1.84 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.042 -1.036 . . . . 0.0 110.102 177.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -154.31 121.8 5.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.394 -0.816 . . . . 0.0 109.065 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.611 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 33.2 m0 -111.28 154.98 23.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.405 -0.81 . . . . 0.0 109.033 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -142.23 155.13 45.24 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.284 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.31 159.68 14.77 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -98.38 -19.69 17.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.077 -1.014 . . . . 0.0 108.36 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -93.42 167.12 11.92 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -93.83 131.38 39.28 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.485 -0.759 . . . . 0.0 109.458 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -93.64 161.97 14.13 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.303 -0.873 . . . . 0.0 109.499 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.36 -96.3 0.11 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.78 107.09 8.84 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.344 -1.092 . . . . 0.0 108.15 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.97 90.02 46.56 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.638 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.57 46.3 1.71 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.819 2.346 . . . . 0.0 111.22 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.53 ' O ' ' OG1' ' A' ' 52' ' ' THR . 0.0 OUTLIER -169.27 139.9 2.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.556 -1.34 . . . . 0.0 108.978 178.061 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.09 -43.89 15.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.521 -1.362 . . . . 0.0 109.353 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -66.67 -4.32 8.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.59 -0.694 . . . . 0.0 110.335 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.53 ' OG1' ' O ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -77.77 -52.88 8.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.762 -1.211 . . . . 0.0 109.941 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.99 -44.67 84.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.112 -0.993 . . . . 0.0 110.253 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 58' ' ' GLN . 13.9 mm -60.3 -41.84 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.959 -1.088 . . . . 0.0 108.517 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.12 -22.87 66.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.445 -0.784 . . . . 0.0 109.89 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.1 -21.63 50.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.999 -1.063 . . . . 0.0 110.265 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 58' ' ' GLN . 59.2 m-85 -115.5 -10.16 11.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.493 -0.754 . . . . 0.0 109.206 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.672 HE21 ' CG1' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -46.89 -34.06 5.11 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.395 -0.922 . . . . 0.0 108.942 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.641 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 26.5 p80 -51.74 -50.48 60.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.891 -1.13 . . . . 0.0 109.573 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.641 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.2 -60.96 2.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.914 -1.116 . . . . 0.0 109.72 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.672 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.5 OUTLIER -61.49 -27.58 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.393 -1.442 . . . . 0.0 109.55 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 58' ' ' GLN . 79.8 m-20 -59.24 -22.33 60.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.066 -1.021 . . . . 0.0 109.807 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 pttp -83.0 -32.9 26.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.949 -1.094 . . . . 0.0 108.633 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mp -65.53 -46.85 78.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.334 -0.854 . . . . 0.0 109.662 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.01 -27.74 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.549 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.32 -49.51 74.12 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.74 -1.225 . . . . 0.0 109.713 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.55 -51.74 7.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.028 -1.045 . . . . 0.0 110.54 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.629 ' O ' ' C ' ' A' ' 69' ' ' GLY . 2.1 mptp? -82.73 13.13 4.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.349 -0.844 . . . . 0.0 110.968 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -6.42 81.7 0.0 OUTLIER Glycine 0 N--CA 1.505 3.27 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 68' ' ' LYS . 84.3 m-85 -75.16 159.95 31.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -1.071 . . . . 0.0 109.193 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.585 ' OE1' ' ND2' ' A' ' 158' ' ' ASN . 85.1 mt-30 -58.33 -41.83 85.46 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.456 -0.777 . . . . 0.0 109.861 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 t -147.21 155.41 42.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.938 -1.101 . . . . 0.0 110.847 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -129.5 133.34 47.21 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.472 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.4 OUTLIER -145.6 165.67 27.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.1 p -97.98 174.8 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 121.308 -0.87 . . . . 0.0 109.084 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.47 HG12 ' HE ' ' A' ' 154' ' ' ARG . 52.5 mt -109.51 118.11 56.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.4 p -92.58 160.33 15.08 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 123.11 1.433 . . . . 0.0 111.548 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.621 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 0.1 OUTLIER -158.0 138.27 12.59 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.652 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.517 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -130.18 139.02 50.89 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.94 0.4 21.2 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.898 -1.126 . . . . 0.0 110.743 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.422 ' H ' ' HD3' ' A' ' 79' ' ' ARG . 93.4 m-20 -111.11 -14.82 13.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 0.0 109.21 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.572 HD22 HD13 ' A' ' 78' ' ' LEU . 44.7 p-10 -63.36 117.91 38.55 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.285 -0.884 . . . . 0.0 110.414 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -88.14 -13.99 3.52 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.35 2.033 . . . . 0.0 113.039 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -92.38 -11.09 35.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.032 -1.043 . . . . 0.0 110.611 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.678 ' CG ' HH12 ' A' ' 89' ' ' ARG . 20.1 tptt -62.54 -38.77 91.3 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.956 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -59.69 -44.2 93.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.834 . . . . 0.0 109.57 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.59 -38.63 66.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.024 -1.048 . . . . 0.0 109.483 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 49.6 mt -60.58 -36.43 78.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 0.0 109.026 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.678 HH12 ' CG ' ' A' ' 85' ' ' LYS . 0.9 OUTLIER -60.09 -30.53 69.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 109.318 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -64.47 -60.39 3.21 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.044 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -58.73 -30.94 67.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.15 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -83.41 -18.74 37.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.5 mt -63.82 -25.31 68.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.066 -1.022 . . . . 0.0 110.012 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -58.62 141.32 52.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 109.6 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -72.99 158.46 35.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 109.347 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -168.01 -168.96 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 110.788 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.9 133.64 6.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 109.11 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.683 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -106.43 154.32 20.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 0.0 109.738 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.21 -7.69 86.87 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -123.42 170.35 10.44 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.345 -1.091 . . . . 0.0 109.417 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -74.61 143.51 44.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.07 -1.019 . . . . 0.0 110.017 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.432 ' HG3' ' CE1' ' A' ' 98' ' ' HIS . 1.6 mt-10 -101.97 96.33 6.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.26 -0.9 . . . . 0.0 109.206 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.7 m -100.85 128.74 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.735 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.564 ' NE ' ' CZ ' ' A' ' 142' ' ' PHE . 6.6 mtm180 -128.9 134.58 48.31 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.611 ' CE2' ' CE3' ' A' ' 38' ' ' TRP . 66.0 t80 -112.99 131.53 55.72 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.77 0.795 . . . . 0.0 109.938 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.18 125.8 34.4 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.359 0.599 . . . . 0.0 109.72 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.89 -39.7 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.455 -0.778 . . . . 0.0 109.941 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -160.47 146.94 15.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.145 -0.972 . . . . 0.0 109.899 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.48 ' O ' ' OE1' ' A' ' 127' ' ' GLU . . . 87.89 164.18 39.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.72 160.59 26.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.513 -0.992 . . . . 0.0 109.664 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.22 -119.62 1.01 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.0 tp -148.31 163.33 37.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -1.106 . . . . 0.0 108.73 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.551 ' CD1' ' C ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -137.99 145.93 42.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.976 -1.078 . . . . 0.0 108.952 177.013 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.445 ' SG ' ' C ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -148.58 139.22 22.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.489 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.86 128.68 20.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.459 -0.776 . . . . 0.0 109.321 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -103.3 111.56 24.02 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.178 -0.952 . . . . 0.0 109.18 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.9 mm -126.1 114.64 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.145 -0.972 . . . . 0.0 110.781 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.66 -142.42 29.93 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 104.422 -3.471 . . . . 0.0 104.422 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -109.92 82.95 1.67 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 115.296 -2.561 . . . . 0.0 107.675 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -165.46 168.33 16.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 83.4 t -131.13 150.03 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.123 -0.986 . . . . 0.0 109.418 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -129.3 134.53 47.97 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.636 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -138.22 134.77 34.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.072 -1.018 . . . . 0.0 108.669 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.8 p -127.16 148.33 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.981 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.559 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 1.0 OUTLIER -123.72 75.16 1.32 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 118.193 -1.403 . . . . 0.0 110.732 179.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.559 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -162.29 119.7 2.1 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.48 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 8.7 tm-20 -115.37 106.24 13.77 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 117.526 -1.67 . . . . 0.0 110.653 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.644 ' C ' ' H ' ' A' ' 130' ' ' ASP . 86.6 mttt -110.92 -178.96 3.61 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 38' ' ' TRP . 71.4 m-80 -58.48 0.47 0.08 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.644 ' H ' ' C ' ' A' ' 128' ' ' LYS . 21.0 t0 -71.71 143.43 49.65 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.723 -1.236 . . . . 0.0 110.451 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.596 ' N ' ' OD1' ' A' ' 130' ' ' ASP . 0.2 OUTLIER -110.85 149.36 30.69 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.657 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.448 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 26.2 mm -114.45 131.93 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -120.31 144.57 47.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.869 . . . . 0.0 110.116 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.7 t -117.14 134.43 23.04 Favored Pre-proline 0 N--CA 1.488 1.436 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.17 151.87 76.65 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.954 1.769 . . . . 0.0 112.284 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.612 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.86 133.04 46.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 109.686 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.612 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 3.7 t-160 92.76 10.27 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 120.964 0.412 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.36 125.92 32.91 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.12 -0.987 . . . . 0.0 108.461 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.52 131.96 31.57 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.622 1.548 . . . . 0.0 111.575 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.504 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.16 163.15 15.55 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.479 -179.062 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 26.5 p90 -128.65 -153.9 0.6 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.533 -0.729 . . . . 0.0 109.67 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.631 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -172.92 124.0 0.43 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.505 -0.747 . . . . 0.0 109.214 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.436 ' OD2' ' N ' ' A' ' 144' ' ' MET . 29.9 t0 -147.96 131.91 17.16 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.147 -0.97 . . . . 0.0 109.453 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.606 ' O ' ' C ' ' A' ' 145' ' ' GLY . 7.4 mtm -111.76 20.02 17.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.273 -0.892 . . . . 0.0 110.815 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.606 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 11.02 -90.82 0.01 OUTLIER Glycine 0 N--CA 1.503 3.165 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.452 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 46.7 t -87.52 119.6 27.97 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.3 -1.36 . . . . 0.0 109.857 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.596 ' OE1' ' NE ' ' A' ' 89' ' ' ARG . 6.5 mp0 -114.08 120.11 39.31 Favored Pre-proline 0 N--CA 1.493 1.68 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.569 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.7 Cg_endo -100.32 28.88 0.12 Allowed 'Trans proline' 0 C--O 1.212 -0.806 0 C-N-CA 122.476 2.117 . . . . 0.0 112.753 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.621 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER 81.33 64.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.762 0.792 . . . . 0.0 110.16 -179.193 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.49 ' C ' ' CD2' ' A' ' 150' ' ' PHE . 15.2 p90 -101.6 171.06 7.78 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.577 0.703 . . . . 0.0 110.292 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 87.7 m -126.42 138.94 53.59 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -146.52 165.72 28.6 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.238 -0.914 . . . . 0.0 109.415 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 75.5 mt -118.09 136.66 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.386 -0.821 . . . . 0.0 109.746 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.47 ' HE ' HG12 ' A' ' 76' ' ' ILE . 2.7 mtm180 -140.15 168.01 20.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.021 -1.049 . . . . 0.0 109.653 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.476 ' CG2' ' CG ' ' A' ' 70' ' ' TYR . 3.9 mp -107.39 155.22 8.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.631 -0.668 . . . . 0.0 109.562 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.2 m-30 -103.06 121.09 41.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.204 -0.935 . . . . 0.0 110.319 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 3.9 t0 -133.27 163.06 30.15 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.668 ' N ' ' ND2' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -93.41 161.9 29.43 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.102 -0.999 . . . . 0.0 109.285 -178.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.3 Cg_endo -62.73 -55.01 0.96 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.237 1.958 . . . . 0.0 112.293 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 160' ' ' GLU . 55.2 mp0 -44.41 -13.28 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.401 -0.812 . . . . 0.0 109.247 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -78.75 -33.94 36.25 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.534 ' N ' ' O ' ' A' ' 159' ' ' PRO . 4.5 p90 -118.8 159.32 23.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.381 -1.07 . . . . 0.0 110.825 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.45 HG22 HD12 ' A' ' 163' ' ' ILE . 81.7 mt -100.2 147.91 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.549 -0.719 . . . . 0.0 109.453 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.65 -73.25 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.5 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -140.9 159.47 42.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.944 -1.097 . . . . 0.0 109.883 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -89.69 -41.87 11.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.393 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 52.7 m -116.06 -31.39 5.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.305 -0.872 . . . . 0.0 108.696 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.63 -5.4 51.3 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.807 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -80.77 149.51 29.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.659 -1.495 . . . . 0.0 107.952 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -105.38 89.97 3.28 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 117.337 -1.745 . . . . 0.0 110.762 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.76 -30.11 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.95 -1.094 . . . . 0.0 109.417 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -63.45 -41.33 98.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.332 -0.855 . . . . 0.0 108.851 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.504 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 15.7 t -51.9 -4.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 110.173 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.568 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -83.19 -34.03 26.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.09 -1.007 . . . . 0.0 110.901 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.591 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.1 m-85 -110.03 27.32 0.07 OUTLIER Pre-proline 0 N--CA 1.515 2.81 0 O-C-N 120.81 -1.181 . . . . 0.0 112.764 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 40.5 Cg_endo -58.97 -24.02 71.11 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 123.559 2.839 . . . . 0.0 114.511 -172.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -88.92 125.7 35.07 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 118.375 -1.33 . . . . 0.0 108.133 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' C ' ' A' ' 179' ' ' ALA . 5.0 tt -87.06 128.95 35.09 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.596 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.596 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.36 170.76 8.63 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.047 -1.033 . . . . 0.0 109.412 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 29.3 tp -158.06 114.98 2.89 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 130.78 55.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.18 -0.95 . . . . 0.0 109.797 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.411 ' CD1' ' CE1' ' A' ' 122' ' ' PHE . 71.5 mt -127.29 138.34 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 178.97 6.87 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.605 0.717 . . . . 0.0 109.444 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.1 t -96.05 174.62 6.83 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.38 -22.88 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.028 -1.045 . . . . 0.0 109.159 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -73.73 -37.76 65.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.148 -0.97 . . . . 0.0 110.512 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.458 ' OD2' ' N ' ' A' ' 10' ' ' ASP . 1.3 p30 -137.51 123.59 13.13 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.029 -1.045 . . . . 0.0 109.461 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -81.86 -38.4 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.944 1.763 . . . . 0.0 112.301 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.32 3.09 2.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 110.275 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -114.67 119.44 36.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.874 . . . . 0.0 109.089 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 p -100.21 122.77 43.55 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.192 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 pp -88.09 -8.97 54.7 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.054 -1.059 . . . . 0.0 108.991 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.676 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 38.7 t90 -157.7 107.69 2.17 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.315 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -120.4 121.86 39.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.409 -0.807 . . . . 0.0 110.026 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.419 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -163.15 164.45 25.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.439 -0.788 . . . . 0.0 109.999 -179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.596 ' OG1' ' O ' ' A' ' 1' ' ' SER . 10.7 t -130.86 88.83 2.66 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 118.955 -1.098 . . . . 0.0 108.16 175.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.534 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 12.0 m120 -125.9 143.68 50.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.098 -1.001 . . . . 0.0 110.684 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.15 -39.62 22.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.342 -1.474 . . . . 0.0 108.664 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.21 -50.89 8.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 109.566 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.7 -21.58 60.81 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.879 -1.138 . . . . 0.0 108.559 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 2.0 mt -70.05 -57.34 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.256 -0.902 . . . . 0.0 108.943 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.517 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 8.7 pt20 -62.65 -44.94 94.99 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.941 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.517 ' N ' ' CG ' ' A' ' 25' ' ' GLN . 25.9 mt-30 -59.88 -42.38 93.62 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.148 -0.97 . . . . 0.0 109.885 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.676 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 5.3 tt0 -80.24 -47.03 15.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.912 -1.118 . . . . 0.0 109.399 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.2 tp -66.14 -55.4 16.58 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.986 -1.071 . . . . 0.0 109.022 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 33' ' ' VAL . 41.2 t-20 -59.63 -19.78 51.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.911 -1.118 . . . . 0.0 109.471 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.58 68.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.859 -1.151 . . . . 0.0 108.601 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -86.5 12.78 9.6 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.737 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.72 23.23 31.26 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.042 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.484 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 70.6 t -94.33 145.44 7.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.469 -1.018 . . . . 0.0 109.176 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -84.45 158.5 21.02 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.345 -0.847 . . . . 0.0 108.737 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CD1' ' CB ' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -152.77 152.31 31.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.881 -1.137 . . . . 0.0 108.006 177.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.548 ' O ' ' OD1' ' A' ' 130' ' ' ASP . 3.4 mm-40 -170.77 169.4 6.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.909 -1.119 . . . . 0.0 109.21 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -150.55 118.58 6.29 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.503 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 23.4 m0 -111.17 150.32 29.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.863 . . . . 0.0 108.996 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -139.68 157.51 45.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.149 -0.969 . . . . 0.0 109.629 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.31 159.53 15.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 108.968 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.47 ' OD2' ' N ' ' A' ' 42' ' ' ARG . 54.1 p30 -100.17 -9.94 21.96 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.47 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 15.8 ttm180 -93.48 150.69 20.25 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.3 117.88 30.03 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.536 -0.727 . . . . 0.0 109.261 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mt -93.28 165.63 12.71 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.32 -0.863 . . . . 0.0 109.383 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.39 -121.33 0.56 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.49 78.57 9.66 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.113 -1.228 . . . . 0.0 108.635 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.3 94.58 48.79 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.509 -0.744 . . . . 0.0 109.087 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.25 85.61 0.43 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.822 1.681 . . . . 0.0 111.646 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.28 109.02 0.64 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.265 -0.897 . . . . 0.0 109.276 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.25 -35.41 31.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.645 -1.284 . . . . 0.0 109.759 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -65.28 -20.78 66.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 110.155 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.9 m -79.83 -35.67 37.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.161 -0.962 . . . . 0.0 110.302 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.95 -46.51 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.957 . . . . 0.0 109.842 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -61.99 -42.18 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.935 . . . . 0.0 108.978 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.34 -29.75 70.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.399 -0.813 . . . . 0.0 109.702 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.12 -19.17 58.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 110.165 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -116.38 -9.0 11.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.794 . . . . 0.0 109.566 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 54' ' ' ILE . 4.8 mm-40 -49.65 -39.04 34.79 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.145 -0.972 . . . . 0.0 108.857 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.598 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 21.5 p80 -52.68 -45.03 66.64 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.427 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.598 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.12 -59.65 4.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.906 -1.121 . . . . 0.0 110.015 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.49 ' CD1' ' C ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -63.42 -28.25 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.025 -1.047 . . . . 0.0 109.289 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.2 t70 -58.35 -24.73 60.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.382 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -84.6 -41.63 16.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 109.978 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.3 tt -66.49 -46.27 76.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.388 -0.82 . . . . 0.0 109.751 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.7 p -67.24 -30.11 48.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 109.283 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.41 -43.52 75.35 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.094 -1.004 . . . . 0.0 109.367 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -78.52 -52.21 8.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 0.0 109.832 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.64 ' O ' ' C ' ' A' ' 69' ' ' GLY . 45.0 mmtm -83.22 12.18 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.389 -0.82 . . . . 0.0 110.342 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.64 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -0.23 80.33 0.0 OUTLIER Glycine 0 N--CA 1.503 3.166 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' LYS . 43.2 m-85 -77.27 166.36 23.29 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.375 -1.073 . . . . 0.0 108.461 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -57.24 -92.24 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.444 -0.785 . . . . 0.0 109.173 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.44 164.9 11.42 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.603 0.716 . . . . 0.0 110.177 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.411 ' HE1' HG21 ' A' ' 153' ' ' ILE . 6.4 t-105 -136.2 140.61 43.67 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.427 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.8 OUTLIER -157.37 175.36 14.09 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.089 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -120.14 143.27 32.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.3 tp -103.07 115.89 45.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.513 ' O ' ' OG ' ' A' ' 77' ' ' SER . 9.8 p -168.57 101.44 0.41 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.503 -0.748 . . . . 0.0 109.003 178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.532 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 9.9 tp -110.45 -179.49 3.78 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 119.564 -1.96 . . . . 0.0 107.751 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.632 ' C ' ' H ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -88.41 147.49 24.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.744 -1.223 . . . . 0.0 109.773 -178.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.22 3.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.656 -0.652 . . . . 0.0 109.571 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.632 ' H ' ' C ' ' A' ' 79' ' ' ARG . 84.6 m-20 -88.39 -25.52 22.65 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.624 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -63.61 128.08 92.24 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.991 -1.068 . . . . 0.0 109.639 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -75.95 -6.49 17.46 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.211 1.941 . . . . 0.0 112.392 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -89.33 10.69 21.43 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.9 -1.125 . . . . 0.0 109.41 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.545 ' CG ' ' H ' ' A' ' 86' ' ' GLU . 2.4 pttm -56.77 -57.28 13.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 108.798 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.545 ' H ' ' CG ' ' A' ' 85' ' ' LYS . 84.1 tt0 -66.15 -40.02 90.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.207 -0.933 . . . . 0.0 109.798 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.31 90.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.692 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.2 mt -61.3 -46.93 88.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 110.203 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.61 -26.41 67.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.947 -1.095 . . . . 0.0 109.721 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -67.21 -59.3 3.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.453 -0.779 . . . . 0.0 110.375 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -57.9 -38.65 76.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.97 . . . . 0.0 109.534 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -74.59 -24.21 58.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.719 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 94' ' ' ASN . 1.5 tt -64.18 -33.98 77.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 109.997 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 94' ' ' ASN . 44.0 p-10 -43.09 148.68 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 109.709 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.565 ' OE2' ' N ' ' A' ' 171' ' ' ILE . 77.5 mt-10 -85.24 157.44 20.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.334 -0.854 . . . . 0.0 109.626 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -174.38 -165.72 0.23 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.011 -1.056 . . . . 0.0 111.488 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.83 131.8 3.02 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.603 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -101.63 155.3 18.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 109.955 -178.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.86 -5.92 86.89 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.461 ' HG3' ' H ' ' A' ' 101' ' ' ASP . 22.6 tp10 -126.57 169.26 13.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -1.07 . . . . 0.0 109.304 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.461 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 89.4 m-20 -70.06 143.42 52.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.245 -0.91 . . . . 0.0 110.06 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.603 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 2.7 tt0 -102.52 95.05 5.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 110.195 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.0 m -94.64 125.52 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.31 126.03 38.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.503 ' CE2' ' CE3' ' A' ' 38' ' ' TRP . 42.3 t80 -101.92 126.89 48.93 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.61 134.24 34.23 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.618 -0.676 . . . . 0.0 110.39 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.2 -25.9 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.814 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' A' ' 109' ' ' GLY . 74.3 tt0 -172.36 163.94 5.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.008 -1.057 . . . . 0.0 108.895 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.619 ' N ' ' OE1' ' A' ' 127' ' ' GLU . . . 43.78 104.61 0.01 OUTLIER Glycine 0 N--CA 1.495 2.569 0 O-C-N 121.104 -0.998 . . . . 0.0 110.792 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.79 111.08 4.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.671 -1.488 . . . . 0.0 109.105 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.51 -140.89 1.78 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -109.9 100.97 9.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.415 -1.05 . . . . 0.0 111.775 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.493 ' C ' ' OE1' ' A' ' 123' ' ' GLN . 30.8 p90 -79.82 128.62 33.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.61 -1.306 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.462 ' SG ' ' NE1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -78.91 143.71 35.58 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.318 0.58 . . . . 0.0 109.939 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 tp -131.38 124.73 30.95 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.2 t-160 -102.43 103.48 13.88 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.927 -1.108 . . . . 0.0 110.012 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.93 105.92 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.203 -0.936 . . . . 0.0 109.889 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.54 -144.24 32.59 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 105.293 -3.123 . . . . 0.0 105.293 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.521 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 41.5 p30 -102.11 79.36 1.87 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 115.225 -2.59 . . . . 0.0 109.589 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.527 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 15.0 tp10 -165.76 170.68 13.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.405 ' H ' ' HG3' ' A' ' 120' ' ' GLU . 55.8 t -127.74 141.94 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.12 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.411 ' CE1' ' CD1' ' A' ' 5' ' ' ILE . 22.1 m-85 -128.49 132.32 48.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.808 -0.557 . . . . 0.0 109.788 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.493 ' OE1' ' C ' ' A' ' 113' ' ' PHE . 11.2 mm-40 -128.73 112.98 14.78 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 2.4 t -100.54 134.99 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.535 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 54.5 tp -126.54 86.05 2.46 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.543 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.535 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -168.2 137.51 2.45 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -104.67 99.42 9.09 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 116.119 -2.232 . . . . 0.0 109.792 -179.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.613 ' C ' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -119.38 159.53 24.01 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.988 176.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.478 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -60.68 2.67 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.002 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.613 ' H ' ' C ' ' A' ' 128' ' ' LYS . 9.6 t70 -66.45 135.3 54.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.86 -1.15 . . . . 0.0 110.353 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.443 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 1.4 tm? -92.37 125.11 36.88 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.748 -177.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.467 ' CD1' ' OD2' ' A' ' 130' ' ' ASP . 1.0 OUTLIER -108.33 127.62 64.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.2 t -120.69 144.15 48.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.451 -0.781 . . . . 0.0 109.673 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -119.13 142.18 31.72 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.39 147.16 70.92 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.343 2.029 . . . . 0.0 113.051 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.614 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.8 134.15 45.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 109.375 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.614 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 2.2 t-80 92.32 11.02 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.68 128.13 27.49 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.117 -0.99 . . . . 0.0 108.797 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.49 132.38 33.13 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.751 1.634 . . . . 0.0 111.53 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.55 164.72 10.39 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.199 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.462 ' NE1' ' SG ' ' A' ' 114' ' ' CYS . 0.4 OUTLIER -136.66 -149.14 0.31 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.195 -0.941 . . . . 0.0 109.597 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.422 ' H ' ' HB2' ' A' ' 141' ' ' TRP . 68.7 t80 -173.61 124.1 0.37 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.997 -1.064 . . . . 0.0 109.018 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -137.66 129.99 29.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.55 -0.719 . . . . 0.0 109.525 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.612 ' SD ' ' CE2' ' A' ' 150' ' ' PHE . 60.5 mtm -100.61 16.97 23.04 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.764 -0.585 . . . . 0.0 111.312 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 32.64 -125.92 0.29 Allowed Glycine 0 N--CA 1.49 2.287 0 O-C-N 120.636 -1.29 . . . . 0.0 110.537 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.521 ' H ' ' HB2' ' A' ' 178' ' ' LEU . 0.4 OUTLIER -81.7 121.37 26.29 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.099 -1.441 . . . . 0.0 108.624 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.89 115.58 45.85 Favored Pre-proline 0 N--CA 1.492 1.636 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.355 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 60.3 Cg_endo -103.69 50.34 0.03 OUTLIER 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 122.957 2.438 . . . . 0.0 110.742 176.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.2 OUTLIER 81.85 70.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.132 -177.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.612 ' CE2' ' SD ' ' A' ' 144' ' ' MET . 20.5 p90 -96.24 163.13 13.22 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.274 -0.891 . . . . 0.0 110.167 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.9 m -128.81 124.5 35.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.469 -0.769 . . . . 0.0 110.533 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.97 160.75 39.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.501 -0.749 . . . . 0.0 109.012 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.411 HG21 ' HE1' ' A' ' 73' ' ' TRP . 79.6 mt -111.14 129.24 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.182 -0.949 . . . . 0.0 109.247 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.29 165.09 26.24 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.475 ' CD1' ' N ' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -107.59 152.66 9.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.49 -0.756 . . . . 0.0 109.381 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.427 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.8 m-30 -96.77 119.63 35.61 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.0 0.905 . . . . 0.0 109.892 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 53.5 p30 -134.99 163.84 28.95 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.525 ' C ' ' ND2' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -94.03 161.54 29.48 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.982 -1.073 . . . . 0.0 109.075 -179.259 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.63 ' O ' ' N ' ' A' ' 161' ' ' GLY . 40.7 Cg_endo -63.77 -55.45 0.67 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.013 1.809 . . . . 0.0 112.045 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 159' ' ' PRO . 94.4 mt-10 -43.77 -14.38 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.369 -0.832 . . . . 0.0 109.197 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -75.93 -40.52 30.29 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.507 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 4.1 p90 -108.83 159.56 16.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 79.2 mt -100.67 147.42 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.402 -0.811 . . . . 0.0 109.509 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -49.2 -74.11 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.263 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.29 161.47 38.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.111 -0.993 . . . . 0.0 109.804 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -88.19 -41.62 12.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.028 -1.045 . . . . 0.0 109.546 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.639 ' HG1' ' H ' ' A' ' 169' ' ' ASP . 63.4 p -112.48 -31.89 6.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.293 -0.879 . . . . 0.0 108.877 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.91 -8.02 53.61 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.639 ' H ' ' HG1' ' A' ' 167' ' ' THR . 90.8 m-20 -80.04 145.92 32.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.624 -1.515 . . . . 0.0 108.039 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -112.36 89.81 3.17 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.316 -1.354 . . . . 0.0 110.872 176.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.565 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -83.21 -20.12 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.049 -1.657 . . . . 0.0 109.284 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.558 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -56.77 -43.82 81.18 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.406 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 47.6 t -56.25 -1.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 109.648 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -87.93 -18.62 28.73 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.382 -0.824 . . . . 0.0 110.842 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.573 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 54.2 m-85 -108.45 27.41 0.07 OUTLIER Pre-proline 0 N--CA 1.518 2.952 0 O-C-N 121.187 -0.946 . . . . 0.0 112.83 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 42.1 Cg_endo -60.86 -5.57 4.86 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 123.916 3.077 . . . . 0.0 113.453 -173.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -84.62 148.94 26.18 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.3 -0.875 . . . . 0.0 109.149 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.576 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 15.9 tp -89.34 101.18 13.85 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.829 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.905 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.62 ' O ' ' OG1' ' A' ' 19' ' ' THR . 7.9 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.2 169.96 9.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.126 -0.983 . . . . 0.0 109.214 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tp -157.24 118.96 3.74 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.79 133.88 52.66 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.179 -0.95 . . . . 0.0 109.795 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' A' ' 121' ' ' VAL . 52.9 mt -127.5 136.08 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.58 166.19 20.22 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.409 ' OG ' ' CD1' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -86.75 174.27 8.93 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 108.796 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.33 -28.31 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.03 -1.044 . . . . 0.0 109.117 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -73.54 -36.91 65.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.28 124.97 15.41 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 109.552 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 13' ' ' ASN . 55.8 Cg_endo -80.82 -37.82 0.31 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.935 1.757 . . . . 0.0 112.407 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.42 ' C ' HD21 ' A' ' 13' ' ' ASN . 1.6 tt0 -69.46 6.26 1.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.093 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.631 ' N ' HD21 ' A' ' 13' ' ' ASN . 0.9 OUTLIER -114.03 120.32 40.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.908 . . . . 0.0 109.055 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.5 p -100.29 122.01 42.4 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.365 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.409 ' CD1' ' OG ' ' A' ' 7' ' ' SER . 7.1 mt -88.9 -7.52 55.94 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.064 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.644 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 48.3 t90 -157.46 105.95 2.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.421 -1.312 . . . . 0.0 109.9 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -117.82 111.11 18.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.329 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.436 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -162.47 162.85 27.7 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.868 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.62 ' OG1' ' O ' ' A' ' 1' ' ' SER . 10.0 t -131.71 90.28 2.82 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 120.966 -1.084 . . . . 0.0 108.181 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.557 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 1.7 m-80 -124.55 143.47 50.67 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.285 -0.884 . . . . 0.0 110.442 177.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.75 -40.88 22.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.012 -1.68 . . . . 0.0 108.536 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.28 -48.41 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 110.021 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -60.62 -23.95 65.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.969 -1.082 . . . . 0.0 108.698 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.557 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 10.9 mt -72.63 -53.68 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.234 -0.916 . . . . 0.0 108.83 178.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 29' ' ' ASN . 52.0 tt0 -59.09 -52.87 63.85 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.141 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.75 -40.14 87.16 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.28 -0.888 . . . . 0.0 109.64 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.644 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 7.0 tt0 -78.1 -50.21 12.46 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.933 -1.104 . . . . 0.0 109.579 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 24' ' ' ILE . 22.6 tp -69.03 -55.87 9.49 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.7 -1.25 . . . . 0.0 109.268 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 25' ' ' GLN . 26.2 t-20 -56.82 -20.89 25.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.876 -1.14 . . . . 0.0 109.448 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.54 -26.37 67.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.889 -1.132 . . . . 0.0 108.374 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 10.63 15.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.296 -0.877 . . . . 0.0 109.695 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.06 21.89 26.69 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.4 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 38.6 t -94.31 146.26 6.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.193 -1.18 . . . . 0.0 108.958 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.429 HH12 ' NZ ' ' A' ' 68' ' ' LYS . 13.4 ttm180 -84.12 157.24 21.78 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.438 ' C ' ' OE1' ' A' ' 36' ' ' GLU . 1.2 t80 -154.98 153.66 31.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.83 -1.169 . . . . 0.0 108.729 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.438 ' OE1' ' C ' ' A' ' 35' ' ' PHE . 1.5 pm0 -175.63 173.21 2.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.861 -1.149 . . . . 0.0 109.837 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -148.82 112.94 5.2 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.642 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 23.9 m0 -111.48 149.76 30.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 38' ' ' TRP . 84.0 mm-40 -138.09 157.87 45.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.776 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.22 158.79 15.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 108.937 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -101.34 -12.98 18.21 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -92.94 158.34 15.87 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.652 0.739 . . . . 0.0 109.051 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -93.0 119.29 32.1 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.615 -0.678 . . . . 0.0 109.507 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.34 164.0 14.01 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.381 -0.824 . . . . 0.0 109.278 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.72 -103.94 0.2 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.0 88.64 4.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.115 -1.226 . . . . 0.0 109.264 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.54 92.92 17.81 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.482 -0.761 . . . . 0.0 109.005 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.54 -28.2 10.26 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.151 1.901 . . . . 0.0 112.574 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 50.1 p -119.86 140.94 50.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.649 -0.657 . . . . 0.0 109.877 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.0 -17.28 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 109.593 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -46.61 -37.53 8.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.33 -0.856 . . . . 0.0 109.119 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.5 p -78.81 -31.12 45.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 0.0 109.338 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.1 t -69.11 -48.87 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.86 . . . . 0.0 109.818 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 58' ' ' GLN . 6.6 mt -59.65 -39.3 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 109.017 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.51 -31.0 71.69 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.434 -0.791 . . . . 0.0 109.657 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.22 -17.79 60.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 0.0 110.042 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -113.98 -6.8 13.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.448 -0.783 . . . . 0.0 109.307 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 62' ' ' ASP . 1.1 mm-40 -48.64 -39.48 24.35 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.305 -0.958 . . . . 0.0 108.993 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 60' ' ' ALA . 35.6 p80 -52.08 -46.78 65.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.039 -1.038 . . . . 0.0 109.652 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.584 ' N ' ' ND1' ' A' ' 59' ' ' HIS . . . -62.49 -61.6 2.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.917 -1.114 . . . . 0.0 109.849 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.502 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.6 OUTLIER -61.16 -29.45 45.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.749 -1.22 . . . . 0.0 109.187 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 58' ' ' GLN . 33.2 t0 -58.1 -26.12 62.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 109.521 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.33 -39.41 59.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.127 -0.983 . . . . 0.0 109.236 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.75 -36.75 84.92 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.268 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 69' ' ' GLY . 2.8 t -70.41 -29.5 39.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.304 -0.872 . . . . 0.0 109.339 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.4 -53.82 51.43 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.488 -1.383 . . . . 0.0 109.392 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -82.64 -50.37 8.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.964 -1.085 . . . . 0.0 110.785 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.582 ' O ' ' C ' ' A' ' 69' ' ' GLY . 70.9 mttt -86.26 14.0 7.18 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.387 -0.821 . . . . 0.0 110.858 -177.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.582 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -15.34 88.97 0.01 OUTLIER Glycine 0 N--CA 1.502 3.068 0 CA-C-O 122.195 0.886 . . . . 0.0 111.731 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 68' ' ' LYS . 84.0 m-85 -77.69 162.3 27.1 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -58.55 -81.7 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 108.742 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.1 m -103.26 157.52 16.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.466 -0.771 . . . . 0.0 109.599 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.469 ' CD1' ' N ' ' A' ' 74' ' ' ASP . 11.0 t-105 -141.27 146.44 36.8 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.469 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.3 OUTLIER -177.44 -165.22 0.1 Allowed 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.58 165.54 18.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.398 -0.814 . . . . 0.0 109.222 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.402 HG22 HD12 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -95.48 140.69 16.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.41 ' O ' ' CD2' ' A' ' 78' ' ' LEU . 58.8 p -91.68 162.38 14.51 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.049 1.404 . . . . 0.0 112.248 -176.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.421 ' HG ' ' CE1' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -158.85 118.48 3.1 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 113.49 -1.687 . . . . 0.0 112.41 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -131.7 139.54 49.05 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.39 -18.3 65.28 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.761 -1.212 . . . . 0.0 109.5 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -104.74 31.77 4.54 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.614 HD21 ' H ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -92.58 125.4 55.93 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.019 -1.05 . . . . 0.0 110.619 178.332 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -78.2 -7.6 16.19 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.997 1.798 . . . . 0.0 112.268 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -90.81 0.93 57.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.978 -1.076 . . . . 0.0 110.024 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.518 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 11.5 ptmm? -58.05 -51.29 70.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.183 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 49.7 tp10 -62.84 -56.61 15.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.093 -1.004 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.92 -44.6 78.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.404 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.4 -42.25 98.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.309 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 144' ' ' MET . 43.3 mtp180 -60.75 -40.69 93.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.725 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -66.7 -58.31 5.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.368 -0.833 . . . . 0.0 110.511 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -53.37 -34.41 57.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.611 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -88.14 -17.66 30.47 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 110.213 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 tp -61.36 -38.23 86.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.866 -1.146 . . . . 0.0 109.97 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.475 ' OD1' ' O ' ' A' ' 94' ' ' ASN . 40.2 p-10 -54.81 131.11 43.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 0.0 110.148 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.49 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 1.7 pp20? -71.55 165.55 23.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.389 -0.819 . . . . 0.0 109.339 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.49 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 38.3 p-80 -175.13 -165.22 0.17 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.294 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.84 135.66 4.83 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.67 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.37 154.98 21.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -0.835 . . . . 0.0 109.676 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.52 -6.98 85.19 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.423 ' OE2' ' OH ' ' A' ' 70' ' ' TYR . 84.9 tt0 -125.93 169.13 13.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.243 -1.151 . . . . 0.0 108.988 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.415 ' N ' ' HG2' ' A' ' 100' ' ' GLU . 90.3 m-20 -74.47 144.06 44.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.859 -1.151 . . . . 0.0 110.613 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.413 ' HG3' ' CE1' ' A' ' 98' ' ' HIS . 2.3 mt-10 -100.88 91.64 4.68 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.401 ' CG1' ' OG ' ' A' ' 133' ' ' SER . 6.4 m -84.63 131.31 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -130.62 112.74 13.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.758 -0.589 . . . . 0.0 109.513 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.65 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 17.3 t80 -101.25 135.87 42.02 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.606 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -92.17 133.66 35.58 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.465 -0.772 . . . . 0.0 110.118 -178.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.33 -36.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.268 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -156.56 143.24 18.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.939 -1.1 . . . . 0.0 109.919 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.43 170.67 40.08 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.56 -170.15 1.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.228 -1.16 . . . . 0.0 109.485 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.53 -138.22 2.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.406 ' HG ' ' H ' ' A' ' 113' ' ' PHE . 5.7 tp -142.71 159.67 41.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.19 -1.182 . . . . 0.0 109.168 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.406 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 57.2 m-85 -134.98 86.94 2.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 109.485 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -80.94 120.24 24.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.875 . . . . 0.0 109.511 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mt -132.64 124.34 28.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.2 -0.937 . . . . 0.0 109.032 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 9.6 t-160 -108.3 114.54 28.48 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.943 -1.098 . . . . 0.0 108.985 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.3 mt -127.79 116.45 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.593 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.14 -143.5 33.29 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 105.916 -2.874 . . . . 0.0 105.916 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -105.57 79.11 1.42 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 115.578 -2.449 . . . . 0.0 108.474 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.5 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 31.5 tt0 -166.08 168.66 15.29 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.426 ' H ' ' HG2' ' A' ' 120' ' ' GLU . 41.9 t -126.37 140.91 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.997 -1.065 . . . . 0.0 110.227 177.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -120.48 130.38 54.26 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.191 0.519 . . . . 0.0 110.249 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -131.08 112.58 13.01 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.496 -0.752 . . . . 0.0 109.107 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.79 137.81 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.54 93.08 2.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.203 -0.936 . . . . 0.0 110.146 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.0 t -165.96 138.49 4.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.545 -1.347 . . . . 0.0 108.195 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.66 94.37 5.16 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 115.779 -2.368 . . . . 0.0 110.759 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.593 ' C ' ' H ' ' A' ' 130' ' ' ASP . 32.6 mtmt -116.18 150.38 37.56 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.585 176.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.691 ' N ' HD21 ' A' ' 129' ' ' ASN . 0.6 OUTLIER -59.72 -1.95 0.32 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.414 -1.428 . . . . 0.0 107.695 177.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.593 ' H ' ' C ' ' A' ' 128' ' ' LYS . 57.0 p30 -68.47 146.13 53.44 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.069 0.937 . . . . 0.0 109.927 -176.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.532 ' CD1' ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -105.15 140.24 38.62 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.576 0.703 . . . . 0.0 109.962 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.532 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 14.1 tt -128.8 120.6 52.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.401 ' OG ' ' CG1' ' A' ' 103' ' ' VAL . 8.1 t -118.59 142.99 47.09 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 12.4 m -99.19 148.57 34.81 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.9 153.48 77.77 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.436 2.091 . . . . 0.0 113.355 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.613 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -74.81 136.64 41.62 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.173 -0.954 . . . . 0.0 109.188 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.613 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 13.2 t-80 94.14 10.94 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.2 t -106.42 127.16 28.75 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.948 -1.095 . . . . 0.0 109.021 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.15 134.4 48.93 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.829 1.686 . . . . 0.0 111.752 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.515 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -171.78 162.15 6.12 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.972 -179.306 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.47 ' CG ' ' CB ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -134.11 -148.67 0.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.222 -0.923 . . . . 0.0 109.446 -178.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.416 ' H ' ' HB2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -175.06 126.6 0.27 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.038 -1.039 . . . . 0.0 109.094 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.499 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 52.5 p-10 -146.88 138.05 24.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.328 -0.858 . . . . 0.0 109.75 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.613 ' O ' ' C ' ' A' ' 145' ' ' GLY . 6.6 mmt -107.06 19.43 20.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.339 -0.851 . . . . 0.0 111.791 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.613 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 2.22 -88.1 0.0 OUTLIER Glycine 0 N--CA 1.506 3.31 0 CA-C-N 119.5 1.046 . . . . 0.0 111.714 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.462 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 69.2 m -85.52 121.32 28.05 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.119 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.599 ' OE2' ' ND2' ' A' ' 82' ' ' ASN . 40.1 mt-10 -103.25 119.64 54.53 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.589 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 56.1 Cg_endo -104.22 0.89 0.28 Allowed 'Trans proline' 0 C--O 1.207 -1.072 0 C-N-CA 123.844 3.029 . . . . 0.0 110.964 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.626 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 0.1 OUTLIER 83.87 63.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 123.489 1.614 . . . . 0.0 110.424 -179.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.43 ' C ' ' CD2' ' A' ' 150' ' ' PHE . 8.8 p90 -100.88 178.48 4.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.575 -1.328 . . . . 0.0 109.528 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 85.7 m -133.43 139.32 46.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.478 -0.764 . . . . 0.0 109.465 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.23 161.69 37.28 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.853 -1.155 . . . . 0.0 109.721 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.4 mt -108.36 127.58 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.017 -1.052 . . . . 0.0 110.195 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -138.96 167.06 22.89 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.427 -0.796 . . . . 0.0 109.905 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.9 mt -101.76 147.24 8.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.449 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.6 m-85 -96.48 118.3 32.7 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.347 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.587 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 14.4 p30 -136.17 161.75 34.86 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.826 -0.546 . . . . 0.0 109.575 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -95.71 161.39 27.75 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 120.871 -1.143 . . . . 0.0 109.332 -179.333 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.615 ' O ' ' N ' ' A' ' 162' ' ' TRP . 42.0 Cg_endo -65.6 -53.91 0.68 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.372 2.048 . . . . 0.0 112.034 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 159' ' ' PRO . 49.7 tp10 -43.48 -16.25 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.328 -0.857 . . . . 0.0 109.177 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -86.0 -23.07 46.72 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.615 ' N ' ' O ' ' A' ' 159' ' ' PRO . 20.3 m95 -116.5 165.94 12.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.339 -1.095 . . . . 0.0 109.926 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 35.2 pt -102.46 153.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.212 -0.93 . . . . 0.0 109.284 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.94 -73.64 0.3 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.137 -0.977 . . . . 0.0 110.292 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -141.18 159.01 43.11 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.083 -1.011 . . . . 0.0 109.662 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -101.24 -41.07 6.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.11 -0.994 . . . . 0.0 109.589 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.477 ' HG1' ' H ' ' A' ' 169' ' ' ASP . 58.4 p -101.47 -30.31 11.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.081 -1.012 . . . . 0.0 109.443 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.412 ' N ' ' HG1' ' A' ' 167' ' ' THR . . . 97.3 -4.03 62.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.477 ' H ' ' HG1' ' A' ' 167' ' ' THR . 94.7 m-20 -79.41 147.64 32.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.829 -1.395 . . . . 0.0 108.361 178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 37.5 p30 -110.65 87.64 2.58 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 117.949 -1.501 . . . . 0.0 111.021 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.7 tt -76.26 -17.26 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.321 -1.487 . . . . 0.0 109.312 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.535 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -59.79 -41.86 92.09 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.799 -0.76 . . . . 0.0 108.952 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.581 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 24.1 t -52.7 -4.64 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.429 -0.794 . . . . 0.0 110.391 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.49 -40.37 29.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.783 -1.198 . . . . 0.0 111.514 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.632 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 6.1 m-85 -113.37 25.49 0.09 OUTLIER Pre-proline 0 N--CA 1.516 2.851 0 O-C-N 120.5 -1.375 . . . . 0.0 112.297 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 44.7 Cg_endo -60.91 -20.41 66.75 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.792 2.995 . . . . 0.0 114.06 -172.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -89.61 126.46 35.63 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.554 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.462 ' HB3' ' H ' ' A' ' 146' ' ' SER . 5.3 tt -87.27 122.36 30.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.045 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.598 0 O-C-N 121.01 -1.056 . . . . 0.0 109.503 -179.845 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.586 ' O ' ' OG1' ' A' ' 19' ' ' THR . 85.0 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.39 172.51 7.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.262 -0.899 . . . . 0.0 109.203 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 34.8 tp -158.71 114.08 2.59 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 123' ' ' GLN . 0.1 OUTLIER -106.34 128.52 54.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.959 -1.088 . . . . 0.0 110.535 -178.379 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.1 mt -122.57 130.47 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.453 ' CD2' ' O ' ' A' ' 11' ' ' PRO . 78.0 m-85 -129.7 167.0 18.68 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.9 m -89.86 173.65 8.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.952 -1.093 . . . . 0.0 108.706 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 m -89.3 -28.25 5.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.029 -1.044 . . . . 0.0 109.495 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -72.14 -39.57 68.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.488 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -138.48 124.6 12.67 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.89 -1.132 . . . . 0.0 109.563 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 55.9 Cg_endo -81.89 -31.52 1.02 Allowed 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.727 1.618 . . . . 0.0 112.193 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.84 1.07 4.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.415 -0.803 . . . . 0.0 110.444 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.37 118.78 32.09 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 p -96.82 127.13 42.5 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.055 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pp -89.93 -13.5 36.14 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.808 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.546 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 53.9 t90 -158.72 106.77 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.412 -1.315 . . . . 0.0 109.713 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -120.14 119.97 34.85 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.287 -0.883 . . . . 0.0 109.835 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.66 165.44 28.24 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.32 -0.863 . . . . 0.0 110.094 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.586 ' OG1' ' O ' ' A' ' 1' ' ' SER . 7.9 t -130.11 89.6 2.82 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.182 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.546 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 20.4 m120 -125.12 137.37 54.17 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.707 -0.62 . . . . 0.0 110.181 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.8 -35.04 29.94 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.152 -1.593 . . . . 0.0 108.76 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.408 ' OE2' ' N ' ' A' ' 22' ' ' GLU . 59.1 mp0 -82.92 -51.11 7.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.268 -0.895 . . . . 0.0 109.275 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.483 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.3 tt0 -61.17 -18.49 58.42 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.546 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 1.9 mt -72.85 -58.4 5.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.144 -0.973 . . . . 0.0 108.514 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.68 -45.59 85.39 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.455 -0.778 . . . . 0.0 109.324 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -62.41 -44.18 97.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 110.144 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.546 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 27.2 mt-30 -79.02 -46.31 18.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.883 -1.136 . . . . 0.0 109.902 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.0 tp -65.82 -58.33 5.88 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.939 -1.1 . . . . 0.0 109.075 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.476 ' CG ' ' O ' ' A' ' 33' ' ' VAL . 19.8 t-20 -60.41 -18.95 54.22 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.735 -1.228 . . . . 0.0 109.715 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.67 -24.93 67.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.785 -1.197 . . . . 0.0 108.025 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -88.64 13.81 11.42 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.566 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.36 21.09 46.14 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.343 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.476 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 34.0 t -93.65 144.35 9.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.366 -1.079 . . . . 0.0 109.278 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -83.76 156.16 22.69 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -153.62 146.92 24.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.807 -1.183 . . . . 0.0 107.973 177.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.9 pt-20 -175.18 175.16 2.29 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.074 -1.016 . . . . 0.0 110.271 178.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -148.37 121.94 9.17 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -112.25 153.61 26.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 108.836 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -139.25 146.58 40.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.689 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.85 159.95 14.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 108.708 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -96.23 -17.06 21.05 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.6 mtm-85 -93.09 147.95 22.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -91.91 137.17 32.59 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.582 -0.699 . . . . 0.0 109.273 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.417 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 4.3 mm? -92.33 163.64 13.81 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.819 0.818 . . . . 0.0 109.378 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.15 -113.5 0.37 Allowed Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.92 -1.134 . . . . 0.0 110.639 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.61 89.01 4.51 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.126 -1.22 . . . . 0.0 109.392 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.49 92.42 19.59 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.1 -25.9 13.39 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.051 1.834 . . . . 0.0 112.285 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.4 p -119.61 141.29 49.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.696 -0.628 . . . . 0.0 109.571 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.63 -27.2 37.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.398 -0.813 . . . . 0.0 109.571 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 50' ' ' ALA . 97.0 mt-10 -43.8 -38.97 3.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.23 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 p -79.82 -32.82 40.69 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.1 -1.0 . . . . 0.0 109.11 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' A' ' 50' ' ' ALA . 43.6 t -67.55 -52.22 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.438 -0.789 . . . . 0.0 109.942 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.618 ' O ' ' N ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -60.85 -30.89 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.044 -1.035 . . . . 0.0 108.795 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.29 -34.56 75.4 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.464 -0.772 . . . . 0.0 109.633 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.97 -18.04 56.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 0.0 110.306 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -114.44 -10.29 12.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.361 -0.837 . . . . 0.0 109.962 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.721 HE21 ' CG1' ' A' ' 61' ' ' ILE . 18.6 tp60 -50.74 -34.02 25.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.17 -0.956 . . . . 0.0 109.014 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.722 ' CD2' ' N ' ' A' ' 60' ' ' ALA . 12.0 p-80 -54.67 -44.22 73.12 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.945 -1.097 . . . . 0.0 109.5 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.722 ' N ' ' CD2' ' A' ' 59' ' ' HIS . . . -64.2 -60.2 3.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 0.0 109.906 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.721 ' CG1' HE21 ' A' ' 58' ' ' GLN . 1.0 OUTLIER -63.94 -22.2 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 109.961 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' GLN . 31.1 t0 -58.15 -65.25 0.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.53 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -51.61 -34.25 36.61 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.656 -1.278 . . . . 0.0 108.773 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.16 -55.18 17.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.086 -1.009 . . . . 0.0 109.672 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -67.37 -25.54 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.391 -0.818 . . . . 0.0 109.11 179.528 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.23 -41.89 72.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.963 -1.086 . . . . 0.0 109.495 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.49 -52.3 8.22 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.954 -1.091 . . . . 0.0 109.99 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.637 ' O ' ' C ' ' A' ' 69' ' ' GLY . 45.9 mttm -82.78 4.73 24.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.258 -0.901 . . . . 0.0 110.405 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.637 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . 8.07 80.33 0.01 OUTLIER Glycine 0 N--CA 1.503 3.126 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.495 ' CG ' ' CG2' ' A' ' 155' ' ' ILE . 30.5 m-85 -74.42 161.67 29.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.164 -1.198 . . . . 0.0 109.497 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -57.01 -46.27 82.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.428 -0.795 . . . . 0.0 109.716 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 m -150.17 160.24 43.82 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.193 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.704 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 19.3 t-105 -125.77 128.14 47.25 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.483 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 2.5 t0 -136.85 157.63 46.31 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.935 -1.103 . . . . 0.0 108.479 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 76' ' ' ILE . 1.0 OUTLIER -97.86 174.13 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.507 ' N ' ' CG1' ' A' ' 75' ' ' VAL . 35.2 mm -106.99 113.77 44.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.7 p -96.76 164.52 12.54 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 123.229 1.49 . . . . 0.0 111.817 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -167.5 164.57 14.88 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.971 176.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.564 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -137.45 140.42 41.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 174.611 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.65 -1.88 20.77 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.157 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -114.99 -14.13 11.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.205 -0.934 . . . . 0.0 109.384 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -66.16 123.68 85.89 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.445 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.66 -2.18 11.73 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.176 1.917 . . . . 0.0 111.212 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -87.01 -2.99 59.04 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.027 -1.046 . . . . 0.0 109.763 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.447 ' HB2' HD22 ' A' ' 82' ' ' ASN . 0.2 OUTLIER -54.52 -43.43 71.88 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.687 -1.258 . . . . 0.0 108.135 178.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.408 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 84.6 tt0 -60.73 -40.92 94.18 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.233 -0.917 . . . . 0.0 109.148 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.48 81.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.0 109.912 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.59 -42.77 99.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.006 -1.059 . . . . 0.0 109.739 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.444 ' NH2' ' O ' ' A' ' 145' ' ' GLY . 82.8 mtm180 -62.01 -27.54 68.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.844 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -65.63 -60.29 3.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.863 . . . . 0.0 109.862 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -57.55 -36.76 72.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -0.913 . . . . 0.0 109.382 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -75.77 -24.26 56.01 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.54 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 94' ' ' ASN . 3.9 mt -74.46 -34.9 63.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 110.602 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 93' ' ' LEU . 16.5 m120 -45.8 127.13 7.77 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.906 -1.122 . . . . 0.0 109.156 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.457 ' O ' ' OE1' ' A' ' 165' ' ' GLN . 3.2 tt0 -55.1 147.64 15.6 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -169.01 -172.55 1.58 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 117.612 -1.635 . . . . 0.0 112.628 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -165.03 135.28 3.79 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.645 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.19 157.04 18.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.942 . . . . 0.0 110.077 -179.052 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.454 ' H ' ' HA ' ' A' ' 162' ' ' TRP . . . -78.8 -6.82 88.5 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -122.93 169.78 10.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.454 -1.027 . . . . 0.0 109.3 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -74.94 142.82 43.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.136 -0.978 . . . . 0.0 110.013 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.614 ' CG ' HH22 ' A' ' 154' ' ' ARG . 17.0 tt0 -100.37 94.97 6.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.296 -0.878 . . . . 0.0 108.953 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.19 128.59 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.501 -0.749 . . . . 0.0 109.173 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -129.39 122.55 29.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 52.2 t80 -109.37 127.06 54.06 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.34 125.68 34.39 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.432 0.634 . . . . 0.0 110.22 -178.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.95 -35.2 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.596 -0.69 . . . . 0.0 109.72 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -160.2 145.34 14.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.085 -1.009 . . . . 0.0 110.303 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.475 ' O ' ' OE2' ' A' ' 127' ' ' GLU . . . 97.11 162.85 32.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.21 163.82 28.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -1.154 . . . . 0.0 110.015 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.92 153.16 11.57 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.403 ' O ' ' CG ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -102.65 101.99 12.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.971 -1.311 . . . . 0.0 109.809 -179.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -88.85 130.04 35.47 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.747 -1.22 . . . . 0.0 110.704 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 31.4 t -77.86 130.59 36.82 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.325 0.584 . . . . 0.0 109.714 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -115.82 124.57 51.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.503 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.5 t-160 -115.42 115.75 27.07 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.19 -0.944 . . . . 0.0 108.945 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.41 125.33 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.194 -0.941 . . . . 0.0 110.345 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.74 -143.94 41.04 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 104.167 -3.573 . . . . 0.0 104.167 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -109.28 81.43 1.44 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 122.212 3.006 . . . . 0.0 109.793 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.503 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 21.7 pt-20 -164.96 168.38 17.58 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.1 t -125.66 136.26 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.109 -0.994 . . . . 0.0 109.933 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 115' ' ' LEU . 5.0 m-85 -124.07 130.55 52.75 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.819 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 4' ' ' THR . 17.5 mt-30 -125.15 118.38 25.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.202 -0.936 . . . . 0.0 108.974 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.9 t -105.69 132.32 52.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.5 tt -126.63 80.05 1.91 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.37 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 1' ' ' SER . 47.4 t -168.99 117.22 0.66 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 177.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.475 ' OE2' ' O ' ' A' ' 109' ' ' GLY . 10.5 tm-20 -113.5 105.7 13.67 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 116.086 -2.245 . . . . 0.0 112.34 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.577 ' C ' ' H ' ' A' ' 130' ' ' ASP . 12.2 mttm -109.31 177.08 4.86 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.16 -1.382 . . . . 0.0 108.68 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.518 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 54.5 m-80 -59.54 -2.0 0.29 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.577 ' H ' ' C ' ' A' ' 128' ' ' LYS . 31.2 p30 -72.39 154.37 40.94 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.516 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 0.3 OUTLIER -120.52 155.71 33.06 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.99 0.9 . . . . 0.0 110.089 -179.171 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.492 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 2.9 tp -122.37 128.33 75.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.9 t -109.04 134.39 51.73 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 108.985 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.63 133.86 20.05 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.01 151.41 73.36 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.893 1.729 . . . . 0.0 112.552 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.39 134.71 48.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.619 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 1.4 t-80 92.97 7.94 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 120.933 0.397 . . . . 0.0 110.262 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.87 125.91 33.3 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.89 -1.131 . . . . 0.0 109.228 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 116' ' ' HIS . 40.6 Cg_endo -64.02 131.55 31.16 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.636 1.557 . . . . 0.0 111.656 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.474 ' C ' ' CE3' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -169.71 160.56 8.83 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.096 -178.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.476 ' CG ' ' CB ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -131.92 -146.6 0.29 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.295 -0.878 . . . . 0.0 109.414 -178.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.435 ' H ' ' HB2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -179.04 128.12 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.772 -1.205 . . . . 0.0 109.088 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.42 136.67 21.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.455 -0.778 . . . . 0.0 109.577 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.586 ' O ' ' C ' ' A' ' 145' ' ' GLY . 9.1 mmt -112.59 18.89 17.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.478 -0.764 . . . . 0.0 111.036 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 10.88 -94.38 0.01 OUTLIER Glycine 0 N--CA 1.506 3.339 0 CA-C-N 118.886 0.766 . . . . 0.0 112.349 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.464 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 18.5 p -85.38 120.89 27.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.351 -1.339 . . . . 0.0 109.02 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.641 ' CD ' ' H ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -113.4 118.17 44.06 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.873 -0.517 . . . . 0.0 109.783 178.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.6 Cg_endo -102.22 34.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.794 2.329 . . . . 0.0 110.742 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 82.66 64.61 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.446 0.641 . . . . 0.0 109.457 -177.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.507 ' N ' HD11 ' A' ' 78' ' ' LEU . 24.8 p90 -99.85 153.24 19.3 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 122.212 1.006 . . . . 0.0 111.327 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.8 m -118.27 137.32 53.13 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.59 163.27 33.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.1 -1.0 . . . . 0.0 109.176 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.704 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 63.6 mt -119.17 136.96 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.219 -0.926 . . . . 0.0 109.874 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.614 HH22 ' CG ' ' A' ' 102' ' ' GLU . 2.6 ttt85 -140.11 167.75 21.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.901 -1.124 . . . . 0.0 110.472 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.495 ' CG2' ' CG ' ' A' ' 70' ' ' TYR . 4.1 mp -109.18 155.19 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.485 -0.759 . . . . 0.0 109.603 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.483 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 2.6 m-30 -106.97 125.42 50.98 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.975 0.893 . . . . 0.0 110.253 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 158' ' ' ASN . 1.1 t70 -131.07 162.03 30.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.439 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -93.85 161.83 28.91 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.105 -0.997 . . . . 0.0 108.464 -179.46 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 162' ' ' TRP . 41.4 Cg_endo -63.53 -55.97 0.61 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.009 1.806 . . . . 0.0 112.376 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 159' ' ' PRO . 48.9 tp10 -44.02 -19.22 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.072 -1.018 . . . . 0.0 108.309 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -90.0 -31.1 11.35 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.598 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -95.74 165.2 12.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.406 -1.055 . . . . 0.0 111.286 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.65 148.02 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.23 -74.87 0.29 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.932 -1.105 . . . . 0.0 110.644 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 95' ' ' GLU . 14.3 mm100 -141.91 161.26 38.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.993 -1.067 . . . . 0.0 109.929 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.629 ' N ' ' CD2' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -101.95 -41.76 6.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.127 -0.983 . . . . 0.0 109.269 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 70.8 p -117.98 -30.42 5.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.346 -0.846 . . . . 0.0 108.887 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.06 -5.45 53.07 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 120.175 -1.012 . . . . 0.0 110.653 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -79.59 148.13 31.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.589 -1.536 . . . . 0.0 108.016 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -108.38 89.51 3.02 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 117.519 -1.672 . . . . 0.0 110.88 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.413 ' CG2' ' OE1' ' A' ' 95' ' ' GLU . 1.3 tt -78.86 -23.57 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.489 -1.382 . . . . 0.0 109.737 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.552 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -56.74 -41.39 77.45 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 108.724 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.52 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 47.5 p -53.52 -3.38 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.348 -0.845 . . . . 0.0 109.973 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.83 -37.05 35.91 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.031 -1.043 . . . . 0.0 111.964 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.618 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.1 m-85 -111.9 25.18 0.08 OUTLIER Pre-proline 0 N--CA 1.517 2.895 0 O-C-N 120.449 -1.407 . . . . 0.0 113.077 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 38.0 Cg_endo -58.97 -24.0 71.04 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 123.902 3.068 . . . . 0.0 115.141 -172.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -89.05 126.25 35.35 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.487 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 0.8 OUTLIER -86.8 123.99 32.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.18 -0.95 . . . . 0.0 108.717 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.591 ' CB ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.471 ' O ' ' CG2' ' A' ' 19' ' ' THR . 3.7 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.92 169.52 9.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.043 -1.036 . . . . 0.0 108.991 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.5 tp -158.0 115.02 2.91 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.0 134.08 52.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.34 -0.85 . . . . 0.0 110.06 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.483 ' CD1' ' OE1' ' A' ' 27' ' ' GLN . 38.4 mt -129.74 132.12 66.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 96.6 m-85 -124.05 167.45 14.18 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -86.31 174.57 8.96 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.269 -0.895 . . . . 0.0 108.948 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.76 -31.32 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.898 -1.126 . . . . 0.0 109.492 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -73.03 -37.34 66.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.947 . . . . 0.0 110.303 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -136.52 124.71 14.96 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 109.519 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.427 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 56.3 Cg_endo -81.09 -35.53 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 122.068 1.845 . . . . 0.0 112.317 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.63 4.99 1.58 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.442 -0.787 . . . . 0.0 110.258 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 11' ' ' PRO . 84.6 m-20 -114.52 118.99 35.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.401 -0.812 . . . . 0.0 109.007 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.4 p -98.65 123.16 42.68 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.277 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 pp -91.0 -7.72 51.18 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.633 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.588 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 31.9 t90 -157.43 105.27 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.338 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -120.6 115.99 24.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.57 -0.706 . . . . 0.0 109.876 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.445 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -162.34 165.01 27.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.33 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' A' ' 1' ' ' SER . 52.1 m -131.37 90.2 2.83 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.573 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 84.0 m-20 -127.04 151.24 48.87 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.288 -0.882 . . . . 0.0 110.491 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.91 -45.02 13.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.037 -1.664 . . . . 0.0 108.279 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 23' ' ' GLU . 10.6 pt-20 -82.89 -46.12 13.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.704 . . . . 0.0 110.18 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.514 ' N ' ' CG ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -62.84 -23.69 67.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.52 -1.362 . . . . 0.0 108.705 -178.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.573 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 4.6 mt -70.42 -58.68 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.522 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 6.6 pt20 -56.36 -44.17 79.88 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.303 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.522 ' N ' ' CG ' ' A' ' 25' ' ' GLN . 74.5 mt-30 -57.73 -33.27 68.27 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.317 -0.865 . . . . 0.0 109.906 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.588 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 5.7 tt0 -70.34 -61.36 1.8 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.024 -1.048 . . . . 0.0 109.41 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -66.98 -55.36 14.8 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.776 -1.202 . . . . 0.0 109.794 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 18.1 t-20 -49.9 -31.95 13.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.886 -1.134 . . . . 0.0 109.333 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.59 -24.61 67.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.021 -1.049 . . . . 0.0 108.44 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.526 ' NZ ' ' OE1' ' A' ' 120' ' ' GLU . 30.0 mttt -92.48 14.12 17.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.54 24.44 26.01 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.714 -1.232 . . . . 0.0 110.089 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.599 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 39.6 t -96.36 146.3 7.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.386 -1.067 . . . . 0.0 109.704 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -85.83 155.85 20.81 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 120.927 -1.108 . . . . 0.0 109.136 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.454 ' CD1' ' CB ' ' A' ' 25' ' ' GLN . 1.2 t80 -154.62 149.44 26.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.912 -1.117 . . . . 0.0 108.912 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 1.3 mt-10 -175.04 172.92 2.74 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.903 -1.123 . . . . 0.0 109.878 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -150.81 114.83 5.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 108.839 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.41 ' CH2' HD21 ' A' ' 131' ' ' LEU . 19.0 m0 -110.67 152.59 26.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.62 -0.675 . . . . 0.0 109.235 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -143.12 167.43 22.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 109.964 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.52 158.66 15.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 108.86 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -102.97 -17.43 15.46 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.204 -0.935 . . . . 0.0 108.534 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -93.38 171.47 8.89 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.591 0.71 . . . . 0.0 109.185 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -94.34 116.88 29.33 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.556 -0.715 . . . . 0.0 109.501 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mt -91.17 163.68 14.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.429 -0.795 . . . . 0.0 109.137 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.62 -101.08 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.68 93.07 4.83 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.108 -1.23 . . . . 0.0 109.48 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.55 91.61 34.56 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -77.02 -26.94 7.32 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.412 2.074 . . . . 0.0 112.701 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.6 p -119.92 141.16 49.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 0.0 109.581 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.93 -20.85 41.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.405 -0.809 . . . . 0.0 109.475 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 50' ' ' ALA . 84.8 tt0 -44.83 -37.89 4.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.005 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.7 p -79.73 -31.95 41.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.275 -0.891 . . . . 0.0 109.42 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ALA . 79.7 t -67.74 -47.67 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 109.777 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 58' ' ' GLN . 9.9 mm -60.26 -37.26 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.957 . . . . 0.0 108.859 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.32 -29.87 70.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.418 -0.802 . . . . 0.0 109.45 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.23 -18.68 60.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 110.317 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -118.42 -7.5 10.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.389 -0.82 . . . . 0.0 109.181 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.686 HE21 ' CG1' ' A' ' 61' ' ' ILE . 28.9 tp60 -50.53 -39.4 48.83 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.313 -0.867 . . . . 0.0 108.774 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.741 ' CD2' ' N ' ' A' ' 60' ' ' ALA . 10.7 p-80 -53.04 -42.99 66.27 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.853 -1.154 . . . . 0.0 109.24 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.741 ' N ' ' CD2' ' A' ' 59' ' ' HIS . . . -61.88 -58.69 6.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.075 -1.015 . . . . 0.0 109.464 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.686 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.5 OUTLIER -64.24 -28.52 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.763 -1.211 . . . . 0.0 109.15 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 58' ' ' GLN . 27.0 t70 -55.29 -25.4 33.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.145 -0.972 . . . . 0.0 109.395 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HG2' ' N ' ' A' ' 64' ' ' LEU . 8.8 ptmt -83.71 -37.26 22.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.08 -1.012 . . . . 0.0 109.493 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.457 ' N ' ' HG2' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -68.86 -45.56 70.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.206 -0.934 . . . . 0.0 109.895 -179.415 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 69' ' ' GLY . 3.3 p -68.56 -32.64 56.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.431 -0.793 . . . . 0.0 109.479 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.1 67.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.209 -0.932 . . . . 0.0 109.538 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -79.44 -50.03 11.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.123 -0.985 . . . . 0.0 109.897 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.659 ' O ' ' C ' ' A' ' 69' ' ' GLY . 20.5 mmtt -85.83 14.12 6.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.464 -0.772 . . . . 0.0 110.14 -177.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.659 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -7.53 85.64 0.0 OUTLIER Glycine 0 N--CA 1.501 2.984 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.467 ' N ' ' O ' ' A' ' 68' ' ' LYS . 11.7 m-85 -75.96 166.84 22.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.463 -1.022 . . . . 0.0 108.977 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -57.53 -40.58 79.12 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.441 -0.787 . . . . 0.0 109.805 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.29 167.53 30.15 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.631 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.559 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 13.2 t-105 -134.24 137.64 44.48 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.269 -0.895 . . . . 0.0 109.126 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.69 179.02 8.9 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.061 -1.025 . . . . 0.0 108.343 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 m -124.17 149.38 28.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.422 -0.799 . . . . 0.0 109.438 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.4 mt -100.86 117.04 45.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.489 ' O ' ' OG ' ' A' ' 77' ' ' SER . 27.8 p -170.13 101.69 0.29 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.453 -0.78 . . . . 0.0 109.399 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.587 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -110.95 179.84 3.94 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.95 1.705 . . . . 0.0 107.864 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.587 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -89.71 144.75 25.72 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.688 -1.258 . . . . 0.0 109.062 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.66 2.21 0.11 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.749 -0.594 . . . . 0.0 109.593 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.568 ' H ' ' C ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -85.63 -28.28 24.88 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.469 -1.292 . . . . 0.0 108.888 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -64.51 123.84 84.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.905 -1.122 . . . . 0.0 109.45 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -79.19 -8.97 15.32 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.134 1.889 . . . . 0.0 112.349 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -90.21 3.13 54.42 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.96 -1.087 . . . . 0.0 109.596 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.547 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 44.6 pttt -60.96 -47.4 86.6 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.211 -0.93 . . . . 0.0 108.96 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.547 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 96.5 mt-10 -64.56 -42.88 95.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.64 76.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.029 -1.044 . . . . 0.0 109.432 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.53 -50.17 72.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 0.0 110.129 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.567 HH12 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -65.06 -24.66 67.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.229 -0.92 . . . . 0.0 109.701 -179.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.567 ' CD ' HH12 ' A' ' 89' ' ' ARG . 58.0 mm-40 -65.41 -60.03 3.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.37 -0.831 . . . . 0.0 109.6 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.405 ' HZ3' ' CB ' ' A' ' 91' ' ' LYS . 8.8 mtmp? -53.32 -27.81 25.23 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.072 -1.018 . . . . 0.0 109.038 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -18.4 33.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.017 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.9 -36.72 70.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.199 -0.938 . . . . 0.0 109.848 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -46.64 137.18 7.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.057 . . . . 0.0 109.337 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -70.93 164.6 25.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 0.0 109.555 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -175.9 -167.26 0.22 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.442 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.8 t -163.88 134.31 4.31 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.619 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -103.73 154.86 19.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 0.0 109.786 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.42 -6.58 86.66 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -123.97 170.06 11.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.443 -1.033 . . . . 0.0 109.38 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -73.84 143.19 46.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.217 -0.927 . . . . 0.0 109.778 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.559 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 4.6 tt0 -104.47 94.45 5.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.214 -0.929 . . . . 0.0 109.053 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.3 t -81.65 131.11 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.199 -0.938 . . . . 0.0 110.161 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.99 109.64 11.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.451 -0.78 . . . . 0.0 109.854 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.624 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 14.7 t80 -104.8 131.52 52.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.335 -0.853 . . . . 0.0 109.071 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.567 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -90.06 132.27 35.49 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.408 0.623 . . . . 0.0 109.861 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.4 t -113.48 -31.01 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.743 -0.598 . . . . 0.0 109.784 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -167.65 156.02 9.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.1 -1.0 . . . . 0.0 109.358 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.29 155.76 8.42 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.69 148.75 37.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -1.072 . . . . 0.0 109.365 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.23 -136.69 3.47 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 26.5 tp -138.24 154.08 49.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.397 -1.06 . . . . 0.0 109.493 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -122.23 145.43 48.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.582 -0.699 . . . . 0.0 109.39 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.67 108.71 4.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.578 -0.701 . . . . 0.0 109.713 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.92 112.87 20.18 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.555 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.1 t-160 -105.25 113.22 26.68 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.204 -0.935 . . . . 0.0 109.601 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.68 119.24 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.25 -0.906 . . . . 0.0 110.203 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.37 -143.16 33.83 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 105.998 -2.841 . . . . 0.0 105.998 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 7.0 p-10 -105.36 79.26 1.45 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 115.185 -2.606 . . . . 0.0 109.61 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.555 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 78.8 tt0 -165.19 166.19 19.13 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.7 t -129.91 152.19 36.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.038 -1.038 . . . . 0.0 109.683 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.28 131.32 46.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.63 -0.669 . . . . 0.0 109.286 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -128.24 115.04 17.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 109.11 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.3 t -108.22 138.08 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 125' ' ' LEU . 0.3 OUTLIER -134.56 90.3 2.64 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.213 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 126' ' ' CYS . 31.2 p -166.35 135.35 3.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.388 -1.445 . . . . 0.0 107.546 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -107.05 94.91 5.35 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 116.195 -2.202 . . . . 0.0 110.642 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.542 ' C ' ' H ' ' A' ' 130' ' ' ASP . 29.8 mtmm -114.55 157.69 22.67 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.655 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.624 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 1.7 m120 -58.68 -4.0 0.38 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.421 -1.424 . . . . 0.0 108.096 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 128' ' ' LYS . 56.2 p30 -72.23 152.72 42.01 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.39 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.508 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 2.3 pp -126.27 162.03 26.4 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.051 0.929 . . . . 0.0 110.944 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 9.7 mt -129.95 130.8 66.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.6 t -106.81 136.92 45.81 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.477 -0.765 . . . . 0.0 109.011 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.98 133.63 20.58 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.743 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.09 151.33 81.81 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.835 1.69 . . . . 0.0 112.484 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.612 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.23 135.05 48.64 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.612 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.0 t-80 91.94 10.4 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.39 125.84 33.08 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.087 -1.008 . . . . 0.0 108.785 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.1 130.57 27.7 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.573 1.516 . . . . 0.0 111.573 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -166.94 165.42 15.97 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.229 -178.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.489 ' CE3' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -136.14 -149.76 0.34 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 109.646 -178.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.409 ' H ' ' HB2' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -175.08 125.0 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 109.167 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.488 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 16.3 p-10 -141.6 132.12 25.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.627 ' O ' ' C ' ' A' ' 145' ' ' GLY . 49.7 mtt -112.73 17.77 18.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.597 -0.69 . . . . 0.0 110.692 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.627 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 8.97 -90.08 0.0 OUTLIER Glycine 0 N--CA 1.502 3.098 0 CA-C-N 119.206 0.912 . . . . 0.0 111.685 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.492 ' H ' ' HB2' ' A' ' 178' ' ' LEU . 70.9 m -86.56 116.13 24.48 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 117.763 -1.575 . . . . 0.0 109.127 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.16 113.44 37.33 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.985 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.558 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.7 Cg_endo -103.36 40.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 122.935 2.423 . . . . 0.0 111.684 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 81.75 72.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.998 -177.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 5.5 p90 -94.53 138.23 32.68 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.215 -0.928 . . . . 0.0 110.476 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.9 m -103.57 118.73 37.4 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.723 -0.61 . . . . 0.0 109.625 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.8 163.34 33.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.454 -0.779 . . . . 0.0 109.283 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.559 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 61.4 mt -109.35 127.04 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.272 -0.893 . . . . 0.0 110.062 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -129.9 157.28 42.7 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.55 0.69 . . . . 0.0 109.514 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.49 ' CD1' ' N ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -102.89 149.26 7.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -96.22 120.86 37.27 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 0.0 110.319 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -133.71 162.99 30.46 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -94.52 161.98 27.32 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.143 -0.973 . . . . 0.0 109.23 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.633 ' O ' ' N ' ' A' ' 161' ' ' GLY . 40.1 Cg_endo -65.21 -57.37 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.014 1.809 . . . . 0.0 111.54 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 159' ' ' PRO . 50.6 mt-10 -43.98 -13.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.793 . . . . 0.0 109.126 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -76.77 -33.05 47.94 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 177.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.52 ' N ' ' O ' ' A' ' 159' ' ' PRO . 4.3 p90 -118.3 159.12 23.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.274 -1.133 . . . . 0.0 110.279 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 26.6 mm -100.99 147.3 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.428 -0.795 . . . . 0.0 109.392 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.464 ' C ' ' NE2' ' A' ' 165' ' ' GLN . . . -57.36 -72.67 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.464 ' NE2' ' C ' ' A' ' 164' ' ' ALA . 11.7 mp0 -141.4 165.29 27.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.14 -0.975 . . . . 0.0 109.646 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -100.03 -41.45 7.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.467 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 59.4 m -105.3 -30.54 9.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.166 -0.958 . . . . 0.0 109.128 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.57 -6.35 52.45 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -81.88 149.33 28.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.78 -1.424 . . . . 0.0 108.522 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 44.2 p30 -107.82 87.54 2.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.116 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.1 tt -78.31 -26.92 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.59 -1.319 . . . . 0.0 109.313 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.583 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -58.22 -42.6 86.63 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.572 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 28.6 p -54.54 -2.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 109.924 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.583 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.03 -39.8 33.03 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.097 -1.002 . . . . 0.0 111.473 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.629 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.3 m-85 -111.38 23.92 0.08 OUTLIER Pre-proline 0 N--CA 1.512 2.64 0 O-C-N 120.603 -1.31 . . . . 0.0 113.039 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 49.9 Cg_endo -65.07 -20.1 63.51 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 123.466 2.777 . . . . 0.0 113.581 -173.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -89.31 126.71 35.63 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.217 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.502 ' O ' ' C ' ' A' ' 179' ' ' ALA . 7.9 mp -86.08 147.75 26.03 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.837 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.589 ' O ' ' OG1' ' A' ' 19' ' ' THR . 89.6 p . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.39 173.39 7.22 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.102 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.517 ' CD2' ' CZ3' ' A' ' 16' ' ' TRP . 18.0 tp -160.06 114.43 2.26 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.51 131.54 55.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.022 -1.049 . . . . 0.0 110.227 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.405 ' CD1' ' CE2' ' A' ' 122' ' ' PHE . 60.5 mt -126.76 133.64 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 11' ' ' PRO . 98.4 m-85 -128.37 165.5 20.47 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.46 0.648 . . . . 0.0 109.72 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.456 ' OG ' ' CD1' ' A' ' 15' ' ' LEU . 64.2 m -89.66 176.29 6.92 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.78 -25.82 5.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 120.732 -1.23 . . . . 0.0 109.428 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -72.56 -40.72 66.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.969 -1.082 . . . . 0.0 110.16 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -137.44 124.57 13.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.018 . . . . 0.0 109.324 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 56.4 Cg_endo -81.86 -29.92 1.54 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.876 1.717 . . . . 0.0 112.35 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -68.37 -27.36 66.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.505 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -94.56 120.87 35.47 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.798 -1.189 . . . . 0.0 108.985 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 p -95.31 132.86 39.86 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.391 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.456 ' CD1' ' OG ' ' A' ' 7' ' ' SER . 11.1 mp -89.34 -10.27 47.31 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.991 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.517 ' CZ3' ' CD2' ' A' ' 3' ' ' LEU . 37.6 t90 -158.45 105.99 1.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.291 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -120.01 116.39 25.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 0.0 109.759 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.73 166.86 25.99 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.476 -0.765 . . . . 0.0 109.776 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.589 ' OG1' ' O ' ' A' ' 1' ' ' SER . 9.0 t -130.33 88.19 2.61 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.524 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 15.0 m-20 -126.04 139.23 53.58 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.52 -35.58 27.18 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.095 -1.628 . . . . 0.0 108.919 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.534 ' CG ' ' N ' ' A' ' 23' ' ' GLU . 19.8 pt-20 -82.49 -49.92 9.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.12 -0.988 . . . . 0.0 108.981 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.534 ' N ' ' CG ' ' A' ' 22' ' ' GLU . 1.6 tm-20 -63.11 -18.97 64.0 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.893 -1.13 . . . . 0.0 108.57 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 1.8 mt -71.32 -56.77 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.246 -0.909 . . . . 0.0 109.504 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.56 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 7.2 pt20 -53.25 -47.6 68.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 109.654 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.56 ' N ' ' CG ' ' A' ' 25' ' ' GLN . 49.3 tt0 -63.1 -26.77 68.98 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.444 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.516 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -69.74 -66.05 0.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.137 0.97 . . . . 0.0 110.871 -178.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.424 HD11 ' H ' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -71.35 -46.79 59.64 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.682 -1.261 . . . . 0.0 109.636 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.573 HD21 ' C ' ' A' ' 33' ' ' VAL . 10.8 m120 -54.8 -27.43 41.65 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.602 -1.311 . . . . 0.0 109.062 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -25.75 68.54 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.483 ' CD ' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -92.6 8.67 37.99 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.367 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.06 25.47 11.26 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.742 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.573 ' C ' HD21 ' A' ' 29' ' ' ASN . 69.5 t -94.08 145.46 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.633 -1.51 . . . . 0.0 109.084 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.592 HH12 ' NZ ' ' A' ' 68' ' ' LYS . 23.9 ttm180 -84.32 156.1 22.07 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.487 ' O ' ' OE1' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -153.43 147.09 25.12 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.1 tp10 -174.24 171.42 3.49 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.79 -1.194 . . . . 0.0 109.381 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -148.06 112.3 5.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.036 -1.04 . . . . 0.0 108.368 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.508 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 22.7 m0 -111.19 155.28 23.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.432 -0.793 . . . . 0.0 108.988 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.32 161.64 37.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.928 . . . . 0.0 109.969 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.86 158.14 16.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 108.931 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -102.64 -14.76 16.59 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.63 163.63 13.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.605 0.717 . . . . 0.0 109.155 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 46.3 p-10 -96.74 120.68 37.51 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.459 -0.775 . . . . 0.0 109.735 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.06 164.69 13.86 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.282 -0.886 . . . . 0.0 109.07 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.4 -105.8 0.22 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.73 90.97 5.24 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.052 -1.263 . . . . 0.0 109.104 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.44 92.17 42.9 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.93 -20.83 19.16 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.151 1.901 . . . . 0.0 112.501 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.8 p -124.27 141.67 51.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.563 -0.71 . . . . 0.0 109.622 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' GLU . . . -80.23 -20.58 44.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.538 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' ALA . 84.6 tt0 -43.12 -37.83 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.063 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.2 p -79.36 -36.35 39.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.149 -0.969 . . . . 0.0 109.144 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 50' ' ' ALA . 60.1 t -67.33 -46.34 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -0.846 . . . . 0.0 109.747 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 58' ' ' GLN . 7.8 mm -60.92 -34.24 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 108.889 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.63 -29.27 70.49 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.449 -0.782 . . . . 0.0 109.627 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.56 -21.89 48.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.988 . . . . 0.0 110.136 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -110.56 -10.31 14.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.48 -0.762 . . . . 0.0 109.769 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 54' ' ' ILE . 5.5 mm-40 -47.59 -36.75 11.19 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.054 -1.029 . . . . 0.0 109.128 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.677 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 5.4 p80 -53.22 -48.01 68.5 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.979 -1.088 . . . . 0.0 109.57 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.677 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.15 -58.1 9.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.941 -1.099 . . . . 0.0 110.054 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.45 HG12 HE21 ' A' ' 58' ' ' GLN . 0.9 OUTLIER -65.19 -26.25 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.924 -1.11 . . . . 0.0 109.462 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 58' ' ' GLN . 21.0 t70 -58.57 -25.19 62.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 109.32 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -83.99 -44.23 14.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.416 -0.803 . . . . 0.0 109.859 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.64 -46.46 79.12 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.422 -0.799 . . . . 0.0 109.761 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' GLY . 5.9 p -66.63 -29.61 47.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.85 -44.53 74.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.907 -1.121 . . . . 0.0 109.425 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -80.39 -51.46 8.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.934 -1.104 . . . . 0.0 110.182 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.599 ' O ' ' C ' ' A' ' 69' ' ' GLY . 33.1 mttt -85.01 13.62 5.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 110.732 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.599 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -5.22 84.16 0.0 OUTLIER Glycine 0 N--CA 1.5 2.932 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 68' ' ' LYS . 32.4 m-85 -77.5 165.08 24.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.663 -0.904 . . . . 0.0 108.703 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -57.21 -89.55 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.164 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.605 ' OG ' ' CG ' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -102.38 163.06 12.44 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.668 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.4 ' CE3' HG22 ' A' ' 155' ' ' ILE . 5.7 t-105 -136.98 141.23 42.58 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.46 -0.775 . . . . 0.0 109.187 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -174.7 -167.42 0.3 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.462 ' CB ' ' O ' ' A' ' 152' ' ' ALA . 4.7 m -124.21 168.21 17.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.492 -0.755 . . . . 0.0 109.488 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.9 mt -94.49 132.95 37.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.5 p -93.0 166.79 12.19 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.857 1.313 . . . . 0.0 112.135 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.607 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 1.0 OUTLIER -169.13 160.49 9.8 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.209 176.295 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -132.4 141.52 48.91 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.47 -0.72 6.95 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.837 -1.164 . . . . 0.0 109.684 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -118.47 -12.44 9.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.086 -1.009 . . . . 0.0 109.196 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.454 ' C ' ' ND2' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -62.72 123.9 81.17 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.938 . . . . 0.0 110.453 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.04 -1.6 11.5 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.758 2.306 . . . . 0.0 112.542 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.439 ' N ' ' ND2' ' A' ' 82' ' ' ASN . 72.9 mt-30 -83.25 16.19 2.58 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.76 -1.212 . . . . 0.0 109.161 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.419 ' HG3' ' H ' ' A' ' 86' ' ' GLU . 6.2 pttt -61.36 -59.88 4.59 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.5 -0.75 . . . . 0.0 109.507 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.419 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 20.1 pt-20 -64.56 -31.74 73.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.312 -0.868 . . . . 0.0 109.666 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.89 -59.27 5.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 110.077 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 72.4 mt -61.95 -42.81 99.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 110.185 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.413 ' HG2' ' H ' ' A' ' 144' ' ' MET . 49.6 mtm180 -59.52 -28.98 67.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.886 . . . . 0.0 110.079 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.96 -59.58 4.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 0.0 109.497 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -51.22 -34.34 31.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.376 -0.827 . . . . 0.0 109.404 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -88.14 -17.74 30.31 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.043 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.603 ' CD2' ' HG ' ' A' ' 173' ' ' SER . 8.6 tp -55.79 -34.39 65.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 109.822 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.477 HD21 HE22 ' A' ' 165' ' ' GLN . 6.1 m120 -63.28 135.29 56.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.121 -0.987 . . . . 0.0 110.22 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -70.71 164.45 25.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.527 -0.733 . . . . 0.0 109.418 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -174.92 -165.6 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.82 -1.175 . . . . 0.0 111.272 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 t -164.56 135.33 4.16 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.607 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -105.93 154.58 20.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.466 -0.771 . . . . 0.0 110.207 -178.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.39 -6.35 86.42 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -124.24 169.93 11.27 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.487 -1.008 . . . . 0.0 109.61 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -74.91 143.62 43.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 0.0 109.827 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.484 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 6.7 tt0 -107.54 93.25 4.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.261 -0.899 . . . . 0.0 108.592 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.5 p -94.67 131.98 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.738 -1.226 . . . . 0.0 111.025 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.692 ' HE ' HH21 ' A' ' 154' ' ' ARG . 78.0 mtt180 -130.2 126.93 38.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.735 -0.603 . . . . 0.0 109.402 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.605 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 13.3 t80 -109.05 132.0 54.53 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.533 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -85.21 126.25 33.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.941 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.4 ' O ' ' CG ' ' A' ' 108' ' ' GLU . 5.0 t -107.15 -41.18 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.369 -0.832 . . . . 0.0 110.692 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 91.1 mt-10 -154.8 141.07 18.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.883 -1.136 . . . . 0.0 109.815 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.97 159.89 36.07 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.92 151.03 32.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -1.223 . . . . 0.0 109.737 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.57 -126.83 1.95 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.9 tp -147.95 163.22 37.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -1.015 . . . . 0.0 109.074 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -134.8 90.81 2.69 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.046 -1.034 . . . . 0.0 109.098 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.589 ' SG ' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -78.13 146.25 35.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.982 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.419 HD23 ' HZ3' ' A' ' 31' ' ' LYS . 1.9 mt -148.53 101.53 3.23 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -102.13 113.4 26.63 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.825 -1.172 . . . . 0.0 109.562 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 118' ' ' GLY . 0.1 OUTLIER -134.97 124.79 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.095 -1.003 . . . . 0.0 110.506 -178.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.401 ' N ' HD13 ' A' ' 117' ' ' ILE . . . 70.22 -142.67 36.24 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 105.636 -2.986 . . . . 0.0 105.636 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.32 79.11 1.18 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 115.157 -2.617 . . . . 0.0 108.303 176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -165.07 166.62 19.05 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.4 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 51.0 t -125.99 140.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.087 -1.008 . . . . 0.0 110.404 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.405 ' CE2' ' CD1' ' A' ' 5' ' ' ILE . 16.0 m-85 -123.83 131.02 53.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.442 0.639 . . . . 0.0 109.791 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -141.94 118.62 11.05 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.169 -0.957 . . . . 0.0 109.785 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -101.79 147.23 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.612 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tp -127.58 81.62 2.03 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.46 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.447 ' SG ' ' CB ' ' A' ' 1' ' ' SER . 35.9 t -166.56 122.65 1.22 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.584 ' H ' ' CD ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -109.3 105.82 15.38 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 116.705 -1.998 . . . . 0.0 112.338 -178.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.58 ' C ' ' H ' ' A' ' 130' ' ' ASP . 42.1 mmtt -113.77 171.04 7.82 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.02 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.605 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 12.5 m120 -58.76 -3.03 0.27 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.832 -1.168 . . . . 0.0 107.895 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.58 ' H ' ' C ' ' A' ' 128' ' ' LYS . 40.2 p30 -73.43 153.99 40.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.793 0.806 . . . . 0.0 109.888 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.54 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 2.3 pp -122.89 161.31 24.37 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.073 0.939 . . . . 0.0 110.366 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.3 mp -131.54 127.83 60.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.664 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.9 t -123.71 135.93 54.15 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.75 148.63 36.1 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.278 -0.889 . . . . 0.0 108.799 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.22 157.95 57.87 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.554 2.169 . . . . 0.0 113.052 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.621 ' O ' ' CD2' ' A' ' 137' ' ' HIS . . . -73.38 135.62 44.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.237 -0.914 . . . . 0.0 108.997 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.703 ' O ' ' ND1' ' A' ' 137' ' ' HIS . 0.1 OUTLIER 95.43 3.92 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.352 0.596 . . . . 0.0 109.732 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.78 125.47 42.19 Favored Pre-proline 0 N--CA 1.487 1.42 0 O-C-N 120.84 -1.162 . . . . 0.0 108.816 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.14 132.9 33.38 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.433 1.422 . . . . 0.0 111.6 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.512 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.42 164.28 15.05 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.189 -0.944 . . . . 0.0 110.161 -178.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.589 ' CD1' ' SG ' ' A' ' 114' ' ' CYS . 14.6 p90 -130.06 -153.78 0.59 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.469 -0.77 . . . . 0.0 109.752 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.616 ' CD1' ' NH1' ' A' ' 104' ' ' ARG . 2.8 t80 -170.78 125.01 0.68 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.303 -0.873 . . . . 0.0 108.999 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.501 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 49.0 p-10 -148.19 130.97 16.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.944 -1.097 . . . . 0.0 109.374 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.615 ' O ' ' C ' ' A' ' 145' ' ' GLY . 8.6 mmt -107.18 18.91 21.1 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 111.334 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 11.56 -99.39 0.01 OUTLIER Glycine 0 N--CA 1.501 3.008 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.433 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 31.6 t -84.16 120.56 26.33 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.897 -1.354 . . . . 0.0 109.351 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 147' ' ' GLU . 1.0 OUTLIER -115.51 117.6 40.32 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 57.2 Cg_endo -100.03 31.2 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.258 1.972 . . . . 0.0 112.209 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER 81.79 63.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.688 -179.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.51 ' C ' ' CD2' ' A' ' 150' ' ' PHE . 15.0 p90 -101.41 169.85 8.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.519 -0.738 . . . . 0.0 109.222 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 53.3 m -130.28 106.53 8.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.57 -0.706 . . . . 0.0 109.489 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' A' ' 75' ' ' VAL . . . -105.91 161.94 14.01 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.987 -1.07 . . . . 0.0 109.827 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 153' ' ' ILE . 23.5 mt -105.45 123.26 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.869 -1.145 . . . . 0.0 110.291 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.692 HH21 ' HE ' ' A' ' 104' ' ' ARG . 1.9 mtt-85 -130.62 159.85 35.97 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.485 ' CD1' ' N ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.98 155.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.605 ' CG ' ' OG ' ' A' ' 72' ' ' SER . 5.8 m-85 -96.19 121.87 38.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 110.224 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 49.2 p30 -132.04 163.28 28.78 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -92.79 161.86 30.65 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.979 -1.076 . . . . 0.0 108.865 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.598 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.0 Cg_endo -62.52 -60.4 0.19 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.747 1.631 . . . . 0.0 112.288 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.7 tt0 -45.92 -13.53 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -72.7 -43.87 41.43 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.563 ' CE3' ' O ' ' A' ' 163' ' ' ILE . 9.9 p-90 -110.13 161.02 15.96 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.518 -0.989 . . . . 0.0 110.348 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.563 ' O ' ' CE3' ' A' ' 162' ' ' TRP . 4.0 tp -99.92 154.44 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.249 -0.907 . . . . 0.0 109.194 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.78 -75.54 0.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.97 . . . . 0.0 110.435 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.477 HE22 HD21 ' A' ' 94' ' ' ASN . 31.1 mt-30 -142.3 164.61 29.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.103 -0.998 . . . . 0.0 110.156 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -101.21 -40.18 7.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.89 . . . . 0.0 109.326 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 22.0 m -114.68 -32.36 5.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.937 . . . . 0.0 108.568 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.61 -1.34 58.38 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.505 ' O ' ' OD2' ' A' ' 169' ' ' ASP . 39.1 p30 -80.29 145.82 31.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.3 -1.706 . . . . 0.0 108.726 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.416 ' OD2' ' ND2' ' A' ' 94' ' ' ASN . 90.4 m-20 -113.21 89.7 3.15 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.113 -1.435 . . . . 0.0 110.263 175.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.71 -17.89 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.241 -1.537 . . . . 0.0 108.854 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.582 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -58.67 -41.59 86.51 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.362 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.603 ' HG ' ' CD2' ' A' ' 93' ' ' LEU . 1.2 m -52.46 -3.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.538 -0.726 . . . . 0.0 109.873 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.71 -39.57 26.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.909 -1.119 . . . . 0.0 111.371 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.639 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -114.57 25.58 0.09 OUTLIER Pre-proline 0 N--CA 1.516 2.842 0 O-C-N 120.668 -1.27 . . . . 0.0 112.089 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 39.1 Cg_endo -59.25 -18.18 43.44 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.333 2.689 . . . . 0.0 114.177 -171.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -89.44 125.57 35.22 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.619 -1.233 . . . . 0.0 108.107 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.433 ' HB3' ' H ' ' A' ' 146' ' ' SER . 3.9 tt -86.68 125.45 33.87 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.092 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.593 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.623 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.492 ' H3 ' ' HG ' ' A' ' 1' ' ' SER . 2.8 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.49 169.32 9.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.066 . . . . 0.0 109.074 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 16.3 tp -157.65 114.99 3.01 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.7 OUTLIER -109.02 138.59 45.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.216 -0.928 . . . . 0.0 110.119 -179.16 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.55 ' CD1' ' OE1' ' A' ' 27' ' ' GLN . 52.9 mt -132.87 131.45 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -125.6 164.29 20.88 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m -85.91 175.0 8.87 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.144 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -26.87 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.023 -1.048 . . . . 0.0 109.677 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -74.11 -38.43 63.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.05 -1.031 . . . . 0.0 110.181 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.33 125.91 14.77 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 109.679 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 13' ' ' ASN . 56.1 Cg_endo -80.42 -36.9 0.43 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 121.974 1.783 . . . . 0.0 112.202 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 7.86 0.77 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.768 . . . . 0.0 110.113 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 11' ' ' PRO . 80.6 m-20 -116.96 119.77 36.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.196 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -98.96 123.65 43.39 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.579 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 3.9 mm? -89.93 -9.84 47.36 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.585 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.528 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 33.1 t90 -157.48 106.87 2.15 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.629 -1.228 . . . . 0.0 110.133 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -121.87 119.92 33.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.512 -0.742 . . . . 0.0 109.729 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.409 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -162.85 164.56 25.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.218 -0.926 . . . . 0.0 110.132 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' A' ' 1' ' ' SER . 76.1 m -130.14 89.11 2.75 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.017 -1.052 . . . . 0.0 108.188 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.534 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 29.9 m120 -127.73 144.26 51.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.458 -0.776 . . . . 0.0 110.422 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.73 -38.74 21.0 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.235 -1.541 . . . . 0.0 108.312 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -82.9 -48.36 10.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.516 -0.74 . . . . 0.0 109.749 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' OE1' ' OD1' ' A' ' 20' ' ' ASN . 1.2 tt0 -62.83 -19.56 64.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.722 -1.236 . . . . 0.0 108.608 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 4.0 mt -74.47 -56.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.871 . . . . 0.0 109.326 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.418 ' CB ' ' CD1' ' A' ' 35' ' ' PHE . 3.0 pp0? -55.41 -34.9 64.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.309 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -68.09 -47.5 68.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.276 -0.89 . . . . 0.0 109.447 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.55 ' OE1' ' CD1' ' A' ' 5' ' ' ILE . 7.6 tt0 -68.16 -40.46 82.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.167 -0.958 . . . . 0.0 109.082 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.18 -62.42 1.41 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.172 -0.955 . . . . 0.0 109.286 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 15.1 t-20 -58.13 -17.98 22.21 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.298 -0.876 . . . . 0.0 109.907 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.1 -32.52 73.73 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.847 -1.158 . . . . 0.0 109.387 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -90.51 9.34 29.72 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.98 24.56 16.82 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.283 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 33.7 t -96.96 147.82 6.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.279 -1.13 . . . . 0.0 109.554 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.415 ' HB3' ' H ' ' A' ' 133' ' ' SER . 19.5 ttt180 -84.02 154.01 23.51 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 120.511 -1.368 . . . . 0.0 108.368 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.538 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 1.1 t80 -154.39 149.97 27.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.023 -1.048 . . . . 0.0 108.276 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 2.9 mt-10 -177.24 177.08 1.26 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.045 -1.034 . . . . 0.0 109.481 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -148.61 112.44 5.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.534 ' NE1' ' OE2' ' A' ' 36' ' ' GLU . 31.4 m0 -111.02 157.4 19.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.271 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -142.72 156.24 44.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 0.0 109.927 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.35 152.75 20.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.205 -0.934 . . . . 0.0 108.997 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -104.03 -6.39 21.22 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -93.34 159.15 15.39 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.781 0.801 . . . . 0.0 109.093 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -94.51 115.31 27.45 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.66 -0.65 . . . . 0.0 109.537 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.7 mt -94.86 164.96 12.7 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.43 -0.794 . . . . 0.0 109.505 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.29 -103.76 0.2 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.6 92.97 4.76 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.989 -1.301 . . . . 0.0 109.187 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.16 92.12 44.88 Favored Pre-proline 0 C--N 1.306 -1.293 0 C-N-CA 119.8 -0.76 . . . . 0.0 108.965 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.54 -21.91 14.41 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.297 1.998 . . . . 0.0 112.763 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 p -122.93 142.12 51.16 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.584 -0.698 . . . . 0.0 109.705 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.34 -16.91 53.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.43 -0.794 . . . . 0.0 109.419 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -46.92 -39.03 11.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.344 -0.847 . . . . 0.0 108.725 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.3 m -79.2 -39.68 32.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.617 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.71 -46.53 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.291 -0.881 . . . . 0.0 109.669 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 58' ' ' GLN . 15.6 mt -60.48 -36.02 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.073 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.06 -28.65 69.75 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.411 -0.806 . . . . 0.0 109.407 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.76 -20.29 50.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.038 -1.039 . . . . 0.0 110.331 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 58' ' ' GLN . 61.7 m-85 -112.02 -12.27 13.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.298 -0.876 . . . . 0.0 109.552 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.702 HE21 ' CG1' ' A' ' 61' ' ' ILE . 30.1 tp60 -45.52 -35.9 4.19 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.567 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.6 -47.64 63.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 109.546 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.567 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.34 -60.08 4.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 109.755 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.702 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.6 OUTLIER -63.17 -29.51 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 120.608 -1.308 . . . . 0.0 109.127 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 58' ' ' GLN . 21.3 t70 -55.9 -26.41 47.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.706 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -78.28 -36.1 47.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.985 -1.072 . . . . 0.0 109.543 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 8.4 mp -63.19 -40.79 98.53 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.545 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -70.13 -29.01 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.173 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.53 -56.66 12.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.431 -1.418 . . . . 0.0 109.191 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -83.53 -48.81 9.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.035 -1.04 . . . . 0.0 110.608 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.627 ' O ' ' C ' ' A' ' 69' ' ' GLY . 7.5 mtpm? -87.79 14.7 8.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.878 . . . . 0.0 110.788 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.627 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -11.68 89.33 0.0 OUTLIER Glycine 0 N--CA 1.501 3.028 0 CA-C-O 121.959 0.755 . . . . 0.0 111.227 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 68' ' ' LYS . 84.3 m-85 -76.86 164.42 25.83 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.586 ' NE2' ' OG ' ' A' ' 72' ' ' SER . 0.6 OUTLIER -63.2 -87.48 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.43 -0.794 . . . . 0.0 109.78 -178.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.586 ' OG ' ' NE2' ' A' ' 71' ' ' GLN . 14.7 m -102.74 160.24 14.76 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 109.595 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 74' ' ' ASP . 7.6 t-105 -140.79 145.75 36.74 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.454 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.2 OUTLIER -165.36 -176.6 4.1 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 152' ' ' ALA . 9.9 p -119.8 142.73 33.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 tp -101.33 115.71 43.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.507 ' O ' ' OG ' ' A' ' 77' ' ' SER . 4.7 p -169.56 102.99 0.33 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.381 -0.825 . . . . 0.0 108.845 177.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.605 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -117.98 179.77 3.99 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.094 1.77 . . . . 0.0 108.12 -179.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.605 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 3.2 tpt180 -89.88 143.85 26.44 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.667 -1.27 . . . . 0.0 109.412 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.42 1.38 0.35 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.568 -0.707 . . . . 0.0 109.593 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 79' ' ' ARG . 84.6 m-20 -78.87 -29.09 44.28 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.213 -1.395 . . . . 0.0 108.872 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.716 HD22 ' CD ' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -64.27 124.85 86.9 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.044 -1.035 . . . . 0.0 109.085 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -78.55 -8.56 16.01 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.171 1.914 . . . . 0.0 112.401 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -89.59 4.14 50.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.006 -1.059 . . . . 0.0 109.482 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.716 ' CD ' HD22 ' A' ' 82' ' ' ASN . 3.5 tptp -60.0 -49.82 76.18 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.194 -0.941 . . . . 0.0 108.919 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -62.82 -41.99 99.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 109.57 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.16 -38.27 76.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.612 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -60.3 -42.75 96.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.345 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.572 ' NH2' ' O ' ' A' ' 85' ' ' LYS . 1.0 OUTLIER -60.49 -30.65 69.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.845 . . . . 0.0 109.873 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.22 -60.22 3.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 109.671 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.403 ' O ' ' ND2' ' A' ' 94' ' ' ASN . 50.4 mttp -57.17 -32.18 66.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.504 -0.747 . . . . 0.0 109.278 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -85.6 -18.25 33.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.415 -0.803 . . . . 0.0 110.243 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -40.17 91.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.125 -0.984 . . . . 0.0 109.85 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 94' ' ' ASN . 21.5 p30 -46.89 125.48 7.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.121 -0.987 . . . . 0.0 109.452 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.53 166.32 1.32 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.504 -0.748 . . . . 0.0 109.366 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -173.17 -169.26 0.52 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.899 -1.12 . . . . 0.0 111.433 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.2 t -164.1 135.58 4.6 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.676 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -107.55 156.2 19.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.443 -0.785 . . . . 0.0 109.735 -178.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.18 -6.94 86.7 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -123.51 170.67 10.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.316 -1.108 . . . . 0.0 109.288 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -76.26 142.99 41.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.972 -1.08 . . . . 0.0 110.161 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -100.24 94.6 6.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.194 -0.942 . . . . 0.0 109.058 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.662 ' CA ' ' HG ' ' A' ' 133' ' ' SER . 1.0 OUTLIER -91.46 130.67 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.507 -0.745 . . . . 0.0 109.878 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.487 HH21 ' CB ' ' A' ' 152' ' ' ALA . 51.2 ttt180 -132.01 123.77 27.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.398 -0.814 . . . . 0.0 109.346 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.586 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 27.2 t80 -104.78 131.89 51.7 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.09 128.42 35.42 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.608 -0.682 . . . . 0.0 110.228 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.0 t -112.63 -29.67 2.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.683 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -169.04 158.04 8.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.027 . . . . 0.0 109.031 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.488 ' O ' ' OE1' ' A' ' 127' ' ' GLU . . . 78.49 150.0 4.69 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.9 156.05 31.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.421 -1.046 . . . . 0.0 109.512 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -151.49 -125.99 1.24 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 mt -148.95 164.32 34.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -1.08 . . . . 0.0 109.659 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.47 91.59 2.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.569 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.643 ' SG ' ' NE2' ' A' ' 123' ' ' GLN . 0.8 OUTLIER -77.97 117.04 18.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 109.476 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.34 106.16 12.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.116 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.5 t-160 -101.33 109.56 21.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.972 . . . . 0.0 109.462 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mm -125.57 111.82 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.005 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.99 -142.12 28.11 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 106.537 -2.625 . . . . 0.0 106.537 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.494 ' CG ' ' O ' ' A' ' 119' ' ' ASP . 48.2 p-10 -103.8 79.2 1.63 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 115.103 -2.639 . . . . 0.0 109.369 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.479 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 75.8 tt0 -165.92 167.34 16.78 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.485 ' CG1' HE22 ' A' ' 123' ' ' GLN . 86.7 t -130.43 151.91 36.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.089 -1.007 . . . . 0.0 109.924 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.439 ' C ' ' OE1' ' A' ' 123' ' ' GLN . 32.7 m-85 -130.87 133.27 45.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.691 -0.631 . . . . 0.0 109.986 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.643 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 4.2 mp0 -122.35 110.07 15.2 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.412 -0.805 . . . . 0.0 109.088 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.84 133.9 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.647 ' CD1' ' N ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.55 90.54 2.62 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.341 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' A' ' 126' ' ' CYS . 30.1 p -166.36 128.8 1.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.393 -1.442 . . . . 0.0 107.329 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 7.0 tt0 -107.39 96.35 6.34 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 116.096 -2.242 . . . . 0.0 110.569 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' A' ' 130' ' ' ASP . 17.1 mtpp -112.73 159.78 18.6 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.66 176.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.586 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 14.6 m120 -57.12 -4.27 0.18 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.442 -1.411 . . . . 0.0 107.761 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.592 ' H ' ' C ' ' A' ' 128' ' ' LYS . 67.3 m-20 -66.73 143.14 57.12 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.705 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.576 ' CD1' ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -110.79 142.67 42.45 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.614 0.721 . . . . 0.0 110.706 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.576 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 47.6 pt -132.64 147.66 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.662 ' HG ' ' CA ' ' A' ' 103' ' ' VAL . 8.9 t -137.03 153.78 50.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.349 -0.844 . . . . 0.0 109.581 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -106.11 143.01 26.06 Favored Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.49 152.65 80.38 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.283 1.989 . . . . 0.0 112.274 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.609 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.59 134.61 47.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.275 -0.891 . . . . 0.0 109.223 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.609 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.1 t-80 91.31 11.21 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.121 0.486 . . . . 0.0 109.742 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.13 126.5 31.48 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 0.0 108.739 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.98 131.49 29.0 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.581 1.52 . . . . 0.0 111.474 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.488 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.9 163.79 9.62 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.223 -179.186 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.45 ' CG ' ' CB ' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -134.53 -146.94 0.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.239 -0.913 . . . . 0.0 109.713 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -177.9 126.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.926 -1.109 . . . . 0.0 109.037 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 143' ' ' ASP . 10.9 p-10 -144.25 134.14 23.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.31 -0.869 . . . . 0.0 109.895 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.618 ' O ' ' C ' ' A' ' 145' ' ' GLY . 84.1 mmm -112.94 20.48 16.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.584 -0.697 . . . . 0.0 111.202 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.61 -92.68 0.01 OUTLIER Glycine 0 N--CA 1.506 3.363 0 CA-C-N 119.265 0.939 . . . . 0.0 111.534 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.472 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 74.5 m -85.85 117.51 24.76 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.92 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.557 ' CD ' ' H ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -117.3 113.18 39.12 Favored Pre-proline 0 C--N 1.299 -1.609 0 C-N-CA 119.764 -0.775 . . . . 0.0 109.804 178.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.3 Cg_endo -103.12 40.95 0.04 OUTLIER 'Trans proline' 0 C--O 1.213 -0.767 0 C-N-CA 122.717 2.278 . . . . 0.0 111.349 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 81.79 71.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.124 -177.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.536 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 8.9 p90 -95.53 144.31 26.11 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.388 -0.82 . . . . 0.0 109.895 -177.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.8 m -113.17 122.96 49.09 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.536 -0.728 . . . . 0.0 109.754 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.487 ' CB ' HH21 ' A' ' 104' ' ' ARG . . . -142.83 162.58 35.1 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 57.6 mt -107.49 126.92 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.076 -1.015 . . . . 0.0 109.374 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -136.51 164.13 28.9 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.113 -0.992 . . . . 0.0 109.803 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 4.7 mp -102.5 145.12 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.579 -0.701 . . . . 0.0 109.562 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.454 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.2 m-85 -95.54 118.81 32.94 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.291 -0.881 . . . . 0.0 109.361 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 0.9 OUTLIER -134.93 164.13 28.29 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.3 OUTLIER -93.65 160.26 33.16 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.167 -0.958 . . . . 0.0 109.052 -179.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.3 Cg_endo -61.76 -55.65 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.198 1.932 . . . . 0.0 112.199 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.4 tt0 -44.09 -15.49 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.336 -0.853 . . . . 0.0 108.986 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -72.72 -46.68 29.68 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 178.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.464 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 6.5 p90 -107.38 165.03 11.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.341 -1.094 . . . . 0.0 110.05 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 163' ' ' ILE . 72.6 mt -100.59 149.58 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.35 -71.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.088 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.583 ' NE2' ' OD1' ' A' ' 170' ' ' ASP . 43.1 mt-30 -140.39 159.01 43.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 109.632 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -101.21 -41.12 6.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 109.564 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.7 p -102.44 -30.43 11.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.085 -1.009 . . . . 0.0 108.856 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.49 -6.49 52.81 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -82.13 148.55 28.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.704 -1.468 . . . . 0.0 108.688 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.583 ' OD1' ' NE2' ' A' ' 165' ' ' GLN . 88.5 m-20 -109.08 88.35 2.71 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 117.568 -1.653 . . . . 0.0 111.096 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.5 tt -77.75 -23.69 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.609 -1.307 . . . . 0.0 109.348 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.554 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -60.41 -41.44 93.92 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.592 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 93.4 p -54.62 -2.95 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.481 -0.762 . . . . 0.0 109.994 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.31 -39.84 31.83 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.942 -1.099 . . . . 0.0 111.298 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.627 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 9.9 m-85 -111.64 24.4 0.08 OUTLIER Pre-proline 0 N--CA 1.514 2.754 0 O-C-N 120.85 -1.156 . . . . 0.0 112.808 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 45.3 Cg_endo -63.59 -19.3 67.32 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.68 2.92 . . . . 0.0 113.348 -173.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.08 125.51 35.05 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.99 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.472 ' HB3' ' H ' ' A' ' 146' ' ' SER . 1.8 tp -88.03 120.41 29.34 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.525 -0.734 . . . . 0.0 109.135 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.786 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.34 -179.858 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . 0.425 ' H2 ' ' CD2' ' A' ' 98' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.608 ' O ' ' OG1' ' A' ' 19' ' ' THR . 1.6 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.96 171.55 8.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 108.925 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.2 tp -158.85 113.1 2.44 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.74 130.32 54.96 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.166 -0.959 . . . . 0.0 110.365 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' CD1' ' OE1' ' A' ' 27' ' ' GLN . 63.9 mt -124.59 133.61 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 97.2 m-85 -126.63 165.36 19.34 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -91.73 176.33 6.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 108.715 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -25.68 5.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.888 -1.133 . . . . 0.0 109.418 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -73.13 -40.68 64.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 110.086 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -136.81 124.01 14.16 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.093 -1.004 . . . . 0.0 109.437 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.565 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 56.4 Cg_endo -82.18 -33.13 0.6 Allowed 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.925 1.75 . . . . 0.0 112.319 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.482 ' O ' ' OE1' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -68.43 -25.99 65.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 110.347 -178.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -95.41 120.79 36.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.959 -1.088 . . . . 0.0 108.977 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.412 ' H ' ' HG ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -95.38 131.99 40.91 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.297 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 pp -90.37 -8.96 49.38 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.209 -0.996 . . . . 0.0 108.822 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.488 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 45.1 t90 -157.54 106.79 2.13 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.506 -1.278 . . . . 0.0 109.943 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -120.77 119.82 33.85 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.535 -0.728 . . . . 0.0 109.801 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.47 161.84 30.24 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.198 -0.939 . . . . 0.0 109.82 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.608 ' OG1' ' O ' ' A' ' 1' ' ' SER . 8.9 t -131.36 89.08 2.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 118.773 -1.171 . . . . 0.0 108.507 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.541 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 1.9 m-20 -126.27 142.37 51.55 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.372 -0.83 . . . . 0.0 110.24 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.85 -37.05 27.57 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.463 -1.398 . . . . 0.0 109.137 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.68 -50.15 9.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.167 -0.958 . . . . 0.0 109.862 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -63.32 -18.53 63.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.036 -1.04 . . . . 0.0 108.719 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 3.1 mt -73.56 -56.07 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 108.912 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.4 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 9.2 pt20 -57.61 -40.77 79.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.211 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -62.04 -43.03 99.7 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.142 -0.974 . . . . 0.0 109.114 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.488 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 7.5 tt0 -72.47 -44.85 61.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.204 -0.935 . . . . 0.0 108.899 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -64.19 -62.56 1.54 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.054 -1.029 . . . . 0.0 109.371 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.618 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -61.23 -17.56 53.93 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.165 -178.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.52 -28.82 70.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.529 -1.357 . . . . 0.0 108.439 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.403 ' CD ' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -94.19 6.81 47.46 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.855 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.81 25.64 12.92 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.046 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.29 145.98 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.149 -1.206 . . . . 0.0 109.191 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -83.59 153.47 24.3 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 121.058 -1.026 . . . . 0.0 108.555 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.593 ' CD2' ' OD2' ' A' ' 130' ' ' ASP . 2.2 t80 -154.21 146.47 23.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.159 -0.963 . . . . 0.0 108.729 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.535 ' O ' ' OD2' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -177.9 178.07 1.0 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.006 -1.059 . . . . 0.0 110.251 178.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 119.3 6.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 108.886 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 23.1 m0 -111.99 156.83 21.51 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -143.05 160.98 39.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.867 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.44 158.17 16.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 108.946 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -101.45 -14.1 17.67 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -92.9 158.79 15.65 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.535 0.684 . . . . 0.0 109.161 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -93.71 123.63 37.16 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 109.46 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 mt -94.39 165.67 12.45 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 109.368 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.7 -105.14 0.22 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.01 93.06 5.04 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.999 -1.295 . . . . 0.0 109.327 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.9 91.65 43.37 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -75.88 -22.04 13.7 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.155 1.903 . . . . 0.0 112.421 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.1 p -120.58 141.19 50.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.618 -0.677 . . . . 0.0 109.679 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.86 -17.86 49.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.478 -0.764 . . . . 0.0 109.535 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.69 -39.22 16.86 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.223 -0.923 . . . . 0.0 108.862 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.8 m -78.92 -34.89 44.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 109.587 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.76 -57.12 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.342 -0.849 . . . . 0.0 110.33 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.458 ' N ' ' CD1' ' A' ' 54' ' ' ILE . 1.7 mp -58.8 -34.99 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.968 -1.083 . . . . 0.0 108.9 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.68 -35.18 72.18 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.413 -0.804 . . . . 0.0 109.365 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.51 -13.7 60.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.21 -0.931 . . . . 0.0 109.632 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.4 m-85 -111.42 -8.39 14.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.489 -0.757 . . . . 0.0 109.762 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 62' ' ' ASP . 10.3 mm-40 -47.06 -36.05 7.63 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.159 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.713 ' CD2' ' N ' ' A' ' 60' ' ' ALA . 11.9 p-80 -53.36 -44.18 68.36 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.74 -1.225 . . . . 0.0 109.516 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.713 ' N ' ' CD2' ' A' ' 59' ' ' HIS . . . -63.6 -61.1 2.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.0 -1.063 . . . . 0.0 110.071 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.419 ' HB ' ' CZ2' ' A' ' 73' ' ' TRP . 1.3 pp -62.36 -27.72 43.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.75 -1.219 . . . . 0.0 108.983 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' A' ' 62' ' ' ASP . 36.8 t0 -58.41 -27.69 64.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.96 . . . . 0.0 109.567 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -74.19 -40.93 62.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.959 . . . . 0.0 109.121 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 7.6 mp -64.42 -34.85 79.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 109.295 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.464 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 11.5 t -68.13 -29.93 46.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.035 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.75 72.82 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.658 -1.276 . . . . 0.0 109.524 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -87.74 -53.86 4.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.083 -1.011 . . . . 0.0 110.5 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.604 ' O ' ' C ' ' A' ' 69' ' ' GLY . 8.2 mmtp -85.96 14.51 6.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.355 -0.84 . . . . 0.0 110.489 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -16.41 87.58 0.0 OUTLIER Glycine 0 N--CA 1.499 2.885 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 68' ' ' LYS . 81.1 m-85 -76.58 164.01 26.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.429 HE21 ' HA ' ' A' ' 157' ' ' ASP . 32.8 mt-30 -57.74 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.312 -0.868 . . . . 0.0 109.673 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.58 163.0 12.58 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.598 0.713 . . . . 0.0 110.058 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.487 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 5.6 t-105 -131.84 135.76 46.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.86 166.81 25.57 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.9 -1.125 . . . . 0.0 108.142 178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -119.55 141.28 40.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 7.6 tp -102.7 115.01 43.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.235 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.497 ' OG ' ' OG1' ' A' ' 151' ' ' THR . 2.0 t -167.63 100.06 0.49 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.34 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.599 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -125.01 -179.26 4.48 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.34 -1.475 . . . . 0.0 107.658 -179.52 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.599 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 23.2 tpt180 -88.91 153.07 21.34 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.671 -1.268 . . . . 0.0 109.075 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.97 0.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.583 ' H ' ' C ' ' A' ' 79' ' ' ARG . 83.8 m-20 -103.43 30.54 4.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.552 ' OD1' ' N ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -82.26 135.08 47.76 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.52 -0.737 . . . . 0.0 110.201 178.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.446 ' C ' ' OE1' ' A' ' 84' ' ' GLN . 55.7 Cg_endo -77.41 -25.75 7.97 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.173 1.915 . . . . 0.0 112.198 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.487 ' N ' ' OE1' ' A' ' 84' ' ' GLN . 0.9 OUTLIER -92.5 8.13 40.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.895 -1.128 . . . . 0.0 109.493 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.576 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 18.0 pttt -58.73 -51.7 68.86 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.214 -0.929 . . . . 0.0 108.774 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.576 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 84.2 tt0 -67.6 -54.24 21.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.146 -0.972 . . . . 0.0 109.504 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.83 -47.02 83.85 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.311 -0.955 . . . . 0.0 109.727 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 84' ' ' GLN . 13.3 tp -63.07 -46.13 88.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.768 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -60.83 -36.96 80.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 109.602 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.7 -58.84 4.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -0.878 . . . . 0.0 109.625 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -50.5 -37.89 41.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.278 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.03 -19.46 51.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.117 -0.99 . . . . 0.0 109.134 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.3 -34.86 75.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 109.758 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -64.26 150.44 45.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.107 -0.995 . . . . 0.0 110.188 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.639 ' CD ' ' H ' ' A' ' 95' ' ' GLU . 7.7 pm0 -80.91 166.31 20.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 0.0 109.567 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -173.96 -169.24 0.47 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.044 -1.062 . . . . 0.0 111.195 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.2 t -163.48 132.97 4.09 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.635 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -104.3 156.74 17.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.516 -0.74 . . . . 0.0 110.125 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.433 ' N ' ' HB3' ' A' ' 162' ' ' TRP . . . -78.78 -6.56 88.49 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -124.36 171.15 10.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.395 -1.062 . . . . 0.0 109.429 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 102' ' ' GLU . 48.3 t0 -75.19 139.91 42.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.109 -0.994 . . . . 0.0 110.248 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.594 ' N ' ' OD2' ' A' ' 101' ' ' ASP . 14.9 tt0 -97.13 95.17 7.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.344 -0.848 . . . . 0.0 108.931 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.426 ' CG1' ' OG ' ' A' ' 133' ' ' SER . 29.5 t -95.29 123.17 47.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.65 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 34.0 ttm105 -127.28 126.3 42.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.46 -0.775 . . . . 0.0 109.018 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.622 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 15.2 t80 -102.36 131.18 49.15 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.825 0.822 . . . . 0.0 109.201 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.405 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -85.9 126.46 34.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.49 0.662 . . . . 0.0 110.154 -178.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.9 t -108.5 -30.24 2.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.73 -0.606 . . . . 0.0 109.476 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -165.94 153.8 10.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 109.27 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.76 157.09 32.8 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.17 162.38 32.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -1.171 . . . . 0.0 109.089 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.63 155.16 13.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.429 ' CG ' ' O ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -103.14 98.93 8.79 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.133 -1.216 . . . . 0.0 110.638 -178.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -80.5 126.41 31.18 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.66 -1.275 . . . . 0.0 110.054 -178.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.652 ' HG ' ' NE2' ' A' ' 123' ' ' GLN . 0.9 OUTLIER -78.5 125.84 29.93 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.312 0.577 . . . . 0.0 109.984 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -113.62 125.53 54.27 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.48 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 8.2 t-160 -107.91 110.37 22.1 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.2 pt -124.64 114.25 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 O-C-N 121.45 -0.781 . . . . 0.0 110.513 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.63 -143.81 33.15 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 104.845 -3.302 . . . . 0.0 104.845 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -106.19 79.93 1.45 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 115.048 -2.661 . . . . 0.0 108.636 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.48 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 12.2 pt-20 -166.35 170.16 13.33 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 88.9 t -125.27 137.56 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.006 -1.059 . . . . 0.0 109.853 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 115' ' ' LEU . 7.2 m-85 -122.09 129.54 52.46 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.652 ' NE2' ' HG ' ' A' ' 114' ' ' CYS . 7.5 mt-30 -128.39 115.24 17.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 108.984 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 11.5 t -101.76 133.54 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.7 tt -134.42 91.0 2.73 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.746 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.402 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 30.7 p -164.77 134.75 3.82 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -106.33 94.64 5.26 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 115.55 -2.46 . . . . 0.0 110.538 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.571 ' C ' ' H ' ' A' ' 130' ' ' ASP . 20.1 tptm -114.2 156.8 23.62 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.088 176.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.622 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 83.3 m-20 -58.35 -3.32 0.26 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.487 -1.383 . . . . 0.0 107.891 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.593 ' OD2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.89 153.03 43.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.199 -178.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 130' ' ' ASP . 2.1 pp -117.56 160.57 21.03 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.893 0.854 . . . . 0.0 110.095 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.6 mm -131.65 128.77 60.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.805 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.426 ' OG ' ' CG1' ' A' ' 103' ' ' VAL . 14.5 m -123.0 142.09 51.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.401 -0.812 . . . . 0.0 109.373 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.499 ' O ' ' OD2' ' A' ' 101' ' ' ASP . 8.3 m -109.31 148.96 39.08 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.407 -0.808 . . . . 0.0 108.98 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -66.81 154.76 73.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.378 2.052 . . . . 0.0 112.966 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.618 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -73.32 136.53 44.49 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.459 -0.776 . . . . 0.0 109.329 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.618 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 4.1 t-80 92.95 10.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.37 126.17 32.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 108.556 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.79 132.2 31.83 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.54 1.493 . . . . 0.0 111.534 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.45 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.86 162.83 9.54 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.219 -0.926 . . . . 0.0 110.18 -178.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.451 ' HB2' ' H ' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -133.71 -147.16 0.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.65 ' CE1' ' NH1' ' A' ' 104' ' ' ARG . 0.2 OUTLIER -178.74 127.7 0.11 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.864 -1.148 . . . . 0.0 109.077 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 143' ' ' ASP . 54.7 p-10 -147.23 139.55 24.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.808 . . . . 0.0 109.852 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.604 ' O ' ' C ' ' A' ' 145' ' ' GLY . 2.6 ptt? -113.7 22.9 13.6 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.579 -0.7 . . . . 0.0 110.72 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 7.11 -90.61 0.0 OUTLIER Glycine 0 N--CA 1.502 3.053 0 CA-C-N 119.517 1.053 . . . . 0.0 112.465 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.494 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 23.0 t -86.05 116.78 24.48 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 117.886 -1.525 . . . . 0.0 108.834 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.56 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -116.74 114.36 39.75 Favored Pre-proline 0 C--N 1.296 -1.719 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.748 178.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.0 Cg_endo -101.41 38.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.885 0 C-N-CA 122.873 2.382 . . . . 0.0 110.705 176.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER 82.56 70.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -176.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 20.2 p90 -95.25 163.35 13.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.747 -0.595 . . . . 0.0 109.635 -177.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.497 ' OG1' ' OG ' ' A' ' 77' ' ' SER . 34.5 m -134.42 126.9 30.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 0.0 109.931 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.65 163.48 33.13 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.539 -0.726 . . . . 0.0 109.14 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.487 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 24.8 mt -110.59 130.04 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.192 -0.943 . . . . 0.0 109.681 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 155' ' ' ILE . 6.5 ptm180 -131.26 159.02 39.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.42 -0.8 . . . . 0.0 110.494 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.512 ' O ' ' NH1' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -108.12 149.63 11.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.501 0.667 . . . . 0.0 109.446 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -97.33 120.62 38.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.866 0.841 . . . . 0.0 110.77 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.582 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 52.0 t0 -133.93 158.93 42.23 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.594 ' O ' ' NE1' ' A' ' 162' ' ' TRP . 80.9 m-20 -96.96 150.8 37.26 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.901 -1.124 . . . . 0.0 109.513 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.625 ' O ' ' N ' ' A' ' 161' ' ' GLY . 45.9 Cg_endo -70.65 -53.23 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.363 2.042 . . . . 0.0 112.121 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.5 tt0 -42.4 -15.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.672 -0.643 . . . . 0.0 109.514 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.27 -41.4 13.74 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 177.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.594 ' NE1' ' O ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -114.4 175.66 5.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.596 -0.944 . . . . 0.0 110.952 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 19.2 pt -96.32 155.44 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.535 -0.728 . . . . 0.0 109.339 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -93.56 -70.84 0.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 110.663 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -107.06 143.07 35.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.07 -1.019 . . . . 0.0 110.197 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -102.07 -40.48 6.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 109.619 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -116.92 -30.12 5.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.323 -0.861 . . . . 0.0 108.688 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.83 -7.41 53.02 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -80.9 149.2 29.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.661 -1.494 . . . . 0.0 108.176 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.484 ' OD2' ' OG ' ' A' ' 173' ' ' SER . 1.7 p30 -107.98 88.42 2.73 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 117.425 -1.71 . . . . 0.0 111.152 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -25.62 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.832 -1.168 . . . . 0.0 109.328 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -60.56 -40.37 91.41 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.567 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 52.8 p -55.45 -4.22 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.577 -0.702 . . . . 0.0 110.22 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -81.58 -37.84 27.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.04 -1.037 . . . . 0.0 111.281 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.624 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.3 m-85 -112.13 23.84 0.08 OUTLIER Pre-proline 0 N--CA 1.509 2.522 0 O-C-N 120.538 -1.351 . . . . 0.0 112.777 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 45.3 Cg_endo -64.0 -18.84 65.26 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 123.153 2.569 . . . . 0.0 113.911 -173.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -88.36 125.07 34.52 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.849 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 0.8 OUTLIER -87.97 120.84 29.71 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.367 -0.833 . . . . 0.0 109.194 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.571 ' CB ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.432 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.597 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.426 ' N ' ' HG ' ' A' ' 126' ' ' CYS . . . -97.35 171.93 8.1 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.097 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.451 ' CD2' ' CZ3' ' A' ' 16' ' ' TRP . 18.3 tp -157.58 115.02 3.03 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.439 ' OG1' ' CD1' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -111.76 131.99 54.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.023 -1.048 . . . . 0.0 110.062 -178.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 53.8 mt -127.11 131.55 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 71.4 m-85 -129.79 164.37 24.19 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.6 m -89.02 174.96 7.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.21 -0.931 . . . . 0.0 108.906 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -23.92 6.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 120.902 -1.124 . . . . 0.0 109.532 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -41.05 62.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.059 -1.026 . . . . 0.0 110.334 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.25 123.08 11.0 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.991 -1.068 . . . . 0.0 109.52 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.588 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 55.6 Cg_endo -82.58 -27.29 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.885 1.724 . . . . 0.0 112.214 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.519 ' O ' ' NE2' ' A' ' 12' ' ' GLN . 1.4 pp0? -70.45 0.55 6.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 110.546 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.578 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -123.12 118.63 28.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 108.923 179.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.32 129.41 41.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.03 -1.044 . . . . 0.0 109.095 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.546 ' CD1' HD22 ' A' ' 13' ' ' ASN . 9.4 mp -88.46 -12.25 43.59 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.046 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.564 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 40.8 t90 -158.44 107.33 1.98 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.747 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -120.03 117.69 28.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.367 -0.833 . . . . 0.0 109.76 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.71 163.43 29.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.532 -0.73 . . . . 0.0 109.753 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.597 ' OG1' ' O ' ' A' ' 1' ' ' SER . 8.9 t -130.63 89.25 2.74 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.039 -1.038 . . . . 0.0 108.297 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.495 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 23.1 m120 -125.17 138.6 54.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.32 -0.862 . . . . 0.0 110.535 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.93 -34.08 30.03 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 119.874 -1.766 . . . . 0.0 108.555 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -82.65 -53.55 5.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.096 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -58.56 -20.22 44.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.134 -0.979 . . . . 0.0 108.666 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.495 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 5.5 mt -75.85 -57.09 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.053 -1.03 . . . . 0.0 108.748 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.499 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 61.5 tt0 -53.47 -41.08 65.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.409 -0.807 . . . . 0.0 109.077 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -71.84 -49.08 41.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.124 -0.985 . . . . 0.0 110.652 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.564 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 27.0 mt-30 -72.23 -47.33 51.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.977 -1.077 . . . . 0.0 110.998 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.22 -54.66 41.36 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.017 -1.052 . . . . 0.0 109.467 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 15.0 m120 -62.78 -16.2 56.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.978 -1.076 . . . . 0.0 109.636 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.86 -28.96 70.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.616 -1.302 . . . . 0.0 108.507 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 12.51 11.82 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.792 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.44 24.65 28.04 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.139 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.564 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 99.9 t -95.64 143.82 11.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.39 -1.065 . . . . 0.0 109.513 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -84.04 158.87 21.31 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.476 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -150.45 146.04 26.4 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 36.7 mt-10 -162.96 162.87 26.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.116 -0.99 . . . . 0.0 108.932 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.2 mtm-85 -148.41 111.59 4.91 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.615 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 18.0 m0 -112.71 155.99 23.57 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -142.65 162.32 35.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 0.0 109.846 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.23 159.59 15.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 108.905 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -100.59 -17.1 17.22 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -92.88 159.68 15.25 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.51 123.36 35.75 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.569 -0.707 . . . . 0.0 109.379 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.3 mt -90.53 166.15 13.38 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.299 -0.876 . . . . 0.0 109.342 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.69 -105.13 0.21 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.26 91.24 4.99 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.133 -1.216 . . . . 0.0 109.388 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.2 92.4 22.07 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.78 -27.43 8.81 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.206 1.937 . . . . 0.0 112.461 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 p -121.24 141.87 50.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.633 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.48 -21.2 42.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 109.532 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 50' ' ' ALA . 83.7 tt0 -43.54 -38.78 3.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -0.825 . . . . 0.0 109.096 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.479 ' HG1' ' N ' ' A' ' 53' ' ' VAL . 62.7 p -78.52 -34.77 47.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 109.244 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.479 ' N ' ' HG1' ' A' ' 52' ' ' THR . 59.1 t -68.28 -46.35 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.349 -0.844 . . . . 0.0 109.916 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 58' ' ' GLN . 6.5 mm -61.62 -35.62 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.957 . . . . 0.0 108.881 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.17 -30.34 71.51 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.52 -0.738 . . . . 0.0 109.653 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.55 -20.47 56.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 110.086 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.404 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.5 m-85 -110.74 -6.76 14.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.454 -0.779 . . . . 0.0 109.479 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.441 HE21 HG12 ' A' ' 61' ' ' ILE . 5.1 mm-40 -47.62 -37.9 13.57 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.068 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.702 ' CD2' ' N ' ' A' ' 60' ' ' ALA . 13.3 p-80 -52.59 -45.0 66.33 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.865 -1.147 . . . . 0.0 109.633 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.702 ' N ' ' CD2' ' A' ' 59' ' ' HIS . . . -63.66 -59.83 4.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.73 -1.232 . . . . 0.0 110.403 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.451 ' CD1' ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -61.83 -28.06 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.763 -1.211 . . . . 0.0 108.826 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 58' ' ' GLN . 25.9 t70 -57.62 -28.91 64.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.239 -0.913 . . . . 0.0 109.441 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' CD ' ' O ' ' A' ' 59' ' ' HIS . 4.7 mptp? -73.74 -41.31 62.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.108 -0.995 . . . . 0.0 109.185 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 9.4 mp -64.09 -35.27 80.21 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.387 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 3.7 t -69.1 -28.9 41.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.227 -0.92 . . . . 0.0 109.321 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.77 -53.84 53.82 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.546 -1.346 . . . . 0.0 109.57 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -85.57 -53.69 5.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.024 -1.048 . . . . 0.0 110.704 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.583 ' O ' ' C ' ' A' ' 69' ' ' GLY . 11.2 mmtp -84.96 14.45 4.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.443 -0.786 . . . . 0.0 110.646 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -18.23 87.93 0.0 OUTLIER Glycine 0 N--CA 1.498 2.805 0 CA-C-O 122.041 0.8 . . . . 0.0 111.332 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 68' ' ' LYS . 58.7 m-85 -76.12 165.07 25.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.71 HE22 ' ND2' ' A' ' 158' ' ' ASN . 81.4 mt-30 -57.14 -88.83 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.431 -0.793 . . . . 0.0 109.522 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.76 163.1 12.56 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.641 0.734 . . . . 0.0 109.999 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.499 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 5.2 t-105 -135.23 139.24 44.31 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -155.48 173.5 16.6 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.98 141.39 39.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.451 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 16.2 tt -102.78 117.09 47.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.517 ' O ' ' OG ' ' A' ' 77' ' ' SER . 8.8 p -168.24 101.78 0.44 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.585 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 9.6 tp -116.01 179.43 3.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 119.31 -2.119 . . . . 0.0 107.781 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.556 ' C ' ' H ' ' A' ' 81' ' ' ASP . 0.8 OUTLIER -89.51 150.01 22.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.032 -1.042 . . . . 0.0 109.173 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.458 ' CA ' ' HZ3' ' A' ' 85' ' ' LYS . . . -60.2 2.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -0.881 . . . . 0.0 109.675 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 79' ' ' ARG . 32.3 t0 -78.77 -28.1 44.7 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.566 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -63.69 123.66 82.13 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.872 -1.143 . . . . 0.0 109.91 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.59 -4.77 12.36 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.048 1.832 . . . . 0.0 111.97 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -87.98 6.26 36.8 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.044 -1.035 . . . . 0.0 109.761 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.532 ' HG3' ' H ' ' A' ' 86' ' ' GLU . 11.9 ptpt -57.27 -50.89 71.48 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.162 -0.961 . . . . 0.0 108.975 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.532 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 84.4 tt0 -66.33 -42.57 87.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.282 -0.886 . . . . 0.0 109.899 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.72 -59.42 4.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.13 -0.981 . . . . 0.0 110.136 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.418 HD13 ' H ' ' A' ' 88' ' ' LEU . 6.1 mp -62.8 -44.53 95.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.953 -1.092 . . . . 0.0 109.49 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 145' ' ' GLY . 47.7 ttp180 -59.54 -30.33 68.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.845 . . . . 0.0 109.627 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.82 -61.66 2.34 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.616 -0.833 . . . . 0.0 109.638 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -54.98 -32.66 61.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.462 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -63.69 -31.34 72.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.902 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 73.6 mt -50.87 -41.37 58.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.001 -1.062 . . . . 0.0 110.014 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.727 HD21 ' H ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -49.22 141.01 8.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.762 -1.211 . . . . 0.0 109.583 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.727 ' H ' HD21 ' A' ' 94' ' ' ASN . 0.7 OUTLIER -81.63 171.65 14.37 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.437 ' CE1' ' H1 ' ' A' ' 182' ' ' HOH . 36.5 p-80 -177.71 -165.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 110.537 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.1 t -163.32 137.74 6.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.625 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -109.33 155.57 21.04 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 109.87 -178.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.87 -7.03 87.49 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -123.51 170.64 10.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.54 -0.977 . . . . 0.0 109.356 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 101' ' ' ASP . 48.3 p30 -75.98 143.9 41.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.056 -1.027 . . . . 0.0 110.07 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.415 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 1.8 mt-10 -104.11 94.28 5.3 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.06 -1.025 . . . . 0.0 108.446 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.1 t -97.55 127.02 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.023 -1.048 . . . . 0.0 110.313 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 129.73 43.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.342 -0.849 . . . . 0.0 109.244 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.641 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 14.2 t80 -106.44 131.92 53.07 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.161 -0.962 . . . . 0.0 109.33 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.54 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -87.86 130.82 34.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 110.279 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.63 -34.17 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.66 -0.65 . . . . 0.0 110.065 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 109' ' ' GLY . 1.4 tm-20 -164.01 151.68 12.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.477 ' N ' ' OE1' ' A' ' 108' ' ' GLU . . . 87.42 148.76 14.63 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.71 155.39 27.83 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.32 -1.106 . . . . 0.0 108.933 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -150.87 -119.61 0.9 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.2 tp -146.71 162.23 38.95 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.368 -1.078 . . . . 0.0 109.097 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -131.31 90.43 2.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.282 -0.886 . . . . 0.0 109.234 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.67 ' SG ' ' CD1' ' A' ' 141' ' ' TRP . 5.1 p -79.47 131.96 36.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 110.107 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.67 104.26 5.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.358 -0.839 . . . . 0.0 108.772 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.52 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 1.7 t-160 -98.41 108.93 21.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.928 -1.108 . . . . 0.0 109.582 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.12 113.19 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.004 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.85 -141.47 27.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 104.968 -3.253 . . . . 0.0 104.968 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.495 ' OD2' ' O ' ' A' ' 119' ' ' ASP . 39.9 p30 -108.25 80.92 1.41 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 115.488 -2.485 . . . . 0.0 108.956 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.52 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 23.2 pt-20 -166.41 168.88 14.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.5 t -129.19 150.8 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.984 . . . . 0.0 109.83 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -125.39 129.8 50.61 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.213 0.53 . . . . 0.0 109.575 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 4' ' ' THR . 28.6 mt-30 -129.23 110.74 12.22 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.2 138.2 27.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.551 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 5.6 mp -122.39 79.51 1.62 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 117.685 -1.606 . . . . 0.0 109.226 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.551 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -165.86 118.42 1.11 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 178.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 7.3 tm-20 -113.9 104.19 11.92 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 116.618 -2.033 . . . . 0.0 110.916 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.535 ' C ' ' H ' ' A' ' 130' ' ' ASP . 44.6 mtmt -110.15 178.01 4.53 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.688 177.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.641 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.3 OUTLIER -59.42 -3.57 0.46 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.592 ' N ' HD21 ' A' ' 129' ' ' ASN . 26.7 p30 -72.28 151.88 42.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.835 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.498 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 1.9 pp -114.9 160.77 19.13 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.023 0.916 . . . . 0.0 110.57 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 6.2 mm -128.07 125.96 65.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.586 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.0 m -123.35 141.26 52.17 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.46 148.58 39.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.852 . . . . 0.0 108.716 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -70.24 156.68 61.55 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.269 1.979 . . . . 0.0 112.926 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.605 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.15 133.51 46.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.438 -0.789 . . . . 0.0 109.036 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.605 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 11.1 t60 92.24 11.75 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.168 0.509 . . . . 0.0 110.012 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.24 126.26 32.07 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.99 133.86 40.47 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.442 1.428 . . . . 0.0 111.699 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.511 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.41 163.49 8.59 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.084 -1.047 . . . . 0.0 110.313 -179.263 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.67 ' CD1' ' SG ' ' A' ' 114' ' ' CYS . 10.7 p90 -130.95 -153.49 0.57 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.365 -0.835 . . . . 0.0 110.031 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.534 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -168.41 125.06 1.03 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.476 -0.765 . . . . 0.0 109.169 179.112 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 143' ' ' ASP . 46.2 p-10 -146.04 129.48 16.86 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.053 -1.029 . . . . 0.0 109.749 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.586 ' O ' ' C ' ' A' ' 145' ' ' GLY . 29.8 mtt -102.95 16.51 26.42 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.369 -0.832 . . . . 0.0 111.198 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 20.86 -113.85 0.01 OUTLIER Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' A' ' 178' ' ' LEU . 67.2 m -81.3 120.77 25.35 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.064 -1.454 . . . . 0.0 109.159 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.04 114.46 46.21 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 120.181 -0.607 . . . . 0.0 109.386 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 59.6 Cg_endo -104.14 44.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 122.614 2.209 . . . . 0.0 111.485 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER 81.68 70.35 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.177 -177.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 23.8 p90 -96.44 159.06 15.14 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.414 -0.804 . . . . 0.0 110.225 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.3 m -125.37 125.39 43.37 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.582 0.706 . . . . 0.0 110.716 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.22 162.76 34.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.37 -0.831 . . . . 0.0 109.295 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.499 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 94.9 mt -110.9 129.87 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.256 -0.902 . . . . 0.0 109.942 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -129.87 158.03 40.63 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.578 -0.701 . . . . 0.0 109.596 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.428 ' CD1' ' N ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.68 154.41 8.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -95.81 120.15 35.57 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.093 -1.004 . . . . 0.0 110.196 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.562 ' CG ' ' CE2' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -134.82 161.89 33.91 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.71 ' ND2' HE22 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -95.92 160.61 29.71 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 120.92 -1.113 . . . . 0.0 109.268 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 161' ' ' GLY . 43.0 Cg_endo -67.9 -54.83 0.3 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.367 2.044 . . . . 0.0 112.088 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 159' ' ' PRO . 16.5 pt-20 -43.98 -14.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.243 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -89.04 -36.7 7.54 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CE2' ' CG ' ' A' ' 157' ' ' ASP . 47.6 m0 -102.26 163.35 12.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.601 -0.941 . . . . 0.0 110.675 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -99.25 139.33 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.362 -0.836 . . . . 0.0 109.238 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.36 -73.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.5 -0.75 . . . . 0.0 110.736 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -142.25 159.69 41.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.941 -1.099 . . . . 0.0 110.062 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.6 -41.45 6.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.753 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.9 -31.74 5.0 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.26 -1.27 64.48 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.467 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 94.6 m-20 -80.71 149.51 29.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.761 -1.435 . . . . 0.0 108.291 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.462 ' OD2' ' OG ' ' A' ' 173' ' ' SER . 5.8 p-10 -109.5 88.07 2.65 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.624 -1.63 . . . . 0.0 110.682 176.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.16 -20.76 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.336 -1.477 . . . . 0.0 109.594 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.567 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -61.51 -39.82 92.4 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.972 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.535 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 38.2 p -52.9 -3.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.711 -0.618 . . . . 0.0 110.193 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.567 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.98 -39.66 29.6 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.957 -1.09 . . . . 0.0 111.491 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.636 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.7 m-85 -113.48 24.27 0.08 OUTLIER Pre-proline 0 N--CA 1.516 2.864 0 O-C-N 120.534 -1.353 . . . . 0.0 112.73 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 43.9 Cg_endo -61.56 -19.59 65.36 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.653 2.902 . . . . 0.0 114.486 -172.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -89.36 127.05 35.77 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.879 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 1.0 OUTLIER -85.5 118.81 25.25 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.085 -1.009 . . . . 0.0 108.698 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.594 ' CB ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.624 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . 0.461 ' H2 ' ' CD2' ' A' ' 98' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . 0.437 ' H1 ' ' CE1' ' A' ' 96' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.556 ' O ' ' OG1' ' A' ' 19' ' ' THR . 1.3 p . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.77 171.08 8.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.237 -0.914 . . . . 0.0 109.437 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.9 tp -158.9 112.53 2.36 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.29 128.97 54.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.829 -1.169 . . . . 0.0 110.091 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.464 ' CD1' ' CE2' ' A' ' 122' ' ' PHE . 60.4 mt -123.7 130.07 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -125.9 165.55 18.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.535 ' OG ' ' CD1' ' A' ' 15' ' ' LEU . 14.3 m -84.35 172.77 11.49 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.32 -0.863 . . . . 0.0 109.019 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.43 -30.45 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.121 . . . . 0.0 109.955 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -73.73 -38.33 64.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 0.0 110.043 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.71 123.93 13.12 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.34 -30.43 1.55 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.234 1.956 . . . . 0.0 112.312 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.708 HE21 ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -69.67 2.27 3.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.466 -0.771 . . . . 0.0 109.928 -179.102 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.708 ' ND2' HE21 ' A' ' 12' ' ' GLN . 0.9 OUTLIER -117.79 119.45 34.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.5 p -96.12 124.38 40.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.292 -0.88 . . . . 0.0 109.334 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.535 ' CD1' ' OG ' ' A' ' 7' ' ' SER . 72.0 mt -87.62 -15.4 37.42 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.607 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 46.2 t90 -158.93 108.59 1.96 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.649 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -120.5 122.08 39.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.136 -0.977 . . . . 0.0 109.275 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.07 164.02 20.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.969 -1.082 . . . . 0.0 109.961 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.57 ' O ' ' CG2' ' A' ' 19' ' ' THR . 10.3 t -131.47 89.89 2.78 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.566 175.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.558 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 29.8 m120 -125.59 145.54 50.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.964 -1.085 . . . . 0.0 110.688 177.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.58 -41.67 19.27 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.34 -1.475 . . . . 0.0 109.072 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -82.77 -48.81 10.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.349 -0.844 . . . . 0.0 109.6 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.486 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.1 tt0 -61.31 -19.95 62.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.974 -1.079 . . . . 0.0 108.533 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.558 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 2.3 mt -73.27 -58.59 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.183 -0.948 . . . . 0.0 109.316 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.516 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 6.2 pt20 -61.28 -42.22 98.27 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.035 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.516 ' N ' ' CG ' ' A' ' 25' ' ' GLN . 62.7 tt0 -61.77 -47.46 85.08 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.347 -0.846 . . . . 0.0 109.48 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.607 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 4.7 tt0 -76.06 -45.44 34.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.062 -1.024 . . . . 0.0 109.332 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.9 tp -64.54 -56.74 12.08 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.02 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.579 HD22 ' CB ' ' A' ' 35' ' ' PHE . 1.2 m-20 -57.26 -17.92 13.95 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.928 -1.108 . . . . 0.0 109.469 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.93 -27.8 69.39 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.916 -1.115 . . . . 0.0 109.084 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -89.75 10.53 23.09 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.721 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.0 23.49 25.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.1 t -93.69 143.35 11.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.249 -1.148 . . . . 0.0 109.672 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 ttt85 -85.08 155.7 21.39 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.385 -0.822 . . . . 0.0 109.055 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.579 ' CB ' HD22 ' A' ' 29' ' ' ASN . 1.5 t80 -155.81 153.59 30.02 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.711 -1.243 . . . . 0.0 109.059 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' OE1' ' O ' ' A' ' 35' ' ' PHE . 13.1 tp10 -175.71 173.34 2.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.763 -1.211 . . . . 0.0 109.576 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.46 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 37.5 mtm180 -148.38 117.56 6.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.813 -1.18 . . . . 0.0 108.665 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.527 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 26.8 m0 -110.2 154.07 23.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 109.283 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.574 HE22 ' ND2' ' A' ' 129' ' ' ASN . 99.5 mm-40 -141.12 155.88 46.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.481 -0.762 . . . . 0.0 109.92 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.99 156.64 17.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.328 -0.857 . . . . 0.0 109.004 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.499 ' OD2' ' N ' ' A' ' 42' ' ' ARG . 53.2 p30 -101.11 -11.81 19.3 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.125 -0.985 . . . . 0.0 108.7 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.499 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -93.38 156.38 16.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.33 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -92.12 119.03 31.4 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.688 -0.632 . . . . 0.0 109.566 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.36 163.65 14.12 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.696 0.76 . . . . 0.0 109.3 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.37 -102.81 0.19 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.18 92.82 4.49 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.928 -1.336 . . . . 0.0 109.23 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.54 91.47 44.61 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -75.58 -22.67 13.6 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.461 2.107 . . . . 0.0 112.756 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 p -121.96 141.97 50.78 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.542 -0.723 . . . . 0.0 109.59 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 51' ' ' GLU . . . -80.29 -18.24 49.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.333 -0.854 . . . . 0.0 109.405 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 50' ' ' ALA . 79.8 mm-40 -45.34 -38.32 5.69 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.911 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.4 m -77.84 -33.3 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.41 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 50' ' ' ALA . 65.3 t -68.22 -47.0 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 109.961 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.513 ' O ' ' N ' ' A' ' 58' ' ' GLN . 14.4 mm -60.61 -39.16 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 109.261 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.26 70.62 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.571 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.34 -19.55 58.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 0.0 110.507 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -116.33 -8.53 11.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.435 -0.791 . . . . 0.0 109.267 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.673 HE21 ' CG1' ' A' ' 61' ' ' ILE . 33.5 tp60 -48.36 -38.03 18.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 108.737 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.599 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.22 -47.95 62.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.01 -1.056 . . . . 0.0 109.885 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.599 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.37 -58.93 6.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.968 -1.082 . . . . 0.0 109.819 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.673 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.5 OUTLIER -62.72 -29.42 46.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.953 -1.092 . . . . 0.0 108.883 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 58' ' ' GLN . 47.4 t0 -57.31 -25.37 59.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.86 . . . . 0.0 109.713 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -78.47 -38.09 41.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 110.126 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -62.99 -39.52 94.97 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.266 -0.973 . . . . 0.0 109.695 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -69.25 -30.38 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.026 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.62 61.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.216 -1.552 . . . . 0.0 109.462 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -83.7 -52.48 6.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.022 -1.049 . . . . 0.0 110.799 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.629 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -86.7 14.88 6.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.544 -0.723 . . . . 0.0 110.666 -177.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -14.7 89.38 0.01 OUTLIER Glycine 0 N--CA 1.5 2.944 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.492 ' N ' ' O ' ' A' ' 68' ' ' LYS . 97.2 m-85 -76.03 160.07 30.19 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -58.93 -40.86 85.88 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.315 -0.866 . . . . 0.0 109.754 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.1 t -144.49 155.22 43.6 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.212 -0.93 . . . . 0.0 109.104 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.537 ' CD1' ' N ' ' A' ' 74' ' ' ASP . 9.8 t-105 -141.68 146.3 35.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.303 -0.873 . . . . 0.0 108.658 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.537 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.3 OUTLIER -176.55 -165.87 0.15 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.57 165.57 27.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.446 -0.784 . . . . 0.0 109.625 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.647 ' CD1' ' HE ' ' A' ' 154' ' ' ARG . 1.4 mp -95.52 136.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.0 p -91.95 165.6 13.14 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.423 1.106 . . . . 0.0 111.412 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.526 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -161.5 137.63 8.07 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.884 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.441 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -123.64 137.78 54.66 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.414 ' H ' ' HD3' ' A' ' 79' ' ' ARG . . . -70.56 -7.03 40.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 0.0 109.709 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.424 ' H ' ' HD2' ' A' ' 79' ' ' ARG . 45.8 t0 -110.64 -18.24 13.21 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.519 -0.738 . . . . 0.0 109.396 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.821 HD22 ' N ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -63.34 116.67 27.16 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.239 -178.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -90.07 -16.53 1.79 Allowed 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.964 2.443 . . . . 0.0 113.032 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.402 ' CG ' ' OD1' ' A' ' 82' ' ' ASN . 16.5 pt20 -80.26 1.18 29.56 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.008 -1.058 . . . . 0.0 109.165 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.821 ' N ' HD22 ' A' ' 82' ' ' ASN . 0.8 OUTLIER -65.84 -42.16 90.87 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.21 178.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -51.45 -47.04 63.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.013 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.87 -43.93 77.62 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.672 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 91.4 mt -61.75 -38.38 87.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.887 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.671 ' NH2' ' HZ2' ' A' ' 85' ' ' LYS . 1.6 mmt-85 -58.78 -25.53 63.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.885 . . . . 0.0 108.865 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -58.57 3.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.465 -0.772 . . . . 0.0 110.248 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -54.81 -45.69 74.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.342 -0.849 . . . . 0.0 109.736 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -67.81 -18.67 64.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.48 -34.38 76.72 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 109.705 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 94' ' ' ASN . 45.9 p-10 -47.58 140.28 6.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 109.944 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' A' ' 96' ' ' HIS . 23.1 tt0 -77.79 163.08 26.43 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.293 -0.88 . . . . 0.0 109.476 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.523 ' N ' ' CG ' ' A' ' 95' ' ' GLU . 50.7 p-80 -174.64 -167.13 0.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.349 -1.341 . . . . 0.0 112.07 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.99 134.39 2.47 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -106.1 156.07 18.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.86 -178.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.6 -6.19 86.63 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -123.04 170.04 10.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.456 -1.026 . . . . 0.0 109.431 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -75.85 142.89 42.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 109.887 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.416 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 1.8 mt-10 -102.79 92.67 4.7 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.405 ' CG2' ' OG ' ' A' ' 133' ' ' SER . 35.1 t -89.65 128.15 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.484 -0.76 . . . . 0.0 109.636 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.2 tmm_? -130.27 122.6 28.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -0.784 . . . . 0.0 109.904 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.632 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 11.0 t80 -100.87 130.92 46.95 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.477 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -87.78 130.25 34.91 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.544 -0.722 . . . . 0.0 110.196 -178.507 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.8 -30.93 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.687 -0.633 . . . . 0.0 109.423 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -162.01 151.48 16.08 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.18 -0.95 . . . . 0.0 109.374 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.81 164.8 39.71 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -147.72 171.53 15.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.478 -1.013 . . . . 0.0 109.281 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.7 154.52 10.74 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.401 ' O ' ' CG ' ' A' ' 112' ' ' LEU . 0.7 OUTLIER -93.65 96.78 10.04 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.744 -1.445 . . . . 0.0 110.08 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.503 ' CE1' ' O ' ' A' ' 114' ' ' CYS . 3.5 t80 -87.75 127.95 35.31 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.767 -1.208 . . . . 0.0 109.332 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.664 ' SG ' ' NE2' ' A' ' 123' ' ' GLN . 1.8 m -78.93 129.96 35.07 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.711 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 122' ' ' PHE . 3.0 tm? -114.62 129.47 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 4.9 t-160 -114.68 112.84 23.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.417 -0.802 . . . . 0.0 109.558 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.3 112.2 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.441 -0.787 . . . . 0.0 109.597 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.42 -127.76 10.08 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 106.437 -2.665 . . . . 0.0 106.437 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.559 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 46.4 p30 -116.23 75.51 0.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 115.374 -2.53 . . . . 0.0 110.342 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.581 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 22.3 pt-20 -166.2 168.25 15.44 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.4 138.96 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.46 -0.775 . . . . 0.0 109.986 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 115' ' ' LEU . 7.6 m-85 -127.61 131.25 49.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 0.0 109.353 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.664 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 11.7 mt-30 -126.45 118.54 25.16 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.031 -1.043 . . . . 0.0 108.983 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.409 ' C ' ' CD2' ' A' ' 125' ' ' LEU . 21.7 t -110.14 135.54 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.557 ' N ' ' CD2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -133.64 90.96 2.78 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.594 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 126' ' ' CYS . 1.7 p -164.64 134.11 3.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 119.685 -1.884 . . . . 0.0 106.827 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -106.34 93.72 4.75 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 115.71 -2.396 . . . . 0.0 110.185 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.595 ' C ' ' H ' ' A' ' 130' ' ' ASP . 51.7 mttm -115.52 158.95 21.85 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.108 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.632 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 23.1 m-80 -58.37 -3.02 0.23 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.345 -1.472 . . . . 0.0 107.622 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.595 ' H ' ' C ' ' A' ' 128' ' ' LYS . 56.1 p30 -72.81 152.78 41.39 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.139 -0.976 . . . . 0.0 109.28 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.516 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 3.0 pp -117.23 161.43 19.49 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.686 0.755 . . . . 0.0 110.052 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 17.3 tt -133.11 126.36 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.281 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.405 ' OG ' ' CG2' ' A' ' 103' ' ' VAL . 19.1 t -122.1 138.53 54.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.452 -0.78 . . . . 0.0 109.605 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.16 147.87 35.02 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.387 -0.821 . . . . 0.0 109.145 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.411 ' O ' ' CG2' ' A' ' 138' ' ' THR . 39.1 Cg_endo -66.81 156.51 65.69 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.269 1.979 . . . . 0.0 112.795 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.644 ' O ' ' ND1' ' A' ' 137' ' ' HIS . . . -71.84 139.74 49.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.311 -0.868 . . . . 0.0 108.675 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.644 ' ND1' ' O ' ' A' ' 136' ' ' ALA . 7.4 m80 88.62 13.46 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.852 -0.53 . . . . 0.0 109.719 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 135' ' ' PRO . 14.9 t -106.7 126.4 30.4 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.288 -0.883 . . . . 0.0 108.864 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 116' ' ' HIS . 39.6 Cg_endo -63.66 134.06 42.39 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.597 1.531 . . . . 0.0 111.452 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.51 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -172.29 162.08 5.45 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.959 -1.088 . . . . 0.0 109.982 -179.088 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.501 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -133.19 -149.01 0.35 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.159 -0.963 . . . . 0.0 109.413 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.417 ' H ' ' HB2' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -176.38 127.99 0.2 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.925 -1.109 . . . . 0.0 108.938 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.76 138.68 18.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 109.143 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.623 ' SD ' ' CZ ' ' A' ' 89' ' ' ARG . 1.4 mpt? -113.17 21.69 15.06 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.395 -0.816 . . . . 0.0 110.574 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.599 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.67 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.501 2.971 0 CA-C-N 119.417 1.008 . . . . 0.0 111.835 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.457 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 74.9 m -86.74 117.24 25.36 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 117.94 -1.504 . . . . 0.0 109.562 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.45 ' N ' ' OE1' ' A' ' 147' ' ' GLU . 22.3 mp0 -115.2 116.92 41.81 Favored Pre-proline 0 C--N 1.294 -1.835 0 O-C-N 121.805 -0.56 . . . . 0.0 109.778 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.616 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 51.1 Cg_endo -103.39 31.96 0.07 OUTLIER 'Trans proline' 0 C--O 1.207 -1.064 0 C-N-CA 123.395 2.73 . . . . 0.0 111.791 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.721 ' CG ' ' O ' ' A' ' 149' ' ' ASN . 0.1 OUTLIER 82.54 63.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 123.102 1.43 . . . . 0.0 109.807 -178.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.526 ' CZ ' ' CD2' ' A' ' 78' ' ' LEU . 11.2 p90 -99.84 -178.86 3.99 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 119.805 -1.809 . . . . 0.0 110.16 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 59.7 m -135.69 131.7 36.0 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.701 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -134.98 153.94 51.91 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.065 -1.022 . . . . 0.0 108.972 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.9 mt -110.21 129.58 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.159 -0.963 . . . . 0.0 109.805 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.647 ' HE ' ' CD1' ' A' ' 76' ' ' ILE . 25.9 mtm-85 -143.97 170.08 16.6 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.192 -0.943 . . . . 0.0 109.481 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.455 ' CG2' ' CG ' ' A' ' 70' ' ' TYR . 4.6 mp -101.33 145.81 10.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.471 -0.768 . . . . 0.0 109.034 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.521 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 5.2 m-85 -96.38 118.73 33.52 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.489 -0.757 . . . . 0.0 109.408 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.563 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 55.3 p30 -134.89 161.57 34.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.848 -0.533 . . . . 0.0 109.607 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.605 ' O ' ' NE1' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -96.08 156.99 36.47 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.096 . . . . 0.0 108.981 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.5 Cg_endo -66.93 -54.06 0.45 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.667 2.245 . . . . 0.0 112.249 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.6 ' N ' ' OD1' ' A' ' 158' ' ' ASN . 95.5 mt-10 -44.4 -17.53 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.312 -0.867 . . . . 0.0 108.856 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.48 -50.84 5.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.605 ' NE1' ' O ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -104.07 169.33 8.56 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.474 -1.016 . . . . 0.0 109.95 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 74.9 mt -96.99 149.81 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 0.0 109.341 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 96' ' ' HIS . . . -83.31 -71.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 0.0 110.349 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -117.6 146.3 43.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.161 -0.962 . . . . 0.0 109.699 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -101.56 -41.71 6.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.436 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 69.4 p -106.44 -31.18 8.67 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.22 -0.925 . . . . 0.0 109.049 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.23 -9.1 56.01 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -82.78 145.98 29.23 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.253 -1.734 . . . . 0.0 108.722 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -112.33 90.6 3.38 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.527 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.07 -16.78 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.036 -1.665 . . . . 0.0 108.758 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.579 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -57.94 -38.05 75.22 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.614 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 22.7 t -51.61 -3.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.232 -0.917 . . . . 0.0 110.191 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.579 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -76.64 -42.05 43.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.784 -1.197 . . . . 0.0 111.701 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.629 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.1 OUTLIER -113.95 26.7 0.1 OUTLIER Pre-proline 0 N--CA 1.511 2.606 0 O-C-N 120.574 -1.328 . . . . 0.0 111.966 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 46.4 Cg_endo -60.95 -24.24 79.03 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 124.146 3.231 . . . . 0.0 113.038 -172.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.11 126.18 35.35 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.895 -1.122 . . . . 0.0 109.186 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.512 ' O ' ' C ' ' A' ' 179' ' ' ALA . 1.3 tp -87.59 122.69 31.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.633 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.633 ' O ' ' OG1' ' A' ' 19' ' ' THR . 11.3 p . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.68 170.76 8.78 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.301 -0.874 . . . . 0.0 109.325 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 tp -159.01 115.92 2.72 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.83 140.78 41.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.1 mt -134.18 134.65 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -126.65 166.89 16.51 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.9 m -86.04 173.92 9.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.051 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.3 -28.09 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.982 -1.074 . . . . 0.0 109.399 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -75.83 -36.59 59.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 110.381 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -137.89 123.75 12.81 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.476 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -81.69 -32.11 0.94 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.066 1.844 . . . . 0.0 112.353 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.577 ' O ' ' NE2' ' A' ' 12' ' ' GLN . 23.5 tp60 -69.81 2.78 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.448 -0.782 . . . . 0.0 110.011 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -114.73 120.11 38.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.912 . . . . 0.0 109.474 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.85 122.15 40.62 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.251 -0.906 . . . . 0.0 109.248 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.43 -6.18 55.21 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.022 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.703 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 39.1 t90 -156.22 105.13 2.29 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.43 -1.308 . . . . 0.0 110.276 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -119.13 110.97 17.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.642 -0.661 . . . . 0.0 109.544 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.448 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -163.01 163.45 26.03 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.002 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.633 ' OG1' ' O ' ' A' ' 1' ' ' SER . 11.7 t -131.47 90.77 2.91 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 120.786 -1.196 . . . . 0.0 108.416 176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.595 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 29.9 m120 -124.66 152.29 43.84 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.851 -1.156 . . . . 0.0 110.613 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.32 -47.54 11.38 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.343 -1.473 . . . . 0.0 108.758 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -82.49 -43.35 17.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.347 -0.846 . . . . 0.0 110.242 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.498 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.2 tt0 -66.07 -24.73 66.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.749 -1.219 . . . . 0.0 108.908 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.595 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 3.3 mt -68.26 -58.45 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.165 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 29' ' ' ASN . 14.2 pt20 -58.39 -43.77 88.69 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.127 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -53.89 -35.11 61.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.463 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.703 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -66.97 -63.55 1.04 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.0 -1.062 . . . . 0.0 109.314 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -69.18 -54.94 12.24 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.822 -1.174 . . . . 0.0 109.834 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 17.1 t-20 -47.52 -33.06 5.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.681 -1.262 . . . . 0.0 109.068 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.68 -25.33 68.16 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.064 -1.022 . . . . 0.0 108.531 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 28' ' ' LEU . 29.0 mttm -91.39 10.53 27.17 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.273 -0.892 . . . . 0.0 110.498 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.92 25.88 12.4 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.048 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.6 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 48.4 t -96.36 146.2 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.449 -1.03 . . . . 0.0 109.347 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.77 155.24 21.93 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.135 -0.978 . . . . 0.0 109.243 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.483 ' O ' ' OE1' ' A' ' 36' ' ' GLU . 2.1 t80 -155.37 154.26 31.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.043 -1.036 . . . . 0.0 109.006 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 35' ' ' PHE . 11.5 tp10 -176.12 173.05 2.27 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.975 -1.078 . . . . 0.0 109.519 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.465 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 65.4 mtm-85 -148.54 118.45 7.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.039 -1.038 . . . . 0.0 108.603 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.44 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 30.2 m0 -110.93 148.37 32.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.324 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.667 HE21 ' ND2' ' A' ' 129' ' ' ASN . 49.6 mm-40 -137.08 159.98 40.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.437 -0.789 . . . . 0.0 109.664 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.27 160.45 14.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 109.044 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -98.45 -18.46 18.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.236 -0.915 . . . . 0.0 108.687 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -93.54 167.85 11.42 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -94.39 121.15 35.63 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.727 . . . . 0.0 109.386 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.33 167.14 11.52 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.05 -121.7 0.59 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.44 78.83 9.63 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.068 -1.254 . . . . 0.0 108.653 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.15 95.62 30.99 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 121.375 -0.828 . . . . 0.0 109.309 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.479 ' O ' ' CG2' ' A' ' 49' ' ' THR . 46.8 Cg_endo -70.61 79.17 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.22 1.947 . . . . 0.0 111.736 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 48' ' ' PRO . 6.0 p -162.99 118.03 1.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.061 -1.024 . . . . 0.0 109.364 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.81 -43.98 17.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.062 -1.024 . . . . 0.0 109.96 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -65.11 -17.17 64.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.392 -0.817 . . . . 0.0 109.728 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.6 m -77.05 -41.78 41.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.229 -0.919 . . . . 0.0 110.373 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.6 t -63.93 -47.87 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.051 -1.031 . . . . 0.0 109.537 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 58' ' ' GLN . 11.7 mm -61.21 -42.25 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 108.722 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.38 -30.3 71.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.332 -0.855 . . . . 0.0 109.83 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.77 -19.38 59.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 110.405 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.0 m-85 -113.75 -6.67 13.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.373 -0.829 . . . . 0.0 109.462 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.649 HE21 ' CG1' ' A' ' 61' ' ' ILE . 26.3 tp60 -47.74 -39.72 18.56 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -50.43 -44.22 55.25 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.619 -1.3 . . . . 0.0 109.369 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.87 -59.42 4.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.869 -1.144 . . . . 0.0 110.452 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.649 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.8 OUTLIER -61.41 -30.39 47.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 120.912 -1.117 . . . . 0.0 108.968 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -55.04 -28.85 55.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.01 -1.056 . . . . 0.0 109.68 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -74.94 -38.94 61.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.034 -1.041 . . . . 0.0 109.4 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 9.8 mp -65.28 -35.34 80.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.069 -1.019 . . . . 0.0 109.739 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.488 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 2.6 t -70.11 -31.18 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.72 64.02 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.639 -1.288 . . . . 0.0 109.386 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -87.33 -52.52 5.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 110.612 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.581 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -85.81 14.85 5.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.843 . . . . 0.0 110.44 -177.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.581 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -19.54 89.08 0.01 OUTLIER Glycine 0 N--CA 1.495 2.572 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 68' ' ' LYS . 48.8 m-85 -76.75 167.71 21.36 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -57.19 -88.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.431 -0.793 . . . . 0.0 109.452 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -104.74 166.13 10.59 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.399 0.619 . . . . 0.0 109.69 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.438 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 5.5 t-105 -137.58 141.61 41.31 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.448 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -158.47 176.64 12.17 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.4 p -122.89 144.58 31.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.1 mt -105.53 116.84 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.484 ' O ' ' OG ' ' A' ' 77' ' ' SER . 11.2 p -168.66 103.05 0.41 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.261 -0.9 . . . . 0.0 109.216 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.461 ' HG ' ' H ' ' A' ' 79' ' ' ARG . 1.0 OUTLIER -115.27 -177.22 3.09 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 120.7 1.591 . . . . 0.0 108.645 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.59 ' C ' ' H ' ' A' ' 81' ' ' ASP . 2.3 ttt180 -92.82 152.61 19.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.375 -1.453 . . . . 0.0 109.129 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.15 -6.87 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.062 -1.024 . . . . 0.0 110.4 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.59 ' H ' ' C ' ' A' ' 79' ' ' ARG . 95.3 m-20 -92.52 33.78 1.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.651 ' ND2' ' N ' ' A' ' 85' ' ' LYS . 23.7 t30 -76.12 124.8 88.42 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.914 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.16 -27.86 3.42 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.645 2.23 . . . . 0.0 112.271 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 88' ' ' LEU . 24.7 mt-30 -90.79 10.66 25.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.917 -1.115 . . . . 0.0 109.194 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.651 ' N ' ' ND2' ' A' ' 82' ' ' ASN . 0.4 OUTLIER -53.34 -58.52 6.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.146 -0.972 . . . . 0.0 108.815 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.38 -51.4 52.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.116 -0.99 . . . . 0.0 109.324 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.99 -42.06 72.0 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.343 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 5.7 tp -59.75 -42.92 94.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.179 -0.95 . . . . 0.0 109.199 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -56.77 -37.67 71.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.568 -1.332 . . . . 0.0 110.174 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -66.06 -22.35 66.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.538 ' CG ' ' N ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -65.64 -45.47 82.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.617 -0.677 . . . . 0.0 110.121 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.668 ' CD2' ' O ' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -88.14 -13.57 40.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 0.0 110.477 -178.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 92' ' ' PHE . 65.5 tp -42.18 -18.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.152 -0.967 . . . . 0.0 109.883 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 92' ' ' PHE . 9.4 p30 -99.8 114.61 27.89 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.055 -1.028 . . . . 0.0 109.235 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.504 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 3.0 pp20? -52.02 173.91 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.504 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 50.2 p-80 -176.5 -166.78 0.17 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.295 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.06 135.47 3.83 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.607 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -103.61 154.8 19.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 109.741 -178.567 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.73 -6.59 87.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -123.97 171.18 9.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.333 -1.099 . . . . 0.0 109.424 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -74.31 141.79 45.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.975 . . . . 0.0 110.068 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.607 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 3.7 tt0 -102.83 89.9 3.62 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.8 p -88.43 130.43 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.082 -1.011 . . . . 0.0 110.521 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.519 ' NH1' ' HE ' ' A' ' 154' ' ' ARG . 52.5 mtt-85 -129.68 121.79 27.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.594 -0.691 . . . . 0.0 109.439 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.615 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 21.7 t80 -101.76 132.97 47.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 108.593 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.542 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.33 129.53 35.36 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.677 -0.639 . . . . 0.0 109.747 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.3 t -112.42 -30.41 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.697 -0.627 . . . . 0.0 109.749 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -168.59 158.69 9.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.04 -1.038 . . . . 0.0 109.108 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.05 156.83 5.61 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.33 -168.79 1.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -1.126 . . . . 0.0 109.35 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.31 -135.75 3.5 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.9 mt -144.74 162.91 35.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -1.138 . . . . 0.0 109.602 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -136.83 89.6 2.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 109.455 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.48 108.68 13.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.428 -0.795 . . . . 0.0 109.904 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.2 mp -115.71 114.13 24.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.289 -0.882 . . . . 0.0 109.118 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.442 ' NE2' ' O ' ' A' ' 118' ' ' GLY . 11.1 t-160 -102.89 109.9 21.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.046 -1.034 . . . . 0.0 109.476 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.2 mt -125.59 111.79 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.281 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.442 ' O ' ' NE2' ' A' ' 116' ' ' HIS . . . 75.45 -142.92 29.78 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 106.427 -2.669 . . . . 0.0 106.427 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.49 ' CG ' ' O ' ' A' ' 119' ' ' ASP . 48.2 p-10 -103.48 79.09 1.66 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 114.909 -2.716 . . . . 0.0 109.167 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.438 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 24.0 tp10 -166.29 167.28 16.13 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.474 -1.391 . . . . 0.0 107.781 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.427 ' H ' ' HG3' ' A' ' 120' ' ' GLU . 57.3 t -128.52 147.06 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.809 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -123.94 131.4 53.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.771 -0.581 . . . . 0.0 109.714 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -126.65 106.66 9.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -0.949 . . . . 0.0 108.905 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.01 136.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.2 tt -136.53 91.57 2.67 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.937 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 20.0 p -166.16 136.37 3.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.598 -1.314 . . . . 0.0 108.468 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.507 ' CD ' ' O ' ' A' ' 127' ' ' GLU . 3.4 tm-20 -107.23 93.95 4.83 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 115.819 -2.352 . . . . 0.0 110.884 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.574 ' C ' ' H ' ' A' ' 130' ' ' ASP . 30.4 mttp -114.5 155.55 26.21 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.755 176.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.667 ' ND2' HE21 ' A' ' 39' ' ' GLN . 12.6 p30 -55.71 -5.15 0.13 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.229 -1.544 . . . . 0.0 107.928 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 128' ' ' LYS . 43.4 p-10 -72.21 150.3 43.82 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.881 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.527 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 3.0 pp -119.03 161.58 20.0 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.753 0.787 . . . . 0.0 110.547 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 17.0 tt -134.84 125.57 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.2 t -120.21 135.84 54.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 0.0 109.444 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.7 m -95.99 148.02 33.88 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.303 -0.873 . . . . 0.0 108.821 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.04 154.9 71.49 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.239 1.96 . . . . 0.0 112.621 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.613 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.93 136.34 46.82 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.613 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 5.7 t-80 91.67 11.12 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.92 126.61 30.67 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.32 131.63 30.82 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.621 1.547 . . . . 0.0 111.449 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.566 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.94 167.66 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.132 -0.98 . . . . 0.0 110.064 -179.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.501 ' CE3' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -138.41 -150.07 0.32 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.269 -0.895 . . . . 0.0 109.52 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.668 ' O ' ' CD2' ' A' ' 92' ' ' PHE . 76.9 t80 -174.95 122.93 0.24 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.893 -1.129 . . . . 0.0 109.034 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.594 ' OD2' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -139.29 134.06 32.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.321 -0.862 . . . . 0.0 110.186 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.622 ' O ' ' C ' ' A' ' 145' ' ' GLY . 4.0 mtp -113.42 20.65 15.9 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.667 -0.646 . . . . 0.0 110.569 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.622 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 5.17 -83.83 0.0 OUTLIER Glycine 0 N--CA 1.503 3.13 0 CA-C-N 119.155 0.889 . . . . 0.0 111.62 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.525 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 22.2 p -87.81 118.8 27.58 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.001 -1.48 . . . . 0.0 109.019 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -112.85 109.68 52.52 Favored Pre-proline 0 C--N 1.292 -1.911 0 C-N-CA 119.514 -0.875 . . . . 0.0 109.054 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.809 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 58.3 Cg_endo -100.06 20.44 0.27 Allowed 'Trans proline' 0 C--O 1.195 -1.629 0 C-N-CA 123.147 2.565 . . . . 0.0 112.129 176.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.888 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 0.0 OUTLIER 90.39 69.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 123.533 1.635 . . . . 0.0 110.14 -176.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 14.2 p90 -89.21 167.44 13.09 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 118.986 -2.322 . . . . 0.0 110.278 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.6 m -131.41 118.69 20.61 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.734 -177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.75 163.71 33.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.505 -0.747 . . . . 0.0 109.041 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.438 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 36.8 mt -110.81 131.18 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.335 -0.853 . . . . 0.0 109.914 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.569 ' NH1' ' O ' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -133.51 161.1 35.5 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.118 -0.988 . . . . 0.0 108.885 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.569 ' O ' ' NH1' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -104.1 146.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.544 -0.722 . . . . 0.0 109.087 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.448 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.7 m-30 -95.97 119.67 34.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.025 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.414 ' HB3' ' CZ2' ' A' ' 162' ' ' TRP . 24.3 t70 -134.65 160.8 36.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.845 -0.535 . . . . 0.0 109.654 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.575 ' N ' ' ND2' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -96.21 161.0 28.56 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 109.172 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.4 Cg_endo -67.89 -54.03 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.564 2.176 . . . . 0.0 111.859 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 159' ' ' PRO . 98.1 mt-10 -42.91 -20.21 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.86 -36.64 7.68 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.558 ' N ' ' O ' ' A' ' 159' ' ' PRO . 45.9 m0 -97.06 165.28 12.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.36 -1.082 . . . . 0.0 110.266 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 21.0 mm -99.1 153.5 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.306 -0.871 . . . . 0.0 109.386 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.76 -72.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.163 -0.96 . . . . 0.0 110.404 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -141.07 153.43 45.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -0.919 . . . . 0.0 109.796 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.32 -41.65 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.249 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.61 -31.29 8.54 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.42 -8.17 62.15 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -80.79 148.24 30.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.686 -1.479 . . . . 0.0 108.591 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.53 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 47.4 p30 -111.02 87.82 2.63 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 117.536 -1.666 . . . . 0.0 111.514 175.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.6 tt -78.37 -17.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 119.968 -1.707 . . . . 0.0 109.352 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.569 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -61.68 -40.45 95.03 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.71 -0.619 . . . . 0.0 109.338 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.596 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 53.9 p -53.43 -3.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.569 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.09 -39.9 28.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.947 -1.096 . . . . 0.0 111.362 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.622 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 7.0 m-85 -111.47 24.8 0.08 OUTLIER Pre-proline 0 N--CA 1.514 2.749 0 O-C-N 120.791 -1.193 . . . . 0.0 112.482 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 53.8 Cg_endo -65.26 -19.62 62.23 Favored 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 123.399 2.732 . . . . 0.0 113.129 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -89.03 125.54 35.04 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.043 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.561 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 1.5 tp -88.44 118.93 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.42 -0.8 . . . . 0.0 109.236 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.566 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . 0.414 ' H2 ' ' CD2' ' A' ' 98' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . 0.45 ' H2 ' HH21 ' A' ' 104' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.624 ' O ' ' OG1' ' A' ' 19' ' ' THR . 10.5 p . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.16 171.24 8.58 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.191 -0.943 . . . . 0.0 109.142 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 tp -158.97 115.84 2.72 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -109.14 139.23 44.32 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.151 -0.968 . . . . 0.0 110.149 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.404 ' CG2' ' O ' ' A' ' 121' ' ' VAL . 45.0 mt -132.99 132.26 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.06 165.03 20.26 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 p -84.99 174.04 10.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.149 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.62 -31.23 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.096 -1.003 . . . . 0.0 109.362 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 tttp -74.13 -37.94 63.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.184 -0.948 . . . . 0.0 110.532 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.85 124.11 14.18 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.005 -1.059 . . . . 0.0 109.537 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.78 -30.06 1.52 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.922 1.748 . . . . 0.0 112.308 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.657 ' NE2' HD21 ' A' ' 13' ' ' ASN . 5.4 pp0? -69.85 4.69 1.86 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.461 -0.774 . . . . 0.0 110.358 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.657 HD21 ' NE2' ' A' ' 12' ' ' GLN . 0.5 OUTLIER -117.83 119.12 33.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.052 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -97.67 126.17 42.85 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.135 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.83 -8.35 46.85 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.94 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.715 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 33.2 t90 -157.47 103.91 1.98 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.276 -1.37 . . . . 0.0 110.587 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -117.47 109.24 16.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.536 -0.727 . . . . 0.0 109.413 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.452 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -163.89 163.95 23.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.261 -0.9 . . . . 0.0 109.724 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.624 ' OG1' ' O ' ' A' ' 1' ' ' SER . 9.9 t -131.47 90.69 2.89 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.508 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.547 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.6 OUTLIER -124.5 146.94 48.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.221 -0.925 . . . . 0.0 110.479 177.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.99 -39.49 23.53 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.266 -1.521 . . . . 0.0 108.423 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -82.86 -48.57 10.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.624 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -59.94 -25.07 64.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.086 -1.009 . . . . 0.0 108.42 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.547 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 13.0 mt -72.38 -50.81 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.025 -1.047 . . . . 0.0 108.999 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 29' ' ' ASN . 23.1 tm0? -62.06 -51.92 66.02 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.287 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -61.21 -40.3 93.47 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.235 -0.916 . . . . 0.0 109.732 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.715 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 5.2 tt0 -75.07 -50.8 15.27 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.062 -1.024 . . . . 0.0 109.478 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.3 tp -70.45 -56.18 7.23 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.847 -1.158 . . . . 0.0 109.832 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 11.5 t-20 -57.1 -19.9 22.34 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.776 -1.202 . . . . 0.0 109.286 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.5 -27.99 67.46 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.796 -1.19 . . . . 0.0 108.637 177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -86.42 12.54 10.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.141 -0.974 . . . . 0.0 109.604 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.24 21.58 32.16 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.185 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.55 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 47.9 t -92.71 146.54 6.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.384 -1.068 . . . . 0.0 109.348 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.1 ttt85 -82.49 156.87 23.82 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -155.21 155.46 33.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.815 -1.178 . . . . 0.0 108.354 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.476 ' OE2' ' N ' ' A' ' 37' ' ' ARG . 1.3 mm-40 -175.42 174.73 2.27 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.051 -1.031 . . . . 0.0 109.3 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.476 ' N ' ' OE2' ' A' ' 36' ' ' GLU . 74.4 mtm-85 -151.93 112.95 4.24 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.529 ' H ' HD21 ' A' ' 129' ' ' ASN . 34.2 m0 -110.73 151.52 27.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.124 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.574 ' NE2' ' OD1' ' A' ' 129' ' ' ASN . 82.0 mm-40 -138.49 154.35 48.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.908 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.93 158.34 16.06 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -101.28 -9.09 21.53 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.2 mtp85 -92.91 155.0 17.86 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.792 0.806 . . . . 0.0 109.216 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -93.25 118.98 31.89 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.569 -0.707 . . . . 0.0 109.524 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.12 161.89 14.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.774 0.797 . . . . 0.0 109.488 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.32 -99.26 0.15 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.98 92.63 4.97 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.134 -1.215 . . . . 0.0 109.483 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.27 92.02 30.33 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.434 -0.791 . . . . 0.0 109.008 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.42 -28.27 7.07 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.314 2.01 . . . . 0.0 112.613 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.6 p -119.57 141.86 48.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.619 -0.675 . . . . 0.0 109.594 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.34 -16.71 53.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.471 -0.768 . . . . 0.0 109.432 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -50.56 -37.49 39.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 109.06 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.5 m -78.64 -33.39 47.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 109.484 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.66 -52.41 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.352 -0.843 . . . . 0.0 110.273 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 58' ' ' GLN . 6.4 mt -59.21 -40.01 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.046 -1.034 . . . . 0.0 108.836 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.34 -32.13 69.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.367 -0.833 . . . . 0.0 109.479 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.416 ' O ' ' CD2' ' A' ' 59' ' ' HIS . . . -74.67 -14.59 60.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.937 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -117.14 -9.4 11.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.0 109.588 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 62' ' ' ASP . 5.8 mm-40 -50.86 -39.75 54.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.102 -0.998 . . . . 0.0 109.07 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.453 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 20.0 p80 -51.71 -46.1 63.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.453 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -60.39 -59.24 5.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.988 -1.07 . . . . 0.0 109.703 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.484 ' CD1' ' C ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -64.48 -28.54 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.717 -1.239 . . . . 0.0 109.364 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 58' ' ' GLN . 24.7 t70 -55.56 -25.09 36.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.372 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -84.36 -37.22 21.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 109.556 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -46.73 74.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.31 -0.869 . . . . 0.0 109.497 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 69' ' ' GLY . 1.1 p -70.03 -30.45 44.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.394 -0.816 . . . . 0.0 109.633 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.54 -46.29 66.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.152 -0.967 . . . . 0.0 109.484 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -77.6 -48.92 15.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.103 -0.998 . . . . 0.0 109.647 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.653 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -85.22 13.75 6.01 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.448 -0.782 . . . . 0.0 110.16 -177.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.653 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -1.46 84.08 0.0 OUTLIER Glycine 0 N--CA 1.502 3.053 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.468 ' CG ' ' CG2' ' A' ' 155' ' ' ILE . 20.3 m-85 -77.06 164.53 25.64 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.21 -1.171 . . . . 0.0 109.446 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -59.85 -43.11 94.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.57 -0.706 . . . . 0.0 110.222 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.27 165.65 36.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.991 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.708 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 6.6 t-105 -135.6 139.4 43.81 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.388 -0.82 . . . . 0.0 109.165 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.461 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -160.08 178.4 9.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.3 t -117.91 141.69 35.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 pt -100.42 116.97 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -174.59 106.7 0.11 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.113 -0.992 . . . . 0.0 109.69 177.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.552 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -101.38 179.99 4.2 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 120.9 1.682 . . . . 0.0 109.052 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' ASP . 9.4 tpt180 -88.81 146.25 25.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.968 -1.083 . . . . 0.0 109.386 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.9 0.38 0.15 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 109.489 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ARG . 23.9 t70 -91.58 -27.13 18.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.175 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.717 HD22 ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -63.52 122.14 74.43 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 120.911 -1.118 . . . . 0.0 109.437 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -83.78 -5.07 10.69 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.159 1.906 . . . . 0.0 112.385 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -86.39 3.02 45.46 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.653 -1.28 . . . . 0.0 109.428 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.717 ' N ' HD22 ' A' ' 82' ' ' ASN . 29.3 tptt -61.08 -46.61 89.94 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.176 -0.952 . . . . 0.0 109.134 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.601 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 15.9 mm-40 -59.85 -50.04 75.33 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.758 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.53 -41.49 88.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.889 . . . . 0.0 109.475 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.08 -55.09 32.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.96 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.601 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 7.4 ptt-85 -64.26 -20.14 65.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.97 -60.57 2.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.863 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -56.28 -37.44 69.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.107 -0.996 . . . . 0.0 109.538 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -72.45 -18.7 61.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 109.719 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.498 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 0.4 OUTLIER -62.33 -26.3 68.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.666 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -48.74 145.9 3.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.918 . . . . 0.0 109.928 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 96' ' ' HIS . 55.1 tt0 -76.54 157.27 32.2 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.5 -0.75 . . . . 0.0 110.095 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.423 ' N ' ' CG ' ' A' ' 95' ' ' GLU . 46.0 p-80 -172.17 -170.6 0.75 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.736 -1.185 . . . . 0.0 111.978 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.8 t -163.01 137.69 6.42 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.689 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.85 155.4 20.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.545 -178.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.66 -5.56 86.3 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 101' ' ' ASP . 23.8 tp10 -124.52 168.49 13.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.378 -1.072 . . . . 0.0 109.221 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 88.5 m-20 -74.52 143.43 44.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.117 . . . . 0.0 110.106 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.424 ' HG3' ' CE1' ' A' ' 98' ' ' HIS . 2.2 mt-10 -101.08 90.37 4.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.12 -0.987 . . . . 0.0 108.491 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.41 ' CG1' ' OG ' ' A' ' 133' ' ' SER . 15.7 m -85.86 130.26 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.693 -0.629 . . . . 0.0 110.138 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.696 ' NE ' HH21 ' A' ' 154' ' ' ARG . 41.0 ttm105 -131.03 128.29 40.02 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.458 -0.777 . . . . 0.0 109.598 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.498 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 36.9 t80 -106.1 129.15 54.24 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.65 129.9 36.02 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.488 -0.757 . . . . 0.0 110.395 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.4 t -115.2 -27.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.651 -0.656 . . . . 0.0 109.672 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -166.29 153.06 9.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.395 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.96 154.25 25.64 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -137.45 165.83 25.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.191 -1.182 . . . . 0.0 108.944 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.34 152.97 10.09 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.423 ' O ' ' CD1' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -99.72 98.61 9.43 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.047 -1.267 . . . . 0.0 110.256 -179.135 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 114' ' ' CYS . 2.3 t80 -84.4 135.02 34.44 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.873 -1.142 . . . . 0.0 109.715 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.568 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -77.77 117.68 19.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.431 0.634 . . . . 0.0 109.815 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 122' ' ' PHE . 2.2 mt -106.71 123.11 47.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 7.0 t-160 -105.53 106.97 17.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.156 -0.965 . . . . 0.0 109.602 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.95 109.34 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.956 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.34 -144.37 31.76 Favored Glycine 0 N--CA 1.502 3.092 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -100.5 78.27 2.0 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 114.891 -2.724 . . . . 0.0 109.521 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 1.6 mt-10 -167.04 171.94 10.6 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.404 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 78.6 t -125.14 140.76 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.076 -1.015 . . . . 0.0 109.907 177.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 115' ' ' LEU . 26.4 m-85 -122.72 128.51 50.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.7 -0.625 . . . . 0.0 110.364 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' THR . 32.6 mm-40 -119.97 104.62 10.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -100.58 133.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tt -133.34 87.57 2.4 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.107 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.616 ' SG ' ' O ' ' A' ' 126' ' ' CYS . 16.8 p -167.88 122.42 0.97 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.47 100.0 9.58 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 116.384 -2.127 . . . . 0.0 110.352 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.62 ' C ' ' H ' ' A' ' 130' ' ' ASP . 1.5 mmmt -117.24 166.02 12.76 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.19 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.574 ' OD1' ' NE2' ' A' ' 39' ' ' GLN . 0.7 OUTLIER -58.62 -0.31 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 128' ' ' LYS . 53.6 p-10 -69.52 139.14 53.8 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.862 -1.149 . . . . 0.0 109.819 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.45 HD13 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -91.28 123.18 34.52 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.884 0.849 . . . . 0.0 109.586 -178.112 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.45 ' N ' HD13 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -115.11 112.18 38.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.41 ' OG ' ' CG1' ' A' ' 103' ' ' VAL . 9.4 t -120.74 151.68 39.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.391 -0.818 . . . . 0.0 109.168 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.72 137.79 20.88 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.564 ' O ' ' OG1' ' A' ' 138' ' ' THR . 36.6 Cg_endo -61.99 154.95 58.41 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.977 1.785 . . . . 0.0 113.46 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -74.85 136.35 41.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.347 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.619 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 24.4 t60 94.77 9.21 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.564 ' OG1' ' O ' ' A' ' 135' ' ' PRO . 0.2 OUTLIER -104.48 127.39 29.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.164 179.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.7 132.03 31.45 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.64 1.56 . . . . 0.0 111.678 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.529 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.0 163.9 9.43 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.142 -179.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.566 ' O ' ' CZ ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -135.3 -148.15 0.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.122 -0.986 . . . . 0.0 109.567 -178.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.68 ' CD1' ' NH2' ' A' ' 154' ' ' ARG . 90.1 t80 -176.42 127.54 0.2 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.962 -1.087 . . . . 0.0 109.281 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.499 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 43.3 p30 -148.2 137.52 22.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -0.871 . . . . 0.0 109.785 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.593 ' O ' ' C ' ' A' ' 145' ' ' GLY . 4.2 mmt -112.59 19.09 17.82 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.451 -0.781 . . . . 0.0 111.122 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.593 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 9.78 -88.12 0.0 OUTLIER Glycine 0 N--CA 1.507 3.395 0 CA-C-N 119.155 0.889 . . . . 0.0 111.922 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.471 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 22.9 p -89.0 119.62 29.68 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.253 -1.379 . . . . 0.0 109.6 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.559 ' CG ' ' O ' ' A' ' 147' ' ' GLU . 8.4 pt-20 -109.14 117.13 54.16 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.621 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 57.2 Cg_endo -102.42 25.48 0.12 Allowed 'Trans proline' 0 N--CA 1.48 0.731 0 C-N-CA 122.361 2.041 . . . . 0.0 111.363 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 80.73 69.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.96 -177.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.479 ' O ' ' CB ' ' A' ' 77' ' ' SER . 20.9 p90 -94.68 -178.21 4.46 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.488 -0.758 . . . . 0.0 109.084 -177.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 86.1 m -148.3 95.9 2.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.543 -0.723 . . . . 0.0 109.988 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -110.47 163.5 13.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.988 -1.07 . . . . 0.0 108.787 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.708 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 25.6 mt -111.57 129.7 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.696 HH21 ' NE ' ' A' ' 104' ' ' ARG . 63.0 mtt180 -138.91 168.32 20.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 110.063 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.468 ' CG2' ' CG ' ' A' ' 70' ' ' TYR . 4.2 mp -105.41 147.87 10.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.642 -0.661 . . . . 0.0 109.667 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.461 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.6 m-30 -95.79 117.75 31.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.545 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.602 ' OD2' ' NE1' ' A' ' 162' ' ' TRP . 17.9 t0 -136.46 160.75 37.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.842 -0.536 . . . . 0.0 109.771 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.52 160.65 29.06 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.176 -0.953 . . . . 0.0 109.106 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.4 Cg_endo -66.56 -50.86 1.14 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.883 2.388 . . . . 0.0 112.306 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 159' ' ' PRO . 96.1 mt-10 -43.34 -20.77 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.481 -0.762 . . . . 0.0 109.073 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -87.75 -42.15 6.15 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.602 ' NE1' ' OD2' ' A' ' 157' ' ' ASP . 45.8 m0 -96.17 166.49 11.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.293 -1.122 . . . . 0.0 109.888 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.3 mm -98.23 148.39 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 109.666 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 96' ' ' HIS . . . -79.09 -71.57 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.096 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -135.42 155.89 49.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.244 -0.91 . . . . 0.0 109.659 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -101.3 -41.1 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.635 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.452 ' HG1' ' N ' ' A' ' 168' ' ' GLY . 60.2 p -108.09 -30.43 8.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.21 -0.931 . . . . 0.0 109.198 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.452 ' N ' ' HG1' ' A' ' 167' ' ' THR . . . 101.75 -8.28 56.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -80.65 148.04 30.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.887 -1.36 . . . . 0.0 108.451 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.503 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 34.6 p30 -111.03 87.55 2.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.966 -1.493 . . . . 0.0 111.122 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.7 tt -78.09 -17.39 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.261 -1.524 . . . . 0.0 109.486 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.558 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -60.2 -41.43 92.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.591 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 59.6 p -53.51 -3.72 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 110.283 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.25 -40.21 31.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.004 . . . . 0.0 111.279 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.612 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 5.8 m-85 -112.63 24.96 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.623 0 O-C-N 120.575 -1.328 . . . . 0.0 112.471 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 44.3 Cg_endo -62.16 -18.82 64.14 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 123.71 2.94 . . . . 0.0 113.75 -172.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.0 ttm-85 -89.11 125.85 35.2 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.363 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.471 ' HB3' ' H ' ' A' ' 146' ' ' SER . 4.5 tt -88.38 123.44 32.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.213 -0.929 . . . . 0.0 109.194 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.656 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.395 -179.829 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.473 ' O ' ' CG2' ' A' ' 19' ' ' THR . 6.4 p . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.96 171.06 8.52 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.881 -1.137 . . . . 0.0 109.053 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 tp -158.99 116.94 2.85 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.83 133.47 53.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.64 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.7 mt -128.16 134.83 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -126.59 168.02 14.86 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m -85.23 174.24 9.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.234 -0.916 . . . . 0.0 108.981 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -28.3 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.954 -1.091 . . . . 0.0 109.415 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -76.69 -34.7 58.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.55 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.39 124.08 14.69 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.202 -0.936 . . . . 0.0 109.429 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.55 -36.85 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.119 1.879 . . . . 0.0 112.347 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.53 3.99 2.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 110.235 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -111.9 119.05 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.418 -0.801 . . . . 0.0 109.211 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -99.41 120.97 40.46 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.379 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -91.32 -4.01 56.25 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.171 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.657 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 41.8 t90 -156.8 104.44 2.13 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 118.433 -1.307 . . . . 0.0 110.542 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -119.07 112.18 19.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.541 -0.725 . . . . 0.0 109.57 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.568 ' OG ' ' CH2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -161.45 163.7 30.26 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.262 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 1' ' ' SER . 45.4 m -131.38 89.56 2.74 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.938 -1.102 . . . . 0.0 108.35 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.55 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 31.0 m120 -127.83 142.23 51.35 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.425 -0.797 . . . . 0.0 110.37 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.13 -37.86 23.17 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.303 -1.498 . . . . 0.0 108.337 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -83.67 -50.64 7.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.855 . . . . 0.0 109.751 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.46 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.2 tt0 -59.13 -21.73 59.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.107 -0.996 . . . . 0.0 108.754 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.55 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 11.2 mt -76.09 -49.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.13 -0.981 . . . . 0.0 109.207 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.717 HE21 ' ND2' ' A' ' 29' ' ' ASN . 24.4 tm0? -59.68 -44.8 93.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.777 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -38.58 73.42 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.243 -0.91 . . . . 0.0 109.344 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.657 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 6.5 tt0 -77.0 -49.81 14.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 110.252 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 24' ' ' ILE . 12.2 tp -62.07 -54.52 40.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.015 -1.053 . . . . 0.0 108.857 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.717 ' ND2' HE21 ' A' ' 25' ' ' GLN . 1.1 m-20 -61.95 -16.45 51.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.905 -1.122 . . . . 0.0 109.856 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.77 -30.07 71.17 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.63 -1.294 . . . . 0.0 108.845 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.96 11.09 12.23 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.009 -1.076 . . . . 0.0 109.558 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.46 25.01 31.84 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.2 t -95.47 145.99 7.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 122.018 0.913 . . . . 0.0 109.471 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -84.32 156.87 21.7 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 121.346 -0.846 . . . . 0.0 108.855 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.558 ' CB ' HD22 ' A' ' 29' ' ' ASN . 1.8 t80 -154.12 149.63 27.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.913 -1.117 . . . . 0.0 109.041 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -169.79 167.78 9.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.006 -1.059 . . . . 0.0 109.866 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.474 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 18.8 ptt-85 -151.82 115.91 4.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.425 -0.797 . . . . 0.0 109.139 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.507 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 11.7 m0 -113.22 157.31 21.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.17 166.39 25.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.678 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.93 162.19 13.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.366 -0.834 . . . . 0.0 108.932 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -94.49 -26.02 16.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.123 -0.986 . . . . 0.0 108.695 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -94.85 172.98 7.83 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -89.86 131.59 35.71 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.368 -0.833 . . . . 0.0 108.993 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.4 mt -92.97 167.95 11.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.239 -0.913 . . . . 0.0 109.812 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.78 -94.28 0.11 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.45 107.47 7.6 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.33 -1.1 . . . . 0.0 108.166 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.4 90.44 45.31 Favored Pre-proline 0 C--N 1.302 -1.494 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.677 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -83.71 40.92 0.96 Allowed 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.795 2.33 . . . . 0.0 111.221 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.1 m -166.24 138.11 3.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.61 -1.306 . . . . 0.0 109.457 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.443 ' C ' ' H ' ' A' ' 52' ' ' THR . . . -82.64 -51.78 7.42 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.905 -1.122 . . . . 0.0 110.262 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.15 -0.68 1.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.422 -0.799 . . . . 0.0 109.75 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.443 ' H ' ' C ' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -77.08 -56.82 4.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 109.806 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.19 -45.53 96.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 O-C-N 121.137 -0.977 . . . . 0.0 109.579 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.4 mt -59.82 -41.07 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.274 -0.97 . . . . 0.0 108.807 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.87 -24.16 67.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.351 -0.843 . . . . 0.0 109.788 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.04 -21.48 56.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.047 -1.033 . . . . 0.0 110.323 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 58' ' ' GLN . 57.0 m-85 -112.28 -6.54 14.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.384 -0.822 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 62' ' ' ASP . 5.5 mm-40 -45.85 -39.05 8.02 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.743 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -50.81 -48.04 59.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.909 -1.116 . . . . 0.0 109.634 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.607 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.37 -60.77 3.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.01 -1.056 . . . . 0.0 110.309 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.459 ' CD1' ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -62.6 -29.71 47.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 120.751 -1.218 . . . . 0.0 109.184 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 58' ' ' GLN . 45.5 t0 -54.85 -27.62 43.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.805 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -77.82 -37.41 48.68 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.018 -1.051 . . . . 0.0 109.812 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 9.6 mp -63.98 -39.22 93.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.126 -0.984 . . . . 0.0 109.865 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.51 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -69.24 -29.06 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 0.0 108.924 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.02 -54.12 47.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.474 -1.391 . . . . 0.0 109.297 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.42 -52.47 5.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.254 -0.904 . . . . 0.0 110.954 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.624 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -86.86 14.53 7.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 110.596 -177.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -15.54 89.31 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.49 ' N ' ' O ' ' A' ' 68' ' ' LYS . 87.4 m-85 -77.58 164.78 25.05 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -58.56 -88.01 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 109.949 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.52 ' OG ' ' CG ' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -101.26 159.72 15.01 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.568 -0.707 . . . . 0.0 109.618 -179.064 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -136.29 140.04 43.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.496 -0.753 . . . . 0.0 109.139 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.1 -173.47 2.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 108.775 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.9 m -122.99 148.45 26.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.513 -0.742 . . . . 0.0 109.587 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.8 tt -100.89 118.09 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 150' ' ' PHE . 91.8 p -171.83 103.79 0.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.604 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.567 ' CD1' ' H ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -105.39 -178.38 3.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 121.078 1.763 . . . . 0.0 108.209 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.609 ' C ' ' H ' ' A' ' 81' ' ' ASP . 8.2 tpt180 -89.45 148.77 23.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.891 -1.131 . . . . 0.0 109.528 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.41 3.91 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.615 -0.678 . . . . 0.0 109.641 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.609 ' H ' ' C ' ' A' ' 79' ' ' ARG . 80.5 m-20 -92.16 -24.11 19.19 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.922 -1.111 . . . . 0.0 109.34 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.728 HD22 ' HZ2' ' A' ' 85' ' ' LYS . 27.7 p-10 -60.63 118.07 31.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.83 -1.169 . . . . 0.0 109.586 -178.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -88.57 -23.77 0.98 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.241 1.96 . . . . 0.0 112.501 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -91.93 -14.8 28.97 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.919 -1.113 . . . . 0.0 109.945 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.728 ' HZ2' HD22 ' A' ' 82' ' ' ASN . 0.0 OUTLIER -60.89 -35.75 77.44 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.794 178.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 96.9 mt-10 -57.17 -40.57 77.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.133 -0.979 . . . . 0.0 108.491 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.41 -27.29 68.43 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.792 -1.193 . . . . 0.0 109.154 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.6 tp -60.67 -47.61 85.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -0.948 . . . . 0.0 109.989 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -64.58 -27.66 69.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.108 -0.995 . . . . 0.0 109.285 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.07 -60.74 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.394 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -58.33 -35.07 71.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.08 -1.013 . . . . 0.0 109.19 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -79.77 -18.35 51.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.414 -0.803 . . . . 0.0 109.956 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 94' ' ' ASN . 0.3 OUTLIER -60.75 -26.49 67.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.49 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 94' ' ' ASN . 32.5 p-10 -46.27 135.22 8.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.293 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.68 159.33 13.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 0.0 109.871 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.484 ' CE1' ' H2 ' ' A' ' 182' ' ' HOH . 46.8 p-80 -171.9 -169.73 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.763 -1.175 . . . . 0.0 111.965 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.81 130.98 4.47 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.549 0.69 . . . . 0.0 109.364 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.621 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -100.67 154.37 18.65 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.625 -0.672 . . . . 0.0 109.716 -179.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.11 -7.98 87.52 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -123.4 170.98 9.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -1.112 . . . . 0.0 109.286 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -74.07 143.06 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.973 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.599 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 5.0 tt0 -103.49 90.02 3.55 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.405 ' CG2' ' OG ' ' A' ' 133' ' ' SER . 26.1 t -85.7 127.06 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.286 -0.884 . . . . 0.0 109.714 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 115.49 17.29 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.501 -0.749 . . . . 0.0 109.617 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.65 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 10.9 t80 -99.94 132.19 45.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 108.612 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.566 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.8 OUTLIER -91.08 135.47 33.74 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.364 0.602 . . . . 0.0 109.939 -179.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.0 t -116.84 -26.97 2.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.371 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 109' ' ' GLY . 73.7 tt0 -169.12 158.02 8.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.155 -0.965 . . . . 0.0 108.949 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 108' ' ' GLU . . . 48.37 107.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.416 ' CB ' ' CE2' ' A' ' 106' ' ' PHE . . . -151.8 112.33 4.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.649 -1.501 . . . . 0.0 109.574 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.93 -141.97 4.36 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 124' ' ' VAL . 0.5 OUTLIER -108.9 100.42 9.63 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.329 -1.101 . . . . 0.0 110.851 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.659 ' CD2' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.47 132.12 36.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.934 -1.104 . . . . 0.0 110.043 -178.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 9.8 m -78.46 154.7 30.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.554 -0.716 . . . . 0.0 110.148 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 122' ' ' PHE . 1.1 tp -145.28 121.0 10.51 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.5 t-160 -111.48 111.15 21.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.224 -0.923 . . . . 0.0 109.677 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.46 113.85 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.744 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.49 -145.14 35.3 Favored Glycine 0 N--CA 1.503 3.15 0 N-CA-C 106.146 -2.782 . . . . 0.0 106.146 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -100.73 77.74 1.91 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 114.581 -2.848 . . . . 0.0 109.688 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.59 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 1.5 mt-10 -166.6 170.0 13.09 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 120.949 -1.095 . . . . 0.0 108.064 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 50.7 t -126.56 140.34 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.573 ' O ' ' N ' ' A' ' 115' ' ' LEU . 2.3 m-85 -126.95 130.71 50.61 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.601 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -131.23 110.14 10.91 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.444 -0.785 . . . . 0.0 109.134 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -98.52 138.22 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.496 ' CD1' ' N ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.8 88.13 2.68 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.425 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.522 ' SG ' ' O ' ' A' ' 126' ' ' CYS . 5.2 p -167.89 136.11 2.37 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.291 -1.506 . . . . 0.0 107.216 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -104.42 96.8 6.86 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 115.292 -2.563 . . . . 0.0 110.05 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.586 ' C ' ' H ' ' A' ' 130' ' ' ASP . 24.5 mmtt -116.75 157.48 25.43 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.324 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.65 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 40.3 m-80 -58.38 -2.11 0.18 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.586 ' H ' ' C ' ' A' ' 128' ' ' LYS . 17.2 m-20 -70.47 147.32 49.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.108 -0.995 . . . . 0.0 109.303 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.533 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 0.8 OUTLIER -111.31 154.66 24.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.605 0.717 . . . . 0.0 110.448 -179.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 29.1 mm -116.65 118.73 59.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.405 ' OG ' ' CG2' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -111.03 129.82 55.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.545 -0.722 . . . . 0.0 109.285 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.48 141.75 23.19 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.06 153.66 71.79 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.058 1.839 . . . . 0.0 112.347 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.623 ' O ' ' CG ' ' A' ' 137' ' ' HIS . . . -71.06 135.45 47.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -0.85 . . . . 0.0 108.895 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.623 ' CG ' ' O ' ' A' ' 136' ' ' ALA . 2.6 m170 89.83 14.95 0.05 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.094 0.473 . . . . 0.0 110.004 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.39 127.21 28.66 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.53 131.65 32.53 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.924 1.749 . . . . 0.0 111.513 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.08 163.09 9.19 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.245 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.449 ' CE3' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -134.52 -148.7 0.32 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.933 . . . . 0.0 109.542 -178.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.42 ' H ' ' HB2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -176.78 126.45 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.937 -1.102 . . . . 0.0 109.196 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.479 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 37.2 p-10 -144.58 134.28 23.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.429 -0.794 . . . . 0.0 109.686 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.671 ' N ' ' SD ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -112.96 19.13 17.55 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.614 -0.679 . . . . 0.0 110.44 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 13.18 -93.13 0.01 OUTLIER Glycine 0 N--CA 1.501 3.02 0 CA-C-N 119.216 0.916 . . . . 0.0 111.663 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.442 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 19.4 p -84.53 119.56 25.32 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.259 -1.376 . . . . 0.0 108.924 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -113.71 112.23 48.27 Favored Pre-proline 0 C--N 1.294 -1.847 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.093 178.447 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.8 Cg_endo -103.52 34.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 123.326 2.684 . . . . 0.0 111.542 176.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 81.56 69.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.529 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 9.0 p90 -95.67 135.89 36.78 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.064 -1.023 . . . . 0.0 109.944 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.7 m -97.73 119.72 36.82 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.779 -0.575 . . . . 0.0 109.686 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.45 159.96 41.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 109.266 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.1 mt -108.69 125.97 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.513 -0.742 . . . . 0.0 110.086 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -132.5 160.72 35.69 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.575 -0.703 . . . . 0.0 109.713 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -108.39 156.91 8.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.416 0.627 . . . . 0.0 109.478 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.52 ' CG ' ' OG ' ' A' ' 72' ' ' SER . 4.5 m-85 -100.51 119.75 38.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.053 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 12.2 p30 -134.55 159.22 41.85 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -98.32 146.76 32.1 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.985 -1.072 . . . . 0.0 109.494 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.618 ' O ' ' N ' ' A' ' 161' ' ' GLY . 47.3 Cg_endo -71.37 -52.61 0.21 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.355 2.037 . . . . 0.0 112.048 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -43.54 -14.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.605 -0.685 . . . . 0.0 109.403 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.49 -32.17 38.87 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.634 ' CD1' ' N ' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -118.71 176.09 5.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.599 -0.942 . . . . 0.0 110.469 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 70.8 mt -94.2 145.75 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.306 -0.871 . . . . 0.0 109.277 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.27 -73.14 0.31 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.372 -0.83 . . . . 0.0 110.643 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -120.91 151.15 40.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.367 -0.833 . . . . 0.0 109.854 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.467 ' CD2' ' N ' ' A' ' 166' ' ' PHE . 2.7 p90 -101.54 -40.43 7.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.564 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 m -110.2 -31.15 7.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.315 -0.866 . . . . 0.0 108.977 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.68 -4.94 53.9 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.421 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -82.76 148.67 27.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.749 -1.442 . . . . 0.0 108.926 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.482 ' OD1' ' OG ' ' A' ' 173' ' ' SER . 60.9 t0 -109.83 89.13 2.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 117.925 -1.51 . . . . 0.0 111.058 176.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.09 -22.38 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.489 -1.382 . . . . 0.0 109.366 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.582 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -60.36 -40.55 91.19 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.619 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 24.1 m -51.17 -3.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 110.19 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -77.4 -41.52 39.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.789 -1.194 . . . . 0.0 111.629 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.631 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 1.0 OUTLIER -112.83 25.24 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.607 0 O-C-N 120.772 -1.205 . . . . 0.0 112.27 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 49.6 Cg_endo -62.41 -22.66 74.36 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.722 2.948 . . . . 0.0 113.522 -172.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 177' ' ' ARG . 28.3 ptt85 -89.42 126.45 35.56 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.003 -1.079 . . . . 0.0 108.885 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.56 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 0.6 OUTLIER -87.78 118.68 27.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.262 -0.899 . . . . 0.0 109.022 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.534 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . 0.484 ' H2 ' ' CE1' ' A' ' 96' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.508 ' O ' ' CG2' ' A' ' 19' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.119 0.485 . . . . 0.0 109.703 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.412 ' HA ' ' HG1' ' A' ' 19' ' ' THR . . . -95.89 171.09 8.85 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.959 -1.097 . . . . 0.0 109.288 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.567 ' CD2' ' CZ3' ' A' ' 16' ' ' TRP . 18.7 tp -157.83 109.36 2.28 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.79 127.09 53.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.51 -0.744 . . . . 0.0 110.523 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.2 mt -120.87 135.62 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.27 169.75 15.02 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.8 p -87.47 173.05 9.34 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.0 -33.37 6.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.084 -1.01 . . . . 0.0 108.874 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -71.72 -37.47 70.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.53 -0.731 . . . . 0.0 110.384 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.14 125.25 14.58 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.98 -1.075 . . . . 0.0 109.634 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -82.26 -30.21 1.28 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.892 1.728 . . . . 0.0 112.266 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -70.22 0.74 5.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.41 -0.806 . . . . 0.0 110.662 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -114.7 118.69 34.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.024 -1.047 . . . . 0.0 108.497 179.168 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -97.13 125.42 41.62 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.846 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.412 ' CD1' HD22 ' A' ' 13' ' ' ASN . 2.6 mp -90.46 -12.25 37.91 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.497 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.687 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 34.7 t90 -159.73 107.41 1.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.222 -1.391 . . . . 0.0 109.939 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -121.09 119.43 32.42 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.09 -1.006 . . . . 0.0 110.332 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.481 ' OG ' ' CH2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -161.02 166.68 27.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.266 -0.897 . . . . 0.0 110.155 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.508 ' CG2' ' O ' ' A' ' 1' ' ' SER . 45.8 m -129.21 86.42 2.43 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.459 ' O ' ' CG1' ' A' ' 24' ' ' ILE . 0.4 OUTLIER -129.45 138.96 51.73 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.794 -0.566 . . . . 0.0 110.369 177.22 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.75 -28.59 30.31 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.592 -1.942 . . . . 0.0 108.905 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -82.95 -53.3 5.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -62.28 -18.76 62.16 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.66 -1.275 . . . . 0.0 107.984 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.459 ' CG1' ' O ' ' A' ' 20' ' ' ASN . 3.0 mt -73.28 -59.14 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.344 -0.847 . . . . 0.0 109.375 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.413 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 21.2 pt20 -58.34 -39.16 78.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.4 ' N ' ' HG3' ' A' ' 25' ' ' GLN . 44.1 tt0 -66.99 -42.64 84.69 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.332 -0.855 . . . . 0.0 109.47 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.687 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -67.2 -46.83 72.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.101 -1.0 . . . . 0.0 109.524 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.95 -53.56 37.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.327 -0.858 . . . . 0.0 109.447 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 17.9 t-20 -64.16 -19.0 65.0 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.58 -0.7 . . . . 0.0 110.573 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.15 71.17 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.535 -1.353 . . . . 0.0 108.164 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -89.38 14.81 10.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.598 -0.689 . . . . 0.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.68 20.38 58.28 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.434 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 21.9 t -93.3 147.09 5.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.277 -1.131 . . . . 0.0 109.078 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.669 ' HE ' ' H ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -83.09 155.59 23.77 Favored 'General case' 0 C--N 1.281 -2.378 0 O-C-N 120.644 -1.285 . . . . 0.0 107.833 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.669 ' H ' ' HE ' ' A' ' 34' ' ' ARG . 2.3 t80 -152.87 147.09 25.59 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 17.0 tp10 -174.35 172.65 3.16 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.592 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.483 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 30.7 ptt-85 -151.95 121.86 7.06 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.115 -0.991 . . . . 0.0 108.732 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.465 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 33.7 m0 -112.75 156.43 22.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.512 -0.742 . . . . 0.0 109.141 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -142.64 157.64 44.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.293 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.71 159.06 15.34 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -98.66 -13.6 20.23 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -93.74 156.97 16.39 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.495 ' O ' ' OD2' ' A' ' 43' ' ' ASP . 46.4 p-10 -95.52 122.23 38.05 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.473 -0.767 . . . . 0.0 109.384 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.8 mt -91.8 165.83 13.07 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.176 -0.952 . . . . 0.0 108.95 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.95 -121.92 0.58 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.13 79.45 9.12 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.086 -1.244 . . . . 0.0 108.497 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.62 93.89 46.65 Favored Pre-proline 0 C--N 1.306 -1.317 0 O-C-N 121.462 -0.773 . . . . 0.0 109.56 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.456 ' O ' ' CG2' ' A' ' 49' ' ' THR . 46.9 Cg_endo -70.2 85.61 0.67 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.084 1.856 . . . . 0.0 111.505 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.525 ' OG1' ' OG1' ' A' ' 52' ' ' THR . 1.5 p -165.05 117.93 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -0.863 . . . . 0.0 109.019 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.43 -36.84 28.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.836 -1.165 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -69.3 -14.92 63.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.943 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.525 ' OG1' ' OG1' ' A' ' 49' ' ' THR . 4.2 p -78.25 -43.67 27.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.051 -1.031 . . . . 0.0 110.89 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 t -67.13 -46.44 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.938 -1.101 . . . . 0.0 109.564 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 58' ' ' GLN . 55.7 mt -61.2 -39.58 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.282 -0.886 . . . . 0.0 108.888 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.22 70.66 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.678 -0.639 . . . . 0.0 109.905 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.85 -21.61 54.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.067 -1.021 . . . . 0.0 110.376 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -114.44 -7.09 12.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.489 -0.757 . . . . 0.0 109.13 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.64 HE21 ' CG1' ' A' ' 61' ' ' ILE . 38.1 tp60 -48.59 -36.93 16.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.242 -0.911 . . . . 0.0 108.546 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.685 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -53.25 -48.84 67.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.043 -1.035 . . . . 0.0 109.941 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.685 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.06 -55.43 32.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.728 -1.232 . . . . 0.0 109.669 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.64 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.5 OUTLIER -65.71 -26.91 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.083 -1.01 . . . . 0.0 109.543 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 58' ' ' GLN . 20.7 t70 -59.2 -25.2 63.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.461 -0.774 . . . . 0.0 109.224 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.7 -43.29 14.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 110.016 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 tt -65.6 -48.46 72.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.307 -0.87 . . . . 0.0 109.819 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' GLY . 3.4 p -66.91 -28.25 42.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.43 -44.21 76.06 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.791 -1.193 . . . . 0.0 109.279 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -80.02 -52.86 7.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.999 -1.063 . . . . 0.0 109.714 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.623 ' O ' ' C ' ' A' ' 69' ' ' GLY . 54.0 mttm -83.08 12.67 4.79 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.401 -0.812 . . . . 0.0 110.685 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -5.63 83.21 0.0 OUTLIER Glycine 0 N--CA 1.506 3.304 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 68' ' ' LYS . 69.6 m-85 -75.66 156.6 34.66 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.433 -1.039 . . . . 0.0 109.88 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -64.82 -49.59 70.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.486 -0.759 . . . . 0.0 110.574 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.9 m -125.27 135.49 52.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.356 -0.84 . . . . 0.0 109.729 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 7.4 t-105 -133.57 138.98 46.29 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.4 -168.87 0.56 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.155 -0.965 . . . . 0.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 t -125.99 155.91 35.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.3 mt -93.88 131.82 39.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.5 p -93.55 167.77 11.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 122.769 1.271 . . . . 0.0 111.839 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.428 HD22 ' H ' ' A' ' 149' ' ' ASN . 10.1 tp -167.78 157.6 10.25 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.497 176.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.99 142.18 51.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.35 -4.79 11.9 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.216 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.426 ' OD2' ' C ' ' A' ' 81' ' ' ASP . 8.5 p-10 -116.64 -8.02 11.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.197 -0.939 . . . . 0.0 109.087 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.468 ' CG ' ' O ' ' A' ' 82' ' ' ASN . 1.6 p30 -62.88 124.72 84.56 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 109.801 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.36 -2.37 12.25 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.291 1.994 . . . . 0.0 111.954 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -90.19 3.75 52.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.976 . . . . 0.0 109.832 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 19.4 pttp -60.31 -51.25 70.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.159 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.579 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 46.1 tp10 -65.45 -43.16 91.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.882 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.99 -43.48 98.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.855 . . . . 0.0 109.981 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.2 tp -59.46 -45.61 91.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 109.171 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.579 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 17.1 ttp-105 -63.0 -28.59 70.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.555 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.93 -60.55 2.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.806 . . . . 0.0 109.377 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -55.88 -31.57 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 109.461 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.06 -18.18 50.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.16 -0.963 . . . . 0.0 110.037 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.478 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -64.67 -27.54 68.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -1.0 . . . . 0.0 110.031 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -60.45 136.97 58.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.07 -1.019 . . . . 0.0 110.233 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 169' ' ' ASP . 20.7 pt-20 -73.95 164.07 27.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.394 -0.816 . . . . 0.0 109.186 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -172.54 -167.52 0.46 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.008 -1.058 . . . . 0.0 110.463 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.96 133.17 5.95 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.6 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -103.63 153.47 20.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 109.804 -179.181 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.22 -7.07 86.8 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -125.28 170.93 10.81 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.285 -1.126 . . . . 0.0 109.53 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -71.64 143.02 49.92 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.117 -0.989 . . . . 0.0 109.821 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.6 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 3.3 tt0 -104.16 97.91 7.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 110.034 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.4 t -97.41 124.71 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.18 126.56 43.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.47 -0.769 . . . . 0.0 109.236 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 33.4 t80 -108.31 129.3 55.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.835 0.826 . . . . 0.0 109.008 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.439 ' CE2' ' HB1' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -80.85 117.05 21.16 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.566 -0.709 . . . . 0.0 110.353 -178.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.5 t -85.14 -47.54 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -0.822 . . . . 0.0 110.346 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -169.27 158.1 7.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.915 -1.116 . . . . 0.0 110.545 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.61 61.56 4.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' HB1' ' CE2' ' A' ' 106' ' ' PHE . . . -119.58 129.9 54.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.877 -1.367 . . . . 0.0 108.446 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -118.57 -29.92 1.79 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -141.66 160.13 40.79 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.387 -1.066 . . . . 0.0 109.748 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.533 ' N ' ' CD1' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -139.35 95.51 2.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.413 ' HG ' HE21 ' A' ' 123' ' ' GLN . 1.8 m -77.78 136.43 38.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.42 -0.8 . . . . 0.0 110.318 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.64 114.19 6.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.409 -0.807 . . . . 0.0 109.734 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 6.8 t-160 -106.73 110.55 22.76 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.901 -1.124 . . . . 0.0 109.342 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.3 mm -128.61 121.53 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.469 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.15 -143.82 36.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 103.682 -3.767 . . . . 0.0 103.682 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.492 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 44.7 p30 -111.0 82.67 1.63 Allowed 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 115.417 -2.513 . . . . 0.0 108.369 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.506 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 60.0 tt0 -164.76 167.69 18.67 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 71.0 t -128.5 140.25 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.986 -1.071 . . . . 0.0 110.085 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -125.57 132.25 52.58 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.928 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.413 HE21 ' HG ' ' A' ' 114' ' ' CYS . 73.8 mt-30 -142.05 122.13 13.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.069 -1.02 . . . . 0.0 109.029 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -106.74 147.09 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.241 -0.912 . . . . 0.0 109.191 179.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.9 mt -118.44 78.33 1.25 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 117.848 -1.541 . . . . 0.0 111.586 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.446 ' SG ' ' N ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -166.79 163.65 16.46 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 103.3 -2.852 . . . . 0.0 103.3 177.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.619 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -117.78 110.74 18.18 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 122.59 2.45 . . . . 0.0 106.312 176.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.611 ' C ' ' H ' ' A' ' 130' ' ' ASP . 13.0 mmtt -113.61 148.51 36.08 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.603 -0.686 . . . . 0.0 111.114 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.579 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 93.5 m-20 -61.12 -0.19 0.31 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.611 ' H ' ' C ' ' A' ' 128' ' ' LYS . 49.2 p30 -70.28 153.06 43.48 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.222 1.011 . . . . 0.0 110.903 -176.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.532 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 0.9 OUTLIER -125.76 161.87 26.37 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.856 0.836 . . . . 0.0 110.972 -178.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 mp -128.43 145.41 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.669 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.6 t -119.12 138.08 53.15 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.308 -0.87 . . . . 0.0 109.789 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -112.14 140.06 23.13 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.33 150.83 59.33 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.099 1.866 . . . . 0.0 112.328 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -72.48 132.57 44.04 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.815 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 12.5 t60 94.53 9.86 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.39 126.94 30.12 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 108.46 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.41 132.59 31.82 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.541 1.494 . . . . 0.0 111.463 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.516 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -166.61 162.84 16.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.315 -0.866 . . . . 0.0 110.177 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.672 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 21.6 p90 -127.22 -154.37 0.63 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.505 -0.747 . . . . 0.0 109.818 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.672 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 47.4 t80 -169.71 119.79 0.65 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 143' ' ' ASP . 34.3 p30 -139.52 119.64 13.63 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.28 -0.887 . . . . 0.0 108.692 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.566 ' SD ' ' CZ ' ' A' ' 150' ' ' PHE . 25.9 mtm -93.31 16.59 12.91 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 111.491 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 50.24 -144.3 10.93 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.404 ' H ' ' CD2' ' A' ' 178' ' ' LEU . 31.6 t -83.29 121.04 26.6 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.0 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -116.27 120.42 35.05 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.88 -0.512 . . . . 0.0 110.536 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 59.3 Cg_endo -102.87 59.41 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.807 0 C-N-CA 122.378 2.052 . . . . 0.0 110.65 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.2 OUTLIER 82.48 64.26 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.304 -0.873 . . . . 0.0 109.691 -177.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.566 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 1.0 OUTLIER -101.42 168.19 9.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.7 m -127.1 133.19 50.46 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.43 -0.794 . . . . 0.0 109.281 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.16 157.35 46.48 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.031 -1.043 . . . . 0.0 109.591 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.3 mt -108.32 124.91 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.062 -1.024 . . . . 0.0 108.985 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.16 164.49 27.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.414 -0.804 . . . . 0.0 109.346 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.43 ' CG2' ' CG ' ' A' ' 70' ' ' TYR . 2.9 mt -119.24 124.46 73.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 156' ' ' PHE . 26.5 m-85 -93.87 133.39 37.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.983 -1.073 . . . . 0.0 110.241 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.62 ' OD2' ' N ' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -129.84 165.57 21.72 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.644 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -91.2 160.63 36.98 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.935 -1.103 . . . . 0.0 108.625 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 161' ' ' GLY . 36.1 Cg_endo -57.02 -54.28 3.88 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.678 2.252 . . . . 0.0 113.12 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 159' ' ' PRO . 11.8 pt-20 -42.27 -23.17 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.506 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.27 -56.07 2.1 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.644 ' CD1' ' O ' ' A' ' 158' ' ' ASN . 39.0 p-90 -98.86 155.97 17.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.121 -1.223 . . . . 0.0 110.633 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 14.8 tt -103.88 159.08 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.497 -0.752 . . . . 0.0 109.184 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.97 -71.73 0.24 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.37 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -139.82 158.63 43.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.014 -1.054 . . . . 0.0 110.242 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -101.09 -41.87 6.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.162 -0.961 . . . . 0.0 109.704 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.6 m -115.92 -34.21 4.84 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.93 -3.95 57.38 Favored Glycine 0 N--CA 1.484 1.863 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.812 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.422 ' O ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -81.7 148.11 29.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.08 -1.835 . . . . 0.0 107.957 178.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -112.35 91.16 3.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.089 -1.444 . . . . 0.0 111.104 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.404 HD13 ' HD1' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -75.3 -20.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.113 -1.617 . . . . 0.0 108.799 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -61.34 -39.91 92.3 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.503 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -51.4 -3.85 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.827 -0.546 . . . . 0.0 110.698 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.547 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.36 -36.34 34.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.915 -1.116 . . . . 0.0 111.053 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.612 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.5 OUTLIER -111.49 20.09 0.07 OUTLIER Pre-proline 0 N--CA 1.511 2.595 0 O-C-N 120.708 -1.245 . . . . 0.0 113.993 -178.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 51.8 Cg_endo -65.48 -23.62 57.6 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.961 2.441 . . . . 0.0 114.636 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -87.81 126.54 35.07 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.268 -1.373 . . . . 0.0 108.41 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.597 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 9.4 tp -85.41 145.2 27.58 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 108.779 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.597 ' CB ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.168 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.619 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.29 168.22 10.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.071 -1.018 . . . . 0.0 109.313 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 4' ' ' THR . 2.6 tp -156.48 125.49 6.01 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.7 OUTLIER -121.73 126.62 49.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.205 -0.935 . . . . 0.0 109.633 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.1 mt -117.43 140.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.794 ' CZ ' ' O ' ' A' ' 7' ' ' SER . 1.2 t80 -144.41 156.19 44.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.794 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 50.7 p -89.57 179.76 5.97 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.984 -1.073 . . . . 0.0 108.132 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.19 3.21 5.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 119.975 -1.703 . . . . 0.0 110.149 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.406 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 1.4 mmmt -76.81 -49.57 15.53 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 120.509 -1.369 . . . . 0.0 114.13 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.787 ' O ' ' CE1' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -145.26 123.7 6.59 Favored Pre-proline 0 N--CA 1.507 2.404 0 O-C-N 119.96 -1.712 . . . . 0.0 109.546 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.43 ' HA ' ' CE2' ' A' ' 6' ' ' PHE . 43.4 Cg_endo -67.71 -33.96 26.21 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.324 1.349 . . . . 0.0 113.413 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.586 ' C ' HD21 ' A' ' 13' ' ' ASN . 0.2 OUTLIER -70.43 6.15 1.5 Allowed 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.281 -0.887 . . . . 0.0 110.127 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.586 HD21 ' C ' ' A' ' 12' ' ' GLN . 4.2 m120 -125.74 124.64 41.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.152 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.6 p -113.44 133.44 55.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.46 -0.775 . . . . 0.0 108.931 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.592 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 6.3 mp -94.19 5.41 51.81 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.105 -0.997 . . . . 0.0 109.881 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.483 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 23.8 t90 -153.91 102.08 2.48 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.788 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -117.99 107.43 14.03 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.197 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.421 ' OG ' ' CZ3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -161.68 161.71 29.57 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.511 179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.619 ' OG1' ' O ' ' A' ' 1' ' ' SER . 8.8 t -132.57 90.54 2.79 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 120.881 -1.137 . . . . 0.0 107.996 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.561 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 12.6 t-20 -123.76 141.96 51.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.254 -0.904 . . . . 0.0 110.037 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.83 -35.53 29.31 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.035 -1.666 . . . . 0.0 108.779 176.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -83.13 -52.27 6.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.168 -0.957 . . . . 0.0 109.548 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.495 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 1.4 tm-20 -60.17 -20.48 58.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.96 . . . . 0.0 108.667 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.586 ' CD1' ' HG ' ' A' ' 1' ' ' SER . 4.6 mt -73.04 -54.76 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.198 -0.939 . . . . 0.0 108.766 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -58.72 -43.0 90.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.488 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -62.08 -40.72 96.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.207 -0.933 . . . . 0.0 108.967 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.483 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 8.9 tt0 -73.25 -45.74 54.16 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.01 -61.16 2.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.031 -1.043 . . . . 0.0 110.089 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.2 t-20 -59.48 -18.88 43.58 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.321 -0.862 . . . . 0.0 110.262 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.04 -31.25 72.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.81 -1.181 . . . . 0.0 108.966 177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.685 ' NZ ' ' CD2' ' A' ' 122' ' ' PHE . 13.6 mtmt -91.47 12.3 21.17 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.296 -0.877 . . . . 0.0 109.963 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.25 24.76 30.58 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.159 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 28.8 t -95.3 147.41 5.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.385 -1.068 . . . . 0.0 109.194 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -82.82 153.23 25.29 Favored 'General case' 0 C--N 1.285 -2.208 0 O-C-N 120.82 -1.175 . . . . 0.0 108.097 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -154.81 149.45 26.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.063 -1.023 . . . . 0.0 108.564 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.533 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 5.5 pt-20 -178.78 179.54 0.7 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.019 -1.051 . . . . 0.0 110.561 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.8 ptt85 -152.97 122.35 6.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.319 -0.863 . . . . 0.0 109.353 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.612 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 33.4 m0 -111.78 153.38 26.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.49 -0.756 . . . . 0.0 109.108 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -140.01 155.01 47.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.901 . . . . 0.0 109.658 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.27 157.55 15.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 108.783 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -102.73 -8.75 20.6 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.61 162.16 14.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.683 0.754 . . . . 0.0 109.184 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 39.8 p-10 -96.41 123.72 40.16 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.425 0.631 . . . . 0.0 109.694 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.94 160.88 14.24 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.369 -0.832 . . . . 0.0 109.43 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.1 -105.3 0.22 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.87 88.62 4.68 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.057 -1.261 . . . . 0.0 109.078 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.99 91.89 40.77 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.145 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.91 -23.7 13.74 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.179 1.919 . . . . 0.0 112.477 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.0 p -119.65 141.93 48.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.782 -0.574 . . . . 0.0 109.494 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.42 -17.68 51.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.804 . . . . 0.0 109.428 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' ALA . 97.8 mt-10 -44.69 -38.2 4.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.476 -0.765 . . . . 0.0 109.094 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 m -76.36 -33.11 58.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.194 -0.941 . . . . 0.0 109.412 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 50' ' ' ALA . 70.1 t -65.84 -45.07 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.385 -0.822 . . . . 0.0 110.042 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.609 ' O ' ' N ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -61.47 -38.54 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.098 -1.001 . . . . 0.0 109.006 -179.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.21 -31.28 70.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.425 -0.797 . . . . 0.0 109.686 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.86 -21.78 50.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.084 -1.01 . . . . 0.0 110.443 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -112.53 -10.22 13.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.332 -0.855 . . . . 0.0 109.526 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.677 HE21 ' CG1' ' A' ' 61' ' ' ILE . 28.2 tp60 -52.64 -43.05 65.2 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.421 -0.911 . . . . 0.0 108.86 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.547 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 6.3 p80 -49.71 -48.52 49.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.017 -1.052 . . . . 0.0 109.653 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.547 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.08 -60.76 3.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.948 -1.095 . . . . 0.0 109.853 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.677 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.6 OUTLIER -62.13 -30.01 47.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.773 -1.204 . . . . 0.0 109.304 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.4 t70 -55.22 -25.85 35.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.069 -1.019 . . . . 0.0 109.624 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -80.3 -35.23 36.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 109.298 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.97 -42.66 94.36 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.42 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -72.04 -28.97 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 109.532 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.66 -52.91 53.67 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.937 -1.102 . . . . 0.0 109.502 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.64 -46.27 17.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.023 -1.048 . . . . 0.0 109.988 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.626 ' O ' ' C ' ' A' ' 69' ' ' GLY . 23.2 mttm -83.59 13.36 4.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.835 . . . . 0.0 110.631 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.626 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -6.11 82.21 0.0 OUTLIER Glycine 0 N--CA 1.504 3.187 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.476 ' N ' ' O ' ' A' ' 68' ' ' LYS . 43.2 m-85 -76.36 161.82 28.39 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.709 -0.877 . . . . 0.0 109.138 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -58.93 -42.85 90.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 0.0 109.974 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.501 ' HG ' ' N ' ' A' ' 73' ' ' TRP . 2.8 t -151.29 161.21 43.12 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.154 -0.967 . . . . 0.0 109.895 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.519 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 12.3 t-105 -137.74 143.0 40.96 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.454 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -160.87 179.13 8.74 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.9 142.04 40.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.47 -0.769 . . . . 0.0 109.264 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.5 mm -100.0 116.25 42.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.515 ' O ' ' OG ' ' A' ' 77' ' ' SER . 5.8 p -168.71 102.07 0.4 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.512 -0.743 . . . . 0.0 109.047 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.622 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 10.3 tp -121.47 179.88 4.3 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 119.581 -1.95 . . . . 0.0 107.712 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.548 ' HE ' ' CG ' ' A' ' 81' ' ' ASP . 4.0 ttp85 -87.94 160.39 17.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.649 -1.282 . . . . 0.0 109.118 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.421 ' CB ' HH21 ' A' ' 79' ' ' ARG . . . -58.52 -2.74 0.23 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.895 0.855 . . . . 0.0 109.849 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.548 ' CG ' ' HE ' ' A' ' 79' ' ' ARG . 89.1 m-20 -97.95 31.98 2.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.618 ' ND2' ' CA ' ' A' ' 85' ' ' LYS . 1.5 t30 -80.19 125.13 82.12 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.7 -0.625 . . . . 0.0 110.771 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -78.73 -23.03 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.042 1.828 . . . . 0.0 112.405 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.493 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 88.8 mm-40 -91.9 10.73 27.52 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.917 -1.114 . . . . 0.0 109.365 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.618 ' CA ' ' ND2' ' A' ' 82' ' ' ASN . 47.1 pttt -57.98 -53.68 55.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.585 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 84.8 tt0 -68.7 -52.06 34.98 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.197 -0.94 . . . . 0.0 109.606 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.68 -45.92 84.99 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.71 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 84' ' ' GLN . 7.3 tt -62.3 -43.98 97.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.718 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -59.0 -36.41 74.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.1 -1.0 . . . . 0.0 109.696 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -66.97 -56.27 10.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 109.803 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -51.03 -36.21 38.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.479 -0.763 . . . . 0.0 109.232 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -87.88 -18.97 28.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.544 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.51 -36.09 81.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 109.889 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -61.36 133.41 55.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 110.017 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.74 151.5 38.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.444 -0.785 . . . . 0.0 109.376 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -163.39 -172.88 3.12 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.5 t -163.0 137.69 6.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.688 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -110.46 154.51 23.52 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.395 -0.815 . . . . 0.0 109.663 -178.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.26 -5.75 82.05 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.458 ' OE2' ' OH ' ' A' ' 70' ' ' TYR . 79.9 tt0 -125.11 168.2 13.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.191 -1.181 . . . . 0.0 109.168 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -73.13 142.99 47.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.893 -1.129 . . . . 0.0 110.315 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.84 95.87 7.49 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.298 -0.876 . . . . 0.0 109.317 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.28 131.5 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.467 0.651 . . . . 0.0 109.302 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.672 ' NH2' ' CE2' ' A' ' 142' ' ' PHE . 20.0 mmm180 -129.26 114.23 16.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.654 -0.654 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.631 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 16.1 t80 -109.75 129.9 55.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.506 ' CD2' ' OE2' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -93.05 137.5 32.35 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 110.396 -179.086 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t -111.92 -30.25 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.686 -0.634 . . . . 0.0 109.817 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -168.57 158.27 9.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.067 -1.021 . . . . 0.0 109.426 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.21 162.18 15.56 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.57 -176.62 2.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -1.137 . . . . 0.0 109.317 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.25 -144.36 5.12 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.6 tt -142.37 160.06 41.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -1.168 . . . . 0.0 109.663 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -137.55 87.68 2.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 109.833 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.592 ' SG ' ' NE1' ' A' ' 141' ' ' TRP . 42.2 t -81.01 114.13 19.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.446 -0.784 . . . . 0.0 109.428 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.8 mt -119.41 117.23 27.92 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.148 -0.97 . . . . 0.0 108.819 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.586 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 4.0 t-160 -106.85 113.56 27.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.053 -1.029 . . . . 0.0 109.635 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.79 117.68 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.678 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.74 -143.1 31.98 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 105.85 -2.9 . . . . 0.0 105.85 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -106.71 79.36 1.34 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 115.739 -2.385 . . . . 0.0 108.538 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.586 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 74.9 tt0 -165.61 167.94 16.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.421 ' H ' ' HG2' ' A' ' 120' ' ' GLU . 3.9 t -130.7 149.18 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.139 -0.976 . . . . 0.0 110.066 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.685 ' CD2' ' NZ ' ' A' ' 31' ' ' LYS . 51.1 m-85 -129.32 133.8 47.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.803 -0.561 . . . . 0.0 109.771 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 4' ' ' THR . 83.7 mm-40 -128.39 108.95 10.99 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.74 138.11 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.686 ' N ' ' CD2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -130.98 83.17 2.09 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.452 178.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.538 ' SG ' ' O ' ' A' ' 126' ' ' CYS . 25.9 p -170.19 116.89 0.53 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.506 ' OE2' ' CD2' ' A' ' 106' ' ' PHE . 79.3 mm-40 -114.82 103.44 10.95 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 116.126 -2.229 . . . . 0.0 111.245 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.598 ' C ' ' H ' ' A' ' 130' ' ' ASP . 93.6 mttt -109.34 177.26 4.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.333 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.631 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 22.5 p30 -55.7 -5.96 0.18 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.598 ' H ' ' C ' ' A' ' 128' ' ' LYS . 29.7 p30 -72.22 144.55 48.44 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.918 0.866 . . . . 0.0 109.362 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.551 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -109.24 148.47 30.92 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.885 0.85 . . . . 0.0 109.974 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.465 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 37.3 mm -122.35 121.11 62.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.4 t -111.74 142.4 44.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.67 143.55 26.92 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.0 108.894 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.17 150.19 85.12 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.317 2.011 . . . . 0.0 112.53 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.58 134.7 46.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.38 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.7 t60 92.71 10.17 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.65 125.46 34.71 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.075 -1.016 . . . . 0.0 108.685 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.57 132.05 31.77 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.482 1.455 . . . . 0.0 111.629 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.477 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.71 163.54 9.96 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.235 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.592 ' NE1' ' SG ' ' A' ' 114' ' ' CYS . 0.6 OUTLIER -133.36 -147.33 0.29 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.312 -0.868 . . . . 0.0 109.851 -178.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.672 ' CE2' ' NH2' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -178.71 126.26 0.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.887 -1.133 . . . . 0.0 109.289 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 176' ' ' PRO . 53.0 t0 -146.57 137.48 24.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.264 -0.898 . . . . 0.0 109.626 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.588 ' O ' ' C ' ' A' ' 145' ' ' GLY . 5.5 ptt? -109.81 21.1 17.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.515 -0.741 . . . . 0.0 111.295 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.588 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.12 -90.46 0.01 OUTLIER Glycine 0 N--CA 1.503 3.117 0 CA-C-N 119.336 0.971 . . . . 0.0 112.073 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.511 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 39.7 t -86.88 120.41 28.13 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.035 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -113.42 111.74 49.39 Favored Pre-proline 0 C--N 1.294 -1.805 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.742 178.335 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.584 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.4 Cg_endo -102.07 28.21 0.1 Allowed 'Trans proline' 0 C--O 1.212 -0.822 0 C-N-CA 123.068 2.512 . . . . 0.0 111.432 176.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.622 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER 84.06 71.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.747 0.784 . . . . 0.0 109.632 -177.229 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 25.6 p90 -94.89 159.55 14.99 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.64 -0.662 . . . . 0.0 109.528 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.7 m -130.26 125.52 35.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.223 -0.923 . . . . 0.0 110.012 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.62 164.16 31.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 109.44 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.519 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 29.1 mt -110.61 129.93 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.075 -1.016 . . . . 0.0 109.346 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.419 ' HE ' ' HD3' ' A' ' 104' ' ' ARG . 4.3 ttt180 -138.6 167.42 21.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.422 -0.799 . . . . 0.0 109.69 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.467 ' CG2' ' CG ' ' A' ' 70' ' ' TYR . 4.1 mp -104.36 146.68 11.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.501 -0.75 . . . . 0.0 109.444 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.454 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.3 m-30 -95.35 118.56 32.32 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.008 0.909 . . . . 0.0 109.732 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.61 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 11.8 p30 -135.89 161.92 34.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.891 -0.505 . . . . 0.0 109.829 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 2.3 m-20 -96.03 160.23 30.46 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.059 -1.025 . . . . 0.0 109.484 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 161' ' ' GLY . 43.8 Cg_endo -69.02 -54.26 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.56 2.173 . . . . 0.0 112.042 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 159' ' ' PRO . 77.4 tt0 -43.45 -16.84 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 109.219 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.61 -25.67 29.55 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.61 ' HE1' ' CG ' ' A' ' 157' ' ' ASP . 32.6 m95 -107.27 169.08 8.78 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.387 -1.067 . . . . 0.0 109.964 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 77.3 mt -97.21 150.55 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.24 -0.912 . . . . 0.0 109.282 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -76.77 -71.63 0.39 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.31 -0.869 . . . . 0.0 110.449 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -133.95 158.71 42.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.215 -0.928 . . . . 0.0 109.819 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -101.08 -39.67 7.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.873 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.18 -30.26 5.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.328 -0.857 . . . . 0.0 108.957 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.66 -9.92 55.75 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.91 148.56 31.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.838 -1.389 . . . . 0.0 108.074 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -111.22 87.55 2.57 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 117.614 -1.635 . . . . 0.0 110.94 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.2 tt -77.79 -16.99 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.602 -1.311 . . . . 0.0 109.147 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -56.25 -38.91 71.75 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.574 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 68.0 m -52.82 -4.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.434 -0.791 . . . . 0.0 109.961 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -76.23 -41.37 49.42 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.68 -1.262 . . . . 0.0 111.894 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.629 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.6 m-85 -113.29 25.04 0.08 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 O-C-N 120.457 -1.402 . . . . 0.0 112.416 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 41.0 Cg_endo -60.66 -25.97 81.97 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 123.898 3.065 . . . . 0.0 113.892 -172.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -89.57 125.5 35.24 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 118.719 -1.192 . . . . 0.0 108.408 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.577 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 0.5 OUTLIER -87.34 120.9 29.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.2 -0.937 . . . . 0.0 109.084 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.491 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . 0.449 ' H2 ' ' CD2' ' A' ' 98' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.641 ' O ' ' OG1' ' A' ' 19' ' ' THR . 6.0 p . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.31 170.48 9.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.208 -0.932 . . . . 0.0 108.699 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 tp -156.93 119.23 3.91 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.74 134.01 52.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.164 -0.96 . . . . 0.0 109.761 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.2 mt -127.97 137.51 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -130.65 166.59 20.36 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.406 ' OG ' ' CD2' ' A' ' 15' ' ' LEU . 51.0 m -87.41 173.9 8.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.048 -1.033 . . . . 0.0 108.579 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.86 -29.53 5.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.913 -1.117 . . . . 0.0 109.413 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -73.02 -38.12 66.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.783 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -139.22 123.93 11.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.996 -1.065 . . . . 0.0 109.743 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -84.1 -21.91 3.65 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.754 1.636 . . . . 0.0 112.471 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.48 -1.87 12.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.484 -0.76 . . . . 0.0 111.579 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.544 ' OD1' ' O ' ' A' ' 13' ' ' ASN . 47.4 p-10 -124.89 122.79 38.37 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.16 -0.962 . . . . 0.0 108.886 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.2 p -93.22 129.76 39.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.874 -1.141 . . . . 0.0 108.53 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.406 ' CD2' ' OG ' ' A' ' 7' ' ' SER . 11.0 mp -90.38 -7.28 53.62 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.166 -1.013 . . . . 0.0 109.068 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.703 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 39.0 t90 -157.58 105.63 2.05 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.253 -1.379 . . . . 0.0 110.055 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -119.0 111.13 17.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.378 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.425 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -161.37 162.71 30.83 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.369 -0.832 . . . . 0.0 109.872 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.641 ' OG1' ' O ' ' A' ' 1' ' ' SER . 10.2 t -131.72 89.18 2.66 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.005 -1.059 . . . . 0.0 108.153 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.574 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.6 OUTLIER -125.52 151.45 46.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.014 -1.054 . . . . 0.0 110.06 177.423 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.26 -41.32 20.36 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.21 -1.557 . . . . 0.0 108.827 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -82.81 -47.35 12.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 110.737 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -64.52 -23.44 67.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.757 -1.215 . . . . 0.0 108.984 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.574 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 7.2 mt -70.73 -51.36 37.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.228 -0.92 . . . . 0.0 108.537 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.429 ' NE2' ' CB ' ' A' ' 29' ' ' ASN . 13.2 tm0? -57.08 -50.1 73.83 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.525 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.416 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 44.6 tt0 -58.42 -35.03 71.46 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.525 -0.735 . . . . 0.0 110.229 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.703 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -64.3 -63.48 1.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.933 -1.105 . . . . 0.0 109.587 -179.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -55.09 14.15 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.114 -0.991 . . . . 0.0 109.76 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 19.8 t-20 -52.46 -27.63 16.91 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.972 -1.08 . . . . 0.0 109.73 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' GLN . . . -64.5 -27.05 68.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.677 -1.264 . . . . 0.0 108.263 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -90.71 11.29 22.7 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.26 -0.9 . . . . 0.0 110.54 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.26 25.69 15.87 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.088 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.615 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 43.3 t -96.8 145.75 8.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.348 -1.089 . . . . 0.0 109.929 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -84.17 157.04 21.8 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -153.1 149.82 28.48 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 37' ' ' ARG . 36.2 tp10 -174.89 166.41 3.61 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.95 -1.094 . . . . 0.0 108.619 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.4 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 11.7 ptt180 -153.77 131.06 11.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -117.38 151.58 36.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.583 -0.698 . . . . 0.0 109.945 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -135.96 158.75 43.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.372 -0.83 . . . . 0.0 109.439 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.38 160.46 14.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.917 . . . . 0.0 109.179 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -98.64 -17.64 18.5 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.222 -0.924 . . . . 0.0 108.544 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -93.61 164.83 13.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.687 0.756 . . . . 0.0 109.161 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.17 119.39 32.93 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.645 -0.659 . . . . 0.0 109.599 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.98 166.05 12.9 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.4 -121.87 0.59 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.46 79.4 8.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.069 -1.254 . . . . 0.0 108.98 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.92 94.93 26.76 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.448 -0.783 . . . . 0.0 109.205 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.467 ' O ' ' CG2' ' A' ' 49' ' ' THR . 50.6 Cg_endo -70.86 79.46 1.29 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.002 1.801 . . . . 0.0 111.854 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.467 ' CG2' ' O ' ' A' ' 48' ' ' PRO . 3.8 p -163.55 119.56 1.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.129 -0.982 . . . . 0.0 109.273 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.95 -43.54 17.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.858 -1.151 . . . . 0.0 110.044 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -66.61 -17.89 65.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.488 -0.757 . . . . 0.0 110.148 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 m -77.11 -40.77 44.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 110.228 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.9 t -66.87 -48.11 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.117 -0.989 . . . . 0.0 109.953 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 58' ' ' GLN . 8.5 mm -61.31 -41.94 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 108.619 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.81 -29.87 70.44 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.435 -0.79 . . . . 0.0 109.691 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.16 -17.85 59.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.98 . . . . 0.0 110.12 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 58' ' ' GLN . 57.4 m-85 -114.34 -7.47 12.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 109.121 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' A' ' 62' ' ' ASP . 5.1 mm-40 -46.52 -39.84 11.54 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.759 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.32 -46.6 62.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.54 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -63.67 -59.63 4.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.804 -1.185 . . . . 0.0 110.341 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.48 ' CD1' ' C ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -62.32 -31.85 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.996 -1.065 . . . . 0.0 109.352 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.7 t70 -59.04 -25.05 63.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.594 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.54 -39.08 47.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.949 . . . . 0.0 109.411 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.19 -38.07 89.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.365 -0.834 . . . . 0.0 108.936 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 69' ' ' GLY . 2.8 t -71.02 -29.68 38.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.368 -0.832 . . . . 0.0 109.458 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.38 -52.36 63.8 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.514 -1.366 . . . . 0.0 109.597 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.05 -49.8 9.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.955 -1.091 . . . . 0.0 110.366 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.602 ' O ' ' C ' ' A' ' 69' ' ' GLY . 20.2 mmtt -83.99 13.0 5.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -0.868 . . . . 0.0 111.37 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.602 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -3.01 80.83 0.0 OUTLIER Glycine 0 N--CA 1.506 3.336 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.433 ' N ' ' O ' ' A' ' 68' ' ' LYS . 69.1 m-85 -77.35 158.94 29.86 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.658 -0.907 . . . . 0.0 108.791 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -57.65 -88.53 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.479 -0.763 . . . . 0.0 109.3 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -103.44 159.58 15.46 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.719 0.771 . . . . 0.0 110.161 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.41 ' CD1' ' N ' ' A' ' 74' ' ' ASP . 7.9 t-105 -139.51 144.7 38.03 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -163.05 -178.6 6.15 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.13 143.87 32.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.521 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 19.8 tt -101.72 115.45 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.502 ' HG ' ' C ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -167.94 101.06 0.46 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.816 -0.753 . . . . 0.0 109.194 177.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.521 ' HG ' ' H ' ' A' ' 79' ' ' ARG . 11.5 tp -106.59 178.34 4.59 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 121.08 1.764 . . . . 0.0 107.939 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.564 ' C ' ' H ' ' A' ' 81' ' ' ASP . 0.7 OUTLIER -89.88 143.84 26.45 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.693 -1.254 . . . . 0.0 109.664 -178.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.03 0.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.594 -0.691 . . . . 0.0 109.588 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.564 ' H ' ' C ' ' A' ' 79' ' ' ARG . 58.5 t0 -83.57 -27.54 29.2 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.471 -1.292 . . . . 0.0 109.444 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.681 HD22 ' CB ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -67.41 122.42 83.03 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.054 -1.029 . . . . 0.0 109.507 179.481 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -85.83 -3.78 8.99 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.021 1.814 . . . . 0.0 112.234 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -88.39 -3.44 58.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.944 -1.097 . . . . 0.0 110.513 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.681 ' CB ' HD22 ' A' ' 82' ' ' ASN . 2.3 mmtt -62.8 -40.57 97.75 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.036 -1.04 . . . . 0.0 109.283 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -54.49 44.1 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.322 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.04 -35.0 75.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.06 -1.025 . . . . 0.0 109.644 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.37 -43.51 98.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.73 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.6 ptt-85 -63.76 -25.78 68.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 109.934 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.72 -59.66 3.69 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.408 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -54.25 -29.39 46.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.962 . . . . 0.0 109.27 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.39 -18.37 36.3 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.306 -0.871 . . . . 0.0 109.661 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.466 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -58.44 -25.88 62.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 109.936 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -55.25 142.37 31.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.108 -0.995 . . . . 0.0 110.211 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.511 ' OE2' ' O ' ' A' ' 169' ' ' ASP . 19.8 pt-20 -72.59 164.24 26.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.395 -0.816 . . . . 0.0 109.663 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -174.24 -170.92 0.56 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.492 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.2 t -160.48 132.28 5.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.65 0.738 . . . . 0.0 109.36 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.665 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -103.4 154.64 19.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.712 -0.617 . . . . 0.0 110.01 -179.037 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.439 ' H ' ' HB3' ' A' ' 162' ' ' TRP . . . -78.83 -6.05 88.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -124.77 170.11 11.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -1.027 . . . . 0.0 109.382 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -74.68 143.54 44.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.956 -1.09 . . . . 0.0 110.103 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' A' ' 98' ' ' HIS . 2.0 mt-10 -101.1 93.64 5.58 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.114 -0.992 . . . . 0.0 108.901 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.1 m -89.11 130.65 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.767 -0.583 . . . . 0.0 109.495 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.693 ' NH1' ' CD1' ' A' ' 142' ' ' PHE . 21.4 mtp180 -129.59 116.94 19.63 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.561 -0.712 . . . . 0.0 109.437 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.457 ' CE2' ' O ' ' A' ' 106' ' ' PHE . 25.4 t80 -101.08 134.08 44.62 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.457 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.88 129.26 35.63 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.422 -0.799 . . . . 0.0 110.388 -178.492 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.9 t -107.96 -33.54 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.577 -0.702 . . . . 0.0 109.711 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -167.97 157.81 10.07 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.094 -1.004 . . . . 0.0 108.88 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.19 161.4 9.14 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.12 -177.51 3.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -1.061 . . . . 0.0 109.107 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.88 -142.51 4.09 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 113' ' ' PHE . 5.8 tp -142.62 159.7 41.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.23 -1.159 . . . . 0.0 109.026 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.41 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 55.7 m-85 -136.83 88.09 2.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.06 -1.025 . . . . 0.0 109.258 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.75 108.87 14.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.473 -0.767 . . . . 0.0 110.026 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 mp -116.43 121.18 41.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -0.924 . . . . 0.0 108.82 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 4.7 t-160 -107.29 113.37 26.72 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.097 -1.002 . . . . 0.0 109.277 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.5 mt -128.34 118.72 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.852 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.17 -142.49 33.05 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 105.429 -3.068 . . . . 0.0 105.429 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -107.8 80.64 1.41 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 121.517 2.658 . . . . 0.0 108.182 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 77.5 tt0 -165.11 166.81 18.82 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.0 t -126.61 142.12 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.244 -0.91 . . . . 0.0 110.037 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -124.19 130.85 53.24 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.038 0.447 . . . . 0.0 109.922 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -132.32 118.08 18.97 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 109.35 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.43 137.89 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.456 ' N ' ' CD2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -135.91 91.07 2.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.061 -1.025 . . . . 0.0 110.634 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 126' ' ' CYS . 20.3 p -166.95 137.47 3.11 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.505 -1.372 . . . . 0.0 108.603 178.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.509 ' CD ' ' O ' ' A' ' 127' ' ' GLU . 2.8 tm-20 -106.99 92.92 4.28 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 115.367 -2.533 . . . . 0.0 110.012 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.664 ' C ' ' H ' ' A' ' 130' ' ' ASP . 39.7 tttp -118.26 157.71 26.53 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.439 175.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -56.12 0.83 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.106 -1.621 . . . . 0.0 108.406 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.664 ' H ' ' C ' ' A' ' 128' ' ' LYS . 49.5 p-10 -66.84 131.36 45.75 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.157 0.979 . . . . 0.0 109.566 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -100.97 132.86 46.18 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.862 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 8.2 tt -125.43 129.96 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.582 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.3 m -125.77 151.59 46.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.48 149.59 39.01 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.41 151.52 75.91 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.569 2.179 . . . . 0.0 112.904 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.609 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -73.31 133.47 43.88 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.182 -0.949 . . . . 0.0 109.186 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.609 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.1 t-80 94.89 9.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.166 0.508 . . . . 0.0 109.705 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.09 126.96 30.26 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 108.579 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.84 132.1 31.37 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.57 1.513 . . . . 0.0 111.548 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -168.95 164.06 11.51 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.999 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.435 ' HB2' ' H ' ' A' ' 142' ' ' PHE . 0.7 OUTLIER -134.46 -148.8 0.33 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 109.348 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.693 ' CD1' ' NH1' ' A' ' 104' ' ' ARG . 83.5 t80 -176.03 126.38 0.21 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.052 -1.03 . . . . 0.0 109.048 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 143' ' ' ASP . 31.9 p-10 -144.69 132.86 21.62 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.368 -0.833 . . . . 0.0 109.361 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.612 ' O ' ' C ' ' A' ' 145' ' ' GLY . 11.3 ptp -110.9 21.36 16.56 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.657 -0.652 . . . . 0.0 111.093 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.612 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 7.52 -86.21 0.0 OUTLIER Glycine 0 N--CA 1.499 2.893 0 CA-C-N 119.061 0.846 . . . . 0.0 111.94 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.47 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 51.2 m -88.07 116.74 26.47 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 117.688 -1.605 . . . . 0.0 108.75 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.28 115.11 36.28 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.517 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 59.1 Cg_endo -105.04 36.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.437 2.091 . . . . 0.0 111.395 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.62 ' CG ' ' O ' ' A' ' 149' ' ' ASN . 0.0 OUTLIER 81.85 69.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 123.246 1.498 . . . . 0.0 108.682 -177.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.435 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 26.7 p90 -95.75 161.68 13.92 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.489 -1.382 . . . . 0.0 109.766 -177.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.7 m -130.54 125.87 35.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.953 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.26 164.55 30.42 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.8 mt -109.73 128.77 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.954 -1.091 . . . . 0.0 109.342 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -134.51 163.18 30.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 36.2 mt -102.64 144.14 14.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.467 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.3 m-85 -96.46 118.55 33.22 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.415 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.579 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -135.73 161.56 35.21 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.04 158.61 33.84 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 120.699 -1.251 . . . . 0.0 109.483 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.584 ' O ' ' N ' ' A' ' 161' ' ' GLY . 46.4 Cg_endo -71.31 -53.86 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.326 2.017 . . . . 0.0 112.737 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 159' ' ' PRO . 83.7 tt0 -43.3 -16.7 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -69.38 -38.76 80.98 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.439 ' HB3' ' H ' ' A' ' 99' ' ' GLY . 4.3 p90 -119.14 175.74 5.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.695 -0.885 . . . . 0.0 111.03 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.404 HD11 HG21 ' A' ' 163' ' ' ILE . 76.2 mt -96.26 147.6 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.597 0.713 . . . . 0.0 109.315 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.92 -73.61 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.425 -0.797 . . . . 0.0 110.525 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -126.76 156.6 40.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.149 -0.969 . . . . 0.0 109.872 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.1 -40.6 7.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 0.0 109.754 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 86.1 m -101.54 -32.23 10.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.043 . . . . 0.0 108.976 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.24 -6.93 58.2 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.518 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 44.4 p30 -80.92 148.35 29.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.568 -1.548 . . . . 0.0 108.545 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -112.17 88.68 2.87 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 117.737 -1.585 . . . . 0.0 110.368 175.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.27 -16.83 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.008 -1.682 . . . . 0.0 109.24 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -55.98 -37.96 69.78 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.521 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 7.3 m -56.09 -3.97 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.824 -0.547 . . . . 0.0 110.161 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.504 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.78 -37.87 29.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.022 -1.049 . . . . 0.0 111.755 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.627 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.5 m-85 -112.83 23.09 0.08 OUTLIER Pre-proline 0 N--CA 1.513 2.717 0 O-C-N 120.558 -1.339 . . . . 0.0 113.037 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 46.1 Cg_endo -63.31 -19.56 68.58 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 123.443 2.762 . . . . 0.0 114.262 -173.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -88.93 126.47 35.41 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.765 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.47 ' HB3' ' H ' ' A' ' 146' ' ' SER . 5.7 tt -87.8 122.25 31.22 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.926 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.691 0 O-C-N 121.138 -0.976 . . . . 0.0 109.367 -179.855 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . 0.505 ' H1 ' ' CD2' ' A' ' 98' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.462 ' O ' ' CG2' ' A' ' 19' ' ' THR . 5.1 p . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.11 169.03 9.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.004 -1.06 . . . . 0.0 109.08 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.8 tp -157.79 117.3 3.29 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.44 135.97 53.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.432 -0.792 . . . . 0.0 109.973 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.7 mt -130.44 133.6 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -127.4 168.26 15.09 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.39 174.81 7.6 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.216 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.73 -23.77 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.066 . . . . 0.0 109.575 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -75.1 -37.93 61.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.051 -1.031 . . . . 0.0 110.413 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -136.93 126.49 15.58 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.655 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 13' ' ' ASN . 56.2 Cg_endo -79.87 -39.16 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.002 1.801 . . . . 0.0 112.156 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 9.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.729 . . . . 0.0 110.041 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -114.69 119.1 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.176 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.9 p -102.29 122.9 45.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.249 -0.907 . . . . 0.0 109.493 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.445 ' CD1' ' OD1' ' A' ' 13' ' ' ASN . 3.6 mp -90.2 -3.86 57.59 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.671 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.734 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 35.4 t90 -156.04 104.25 2.26 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.667 -1.213 . . . . 0.0 110.256 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -118.8 110.36 17.14 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.736 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.464 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -162.58 163.62 27.16 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.079 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.462 ' CG2' ' O ' ' A' ' 1' ' ' SER . 54.6 m -130.93 89.46 2.75 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.15 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.55 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 0.7 OUTLIER -128.16 148.46 50.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.429 -0.794 . . . . 0.0 110.401 177.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.38 -38.27 22.2 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.311 -1.493 . . . . 0.0 108.107 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -83.69 -48.8 9.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.472 -0.767 . . . . 0.0 109.855 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 27' ' ' GLN . 43.9 tt0 -60.99 -24.02 65.81 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.831 -1.168 . . . . 0.0 108.604 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.55 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 10.4 mt -73.04 -62.75 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.174 -0.953 . . . . 0.0 109.497 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.514 ' CD ' ' N ' ' A' ' 26' ' ' GLN . 3.8 pp0? -61.41 -43.34 99.04 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.879 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 25' ' ' GLN . 11.0 tm0? -61.49 -43.99 97.88 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.129 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.734 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -77.67 -47.23 19.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.977 . . . . 0.0 109.229 179.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 24' ' ' ILE . 23.9 tp -66.45 -54.41 24.47 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.999 -1.063 . . . . 0.0 109.149 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 25' ' ' GLN . 40.7 t-20 -57.9 -20.08 34.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.0 109.411 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.25 -27.63 68.78 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.06 -1.025 . . . . 0.0 108.796 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.78 13.39 10.73 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.217 -0.927 . . . . 0.0 109.867 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.13 22.95 30.97 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.179 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.479 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 56.3 t -94.13 145.43 7.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.424 -1.044 . . . . 0.0 109.344 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.442 ' NE ' ' OG ' ' A' ' 133' ' ' SER . 2.4 ttm-85 -84.0 158.4 21.51 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.24 -0.912 . . . . 0.0 108.724 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.541 ' CE1' ' OD2' ' A' ' 130' ' ' ASP . 1.2 t80 -153.38 145.67 23.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.943 -1.098 . . . . 0.0 108.682 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.554 ' O ' ' OD1' ' A' ' 130' ' ' ASP . 43.8 mt-10 -165.81 168.64 15.78 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.188 -0.945 . . . . 0.0 109.961 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -148.53 113.91 5.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.587 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 22.1 m0 -109.98 153.81 24.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.273 -0.892 . . . . 0.0 109.308 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -142.79 159.09 42.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.902 . . . . 0.0 109.685 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.19 159.05 15.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.263 -0.898 . . . . 0.0 109.08 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -101.98 -13.64 17.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.152 -0.967 . . . . 0.0 108.535 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -93.05 161.55 14.39 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.234 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -95.08 118.94 32.74 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.734 -0.604 . . . . 0.0 109.666 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.0 mt -90.26 163.11 14.9 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.732 0.777 . . . . 0.0 109.292 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.08 -99.8 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.36 91.95 5.13 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.044 -1.269 . . . . 0.0 109.187 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.16 91.88 37.99 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.416 -0.802 . . . . 0.0 109.008 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -76.21 -26.41 9.07 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.316 2.011 . . . . 0.0 112.588 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.7 p -122.61 141.74 51.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.645 -0.66 . . . . 0.0 109.504 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.69 -16.5 53.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.426 -0.796 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -47.63 -38.96 15.77 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.796 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.1 m -79.43 -35.31 40.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.573 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.92 -48.78 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.887 . . . . 0.0 109.802 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 58' ' ' GLN . 17.7 mt -59.91 -36.77 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 108.796 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.51 -30.44 70.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.815 . . . . 0.0 109.527 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.59 -17.4 60.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.139 -0.975 . . . . 0.0 110.158 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -114.41 -8.59 12.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.393 -0.817 . . . . 0.0 109.507 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.708 HE21 ' CG1' ' A' ' 61' ' ' ILE . 26.9 tp60 -48.95 -38.57 23.35 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 108.86 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.624 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 20.2 p80 -50.62 -46.81 58.32 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.54 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.624 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.39 -60.51 3.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.065 -1.022 . . . . 0.0 109.977 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.708 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.7 OUTLIER -61.71 -30.16 47.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.85 -1.156 . . . . 0.0 109.024 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 58' ' ' GLN . 40.3 t0 -57.44 -26.43 61.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 0.0 109.645 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.75 -40.53 61.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.078 -1.013 . . . . 0.0 109.261 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.66 -34.65 78.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.064 -1.023 . . . . 0.0 109.653 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.0 t -71.47 -33.95 51.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.245 -0.909 . . . . 0.0 109.442 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.37 -51.76 57.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.534 -1.354 . . . . 0.0 109.489 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -83.23 -50.07 8.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.013 -1.054 . . . . 0.0 110.472 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.605 ' O ' ' C ' ' A' ' 69' ' ' GLY . 15.7 mttm -86.65 15.79 5.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.608 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -12.01 85.52 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.497 ' N ' ' O ' ' A' ' 68' ' ' LYS . 53.9 m-85 -78.5 165.57 23.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.532 ' CD ' ' H ' ' A' ' 71' ' ' GLN . 25.4 mp0 -63.98 -83.99 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.372 -0.83 . . . . 0.0 109.401 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.23 157.3 17.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.597 -0.689 . . . . 0.0 109.566 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.401 ' HE1' HG23 ' A' ' 153' ' ' ILE . 6.7 t-105 -136.15 139.36 42.83 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -167.38 -174.42 2.55 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.341 -0.849 . . . . 0.0 108.734 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.409 ' CB ' ' O ' ' A' ' 152' ' ' ALA . 3.2 m -118.92 146.76 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.0 109.45 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.24 116.53 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.542 ' OG ' ' O ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -174.42 108.84 0.13 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.828 -1.17 . . . . 0.0 109.563 177.464 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.432 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -100.39 -178.83 3.93 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 121.403 1.91 . . . . 0.0 109.331 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.495 ' C ' ' H ' ' A' ' 81' ' ' ASP . 7.8 tpt180 -88.88 143.81 26.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.856 -1.152 . . . . 0.0 109.207 -178.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.46 0.83 0.63 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.56 -0.712 . . . . 0.0 109.788 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 79' ' ' ARG . 57.5 t0 -94.08 -27.16 16.42 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.348 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -64.29 127.95 92.68 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.924 -1.11 . . . . 0.0 109.996 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.75 -1.79 11.96 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.323 2.015 . . . . 0.0 112.003 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -84.41 15.04 3.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.902 -1.124 . . . . 0.0 109.547 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.642 ' HZ1' ' CB ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -57.55 -58.54 7.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.305 -0.872 . . . . 0.0 108.809 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.01 -33.91 77.16 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.304 -0.873 . . . . 0.0 109.164 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.88 -58.2 8.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.0 110.023 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.0 tp -61.0 -43.98 98.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.639 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.445 ' NE ' ' N ' ' A' ' 145' ' ' GLY . 23.2 mtp-105 -60.71 -31.34 70.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.646 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -66.99 -58.28 5.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.454 -0.779 . . . . 0.0 110.322 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -53.98 -35.04 61.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 109.268 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -87.57 -18.21 30.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.274 -0.891 . . . . 0.0 109.629 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 89' ' ' ARG . 39.0 tp -56.9 -37.06 70.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.155 -0.966 . . . . 0.0 109.912 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -54.15 134.1 44.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.143 -0.973 . . . . 0.0 109.441 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.553 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 0.9 OUTLIER -64.77 164.7 11.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.418 -0.801 . . . . 0.0 109.537 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.553 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 42.8 p-80 -170.38 -171.44 1.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.066 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.7 p -159.04 131.97 7.02 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.626 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -100.39 155.84 17.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' A' ' 162' ' ' TRP . . . -79.53 -7.22 88.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.56 171.83 10.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.33 -1.1 . . . . 0.0 109.515 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -72.2 142.97 49.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.345 -0.847 . . . . 0.0 110.141 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.606 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 2.6 tt0 -101.7 93.33 5.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.5 m -92.38 127.88 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.41 0.624 . . . . 0.0 109.786 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -127.41 126.64 42.79 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.632 -0.667 . . . . 0.0 109.318 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.629 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 18.7 t80 -108.51 133.23 52.93 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.785 0.802 . . . . 0.0 109.153 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.49 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.05 127.59 35.4 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.476 0.655 . . . . 0.0 110.022 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.8 t -108.83 -35.17 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.644 -0.66 . . . . 0.0 109.624 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -160.31 146.6 15.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 0.0 109.339 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.3 165.92 35.41 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.41 154.02 39.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.501 -0.999 . . . . 0.0 109.591 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.59 -132.08 2.65 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.1 tp -147.08 161.93 39.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.333 -1.098 . . . . 0.0 109.32 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -134.58 88.9 2.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.88 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.54 110.16 15.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.536 -0.727 . . . . 0.0 109.642 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.4 mp -117.31 114.77 24.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.195 -0.94 . . . . 0.0 109.38 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.6 t-160 -105.05 112.86 26.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.067 -1.021 . . . . 0.0 109.483 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.4 pt -129.57 115.51 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.238 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.99 -143.34 30.83 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 106.424 -2.671 . . . . 0.0 106.424 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -104.04 78.69 1.55 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 115.116 -2.634 . . . . 0.0 108.895 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.564 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 15.3 pt-20 -166.85 168.58 13.98 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.6 t -128.84 151.46 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.257 -0.902 . . . . 0.0 109.949 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -129.12 131.99 47.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.612 . . . . 0.0 109.823 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -131.87 111.07 11.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 0.0 109.277 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.7 t -102.55 139.41 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.624 ' CD1' ' N ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.0 91.18 2.72 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.078 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 31.6 p -165.47 138.34 4.36 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.176 -1.577 . . . . 0.0 107.783 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -106.37 93.39 4.58 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 115.836 -2.345 . . . . 0.0 110.387 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.571 ' C ' ' H ' ' A' ' 130' ' ' ASP . 46.3 mtpt -114.7 154.57 28.22 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.917 176.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.629 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 89.7 m-20 -58.99 -3.03 0.29 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.479 -1.388 . . . . 0.0 107.778 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' A' ' 131' ' ' LEU . 7.3 t0 -70.58 148.57 48.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.066 -1.021 . . . . 0.0 109.314 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.633 ' N ' ' OD1' ' A' ' 130' ' ' ASP . 0.3 OUTLIER -111.08 149.83 30.24 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.512 0.672 . . . . 0.0 110.545 -179.681 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.426 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 29.5 mm -115.31 138.59 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.442 ' OG ' ' NE ' ' A' ' 34' ' ' ARG . 5.0 m -121.25 145.64 47.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.486 -0.759 . . . . 0.0 110.193 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.5 t -116.12 135.47 22.8 Favored Pre-proline 0 N--CA 1.485 1.308 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.55 147.96 94.04 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.147 1.898 . . . . 0.0 113.126 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.617 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -72.31 134.61 45.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.136 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.617 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 8.8 t-80 92.28 11.13 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.1 126.51 30.85 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.015 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.21 130.3 28.33 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.959 1.773 . . . . 0.0 111.648 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.551 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.37 165.86 14.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.197 -0.94 . . . . 0.0 110.196 -179.189 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.471 ' CG ' ' CB ' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -137.03 -149.58 0.32 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -178.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.4 ' CZ ' ' HG2' ' A' ' 144' ' ' MET . 11.5 t80 -175.61 125.27 0.23 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.934 -1.104 . . . . 0.0 109.018 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -143.81 135.17 25.89 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.373 -0.829 . . . . 0.0 109.942 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.642 ' O ' ' C ' ' A' ' 145' ' ' GLY . 52.1 mmm -113.38 21.29 15.34 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.886 -0.509 . . . . 0.0 110.852 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.642 ' C ' ' O ' ' A' ' 144' ' ' MET . . . -1.32 -74.21 0.0 OUTLIER Glycine 0 N--CA 1.503 3.151 0 CA-C-N 119.279 0.945 . . . . 0.0 111.407 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 144' ' ' MET . 22.9 t -91.4 115.49 28.08 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 117.671 -1.612 . . . . 0.0 109.171 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -119.23 116.81 33.64 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.41 -0.806 . . . . 0.0 110.164 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.2 Cg_endo -100.18 33.37 0.09 OUTLIER 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 122.56 2.173 . . . . 0.0 111.628 176.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 79.8 68.39 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.521 -0.872 . . . . 0.0 108.721 -178.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.542 ' O ' ' OG ' ' A' ' 77' ' ' SER . 14.2 p90 -96.41 -179.5 4.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.307 -0.871 . . . . 0.0 109.37 -177.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 87.1 m -149.15 100.35 3.04 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.629 -0.669 . . . . 0.0 109.574 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 75' ' ' VAL . . . -110.69 163.77 13.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.918 -1.114 . . . . 0.0 109.19 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.401 HG23 ' HE1' ' A' ' 73' ' ' TRP . 94.7 mt -107.25 127.29 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.13 -0.981 . . . . 0.0 110.222 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.87 162.49 32.25 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.419 0.628 . . . . 0.0 109.427 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.453 ' CG2' ' CG ' ' A' ' 70' ' ' TYR . 4.0 mp -106.78 149.46 10.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.522 -0.736 . . . . 0.0 109.369 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -96.87 118.95 34.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.583 ' OD2' ' N ' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -135.72 162.19 33.44 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.695 -0.628 . . . . 0.0 109.569 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -95.87 157.42 35.92 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.97 -1.081 . . . . 0.0 109.33 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 161' ' ' GLY . 47.4 Cg_endo -71.77 -52.58 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.614 2.209 . . . . 0.0 112.395 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 159' ' ' PRO . 95.1 mt-10 -43.83 -16.53 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.475 -0.765 . . . . 0.0 109.381 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -70.26 -39.88 70.91 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.461 ' HB3' ' H ' ' A' ' 99' ' ' GLY . 2.7 p90 -119.05 177.26 4.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.761 -0.847 . . . . 0.0 110.617 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.9 mm -95.37 152.05 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.417 -0.802 . . . . 0.0 109.219 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.34 -74.0 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 110.575 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -131.11 157.01 44.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -101.1 -41.54 6.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.707 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 60.0 p -105.86 -32.35 8.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.931 . . . . 0.0 109.235 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.29 -4.15 60.21 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.545 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -80.46 145.81 31.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.773 -1.428 . . . . 0.0 108.957 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -110.32 89.22 2.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.776 -1.569 . . . . 0.0 111.402 176.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.5 tt -78.63 -17.92 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.525 -1.359 . . . . 0.0 109.167 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.524 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -57.59 -42.7 83.7 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.596 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 45.8 m -54.17 -4.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.391 -0.818 . . . . 0.0 109.985 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.04 -40.5 31.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.958 -1.089 . . . . 0.0 111.549 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.618 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 9.3 m-85 -112.23 25.59 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.619 0 O-C-N 120.707 -1.246 . . . . 0.0 112.495 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 43.6 Cg_endo -62.42 -21.03 72.19 Favored 'Trans proline' 0 N--CA 1.503 2.088 0 C-N-CA 123.588 2.859 . . . . 0.0 113.168 -172.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -89.45 127.07 35.8 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.157 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' C ' ' A' ' 179' ' ' ALA . 0.7 OUTLIER -85.91 145.68 27.05 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.403 ' CA ' ' SG ' ' A' ' 126' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.538 ' N ' ' SG ' ' A' ' 126' ' ' CYS . . . -99.2 172.04 7.62 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.147 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.485 ' CD2' ' CZ3' ' A' ' 16' ' ' TRP . 25.2 tp -157.05 114.26 3.09 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.26 130.69 55.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 110.72 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.9 mt -124.76 134.0 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.2 168.93 14.75 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t -92.18 175.75 6.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.058 -1.026 . . . . 0.0 108.306 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.95 -26.7 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.728 -1.232 . . . . 0.0 109.396 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -72.35 -38.54 68.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.175 -0.953 . . . . 0.0 110.57 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.489 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 9.1 m-20 -139.41 123.38 11.02 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 109.766 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.3 -27.84 1.33 Allowed 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.021 1.814 . . . . 0.0 112.52 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -69.79 -0.49 7.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.455 -0.778 . . . . 0.0 111.178 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 6.7 p-10 -123.08 126.13 46.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.079 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 p -97.84 128.49 44.49 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 108.748 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pp -90.13 -9.93 46.47 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.801 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.702 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 31.1 t90 -158.01 108.79 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.052 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -122.37 124.58 44.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.334 -0.854 . . . . 0.0 110.241 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.61 168.62 21.47 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.053 -1.029 . . . . 0.0 110.594 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.526 ' O ' ' CG2' ' A' ' 19' ' ' THR . 1.0 OUTLIER -127.99 88.35 2.75 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 176.377 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.515 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 19.5 m120 -127.37 139.37 52.91 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.538 -0.726 . . . . 0.0 109.984 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.4 -36.13 24.52 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 119.676 -1.89 . . . . 0.0 108.675 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.35 -49.39 10.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.719 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.09 -22.94 67.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.875 -1.141 . . . . 0.0 108.128 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.515 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 1.7 mt -66.8 -50.32 66.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 29' ' ' ASN . 53.3 tt0 -56.2 -55.12 37.11 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.432 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.428 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 62.1 tt0 -56.66 -34.28 67.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 0.0 110.45 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.702 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -62.36 -65.13 0.73 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.912 -1.117 . . . . 0.0 109.656 -179.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.27 -46.97 63.29 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.662 -1.274 . . . . 0.0 109.677 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.626 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 20.4 t-20 -57.0 -25.71 59.0 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.045 -1.035 . . . . 0.0 109.427 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 26' ' ' GLN . . . -65.78 -28.08 68.76 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.76 -1.213 . . . . 0.0 107.762 177.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -87.58 14.6 8.03 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.975 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.91 23.38 35.63 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.434 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.626 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 56.7 t -94.53 144.73 9.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.226 -1.161 . . . . 0.0 109.89 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.7 ttt-85 -84.62 157.73 21.08 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.501 ' CZ ' ' OD2' ' A' ' 130' ' ' ASP . 1.3 t80 -155.22 153.68 31.04 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.3 pt-20 -175.81 176.45 1.84 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.042 -1.036 . . . . 0.0 110.102 177.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -154.31 121.8 5.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.394 -0.816 . . . . 0.0 109.065 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.611 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 33.2 m0 -111.28 154.98 23.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.405 -0.81 . . . . 0.0 109.033 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -142.23 155.13 45.24 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.284 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.31 159.68 14.77 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -98.38 -19.69 17.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.077 -1.014 . . . . 0.0 108.36 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -93.42 167.12 11.92 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -93.83 131.38 39.28 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.485 -0.759 . . . . 0.0 109.458 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -93.64 161.97 14.13 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.303 -0.873 . . . . 0.0 109.499 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.36 -96.3 0.11 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.78 107.09 8.84 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.344 -1.092 . . . . 0.0 108.15 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.97 90.02 46.56 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.638 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.57 46.3 1.71 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.819 2.346 . . . . 0.0 111.22 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.53 ' O ' ' OG1' ' A' ' 52' ' ' THR . 0.0 OUTLIER -169.27 139.9 2.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.556 -1.34 . . . . 0.0 108.978 178.061 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.09 -43.89 15.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.521 -1.362 . . . . 0.0 109.353 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -66.67 -4.32 8.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.59 -0.694 . . . . 0.0 110.335 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.53 ' OG1' ' O ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -77.77 -52.88 8.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.762 -1.211 . . . . 0.0 109.941 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.99 -44.67 84.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.112 -0.993 . . . . 0.0 110.253 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 58' ' ' GLN . 13.9 mm -60.3 -41.84 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.959 -1.088 . . . . 0.0 108.517 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.12 -22.87 66.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.445 -0.784 . . . . 0.0 109.89 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.1 -21.63 50.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.999 -1.063 . . . . 0.0 110.265 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 58' ' ' GLN . 59.2 m-85 -115.5 -10.16 11.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.493 -0.754 . . . . 0.0 109.206 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.672 HE21 ' CG1' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -46.89 -34.06 5.11 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.395 -0.922 . . . . 0.0 108.942 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.641 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 26.5 p80 -51.74 -50.48 60.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.891 -1.13 . . . . 0.0 109.573 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.641 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.2 -60.96 2.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.914 -1.116 . . . . 0.0 109.72 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.672 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.5 OUTLIER -61.49 -27.58 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.393 -1.442 . . . . 0.0 109.55 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 58' ' ' GLN . 79.8 m-20 -59.24 -22.33 60.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.066 -1.021 . . . . 0.0 109.807 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 pttp -83.0 -32.9 26.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.949 -1.094 . . . . 0.0 108.633 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mp -65.53 -46.85 78.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.334 -0.854 . . . . 0.0 109.662 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.01 -27.74 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.549 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.32 -49.51 74.12 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.74 -1.225 . . . . 0.0 109.713 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.55 -51.74 7.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.028 -1.045 . . . . 0.0 110.54 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.629 ' O ' ' C ' ' A' ' 69' ' ' GLY . 2.1 mptp? -82.73 13.13 4.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.349 -0.844 . . . . 0.0 110.968 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -6.42 81.7 0.0 OUTLIER Glycine 0 N--CA 1.505 3.27 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 68' ' ' LYS . 84.3 m-85 -75.16 159.95 31.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -1.071 . . . . 0.0 109.193 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.585 ' OE1' ' ND2' ' A' ' 158' ' ' ASN . 85.1 mt-30 -58.33 -41.83 85.46 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.456 -0.777 . . . . 0.0 109.861 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 t -147.21 155.41 42.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.938 -1.101 . . . . 0.0 110.847 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -129.5 133.34 47.21 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.472 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.4 OUTLIER -145.6 165.67 27.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.1 p -97.98 174.8 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 121.308 -0.87 . . . . 0.0 109.084 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.47 HG12 ' HE ' ' A' ' 154' ' ' ARG . 52.5 mt -109.51 118.11 56.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.4 p -92.58 160.33 15.08 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 123.11 1.433 . . . . 0.0 111.548 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.621 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 0.1 OUTLIER -158.0 138.27 12.59 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.652 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.517 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -130.18 139.02 50.89 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.94 0.4 21.2 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.898 -1.126 . . . . 0.0 110.743 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.422 ' H ' ' HD3' ' A' ' 79' ' ' ARG . 93.4 m-20 -111.11 -14.82 13.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 0.0 109.21 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.572 HD22 HD13 ' A' ' 78' ' ' LEU . 44.7 p-10 -63.36 117.91 38.55 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.285 -0.884 . . . . 0.0 110.414 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -88.14 -13.99 3.52 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.35 2.033 . . . . 0.0 113.039 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -92.38 -11.09 35.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.032 -1.043 . . . . 0.0 110.611 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.678 ' CG ' HH12 ' A' ' 89' ' ' ARG . 20.1 tptt -62.54 -38.77 91.3 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.956 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -59.69 -44.2 93.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.834 . . . . 0.0 109.57 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.59 -38.63 66.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.024 -1.048 . . . . 0.0 109.483 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 49.6 mt -60.58 -36.43 78.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 0.0 109.026 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.678 HH12 ' CG ' ' A' ' 85' ' ' LYS . 0.9 OUTLIER -60.09 -30.53 69.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 109.318 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -64.47 -60.39 3.21 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.044 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -58.73 -30.94 67.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.15 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -83.41 -18.74 37.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.5 mt -63.82 -25.31 68.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.066 -1.022 . . . . 0.0 110.012 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -58.62 141.32 52.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 109.6 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -72.99 158.46 35.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 109.347 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -168.01 -168.96 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 110.788 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.9 133.64 6.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 109.11 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.683 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -106.43 154.32 20.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 0.0 109.738 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.21 -7.69 86.87 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -123.42 170.35 10.44 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.345 -1.091 . . . . 0.0 109.417 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -74.61 143.51 44.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.07 -1.019 . . . . 0.0 110.017 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' HG3' ' CE1' ' A' ' 98' ' ' HIS . 1.6 mt-10 -101.97 96.33 6.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.26 -0.9 . . . . 0.0 109.206 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.7 m -100.85 128.74 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.735 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.564 ' NE ' ' CZ ' ' A' ' 142' ' ' PHE . 6.6 mtm180 -128.9 134.58 48.31 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.611 ' CE2' ' CE3' ' A' ' 38' ' ' TRP . 66.0 t80 -112.99 131.53 55.72 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.77 0.795 . . . . 0.0 109.938 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.18 125.8 34.4 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.359 0.599 . . . . 0.0 109.72 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.89 -39.7 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.455 -0.778 . . . . 0.0 109.941 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -160.47 146.94 15.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.145 -0.972 . . . . 0.0 109.899 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.48 ' O ' ' OE1' ' A' ' 127' ' ' GLU . . . 87.89 164.18 39.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.72 160.59 26.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.513 -0.992 . . . . 0.0 109.664 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.22 -119.62 1.01 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.0 tp -148.31 163.33 37.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -1.106 . . . . 0.0 108.73 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.551 ' CD1' ' C ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -137.99 145.93 42.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.976 -1.078 . . . . 0.0 108.952 177.013 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.445 ' SG ' ' C ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -148.58 139.22 22.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.489 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.86 128.68 20.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.459 -0.776 . . . . 0.0 109.321 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -103.3 111.56 24.02 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.178 -0.952 . . . . 0.0 109.18 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.9 mm -126.1 114.64 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.145 -0.972 . . . . 0.0 110.781 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.66 -142.42 29.93 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 104.422 -3.471 . . . . 0.0 104.422 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -109.92 82.95 1.67 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 115.296 -2.561 . . . . 0.0 107.675 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -165.46 168.33 16.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 83.4 t -131.13 150.03 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.123 -0.986 . . . . 0.0 109.418 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -129.3 134.53 47.97 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.636 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -138.22 134.77 34.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.072 -1.018 . . . . 0.0 108.669 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.8 p -127.16 148.33 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.981 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.559 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 1.0 OUTLIER -123.72 75.16 1.32 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 118.193 -1.403 . . . . 0.0 110.732 179.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.559 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -162.29 119.7 2.1 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.48 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 8.7 tm-20 -115.37 106.24 13.77 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 117.526 -1.67 . . . . 0.0 110.653 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.644 ' C ' ' H ' ' A' ' 130' ' ' ASP . 86.6 mttt -110.92 -178.96 3.61 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 38' ' ' TRP . 71.4 m-80 -58.48 0.47 0.08 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.644 ' H ' ' C ' ' A' ' 128' ' ' LYS . 21.0 t0 -71.71 143.43 49.65 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.723 -1.236 . . . . 0.0 110.451 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.596 ' N ' ' OD1' ' A' ' 130' ' ' ASP . 0.2 OUTLIER -110.85 149.36 30.69 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.657 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.448 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 26.2 mm -114.45 131.93 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -120.31 144.57 47.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.869 . . . . 0.0 110.116 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.7 t -117.14 134.43 23.04 Favored Pre-proline 0 N--CA 1.488 1.436 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.17 151.87 76.65 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.954 1.769 . . . . 0.0 112.284 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.612 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.86 133.04 46.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 109.686 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.612 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 3.7 t-160 92.76 10.27 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 120.964 0.412 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.36 125.92 32.91 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.12 -0.987 . . . . 0.0 108.461 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.52 131.96 31.57 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.622 1.548 . . . . 0.0 111.575 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.504 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.16 163.15 15.55 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.479 -179.062 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 26.5 p90 -128.65 -153.9 0.6 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.533 -0.729 . . . . 0.0 109.67 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.631 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -172.92 124.0 0.43 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.505 -0.747 . . . . 0.0 109.214 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.436 ' OD2' ' N ' ' A' ' 144' ' ' MET . 29.9 t0 -147.96 131.91 17.16 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.147 -0.97 . . . . 0.0 109.453 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.606 ' O ' ' C ' ' A' ' 145' ' ' GLY . 7.4 mtm -111.76 20.02 17.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.273 -0.892 . . . . 0.0 110.815 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.606 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 11.02 -90.82 0.01 OUTLIER Glycine 0 N--CA 1.503 3.165 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.452 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 46.7 t -87.52 119.6 27.97 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.3 -1.36 . . . . 0.0 109.857 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.596 ' OE1' ' NE ' ' A' ' 89' ' ' ARG . 6.5 mp0 -114.08 120.11 39.31 Favored Pre-proline 0 N--CA 1.493 1.68 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.569 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.7 Cg_endo -100.32 28.88 0.12 Allowed 'Trans proline' 0 C--O 1.212 -0.806 0 C-N-CA 122.476 2.117 . . . . 0.0 112.753 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.621 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER 81.33 64.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.762 0.792 . . . . 0.0 110.16 -179.193 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.49 ' C ' ' CD2' ' A' ' 150' ' ' PHE . 15.2 p90 -101.6 171.06 7.78 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.577 0.703 . . . . 0.0 110.292 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 87.7 m -126.42 138.94 53.59 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -146.52 165.72 28.6 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.238 -0.914 . . . . 0.0 109.415 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 75.5 mt -118.09 136.66 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.386 -0.821 . . . . 0.0 109.746 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.47 ' HE ' HG12 ' A' ' 76' ' ' ILE . 2.7 mtm180 -140.15 168.01 20.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.021 -1.049 . . . . 0.0 109.653 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.476 ' CG2' ' CG ' ' A' ' 70' ' ' TYR . 3.9 mp -107.39 155.22 8.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.631 -0.668 . . . . 0.0 109.562 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.2 m-30 -103.06 121.09 41.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.204 -0.935 . . . . 0.0 110.319 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 3.9 t0 -133.27 163.06 30.15 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.668 ' N ' ' ND2' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -93.41 161.9 29.43 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.102 -0.999 . . . . 0.0 109.285 -178.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.3 Cg_endo -62.73 -55.01 0.96 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.237 1.958 . . . . 0.0 112.293 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 160' ' ' GLU . 55.2 mp0 -44.41 -13.28 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.401 -0.812 . . . . 0.0 109.247 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -78.75 -33.94 36.25 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.534 ' N ' ' O ' ' A' ' 159' ' ' PRO . 4.5 p90 -118.8 159.32 23.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.381 -1.07 . . . . 0.0 110.825 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.45 HG22 HD12 ' A' ' 163' ' ' ILE . 81.7 mt -100.2 147.91 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.549 -0.719 . . . . 0.0 109.453 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.65 -73.25 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.5 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -140.9 159.47 42.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.944 -1.097 . . . . 0.0 109.883 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -89.69 -41.87 11.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.393 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 52.7 m -116.06 -31.39 5.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.305 -0.872 . . . . 0.0 108.696 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.63 -5.4 51.3 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.807 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -80.77 149.51 29.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.659 -1.495 . . . . 0.0 107.952 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -105.38 89.97 3.28 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 117.337 -1.745 . . . . 0.0 110.762 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.76 -30.11 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.95 -1.094 . . . . 0.0 109.417 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -63.45 -41.33 98.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.332 -0.855 . . . . 0.0 108.851 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.504 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 15.7 t -51.9 -4.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 110.173 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.568 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -83.19 -34.03 26.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.09 -1.007 . . . . 0.0 110.901 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.591 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.1 m-85 -110.03 27.32 0.07 OUTLIER Pre-proline 0 N--CA 1.515 2.81 0 O-C-N 120.81 -1.181 . . . . 0.0 112.764 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 40.5 Cg_endo -58.97 -24.02 71.11 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 123.559 2.839 . . . . 0.0 114.511 -172.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -88.92 125.7 35.07 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 118.375 -1.33 . . . . 0.0 108.133 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' C ' ' A' ' 179' ' ' ALA . 5.0 tt -87.06 128.95 35.09 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.596 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.596 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.36 170.76 8.63 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.047 -1.033 . . . . 0.0 109.412 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 29.3 tp -158.06 114.98 2.89 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 130.78 55.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.18 -0.95 . . . . 0.0 109.797 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.411 ' CD1' ' CE1' ' A' ' 122' ' ' PHE . 71.5 mt -127.29 138.34 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 178.97 6.87 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.605 0.717 . . . . 0.0 109.444 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.1 t -96.05 174.62 6.83 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.38 -22.88 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.028 -1.045 . . . . 0.0 109.159 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -73.73 -37.76 65.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.148 -0.97 . . . . 0.0 110.512 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.458 ' OD2' ' N ' ' A' ' 10' ' ' ASP . 1.3 p30 -137.51 123.59 13.13 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.029 -1.045 . . . . 0.0 109.461 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -81.86 -38.4 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.944 1.763 . . . . 0.0 112.301 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.32 3.09 2.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 110.275 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -114.67 119.44 36.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.874 . . . . 0.0 109.089 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 p -100.21 122.77 43.55 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.192 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 pp -88.09 -8.97 54.7 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.054 -1.059 . . . . 0.0 108.991 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.676 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 38.7 t90 -157.7 107.69 2.17 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.315 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -120.4 121.86 39.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.409 -0.807 . . . . 0.0 110.026 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.419 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -163.15 164.45 25.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.439 -0.788 . . . . 0.0 109.999 -179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.596 ' OG1' ' O ' ' A' ' 1' ' ' SER . 10.7 t -130.86 88.83 2.66 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 118.955 -1.098 . . . . 0.0 108.16 175.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.534 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 12.0 m120 -125.9 143.68 50.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.098 -1.001 . . . . 0.0 110.684 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.15 -39.62 22.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.342 -1.474 . . . . 0.0 108.664 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.21 -50.89 8.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 109.566 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.7 -21.58 60.81 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.879 -1.138 . . . . 0.0 108.559 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 2.0 mt -70.05 -57.34 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.256 -0.902 . . . . 0.0 108.943 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.517 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 8.7 pt20 -62.65 -44.94 94.99 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.941 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.517 ' N ' ' CG ' ' A' ' 25' ' ' GLN . 25.9 mt-30 -59.88 -42.38 93.62 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.148 -0.97 . . . . 0.0 109.885 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.676 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 5.3 tt0 -80.24 -47.03 15.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.912 -1.118 . . . . 0.0 109.399 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.2 tp -66.14 -55.4 16.58 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.986 -1.071 . . . . 0.0 109.022 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 33' ' ' VAL . 41.2 t-20 -59.63 -19.78 51.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.911 -1.118 . . . . 0.0 109.471 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.58 68.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.859 -1.151 . . . . 0.0 108.601 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -86.5 12.78 9.6 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.737 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.72 23.23 31.26 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.042 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.484 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 70.6 t -94.33 145.44 7.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.469 -1.018 . . . . 0.0 109.176 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -84.45 158.5 21.02 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.345 -0.847 . . . . 0.0 108.737 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CD1' ' CB ' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -152.77 152.31 31.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.881 -1.137 . . . . 0.0 108.006 177.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.548 ' O ' ' OD1' ' A' ' 130' ' ' ASP . 3.4 mm-40 -170.77 169.4 6.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.909 -1.119 . . . . 0.0 109.21 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -150.55 118.58 6.29 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.503 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 23.4 m0 -111.17 150.32 29.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.863 . . . . 0.0 108.996 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -139.68 157.51 45.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.149 -0.969 . . . . 0.0 109.629 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.31 159.53 15.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 108.968 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.47 ' OD2' ' N ' ' A' ' 42' ' ' ARG . 54.1 p30 -100.17 -9.94 21.96 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.47 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 15.8 ttm180 -93.48 150.69 20.25 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.3 117.88 30.03 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.536 -0.727 . . . . 0.0 109.261 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mt -93.28 165.63 12.71 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.32 -0.863 . . . . 0.0 109.383 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.39 -121.33 0.56 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.49 78.57 9.66 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.113 -1.228 . . . . 0.0 108.635 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.3 94.58 48.79 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.509 -0.744 . . . . 0.0 109.087 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.25 85.61 0.43 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.822 1.681 . . . . 0.0 111.646 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.28 109.02 0.64 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.265 -0.897 . . . . 0.0 109.276 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.25 -35.41 31.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.645 -1.284 . . . . 0.0 109.759 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -65.28 -20.78 66.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 110.155 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.9 m -79.83 -35.67 37.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.161 -0.962 . . . . 0.0 110.302 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.95 -46.51 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.957 . . . . 0.0 109.842 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -61.99 -42.18 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.935 . . . . 0.0 108.978 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.34 -29.75 70.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.399 -0.813 . . . . 0.0 109.702 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.12 -19.17 58.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 110.165 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -116.38 -9.0 11.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.794 . . . . 0.0 109.566 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 54' ' ' ILE . 4.8 mm-40 -49.65 -39.04 34.79 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.145 -0.972 . . . . 0.0 108.857 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.598 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 21.5 p80 -52.68 -45.03 66.64 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.427 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.598 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.12 -59.65 4.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.906 -1.121 . . . . 0.0 110.015 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.49 ' CD1' ' C ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -63.42 -28.25 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.025 -1.047 . . . . 0.0 109.289 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.2 t70 -58.35 -24.73 60.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.382 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -84.6 -41.63 16.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 109.978 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.3 tt -66.49 -46.27 76.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.388 -0.82 . . . . 0.0 109.751 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.7 p -67.24 -30.11 48.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 109.283 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.41 -43.52 75.35 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.094 -1.004 . . . . 0.0 109.367 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -78.52 -52.21 8.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 0.0 109.832 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.64 ' O ' ' C ' ' A' ' 69' ' ' GLY . 45.0 mmtm -83.22 12.18 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.389 -0.82 . . . . 0.0 110.342 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.64 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -0.23 80.33 0.0 OUTLIER Glycine 0 N--CA 1.503 3.166 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' LYS . 43.2 m-85 -77.27 166.36 23.29 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.375 -1.073 . . . . 0.0 108.461 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -57.24 -92.24 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.444 -0.785 . . . . 0.0 109.173 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.44 164.9 11.42 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.603 0.716 . . . . 0.0 110.177 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.411 ' HE1' HG21 ' A' ' 153' ' ' ILE . 6.4 t-105 -136.2 140.61 43.67 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.427 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.8 OUTLIER -157.37 175.36 14.09 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.089 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -120.14 143.27 32.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.3 tp -103.07 115.89 45.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.513 ' O ' ' OG ' ' A' ' 77' ' ' SER . 9.8 p -168.57 101.44 0.41 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.503 -0.748 . . . . 0.0 109.003 178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.532 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 9.9 tp -110.45 -179.49 3.78 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 119.564 -1.96 . . . . 0.0 107.751 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.632 ' C ' ' H ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -88.41 147.49 24.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.744 -1.223 . . . . 0.0 109.773 -178.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.22 3.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.656 -0.652 . . . . 0.0 109.571 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.632 ' H ' ' C ' ' A' ' 79' ' ' ARG . 84.6 m-20 -88.39 -25.52 22.65 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.624 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -63.61 128.08 92.24 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.991 -1.068 . . . . 0.0 109.639 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -75.95 -6.49 17.46 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.211 1.941 . . . . 0.0 112.392 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -89.33 10.69 21.43 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.9 -1.125 . . . . 0.0 109.41 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.545 ' CG ' ' H ' ' A' ' 86' ' ' GLU . 2.4 pttm -56.77 -57.28 13.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 108.798 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.545 ' H ' ' CG ' ' A' ' 85' ' ' LYS . 84.1 tt0 -66.15 -40.02 90.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.207 -0.933 . . . . 0.0 109.798 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.31 90.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.692 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.2 mt -61.3 -46.93 88.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 110.203 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.61 -26.41 67.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.947 -1.095 . . . . 0.0 109.721 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -67.21 -59.3 3.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.453 -0.779 . . . . 0.0 110.375 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -57.9 -38.65 76.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.97 . . . . 0.0 109.534 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -74.59 -24.21 58.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.719 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 94' ' ' ASN . 1.5 tt -64.18 -33.98 77.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 109.997 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 94' ' ' ASN . 44.0 p-10 -43.09 148.68 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 109.709 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.565 ' OE2' ' N ' ' A' ' 171' ' ' ILE . 77.5 mt-10 -85.24 157.44 20.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.334 -0.854 . . . . 0.0 109.626 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -174.38 -165.72 0.23 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.011 -1.056 . . . . 0.0 111.488 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.83 131.8 3.02 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.603 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -101.63 155.3 18.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 109.955 -178.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.86 -5.92 86.89 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.461 ' HG3' ' H ' ' A' ' 101' ' ' ASP . 22.6 tp10 -126.57 169.26 13.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -1.07 . . . . 0.0 109.304 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.461 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 89.4 m-20 -70.06 143.42 52.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.245 -0.91 . . . . 0.0 110.06 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.603 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 2.7 tt0 -102.52 95.05 5.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 110.195 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.0 m -94.64 125.52 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.31 126.03 38.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.503 ' CE2' ' CE3' ' A' ' 38' ' ' TRP . 42.3 t80 -101.92 126.89 48.93 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.61 134.24 34.23 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.618 -0.676 . . . . 0.0 110.39 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.2 -25.9 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.814 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' A' ' 109' ' ' GLY . 74.3 tt0 -172.36 163.94 5.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.008 -1.057 . . . . 0.0 108.895 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.619 ' N ' ' OE1' ' A' ' 127' ' ' GLU . . . 43.78 104.61 0.01 OUTLIER Glycine 0 N--CA 1.495 2.569 0 O-C-N 121.104 -0.998 . . . . 0.0 110.792 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.79 111.08 4.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.671 -1.488 . . . . 0.0 109.105 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.51 -140.89 1.78 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -109.9 100.97 9.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.415 -1.05 . . . . 0.0 111.775 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.493 ' C ' ' OE1' ' A' ' 123' ' ' GLN . 30.8 p90 -79.82 128.62 33.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.61 -1.306 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.462 ' SG ' ' NE1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -78.91 143.71 35.58 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.318 0.58 . . . . 0.0 109.939 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 tp -131.38 124.73 30.95 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.2 t-160 -102.43 103.48 13.88 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.927 -1.108 . . . . 0.0 110.012 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.93 105.92 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.203 -0.936 . . . . 0.0 109.889 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.54 -144.24 32.59 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 105.293 -3.123 . . . . 0.0 105.293 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.521 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 41.5 p30 -102.11 79.36 1.87 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 115.225 -2.59 . . . . 0.0 109.589 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.527 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 15.0 tp10 -165.76 170.68 13.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.405 ' H ' ' HG3' ' A' ' 120' ' ' GLU . 55.8 t -127.74 141.94 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.12 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.411 ' CE1' ' CD1' ' A' ' 5' ' ' ILE . 22.1 m-85 -128.49 132.32 48.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.808 -0.557 . . . . 0.0 109.788 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.493 ' OE1' ' C ' ' A' ' 113' ' ' PHE . 11.2 mm-40 -128.73 112.98 14.78 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 2.4 t -100.54 134.99 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.535 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 54.5 tp -126.54 86.05 2.46 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.543 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.535 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -168.2 137.51 2.45 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -104.67 99.42 9.09 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 116.119 -2.232 . . . . 0.0 109.792 -179.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.613 ' C ' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -119.38 159.53 24.01 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.988 176.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.478 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -60.68 2.67 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.002 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.613 ' H ' ' C ' ' A' ' 128' ' ' LYS . 9.6 t70 -66.45 135.3 54.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.86 -1.15 . . . . 0.0 110.353 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.443 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 1.4 tm? -92.37 125.11 36.88 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.748 -177.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.467 ' CD1' ' OD2' ' A' ' 130' ' ' ASP . 1.0 OUTLIER -108.33 127.62 64.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.2 t -120.69 144.15 48.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.451 -0.781 . . . . 0.0 109.673 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -119.13 142.18 31.72 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.39 147.16 70.92 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.343 2.029 . . . . 0.0 113.051 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.614 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.8 134.15 45.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 109.375 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.614 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 2.2 t-80 92.32 11.02 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.68 128.13 27.49 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.117 -0.99 . . . . 0.0 108.797 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.49 132.38 33.13 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.751 1.634 . . . . 0.0 111.53 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.55 164.72 10.39 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.199 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.462 ' NE1' ' SG ' ' A' ' 114' ' ' CYS . 0.4 OUTLIER -136.66 -149.14 0.31 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.195 -0.941 . . . . 0.0 109.597 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.422 ' H ' ' HB2' ' A' ' 141' ' ' TRP . 68.7 t80 -173.61 124.1 0.37 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.997 -1.064 . . . . 0.0 109.018 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -137.66 129.99 29.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.55 -0.719 . . . . 0.0 109.525 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.612 ' SD ' ' CE2' ' A' ' 150' ' ' PHE . 60.5 mtm -100.61 16.97 23.04 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.764 -0.585 . . . . 0.0 111.312 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 32.64 -125.92 0.29 Allowed Glycine 0 N--CA 1.49 2.287 0 O-C-N 120.636 -1.29 . . . . 0.0 110.537 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.521 ' H ' ' HB2' ' A' ' 178' ' ' LEU . 0.4 OUTLIER -81.7 121.37 26.29 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.099 -1.441 . . . . 0.0 108.624 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.89 115.58 45.85 Favored Pre-proline 0 N--CA 1.492 1.636 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.355 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 60.3 Cg_endo -103.69 50.34 0.03 OUTLIER 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 122.957 2.438 . . . . 0.0 110.742 176.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.2 OUTLIER 81.85 70.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.132 -177.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.612 ' CE2' ' SD ' ' A' ' 144' ' ' MET . 20.5 p90 -96.24 163.13 13.22 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.274 -0.891 . . . . 0.0 110.167 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.9 m -128.81 124.5 35.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.469 -0.769 . . . . 0.0 110.533 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.97 160.75 39.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.501 -0.749 . . . . 0.0 109.012 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.411 HG21 ' HE1' ' A' ' 73' ' ' TRP . 79.6 mt -111.14 129.24 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.182 -0.949 . . . . 0.0 109.247 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.29 165.09 26.24 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.475 ' CD1' ' N ' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -107.59 152.66 9.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.49 -0.756 . . . . 0.0 109.381 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.427 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.8 m-30 -96.77 119.63 35.61 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.0 0.905 . . . . 0.0 109.892 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 53.5 p30 -134.99 163.84 28.95 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.525 ' C ' ' ND2' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -94.03 161.54 29.48 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.982 -1.073 . . . . 0.0 109.075 -179.259 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.63 ' O ' ' N ' ' A' ' 161' ' ' GLY . 40.7 Cg_endo -63.77 -55.45 0.67 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.013 1.809 . . . . 0.0 112.045 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 159' ' ' PRO . 94.4 mt-10 -43.77 -14.38 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.369 -0.832 . . . . 0.0 109.197 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -75.93 -40.52 30.29 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.507 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 4.1 p90 -108.83 159.56 16.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 79.2 mt -100.67 147.42 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.402 -0.811 . . . . 0.0 109.509 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -49.2 -74.11 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.263 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.29 161.47 38.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.111 -0.993 . . . . 0.0 109.804 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -88.19 -41.62 12.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.028 -1.045 . . . . 0.0 109.546 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.639 ' HG1' ' H ' ' A' ' 169' ' ' ASP . 63.4 p -112.48 -31.89 6.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.293 -0.879 . . . . 0.0 108.877 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.91 -8.02 53.61 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.639 ' H ' ' HG1' ' A' ' 167' ' ' THR . 90.8 m-20 -80.04 145.92 32.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.624 -1.515 . . . . 0.0 108.039 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -112.36 89.81 3.17 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.316 -1.354 . . . . 0.0 110.872 176.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.565 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -83.21 -20.12 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.049 -1.657 . . . . 0.0 109.284 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.558 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -56.77 -43.82 81.18 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.406 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 47.6 t -56.25 -1.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 109.648 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -87.93 -18.62 28.73 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.382 -0.824 . . . . 0.0 110.842 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.573 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 54.2 m-85 -108.45 27.41 0.07 OUTLIER Pre-proline 0 N--CA 1.518 2.952 0 O-C-N 121.187 -0.946 . . . . 0.0 112.83 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 42.1 Cg_endo -60.86 -5.57 4.86 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 123.916 3.077 . . . . 0.0 113.453 -173.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -84.62 148.94 26.18 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.3 -0.875 . . . . 0.0 109.149 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.576 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 15.9 tp -89.34 101.18 13.85 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.829 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.905 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.62 ' O ' ' OG1' ' A' ' 19' ' ' THR . 7.9 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.2 169.96 9.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.126 -0.983 . . . . 0.0 109.214 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tp -157.24 118.96 3.74 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.79 133.88 52.66 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.179 -0.95 . . . . 0.0 109.795 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' A' ' 121' ' ' VAL . 52.9 mt -127.5 136.08 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.58 166.19 20.22 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.409 ' OG ' ' CD1' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -86.75 174.27 8.93 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 108.796 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.33 -28.31 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.03 -1.044 . . . . 0.0 109.117 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -73.54 -36.91 65.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.28 124.97 15.41 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 109.552 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 13' ' ' ASN . 55.8 Cg_endo -80.82 -37.82 0.31 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.935 1.757 . . . . 0.0 112.407 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.42 ' C ' HD21 ' A' ' 13' ' ' ASN . 1.6 tt0 -69.46 6.26 1.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.093 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.631 ' N ' HD21 ' A' ' 13' ' ' ASN . 0.9 OUTLIER -114.03 120.32 40.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.908 . . . . 0.0 109.055 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.5 p -100.29 122.01 42.4 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.365 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.409 ' CD1' ' OG ' ' A' ' 7' ' ' SER . 7.1 mt -88.9 -7.52 55.94 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.064 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.644 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 48.3 t90 -157.46 105.95 2.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.421 -1.312 . . . . 0.0 109.9 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -117.82 111.11 18.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.329 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.436 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -162.47 162.85 27.7 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.868 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.62 ' OG1' ' O ' ' A' ' 1' ' ' SER . 10.0 t -131.71 90.28 2.82 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 120.966 -1.084 . . . . 0.0 108.181 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.557 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 1.7 m-80 -124.55 143.47 50.67 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.285 -0.884 . . . . 0.0 110.442 177.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.75 -40.88 22.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.012 -1.68 . . . . 0.0 108.536 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.28 -48.41 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 110.021 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -60.62 -23.95 65.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.969 -1.082 . . . . 0.0 108.698 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.557 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 10.9 mt -72.63 -53.68 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.234 -0.916 . . . . 0.0 108.83 178.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 29' ' ' ASN . 52.0 tt0 -59.09 -52.87 63.85 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.141 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.75 -40.14 87.16 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.28 -0.888 . . . . 0.0 109.64 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.644 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 7.0 tt0 -78.1 -50.21 12.46 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.933 -1.104 . . . . 0.0 109.579 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 24' ' ' ILE . 22.6 tp -69.03 -55.87 9.49 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.7 -1.25 . . . . 0.0 109.268 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 25' ' ' GLN . 26.2 t-20 -56.82 -20.89 25.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.876 -1.14 . . . . 0.0 109.448 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.54 -26.37 67.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.889 -1.132 . . . . 0.0 108.374 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 10.63 15.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.296 -0.877 . . . . 0.0 109.695 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.06 21.89 26.69 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.4 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 38.6 t -94.31 146.26 6.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.193 -1.18 . . . . 0.0 108.958 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.429 HH12 ' NZ ' ' A' ' 68' ' ' LYS . 13.4 ttm180 -84.12 157.24 21.78 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.438 ' C ' ' OE1' ' A' ' 36' ' ' GLU . 1.2 t80 -154.98 153.66 31.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.83 -1.169 . . . . 0.0 108.729 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.438 ' OE1' ' C ' ' A' ' 35' ' ' PHE . 1.5 pm0 -175.63 173.21 2.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.861 -1.149 . . . . 0.0 109.837 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -148.82 112.94 5.2 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.642 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 23.9 m0 -111.48 149.76 30.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 38' ' ' TRP . 84.0 mm-40 -138.09 157.87 45.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.776 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.22 158.79 15.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 108.937 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -101.34 -12.98 18.21 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -92.94 158.34 15.87 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.652 0.739 . . . . 0.0 109.051 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -93.0 119.29 32.1 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.615 -0.678 . . . . 0.0 109.507 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.34 164.0 14.01 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.381 -0.824 . . . . 0.0 109.278 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.72 -103.94 0.2 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.0 88.64 4.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.115 -1.226 . . . . 0.0 109.264 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.54 92.92 17.81 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.482 -0.761 . . . . 0.0 109.005 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.54 -28.2 10.26 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.151 1.901 . . . . 0.0 112.574 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 50.1 p -119.86 140.94 50.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.649 -0.657 . . . . 0.0 109.877 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.0 -17.28 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 109.593 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -46.61 -37.53 8.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.33 -0.856 . . . . 0.0 109.119 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.5 p -78.81 -31.12 45.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 0.0 109.338 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.1 t -69.11 -48.87 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.86 . . . . 0.0 109.818 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 58' ' ' GLN . 6.6 mt -59.65 -39.3 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 109.017 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.51 -31.0 71.69 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.434 -0.791 . . . . 0.0 109.657 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.22 -17.79 60.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 0.0 110.042 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -113.98 -6.8 13.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.448 -0.783 . . . . 0.0 109.307 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 62' ' ' ASP . 1.1 mm-40 -48.64 -39.48 24.35 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.305 -0.958 . . . . 0.0 108.993 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 60' ' ' ALA . 35.6 p80 -52.08 -46.78 65.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.039 -1.038 . . . . 0.0 109.652 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.584 ' N ' ' ND1' ' A' ' 59' ' ' HIS . . . -62.49 -61.6 2.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.917 -1.114 . . . . 0.0 109.849 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.502 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.6 OUTLIER -61.16 -29.45 45.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.749 -1.22 . . . . 0.0 109.187 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 58' ' ' GLN . 33.2 t0 -58.1 -26.12 62.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 109.521 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.33 -39.41 59.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.127 -0.983 . . . . 0.0 109.236 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.75 -36.75 84.92 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.268 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 69' ' ' GLY . 2.8 t -70.41 -29.5 39.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.304 -0.872 . . . . 0.0 109.339 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.4 -53.82 51.43 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.488 -1.383 . . . . 0.0 109.392 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -82.64 -50.37 8.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.964 -1.085 . . . . 0.0 110.785 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.582 ' O ' ' C ' ' A' ' 69' ' ' GLY . 70.9 mttt -86.26 14.0 7.18 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.387 -0.821 . . . . 0.0 110.858 -177.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.582 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -15.34 88.97 0.01 OUTLIER Glycine 0 N--CA 1.502 3.068 0 CA-C-O 122.195 0.886 . . . . 0.0 111.731 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 68' ' ' LYS . 84.0 m-85 -77.69 162.3 27.1 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -58.55 -81.7 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 108.742 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.1 m -103.26 157.52 16.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.466 -0.771 . . . . 0.0 109.599 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.469 ' CD1' ' N ' ' A' ' 74' ' ' ASP . 11.0 t-105 -141.27 146.44 36.8 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.469 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.3 OUTLIER -177.44 -165.22 0.1 Allowed 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.58 165.54 18.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.398 -0.814 . . . . 0.0 109.222 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.402 HG22 HD12 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -95.48 140.69 16.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.41 ' O ' ' CD2' ' A' ' 78' ' ' LEU . 58.8 p -91.68 162.38 14.51 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.049 1.404 . . . . 0.0 112.248 -176.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.421 ' HG ' ' CE1' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -158.85 118.48 3.1 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 113.49 -1.687 . . . . 0.0 112.41 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -131.7 139.54 49.05 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.39 -18.3 65.28 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.761 -1.212 . . . . 0.0 109.5 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -104.74 31.77 4.54 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.614 HD21 ' H ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -92.58 125.4 55.93 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.019 -1.05 . . . . 0.0 110.619 178.332 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -78.2 -7.6 16.19 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.997 1.798 . . . . 0.0 112.268 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -90.81 0.93 57.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.978 -1.076 . . . . 0.0 110.024 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.518 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 11.5 ptmm? -58.05 -51.29 70.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.183 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 49.7 tp10 -62.84 -56.61 15.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.093 -1.004 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.92 -44.6 78.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.404 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.4 -42.25 98.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.309 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 144' ' ' MET . 43.3 mtp180 -60.75 -40.69 93.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.725 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -66.7 -58.31 5.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.368 -0.833 . . . . 0.0 110.511 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -53.37 -34.41 57.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.611 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -88.14 -17.66 30.47 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 110.213 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 tp -61.36 -38.23 86.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.866 -1.146 . . . . 0.0 109.97 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.475 ' OD1' ' O ' ' A' ' 94' ' ' ASN . 40.2 p-10 -54.81 131.11 43.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 0.0 110.148 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.49 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 1.7 pp20? -71.55 165.55 23.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.389 -0.819 . . . . 0.0 109.339 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.49 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 38.3 p-80 -175.13 -165.22 0.17 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.294 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.84 135.66 4.83 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.67 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.37 154.98 21.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -0.835 . . . . 0.0 109.676 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.52 -6.98 85.19 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.423 ' OE2' ' OH ' ' A' ' 70' ' ' TYR . 84.9 tt0 -125.93 169.13 13.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.243 -1.151 . . . . 0.0 108.988 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.415 ' N ' ' HG2' ' A' ' 100' ' ' GLU . 90.3 m-20 -74.47 144.06 44.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.859 -1.151 . . . . 0.0 110.613 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.413 ' HG3' ' CE1' ' A' ' 98' ' ' HIS . 2.3 mt-10 -100.88 91.64 4.68 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.401 ' CG1' ' OG ' ' A' ' 133' ' ' SER . 6.4 m -84.63 131.31 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -130.62 112.74 13.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.758 -0.589 . . . . 0.0 109.513 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.65 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 17.3 t80 -101.25 135.87 42.02 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.606 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -92.17 133.66 35.58 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.465 -0.772 . . . . 0.0 110.118 -178.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.33 -36.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.268 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -156.56 143.24 18.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.939 -1.1 . . . . 0.0 109.919 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.43 170.67 40.08 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.56 -170.15 1.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.228 -1.16 . . . . 0.0 109.485 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.53 -138.22 2.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.406 ' HG ' ' H ' ' A' ' 113' ' ' PHE . 5.7 tp -142.71 159.67 41.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.19 -1.182 . . . . 0.0 109.168 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.406 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 57.2 m-85 -134.98 86.94 2.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 109.485 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -80.94 120.24 24.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.875 . . . . 0.0 109.511 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mt -132.64 124.34 28.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.2 -0.937 . . . . 0.0 109.032 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 9.6 t-160 -108.3 114.54 28.48 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.943 -1.098 . . . . 0.0 108.985 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.3 mt -127.79 116.45 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.593 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.14 -143.5 33.29 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 105.916 -2.874 . . . . 0.0 105.916 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -105.57 79.11 1.42 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 115.578 -2.449 . . . . 0.0 108.474 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.5 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 31.5 tt0 -166.08 168.66 15.29 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.426 ' H ' ' HG2' ' A' ' 120' ' ' GLU . 41.9 t -126.37 140.91 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.997 -1.065 . . . . 0.0 110.227 177.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -120.48 130.38 54.26 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.191 0.519 . . . . 0.0 110.249 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -131.08 112.58 13.01 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.496 -0.752 . . . . 0.0 109.107 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.79 137.81 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.54 93.08 2.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.203 -0.936 . . . . 0.0 110.146 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.0 t -165.96 138.49 4.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.545 -1.347 . . . . 0.0 108.195 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.66 94.37 5.16 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 115.779 -2.368 . . . . 0.0 110.759 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.593 ' C ' ' H ' ' A' ' 130' ' ' ASP . 32.6 mtmt -116.18 150.38 37.56 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.585 176.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.691 ' N ' HD21 ' A' ' 129' ' ' ASN . 0.6 OUTLIER -59.72 -1.95 0.32 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.414 -1.428 . . . . 0.0 107.695 177.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.593 ' H ' ' C ' ' A' ' 128' ' ' LYS . 57.0 p30 -68.47 146.13 53.44 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.069 0.937 . . . . 0.0 109.927 -176.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.532 ' CD1' ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -105.15 140.24 38.62 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.576 0.703 . . . . 0.0 109.962 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.532 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 14.1 tt -128.8 120.6 52.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.401 ' OG ' ' CG1' ' A' ' 103' ' ' VAL . 8.1 t -118.59 142.99 47.09 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 12.4 m -99.19 148.57 34.81 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.9 153.48 77.77 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.436 2.091 . . . . 0.0 113.355 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.613 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -74.81 136.64 41.62 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.173 -0.954 . . . . 0.0 109.188 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.613 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 13.2 t-80 94.14 10.94 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.2 t -106.42 127.16 28.75 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.948 -1.095 . . . . 0.0 109.021 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.15 134.4 48.93 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.829 1.686 . . . . 0.0 111.752 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.515 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -171.78 162.15 6.12 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.972 -179.306 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.47 ' CG ' ' CB ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -134.11 -148.67 0.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.222 -0.923 . . . . 0.0 109.446 -178.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.416 ' H ' ' HB2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -175.06 126.6 0.27 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.038 -1.039 . . . . 0.0 109.094 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.499 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 52.5 p-10 -146.88 138.05 24.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.328 -0.858 . . . . 0.0 109.75 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.613 ' O ' ' C ' ' A' ' 145' ' ' GLY . 6.6 mmt -107.06 19.43 20.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.339 -0.851 . . . . 0.0 111.791 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.613 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 2.22 -88.1 0.0 OUTLIER Glycine 0 N--CA 1.506 3.31 0 CA-C-N 119.5 1.046 . . . . 0.0 111.714 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.462 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 69.2 m -85.52 121.32 28.05 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.119 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.599 ' OE2' ' ND2' ' A' ' 82' ' ' ASN . 40.1 mt-10 -103.25 119.64 54.53 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.589 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 56.1 Cg_endo -104.22 0.89 0.28 Allowed 'Trans proline' 0 C--O 1.207 -1.072 0 C-N-CA 123.844 3.029 . . . . 0.0 110.964 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.626 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 0.1 OUTLIER 83.87 63.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 123.489 1.614 . . . . 0.0 110.424 -179.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.43 ' C ' ' CD2' ' A' ' 150' ' ' PHE . 8.8 p90 -100.88 178.48 4.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.575 -1.328 . . . . 0.0 109.528 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 85.7 m -133.43 139.32 46.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.478 -0.764 . . . . 0.0 109.465 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.23 161.69 37.28 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.853 -1.155 . . . . 0.0 109.721 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.4 mt -108.36 127.58 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.017 -1.052 . . . . 0.0 110.195 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -138.96 167.06 22.89 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.427 -0.796 . . . . 0.0 109.905 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.9 mt -101.76 147.24 8.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.449 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.6 m-85 -96.48 118.3 32.7 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.347 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.587 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 14.4 p30 -136.17 161.75 34.86 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.826 -0.546 . . . . 0.0 109.575 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -95.71 161.39 27.75 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 120.871 -1.143 . . . . 0.0 109.332 -179.333 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.615 ' O ' ' N ' ' A' ' 162' ' ' TRP . 42.0 Cg_endo -65.6 -53.91 0.68 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.372 2.048 . . . . 0.0 112.034 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 159' ' ' PRO . 49.7 tp10 -43.48 -16.25 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.328 -0.857 . . . . 0.0 109.177 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -86.0 -23.07 46.72 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.615 ' N ' ' O ' ' A' ' 159' ' ' PRO . 20.3 m95 -116.5 165.94 12.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.339 -1.095 . . . . 0.0 109.926 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 35.2 pt -102.46 153.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.212 -0.93 . . . . 0.0 109.284 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.94 -73.64 0.3 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.137 -0.977 . . . . 0.0 110.292 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -141.18 159.01 43.11 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.083 -1.011 . . . . 0.0 109.662 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -101.24 -41.07 6.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.11 -0.994 . . . . 0.0 109.589 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.477 ' HG1' ' H ' ' A' ' 169' ' ' ASP . 58.4 p -101.47 -30.31 11.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.081 -1.012 . . . . 0.0 109.443 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.412 ' N ' ' HG1' ' A' ' 167' ' ' THR . . . 97.3 -4.03 62.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.477 ' H ' ' HG1' ' A' ' 167' ' ' THR . 94.7 m-20 -79.41 147.64 32.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.829 -1.395 . . . . 0.0 108.361 178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 37.5 p30 -110.65 87.64 2.58 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 117.949 -1.501 . . . . 0.0 111.021 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.7 tt -76.26 -17.26 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.321 -1.487 . . . . 0.0 109.312 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.535 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -59.79 -41.86 92.09 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.799 -0.76 . . . . 0.0 108.952 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.581 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 24.1 t -52.7 -4.64 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.429 -0.794 . . . . 0.0 110.391 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.49 -40.37 29.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.783 -1.198 . . . . 0.0 111.514 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.632 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 6.1 m-85 -113.37 25.49 0.09 OUTLIER Pre-proline 0 N--CA 1.516 2.851 0 O-C-N 120.5 -1.375 . . . . 0.0 112.297 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 44.7 Cg_endo -60.91 -20.41 66.75 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.792 2.995 . . . . 0.0 114.06 -172.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -89.61 126.46 35.63 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.554 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.462 ' HB3' ' H ' ' A' ' 146' ' ' SER . 5.3 tt -87.27 122.36 30.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.045 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.598 0 O-C-N 121.01 -1.056 . . . . 0.0 109.503 -179.845 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.586 ' O ' ' OG1' ' A' ' 19' ' ' THR . 85.0 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.39 172.51 7.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.262 -0.899 . . . . 0.0 109.203 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 34.8 tp -158.71 114.08 2.59 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 123' ' ' GLN . 0.1 OUTLIER -106.34 128.52 54.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.959 -1.088 . . . . 0.0 110.535 -178.379 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.1 mt -122.57 130.47 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.453 ' CD2' ' O ' ' A' ' 11' ' ' PRO . 78.0 m-85 -129.7 167.0 18.68 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.9 m -89.86 173.65 8.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.952 -1.093 . . . . 0.0 108.706 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 m -89.3 -28.25 5.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.029 -1.044 . . . . 0.0 109.495 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -72.14 -39.57 68.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.488 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -138.48 124.6 12.67 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.89 -1.132 . . . . 0.0 109.563 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 55.9 Cg_endo -81.89 -31.52 1.02 Allowed 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.727 1.618 . . . . 0.0 112.193 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.84 1.07 4.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.415 -0.803 . . . . 0.0 110.444 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.37 118.78 32.09 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 p -96.82 127.13 42.5 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.055 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pp -89.93 -13.5 36.14 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.808 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.546 ' CZ2' ' NE2' ' A' ' 27' ' ' GLN . 53.9 t90 -158.72 106.77 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.412 -1.315 . . . . 0.0 109.713 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -120.14 119.97 34.85 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.287 -0.883 . . . . 0.0 109.835 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.66 165.44 28.24 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.32 -0.863 . . . . 0.0 110.094 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.586 ' OG1' ' O ' ' A' ' 1' ' ' SER . 7.9 t -130.11 89.6 2.82 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.182 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.546 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 20.4 m120 -125.12 137.37 54.17 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.707 -0.62 . . . . 0.0 110.181 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.8 -35.04 29.94 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.152 -1.593 . . . . 0.0 108.76 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.408 ' OE2' ' N ' ' A' ' 22' ' ' GLU . 59.1 mp0 -82.92 -51.11 7.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.268 -0.895 . . . . 0.0 109.275 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.483 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.3 tt0 -61.17 -18.49 58.42 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.546 ' CD1' ' O ' ' A' ' 20' ' ' ASN . 1.9 mt -72.85 -58.4 5.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.144 -0.973 . . . . 0.0 108.514 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.68 -45.59 85.39 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.455 -0.778 . . . . 0.0 109.324 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -62.41 -44.18 97.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 110.144 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.546 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 27.2 mt-30 -79.02 -46.31 18.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.883 -1.136 . . . . 0.0 109.902 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.0 tp -65.82 -58.33 5.88 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.939 -1.1 . . . . 0.0 109.075 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.476 ' CG ' ' O ' ' A' ' 33' ' ' VAL . 19.8 t-20 -60.41 -18.95 54.22 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.735 -1.228 . . . . 0.0 109.715 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.67 -24.93 67.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.785 -1.197 . . . . 0.0 108.025 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -88.64 13.81 11.42 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.566 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.36 21.09 46.14 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.343 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.476 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 34.0 t -93.65 144.35 9.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.366 -1.079 . . . . 0.0 109.278 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -83.76 156.16 22.69 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -153.62 146.92 24.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.807 -1.183 . . . . 0.0 107.973 177.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.9 pt-20 -175.18 175.16 2.29 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.074 -1.016 . . . . 0.0 110.271 178.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -148.37 121.94 9.17 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -112.25 153.61 26.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 108.836 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -139.25 146.58 40.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.689 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.85 159.95 14.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 108.708 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -96.23 -17.06 21.05 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.6 mtm-85 -93.09 147.95 22.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -91.91 137.17 32.59 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.582 -0.699 . . . . 0.0 109.273 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.417 ' CD2' ' N ' ' A' ' 44' ' ' LEU . 4.3 mm? -92.33 163.64 13.81 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.819 0.818 . . . . 0.0 109.378 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.15 -113.5 0.37 Allowed Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.92 -1.134 . . . . 0.0 110.639 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.61 89.01 4.51 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.126 -1.22 . . . . 0.0 109.392 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.49 92.42 19.59 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.1 -25.9 13.39 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.051 1.834 . . . . 0.0 112.285 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.4 p -119.61 141.29 49.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.696 -0.628 . . . . 0.0 109.571 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.63 -27.2 37.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.398 -0.813 . . . . 0.0 109.571 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 50' ' ' ALA . 97.0 mt-10 -43.8 -38.97 3.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.23 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 p -79.82 -32.82 40.69 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.1 -1.0 . . . . 0.0 109.11 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' A' ' 50' ' ' ALA . 43.6 t -67.55 -52.22 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.438 -0.789 . . . . 0.0 109.942 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.618 ' O ' ' N ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -60.85 -30.89 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.044 -1.035 . . . . 0.0 108.795 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.29 -34.56 75.4 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.464 -0.772 . . . . 0.0 109.633 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.97 -18.04 56.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 0.0 110.306 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -114.44 -10.29 12.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.361 -0.837 . . . . 0.0 109.962 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.721 HE21 ' CG1' ' A' ' 61' ' ' ILE . 18.6 tp60 -50.74 -34.02 25.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.17 -0.956 . . . . 0.0 109.014 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.722 ' CD2' ' N ' ' A' ' 60' ' ' ALA . 12.0 p-80 -54.67 -44.22 73.12 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.945 -1.097 . . . . 0.0 109.5 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.722 ' N ' ' CD2' ' A' ' 59' ' ' HIS . . . -64.2 -60.2 3.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 0.0 109.906 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.721 ' CG1' HE21 ' A' ' 58' ' ' GLN . 1.0 OUTLIER -63.94 -22.2 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 109.961 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' GLN . 31.1 t0 -58.15 -65.25 0.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.53 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -51.61 -34.25 36.61 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.656 -1.278 . . . . 0.0 108.773 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.16 -55.18 17.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.086 -1.009 . . . . 0.0 109.672 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -67.37 -25.54 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.391 -0.818 . . . . 0.0 109.11 179.528 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.23 -41.89 72.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.963 -1.086 . . . . 0.0 109.495 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.49 -52.3 8.22 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.954 -1.091 . . . . 0.0 109.99 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.637 ' O ' ' C ' ' A' ' 69' ' ' GLY . 45.9 mttm -82.78 4.73 24.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.258 -0.901 . . . . 0.0 110.405 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.637 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . 8.07 80.33 0.01 OUTLIER Glycine 0 N--CA 1.503 3.126 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.495 ' CG ' ' CG2' ' A' ' 155' ' ' ILE . 30.5 m-85 -74.42 161.67 29.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.164 -1.198 . . . . 0.0 109.497 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -57.01 -46.27 82.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.428 -0.795 . . . . 0.0 109.716 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 m -150.17 160.24 43.82 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.193 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.704 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 19.3 t-105 -125.77 128.14 47.25 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.483 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 2.5 t0 -136.85 157.63 46.31 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.935 -1.103 . . . . 0.0 108.479 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 76' ' ' ILE . 1.0 OUTLIER -97.86 174.13 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.507 ' N ' ' CG1' ' A' ' 75' ' ' VAL . 35.2 mm -106.99 113.77 44.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.7 p -96.76 164.52 12.54 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 123.229 1.49 . . . . 0.0 111.817 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -167.5 164.57 14.88 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.971 176.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.564 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -137.45 140.42 41.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 174.611 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.65 -1.88 20.77 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.157 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -114.99 -14.13 11.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.205 -0.934 . . . . 0.0 109.384 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -66.16 123.68 85.89 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.445 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.66 -2.18 11.73 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.176 1.917 . . . . 0.0 111.212 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -87.01 -2.99 59.04 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.027 -1.046 . . . . 0.0 109.763 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.447 ' HB2' HD22 ' A' ' 82' ' ' ASN . 0.2 OUTLIER -54.52 -43.43 71.88 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.687 -1.258 . . . . 0.0 108.135 178.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.408 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 84.6 tt0 -60.73 -40.92 94.18 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.233 -0.917 . . . . 0.0 109.148 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.48 81.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.0 109.912 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.59 -42.77 99.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.006 -1.059 . . . . 0.0 109.739 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.444 ' NH2' ' O ' ' A' ' 145' ' ' GLY . 82.8 mtm180 -62.01 -27.54 68.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.844 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -65.63 -60.29 3.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.863 . . . . 0.0 109.862 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -57.55 -36.76 72.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -0.913 . . . . 0.0 109.382 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -75.77 -24.26 56.01 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.54 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 94' ' ' ASN . 3.9 mt -74.46 -34.9 63.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 110.602 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 93' ' ' LEU . 16.5 m120 -45.8 127.13 7.77 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.906 -1.122 . . . . 0.0 109.156 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.457 ' O ' ' OE1' ' A' ' 165' ' ' GLN . 3.2 tt0 -55.1 147.64 15.6 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -169.01 -172.55 1.58 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 117.612 -1.635 . . . . 0.0 112.628 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -165.03 135.28 3.79 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.645 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.19 157.04 18.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.942 . . . . 0.0 110.077 -179.052 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.454 ' H ' ' HA ' ' A' ' 162' ' ' TRP . . . -78.8 -6.82 88.5 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -122.93 169.78 10.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.454 -1.027 . . . . 0.0 109.3 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -74.94 142.82 43.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.136 -0.978 . . . . 0.0 110.013 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.614 ' CG ' HH22 ' A' ' 154' ' ' ARG . 17.0 tt0 -100.37 94.97 6.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.296 -0.878 . . . . 0.0 108.953 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.19 128.59 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.501 -0.749 . . . . 0.0 109.173 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -129.39 122.55 29.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 52.2 t80 -109.37 127.06 54.06 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.34 125.68 34.39 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.432 0.634 . . . . 0.0 110.22 -178.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.95 -35.2 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.596 -0.69 . . . . 0.0 109.72 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -160.2 145.34 14.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.085 -1.009 . . . . 0.0 110.303 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.475 ' O ' ' OE2' ' A' ' 127' ' ' GLU . . . 97.11 162.85 32.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.21 163.82 28.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -1.154 . . . . 0.0 110.015 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.92 153.16 11.57 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.403 ' O ' ' CG ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -102.65 101.99 12.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.971 -1.311 . . . . 0.0 109.809 -179.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -88.85 130.04 35.47 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.747 -1.22 . . . . 0.0 110.704 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 31.4 t -77.86 130.59 36.82 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.325 0.584 . . . . 0.0 109.714 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -115.82 124.57 51.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.503 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.5 t-160 -115.42 115.75 27.07 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.19 -0.944 . . . . 0.0 108.945 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.41 125.33 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.194 -0.941 . . . . 0.0 110.345 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.74 -143.94 41.04 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 104.167 -3.573 . . . . 0.0 104.167 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -109.28 81.43 1.44 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 122.212 3.006 . . . . 0.0 109.793 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.503 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 21.7 pt-20 -164.96 168.38 17.58 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.1 t -125.66 136.26 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.109 -0.994 . . . . 0.0 109.933 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 115' ' ' LEU . 5.0 m-85 -124.07 130.55 52.75 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.819 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 4' ' ' THR . 17.5 mt-30 -125.15 118.38 25.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.202 -0.936 . . . . 0.0 108.974 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.9 t -105.69 132.32 52.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.5 tt -126.63 80.05 1.91 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.37 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 1' ' ' SER . 47.4 t -168.99 117.22 0.66 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 177.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.475 ' OE2' ' O ' ' A' ' 109' ' ' GLY . 10.5 tm-20 -113.5 105.7 13.67 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 116.086 -2.245 . . . . 0.0 112.34 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.577 ' C ' ' H ' ' A' ' 130' ' ' ASP . 12.2 mttm -109.31 177.08 4.86 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.16 -1.382 . . . . 0.0 108.68 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.518 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 54.5 m-80 -59.54 -2.0 0.29 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.577 ' H ' ' C ' ' A' ' 128' ' ' LYS . 31.2 p30 -72.39 154.37 40.94 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.516 ' CD1' ' C ' ' A' ' 131' ' ' LEU . 0.3 OUTLIER -120.52 155.71 33.06 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.99 0.9 . . . . 0.0 110.089 -179.171 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.492 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 2.9 tp -122.37 128.33 75.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.9 t -109.04 134.39 51.73 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 108.985 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.63 133.86 20.05 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.01 151.41 73.36 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.893 1.729 . . . . 0.0 112.552 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.39 134.71 48.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.619 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 1.4 t-80 92.97 7.94 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 120.933 0.397 . . . . 0.0 110.262 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.87 125.91 33.3 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.89 -1.131 . . . . 0.0 109.228 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 116' ' ' HIS . 40.6 Cg_endo -64.02 131.55 31.16 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.636 1.557 . . . . 0.0 111.656 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.474 ' C ' ' CE3' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -169.71 160.56 8.83 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.096 -178.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.476 ' CG ' ' CB ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -131.92 -146.6 0.29 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.295 -0.878 . . . . 0.0 109.414 -178.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.435 ' H ' ' HB2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -179.04 128.12 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.772 -1.205 . . . . 0.0 109.088 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.42 136.67 21.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.455 -0.778 . . . . 0.0 109.577 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.586 ' O ' ' C ' ' A' ' 145' ' ' GLY . 9.1 mmt -112.59 18.89 17.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.478 -0.764 . . . . 0.0 111.036 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 10.88 -94.38 0.01 OUTLIER Glycine 0 N--CA 1.506 3.339 0 CA-C-N 118.886 0.766 . . . . 0.0 112.349 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.464 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 18.5 p -85.38 120.89 27.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.351 -1.339 . . . . 0.0 109.02 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.641 ' CD ' ' H ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -113.4 118.17 44.06 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.873 -0.517 . . . . 0.0 109.783 178.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.6 Cg_endo -102.22 34.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.794 2.329 . . . . 0.0 110.742 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 82.66 64.61 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.446 0.641 . . . . 0.0 109.457 -177.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.507 ' N ' HD11 ' A' ' 78' ' ' LEU . 24.8 p90 -99.85 153.24 19.3 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 122.212 1.006 . . . . 0.0 111.327 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.8 m -118.27 137.32 53.13 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.59 163.27 33.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.1 -1.0 . . . . 0.0 109.176 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.704 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 63.6 mt -119.17 136.96 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.219 -0.926 . . . . 0.0 109.874 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.614 HH22 ' CG ' ' A' ' 102' ' ' GLU . 2.6 ttt85 -140.11 167.75 21.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.901 -1.124 . . . . 0.0 110.472 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.495 ' CG2' ' CG ' ' A' ' 70' ' ' TYR . 4.1 mp -109.18 155.19 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.485 -0.759 . . . . 0.0 109.603 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.483 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 2.6 m-30 -106.97 125.42 50.98 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.975 0.893 . . . . 0.0 110.253 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 158' ' ' ASN . 1.1 t70 -131.07 162.03 30.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.439 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -93.85 161.83 28.91 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.105 -0.997 . . . . 0.0 108.464 -179.46 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 162' ' ' TRP . 41.4 Cg_endo -63.53 -55.97 0.61 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.009 1.806 . . . . 0.0 112.376 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 159' ' ' PRO . 48.9 tp10 -44.02 -19.22 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.072 -1.018 . . . . 0.0 108.309 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -90.0 -31.1 11.35 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.598 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -95.74 165.2 12.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.406 -1.055 . . . . 0.0 111.286 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.65 148.02 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.23 -74.87 0.29 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.932 -1.105 . . . . 0.0 110.644 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 95' ' ' GLU . 14.3 mm100 -141.91 161.26 38.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.993 -1.067 . . . . 0.0 109.929 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.629 ' N ' ' CD2' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -101.95 -41.76 6.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.127 -0.983 . . . . 0.0 109.269 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 70.8 p -117.98 -30.42 5.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.346 -0.846 . . . . 0.0 108.887 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.06 -5.45 53.07 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 120.175 -1.012 . . . . 0.0 110.653 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -79.59 148.13 31.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.589 -1.536 . . . . 0.0 108.016 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -108.38 89.51 3.02 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 117.519 -1.672 . . . . 0.0 110.88 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.413 ' CG2' ' OE1' ' A' ' 95' ' ' GLU . 1.3 tt -78.86 -23.57 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.489 -1.382 . . . . 0.0 109.737 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.552 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -56.74 -41.39 77.45 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 108.724 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.52 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 47.5 p -53.52 -3.38 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.348 -0.845 . . . . 0.0 109.973 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.83 -37.05 35.91 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.031 -1.043 . . . . 0.0 111.964 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.618 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.1 m-85 -111.9 25.18 0.08 OUTLIER Pre-proline 0 N--CA 1.517 2.895 0 O-C-N 120.449 -1.407 . . . . 0.0 113.077 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 38.0 Cg_endo -58.97 -24.0 71.04 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 123.902 3.068 . . . . 0.0 115.141 -172.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -89.05 126.25 35.35 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.487 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 0.8 OUTLIER -86.8 123.99 32.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.18 -0.95 . . . . 0.0 108.717 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.591 ' CB ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.812 ' O ' HG23 ' A' ' 19' ' ' THR . 3.7 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.92 169.52 9.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.043 -1.036 . . . . 0.0 108.991 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.536 HD12 ' O ' ' A' ' 123' ' ' GLN . 5.5 tp -158.0 115.02 2.91 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.516 ' OG1' HD11 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -110.0 134.08 52.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.34 -0.85 . . . . 0.0 110.06 -178.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 121' ' ' VAL . 38.4 mt -129.74 132.12 66.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 96.6 m-85 -124.05 167.45 14.18 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -86.31 174.57 8.96 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.269 -0.895 . . . . 0.0 108.948 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.76 -31.32 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.898 -1.126 . . . . 0.0 109.492 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -73.03 -37.34 66.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.947 . . . . 0.0 110.303 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -136.52 124.71 14.96 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 109.519 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.427 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 56.3 Cg_endo -81.09 -35.53 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 122.068 1.845 . . . . 0.0 112.317 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.63 4.99 1.58 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.442 -0.787 . . . . 0.0 110.258 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -114.52 118.99 35.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.401 -0.812 . . . . 0.0 109.007 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.4 p -98.65 123.16 42.68 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.277 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 pp -91.0 -7.72 51.18 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.633 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.687 ' HB3' HD12 ' A' ' 5' ' ' ILE . 31.9 t90 -157.43 105.27 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.338 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -120.6 115.99 24.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.57 -0.706 . . . . 0.0 109.876 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.445 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -162.34 165.01 27.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.33 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 1' ' ' SER . 52.1 m -131.37 90.2 2.83 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.805 ' O ' HD12 ' A' ' 24' ' ' ILE . 84.0 m-20 -127.04 151.24 48.87 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.288 -0.882 . . . . 0.0 110.491 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.91 -45.02 13.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.037 -1.664 . . . . 0.0 108.279 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 23' ' ' GLU . 10.6 pt-20 -82.89 -46.12 13.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.704 . . . . 0.0 110.18 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.514 ' N ' ' CG ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -62.84 -23.69 67.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.52 -1.362 . . . . 0.0 108.705 -178.145 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.805 HD12 ' O ' ' A' ' 20' ' ' ASN . 4.6 mt -70.42 -58.68 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.522 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 6.6 pt20 -56.36 -44.17 79.88 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.303 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.551 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 74.5 mt-30 -57.73 -33.27 68.27 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.317 -0.865 . . . . 0.0 109.906 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.588 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 5.7 tt0 -70.34 -61.36 1.8 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.024 -1.048 . . . . 0.0 109.41 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -66.98 -55.36 14.8 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.776 -1.202 . . . . 0.0 109.794 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 18.1 t-20 -49.9 -31.95 13.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.886 -1.134 . . . . 0.0 109.333 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -63.59 -24.61 67.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.021 -1.049 . . . . 0.0 108.44 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.526 ' NZ ' ' OE1' ' A' ' 120' ' ' GLU . 30.0 mttt -92.48 14.12 17.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.54 24.44 26.01 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.714 -1.232 . . . . 0.0 110.089 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.599 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 39.6 t -96.36 146.3 7.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.386 -1.067 . . . . 0.0 109.704 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.448 ' HB3' ' H ' ' A' ' 133' ' ' SER . 18.2 ttt180 -85.83 155.85 20.81 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 120.927 -1.108 . . . . 0.0 109.136 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 25' ' ' GLN . 1.2 t80 -154.62 149.44 26.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.912 -1.117 . . . . 0.0 108.912 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 1.3 mt-10 -175.04 172.92 2.74 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.903 -1.123 . . . . 0.0 109.878 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -150.81 114.83 5.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 108.839 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -110.67 152.59 26.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.62 -0.675 . . . . 0.0 109.235 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -143.12 167.43 22.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 109.964 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.457 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . . . -93.52 158.66 15.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 108.86 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -102.97 -17.43 15.46 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.204 -0.935 . . . . 0.0 108.534 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -93.38 171.47 8.89 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.591 0.71 . . . . 0.0 109.185 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -94.34 116.88 29.33 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.556 -0.715 . . . . 0.0 109.501 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mt -91.17 163.68 14.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.429 -0.795 . . . . 0.0 109.137 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.62 -101.08 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.68 93.07 4.83 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.108 -1.23 . . . . 0.0 109.48 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.55 91.61 34.56 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -77.02 -26.94 7.32 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.412 2.074 . . . . 0.0 112.701 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.6 p -119.92 141.16 49.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 0.0 109.581 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.93 -20.85 41.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.405 -0.809 . . . . 0.0 109.475 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 50' ' ' ALA . 84.8 tt0 -44.83 -37.89 4.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.005 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.7 p -79.73 -31.95 41.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.275 -0.891 . . . . 0.0 109.42 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ALA . 79.7 t -67.74 -47.67 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 109.777 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 58' ' ' GLN . 9.9 mm -60.26 -37.26 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.957 . . . . 0.0 108.859 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.32 -29.87 70.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.418 -0.802 . . . . 0.0 109.45 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.23 -18.68 60.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 110.317 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.457 ' HE2' ' HB2' ' A' ' 40' ' ' ALA . 8.9 m-85 -118.42 -7.5 10.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.389 -0.82 . . . . 0.0 109.181 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.532 ' N ' ' O ' ' A' ' 54' ' ' ILE . 3.4 tp-100 -50.53 -39.4 48.83 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.313 -0.867 . . . . 0.0 108.774 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.541 ' ND1' ' N ' ' A' ' 60' ' ' ALA . 27.0 p80 -53.04 -42.99 66.27 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.853 -1.154 . . . . 0.0 109.24 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.541 ' N ' ' ND1' ' A' ' 59' ' ' HIS . . . -61.88 -58.69 6.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.075 -1.015 . . . . 0.0 109.464 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.711 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -64.24 -28.52 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.763 -1.211 . . . . 0.0 109.15 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 58' ' ' GLN . 27.0 t70 -55.29 -25.4 33.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.145 -0.972 . . . . 0.0 109.395 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HG2' ' N ' ' A' ' 64' ' ' LEU . 8.8 ptmt -83.71 -37.26 22.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.08 -1.012 . . . . 0.0 109.493 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.545 HD21 HG21 ' A' ' 103' ' ' VAL . 0.5 OUTLIER -68.86 -45.56 70.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.206 -0.934 . . . . 0.0 109.895 -179.415 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 69' ' ' GLY . 3.3 p -68.56 -32.64 56.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.431 -0.793 . . . . 0.0 109.479 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.1 67.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.209 -0.932 . . . . 0.0 109.538 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -79.44 -50.03 11.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.123 -0.985 . . . . 0.0 109.897 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.659 ' O ' ' C ' ' A' ' 69' ' ' GLY . 20.5 mmtt -85.83 14.12 6.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.464 -0.772 . . . . 0.0 110.14 -177.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.659 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -7.53 85.64 0.0 OUTLIER Glycine 0 N--CA 1.501 2.984 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.487 ' CG ' HG21 ' A' ' 155' ' ' ILE . 11.7 m-85 -75.96 166.84 22.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.463 -1.022 . . . . 0.0 108.977 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -57.53 -40.58 79.12 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.441 -0.787 . . . . 0.0 109.805 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.29 167.53 30.15 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.631 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.666 ' HE1' HG23 ' A' ' 153' ' ' ILE . 13.2 t-105 -134.24 137.64 44.48 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.269 -0.895 . . . . 0.0 109.126 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.69 179.02 8.9 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.061 -1.025 . . . . 0.0 108.343 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' A' ' 153' ' ' ILE . 3.8 m -124.17 149.38 28.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.422 -0.799 . . . . 0.0 109.438 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.4 mt -100.86 117.04 45.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 77' ' ' SER . 27.8 p -170.13 101.69 0.29 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.453 -0.78 . . . . 0.0 109.399 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -110.95 179.84 3.94 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.95 1.705 . . . . 0.0 107.864 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.648 ' H ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -89.71 144.75 25.72 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.688 -1.258 . . . . 0.0 109.062 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.66 2.21 0.11 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.749 -0.594 . . . . 0.0 109.593 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -85.63 -28.28 24.88 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.469 -1.292 . . . . 0.0 108.888 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.466 HD22 ' HB3' ' A' ' 85' ' ' LYS . 20.8 p-10 -64.51 123.84 84.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.905 -1.122 . . . . 0.0 109.45 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -79.19 -8.97 15.32 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.134 1.889 . . . . 0.0 112.349 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -90.21 3.13 54.42 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.96 -1.087 . . . . 0.0 109.596 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.547 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 44.6 pttt -60.96 -47.4 86.6 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.211 -0.93 . . . . 0.0 108.96 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.547 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 96.5 mt-10 -64.56 -42.88 95.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.64 76.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.029 -1.044 . . . . 0.0 109.432 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.53 -50.17 72.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 0.0 110.129 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.585 HH12 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -65.06 -24.66 67.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.229 -0.92 . . . . 0.0 109.701 -179.565 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.585 ' CD ' HH12 ' A' ' 89' ' ' ARG . 58.0 mm-40 -65.41 -60.03 3.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.37 -0.831 . . . . 0.0 109.6 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -53.32 -27.81 25.23 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.072 -1.018 . . . . 0.0 109.038 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -18.4 33.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.017 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.9 -36.72 70.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.199 -0.938 . . . . 0.0 109.848 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -46.64 137.18 7.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.057 . . . . 0.0 109.337 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -70.93 164.6 25.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 0.0 109.555 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -175.9 -167.26 0.22 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.442 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.8 t -163.88 134.31 4.31 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.619 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -103.73 154.86 19.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 0.0 109.786 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.42 -6.58 86.66 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -123.97 170.06 11.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.443 -1.033 . . . . 0.0 109.38 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -73.84 143.19 46.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.217 -0.927 . . . . 0.0 109.778 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.559 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 4.6 tt0 -104.47 94.45 5.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.214 -0.929 . . . . 0.0 109.053 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.545 HG21 HD21 ' A' ' 64' ' ' LEU . 38.3 t -81.65 131.11 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.199 -0.938 . . . . 0.0 110.161 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.99 109.64 11.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.451 -0.78 . . . . 0.0 109.854 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.624 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 14.7 t80 -104.8 131.52 52.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.335 -0.853 . . . . 0.0 109.071 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.567 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -90.06 132.27 35.49 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.408 0.623 . . . . 0.0 109.861 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.408 ' HB ' HG22 ' A' ' 151' ' ' THR . 9.4 t -113.48 -31.01 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.743 -0.598 . . . . 0.0 109.784 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -167.65 156.02 9.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.1 -1.0 . . . . 0.0 109.358 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.29 155.76 8.42 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.62 ' HB2' ' CD ' ' A' ' 127' ' ' GLU . . . -114.69 148.75 37.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -1.072 . . . . 0.0 109.365 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.23 -136.69 3.47 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 26.5 tp -138.24 154.08 49.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.397 -1.06 . . . . 0.0 109.493 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -122.23 145.43 48.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.582 -0.699 . . . . 0.0 109.39 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.67 108.71 4.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.578 -0.701 . . . . 0.0 109.713 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.611 HD21 HG13 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -118.92 112.87 20.18 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.555 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.1 t-160 -105.25 113.22 26.68 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.204 -0.935 . . . . 0.0 109.601 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -131.68 119.24 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.25 -0.906 . . . . 0.0 110.203 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.37 -143.16 33.83 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 105.998 -2.841 . . . . 0.0 105.998 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 7.0 p-10 -105.36 79.26 1.45 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 115.185 -2.606 . . . . 0.0 109.61 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.555 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 78.8 tt0 -165.19 166.19 19.13 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.765 ' O ' HG23 ' A' ' 5' ' ' ILE . 45.7 t -129.91 152.19 36.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.038 -1.038 . . . . 0.0 109.683 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.28 131.32 46.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.63 -0.669 . . . . 0.0 109.286 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.536 ' O ' HD12 ' A' ' 3' ' ' LEU . 16.7 mt-30 -128.24 115.04 17.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 109.11 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.3 t -108.22 138.08 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -134.56 90.3 2.64 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.213 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 31.2 p -166.35 135.35 3.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.388 -1.445 . . . . 0.0 107.546 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.62 ' CD ' ' HB2' ' A' ' 110' ' ' ALA . 1.3 pt-20 -107.05 94.91 5.35 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 116.195 -2.202 . . . . 0.0 110.642 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 130' ' ' ASP . 29.8 mtmm -114.55 157.69 22.67 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.655 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.624 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 14.6 m-20 -58.68 -4.0 0.38 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.421 -1.424 . . . . 0.0 108.096 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 128' ' ' LYS . 56.2 p30 -72.23 152.72 42.01 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.39 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.747 ' C ' HD12 ' A' ' 131' ' ' LEU . 2.3 pp -126.27 162.03 26.4 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.051 0.929 . . . . 0.0 110.944 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 131' ' ' LEU . 9.7 mt -129.95 130.8 66.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.448 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 5.6 t -106.81 136.92 45.81 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.477 -0.765 . . . . 0.0 109.011 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.611 HG13 HD21 ' A' ' 115' ' ' LEU . 2.3 t -101.98 133.63 20.58 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.743 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.09 151.33 81.81 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.835 1.69 . . . . 0.0 112.484 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.612 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.23 135.05 48.64 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.612 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.0 t-80 91.94 10.4 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.39 125.84 33.08 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.087 -1.008 . . . . 0.0 108.785 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.1 130.57 27.7 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.573 1.516 . . . . 0.0 111.573 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -166.94 165.42 15.97 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.229 -178.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.567 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -136.14 -149.76 0.34 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 109.646 -178.639 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.08 125.0 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 109.167 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.488 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 16.3 p-10 -141.6 132.12 25.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.627 ' O ' ' C ' ' A' ' 145' ' ' GLY . 49.7 mtt -112.73 17.77 18.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.597 -0.69 . . . . 0.0 110.692 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.67 ' N ' HD13 ' A' ' 178' ' ' LEU . . . 8.97 -90.08 0.0 OUTLIER Glycine 0 N--CA 1.502 3.098 0 CA-C-N 119.206 0.912 . . . . 0.0 111.685 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.517 ' H ' ' HB2' ' A' ' 178' ' ' LEU . 70.9 m -86.56 116.13 24.48 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 117.763 -1.575 . . . . 0.0 109.127 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.16 113.44 37.33 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.985 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.558 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.7 Cg_endo -103.36 40.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 122.935 2.423 . . . . 0.0 111.684 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 13.5 t-20 81.75 72.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.998 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 5.5 p90 -94.53 138.23 32.68 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.215 -0.928 . . . . 0.0 110.476 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.408 HG22 ' HB ' ' A' ' 107' ' ' VAL . 15.9 m -103.57 118.73 37.4 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.723 -0.61 . . . . 0.0 109.625 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.8 163.34 33.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.454 -0.779 . . . . 0.0 109.283 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.741 ' HA ' HG12 ' A' ' 75' ' ' VAL . 61.4 mt -109.35 127.04 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.272 -0.893 . . . . 0.0 110.062 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.515 ' C ' HD13 ' A' ' 155' ' ' ILE . 9.0 tpt180 -129.9 157.28 42.7 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.55 0.69 . . . . 0.0 109.514 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.598 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -102.89 149.26 7.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -96.22 120.86 37.27 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 0.0 110.319 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -133.71 162.99 30.46 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -94.52 161.98 27.32 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.143 -0.973 . . . . 0.0 109.23 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.633 ' O ' ' N ' ' A' ' 161' ' ' GLY . 40.1 Cg_endo -65.21 -57.37 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.014 1.809 . . . . 0.0 111.54 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 159' ' ' PRO . 50.6 mt-10 -43.98 -13.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.793 . . . . 0.0 109.126 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -76.77 -33.05 47.94 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 177.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.52 ' N ' ' O ' ' A' ' 159' ' ' PRO . 4.3 p90 -118.3 159.12 23.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.274 -1.133 . . . . 0.0 110.279 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 26.6 mm -100.99 147.3 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.428 -0.795 . . . . 0.0 109.392 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.654 ' HB1' ' OE1' ' A' ' 165' ' ' GLN . . . -57.36 -72.67 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.654 ' OE1' ' HB1' ' A' ' 164' ' ' ALA . 1.9 mp0 -141.4 165.29 27.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.14 -0.975 . . . . 0.0 109.646 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -100.03 -41.45 7.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.467 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 59.4 m -105.3 -30.54 9.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.166 -0.958 . . . . 0.0 109.128 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.57 -6.35 52.45 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -81.88 149.33 28.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.78 -1.424 . . . . 0.0 108.522 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 44.2 p30 -107.82 87.54 2.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.116 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.1 tt -78.31 -26.92 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.59 -1.319 . . . . 0.0 109.313 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.567 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -58.22 -42.6 86.63 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.608 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 28.6 p -54.54 -2.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 109.924 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.03 -39.8 33.03 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.097 -1.002 . . . . 0.0 111.473 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.629 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.3 m-85 -111.38 23.92 0.08 OUTLIER Pre-proline 0 N--CA 1.512 2.64 0 O-C-N 120.603 -1.31 . . . . 0.0 113.039 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 49.9 Cg_endo -65.07 -20.1 63.51 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 123.466 2.777 . . . . 0.0 113.581 -173.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -89.31 126.71 35.63 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.217 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.67 HD13 ' N ' ' A' ' 145' ' ' GLY . 7.9 mp -86.08 147.75 26.03 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.837 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.587 ' O ' ' OG1' ' A' ' 19' ' ' THR . 89.6 p . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.39 173.39 7.22 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.102 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.904 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 18.0 tp -160.06 114.43 2.26 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.51 131.54 55.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.022 -1.049 . . . . 0.0 110.227 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.728 HD13 ' CE2' ' A' ' 122' ' ' PHE . 60.5 mt -126.76 133.64 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 11' ' ' PRO . 98.4 m-85 -128.37 165.5 20.47 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.46 0.648 . . . . 0.0 109.72 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.475 ' OG ' HD13 ' A' ' 15' ' ' LEU . 64.2 m -89.66 176.29 6.92 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.78 -25.82 5.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 120.732 -1.23 . . . . 0.0 109.428 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -72.56 -40.72 66.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.969 -1.082 . . . . 0.0 110.16 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -137.44 124.57 13.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.018 . . . . 0.0 109.324 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 56.4 Cg_endo -81.86 -29.92 1.54 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.876 1.717 . . . . 0.0 112.35 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -68.37 -27.36 66.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.505 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -94.56 120.87 35.47 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.798 -1.189 . . . . 0.0 108.985 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 p -95.31 132.86 39.86 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.391 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 15' ' ' LEU . 11.1 mp -89.34 -10.27 47.31 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.991 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.904 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 37.6 t90 -158.45 105.99 1.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.291 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -120.01 116.39 25.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 0.0 109.759 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.73 166.86 25.99 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.476 -0.765 . . . . 0.0 109.776 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.831 HG23 ' O ' ' A' ' 19' ' ' THR . 9.0 t -130.33 88.19 2.61 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.717 ' O ' HD12 ' A' ' 24' ' ' ILE . 15.0 m-20 -126.04 139.23 53.58 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.52 -35.58 27.18 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.095 -1.628 . . . . 0.0 108.919 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.534 ' CG ' ' N ' ' A' ' 23' ' ' GLU . 19.8 pt-20 -82.49 -49.92 9.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.12 -0.988 . . . . 0.0 108.981 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.534 ' N ' ' CG ' ' A' ' 22' ' ' GLU . 1.6 tm-20 -63.11 -18.97 64.0 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.893 -1.13 . . . . 0.0 108.57 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 20' ' ' ASN . 1.8 mt -71.32 -56.77 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.246 -0.909 . . . . 0.0 109.504 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.56 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 7.2 pt20 -53.25 -47.6 68.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 109.654 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.56 ' N ' ' CG ' ' A' ' 25' ' ' GLN . 49.3 tt0 -63.1 -26.77 68.98 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.444 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -69.74 -66.05 0.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.137 0.97 . . . . 0.0 110.871 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.552 HD12 ' H ' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -71.35 -46.79 59.64 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.682 -1.261 . . . . 0.0 109.636 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.601 HD22 ' C ' ' A' ' 33' ' ' VAL . 10.8 m120 -54.8 -27.43 41.65 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.602 -1.311 . . . . 0.0 109.062 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -63.0 -25.75 68.54 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.7 ' HG3' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -92.6 8.67 37.99 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.367 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.06 25.47 11.26 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.742 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' HG3' ' A' ' 31' ' ' LYS . 69.5 t -94.08 145.46 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.633 -1.51 . . . . 0.0 109.084 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.608 HH12 ' NZ ' ' A' ' 68' ' ' LYS . 23.9 ttm180 -84.32 156.1 22.07 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.832 ' CE2' HD11 ' A' ' 132' ' ' ILE . 0.3 OUTLIER -153.43 147.09 25.12 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.166 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.1 tp10 -174.24 171.42 3.49 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.79 -1.194 . . . . 0.0 109.381 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -148.06 112.3 5.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.036 -1.04 . . . . 0.0 108.368 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.508 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 22.7 m0 -111.19 155.28 23.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.432 -0.793 . . . . 0.0 108.988 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.32 161.64 37.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.928 . . . . 0.0 109.969 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.86 158.14 16.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 108.931 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -102.64 -14.76 16.59 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.63 163.63 13.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.605 0.717 . . . . 0.0 109.155 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.504 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 46.3 p-10 -96.74 120.68 37.51 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.459 -0.775 . . . . 0.0 109.735 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.06 164.69 13.86 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.282 -0.886 . . . . 0.0 109.07 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.4 -105.8 0.22 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.73 90.97 5.24 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.052 -1.263 . . . . 0.0 109.104 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.44 92.17 42.9 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.93 -20.83 19.16 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.151 1.901 . . . . 0.0 112.501 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.8 p -124.27 141.67 51.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.563 -0.71 . . . . 0.0 109.622 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' GLU . . . -80.23 -20.58 44.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.538 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' ALA . 84.6 tt0 -43.12 -37.83 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.063 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.2 p -79.36 -36.35 39.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.149 -0.969 . . . . 0.0 109.144 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 50' ' ' ALA . 60.1 t -67.33 -46.34 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -0.846 . . . . 0.0 109.747 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.588 HG22 ' HG2' ' A' ' 58' ' ' GLN . 7.8 mm -60.92 -34.24 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 108.889 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.63 -29.27 70.49 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.449 -0.782 . . . . 0.0 109.627 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.56 -21.89 48.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.988 . . . . 0.0 110.136 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -110.56 -10.31 14.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.48 -0.762 . . . . 0.0 109.769 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.588 ' HG2' HG22 ' A' ' 54' ' ' ILE . 3.9 mm100 -47.59 -36.75 11.19 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.054 -1.029 . . . . 0.0 109.128 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.677 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 5.4 p80 -53.22 -48.01 68.5 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.979 -1.088 . . . . 0.0 109.57 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.677 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.15 -58.1 9.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.941 -1.099 . . . . 0.0 110.054 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.61 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -65.19 -26.25 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.924 -1.11 . . . . 0.0 109.462 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 58' ' ' GLN . 21.0 t70 -58.57 -25.19 62.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 109.32 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -83.99 -44.23 14.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.416 -0.803 . . . . 0.0 109.859 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.64 -46.46 79.12 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.422 -0.799 . . . . 0.0 109.761 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' GLY . 5.9 p -66.63 -29.61 47.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.85 -44.53 74.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.907 -1.121 . . . . 0.0 109.425 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -80.39 -51.46 8.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.934 -1.104 . . . . 0.0 110.182 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.608 ' NZ ' HH12 ' A' ' 34' ' ' ARG . 33.1 mttt -85.01 13.62 5.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 110.732 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.599 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -5.22 84.16 0.0 OUTLIER Glycine 0 N--CA 1.5 2.932 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.434 ' CG ' HG21 ' A' ' 155' ' ' ILE . 32.4 m-85 -77.5 165.08 24.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.663 -0.904 . . . . 0.0 108.703 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -57.21 -89.55 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.164 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.605 ' OG ' ' CG ' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -102.38 163.06 12.44 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.668 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.409 ' CE3' HG23 ' A' ' 155' ' ' ILE . 5.7 t-105 -136.98 141.23 42.58 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.46 -0.775 . . . . 0.0 109.187 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -174.7 -167.42 0.3 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 153' ' ' ILE . 4.7 m -124.21 168.21 17.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.492 -0.755 . . . . 0.0 109.488 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.664 HD11 ' HD2' ' A' ' 154' ' ' ARG . 75.9 mt -94.49 132.95 37.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.5 p -93.0 166.79 12.19 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.857 1.313 . . . . 0.0 112.135 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.559 HD12 ' CZ ' ' A' ' 150' ' ' PHE . 1.0 OUTLIER -169.13 160.49 9.8 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.209 176.295 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.433 ' HG3' ' H ' ' A' ' 81' ' ' ASP . 1.3 tpt180 -132.4 141.52 48.91 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 174.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.47 -0.72 6.95 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.837 -1.164 . . . . 0.0 109.684 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.433 ' H ' ' HG3' ' A' ' 79' ' ' ARG . 91.2 m-20 -118.47 -12.44 9.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.086 -1.009 . . . . 0.0 109.196 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -62.72 123.9 81.17 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.938 . . . . 0.0 110.453 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.04 -1.6 11.5 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.758 2.306 . . . . 0.0 112.542 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.481 ' H ' ' ND2' ' A' ' 82' ' ' ASN . 72.9 mt-30 -83.25 16.19 2.58 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.76 -1.212 . . . . 0.0 109.161 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.456 ' HG2' ' H ' ' A' ' 85' ' ' LYS . 6.2 pttt -61.36 -59.88 4.59 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.5 -0.75 . . . . 0.0 109.507 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.405 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 20.1 pt-20 -64.56 -31.74 73.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.312 -0.868 . . . . 0.0 109.666 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.89 -59.27 5.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 110.077 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 72.4 mt -61.95 -42.81 99.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 110.185 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.451 ' HE ' ' C ' ' A' ' 85' ' ' LYS . 49.6 mtm180 -59.52 -28.98 67.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.886 . . . . 0.0 110.079 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.96 -59.58 4.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 0.0 109.497 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -51.22 -34.34 31.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.376 -0.827 . . . . 0.0 109.404 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -88.14 -17.74 30.31 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.043 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.711 HD21 ' OG ' ' A' ' 173' ' ' SER . 8.6 tp -55.79 -34.39 65.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 109.822 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -63.28 135.29 56.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.121 -0.987 . . . . 0.0 110.22 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -70.71 164.45 25.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.527 -0.733 . . . . 0.0 109.418 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -174.92 -165.6 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.82 -1.175 . . . . 0.0 111.272 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 163' ' ' ILE . 9.5 t -164.56 135.33 4.16 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.607 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -105.93 154.58 20.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.466 -0.771 . . . . 0.0 110.207 -178.539 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.39 -6.35 86.42 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.441 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 95.5 mt-10 -124.24 169.93 11.27 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.487 -1.008 . . . . 0.0 109.61 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -74.91 143.62 43.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 0.0 109.827 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.484 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 6.7 tt0 -107.54 93.25 4.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.261 -0.899 . . . . 0.0 108.592 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 103' ' ' VAL . 10.5 p -94.67 131.98 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.738 -1.226 . . . . 0.0 111.025 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.74 ' HE ' HH21 ' A' ' 154' ' ' ARG . 78.0 mtt180 -130.2 126.93 38.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.735 -0.603 . . . . 0.0 109.402 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.605 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 13.3 t80 -109.05 132.0 54.53 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.533 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -85.21 126.25 33.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.941 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.4 ' O ' ' CG ' ' A' ' 108' ' ' GLU . 5.0 t -107.15 -41.18 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.369 -0.832 . . . . 0.0 110.692 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 91.1 mt-10 -154.8 141.07 18.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.883 -1.136 . . . . 0.0 109.815 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.97 159.89 36.07 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.503 ' HB2' ' HG3' ' A' ' 127' ' ' GLU . . . -113.92 151.03 32.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -1.223 . . . . 0.0 109.737 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.57 -126.83 1.95 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.9 tp -147.95 163.22 37.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -1.015 . . . . 0.0 109.074 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -134.8 90.81 2.69 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.046 -1.034 . . . . 0.0 109.098 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.589 ' SG ' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -78.13 146.25 35.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.982 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mt -148.53 101.53 3.23 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -102.13 113.4 26.63 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.825 -1.172 . . . . 0.0 109.562 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.746 HD12 ' N ' ' A' ' 118' ' ' GLY . 0.1 OUTLIER -134.97 124.79 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.095 -1.003 . . . . 0.0 110.506 -178.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.746 ' N ' HD12 ' A' ' 117' ' ' ILE . . . 70.22 -142.67 36.24 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 105.636 -2.986 . . . . 0.0 105.636 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.32 79.11 1.18 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 115.157 -2.617 . . . . 0.0 108.303 176.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -165.07 166.62 19.05 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.682 ' O ' HG23 ' A' ' 5' ' ' ILE . 51.0 t -125.99 140.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.087 -1.008 . . . . 0.0 110.404 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.728 ' CE2' HD13 ' A' ' 5' ' ' ILE . 16.0 m-85 -123.83 131.02 53.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.442 0.639 . . . . 0.0 109.791 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -141.94 118.62 11.05 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.169 -0.957 . . . . 0.0 109.785 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -101.79 147.23 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.612 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tp -127.58 81.62 2.03 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.46 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.447 ' SG ' ' CB ' ' A' ' 1' ' ' SER . 35.9 t -166.56 122.65 1.22 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.703 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -109.3 105.82 15.38 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 116.705 -1.998 . . . . 0.0 112.338 -178.648 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.56 ' C ' ' H ' ' A' ' 130' ' ' ASP . 42.1 mmtt -113.77 171.04 7.82 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.02 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.605 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 68.1 m-20 -58.76 -3.03 0.27 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.832 -1.168 . . . . 0.0 107.895 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 128' ' ' LYS . 40.2 p30 -73.43 153.99 40.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.793 0.806 . . . . 0.0 109.888 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.79 ' C ' HD12 ' A' ' 131' ' ' LEU . 2.3 pp -122.89 161.31 24.37 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.073 0.939 . . . . 0.0 110.366 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.832 HD11 ' CE2' ' A' ' 35' ' ' PHE . 1.3 mp -131.54 127.83 60.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.664 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.9 t -123.71 135.93 54.15 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.75 148.63 36.1 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.278 -0.889 . . . . 0.0 108.799 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.22 157.95 57.87 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.554 2.169 . . . . 0.0 113.052 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.621 ' O ' ' CD2' ' A' ' 137' ' ' HIS . . . -73.38 135.62 44.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.237 -0.914 . . . . 0.0 108.997 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.703 ' O ' ' ND1' ' A' ' 137' ' ' HIS . 0.1 OUTLIER 95.43 3.92 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.352 0.596 . . . . 0.0 109.732 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.78 125.47 42.19 Favored Pre-proline 0 N--CA 1.487 1.42 0 O-C-N 120.84 -1.162 . . . . 0.0 108.816 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.14 132.9 33.38 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.433 1.422 . . . . 0.0 111.6 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.512 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.42 164.28 15.05 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.189 -0.944 . . . . 0.0 110.161 -178.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.589 ' CD1' ' SG ' ' A' ' 114' ' ' CYS . 14.6 p90 -130.06 -153.78 0.59 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.469 -0.77 . . . . 0.0 109.752 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.616 ' CD1' ' NH1' ' A' ' 104' ' ' ARG . 2.8 t80 -170.78 125.01 0.68 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.303 -0.873 . . . . 0.0 108.999 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.501 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 49.0 p-10 -148.19 130.97 16.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.944 -1.097 . . . . 0.0 109.374 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.615 ' O ' ' C ' ' A' ' 145' ' ' GLY . 8.6 mmt -107.18 18.91 21.1 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 111.334 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 11.56 -99.39 0.01 OUTLIER Glycine 0 N--CA 1.501 3.008 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.507 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 31.6 t -84.16 120.56 26.33 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.897 -1.354 . . . . 0.0 109.351 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 147' ' ' GLU . 1.0 OUTLIER -115.51 117.6 40.32 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 57.2 Cg_endo -100.03 31.2 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.258 1.972 . . . . 0.0 112.209 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 13.3 t-20 81.79 63.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.688 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.559 ' CZ ' HD12 ' A' ' 78' ' ' LEU . 15.0 p90 -101.41 169.85 8.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.519 -0.738 . . . . 0.0 109.222 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 53.3 m -130.28 106.53 8.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.57 -0.706 . . . . 0.0 109.489 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' A' ' 75' ' ' VAL . . . -105.91 161.94 14.01 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.987 -1.07 . . . . 0.0 109.827 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.648 ' HA ' HG12 ' A' ' 75' ' ' VAL . 23.5 mt -105.45 123.26 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.869 -1.145 . . . . 0.0 110.291 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.74 HH21 ' HE ' ' A' ' 104' ' ' ARG . 1.9 mtt-85 -130.62 159.85 35.97 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.624 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.98 155.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.605 ' CG ' ' OG ' ' A' ' 72' ' ' SER . 5.8 m-85 -96.19 121.87 38.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 110.224 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 49.2 p30 -132.04 163.28 28.78 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -92.79 161.86 30.65 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.979 -1.076 . . . . 0.0 108.865 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.598 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.0 Cg_endo -62.52 -60.4 0.19 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.747 1.631 . . . . 0.0 112.288 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.7 tt0 -45.92 -13.53 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -72.7 -43.87 41.43 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.563 ' CE3' ' O ' ' A' ' 163' ' ' ILE . 9.9 p-90 -110.13 161.02 15.96 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.518 -0.989 . . . . 0.0 110.348 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.563 ' O ' ' CE3' ' A' ' 162' ' ' TRP . 4.0 tp -99.92 154.44 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.249 -0.907 . . . . 0.0 109.194 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.78 -75.54 0.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.97 . . . . 0.0 110.435 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -142.3 164.61 29.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.103 -0.998 . . . . 0.0 110.156 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -101.21 -40.18 7.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.89 . . . . 0.0 109.326 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 22.0 m -114.68 -32.36 5.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.937 . . . . 0.0 108.568 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.61 -1.34 58.38 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.505 ' OD2' ' O ' ' A' ' 169' ' ' ASP . 39.1 p30 -80.29 145.82 31.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.3 -1.706 . . . . 0.0 108.726 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -113.21 89.7 3.15 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.113 -1.435 . . . . 0.0 110.263 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.455 HD11 ' HZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -78.71 -17.89 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.241 -1.537 . . . . 0.0 108.854 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -58.67 -41.59 86.51 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.362 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.711 ' OG ' HD21 ' A' ' 93' ' ' LEU . 1.2 m -52.46 -3.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.538 -0.726 . . . . 0.0 109.873 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.71 -39.57 26.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.909 -1.119 . . . . 0.0 111.371 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.639 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -114.57 25.58 0.09 OUTLIER Pre-proline 0 N--CA 1.516 2.842 0 O-C-N 120.668 -1.27 . . . . 0.0 112.089 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 39.1 Cg_endo -59.25 -18.18 43.44 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.333 2.689 . . . . 0.0 114.177 -171.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -89.44 125.57 35.22 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.619 -1.233 . . . . 0.0 108.107 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.507 ' HB3' ' H ' ' A' ' 146' ' ' SER . 3.9 tt -86.68 125.45 33.87 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.092 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.299 -1.593 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.623 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.776 ' O ' HG23 ' A' ' 19' ' ' THR . 2.8 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.49 169.32 9.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.066 . . . . 0.0 109.074 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.85 HD13 HG22 ' A' ' 124' ' ' VAL . 16.3 tp -157.65 114.99 3.01 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.7 OUTLIER -109.02 138.59 45.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.216 -0.928 . . . . 0.0 110.119 -179.16 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.708 HD12 ' HB3' ' A' ' 16' ' ' TRP . 52.9 mt -132.87 131.45 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -125.6 164.29 20.88 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m -85.91 175.0 8.87 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.144 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -26.87 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.023 -1.048 . . . . 0.0 109.677 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -74.11 -38.43 63.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.05 -1.031 . . . . 0.0 110.181 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.33 125.91 14.77 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 109.679 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 13' ' ' ASN . 56.1 Cg_endo -80.42 -36.9 0.43 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 121.974 1.783 . . . . 0.0 112.202 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 7.86 0.77 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.768 . . . . 0.0 110.113 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 11' ' ' PRO . 80.6 m-20 -116.96 119.77 36.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.196 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.419 ' C ' HD22 ' A' ' 15' ' ' LEU . 6.1 p -98.96 123.65 43.39 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.65 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.9 mm? -89.93 -9.84 47.36 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.585 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.708 ' HB3' HD12 ' A' ' 5' ' ' ILE . 33.1 t90 -157.48 106.87 2.15 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.629 -1.228 . . . . 0.0 110.133 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -121.87 119.92 33.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.512 -0.742 . . . . 0.0 109.729 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.409 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -162.85 164.56 25.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.218 -0.926 . . . . 0.0 110.132 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 1' ' ' SER . 76.1 m -130.14 89.11 2.75 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.017 -1.052 . . . . 0.0 108.188 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.754 ' O ' HD12 ' A' ' 24' ' ' ILE . 83.4 m-20 -127.73 144.26 51.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.458 -0.776 . . . . 0.0 110.422 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.73 -38.74 21.0 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.235 -1.541 . . . . 0.0 108.312 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -82.9 -48.36 10.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.516 -0.74 . . . . 0.0 109.749 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.627 ' OE1' ' ND2' ' A' ' 20' ' ' ASN . 1.2 tt0 -62.83 -19.56 64.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.722 -1.236 . . . . 0.0 108.608 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.754 HD12 ' O ' ' A' ' 20' ' ' ASN . 4.0 mt -74.47 -56.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.871 . . . . 0.0 109.326 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.445 ' HB2' ' CG ' ' A' ' 35' ' ' PHE . 3.0 pp0? -55.41 -34.9 64.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.309 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.54 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 49.8 tt0 -68.09 -47.5 68.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.276 -0.89 . . . . 0.0 109.447 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.55 ' OE1' ' CD1' ' A' ' 5' ' ' ILE . 7.6 tt0 -68.16 -40.46 82.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.167 -0.958 . . . . 0.0 109.082 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.568 HD12 HG11 ' A' ' 33' ' ' VAL . 3.5 mm? -68.18 -62.42 1.41 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.172 -0.955 . . . . 0.0 109.286 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 15.1 t-20 -58.13 -17.98 22.21 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.298 -0.876 . . . . 0.0 109.907 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -67.1 -32.52 73.73 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.847 -1.158 . . . . 0.0 109.387 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -90.51 9.34 29.72 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.98 24.56 16.82 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.283 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.568 HG11 HD12 ' A' ' 28' ' ' LEU . 33.7 t -96.96 147.82 6.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.279 -1.13 . . . . 0.0 109.554 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' HB3' ' H ' ' A' ' 133' ' ' SER . 19.5 ttt180 -84.02 154.01 23.51 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 120.511 -1.368 . . . . 0.0 108.368 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.538 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 1.1 t80 -154.39 149.97 27.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.023 -1.048 . . . . 0.0 108.276 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 2.9 mt-10 -177.24 177.08 1.26 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.045 -1.034 . . . . 0.0 109.481 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -148.61 112.44 5.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.705 ' CH2' HD23 ' A' ' 131' ' ' LEU . 31.4 m0 -111.02 157.4 19.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.271 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -142.72 156.24 44.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 0.0 109.927 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.35 152.75 20.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.205 -0.934 . . . . 0.0 108.997 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -104.03 -6.39 21.22 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -93.34 159.15 15.39 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.781 0.801 . . . . 0.0 109.093 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -94.51 115.31 27.45 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.66 -0.65 . . . . 0.0 109.537 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.7 mt -94.86 164.96 12.7 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.43 -0.794 . . . . 0.0 109.505 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.29 -103.76 0.2 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.6 92.97 4.76 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.989 -1.301 . . . . 0.0 109.187 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.16 92.12 44.88 Favored Pre-proline 0 C--N 1.306 -1.293 0 C-N-CA 119.8 -0.76 . . . . 0.0 108.965 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.54 -21.91 14.41 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.297 1.998 . . . . 0.0 112.763 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 p -122.93 142.12 51.16 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.584 -0.698 . . . . 0.0 109.705 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.34 -16.91 53.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.43 -0.794 . . . . 0.0 109.419 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -46.92 -39.03 11.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.344 -0.847 . . . . 0.0 108.725 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.3 m -79.2 -39.68 32.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.617 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.71 -46.53 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.291 -0.881 . . . . 0.0 109.669 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 58' ' ' GLN . 15.6 mt -60.48 -36.02 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.073 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.06 -28.65 69.75 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.411 -0.806 . . . . 0.0 109.407 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.76 -20.29 50.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.038 -1.039 . . . . 0.0 110.331 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 58' ' ' GLN . 61.7 m-85 -112.02 -12.27 13.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.298 -0.876 . . . . 0.0 109.552 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 62' ' ' ASP . 3.8 tp-100 -45.52 -35.9 4.19 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.567 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.6 -47.64 63.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 109.546 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.567 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.34 -60.08 4.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 109.755 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.677 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -63.17 -29.51 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 120.608 -1.308 . . . . 0.0 109.127 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 58' ' ' GLN . 21.3 t70 -55.9 -26.41 47.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.706 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -78.28 -36.1 47.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.985 -1.072 . . . . 0.0 109.543 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 64' ' ' LEU . 8.4 mp -63.19 -40.79 98.53 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.545 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -70.13 -29.01 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.173 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.53 -56.66 12.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.431 -1.418 . . . . 0.0 109.191 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -83.53 -48.81 9.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.035 -1.04 . . . . 0.0 110.608 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.627 ' O ' ' C ' ' A' ' 69' ' ' GLY . 7.5 mtpm? -87.79 14.7 8.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.878 . . . . 0.0 110.788 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.627 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -11.68 89.33 0.0 OUTLIER Glycine 0 N--CA 1.501 3.028 0 CA-C-O 121.959 0.755 . . . . 0.0 111.227 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.472 ' CG ' HG21 ' A' ' 155' ' ' ILE . 84.3 m-85 -76.86 164.42 25.83 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.589 ' C ' ' NE2' ' A' ' 71' ' ' GLN . 0.2 OUTLIER -63.2 -87.48 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.43 -0.794 . . . . 0.0 109.78 -178.808 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.401 ' OG ' ' OE1' ' A' ' 71' ' ' GLN . 14.7 m -102.74 160.24 14.76 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 109.595 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 74' ' ' ASP . 7.6 t-105 -140.79 145.75 36.74 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.454 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.2 OUTLIER -165.36 -176.6 4.1 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 152' ' ' ALA . 9.9 p -119.8 142.73 33.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 76' ' ' ILE . 2.5 tp -101.33 115.71 43.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 77' ' ' SER . 4.7 p -169.56 102.99 0.33 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.381 -0.825 . . . . 0.0 108.845 177.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.722 HD23 ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -117.98 179.77 3.99 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.094 1.77 . . . . 0.0 108.12 -179.55 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.722 ' H ' HD23 ' A' ' 78' ' ' LEU . 3.2 tpt180 -89.88 143.85 26.44 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.667 -1.27 . . . . 0.0 109.412 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.42 1.38 0.35 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.568 -0.707 . . . . 0.0 109.593 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 79' ' ' ARG . 84.6 m-20 -78.87 -29.09 44.28 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.213 -1.395 . . . . 0.0 108.872 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.75 HD21 ' CD ' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -64.27 124.85 86.9 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.044 -1.035 . . . . 0.0 109.085 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -78.55 -8.56 16.01 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.171 1.914 . . . . 0.0 112.401 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -89.59 4.14 50.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.006 -1.059 . . . . 0.0 109.482 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.75 ' CD ' HD21 ' A' ' 82' ' ' ASN . 3.5 tptp -60.0 -49.82 76.18 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.194 -0.941 . . . . 0.0 108.919 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -62.82 -41.99 99.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 109.57 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.16 -38.27 76.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.612 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 88' ' ' LEU . 2.7 mm? -60.3 -42.75 96.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.345 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.572 ' NH2' ' O ' ' A' ' 85' ' ' LYS . 1.0 OUTLIER -60.49 -30.65 69.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.845 . . . . 0.0 109.873 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.22 -60.22 3.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 109.671 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.403 ' O ' ' ND2' ' A' ' 94' ' ' ASN . 50.4 mttp -57.17 -32.18 66.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.504 -0.747 . . . . 0.0 109.278 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -85.6 -18.25 33.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.415 -0.803 . . . . 0.0 110.243 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -60.86 -40.17 91.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.125 -0.984 . . . . 0.0 109.85 -179.315 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 21.5 p30 -46.89 125.48 7.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.121 -0.987 . . . . 0.0 109.452 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.53 166.32 1.32 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.504 -0.748 . . . . 0.0 109.366 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -173.17 -169.26 0.52 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.899 -1.12 . . . . 0.0 111.433 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.2 t -164.1 135.58 4.6 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.676 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -107.55 156.2 19.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.443 -0.785 . . . . 0.0 109.735 -178.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.18 -6.94 86.7 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -123.51 170.67 10.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.316 -1.108 . . . . 0.0 109.288 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -76.26 142.99 41.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.972 -1.08 . . . . 0.0 110.161 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -100.24 94.6 6.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.194 -0.942 . . . . 0.0 109.058 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.627 HG22 HD11 ' A' ' 155' ' ' ILE . 1.0 OUTLIER -91.46 130.67 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.507 -0.745 . . . . 0.0 109.878 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.5 HH21 ' CB ' ' A' ' 152' ' ' ALA . 51.2 ttt180 -132.01 123.77 27.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.398 -0.814 . . . . 0.0 109.346 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.615 ' HB3' HD12 ' A' ' 153' ' ' ILE . 27.2 t80 -104.78 131.89 51.7 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.09 128.42 35.42 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.608 -0.682 . . . . 0.0 110.228 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.0 t -112.63 -29.67 2.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.683 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -169.04 158.04 8.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.027 . . . . 0.0 109.031 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.488 ' O ' ' OE1' ' A' ' 127' ' ' GLU . . . 78.49 150.0 4.69 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.9 156.05 31.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.421 -1.046 . . . . 0.0 109.512 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.483 ' C ' HD11 ' A' ' 178' ' ' LEU . . . -151.49 -125.99 1.24 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.88 HD12 HD12 ' A' ' 178' ' ' LEU . 1.6 mt -148.95 164.32 34.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -1.08 . . . . 0.0 109.659 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.518 ' CG ' HD11 ' A' ' 132' ' ' ILE . 0.2 OUTLIER -138.47 91.59 2.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.569 179.21 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.643 ' SG ' ' NE2' ' A' ' 123' ' ' GLN . 0.8 OUTLIER -77.97 117.04 18.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 109.476 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.582 HD11 HG22 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -118.34 106.16 12.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.116 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -101.33 109.56 21.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.972 . . . . 0.0 109.462 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mm -125.57 111.82 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.005 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.99 -142.12 28.11 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 106.537 -2.625 . . . . 0.0 106.537 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.494 ' O ' ' CG ' ' A' ' 119' ' ' ASP . 48.2 p-10 -103.8 79.2 1.63 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 115.103 -2.639 . . . . 0.0 109.369 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 121' ' ' VAL . 75.8 tt0 -165.92 167.34 16.78 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.64 ' O ' HG23 ' A' ' 5' ' ' ILE . 86.7 t -130.43 151.91 36.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.089 -1.007 . . . . 0.0 109.924 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.439 ' C ' ' OE1' ' A' ' 123' ' ' GLN . 32.7 m-85 -130.87 133.27 45.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.691 -0.631 . . . . 0.0 109.986 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.643 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 4.2 mp0 -122.35 110.07 15.2 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.412 -0.805 . . . . 0.0 109.088 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.85 HG22 HD13 ' A' ' 3' ' ' LEU . 21.2 t -104.84 133.9 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.948 ' H ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.55 90.54 2.62 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.341 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 30.1 p -166.36 128.8 1.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.393 -1.442 . . . . 0.0 107.329 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 7.0 tt0 -107.39 96.35 6.34 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 116.096 -2.242 . . . . 0.0 110.569 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.591 ' C ' ' H ' ' A' ' 130' ' ' ASP . 17.1 mtpp -112.73 159.78 18.6 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.66 176.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.586 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 88.6 m-20 -57.12 -4.27 0.18 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.442 -1.411 . . . . 0.0 107.761 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.591 ' H ' ' C ' ' A' ' 128' ' ' LYS . 67.3 m-20 -66.73 143.14 57.12 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.705 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.101 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -110.79 142.67 42.45 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.614 0.721 . . . . 0.0 110.706 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 1.101 ' N ' HD12 ' A' ' 131' ' ' LEU . 47.6 pt -132.64 147.66 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.432 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 8.9 t -137.03 153.78 50.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.349 -0.844 . . . . 0.0 109.581 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.582 HG22 HD11 ' A' ' 115' ' ' LEU . 1.1 t -106.11 143.01 26.06 Favored Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.49 152.65 80.38 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.283 1.989 . . . . 0.0 112.274 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.609 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.59 134.61 47.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.275 -0.891 . . . . 0.0 109.223 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.609 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.1 t-80 91.31 11.21 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.121 0.486 . . . . 0.0 109.742 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 138' ' ' THR . 0.8 OUTLIER -104.13 126.5 31.48 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 0.0 108.739 179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.98 131.49 29.0 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.581 1.52 . . . . 0.0 111.474 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.488 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.9 163.79 9.62 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.223 -179.186 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.505 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -134.53 -146.94 0.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.239 -0.913 . . . . 0.0 109.713 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -177.9 126.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.926 -1.109 . . . . 0.0 109.037 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.496 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 10.9 p-10 -144.25 134.14 23.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.31 -0.869 . . . . 0.0 109.895 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.618 ' O ' ' C ' ' A' ' 145' ' ' GLY . 84.1 mmm -112.94 20.48 16.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.584 -0.697 . . . . 0.0 111.202 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.61 -92.68 0.01 OUTLIER Glycine 0 N--CA 1.506 3.363 0 CA-C-N 119.265 0.939 . . . . 0.0 111.534 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.486 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 74.5 m -85.85 117.51 24.76 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.92 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.653 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -117.3 113.18 39.12 Favored Pre-proline 0 C--N 1.299 -1.609 0 C-N-CA 119.764 -0.775 . . . . 0.0 109.804 178.095 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.3 Cg_endo -103.12 40.95 0.04 OUTLIER 'Trans proline' 0 C--O 1.213 -0.767 0 C-N-CA 122.717 2.278 . . . . 0.0 111.349 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 13.6 t-20 81.79 71.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.124 -177.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.536 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 8.9 p90 -95.53 144.31 26.11 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.388 -0.82 . . . . 0.0 109.895 -177.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.8 m -113.17 122.96 49.09 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.536 -0.728 . . . . 0.0 109.754 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.628 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -142.83 162.58 35.1 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.615 HD12 ' HB3' ' A' ' 105' ' ' PHE . 57.6 mt -107.49 126.92 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.076 -1.015 . . . . 0.0 109.374 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -136.51 164.13 28.9 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.113 -0.992 . . . . 0.0 109.803 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.627 HD11 HG22 ' A' ' 103' ' ' VAL . 4.7 mp -102.5 145.12 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.579 -0.701 . . . . 0.0 109.562 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.454 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.2 m-85 -95.54 118.81 32.94 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.291 -0.881 . . . . 0.0 109.361 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 0.9 OUTLIER -134.93 164.13 28.29 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 3.9 m-20 -93.65 160.26 33.16 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.167 -0.958 . . . . 0.0 109.052 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.3 Cg_endo -61.76 -55.65 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.198 1.932 . . . . 0.0 112.199 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.4 tt0 -44.09 -15.49 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.336 -0.853 . . . . 0.0 108.986 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -72.72 -46.68 29.68 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 178.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.464 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 6.5 p90 -107.38 165.03 11.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.341 -1.094 . . . . 0.0 110.05 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 72.6 mt -100.59 149.58 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.35 -71.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.088 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.583 ' NE2' ' OD1' ' A' ' 170' ' ' ASP . 43.1 mt-30 -140.39 159.01 43.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 109.632 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -101.21 -41.12 6.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 109.564 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.7 p -102.44 -30.43 11.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.085 -1.009 . . . . 0.0 108.856 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.49 -6.49 52.81 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -82.13 148.55 28.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.704 -1.468 . . . . 0.0 108.688 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.583 ' OD1' ' NE2' ' A' ' 165' ' ' GLN . 88.5 m-20 -109.08 88.35 2.71 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 117.568 -1.653 . . . . 0.0 111.096 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.5 tt -77.75 -23.69 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.609 -1.307 . . . . 0.0 109.348 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.505 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -60.41 -41.44 93.92 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.632 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 93.4 p -54.62 -2.95 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.481 -0.762 . . . . 0.0 109.994 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.31 -39.84 31.83 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.942 -1.099 . . . . 0.0 111.298 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.627 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 9.9 m-85 -111.64 24.4 0.08 OUTLIER Pre-proline 0 N--CA 1.514 2.754 0 O-C-N 120.85 -1.156 . . . . 0.0 112.808 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.632 ' HD3' ' C ' ' A' ' 173' ' ' SER . 45.3 Cg_endo -63.59 -19.3 67.32 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.68 2.92 . . . . 0.0 113.348 -173.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.08 125.51 35.05 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.99 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.88 HD12 HD12 ' A' ' 112' ' ' LEU . 1.8 tp -88.03 120.41 29.34 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.525 -0.734 . . . . 0.0 109.135 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.295 -1.786 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.34 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.608 ' O ' ' OG1' ' A' ' 19' ' ' THR . 1.6 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.96 171.55 8.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 108.925 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.751 ' CD1' HG22 ' A' ' 124' ' ' VAL . 28.2 tp -158.85 113.1 2.44 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.74 130.32 54.96 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.166 -0.959 . . . . 0.0 110.365 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 121' ' ' VAL . 63.9 mt -124.59 133.61 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 97.2 m-85 -126.63 165.36 19.34 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -91.73 176.33 6.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 108.715 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -25.68 5.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.888 -1.133 . . . . 0.0 109.418 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -73.13 -40.68 64.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 110.086 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -136.81 124.01 14.16 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.093 -1.004 . . . . 0.0 109.437 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.565 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 56.4 Cg_endo -82.18 -33.13 0.6 Allowed 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.925 1.75 . . . . 0.0 112.319 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.482 ' OE1' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -68.43 -25.99 65.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 110.347 -178.604 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -95.41 120.79 36.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.959 -1.088 . . . . 0.0 108.977 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.38 131.99 40.91 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.297 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 pp -90.37 -8.96 49.38 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.209 -0.996 . . . . 0.0 108.822 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.66 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 45.1 t90 -157.54 106.79 2.13 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.506 -1.278 . . . . 0.0 109.943 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -120.77 119.82 33.85 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.535 -0.728 . . . . 0.0 109.801 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.47 161.84 30.24 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.198 -0.939 . . . . 0.0 109.82 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 19' ' ' THR . 8.9 t -131.36 89.08 2.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 118.773 -1.171 . . . . 0.0 108.507 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.752 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -126.27 142.37 51.55 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.372 -0.83 . . . . 0.0 110.24 177.351 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.85 -37.05 27.57 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.463 -1.398 . . . . 0.0 109.137 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.68 -50.15 9.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.167 -0.958 . . . . 0.0 109.862 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -63.32 -18.53 63.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.036 -1.04 . . . . 0.0 108.719 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.752 HD12 ' O ' ' A' ' 20' ' ' ASN . 3.1 mt -73.56 -56.07 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 108.912 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.427 ' N ' HG22 ' A' ' 24' ' ' ILE . 9.2 pt20 -57.61 -40.77 79.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.211 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.683 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 68.5 mt-30 -62.04 -43.03 99.7 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.142 -0.974 . . . . 0.0 109.114 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.488 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 7.5 tt0 -72.47 -44.85 61.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.204 -0.935 . . . . 0.0 108.899 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.597 HD12 HG11 ' A' ' 33' ' ' VAL . 2.8 mm? -64.19 -62.56 1.54 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.054 -1.029 . . . . 0.0 109.371 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.618 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -61.23 -17.56 53.93 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.165 -178.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -62.52 -28.82 70.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.529 -1.357 . . . . 0.0 108.439 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.679 ' HG3' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -94.19 6.81 47.46 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.855 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.81 25.64 12.92 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.046 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.679 HG23 ' HG3' ' A' ' 31' ' ' LYS . 61.8 t -95.29 145.98 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.149 -1.206 . . . . 0.0 109.191 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -83.59 153.47 24.3 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 121.058 -1.026 . . . . 0.0 108.555 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CB ' HD21 ' A' ' 29' ' ' ASN . 2.2 t80 -154.21 146.47 23.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.159 -0.963 . . . . 0.0 108.729 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.535 ' O ' ' OD2' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -177.9 178.07 1.0 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.006 -1.059 . . . . 0.0 110.251 178.147 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 119.3 6.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 108.886 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.428 ' CE3' ' HB1' ' A' ' 60' ' ' ALA . 23.1 m0 -111.99 156.83 21.51 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -143.05 160.98 39.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.867 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.44 158.17 16.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 108.946 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -101.45 -14.1 17.67 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -92.9 158.79 15.65 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.535 0.684 . . . . 0.0 109.161 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -93.71 123.63 37.16 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 109.46 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 mt -94.39 165.67 12.45 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 109.368 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.7 -105.14 0.22 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.01 93.06 5.04 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.999 -1.295 . . . . 0.0 109.327 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.9 91.65 43.37 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -75.88 -22.04 13.7 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.155 1.903 . . . . 0.0 112.421 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.1 p -120.58 141.19 50.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.618 -0.677 . . . . 0.0 109.679 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.681 ' HB1' HD13 ' A' ' 54' ' ' ILE . . . -80.86 -17.86 49.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.478 -0.764 . . . . 0.0 109.535 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.69 -39.22 16.86 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.223 -0.923 . . . . 0.0 108.862 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.8 m -78.92 -34.89 44.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 109.587 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.418 HG11 ' CG1' ' A' ' 107' ' ' VAL . 60.1 t -67.76 -57.12 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.342 -0.849 . . . . 0.0 110.33 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.681 HD13 ' HB1' ' A' ' 50' ' ' ALA . 1.7 mp -58.8 -34.99 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.968 -1.083 . . . . 0.0 108.9 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.68 -35.18 72.18 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.413 -0.804 . . . . 0.0 109.365 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.51 -13.7 60.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.21 -0.931 . . . . 0.0 109.632 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.4 m-85 -111.42 -8.39 14.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.489 -0.757 . . . . 0.0 109.762 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 62' ' ' ASP . 8.8 mm100 -47.06 -36.05 7.63 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.159 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.514 ' ND1' ' N ' ' A' ' 60' ' ' ALA . 29.7 p80 -53.36 -44.18 68.36 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.74 -1.225 . . . . 0.0 109.516 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.514 ' N ' ' ND1' ' A' ' 59' ' ' HIS . . . -63.6 -61.1 2.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.0 -1.063 . . . . 0.0 110.071 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.643 ' O ' HG23 ' A' ' 65' ' ' VAL . 1.3 pp -62.36 -27.72 43.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.75 -1.219 . . . . 0.0 108.983 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' A' ' 62' ' ' ASP . 36.8 t0 -58.41 -27.69 64.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.96 . . . . 0.0 109.567 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -74.19 -40.93 62.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.959 . . . . 0.0 109.121 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 64' ' ' LEU . 7.6 mp -64.42 -34.85 79.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 109.295 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 61' ' ' ILE . 11.5 t -68.13 -29.93 46.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.035 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.75 72.82 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.658 -1.276 . . . . 0.0 109.524 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -87.74 -53.86 4.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.083 -1.011 . . . . 0.0 110.5 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.604 ' O ' ' C ' ' A' ' 69' ' ' GLY . 8.2 mmtp -85.96 14.51 6.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.355 -0.84 . . . . 0.0 110.489 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -16.41 87.58 0.0 OUTLIER Glycine 0 N--CA 1.499 2.885 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 68' ' ' LYS . 81.1 m-85 -76.58 164.01 26.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -57.74 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.312 -0.868 . . . . 0.0 109.673 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.58 163.0 12.58 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.598 0.713 . . . . 0.0 110.058 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.775 ' HE1' HG23 ' A' ' 153' ' ' ILE . 5.6 t-105 -131.84 135.76 46.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HB2' ' CE2' ' A' ' 156' ' ' PHE . 0.7 OUTLIER -146.86 166.81 25.57 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.9 -1.125 . . . . 0.0 108.142 178.475 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 152' ' ' ALA . 8.8 p -119.55 141.28 40.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 76' ' ' ILE . 7.6 tp -102.7 115.01 43.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.235 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.0 t -167.63 100.06 0.49 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.34 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.657 HD23 ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -125.01 -179.26 4.48 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.34 -1.475 . . . . 0.0 107.658 -179.52 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.657 ' H ' HD23 ' A' ' 78' ' ' LEU . 23.2 tpt180 -88.91 153.07 21.34 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.671 -1.268 . . . . 0.0 109.075 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.97 0.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ARG . 83.8 m-20 -103.43 30.54 4.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.552 ' OD1' ' N ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -82.26 135.08 47.76 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.52 -0.737 . . . . 0.0 110.201 178.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.446 ' C ' ' OE1' ' A' ' 84' ' ' GLN . 55.7 Cg_endo -77.41 -25.75 7.97 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.173 1.915 . . . . 0.0 112.198 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.487 ' N ' ' OE1' ' A' ' 84' ' ' GLN . 0.9 OUTLIER -92.5 8.13 40.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.895 -1.128 . . . . 0.0 109.493 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.576 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 18.0 pttt -58.73 -51.7 68.86 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.214 -0.929 . . . . 0.0 108.774 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.576 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 84.2 tt0 -67.6 -54.24 21.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.146 -0.972 . . . . 0.0 109.504 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.83 -47.02 83.85 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.311 -0.955 . . . . 0.0 109.727 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 84' ' ' GLN . 13.3 tp -63.07 -46.13 88.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.768 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -60.83 -36.96 80.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 109.602 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.7 -58.84 4.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -0.878 . . . . 0.0 109.625 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -50.5 -37.89 41.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.278 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.03 -19.46 51.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.117 -0.99 . . . . 0.0 109.134 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 93' ' ' LEU . 8.0 tt -61.3 -34.86 75.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 109.758 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -64.26 150.44 45.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.107 -0.995 . . . . 0.0 110.188 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.726 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 7.7 pm0 -80.91 166.31 20.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 0.0 109.567 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -173.96 -169.24 0.47 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.044 -1.062 . . . . 0.0 111.195 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.2 t -163.48 132.97 4.09 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.635 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -104.3 156.74 17.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.516 -0.74 . . . . 0.0 110.125 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.446 ' N ' ' HB3' ' A' ' 162' ' ' TRP . . . -78.78 -6.56 88.49 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 95.7 mt-10 -124.36 171.15 10.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.395 -1.062 . . . . 0.0 109.429 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 102' ' ' GLU . 48.3 t0 -75.19 139.91 42.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.109 -0.994 . . . . 0.0 110.248 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.594 ' N ' ' OD2' ' A' ' 101' ' ' ASP . 14.9 tt0 -97.13 95.17 7.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.344 -0.848 . . . . 0.0 108.931 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.838 HG13 ' OG ' ' A' ' 133' ' ' SER . 29.5 t -95.29 123.17 47.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.65 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 34.0 ttm105 -127.28 126.3 42.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.46 -0.775 . . . . 0.0 109.018 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.622 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 15.2 t80 -102.36 131.18 49.15 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.825 0.822 . . . . 0.0 109.201 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.405 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -85.9 126.46 34.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.49 0.662 . . . . 0.0 110.154 -178.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.418 ' CG1' HG11 ' A' ' 53' ' ' VAL . 12.9 t -108.5 -30.24 2.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.73 -0.606 . . . . 0.0 109.476 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -165.94 153.8 10.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 109.27 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.76 157.09 32.8 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.46 ' HB2' ' CD ' ' A' ' 127' ' ' GLU . . . -134.17 162.38 32.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -1.171 . . . . 0.0 109.089 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.63 155.16 13.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.533 ' HB3' HD12 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -103.14 98.93 8.79 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.133 -1.216 . . . . 0.0 110.638 -178.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -80.5 126.41 31.18 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.66 -1.275 . . . . 0.0 110.054 -178.61 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.497 ' SG ' ' OE1' ' A' ' 123' ' ' GLN . 0.9 OUTLIER -78.5 125.84 29.93 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.312 0.577 . . . . 0.0 109.984 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.669 HD21 HG11 ' A' ' 134' ' ' VAL . 0.5 OUTLIER -113.62 125.53 54.27 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.48 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 8.2 t-160 -107.91 110.37 22.1 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.446 HG21 ' HD3' ' A' ' 31' ' ' LYS . 2.2 pt -124.64 114.25 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 O-C-N 121.45 -0.781 . . . . 0.0 110.513 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.63 -143.81 33.15 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 104.845 -3.302 . . . . 0.0 104.845 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -106.19 79.93 1.45 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 115.048 -2.661 . . . . 0.0 108.636 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.48 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 12.2 pt-20 -166.35 170.16 13.33 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.669 ' O ' HG23 ' A' ' 5' ' ' ILE . 88.9 t -125.27 137.56 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.006 -1.059 . . . . 0.0 109.853 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.556 ' CE2' HD13 ' A' ' 5' ' ' ILE . 7.2 m-85 -122.09 129.54 52.46 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.497 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 8.9 mt-30 -128.39 115.24 17.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 108.984 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.751 HG22 ' CD1' ' A' ' 3' ' ' LEU . 11.5 t -101.76 133.54 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.546 ' C ' HD23 ' A' ' 125' ' ' LEU . 5.7 tt -134.42 91.0 2.73 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.746 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.402 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 30.7 p -164.77 134.75 3.82 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.46 ' CD ' ' HB2' ' A' ' 110' ' ' ALA . 5.7 pt-20 -106.33 94.64 5.26 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 115.55 -2.46 . . . . 0.0 110.538 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.545 ' C ' ' H ' ' A' ' 130' ' ' ASP . 20.1 tptm -114.2 156.8 23.62 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.088 176.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.622 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 83.3 m-20 -58.35 -3.32 0.26 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.487 -1.383 . . . . 0.0 107.891 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.593 ' OD2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.89 153.03 43.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.199 -178.5 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.759 ' C ' HD12 ' A' ' 131' ' ' LEU . 2.1 pp -117.56 160.57 21.03 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.893 0.854 . . . . 0.0 110.095 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.645 ' N ' HD12 ' A' ' 131' ' ' LEU . 5.6 mm -131.65 128.77 60.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.805 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.838 ' OG ' HG13 ' A' ' 103' ' ' VAL . 14.5 m -123.0 142.09 51.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.401 -0.812 . . . . 0.0 109.373 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.669 HG11 HD21 ' A' ' 115' ' ' LEU . 8.3 m -109.31 148.96 39.08 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.407 -0.808 . . . . 0.0 108.98 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -66.81 154.76 73.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.378 2.052 . . . . 0.0 112.966 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.618 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -73.32 136.53 44.49 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.459 -0.776 . . . . 0.0 109.329 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.618 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 4.1 t-80 92.95 10.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.37 126.17 32.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 108.556 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.79 132.2 31.83 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.54 1.493 . . . . 0.0 111.534 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.45 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.86 162.83 9.54 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.219 -0.926 . . . . 0.0 110.18 -178.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.513 ' CD2' ' HB2' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -133.71 -147.16 0.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.65 ' CE1' ' NH1' ' A' ' 104' ' ' ARG . 0.2 OUTLIER -178.74 127.7 0.11 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.864 -1.148 . . . . 0.0 109.077 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 54.7 p-10 -147.23 139.55 24.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.808 . . . . 0.0 109.852 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.604 ' O ' ' C ' ' A' ' 145' ' ' GLY . 2.6 ptt? -113.7 22.9 13.6 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.579 -0.7 . . . . 0.0 110.72 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 7.11 -90.61 0.0 OUTLIER Glycine 0 N--CA 1.502 3.053 0 CA-C-N 119.517 1.053 . . . . 0.0 112.465 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.525 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 23.0 t -86.05 116.78 24.48 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 117.886 -1.525 . . . . 0.0 108.834 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.662 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -116.74 114.36 39.75 Favored Pre-proline 0 C--N 1.296 -1.719 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.748 178.486 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.0 Cg_endo -101.41 38.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.885 0 C-N-CA 122.873 2.382 . . . . 0.0 110.705 176.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 16.4 t-20 82.56 70.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -176.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 20.2 p90 -95.25 163.35 13.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.747 -0.595 . . . . 0.0 109.635 -177.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.5 m -134.42 126.9 30.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 0.0 109.931 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.617 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . . . -143.65 163.48 33.13 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.539 -0.726 . . . . 0.0 109.14 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.775 HG23 ' HE1' ' A' ' 73' ' ' TRP . 24.8 mt -110.59 130.04 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.192 -0.943 . . . . 0.0 109.681 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.567 ' C ' HD13 ' A' ' 155' ' ' ILE . 6.5 ptm180 -131.26 159.02 39.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.42 -0.8 . . . . 0.0 110.494 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.581 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -108.12 149.63 11.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.501 0.667 . . . . 0.0 109.446 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 74' ' ' ASP . 4.0 m-30 -97.33 120.62 38.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.866 0.841 . . . . 0.0 110.77 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.614 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 52.0 t0 -133.93 158.93 42.23 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.594 ' O ' ' NE1' ' A' ' 162' ' ' TRP . 80.9 m-20 -96.96 150.8 37.26 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.901 -1.124 . . . . 0.0 109.513 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.625 ' O ' ' N ' ' A' ' 161' ' ' GLY . 45.9 Cg_endo -70.65 -53.23 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.363 2.042 . . . . 0.0 112.121 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.5 tt0 -42.4 -15.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.672 -0.643 . . . . 0.0 109.514 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.27 -41.4 13.74 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 177.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.614 ' HE1' ' CG ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -114.4 175.66 5.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.596 -0.944 . . . . 0.0 110.952 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 19.2 pt -96.32 155.44 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.535 -0.728 . . . . 0.0 109.339 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -93.56 -70.84 0.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 110.663 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -107.06 143.07 35.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.07 -1.019 . . . . 0.0 110.197 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -102.07 -40.48 6.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 109.619 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -116.92 -30.12 5.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.323 -0.861 . . . . 0.0 108.688 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.83 -7.41 53.02 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -80.9 149.2 29.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.661 -1.494 . . . . 0.0 108.176 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.484 ' OD2' ' OG ' ' A' ' 173' ' ' SER . 1.7 p30 -107.98 88.42 2.73 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 117.425 -1.71 . . . . 0.0 111.152 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.0 OUTLIER -75.83 -25.62 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.832 -1.168 . . . . 0.0 109.328 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.513 ' HB2' ' CD2' ' A' ' 141' ' ' TRP . . . -60.56 -40.37 91.41 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.61 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 52.8 p -55.45 -4.22 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.577 -0.702 . . . . 0.0 110.22 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.466 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -81.58 -37.84 27.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.04 -1.037 . . . . 0.0 111.281 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.624 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.3 m-85 -112.13 23.84 0.08 OUTLIER Pre-proline 0 N--CA 1.509 2.522 0 O-C-N 120.538 -1.351 . . . . 0.0 112.777 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 45.3 Cg_endo -64.0 -18.84 65.26 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 123.153 2.569 . . . . 0.0 113.911 -173.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -88.36 125.07 34.52 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.849 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.726 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.8 OUTLIER -87.97 120.84 29.71 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.367 -0.833 . . . . 0.0 109.194 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.432 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.57 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.35 171.93 8.1 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.097 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.837 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 18.3 tp -157.58 115.02 3.03 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.547 ' OG1' HD11 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -111.76 131.99 54.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.023 -1.048 . . . . 0.0 110.062 -178.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 121' ' ' VAL . 53.8 mt -127.11 131.55 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 71.4 m-85 -129.79 164.37 24.19 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.6 m -89.02 174.96 7.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.21 -0.931 . . . . 0.0 108.906 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -23.92 6.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 120.902 -1.124 . . . . 0.0 109.532 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -41.05 62.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.059 -1.026 . . . . 0.0 110.334 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.25 123.08 11.0 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.991 -1.068 . . . . 0.0 109.52 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.588 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 55.6 Cg_endo -82.58 -27.29 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.885 1.724 . . . . 0.0 112.214 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.411 ' O ' ' CD ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -70.45 0.55 6.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 110.546 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.578 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -123.12 118.63 28.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 108.923 179.472 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.32 129.41 41.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.03 -1.044 . . . . 0.0 109.095 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.578 ' CD1' HD21 ' A' ' 13' ' ' ASN . 9.4 mp -88.46 -12.25 43.59 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.046 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.837 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 40.8 t90 -158.44 107.33 1.98 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.747 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -120.03 117.69 28.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.367 -0.833 . . . . 0.0 109.76 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.71 163.43 29.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.532 -0.73 . . . . 0.0 109.753 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 19' ' ' THR . 8.9 t -130.63 89.25 2.74 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.039 -1.038 . . . . 0.0 108.297 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.713 ' O ' HD12 ' A' ' 24' ' ' ILE . 87.4 m-20 -125.17 138.6 54.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.32 -0.862 . . . . 0.0 110.535 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.93 -34.08 30.03 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 119.874 -1.766 . . . . 0.0 108.555 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -82.65 -53.55 5.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.096 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -58.56 -20.22 44.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.134 -0.979 . . . . 0.0 108.666 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.713 HD12 ' O ' ' A' ' 20' ' ' ASN . 5.5 mt -75.85 -57.09 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.053 -1.03 . . . . 0.0 108.748 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.499 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 61.5 tt0 -53.47 -41.08 65.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.409 -0.807 . . . . 0.0 109.077 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -71.84 -49.08 41.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.124 -0.985 . . . . 0.0 110.652 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.564 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 27.0 mt-30 -72.23 -47.33 51.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.977 -1.077 . . . . 0.0 110.998 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 33' ' ' VAL . 14.7 tp -61.22 -54.66 41.36 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.017 -1.052 . . . . 0.0 109.467 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 15.0 m120 -62.78 -16.2 56.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.978 -1.076 . . . . 0.0 109.636 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 27' ' ' GLN . . . -62.86 -28.96 70.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.616 -1.302 . . . . 0.0 108.507 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 12.51 11.82 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.792 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.44 24.65 28.04 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.139 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.564 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 99.9 t -95.64 143.82 11.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.39 -1.065 . . . . 0.0 109.513 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -84.04 158.87 21.31 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.476 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -150.45 146.04 26.4 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.295 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 36.7 mt-10 -162.96 162.87 26.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.116 -0.99 . . . . 0.0 108.932 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.2 mtm-85 -148.41 111.59 4.91 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.615 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 18.0 m0 -112.71 155.99 23.57 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -142.65 162.32 35.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 0.0 109.846 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.23 159.59 15.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 108.905 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -100.59 -17.1 17.22 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -92.88 159.68 15.25 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.51 123.36 35.75 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.569 -0.707 . . . . 0.0 109.379 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.3 mt -90.53 166.15 13.38 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.299 -0.876 . . . . 0.0 109.342 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.69 -105.13 0.21 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.26 91.24 4.99 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.133 -1.216 . . . . 0.0 109.388 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.2 92.4 22.07 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.78 -27.43 8.81 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.206 1.937 . . . . 0.0 112.461 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 p -121.24 141.87 50.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.633 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.48 -21.2 42.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 109.532 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 50' ' ' ALA . 83.7 tt0 -43.54 -38.78 3.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -0.825 . . . . 0.0 109.096 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.7 p -78.52 -34.77 47.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 109.244 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 50' ' ' ALA . 59.1 t -68.28 -46.35 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.349 -0.844 . . . . 0.0 109.916 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.444 HD13 ' N ' ' A' ' 54' ' ' ILE . 6.5 mm -61.62 -35.62 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.957 . . . . 0.0 108.881 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.17 -30.34 71.51 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.52 -0.738 . . . . 0.0 109.653 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.55 -20.47 56.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 110.086 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.404 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.5 m-85 -110.74 -6.76 14.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.454 -0.779 . . . . 0.0 109.479 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 54' ' ' ILE . 4.0 mm100 -47.62 -37.9 13.57 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.068 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.5 ' ND1' ' N ' ' A' ' 60' ' ' ALA . 30.9 p80 -52.59 -45.0 66.33 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.865 -1.147 . . . . 0.0 109.633 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.5 ' N ' ' ND1' ' A' ' 59' ' ' HIS . . . -63.66 -59.83 4.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.73 -1.232 . . . . 0.0 110.403 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.693 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.9 OUTLIER -61.83 -28.06 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.763 -1.211 . . . . 0.0 108.826 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 58' ' ' GLN . 25.9 t70 -57.62 -28.91 64.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.239 -0.913 . . . . 0.0 109.441 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.406 ' CD ' ' O ' ' A' ' 59' ' ' HIS . 4.7 mptp? -73.74 -41.31 62.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.108 -0.995 . . . . 0.0 109.185 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.4 mp -64.09 -35.27 80.21 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.387 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 61' ' ' ILE . 3.7 t -69.1 -28.9 41.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.227 -0.92 . . . . 0.0 109.321 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.77 -53.84 53.82 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.546 -1.346 . . . . 0.0 109.57 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -85.57 -53.69 5.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.024 -1.048 . . . . 0.0 110.704 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.583 ' O ' ' C ' ' A' ' 69' ' ' GLY . 11.2 mmtp -84.96 14.45 4.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.443 -0.786 . . . . 0.0 110.646 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -18.23 87.93 0.0 OUTLIER Glycine 0 N--CA 1.498 2.805 0 CA-C-O 122.041 0.8 . . . . 0.0 111.332 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 68' ' ' LYS . 58.7 m-85 -76.12 165.07 25.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -57.14 -88.83 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.431 -0.793 . . . . 0.0 109.522 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.404 ' CB ' ' HB2' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -103.76 163.1 12.56 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.641 0.734 . . . . 0.0 109.999 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.617 ' HE1' HG23 ' A' ' 153' ' ' ILE . 5.2 t-105 -135.23 139.24 44.31 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -155.48 173.5 16.6 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.98 141.39 39.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 76' ' ' ILE . 16.2 tt -102.78 117.09 47.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.517 ' O ' ' OG ' ' A' ' 77' ' ' SER . 8.8 p -168.24 101.78 0.44 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.473 ' HG ' ' H ' ' A' ' 79' ' ' ARG . 9.6 tp -116.01 179.43 3.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 119.31 -2.119 . . . . 0.0 107.781 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.531 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -89.51 150.01 22.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.032 -1.042 . . . . 0.0 109.173 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.2 2.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -0.881 . . . . 0.0 109.675 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 79' ' ' ARG . 32.3 t0 -78.77 -28.1 44.7 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.566 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -63.69 123.66 82.13 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.872 -1.143 . . . . 0.0 109.91 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.59 -4.77 12.36 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.048 1.832 . . . . 0.0 111.97 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -87.98 6.26 36.8 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.044 -1.035 . . . . 0.0 109.761 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.532 ' HG3' ' H ' ' A' ' 86' ' ' GLU . 11.9 ptpt -57.27 -50.89 71.48 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.162 -0.961 . . . . 0.0 108.975 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.532 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 84.4 tt0 -66.33 -42.57 87.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.282 -0.886 . . . . 0.0 109.899 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.72 -59.42 4.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.13 -0.981 . . . . 0.0 110.136 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.537 ' H ' HD12 ' A' ' 88' ' ' LEU . 6.1 mp -62.8 -44.53 95.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.953 -1.092 . . . . 0.0 109.49 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 145' ' ' GLY . 47.7 ttp180 -59.54 -30.33 68.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.845 . . . . 0.0 109.627 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.82 -61.66 2.34 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.616 -0.833 . . . . 0.0 109.638 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -54.98 -32.66 61.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.462 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -63.69 -31.34 72.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.902 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.601 ' O ' ' HB3' ' A' ' 172' ' ' ALA . 73.6 mt -50.87 -41.37 58.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.001 -1.062 . . . . 0.0 110.014 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -49.22 141.01 8.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.762 -1.211 . . . . 0.0 109.583 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.467 ' CG ' ' O ' ' A' ' 169' ' ' ASP . 0.7 OUTLIER -81.63 171.65 14.37 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.707 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.5 p-80 -177.71 -165.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 110.537 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.1 t -163.32 137.74 6.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.625 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -109.33 155.57 21.04 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 109.87 -178.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.87 -7.03 87.49 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -123.51 170.64 10.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.54 -0.977 . . . . 0.0 109.356 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' A' ' 101' ' ' ASP . 48.3 p30 -75.98 143.9 41.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.056 -1.027 . . . . 0.0 110.07 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.434 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 1.8 mt-10 -104.11 94.28 5.3 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.06 -1.025 . . . . 0.0 108.446 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.781 HG13 ' OG ' ' A' ' 133' ' ' SER . 44.1 t -97.55 127.02 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.023 -1.048 . . . . 0.0 110.313 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 129.73 43.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.342 -0.849 . . . . 0.0 109.244 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.641 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 14.2 t80 -106.44 131.92 53.07 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.161 -0.962 . . . . 0.0 109.33 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.54 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -87.86 130.82 34.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 110.279 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.429 HG12 HG11 ' A' ' 53' ' ' VAL . 3.0 t -109.63 -34.17 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.66 -0.65 . . . . 0.0 110.065 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 109' ' ' GLY . 1.4 tm-20 -164.01 151.68 12.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.477 ' N ' ' OE1' ' A' ' 108' ' ' GLU . . . 87.42 148.76 14.63 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.71 155.39 27.83 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.32 -1.106 . . . . 0.0 108.933 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -150.87 -119.61 0.9 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.2 tp -146.71 162.23 38.95 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.368 -1.078 . . . . 0.0 109.097 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -131.31 90.43 2.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.282 -0.886 . . . . 0.0 109.234 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.719 ' O ' HD22 ' A' ' 115' ' ' LEU . 5.1 p -79.47 131.96 36.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 110.107 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.719 HD22 ' O ' ' A' ' 114' ' ' CYS . 0.6 OUTLIER -136.67 104.26 5.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.358 -0.839 . . . . 0.0 108.772 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.427 ' CD2' HG22 ' A' ' 121' ' ' VAL . 3.2 t-80 -98.41 108.93 21.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.928 -1.108 . . . . 0.0 109.582 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.443 ' H ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -126.12 113.19 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.004 -178.674 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.85 -141.47 27.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 104.968 -3.253 . . . . 0.0 104.968 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.495 ' O ' ' OD2' ' A' ' 119' ' ' ASP . 39.9 p30 -108.25 80.92 1.41 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 115.488 -2.485 . . . . 0.0 108.956 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -166.41 168.88 14.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.727 ' O ' HG23 ' A' ' 5' ' ' ILE . 55.5 t -129.19 150.8 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.984 . . . . 0.0 109.83 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.5 ' CZ ' HD13 ' A' ' 5' ' ' ILE . 1.5 m-85 -125.39 129.8 50.61 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.213 0.53 . . . . 0.0 109.575 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 4' ' ' THR . 28.6 mt-30 -129.23 110.74 12.22 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.664 HG22 ' CD1' ' A' ' 3' ' ' LEU . 3.1 t -102.2 138.2 27.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.551 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 5.6 mp -122.39 79.51 1.62 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 117.685 -1.606 . . . . 0.0 109.226 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.551 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -165.86 118.42 1.11 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 178.373 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 7.3 tm-20 -113.9 104.19 11.92 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 116.618 -2.033 . . . . 0.0 110.916 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 130' ' ' ASP . 44.6 mtmt -110.15 178.01 4.53 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.688 177.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.641 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 5.1 p30 -59.42 -3.57 0.46 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 36' ' ' GLU . 26.7 p30 -72.28 151.88 42.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.835 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.76 ' C ' HD12 ' A' ' 131' ' ' LEU . 1.9 pp -114.9 160.77 19.13 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.023 0.916 . . . . 0.0 110.57 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.623 ' N ' HD12 ' A' ' 131' ' ' LEU . 6.2 mm -128.07 125.96 65.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.586 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.781 ' OG ' HG13 ' A' ' 103' ' ' VAL . 28.0 m -123.35 141.26 52.17 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.46 148.58 39.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.852 . . . . 0.0 108.716 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -70.24 156.68 61.55 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.269 1.979 . . . . 0.0 112.926 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.605 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.15 133.51 46.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.438 -0.789 . . . . 0.0 109.036 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.605 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 11.1 t60 92.24 11.75 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.168 0.509 . . . . 0.0 110.012 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.24 126.26 32.07 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.99 133.86 40.47 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.442 1.428 . . . . 0.0 111.699 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.511 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.41 163.49 8.59 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.084 -1.047 . . . . 0.0 110.313 -179.263 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.72 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 10.7 p90 -130.95 -153.49 0.57 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.365 -0.835 . . . . 0.0 110.031 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.534 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -168.41 125.06 1.03 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.476 -0.765 . . . . 0.0 109.169 179.112 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 46.2 p-10 -146.04 129.48 16.86 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.053 -1.029 . . . . 0.0 109.749 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.586 ' O ' ' C ' ' A' ' 145' ' ' GLY . 29.8 mtt -102.95 16.51 26.42 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.369 -0.832 . . . . 0.0 111.198 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 20.86 -113.85 0.01 OUTLIER Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.424 ' H ' ' HB2' ' A' ' 178' ' ' LEU . 67.2 m -81.3 120.77 25.35 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.064 -1.454 . . . . 0.0 109.159 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.04 114.46 46.21 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 120.181 -0.607 . . . . 0.0 109.386 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 59.6 Cg_endo -104.14 44.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 122.614 2.209 . . . . 0.0 111.485 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 12.0 t-20 81.68 70.35 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.177 -177.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 23.8 p90 -96.44 159.06 15.14 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.414 -0.804 . . . . 0.0 110.225 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.3 m -125.37 125.39 43.37 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.582 0.706 . . . . 0.0 110.716 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.491 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . . . -143.22 162.76 34.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.37 -0.831 . . . . 0.0 109.295 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.617 HG23 ' HE1' ' A' ' 73' ' ' TRP . 94.9 mt -110.9 129.87 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.256 -0.902 . . . . 0.0 109.942 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.526 ' C ' HD13 ' A' ' 155' ' ' ILE . 95.5 mtt-85 -129.87 158.03 40.63 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.578 -0.701 . . . . 0.0 109.596 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.68 154.41 8.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.404 ' HB2' ' CB ' ' A' ' 72' ' ' SER . 4.2 m-30 -95.81 120.15 35.57 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.093 -1.004 . . . . 0.0 110.196 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.562 ' CG ' ' CE2' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -134.82 161.89 33.91 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.591 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -95.92 160.61 29.71 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 120.92 -1.113 . . . . 0.0 109.268 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 161' ' ' GLY . 43.0 Cg_endo -67.9 -54.83 0.3 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.367 2.044 . . . . 0.0 112.088 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 159' ' ' PRO . 16.5 pt-20 -43.98 -14.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.243 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -89.04 -36.7 7.54 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CE2' ' CG ' ' A' ' 157' ' ' ASP . 47.6 m0 -102.26 163.35 12.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.601 -0.941 . . . . 0.0 110.675 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -99.25 139.33 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.362 -0.836 . . . . 0.0 109.238 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.36 -73.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.5 -0.75 . . . . 0.0 110.736 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -142.25 159.69 41.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.941 -1.099 . . . . 0.0 110.062 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.6 -41.45 6.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.753 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.9 -31.74 5.0 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.26 -1.27 64.48 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.467 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 94.6 m-20 -80.71 149.51 29.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.761 -1.435 . . . . 0.0 108.291 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.462 ' OD2' ' OG ' ' A' ' 173' ' ' SER . 5.8 p-10 -109.5 88.07 2.65 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.624 -1.63 . . . . 0.0 110.682 176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.0 OUTLIER -76.16 -20.76 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.336 -1.477 . . . . 0.0 109.594 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.72 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -61.51 -39.82 92.4 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.972 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.583 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 38.2 p -52.9 -3.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.711 -0.618 . . . . 0.0 110.193 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.98 -39.66 29.6 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.957 -1.09 . . . . 0.0 111.491 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.636 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.7 m-85 -113.48 24.27 0.08 OUTLIER Pre-proline 0 N--CA 1.516 2.864 0 O-C-N 120.534 -1.353 . . . . 0.0 112.73 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 43.9 Cg_endo -61.56 -19.59 65.36 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.653 2.902 . . . . 0.0 114.486 -172.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -89.36 127.05 35.77 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.879 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.739 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 1.0 OUTLIER -85.5 118.81 25.25 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.085 -1.009 . . . . 0.0 108.698 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.624 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.492 ' O ' ' OG1' ' A' ' 19' ' ' THR . 1.3 p . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.77 171.08 8.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.237 -0.914 . . . . 0.0 109.437 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.775 HD13 HG22 ' A' ' 124' ' ' VAL . 30.9 tp -158.9 112.53 2.36 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.29 128.97 54.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.829 -1.169 . . . . 0.0 110.091 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 121' ' ' VAL . 60.4 mt -123.7 130.07 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -125.9 165.55 18.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.54 ' OG ' HD11 ' A' ' 15' ' ' LEU . 14.3 m -84.35 172.77 11.49 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.32 -0.863 . . . . 0.0 109.019 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -89.43 -30.45 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.121 . . . . 0.0 109.955 179.452 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -73.73 -38.33 64.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 0.0 110.043 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.71 123.93 13.12 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.34 -30.43 1.55 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.234 1.956 . . . . 0.0 112.312 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.67 2.27 3.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.466 -0.771 . . . . 0.0 109.928 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -117.79 119.45 34.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.5 p -96.12 124.38 40.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.292 -0.88 . . . . 0.0 109.334 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.54 HD11 ' OG ' ' A' ' 7' ' ' SER . 72.0 mt -87.62 -15.4 37.42 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.715 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 46.2 t90 -158.93 108.59 1.96 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.649 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -120.5 122.08 39.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.136 -0.977 . . . . 0.0 109.275 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.07 164.02 20.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.969 -1.082 . . . . 0.0 109.961 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 19' ' ' THR . 10.3 t -131.47 89.89 2.78 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.566 175.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.779 ' O ' HD12 ' A' ' 24' ' ' ILE . 29.8 m120 -125.59 145.54 50.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.964 -1.085 . . . . 0.0 110.688 177.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.58 -41.67 19.27 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.34 -1.475 . . . . 0.0 109.072 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -82.77 -48.81 10.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.349 -0.844 . . . . 0.0 109.6 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.486 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.1 tt0 -61.31 -19.95 62.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.974 -1.079 . . . . 0.0 108.533 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.779 HD12 ' O ' ' A' ' 20' ' ' ASN . 2.3 mt -73.27 -58.59 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.183 -0.948 . . . . 0.0 109.316 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.516 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 6.2 pt20 -61.28 -42.22 98.27 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.035 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.516 ' N ' ' CG ' ' A' ' 25' ' ' GLN . 62.7 tt0 -61.77 -47.46 85.08 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.347 -0.846 . . . . 0.0 109.48 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.545 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 36.1 tt0 -76.06 -45.44 34.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.062 -1.024 . . . . 0.0 109.332 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 28' ' ' LEU . 16.9 tp -64.54 -56.74 12.08 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.02 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.622 HD21 ' CB ' ' A' ' 35' ' ' PHE . 1.2 m-20 -57.26 -17.92 13.95 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.928 -1.108 . . . . 0.0 109.469 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 27' ' ' GLN . . . -63.93 -27.8 69.39 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.916 -1.115 . . . . 0.0 109.084 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -89.75 10.53 23.09 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.721 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.0 23.49 25.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.1 t -93.69 143.35 11.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.249 -1.148 . . . . 0.0 109.672 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 ttt85 -85.08 155.7 21.39 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.385 -0.822 . . . . 0.0 109.055 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.622 ' CB ' HD21 ' A' ' 29' ' ' ASN . 1.5 t80 -155.81 153.59 30.02 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.711 -1.243 . . . . 0.0 109.059 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' OE1' ' O ' ' A' ' 35' ' ' PHE . 13.1 tp10 -175.71 173.34 2.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.763 -1.211 . . . . 0.0 109.576 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.449 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 37.5 mtm180 -148.38 117.56 6.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.813 -1.18 . . . . 0.0 108.665 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.527 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 26.8 m0 -110.2 154.07 23.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 109.283 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 38' ' ' TRP . 99.5 mm-40 -141.12 155.88 46.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.481 -0.762 . . . . 0.0 109.92 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.99 156.64 17.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.328 -0.857 . . . . 0.0 109.004 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.499 ' OD2' ' N ' ' A' ' 42' ' ' ARG . 53.2 p30 -101.11 -11.81 19.3 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.125 -0.985 . . . . 0.0 108.7 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.499 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -93.38 156.38 16.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.33 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -92.12 119.03 31.4 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.688 -0.632 . . . . 0.0 109.566 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.36 163.65 14.12 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.696 0.76 . . . . 0.0 109.3 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.37 -102.81 0.19 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.18 92.82 4.49 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.928 -1.336 . . . . 0.0 109.23 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.54 91.47 44.61 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -75.58 -22.67 13.6 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.461 2.107 . . . . 0.0 112.756 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 p -121.96 141.97 50.78 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.542 -0.723 . . . . 0.0 109.59 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 51' ' ' GLU . . . -80.29 -18.24 49.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.333 -0.854 . . . . 0.0 109.405 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 50' ' ' ALA . 79.8 mm-40 -45.34 -38.32 5.69 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.911 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.4 m -77.84 -33.3 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.41 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 50' ' ' ALA . 65.3 t -68.22 -47.0 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 109.961 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.513 ' O ' ' N ' ' A' ' 58' ' ' GLN . 14.4 mm -60.61 -39.16 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 109.261 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.26 70.62 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.571 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.34 -19.55 58.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 0.0 110.507 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -116.33 -8.53 11.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.435 -0.791 . . . . 0.0 109.267 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 62' ' ' ASP . 4.4 tp-100 -48.36 -38.03 18.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 108.737 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.599 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.22 -47.95 62.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.01 -1.056 . . . . 0.0 109.885 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.599 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.37 -58.93 6.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.968 -1.082 . . . . 0.0 109.819 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.702 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -62.72 -29.42 46.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.953 -1.092 . . . . 0.0 108.883 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 58' ' ' GLN . 47.4 t0 -57.31 -25.37 59.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.86 . . . . 0.0 109.713 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -78.47 -38.09 41.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 110.126 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -62.99 -39.52 94.97 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.266 -0.973 . . . . 0.0 109.695 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -69.25 -30.38 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.026 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.62 61.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.216 -1.552 . . . . 0.0 109.462 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -83.7 -52.48 6.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.022 -1.049 . . . . 0.0 110.799 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.629 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -86.7 14.88 6.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.544 -0.723 . . . . 0.0 110.666 -177.643 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -14.7 89.38 0.01 OUTLIER Glycine 0 N--CA 1.5 2.944 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.855 ' CG ' HG21 ' A' ' 155' ' ' ILE . 97.2 m-85 -76.03 160.07 30.19 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -58.93 -40.86 85.88 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.315 -0.866 . . . . 0.0 109.754 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.1 t -144.49 155.22 43.6 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.212 -0.93 . . . . 0.0 109.104 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.669 ' CE2' HD13 ' A' ' 61' ' ' ILE . 9.8 t-105 -141.68 146.3 35.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.303 -0.873 . . . . 0.0 108.658 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.537 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.3 OUTLIER -176.55 -165.87 0.15 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 153' ' ' ILE . 36.0 m -128.57 165.57 27.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.446 -0.784 . . . . 0.0 109.625 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.684 ' CD1' ' HE ' ' A' ' 154' ' ' ARG . 1.4 mp -95.52 136.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.0 p -91.95 165.6 13.14 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.423 1.106 . . . . 0.0 111.412 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.744 HD23 ' CZ ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -161.5 137.63 8.07 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.884 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.559 ' H ' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -123.64 137.78 54.66 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.601 ' HB2' ' HB3' ' A' ' 149' ' ' ASN . . . -70.56 -7.03 40.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 0.0 109.709 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.519 ' H ' ' HD2' ' A' ' 79' ' ' ARG . 45.8 t0 -110.64 -18.24 13.21 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.519 -0.738 . . . . 0.0 109.396 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.785 HD22 ' HG3' ' A' ' 84' ' ' GLN . 1.7 t-20 -63.34 116.67 27.16 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.239 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -90.07 -16.53 1.79 Allowed 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.964 2.443 . . . . 0.0 113.032 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.785 ' HG3' HD22 ' A' ' 82' ' ' ASN . 16.5 pt20 -80.26 1.18 29.56 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.008 -1.058 . . . . 0.0 109.165 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.431 ' HE2' HD12 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -65.84 -42.16 90.87 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.21 178.497 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -51.45 -47.04 63.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.013 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.87 -43.93 77.62 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.672 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.431 HD12 ' HE2' ' A' ' 85' ' ' LYS . 91.4 mt -61.75 -38.38 87.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.887 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.63 ' CA ' HH11 ' A' ' 89' ' ' ARG . 1.6 mmt-85 -58.78 -25.53 63.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.885 . . . . 0.0 108.865 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -58.57 3.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.465 -0.772 . . . . 0.0 110.248 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -54.81 -45.69 74.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.342 -0.849 . . . . 0.0 109.736 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -67.81 -18.67 64.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.555 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -62.48 -34.38 76.72 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 109.705 -179.483 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.495 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 45.9 p-10 -47.58 140.28 6.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 109.944 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' A' ' 96' ' ' HIS . 23.1 tt0 -77.79 163.08 26.43 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.293 -0.88 . . . . 0.0 109.476 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.523 ' N ' ' CG ' ' A' ' 95' ' ' GLU . 50.7 p-80 -174.64 -167.13 0.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.349 -1.341 . . . . 0.0 112.07 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.99 134.39 2.47 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -106.1 156.07 18.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.86 -178.499 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.6 -6.19 86.63 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -123.04 170.04 10.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.456 -1.026 . . . . 0.0 109.431 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -75.85 142.89 42.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 109.887 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.437 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 1.8 mt-10 -102.79 92.67 4.7 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.749 HG22 ' OG ' ' A' ' 133' ' ' SER . 35.1 t -89.65 128.15 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.484 -0.76 . . . . 0.0 109.636 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.459 ' NH1' HG22 ' A' ' 132' ' ' ILE . 9.2 tmm_? -130.27 122.6 28.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -0.784 . . . . 0.0 109.904 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.632 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 11.0 t80 -100.87 130.92 46.95 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.477 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -87.78 130.25 34.91 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.544 -0.722 . . . . 0.0 110.196 -178.507 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.8 -30.93 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.687 -0.633 . . . . 0.0 109.423 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -162.01 151.48 16.08 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.18 -0.95 . . . . 0.0 109.374 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.81 164.8 39.71 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' A' ' 127' ' ' GLU . . . -147.72 171.53 15.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.478 -1.013 . . . . 0.0 109.281 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.7 154.52 10.74 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.586 ' CB ' HD22 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -93.65 96.78 10.04 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.744 -1.445 . . . . 0.0 110.08 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.503 ' CE1' ' O ' ' A' ' 114' ' ' CYS . 3.5 t80 -87.75 127.95 35.31 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.767 -1.208 . . . . 0.0 109.332 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.514 ' SG ' ' OE1' ' A' ' 123' ' ' GLN . 1.8 m -78.93 129.96 35.07 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.711 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.751 ' C ' HD13 ' A' ' 115' ' ' LEU . 3.0 tm? -114.62 129.47 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.623 ' N ' HD13 ' A' ' 115' ' ' LEU . 4.9 t-160 -114.68 112.84 23.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.417 -0.802 . . . . 0.0 109.558 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.3 112.2 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.441 -0.787 . . . . 0.0 109.597 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.42 -127.76 10.08 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 106.437 -2.665 . . . . 0.0 106.437 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.559 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 46.4 p30 -116.23 75.51 0.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 115.374 -2.53 . . . . 0.0 110.342 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.581 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 22.3 pt-20 -166.2 168.25 15.44 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 5' ' ' ILE . 55.7 t -125.4 138.96 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.46 -0.775 . . . . 0.0 109.986 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 115' ' ' LEU . 7.6 m-85 -127.61 131.25 49.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 0.0 109.353 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.514 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 7.0 mt-30 -126.45 118.54 25.16 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.031 -1.043 . . . . 0.0 108.983 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.909 ' C ' HD23 ' A' ' 125' ' ' LEU . 21.7 t -110.14 135.54 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.909 HD23 ' C ' ' A' ' 124' ' ' VAL . 0.1 OUTLIER -133.64 90.96 2.78 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.594 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 1.7 p -164.64 134.11 3.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 119.685 -1.884 . . . . 0.0 106.827 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 110' ' ' ALA . 2.5 pt-20 -106.34 93.72 4.75 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 115.71 -2.396 . . . . 0.0 110.185 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.558 ' C ' ' H ' ' A' ' 130' ' ' ASP . 51.7 mttm -115.52 158.95 21.85 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.108 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.632 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 13.4 m120 -58.37 -3.02 0.23 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.345 -1.472 . . . . 0.0 107.622 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 128' ' ' LYS . 56.1 p30 -72.81 152.78 41.39 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.139 -0.976 . . . . 0.0 109.28 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.768 ' C ' HD12 ' A' ' 131' ' ' LEU . 3.0 pp -117.23 161.43 19.49 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.686 0.755 . . . . 0.0 110.052 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.58 ' N ' HD12 ' A' ' 131' ' ' LEU . 17.3 tt -133.11 126.36 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.281 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.749 ' OG ' HG22 ' A' ' 103' ' ' VAL . 19.1 t -122.1 138.53 54.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.452 -0.78 . . . . 0.0 109.605 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.16 147.87 35.02 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.387 -0.821 . . . . 0.0 109.145 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.723 ' O ' HG22 ' A' ' 138' ' ' THR . 39.1 Cg_endo -66.81 156.51 65.69 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.269 1.979 . . . . 0.0 112.795 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.644 ' O ' ' ND1' ' A' ' 137' ' ' HIS . . . -71.84 139.74 49.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.311 -0.868 . . . . 0.0 108.675 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.644 ' ND1' ' O ' ' A' ' 136' ' ' ALA . 7.4 m80 88.62 13.46 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.852 -0.53 . . . . 0.0 109.719 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.723 HG22 ' O ' ' A' ' 135' ' ' PRO . 14.9 t -106.7 126.4 30.4 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.288 -0.883 . . . . 0.0 108.864 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 116' ' ' HIS . 39.6 Cg_endo -63.66 134.06 42.39 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.597 1.531 . . . . 0.0 111.452 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.51 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -172.29 162.08 5.45 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.959 -1.088 . . . . 0.0 109.982 -179.088 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.501 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -133.19 -149.01 0.35 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.159 -0.963 . . . . 0.0 109.413 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -176.38 127.99 0.2 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.925 -1.109 . . . . 0.0 108.938 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.76 138.68 18.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 109.143 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.623 ' SD ' ' CZ ' ' A' ' 89' ' ' ARG . 1.4 mpt? -113.17 21.69 15.06 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.395 -0.816 . . . . 0.0 110.574 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.599 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.67 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.501 2.971 0 CA-C-N 119.417 1.008 . . . . 0.0 111.835 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.477 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 74.9 m -86.74 117.24 25.36 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 117.94 -1.504 . . . . 0.0 109.562 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.45 ' N ' ' OE1' ' A' ' 147' ' ' GLU . 22.3 mp0 -115.2 116.92 41.81 Favored Pre-proline 0 C--N 1.294 -1.835 0 O-C-N 121.805 -0.56 . . . . 0.0 109.778 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.751 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 51.1 Cg_endo -103.39 31.96 0.07 OUTLIER 'Trans proline' 0 C--O 1.207 -1.064 0 C-N-CA 123.395 2.73 . . . . 0.0 111.791 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.751 ' ND2' ' O ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER 82.54 63.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 123.102 1.43 . . . . 0.0 109.807 -178.491 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.744 ' CZ ' HD23 ' A' ' 78' ' ' LEU . 11.2 p90 -99.84 -178.86 3.99 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 119.805 -1.809 . . . . 0.0 110.16 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 59.7 m -135.69 131.7 36.0 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.701 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -134.98 153.94 51.91 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.065 -1.022 . . . . 0.0 108.972 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.459 HG12 HG12 ' A' ' 75' ' ' VAL . 10.9 mt -110.21 129.58 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.159 -0.963 . . . . 0.0 109.805 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.684 ' HE ' ' CD1' ' A' ' 76' ' ' ILE . 25.9 mtm-85 -143.97 170.08 16.6 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.192 -0.943 . . . . 0.0 109.481 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.855 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.6 mp -101.33 145.81 10.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.471 -0.768 . . . . 0.0 109.034 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.521 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 5.2 m-85 -96.38 118.73 33.52 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.489 -0.757 . . . . 0.0 109.408 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.575 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 55.3 p30 -134.89 161.57 34.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.848 -0.533 . . . . 0.0 109.607 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.605 ' O ' ' NE1' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -96.08 156.99 36.47 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.096 . . . . 0.0 108.981 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.5 Cg_endo -66.93 -54.06 0.45 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.667 2.245 . . . . 0.0 112.249 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.6 ' N ' ' OD1' ' A' ' 158' ' ' ASN . 95.5 mt-10 -44.4 -17.53 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.312 -0.867 . . . . 0.0 108.856 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.48 -50.84 5.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.605 ' NE1' ' O ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -104.07 169.33 8.56 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.474 -1.016 . . . . 0.0 109.95 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 74.9 mt -96.99 149.81 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 0.0 109.341 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 96' ' ' HIS . . . -83.31 -71.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 0.0 110.349 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -117.6 146.3 43.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.161 -0.962 . . . . 0.0 109.699 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -101.56 -41.71 6.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.436 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 69.4 p -106.44 -31.18 8.67 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.22 -0.925 . . . . 0.0 109.049 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.23 -9.1 56.01 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -82.78 145.98 29.23 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.253 -1.734 . . . . 0.0 108.722 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -112.33 90.6 3.38 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.527 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.07 -16.78 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.036 -1.665 . . . . 0.0 108.758 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -57.94 -38.05 75.22 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.672 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 22.7 t -51.61 -3.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.232 -0.917 . . . . 0.0 110.191 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.664 ' HB3' ' CE2' ' A' ' 175' ' ' TYR . . . -76.64 -42.05 43.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.784 -1.197 . . . . 0.0 111.701 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.664 ' CE2' ' HB3' ' A' ' 174' ' ' ALA . 0.1 OUTLIER -113.95 26.7 0.1 OUTLIER Pre-proline 0 N--CA 1.511 2.606 0 O-C-N 120.574 -1.328 . . . . 0.0 111.966 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.672 ' HD3' ' C ' ' A' ' 173' ' ' SER . 46.4 Cg_endo -60.95 -24.24 79.03 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 124.146 3.231 . . . . 0.0 113.038 -172.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.11 126.18 35.35 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.895 -1.122 . . . . 0.0 109.186 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.512 ' O ' ' C ' ' A' ' 179' ' ' ALA . 1.3 tp -87.59 122.69 31.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.633 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.633 ' O ' ' OG1' ' A' ' 19' ' ' THR . 11.3 p . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.68 170.76 8.78 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.301 -0.874 . . . . 0.0 109.325 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 4' ' ' THR . 3.8 tp -159.01 115.92 2.72 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.437 ' N ' HD12 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -108.83 140.78 41.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.746 HG23 ' O ' ' A' ' 121' ' ' VAL . 32.1 mt -134.18 134.65 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -126.65 166.89 16.51 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.9 m -86.04 173.92 9.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.051 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.3 -28.09 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.982 -1.074 . . . . 0.0 109.399 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -75.83 -36.59 59.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 110.381 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -137.89 123.75 12.81 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.476 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -81.69 -32.11 0.94 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.066 1.844 . . . . 0.0 112.353 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.577 ' NE2' ' O ' ' A' ' 12' ' ' GLN . 23.5 tp60 -69.81 2.78 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.448 -0.782 . . . . 0.0 110.011 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -114.73 120.11 38.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.912 . . . . 0.0 109.474 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.85 122.15 40.62 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.251 -0.906 . . . . 0.0 109.248 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 15' ' ' LEU . 10.8 mp -90.43 -6.18 55.21 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.022 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.707 ' HB3' HD12 ' A' ' 5' ' ' ILE . 39.1 t90 -156.22 105.13 2.29 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.43 -1.308 . . . . 0.0 110.276 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -119.13 110.97 17.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.642 -0.661 . . . . 0.0 109.544 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.448 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -163.01 163.45 26.03 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.002 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 19' ' ' THR . 11.7 t -131.47 90.77 2.91 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 120.786 -1.196 . . . . 0.0 108.416 176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.806 ' O ' HD12 ' A' ' 24' ' ' ILE . 29.9 m120 -124.66 152.29 43.84 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.851 -1.156 . . . . 0.0 110.613 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.32 -47.54 11.38 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.343 -1.473 . . . . 0.0 108.758 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -82.49 -43.35 17.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.347 -0.846 . . . . 0.0 110.242 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.498 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.2 tt0 -66.07 -24.73 66.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.749 -1.219 . . . . 0.0 108.908 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 20' ' ' ASN . 3.3 mt -68.26 -58.45 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.165 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.61 ' NE2' ' CD1' ' A' ' 35' ' ' PHE . 3.3 pt20 -58.39 -43.77 88.69 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.127 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.586 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 50.4 tt0 -53.89 -35.11 61.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.463 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.551 ' OE1' ' CE2' ' A' ' 16' ' ' TRP . 3.3 tp60 -66.97 -63.55 1.04 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.0 -1.062 . . . . 0.0 109.314 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.571 ' HB2' HG21 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -69.18 -54.94 12.24 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.822 -1.174 . . . . 0.0 109.834 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 17.1 t-20 -47.52 -33.06 5.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.681 -1.262 . . . . 0.0 109.068 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -63.68 -25.33 68.16 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.064 -1.022 . . . . 0.0 108.531 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 28' ' ' LEU . 29.0 mttm -91.39 10.53 27.17 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.273 -0.892 . . . . 0.0 110.498 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.92 25.88 12.4 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.048 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.6 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 48.4 t -96.36 146.2 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.449 -1.03 . . . . 0.0 109.347 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.458 ' CD ' HD11 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -84.77 155.24 21.93 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.135 -0.978 . . . . 0.0 109.243 -179.045 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.61 ' CD1' ' NE2' ' A' ' 25' ' ' GLN . 2.1 t80 -155.37 154.26 31.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.043 -1.036 . . . . 0.0 109.006 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 35' ' ' PHE . 11.5 tp10 -176.12 173.05 2.27 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.975 -1.078 . . . . 0.0 109.519 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.45 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 65.4 mtm-85 -148.54 118.45 7.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.039 -1.038 . . . . 0.0 108.603 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.44 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 30.2 m0 -110.93 148.37 32.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.324 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -137.08 159.98 40.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.437 -0.789 . . . . 0.0 109.664 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.27 160.45 14.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 109.044 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -98.45 -18.46 18.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.236 -0.915 . . . . 0.0 108.687 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -93.54 167.85 11.42 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -94.39 121.15 35.63 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.727 . . . . 0.0 109.386 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.33 167.14 11.52 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.05 -121.7 0.59 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.44 78.83 9.63 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.068 -1.254 . . . . 0.0 108.653 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.15 95.62 30.99 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 121.375 -0.828 . . . . 0.0 109.309 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.689 ' O ' HG23 ' A' ' 49' ' ' THR . 46.8 Cg_endo -70.61 79.17 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.22 1.947 . . . . 0.0 111.736 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.689 HG23 ' O ' ' A' ' 48' ' ' PRO . 6.0 p -162.99 118.03 1.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.061 -1.024 . . . . 0.0 109.364 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.81 -43.98 17.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.062 -1.024 . . . . 0.0 109.96 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -65.11 -17.17 64.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.392 -0.817 . . . . 0.0 109.728 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.6 m -77.05 -41.78 41.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.229 -0.919 . . . . 0.0 110.373 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.445 HG11 ' CG1' ' A' ' 107' ' ' VAL . 20.6 t -63.93 -47.87 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.051 -1.031 . . . . 0.0 109.537 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 58' ' ' GLN . 11.7 mm -61.21 -42.25 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 108.722 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.38 -30.3 71.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.332 -0.855 . . . . 0.0 109.83 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.77 -19.38 59.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 110.405 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.0 m-85 -113.75 -6.67 13.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.373 -0.829 . . . . 0.0 109.462 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 57' ' ' TYR . 3.2 tp-100 -47.74 -39.72 18.56 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -50.43 -44.22 55.25 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.619 -1.3 . . . . 0.0 109.369 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.87 -59.42 4.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.869 -1.144 . . . . 0.0 110.452 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -61.41 -30.39 47.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 120.912 -1.117 . . . . 0.0 108.968 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -55.04 -28.85 55.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.01 -1.056 . . . . 0.0 109.68 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -74.94 -38.94 61.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.034 -1.041 . . . . 0.0 109.4 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.8 mp -65.28 -35.34 80.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.069 -1.019 . . . . 0.0 109.739 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 61' ' ' ILE . 2.6 t -70.11 -31.18 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.72 64.02 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.639 -1.288 . . . . 0.0 109.386 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -87.33 -52.52 5.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 110.612 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.581 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -85.81 14.85 5.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.843 . . . . 0.0 110.44 -177.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.581 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -19.54 89.08 0.01 OUTLIER Glycine 0 N--CA 1.495 2.572 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.518 ' CG ' HG21 ' A' ' 155' ' ' ILE . 48.8 m-85 -76.75 167.71 21.36 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -57.19 -88.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.431 -0.793 . . . . 0.0 109.452 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -104.74 166.13 10.59 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.399 0.619 . . . . 0.0 109.69 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.562 ' HE1' HG23 ' A' ' 153' ' ' ILE . 5.5 t-105 -137.58 141.61 41.31 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.448 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -158.47 176.64 12.17 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.4 p -122.89 144.58 31.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.1 mt -105.53 116.84 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.484 ' O ' ' OG ' ' A' ' 77' ' ' SER . 11.2 p -168.66 103.05 0.41 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.261 -0.9 . . . . 0.0 109.216 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 79' ' ' ARG . 1.0 OUTLIER -115.27 -177.22 3.09 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 120.7 1.591 . . . . 0.0 108.645 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' ASP . 2.3 ttt180 -92.82 152.61 19.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.375 -1.453 . . . . 0.0 109.129 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.15 -6.87 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.062 -1.024 . . . . 0.0 110.4 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ARG . 95.3 m-20 -92.52 33.78 1.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.501 HD21 ' HD2' ' A' ' 83' ' ' PRO . 6.3 t-20 -76.12 124.8 88.42 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.914 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.501 ' HD2' HD21 ' A' ' 82' ' ' ASN . 55.8 Cg_endo -80.16 -27.86 3.42 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.645 2.23 . . . . 0.0 112.271 177.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -90.79 10.66 25.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.917 -1.115 . . . . 0.0 109.194 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.501 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 0.4 OUTLIER -53.34 -58.52 6.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.146 -0.972 . . . . 0.0 108.815 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.38 -51.4 52.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.116 -0.99 . . . . 0.0 109.324 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.99 -42.06 72.0 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.343 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 5.7 tp -59.75 -42.92 94.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.179 -0.95 . . . . 0.0 109.199 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -56.77 -37.67 71.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.568 -1.332 . . . . 0.0 110.174 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -66.06 -22.35 66.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.538 ' CG ' ' N ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -65.64 -45.47 82.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.617 -0.677 . . . . 0.0 110.121 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.668 ' CD2' ' O ' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -88.14 -13.57 40.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 0.0 110.477 -178.506 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 92' ' ' PHE . 65.5 tp -42.18 -18.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.152 -0.967 . . . . 0.0 109.883 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 92' ' ' PHE . 9.4 p30 -99.8 114.61 27.89 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.055 -1.028 . . . . 0.0 109.235 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.504 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 3.0 pp20? -52.02 173.91 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.504 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 50.2 p-80 -176.5 -166.78 0.17 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.295 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.06 135.47 3.83 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.607 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -103.61 154.8 19.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 109.741 -178.567 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.73 -6.59 87.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -123.97 171.18 9.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.333 -1.099 . . . . 0.0 109.424 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -74.31 141.79 45.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.975 . . . . 0.0 110.068 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.607 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 3.7 tt0 -102.83 89.9 3.62 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 103' ' ' VAL . 13.8 p -88.43 130.43 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.082 -1.011 . . . . 0.0 110.521 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.544 ' NH1' ' HE ' ' A' ' 154' ' ' ARG . 52.5 mtt-85 -129.68 121.79 27.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.594 -0.691 . . . . 0.0 109.439 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.615 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 21.7 t80 -101.76 132.97 47.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 108.593 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.542 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.33 129.53 35.36 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.677 -0.639 . . . . 0.0 109.747 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.474 ' HB ' HG22 ' A' ' 151' ' ' THR . 19.3 t -112.42 -30.41 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.697 -0.627 . . . . 0.0 109.749 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -168.59 158.69 9.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.04 -1.038 . . . . 0.0 109.108 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.05 156.83 5.61 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.33 -168.79 1.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -1.126 . . . . 0.0 109.35 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.31 -135.75 3.5 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.708 HD12 HD12 ' A' ' 178' ' ' LEU . 3.9 mt -144.74 162.91 35.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -1.138 . . . . 0.0 109.602 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -136.83 89.6 2.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 109.455 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.49 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -79.48 108.68 13.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.428 -0.795 . . . . 0.0 109.904 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.49 HD12 ' C ' ' A' ' 114' ' ' CYS . 9.2 mp -115.71 114.13 24.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.289 -0.882 . . . . 0.0 109.118 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.442 ' NE2' ' O ' ' A' ' 118' ' ' GLY . 11.1 t-160 -102.89 109.9 21.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.046 -1.034 . . . . 0.0 109.476 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.2 mt -125.59 111.79 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.281 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.442 ' O ' ' NE2' ' A' ' 116' ' ' HIS . . . 75.45 -142.92 29.78 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 106.427 -2.669 . . . . 0.0 106.427 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.49 ' O ' ' CG ' ' A' ' 119' ' ' ASP . 48.2 p-10 -103.48 79.09 1.66 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 114.909 -2.716 . . . . 0.0 109.167 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.438 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 24.0 tp10 -166.29 167.28 16.13 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.474 -1.391 . . . . 0.0 107.781 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.746 ' O ' HG23 ' A' ' 5' ' ' ILE . 57.3 t -128.52 147.06 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.809 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -123.94 131.4 53.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.771 -0.581 . . . . 0.0 109.714 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.417 ' O ' HD12 ' A' ' 3' ' ' LEU . 38.6 mm-40 -126.65 106.66 9.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -0.949 . . . . 0.0 108.905 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.01 136.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.2 tt -136.53 91.57 2.67 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.937 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 20.0 p -166.16 136.37 3.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.598 -1.314 . . . . 0.0 108.468 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.507 ' O ' ' CD ' ' A' ' 127' ' ' GLU . 3.4 tm-20 -107.23 93.95 4.83 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 115.819 -2.352 . . . . 0.0 110.884 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.551 ' C ' ' H ' ' A' ' 130' ' ' ASP . 30.4 mttp -114.5 155.55 26.21 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.755 176.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.615 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 12.6 p30 -55.71 -5.15 0.13 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.229 -1.544 . . . . 0.0 107.928 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 128' ' ' LYS . 43.4 p-10 -72.21 150.3 43.82 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.881 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.783 ' C ' HD12 ' A' ' 131' ' ' LEU . 3.0 pp -119.03 161.58 20.0 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.753 0.787 . . . . 0.0 110.547 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 131' ' ' LEU . 17.0 tt -134.84 125.57 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.2 t -120.21 135.84 54.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 0.0 109.444 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.7 m -95.99 148.02 33.88 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.303 -0.873 . . . . 0.0 108.821 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.04 154.9 71.49 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.239 1.96 . . . . 0.0 112.621 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.613 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.93 136.34 46.82 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.613 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 5.7 t-80 91.67 11.12 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.92 126.61 30.67 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.32 131.63 30.82 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.621 1.547 . . . . 0.0 111.449 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.566 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.94 167.66 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.132 -0.98 . . . . 0.0 110.064 -179.145 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.536 ' CD2' ' HB2' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -138.41 -150.07 0.32 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.269 -0.895 . . . . 0.0 109.52 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.668 ' O ' ' CD2' ' A' ' 92' ' ' PHE . 76.9 t80 -174.95 122.93 0.24 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.893 -1.129 . . . . 0.0 109.034 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.594 ' OD2' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -139.29 134.06 32.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.321 -0.862 . . . . 0.0 110.186 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.622 ' O ' ' C ' ' A' ' 145' ' ' GLY . 4.0 mtp -113.42 20.65 15.9 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.667 -0.646 . . . . 0.0 110.569 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.622 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 5.17 -83.83 0.0 OUTLIER Glycine 0 N--CA 1.503 3.13 0 CA-C-N 119.155 0.889 . . . . 0.0 111.62 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.558 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 22.2 p -87.81 118.8 27.58 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.001 -1.48 . . . . 0.0 109.019 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -112.85 109.68 52.52 Favored Pre-proline 0 C--N 1.292 -1.911 0 C-N-CA 119.514 -0.875 . . . . 0.0 109.054 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.659 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 58.3 Cg_endo -100.06 20.44 0.27 Allowed 'Trans proline' 0 C--O 1.195 -1.629 0 C-N-CA 123.147 2.565 . . . . 0.0 112.129 176.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.738 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 9.4 p-10 90.39 69.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 123.533 1.635 . . . . 0.0 110.14 -176.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 14.2 p90 -89.21 167.44 13.09 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 118.986 -2.322 . . . . 0.0 110.278 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.474 HG22 ' HB ' ' A' ' 107' ' ' VAL . 13.6 m -131.41 118.69 20.61 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.734 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.75 163.71 33.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.505 -0.747 . . . . 0.0 109.041 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.562 HG23 ' HE1' ' A' ' 73' ' ' TRP . 36.8 mt -110.81 131.18 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.335 -0.853 . . . . 0.0 109.914 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.569 ' NH1' ' O ' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -133.51 161.1 35.5 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.118 -0.988 . . . . 0.0 108.885 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.569 ' O ' ' NH1' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -104.1 146.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.544 -0.722 . . . . 0.0 109.087 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.448 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.7 m-30 -95.97 119.67 34.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.025 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.44 ' HB3' ' CZ2' ' A' ' 162' ' ' TRP . 24.3 t70 -134.65 160.8 36.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.845 -0.535 . . . . 0.0 109.654 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -96.21 161.0 28.56 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 109.172 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.4 Cg_endo -67.89 -54.03 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.564 2.176 . . . . 0.0 111.859 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 159' ' ' PRO . 98.1 mt-10 -42.91 -20.21 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.86 -36.64 7.68 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.558 ' N ' ' O ' ' A' ' 159' ' ' PRO . 45.9 m0 -97.06 165.28 12.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.36 -1.082 . . . . 0.0 110.266 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 21.0 mm -99.1 153.5 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.306 -0.871 . . . . 0.0 109.386 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.76 -72.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.163 -0.96 . . . . 0.0 110.404 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -141.07 153.43 45.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -0.919 . . . . 0.0 109.796 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.32 -41.65 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.249 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.61 -31.29 8.54 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.42 -8.17 62.15 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -80.79 148.24 30.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.686 -1.479 . . . . 0.0 108.591 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.53 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 47.4 p30 -111.02 87.82 2.63 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 117.536 -1.666 . . . . 0.0 111.514 175.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.6 tt -78.37 -17.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 119.968 -1.707 . . . . 0.0 109.352 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 141' ' ' TRP . . . -61.68 -40.45 95.03 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.71 -0.619 . . . . 0.0 109.338 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.638 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 53.9 p -53.43 -3.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.526 ' HB3' ' CE2' ' A' ' 175' ' ' TYR . . . -80.09 -39.9 28.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.947 -1.096 . . . . 0.0 111.362 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.622 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 7.0 m-85 -111.47 24.8 0.08 OUTLIER Pre-proline 0 N--CA 1.514 2.749 0 O-C-N 120.791 -1.193 . . . . 0.0 112.482 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.638 ' HD3' ' C ' ' A' ' 173' ' ' SER . 53.8 Cg_endo -65.26 -19.62 62.23 Favored 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 123.399 2.732 . . . . 0.0 113.129 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -89.03 125.54 35.04 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.043 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.727 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 1.5 tp -88.44 118.93 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.42 -0.8 . . . . 0.0 109.236 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.566 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.624 ' O ' ' OG1' ' A' ' 19' ' ' THR . 10.5 p . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.16 171.24 8.58 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.191 -0.943 . . . . 0.0 109.142 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 4' ' ' THR . 3.4 tp -158.97 115.84 2.72 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -109.14 139.23 44.32 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.151 -0.968 . . . . 0.0 110.149 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.757 HD12 ' HB3' ' A' ' 16' ' ' TRP . 45.0 mt -132.99 132.26 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.06 165.03 20.26 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 p -84.99 174.04 10.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.149 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.62 -31.23 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.096 -1.003 . . . . 0.0 109.362 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 tttp -74.13 -37.94 63.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.184 -0.948 . . . . 0.0 110.532 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.85 124.11 14.18 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.005 -1.059 . . . . 0.0 109.537 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.78 -30.06 1.52 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.922 1.748 . . . . 0.0 112.308 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -69.85 4.69 1.86 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.461 -0.774 . . . . 0.0 110.358 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -117.83 119.12 33.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.052 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -97.67 126.17 42.85 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.135 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 15' ' ' LEU . 4.0 mm? -91.83 -8.35 46.85 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.94 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.757 ' HB3' HD12 ' A' ' 5' ' ' ILE . 33.2 t90 -157.47 103.91 1.98 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.276 -1.37 . . . . 0.0 110.587 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -117.47 109.24 16.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.536 -0.727 . . . . 0.0 109.413 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.452 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -163.89 163.95 23.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.261 -0.9 . . . . 0.0 109.724 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 19' ' ' THR . 9.9 t -131.47 90.69 2.89 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.508 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.75 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -124.5 146.94 48.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.221 -0.925 . . . . 0.0 110.479 177.249 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.99 -39.49 23.53 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.266 -1.521 . . . . 0.0 108.423 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -82.86 -48.57 10.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.624 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -59.94 -25.07 64.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.086 -1.009 . . . . 0.0 108.42 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.75 HD12 ' O ' ' A' ' 20' ' ' ASN . 13.0 mt -72.38 -50.81 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.025 -1.047 . . . . 0.0 108.999 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 29' ' ' ASN . 1.1 tm0? -62.06 -51.92 66.02 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.287 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.706 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 14.9 mm100 -61.21 -40.3 93.47 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.235 -0.916 . . . . 0.0 109.732 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.664 ' NE2' ' CD1' ' A' ' 16' ' ' TRP . 39.6 tt0 -75.07 -50.8 15.27 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.062 -1.024 . . . . 0.0 109.478 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 28' ' ' LEU . 17.3 tp -70.45 -56.18 7.23 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.847 -1.158 . . . . 0.0 109.832 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 25' ' ' GLN . 0.7 OUTLIER -57.1 -19.9 22.34 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.776 -1.202 . . . . 0.0 109.286 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -67.5 -27.99 67.46 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.796 -1.19 . . . . 0.0 108.637 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -86.42 12.54 10.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.141 -0.974 . . . . 0.0 109.604 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.24 21.58 32.16 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.185 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.428 HG21 ' HG ' ' A' ' 28' ' ' LEU . 47.9 t -92.71 146.54 6.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.384 -1.068 . . . . 0.0 109.348 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.1 ttt85 -82.49 156.87 23.82 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -155.21 155.46 33.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.815 -1.178 . . . . 0.0 108.354 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.476 ' OE2' ' N ' ' A' ' 37' ' ' ARG . 1.3 mm-40 -175.42 174.73 2.27 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.051 -1.031 . . . . 0.0 109.3 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.476 ' N ' ' OE2' ' A' ' 36' ' ' GLU . 74.4 mtm-85 -151.93 112.95 4.24 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -110.73 151.52 27.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.124 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.577 ' OE1' ' ND2' ' A' ' 129' ' ' ASN . 16.8 mm100 -138.49 154.35 48.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.908 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.93 158.34 16.06 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -101.28 -9.09 21.53 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.2 mtp85 -92.91 155.0 17.86 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.792 0.806 . . . . 0.0 109.216 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -93.25 118.98 31.89 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.569 -0.707 . . . . 0.0 109.524 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.12 161.89 14.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.774 0.797 . . . . 0.0 109.488 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.32 -99.26 0.15 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.98 92.63 4.97 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.134 -1.215 . . . . 0.0 109.483 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.27 92.02 30.33 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.434 -0.791 . . . . 0.0 109.008 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.42 -28.27 7.07 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.314 2.01 . . . . 0.0 112.613 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.6 p -119.57 141.86 48.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.619 -0.675 . . . . 0.0 109.594 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.34 -16.71 53.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.471 -0.768 . . . . 0.0 109.432 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -50.56 -37.49 39.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 109.06 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.5 m -78.64 -33.39 47.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 109.484 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.66 -52.41 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.352 -0.843 . . . . 0.0 110.273 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.505 HG22 ' HG2' ' A' ' 58' ' ' GLN . 6.4 mt -59.21 -40.01 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.046 -1.034 . . . . 0.0 108.836 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.34 -32.13 69.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.367 -0.833 . . . . 0.0 109.479 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.416 ' O ' ' CD2' ' A' ' 59' ' ' HIS . . . -74.67 -14.59 60.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.937 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -117.14 -9.4 11.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.0 109.588 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.505 ' HG2' HG22 ' A' ' 54' ' ' ILE . 6.1 mm100 -50.86 -39.75 54.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.102 -0.998 . . . . 0.0 109.07 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.453 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 20.0 p80 -51.71 -46.1 63.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.453 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -60.39 -59.24 5.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.988 -1.07 . . . . 0.0 109.703 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.679 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -64.48 -28.54 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.717 -1.239 . . . . 0.0 109.364 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 58' ' ' GLN . 24.7 t70 -55.56 -25.09 36.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.372 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -84.36 -37.22 21.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 109.556 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -46.73 74.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.31 -0.869 . . . . 0.0 109.497 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 69' ' ' GLY . 1.1 p -70.03 -30.45 44.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.394 -0.816 . . . . 0.0 109.633 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.54 -46.29 66.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.152 -0.967 . . . . 0.0 109.484 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -77.6 -48.92 15.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.103 -0.998 . . . . 0.0 109.647 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.653 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -85.22 13.75 6.01 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.448 -0.782 . . . . 0.0 110.16 -177.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.653 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -1.46 84.08 0.0 OUTLIER Glycine 0 N--CA 1.502 3.053 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.91 ' CG ' HG21 ' A' ' 155' ' ' ILE . 20.3 m-85 -77.06 164.53 25.64 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.21 -1.171 . . . . 0.0 109.446 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -59.85 -43.11 94.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.57 -0.706 . . . . 0.0 110.222 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.27 165.65 36.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.991 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.736 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 6.6 t-105 -135.6 139.4 43.81 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.388 -0.82 . . . . 0.0 109.165 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.461 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -160.08 178.4 9.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 152' ' ' ALA . 1.3 t -117.91 141.69 35.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 pt -100.42 116.97 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.511 ' HB3' ' O ' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -174.59 106.7 0.11 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.113 -0.992 . . . . 0.0 109.69 177.487 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.547 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -101.38 179.99 4.2 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 120.9 1.682 . . . . 0.0 109.052 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.547 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 9.4 tpt180 -88.81 146.25 25.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.968 -1.083 . . . . 0.0 109.386 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.9 0.38 0.15 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 109.489 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 79' ' ' ARG . 23.9 t70 -91.58 -27.13 18.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.175 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.646 HD22 ' HB2' ' A' ' 84' ' ' GLN . 0.1 OUTLIER -63.52 122.14 74.43 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 120.911 -1.118 . . . . 0.0 109.437 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -83.78 -5.07 10.69 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.159 1.906 . . . . 0.0 112.385 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.646 ' HB2' HD22 ' A' ' 82' ' ' ASN . 55.6 mt-30 -86.39 3.02 45.46 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.653 -1.28 . . . . 0.0 109.428 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 144' ' ' MET . 29.3 tptt -61.08 -46.61 89.94 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.176 -0.952 . . . . 0.0 109.134 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.601 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 15.9 mm-40 -59.85 -50.04 75.33 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.758 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.53 -41.49 88.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.889 . . . . 0.0 109.475 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.08 -55.09 32.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.96 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.601 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 7.4 ptt-85 -64.26 -20.14 65.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.97 -60.57 2.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.863 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -56.28 -37.44 69.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.107 -0.996 . . . . 0.0 109.538 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -72.45 -18.7 61.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 109.719 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 93' ' ' LEU . 0.4 OUTLIER -62.33 -26.3 68.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.666 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -48.74 145.9 3.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.918 . . . . 0.0 109.928 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.502 ' OE1' HG22 ' A' ' 171' ' ' ILE . 55.1 tt0 -76.54 157.27 32.2 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.5 -0.75 . . . . 0.0 110.095 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.423 ' N ' ' CG ' ' A' ' 95' ' ' GLU . 46.0 p-80 -172.17 -170.6 0.75 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.736 -1.185 . . . . 0.0 111.978 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.8 t -163.01 137.69 6.42 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.689 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.85 155.4 20.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.545 -178.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.66 -5.56 86.3 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.459 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 23.8 tp10 -124.52 168.49 13.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.378 -1.072 . . . . 0.0 109.221 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.415 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 88.5 m-20 -74.52 143.43 44.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.117 . . . . 0.0 110.106 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' A' ' 98' ' ' HIS . 2.2 mt-10 -101.08 90.37 4.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.12 -0.987 . . . . 0.0 108.491 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.674 HG12 ' OG ' ' A' ' 133' ' ' SER . 15.7 m -85.86 130.26 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.693 -0.629 . . . . 0.0 110.138 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.712 ' NE ' HH21 ' A' ' 154' ' ' ARG . 41.0 ttm105 -131.03 128.29 40.02 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.458 -0.777 . . . . 0.0 109.598 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.498 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 36.9 t80 -106.1 129.15 54.24 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.65 129.9 36.02 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.488 -0.757 . . . . 0.0 110.395 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.4 t -115.2 -27.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.651 -0.656 . . . . 0.0 109.672 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -166.29 153.06 9.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.395 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.96 154.25 25.64 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.695 ' HB2' ' HG2' ' A' ' 127' ' ' GLU . . . -137.45 165.83 25.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.191 -1.182 . . . . 0.0 108.944 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.34 152.97 10.09 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.628 HD23 HD12 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -99.72 98.61 9.43 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.047 -1.267 . . . . 0.0 110.256 -179.135 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 114' ' ' CYS . 2.3 t80 -84.4 135.02 34.44 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.873 -1.142 . . . . 0.0 109.715 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.568 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -77.77 117.68 19.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.431 0.634 . . . . 0.0 109.815 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 122' ' ' PHE . 2.2 mt -106.71 123.11 47.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 7.0 t-160 -105.53 106.97 17.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.156 -0.965 . . . . 0.0 109.602 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.424 HG23 HG21 ' A' ' 138' ' ' THR . 3.2 mt -119.95 109.34 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.956 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.34 -144.37 31.76 Favored Glycine 0 N--CA 1.502 3.092 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -100.5 78.27 2.0 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 114.891 -2.724 . . . . 0.0 109.521 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 1.6 mt-10 -167.04 171.94 10.6 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.724 ' O ' HG23 ' A' ' 5' ' ' ILE . 78.6 t -125.14 140.76 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.076 -1.015 . . . . 0.0 109.907 177.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 115' ' ' LEU . 26.4 m-85 -122.72 128.51 50.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.7 -0.625 . . . . 0.0 110.364 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' THR . 32.6 mm-40 -119.97 104.62 10.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -100.58 133.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.628 HD12 HD23 ' A' ' 112' ' ' LEU . 1.3 tt -133.34 87.57 2.4 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.107 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.616 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 16.8 p -167.88 122.42 0.97 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.695 ' HG2' ' HB2' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -105.47 100.0 9.58 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 116.384 -2.127 . . . . 0.0 110.352 -178.502 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.611 ' C ' ' H ' ' A' ' 130' ' ' ASP . 1.5 mmmt -117.24 166.02 12.76 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.19 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.577 ' ND2' ' OE1' ' A' ' 39' ' ' GLN . 11.2 p30 -58.62 -0.31 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.611 ' H ' ' C ' ' A' ' 128' ' ' LYS . 53.6 p-10 -69.52 139.14 53.8 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.862 -1.149 . . . . 0.0 109.819 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.583 HD13 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -91.28 123.18 34.52 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.884 0.849 . . . . 0.0 109.586 -178.112 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.583 ' N ' HD13 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -115.11 112.18 38.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.111 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.674 ' OG ' HG12 ' A' ' 103' ' ' VAL . 9.4 t -120.74 151.68 39.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.391 -0.818 . . . . 0.0 109.168 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.72 137.79 20.88 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.564 ' O ' ' OG1' ' A' ' 138' ' ' THR . 36.6 Cg_endo -61.99 154.95 58.41 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.977 1.785 . . . . 0.0 113.46 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -74.85 136.35 41.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.347 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.619 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 24.4 t60 94.77 9.21 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.564 ' OG1' ' O ' ' A' ' 135' ' ' PRO . 0.2 OUTLIER -104.48 127.39 29.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.164 179.684 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.7 132.03 31.45 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.64 1.56 . . . . 0.0 111.678 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.529 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.0 163.9 9.43 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.142 -179.343 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.566 ' O ' ' CZ ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -135.3 -148.15 0.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.122 -0.986 . . . . 0.0 109.567 -178.707 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.68 ' CD1' ' NH2' ' A' ' 154' ' ' ARG . 90.1 t80 -176.42 127.54 0.2 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.962 -1.087 . . . . 0.0 109.281 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.499 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 43.3 p30 -148.2 137.52 22.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -0.871 . . . . 0.0 109.785 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.593 ' O ' ' C ' ' A' ' 145' ' ' GLY . 4.2 mmt -112.59 19.09 17.82 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.451 -0.781 . . . . 0.0 111.122 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.593 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 9.78 -88.12 0.0 OUTLIER Glycine 0 N--CA 1.507 3.395 0 CA-C-N 119.155 0.889 . . . . 0.0 111.922 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.489 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 22.9 p -89.0 119.62 29.68 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.253 -1.379 . . . . 0.0 109.6 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.559 ' O ' ' CG ' ' A' ' 147' ' ' GLU . 8.4 pt-20 -109.14 117.13 54.16 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.621 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 57.2 Cg_endo -102.42 25.48 0.12 Allowed 'Trans proline' 0 N--CA 1.48 0.731 0 C-N-CA 122.361 2.041 . . . . 0.0 111.363 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 13.9 t-20 80.73 69.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.96 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.511 ' O ' ' HB3' ' A' ' 77' ' ' SER . 20.9 p90 -94.68 -178.21 4.46 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.488 -0.758 . . . . 0.0 109.084 -177.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 86.1 m -148.3 95.9 2.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.543 -0.723 . . . . 0.0 109.988 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -110.47 163.5 13.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.988 -1.07 . . . . 0.0 108.787 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.736 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 25.6 mt -111.57 129.7 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.712 HH21 ' NE ' ' A' ' 104' ' ' ARG . 63.0 mtt180 -138.91 168.32 20.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 110.063 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.91 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.2 mp -105.41 147.87 10.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.642 -0.661 . . . . 0.0 109.667 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.461 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.6 m-30 -95.79 117.75 31.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.545 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.602 ' OD2' ' NE1' ' A' ' 162' ' ' TRP . 17.9 t0 -136.46 160.75 37.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.842 -0.536 . . . . 0.0 109.771 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.52 160.65 29.06 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.176 -0.953 . . . . 0.0 109.106 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.4 Cg_endo -66.56 -50.86 1.14 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.883 2.388 . . . . 0.0 112.306 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 159' ' ' PRO . 96.1 mt-10 -43.34 -20.77 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.481 -0.762 . . . . 0.0 109.073 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -87.75 -42.15 6.15 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.602 ' NE1' ' OD2' ' A' ' 157' ' ' ASP . 45.8 m0 -96.17 166.49 11.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.293 -1.122 . . . . 0.0 109.888 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.3 mm -98.23 148.39 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 109.666 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 96' ' ' HIS . . . -79.09 -71.57 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.096 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -135.42 155.89 49.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.244 -0.91 . . . . 0.0 109.659 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -101.3 -41.1 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.635 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 60.2 p -108.09 -30.43 8.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.21 -0.931 . . . . 0.0 109.198 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.75 -8.28 56.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -80.65 148.04 30.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.887 -1.36 . . . . 0.0 108.451 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.503 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 34.6 p30 -111.03 87.55 2.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.966 -1.493 . . . . 0.0 111.122 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.502 HG22 ' OE1' ' A' ' 95' ' ' GLU . 1.7 tt -78.09 -17.39 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.261 -1.524 . . . . 0.0 109.486 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.504 ' HB2' ' CD2' ' A' ' 141' ' ' TRP . . . -60.2 -41.43 92.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.636 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 59.6 p -53.51 -3.72 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 110.283 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.518 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . . . -79.25 -40.21 31.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.004 . . . . 0.0 111.279 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.612 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 5.8 m-85 -112.63 24.96 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.623 0 O-C-N 120.575 -1.328 . . . . 0.0 112.471 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.636 ' HD3' ' C ' ' A' ' 173' ' ' SER . 44.3 Cg_endo -62.16 -18.82 64.14 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 123.71 2.94 . . . . 0.0 113.75 -172.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.0 ttm-85 -89.11 125.85 35.2 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.363 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.489 ' HB3' ' H ' ' A' ' 146' ' ' SER . 4.5 tt -88.38 123.44 32.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.213 -0.929 . . . . 0.0 109.194 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.298 -1.656 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.395 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.838 ' O ' HG23 ' A' ' 19' ' ' THR . 6.4 p . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.96 171.06 8.52 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.881 -1.137 . . . . 0.0 109.053 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 4' ' ' THR . 3.2 tp -158.99 116.94 2.85 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.674 ' OG1' HD11 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -109.83 133.47 53.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.64 -178.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.688 HD12 ' HB3' ' A' ' 16' ' ' TRP . 5.7 mt -128.16 134.83 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -126.59 168.02 14.86 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m -85.23 174.24 9.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.234 -0.916 . . . . 0.0 108.981 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -28.3 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.954 -1.091 . . . . 0.0 109.415 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -76.69 -34.7 58.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.55 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.39 124.08 14.69 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.202 -0.936 . . . . 0.0 109.429 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.55 -36.85 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.119 1.879 . . . . 0.0 112.347 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.53 3.99 2.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 110.235 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -111.9 119.05 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.418 -0.801 . . . . 0.0 109.211 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -99.41 120.97 40.46 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.379 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 15' ' ' LEU . 11.0 mp -91.32 -4.01 56.25 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.171 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.73 ' NE1' ' NE2' ' A' ' 27' ' ' GLN . 41.8 t90 -156.8 104.44 2.13 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 118.433 -1.307 . . . . 0.0 110.542 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -119.07 112.18 19.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.541 -0.725 . . . . 0.0 109.57 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.555 ' OG ' ' CH2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -161.45 163.7 30.26 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.262 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.838 HG23 ' O ' ' A' ' 1' ' ' SER . 45.4 m -131.38 89.56 2.74 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.938 -1.102 . . . . 0.0 108.35 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.762 ' O ' HD12 ' A' ' 24' ' ' ILE . 31.0 m120 -127.83 142.23 51.35 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.425 -0.797 . . . . 0.0 110.37 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.13 -37.86 23.17 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.303 -1.498 . . . . 0.0 108.337 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -83.67 -50.64 7.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.855 . . . . 0.0 109.751 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.46 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.2 tt0 -59.13 -21.73 59.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.107 -0.996 . . . . 0.0 108.754 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.762 HD12 ' O ' ' A' ' 20' ' ' ASN . 11.2 mt -76.09 -49.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.13 -0.981 . . . . 0.0 109.207 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -59.68 -44.8 93.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.777 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -70.78 -38.58 73.42 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.243 -0.91 . . . . 0.0 109.344 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.73 ' NE2' ' NE1' ' A' ' 16' ' ' TRP . 50.4 tt0 -77.0 -49.81 14.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 110.252 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 33' ' ' VAL . 12.2 tp -62.07 -54.52 40.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.015 -1.053 . . . . 0.0 108.857 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.884 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -61.95 -16.45 51.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.905 -1.122 . . . . 0.0 109.856 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 27' ' ' GLN . . . -62.77 -30.07 71.17 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.63 -1.294 . . . . 0.0 108.845 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.96 11.09 12.23 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.009 -1.076 . . . . 0.0 109.558 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.46 25.01 31.84 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.513 HG21 HD11 ' A' ' 28' ' ' LEU . 75.2 t -95.47 145.99 7.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 122.018 0.913 . . . . 0.0 109.471 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -84.32 156.87 21.7 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 121.346 -0.846 . . . . 0.0 108.855 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.614 ' HB2' HD22 ' A' ' 29' ' ' ASN . 1.8 t80 -154.12 149.63 27.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.913 -1.117 . . . . 0.0 109.041 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -169.79 167.78 9.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.006 -1.059 . . . . 0.0 109.866 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.474 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 18.8 ptt-85 -151.82 115.91 4.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.425 -0.797 . . . . 0.0 109.139 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.507 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 11.7 m0 -113.22 157.31 21.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.17 166.39 25.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.678 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.93 162.19 13.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.366 -0.834 . . . . 0.0 108.932 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -94.49 -26.02 16.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.123 -0.986 . . . . 0.0 108.695 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -94.85 172.98 7.83 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -89.86 131.59 35.71 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.368 -0.833 . . . . 0.0 108.993 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.4 mt -92.97 167.95 11.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.239 -0.913 . . . . 0.0 109.812 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.78 -94.28 0.11 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.45 107.47 7.6 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.33 -1.1 . . . . 0.0 108.166 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.4 90.44 45.31 Favored Pre-proline 0 C--N 1.302 -1.494 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.677 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -83.71 40.92 0.96 Allowed 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.795 2.33 . . . . 0.0 111.221 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 52' ' ' THR . 19.1 m -166.24 138.11 3.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.61 -1.306 . . . . 0.0 109.457 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 52' ' ' THR . . . -82.64 -51.78 7.42 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.905 -1.122 . . . . 0.0 110.262 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.15 -0.68 1.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.422 -0.799 . . . . 0.0 109.75 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -77.08 -56.82 4.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 109.806 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.486 ' N ' HG22 ' A' ' 52' ' ' THR . 49.0 t -64.19 -45.53 96.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 O-C-N 121.137 -0.977 . . . . 0.0 109.579 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.4 mt -59.82 -41.07 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.274 -0.97 . . . . 0.0 108.807 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.87 -24.16 67.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.351 -0.843 . . . . 0.0 109.788 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.04 -21.48 56.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.047 -1.033 . . . . 0.0 110.323 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 58' ' ' GLN . 57.0 m-85 -112.28 -6.54 14.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.384 -0.822 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 62' ' ' ASP . 4.2 mm100 -45.85 -39.05 8.02 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.743 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -50.81 -48.04 59.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.909 -1.116 . . . . 0.0 109.634 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.607 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.37 -60.77 3.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.01 -1.056 . . . . 0.0 110.309 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.654 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -62.6 -29.71 47.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 120.751 -1.218 . . . . 0.0 109.184 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 58' ' ' GLN . 45.5 t0 -54.85 -27.62 43.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.805 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -77.82 -37.41 48.68 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.018 -1.051 . . . . 0.0 109.812 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.6 mp -63.98 -39.22 93.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.126 -0.984 . . . . 0.0 109.865 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.51 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -69.24 -29.06 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 0.0 108.924 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.02 -54.12 47.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.474 -1.391 . . . . 0.0 109.297 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.42 -52.47 5.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.254 -0.904 . . . . 0.0 110.954 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.624 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -86.86 14.53 7.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 110.596 -177.565 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -15.54 89.31 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.525 ' CG ' HG21 ' A' ' 155' ' ' ILE . 87.4 m-85 -77.58 164.78 25.05 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -58.56 -88.01 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 109.949 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.52 ' OG ' ' CG ' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -101.26 159.72 15.01 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.568 -0.707 . . . . 0.0 109.618 -179.064 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.497 ' HE1' HG23 ' A' ' 153' ' ' ILE . 6.5 t-105 -136.29 140.04 43.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.496 -0.753 . . . . 0.0 109.139 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.1 -173.47 2.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 108.775 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.677 HG12 ' HA ' ' A' ' 153' ' ' ILE . 1.9 m -122.99 148.45 26.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.513 -0.742 . . . . 0.0 109.587 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.574 HG23 ' O ' ' A' ' 76' ' ' ILE . 2.8 tt -100.89 118.09 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 150' ' ' PHE . 91.8 p -171.83 103.79 0.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.604 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.556 ' CD1' ' H ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -105.39 -178.38 3.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 121.078 1.763 . . . . 0.0 108.209 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.617 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 8.2 tpt180 -89.45 148.77 23.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.891 -1.131 . . . . 0.0 109.528 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.41 3.91 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.615 -0.678 . . . . 0.0 109.641 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 79' ' ' ARG . 80.5 m-20 -92.16 -24.11 19.19 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.922 -1.111 . . . . 0.0 109.34 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.822 ' N ' HD21 ' A' ' 82' ' ' ASN . 0.0 OUTLIER -60.63 118.07 31.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.83 -1.169 . . . . 0.0 109.586 -178.412 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -88.57 -23.77 0.98 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.241 1.96 . . . . 0.0 112.501 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -91.93 -14.8 28.97 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.919 -1.113 . . . . 0.0 109.945 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.511 ' CB ' ' OD1' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -60.89 -35.75 77.44 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.794 178.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 96.9 mt-10 -57.17 -40.57 77.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.133 -0.979 . . . . 0.0 108.491 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.41 -27.29 68.43 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.792 -1.193 . . . . 0.0 109.154 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.6 tp -60.67 -47.61 85.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -0.948 . . . . 0.0 109.989 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -64.58 -27.66 69.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.108 -0.995 . . . . 0.0 109.285 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.07 -60.74 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.394 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -58.33 -35.07 71.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.08 -1.013 . . . . 0.0 109.19 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -79.77 -18.35 51.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.414 -0.803 . . . . 0.0 109.956 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 94' ' ' ASN . 0.3 OUTLIER -60.75 -26.49 67.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.49 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.483 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 32.5 p-10 -46.27 135.22 8.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.293 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.68 159.33 13.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 0.0 109.871 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -171.9 -169.73 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.763 -1.175 . . . . 0.0 111.965 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.81 130.98 4.47 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.549 0.69 . . . . 0.0 109.364 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.621 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -100.67 154.37 18.65 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.625 -0.672 . . . . 0.0 109.716 -179.453 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.11 -7.98 87.52 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -123.4 170.98 9.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -1.112 . . . . 0.0 109.286 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -74.07 143.06 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.973 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.599 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 5.0 tt0 -103.49 90.02 3.55 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.947 HG22 ' OG ' ' A' ' 133' ' ' SER . 26.1 t -85.7 127.06 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.286 -0.884 . . . . 0.0 109.714 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 115.49 17.29 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.501 -0.749 . . . . 0.0 109.617 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.65 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 10.9 t80 -99.94 132.19 45.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 108.612 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.723 ' CD2' ' HB2' ' A' ' 110' ' ' ALA . 0.8 OUTLIER -91.08 135.47 33.74 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.364 0.602 . . . . 0.0 109.939 -179.01 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.0 t -116.84 -26.97 2.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.371 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 109' ' ' GLY . 73.7 tt0 -169.12 158.02 8.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.155 -0.965 . . . . 0.0 108.949 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 108' ' ' GLU . . . 48.37 107.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.723 ' HB2' ' CD2' ' A' ' 106' ' ' PHE . . . -151.8 112.33 4.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.649 -1.501 . . . . 0.0 109.574 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.93 -141.97 4.36 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.502 HD22 HD23 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -108.9 100.42 9.63 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.329 -1.101 . . . . 0.0 110.851 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.659 ' CD2' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.47 132.12 36.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.934 -1.104 . . . . 0.0 110.043 -178.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 9.8 m -78.46 154.7 30.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.554 -0.716 . . . . 0.0 110.148 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 122' ' ' PHE . 1.1 tp -145.28 121.0 10.51 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.5 t-160 -111.48 111.15 21.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.224 -0.923 . . . . 0.0 109.677 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.46 113.85 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.744 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.49 -145.14 35.3 Favored Glycine 0 N--CA 1.503 3.15 0 N-CA-C 106.146 -2.782 . . . . 0.0 106.146 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -100.73 77.74 1.91 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 114.581 -2.848 . . . . 0.0 109.688 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.59 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 1.5 mt-10 -166.6 170.0 13.09 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 120.949 -1.095 . . . . 0.0 108.064 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 5' ' ' ILE . 50.7 t -126.56 140.34 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.573 ' O ' ' N ' ' A' ' 115' ' ' LEU . 2.3 m-85 -126.95 130.71 50.61 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.601 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -131.23 110.14 10.91 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.444 -0.785 . . . . 0.0 109.134 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -98.52 138.22 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.113 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.727 ' H ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.8 88.13 2.68 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.425 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.522 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 5.2 p -167.89 136.11 2.37 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.291 -1.506 . . . . 0.0 107.216 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -104.42 96.8 6.86 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 115.292 -2.563 . . . . 0.0 110.05 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.586 ' C ' ' H ' ' A' ' 130' ' ' ASP . 24.5 mmtt -116.75 157.48 25.43 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.324 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.65 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 40.3 m-80 -58.38 -2.11 0.18 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.586 ' H ' ' C ' ' A' ' 128' ' ' LYS . 17.2 m-20 -70.47 147.32 49.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.108 -0.995 . . . . 0.0 109.303 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.754 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.8 OUTLIER -111.31 154.66 24.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.605 0.717 . . . . 0.0 110.448 -179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.754 ' N ' HD12 ' A' ' 131' ' ' LEU . 29.1 mm -116.65 118.73 59.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.947 ' OG ' HG22 ' A' ' 103' ' ' VAL . 0.3 OUTLIER -111.03 129.82 55.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.545 -0.722 . . . . 0.0 109.285 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.48 141.75 23.19 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.06 153.66 71.79 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.058 1.839 . . . . 0.0 112.347 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.623 ' O ' ' CG ' ' A' ' 137' ' ' HIS . . . -71.06 135.45 47.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -0.85 . . . . 0.0 108.895 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.623 ' CG ' ' O ' ' A' ' 136' ' ' ALA . 2.6 m170 89.83 14.95 0.05 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.094 0.473 . . . . 0.0 110.004 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.39 127.21 28.66 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.53 131.65 32.53 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.924 1.749 . . . . 0.0 111.513 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.08 163.09 9.19 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.245 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.516 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -134.52 -148.7 0.32 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.933 . . . . 0.0 109.542 -178.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.78 126.45 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.937 -1.102 . . . . 0.0 109.196 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.479 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 37.2 p-10 -144.58 134.28 23.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.429 -0.794 . . . . 0.0 109.686 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.671 ' SD ' ' N ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -112.96 19.13 17.55 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.614 -0.679 . . . . 0.0 110.44 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 13.18 -93.13 0.01 OUTLIER Glycine 0 N--CA 1.501 3.02 0 CA-C-N 119.216 0.916 . . . . 0.0 111.663 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.447 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 19.4 p -84.53 119.56 25.32 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.259 -1.376 . . . . 0.0 108.924 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -113.71 112.23 48.27 Favored Pre-proline 0 C--N 1.294 -1.847 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.093 178.447 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.8 Cg_endo -103.52 34.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 123.326 2.684 . . . . 0.0 111.542 176.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 12.6 t-20 81.56 69.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.529 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 9.0 p90 -95.67 135.89 36.78 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.064 -1.023 . . . . 0.0 109.944 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.7 m -97.73 119.72 36.82 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.779 -0.575 . . . . 0.0 109.686 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.45 159.96 41.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 109.266 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.677 ' HA ' HG12 ' A' ' 75' ' ' VAL . 96.1 mt -108.69 125.97 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.513 -0.742 . . . . 0.0 110.086 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.552 ' C ' HD13 ' A' ' 155' ' ' ILE . 62.9 mtp180 -132.5 160.72 35.69 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.575 -0.703 . . . . 0.0 109.713 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -108.39 156.91 8.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.416 0.627 . . . . 0.0 109.478 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.52 ' CG ' ' OG ' ' A' ' 72' ' ' SER . 4.5 m-85 -100.51 119.75 38.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.053 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 12.2 p30 -134.55 159.22 41.85 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -98.32 146.76 32.1 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.985 -1.072 . . . . 0.0 109.494 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.618 ' O ' ' N ' ' A' ' 161' ' ' GLY . 47.3 Cg_endo -71.37 -52.61 0.21 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.355 2.037 . . . . 0.0 112.048 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -43.54 -14.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.605 -0.685 . . . . 0.0 109.403 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.49 -32.17 38.87 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.634 ' N ' ' CD1' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -118.71 176.09 5.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.599 -0.942 . . . . 0.0 110.469 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 70.8 mt -94.2 145.75 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.306 -0.871 . . . . 0.0 109.277 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.27 -73.14 0.31 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.372 -0.83 . . . . 0.0 110.643 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -120.91 151.15 40.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.367 -0.833 . . . . 0.0 109.854 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.467 ' CD2' ' N ' ' A' ' 166' ' ' PHE . 2.7 p90 -101.54 -40.43 7.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.564 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 m -110.2 -31.15 7.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.315 -0.866 . . . . 0.0 108.977 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.68 -4.94 53.9 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.421 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -82.76 148.67 27.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.749 -1.442 . . . . 0.0 108.926 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.482 ' OD1' ' OG ' ' A' ' 173' ' ' SER . 60.9 t0 -109.83 89.13 2.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 117.925 -1.51 . . . . 0.0 111.058 176.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 171' ' ' ILE . 0.7 OUTLIER -76.09 -22.38 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.489 -1.382 . . . . 0.0 109.366 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -60.36 -40.55 91.19 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.662 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 24.1 m -51.17 -3.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 110.19 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.573 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . . . -77.4 -41.52 39.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.789 -1.194 . . . . 0.0 111.629 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.631 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 1.0 OUTLIER -112.83 25.24 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.607 0 O-C-N 120.772 -1.205 . . . . 0.0 112.27 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.662 ' HD3' ' C ' ' A' ' 173' ' ' SER . 49.6 Cg_endo -62.41 -22.66 74.36 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.722 2.948 . . . . 0.0 113.522 -172.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 177' ' ' ARG . 28.3 ptt85 -89.42 126.45 35.56 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.003 -1.079 . . . . 0.0 108.885 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.73 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.6 OUTLIER -87.78 118.68 27.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.262 -0.899 . . . . 0.0 109.022 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.534 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.849 ' O ' HG23 ' A' ' 19' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.119 0.485 . . . . 0.0 109.703 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 125' ' ' LEU . . . -95.89 171.09 8.85 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.959 -1.097 . . . . 0.0 109.288 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.95 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 18.7 tp -157.83 109.36 2.28 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.79 127.09 53.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.51 -0.744 . . . . 0.0 110.523 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.664 HD12 ' HB3' ' A' ' 16' ' ' TRP . 51.2 mt -120.87 135.62 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.27 169.75 15.02 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.8 p -87.47 173.05 9.34 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.0 -33.37 6.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.084 -1.01 . . . . 0.0 108.874 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -71.72 -37.47 70.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.53 -0.731 . . . . 0.0 110.384 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.14 125.25 14.58 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.98 -1.075 . . . . 0.0 109.634 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -82.26 -30.21 1.28 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.892 1.728 . . . . 0.0 112.266 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -70.22 0.74 5.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.41 -0.806 . . . . 0.0 110.662 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.769 HD21 HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.7 118.69 34.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.024 -1.047 . . . . 0.0 108.497 179.168 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -97.13 125.42 41.62 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.846 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.769 HD13 HD21 ' A' ' 13' ' ' ASN . 2.6 mp -90.46 -12.25 37.91 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.497 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.95 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 34.7 t90 -159.73 107.41 1.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.222 -1.391 . . . . 0.0 109.939 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -121.09 119.43 32.42 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.09 -1.006 . . . . 0.0 110.332 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.454 ' OG ' ' CZ2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -161.02 166.68 27.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.266 -0.897 . . . . 0.0 110.155 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.849 HG23 ' O ' ' A' ' 1' ' ' SER . 45.8 m -129.21 86.42 2.43 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.634 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -129.45 138.96 51.73 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.794 -0.566 . . . . 0.0 110.369 177.22 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.75 -28.59 30.31 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.592 -1.942 . . . . 0.0 108.905 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -82.95 -53.3 5.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -62.28 -18.76 62.16 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.66 -1.275 . . . . 0.0 107.984 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.728 HG12 HD22 ' A' ' 3' ' ' LEU . 3.0 mt -73.28 -59.14 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.344 -0.847 . . . . 0.0 109.375 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.486 ' N ' HG22 ' A' ' 24' ' ' ILE . 21.2 pt20 -58.34 -39.16 78.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.416 ' N ' ' HG3' ' A' ' 25' ' ' GLN . 44.1 tt0 -66.99 -42.64 84.69 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.332 -0.855 . . . . 0.0 109.47 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.536 ' OE1' ' CE2' ' A' ' 16' ' ' TRP . 1.6 tt0 -67.2 -46.83 72.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.101 -1.0 . . . . 0.0 109.524 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 28' ' ' LEU . 3.7 mm? -65.95 -53.56 37.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.327 -0.858 . . . . 0.0 109.447 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 17.9 t-20 -64.16 -19.0 65.0 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.58 -0.7 . . . . 0.0 110.573 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.15 71.17 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.535 -1.353 . . . . 0.0 108.164 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -89.38 14.81 10.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.598 -0.689 . . . . 0.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.68 20.38 58.28 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.434 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 21.9 t -93.3 147.09 5.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.277 -1.131 . . . . 0.0 109.078 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.684 ' HE ' ' H ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -83.09 155.59 23.77 Favored 'General case' 0 C--N 1.281 -2.378 0 O-C-N 120.644 -1.285 . . . . 0.0 107.833 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.684 ' H ' ' HE ' ' A' ' 34' ' ' ARG . 2.3 t80 -152.87 147.09 25.59 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 17.0 tp10 -174.35 172.65 3.16 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.592 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.466 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 30.7 ptt-85 -151.95 121.86 7.06 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.115 -0.991 . . . . 0.0 108.732 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.465 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 33.7 m0 -112.75 156.43 22.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.512 -0.742 . . . . 0.0 109.141 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -142.64 157.64 44.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.293 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.71 159.06 15.34 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -98.66 -13.6 20.23 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -93.74 156.97 16.39 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.495 ' O ' ' OD2' ' A' ' 43' ' ' ASP . 46.4 p-10 -95.52 122.23 38.05 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.473 -0.767 . . . . 0.0 109.384 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.8 mt -91.8 165.83 13.07 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.176 -0.952 . . . . 0.0 108.95 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.95 -121.92 0.58 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.13 79.45 9.12 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.086 -1.244 . . . . 0.0 108.497 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.62 93.89 46.65 Favored Pre-proline 0 C--N 1.306 -1.317 0 O-C-N 121.462 -0.773 . . . . 0.0 109.56 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.745 ' O ' HG23 ' A' ' 49' ' ' THR . 46.9 Cg_endo -70.2 85.61 0.67 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.084 1.856 . . . . 0.0 111.505 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 48' ' ' PRO . 1.5 p -165.05 117.93 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -0.863 . . . . 0.0 109.019 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.43 -36.84 28.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.836 -1.165 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -69.3 -14.92 63.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.943 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 49' ' ' THR . 4.2 p -78.25 -43.67 27.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.051 -1.031 . . . . 0.0 110.89 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 t -67.13 -46.44 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.938 -1.101 . . . . 0.0 109.564 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 58' ' ' GLN . 55.7 mt -61.2 -39.58 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.282 -0.886 . . . . 0.0 108.888 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.22 70.66 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.678 -0.639 . . . . 0.0 109.905 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.85 -21.61 54.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.067 -1.021 . . . . 0.0 110.376 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -114.44 -7.09 12.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.489 -0.757 . . . . 0.0 109.13 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 62' ' ' ASP . 5.5 tp-100 -48.59 -36.93 16.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.242 -0.911 . . . . 0.0 108.546 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.685 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -53.25 -48.84 67.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.043 -1.035 . . . . 0.0 109.941 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.685 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.06 -55.43 32.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.728 -1.232 . . . . 0.0 109.669 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.653 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -65.71 -26.91 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.083 -1.01 . . . . 0.0 109.543 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 58' ' ' GLN . 20.7 t70 -59.2 -25.2 63.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.461 -0.774 . . . . 0.0 109.224 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.7 -43.29 14.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 110.016 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 tt -65.6 -48.46 72.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.307 -0.87 . . . . 0.0 109.819 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' GLY . 3.4 p -66.91 -28.25 42.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.43 -44.21 76.06 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.791 -1.193 . . . . 0.0 109.279 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -80.02 -52.86 7.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.999 -1.063 . . . . 0.0 109.714 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.623 ' O ' ' C ' ' A' ' 69' ' ' GLY . 54.0 mttm -83.08 12.67 4.79 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.401 -0.812 . . . . 0.0 110.685 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -5.63 83.21 0.0 OUTLIER Glycine 0 N--CA 1.506 3.304 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.838 ' CG ' HG21 ' A' ' 155' ' ' ILE . 69.6 m-85 -75.66 156.6 34.66 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.433 -1.039 . . . . 0.0 109.88 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -64.82 -49.59 70.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.486 -0.759 . . . . 0.0 110.574 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.9 m -125.27 135.49 52.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.356 -0.84 . . . . 0.0 109.729 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.482 ' CZ2' HD13 ' A' ' 61' ' ' ILE . 7.4 t-105 -133.57 138.98 46.29 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.4 -168.87 0.56 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.155 -0.965 . . . . 0.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 152' ' ' ALA . 1.5 t -125.99 155.91 35.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.3 mt -93.88 131.82 39.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.5 p -93.55 167.77 11.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 122.769 1.271 . . . . 0.0 111.839 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.586 HD23 ' H ' ' A' ' 149' ' ' ASN . 10.1 tp -167.78 157.6 10.25 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.497 176.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.456 HH11 HD21 ' A' ' 149' ' ' ASN . 0.0 OUTLIER -128.99 142.18 51.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.412 ' H ' ' HD3' ' A' ' 79' ' ' ARG . . . -67.35 -4.79 11.9 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.216 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.426 ' OD2' ' C ' ' A' ' 81' ' ' ASP . 8.5 p-10 -116.64 -8.02 11.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.197 -0.939 . . . . 0.0 109.087 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.468 ' CG ' ' O ' ' A' ' 82' ' ' ASN . 1.6 p30 -62.88 124.72 84.56 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 109.801 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.36 -2.37 12.25 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.291 1.994 . . . . 0.0 111.954 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -90.19 3.75 52.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.976 . . . . 0.0 109.832 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 19.4 pttp -60.31 -51.25 70.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.159 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.579 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 46.1 tp10 -65.45 -43.16 91.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.882 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.99 -43.48 98.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.855 . . . . 0.0 109.981 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.2 tp -59.46 -45.61 91.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 109.171 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.579 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 17.1 ttp-105 -63.0 -28.59 70.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.555 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HA ' HD23 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -65.93 -60.55 2.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.806 . . . . 0.0 109.377 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -55.88 -31.57 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 109.461 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.06 -18.18 50.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.16 -0.963 . . . . 0.0 110.037 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -64.67 -27.54 68.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -1.0 . . . . 0.0 110.031 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -60.45 136.97 58.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.07 -1.019 . . . . 0.0 110.233 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 169' ' ' ASP . 20.7 pt-20 -73.95 164.07 27.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.394 -0.816 . . . . 0.0 109.186 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -172.54 -167.52 0.46 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.008 -1.058 . . . . 0.0 110.463 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.96 133.17 5.95 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.6 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -103.63 153.47 20.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 109.804 -179.181 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.22 -7.07 86.8 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -125.28 170.93 10.81 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.285 -1.126 . . . . 0.0 109.53 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -71.64 143.02 49.92 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.117 -0.989 . . . . 0.0 109.821 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.6 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 3.3 tt0 -104.16 97.91 7.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 110.034 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.719 HG22 ' OG ' ' A' ' 133' ' ' SER . 5.4 t -97.41 124.71 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.18 126.56 43.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.47 -0.769 . . . . 0.0 109.236 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 33.4 t80 -108.31 129.3 55.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.835 0.826 . . . . 0.0 109.008 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -80.85 117.05 21.16 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.566 -0.709 . . . . 0.0 110.353 -178.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.5 t -85.14 -47.54 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -0.822 . . . . 0.0 110.346 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -169.27 158.1 7.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.915 -1.116 . . . . 0.0 110.545 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.61 61.56 4.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.778 ' HB3' ' HB3' ' A' ' 127' ' ' GLU . . . -119.58 129.9 54.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.877 -1.367 . . . . 0.0 108.446 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -118.57 -29.92 1.79 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.004 HD12 ' N ' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -141.66 160.13 40.79 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.387 -1.066 . . . . 0.0 109.748 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 1.004 ' N ' HD12 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -139.35 95.51 2.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.715 ' O ' HD22 ' A' ' 115' ' ' LEU . 1.8 m -77.78 136.43 38.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.42 -0.8 . . . . 0.0 110.318 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.715 HD22 ' O ' ' A' ' 114' ' ' CYS . 0.3 OUTLIER -145.64 114.19 6.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.409 -0.807 . . . . 0.0 109.734 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 6.8 t-160 -106.73 110.55 22.76 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.901 -1.124 . . . . 0.0 109.342 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.3 mm -128.61 121.53 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.469 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.15 -143.82 36.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 103.682 -3.767 . . . . 0.0 103.682 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.492 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 44.7 p30 -111.0 82.67 1.63 Allowed 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 115.417 -2.513 . . . . 0.0 108.369 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.506 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 60.0 tt0 -164.76 167.69 18.67 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 5' ' ' ILE . 71.0 t -128.5 140.25 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.986 -1.071 . . . . 0.0 110.085 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -125.57 132.25 52.58 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.928 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -142.05 122.13 13.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.069 -1.02 . . . . 0.0 109.029 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -106.74 147.09 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.241 -0.912 . . . . 0.0 109.191 179.621 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 12.9 mt -118.44 78.33 1.25 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 117.848 -1.541 . . . . 0.0 111.586 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.446 ' SG ' ' N ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -166.79 163.65 16.46 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 103.3 -2.852 . . . . 0.0 103.3 177.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.778 ' HB3' ' HB3' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -117.78 110.74 18.18 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 122.59 2.45 . . . . 0.0 106.312 176.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.595 ' C ' ' H ' ' A' ' 130' ' ' ASP . 13.0 mmtt -113.61 148.51 36.08 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.603 -0.686 . . . . 0.0 111.114 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.579 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 93.5 m-20 -61.12 -0.19 0.31 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.595 ' H ' ' C ' ' A' ' 128' ' ' LYS . 49.2 p30 -70.28 153.06 43.48 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.222 1.011 . . . . 0.0 110.903 -176.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.771 ' C ' HD12 ' A' ' 131' ' ' LEU . 0.9 OUTLIER -125.76 161.87 26.37 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.856 0.836 . . . . 0.0 110.972 -178.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.77 ' N ' HD12 ' A' ' 131' ' ' LEU . 1.6 mp -128.43 145.41 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.669 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.719 ' OG ' HG22 ' A' ' 103' ' ' VAL . 2.6 t -119.12 138.08 53.15 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.308 -0.87 . . . . 0.0 109.789 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -112.14 140.06 23.13 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.33 150.83 59.33 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.099 1.866 . . . . 0.0 112.328 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -72.48 132.57 44.04 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.815 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 12.5 t60 94.53 9.86 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.39 126.94 30.12 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 108.46 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.41 132.59 31.82 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.541 1.494 . . . . 0.0 111.463 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.516 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -166.61 162.84 16.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.315 -0.866 . . . . 0.0 110.177 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.672 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 21.6 p90 -127.22 -154.37 0.63 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.505 -0.747 . . . . 0.0 109.818 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.672 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 47.4 t80 -169.71 119.79 0.65 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.491 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 34.3 p30 -139.52 119.64 13.63 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.28 -0.887 . . . . 0.0 108.692 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.566 ' SD ' ' CZ ' ' A' ' 150' ' ' PHE . 25.9 mtm -93.31 16.59 12.91 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 111.491 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.806 ' HA3' HD13 ' A' ' 178' ' ' LEU . . . 50.24 -144.3 10.93 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.587 ' H ' HD22 ' A' ' 178' ' ' LEU . 31.6 t -83.29 121.04 26.6 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.0 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -116.27 120.42 35.05 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.88 -0.512 . . . . 0.0 110.536 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 59.3 Cg_endo -102.87 59.41 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.807 0 C-N-CA 122.378 2.052 . . . . 0.0 110.65 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.586 ' H ' HD23 ' A' ' 78' ' ' LEU . 12.3 t-20 82.48 64.26 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.304 -0.873 . . . . 0.0 109.691 -177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.566 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 1.0 OUTLIER -101.42 168.19 9.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.7 m -127.1 133.19 50.46 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.43 -0.794 . . . . 0.0 109.281 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -138.16 157.35 46.48 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.031 -1.043 . . . . 0.0 109.591 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.3 mt -108.32 124.91 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.062 -1.024 . . . . 0.0 108.985 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.16 164.49 27.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.414 -0.804 . . . . 0.0 109.346 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.838 HG21 ' CG ' ' A' ' 70' ' ' TYR . 2.9 mt -119.24 124.46 73.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.46 ' N ' ' CD1' ' A' ' 156' ' ' PHE . 26.5 m-85 -93.87 133.39 37.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.983 -1.073 . . . . 0.0 110.241 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.62 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -129.84 165.57 21.72 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.644 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -91.2 160.63 36.98 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.935 -1.103 . . . . 0.0 108.625 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 161' ' ' GLY . 36.1 Cg_endo -57.02 -54.28 3.88 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.678 2.252 . . . . 0.0 113.12 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 159' ' ' PRO . 11.8 pt-20 -42.27 -23.17 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.506 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.27 -56.07 2.1 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.644 ' CD1' ' O ' ' A' ' 158' ' ' ASN . 39.0 p-90 -98.86 155.97 17.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.121 -1.223 . . . . 0.0 110.633 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 14.8 tt -103.88 159.08 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.497 -0.752 . . . . 0.0 109.184 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.97 -71.73 0.24 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.37 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -139.82 158.63 43.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.014 -1.054 . . . . 0.0 110.242 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -101.09 -41.87 6.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.162 -0.961 . . . . 0.0 109.704 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.6 m -115.92 -34.21 4.84 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.93 -3.95 57.38 Favored Glycine 0 N--CA 1.484 1.863 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.812 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.422 ' O ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -81.7 148.11 29.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.08 -1.835 . . . . 0.0 107.957 178.498 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -112.35 91.16 3.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.089 -1.444 . . . . 0.0 111.104 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.419 HD11 ' HZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -75.3 -20.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.113 -1.617 . . . . 0.0 108.799 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.624 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -61.34 -39.91 92.3 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.549 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -51.4 -3.85 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.827 -0.546 . . . . 0.0 110.698 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.36 -36.34 34.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.915 -1.116 . . . . 0.0 111.053 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.612 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.5 OUTLIER -111.49 20.09 0.07 OUTLIER Pre-proline 0 N--CA 1.511 2.595 0 O-C-N 120.708 -1.245 . . . . 0.0 113.993 -178.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 51.8 Cg_endo -65.48 -23.62 57.6 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.961 2.441 . . . . 0.0 114.636 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -87.81 126.54 35.07 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.268 -1.373 . . . . 0.0 108.41 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.806 HD13 ' HA3' ' A' ' 145' ' ' GLY . 9.4 tp -85.41 145.2 27.58 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 108.779 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.168 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.584 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.29 168.22 10.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.071 -1.018 . . . . 0.0 109.313 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 4' ' ' THR . 2.6 tp -156.48 125.49 6.01 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.761 ' OG1' HD21 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -121.73 126.62 49.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.205 -0.935 . . . . 0.0 109.633 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.444 HG23 ' CD2' ' A' ' 122' ' ' PHE . 28.1 mt -117.43 140.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.794 ' CZ ' ' O ' ' A' ' 7' ' ' SER . 1.2 t80 -144.41 156.19 44.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.794 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 50.7 p -89.57 179.76 5.97 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.984 -1.073 . . . . 0.0 108.132 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 8' ' ' VAL . 18.7 m -88.19 3.21 5.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 119.975 -1.703 . . . . 0.0 110.149 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.406 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 1.4 mmmt -76.81 -49.57 15.53 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 120.509 -1.369 . . . . 0.0 114.13 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.787 ' O ' ' CE1' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -145.26 123.7 6.59 Favored Pre-proline 0 N--CA 1.507 2.404 0 O-C-N 119.96 -1.712 . . . . 0.0 109.546 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.71 -33.96 26.21 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.324 1.349 . . . . 0.0 113.413 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.43 6.15 1.5 Allowed 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.281 -0.887 . . . . 0.0 110.127 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -125.74 124.64 41.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.152 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.477 ' C ' HD12 ' A' ' 15' ' ' LEU . 92.6 p -113.44 133.44 55.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.46 -0.775 . . . . 0.0 108.931 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.842 ' N ' HD12 ' A' ' 15' ' ' LEU . 6.3 mp -94.19 5.41 51.81 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.105 -0.997 . . . . 0.0 109.881 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.407 ' NE1' ' NE2' ' A' ' 27' ' ' GLN . 23.8 t90 -153.91 102.08 2.48 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.788 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -117.99 107.43 14.03 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.197 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.68 161.71 29.57 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.511 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.822 HG23 ' O ' ' A' ' 19' ' ' THR . 8.8 t -132.57 90.54 2.79 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 120.881 -1.137 . . . . 0.0 107.996 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.782 ' O ' HD12 ' A' ' 24' ' ' ILE . 12.6 t-20 -123.76 141.96 51.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.254 -0.904 . . . . 0.0 110.037 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.83 -35.53 29.31 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.035 -1.666 . . . . 0.0 108.779 176.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -83.13 -52.27 6.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.168 -0.957 . . . . 0.0 109.548 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 1.4 tm-20 -60.17 -20.48 58.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.96 . . . . 0.0 108.667 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.782 HD12 ' O ' ' A' ' 20' ' ' ASN . 4.6 mt -73.04 -54.76 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.198 -0.939 . . . . 0.0 108.766 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -58.72 -43.0 90.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.488 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.692 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 94.9 mt-30 -62.08 -40.72 96.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.207 -0.933 . . . . 0.0 108.967 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.407 ' NE2' ' NE1' ' A' ' 16' ' ' TRP . 55.8 tt0 -73.25 -45.74 54.16 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.79 HD12 HG11 ' A' ' 33' ' ' VAL . 3.3 mm? -67.01 -61.16 2.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.031 -1.043 . . . . 0.0 110.089 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.2 t-20 -59.48 -18.88 43.58 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.321 -0.862 . . . . 0.0 110.262 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.692 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -66.04 -31.25 72.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.81 -1.181 . . . . 0.0 108.966 177.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.644 ' NZ ' ' CE2' ' A' ' 122' ' ' PHE . 13.6 mtmt -91.47 12.3 21.17 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.296 -0.877 . . . . 0.0 109.963 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.25 24.76 30.58 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.159 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.79 HG11 HD12 ' A' ' 28' ' ' LEU . 28.8 t -95.3 147.41 5.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.385 -1.068 . . . . 0.0 109.194 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.457 ' HD3' HD11 ' A' ' 131' ' ' LEU . 18.9 ttt180 -82.82 153.23 25.29 Favored 'General case' 0 C--N 1.285 -2.208 0 O-C-N 120.82 -1.175 . . . . 0.0 108.097 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -154.81 149.45 26.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.063 -1.023 . . . . 0.0 108.564 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.533 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 5.5 pt-20 -178.78 179.54 0.7 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.019 -1.051 . . . . 0.0 110.561 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.8 ptt85 -152.97 122.35 6.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.319 -0.863 . . . . 0.0 109.353 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.612 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 33.4 m0 -111.78 153.38 26.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.49 -0.756 . . . . 0.0 109.108 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -140.01 155.01 47.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.901 . . . . 0.0 109.658 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.27 157.55 15.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 108.783 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -102.73 -8.75 20.6 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.61 162.16 14.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.683 0.754 . . . . 0.0 109.184 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 39.8 p-10 -96.41 123.72 40.16 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.425 0.631 . . . . 0.0 109.694 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.94 160.88 14.24 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.369 -0.832 . . . . 0.0 109.43 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.1 -105.3 0.22 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.87 88.62 4.68 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.057 -1.261 . . . . 0.0 109.078 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.99 91.89 40.77 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.145 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.91 -23.7 13.74 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.179 1.919 . . . . 0.0 112.477 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.0 p -119.65 141.93 48.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.782 -0.574 . . . . 0.0 109.494 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.42 -17.68 51.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.804 . . . . 0.0 109.428 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' ALA . 97.8 mt-10 -44.69 -38.2 4.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.476 -0.765 . . . . 0.0 109.094 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 m -76.36 -33.11 58.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.194 -0.941 . . . . 0.0 109.412 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.561 HG11 ' CG1' ' A' ' 107' ' ' VAL . 70.1 t -65.84 -45.07 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.385 -0.822 . . . . 0.0 110.042 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.935 HD13 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -61.47 -38.54 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.098 -1.001 . . . . 0.0 109.006 -179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.21 -31.28 70.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.425 -0.797 . . . . 0.0 109.686 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.86 -21.78 50.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.084 -1.01 . . . . 0.0 110.443 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -112.53 -10.22 13.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.332 -0.855 . . . . 0.0 109.526 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.609 ' N ' ' O ' ' A' ' 54' ' ' ILE . 4.6 tp-100 -52.64 -43.05 65.2 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.421 -0.911 . . . . 0.0 108.86 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.547 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 27.7 p-80 -49.71 -48.52 49.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.017 -1.052 . . . . 0.0 109.653 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.547 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.08 -60.76 3.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.948 -1.095 . . . . 0.0 109.853 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.686 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -62.13 -30.01 47.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.773 -1.204 . . . . 0.0 109.304 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.4 t70 -55.22 -25.85 35.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.069 -1.019 . . . . 0.0 109.624 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -80.3 -35.23 36.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 109.298 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.97 -42.66 94.36 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.42 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.716 HG22 ' CZ3' ' A' ' 73' ' ' TRP . 0.6 OUTLIER -72.04 -28.97 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 109.532 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.66 -52.91 53.67 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.937 -1.102 . . . . 0.0 109.502 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.64 -46.27 17.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.023 -1.048 . . . . 0.0 109.988 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.626 ' O ' ' C ' ' A' ' 69' ' ' GLY . 23.2 mttm -83.59 13.36 4.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.835 . . . . 0.0 110.631 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.626 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -6.11 82.21 0.0 OUTLIER Glycine 0 N--CA 1.504 3.187 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.896 ' CG ' HG21 ' A' ' 155' ' ' ILE . 43.2 m-85 -76.36 161.82 28.39 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.709 -0.877 . . . . 0.0 109.138 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -58.93 -42.85 90.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 0.0 109.974 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.8 t -151.29 161.21 43.12 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.154 -0.967 . . . . 0.0 109.895 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.716 ' CZ3' HG22 ' A' ' 65' ' ' VAL . 12.3 t-105 -137.74 143.0 40.96 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.454 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -160.87 179.13 8.74 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.935 HG21 HD13 ' A' ' 54' ' ' ILE . 2.7 t -122.9 142.04 40.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.47 -0.769 . . . . 0.0 109.264 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.5 mm -100.0 116.25 42.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.515 ' O ' ' OG ' ' A' ' 77' ' ' SER . 5.8 p -168.71 102.07 0.4 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.512 -0.743 . . . . 0.0 109.047 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.677 HD23 ' HB2' ' A' ' 82' ' ' ASN . 10.3 tp -121.47 179.88 4.3 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 119.581 -1.95 . . . . 0.0 107.712 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.848 HH21 ' HB3' ' A' ' 80' ' ' ALA . 4.0 ttp85 -87.94 160.39 17.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.649 -1.282 . . . . 0.0 109.118 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.848 ' HB3' HH21 ' A' ' 79' ' ' ARG . . . -58.52 -2.74 0.23 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.895 0.855 . . . . 0.0 109.849 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.561 ' CG ' ' HE ' ' A' ' 79' ' ' ARG . 89.1 m-20 -97.95 31.98 2.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.677 ' HB2' HD23 ' A' ' 78' ' ' LEU . 1.5 t30 -80.19 125.13 82.12 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.7 -0.625 . . . . 0.0 110.771 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -78.73 -23.03 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.042 1.828 . . . . 0.0 112.405 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.491 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 88.8 mm-40 -91.9 10.73 27.52 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.917 -1.114 . . . . 0.0 109.365 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.618 ' CA ' ' ND2' ' A' ' 82' ' ' ASN . 47.1 pttt -57.98 -53.68 55.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.585 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 84.8 tt0 -68.7 -52.06 34.98 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.197 -0.94 . . . . 0.0 109.606 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.68 -45.92 84.99 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.71 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 84' ' ' GLN . 7.3 tt -62.3 -43.98 97.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.718 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -59.0 -36.41 74.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.1 -1.0 . . . . 0.0 109.696 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -66.97 -56.27 10.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 109.803 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -51.03 -36.21 38.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.479 -0.763 . . . . 0.0 109.232 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -87.88 -18.97 28.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.544 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.51 -36.09 81.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 109.889 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -61.36 133.41 55.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 110.017 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.74 151.5 38.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.444 -0.785 . . . . 0.0 109.376 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -163.39 -172.88 3.12 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.5 t -163.0 137.69 6.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.688 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -110.46 154.51 23.52 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.395 -0.815 . . . . 0.0 109.663 -178.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.26 -5.75 82.05 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 101' ' ' ASP . 79.9 tt0 -125.11 168.2 13.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.191 -1.181 . . . . 0.0 109.168 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.416 ' N ' ' HG2' ' A' ' 100' ' ' GLU . 92.4 m-20 -73.13 142.99 47.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.893 -1.129 . . . . 0.0 110.315 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.84 95.87 7.49 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.298 -0.876 . . . . 0.0 109.317 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.472 HG13 HD13 ' A' ' 131' ' ' LEU . 20.1 t -80.28 131.5 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.467 0.651 . . . . 0.0 109.302 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.672 ' NH2' ' CE2' ' A' ' 142' ' ' PHE . 20.0 mmm180 -129.26 114.23 16.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.654 -0.654 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.631 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 16.1 t80 -109.75 129.9 55.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.506 ' CD2' ' OE2' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -93.05 137.5 32.35 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 110.396 -179.086 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.561 ' CG1' HG11 ' A' ' 53' ' ' VAL . 38.5 t -111.92 -30.25 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.686 -0.634 . . . . 0.0 109.817 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -168.57 158.27 9.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.067 -1.021 . . . . 0.0 109.426 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.21 162.18 15.56 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.57 -176.62 2.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -1.137 . . . . 0.0 109.317 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.25 -144.36 5.12 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 113' ' ' PHE . 7.6 tt -142.37 160.06 41.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -1.168 . . . . 0.0 109.663 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.607 ' N ' HD23 ' A' ' 112' ' ' LEU . 6.1 m-85 -137.55 87.68 2.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 109.833 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.592 ' SG ' ' NE1' ' A' ' 141' ' ' TRP . 42.2 t -81.01 114.13 19.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.446 -0.784 . . . . 0.0 109.428 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 114' ' ' CYS . 7.8 mt -119.41 117.23 27.92 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.148 -0.97 . . . . 0.0 108.819 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -106.85 113.56 27.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.053 -1.029 . . . . 0.0 109.635 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.79 117.68 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.678 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.74 -143.1 31.98 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 105.85 -2.9 . . . . 0.0 105.85 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -106.71 79.36 1.34 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 115.739 -2.385 . . . . 0.0 108.538 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 121' ' ' VAL . 74.9 tt0 -165.61 167.94 16.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.401 ' N ' ' HG2' ' A' ' 120' ' ' GLU . 3.9 t -130.7 149.18 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.139 -0.976 . . . . 0.0 110.066 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.644 ' CE2' ' NZ ' ' A' ' 31' ' ' LYS . 51.1 m-85 -129.32 133.8 47.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.803 -0.561 . . . . 0.0 109.771 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.552 ' OE1' HD21 ' A' ' 112' ' ' LEU . 83.7 mm-40 -128.39 108.95 10.99 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.792 ' C ' HD13 ' A' ' 125' ' ' LEU . 3.3 t -103.74 138.11 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.978 HD22 ' N ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -130.98 83.17 2.09 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.452 178.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.538 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 25.9 p -170.19 116.89 0.53 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.506 ' OE2' ' CD2' ' A' ' 106' ' ' PHE . 79.3 mm-40 -114.82 103.44 10.95 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 116.126 -2.229 . . . . 0.0 111.245 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.58 ' C ' ' H ' ' A' ' 130' ' ' ASP . 93.6 mttt -109.34 177.26 4.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.333 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.631 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 22.5 p30 -55.7 -5.96 0.18 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.58 ' H ' ' C ' ' A' ' 128' ' ' LYS . 29.7 p30 -72.22 144.55 48.44 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.918 0.866 . . . . 0.0 109.362 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.922 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.2 OUTLIER -109.24 148.47 30.92 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.885 0.85 . . . . 0.0 109.974 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.922 ' N ' HD12 ' A' ' 131' ' ' LEU . 37.3 mm -122.35 121.11 62.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.4 t -111.74 142.4 44.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.67 143.55 26.92 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.0 108.894 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.17 150.19 85.12 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.317 2.011 . . . . 0.0 112.53 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.58 134.7 46.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.38 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.7 t60 92.71 10.17 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.65 125.46 34.71 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.075 -1.016 . . . . 0.0 108.685 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.57 132.05 31.77 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.482 1.455 . . . . 0.0 111.629 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.477 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.71 163.54 9.96 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.235 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.592 ' NE1' ' SG ' ' A' ' 114' ' ' CYS . 0.6 OUTLIER -133.36 -147.33 0.29 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.312 -0.868 . . . . 0.0 109.851 -178.582 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.672 ' CE2' ' NH2' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -178.71 126.26 0.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.887 -1.133 . . . . 0.0 109.289 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 176' ' ' PRO . 53.0 t0 -146.57 137.48 24.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.264 -0.898 . . . . 0.0 109.626 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.588 ' O ' ' C ' ' A' ' 145' ' ' GLY . 5.5 ptt? -109.81 21.1 17.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.515 -0.741 . . . . 0.0 111.295 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.588 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.12 -90.46 0.01 OUTLIER Glycine 0 N--CA 1.503 3.117 0 CA-C-N 119.336 0.971 . . . . 0.0 112.073 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.542 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 39.7 t -86.88 120.41 28.13 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.035 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.671 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -113.42 111.74 49.39 Favored Pre-proline 0 C--N 1.294 -1.805 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.742 178.335 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.584 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.4 Cg_endo -102.07 28.21 0.1 Allowed 'Trans proline' 0 C--O 1.212 -0.822 0 C-N-CA 123.068 2.512 . . . . 0.0 111.432 176.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.584 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 15.0 t-20 84.06 71.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.747 0.784 . . . . 0.0 109.632 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 25.6 p90 -94.89 159.55 14.99 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.64 -0.662 . . . . 0.0 109.528 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.468 HG22 ' HB ' ' A' ' 107' ' ' VAL . 29.7 m -130.26 125.52 35.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.223 -0.923 . . . . 0.0 110.012 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.505 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -144.62 164.16 31.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 109.44 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.538 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 29.1 mt -110.61 129.93 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.075 -1.016 . . . . 0.0 109.346 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.478 ' HE ' ' HD3' ' A' ' 104' ' ' ARG . 4.3 ttt180 -138.6 167.42 21.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.422 -0.799 . . . . 0.0 109.69 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.896 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.1 mp -104.36 146.68 11.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.501 -0.75 . . . . 0.0 109.444 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.454 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.3 m-30 -95.35 118.56 32.32 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.008 0.909 . . . . 0.0 109.732 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.63 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 11.8 p30 -135.89 161.92 34.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.891 -0.505 . . . . 0.0 109.829 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 2.3 m-20 -96.03 160.23 30.46 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.059 -1.025 . . . . 0.0 109.484 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.62 ' O ' ' N ' ' A' ' 162' ' ' TRP . 43.8 Cg_endo -69.02 -54.26 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.56 2.173 . . . . 0.0 112.042 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 159' ' ' PRO . 77.4 tt0 -43.45 -16.84 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 109.219 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.61 -25.67 29.55 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.63 ' HE1' ' CG ' ' A' ' 157' ' ' ASP . 32.6 m95 -107.27 169.08 8.78 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.387 -1.067 . . . . 0.0 109.964 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 77.3 mt -97.21 150.55 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.24 -0.912 . . . . 0.0 109.282 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -76.77 -71.63 0.39 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.31 -0.869 . . . . 0.0 110.449 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -133.95 158.71 42.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.215 -0.928 . . . . 0.0 109.819 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -101.08 -39.67 7.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.873 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.18 -30.26 5.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.328 -0.857 . . . . 0.0 108.957 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.66 -9.92 55.75 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.91 148.56 31.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.838 -1.389 . . . . 0.0 108.074 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -111.22 87.55 2.57 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 117.614 -1.635 . . . . 0.0 110.94 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.516 HG23 ' CH2' ' A' ' 141' ' ' TRP . 2.2 tt -77.79 -16.99 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.602 -1.311 . . . . 0.0 109.147 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -56.25 -38.91 71.75 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.632 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 68.0 m -52.82 -4.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.434 -0.791 . . . . 0.0 109.961 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.551 ' HB3' ' CE2' ' A' ' 175' ' ' TYR . . . -76.23 -41.37 49.42 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.68 -1.262 . . . . 0.0 111.894 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.629 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.6 m-85 -113.29 25.04 0.08 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 O-C-N 120.457 -1.402 . . . . 0.0 112.416 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.632 ' HD3' ' C ' ' A' ' 173' ' ' SER . 41.0 Cg_endo -60.66 -25.97 81.97 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 123.898 3.065 . . . . 0.0 113.892 -172.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -89.57 125.5 35.24 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 118.719 -1.192 . . . . 0.0 108.408 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.725 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.5 OUTLIER -87.34 120.9 29.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.2 -0.937 . . . . 0.0 109.084 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.491 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.641 ' O ' ' OG1' ' A' ' 19' ' ' THR . 6.0 p . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.31 170.48 9.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.208 -0.932 . . . . 0.0 108.699 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 123' ' ' GLN . 2.8 tp -156.93 119.23 3.91 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.505 ' N ' HD12 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -110.74 134.01 52.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.164 -0.96 . . . . 0.0 109.761 -178.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.71 HD12 ' HB3' ' A' ' 16' ' ' TRP . 6.2 mt -127.97 137.51 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.415 ' CE1' HG22 ' A' ' 4' ' ' THR . 96.8 m-85 -130.65 166.59 20.36 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.406 ' OG ' ' CD2' ' A' ' 15' ' ' LEU . 51.0 m -87.41 173.9 8.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.048 -1.033 . . . . 0.0 108.579 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.86 -29.53 5.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.913 -1.117 . . . . 0.0 109.413 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -73.02 -38.12 66.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.783 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -139.22 123.93 11.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.996 -1.065 . . . . 0.0 109.743 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -84.1 -21.91 3.65 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.754 1.636 . . . . 0.0 112.471 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -70.48 -1.87 12.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.484 -0.76 . . . . 0.0 111.579 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.544 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 47.4 p-10 -124.89 122.79 38.37 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.16 -0.962 . . . . 0.0 108.886 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.2 p -93.22 129.76 39.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.874 -1.141 . . . . 0.0 108.53 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 15' ' ' LEU . 11.0 mp -90.38 -7.28 53.62 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.166 -1.013 . . . . 0.0 109.068 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.71 ' HB3' HD12 ' A' ' 5' ' ' ILE . 39.0 t90 -157.58 105.63 2.05 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.253 -1.379 . . . . 0.0 110.055 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -119.0 111.13 17.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.378 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.425 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -161.37 162.71 30.83 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.369 -0.832 . . . . 0.0 109.872 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 19' ' ' THR . 10.2 t -131.72 89.18 2.66 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.005 -1.059 . . . . 0.0 108.153 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.773 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -125.52 151.45 46.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.014 -1.054 . . . . 0.0 110.06 177.423 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.26 -41.32 20.36 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.21 -1.557 . . . . 0.0 108.827 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -82.81 -47.35 12.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 110.737 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -64.52 -23.44 67.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.757 -1.215 . . . . 0.0 108.984 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.773 HD12 ' O ' ' A' ' 20' ' ' ASN . 7.2 mt -70.73 -51.36 37.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.228 -0.92 . . . . 0.0 108.537 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.429 ' NE2' ' CB ' ' A' ' 29' ' ' ASN . 13.2 tm0? -57.08 -50.1 73.83 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.525 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.604 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 44.6 tt0 -58.42 -35.03 71.46 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.525 -0.735 . . . . 0.0 110.229 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.551 ' OE1' ' CE2' ' A' ' 16' ' ' TRP . 3.5 tp60 -64.3 -63.48 1.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.933 -1.105 . . . . 0.0 109.587 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -55.09 14.15 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.114 -0.991 . . . . 0.0 109.76 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 19.8 t-20 -52.46 -27.63 16.91 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.972 -1.08 . . . . 0.0 109.73 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -64.5 -27.05 68.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.677 -1.264 . . . . 0.0 108.263 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -90.71 11.29 22.7 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.26 -0.9 . . . . 0.0 110.54 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.26 25.69 15.87 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.088 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.615 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 43.3 t -96.8 145.75 8.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.348 -1.089 . . . . 0.0 109.929 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -84.17 157.04 21.8 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -153.1 149.82 28.48 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.401 ' HG2' ' HE1' ' A' ' 38' ' ' TRP . 36.2 tp10 -174.89 166.41 3.61 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.95 -1.094 . . . . 0.0 108.619 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -153.77 131.06 11.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.401 ' HE1' ' HG2' ' A' ' 36' ' ' GLU . 11.0 m0 -117.38 151.58 36.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.583 -0.698 . . . . 0.0 109.945 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -135.96 158.75 43.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.372 -0.83 . . . . 0.0 109.439 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.38 160.46 14.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.917 . . . . 0.0 109.179 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -98.64 -17.64 18.5 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.222 -0.924 . . . . 0.0 108.544 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -93.61 164.83 13.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.687 0.756 . . . . 0.0 109.161 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.17 119.39 32.93 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.645 -0.659 . . . . 0.0 109.599 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.98 166.05 12.9 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.4 -121.87 0.59 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.46 79.4 8.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.069 -1.254 . . . . 0.0 108.98 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.92 94.93 26.76 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.448 -0.783 . . . . 0.0 109.205 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.706 ' O ' HG23 ' A' ' 49' ' ' THR . 50.6 Cg_endo -70.86 79.46 1.29 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.002 1.801 . . . . 0.0 111.854 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 48' ' ' PRO . 3.8 p -163.55 119.56 1.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.129 -0.982 . . . . 0.0 109.273 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.95 -43.54 17.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.858 -1.151 . . . . 0.0 110.044 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -66.61 -17.89 65.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.488 -0.757 . . . . 0.0 110.148 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 m -77.11 -40.77 44.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 110.228 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.402 HG11 ' CG1' ' A' ' 107' ' ' VAL . 43.9 t -66.87 -48.11 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.117 -0.989 . . . . 0.0 109.953 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 58' ' ' GLN . 8.5 mm -61.31 -41.94 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 108.619 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.81 -29.87 70.44 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.435 -0.79 . . . . 0.0 109.691 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.16 -17.85 59.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.98 . . . . 0.0 110.12 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 58' ' ' GLN . 57.4 m-85 -114.34 -7.47 12.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 109.121 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 54' ' ' ILE . 4.7 mm100 -46.52 -39.84 11.54 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.759 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.32 -46.6 62.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.54 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -63.67 -59.63 4.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.804 -1.185 . . . . 0.0 110.341 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.681 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -62.32 -31.85 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.996 -1.065 . . . . 0.0 109.352 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.7 t70 -59.04 -25.05 63.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.594 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.54 -39.08 47.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.949 . . . . 0.0 109.411 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.0 mp -64.19 -38.07 89.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.365 -0.834 . . . . 0.0 108.936 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.639 HG22 ' CZ3' ' A' ' 73' ' ' TRP . 2.8 t -71.02 -29.68 38.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.368 -0.832 . . . . 0.0 109.458 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.38 -52.36 63.8 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.514 -1.366 . . . . 0.0 109.597 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.05 -49.8 9.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.955 -1.091 . . . . 0.0 110.366 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.602 ' O ' ' C ' ' A' ' 69' ' ' GLY . 20.2 mmtt -83.99 13.0 5.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -0.868 . . . . 0.0 111.37 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.602 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -3.01 80.83 0.0 OUTLIER Glycine 0 N--CA 1.506 3.336 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.583 ' CG ' HG21 ' A' ' 155' ' ' ILE . 69.1 m-85 -77.35 158.94 29.86 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.658 -0.907 . . . . 0.0 108.791 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -57.65 -88.53 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.479 -0.763 . . . . 0.0 109.3 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -103.44 159.58 15.46 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.719 0.771 . . . . 0.0 110.161 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.639 ' CZ3' HG22 ' A' ' 65' ' ' VAL . 7.9 t-105 -139.51 144.7 38.03 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -163.05 -178.6 6.15 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 152' ' ' ALA . 7.3 p -121.13 143.87 32.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.729 HG23 ' O ' ' A' ' 76' ' ' ILE . 19.8 tt -101.72 115.45 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.625 ' OG ' HG23 ' A' ' 151' ' ' THR . 0.7 OUTLIER -167.94 101.06 0.46 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.816 -0.753 . . . . 0.0 109.194 177.346 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.535 ' HG ' ' H ' ' A' ' 79' ' ' ARG . 11.5 tp -106.59 178.34 4.59 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 121.08 1.764 . . . . 0.0 107.939 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.535 ' H ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -89.88 143.84 26.45 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.693 -1.254 . . . . 0.0 109.664 -178.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.03 0.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.594 -0.691 . . . . 0.0 109.588 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' A' ' 79' ' ' ARG . 58.5 t0 -83.57 -27.54 29.2 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.471 -1.292 . . . . 0.0 109.444 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.494 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -67.41 122.42 83.03 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.054 -1.029 . . . . 0.0 109.507 179.481 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -85.83 -3.78 8.99 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.021 1.814 . . . . 0.0 112.234 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -88.39 -3.44 58.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.944 -1.097 . . . . 0.0 110.513 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.462 ' CG ' ' OD1' ' A' ' 82' ' ' ASN . 2.3 mmtt -62.8 -40.57 97.75 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.036 -1.04 . . . . 0.0 109.283 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -61.05 -54.49 44.1 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.322 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.04 -35.0 75.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.06 -1.025 . . . . 0.0 109.644 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.732 HD23 ' O ' ' A' ' 88' ' ' LEU . 4.3 tt -61.37 -43.51 98.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.73 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.6 ptt-85 -63.76 -25.78 68.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 109.934 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.72 -59.66 3.69 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.408 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -54.25 -29.39 46.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.962 . . . . 0.0 109.27 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.39 -18.37 36.3 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.306 -0.871 . . . . 0.0 109.661 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.666 ' C ' HD12 ' A' ' 93' ' ' LEU . 0.8 OUTLIER -58.44 -25.88 62.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 109.936 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -55.25 142.37 31.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.108 -0.995 . . . . 0.0 110.211 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.511 ' OE2' ' O ' ' A' ' 169' ' ' ASP . 19.8 pt-20 -72.59 164.24 26.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.395 -0.816 . . . . 0.0 109.663 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -174.24 -170.92 0.56 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.492 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.2 t -160.48 132.28 5.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.65 0.738 . . . . 0.0 109.36 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.665 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -103.4 154.64 19.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.712 -0.617 . . . . 0.0 110.01 -179.037 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' A' ' 162' ' ' TRP . . . -78.83 -6.05 88.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.426 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 96.6 mt-10 -124.77 170.11 11.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -1.027 . . . . 0.0 109.382 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -74.68 143.54 44.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.956 -1.09 . . . . 0.0 110.103 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.444 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 2.0 mt-10 -101.1 93.64 5.58 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.114 -0.992 . . . . 0.0 108.901 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.519 HG12 ' CB ' ' A' ' 133' ' ' SER . 9.1 m -89.11 130.65 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.767 -0.583 . . . . 0.0 109.495 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.693 ' NH1' ' CD1' ' A' ' 142' ' ' PHE . 21.4 mtp180 -129.59 116.94 19.63 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.561 -0.712 . . . . 0.0 109.437 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.457 ' CE2' ' O ' ' A' ' 106' ' ' PHE . 25.4 t80 -101.08 134.08 44.62 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.457 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.88 129.26 35.63 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.422 -0.799 . . . . 0.0 110.388 -178.492 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.402 ' CG1' HG11 ' A' ' 53' ' ' VAL . 17.9 t -107.96 -33.54 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.577 -0.702 . . . . 0.0 109.711 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -167.97 157.81 10.07 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.094 -1.004 . . . . 0.0 108.88 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.19 161.4 9.14 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.12 -177.51 3.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -1.061 . . . . 0.0 109.107 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.88 -142.51 4.09 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.8 tp -142.62 159.7 41.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.23 -1.159 . . . . 0.0 109.026 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -136.83 88.09 2.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.06 -1.025 . . . . 0.0 109.258 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.75 108.87 14.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.473 -0.767 . . . . 0.0 110.026 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.402 HD23 HG12 ' A' ' 134' ' ' VAL . 1.2 mp -116.43 121.18 41.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -0.924 . . . . 0.0 108.82 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 4.7 t-160 -107.29 113.37 26.72 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.097 -1.002 . . . . 0.0 109.277 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.5 mt -128.34 118.72 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.852 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.17 -142.49 33.05 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 105.429 -3.068 . . . . 0.0 105.429 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -107.8 80.64 1.41 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 121.517 2.658 . . . . 0.0 108.182 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 77.5 tt0 -165.11 166.81 18.82 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 5' ' ' ILE . 41.0 t -126.61 142.12 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.244 -0.91 . . . . 0.0 110.037 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.452 ' CZ ' HD13 ' A' ' 5' ' ' ILE . 2.2 m-85 -124.19 130.85 53.24 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.038 0.447 . . . . 0.0 109.922 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.584 ' O ' HD12 ' A' ' 3' ' ' LEU . 91.2 mt-30 -132.32 118.08 18.97 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 109.35 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.664 ' C ' HD23 ' A' ' 125' ' ' LEU . 2.9 t -106.43 137.89 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.664 HD23 ' C ' ' A' ' 124' ' ' VAL . 0.1 OUTLIER -135.91 91.07 2.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.061 -1.025 . . . . 0.0 110.634 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 20.3 p -166.95 137.47 3.11 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.505 -1.372 . . . . 0.0 108.603 178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.509 ' O ' ' CD ' ' A' ' 127' ' ' GLU . 2.8 tm-20 -106.99 92.92 4.28 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 115.367 -2.533 . . . . 0.0 110.012 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.632 ' C ' ' H ' ' A' ' 130' ' ' ASP . 39.7 tttp -118.26 157.71 26.53 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.439 175.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -56.12 0.83 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.106 -1.621 . . . . 0.0 108.406 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.632 ' H ' ' C ' ' A' ' 128' ' ' LYS . 49.5 p-10 -66.84 131.36 45.75 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.157 0.979 . . . . 0.0 109.566 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.004 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -100.97 132.86 46.18 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.862 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 1.004 ' N ' HD12 ' A' ' 131' ' ' LEU . 8.2 tt -125.43 129.96 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.582 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.519 ' CB ' HG12 ' A' ' 103' ' ' VAL . 3.3 m -125.77 151.59 46.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.402 HG12 HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -107.48 149.59 39.01 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.41 151.52 75.91 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.569 2.179 . . . . 0.0 112.904 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.609 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -73.31 133.47 43.88 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.182 -0.949 . . . . 0.0 109.186 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.609 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.1 t-80 94.89 9.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.166 0.508 . . . . 0.0 109.705 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.09 126.96 30.26 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 108.579 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.84 132.1 31.37 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.57 1.513 . . . . 0.0 111.548 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -168.95 164.06 11.51 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.999 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.415 ' CG ' ' CB ' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -134.46 -148.8 0.33 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 109.348 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.693 ' CD1' ' NH1' ' A' ' 104' ' ' ARG . 83.5 t80 -176.03 126.38 0.21 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.052 -1.03 . . . . 0.0 109.048 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 31.9 p-10 -144.69 132.86 21.62 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.368 -0.833 . . . . 0.0 109.361 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.612 ' O ' ' C ' ' A' ' 145' ' ' GLY . 11.3 ptp -110.9 21.36 16.56 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.657 -0.652 . . . . 0.0 111.093 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.612 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 7.52 -86.21 0.0 OUTLIER Glycine 0 N--CA 1.499 2.893 0 CA-C-N 119.061 0.846 . . . . 0.0 111.94 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.479 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 51.2 m -88.07 116.74 26.47 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 117.688 -1.605 . . . . 0.0 108.75 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.486 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -118.28 115.11 36.28 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.671 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 59.1 Cg_endo -105.04 36.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.437 2.091 . . . . 0.0 111.395 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.671 ' ND2' ' O ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER 81.85 69.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 123.246 1.498 . . . . 0.0 108.682 -177.584 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.412 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 26.7 p90 -95.75 161.68 13.92 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.489 -1.382 . . . . 0.0 109.766 -177.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.625 HG23 ' OG ' ' A' ' 77' ' ' SER . 11.7 m -130.54 125.87 35.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.953 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.455 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -144.26 164.55 30.42 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.8 mt -109.73 128.77 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.954 -1.091 . . . . 0.0 109.342 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -134.51 163.18 30.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.583 HG21 ' CG ' ' A' ' 70' ' ' TYR . 36.2 mt -102.64 144.14 14.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.467 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.3 m-85 -96.46 118.55 33.22 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.415 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -135.73 161.56 35.21 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.04 158.61 33.84 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 120.699 -1.251 . . . . 0.0 109.483 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.584 ' O ' ' N ' ' A' ' 161' ' ' GLY . 46.4 Cg_endo -71.31 -53.86 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.326 2.017 . . . . 0.0 112.737 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 159' ' ' PRO . 83.7 tt0 -43.3 -16.7 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -69.38 -38.76 80.98 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.465 ' HB3' ' H ' ' A' ' 99' ' ' GLY . 4.3 p90 -119.14 175.74 5.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.695 -0.885 . . . . 0.0 111.03 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 76.2 mt -96.26 147.6 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.597 0.713 . . . . 0.0 109.315 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.92 -73.61 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.425 -0.797 . . . . 0.0 110.525 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -126.76 156.6 40.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.149 -0.969 . . . . 0.0 109.872 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.1 -40.6 7.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 0.0 109.754 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 86.1 m -101.54 -32.23 10.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.043 . . . . 0.0 108.976 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.24 -6.93 58.2 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.518 ' O ' ' OD1' ' A' ' 169' ' ' ASP . 44.4 p30 -80.92 148.35 29.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.568 -1.548 . . . . 0.0 108.545 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -112.17 88.68 2.87 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 117.737 -1.585 . . . . 0.0 110.368 175.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.41 HG23 ' H ' ' A' ' 171' ' ' ILE . 0.1 OUTLIER -82.27 -16.83 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.008 -1.682 . . . . 0.0 109.24 179.779 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.455 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -55.98 -37.96 69.78 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.568 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 7.3 m -56.09 -3.97 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.824 -0.547 . . . . 0.0 110.161 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.78 -37.87 29.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.022 -1.049 . . . . 0.0 111.755 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.627 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.5 m-85 -112.83 23.09 0.08 OUTLIER Pre-proline 0 N--CA 1.513 2.717 0 O-C-N 120.558 -1.339 . . . . 0.0 113.037 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 46.1 Cg_endo -63.31 -19.56 68.58 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 123.443 2.762 . . . . 0.0 114.262 -173.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -88.93 126.47 35.41 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.765 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.502 ' H ' ' HA3' ' A' ' 145' ' ' GLY . 5.7 tt -87.8 122.25 31.22 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.926 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.297 -1.691 0 O-C-N 121.138 -0.976 . . . . 0.0 109.367 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.81 ' O ' HG23 ' A' ' 19' ' ' THR . 5.1 p . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.11 169.03 9.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.004 -1.06 . . . . 0.0 109.08 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.454 HD13 HG22 ' A' ' 124' ' ' VAL . 4.8 tp -157.79 117.3 3.29 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.49 ' OG1' HD11 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -114.44 135.97 53.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.432 -0.792 . . . . 0.0 109.973 -178.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.679 HD12 ' HB3' ' A' ' 16' ' ' TRP . 25.7 mt -130.44 133.6 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -127.4 168.26 15.09 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.413 ' HB2' HD21 ' A' ' 13' ' ' ASN . 0.1 OUTLIER -89.39 174.81 7.6 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.216 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -87.73 -23.77 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.066 . . . . 0.0 109.575 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -75.1 -37.93 61.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.051 -1.031 . . . . 0.0 110.413 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -136.93 126.49 15.58 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.655 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 13' ' ' ASN . 56.2 Cg_endo -79.87 -39.16 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.002 1.801 . . . . 0.0 112.156 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 9.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.729 . . . . 0.0 110.041 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -114.69 119.1 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.176 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.9 p -102.29 122.9 45.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.249 -0.907 . . . . 0.0 109.493 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.446 HD13 HD21 ' A' ' 13' ' ' ASN . 3.6 mp -90.2 -3.86 57.59 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.671 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.679 ' HB3' HD12 ' A' ' 5' ' ' ILE . 35.4 t90 -156.04 104.25 2.26 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.667 -1.213 . . . . 0.0 110.256 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -118.8 110.36 17.14 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.736 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.464 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -162.58 163.62 27.16 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.079 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.81 HG23 ' O ' ' A' ' 1' ' ' SER . 54.6 m -130.93 89.46 2.75 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.15 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.773 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -128.16 148.46 50.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.429 -0.794 . . . . 0.0 110.401 177.099 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.38 -38.27 22.2 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.311 -1.493 . . . . 0.0 108.107 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -83.69 -48.8 9.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.472 -0.767 . . . . 0.0 109.855 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 27' ' ' GLN . 43.9 tt0 -60.99 -24.02 65.81 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.831 -1.168 . . . . 0.0 108.604 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.773 HD12 ' O ' ' A' ' 20' ' ' ASN . 10.4 mt -73.04 -62.75 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.174 -0.953 . . . . 0.0 109.497 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.514 ' CD ' ' N ' ' A' ' 26' ' ' GLN . 3.8 pp0? -61.41 -43.34 99.04 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.879 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 25' ' ' GLN . 11.0 tm0? -61.49 -43.99 97.88 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.129 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.588 ' OE1' ' CE2' ' A' ' 16' ' ' TRP . 5.3 tt0 -77.67 -47.23 19.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.977 . . . . 0.0 109.229 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 24' ' ' ILE . 23.9 tp -66.45 -54.41 24.47 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.999 -1.063 . . . . 0.0 109.149 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 25' ' ' GLN . 40.7 t-20 -57.9 -20.08 34.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.0 109.411 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 27' ' ' GLN . . . -65.25 -27.63 68.78 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.06 -1.025 . . . . 0.0 108.796 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.78 13.39 10.73 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.217 -0.927 . . . . 0.0 109.867 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.13 22.95 30.97 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.179 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.479 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 56.3 t -94.13 145.43 7.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.424 -1.044 . . . . 0.0 109.344 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.442 ' NE ' ' OG ' ' A' ' 133' ' ' SER . 2.4 ttm-85 -84.0 158.4 21.51 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.24 -0.912 . . . . 0.0 108.724 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.541 ' CE1' ' OD2' ' A' ' 130' ' ' ASP . 1.2 t80 -153.38 145.67 23.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.943 -1.098 . . . . 0.0 108.682 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.554 ' O ' ' OD1' ' A' ' 130' ' ' ASP . 43.8 mt-10 -165.81 168.64 15.78 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.188 -0.945 . . . . 0.0 109.961 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -148.53 113.91 5.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.587 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 22.1 m0 -109.98 153.81 24.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.273 -0.892 . . . . 0.0 109.308 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -142.79 159.09 42.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.902 . . . . 0.0 109.685 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.19 159.05 15.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.263 -0.898 . . . . 0.0 109.08 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -101.98 -13.64 17.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.152 -0.967 . . . . 0.0 108.535 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -93.05 161.55 14.39 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.234 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -95.08 118.94 32.74 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.734 -0.604 . . . . 0.0 109.666 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.0 mt -90.26 163.11 14.9 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.732 0.777 . . . . 0.0 109.292 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.08 -99.8 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.36 91.95 5.13 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.044 -1.269 . . . . 0.0 109.187 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.16 91.88 37.99 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.416 -0.802 . . . . 0.0 109.008 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -76.21 -26.41 9.07 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.316 2.011 . . . . 0.0 112.588 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.7 p -122.61 141.74 51.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.645 -0.66 . . . . 0.0 109.504 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.612 ' CB ' HG21 ' A' ' 151' ' ' THR . . . -80.69 -16.5 53.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.426 -0.796 . . . . 0.0 109.52 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -47.63 -38.96 15.77 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.796 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.1 m -79.43 -35.31 40.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.573 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.92 -48.78 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.887 . . . . 0.0 109.802 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 58' ' ' GLN . 17.7 mt -59.91 -36.77 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 108.796 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.51 -30.44 70.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.815 . . . . 0.0 109.527 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.59 -17.4 60.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.139 -0.975 . . . . 0.0 110.158 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -114.41 -8.59 12.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.393 -0.817 . . . . 0.0 109.507 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.511 ' OE1' HD11 ' A' ' 61' ' ' ILE . 3.6 tp-100 -48.95 -38.57 23.35 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 108.86 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.624 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 20.2 p80 -50.62 -46.81 58.32 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.54 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.624 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.39 -60.51 3.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.065 -1.022 . . . . 0.0 109.977 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.658 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -61.71 -30.16 47.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.85 -1.156 . . . . 0.0 109.024 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 58' ' ' GLN . 40.3 t0 -57.44 -26.43 61.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 0.0 109.645 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.75 -40.53 61.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.078 -1.013 . . . . 0.0 109.261 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -63.66 -34.65 78.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.064 -1.023 . . . . 0.0 109.653 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.649 HG22 ' CZ3' ' A' ' 73' ' ' TRP . 4.0 t -71.47 -33.95 51.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.245 -0.909 . . . . 0.0 109.442 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.37 -51.76 57.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.534 -1.354 . . . . 0.0 109.489 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -83.23 -50.07 8.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.013 -1.054 . . . . 0.0 110.472 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.605 ' O ' ' C ' ' A' ' 69' ' ' GLY . 15.7 mttm -86.65 15.79 5.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.608 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -12.01 85.52 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.866 ' CG ' HG21 ' A' ' 155' ' ' ILE . 53.9 m-85 -78.5 165.57 23.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.603 ' CD ' ' H ' ' A' ' 71' ' ' GLN . 25.4 mp0 -63.98 -83.99 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.372 -0.83 . . . . 0.0 109.401 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.23 157.3 17.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.597 -0.689 . . . . 0.0 109.566 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.649 ' CZ3' HG22 ' A' ' 65' ' ' VAL . 6.7 t-105 -136.15 139.36 42.83 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -167.38 -174.42 2.55 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.341 -0.849 . . . . 0.0 108.734 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 153' ' ' ILE . 3.2 m -118.92 146.76 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.0 109.45 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.24 116.53 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -174.42 108.84 0.13 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.828 -1.17 . . . . 0.0 109.563 177.464 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.427 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -100.39 -178.83 3.93 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 121.403 1.91 . . . . 0.0 109.331 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.452 ' HD2' ' ND2' ' A' ' 149' ' ' ASN . 7.8 tpt180 -88.88 143.81 26.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.856 -1.152 . . . . 0.0 109.207 -178.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.46 0.83 0.63 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.56 -0.712 . . . . 0.0 109.788 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 79' ' ' ARG . 57.5 t0 -94.08 -27.16 16.42 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.348 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -64.29 127.95 92.68 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.924 -1.11 . . . . 0.0 109.996 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.75 -1.79 11.96 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.323 2.015 . . . . 0.0 112.003 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -84.41 15.04 3.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.902 -1.124 . . . . 0.0 109.547 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -57.55 -58.54 7.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.305 -0.872 . . . . 0.0 108.809 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.01 -33.91 77.16 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.304 -0.873 . . . . 0.0 109.164 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.88 -58.2 8.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.0 110.023 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.0 tp -61.0 -43.98 98.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.639 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.483 ' HE ' ' H ' ' A' ' 145' ' ' GLY . 23.2 mtp-105 -60.71 -31.34 70.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.646 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -66.99 -58.28 5.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.454 -0.779 . . . . 0.0 110.322 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -53.98 -35.04 61.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 109.268 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -87.57 -18.21 30.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.274 -0.891 . . . . 0.0 109.629 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 89' ' ' ARG . 39.0 tp -56.9 -37.06 70.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.155 -0.966 . . . . 0.0 109.912 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -54.15 134.1 44.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.143 -0.973 . . . . 0.0 109.441 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.553 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 0.9 OUTLIER -64.77 164.7 11.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.418 -0.801 . . . . 0.0 109.537 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.562 ' O ' HG23 ' A' ' 97' ' ' THR . 42.8 p-80 -170.38 -171.44 1.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.066 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 96' ' ' HIS . 8.7 p -159.04 131.97 7.02 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.626 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -100.39 155.84 17.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.482 ' H ' ' HB3' ' A' ' 162' ' ' TRP . . . -79.53 -7.22 88.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.407 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 44.6 mt-10 -125.56 171.83 10.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.33 -1.1 . . . . 0.0 109.515 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -72.2 142.97 49.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.345 -0.847 . . . . 0.0 110.141 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.606 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 2.6 tt0 -101.7 93.33 5.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 103' ' ' VAL . 34.5 m -92.38 127.88 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.41 0.624 . . . . 0.0 109.786 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -127.41 126.64 42.79 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.632 -0.667 . . . . 0.0 109.318 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.629 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 18.7 t80 -108.51 133.23 52.93 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.785 0.802 . . . . 0.0 109.153 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.49 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.05 127.59 35.4 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.476 0.655 . . . . 0.0 110.022 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.8 t -108.83 -35.17 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.644 -0.66 . . . . 0.0 109.624 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -160.31 146.6 15.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 0.0 109.339 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.3 165.92 35.41 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.41 154.02 39.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.501 -0.999 . . . . 0.0 109.591 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.59 -132.08 2.65 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.1 tp -147.08 161.93 39.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.333 -1.098 . . . . 0.0 109.32 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -134.58 88.9 2.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.88 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.479 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -80.54 110.16 15.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.536 -0.727 . . . . 0.0 109.642 179.015 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 114' ' ' CYS . 8.4 mp -117.31 114.77 24.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.195 -0.94 . . . . 0.0 109.38 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -105.05 112.86 26.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.067 -1.021 . . . . 0.0 109.483 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.4 pt -129.57 115.51 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.238 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.99 -143.34 30.83 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 106.424 -2.671 . . . . 0.0 106.424 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -104.04 78.69 1.55 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 115.116 -2.634 . . . . 0.0 108.895 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -166.85 168.58 13.98 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 177.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.613 ' O ' HG23 ' A' ' 5' ' ' ILE . 38.6 t -128.84 151.46 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.257 -0.902 . . . . 0.0 109.949 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -129.12 131.99 47.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.612 . . . . 0.0 109.823 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -131.87 111.07 11.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 0.0 109.277 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.454 HG22 HD13 ' A' ' 3' ' ' LEU . 2.7 t -102.55 139.41 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.847 ' H ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.0 91.18 2.72 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.078 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 31.6 p -165.47 138.34 4.36 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.176 -1.577 . . . . 0.0 107.783 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -106.37 93.39 4.58 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 115.836 -2.345 . . . . 0.0 110.387 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.522 ' C ' ' H ' ' A' ' 130' ' ' ASP . 46.3 mtpt -114.7 154.57 28.22 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.917 176.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.629 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 89.7 m-20 -58.99 -3.03 0.29 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.479 -1.388 . . . . 0.0 107.778 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' A' ' 131' ' ' LEU . 7.3 t0 -70.58 148.57 48.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.066 -1.021 . . . . 0.0 109.314 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.885 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -111.08 149.83 30.24 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.512 0.672 . . . . 0.0 110.545 -179.681 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.885 ' N ' HD12 ' A' ' 131' ' ' LEU . 29.5 mm -115.31 138.59 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.502 ' HG ' HD11 ' A' ' 131' ' ' LEU . 5.0 m -121.25 145.64 47.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.486 -0.759 . . . . 0.0 110.193 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.5 t -116.12 135.47 22.8 Favored Pre-proline 0 N--CA 1.485 1.308 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.55 147.96 94.04 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.147 1.898 . . . . 0.0 113.126 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.617 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -72.31 134.61 45.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.136 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.617 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 8.8 t-80 92.28 11.13 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.1 126.51 30.85 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.015 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.21 130.3 28.33 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.959 1.773 . . . . 0.0 111.648 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.551 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.37 165.86 14.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.197 -0.94 . . . . 0.0 110.196 -179.189 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.59 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -137.03 -149.58 0.32 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -178.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.429 ' CZ ' ' HG2' ' A' ' 144' ' ' MET . 11.5 t80 -175.61 125.27 0.23 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.934 -1.104 . . . . 0.0 109.018 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -143.81 135.17 25.89 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.373 -0.829 . . . . 0.0 109.942 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.642 ' O ' ' C ' ' A' ' 145' ' ' GLY . 52.1 mmm -113.38 21.29 15.34 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.886 -0.509 . . . . 0.0 110.852 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.642 ' C ' ' O ' ' A' ' 144' ' ' MET . . . -1.32 -74.21 0.0 OUTLIER Glycine 0 N--CA 1.503 3.151 0 CA-C-N 119.279 0.945 . . . . 0.0 111.407 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 144' ' ' MET . 22.9 t -91.4 115.49 28.08 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 117.671 -1.612 . . . . 0.0 109.171 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -119.23 116.81 33.64 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.41 -0.806 . . . . 0.0 110.164 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.2 Cg_endo -100.18 33.37 0.09 OUTLIER 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 122.56 2.173 . . . . 0.0 111.628 176.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 11.9 t-20 79.8 68.39 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.521 -0.872 . . . . 0.0 108.721 -178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.522 ' O ' ' OG ' ' A' ' 77' ' ' SER . 14.2 p90 -96.41 -179.5 4.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.307 -0.871 . . . . 0.0 109.37 -177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.612 HG21 ' CB ' ' A' ' 50' ' ' ALA . 87.1 m -149.15 100.35 3.04 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.629 -0.669 . . . . 0.0 109.574 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 75' ' ' VAL . . . -110.69 163.77 13.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.918 -1.114 . . . . 0.0 109.19 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.679 ' HA ' HG12 ' A' ' 75' ' ' VAL . 94.7 mt -107.25 127.29 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.13 -0.981 . . . . 0.0 110.222 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.87 162.49 32.25 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.419 0.628 . . . . 0.0 109.427 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.866 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.0 mp -106.78 149.46 10.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.522 -0.736 . . . . 0.0 109.369 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -96.87 118.95 34.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.583 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -135.72 162.19 33.44 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.695 -0.628 . . . . 0.0 109.569 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -95.87 157.42 35.92 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.97 -1.081 . . . . 0.0 109.33 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 161' ' ' GLY . 47.4 Cg_endo -71.77 -52.58 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.614 2.209 . . . . 0.0 112.395 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 159' ' ' PRO . 95.1 mt-10 -43.83 -16.53 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.475 -0.765 . . . . 0.0 109.381 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -70.26 -39.88 70.91 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.482 ' HB3' ' H ' ' A' ' 99' ' ' GLY . 2.7 p90 -119.05 177.26 4.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.761 -0.847 . . . . 0.0 110.617 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.9 mm -95.37 152.05 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.417 -0.802 . . . . 0.0 109.219 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.34 -74.0 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 110.575 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -131.11 157.01 44.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -101.1 -41.54 6.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.707 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 60.0 p -105.86 -32.35 8.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.931 . . . . 0.0 109.235 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.29 -4.15 60.21 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.545 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -80.46 145.81 31.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.773 -1.428 . . . . 0.0 108.957 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -110.32 89.22 2.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.776 -1.569 . . . . 0.0 111.402 176.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.461 HG23 ' CH2' ' A' ' 141' ' ' TRP . 1.5 tt -78.63 -17.92 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.525 -1.359 . . . . 0.0 109.167 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.59 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -57.59 -42.7 83.7 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.637 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 45.8 m -54.17 -4.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.391 -0.818 . . . . 0.0 109.985 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.04 -40.5 31.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.958 -1.089 . . . . 0.0 111.549 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.618 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 9.3 m-85 -112.23 25.59 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.619 0 O-C-N 120.707 -1.246 . . . . 0.0 112.495 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.637 ' HD3' ' C ' ' A' ' 173' ' ' SER . 43.6 Cg_endo -62.42 -21.03 72.19 Favored 'Trans proline' 0 N--CA 1.503 2.088 0 C-N-CA 123.588 2.859 . . . . 0.0 113.168 -172.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -89.45 127.07 35.8 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.157 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' C ' ' A' ' 179' ' ' ALA . 0.7 OUTLIER -85.91 145.68 27.05 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.638 ' O ' HG23 ' A' ' 19' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.538 ' N ' ' SG ' ' A' ' 126' ' ' CYS . . . -99.2 172.04 7.62 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.147 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.891 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 25.2 tp -157.05 114.26 3.09 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.26 130.69 55.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 110.72 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.477 HD13 ' CE1' ' A' ' 122' ' ' PHE . 64.9 mt -124.76 134.0 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.2 168.93 14.75 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t -92.18 175.75 6.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.058 -1.026 . . . . 0.0 108.306 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.95 -26.7 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.728 -1.232 . . . . 0.0 109.396 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -72.35 -38.54 68.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.175 -0.953 . . . . 0.0 110.57 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.489 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 9.1 m-20 -139.41 123.38 11.02 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 109.766 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.3 -27.84 1.33 Allowed 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.021 1.814 . . . . 0.0 112.52 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -69.79 -0.49 7.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.455 -0.778 . . . . 0.0 111.178 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 6.7 p-10 -123.08 126.13 46.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.079 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 p -97.84 128.49 44.49 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 108.748 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pp -90.13 -9.93 46.47 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.801 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.891 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 31.1 t90 -158.01 108.79 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.052 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -122.37 124.58 44.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.334 -0.854 . . . . 0.0 110.241 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.61 168.62 21.47 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.053 -1.029 . . . . 0.0 110.594 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 19' ' ' THR . 1.0 OUTLIER -127.99 88.35 2.75 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 176.377 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.7 ' O ' HD12 ' A' ' 24' ' ' ILE . 82.1 m-20 -127.37 139.37 52.91 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.538 -0.726 . . . . 0.0 109.984 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.4 -36.13 24.52 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 119.676 -1.89 . . . . 0.0 108.675 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.35 -49.39 10.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.719 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.09 -22.94 67.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.875 -1.141 . . . . 0.0 108.128 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.74 HG12 HD22 ' A' ' 3' ' ' LEU . 1.7 mt -66.8 -50.32 66.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 29' ' ' ASN . 53.3 tt0 -56.2 -55.12 37.11 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.432 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.602 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 62.1 tt0 -56.66 -34.28 67.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 0.0 110.45 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.549 ' OE1' ' CE2' ' A' ' 16' ' ' TRP . 3.6 mm-40 -62.36 -65.13 0.73 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.912 -1.117 . . . . 0.0 109.656 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.429 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -70.27 -46.97 63.29 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.662 -1.274 . . . . 0.0 109.677 179.04 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.626 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 20.4 t-20 -57.0 -25.71 59.0 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.045 -1.035 . . . . 0.0 109.427 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -65.78 -28.08 68.76 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.76 -1.213 . . . . 0.0 107.762 177.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -87.58 14.6 8.03 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.975 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.91 23.38 35.63 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.434 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.626 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 56.7 t -94.53 144.73 9.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.226 -1.161 . . . . 0.0 109.89 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.7 ttt-85 -84.62 157.73 21.08 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.501 ' CZ ' ' OD2' ' A' ' 130' ' ' ASP . 1.3 t80 -155.22 153.68 31.04 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.3 pt-20 -175.81 176.45 1.84 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.042 -1.036 . . . . 0.0 110.102 177.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -154.31 121.8 5.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.394 -0.816 . . . . 0.0 109.065 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.611 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 33.2 m0 -111.28 154.98 23.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.405 -0.81 . . . . 0.0 109.033 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -142.23 155.13 45.24 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.284 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.31 159.68 14.77 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -98.38 -19.69 17.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.077 -1.014 . . . . 0.0 108.36 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -93.42 167.12 11.92 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -93.83 131.38 39.28 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.485 -0.759 . . . . 0.0 109.458 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -93.64 161.97 14.13 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.303 -0.873 . . . . 0.0 109.499 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.36 -96.3 0.11 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.78 107.09 8.84 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.344 -1.092 . . . . 0.0 108.15 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.97 90.02 46.56 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.638 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.57 46.3 1.71 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.819 2.346 . . . . 0.0 111.22 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.53 ' O ' ' OG1' ' A' ' 52' ' ' THR . 0.0 OUTLIER -169.27 139.9 2.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.556 -1.34 . . . . 0.0 108.978 178.061 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.09 -43.89 15.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.521 -1.362 . . . . 0.0 109.353 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -66.67 -4.32 8.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.59 -0.694 . . . . 0.0 110.335 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.53 ' OG1' ' O ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -77.77 -52.88 8.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.762 -1.211 . . . . 0.0 109.941 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.99 -44.67 84.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.112 -0.993 . . . . 0.0 110.253 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 58' ' ' GLN . 13.9 mm -60.3 -41.84 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.959 -1.088 . . . . 0.0 108.517 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.12 -22.87 66.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.445 -0.784 . . . . 0.0 109.89 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.1 -21.63 50.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.999 -1.063 . . . . 0.0 110.265 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 58' ' ' GLN . 59.2 m-85 -115.5 -10.16 11.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.493 -0.754 . . . . 0.0 109.206 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 62' ' ' ASP . 3.6 mm100 -46.89 -34.06 5.11 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.395 -0.922 . . . . 0.0 108.942 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.641 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 26.5 p80 -51.74 -50.48 60.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.891 -1.13 . . . . 0.0 109.573 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.641 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.2 -60.96 2.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.914 -1.116 . . . . 0.0 109.72 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.675 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -61.49 -27.58 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.393 -1.442 . . . . 0.0 109.55 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 58' ' ' GLN . 79.8 m-20 -59.24 -22.33 60.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.066 -1.021 . . . . 0.0 109.807 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 64' ' ' LEU . 3.3 pttp -83.0 -32.9 26.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.949 -1.094 . . . . 0.0 108.633 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.57 HD23 HG21 ' A' ' 103' ' ' VAL . 1.9 mp -65.53 -46.85 78.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.334 -0.854 . . . . 0.0 109.662 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.669 HG22 ' CZ3' ' A' ' 73' ' ' TRP . 0.9 OUTLIER -69.01 -27.74 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.549 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.32 -49.51 74.12 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.74 -1.225 . . . . 0.0 109.713 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.55 -51.74 7.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.028 -1.045 . . . . 0.0 110.54 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.629 ' O ' ' C ' ' A' ' 69' ' ' GLY . 2.1 mptp? -82.73 13.13 4.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.349 -0.844 . . . . 0.0 110.968 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -6.42 81.7 0.0 OUTLIER Glycine 0 N--CA 1.505 3.27 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.888 ' CG ' HG21 ' A' ' 155' ' ' ILE . 84.3 m-85 -75.16 159.95 31.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -1.071 . . . . 0.0 109.193 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.435 ' OE1' ' OD1' ' A' ' 158' ' ' ASN . 85.1 mt-30 -58.33 -41.83 85.46 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.456 -0.777 . . . . 0.0 109.861 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 t -147.21 155.41 42.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.938 -1.101 . . . . 0.0 110.847 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.669 ' CZ3' HG22 ' A' ' 65' ' ' VAL . 29.8 t-105 -129.5 133.34 47.21 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.472 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.4 OUTLIER -145.6 165.67 27.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.557 HG22 ' H ' ' A' ' 76' ' ' ILE . 3.1 p -97.98 174.8 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 121.308 -0.87 . . . . 0.0 109.084 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.557 ' H ' HG22 ' A' ' 75' ' ' VAL . 52.5 mt -109.51 118.11 56.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.4 p -92.58 160.33 15.08 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 123.11 1.433 . . . . 0.0 111.548 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.623 HD13 ' H ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -158.0 138.27 12.59 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.652 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.623 ' H ' HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -130.18 139.02 50.89 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.518 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 149' ' ' ASN . . . -76.94 0.4 21.2 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.898 -1.126 . . . . 0.0 110.743 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.488 ' H ' ' HD3' ' A' ' 79' ' ' ARG . 93.4 m-20 -111.11 -14.82 13.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 0.0 109.21 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.557 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 44.7 p-10 -63.36 117.91 38.55 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.285 -0.884 . . . . 0.0 110.414 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -88.14 -13.99 3.52 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.35 2.033 . . . . 0.0 113.039 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -92.38 -11.09 35.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.032 -1.043 . . . . 0.0 110.611 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.699 ' CG ' HH12 ' A' ' 89' ' ' ARG . 20.1 tptt -62.54 -38.77 91.3 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.956 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -59.69 -44.2 93.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.834 . . . . 0.0 109.57 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.59 -38.63 66.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.024 -1.048 . . . . 0.0 109.483 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 49.6 mt -60.58 -36.43 78.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 0.0 109.026 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.699 HH12 ' CG ' ' A' ' 85' ' ' LYS . 0.9 OUTLIER -60.09 -30.53 69.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 109.318 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 93' ' ' LEU . 15.1 tt0 -64.47 -60.39 3.21 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.044 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -58.73 -30.94 67.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.15 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -83.41 -18.74 37.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 90' ' ' GLU . 2.5 mt -63.82 -25.31 68.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.066 -1.022 . . . . 0.0 110.012 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -58.62 141.32 52.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 109.6 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -72.99 158.46 35.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 109.347 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -168.01 -168.96 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 110.788 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.9 133.64 6.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 109.11 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.683 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -106.43 154.32 20.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 0.0 109.738 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.21 -7.69 86.87 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -123.42 170.35 10.44 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.345 -1.091 . . . . 0.0 109.417 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -74.61 143.51 44.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.07 -1.019 . . . . 0.0 110.017 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.447 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 1.6 mt-10 -101.97 96.33 6.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.26 -0.9 . . . . 0.0 109.206 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.57 HG21 HD23 ' A' ' 64' ' ' LEU . 35.7 m -100.85 128.74 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.735 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.564 ' NE ' ' CZ ' ' A' ' 142' ' ' PHE . 6.6 mtm180 -128.9 134.58 48.31 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.611 ' CE2' ' CE3' ' A' ' 38' ' ' TRP . 66.0 t80 -112.99 131.53 55.72 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.77 0.795 . . . . 0.0 109.938 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.421 ' CG ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -87.18 125.8 34.4 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.359 0.599 . . . . 0.0 109.72 -179.555 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.89 -39.7 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.455 -0.778 . . . . 0.0 109.941 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -160.47 146.94 15.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.145 -0.972 . . . . 0.0 109.899 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.48 ' O ' ' OE1' ' A' ' 127' ' ' GLU . . . 87.89 164.18 39.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.72 160.59 26.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.513 -0.992 . . . . 0.0 109.664 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.22 -119.62 1.01 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.545 ' CD1' HD12 ' A' ' 125' ' ' LEU . 22.0 tp -148.31 163.33 37.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -1.106 . . . . 0.0 108.73 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.805 ' CD2' HG21 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -137.99 145.93 42.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.976 -1.078 . . . . 0.0 108.952 177.013 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.445 ' SG ' ' C ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -148.58 139.22 22.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.489 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.794 HD21 HG13 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -141.86 128.68 20.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.459 -0.776 . . . . 0.0 109.321 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.402 ' O ' HD13 ' A' ' 117' ' ' ILE . 2.2 t60 -103.3 111.56 24.02 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.178 -0.952 . . . . 0.0 109.18 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.459 HD11 HD12 ' A' ' 115' ' ' LEU . 51.9 mm -126.1 114.64 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.145 -0.972 . . . . 0.0 110.781 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.66 -142.42 29.93 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 104.422 -3.471 . . . . 0.0 104.422 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -109.92 82.95 1.67 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 115.296 -2.561 . . . . 0.0 107.675 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -165.46 168.33 16.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 83.4 t -131.13 150.03 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.123 -0.986 . . . . 0.0 109.418 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.477 ' CE1' HD13 ' A' ' 5' ' ' ILE . 7.1 m-85 -129.3 134.53 47.97 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.636 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -138.22 134.77 34.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.072 -1.018 . . . . 0.0 108.669 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.772 HG12 ' CD1' ' A' ' 113' ' ' PHE . 8.8 p -127.16 148.33 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.981 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.559 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 1.0 OUTLIER -123.72 75.16 1.32 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 118.193 -1.403 . . . . 0.0 110.732 179.541 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.559 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -162.29 119.7 2.1 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.48 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 8.7 tm-20 -115.37 106.24 13.77 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 117.526 -1.67 . . . . 0.0 110.653 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.605 ' C ' ' H ' ' A' ' 130' ' ' ASP . 86.6 mttt -110.92 -178.96 3.61 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 38' ' ' TRP . 71.4 m-80 -58.48 0.47 0.08 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.605 ' H ' ' C ' ' A' ' 128' ' ' LYS . 21.0 t0 -71.71 143.43 49.65 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.723 -1.236 . . . . 0.0 110.451 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.921 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.2 OUTLIER -110.85 149.36 30.69 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.657 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.921 ' N ' HD12 ' A' ' 131' ' ' LEU . 26.2 mm -114.45 131.93 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.646 ' OG ' HD11 ' A' ' 131' ' ' LEU . 4.4 m -120.31 144.57 47.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.869 . . . . 0.0 110.116 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.794 HG13 HD21 ' A' ' 115' ' ' LEU . 1.7 t -117.14 134.43 23.04 Favored Pre-proline 0 N--CA 1.488 1.436 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.17 151.87 76.65 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.954 1.769 . . . . 0.0 112.284 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.612 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.86 133.04 46.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 109.686 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.612 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 3.7 t-160 92.76 10.27 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 120.964 0.412 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.36 125.92 32.91 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.12 -0.987 . . . . 0.0 108.461 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.52 131.96 31.57 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.622 1.548 . . . . 0.0 111.575 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.504 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.16 163.15 15.55 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.479 -179.062 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.677 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 26.5 p90 -128.65 -153.9 0.6 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.533 -0.729 . . . . 0.0 109.67 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.631 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -172.92 124.0 0.43 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.505 -0.747 . . . . 0.0 109.214 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.472 ' OD1' HD11 ' A' ' 93' ' ' LEU . 29.9 t0 -147.96 131.91 17.16 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.147 -0.97 . . . . 0.0 109.453 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.606 ' O ' ' C ' ' A' ' 145' ' ' GLY . 7.4 mtm -111.76 20.02 17.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.273 -0.892 . . . . 0.0 110.815 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.606 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 11.02 -90.82 0.01 OUTLIER Glycine 0 N--CA 1.503 3.165 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.524 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 46.7 t -87.52 119.6 27.97 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.3 -1.36 . . . . 0.0 109.857 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.596 ' OE1' ' NE ' ' A' ' 89' ' ' ARG . 6.5 mp0 -114.08 120.11 39.31 Favored Pre-proline 0 N--CA 1.493 1.68 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.569 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.7 Cg_endo -100.32 28.88 0.12 Allowed 'Trans proline' 0 C--O 1.212 -0.806 0 C-N-CA 122.476 2.117 . . . . 0.0 112.753 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.621 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER 81.33 64.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.762 0.792 . . . . 0.0 110.16 -179.193 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.615 ' CZ ' HD23 ' A' ' 78' ' ' LEU . 15.2 p90 -101.6 171.06 7.78 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.577 0.703 . . . . 0.0 110.292 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 87.7 m -126.42 138.94 53.59 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.556 ' HB3' HD12 ' A' ' 76' ' ' ILE . . . -146.52 165.72 28.6 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.238 -0.914 . . . . 0.0 109.415 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 75.5 mt -118.09 136.66 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.386 -0.821 . . . . 0.0 109.746 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.518 ' HE ' HG12 ' A' ' 76' ' ' ILE . 2.7 mtm180 -140.15 168.01 20.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.021 -1.049 . . . . 0.0 109.653 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.888 HG21 ' CG ' ' A' ' 70' ' ' TYR . 3.9 mp -107.39 155.22 8.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.631 -0.668 . . . . 0.0 109.562 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.2 m-30 -103.06 121.09 41.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.204 -0.935 . . . . 0.0 110.319 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 3.9 t0 -133.27 163.06 30.15 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -93.41 161.9 29.43 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.102 -0.999 . . . . 0.0 109.285 -178.865 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.3 Cg_endo -62.73 -55.01 0.96 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.237 1.958 . . . . 0.0 112.293 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 55.2 mp0 -44.41 -13.28 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.401 -0.812 . . . . 0.0 109.247 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -78.75 -33.94 36.25 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.534 ' N ' ' O ' ' A' ' 159' ' ' PRO . 4.5 p90 -118.8 159.32 23.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.381 -1.07 . . . . 0.0 110.825 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 81.7 mt -100.2 147.91 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.549 -0.719 . . . . 0.0 109.453 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.65 -73.25 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.5 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -140.9 159.47 42.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.944 -1.097 . . . . 0.0 109.883 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -89.69 -41.87 11.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.393 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 52.7 m -116.06 -31.39 5.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.305 -0.872 . . . . 0.0 108.696 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.63 -5.4 51.3 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.807 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -80.77 149.51 29.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.659 -1.495 . . . . 0.0 107.952 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -105.38 89.97 3.28 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 117.337 -1.745 . . . . 0.0 110.762 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.435 HG22 ' H ' ' A' ' 171' ' ' ILE . 0.2 OUTLIER -71.76 -30.11 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.95 -1.094 . . . . 0.0 109.417 -179.689 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.677 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -63.45 -41.33 98.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.332 -0.855 . . . . 0.0 108.851 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.546 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 15.7 t -51.9 -4.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 110.173 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -83.19 -34.03 26.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.09 -1.007 . . . . 0.0 110.901 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.591 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.1 m-85 -110.03 27.32 0.07 OUTLIER Pre-proline 0 N--CA 1.515 2.81 0 O-C-N 120.81 -1.181 . . . . 0.0 112.764 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 40.5 Cg_endo -58.97 -24.02 71.11 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 123.559 2.839 . . . . 0.0 114.511 -172.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -88.92 125.7 35.07 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 118.375 -1.33 . . . . 0.0 108.133 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' C ' ' A' ' 179' ' ' ALA . 5.0 tt -87.06 128.95 35.09 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.596 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.596 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.36 170.76 8.63 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.047 -1.033 . . . . 0.0 109.412 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.725 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 29.3 tp -158.06 114.98 2.89 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 130.78 55.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.18 -0.95 . . . . 0.0 109.797 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 121' ' ' VAL . 71.5 mt -127.29 138.34 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 178.97 6.87 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.605 0.717 . . . . 0.0 109.444 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.1 t -96.05 174.62 6.83 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.38 -22.88 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.028 -1.045 . . . . 0.0 109.159 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -73.73 -37.76 65.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.148 -0.97 . . . . 0.0 110.512 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.458 ' OD2' ' N ' ' A' ' 10' ' ' ASP . 1.3 p30 -137.51 123.59 13.13 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.029 -1.045 . . . . 0.0 109.461 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -81.86 -38.4 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.944 1.763 . . . . 0.0 112.301 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.32 3.09 2.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 110.275 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -114.67 119.44 36.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.874 . . . . 0.0 109.089 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 p -100.21 122.77 43.55 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.192 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 pp -88.09 -8.97 54.7 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.054 -1.059 . . . . 0.0 108.991 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.725 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 38.7 t90 -157.7 107.69 2.17 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.315 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -120.4 121.86 39.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.409 -0.807 . . . . 0.0 110.026 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.405 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -163.15 164.45 25.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.439 -0.788 . . . . 0.0 109.999 -179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.866 HG23 ' O ' ' A' ' 19' ' ' THR . 10.7 t -130.86 88.83 2.66 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 118.955 -1.098 . . . . 0.0 108.16 175.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.749 ' O ' HD12 ' A' ' 24' ' ' ILE . 85.3 m-20 -125.9 143.68 50.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.098 -1.001 . . . . 0.0 110.684 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.15 -39.62 22.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.342 -1.474 . . . . 0.0 108.664 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.21 -50.89 8.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 109.566 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.7 -21.58 60.81 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.879 -1.138 . . . . 0.0 108.559 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 20' ' ' ASN . 2.0 mt -70.05 -57.34 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.256 -0.902 . . . . 0.0 108.943 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.517 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 8.7 pt20 -62.65 -44.94 94.99 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.941 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 25.9 mt-30 -59.88 -42.38 93.62 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.148 -0.97 . . . . 0.0 109.885 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.533 ' OE1' ' CZ2' ' A' ' 16' ' ' TRP . 39.8 tt0 -80.24 -47.03 15.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.912 -1.118 . . . . 0.0 109.399 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.49 ' CD1' HG21 ' A' ' 33' ' ' VAL . 20.2 tp -66.14 -55.4 16.58 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.986 -1.071 . . . . 0.0 109.022 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 33' ' ' VAL . 41.2 t-20 -59.63 -19.78 51.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.911 -1.118 . . . . 0.0 109.471 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -65.15 -27.58 68.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.859 -1.151 . . . . 0.0 108.601 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -86.5 12.78 9.6 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.737 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.72 23.23 31.26 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.042 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.49 HG21 ' CD1' ' A' ' 28' ' ' LEU . 70.6 t -94.33 145.44 7.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.469 -1.018 . . . . 0.0 109.176 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -84.45 158.5 21.02 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.345 -0.847 . . . . 0.0 108.737 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.475 ' CE2' HD11 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -152.77 152.31 31.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.881 -1.137 . . . . 0.0 108.006 177.749 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 130' ' ' ASP . 3.4 mm-40 -170.77 169.4 6.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.909 -1.119 . . . . 0.0 109.21 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -150.55 118.58 6.29 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.503 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 23.4 m0 -111.17 150.32 29.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.863 . . . . 0.0 108.996 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -139.68 157.51 45.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.149 -0.969 . . . . 0.0 109.629 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.31 159.53 15.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 108.968 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.47 ' OD2' ' N ' ' A' ' 42' ' ' ARG . 54.1 p30 -100.17 -9.94 21.96 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.47 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 15.8 ttm180 -93.48 150.69 20.25 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.3 117.88 30.03 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.536 -0.727 . . . . 0.0 109.261 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mt -93.28 165.63 12.71 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.32 -0.863 . . . . 0.0 109.383 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.39 -121.33 0.56 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.49 78.57 9.66 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.113 -1.228 . . . . 0.0 108.635 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.3 94.58 48.79 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.509 -0.744 . . . . 0.0 109.087 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.25 85.61 0.43 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.822 1.681 . . . . 0.0 111.646 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.28 109.02 0.64 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.265 -0.897 . . . . 0.0 109.276 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.25 -35.41 31.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.645 -1.284 . . . . 0.0 109.759 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 6.3 pt-20 -65.28 -20.78 66.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 110.155 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.9 m -79.83 -35.67 37.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.161 -0.962 . . . . 0.0 110.302 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.95 -46.51 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.957 . . . . 0.0 109.842 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -61.99 -42.18 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.935 . . . . 0.0 108.978 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.34 -29.75 70.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.399 -0.813 . . . . 0.0 109.702 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.12 -19.17 58.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 110.165 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -116.38 -9.0 11.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.794 . . . . 0.0 109.566 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 54' ' ' ILE . 4.2 mm100 -49.65 -39.04 34.79 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.145 -0.972 . . . . 0.0 108.857 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.598 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 21.5 p80 -52.68 -45.03 66.64 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.427 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.598 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.12 -59.65 4.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.906 -1.121 . . . . 0.0 110.015 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.699 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -63.42 -28.25 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.025 -1.047 . . . . 0.0 109.289 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.2 t70 -58.35 -24.73 60.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.382 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -84.6 -41.63 16.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 109.978 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.477 HD21 HG21 ' A' ' 103' ' ' VAL . 2.3 tt -66.49 -46.27 76.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.388 -0.82 . . . . 0.0 109.751 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.7 p -67.24 -30.11 48.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 109.283 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.41 -43.52 75.35 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.094 -1.004 . . . . 0.0 109.367 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -78.52 -52.21 8.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 0.0 109.832 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.64 ' O ' ' C ' ' A' ' 69' ' ' GLY . 45.0 mmtm -83.22 12.18 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.389 -0.82 . . . . 0.0 110.342 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.64 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -0.23 80.33 0.0 OUTLIER Glycine 0 N--CA 1.503 3.166 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.484 ' CG ' HG21 ' A' ' 155' ' ' ILE . 43.2 m-85 -77.27 166.36 23.29 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.375 -1.073 . . . . 0.0 108.461 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -57.24 -92.24 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.444 -0.785 . . . . 0.0 109.173 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.44 164.9 11.42 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.603 0.716 . . . . 0.0 110.177 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.506 ' CZ3' HD12 ' A' ' 155' ' ' ILE . 6.4 t-105 -136.2 140.61 43.67 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.427 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.8 OUTLIER -157.37 175.36 14.09 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.089 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -120.14 143.27 32.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 76' ' ' ILE . 4.3 tp -103.07 115.89 45.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 77' ' ' SER . 9.8 p -168.57 101.44 0.41 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.503 -0.748 . . . . 0.0 109.003 178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.662 HD23 ' CB ' ' A' ' 82' ' ' ASN . 9.9 tp -110.45 -179.49 3.78 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 119.564 -1.96 . . . . 0.0 107.751 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.56 ' C ' ' H ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -88.41 147.49 24.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.744 -1.223 . . . . 0.0 109.773 -178.81 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.423 ' H ' ' HD3' ' A' ' 79' ' ' ARG . . . -59.22 3.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.656 -0.652 . . . . 0.0 109.571 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 79' ' ' ARG . 84.6 m-20 -88.39 -25.52 22.65 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.624 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.662 ' CB ' HD23 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -63.61 128.08 92.24 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.991 -1.068 . . . . 0.0 109.639 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -75.95 -6.49 17.46 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.211 1.941 . . . . 0.0 112.392 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -89.33 10.69 21.43 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.9 -1.125 . . . . 0.0 109.41 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.509 ' CG ' ' H ' ' A' ' 86' ' ' GLU . 2.4 pttm -56.77 -57.28 13.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 108.798 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.509 ' H ' ' CG ' ' A' ' 85' ' ' LYS . 84.1 tt0 -66.15 -40.02 90.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.207 -0.933 . . . . 0.0 109.798 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.31 90.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.692 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.2 mt -61.3 -46.93 88.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 110.203 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.61 -26.41 67.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.947 -1.095 . . . . 0.0 109.721 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -67.21 -59.3 3.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.453 -0.779 . . . . 0.0 110.375 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -57.9 -38.65 76.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.97 . . . . 0.0 109.534 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -74.59 -24.21 58.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.719 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.439 HD21 ' N ' ' A' ' 173' ' ' SER . 1.5 tt -64.18 -33.98 77.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 109.997 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.473 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 44.0 p-10 -43.09 148.68 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 109.709 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.565 ' OE2' ' N ' ' A' ' 171' ' ' ILE . 77.5 mt-10 -85.24 157.44 20.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.334 -0.854 . . . . 0.0 109.626 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -174.38 -165.72 0.23 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.011 -1.056 . . . . 0.0 111.488 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.83 131.8 3.02 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.603 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -101.63 155.3 18.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 109.955 -178.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.86 -5.92 86.89 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' A' ' 101' ' ' ASP . 22.6 tp10 -126.57 169.26 13.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -1.07 . . . . 0.0 109.304 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.447 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 89.4 m-20 -70.06 143.42 52.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.245 -0.91 . . . . 0.0 110.06 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.603 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 2.7 tt0 -102.52 95.05 5.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 110.195 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.535 HG12 ' OG ' ' A' ' 133' ' ' SER . 18.0 m -94.64 125.52 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.31 126.03 38.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.503 ' CE2' ' CE3' ' A' ' 38' ' ' TRP . 42.3 t80 -101.92 126.89 48.93 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.492 ' CD1' ' HB2' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -89.61 134.24 34.23 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.618 -0.676 . . . . 0.0 110.39 -178.759 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.2 -25.9 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.814 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' A' ' 109' ' ' GLY . 74.3 tt0 -172.36 163.94 5.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.008 -1.057 . . . . 0.0 108.895 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.619 ' N ' ' OE1' ' A' ' 127' ' ' GLU . . . 43.78 104.61 0.01 OUTLIER Glycine 0 N--CA 1.495 2.569 0 O-C-N 121.104 -0.998 . . . . 0.0 110.792 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.492 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . . . -149.79 111.08 4.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.671 -1.488 . . . . 0.0 109.105 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.48 ' C ' HD12 ' A' ' 125' ' ' LEU . . . -78.51 -140.89 1.78 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -109.9 100.97 9.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.415 -1.05 . . . . 0.0 111.775 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.493 ' C ' ' OE1' ' A' ' 123' ' ' GLN . 30.8 p90 -79.82 128.62 33.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.61 -1.306 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.462 ' SG ' ' NE1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -78.91 143.71 35.58 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.318 0.58 . . . . 0.0 109.939 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.544 HD11 HG21 ' A' ' 134' ' ' VAL . 4.7 tp -131.38 124.73 30.95 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.2 t-160 -102.43 103.48 13.88 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.927 -1.108 . . . . 0.0 110.012 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.624 ' H ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -115.93 105.92 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.203 -0.936 . . . . 0.0 109.889 -179.152 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.54 -144.24 32.59 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 105.293 -3.123 . . . . 0.0 105.293 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.521 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 41.5 p30 -102.11 79.36 1.87 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 115.225 -2.59 . . . . 0.0 109.589 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.527 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 15.0 tp10 -165.76 170.68 13.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.666 ' O ' HG23 ' A' ' 5' ' ' ILE . 55.8 t -127.74 141.94 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.12 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.474 ' CE1' HD13 ' A' ' 5' ' ' ILE . 22.1 m-85 -128.49 132.32 48.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.808 -0.557 . . . . 0.0 109.788 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.493 ' OE1' ' C ' ' A' ' 113' ' ' PHE . 11.2 mm-40 -128.73 112.98 14.78 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 2.4 t -100.54 134.99 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.535 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 54.5 tp -126.54 86.05 2.46 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.543 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.535 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -168.2 137.51 2.45 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -104.67 99.42 9.09 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 116.119 -2.232 . . . . 0.0 109.792 -179.287 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.578 ' C ' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -119.38 159.53 24.01 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.988 176.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.478 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 13.0 p30 -60.68 2.67 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.578 ' H ' ' C ' ' A' ' 128' ' ' LYS . 9.6 t70 -66.45 135.3 54.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.86 -1.15 . . . . 0.0 110.353 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.777 HD13 ' N ' ' A' ' 132' ' ' ILE . 1.4 tm? -92.37 125.11 36.88 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.748 -177.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.777 ' N ' HD13 ' A' ' 131' ' ' LEU . 1.0 OUTLIER -108.33 127.62 64.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.535 ' OG ' HG12 ' A' ' 103' ' ' VAL . 5.2 t -120.69 144.15 48.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.451 -0.781 . . . . 0.0 109.673 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.544 HG21 HD11 ' A' ' 115' ' ' LEU . 1.1 t -119.13 142.18 31.72 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.39 147.16 70.92 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.343 2.029 . . . . 0.0 113.051 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.614 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.8 134.15 45.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 109.375 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.614 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 2.2 t-80 92.32 11.02 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.68 128.13 27.49 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.117 -0.99 . . . . 0.0 108.797 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.49 132.38 33.13 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.751 1.634 . . . . 0.0 111.53 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.55 164.72 10.39 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.199 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.48 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.4 OUTLIER -136.66 -149.14 0.31 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.195 -0.941 . . . . 0.0 109.597 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -173.61 124.1 0.37 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.997 -1.064 . . . . 0.0 109.018 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -137.66 129.99 29.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.55 -0.719 . . . . 0.0 109.525 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.612 ' SD ' ' CE2' ' A' ' 150' ' ' PHE . 60.5 mtm -100.61 16.97 23.04 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.764 -0.585 . . . . 0.0 111.312 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 32.64 -125.92 0.29 Allowed Glycine 0 N--CA 1.49 2.287 0 O-C-N 120.636 -1.29 . . . . 0.0 110.537 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.597 ' CB ' HD22 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -81.7 121.37 26.29 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.099 -1.441 . . . . 0.0 108.624 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.89 115.58 45.85 Favored Pre-proline 0 N--CA 1.492 1.636 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.355 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 60.3 Cg_endo -103.69 50.34 0.03 OUTLIER 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 122.957 2.438 . . . . 0.0 110.742 176.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 20.5 t-20 81.85 70.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.132 -177.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.612 ' CE2' ' SD ' ' A' ' 144' ' ' MET . 20.5 p90 -96.24 163.13 13.22 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.274 -0.891 . . . . 0.0 110.167 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.9 m -128.81 124.5 35.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.469 -0.769 . . . . 0.0 110.533 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.562 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . . . -141.97 160.75 39.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.501 -0.749 . . . . 0.0 109.012 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.505 HG23 ' HE1' ' A' ' 73' ' ' TRP . 79.6 mt -111.14 129.24 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.182 -0.949 . . . . 0.0 109.247 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.643 ' C ' HD13 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -135.29 165.09 26.24 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.643 HD13 ' C ' ' A' ' 154' ' ' ARG . 0.6 OUTLIER -107.59 152.66 9.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.49 -0.756 . . . . 0.0 109.381 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.427 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.8 m-30 -96.77 119.63 35.61 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.0 0.905 . . . . 0.0 109.892 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 53.5 p30 -134.99 163.84 28.95 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.03 161.54 29.48 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.982 -1.073 . . . . 0.0 109.075 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.63 ' O ' ' N ' ' A' ' 161' ' ' GLY . 40.7 Cg_endo -63.77 -55.45 0.67 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.013 1.809 . . . . 0.0 112.045 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 159' ' ' PRO . 94.4 mt-10 -43.77 -14.38 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.369 -0.832 . . . . 0.0 109.197 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -75.93 -40.52 30.29 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.507 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 4.1 p90 -108.83 159.56 16.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 79.2 mt -100.67 147.42 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.402 -0.811 . . . . 0.0 109.509 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -49.2 -74.11 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.263 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.29 161.47 38.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.111 -0.993 . . . . 0.0 109.804 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -88.19 -41.62 12.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.028 -1.045 . . . . 0.0 109.546 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 63.4 p -112.48 -31.89 6.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.293 -0.879 . . . . 0.0 108.877 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.91 -8.02 53.61 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -80.04 145.92 32.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.624 -1.515 . . . . 0.0 108.039 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -112.36 89.81 3.17 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.316 -1.354 . . . . 0.0 110.872 176.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.565 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -83.21 -20.12 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.049 -1.657 . . . . 0.0 109.284 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -56.77 -43.82 81.18 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.445 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 47.6 t -56.25 -1.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 109.648 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -87.93 -18.62 28.73 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.382 -0.824 . . . . 0.0 110.842 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.573 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 54.2 m-85 -108.45 27.41 0.07 OUTLIER Pre-proline 0 N--CA 1.518 2.952 0 O-C-N 121.187 -0.946 . . . . 0.0 112.83 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 42.1 Cg_endo -60.86 -5.57 4.86 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 123.916 3.077 . . . . 0.0 113.453 -173.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -84.62 148.94 26.18 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.3 -0.875 . . . . 0.0 109.149 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.747 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 15.9 tp -89.34 101.18 13.85 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.829 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.905 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.619 ' O ' ' OG1' ' A' ' 19' ' ' THR . 7.9 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.2 169.96 9.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.126 -0.983 . . . . 0.0 109.214 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 4' ' ' THR . 2.7 tp -157.24 118.96 3.74 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.534 ' N ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -109.79 133.88 52.66 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.179 -0.95 . . . . 0.0 109.795 -178.767 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.769 HG23 ' O ' ' A' ' 121' ' ' VAL . 52.9 mt -127.5 136.08 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.58 166.19 20.22 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.409 ' OG ' ' CD1' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -86.75 174.27 8.93 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 108.796 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.33 -28.31 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.03 -1.044 . . . . 0.0 109.117 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -73.54 -36.91 65.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.28 124.97 15.41 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 109.552 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.82 -37.82 0.31 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.935 1.757 . . . . 0.0 112.407 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -69.46 6.26 1.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.093 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -114.03 120.32 40.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.908 . . . . 0.0 109.055 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.5 p -100.29 122.01 42.4 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.365 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.409 ' CD1' ' OG ' ' A' ' 7' ' ' SER . 7.1 mt -88.9 -7.52 55.94 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.064 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.736 ' NE1' ' NE2' ' A' ' 27' ' ' GLN . 48.3 t90 -157.46 105.95 2.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.421 -1.312 . . . . 0.0 109.9 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -117.82 111.11 18.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.329 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.436 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -162.47 162.85 27.7 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.868 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.837 HG23 ' O ' ' A' ' 19' ' ' THR . 10.0 t -131.71 90.28 2.82 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 120.966 -1.084 . . . . 0.0 108.181 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.759 ' O ' HD12 ' A' ' 24' ' ' ILE . 1.7 m-80 -124.55 143.47 50.67 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.285 -0.884 . . . . 0.0 110.442 177.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.75 -40.88 22.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.012 -1.68 . . . . 0.0 108.536 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.28 -48.41 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 110.021 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -60.62 -23.95 65.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.969 -1.082 . . . . 0.0 108.698 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.759 HD12 ' O ' ' A' ' 20' ' ' ASN . 10.9 mt -72.63 -53.68 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.234 -0.916 . . . . 0.0 108.83 178.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 29' ' ' ASN . 52.0 tt0 -59.09 -52.87 63.85 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.141 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.656 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 1.0 OUTLIER -59.75 -40.14 87.16 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.28 -0.888 . . . . 0.0 109.64 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.736 ' NE2' ' NE1' ' A' ' 16' ' ' TRP . 54.8 tt0 -78.1 -50.21 12.46 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.933 -1.104 . . . . 0.0 109.579 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 24' ' ' ILE . 22.6 tp -69.03 -55.87 9.49 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.7 -1.25 . . . . 0.0 109.268 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 25' ' ' GLN . 26.2 t-20 -56.82 -20.89 25.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.876 -1.14 . . . . 0.0 109.448 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -66.54 -26.37 67.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.889 -1.132 . . . . 0.0 108.374 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 10.63 15.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.296 -0.877 . . . . 0.0 109.695 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.06 21.89 26.69 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.4 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 38.6 t -94.31 146.26 6.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.193 -1.18 . . . . 0.0 108.958 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.448 HH12 ' NZ ' ' A' ' 68' ' ' LYS . 13.4 ttm180 -84.12 157.24 21.78 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.438 ' C ' ' OE1' ' A' ' 36' ' ' GLU . 1.2 t80 -154.98 153.66 31.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.83 -1.169 . . . . 0.0 108.729 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.438 ' OE1' ' C ' ' A' ' 35' ' ' PHE . 1.5 pm0 -175.63 173.21 2.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.861 -1.149 . . . . 0.0 109.837 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -148.82 112.94 5.2 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.642 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 23.9 m0 -111.48 149.76 30.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 38' ' ' TRP . 84.0 mm-40 -138.09 157.87 45.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.776 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.22 158.79 15.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 108.937 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -101.34 -12.98 18.21 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -92.94 158.34 15.87 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.652 0.739 . . . . 0.0 109.051 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -93.0 119.29 32.1 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.615 -0.678 . . . . 0.0 109.507 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.34 164.0 14.01 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.381 -0.824 . . . . 0.0 109.278 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.72 -103.94 0.2 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.0 88.64 4.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.115 -1.226 . . . . 0.0 109.264 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.54 92.92 17.81 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.482 -0.761 . . . . 0.0 109.005 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.54 -28.2 10.26 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.151 1.901 . . . . 0.0 112.574 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 50.1 p -119.86 140.94 50.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.649 -0.657 . . . . 0.0 109.877 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.655 ' CB ' HG21 ' A' ' 151' ' ' THR . . . -81.0 -17.28 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 109.593 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -46.61 -37.53 8.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.33 -0.856 . . . . 0.0 109.119 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.5 p -78.81 -31.12 45.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 0.0 109.338 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 107' ' ' VAL . 25.1 t -69.11 -48.87 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.86 . . . . 0.0 109.818 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 58' ' ' GLN . 6.6 mt -59.65 -39.3 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 109.017 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.51 -31.0 71.69 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.434 -0.791 . . . . 0.0 109.657 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.22 -17.79 60.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 0.0 110.042 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -113.98 -6.8 13.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.448 -0.783 . . . . 0.0 109.307 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 62' ' ' ASP . 3.1 mm100 -48.64 -39.48 24.35 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.305 -0.958 . . . . 0.0 108.993 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 60' ' ' ALA . 35.6 p80 -52.08 -46.78 65.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.039 -1.038 . . . . 0.0 109.652 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.584 ' N ' ' ND1' ' A' ' 59' ' ' HIS . . . -62.49 -61.6 2.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.917 -1.114 . . . . 0.0 109.849 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.683 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -61.16 -29.45 45.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.749 -1.22 . . . . 0.0 109.187 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 58' ' ' GLN . 33.2 t0 -58.1 -26.12 62.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 109.521 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.33 -39.41 59.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.127 -0.983 . . . . 0.0 109.236 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.2 mp -63.75 -36.75 84.92 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.268 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 61' ' ' ILE . 2.8 t -70.41 -29.5 39.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.304 -0.872 . . . . 0.0 109.339 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.4 -53.82 51.43 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.488 -1.383 . . . . 0.0 109.392 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -82.64 -50.37 8.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.964 -1.085 . . . . 0.0 110.785 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.582 ' O ' ' C ' ' A' ' 69' ' ' GLY . 70.9 mttt -86.26 14.0 7.18 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.387 -0.821 . . . . 0.0 110.858 -177.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.582 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -15.34 88.97 0.01 OUTLIER Glycine 0 N--CA 1.502 3.068 0 CA-C-O 122.195 0.886 . . . . 0.0 111.731 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.785 ' CG ' HG21 ' A' ' 155' ' ' ILE . 84.0 m-85 -77.69 162.3 27.1 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -58.55 -81.7 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 108.742 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.1 m -103.26 157.52 16.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.466 -0.771 . . . . 0.0 109.599 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.672 ' CE2' HD13 ' A' ' 61' ' ' ILE . 11.0 t-105 -141.27 146.44 36.8 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.469 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.3 OUTLIER -177.44 -165.22 0.1 Allowed 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.905 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 153' ' ' ILE . 3.2 m -122.58 165.54 18.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.398 -0.814 . . . . 0.0 109.222 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -95.48 140.69 16.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.589 ' O ' HD22 ' A' ' 78' ' ' LEU . 58.8 p -91.68 162.38 14.51 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.049 1.404 . . . . 0.0 112.248 -176.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -158.85 118.48 3.1 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 113.49 -1.687 . . . . 0.0 112.41 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -131.7 139.54 49.05 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.39 -18.3 65.28 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.761 -1.212 . . . . 0.0 109.5 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -104.74 31.77 4.54 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.659 HD22 ' H ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -92.58 125.4 55.93 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.019 -1.05 . . . . 0.0 110.619 178.332 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -78.2 -7.6 16.19 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.997 1.798 . . . . 0.0 112.268 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -90.81 0.93 57.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.978 -1.076 . . . . 0.0 110.024 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.518 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 11.5 ptmm? -58.05 -51.29 70.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.183 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 49.7 tp10 -62.84 -56.61 15.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.093 -1.004 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.92 -44.6 78.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.404 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.4 -42.25 98.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.309 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.49 ' HG2' ' H ' ' A' ' 144' ' ' MET . 43.3 mtp180 -60.75 -40.69 93.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.725 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -66.7 -58.31 5.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.368 -0.833 . . . . 0.0 110.511 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -53.37 -34.41 57.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.611 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -88.14 -17.66 30.47 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 110.213 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 176' ' ' PRO . 6.0 tp -61.36 -38.23 86.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.866 -1.146 . . . . 0.0 109.97 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 40.2 p-10 -54.81 131.11 43.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 0.0 110.148 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.49 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 1.7 pp20? -71.55 165.55 23.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.389 -0.819 . . . . 0.0 109.339 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.49 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 38.3 p-80 -175.13 -165.22 0.17 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.294 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.84 135.66 4.83 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.67 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.37 154.98 21.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -0.835 . . . . 0.0 109.676 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.52 -6.98 85.19 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.515 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 84.9 tt0 -125.93 169.13 13.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.243 -1.151 . . . . 0.0 108.988 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.433 ' N ' ' HG2' ' A' ' 100' ' ' GLU . 90.3 m-20 -74.47 144.06 44.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.859 -1.151 . . . . 0.0 110.613 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.415 ' HG3' ' CE1' ' A' ' 98' ' ' HIS . 2.3 mt-10 -100.88 91.64 4.68 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.68 HG12 ' OG ' ' A' ' 133' ' ' SER . 6.4 m -84.63 131.31 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -130.62 112.74 13.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.758 -0.589 . . . . 0.0 109.513 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.65 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 17.3 t80 -101.25 135.87 42.02 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.606 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -92.17 133.66 35.58 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.465 -0.772 . . . . 0.0 110.118 -178.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -112.33 -36.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.268 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -156.56 143.24 18.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.939 -1.1 . . . . 0.0 109.919 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.43 170.67 40.08 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.56 -170.15 1.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.228 -1.16 . . . . 0.0 109.485 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.53 -138.22 2.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.7 tp -142.71 159.67 41.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.19 -1.182 . . . . 0.0 109.168 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -134.98 86.94 2.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 109.485 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.817 ' O ' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -80.94 120.24 24.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.875 . . . . 0.0 109.511 178.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.817 HD23 ' O ' ' A' ' 114' ' ' CYS . 2.2 mt -132.64 124.34 28.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.2 -0.937 . . . . 0.0 109.032 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 9.6 t-160 -108.3 114.54 28.48 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.943 -1.098 . . . . 0.0 108.985 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.3 mt -127.79 116.45 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.593 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.14 -143.5 33.29 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 105.916 -2.874 . . . . 0.0 105.916 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -105.57 79.11 1.42 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 115.578 -2.449 . . . . 0.0 108.474 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.5 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 31.5 tt0 -166.08 168.66 15.29 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 5' ' ' ILE . 41.9 t -126.37 140.91 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.997 -1.065 . . . . 0.0 110.227 177.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -120.48 130.38 54.26 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.191 0.519 . . . . 0.0 110.249 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.496 ' O ' HD12 ' A' ' 3' ' ' LEU . 19.0 mt-30 -131.08 112.58 13.01 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.496 -0.752 . . . . 0.0 109.107 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.79 137.81 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.6 mp -136.54 93.08 2.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.203 -0.936 . . . . 0.0 110.146 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 1' ' ' SER . 44.0 t -165.96 138.49 4.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.545 -1.347 . . . . 0.0 108.195 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.66 94.37 5.16 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 115.779 -2.368 . . . . 0.0 110.759 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.585 ' C ' ' H ' ' A' ' 130' ' ' ASP . 32.6 mtmt -116.18 150.38 37.56 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.585 176.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.65 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 1.4 m-20 -59.72 -1.95 0.32 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.414 -1.428 . . . . 0.0 107.695 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' A' ' 128' ' ' LYS . 57.0 p30 -68.47 146.13 53.44 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.069 0.937 . . . . 0.0 109.927 -176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.037 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -105.15 140.24 38.62 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.576 0.703 . . . . 0.0 109.962 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 1.037 ' N ' HD12 ' A' ' 131' ' ' LEU . 14.1 tt -128.8 120.6 52.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.68 ' OG ' HG12 ' A' ' 103' ' ' VAL . 8.1 t -118.59 142.99 47.09 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.57 HG11 HD22 ' A' ' 115' ' ' LEU . 12.4 m -99.19 148.57 34.81 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.751 ' O ' HG22 ' A' ' 138' ' ' THR . 38.6 Cg_endo -66.9 153.48 77.77 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.436 2.091 . . . . 0.0 113.355 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.613 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -74.81 136.64 41.62 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.173 -0.954 . . . . 0.0 109.188 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.613 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 13.2 t-80 94.14 10.94 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.751 HG22 ' O ' ' A' ' 135' ' ' PRO . 12.2 t -106.42 127.16 28.75 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.948 -1.095 . . . . 0.0 109.021 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.15 134.4 48.93 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.829 1.686 . . . . 0.0 111.752 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.515 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -171.78 162.15 6.12 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.972 -179.306 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.492 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -134.11 -148.67 0.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.222 -0.923 . . . . 0.0 109.446 -178.696 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -175.06 126.6 0.27 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.038 -1.039 . . . . 0.0 109.094 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.499 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 52.5 p-10 -146.88 138.05 24.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.328 -0.858 . . . . 0.0 109.75 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.613 ' O ' ' C ' ' A' ' 145' ' ' GLY . 6.6 mmt -107.06 19.43 20.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.339 -0.851 . . . . 0.0 111.791 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.613 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 2.22 -88.1 0.0 OUTLIER Glycine 0 N--CA 1.506 3.31 0 CA-C-N 119.5 1.046 . . . . 0.0 111.714 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.484 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 69.2 m -85.52 121.32 28.05 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.119 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.599 ' OE2' ' ND2' ' A' ' 82' ' ' ASN . 40.1 mt-10 -103.25 119.64 54.53 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.731 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 56.1 Cg_endo -104.22 0.89 0.28 Allowed 'Trans proline' 0 C--O 1.207 -1.072 0 C-N-CA 123.844 3.029 . . . . 0.0 110.964 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.731 ' ND2' ' O ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER 83.87 63.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 123.489 1.614 . . . . 0.0 110.424 -179.29 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.435 ' CE1' ' HG ' ' A' ' 78' ' ' LEU . 8.8 p90 -100.88 178.48 4.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.575 -1.328 . . . . 0.0 109.528 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.655 HG21 ' CB ' ' A' ' 50' ' ' ALA . 85.7 m -133.43 139.32 46.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.478 -0.764 . . . . 0.0 109.465 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 76' ' ' ILE . . . -141.23 161.69 37.28 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.853 -1.155 . . . . 0.0 109.721 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.76 ' HA ' HG12 ' A' ' 75' ' ' VAL . 64.4 mt -108.36 127.58 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.017 -1.052 . . . . 0.0 110.195 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -138.96 167.06 22.89 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.427 -0.796 . . . . 0.0 109.905 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.785 HG21 ' CG ' ' A' ' 70' ' ' TYR . 2.9 mt -101.76 147.24 8.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.449 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.6 m-85 -96.48 118.3 32.7 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.347 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.605 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 14.4 p30 -136.17 161.75 34.86 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.826 -0.546 . . . . 0.0 109.575 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -95.71 161.39 27.75 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 120.871 -1.143 . . . . 0.0 109.332 -179.333 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.615 ' O ' ' N ' ' A' ' 162' ' ' TRP . 42.0 Cg_endo -65.6 -53.91 0.68 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.372 2.048 . . . . 0.0 112.034 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 159' ' ' PRO . 49.7 tp10 -43.48 -16.25 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.328 -0.857 . . . . 0.0 109.177 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -86.0 -23.07 46.72 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.615 ' N ' ' O ' ' A' ' 159' ' ' PRO . 20.3 m95 -116.5 165.94 12.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.339 -1.095 . . . . 0.0 109.926 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 35.2 pt -102.46 153.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.212 -0.93 . . . . 0.0 109.284 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.94 -73.64 0.3 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.137 -0.977 . . . . 0.0 110.292 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -141.18 159.01 43.11 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.083 -1.011 . . . . 0.0 109.662 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -101.24 -41.07 6.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.11 -0.994 . . . . 0.0 109.589 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 58.4 p -101.47 -30.31 11.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.081 -1.012 . . . . 0.0 109.443 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.3 -4.03 62.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -79.41 147.64 32.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.829 -1.395 . . . . 0.0 108.361 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 37.5 p30 -110.65 87.64 2.58 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 117.949 -1.501 . . . . 0.0 111.021 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.46 ' H ' HG22 ' A' ' 171' ' ' ILE . 1.7 tt -76.26 -17.26 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.321 -1.487 . . . . 0.0 109.312 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.492 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -59.79 -41.86 92.09 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.799 -0.76 . . . . 0.0 108.952 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.63 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 24.1 t -52.7 -4.64 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.429 -0.794 . . . . 0.0 110.391 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.485 ' HB3' ' CE2' ' A' ' 175' ' ' TYR . . . -79.49 -40.37 29.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.783 -1.198 . . . . 0.0 111.514 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.632 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 6.1 m-85 -113.37 25.49 0.09 OUTLIER Pre-proline 0 N--CA 1.516 2.851 0 O-C-N 120.5 -1.375 . . . . 0.0 112.297 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.743 ' HB3' HD11 ' A' ' 93' ' ' LEU . 44.7 Cg_endo -60.91 -20.41 66.75 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.792 2.995 . . . . 0.0 114.06 -172.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -89.61 126.46 35.63 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.554 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 179' ' ' ALA . 5.3 tt -87.27 122.36 30.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.045 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.668 ' N ' HD23 ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.299 -1.598 0 O-C-N 121.01 -1.056 . . . . 0.0 109.503 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.558 ' O ' ' OG1' ' A' ' 19' ' ' THR . 85.0 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.39 172.51 7.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.262 -0.899 . . . . 0.0 109.203 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.817 ' CD1' HG22 ' A' ' 124' ' ' VAL . 34.8 tp -158.71 114.08 2.59 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 123' ' ' GLN . 0.1 OUTLIER -106.34 128.52 54.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.959 -1.088 . . . . 0.0 110.535 -178.379 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.523 HD12 ' CE3' ' A' ' 16' ' ' TRP . 58.1 mt -122.57 130.47 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.453 ' CD2' ' O ' ' A' ' 11' ' ' PRO . 78.0 m-85 -129.7 167.0 18.68 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.9 m -89.86 173.65 8.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.952 -1.093 . . . . 0.0 108.706 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 8' ' ' VAL . 2.0 m -89.3 -28.25 5.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.029 -1.044 . . . . 0.0 109.495 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -72.14 -39.57 68.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.488 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -138.48 124.6 12.67 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.89 -1.132 . . . . 0.0 109.563 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 55.9 Cg_endo -81.89 -31.52 1.02 Allowed 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.727 1.618 . . . . 0.0 112.193 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.84 1.07 4.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.415 -0.803 . . . . 0.0 110.444 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.37 118.78 32.09 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 p -96.82 127.13 42.5 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.055 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pp -89.93 -13.5 36.14 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.808 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.793 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 53.9 t90 -158.72 106.77 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.412 -1.315 . . . . 0.0 109.713 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -120.14 119.97 34.85 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.287 -0.883 . . . . 0.0 109.835 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.412 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -161.66 165.44 28.24 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.32 -0.863 . . . . 0.0 110.094 -179.737 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 19' ' ' THR . 7.9 t -130.11 89.6 2.82 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.182 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.766 ' O ' HD12 ' A' ' 24' ' ' ILE . 85.1 m-20 -125.12 137.37 54.17 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.707 -0.62 . . . . 0.0 110.181 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.8 -35.04 29.94 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.152 -1.593 . . . . 0.0 108.76 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.1 mp0 -82.92 -51.11 7.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.268 -0.895 . . . . 0.0 109.275 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.629 ' OE2' ' ND2' ' A' ' 20' ' ' ASN . 1.3 tt0 -61.17 -18.49 58.42 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.766 HD12 ' O ' ' A' ' 20' ' ' ASN . 1.9 mt -72.85 -58.4 5.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.144 -0.973 . . . . 0.0 108.514 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.514 ' N ' HG22 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -57.68 -45.59 85.39 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.455 -0.778 . . . . 0.0 109.324 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.671 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 7.9 tt0 -62.41 -44.18 97.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 110.144 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.546 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 27.2 mt-30 -79.02 -46.31 18.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.883 -1.136 . . . . 0.0 109.902 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.421 ' HG ' HG11 ' A' ' 33' ' ' VAL . 16.0 tp -65.82 -58.33 5.88 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.939 -1.1 . . . . 0.0 109.075 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.476 ' CG ' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -60.41 -18.95 54.22 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.735 -1.228 . . . . 0.0 109.715 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -64.67 -24.93 67.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.785 -1.197 . . . . 0.0 108.025 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -88.64 13.81 11.42 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.566 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.36 21.09 46.14 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.343 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.476 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 34.0 t -93.65 144.35 9.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.366 -1.079 . . . . 0.0 109.278 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -83.76 156.16 22.69 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -153.62 146.92 24.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.807 -1.183 . . . . 0.0 107.973 177.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.9 pt-20 -175.18 175.16 2.29 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.074 -1.016 . . . . 0.0 110.271 178.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -148.37 121.94 9.17 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.456 ' CZ2' HD23 ' A' ' 131' ' ' LEU . 34.5 m0 -112.25 153.61 26.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 108.836 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -139.25 146.58 40.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.689 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.597 ' HB2' ' CE1' ' A' ' 57' ' ' TYR . . . -101.85 159.95 14.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 108.708 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -96.23 -17.06 21.05 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.6 mtm-85 -93.09 147.95 22.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -91.91 137.17 32.59 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.582 -0.699 . . . . 0.0 109.273 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.445 ' N ' HD22 ' A' ' 44' ' ' LEU . 4.3 mm? -92.33 163.64 13.81 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.819 0.818 . . . . 0.0 109.378 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.15 -113.5 0.37 Allowed Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.92 -1.134 . . . . 0.0 110.639 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.61 89.01 4.51 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.126 -1.22 . . . . 0.0 109.392 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.49 92.42 19.59 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.1 -25.9 13.39 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.051 1.834 . . . . 0.0 112.285 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.4 p -119.61 141.29 49.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.696 -0.628 . . . . 0.0 109.571 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.63 -27.2 37.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.398 -0.813 . . . . 0.0 109.571 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' HA ' HD11 ' A' ' 54' ' ' ILE . 97.0 mt-10 -43.8 -38.97 3.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.23 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 p -79.82 -32.82 40.69 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.1 -1.0 . . . . 0.0 109.11 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' A' ' 50' ' ' ALA . 43.6 t -67.55 -52.22 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.438 -0.789 . . . . 0.0 109.942 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.618 ' O ' ' N ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -60.85 -30.89 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.044 -1.035 . . . . 0.0 108.795 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.29 -34.56 75.4 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.464 -0.772 . . . . 0.0 109.633 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.97 -18.04 56.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 0.0 110.306 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.597 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 82.5 m-85 -114.44 -10.29 12.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.361 -0.837 . . . . 0.0 109.962 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.618 ' N ' ' O ' ' A' ' 54' ' ' ILE . 2.8 tp-100 -50.74 -34.02 25.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.17 -0.956 . . . . 0.0 109.014 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.522 ' ND1' ' N ' ' A' ' 60' ' ' ALA . 29.0 p80 -54.67 -44.22 73.12 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.945 -1.097 . . . . 0.0 109.5 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.522 ' N ' ' ND1' ' A' ' 59' ' ' HIS . . . -64.2 -60.2 3.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 0.0 109.906 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -63.94 -22.2 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 109.961 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' GLN . 31.1 t0 -58.15 -65.25 0.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.53 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -51.61 -34.25 36.61 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.656 -1.278 . . . . 0.0 108.773 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.16 -55.18 17.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.086 -1.009 . . . . 0.0 109.672 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -67.37 -25.54 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.391 -0.818 . . . . 0.0 109.11 179.528 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.23 -41.89 72.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.963 -1.086 . . . . 0.0 109.495 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.49 -52.3 8.22 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.954 -1.091 . . . . 0.0 109.99 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.637 ' O ' ' C ' ' A' ' 69' ' ' GLY . 45.9 mttm -82.78 4.73 24.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.258 -0.901 . . . . 0.0 110.405 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.637 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . 8.07 80.33 0.01 OUTLIER Glycine 0 N--CA 1.503 3.126 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.832 ' CG ' HG21 ' A' ' 155' ' ' ILE . 30.5 m-85 -74.42 161.67 29.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.164 -1.198 . . . . 0.0 109.497 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.404 ' HG3' HD21 ' A' ' 158' ' ' ASN . 94.7 mm-40 -57.01 -46.27 82.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.428 -0.795 . . . . 0.0 109.716 -177.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 m -150.17 160.24 43.82 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.193 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.733 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 19.3 t-105 -125.77 128.14 47.25 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.483 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 2.5 t0 -136.85 157.63 46.31 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.935 -1.103 . . . . 0.0 108.479 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 76' ' ' ILE . 1.0 OUTLIER -97.86 174.13 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.64 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 35.2 mm -106.99 113.77 44.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.7 p -96.76 164.52 12.54 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 123.229 1.49 . . . . 0.0 111.817 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.016 HD22 ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -167.5 164.57 14.88 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.971 176.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 1.016 ' N ' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -137.45 140.42 41.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 174.611 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.65 -1.88 20.77 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.157 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -114.99 -14.13 11.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.205 -0.934 . . . . 0.0 109.384 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -66.16 123.68 85.89 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.445 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.66 -2.18 11.73 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.176 1.917 . . . . 0.0 111.212 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -87.01 -2.99 59.04 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.027 -1.046 . . . . 0.0 109.763 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.492 ' HB2' HD21 ' A' ' 82' ' ' ASN . 0.2 OUTLIER -54.52 -43.43 71.88 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.687 -1.258 . . . . 0.0 108.135 178.721 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.437 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 84.6 tt0 -60.73 -40.92 94.18 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.233 -0.917 . . . . 0.0 109.148 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.48 81.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.0 109.912 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 88' ' ' LEU . 4.5 mm? -61.59 -42.77 99.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.006 -1.059 . . . . 0.0 109.739 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.45 ' HG2' ' H ' ' A' ' 144' ' ' MET . 82.8 mtm180 -62.01 -27.54 68.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.844 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -65.63 -60.29 3.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.863 . . . . 0.0 109.862 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.427 ' HD3' HD13 ' A' ' 88' ' ' LEU . 12.8 ptmt -57.55 -36.76 72.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -0.913 . . . . 0.0 109.382 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -75.77 -24.26 56.01 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.54 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 94' ' ' ASN . 3.9 mt -74.46 -34.9 63.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 110.602 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 93' ' ' LEU . 16.5 m120 -45.8 127.13 7.77 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.906 -1.122 . . . . 0.0 109.156 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.472 ' HB3' HE22 ' A' ' 165' ' ' GLN . 3.2 tt0 -55.1 147.64 15.6 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -169.01 -172.55 1.58 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 117.612 -1.635 . . . . 0.0 112.628 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -165.03 135.28 3.79 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.645 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.19 157.04 18.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.942 . . . . 0.0 110.077 -179.052 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.485 ' H ' ' HA ' ' A' ' 162' ' ' TRP . . . -78.8 -6.82 88.5 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -122.93 169.78 10.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.454 -1.027 . . . . 0.0 109.3 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -74.94 142.82 43.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.136 -0.978 . . . . 0.0 110.013 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.634 ' CG ' HH22 ' A' ' 154' ' ' ARG . 17.0 tt0 -100.37 94.97 6.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.296 -0.878 . . . . 0.0 108.953 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.511 HG22 ' OG ' ' A' ' 133' ' ' SER . 47.5 t -88.19 128.59 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.501 -0.749 . . . . 0.0 109.173 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.402 ' NH1' ' HB1' ' A' ' 152' ' ' ALA . 5.9 tpt180 -129.39 122.55 29.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 52.2 t80 -109.37 127.06 54.06 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CG ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -87.34 125.68 34.39 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.432 0.634 . . . . 0.0 110.22 -178.494 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.95 -35.2 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.596 -0.69 . . . . 0.0 109.72 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -160.2 145.34 14.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.085 -1.009 . . . . 0.0 110.303 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.475 ' O ' ' OE2' ' A' ' 127' ' ' GLU . . . 97.11 162.85 32.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.21 163.82 28.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -1.154 . . . . 0.0 110.015 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.92 153.16 11.57 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.527 HD22 HD12 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -102.65 101.99 12.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.971 -1.311 . . . . 0.0 109.809 -179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -88.85 130.04 35.47 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.747 -1.22 . . . . 0.0 110.704 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.546 ' SG ' HG13 ' A' ' 121' ' ' VAL . 31.4 t -77.86 130.59 36.82 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.325 0.584 . . . . 0.0 109.714 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.417 HD11 HG13 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -115.82 124.57 51.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.431 ' CD2' ' HH2' ' A' ' 141' ' ' TRP . 2.2 t-80 -115.42 115.75 27.07 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.19 -0.944 . . . . 0.0 108.945 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.41 125.33 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.194 -0.941 . . . . 0.0 110.345 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.74 -143.94 41.04 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 104.167 -3.573 . . . . 0.0 104.167 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -109.28 81.43 1.44 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 122.212 3.006 . . . . 0.0 109.793 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -164.96 168.38 17.58 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.546 HG13 ' SG ' ' A' ' 114' ' ' CYS . 54.1 t -125.66 136.26 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.109 -0.994 . . . . 0.0 109.933 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -124.07 130.55 52.75 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.819 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 4' ' ' THR . 9.0 mt-30 -125.15 118.38 25.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.202 -0.936 . . . . 0.0 108.974 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.817 HG22 ' CD1' ' A' ' 3' ' ' LEU . 31.9 t -105.69 132.32 52.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 125' ' ' LEU . 7.5 tt -126.63 80.05 1.91 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.37 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 1' ' ' SER . 47.4 t -168.99 117.22 0.66 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 177.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.475 ' OE2' ' O ' ' A' ' 109' ' ' GLY . 10.5 tm-20 -113.5 105.7 13.67 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 116.086 -2.245 . . . . 0.0 112.34 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.547 ' C ' ' H ' ' A' ' 130' ' ' ASP . 12.2 mttm -109.31 177.08 4.86 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.16 -1.382 . . . . 0.0 108.68 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.518 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 54.5 m-80 -59.54 -2.0 0.29 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' A' ' 128' ' ' LYS . 31.2 p30 -72.39 154.37 40.94 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.943 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -120.52 155.71 33.06 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.99 0.9 . . . . 0.0 110.089 -179.171 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.943 ' N ' HD12 ' A' ' 131' ' ' LEU . 2.9 tp -122.37 128.33 75.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.511 ' OG ' HG22 ' A' ' 103' ' ' VAL . 4.9 t -109.04 134.39 51.73 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 108.985 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.417 HG13 HD11 ' A' ' 115' ' ' LEU . 2.3 t -103.63 133.86 20.05 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.01 151.41 73.36 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.893 1.729 . . . . 0.0 112.552 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.39 134.71 48.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.619 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 1.4 t-80 92.97 7.94 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 120.933 0.397 . . . . 0.0 110.262 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.87 125.91 33.3 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.89 -1.131 . . . . 0.0 109.228 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 166' ' ' PHE . 40.6 Cg_endo -64.02 131.55 31.16 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.636 1.557 . . . . 0.0 111.656 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.474 ' C ' ' CE3' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -169.71 160.56 8.83 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.096 -178.923 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.501 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -131.92 -146.6 0.29 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.295 -0.878 . . . . 0.0 109.414 -178.515 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.04 128.12 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.772 -1.205 . . . . 0.0 109.088 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.42 136.67 21.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.455 -0.778 . . . . 0.0 109.577 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.586 ' O ' ' C ' ' A' ' 145' ' ' GLY . 9.1 mmt -112.59 18.89 17.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.478 -0.764 . . . . 0.0 111.036 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 10.88 -94.38 0.01 OUTLIER Glycine 0 N--CA 1.506 3.339 0 CA-C-N 118.886 0.766 . . . . 0.0 112.349 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.488 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 18.5 p -85.38 120.89 27.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.351 -1.339 . . . . 0.0 109.02 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.743 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -113.4 118.17 44.06 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.873 -0.517 . . . . 0.0 109.783 178.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.6 Cg_endo -102.22 34.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.794 2.329 . . . . 0.0 110.742 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.681 ' HA ' HD11 ' A' ' 78' ' ' LEU . 13.4 t-20 82.66 64.61 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.446 0.641 . . . . 0.0 109.457 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.486 ' O ' HD12 ' A' ' 78' ' ' LEU . 24.8 p90 -99.85 153.24 19.3 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 122.212 1.006 . . . . 0.0 111.327 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.8 m -118.27 137.32 53.13 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.64 ' HB3' ' HB ' ' A' ' 76' ' ' ILE . . . -142.59 163.27 33.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.1 -1.0 . . . . 0.0 109.176 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.733 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 63.6 mt -119.17 136.96 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.219 -0.926 . . . . 0.0 109.874 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.634 HH22 ' CG ' ' A' ' 102' ' ' GLU . 2.6 ttt85 -140.11 167.75 21.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.901 -1.124 . . . . 0.0 110.472 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.832 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.1 mp -109.18 155.19 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.485 -0.759 . . . . 0.0 109.603 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.483 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 2.6 m-30 -106.97 125.42 50.98 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.975 0.893 . . . . 0.0 110.253 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 158' ' ' ASN . 1.1 t70 -131.07 162.03 30.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.439 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -93.85 161.83 28.91 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.105 -0.997 . . . . 0.0 108.464 -179.46 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 162' ' ' TRP . 41.4 Cg_endo -63.53 -55.97 0.61 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.009 1.806 . . . . 0.0 112.376 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 159' ' ' PRO . 48.9 tp10 -44.02 -19.22 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.072 -1.018 . . . . 0.0 108.309 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -90.0 -31.1 11.35 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.598 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -95.74 165.2 12.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.406 -1.055 . . . . 0.0 111.286 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.65 148.02 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.23 -74.87 0.29 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.932 -1.105 . . . . 0.0 110.644 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.472 HE22 ' HB3' ' A' ' 95' ' ' GLU . 14.3 mm100 -141.91 161.26 38.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.993 -1.067 . . . . 0.0 109.929 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.629 ' CD2' ' N ' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -101.95 -41.76 6.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.127 -0.983 . . . . 0.0 109.269 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 70.8 p -117.98 -30.42 5.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.346 -0.846 . . . . 0.0 108.887 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.06 -5.45 53.07 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 120.175 -1.012 . . . . 0.0 110.653 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -79.59 148.13 31.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.589 -1.536 . . . . 0.0 108.016 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -108.38 89.51 3.02 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 117.519 -1.672 . . . . 0.0 110.88 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.422 ' H ' HG22 ' A' ' 171' ' ' ILE . 1.3 tt -78.86 -23.57 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.489 -1.382 . . . . 0.0 109.737 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -56.74 -41.39 77.45 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 108.724 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.565 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 47.5 p -53.52 -3.38 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.348 -0.845 . . . . 0.0 109.973 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.83 -37.05 35.91 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.031 -1.043 . . . . 0.0 111.964 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.618 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.1 m-85 -111.9 25.18 0.08 OUTLIER Pre-proline 0 N--CA 1.517 2.895 0 O-C-N 120.449 -1.407 . . . . 0.0 113.077 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 38.0 Cg_endo -58.97 -24.0 71.04 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 123.902 3.068 . . . . 0.0 115.141 -172.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -89.05 126.25 35.35 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.487 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.734 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.8 OUTLIER -86.8 123.99 32.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.18 -0.95 . . . . 0.0 108.717 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.812 ' O ' HG23 ' A' ' 19' ' ' THR . 3.7 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.92 169.52 9.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.043 -1.036 . . . . 0.0 108.991 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.536 HD12 ' O ' ' A' ' 123' ' ' GLN . 5.5 tp -158.0 115.02 2.91 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.516 ' OG1' HD11 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -110.0 134.08 52.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.34 -0.85 . . . . 0.0 110.06 -178.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 121' ' ' VAL . 38.4 mt -129.74 132.12 66.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 96.6 m-85 -124.05 167.45 14.18 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -86.31 174.57 8.96 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.269 -0.895 . . . . 0.0 108.948 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.76 -31.32 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.898 -1.126 . . . . 0.0 109.492 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -73.03 -37.34 66.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.947 . . . . 0.0 110.303 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -136.52 124.71 14.96 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 109.519 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.427 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 56.3 Cg_endo -81.09 -35.53 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 122.068 1.845 . . . . 0.0 112.317 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.63 4.99 1.58 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.442 -0.787 . . . . 0.0 110.258 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -114.52 118.99 35.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.401 -0.812 . . . . 0.0 109.007 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.4 p -98.65 123.16 42.68 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.277 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 pp -91.0 -7.72 51.18 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.633 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.687 ' HB3' HD12 ' A' ' 5' ' ' ILE . 31.9 t90 -157.43 105.27 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.338 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -120.6 115.99 24.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.57 -0.706 . . . . 0.0 109.876 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.445 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -162.34 165.01 27.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.33 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 1' ' ' SER . 52.1 m -131.37 90.2 2.83 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.805 ' O ' HD12 ' A' ' 24' ' ' ILE . 84.0 m-20 -127.04 151.24 48.87 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.288 -0.882 . . . . 0.0 110.491 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.91 -45.02 13.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.037 -1.664 . . . . 0.0 108.279 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 23' ' ' GLU . 10.6 pt-20 -82.89 -46.12 13.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.704 . . . . 0.0 110.18 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.514 ' N ' ' CG ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -62.84 -23.69 67.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.52 -1.362 . . . . 0.0 108.705 -178.145 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.805 HD12 ' O ' ' A' ' 20' ' ' ASN . 4.6 mt -70.42 -58.68 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.522 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 6.6 pt20 -56.36 -44.17 79.88 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.303 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.551 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 74.5 mt-30 -57.73 -33.27 68.27 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.317 -0.865 . . . . 0.0 109.906 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.588 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 5.7 tt0 -70.34 -61.36 1.8 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.024 -1.048 . . . . 0.0 109.41 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -66.98 -55.36 14.8 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.776 -1.202 . . . . 0.0 109.794 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 18.1 t-20 -49.9 -31.95 13.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.886 -1.134 . . . . 0.0 109.333 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -63.59 -24.61 67.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.021 -1.049 . . . . 0.0 108.44 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.526 ' NZ ' ' OE1' ' A' ' 120' ' ' GLU . 30.0 mttt -92.48 14.12 17.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.54 24.44 26.01 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.714 -1.232 . . . . 0.0 110.089 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.599 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 39.6 t -96.36 146.3 7.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.386 -1.067 . . . . 0.0 109.704 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.448 ' HB3' ' H ' ' A' ' 133' ' ' SER . 18.2 ttt180 -85.83 155.85 20.81 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 120.927 -1.108 . . . . 0.0 109.136 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 25' ' ' GLN . 1.2 t80 -154.62 149.44 26.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.912 -1.117 . . . . 0.0 108.912 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 1.3 mt-10 -175.04 172.92 2.74 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.903 -1.123 . . . . 0.0 109.878 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -150.81 114.83 5.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 108.839 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -110.67 152.59 26.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.62 -0.675 . . . . 0.0 109.235 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -143.12 167.43 22.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 109.964 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.457 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . . . -93.52 158.66 15.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 108.86 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -102.97 -17.43 15.46 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.204 -0.935 . . . . 0.0 108.534 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -93.38 171.47 8.89 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.591 0.71 . . . . 0.0 109.185 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -94.34 116.88 29.33 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.556 -0.715 . . . . 0.0 109.501 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mt -91.17 163.68 14.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.429 -0.795 . . . . 0.0 109.137 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.62 -101.08 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.68 93.07 4.83 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.108 -1.23 . . . . 0.0 109.48 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.55 91.61 34.56 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -77.02 -26.94 7.32 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.412 2.074 . . . . 0.0 112.701 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.6 p -119.92 141.16 49.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 0.0 109.581 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.93 -20.85 41.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.405 -0.809 . . . . 0.0 109.475 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 50' ' ' ALA . 84.8 tt0 -44.83 -37.89 4.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.005 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.7 p -79.73 -31.95 41.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.275 -0.891 . . . . 0.0 109.42 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ALA . 79.7 t -67.74 -47.67 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 109.777 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 58' ' ' GLN . 9.9 mm -60.26 -37.26 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.957 . . . . 0.0 108.859 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.32 -29.87 70.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.418 -0.802 . . . . 0.0 109.45 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.23 -18.68 60.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 110.317 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.457 ' HE2' ' HB2' ' A' ' 40' ' ' ALA . 8.9 m-85 -118.42 -7.5 10.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.389 -0.82 . . . . 0.0 109.181 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.532 ' N ' ' O ' ' A' ' 54' ' ' ILE . 3.4 tp-100 -50.53 -39.4 48.83 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.313 -0.867 . . . . 0.0 108.774 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.541 ' ND1' ' N ' ' A' ' 60' ' ' ALA . 27.0 p80 -53.04 -42.99 66.27 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.853 -1.154 . . . . 0.0 109.24 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.541 ' N ' ' ND1' ' A' ' 59' ' ' HIS . . . -61.88 -58.69 6.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.075 -1.015 . . . . 0.0 109.464 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.711 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -64.24 -28.52 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.763 -1.211 . . . . 0.0 109.15 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 58' ' ' GLN . 27.0 t70 -55.29 -25.4 33.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.145 -0.972 . . . . 0.0 109.395 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HG2' ' N ' ' A' ' 64' ' ' LEU . 8.8 ptmt -83.71 -37.26 22.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.08 -1.012 . . . . 0.0 109.493 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.545 HD21 HG21 ' A' ' 103' ' ' VAL . 0.5 OUTLIER -68.86 -45.56 70.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.206 -0.934 . . . . 0.0 109.895 -179.415 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 69' ' ' GLY . 3.3 p -68.56 -32.64 56.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.431 -0.793 . . . . 0.0 109.479 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.1 67.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.209 -0.932 . . . . 0.0 109.538 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -79.44 -50.03 11.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.123 -0.985 . . . . 0.0 109.897 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.659 ' O ' ' C ' ' A' ' 69' ' ' GLY . 20.5 mmtt -85.83 14.12 6.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.464 -0.772 . . . . 0.0 110.14 -177.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.659 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -7.53 85.64 0.0 OUTLIER Glycine 0 N--CA 1.501 2.984 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.487 ' CG ' HG21 ' A' ' 155' ' ' ILE . 11.7 m-85 -75.96 166.84 22.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.463 -1.022 . . . . 0.0 108.977 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -57.53 -40.58 79.12 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.441 -0.787 . . . . 0.0 109.805 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.29 167.53 30.15 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.631 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.666 ' HE1' HG23 ' A' ' 153' ' ' ILE . 13.2 t-105 -134.24 137.64 44.48 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.269 -0.895 . . . . 0.0 109.126 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.69 179.02 8.9 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.061 -1.025 . . . . 0.0 108.343 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' A' ' 153' ' ' ILE . 3.8 m -124.17 149.38 28.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.422 -0.799 . . . . 0.0 109.438 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.4 mt -100.86 117.04 45.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 77' ' ' SER . 27.8 p -170.13 101.69 0.29 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.453 -0.78 . . . . 0.0 109.399 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -110.95 179.84 3.94 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.95 1.705 . . . . 0.0 107.864 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.648 ' H ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -89.71 144.75 25.72 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.688 -1.258 . . . . 0.0 109.062 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.66 2.21 0.11 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.749 -0.594 . . . . 0.0 109.593 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -85.63 -28.28 24.88 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.469 -1.292 . . . . 0.0 108.888 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.466 HD22 ' HB3' ' A' ' 85' ' ' LYS . 20.8 p-10 -64.51 123.84 84.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.905 -1.122 . . . . 0.0 109.45 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -79.19 -8.97 15.32 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.134 1.889 . . . . 0.0 112.349 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -90.21 3.13 54.42 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.96 -1.087 . . . . 0.0 109.596 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.547 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 44.6 pttt -60.96 -47.4 86.6 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.211 -0.93 . . . . 0.0 108.96 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.547 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 96.5 mt-10 -64.56 -42.88 95.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.64 76.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.029 -1.044 . . . . 0.0 109.432 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.53 -50.17 72.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 0.0 110.129 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.585 HH12 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -65.06 -24.66 67.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.229 -0.92 . . . . 0.0 109.701 -179.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.585 ' CD ' HH12 ' A' ' 89' ' ' ARG . 58.0 mm-40 -65.41 -60.03 3.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.37 -0.831 . . . . 0.0 109.6 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -53.32 -27.81 25.23 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.072 -1.018 . . . . 0.0 109.038 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -18.4 33.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.017 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.9 -36.72 70.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.199 -0.938 . . . . 0.0 109.848 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -46.64 137.18 7.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.057 . . . . 0.0 109.337 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -70.93 164.6 25.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 0.0 109.555 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -175.9 -167.26 0.22 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.442 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.8 t -163.88 134.31 4.31 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.619 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -103.73 154.86 19.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 0.0 109.786 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.42 -6.58 86.66 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -123.97 170.06 11.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.443 -1.033 . . . . 0.0 109.38 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -73.84 143.19 46.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.217 -0.927 . . . . 0.0 109.778 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.559 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 4.6 tt0 -104.47 94.45 5.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.214 -0.929 . . . . 0.0 109.053 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.545 HG21 HD21 ' A' ' 64' ' ' LEU . 38.3 t -81.65 131.11 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.199 -0.938 . . . . 0.0 110.161 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.99 109.64 11.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.451 -0.78 . . . . 0.0 109.854 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.624 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 14.7 t80 -104.8 131.52 52.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.335 -0.853 . . . . 0.0 109.071 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.567 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -90.06 132.27 35.49 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.408 0.623 . . . . 0.0 109.861 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.408 ' HB ' HG22 ' A' ' 151' ' ' THR . 9.4 t -113.48 -31.01 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.743 -0.598 . . . . 0.0 109.784 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -167.65 156.02 9.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.1 -1.0 . . . . 0.0 109.358 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.29 155.76 8.42 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.62 ' HB2' ' CD ' ' A' ' 127' ' ' GLU . . . -114.69 148.75 37.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -1.072 . . . . 0.0 109.365 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.23 -136.69 3.47 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 26.5 tp -138.24 154.08 49.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.397 -1.06 . . . . 0.0 109.493 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -122.23 145.43 48.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.582 -0.699 . . . . 0.0 109.39 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.67 108.71 4.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.578 -0.701 . . . . 0.0 109.713 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.611 HD21 HG13 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -118.92 112.87 20.18 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.555 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.1 t-160 -105.25 113.22 26.68 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.204 -0.935 . . . . 0.0 109.601 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -131.68 119.24 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.25 -0.906 . . . . 0.0 110.203 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.37 -143.16 33.83 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 105.998 -2.841 . . . . 0.0 105.998 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 7.0 p-10 -105.36 79.26 1.45 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 115.185 -2.606 . . . . 0.0 109.61 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.555 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 78.8 tt0 -165.19 166.19 19.13 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.765 ' O ' HG23 ' A' ' 5' ' ' ILE . 45.7 t -129.91 152.19 36.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.038 -1.038 . . . . 0.0 109.683 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.28 131.32 46.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.63 -0.669 . . . . 0.0 109.286 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.536 ' O ' HD12 ' A' ' 3' ' ' LEU . 16.7 mt-30 -128.24 115.04 17.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 109.11 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.3 t -108.22 138.08 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -134.56 90.3 2.64 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.213 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 31.2 p -166.35 135.35 3.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.388 -1.445 . . . . 0.0 107.546 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.62 ' CD ' ' HB2' ' A' ' 110' ' ' ALA . 1.3 pt-20 -107.05 94.91 5.35 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 116.195 -2.202 . . . . 0.0 110.642 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 130' ' ' ASP . 29.8 mtmm -114.55 157.69 22.67 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.655 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.624 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 14.6 m-20 -58.68 -4.0 0.38 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.421 -1.424 . . . . 0.0 108.096 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 128' ' ' LYS . 56.2 p30 -72.23 152.72 42.01 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.39 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.747 ' C ' HD12 ' A' ' 131' ' ' LEU . 2.3 pp -126.27 162.03 26.4 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.051 0.929 . . . . 0.0 110.944 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 131' ' ' LEU . 9.7 mt -129.95 130.8 66.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.448 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 5.6 t -106.81 136.92 45.81 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.477 -0.765 . . . . 0.0 109.011 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.611 HG13 HD21 ' A' ' 115' ' ' LEU . 2.3 t -101.98 133.63 20.58 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.743 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.09 151.33 81.81 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.835 1.69 . . . . 0.0 112.484 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.612 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.23 135.05 48.64 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.612 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.0 t-80 91.94 10.4 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.39 125.84 33.08 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.087 -1.008 . . . . 0.0 108.785 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.1 130.57 27.7 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.573 1.516 . . . . 0.0 111.573 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -166.94 165.42 15.97 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.229 -178.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.567 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -136.14 -149.76 0.34 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 109.646 -178.639 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.08 125.0 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 109.167 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.488 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 16.3 p-10 -141.6 132.12 25.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.627 ' O ' ' C ' ' A' ' 145' ' ' GLY . 49.7 mtt -112.73 17.77 18.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.597 -0.69 . . . . 0.0 110.692 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.67 ' N ' HD13 ' A' ' 178' ' ' LEU . . . 8.97 -90.08 0.0 OUTLIER Glycine 0 N--CA 1.502 3.098 0 CA-C-N 119.206 0.912 . . . . 0.0 111.685 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.517 ' H ' ' HB2' ' A' ' 178' ' ' LEU . 70.9 m -86.56 116.13 24.48 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 117.763 -1.575 . . . . 0.0 109.127 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.16 113.44 37.33 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.985 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.558 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.7 Cg_endo -103.36 40.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 122.935 2.423 . . . . 0.0 111.684 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 13.5 t-20 81.75 72.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.998 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 5.5 p90 -94.53 138.23 32.68 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.215 -0.928 . . . . 0.0 110.476 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.408 HG22 ' HB ' ' A' ' 107' ' ' VAL . 15.9 m -103.57 118.73 37.4 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.723 -0.61 . . . . 0.0 109.625 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.8 163.34 33.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.454 -0.779 . . . . 0.0 109.283 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.741 ' HA ' HG12 ' A' ' 75' ' ' VAL . 61.4 mt -109.35 127.04 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.272 -0.893 . . . . 0.0 110.062 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.515 ' C ' HD13 ' A' ' 155' ' ' ILE . 9.0 tpt180 -129.9 157.28 42.7 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.55 0.69 . . . . 0.0 109.514 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.598 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -102.89 149.26 7.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -96.22 120.86 37.27 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 0.0 110.319 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -133.71 162.99 30.46 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -94.52 161.98 27.32 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.143 -0.973 . . . . 0.0 109.23 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.633 ' O ' ' N ' ' A' ' 161' ' ' GLY . 40.1 Cg_endo -65.21 -57.37 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.014 1.809 . . . . 0.0 111.54 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 159' ' ' PRO . 50.6 mt-10 -43.98 -13.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.793 . . . . 0.0 109.126 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -76.77 -33.05 47.94 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 177.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.52 ' N ' ' O ' ' A' ' 159' ' ' PRO . 4.3 p90 -118.3 159.12 23.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.274 -1.133 . . . . 0.0 110.279 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 26.6 mm -100.99 147.3 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.428 -0.795 . . . . 0.0 109.392 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.654 ' HB1' ' OE1' ' A' ' 165' ' ' GLN . . . -57.36 -72.67 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.654 ' OE1' ' HB1' ' A' ' 164' ' ' ALA . 1.9 mp0 -141.4 165.29 27.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.14 -0.975 . . . . 0.0 109.646 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -100.03 -41.45 7.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.467 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 59.4 m -105.3 -30.54 9.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.166 -0.958 . . . . 0.0 109.128 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.57 -6.35 52.45 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -81.88 149.33 28.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.78 -1.424 . . . . 0.0 108.522 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 44.2 p30 -107.82 87.54 2.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.116 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.1 tt -78.31 -26.92 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.59 -1.319 . . . . 0.0 109.313 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.567 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -58.22 -42.6 86.63 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.608 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 28.6 p -54.54 -2.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 109.924 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.03 -39.8 33.03 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.097 -1.002 . . . . 0.0 111.473 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.629 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.3 m-85 -111.38 23.92 0.08 OUTLIER Pre-proline 0 N--CA 1.512 2.64 0 O-C-N 120.603 -1.31 . . . . 0.0 113.039 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 49.9 Cg_endo -65.07 -20.1 63.51 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 123.466 2.777 . . . . 0.0 113.581 -173.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -89.31 126.71 35.63 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.217 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.67 HD13 ' N ' ' A' ' 145' ' ' GLY . 7.9 mp -86.08 147.75 26.03 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.837 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.587 ' O ' ' OG1' ' A' ' 19' ' ' THR . 89.6 p . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.39 173.39 7.22 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.102 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.904 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 18.0 tp -160.06 114.43 2.26 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.51 131.54 55.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.022 -1.049 . . . . 0.0 110.227 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.728 HD13 ' CE2' ' A' ' 122' ' ' PHE . 60.5 mt -126.76 133.64 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 11' ' ' PRO . 98.4 m-85 -128.37 165.5 20.47 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.46 0.648 . . . . 0.0 109.72 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.475 ' OG ' HD13 ' A' ' 15' ' ' LEU . 64.2 m -89.66 176.29 6.92 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.78 -25.82 5.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 120.732 -1.23 . . . . 0.0 109.428 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -72.56 -40.72 66.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.969 -1.082 . . . . 0.0 110.16 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -137.44 124.57 13.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.018 . . . . 0.0 109.324 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 56.4 Cg_endo -81.86 -29.92 1.54 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.876 1.717 . . . . 0.0 112.35 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -68.37 -27.36 66.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.505 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -94.56 120.87 35.47 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.798 -1.189 . . . . 0.0 108.985 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 p -95.31 132.86 39.86 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.391 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 15' ' ' LEU . 11.1 mp -89.34 -10.27 47.31 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.991 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.904 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 37.6 t90 -158.45 105.99 1.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.291 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -120.01 116.39 25.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 0.0 109.759 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.73 166.86 25.99 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.476 -0.765 . . . . 0.0 109.776 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.831 HG23 ' O ' ' A' ' 19' ' ' THR . 9.0 t -130.33 88.19 2.61 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.717 ' O ' HD12 ' A' ' 24' ' ' ILE . 15.0 m-20 -126.04 139.23 53.58 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.52 -35.58 27.18 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.095 -1.628 . . . . 0.0 108.919 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.534 ' CG ' ' N ' ' A' ' 23' ' ' GLU . 19.8 pt-20 -82.49 -49.92 9.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.12 -0.988 . . . . 0.0 108.981 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.534 ' N ' ' CG ' ' A' ' 22' ' ' GLU . 1.6 tm-20 -63.11 -18.97 64.0 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.893 -1.13 . . . . 0.0 108.57 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 20' ' ' ASN . 1.8 mt -71.32 -56.77 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.246 -0.909 . . . . 0.0 109.504 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.56 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 7.2 pt20 -53.25 -47.6 68.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 109.654 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.56 ' N ' ' CG ' ' A' ' 25' ' ' GLN . 49.3 tt0 -63.1 -26.77 68.98 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.444 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -69.74 -66.05 0.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.137 0.97 . . . . 0.0 110.871 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.552 HD12 ' H ' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -71.35 -46.79 59.64 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.682 -1.261 . . . . 0.0 109.636 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.601 HD22 ' C ' ' A' ' 33' ' ' VAL . 10.8 m120 -54.8 -27.43 41.65 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.602 -1.311 . . . . 0.0 109.062 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -63.0 -25.75 68.54 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.7 ' HG3' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -92.6 8.67 37.99 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.367 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.06 25.47 11.26 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.742 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' HG3' ' A' ' 31' ' ' LYS . 69.5 t -94.08 145.46 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.633 -1.51 . . . . 0.0 109.084 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.608 HH12 ' NZ ' ' A' ' 68' ' ' LYS . 23.9 ttm180 -84.32 156.1 22.07 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.832 ' CE2' HD11 ' A' ' 132' ' ' ILE . 0.3 OUTLIER -153.43 147.09 25.12 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.166 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.1 tp10 -174.24 171.42 3.49 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.79 -1.194 . . . . 0.0 109.381 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -148.06 112.3 5.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.036 -1.04 . . . . 0.0 108.368 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.508 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 22.7 m0 -111.19 155.28 23.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.432 -0.793 . . . . 0.0 108.988 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.32 161.64 37.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.928 . . . . 0.0 109.969 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.86 158.14 16.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 108.931 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -102.64 -14.76 16.59 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.63 163.63 13.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.605 0.717 . . . . 0.0 109.155 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.504 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 46.3 p-10 -96.74 120.68 37.51 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.459 -0.775 . . . . 0.0 109.735 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.06 164.69 13.86 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.282 -0.886 . . . . 0.0 109.07 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.4 -105.8 0.22 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.73 90.97 5.24 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.052 -1.263 . . . . 0.0 109.104 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.44 92.17 42.9 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.93 -20.83 19.16 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.151 1.901 . . . . 0.0 112.501 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.8 p -124.27 141.67 51.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.563 -0.71 . . . . 0.0 109.622 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' GLU . . . -80.23 -20.58 44.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.538 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' ALA . 84.6 tt0 -43.12 -37.83 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.063 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.2 p -79.36 -36.35 39.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.149 -0.969 . . . . 0.0 109.144 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 50' ' ' ALA . 60.1 t -67.33 -46.34 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -0.846 . . . . 0.0 109.747 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.588 HG22 ' HG2' ' A' ' 58' ' ' GLN . 7.8 mm -60.92 -34.24 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 108.889 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.63 -29.27 70.49 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.449 -0.782 . . . . 0.0 109.627 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.56 -21.89 48.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.988 . . . . 0.0 110.136 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -110.56 -10.31 14.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.48 -0.762 . . . . 0.0 109.769 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.588 ' HG2' HG22 ' A' ' 54' ' ' ILE . 3.9 mm100 -47.59 -36.75 11.19 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.054 -1.029 . . . . 0.0 109.128 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.677 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 5.4 p80 -53.22 -48.01 68.5 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.979 -1.088 . . . . 0.0 109.57 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.677 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.15 -58.1 9.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.941 -1.099 . . . . 0.0 110.054 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.61 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -65.19 -26.25 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.924 -1.11 . . . . 0.0 109.462 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 58' ' ' GLN . 21.0 t70 -58.57 -25.19 62.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 109.32 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -83.99 -44.23 14.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.416 -0.803 . . . . 0.0 109.859 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.64 -46.46 79.12 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.422 -0.799 . . . . 0.0 109.761 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' GLY . 5.9 p -66.63 -29.61 47.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.85 -44.53 74.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.907 -1.121 . . . . 0.0 109.425 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -80.39 -51.46 8.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.934 -1.104 . . . . 0.0 110.182 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.608 ' NZ ' HH12 ' A' ' 34' ' ' ARG . 33.1 mttt -85.01 13.62 5.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 110.732 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.599 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -5.22 84.16 0.0 OUTLIER Glycine 0 N--CA 1.5 2.932 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.434 ' CG ' HG21 ' A' ' 155' ' ' ILE . 32.4 m-85 -77.5 165.08 24.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.663 -0.904 . . . . 0.0 108.703 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -57.21 -89.55 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.164 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.605 ' OG ' ' CG ' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -102.38 163.06 12.44 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.668 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.409 ' CE3' HG23 ' A' ' 155' ' ' ILE . 5.7 t-105 -136.98 141.23 42.58 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.46 -0.775 . . . . 0.0 109.187 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -174.7 -167.42 0.3 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 153' ' ' ILE . 4.7 m -124.21 168.21 17.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.492 -0.755 . . . . 0.0 109.488 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.664 HD11 ' HD2' ' A' ' 154' ' ' ARG . 75.9 mt -94.49 132.95 37.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.5 p -93.0 166.79 12.19 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.857 1.313 . . . . 0.0 112.135 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.559 HD12 ' CZ ' ' A' ' 150' ' ' PHE . 1.0 OUTLIER -169.13 160.49 9.8 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.209 176.295 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.433 ' HG3' ' H ' ' A' ' 81' ' ' ASP . 1.3 tpt180 -132.4 141.52 48.91 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 174.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.47 -0.72 6.95 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.837 -1.164 . . . . 0.0 109.684 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.433 ' H ' ' HG3' ' A' ' 79' ' ' ARG . 91.2 m-20 -118.47 -12.44 9.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.086 -1.009 . . . . 0.0 109.196 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -62.72 123.9 81.17 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.938 . . . . 0.0 110.453 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.04 -1.6 11.5 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.758 2.306 . . . . 0.0 112.542 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.481 ' H ' ' ND2' ' A' ' 82' ' ' ASN . 72.9 mt-30 -83.25 16.19 2.58 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.76 -1.212 . . . . 0.0 109.161 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.456 ' HG2' ' H ' ' A' ' 85' ' ' LYS . 6.2 pttt -61.36 -59.88 4.59 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.5 -0.75 . . . . 0.0 109.507 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.405 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 20.1 pt-20 -64.56 -31.74 73.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.312 -0.868 . . . . 0.0 109.666 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.89 -59.27 5.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 110.077 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 72.4 mt -61.95 -42.81 99.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 110.185 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.451 ' HE ' ' C ' ' A' ' 85' ' ' LYS . 49.6 mtm180 -59.52 -28.98 67.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.886 . . . . 0.0 110.079 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.96 -59.58 4.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 0.0 109.497 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -51.22 -34.34 31.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.376 -0.827 . . . . 0.0 109.404 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -88.14 -17.74 30.31 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.043 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.711 HD21 ' OG ' ' A' ' 173' ' ' SER . 8.6 tp -55.79 -34.39 65.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 109.822 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -63.28 135.29 56.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.121 -0.987 . . . . 0.0 110.22 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -70.71 164.45 25.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.527 -0.733 . . . . 0.0 109.418 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -174.92 -165.6 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.82 -1.175 . . . . 0.0 111.272 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 163' ' ' ILE . 9.5 t -164.56 135.33 4.16 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.607 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -105.93 154.58 20.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.466 -0.771 . . . . 0.0 110.207 -178.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.39 -6.35 86.42 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.441 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 95.5 mt-10 -124.24 169.93 11.27 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.487 -1.008 . . . . 0.0 109.61 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -74.91 143.62 43.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 0.0 109.827 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.484 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 6.7 tt0 -107.54 93.25 4.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.261 -0.899 . . . . 0.0 108.592 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 103' ' ' VAL . 10.5 p -94.67 131.98 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.738 -1.226 . . . . 0.0 111.025 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.74 ' HE ' HH21 ' A' ' 154' ' ' ARG . 78.0 mtt180 -130.2 126.93 38.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.735 -0.603 . . . . 0.0 109.402 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.605 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 13.3 t80 -109.05 132.0 54.53 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.533 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -85.21 126.25 33.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.941 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.4 ' O ' ' CG ' ' A' ' 108' ' ' GLU . 5.0 t -107.15 -41.18 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.369 -0.832 . . . . 0.0 110.692 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 91.1 mt-10 -154.8 141.07 18.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.883 -1.136 . . . . 0.0 109.815 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.97 159.89 36.07 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.503 ' HB2' ' HG3' ' A' ' 127' ' ' GLU . . . -113.92 151.03 32.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -1.223 . . . . 0.0 109.737 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.57 -126.83 1.95 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.9 tp -147.95 163.22 37.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -1.015 . . . . 0.0 109.074 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -134.8 90.81 2.69 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.046 -1.034 . . . . 0.0 109.098 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.589 ' SG ' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -78.13 146.25 35.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.982 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mt -148.53 101.53 3.23 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -102.13 113.4 26.63 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.825 -1.172 . . . . 0.0 109.562 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.746 HD12 ' N ' ' A' ' 118' ' ' GLY . 0.1 OUTLIER -134.97 124.79 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.095 -1.003 . . . . 0.0 110.506 -178.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.746 ' N ' HD12 ' A' ' 117' ' ' ILE . . . 70.22 -142.67 36.24 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 105.636 -2.986 . . . . 0.0 105.636 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.32 79.11 1.18 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 115.157 -2.617 . . . . 0.0 108.303 176.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -165.07 166.62 19.05 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.682 ' O ' HG23 ' A' ' 5' ' ' ILE . 51.0 t -125.99 140.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.087 -1.008 . . . . 0.0 110.404 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.728 ' CE2' HD13 ' A' ' 5' ' ' ILE . 16.0 m-85 -123.83 131.02 53.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.442 0.639 . . . . 0.0 109.791 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -141.94 118.62 11.05 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.169 -0.957 . . . . 0.0 109.785 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -101.79 147.23 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.612 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tp -127.58 81.62 2.03 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.46 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.447 ' SG ' ' CB ' ' A' ' 1' ' ' SER . 35.9 t -166.56 122.65 1.22 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.703 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -109.3 105.82 15.38 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 116.705 -1.998 . . . . 0.0 112.338 -178.648 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.56 ' C ' ' H ' ' A' ' 130' ' ' ASP . 42.1 mmtt -113.77 171.04 7.82 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.02 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.605 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 68.1 m-20 -58.76 -3.03 0.27 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.832 -1.168 . . . . 0.0 107.895 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 128' ' ' LYS . 40.2 p30 -73.43 153.99 40.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.793 0.806 . . . . 0.0 109.888 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.79 ' C ' HD12 ' A' ' 131' ' ' LEU . 2.3 pp -122.89 161.31 24.37 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.073 0.939 . . . . 0.0 110.366 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.832 HD11 ' CE2' ' A' ' 35' ' ' PHE . 1.3 mp -131.54 127.83 60.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.664 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.9 t -123.71 135.93 54.15 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.75 148.63 36.1 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.278 -0.889 . . . . 0.0 108.799 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.22 157.95 57.87 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.554 2.169 . . . . 0.0 113.052 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.621 ' O ' ' CD2' ' A' ' 137' ' ' HIS . . . -73.38 135.62 44.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.237 -0.914 . . . . 0.0 108.997 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.703 ' O ' ' ND1' ' A' ' 137' ' ' HIS . 0.1 OUTLIER 95.43 3.92 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.352 0.596 . . . . 0.0 109.732 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.78 125.47 42.19 Favored Pre-proline 0 N--CA 1.487 1.42 0 O-C-N 120.84 -1.162 . . . . 0.0 108.816 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.14 132.9 33.38 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.433 1.422 . . . . 0.0 111.6 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.512 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.42 164.28 15.05 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.189 -0.944 . . . . 0.0 110.161 -178.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.589 ' CD1' ' SG ' ' A' ' 114' ' ' CYS . 14.6 p90 -130.06 -153.78 0.59 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.469 -0.77 . . . . 0.0 109.752 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.616 ' CD1' ' NH1' ' A' ' 104' ' ' ARG . 2.8 t80 -170.78 125.01 0.68 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.303 -0.873 . . . . 0.0 108.999 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.501 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 49.0 p-10 -148.19 130.97 16.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.944 -1.097 . . . . 0.0 109.374 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.615 ' O ' ' C ' ' A' ' 145' ' ' GLY . 8.6 mmt -107.18 18.91 21.1 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 111.334 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 11.56 -99.39 0.01 OUTLIER Glycine 0 N--CA 1.501 3.008 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.507 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 31.6 t -84.16 120.56 26.33 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.897 -1.354 . . . . 0.0 109.351 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 147' ' ' GLU . 1.0 OUTLIER -115.51 117.6 40.32 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 57.2 Cg_endo -100.03 31.2 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.258 1.972 . . . . 0.0 112.209 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 13.3 t-20 81.79 63.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.688 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.559 ' CZ ' HD12 ' A' ' 78' ' ' LEU . 15.0 p90 -101.41 169.85 8.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.519 -0.738 . . . . 0.0 109.222 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 53.3 m -130.28 106.53 8.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.57 -0.706 . . . . 0.0 109.489 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' A' ' 75' ' ' VAL . . . -105.91 161.94 14.01 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.987 -1.07 . . . . 0.0 109.827 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.648 ' HA ' HG12 ' A' ' 75' ' ' VAL . 23.5 mt -105.45 123.26 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.869 -1.145 . . . . 0.0 110.291 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.74 HH21 ' HE ' ' A' ' 104' ' ' ARG . 1.9 mtt-85 -130.62 159.85 35.97 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.624 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.98 155.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.605 ' CG ' ' OG ' ' A' ' 72' ' ' SER . 5.8 m-85 -96.19 121.87 38.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 110.224 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 49.2 p30 -132.04 163.28 28.78 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -92.79 161.86 30.65 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.979 -1.076 . . . . 0.0 108.865 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.598 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.0 Cg_endo -62.52 -60.4 0.19 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.747 1.631 . . . . 0.0 112.288 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.7 tt0 -45.92 -13.53 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -72.7 -43.87 41.43 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.563 ' CE3' ' O ' ' A' ' 163' ' ' ILE . 9.9 p-90 -110.13 161.02 15.96 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.518 -0.989 . . . . 0.0 110.348 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.563 ' O ' ' CE3' ' A' ' 162' ' ' TRP . 4.0 tp -99.92 154.44 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.249 -0.907 . . . . 0.0 109.194 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.78 -75.54 0.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.97 . . . . 0.0 110.435 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -142.3 164.61 29.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.103 -0.998 . . . . 0.0 110.156 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -101.21 -40.18 7.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.89 . . . . 0.0 109.326 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 22.0 m -114.68 -32.36 5.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.937 . . . . 0.0 108.568 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.61 -1.34 58.38 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.505 ' OD2' ' O ' ' A' ' 169' ' ' ASP . 39.1 p30 -80.29 145.82 31.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.3 -1.706 . . . . 0.0 108.726 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -113.21 89.7 3.15 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.113 -1.435 . . . . 0.0 110.263 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.455 HD11 ' HZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -78.71 -17.89 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.241 -1.537 . . . . 0.0 108.854 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -58.67 -41.59 86.51 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.362 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.711 ' OG ' HD21 ' A' ' 93' ' ' LEU . 1.2 m -52.46 -3.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.538 -0.726 . . . . 0.0 109.873 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.71 -39.57 26.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.909 -1.119 . . . . 0.0 111.371 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.639 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -114.57 25.58 0.09 OUTLIER Pre-proline 0 N--CA 1.516 2.842 0 O-C-N 120.668 -1.27 . . . . 0.0 112.089 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 39.1 Cg_endo -59.25 -18.18 43.44 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.333 2.689 . . . . 0.0 114.177 -171.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -89.44 125.57 35.22 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.619 -1.233 . . . . 0.0 108.107 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.507 ' HB3' ' H ' ' A' ' 146' ' ' SER . 3.9 tt -86.68 125.45 33.87 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.092 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.299 -1.593 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.623 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.776 ' O ' HG23 ' A' ' 19' ' ' THR . 2.8 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.49 169.32 9.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.066 . . . . 0.0 109.074 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.85 HD13 HG22 ' A' ' 124' ' ' VAL . 16.3 tp -157.65 114.99 3.01 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.7 OUTLIER -109.02 138.59 45.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.216 -0.928 . . . . 0.0 110.119 -179.16 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.708 HD12 ' HB3' ' A' ' 16' ' ' TRP . 52.9 mt -132.87 131.45 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -125.6 164.29 20.88 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m -85.91 175.0 8.87 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.144 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -26.87 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.023 -1.048 . . . . 0.0 109.677 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -74.11 -38.43 63.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.05 -1.031 . . . . 0.0 110.181 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.33 125.91 14.77 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 109.679 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 13' ' ' ASN . 56.1 Cg_endo -80.42 -36.9 0.43 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 121.974 1.783 . . . . 0.0 112.202 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 7.86 0.77 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.768 . . . . 0.0 110.113 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 11' ' ' PRO . 80.6 m-20 -116.96 119.77 36.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.196 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.419 ' C ' HD22 ' A' ' 15' ' ' LEU . 6.1 p -98.96 123.65 43.39 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.65 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.9 mm? -89.93 -9.84 47.36 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.585 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.708 ' HB3' HD12 ' A' ' 5' ' ' ILE . 33.1 t90 -157.48 106.87 2.15 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.629 -1.228 . . . . 0.0 110.133 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -121.87 119.92 33.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.512 -0.742 . . . . 0.0 109.729 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.409 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -162.85 164.56 25.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.218 -0.926 . . . . 0.0 110.132 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 1' ' ' SER . 76.1 m -130.14 89.11 2.75 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.017 -1.052 . . . . 0.0 108.188 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.754 ' O ' HD12 ' A' ' 24' ' ' ILE . 83.4 m-20 -127.73 144.26 51.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.458 -0.776 . . . . 0.0 110.422 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.73 -38.74 21.0 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.235 -1.541 . . . . 0.0 108.312 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -82.9 -48.36 10.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.516 -0.74 . . . . 0.0 109.749 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.627 ' OE1' ' ND2' ' A' ' 20' ' ' ASN . 1.2 tt0 -62.83 -19.56 64.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.722 -1.236 . . . . 0.0 108.608 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.754 HD12 ' O ' ' A' ' 20' ' ' ASN . 4.0 mt -74.47 -56.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.871 . . . . 0.0 109.326 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.445 ' HB2' ' CG ' ' A' ' 35' ' ' PHE . 3.0 pp0? -55.41 -34.9 64.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.309 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.54 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 49.8 tt0 -68.09 -47.5 68.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.276 -0.89 . . . . 0.0 109.447 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.55 ' OE1' ' CD1' ' A' ' 5' ' ' ILE . 7.6 tt0 -68.16 -40.46 82.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.167 -0.958 . . . . 0.0 109.082 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.568 HD12 HG11 ' A' ' 33' ' ' VAL . 3.5 mm? -68.18 -62.42 1.41 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.172 -0.955 . . . . 0.0 109.286 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 15.1 t-20 -58.13 -17.98 22.21 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.298 -0.876 . . . . 0.0 109.907 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -67.1 -32.52 73.73 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.847 -1.158 . . . . 0.0 109.387 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -90.51 9.34 29.72 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.98 24.56 16.82 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.283 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.568 HG11 HD12 ' A' ' 28' ' ' LEU . 33.7 t -96.96 147.82 6.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.279 -1.13 . . . . 0.0 109.554 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' HB3' ' H ' ' A' ' 133' ' ' SER . 19.5 ttt180 -84.02 154.01 23.51 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 120.511 -1.368 . . . . 0.0 108.368 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.538 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 1.1 t80 -154.39 149.97 27.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.023 -1.048 . . . . 0.0 108.276 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 2.9 mt-10 -177.24 177.08 1.26 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.045 -1.034 . . . . 0.0 109.481 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -148.61 112.44 5.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.705 ' CH2' HD23 ' A' ' 131' ' ' LEU . 31.4 m0 -111.02 157.4 19.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.271 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -142.72 156.24 44.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 0.0 109.927 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.35 152.75 20.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.205 -0.934 . . . . 0.0 108.997 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -104.03 -6.39 21.22 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -93.34 159.15 15.39 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.781 0.801 . . . . 0.0 109.093 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -94.51 115.31 27.45 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.66 -0.65 . . . . 0.0 109.537 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.7 mt -94.86 164.96 12.7 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.43 -0.794 . . . . 0.0 109.505 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.29 -103.76 0.2 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.6 92.97 4.76 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.989 -1.301 . . . . 0.0 109.187 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.16 92.12 44.88 Favored Pre-proline 0 C--N 1.306 -1.293 0 C-N-CA 119.8 -0.76 . . . . 0.0 108.965 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.54 -21.91 14.41 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.297 1.998 . . . . 0.0 112.763 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 p -122.93 142.12 51.16 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.584 -0.698 . . . . 0.0 109.705 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.34 -16.91 53.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.43 -0.794 . . . . 0.0 109.419 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -46.92 -39.03 11.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.344 -0.847 . . . . 0.0 108.725 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.3 m -79.2 -39.68 32.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.617 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.71 -46.53 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.291 -0.881 . . . . 0.0 109.669 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 58' ' ' GLN . 15.6 mt -60.48 -36.02 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.073 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.06 -28.65 69.75 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.411 -0.806 . . . . 0.0 109.407 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.76 -20.29 50.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.038 -1.039 . . . . 0.0 110.331 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 58' ' ' GLN . 61.7 m-85 -112.02 -12.27 13.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.298 -0.876 . . . . 0.0 109.552 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 62' ' ' ASP . 3.8 tp-100 -45.52 -35.9 4.19 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.567 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.6 -47.64 63.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 109.546 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.567 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.34 -60.08 4.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 109.755 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.677 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -63.17 -29.51 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 120.608 -1.308 . . . . 0.0 109.127 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 58' ' ' GLN . 21.3 t70 -55.9 -26.41 47.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.706 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -78.28 -36.1 47.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.985 -1.072 . . . . 0.0 109.543 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 64' ' ' LEU . 8.4 mp -63.19 -40.79 98.53 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.545 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -70.13 -29.01 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.173 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.53 -56.66 12.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.431 -1.418 . . . . 0.0 109.191 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -83.53 -48.81 9.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.035 -1.04 . . . . 0.0 110.608 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.627 ' O ' ' C ' ' A' ' 69' ' ' GLY . 7.5 mtpm? -87.79 14.7 8.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.878 . . . . 0.0 110.788 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.627 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -11.68 89.33 0.0 OUTLIER Glycine 0 N--CA 1.501 3.028 0 CA-C-O 121.959 0.755 . . . . 0.0 111.227 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.472 ' CG ' HG21 ' A' ' 155' ' ' ILE . 84.3 m-85 -76.86 164.42 25.83 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.589 ' C ' ' NE2' ' A' ' 71' ' ' GLN . 0.2 OUTLIER -63.2 -87.48 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.43 -0.794 . . . . 0.0 109.78 -178.808 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.401 ' OG ' ' OE1' ' A' ' 71' ' ' GLN . 14.7 m -102.74 160.24 14.76 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 109.595 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 74' ' ' ASP . 7.6 t-105 -140.79 145.75 36.74 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.454 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.2 OUTLIER -165.36 -176.6 4.1 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 152' ' ' ALA . 9.9 p -119.8 142.73 33.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 76' ' ' ILE . 2.5 tp -101.33 115.71 43.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 77' ' ' SER . 4.7 p -169.56 102.99 0.33 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.381 -0.825 . . . . 0.0 108.845 177.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.722 HD23 ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -117.98 179.77 3.99 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.094 1.77 . . . . 0.0 108.12 -179.55 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.722 ' H ' HD23 ' A' ' 78' ' ' LEU . 3.2 tpt180 -89.88 143.85 26.44 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.667 -1.27 . . . . 0.0 109.412 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.42 1.38 0.35 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.568 -0.707 . . . . 0.0 109.593 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 79' ' ' ARG . 84.6 m-20 -78.87 -29.09 44.28 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.213 -1.395 . . . . 0.0 108.872 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.75 HD21 ' CD ' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -64.27 124.85 86.9 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.044 -1.035 . . . . 0.0 109.085 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -78.55 -8.56 16.01 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.171 1.914 . . . . 0.0 112.401 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -89.59 4.14 50.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.006 -1.059 . . . . 0.0 109.482 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.75 ' CD ' HD21 ' A' ' 82' ' ' ASN . 3.5 tptp -60.0 -49.82 76.18 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.194 -0.941 . . . . 0.0 108.919 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -62.82 -41.99 99.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 109.57 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.16 -38.27 76.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.612 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 88' ' ' LEU . 2.7 mm? -60.3 -42.75 96.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.345 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.572 ' NH2' ' O ' ' A' ' 85' ' ' LYS . 1.0 OUTLIER -60.49 -30.65 69.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.845 . . . . 0.0 109.873 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.22 -60.22 3.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 109.671 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.403 ' O ' ' ND2' ' A' ' 94' ' ' ASN . 50.4 mttp -57.17 -32.18 66.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.504 -0.747 . . . . 0.0 109.278 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -85.6 -18.25 33.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.415 -0.803 . . . . 0.0 110.243 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -60.86 -40.17 91.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.125 -0.984 . . . . 0.0 109.85 -179.315 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 21.5 p30 -46.89 125.48 7.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.121 -0.987 . . . . 0.0 109.452 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.53 166.32 1.32 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.504 -0.748 . . . . 0.0 109.366 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -173.17 -169.26 0.52 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.899 -1.12 . . . . 0.0 111.433 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.2 t -164.1 135.58 4.6 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.676 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -107.55 156.2 19.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.443 -0.785 . . . . 0.0 109.735 -178.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.18 -6.94 86.7 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -123.51 170.67 10.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.316 -1.108 . . . . 0.0 109.288 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -76.26 142.99 41.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.972 -1.08 . . . . 0.0 110.161 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -100.24 94.6 6.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.194 -0.942 . . . . 0.0 109.058 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.627 HG22 HD11 ' A' ' 155' ' ' ILE . 1.0 OUTLIER -91.46 130.67 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.507 -0.745 . . . . 0.0 109.878 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.5 HH21 ' CB ' ' A' ' 152' ' ' ALA . 51.2 ttt180 -132.01 123.77 27.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.398 -0.814 . . . . 0.0 109.346 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.615 ' HB3' HD12 ' A' ' 153' ' ' ILE . 27.2 t80 -104.78 131.89 51.7 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.09 128.42 35.42 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.608 -0.682 . . . . 0.0 110.228 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.0 t -112.63 -29.67 2.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.683 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -169.04 158.04 8.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.027 . . . . 0.0 109.031 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.488 ' O ' ' OE1' ' A' ' 127' ' ' GLU . . . 78.49 150.0 4.69 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.9 156.05 31.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.421 -1.046 . . . . 0.0 109.512 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.483 ' C ' HD11 ' A' ' 178' ' ' LEU . . . -151.49 -125.99 1.24 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.88 HD12 HD12 ' A' ' 178' ' ' LEU . 1.6 mt -148.95 164.32 34.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -1.08 . . . . 0.0 109.659 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.518 ' CG ' HD11 ' A' ' 132' ' ' ILE . 0.2 OUTLIER -138.47 91.59 2.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.569 179.21 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.643 ' SG ' ' NE2' ' A' ' 123' ' ' GLN . 0.8 OUTLIER -77.97 117.04 18.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 109.476 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.582 HD11 HG22 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -118.34 106.16 12.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.116 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -101.33 109.56 21.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.972 . . . . 0.0 109.462 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mm -125.57 111.82 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.005 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.99 -142.12 28.11 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 106.537 -2.625 . . . . 0.0 106.537 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.494 ' O ' ' CG ' ' A' ' 119' ' ' ASP . 48.2 p-10 -103.8 79.2 1.63 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 115.103 -2.639 . . . . 0.0 109.369 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 121' ' ' VAL . 75.8 tt0 -165.92 167.34 16.78 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.64 ' O ' HG23 ' A' ' 5' ' ' ILE . 86.7 t -130.43 151.91 36.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.089 -1.007 . . . . 0.0 109.924 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.439 ' C ' ' OE1' ' A' ' 123' ' ' GLN . 32.7 m-85 -130.87 133.27 45.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.691 -0.631 . . . . 0.0 109.986 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.643 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 4.2 mp0 -122.35 110.07 15.2 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.412 -0.805 . . . . 0.0 109.088 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.85 HG22 HD13 ' A' ' 3' ' ' LEU . 21.2 t -104.84 133.9 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.948 ' H ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.55 90.54 2.62 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.341 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 30.1 p -166.36 128.8 1.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.393 -1.442 . . . . 0.0 107.329 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 7.0 tt0 -107.39 96.35 6.34 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 116.096 -2.242 . . . . 0.0 110.569 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.591 ' C ' ' H ' ' A' ' 130' ' ' ASP . 17.1 mtpp -112.73 159.78 18.6 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.66 176.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.586 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 88.6 m-20 -57.12 -4.27 0.18 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.442 -1.411 . . . . 0.0 107.761 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.591 ' H ' ' C ' ' A' ' 128' ' ' LYS . 67.3 m-20 -66.73 143.14 57.12 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.705 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.101 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -110.79 142.67 42.45 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.614 0.721 . . . . 0.0 110.706 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 1.101 ' N ' HD12 ' A' ' 131' ' ' LEU . 47.6 pt -132.64 147.66 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.432 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 8.9 t -137.03 153.78 50.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.349 -0.844 . . . . 0.0 109.581 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.582 HG22 HD11 ' A' ' 115' ' ' LEU . 1.1 t -106.11 143.01 26.06 Favored Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.49 152.65 80.38 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.283 1.989 . . . . 0.0 112.274 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.609 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.59 134.61 47.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.275 -0.891 . . . . 0.0 109.223 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.609 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.1 t-80 91.31 11.21 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.121 0.486 . . . . 0.0 109.742 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 138' ' ' THR . 0.8 OUTLIER -104.13 126.5 31.48 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 0.0 108.739 179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.98 131.49 29.0 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.581 1.52 . . . . 0.0 111.474 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.488 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.9 163.79 9.62 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.223 -179.186 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.505 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -134.53 -146.94 0.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.239 -0.913 . . . . 0.0 109.713 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -177.9 126.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.926 -1.109 . . . . 0.0 109.037 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.496 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 10.9 p-10 -144.25 134.14 23.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.31 -0.869 . . . . 0.0 109.895 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.618 ' O ' ' C ' ' A' ' 145' ' ' GLY . 84.1 mmm -112.94 20.48 16.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.584 -0.697 . . . . 0.0 111.202 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.61 -92.68 0.01 OUTLIER Glycine 0 N--CA 1.506 3.363 0 CA-C-N 119.265 0.939 . . . . 0.0 111.534 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.486 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 74.5 m -85.85 117.51 24.76 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.92 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.653 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -117.3 113.18 39.12 Favored Pre-proline 0 C--N 1.299 -1.609 0 C-N-CA 119.764 -0.775 . . . . 0.0 109.804 178.095 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.3 Cg_endo -103.12 40.95 0.04 OUTLIER 'Trans proline' 0 C--O 1.213 -0.767 0 C-N-CA 122.717 2.278 . . . . 0.0 111.349 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 13.6 t-20 81.79 71.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.124 -177.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.536 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 8.9 p90 -95.53 144.31 26.11 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.388 -0.82 . . . . 0.0 109.895 -177.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.8 m -113.17 122.96 49.09 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.536 -0.728 . . . . 0.0 109.754 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.628 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -142.83 162.58 35.1 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.615 HD12 ' HB3' ' A' ' 105' ' ' PHE . 57.6 mt -107.49 126.92 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.076 -1.015 . . . . 0.0 109.374 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -136.51 164.13 28.9 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.113 -0.992 . . . . 0.0 109.803 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.627 HD11 HG22 ' A' ' 103' ' ' VAL . 4.7 mp -102.5 145.12 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.579 -0.701 . . . . 0.0 109.562 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.454 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.2 m-85 -95.54 118.81 32.94 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.291 -0.881 . . . . 0.0 109.361 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 0.9 OUTLIER -134.93 164.13 28.29 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 3.9 m-20 -93.65 160.26 33.16 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.167 -0.958 . . . . 0.0 109.052 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.3 Cg_endo -61.76 -55.65 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.198 1.932 . . . . 0.0 112.199 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.4 tt0 -44.09 -15.49 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.336 -0.853 . . . . 0.0 108.986 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -72.72 -46.68 29.68 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 178.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.464 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 6.5 p90 -107.38 165.03 11.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.341 -1.094 . . . . 0.0 110.05 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 72.6 mt -100.59 149.58 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.35 -71.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.088 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.583 ' NE2' ' OD1' ' A' ' 170' ' ' ASP . 43.1 mt-30 -140.39 159.01 43.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 109.632 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -101.21 -41.12 6.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 109.564 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.7 p -102.44 -30.43 11.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.085 -1.009 . . . . 0.0 108.856 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.49 -6.49 52.81 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -82.13 148.55 28.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.704 -1.468 . . . . 0.0 108.688 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.583 ' OD1' ' NE2' ' A' ' 165' ' ' GLN . 88.5 m-20 -109.08 88.35 2.71 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 117.568 -1.653 . . . . 0.0 111.096 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.5 tt -77.75 -23.69 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.609 -1.307 . . . . 0.0 109.348 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.505 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -60.41 -41.44 93.92 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.632 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 93.4 p -54.62 -2.95 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.481 -0.762 . . . . 0.0 109.994 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.31 -39.84 31.83 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.942 -1.099 . . . . 0.0 111.298 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.627 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 9.9 m-85 -111.64 24.4 0.08 OUTLIER Pre-proline 0 N--CA 1.514 2.754 0 O-C-N 120.85 -1.156 . . . . 0.0 112.808 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.632 ' HD3' ' C ' ' A' ' 173' ' ' SER . 45.3 Cg_endo -63.59 -19.3 67.32 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.68 2.92 . . . . 0.0 113.348 -173.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.08 125.51 35.05 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.99 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.88 HD12 HD12 ' A' ' 112' ' ' LEU . 1.8 tp -88.03 120.41 29.34 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.525 -0.734 . . . . 0.0 109.135 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.295 -1.786 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.34 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.608 ' O ' ' OG1' ' A' ' 19' ' ' THR . 1.6 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.96 171.55 8.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 108.925 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.751 ' CD1' HG22 ' A' ' 124' ' ' VAL . 28.2 tp -158.85 113.1 2.44 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.74 130.32 54.96 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.166 -0.959 . . . . 0.0 110.365 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 121' ' ' VAL . 63.9 mt -124.59 133.61 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 97.2 m-85 -126.63 165.36 19.34 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -91.73 176.33 6.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 108.715 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -25.68 5.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.888 -1.133 . . . . 0.0 109.418 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -73.13 -40.68 64.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 110.086 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -136.81 124.01 14.16 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.093 -1.004 . . . . 0.0 109.437 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.565 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 56.4 Cg_endo -82.18 -33.13 0.6 Allowed 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.925 1.75 . . . . 0.0 112.319 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.482 ' OE1' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -68.43 -25.99 65.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 110.347 -178.604 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -95.41 120.79 36.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.959 -1.088 . . . . 0.0 108.977 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.38 131.99 40.91 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.297 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 pp -90.37 -8.96 49.38 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.209 -0.996 . . . . 0.0 108.822 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.66 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 45.1 t90 -157.54 106.79 2.13 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.506 -1.278 . . . . 0.0 109.943 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -120.77 119.82 33.85 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.535 -0.728 . . . . 0.0 109.801 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.47 161.84 30.24 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.198 -0.939 . . . . 0.0 109.82 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 19' ' ' THR . 8.9 t -131.36 89.08 2.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 118.773 -1.171 . . . . 0.0 108.507 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.752 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -126.27 142.37 51.55 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.372 -0.83 . . . . 0.0 110.24 177.351 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.85 -37.05 27.57 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.463 -1.398 . . . . 0.0 109.137 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.68 -50.15 9.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.167 -0.958 . . . . 0.0 109.862 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -63.32 -18.53 63.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.036 -1.04 . . . . 0.0 108.719 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.752 HD12 ' O ' ' A' ' 20' ' ' ASN . 3.1 mt -73.56 -56.07 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 108.912 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.427 ' N ' HG22 ' A' ' 24' ' ' ILE . 9.2 pt20 -57.61 -40.77 79.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.211 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.683 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 68.5 mt-30 -62.04 -43.03 99.7 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.142 -0.974 . . . . 0.0 109.114 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.488 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 7.5 tt0 -72.47 -44.85 61.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.204 -0.935 . . . . 0.0 108.899 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.597 HD12 HG11 ' A' ' 33' ' ' VAL . 2.8 mm? -64.19 -62.56 1.54 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.054 -1.029 . . . . 0.0 109.371 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.618 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -61.23 -17.56 53.93 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.165 -178.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -62.52 -28.82 70.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.529 -1.357 . . . . 0.0 108.439 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.679 ' HG3' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -94.19 6.81 47.46 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.855 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.81 25.64 12.92 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.046 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.679 HG23 ' HG3' ' A' ' 31' ' ' LYS . 61.8 t -95.29 145.98 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.149 -1.206 . . . . 0.0 109.191 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -83.59 153.47 24.3 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 121.058 -1.026 . . . . 0.0 108.555 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CB ' HD21 ' A' ' 29' ' ' ASN . 2.2 t80 -154.21 146.47 23.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.159 -0.963 . . . . 0.0 108.729 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.535 ' O ' ' OD2' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -177.9 178.07 1.0 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.006 -1.059 . . . . 0.0 110.251 178.147 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 119.3 6.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 108.886 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.428 ' CE3' ' HB1' ' A' ' 60' ' ' ALA . 23.1 m0 -111.99 156.83 21.51 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -143.05 160.98 39.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.867 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.44 158.17 16.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 108.946 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -101.45 -14.1 17.67 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -92.9 158.79 15.65 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.535 0.684 . . . . 0.0 109.161 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -93.71 123.63 37.16 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 109.46 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 mt -94.39 165.67 12.45 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 109.368 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.7 -105.14 0.22 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.01 93.06 5.04 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.999 -1.295 . . . . 0.0 109.327 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.9 91.65 43.37 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -75.88 -22.04 13.7 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.155 1.903 . . . . 0.0 112.421 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.1 p -120.58 141.19 50.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.618 -0.677 . . . . 0.0 109.679 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.681 ' HB1' HD13 ' A' ' 54' ' ' ILE . . . -80.86 -17.86 49.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.478 -0.764 . . . . 0.0 109.535 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.69 -39.22 16.86 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.223 -0.923 . . . . 0.0 108.862 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.8 m -78.92 -34.89 44.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 109.587 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.418 HG11 ' CG1' ' A' ' 107' ' ' VAL . 60.1 t -67.76 -57.12 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.342 -0.849 . . . . 0.0 110.33 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.681 HD13 ' HB1' ' A' ' 50' ' ' ALA . 1.7 mp -58.8 -34.99 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.968 -1.083 . . . . 0.0 108.9 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.68 -35.18 72.18 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.413 -0.804 . . . . 0.0 109.365 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.51 -13.7 60.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.21 -0.931 . . . . 0.0 109.632 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.4 m-85 -111.42 -8.39 14.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.489 -0.757 . . . . 0.0 109.762 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 62' ' ' ASP . 8.8 mm100 -47.06 -36.05 7.63 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.159 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.514 ' ND1' ' N ' ' A' ' 60' ' ' ALA . 29.7 p80 -53.36 -44.18 68.36 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.74 -1.225 . . . . 0.0 109.516 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.514 ' N ' ' ND1' ' A' ' 59' ' ' HIS . . . -63.6 -61.1 2.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.0 -1.063 . . . . 0.0 110.071 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.643 ' O ' HG23 ' A' ' 65' ' ' VAL . 1.3 pp -62.36 -27.72 43.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.75 -1.219 . . . . 0.0 108.983 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' A' ' 62' ' ' ASP . 36.8 t0 -58.41 -27.69 64.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.96 . . . . 0.0 109.567 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -74.19 -40.93 62.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.959 . . . . 0.0 109.121 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 64' ' ' LEU . 7.6 mp -64.42 -34.85 79.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 109.295 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 61' ' ' ILE . 11.5 t -68.13 -29.93 46.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.035 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.75 72.82 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.658 -1.276 . . . . 0.0 109.524 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -87.74 -53.86 4.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.083 -1.011 . . . . 0.0 110.5 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.604 ' O ' ' C ' ' A' ' 69' ' ' GLY . 8.2 mmtp -85.96 14.51 6.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.355 -0.84 . . . . 0.0 110.489 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -16.41 87.58 0.0 OUTLIER Glycine 0 N--CA 1.499 2.885 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 68' ' ' LYS . 81.1 m-85 -76.58 164.01 26.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -57.74 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.312 -0.868 . . . . 0.0 109.673 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.58 163.0 12.58 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.598 0.713 . . . . 0.0 110.058 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.775 ' HE1' HG23 ' A' ' 153' ' ' ILE . 5.6 t-105 -131.84 135.76 46.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HB2' ' CE2' ' A' ' 156' ' ' PHE . 0.7 OUTLIER -146.86 166.81 25.57 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.9 -1.125 . . . . 0.0 108.142 178.475 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 152' ' ' ALA . 8.8 p -119.55 141.28 40.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 76' ' ' ILE . 7.6 tp -102.7 115.01 43.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.235 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.0 t -167.63 100.06 0.49 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.34 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.657 HD23 ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -125.01 -179.26 4.48 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.34 -1.475 . . . . 0.0 107.658 -179.52 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.657 ' H ' HD23 ' A' ' 78' ' ' LEU . 23.2 tpt180 -88.91 153.07 21.34 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.671 -1.268 . . . . 0.0 109.075 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.97 0.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ARG . 83.8 m-20 -103.43 30.54 4.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.552 ' OD1' ' N ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -82.26 135.08 47.76 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.52 -0.737 . . . . 0.0 110.201 178.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.446 ' C ' ' OE1' ' A' ' 84' ' ' GLN . 55.7 Cg_endo -77.41 -25.75 7.97 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.173 1.915 . . . . 0.0 112.198 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.487 ' N ' ' OE1' ' A' ' 84' ' ' GLN . 0.9 OUTLIER -92.5 8.13 40.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.895 -1.128 . . . . 0.0 109.493 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.576 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 18.0 pttt -58.73 -51.7 68.86 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.214 -0.929 . . . . 0.0 108.774 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.576 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 84.2 tt0 -67.6 -54.24 21.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.146 -0.972 . . . . 0.0 109.504 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.83 -47.02 83.85 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.311 -0.955 . . . . 0.0 109.727 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 84' ' ' GLN . 13.3 tp -63.07 -46.13 88.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.768 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -60.83 -36.96 80.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 109.602 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.7 -58.84 4.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -0.878 . . . . 0.0 109.625 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -50.5 -37.89 41.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.278 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.03 -19.46 51.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.117 -0.99 . . . . 0.0 109.134 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 93' ' ' LEU . 8.0 tt -61.3 -34.86 75.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 109.758 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -64.26 150.44 45.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.107 -0.995 . . . . 0.0 110.188 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.726 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 7.7 pm0 -80.91 166.31 20.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 0.0 109.567 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -173.96 -169.24 0.47 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.044 -1.062 . . . . 0.0 111.195 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.2 t -163.48 132.97 4.09 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.635 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -104.3 156.74 17.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.516 -0.74 . . . . 0.0 110.125 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.446 ' N ' ' HB3' ' A' ' 162' ' ' TRP . . . -78.78 -6.56 88.49 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 95.7 mt-10 -124.36 171.15 10.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.395 -1.062 . . . . 0.0 109.429 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 102' ' ' GLU . 48.3 t0 -75.19 139.91 42.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.109 -0.994 . . . . 0.0 110.248 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.594 ' N ' ' OD2' ' A' ' 101' ' ' ASP . 14.9 tt0 -97.13 95.17 7.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.344 -0.848 . . . . 0.0 108.931 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.838 HG13 ' OG ' ' A' ' 133' ' ' SER . 29.5 t -95.29 123.17 47.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.65 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 34.0 ttm105 -127.28 126.3 42.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.46 -0.775 . . . . 0.0 109.018 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.622 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 15.2 t80 -102.36 131.18 49.15 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.825 0.822 . . . . 0.0 109.201 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.405 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -85.9 126.46 34.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.49 0.662 . . . . 0.0 110.154 -178.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.418 ' CG1' HG11 ' A' ' 53' ' ' VAL . 12.9 t -108.5 -30.24 2.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.73 -0.606 . . . . 0.0 109.476 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -165.94 153.8 10.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 109.27 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.76 157.09 32.8 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.46 ' HB2' ' CD ' ' A' ' 127' ' ' GLU . . . -134.17 162.38 32.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -1.171 . . . . 0.0 109.089 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.63 155.16 13.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.533 ' HB3' HD12 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -103.14 98.93 8.79 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.133 -1.216 . . . . 0.0 110.638 -178.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -80.5 126.41 31.18 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.66 -1.275 . . . . 0.0 110.054 -178.61 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.497 ' SG ' ' OE1' ' A' ' 123' ' ' GLN . 0.9 OUTLIER -78.5 125.84 29.93 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.312 0.577 . . . . 0.0 109.984 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.669 HD21 HG11 ' A' ' 134' ' ' VAL . 0.5 OUTLIER -113.62 125.53 54.27 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.48 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 8.2 t-160 -107.91 110.37 22.1 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.446 HG21 ' HD3' ' A' ' 31' ' ' LYS . 2.2 pt -124.64 114.25 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 O-C-N 121.45 -0.781 . . . . 0.0 110.513 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.63 -143.81 33.15 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 104.845 -3.302 . . . . 0.0 104.845 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -106.19 79.93 1.45 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 115.048 -2.661 . . . . 0.0 108.636 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.48 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 12.2 pt-20 -166.35 170.16 13.33 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.669 ' O ' HG23 ' A' ' 5' ' ' ILE . 88.9 t -125.27 137.56 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.006 -1.059 . . . . 0.0 109.853 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.556 ' CE2' HD13 ' A' ' 5' ' ' ILE . 7.2 m-85 -122.09 129.54 52.46 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.497 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 8.9 mt-30 -128.39 115.24 17.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 108.984 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.751 HG22 ' CD1' ' A' ' 3' ' ' LEU . 11.5 t -101.76 133.54 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.546 ' C ' HD23 ' A' ' 125' ' ' LEU . 5.7 tt -134.42 91.0 2.73 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.746 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.402 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 30.7 p -164.77 134.75 3.82 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.46 ' CD ' ' HB2' ' A' ' 110' ' ' ALA . 5.7 pt-20 -106.33 94.64 5.26 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 115.55 -2.46 . . . . 0.0 110.538 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.545 ' C ' ' H ' ' A' ' 130' ' ' ASP . 20.1 tptm -114.2 156.8 23.62 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.088 176.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.622 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 83.3 m-20 -58.35 -3.32 0.26 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.487 -1.383 . . . . 0.0 107.891 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.593 ' OD2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.89 153.03 43.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.199 -178.5 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.759 ' C ' HD12 ' A' ' 131' ' ' LEU . 2.1 pp -117.56 160.57 21.03 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.893 0.854 . . . . 0.0 110.095 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.645 ' N ' HD12 ' A' ' 131' ' ' LEU . 5.6 mm -131.65 128.77 60.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.805 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.838 ' OG ' HG13 ' A' ' 103' ' ' VAL . 14.5 m -123.0 142.09 51.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.401 -0.812 . . . . 0.0 109.373 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.669 HG11 HD21 ' A' ' 115' ' ' LEU . 8.3 m -109.31 148.96 39.08 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.407 -0.808 . . . . 0.0 108.98 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -66.81 154.76 73.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.378 2.052 . . . . 0.0 112.966 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.618 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -73.32 136.53 44.49 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.459 -0.776 . . . . 0.0 109.329 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.618 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 4.1 t-80 92.95 10.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.37 126.17 32.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 108.556 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.79 132.2 31.83 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.54 1.493 . . . . 0.0 111.534 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.45 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.86 162.83 9.54 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.219 -0.926 . . . . 0.0 110.18 -178.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.513 ' CD2' ' HB2' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -133.71 -147.16 0.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.65 ' CE1' ' NH1' ' A' ' 104' ' ' ARG . 0.2 OUTLIER -178.74 127.7 0.11 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.864 -1.148 . . . . 0.0 109.077 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 54.7 p-10 -147.23 139.55 24.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.808 . . . . 0.0 109.852 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.604 ' O ' ' C ' ' A' ' 145' ' ' GLY . 2.6 ptt? -113.7 22.9 13.6 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.579 -0.7 . . . . 0.0 110.72 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 7.11 -90.61 0.0 OUTLIER Glycine 0 N--CA 1.502 3.053 0 CA-C-N 119.517 1.053 . . . . 0.0 112.465 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.525 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 23.0 t -86.05 116.78 24.48 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 117.886 -1.525 . . . . 0.0 108.834 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.662 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -116.74 114.36 39.75 Favored Pre-proline 0 C--N 1.296 -1.719 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.748 178.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.0 Cg_endo -101.41 38.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.885 0 C-N-CA 122.873 2.382 . . . . 0.0 110.705 176.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 16.4 t-20 82.56 70.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -176.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 20.2 p90 -95.25 163.35 13.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.747 -0.595 . . . . 0.0 109.635 -177.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.5 m -134.42 126.9 30.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 0.0 109.931 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.617 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . . . -143.65 163.48 33.13 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.539 -0.726 . . . . 0.0 109.14 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.775 HG23 ' HE1' ' A' ' 73' ' ' TRP . 24.8 mt -110.59 130.04 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.192 -0.943 . . . . 0.0 109.681 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.567 ' C ' HD13 ' A' ' 155' ' ' ILE . 6.5 ptm180 -131.26 159.02 39.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.42 -0.8 . . . . 0.0 110.494 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.581 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -108.12 149.63 11.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.501 0.667 . . . . 0.0 109.446 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 74' ' ' ASP . 4.0 m-30 -97.33 120.62 38.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.866 0.841 . . . . 0.0 110.77 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.614 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 52.0 t0 -133.93 158.93 42.23 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.594 ' O ' ' NE1' ' A' ' 162' ' ' TRP . 80.9 m-20 -96.96 150.8 37.26 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.901 -1.124 . . . . 0.0 109.513 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.625 ' O ' ' N ' ' A' ' 161' ' ' GLY . 45.9 Cg_endo -70.65 -53.23 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.363 2.042 . . . . 0.0 112.121 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.5 tt0 -42.4 -15.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.672 -0.643 . . . . 0.0 109.514 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.27 -41.4 13.74 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 177.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.614 ' HE1' ' CG ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -114.4 175.66 5.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.596 -0.944 . . . . 0.0 110.952 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 19.2 pt -96.32 155.44 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.535 -0.728 . . . . 0.0 109.339 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -93.56 -70.84 0.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 110.663 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -107.06 143.07 35.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.07 -1.019 . . . . 0.0 110.197 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -102.07 -40.48 6.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 109.619 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -116.92 -30.12 5.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.323 -0.861 . . . . 0.0 108.688 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.83 -7.41 53.02 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -80.9 149.2 29.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.661 -1.494 . . . . 0.0 108.176 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.484 ' OD2' ' OG ' ' A' ' 173' ' ' SER . 1.7 p30 -107.98 88.42 2.73 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 117.425 -1.71 . . . . 0.0 111.152 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.0 OUTLIER -75.83 -25.62 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.832 -1.168 . . . . 0.0 109.328 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.513 ' HB2' ' CD2' ' A' ' 141' ' ' TRP . . . -60.56 -40.37 91.41 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.61 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 52.8 p -55.45 -4.22 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.577 -0.702 . . . . 0.0 110.22 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.466 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -81.58 -37.84 27.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.04 -1.037 . . . . 0.0 111.281 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.624 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.3 m-85 -112.13 23.84 0.08 OUTLIER Pre-proline 0 N--CA 1.509 2.522 0 O-C-N 120.538 -1.351 . . . . 0.0 112.777 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 45.3 Cg_endo -64.0 -18.84 65.26 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 123.153 2.569 . . . . 0.0 113.911 -173.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -88.36 125.07 34.52 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.849 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.726 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.8 OUTLIER -87.97 120.84 29.71 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.367 -0.833 . . . . 0.0 109.194 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.432 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.57 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.35 171.93 8.1 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.097 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.837 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 18.3 tp -157.58 115.02 3.03 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.547 ' OG1' HD11 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -111.76 131.99 54.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.023 -1.048 . . . . 0.0 110.062 -178.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 121' ' ' VAL . 53.8 mt -127.11 131.55 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 71.4 m-85 -129.79 164.37 24.19 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.6 m -89.02 174.96 7.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.21 -0.931 . . . . 0.0 108.906 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -23.92 6.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 120.902 -1.124 . . . . 0.0 109.532 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -41.05 62.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.059 -1.026 . . . . 0.0 110.334 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.25 123.08 11.0 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.991 -1.068 . . . . 0.0 109.52 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.588 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 55.6 Cg_endo -82.58 -27.29 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.885 1.724 . . . . 0.0 112.214 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.411 ' O ' ' CD ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -70.45 0.55 6.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 110.546 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.578 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -123.12 118.63 28.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 108.923 179.472 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.32 129.41 41.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.03 -1.044 . . . . 0.0 109.095 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.578 ' CD1' HD21 ' A' ' 13' ' ' ASN . 9.4 mp -88.46 -12.25 43.59 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.046 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.837 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 40.8 t90 -158.44 107.33 1.98 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.747 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -120.03 117.69 28.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.367 -0.833 . . . . 0.0 109.76 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.71 163.43 29.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.532 -0.73 . . . . 0.0 109.753 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 19' ' ' THR . 8.9 t -130.63 89.25 2.74 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.039 -1.038 . . . . 0.0 108.297 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.713 ' O ' HD12 ' A' ' 24' ' ' ILE . 87.4 m-20 -125.17 138.6 54.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.32 -0.862 . . . . 0.0 110.535 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.93 -34.08 30.03 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 119.874 -1.766 . . . . 0.0 108.555 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -82.65 -53.55 5.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.096 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -58.56 -20.22 44.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.134 -0.979 . . . . 0.0 108.666 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.713 HD12 ' O ' ' A' ' 20' ' ' ASN . 5.5 mt -75.85 -57.09 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.053 -1.03 . . . . 0.0 108.748 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.499 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 61.5 tt0 -53.47 -41.08 65.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.409 -0.807 . . . . 0.0 109.077 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -71.84 -49.08 41.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.124 -0.985 . . . . 0.0 110.652 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.564 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 27.0 mt-30 -72.23 -47.33 51.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.977 -1.077 . . . . 0.0 110.998 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 33' ' ' VAL . 14.7 tp -61.22 -54.66 41.36 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.017 -1.052 . . . . 0.0 109.467 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 15.0 m120 -62.78 -16.2 56.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.978 -1.076 . . . . 0.0 109.636 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 27' ' ' GLN . . . -62.86 -28.96 70.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.616 -1.302 . . . . 0.0 108.507 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 12.51 11.82 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.792 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.44 24.65 28.04 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.139 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.564 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 99.9 t -95.64 143.82 11.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.39 -1.065 . . . . 0.0 109.513 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -84.04 158.87 21.31 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.476 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -150.45 146.04 26.4 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.295 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 36.7 mt-10 -162.96 162.87 26.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.116 -0.99 . . . . 0.0 108.932 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.2 mtm-85 -148.41 111.59 4.91 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.615 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 18.0 m0 -112.71 155.99 23.57 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -142.65 162.32 35.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 0.0 109.846 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.23 159.59 15.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 108.905 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -100.59 -17.1 17.22 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -92.88 159.68 15.25 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.51 123.36 35.75 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.569 -0.707 . . . . 0.0 109.379 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.3 mt -90.53 166.15 13.38 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.299 -0.876 . . . . 0.0 109.342 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.69 -105.13 0.21 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.26 91.24 4.99 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.133 -1.216 . . . . 0.0 109.388 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.2 92.4 22.07 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.78 -27.43 8.81 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.206 1.937 . . . . 0.0 112.461 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 p -121.24 141.87 50.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.633 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.48 -21.2 42.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 109.532 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 50' ' ' ALA . 83.7 tt0 -43.54 -38.78 3.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -0.825 . . . . 0.0 109.096 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.7 p -78.52 -34.77 47.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 109.244 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 50' ' ' ALA . 59.1 t -68.28 -46.35 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.349 -0.844 . . . . 0.0 109.916 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.444 HD13 ' N ' ' A' ' 54' ' ' ILE . 6.5 mm -61.62 -35.62 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.957 . . . . 0.0 108.881 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.17 -30.34 71.51 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.52 -0.738 . . . . 0.0 109.653 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.55 -20.47 56.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 110.086 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.404 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.5 m-85 -110.74 -6.76 14.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.454 -0.779 . . . . 0.0 109.479 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 54' ' ' ILE . 4.0 mm100 -47.62 -37.9 13.57 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.068 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.5 ' ND1' ' N ' ' A' ' 60' ' ' ALA . 30.9 p80 -52.59 -45.0 66.33 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.865 -1.147 . . . . 0.0 109.633 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.5 ' N ' ' ND1' ' A' ' 59' ' ' HIS . . . -63.66 -59.83 4.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.73 -1.232 . . . . 0.0 110.403 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.693 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.9 OUTLIER -61.83 -28.06 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.763 -1.211 . . . . 0.0 108.826 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 58' ' ' GLN . 25.9 t70 -57.62 -28.91 64.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.239 -0.913 . . . . 0.0 109.441 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' CD ' ' O ' ' A' ' 59' ' ' HIS . 4.7 mptp? -73.74 -41.31 62.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.108 -0.995 . . . . 0.0 109.185 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.4 mp -64.09 -35.27 80.21 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.387 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 61' ' ' ILE . 3.7 t -69.1 -28.9 41.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.227 -0.92 . . . . 0.0 109.321 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.77 -53.84 53.82 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.546 -1.346 . . . . 0.0 109.57 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -85.57 -53.69 5.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.024 -1.048 . . . . 0.0 110.704 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.583 ' O ' ' C ' ' A' ' 69' ' ' GLY . 11.2 mmtp -84.96 14.45 4.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.443 -0.786 . . . . 0.0 110.646 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -18.23 87.93 0.0 OUTLIER Glycine 0 N--CA 1.498 2.805 0 CA-C-O 122.041 0.8 . . . . 0.0 111.332 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 68' ' ' LYS . 58.7 m-85 -76.12 165.07 25.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -57.14 -88.83 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.431 -0.793 . . . . 0.0 109.522 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.404 ' CB ' ' HB2' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -103.76 163.1 12.56 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.641 0.734 . . . . 0.0 109.999 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.617 ' HE1' HG23 ' A' ' 153' ' ' ILE . 5.2 t-105 -135.23 139.24 44.31 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -155.48 173.5 16.6 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.98 141.39 39.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 76' ' ' ILE . 16.2 tt -102.78 117.09 47.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.517 ' O ' ' OG ' ' A' ' 77' ' ' SER . 8.8 p -168.24 101.78 0.44 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.473 ' HG ' ' H ' ' A' ' 79' ' ' ARG . 9.6 tp -116.01 179.43 3.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 119.31 -2.119 . . . . 0.0 107.781 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.531 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -89.51 150.01 22.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.032 -1.042 . . . . 0.0 109.173 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.2 2.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -0.881 . . . . 0.0 109.675 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 79' ' ' ARG . 32.3 t0 -78.77 -28.1 44.7 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.566 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -63.69 123.66 82.13 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.872 -1.143 . . . . 0.0 109.91 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.59 -4.77 12.36 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.048 1.832 . . . . 0.0 111.97 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -87.98 6.26 36.8 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.044 -1.035 . . . . 0.0 109.761 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.532 ' HG3' ' H ' ' A' ' 86' ' ' GLU . 11.9 ptpt -57.27 -50.89 71.48 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.162 -0.961 . . . . 0.0 108.975 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.532 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 84.4 tt0 -66.33 -42.57 87.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.282 -0.886 . . . . 0.0 109.899 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.72 -59.42 4.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.13 -0.981 . . . . 0.0 110.136 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.537 ' H ' HD12 ' A' ' 88' ' ' LEU . 6.1 mp -62.8 -44.53 95.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.953 -1.092 . . . . 0.0 109.49 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 145' ' ' GLY . 47.7 ttp180 -59.54 -30.33 68.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.845 . . . . 0.0 109.627 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.82 -61.66 2.34 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.616 -0.833 . . . . 0.0 109.638 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -54.98 -32.66 61.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.462 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -63.69 -31.34 72.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.902 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.601 ' O ' ' HB3' ' A' ' 172' ' ' ALA . 73.6 mt -50.87 -41.37 58.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.001 -1.062 . . . . 0.0 110.014 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -49.22 141.01 8.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.762 -1.211 . . . . 0.0 109.583 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.467 ' CG ' ' O ' ' A' ' 169' ' ' ASP . 0.7 OUTLIER -81.63 171.65 14.37 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.5 p-80 -177.71 -165.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 110.537 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.1 t -163.32 137.74 6.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.625 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -109.33 155.57 21.04 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 109.87 -178.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.87 -7.03 87.49 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -123.51 170.64 10.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.54 -0.977 . . . . 0.0 109.356 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' A' ' 101' ' ' ASP . 48.3 p30 -75.98 143.9 41.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.056 -1.027 . . . . 0.0 110.07 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.434 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 1.8 mt-10 -104.11 94.28 5.3 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.06 -1.025 . . . . 0.0 108.446 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.781 HG13 ' OG ' ' A' ' 133' ' ' SER . 44.1 t -97.55 127.02 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.023 -1.048 . . . . 0.0 110.313 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 129.73 43.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.342 -0.849 . . . . 0.0 109.244 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.641 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 14.2 t80 -106.44 131.92 53.07 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.161 -0.962 . . . . 0.0 109.33 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.54 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -87.86 130.82 34.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 110.279 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.429 HG12 HG11 ' A' ' 53' ' ' VAL . 3.0 t -109.63 -34.17 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.66 -0.65 . . . . 0.0 110.065 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 109' ' ' GLY . 1.4 tm-20 -164.01 151.68 12.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.477 ' N ' ' OE1' ' A' ' 108' ' ' GLU . . . 87.42 148.76 14.63 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.71 155.39 27.83 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.32 -1.106 . . . . 0.0 108.933 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -150.87 -119.61 0.9 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.2 tp -146.71 162.23 38.95 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.368 -1.078 . . . . 0.0 109.097 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -131.31 90.43 2.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.282 -0.886 . . . . 0.0 109.234 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.719 ' O ' HD22 ' A' ' 115' ' ' LEU . 5.1 p -79.47 131.96 36.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 110.107 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.719 HD22 ' O ' ' A' ' 114' ' ' CYS . 0.6 OUTLIER -136.67 104.26 5.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.358 -0.839 . . . . 0.0 108.772 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.427 ' CD2' HG22 ' A' ' 121' ' ' VAL . 3.2 t-80 -98.41 108.93 21.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.928 -1.108 . . . . 0.0 109.582 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.443 ' H ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -126.12 113.19 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.004 -178.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.85 -141.47 27.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 104.968 -3.253 . . . . 0.0 104.968 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.495 ' O ' ' OD2' ' A' ' 119' ' ' ASP . 39.9 p30 -108.25 80.92 1.41 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 115.488 -2.485 . . . . 0.0 108.956 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -166.41 168.88 14.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.727 ' O ' HG23 ' A' ' 5' ' ' ILE . 55.5 t -129.19 150.8 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.984 . . . . 0.0 109.83 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.5 ' CZ ' HD13 ' A' ' 5' ' ' ILE . 1.5 m-85 -125.39 129.8 50.61 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.213 0.53 . . . . 0.0 109.575 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 4' ' ' THR . 28.6 mt-30 -129.23 110.74 12.22 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.664 HG22 ' CD1' ' A' ' 3' ' ' LEU . 3.1 t -102.2 138.2 27.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.551 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 5.6 mp -122.39 79.51 1.62 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 117.685 -1.606 . . . . 0.0 109.226 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.551 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -165.86 118.42 1.11 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 178.373 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 7.3 tm-20 -113.9 104.19 11.92 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 116.618 -2.033 . . . . 0.0 110.916 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 130' ' ' ASP . 44.6 mtmt -110.15 178.01 4.53 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.688 177.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.641 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 5.1 p30 -59.42 -3.57 0.46 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 36' ' ' GLU . 26.7 p30 -72.28 151.88 42.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.835 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.76 ' C ' HD12 ' A' ' 131' ' ' LEU . 1.9 pp -114.9 160.77 19.13 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.023 0.916 . . . . 0.0 110.57 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.623 ' N ' HD12 ' A' ' 131' ' ' LEU . 6.2 mm -128.07 125.96 65.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.586 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.781 ' OG ' HG13 ' A' ' 103' ' ' VAL . 28.0 m -123.35 141.26 52.17 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.46 148.58 39.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.852 . . . . 0.0 108.716 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -70.24 156.68 61.55 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.269 1.979 . . . . 0.0 112.926 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.605 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.15 133.51 46.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.438 -0.789 . . . . 0.0 109.036 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.605 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 11.1 t60 92.24 11.75 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.168 0.509 . . . . 0.0 110.012 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.24 126.26 32.07 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.99 133.86 40.47 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.442 1.428 . . . . 0.0 111.699 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.511 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.41 163.49 8.59 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.084 -1.047 . . . . 0.0 110.313 -179.263 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.72 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 10.7 p90 -130.95 -153.49 0.57 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.365 -0.835 . . . . 0.0 110.031 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.534 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -168.41 125.06 1.03 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.476 -0.765 . . . . 0.0 109.169 179.112 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 46.2 p-10 -146.04 129.48 16.86 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.053 -1.029 . . . . 0.0 109.749 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.586 ' O ' ' C ' ' A' ' 145' ' ' GLY . 29.8 mtt -102.95 16.51 26.42 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.369 -0.832 . . . . 0.0 111.198 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 20.86 -113.85 0.01 OUTLIER Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.424 ' H ' ' HB2' ' A' ' 178' ' ' LEU . 67.2 m -81.3 120.77 25.35 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.064 -1.454 . . . . 0.0 109.159 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.04 114.46 46.21 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 120.181 -0.607 . . . . 0.0 109.386 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 59.6 Cg_endo -104.14 44.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 122.614 2.209 . . . . 0.0 111.485 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 12.0 t-20 81.68 70.35 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.177 -177.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 23.8 p90 -96.44 159.06 15.14 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.414 -0.804 . . . . 0.0 110.225 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.3 m -125.37 125.39 43.37 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.582 0.706 . . . . 0.0 110.716 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.491 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . . . -143.22 162.76 34.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.37 -0.831 . . . . 0.0 109.295 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.617 HG23 ' HE1' ' A' ' 73' ' ' TRP . 94.9 mt -110.9 129.87 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.256 -0.902 . . . . 0.0 109.942 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.526 ' C ' HD13 ' A' ' 155' ' ' ILE . 95.5 mtt-85 -129.87 158.03 40.63 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.578 -0.701 . . . . 0.0 109.596 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.68 154.41 8.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.404 ' HB2' ' CB ' ' A' ' 72' ' ' SER . 4.2 m-30 -95.81 120.15 35.57 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.093 -1.004 . . . . 0.0 110.196 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.562 ' CG ' ' CE2' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -134.82 161.89 33.91 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.591 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -95.92 160.61 29.71 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 120.92 -1.113 . . . . 0.0 109.268 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 161' ' ' GLY . 43.0 Cg_endo -67.9 -54.83 0.3 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.367 2.044 . . . . 0.0 112.088 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 159' ' ' PRO . 16.5 pt-20 -43.98 -14.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.243 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -89.04 -36.7 7.54 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CE2' ' CG ' ' A' ' 157' ' ' ASP . 47.6 m0 -102.26 163.35 12.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.601 -0.941 . . . . 0.0 110.675 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -99.25 139.33 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.362 -0.836 . . . . 0.0 109.238 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.36 -73.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.5 -0.75 . . . . 0.0 110.736 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -142.25 159.69 41.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.941 -1.099 . . . . 0.0 110.062 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.6 -41.45 6.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.753 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.9 -31.74 5.0 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.26 -1.27 64.48 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.467 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 94.6 m-20 -80.71 149.51 29.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.761 -1.435 . . . . 0.0 108.291 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.462 ' OD2' ' OG ' ' A' ' 173' ' ' SER . 5.8 p-10 -109.5 88.07 2.65 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.624 -1.63 . . . . 0.0 110.682 176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.0 OUTLIER -76.16 -20.76 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.336 -1.477 . . . . 0.0 109.594 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.72 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -61.51 -39.82 92.4 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.972 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.583 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 38.2 p -52.9 -3.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.711 -0.618 . . . . 0.0 110.193 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.98 -39.66 29.6 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.957 -1.09 . . . . 0.0 111.491 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.636 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.7 m-85 -113.48 24.27 0.08 OUTLIER Pre-proline 0 N--CA 1.516 2.864 0 O-C-N 120.534 -1.353 . . . . 0.0 112.73 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 43.9 Cg_endo -61.56 -19.59 65.36 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.653 2.902 . . . . 0.0 114.486 -172.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -89.36 127.05 35.77 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.879 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.739 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 1.0 OUTLIER -85.5 118.81 25.25 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.085 -1.009 . . . . 0.0 108.698 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.624 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.492 ' O ' ' OG1' ' A' ' 19' ' ' THR . 1.3 p . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.77 171.08 8.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.237 -0.914 . . . . 0.0 109.437 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.775 HD13 HG22 ' A' ' 124' ' ' VAL . 30.9 tp -158.9 112.53 2.36 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.29 128.97 54.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.829 -1.169 . . . . 0.0 110.091 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 121' ' ' VAL . 60.4 mt -123.7 130.07 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -125.9 165.55 18.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.54 ' OG ' HD11 ' A' ' 15' ' ' LEU . 14.3 m -84.35 172.77 11.49 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.32 -0.863 . . . . 0.0 109.019 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -89.43 -30.45 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.121 . . . . 0.0 109.955 179.452 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -73.73 -38.33 64.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 0.0 110.043 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.71 123.93 13.12 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.34 -30.43 1.55 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.234 1.956 . . . . 0.0 112.312 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.67 2.27 3.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.466 -0.771 . . . . 0.0 109.928 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -117.79 119.45 34.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.5 p -96.12 124.38 40.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.292 -0.88 . . . . 0.0 109.334 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.54 HD11 ' OG ' ' A' ' 7' ' ' SER . 72.0 mt -87.62 -15.4 37.42 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.715 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 46.2 t90 -158.93 108.59 1.96 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.649 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -120.5 122.08 39.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.136 -0.977 . . . . 0.0 109.275 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.07 164.02 20.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.969 -1.082 . . . . 0.0 109.961 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 19' ' ' THR . 10.3 t -131.47 89.89 2.78 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.566 175.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.779 ' O ' HD12 ' A' ' 24' ' ' ILE . 29.8 m120 -125.59 145.54 50.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.964 -1.085 . . . . 0.0 110.688 177.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.58 -41.67 19.27 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.34 -1.475 . . . . 0.0 109.072 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -82.77 -48.81 10.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.349 -0.844 . . . . 0.0 109.6 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.486 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.1 tt0 -61.31 -19.95 62.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.974 -1.079 . . . . 0.0 108.533 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.779 HD12 ' O ' ' A' ' 20' ' ' ASN . 2.3 mt -73.27 -58.59 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.183 -0.948 . . . . 0.0 109.316 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.516 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 6.2 pt20 -61.28 -42.22 98.27 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.035 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.516 ' N ' ' CG ' ' A' ' 25' ' ' GLN . 62.7 tt0 -61.77 -47.46 85.08 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.347 -0.846 . . . . 0.0 109.48 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.545 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 36.1 tt0 -76.06 -45.44 34.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.062 -1.024 . . . . 0.0 109.332 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 28' ' ' LEU . 16.9 tp -64.54 -56.74 12.08 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.02 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.622 HD21 ' CB ' ' A' ' 35' ' ' PHE . 1.2 m-20 -57.26 -17.92 13.95 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.928 -1.108 . . . . 0.0 109.469 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 27' ' ' GLN . . . -63.93 -27.8 69.39 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.916 -1.115 . . . . 0.0 109.084 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -89.75 10.53 23.09 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.721 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.0 23.49 25.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.1 t -93.69 143.35 11.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.249 -1.148 . . . . 0.0 109.672 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 ttt85 -85.08 155.7 21.39 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.385 -0.822 . . . . 0.0 109.055 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.622 ' CB ' HD21 ' A' ' 29' ' ' ASN . 1.5 t80 -155.81 153.59 30.02 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.711 -1.243 . . . . 0.0 109.059 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' OE1' ' O ' ' A' ' 35' ' ' PHE . 13.1 tp10 -175.71 173.34 2.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.763 -1.211 . . . . 0.0 109.576 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.449 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 37.5 mtm180 -148.38 117.56 6.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.813 -1.18 . . . . 0.0 108.665 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.527 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 26.8 m0 -110.2 154.07 23.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 109.283 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 38' ' ' TRP . 99.5 mm-40 -141.12 155.88 46.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.481 -0.762 . . . . 0.0 109.92 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.99 156.64 17.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.328 -0.857 . . . . 0.0 109.004 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.499 ' OD2' ' N ' ' A' ' 42' ' ' ARG . 53.2 p30 -101.11 -11.81 19.3 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.125 -0.985 . . . . 0.0 108.7 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.499 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -93.38 156.38 16.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.33 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -92.12 119.03 31.4 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.688 -0.632 . . . . 0.0 109.566 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.36 163.65 14.12 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.696 0.76 . . . . 0.0 109.3 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.37 -102.81 0.19 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.18 92.82 4.49 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.928 -1.336 . . . . 0.0 109.23 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.54 91.47 44.61 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -75.58 -22.67 13.6 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.461 2.107 . . . . 0.0 112.756 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 p -121.96 141.97 50.78 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.542 -0.723 . . . . 0.0 109.59 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 51' ' ' GLU . . . -80.29 -18.24 49.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.333 -0.854 . . . . 0.0 109.405 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 50' ' ' ALA . 79.8 mm-40 -45.34 -38.32 5.69 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.911 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.4 m -77.84 -33.3 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.41 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 50' ' ' ALA . 65.3 t -68.22 -47.0 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 109.961 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.513 ' O ' ' N ' ' A' ' 58' ' ' GLN . 14.4 mm -60.61 -39.16 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 109.261 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.26 70.62 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.571 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.34 -19.55 58.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 0.0 110.507 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -116.33 -8.53 11.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.435 -0.791 . . . . 0.0 109.267 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 62' ' ' ASP . 4.4 tp-100 -48.36 -38.03 18.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 108.737 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.599 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.22 -47.95 62.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.01 -1.056 . . . . 0.0 109.885 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.599 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.37 -58.93 6.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.968 -1.082 . . . . 0.0 109.819 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.702 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -62.72 -29.42 46.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.953 -1.092 . . . . 0.0 108.883 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 58' ' ' GLN . 47.4 t0 -57.31 -25.37 59.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.86 . . . . 0.0 109.713 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -78.47 -38.09 41.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 110.126 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -62.99 -39.52 94.97 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.266 -0.973 . . . . 0.0 109.695 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -69.25 -30.38 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.026 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.62 61.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.216 -1.552 . . . . 0.0 109.462 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -83.7 -52.48 6.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.022 -1.049 . . . . 0.0 110.799 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.629 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -86.7 14.88 6.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.544 -0.723 . . . . 0.0 110.666 -177.643 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -14.7 89.38 0.01 OUTLIER Glycine 0 N--CA 1.5 2.944 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.855 ' CG ' HG21 ' A' ' 155' ' ' ILE . 97.2 m-85 -76.03 160.07 30.19 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -58.93 -40.86 85.88 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.315 -0.866 . . . . 0.0 109.754 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.1 t -144.49 155.22 43.6 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.212 -0.93 . . . . 0.0 109.104 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.669 ' CE2' HD13 ' A' ' 61' ' ' ILE . 9.8 t-105 -141.68 146.3 35.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.303 -0.873 . . . . 0.0 108.658 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.537 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.3 OUTLIER -176.55 -165.87 0.15 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 153' ' ' ILE . 36.0 m -128.57 165.57 27.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.446 -0.784 . . . . 0.0 109.625 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.684 ' CD1' ' HE ' ' A' ' 154' ' ' ARG . 1.4 mp -95.52 136.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.0 p -91.95 165.6 13.14 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.423 1.106 . . . . 0.0 111.412 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.744 HD23 ' CZ ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -161.5 137.63 8.07 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.884 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.559 ' H ' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -123.64 137.78 54.66 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.601 ' HB2' ' HB3' ' A' ' 149' ' ' ASN . . . -70.56 -7.03 40.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 0.0 109.709 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.519 ' H ' ' HD2' ' A' ' 79' ' ' ARG . 45.8 t0 -110.64 -18.24 13.21 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.519 -0.738 . . . . 0.0 109.396 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.785 HD22 ' HG3' ' A' ' 84' ' ' GLN . 1.7 t-20 -63.34 116.67 27.16 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.239 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -90.07 -16.53 1.79 Allowed 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.964 2.443 . . . . 0.0 113.032 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.785 ' HG3' HD22 ' A' ' 82' ' ' ASN . 16.5 pt20 -80.26 1.18 29.56 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.008 -1.058 . . . . 0.0 109.165 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.431 ' HE2' HD12 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -65.84 -42.16 90.87 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.21 178.497 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -51.45 -47.04 63.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.013 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.87 -43.93 77.62 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.672 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.431 HD12 ' HE2' ' A' ' 85' ' ' LYS . 91.4 mt -61.75 -38.38 87.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.887 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.63 ' CA ' HH11 ' A' ' 89' ' ' ARG . 1.6 mmt-85 -58.78 -25.53 63.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.885 . . . . 0.0 108.865 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -58.57 3.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.465 -0.772 . . . . 0.0 110.248 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -54.81 -45.69 74.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.342 -0.849 . . . . 0.0 109.736 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -67.81 -18.67 64.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.555 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -62.48 -34.38 76.72 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 109.705 -179.483 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.495 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 45.9 p-10 -47.58 140.28 6.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 109.944 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' A' ' 96' ' ' HIS . 23.1 tt0 -77.79 163.08 26.43 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.293 -0.88 . . . . 0.0 109.476 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.523 ' N ' ' CG ' ' A' ' 95' ' ' GLU . 50.7 p-80 -174.64 -167.13 0.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.349 -1.341 . . . . 0.0 112.07 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.99 134.39 2.47 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -106.1 156.07 18.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.86 -178.499 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.6 -6.19 86.63 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -123.04 170.04 10.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.456 -1.026 . . . . 0.0 109.431 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -75.85 142.89 42.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 109.887 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.437 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 1.8 mt-10 -102.79 92.67 4.7 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.749 HG22 ' OG ' ' A' ' 133' ' ' SER . 35.1 t -89.65 128.15 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.484 -0.76 . . . . 0.0 109.636 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.459 ' NH1' HG22 ' A' ' 132' ' ' ILE . 9.2 tmm_? -130.27 122.6 28.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -0.784 . . . . 0.0 109.904 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.632 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 11.0 t80 -100.87 130.92 46.95 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.477 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -87.78 130.25 34.91 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.544 -0.722 . . . . 0.0 110.196 -178.507 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.8 -30.93 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.687 -0.633 . . . . 0.0 109.423 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -162.01 151.48 16.08 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.18 -0.95 . . . . 0.0 109.374 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.81 164.8 39.71 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' A' ' 127' ' ' GLU . . . -147.72 171.53 15.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.478 -1.013 . . . . 0.0 109.281 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.7 154.52 10.74 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.586 ' CB ' HD22 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -93.65 96.78 10.04 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.744 -1.445 . . . . 0.0 110.08 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.503 ' CE1' ' O ' ' A' ' 114' ' ' CYS . 3.5 t80 -87.75 127.95 35.31 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.767 -1.208 . . . . 0.0 109.332 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.514 ' SG ' ' OE1' ' A' ' 123' ' ' GLN . 1.8 m -78.93 129.96 35.07 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.711 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.751 ' C ' HD13 ' A' ' 115' ' ' LEU . 3.0 tm? -114.62 129.47 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.623 ' N ' HD13 ' A' ' 115' ' ' LEU . 4.9 t-160 -114.68 112.84 23.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.417 -0.802 . . . . 0.0 109.558 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.3 112.2 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.441 -0.787 . . . . 0.0 109.597 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.42 -127.76 10.08 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 106.437 -2.665 . . . . 0.0 106.437 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.559 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 46.4 p30 -116.23 75.51 0.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 115.374 -2.53 . . . . 0.0 110.342 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.581 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 22.3 pt-20 -166.2 168.25 15.44 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 5' ' ' ILE . 55.7 t -125.4 138.96 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.46 -0.775 . . . . 0.0 109.986 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 115' ' ' LEU . 7.6 m-85 -127.61 131.25 49.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 0.0 109.353 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.514 ' OE1' ' SG ' ' A' ' 114' ' ' CYS . 7.0 mt-30 -126.45 118.54 25.16 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.031 -1.043 . . . . 0.0 108.983 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.909 ' C ' HD23 ' A' ' 125' ' ' LEU . 21.7 t -110.14 135.54 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.909 HD23 ' C ' ' A' ' 124' ' ' VAL . 0.1 OUTLIER -133.64 90.96 2.78 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.594 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 1.7 p -164.64 134.11 3.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 119.685 -1.884 . . . . 0.0 106.827 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 110' ' ' ALA . 2.5 pt-20 -106.34 93.72 4.75 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 115.71 -2.396 . . . . 0.0 110.185 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.558 ' C ' ' H ' ' A' ' 130' ' ' ASP . 51.7 mttm -115.52 158.95 21.85 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.108 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.632 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 13.4 m120 -58.37 -3.02 0.23 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.345 -1.472 . . . . 0.0 107.622 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 128' ' ' LYS . 56.1 p30 -72.81 152.78 41.39 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.139 -0.976 . . . . 0.0 109.28 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.768 ' C ' HD12 ' A' ' 131' ' ' LEU . 3.0 pp -117.23 161.43 19.49 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.686 0.755 . . . . 0.0 110.052 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.58 ' N ' HD12 ' A' ' 131' ' ' LEU . 17.3 tt -133.11 126.36 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.281 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.749 ' OG ' HG22 ' A' ' 103' ' ' VAL . 19.1 t -122.1 138.53 54.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.452 -0.78 . . . . 0.0 109.605 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.16 147.87 35.02 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.387 -0.821 . . . . 0.0 109.145 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.723 ' O ' HG22 ' A' ' 138' ' ' THR . 39.1 Cg_endo -66.81 156.51 65.69 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.269 1.979 . . . . 0.0 112.795 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.644 ' O ' ' ND1' ' A' ' 137' ' ' HIS . . . -71.84 139.74 49.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.311 -0.868 . . . . 0.0 108.675 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.644 ' ND1' ' O ' ' A' ' 136' ' ' ALA . 7.4 m80 88.62 13.46 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.852 -0.53 . . . . 0.0 109.719 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.723 HG22 ' O ' ' A' ' 135' ' ' PRO . 14.9 t -106.7 126.4 30.4 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.288 -0.883 . . . . 0.0 108.864 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 116' ' ' HIS . 39.6 Cg_endo -63.66 134.06 42.39 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.597 1.531 . . . . 0.0 111.452 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.51 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -172.29 162.08 5.45 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.959 -1.088 . . . . 0.0 109.982 -179.088 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.501 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -133.19 -149.01 0.35 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.159 -0.963 . . . . 0.0 109.413 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -176.38 127.99 0.2 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.925 -1.109 . . . . 0.0 108.938 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.76 138.68 18.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 109.143 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.623 ' SD ' ' CZ ' ' A' ' 89' ' ' ARG . 1.4 mpt? -113.17 21.69 15.06 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.395 -0.816 . . . . 0.0 110.574 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.599 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.67 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.501 2.971 0 CA-C-N 119.417 1.008 . . . . 0.0 111.835 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.477 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 74.9 m -86.74 117.24 25.36 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 117.94 -1.504 . . . . 0.0 109.562 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.45 ' N ' ' OE1' ' A' ' 147' ' ' GLU . 22.3 mp0 -115.2 116.92 41.81 Favored Pre-proline 0 C--N 1.294 -1.835 0 O-C-N 121.805 -0.56 . . . . 0.0 109.778 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.751 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 51.1 Cg_endo -103.39 31.96 0.07 OUTLIER 'Trans proline' 0 C--O 1.207 -1.064 0 C-N-CA 123.395 2.73 . . . . 0.0 111.791 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.751 ' ND2' ' O ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER 82.54 63.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 123.102 1.43 . . . . 0.0 109.807 -178.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.744 ' CZ ' HD23 ' A' ' 78' ' ' LEU . 11.2 p90 -99.84 -178.86 3.99 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 119.805 -1.809 . . . . 0.0 110.16 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 59.7 m -135.69 131.7 36.0 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.701 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -134.98 153.94 51.91 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.065 -1.022 . . . . 0.0 108.972 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.459 HG12 HG12 ' A' ' 75' ' ' VAL . 10.9 mt -110.21 129.58 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.159 -0.963 . . . . 0.0 109.805 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.684 ' HE ' ' CD1' ' A' ' 76' ' ' ILE . 25.9 mtm-85 -143.97 170.08 16.6 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.192 -0.943 . . . . 0.0 109.481 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.855 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.6 mp -101.33 145.81 10.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.471 -0.768 . . . . 0.0 109.034 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.521 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 5.2 m-85 -96.38 118.73 33.52 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.489 -0.757 . . . . 0.0 109.408 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.575 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 55.3 p30 -134.89 161.57 34.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.848 -0.533 . . . . 0.0 109.607 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.605 ' O ' ' NE1' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -96.08 156.99 36.47 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.096 . . . . 0.0 108.981 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.5 Cg_endo -66.93 -54.06 0.45 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.667 2.245 . . . . 0.0 112.249 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.6 ' N ' ' OD1' ' A' ' 158' ' ' ASN . 95.5 mt-10 -44.4 -17.53 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.312 -0.867 . . . . 0.0 108.856 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.48 -50.84 5.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.605 ' NE1' ' O ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -104.07 169.33 8.56 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.474 -1.016 . . . . 0.0 109.95 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 74.9 mt -96.99 149.81 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 0.0 109.341 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 96' ' ' HIS . . . -83.31 -71.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 0.0 110.349 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -117.6 146.3 43.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.161 -0.962 . . . . 0.0 109.699 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -101.56 -41.71 6.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.436 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 69.4 p -106.44 -31.18 8.67 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.22 -0.925 . . . . 0.0 109.049 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.23 -9.1 56.01 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -82.78 145.98 29.23 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.253 -1.734 . . . . 0.0 108.722 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -112.33 90.6 3.38 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.527 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.07 -16.78 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.036 -1.665 . . . . 0.0 108.758 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -57.94 -38.05 75.22 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.672 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 22.7 t -51.61 -3.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.232 -0.917 . . . . 0.0 110.191 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.664 ' HB3' ' CE2' ' A' ' 175' ' ' TYR . . . -76.64 -42.05 43.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.784 -1.197 . . . . 0.0 111.701 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.664 ' CE2' ' HB3' ' A' ' 174' ' ' ALA . 0.1 OUTLIER -113.95 26.7 0.1 OUTLIER Pre-proline 0 N--CA 1.511 2.606 0 O-C-N 120.574 -1.328 . . . . 0.0 111.966 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.672 ' HD3' ' C ' ' A' ' 173' ' ' SER . 46.4 Cg_endo -60.95 -24.24 79.03 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 124.146 3.231 . . . . 0.0 113.038 -172.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.11 126.18 35.35 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.895 -1.122 . . . . 0.0 109.186 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.512 ' O ' ' C ' ' A' ' 179' ' ' ALA . 1.3 tp -87.59 122.69 31.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.633 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.633 ' O ' ' OG1' ' A' ' 19' ' ' THR . 11.3 p . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.68 170.76 8.78 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.301 -0.874 . . . . 0.0 109.325 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 4' ' ' THR . 3.8 tp -159.01 115.92 2.72 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.437 ' N ' HD12 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -108.83 140.78 41.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.746 HG23 ' O ' ' A' ' 121' ' ' VAL . 32.1 mt -134.18 134.65 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -126.65 166.89 16.51 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.9 m -86.04 173.92 9.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.051 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.3 -28.09 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.982 -1.074 . . . . 0.0 109.399 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -75.83 -36.59 59.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 110.381 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -137.89 123.75 12.81 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.476 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -81.69 -32.11 0.94 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.066 1.844 . . . . 0.0 112.353 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.577 ' NE2' ' O ' ' A' ' 12' ' ' GLN . 23.5 tp60 -69.81 2.78 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.448 -0.782 . . . . 0.0 110.011 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -114.73 120.11 38.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.912 . . . . 0.0 109.474 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.85 122.15 40.62 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.251 -0.906 . . . . 0.0 109.248 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 15' ' ' LEU . 10.8 mp -90.43 -6.18 55.21 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.022 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.707 ' HB3' HD12 ' A' ' 5' ' ' ILE . 39.1 t90 -156.22 105.13 2.29 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.43 -1.308 . . . . 0.0 110.276 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -119.13 110.97 17.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.642 -0.661 . . . . 0.0 109.544 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.448 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -163.01 163.45 26.03 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.002 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 19' ' ' THR . 11.7 t -131.47 90.77 2.91 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 120.786 -1.196 . . . . 0.0 108.416 176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.806 ' O ' HD12 ' A' ' 24' ' ' ILE . 29.9 m120 -124.66 152.29 43.84 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.851 -1.156 . . . . 0.0 110.613 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.32 -47.54 11.38 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.343 -1.473 . . . . 0.0 108.758 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -82.49 -43.35 17.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.347 -0.846 . . . . 0.0 110.242 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.498 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.2 tt0 -66.07 -24.73 66.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.749 -1.219 . . . . 0.0 108.908 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 20' ' ' ASN . 3.3 mt -68.26 -58.45 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.165 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.61 ' NE2' ' CD1' ' A' ' 35' ' ' PHE . 3.3 pt20 -58.39 -43.77 88.69 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.127 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.586 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 50.4 tt0 -53.89 -35.11 61.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.463 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.551 ' OE1' ' CE2' ' A' ' 16' ' ' TRP . 3.3 tp60 -66.97 -63.55 1.04 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.0 -1.062 . . . . 0.0 109.314 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.571 ' HB2' HG21 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -69.18 -54.94 12.24 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.822 -1.174 . . . . 0.0 109.834 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 17.1 t-20 -47.52 -33.06 5.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.681 -1.262 . . . . 0.0 109.068 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -63.68 -25.33 68.16 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.064 -1.022 . . . . 0.0 108.531 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 28' ' ' LEU . 29.0 mttm -91.39 10.53 27.17 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.273 -0.892 . . . . 0.0 110.498 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.92 25.88 12.4 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.048 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.6 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 48.4 t -96.36 146.2 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.449 -1.03 . . . . 0.0 109.347 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.458 ' CD ' HD11 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -84.77 155.24 21.93 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.135 -0.978 . . . . 0.0 109.243 -179.045 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.61 ' CD1' ' NE2' ' A' ' 25' ' ' GLN . 2.1 t80 -155.37 154.26 31.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.043 -1.036 . . . . 0.0 109.006 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 35' ' ' PHE . 11.5 tp10 -176.12 173.05 2.27 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.975 -1.078 . . . . 0.0 109.519 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.45 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 65.4 mtm-85 -148.54 118.45 7.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.039 -1.038 . . . . 0.0 108.603 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.44 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 30.2 m0 -110.93 148.37 32.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.324 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -137.08 159.98 40.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.437 -0.789 . . . . 0.0 109.664 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.27 160.45 14.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 109.044 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -98.45 -18.46 18.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.236 -0.915 . . . . 0.0 108.687 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -93.54 167.85 11.42 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -94.39 121.15 35.63 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.727 . . . . 0.0 109.386 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.33 167.14 11.52 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.05 -121.7 0.59 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.44 78.83 9.63 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.068 -1.254 . . . . 0.0 108.653 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.15 95.62 30.99 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 121.375 -0.828 . . . . 0.0 109.309 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.689 ' O ' HG23 ' A' ' 49' ' ' THR . 46.8 Cg_endo -70.61 79.17 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.22 1.947 . . . . 0.0 111.736 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.689 HG23 ' O ' ' A' ' 48' ' ' PRO . 6.0 p -162.99 118.03 1.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.061 -1.024 . . . . 0.0 109.364 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.81 -43.98 17.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.062 -1.024 . . . . 0.0 109.96 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -65.11 -17.17 64.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.392 -0.817 . . . . 0.0 109.728 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.6 m -77.05 -41.78 41.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.229 -0.919 . . . . 0.0 110.373 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.445 HG11 ' CG1' ' A' ' 107' ' ' VAL . 20.6 t -63.93 -47.87 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.051 -1.031 . . . . 0.0 109.537 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 58' ' ' GLN . 11.7 mm -61.21 -42.25 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 108.722 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.38 -30.3 71.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.332 -0.855 . . . . 0.0 109.83 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.77 -19.38 59.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 110.405 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.0 m-85 -113.75 -6.67 13.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.373 -0.829 . . . . 0.0 109.462 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 57' ' ' TYR . 3.2 tp-100 -47.74 -39.72 18.56 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -50.43 -44.22 55.25 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.619 -1.3 . . . . 0.0 109.369 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.87 -59.42 4.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.869 -1.144 . . . . 0.0 110.452 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -61.41 -30.39 47.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 120.912 -1.117 . . . . 0.0 108.968 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -55.04 -28.85 55.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.01 -1.056 . . . . 0.0 109.68 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -74.94 -38.94 61.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.034 -1.041 . . . . 0.0 109.4 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.8 mp -65.28 -35.34 80.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.069 -1.019 . . . . 0.0 109.739 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 61' ' ' ILE . 2.6 t -70.11 -31.18 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.72 64.02 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.639 -1.288 . . . . 0.0 109.386 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -87.33 -52.52 5.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 110.612 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.581 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -85.81 14.85 5.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.843 . . . . 0.0 110.44 -177.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.581 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -19.54 89.08 0.01 OUTLIER Glycine 0 N--CA 1.495 2.572 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.518 ' CG ' HG21 ' A' ' 155' ' ' ILE . 48.8 m-85 -76.75 167.71 21.36 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -57.19 -88.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.431 -0.793 . . . . 0.0 109.452 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -104.74 166.13 10.59 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.399 0.619 . . . . 0.0 109.69 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.562 ' HE1' HG23 ' A' ' 153' ' ' ILE . 5.5 t-105 -137.58 141.61 41.31 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.448 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -158.47 176.64 12.17 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.4 p -122.89 144.58 31.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.1 mt -105.53 116.84 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.484 ' O ' ' OG ' ' A' ' 77' ' ' SER . 11.2 p -168.66 103.05 0.41 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.261 -0.9 . . . . 0.0 109.216 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 79' ' ' ARG . 1.0 OUTLIER -115.27 -177.22 3.09 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 120.7 1.591 . . . . 0.0 108.645 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' ASP . 2.3 ttt180 -92.82 152.61 19.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.375 -1.453 . . . . 0.0 109.129 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.15 -6.87 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.062 -1.024 . . . . 0.0 110.4 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ARG . 95.3 m-20 -92.52 33.78 1.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.501 HD21 ' HD2' ' A' ' 83' ' ' PRO . 6.3 t-20 -76.12 124.8 88.42 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.914 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.501 ' HD2' HD21 ' A' ' 82' ' ' ASN . 55.8 Cg_endo -80.16 -27.86 3.42 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.645 2.23 . . . . 0.0 112.271 177.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -90.79 10.66 25.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.917 -1.115 . . . . 0.0 109.194 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.501 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 0.4 OUTLIER -53.34 -58.52 6.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.146 -0.972 . . . . 0.0 108.815 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.38 -51.4 52.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.116 -0.99 . . . . 0.0 109.324 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.99 -42.06 72.0 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.343 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 5.7 tp -59.75 -42.92 94.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.179 -0.95 . . . . 0.0 109.199 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -56.77 -37.67 71.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.568 -1.332 . . . . 0.0 110.174 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -66.06 -22.35 66.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.538 ' CG ' ' N ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -65.64 -45.47 82.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.617 -0.677 . . . . 0.0 110.121 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.668 ' CD2' ' O ' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -88.14 -13.57 40.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 0.0 110.477 -178.506 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 92' ' ' PHE . 65.5 tp -42.18 -18.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.152 -0.967 . . . . 0.0 109.883 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 92' ' ' PHE . 9.4 p30 -99.8 114.61 27.89 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.055 -1.028 . . . . 0.0 109.235 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.504 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 3.0 pp20? -52.02 173.91 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.504 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 50.2 p-80 -176.5 -166.78 0.17 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.295 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.06 135.47 3.83 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.607 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -103.61 154.8 19.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 109.741 -178.567 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.73 -6.59 87.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -123.97 171.18 9.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.333 -1.099 . . . . 0.0 109.424 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -74.31 141.79 45.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.975 . . . . 0.0 110.068 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.607 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 3.7 tt0 -102.83 89.9 3.62 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 103' ' ' VAL . 13.8 p -88.43 130.43 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.082 -1.011 . . . . 0.0 110.521 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.544 ' NH1' ' HE ' ' A' ' 154' ' ' ARG . 52.5 mtt-85 -129.68 121.79 27.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.594 -0.691 . . . . 0.0 109.439 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.615 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 21.7 t80 -101.76 132.97 47.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 108.593 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.542 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.33 129.53 35.36 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.677 -0.639 . . . . 0.0 109.747 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.474 ' HB ' HG22 ' A' ' 151' ' ' THR . 19.3 t -112.42 -30.41 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.697 -0.627 . . . . 0.0 109.749 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -168.59 158.69 9.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.04 -1.038 . . . . 0.0 109.108 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.05 156.83 5.61 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.33 -168.79 1.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -1.126 . . . . 0.0 109.35 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.31 -135.75 3.5 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.708 HD12 HD12 ' A' ' 178' ' ' LEU . 3.9 mt -144.74 162.91 35.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -1.138 . . . . 0.0 109.602 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -136.83 89.6 2.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 109.455 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.49 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -79.48 108.68 13.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.428 -0.795 . . . . 0.0 109.904 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.49 HD12 ' C ' ' A' ' 114' ' ' CYS . 9.2 mp -115.71 114.13 24.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.289 -0.882 . . . . 0.0 109.118 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.442 ' NE2' ' O ' ' A' ' 118' ' ' GLY . 11.1 t-160 -102.89 109.9 21.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.046 -1.034 . . . . 0.0 109.476 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.2 mt -125.59 111.79 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.281 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.442 ' O ' ' NE2' ' A' ' 116' ' ' HIS . . . 75.45 -142.92 29.78 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 106.427 -2.669 . . . . 0.0 106.427 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.49 ' O ' ' CG ' ' A' ' 119' ' ' ASP . 48.2 p-10 -103.48 79.09 1.66 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 114.909 -2.716 . . . . 0.0 109.167 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.438 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 24.0 tp10 -166.29 167.28 16.13 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.474 -1.391 . . . . 0.0 107.781 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.746 ' O ' HG23 ' A' ' 5' ' ' ILE . 57.3 t -128.52 147.06 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.809 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -123.94 131.4 53.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.771 -0.581 . . . . 0.0 109.714 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.417 ' O ' HD12 ' A' ' 3' ' ' LEU . 38.6 mm-40 -126.65 106.66 9.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -0.949 . . . . 0.0 108.905 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.01 136.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.2 tt -136.53 91.57 2.67 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.937 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 20.0 p -166.16 136.37 3.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.598 -1.314 . . . . 0.0 108.468 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.507 ' O ' ' CD ' ' A' ' 127' ' ' GLU . 3.4 tm-20 -107.23 93.95 4.83 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 115.819 -2.352 . . . . 0.0 110.884 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.551 ' C ' ' H ' ' A' ' 130' ' ' ASP . 30.4 mttp -114.5 155.55 26.21 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.755 176.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.615 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 12.6 p30 -55.71 -5.15 0.13 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.229 -1.544 . . . . 0.0 107.928 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 128' ' ' LYS . 43.4 p-10 -72.21 150.3 43.82 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.881 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.783 ' C ' HD12 ' A' ' 131' ' ' LEU . 3.0 pp -119.03 161.58 20.0 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.753 0.787 . . . . 0.0 110.547 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 131' ' ' LEU . 17.0 tt -134.84 125.57 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.2 t -120.21 135.84 54.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 0.0 109.444 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.7 m -95.99 148.02 33.88 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.303 -0.873 . . . . 0.0 108.821 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.04 154.9 71.49 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.239 1.96 . . . . 0.0 112.621 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.613 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.93 136.34 46.82 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.613 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 5.7 t-80 91.67 11.12 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.92 126.61 30.67 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.32 131.63 30.82 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.621 1.547 . . . . 0.0 111.449 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.566 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.94 167.66 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.132 -0.98 . . . . 0.0 110.064 -179.145 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.536 ' CD2' ' HB2' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -138.41 -150.07 0.32 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.269 -0.895 . . . . 0.0 109.52 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.668 ' O ' ' CD2' ' A' ' 92' ' ' PHE . 76.9 t80 -174.95 122.93 0.24 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.893 -1.129 . . . . 0.0 109.034 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.594 ' OD2' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -139.29 134.06 32.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.321 -0.862 . . . . 0.0 110.186 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.622 ' O ' ' C ' ' A' ' 145' ' ' GLY . 4.0 mtp -113.42 20.65 15.9 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.667 -0.646 . . . . 0.0 110.569 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.622 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 5.17 -83.83 0.0 OUTLIER Glycine 0 N--CA 1.503 3.13 0 CA-C-N 119.155 0.889 . . . . 0.0 111.62 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.558 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 22.2 p -87.81 118.8 27.58 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.001 -1.48 . . . . 0.0 109.019 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -112.85 109.68 52.52 Favored Pre-proline 0 C--N 1.292 -1.911 0 C-N-CA 119.514 -0.875 . . . . 0.0 109.054 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.659 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 58.3 Cg_endo -100.06 20.44 0.27 Allowed 'Trans proline' 0 C--O 1.195 -1.629 0 C-N-CA 123.147 2.565 . . . . 0.0 112.129 176.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.738 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 9.4 p-10 90.39 69.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 123.533 1.635 . . . . 0.0 110.14 -176.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 14.2 p90 -89.21 167.44 13.09 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 118.986 -2.322 . . . . 0.0 110.278 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.474 HG22 ' HB ' ' A' ' 107' ' ' VAL . 13.6 m -131.41 118.69 20.61 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.734 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.75 163.71 33.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.505 -0.747 . . . . 0.0 109.041 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.562 HG23 ' HE1' ' A' ' 73' ' ' TRP . 36.8 mt -110.81 131.18 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.335 -0.853 . . . . 0.0 109.914 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.569 ' NH1' ' O ' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -133.51 161.1 35.5 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.118 -0.988 . . . . 0.0 108.885 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.569 ' O ' ' NH1' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -104.1 146.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.544 -0.722 . . . . 0.0 109.087 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.448 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.7 m-30 -95.97 119.67 34.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.025 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.44 ' HB3' ' CZ2' ' A' ' 162' ' ' TRP . 24.3 t70 -134.65 160.8 36.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.845 -0.535 . . . . 0.0 109.654 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -96.21 161.0 28.56 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 109.172 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.4 Cg_endo -67.89 -54.03 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.564 2.176 . . . . 0.0 111.859 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 159' ' ' PRO . 98.1 mt-10 -42.91 -20.21 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.86 -36.64 7.68 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.558 ' N ' ' O ' ' A' ' 159' ' ' PRO . 45.9 m0 -97.06 165.28 12.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.36 -1.082 . . . . 0.0 110.266 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 21.0 mm -99.1 153.5 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.306 -0.871 . . . . 0.0 109.386 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.76 -72.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.163 -0.96 . . . . 0.0 110.404 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -141.07 153.43 45.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -0.919 . . . . 0.0 109.796 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.32 -41.65 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.249 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.61 -31.29 8.54 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.42 -8.17 62.15 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -80.79 148.24 30.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.686 -1.479 . . . . 0.0 108.591 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.53 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 47.4 p30 -111.02 87.82 2.63 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 117.536 -1.666 . . . . 0.0 111.514 175.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.6 tt -78.37 -17.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 119.968 -1.707 . . . . 0.0 109.352 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 141' ' ' TRP . . . -61.68 -40.45 95.03 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.71 -0.619 . . . . 0.0 109.338 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.638 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 53.9 p -53.43 -3.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.526 ' HB3' ' CE2' ' A' ' 175' ' ' TYR . . . -80.09 -39.9 28.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.947 -1.096 . . . . 0.0 111.362 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.622 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 7.0 m-85 -111.47 24.8 0.08 OUTLIER Pre-proline 0 N--CA 1.514 2.749 0 O-C-N 120.791 -1.193 . . . . 0.0 112.482 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.638 ' HD3' ' C ' ' A' ' 173' ' ' SER . 53.8 Cg_endo -65.26 -19.62 62.23 Favored 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 123.399 2.732 . . . . 0.0 113.129 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -89.03 125.54 35.04 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.043 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.727 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 1.5 tp -88.44 118.93 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.42 -0.8 . . . . 0.0 109.236 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.566 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.624 ' O ' ' OG1' ' A' ' 19' ' ' THR . 10.5 p . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.16 171.24 8.58 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.191 -0.943 . . . . 0.0 109.142 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 4' ' ' THR . 3.4 tp -158.97 115.84 2.72 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -109.14 139.23 44.32 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.151 -0.968 . . . . 0.0 110.149 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.757 HD12 ' HB3' ' A' ' 16' ' ' TRP . 45.0 mt -132.99 132.26 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.06 165.03 20.26 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 p -84.99 174.04 10.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.149 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.62 -31.23 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.096 -1.003 . . . . 0.0 109.362 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 tttp -74.13 -37.94 63.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.184 -0.948 . . . . 0.0 110.532 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.85 124.11 14.18 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.005 -1.059 . . . . 0.0 109.537 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.78 -30.06 1.52 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.922 1.748 . . . . 0.0 112.308 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -69.85 4.69 1.86 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.461 -0.774 . . . . 0.0 110.358 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -117.83 119.12 33.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.052 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -97.67 126.17 42.85 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.135 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 15' ' ' LEU . 4.0 mm? -91.83 -8.35 46.85 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.94 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.757 ' HB3' HD12 ' A' ' 5' ' ' ILE . 33.2 t90 -157.47 103.91 1.98 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.276 -1.37 . . . . 0.0 110.587 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -117.47 109.24 16.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.536 -0.727 . . . . 0.0 109.413 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.452 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -163.89 163.95 23.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.261 -0.9 . . . . 0.0 109.724 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 19' ' ' THR . 9.9 t -131.47 90.69 2.89 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.508 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.75 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -124.5 146.94 48.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.221 -0.925 . . . . 0.0 110.479 177.249 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.99 -39.49 23.53 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.266 -1.521 . . . . 0.0 108.423 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -82.86 -48.57 10.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.624 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -59.94 -25.07 64.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.086 -1.009 . . . . 0.0 108.42 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.75 HD12 ' O ' ' A' ' 20' ' ' ASN . 13.0 mt -72.38 -50.81 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.025 -1.047 . . . . 0.0 108.999 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 29' ' ' ASN . 1.1 tm0? -62.06 -51.92 66.02 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.287 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.706 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 14.9 mm100 -61.21 -40.3 93.47 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.235 -0.916 . . . . 0.0 109.732 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.664 ' NE2' ' CD1' ' A' ' 16' ' ' TRP . 39.6 tt0 -75.07 -50.8 15.27 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.062 -1.024 . . . . 0.0 109.478 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 28' ' ' LEU . 17.3 tp -70.45 -56.18 7.23 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.847 -1.158 . . . . 0.0 109.832 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 25' ' ' GLN . 0.7 OUTLIER -57.1 -19.9 22.34 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.776 -1.202 . . . . 0.0 109.286 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -67.5 -27.99 67.46 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.796 -1.19 . . . . 0.0 108.637 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -86.42 12.54 10.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.141 -0.974 . . . . 0.0 109.604 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.24 21.58 32.16 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.185 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.428 HG21 ' HG ' ' A' ' 28' ' ' LEU . 47.9 t -92.71 146.54 6.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.384 -1.068 . . . . 0.0 109.348 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.1 ttt85 -82.49 156.87 23.82 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -155.21 155.46 33.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.815 -1.178 . . . . 0.0 108.354 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.476 ' OE2' ' N ' ' A' ' 37' ' ' ARG . 1.3 mm-40 -175.42 174.73 2.27 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.051 -1.031 . . . . 0.0 109.3 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.476 ' N ' ' OE2' ' A' ' 36' ' ' GLU . 74.4 mtm-85 -151.93 112.95 4.24 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -110.73 151.52 27.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.124 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.577 ' OE1' ' ND2' ' A' ' 129' ' ' ASN . 16.8 mm100 -138.49 154.35 48.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.908 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.93 158.34 16.06 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -101.28 -9.09 21.53 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.2 mtp85 -92.91 155.0 17.86 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.792 0.806 . . . . 0.0 109.216 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -93.25 118.98 31.89 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.569 -0.707 . . . . 0.0 109.524 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.12 161.89 14.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.774 0.797 . . . . 0.0 109.488 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.32 -99.26 0.15 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.98 92.63 4.97 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.134 -1.215 . . . . 0.0 109.483 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.27 92.02 30.33 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.434 -0.791 . . . . 0.0 109.008 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.42 -28.27 7.07 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.314 2.01 . . . . 0.0 112.613 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.6 p -119.57 141.86 48.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.619 -0.675 . . . . 0.0 109.594 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.34 -16.71 53.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.471 -0.768 . . . . 0.0 109.432 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -50.56 -37.49 39.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 109.06 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.5 m -78.64 -33.39 47.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 109.484 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.66 -52.41 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.352 -0.843 . . . . 0.0 110.273 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.505 HG22 ' HG2' ' A' ' 58' ' ' GLN . 6.4 mt -59.21 -40.01 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.046 -1.034 . . . . 0.0 108.836 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.34 -32.13 69.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.367 -0.833 . . . . 0.0 109.479 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.416 ' O ' ' CD2' ' A' ' 59' ' ' HIS . . . -74.67 -14.59 60.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.937 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -117.14 -9.4 11.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.0 109.588 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.505 ' HG2' HG22 ' A' ' 54' ' ' ILE . 6.1 mm100 -50.86 -39.75 54.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.102 -0.998 . . . . 0.0 109.07 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.453 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 20.0 p80 -51.71 -46.1 63.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.453 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -60.39 -59.24 5.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.988 -1.07 . . . . 0.0 109.703 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.679 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -64.48 -28.54 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.717 -1.239 . . . . 0.0 109.364 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 58' ' ' GLN . 24.7 t70 -55.56 -25.09 36.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.372 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -84.36 -37.22 21.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 109.556 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -46.73 74.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.31 -0.869 . . . . 0.0 109.497 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 69' ' ' GLY . 1.1 p -70.03 -30.45 44.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.394 -0.816 . . . . 0.0 109.633 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.54 -46.29 66.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.152 -0.967 . . . . 0.0 109.484 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -77.6 -48.92 15.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.103 -0.998 . . . . 0.0 109.647 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.653 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -85.22 13.75 6.01 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.448 -0.782 . . . . 0.0 110.16 -177.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.653 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -1.46 84.08 0.0 OUTLIER Glycine 0 N--CA 1.502 3.053 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.91 ' CG ' HG21 ' A' ' 155' ' ' ILE . 20.3 m-85 -77.06 164.53 25.64 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.21 -1.171 . . . . 0.0 109.446 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -59.85 -43.11 94.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.57 -0.706 . . . . 0.0 110.222 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.27 165.65 36.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.991 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.736 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 6.6 t-105 -135.6 139.4 43.81 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.388 -0.82 . . . . 0.0 109.165 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.461 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -160.08 178.4 9.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 152' ' ' ALA . 1.3 t -117.91 141.69 35.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 pt -100.42 116.97 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.511 ' HB3' ' O ' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -174.59 106.7 0.11 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.113 -0.992 . . . . 0.0 109.69 177.487 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.547 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -101.38 179.99 4.2 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 120.9 1.682 . . . . 0.0 109.052 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.547 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 9.4 tpt180 -88.81 146.25 25.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.968 -1.083 . . . . 0.0 109.386 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.9 0.38 0.15 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 109.489 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 79' ' ' ARG . 23.9 t70 -91.58 -27.13 18.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.175 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.646 HD22 ' HB2' ' A' ' 84' ' ' GLN . 0.1 OUTLIER -63.52 122.14 74.43 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 120.911 -1.118 . . . . 0.0 109.437 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -83.78 -5.07 10.69 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.159 1.906 . . . . 0.0 112.385 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.646 ' HB2' HD22 ' A' ' 82' ' ' ASN . 55.6 mt-30 -86.39 3.02 45.46 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.653 -1.28 . . . . 0.0 109.428 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 144' ' ' MET . 29.3 tptt -61.08 -46.61 89.94 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.176 -0.952 . . . . 0.0 109.134 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.601 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 15.9 mm-40 -59.85 -50.04 75.33 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.758 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.53 -41.49 88.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.889 . . . . 0.0 109.475 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.08 -55.09 32.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.96 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.601 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 7.4 ptt-85 -64.26 -20.14 65.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.97 -60.57 2.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.863 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -56.28 -37.44 69.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.107 -0.996 . . . . 0.0 109.538 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -72.45 -18.7 61.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 109.719 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 93' ' ' LEU . 0.4 OUTLIER -62.33 -26.3 68.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.666 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -48.74 145.9 3.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.918 . . . . 0.0 109.928 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.502 ' OE1' HG22 ' A' ' 171' ' ' ILE . 55.1 tt0 -76.54 157.27 32.2 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.5 -0.75 . . . . 0.0 110.095 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.423 ' N ' ' CG ' ' A' ' 95' ' ' GLU . 46.0 p-80 -172.17 -170.6 0.75 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.736 -1.185 . . . . 0.0 111.978 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.8 t -163.01 137.69 6.42 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.689 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.85 155.4 20.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.545 -178.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.66 -5.56 86.3 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.459 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 23.8 tp10 -124.52 168.49 13.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.378 -1.072 . . . . 0.0 109.221 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.415 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 88.5 m-20 -74.52 143.43 44.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.117 . . . . 0.0 110.106 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' A' ' 98' ' ' HIS . 2.2 mt-10 -101.08 90.37 4.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.12 -0.987 . . . . 0.0 108.491 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.674 HG12 ' OG ' ' A' ' 133' ' ' SER . 15.7 m -85.86 130.26 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.693 -0.629 . . . . 0.0 110.138 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.712 ' NE ' HH21 ' A' ' 154' ' ' ARG . 41.0 ttm105 -131.03 128.29 40.02 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.458 -0.777 . . . . 0.0 109.598 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.498 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 36.9 t80 -106.1 129.15 54.24 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.65 129.9 36.02 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.488 -0.757 . . . . 0.0 110.395 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.4 t -115.2 -27.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.651 -0.656 . . . . 0.0 109.672 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -166.29 153.06 9.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.395 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.96 154.25 25.64 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.695 ' HB2' ' HG2' ' A' ' 127' ' ' GLU . . . -137.45 165.83 25.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.191 -1.182 . . . . 0.0 108.944 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.34 152.97 10.09 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.628 HD23 HD12 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -99.72 98.61 9.43 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.047 -1.267 . . . . 0.0 110.256 -179.135 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 114' ' ' CYS . 2.3 t80 -84.4 135.02 34.44 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.873 -1.142 . . . . 0.0 109.715 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.568 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -77.77 117.68 19.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.431 0.634 . . . . 0.0 109.815 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 122' ' ' PHE . 2.2 mt -106.71 123.11 47.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 7.0 t-160 -105.53 106.97 17.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.156 -0.965 . . . . 0.0 109.602 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.424 HG23 HG21 ' A' ' 138' ' ' THR . 3.2 mt -119.95 109.34 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.956 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.34 -144.37 31.76 Favored Glycine 0 N--CA 1.502 3.092 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -100.5 78.27 2.0 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 114.891 -2.724 . . . . 0.0 109.521 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 1.6 mt-10 -167.04 171.94 10.6 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.724 ' O ' HG23 ' A' ' 5' ' ' ILE . 78.6 t -125.14 140.76 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.076 -1.015 . . . . 0.0 109.907 177.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 115' ' ' LEU . 26.4 m-85 -122.72 128.51 50.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.7 -0.625 . . . . 0.0 110.364 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' THR . 32.6 mm-40 -119.97 104.62 10.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -100.58 133.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.628 HD12 HD23 ' A' ' 112' ' ' LEU . 1.3 tt -133.34 87.57 2.4 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.107 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.616 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 16.8 p -167.88 122.42 0.97 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.695 ' HG2' ' HB2' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -105.47 100.0 9.58 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 116.384 -2.127 . . . . 0.0 110.352 -178.502 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.611 ' C ' ' H ' ' A' ' 130' ' ' ASP . 1.5 mmmt -117.24 166.02 12.76 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.19 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.577 ' ND2' ' OE1' ' A' ' 39' ' ' GLN . 11.2 p30 -58.62 -0.31 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.611 ' H ' ' C ' ' A' ' 128' ' ' LYS . 53.6 p-10 -69.52 139.14 53.8 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.862 -1.149 . . . . 0.0 109.819 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.583 HD13 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -91.28 123.18 34.52 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.884 0.849 . . . . 0.0 109.586 -178.112 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.583 ' N ' HD13 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -115.11 112.18 38.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.111 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.674 ' OG ' HG12 ' A' ' 103' ' ' VAL . 9.4 t -120.74 151.68 39.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.391 -0.818 . . . . 0.0 109.168 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.72 137.79 20.88 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.564 ' O ' ' OG1' ' A' ' 138' ' ' THR . 36.6 Cg_endo -61.99 154.95 58.41 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.977 1.785 . . . . 0.0 113.46 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -74.85 136.35 41.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.347 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.619 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 24.4 t60 94.77 9.21 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.564 ' OG1' ' O ' ' A' ' 135' ' ' PRO . 0.2 OUTLIER -104.48 127.39 29.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.164 179.684 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.7 132.03 31.45 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.64 1.56 . . . . 0.0 111.678 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.529 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.0 163.9 9.43 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.142 -179.343 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.566 ' O ' ' CZ ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -135.3 -148.15 0.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.122 -0.986 . . . . 0.0 109.567 -178.707 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.68 ' CD1' ' NH2' ' A' ' 154' ' ' ARG . 90.1 t80 -176.42 127.54 0.2 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.962 -1.087 . . . . 0.0 109.281 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.499 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 43.3 p30 -148.2 137.52 22.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -0.871 . . . . 0.0 109.785 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.593 ' O ' ' C ' ' A' ' 145' ' ' GLY . 4.2 mmt -112.59 19.09 17.82 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.451 -0.781 . . . . 0.0 111.122 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.593 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 9.78 -88.12 0.0 OUTLIER Glycine 0 N--CA 1.507 3.395 0 CA-C-N 119.155 0.889 . . . . 0.0 111.922 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.489 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 22.9 p -89.0 119.62 29.68 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.253 -1.379 . . . . 0.0 109.6 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.559 ' O ' ' CG ' ' A' ' 147' ' ' GLU . 8.4 pt-20 -109.14 117.13 54.16 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.621 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 57.2 Cg_endo -102.42 25.48 0.12 Allowed 'Trans proline' 0 N--CA 1.48 0.731 0 C-N-CA 122.361 2.041 . . . . 0.0 111.363 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 13.9 t-20 80.73 69.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.96 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.511 ' O ' ' HB3' ' A' ' 77' ' ' SER . 20.9 p90 -94.68 -178.21 4.46 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.488 -0.758 . . . . 0.0 109.084 -177.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 86.1 m -148.3 95.9 2.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.543 -0.723 . . . . 0.0 109.988 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -110.47 163.5 13.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.988 -1.07 . . . . 0.0 108.787 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.736 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 25.6 mt -111.57 129.7 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.712 HH21 ' NE ' ' A' ' 104' ' ' ARG . 63.0 mtt180 -138.91 168.32 20.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 110.063 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.91 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.2 mp -105.41 147.87 10.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.642 -0.661 . . . . 0.0 109.667 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.461 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.6 m-30 -95.79 117.75 31.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.545 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.602 ' OD2' ' NE1' ' A' ' 162' ' ' TRP . 17.9 t0 -136.46 160.75 37.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.842 -0.536 . . . . 0.0 109.771 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.52 160.65 29.06 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.176 -0.953 . . . . 0.0 109.106 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.4 Cg_endo -66.56 -50.86 1.14 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.883 2.388 . . . . 0.0 112.306 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 159' ' ' PRO . 96.1 mt-10 -43.34 -20.77 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.481 -0.762 . . . . 0.0 109.073 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -87.75 -42.15 6.15 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.602 ' NE1' ' OD2' ' A' ' 157' ' ' ASP . 45.8 m0 -96.17 166.49 11.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.293 -1.122 . . . . 0.0 109.888 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.3 mm -98.23 148.39 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 109.666 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 96' ' ' HIS . . . -79.09 -71.57 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.096 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -135.42 155.89 49.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.244 -0.91 . . . . 0.0 109.659 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -101.3 -41.1 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.635 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 60.2 p -108.09 -30.43 8.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.21 -0.931 . . . . 0.0 109.198 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.75 -8.28 56.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -80.65 148.04 30.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.887 -1.36 . . . . 0.0 108.451 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.503 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 34.6 p30 -111.03 87.55 2.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.966 -1.493 . . . . 0.0 111.122 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.502 HG22 ' OE1' ' A' ' 95' ' ' GLU . 1.7 tt -78.09 -17.39 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.261 -1.524 . . . . 0.0 109.486 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.504 ' HB2' ' CD2' ' A' ' 141' ' ' TRP . . . -60.2 -41.43 92.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.636 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 59.6 p -53.51 -3.72 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 110.283 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.518 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . . . -79.25 -40.21 31.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.004 . . . . 0.0 111.279 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.612 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 5.8 m-85 -112.63 24.96 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.623 0 O-C-N 120.575 -1.328 . . . . 0.0 112.471 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.636 ' HD3' ' C ' ' A' ' 173' ' ' SER . 44.3 Cg_endo -62.16 -18.82 64.14 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 123.71 2.94 . . . . 0.0 113.75 -172.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.0 ttm-85 -89.11 125.85 35.2 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.363 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.489 ' HB3' ' H ' ' A' ' 146' ' ' SER . 4.5 tt -88.38 123.44 32.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.213 -0.929 . . . . 0.0 109.194 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.298 -1.656 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.395 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.838 ' O ' HG23 ' A' ' 19' ' ' THR . 6.4 p . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.96 171.06 8.52 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.881 -1.137 . . . . 0.0 109.053 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 4' ' ' THR . 3.2 tp -158.99 116.94 2.85 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.674 ' OG1' HD11 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -109.83 133.47 53.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.64 -178.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.688 HD12 ' HB3' ' A' ' 16' ' ' TRP . 5.7 mt -128.16 134.83 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -126.59 168.02 14.86 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m -85.23 174.24 9.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.234 -0.916 . . . . 0.0 108.981 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -28.3 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.954 -1.091 . . . . 0.0 109.415 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -76.69 -34.7 58.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.55 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.39 124.08 14.69 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.202 -0.936 . . . . 0.0 109.429 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.55 -36.85 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.119 1.879 . . . . 0.0 112.347 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.53 3.99 2.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 110.235 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -111.9 119.05 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.418 -0.801 . . . . 0.0 109.211 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -99.41 120.97 40.46 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.379 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 15' ' ' LEU . 11.0 mp -91.32 -4.01 56.25 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.171 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.73 ' NE1' ' NE2' ' A' ' 27' ' ' GLN . 41.8 t90 -156.8 104.44 2.13 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 118.433 -1.307 . . . . 0.0 110.542 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -119.07 112.18 19.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.541 -0.725 . . . . 0.0 109.57 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.555 ' OG ' ' CH2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -161.45 163.7 30.26 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.262 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.838 HG23 ' O ' ' A' ' 1' ' ' SER . 45.4 m -131.38 89.56 2.74 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.938 -1.102 . . . . 0.0 108.35 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.762 ' O ' HD12 ' A' ' 24' ' ' ILE . 31.0 m120 -127.83 142.23 51.35 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.425 -0.797 . . . . 0.0 110.37 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.13 -37.86 23.17 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.303 -1.498 . . . . 0.0 108.337 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -83.67 -50.64 7.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.855 . . . . 0.0 109.751 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.46 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.2 tt0 -59.13 -21.73 59.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.107 -0.996 . . . . 0.0 108.754 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.762 HD12 ' O ' ' A' ' 20' ' ' ASN . 11.2 mt -76.09 -49.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.13 -0.981 . . . . 0.0 109.207 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -59.68 -44.8 93.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.777 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -70.78 -38.58 73.42 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.243 -0.91 . . . . 0.0 109.344 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.73 ' NE2' ' NE1' ' A' ' 16' ' ' TRP . 50.4 tt0 -77.0 -49.81 14.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 110.252 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 33' ' ' VAL . 12.2 tp -62.07 -54.52 40.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.015 -1.053 . . . . 0.0 108.857 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.884 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -61.95 -16.45 51.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.905 -1.122 . . . . 0.0 109.856 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 27' ' ' GLN . . . -62.77 -30.07 71.17 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.63 -1.294 . . . . 0.0 108.845 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.96 11.09 12.23 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.009 -1.076 . . . . 0.0 109.558 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.46 25.01 31.84 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.513 HG21 HD11 ' A' ' 28' ' ' LEU . 75.2 t -95.47 145.99 7.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 122.018 0.913 . . . . 0.0 109.471 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -84.32 156.87 21.7 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 121.346 -0.846 . . . . 0.0 108.855 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.614 ' HB2' HD22 ' A' ' 29' ' ' ASN . 1.8 t80 -154.12 149.63 27.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.913 -1.117 . . . . 0.0 109.041 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -169.79 167.78 9.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.006 -1.059 . . . . 0.0 109.866 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.474 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 18.8 ptt-85 -151.82 115.91 4.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.425 -0.797 . . . . 0.0 109.139 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.507 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 11.7 m0 -113.22 157.31 21.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.17 166.39 25.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.678 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.93 162.19 13.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.366 -0.834 . . . . 0.0 108.932 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -94.49 -26.02 16.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.123 -0.986 . . . . 0.0 108.695 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -94.85 172.98 7.83 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -89.86 131.59 35.71 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.368 -0.833 . . . . 0.0 108.993 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.4 mt -92.97 167.95 11.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.239 -0.913 . . . . 0.0 109.812 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.78 -94.28 0.11 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.45 107.47 7.6 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.33 -1.1 . . . . 0.0 108.166 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.4 90.44 45.31 Favored Pre-proline 0 C--N 1.302 -1.494 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.677 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -83.71 40.92 0.96 Allowed 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.795 2.33 . . . . 0.0 111.221 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 52' ' ' THR . 19.1 m -166.24 138.11 3.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.61 -1.306 . . . . 0.0 109.457 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 52' ' ' THR . . . -82.64 -51.78 7.42 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.905 -1.122 . . . . 0.0 110.262 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.15 -0.68 1.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.422 -0.799 . . . . 0.0 109.75 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -77.08 -56.82 4.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 109.806 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.486 ' N ' HG22 ' A' ' 52' ' ' THR . 49.0 t -64.19 -45.53 96.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 O-C-N 121.137 -0.977 . . . . 0.0 109.579 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.4 mt -59.82 -41.07 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.274 -0.97 . . . . 0.0 108.807 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.87 -24.16 67.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.351 -0.843 . . . . 0.0 109.788 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.04 -21.48 56.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.047 -1.033 . . . . 0.0 110.323 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 58' ' ' GLN . 57.0 m-85 -112.28 -6.54 14.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.384 -0.822 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 62' ' ' ASP . 4.2 mm100 -45.85 -39.05 8.02 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.743 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -50.81 -48.04 59.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.909 -1.116 . . . . 0.0 109.634 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.607 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.37 -60.77 3.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.01 -1.056 . . . . 0.0 110.309 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.654 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -62.6 -29.71 47.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 120.751 -1.218 . . . . 0.0 109.184 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 58' ' ' GLN . 45.5 t0 -54.85 -27.62 43.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.805 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -77.82 -37.41 48.68 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.018 -1.051 . . . . 0.0 109.812 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.6 mp -63.98 -39.22 93.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.126 -0.984 . . . . 0.0 109.865 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.51 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -69.24 -29.06 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 0.0 108.924 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.02 -54.12 47.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.474 -1.391 . . . . 0.0 109.297 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.42 -52.47 5.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.254 -0.904 . . . . 0.0 110.954 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.624 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -86.86 14.53 7.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 110.596 -177.565 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -15.54 89.31 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.525 ' CG ' HG21 ' A' ' 155' ' ' ILE . 87.4 m-85 -77.58 164.78 25.05 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -58.56 -88.01 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 109.949 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.52 ' OG ' ' CG ' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -101.26 159.72 15.01 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.568 -0.707 . . . . 0.0 109.618 -179.064 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.497 ' HE1' HG23 ' A' ' 153' ' ' ILE . 6.5 t-105 -136.29 140.04 43.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.496 -0.753 . . . . 0.0 109.139 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.1 -173.47 2.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 108.775 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.677 HG12 ' HA ' ' A' ' 153' ' ' ILE . 1.9 m -122.99 148.45 26.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.513 -0.742 . . . . 0.0 109.587 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.574 HG23 ' O ' ' A' ' 76' ' ' ILE . 2.8 tt -100.89 118.09 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 150' ' ' PHE . 91.8 p -171.83 103.79 0.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.604 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.556 ' CD1' ' H ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -105.39 -178.38 3.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 121.078 1.763 . . . . 0.0 108.209 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.617 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 8.2 tpt180 -89.45 148.77 23.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.891 -1.131 . . . . 0.0 109.528 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.41 3.91 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.615 -0.678 . . . . 0.0 109.641 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 79' ' ' ARG . 80.5 m-20 -92.16 -24.11 19.19 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.922 -1.111 . . . . 0.0 109.34 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.822 ' N ' HD21 ' A' ' 82' ' ' ASN . 0.0 OUTLIER -60.63 118.07 31.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.83 -1.169 . . . . 0.0 109.586 -178.412 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -88.57 -23.77 0.98 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.241 1.96 . . . . 0.0 112.501 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -91.93 -14.8 28.97 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.919 -1.113 . . . . 0.0 109.945 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.511 ' CB ' ' OD1' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -60.89 -35.75 77.44 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.794 178.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 96.9 mt-10 -57.17 -40.57 77.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.133 -0.979 . . . . 0.0 108.491 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.41 -27.29 68.43 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.792 -1.193 . . . . 0.0 109.154 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.6 tp -60.67 -47.61 85.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -0.948 . . . . 0.0 109.989 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -64.58 -27.66 69.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.108 -0.995 . . . . 0.0 109.285 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.07 -60.74 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.394 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -58.33 -35.07 71.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.08 -1.013 . . . . 0.0 109.19 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -79.77 -18.35 51.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.414 -0.803 . . . . 0.0 109.956 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 94' ' ' ASN . 0.3 OUTLIER -60.75 -26.49 67.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.49 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.483 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 32.5 p-10 -46.27 135.22 8.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.293 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.68 159.33 13.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 0.0 109.871 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -171.9 -169.73 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.763 -1.175 . . . . 0.0 111.965 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.81 130.98 4.47 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.549 0.69 . . . . 0.0 109.364 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.621 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -100.67 154.37 18.65 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.625 -0.672 . . . . 0.0 109.716 -179.453 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.11 -7.98 87.52 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -123.4 170.98 9.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -1.112 . . . . 0.0 109.286 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -74.07 143.06 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.973 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.599 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 5.0 tt0 -103.49 90.02 3.55 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.947 HG22 ' OG ' ' A' ' 133' ' ' SER . 26.1 t -85.7 127.06 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.286 -0.884 . . . . 0.0 109.714 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 115.49 17.29 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.501 -0.749 . . . . 0.0 109.617 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.65 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 10.9 t80 -99.94 132.19 45.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 108.612 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.723 ' CD2' ' HB2' ' A' ' 110' ' ' ALA . 0.8 OUTLIER -91.08 135.47 33.74 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.364 0.602 . . . . 0.0 109.939 -179.01 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.0 t -116.84 -26.97 2.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.371 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 109' ' ' GLY . 73.7 tt0 -169.12 158.02 8.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.155 -0.965 . . . . 0.0 108.949 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 108' ' ' GLU . . . 48.37 107.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.723 ' HB2' ' CD2' ' A' ' 106' ' ' PHE . . . -151.8 112.33 4.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.649 -1.501 . . . . 0.0 109.574 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.93 -141.97 4.36 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.502 HD22 HD23 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -108.9 100.42 9.63 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.329 -1.101 . . . . 0.0 110.851 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.659 ' CD2' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.47 132.12 36.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.934 -1.104 . . . . 0.0 110.043 -178.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 9.8 m -78.46 154.7 30.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.554 -0.716 . . . . 0.0 110.148 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 122' ' ' PHE . 1.1 tp -145.28 121.0 10.51 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.5 t-160 -111.48 111.15 21.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.224 -0.923 . . . . 0.0 109.677 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.46 113.85 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.744 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.49 -145.14 35.3 Favored Glycine 0 N--CA 1.503 3.15 0 N-CA-C 106.146 -2.782 . . . . 0.0 106.146 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -100.73 77.74 1.91 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 114.581 -2.848 . . . . 0.0 109.688 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.59 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 1.5 mt-10 -166.6 170.0 13.09 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 120.949 -1.095 . . . . 0.0 108.064 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 5' ' ' ILE . 50.7 t -126.56 140.34 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.573 ' O ' ' N ' ' A' ' 115' ' ' LEU . 2.3 m-85 -126.95 130.71 50.61 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.601 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -131.23 110.14 10.91 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.444 -0.785 . . . . 0.0 109.134 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -98.52 138.22 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.113 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.727 ' H ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.8 88.13 2.68 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.425 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.522 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 5.2 p -167.89 136.11 2.37 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.291 -1.506 . . . . 0.0 107.216 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -104.42 96.8 6.86 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 115.292 -2.563 . . . . 0.0 110.05 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.586 ' C ' ' H ' ' A' ' 130' ' ' ASP . 24.5 mmtt -116.75 157.48 25.43 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.324 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.65 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 40.3 m-80 -58.38 -2.11 0.18 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.586 ' H ' ' C ' ' A' ' 128' ' ' LYS . 17.2 m-20 -70.47 147.32 49.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.108 -0.995 . . . . 0.0 109.303 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.754 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.8 OUTLIER -111.31 154.66 24.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.605 0.717 . . . . 0.0 110.448 -179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.754 ' N ' HD12 ' A' ' 131' ' ' LEU . 29.1 mm -116.65 118.73 59.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.947 ' OG ' HG22 ' A' ' 103' ' ' VAL . 0.3 OUTLIER -111.03 129.82 55.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.545 -0.722 . . . . 0.0 109.285 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.48 141.75 23.19 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.06 153.66 71.79 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.058 1.839 . . . . 0.0 112.347 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.623 ' O ' ' CG ' ' A' ' 137' ' ' HIS . . . -71.06 135.45 47.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -0.85 . . . . 0.0 108.895 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.623 ' CG ' ' O ' ' A' ' 136' ' ' ALA . 2.6 m170 89.83 14.95 0.05 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.094 0.473 . . . . 0.0 110.004 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.39 127.21 28.66 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.53 131.65 32.53 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.924 1.749 . . . . 0.0 111.513 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.08 163.09 9.19 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.245 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.516 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -134.52 -148.7 0.32 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.933 . . . . 0.0 109.542 -178.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.78 126.45 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.937 -1.102 . . . . 0.0 109.196 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.479 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 37.2 p-10 -144.58 134.28 23.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.429 -0.794 . . . . 0.0 109.686 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.671 ' SD ' ' N ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -112.96 19.13 17.55 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.614 -0.679 . . . . 0.0 110.44 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 13.18 -93.13 0.01 OUTLIER Glycine 0 N--CA 1.501 3.02 0 CA-C-N 119.216 0.916 . . . . 0.0 111.663 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.447 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 19.4 p -84.53 119.56 25.32 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.259 -1.376 . . . . 0.0 108.924 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -113.71 112.23 48.27 Favored Pre-proline 0 C--N 1.294 -1.847 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.093 178.447 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.8 Cg_endo -103.52 34.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 123.326 2.684 . . . . 0.0 111.542 176.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 12.6 t-20 81.56 69.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.529 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 9.0 p90 -95.67 135.89 36.78 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.064 -1.023 . . . . 0.0 109.944 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.7 m -97.73 119.72 36.82 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.779 -0.575 . . . . 0.0 109.686 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.45 159.96 41.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 109.266 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.677 ' HA ' HG12 ' A' ' 75' ' ' VAL . 96.1 mt -108.69 125.97 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.513 -0.742 . . . . 0.0 110.086 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.552 ' C ' HD13 ' A' ' 155' ' ' ILE . 62.9 mtp180 -132.5 160.72 35.69 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.575 -0.703 . . . . 0.0 109.713 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -108.39 156.91 8.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.416 0.627 . . . . 0.0 109.478 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.52 ' CG ' ' OG ' ' A' ' 72' ' ' SER . 4.5 m-85 -100.51 119.75 38.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.053 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 12.2 p30 -134.55 159.22 41.85 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -98.32 146.76 32.1 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.985 -1.072 . . . . 0.0 109.494 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.618 ' O ' ' N ' ' A' ' 161' ' ' GLY . 47.3 Cg_endo -71.37 -52.61 0.21 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.355 2.037 . . . . 0.0 112.048 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -43.54 -14.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.605 -0.685 . . . . 0.0 109.403 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.49 -32.17 38.87 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.634 ' N ' ' CD1' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -118.71 176.09 5.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.599 -0.942 . . . . 0.0 110.469 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 70.8 mt -94.2 145.75 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.306 -0.871 . . . . 0.0 109.277 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.27 -73.14 0.31 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.372 -0.83 . . . . 0.0 110.643 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -120.91 151.15 40.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.367 -0.833 . . . . 0.0 109.854 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.467 ' CD2' ' N ' ' A' ' 166' ' ' PHE . 2.7 p90 -101.54 -40.43 7.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.564 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 m -110.2 -31.15 7.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.315 -0.866 . . . . 0.0 108.977 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.68 -4.94 53.9 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.421 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -82.76 148.67 27.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.749 -1.442 . . . . 0.0 108.926 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.482 ' OD1' ' OG ' ' A' ' 173' ' ' SER . 60.9 t0 -109.83 89.13 2.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 117.925 -1.51 . . . . 0.0 111.058 176.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 171' ' ' ILE . 0.7 OUTLIER -76.09 -22.38 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.489 -1.382 . . . . 0.0 109.366 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -60.36 -40.55 91.19 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.662 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 24.1 m -51.17 -3.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 110.19 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.573 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . . . -77.4 -41.52 39.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.789 -1.194 . . . . 0.0 111.629 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.631 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 1.0 OUTLIER -112.83 25.24 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.607 0 O-C-N 120.772 -1.205 . . . . 0.0 112.27 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.662 ' HD3' ' C ' ' A' ' 173' ' ' SER . 49.6 Cg_endo -62.41 -22.66 74.36 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.722 2.948 . . . . 0.0 113.522 -172.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 177' ' ' ARG . 28.3 ptt85 -89.42 126.45 35.56 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.003 -1.079 . . . . 0.0 108.885 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.73 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.6 OUTLIER -87.78 118.68 27.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.262 -0.899 . . . . 0.0 109.022 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.534 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.849 ' O ' HG23 ' A' ' 19' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.119 0.485 . . . . 0.0 109.703 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 125' ' ' LEU . . . -95.89 171.09 8.85 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.959 -1.097 . . . . 0.0 109.288 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.95 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 18.7 tp -157.83 109.36 2.28 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.79 127.09 53.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.51 -0.744 . . . . 0.0 110.523 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.664 HD12 ' HB3' ' A' ' 16' ' ' TRP . 51.2 mt -120.87 135.62 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.27 169.75 15.02 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.8 p -87.47 173.05 9.34 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.0 -33.37 6.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.084 -1.01 . . . . 0.0 108.874 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -71.72 -37.47 70.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.53 -0.731 . . . . 0.0 110.384 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.14 125.25 14.58 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.98 -1.075 . . . . 0.0 109.634 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -82.26 -30.21 1.28 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.892 1.728 . . . . 0.0 112.266 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -70.22 0.74 5.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.41 -0.806 . . . . 0.0 110.662 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.769 HD21 HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.7 118.69 34.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.024 -1.047 . . . . 0.0 108.497 179.168 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -97.13 125.42 41.62 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.846 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.769 HD13 HD21 ' A' ' 13' ' ' ASN . 2.6 mp -90.46 -12.25 37.91 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.497 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.95 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 34.7 t90 -159.73 107.41 1.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.222 -1.391 . . . . 0.0 109.939 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -121.09 119.43 32.42 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.09 -1.006 . . . . 0.0 110.332 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.454 ' OG ' ' CZ2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -161.02 166.68 27.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.266 -0.897 . . . . 0.0 110.155 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.849 HG23 ' O ' ' A' ' 1' ' ' SER . 45.8 m -129.21 86.42 2.43 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.634 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -129.45 138.96 51.73 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.794 -0.566 . . . . 0.0 110.369 177.22 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.75 -28.59 30.31 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.592 -1.942 . . . . 0.0 108.905 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -82.95 -53.3 5.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -62.28 -18.76 62.16 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.66 -1.275 . . . . 0.0 107.984 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.728 HG12 HD22 ' A' ' 3' ' ' LEU . 3.0 mt -73.28 -59.14 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.344 -0.847 . . . . 0.0 109.375 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.486 ' N ' HG22 ' A' ' 24' ' ' ILE . 21.2 pt20 -58.34 -39.16 78.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.416 ' N ' ' HG3' ' A' ' 25' ' ' GLN . 44.1 tt0 -66.99 -42.64 84.69 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.332 -0.855 . . . . 0.0 109.47 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.536 ' OE1' ' CE2' ' A' ' 16' ' ' TRP . 1.6 tt0 -67.2 -46.83 72.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.101 -1.0 . . . . 0.0 109.524 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 28' ' ' LEU . 3.7 mm? -65.95 -53.56 37.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.327 -0.858 . . . . 0.0 109.447 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 17.9 t-20 -64.16 -19.0 65.0 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.58 -0.7 . . . . 0.0 110.573 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.15 71.17 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.535 -1.353 . . . . 0.0 108.164 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -89.38 14.81 10.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.598 -0.689 . . . . 0.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.68 20.38 58.28 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.434 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 21.9 t -93.3 147.09 5.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.277 -1.131 . . . . 0.0 109.078 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.684 ' HE ' ' H ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -83.09 155.59 23.77 Favored 'General case' 0 C--N 1.281 -2.378 0 O-C-N 120.644 -1.285 . . . . 0.0 107.833 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.684 ' H ' ' HE ' ' A' ' 34' ' ' ARG . 2.3 t80 -152.87 147.09 25.59 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 17.0 tp10 -174.35 172.65 3.16 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.592 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.466 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 30.7 ptt-85 -151.95 121.86 7.06 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.115 -0.991 . . . . 0.0 108.732 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.465 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 33.7 m0 -112.75 156.43 22.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.512 -0.742 . . . . 0.0 109.141 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -142.64 157.64 44.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.293 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.71 159.06 15.34 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -98.66 -13.6 20.23 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -93.74 156.97 16.39 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.495 ' O ' ' OD2' ' A' ' 43' ' ' ASP . 46.4 p-10 -95.52 122.23 38.05 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.473 -0.767 . . . . 0.0 109.384 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.8 mt -91.8 165.83 13.07 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.176 -0.952 . . . . 0.0 108.95 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.95 -121.92 0.58 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.13 79.45 9.12 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.086 -1.244 . . . . 0.0 108.497 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.62 93.89 46.65 Favored Pre-proline 0 C--N 1.306 -1.317 0 O-C-N 121.462 -0.773 . . . . 0.0 109.56 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.745 ' O ' HG23 ' A' ' 49' ' ' THR . 46.9 Cg_endo -70.2 85.61 0.67 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.084 1.856 . . . . 0.0 111.505 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 48' ' ' PRO . 1.5 p -165.05 117.93 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -0.863 . . . . 0.0 109.019 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.43 -36.84 28.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.836 -1.165 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -69.3 -14.92 63.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.943 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 49' ' ' THR . 4.2 p -78.25 -43.67 27.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.051 -1.031 . . . . 0.0 110.89 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 t -67.13 -46.44 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.938 -1.101 . . . . 0.0 109.564 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 58' ' ' GLN . 55.7 mt -61.2 -39.58 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.282 -0.886 . . . . 0.0 108.888 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.22 70.66 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.678 -0.639 . . . . 0.0 109.905 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.85 -21.61 54.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.067 -1.021 . . . . 0.0 110.376 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -114.44 -7.09 12.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.489 -0.757 . . . . 0.0 109.13 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 62' ' ' ASP . 5.5 tp-100 -48.59 -36.93 16.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.242 -0.911 . . . . 0.0 108.546 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.685 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -53.25 -48.84 67.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.043 -1.035 . . . . 0.0 109.941 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.685 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.06 -55.43 32.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.728 -1.232 . . . . 0.0 109.669 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.653 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -65.71 -26.91 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.083 -1.01 . . . . 0.0 109.543 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 58' ' ' GLN . 20.7 t70 -59.2 -25.2 63.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.461 -0.774 . . . . 0.0 109.224 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.7 -43.29 14.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 110.016 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 tt -65.6 -48.46 72.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.307 -0.87 . . . . 0.0 109.819 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' GLY . 3.4 p -66.91 -28.25 42.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.43 -44.21 76.06 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.791 -1.193 . . . . 0.0 109.279 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -80.02 -52.86 7.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.999 -1.063 . . . . 0.0 109.714 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.623 ' O ' ' C ' ' A' ' 69' ' ' GLY . 54.0 mttm -83.08 12.67 4.79 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.401 -0.812 . . . . 0.0 110.685 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -5.63 83.21 0.0 OUTLIER Glycine 0 N--CA 1.506 3.304 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.838 ' CG ' HG21 ' A' ' 155' ' ' ILE . 69.6 m-85 -75.66 156.6 34.66 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.433 -1.039 . . . . 0.0 109.88 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -64.82 -49.59 70.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.486 -0.759 . . . . 0.0 110.574 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.9 m -125.27 135.49 52.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.356 -0.84 . . . . 0.0 109.729 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.482 ' CZ2' HD13 ' A' ' 61' ' ' ILE . 7.4 t-105 -133.57 138.98 46.29 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.4 -168.87 0.56 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.155 -0.965 . . . . 0.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 152' ' ' ALA . 1.5 t -125.99 155.91 35.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.3 mt -93.88 131.82 39.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.5 p -93.55 167.77 11.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 122.769 1.271 . . . . 0.0 111.839 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.586 HD23 ' H ' ' A' ' 149' ' ' ASN . 10.1 tp -167.78 157.6 10.25 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.497 176.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.456 HH11 HD21 ' A' ' 149' ' ' ASN . 0.0 OUTLIER -128.99 142.18 51.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.412 ' H ' ' HD3' ' A' ' 79' ' ' ARG . . . -67.35 -4.79 11.9 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.216 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.426 ' OD2' ' C ' ' A' ' 81' ' ' ASP . 8.5 p-10 -116.64 -8.02 11.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.197 -0.939 . . . . 0.0 109.087 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.468 ' CG ' ' O ' ' A' ' 82' ' ' ASN . 1.6 p30 -62.88 124.72 84.56 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 109.801 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.36 -2.37 12.25 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.291 1.994 . . . . 0.0 111.954 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -90.19 3.75 52.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.976 . . . . 0.0 109.832 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 19.4 pttp -60.31 -51.25 70.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.159 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.579 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 46.1 tp10 -65.45 -43.16 91.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.882 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.99 -43.48 98.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.855 . . . . 0.0 109.981 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.2 tp -59.46 -45.61 91.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 109.171 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.579 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 17.1 ttp-105 -63.0 -28.59 70.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.555 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HA ' HD23 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -65.93 -60.55 2.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.806 . . . . 0.0 109.377 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -55.88 -31.57 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 109.461 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.06 -18.18 50.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.16 -0.963 . . . . 0.0 110.037 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -64.67 -27.54 68.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -1.0 . . . . 0.0 110.031 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -60.45 136.97 58.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.07 -1.019 . . . . 0.0 110.233 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 169' ' ' ASP . 20.7 pt-20 -73.95 164.07 27.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.394 -0.816 . . . . 0.0 109.186 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -172.54 -167.52 0.46 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.008 -1.058 . . . . 0.0 110.463 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.96 133.17 5.95 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.6 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -103.63 153.47 20.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 109.804 -179.181 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.22 -7.07 86.8 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -125.28 170.93 10.81 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.285 -1.126 . . . . 0.0 109.53 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -71.64 143.02 49.92 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.117 -0.989 . . . . 0.0 109.821 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.6 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 3.3 tt0 -104.16 97.91 7.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 110.034 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.719 HG22 ' OG ' ' A' ' 133' ' ' SER . 5.4 t -97.41 124.71 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.18 126.56 43.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.47 -0.769 . . . . 0.0 109.236 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 33.4 t80 -108.31 129.3 55.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.835 0.826 . . . . 0.0 109.008 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -80.85 117.05 21.16 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.566 -0.709 . . . . 0.0 110.353 -178.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.5 t -85.14 -47.54 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -0.822 . . . . 0.0 110.346 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -169.27 158.1 7.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.915 -1.116 . . . . 0.0 110.545 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.61 61.56 4.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.778 ' HB3' ' HB3' ' A' ' 127' ' ' GLU . . . -119.58 129.9 54.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.877 -1.367 . . . . 0.0 108.446 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -118.57 -29.92 1.79 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.004 HD12 ' N ' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -141.66 160.13 40.79 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.387 -1.066 . . . . 0.0 109.748 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 1.004 ' N ' HD12 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -139.35 95.51 2.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.715 ' O ' HD22 ' A' ' 115' ' ' LEU . 1.8 m -77.78 136.43 38.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.42 -0.8 . . . . 0.0 110.318 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.715 HD22 ' O ' ' A' ' 114' ' ' CYS . 0.3 OUTLIER -145.64 114.19 6.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.409 -0.807 . . . . 0.0 109.734 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 6.8 t-160 -106.73 110.55 22.76 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.901 -1.124 . . . . 0.0 109.342 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.3 mm -128.61 121.53 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.469 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.15 -143.82 36.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 103.682 -3.767 . . . . 0.0 103.682 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.492 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 44.7 p30 -111.0 82.67 1.63 Allowed 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 115.417 -2.513 . . . . 0.0 108.369 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.506 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 60.0 tt0 -164.76 167.69 18.67 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 5' ' ' ILE . 71.0 t -128.5 140.25 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.986 -1.071 . . . . 0.0 110.085 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -125.57 132.25 52.58 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.928 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -142.05 122.13 13.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.069 -1.02 . . . . 0.0 109.029 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -106.74 147.09 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.241 -0.912 . . . . 0.0 109.191 179.621 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 12.9 mt -118.44 78.33 1.25 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 117.848 -1.541 . . . . 0.0 111.586 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.446 ' SG ' ' N ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -166.79 163.65 16.46 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 103.3 -2.852 . . . . 0.0 103.3 177.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.778 ' HB3' ' HB3' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -117.78 110.74 18.18 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 122.59 2.45 . . . . 0.0 106.312 176.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.595 ' C ' ' H ' ' A' ' 130' ' ' ASP . 13.0 mmtt -113.61 148.51 36.08 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.603 -0.686 . . . . 0.0 111.114 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.579 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 93.5 m-20 -61.12 -0.19 0.31 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.595 ' H ' ' C ' ' A' ' 128' ' ' LYS . 49.2 p30 -70.28 153.06 43.48 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.222 1.011 . . . . 0.0 110.903 -176.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.771 ' C ' HD12 ' A' ' 131' ' ' LEU . 0.9 OUTLIER -125.76 161.87 26.37 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.856 0.836 . . . . 0.0 110.972 -178.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.77 ' N ' HD12 ' A' ' 131' ' ' LEU . 1.6 mp -128.43 145.41 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.669 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.719 ' OG ' HG22 ' A' ' 103' ' ' VAL . 2.6 t -119.12 138.08 53.15 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.308 -0.87 . . . . 0.0 109.789 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -112.14 140.06 23.13 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.33 150.83 59.33 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.099 1.866 . . . . 0.0 112.328 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -72.48 132.57 44.04 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.815 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 12.5 t60 94.53 9.86 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.39 126.94 30.12 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 108.46 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.41 132.59 31.82 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.541 1.494 . . . . 0.0 111.463 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.516 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -166.61 162.84 16.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.315 -0.866 . . . . 0.0 110.177 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.672 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 21.6 p90 -127.22 -154.37 0.63 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.505 -0.747 . . . . 0.0 109.818 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.672 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 47.4 t80 -169.71 119.79 0.65 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.491 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 34.3 p30 -139.52 119.64 13.63 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.28 -0.887 . . . . 0.0 108.692 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.566 ' SD ' ' CZ ' ' A' ' 150' ' ' PHE . 25.9 mtm -93.31 16.59 12.91 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 111.491 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.806 ' HA3' HD13 ' A' ' 178' ' ' LEU . . . 50.24 -144.3 10.93 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.587 ' H ' HD22 ' A' ' 178' ' ' LEU . 31.6 t -83.29 121.04 26.6 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.0 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -116.27 120.42 35.05 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.88 -0.512 . . . . 0.0 110.536 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 59.3 Cg_endo -102.87 59.41 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.807 0 C-N-CA 122.378 2.052 . . . . 0.0 110.65 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.586 ' H ' HD23 ' A' ' 78' ' ' LEU . 12.3 t-20 82.48 64.26 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.304 -0.873 . . . . 0.0 109.691 -177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.566 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 1.0 OUTLIER -101.42 168.19 9.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.7 m -127.1 133.19 50.46 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.43 -0.794 . . . . 0.0 109.281 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -138.16 157.35 46.48 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.031 -1.043 . . . . 0.0 109.591 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.3 mt -108.32 124.91 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.062 -1.024 . . . . 0.0 108.985 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.16 164.49 27.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.414 -0.804 . . . . 0.0 109.346 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.838 HG21 ' CG ' ' A' ' 70' ' ' TYR . 2.9 mt -119.24 124.46 73.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.46 ' N ' ' CD1' ' A' ' 156' ' ' PHE . 26.5 m-85 -93.87 133.39 37.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.983 -1.073 . . . . 0.0 110.241 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.62 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -129.84 165.57 21.72 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.644 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -91.2 160.63 36.98 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.935 -1.103 . . . . 0.0 108.625 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 161' ' ' GLY . 36.1 Cg_endo -57.02 -54.28 3.88 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.678 2.252 . . . . 0.0 113.12 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 159' ' ' PRO . 11.8 pt-20 -42.27 -23.17 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.506 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.27 -56.07 2.1 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.644 ' CD1' ' O ' ' A' ' 158' ' ' ASN . 39.0 p-90 -98.86 155.97 17.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.121 -1.223 . . . . 0.0 110.633 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 14.8 tt -103.88 159.08 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.497 -0.752 . . . . 0.0 109.184 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.97 -71.73 0.24 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.37 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -139.82 158.63 43.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.014 -1.054 . . . . 0.0 110.242 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -101.09 -41.87 6.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.162 -0.961 . . . . 0.0 109.704 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.6 m -115.92 -34.21 4.84 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.93 -3.95 57.38 Favored Glycine 0 N--CA 1.484 1.863 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.812 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.422 ' O ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -81.7 148.11 29.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.08 -1.835 . . . . 0.0 107.957 178.498 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -112.35 91.16 3.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.089 -1.444 . . . . 0.0 111.104 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.419 HD11 ' HZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -75.3 -20.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.113 -1.617 . . . . 0.0 108.799 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.624 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -61.34 -39.91 92.3 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.549 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -51.4 -3.85 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.827 -0.546 . . . . 0.0 110.698 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.36 -36.34 34.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.915 -1.116 . . . . 0.0 111.053 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.612 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.5 OUTLIER -111.49 20.09 0.07 OUTLIER Pre-proline 0 N--CA 1.511 2.595 0 O-C-N 120.708 -1.245 . . . . 0.0 113.993 -178.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 51.8 Cg_endo -65.48 -23.62 57.6 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.961 2.441 . . . . 0.0 114.636 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -87.81 126.54 35.07 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.268 -1.373 . . . . 0.0 108.41 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.806 HD13 ' HA3' ' A' ' 145' ' ' GLY . 9.4 tp -85.41 145.2 27.58 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 108.779 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.168 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.584 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.29 168.22 10.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.071 -1.018 . . . . 0.0 109.313 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 4' ' ' THR . 2.6 tp -156.48 125.49 6.01 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.761 ' OG1' HD21 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -121.73 126.62 49.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.205 -0.935 . . . . 0.0 109.633 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.444 HG23 ' CD2' ' A' ' 122' ' ' PHE . 28.1 mt -117.43 140.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.794 ' CZ ' ' O ' ' A' ' 7' ' ' SER . 1.2 t80 -144.41 156.19 44.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.794 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 50.7 p -89.57 179.76 5.97 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.984 -1.073 . . . . 0.0 108.132 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 8' ' ' VAL . 18.7 m -88.19 3.21 5.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 119.975 -1.703 . . . . 0.0 110.149 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.406 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 1.4 mmmt -76.81 -49.57 15.53 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 120.509 -1.369 . . . . 0.0 114.13 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.787 ' O ' ' CE1' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -145.26 123.7 6.59 Favored Pre-proline 0 N--CA 1.507 2.404 0 O-C-N 119.96 -1.712 . . . . 0.0 109.546 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.71 -33.96 26.21 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.324 1.349 . . . . 0.0 113.413 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.43 6.15 1.5 Allowed 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.281 -0.887 . . . . 0.0 110.127 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -125.74 124.64 41.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.152 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.477 ' C ' HD12 ' A' ' 15' ' ' LEU . 92.6 p -113.44 133.44 55.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.46 -0.775 . . . . 0.0 108.931 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.842 ' N ' HD12 ' A' ' 15' ' ' LEU . 6.3 mp -94.19 5.41 51.81 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.105 -0.997 . . . . 0.0 109.881 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.407 ' NE1' ' NE2' ' A' ' 27' ' ' GLN . 23.8 t90 -153.91 102.08 2.48 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.788 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -117.99 107.43 14.03 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.197 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.68 161.71 29.57 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.511 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.822 HG23 ' O ' ' A' ' 19' ' ' THR . 8.8 t -132.57 90.54 2.79 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 120.881 -1.137 . . . . 0.0 107.996 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.782 ' O ' HD12 ' A' ' 24' ' ' ILE . 12.6 t-20 -123.76 141.96 51.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.254 -0.904 . . . . 0.0 110.037 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.83 -35.53 29.31 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.035 -1.666 . . . . 0.0 108.779 176.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -83.13 -52.27 6.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.168 -0.957 . . . . 0.0 109.548 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 1.4 tm-20 -60.17 -20.48 58.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.96 . . . . 0.0 108.667 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.782 HD12 ' O ' ' A' ' 20' ' ' ASN . 4.6 mt -73.04 -54.76 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.198 -0.939 . . . . 0.0 108.766 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -58.72 -43.0 90.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.488 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.692 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 94.9 mt-30 -62.08 -40.72 96.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.207 -0.933 . . . . 0.0 108.967 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.407 ' NE2' ' NE1' ' A' ' 16' ' ' TRP . 55.8 tt0 -73.25 -45.74 54.16 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.79 HD12 HG11 ' A' ' 33' ' ' VAL . 3.3 mm? -67.01 -61.16 2.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.031 -1.043 . . . . 0.0 110.089 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.2 t-20 -59.48 -18.88 43.58 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.321 -0.862 . . . . 0.0 110.262 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.692 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -66.04 -31.25 72.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.81 -1.181 . . . . 0.0 108.966 177.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.644 ' NZ ' ' CE2' ' A' ' 122' ' ' PHE . 13.6 mtmt -91.47 12.3 21.17 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.296 -0.877 . . . . 0.0 109.963 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.25 24.76 30.58 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.159 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.79 HG11 HD12 ' A' ' 28' ' ' LEU . 28.8 t -95.3 147.41 5.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.385 -1.068 . . . . 0.0 109.194 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.457 ' HD3' HD11 ' A' ' 131' ' ' LEU . 18.9 ttt180 -82.82 153.23 25.29 Favored 'General case' 0 C--N 1.285 -2.208 0 O-C-N 120.82 -1.175 . . . . 0.0 108.097 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -154.81 149.45 26.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.063 -1.023 . . . . 0.0 108.564 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.533 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 5.5 pt-20 -178.78 179.54 0.7 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.019 -1.051 . . . . 0.0 110.561 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.8 ptt85 -152.97 122.35 6.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.319 -0.863 . . . . 0.0 109.353 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.612 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 33.4 m0 -111.78 153.38 26.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.49 -0.756 . . . . 0.0 109.108 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -140.01 155.01 47.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.901 . . . . 0.0 109.658 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.27 157.55 15.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 108.783 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -102.73 -8.75 20.6 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.61 162.16 14.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.683 0.754 . . . . 0.0 109.184 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 39.8 p-10 -96.41 123.72 40.16 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.425 0.631 . . . . 0.0 109.694 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.94 160.88 14.24 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.369 -0.832 . . . . 0.0 109.43 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.1 -105.3 0.22 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.87 88.62 4.68 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.057 -1.261 . . . . 0.0 109.078 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.99 91.89 40.77 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.145 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.91 -23.7 13.74 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.179 1.919 . . . . 0.0 112.477 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.0 p -119.65 141.93 48.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.782 -0.574 . . . . 0.0 109.494 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.42 -17.68 51.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.804 . . . . 0.0 109.428 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' ALA . 97.8 mt-10 -44.69 -38.2 4.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.476 -0.765 . . . . 0.0 109.094 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 m -76.36 -33.11 58.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.194 -0.941 . . . . 0.0 109.412 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.561 HG11 ' CG1' ' A' ' 107' ' ' VAL . 70.1 t -65.84 -45.07 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.385 -0.822 . . . . 0.0 110.042 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.935 HD13 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -61.47 -38.54 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.098 -1.001 . . . . 0.0 109.006 -179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.21 -31.28 70.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.425 -0.797 . . . . 0.0 109.686 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.86 -21.78 50.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.084 -1.01 . . . . 0.0 110.443 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -112.53 -10.22 13.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.332 -0.855 . . . . 0.0 109.526 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.609 ' N ' ' O ' ' A' ' 54' ' ' ILE . 4.6 tp-100 -52.64 -43.05 65.2 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.421 -0.911 . . . . 0.0 108.86 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.547 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 27.7 p-80 -49.71 -48.52 49.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.017 -1.052 . . . . 0.0 109.653 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.547 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.08 -60.76 3.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.948 -1.095 . . . . 0.0 109.853 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.686 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -62.13 -30.01 47.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.773 -1.204 . . . . 0.0 109.304 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.4 t70 -55.22 -25.85 35.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.069 -1.019 . . . . 0.0 109.624 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -80.3 -35.23 36.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 109.298 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.97 -42.66 94.36 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.42 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.716 HG22 ' CZ3' ' A' ' 73' ' ' TRP . 0.6 OUTLIER -72.04 -28.97 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 109.532 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.66 -52.91 53.67 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.937 -1.102 . . . . 0.0 109.502 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.64 -46.27 17.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.023 -1.048 . . . . 0.0 109.988 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.626 ' O ' ' C ' ' A' ' 69' ' ' GLY . 23.2 mttm -83.59 13.36 4.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.835 . . . . 0.0 110.631 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.626 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -6.11 82.21 0.0 OUTLIER Glycine 0 N--CA 1.504 3.187 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.896 ' CG ' HG21 ' A' ' 155' ' ' ILE . 43.2 m-85 -76.36 161.82 28.39 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.709 -0.877 . . . . 0.0 109.138 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -58.93 -42.85 90.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 0.0 109.974 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.8 t -151.29 161.21 43.12 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.154 -0.967 . . . . 0.0 109.895 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.716 ' CZ3' HG22 ' A' ' 65' ' ' VAL . 12.3 t-105 -137.74 143.0 40.96 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.454 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -160.87 179.13 8.74 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.935 HG21 HD13 ' A' ' 54' ' ' ILE . 2.7 t -122.9 142.04 40.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.47 -0.769 . . . . 0.0 109.264 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.5 mm -100.0 116.25 42.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.515 ' O ' ' OG ' ' A' ' 77' ' ' SER . 5.8 p -168.71 102.07 0.4 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.512 -0.743 . . . . 0.0 109.047 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.677 HD23 ' HB2' ' A' ' 82' ' ' ASN . 10.3 tp -121.47 179.88 4.3 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 119.581 -1.95 . . . . 0.0 107.712 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.848 HH21 ' HB3' ' A' ' 80' ' ' ALA . 4.0 ttp85 -87.94 160.39 17.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.649 -1.282 . . . . 0.0 109.118 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.848 ' HB3' HH21 ' A' ' 79' ' ' ARG . . . -58.52 -2.74 0.23 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.895 0.855 . . . . 0.0 109.849 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.561 ' CG ' ' HE ' ' A' ' 79' ' ' ARG . 89.1 m-20 -97.95 31.98 2.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.677 ' HB2' HD23 ' A' ' 78' ' ' LEU . 1.5 t30 -80.19 125.13 82.12 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.7 -0.625 . . . . 0.0 110.771 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -78.73 -23.03 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.042 1.828 . . . . 0.0 112.405 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.491 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 88.8 mm-40 -91.9 10.73 27.52 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.917 -1.114 . . . . 0.0 109.365 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.618 ' CA ' ' ND2' ' A' ' 82' ' ' ASN . 47.1 pttt -57.98 -53.68 55.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.585 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 84.8 tt0 -68.7 -52.06 34.98 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.197 -0.94 . . . . 0.0 109.606 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.68 -45.92 84.99 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.71 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 84' ' ' GLN . 7.3 tt -62.3 -43.98 97.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.718 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -59.0 -36.41 74.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.1 -1.0 . . . . 0.0 109.696 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -66.97 -56.27 10.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 109.803 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -51.03 -36.21 38.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.479 -0.763 . . . . 0.0 109.232 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -87.88 -18.97 28.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.544 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.51 -36.09 81.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 109.889 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -61.36 133.41 55.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 110.017 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.74 151.5 38.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.444 -0.785 . . . . 0.0 109.376 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -163.39 -172.88 3.12 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.5 t -163.0 137.69 6.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.688 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -110.46 154.51 23.52 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.395 -0.815 . . . . 0.0 109.663 -178.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.26 -5.75 82.05 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 101' ' ' ASP . 79.9 tt0 -125.11 168.2 13.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.191 -1.181 . . . . 0.0 109.168 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.416 ' N ' ' HG2' ' A' ' 100' ' ' GLU . 92.4 m-20 -73.13 142.99 47.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.893 -1.129 . . . . 0.0 110.315 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.84 95.87 7.49 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.298 -0.876 . . . . 0.0 109.317 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.472 HG13 HD13 ' A' ' 131' ' ' LEU . 20.1 t -80.28 131.5 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.467 0.651 . . . . 0.0 109.302 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.672 ' NH2' ' CE2' ' A' ' 142' ' ' PHE . 20.0 mmm180 -129.26 114.23 16.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.654 -0.654 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.631 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 16.1 t80 -109.75 129.9 55.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.506 ' CD2' ' OE2' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -93.05 137.5 32.35 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 110.396 -179.086 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.561 ' CG1' HG11 ' A' ' 53' ' ' VAL . 38.5 t -111.92 -30.25 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.686 -0.634 . . . . 0.0 109.817 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -168.57 158.27 9.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.067 -1.021 . . . . 0.0 109.426 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.21 162.18 15.56 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.57 -176.62 2.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -1.137 . . . . 0.0 109.317 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.25 -144.36 5.12 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 113' ' ' PHE . 7.6 tt -142.37 160.06 41.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -1.168 . . . . 0.0 109.663 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.607 ' N ' HD23 ' A' ' 112' ' ' LEU . 6.1 m-85 -137.55 87.68 2.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 109.833 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.592 ' SG ' ' NE1' ' A' ' 141' ' ' TRP . 42.2 t -81.01 114.13 19.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.446 -0.784 . . . . 0.0 109.428 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 114' ' ' CYS . 7.8 mt -119.41 117.23 27.92 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.148 -0.97 . . . . 0.0 108.819 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -106.85 113.56 27.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.053 -1.029 . . . . 0.0 109.635 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.79 117.68 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.678 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.74 -143.1 31.98 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 105.85 -2.9 . . . . 0.0 105.85 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -106.71 79.36 1.34 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 115.739 -2.385 . . . . 0.0 108.538 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 121' ' ' VAL . 74.9 tt0 -165.61 167.94 16.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.401 ' N ' ' HG2' ' A' ' 120' ' ' GLU . 3.9 t -130.7 149.18 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.139 -0.976 . . . . 0.0 110.066 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.644 ' CE2' ' NZ ' ' A' ' 31' ' ' LYS . 51.1 m-85 -129.32 133.8 47.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.803 -0.561 . . . . 0.0 109.771 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.552 ' OE1' HD21 ' A' ' 112' ' ' LEU . 83.7 mm-40 -128.39 108.95 10.99 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.792 ' C ' HD13 ' A' ' 125' ' ' LEU . 3.3 t -103.74 138.11 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.978 HD22 ' N ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -130.98 83.17 2.09 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.452 178.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.538 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 25.9 p -170.19 116.89 0.53 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.506 ' OE2' ' CD2' ' A' ' 106' ' ' PHE . 79.3 mm-40 -114.82 103.44 10.95 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 116.126 -2.229 . . . . 0.0 111.245 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.58 ' C ' ' H ' ' A' ' 130' ' ' ASP . 93.6 mttt -109.34 177.26 4.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.333 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.631 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 22.5 p30 -55.7 -5.96 0.18 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.58 ' H ' ' C ' ' A' ' 128' ' ' LYS . 29.7 p30 -72.22 144.55 48.44 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.918 0.866 . . . . 0.0 109.362 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.922 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.2 OUTLIER -109.24 148.47 30.92 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.885 0.85 . . . . 0.0 109.974 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.922 ' N ' HD12 ' A' ' 131' ' ' LEU . 37.3 mm -122.35 121.11 62.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.4 t -111.74 142.4 44.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.67 143.55 26.92 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.0 108.894 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.17 150.19 85.12 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.317 2.011 . . . . 0.0 112.53 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.58 134.7 46.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.38 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.7 t60 92.71 10.17 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.65 125.46 34.71 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.075 -1.016 . . . . 0.0 108.685 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.57 132.05 31.77 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.482 1.455 . . . . 0.0 111.629 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.477 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.71 163.54 9.96 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.235 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.592 ' NE1' ' SG ' ' A' ' 114' ' ' CYS . 0.6 OUTLIER -133.36 -147.33 0.29 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.312 -0.868 . . . . 0.0 109.851 -178.582 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.672 ' CE2' ' NH2' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -178.71 126.26 0.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.887 -1.133 . . . . 0.0 109.289 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 176' ' ' PRO . 53.0 t0 -146.57 137.48 24.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.264 -0.898 . . . . 0.0 109.626 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.588 ' O ' ' C ' ' A' ' 145' ' ' GLY . 5.5 ptt? -109.81 21.1 17.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.515 -0.741 . . . . 0.0 111.295 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.588 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.12 -90.46 0.01 OUTLIER Glycine 0 N--CA 1.503 3.117 0 CA-C-N 119.336 0.971 . . . . 0.0 112.073 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.542 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 39.7 t -86.88 120.41 28.13 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.035 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.671 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -113.42 111.74 49.39 Favored Pre-proline 0 C--N 1.294 -1.805 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.742 178.335 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.584 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.4 Cg_endo -102.07 28.21 0.1 Allowed 'Trans proline' 0 C--O 1.212 -0.822 0 C-N-CA 123.068 2.512 . . . . 0.0 111.432 176.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.584 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 15.0 t-20 84.06 71.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.747 0.784 . . . . 0.0 109.632 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 25.6 p90 -94.89 159.55 14.99 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.64 -0.662 . . . . 0.0 109.528 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.468 HG22 ' HB ' ' A' ' 107' ' ' VAL . 29.7 m -130.26 125.52 35.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.223 -0.923 . . . . 0.0 110.012 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.505 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -144.62 164.16 31.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 109.44 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.538 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 29.1 mt -110.61 129.93 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.075 -1.016 . . . . 0.0 109.346 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.478 ' HE ' ' HD3' ' A' ' 104' ' ' ARG . 4.3 ttt180 -138.6 167.42 21.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.422 -0.799 . . . . 0.0 109.69 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.896 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.1 mp -104.36 146.68 11.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.501 -0.75 . . . . 0.0 109.444 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.454 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.3 m-30 -95.35 118.56 32.32 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.008 0.909 . . . . 0.0 109.732 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.63 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 11.8 p30 -135.89 161.92 34.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.891 -0.505 . . . . 0.0 109.829 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 2.3 m-20 -96.03 160.23 30.46 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.059 -1.025 . . . . 0.0 109.484 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.62 ' O ' ' N ' ' A' ' 162' ' ' TRP . 43.8 Cg_endo -69.02 -54.26 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.56 2.173 . . . . 0.0 112.042 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 159' ' ' PRO . 77.4 tt0 -43.45 -16.84 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 109.219 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.61 -25.67 29.55 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.63 ' HE1' ' CG ' ' A' ' 157' ' ' ASP . 32.6 m95 -107.27 169.08 8.78 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.387 -1.067 . . . . 0.0 109.964 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 77.3 mt -97.21 150.55 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.24 -0.912 . . . . 0.0 109.282 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -76.77 -71.63 0.39 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.31 -0.869 . . . . 0.0 110.449 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -133.95 158.71 42.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.215 -0.928 . . . . 0.0 109.819 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -101.08 -39.67 7.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.873 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.18 -30.26 5.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.328 -0.857 . . . . 0.0 108.957 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.66 -9.92 55.75 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.91 148.56 31.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.838 -1.389 . . . . 0.0 108.074 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -111.22 87.55 2.57 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 117.614 -1.635 . . . . 0.0 110.94 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.516 HG23 ' CH2' ' A' ' 141' ' ' TRP . 2.2 tt -77.79 -16.99 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.602 -1.311 . . . . 0.0 109.147 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -56.25 -38.91 71.75 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.632 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 68.0 m -52.82 -4.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.434 -0.791 . . . . 0.0 109.961 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.551 ' HB3' ' CE2' ' A' ' 175' ' ' TYR . . . -76.23 -41.37 49.42 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.68 -1.262 . . . . 0.0 111.894 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.629 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.6 m-85 -113.29 25.04 0.08 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 O-C-N 120.457 -1.402 . . . . 0.0 112.416 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.632 ' HD3' ' C ' ' A' ' 173' ' ' SER . 41.0 Cg_endo -60.66 -25.97 81.97 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 123.898 3.065 . . . . 0.0 113.892 -172.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -89.57 125.5 35.24 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 118.719 -1.192 . . . . 0.0 108.408 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.725 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.5 OUTLIER -87.34 120.9 29.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.2 -0.937 . . . . 0.0 109.084 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.491 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.641 ' O ' ' OG1' ' A' ' 19' ' ' THR . 6.0 p . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.31 170.48 9.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.208 -0.932 . . . . 0.0 108.699 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 123' ' ' GLN . 2.8 tp -156.93 119.23 3.91 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.505 ' N ' HD12 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -110.74 134.01 52.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.164 -0.96 . . . . 0.0 109.761 -178.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.71 HD12 ' HB3' ' A' ' 16' ' ' TRP . 6.2 mt -127.97 137.51 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.415 ' CE1' HG22 ' A' ' 4' ' ' THR . 96.8 m-85 -130.65 166.59 20.36 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.406 ' OG ' ' CD2' ' A' ' 15' ' ' LEU . 51.0 m -87.41 173.9 8.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.048 -1.033 . . . . 0.0 108.579 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.86 -29.53 5.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.913 -1.117 . . . . 0.0 109.413 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -73.02 -38.12 66.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.783 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -139.22 123.93 11.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.996 -1.065 . . . . 0.0 109.743 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -84.1 -21.91 3.65 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.754 1.636 . . . . 0.0 112.471 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -70.48 -1.87 12.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.484 -0.76 . . . . 0.0 111.579 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.544 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 47.4 p-10 -124.89 122.79 38.37 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.16 -0.962 . . . . 0.0 108.886 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.2 p -93.22 129.76 39.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.874 -1.141 . . . . 0.0 108.53 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 15' ' ' LEU . 11.0 mp -90.38 -7.28 53.62 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.166 -1.013 . . . . 0.0 109.068 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.71 ' HB3' HD12 ' A' ' 5' ' ' ILE . 39.0 t90 -157.58 105.63 2.05 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.253 -1.379 . . . . 0.0 110.055 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -119.0 111.13 17.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.378 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.425 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -161.37 162.71 30.83 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.369 -0.832 . . . . 0.0 109.872 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 19' ' ' THR . 10.2 t -131.72 89.18 2.66 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.005 -1.059 . . . . 0.0 108.153 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.773 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -125.52 151.45 46.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.014 -1.054 . . . . 0.0 110.06 177.423 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.26 -41.32 20.36 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.21 -1.557 . . . . 0.0 108.827 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -82.81 -47.35 12.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 110.737 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -64.52 -23.44 67.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.757 -1.215 . . . . 0.0 108.984 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.773 HD12 ' O ' ' A' ' 20' ' ' ASN . 7.2 mt -70.73 -51.36 37.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.228 -0.92 . . . . 0.0 108.537 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.429 ' NE2' ' CB ' ' A' ' 29' ' ' ASN . 13.2 tm0? -57.08 -50.1 73.83 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.525 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.604 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 44.6 tt0 -58.42 -35.03 71.46 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.525 -0.735 . . . . 0.0 110.229 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.551 ' OE1' ' CE2' ' A' ' 16' ' ' TRP . 3.5 tp60 -64.3 -63.48 1.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.933 -1.105 . . . . 0.0 109.587 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -55.09 14.15 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.114 -0.991 . . . . 0.0 109.76 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 19.8 t-20 -52.46 -27.63 16.91 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.972 -1.08 . . . . 0.0 109.73 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -64.5 -27.05 68.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.677 -1.264 . . . . 0.0 108.263 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -90.71 11.29 22.7 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.26 -0.9 . . . . 0.0 110.54 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.26 25.69 15.87 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.088 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.615 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 43.3 t -96.8 145.75 8.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.348 -1.089 . . . . 0.0 109.929 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -84.17 157.04 21.8 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -153.1 149.82 28.48 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.401 ' HG2' ' HE1' ' A' ' 38' ' ' TRP . 36.2 tp10 -174.89 166.41 3.61 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.95 -1.094 . . . . 0.0 108.619 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -153.77 131.06 11.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.401 ' HE1' ' HG2' ' A' ' 36' ' ' GLU . 11.0 m0 -117.38 151.58 36.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.583 -0.698 . . . . 0.0 109.945 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -135.96 158.75 43.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.372 -0.83 . . . . 0.0 109.439 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.38 160.46 14.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.917 . . . . 0.0 109.179 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -98.64 -17.64 18.5 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.222 -0.924 . . . . 0.0 108.544 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -93.61 164.83 13.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.687 0.756 . . . . 0.0 109.161 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.17 119.39 32.93 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.645 -0.659 . . . . 0.0 109.599 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.98 166.05 12.9 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.4 -121.87 0.59 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.46 79.4 8.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.069 -1.254 . . . . 0.0 108.98 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.92 94.93 26.76 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.448 -0.783 . . . . 0.0 109.205 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.706 ' O ' HG23 ' A' ' 49' ' ' THR . 50.6 Cg_endo -70.86 79.46 1.29 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.002 1.801 . . . . 0.0 111.854 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 48' ' ' PRO . 3.8 p -163.55 119.56 1.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.129 -0.982 . . . . 0.0 109.273 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.95 -43.54 17.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.858 -1.151 . . . . 0.0 110.044 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -66.61 -17.89 65.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.488 -0.757 . . . . 0.0 110.148 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 m -77.11 -40.77 44.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 110.228 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.402 HG11 ' CG1' ' A' ' 107' ' ' VAL . 43.9 t -66.87 -48.11 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.117 -0.989 . . . . 0.0 109.953 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 58' ' ' GLN . 8.5 mm -61.31 -41.94 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 108.619 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.81 -29.87 70.44 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.435 -0.79 . . . . 0.0 109.691 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.16 -17.85 59.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.98 . . . . 0.0 110.12 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 58' ' ' GLN . 57.4 m-85 -114.34 -7.47 12.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 109.121 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 54' ' ' ILE . 4.7 mm100 -46.52 -39.84 11.54 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.759 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.32 -46.6 62.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.54 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -63.67 -59.63 4.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.804 -1.185 . . . . 0.0 110.341 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.681 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -62.32 -31.85 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.996 -1.065 . . . . 0.0 109.352 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.7 t70 -59.04 -25.05 63.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.594 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.54 -39.08 47.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.949 . . . . 0.0 109.411 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.0 mp -64.19 -38.07 89.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.365 -0.834 . . . . 0.0 108.936 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.639 HG22 ' CZ3' ' A' ' 73' ' ' TRP . 2.8 t -71.02 -29.68 38.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.368 -0.832 . . . . 0.0 109.458 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.38 -52.36 63.8 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.514 -1.366 . . . . 0.0 109.597 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.05 -49.8 9.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.955 -1.091 . . . . 0.0 110.366 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.602 ' O ' ' C ' ' A' ' 69' ' ' GLY . 20.2 mmtt -83.99 13.0 5.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -0.868 . . . . 0.0 111.37 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.602 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -3.01 80.83 0.0 OUTLIER Glycine 0 N--CA 1.506 3.336 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.583 ' CG ' HG21 ' A' ' 155' ' ' ILE . 69.1 m-85 -77.35 158.94 29.86 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.658 -0.907 . . . . 0.0 108.791 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -57.65 -88.53 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.479 -0.763 . . . . 0.0 109.3 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -103.44 159.58 15.46 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.719 0.771 . . . . 0.0 110.161 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.639 ' CZ3' HG22 ' A' ' 65' ' ' VAL . 7.9 t-105 -139.51 144.7 38.03 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -163.05 -178.6 6.15 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 152' ' ' ALA . 7.3 p -121.13 143.87 32.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.729 HG23 ' O ' ' A' ' 76' ' ' ILE . 19.8 tt -101.72 115.45 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.625 ' OG ' HG23 ' A' ' 151' ' ' THR . 0.7 OUTLIER -167.94 101.06 0.46 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.816 -0.753 . . . . 0.0 109.194 177.346 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.535 ' HG ' ' H ' ' A' ' 79' ' ' ARG . 11.5 tp -106.59 178.34 4.59 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 121.08 1.764 . . . . 0.0 107.939 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.535 ' H ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -89.88 143.84 26.45 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.693 -1.254 . . . . 0.0 109.664 -178.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.03 0.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.594 -0.691 . . . . 0.0 109.588 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' A' ' 79' ' ' ARG . 58.5 t0 -83.57 -27.54 29.2 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.471 -1.292 . . . . 0.0 109.444 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.494 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -67.41 122.42 83.03 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.054 -1.029 . . . . 0.0 109.507 179.481 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -85.83 -3.78 8.99 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.021 1.814 . . . . 0.0 112.234 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -88.39 -3.44 58.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.944 -1.097 . . . . 0.0 110.513 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.462 ' CG ' ' OD1' ' A' ' 82' ' ' ASN . 2.3 mmtt -62.8 -40.57 97.75 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.036 -1.04 . . . . 0.0 109.283 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -61.05 -54.49 44.1 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.322 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.04 -35.0 75.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.06 -1.025 . . . . 0.0 109.644 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.732 HD23 ' O ' ' A' ' 88' ' ' LEU . 4.3 tt -61.37 -43.51 98.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.73 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.6 ptt-85 -63.76 -25.78 68.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 109.934 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.72 -59.66 3.69 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.408 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -54.25 -29.39 46.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.962 . . . . 0.0 109.27 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.39 -18.37 36.3 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.306 -0.871 . . . . 0.0 109.661 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.666 ' C ' HD12 ' A' ' 93' ' ' LEU . 0.8 OUTLIER -58.44 -25.88 62.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 109.936 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -55.25 142.37 31.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.108 -0.995 . . . . 0.0 110.211 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.511 ' OE2' ' O ' ' A' ' 169' ' ' ASP . 19.8 pt-20 -72.59 164.24 26.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.395 -0.816 . . . . 0.0 109.663 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -174.24 -170.92 0.56 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.492 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.2 t -160.48 132.28 5.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.65 0.738 . . . . 0.0 109.36 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.665 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -103.4 154.64 19.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.712 -0.617 . . . . 0.0 110.01 -179.037 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' A' ' 162' ' ' TRP . . . -78.83 -6.05 88.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 96.6 mt-10 -124.77 170.11 11.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -1.027 . . . . 0.0 109.382 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -74.68 143.54 44.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.956 -1.09 . . . . 0.0 110.103 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.444 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 2.0 mt-10 -101.1 93.64 5.58 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.114 -0.992 . . . . 0.0 108.901 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.519 HG12 ' CB ' ' A' ' 133' ' ' SER . 9.1 m -89.11 130.65 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.767 -0.583 . . . . 0.0 109.495 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.693 ' NH1' ' CD1' ' A' ' 142' ' ' PHE . 21.4 mtp180 -129.59 116.94 19.63 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.561 -0.712 . . . . 0.0 109.437 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.457 ' CE2' ' O ' ' A' ' 106' ' ' PHE . 25.4 t80 -101.08 134.08 44.62 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.457 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.88 129.26 35.63 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.422 -0.799 . . . . 0.0 110.388 -178.492 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.402 ' CG1' HG11 ' A' ' 53' ' ' VAL . 17.9 t -107.96 -33.54 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.577 -0.702 . . . . 0.0 109.711 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -167.97 157.81 10.07 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.094 -1.004 . . . . 0.0 108.88 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.19 161.4 9.14 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.12 -177.51 3.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -1.061 . . . . 0.0 109.107 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.88 -142.51 4.09 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.8 tp -142.62 159.7 41.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.23 -1.159 . . . . 0.0 109.026 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -136.83 88.09 2.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.06 -1.025 . . . . 0.0 109.258 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.75 108.87 14.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.473 -0.767 . . . . 0.0 110.026 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.402 HD23 HG12 ' A' ' 134' ' ' VAL . 1.2 mp -116.43 121.18 41.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -0.924 . . . . 0.0 108.82 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 4.7 t-160 -107.29 113.37 26.72 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.097 -1.002 . . . . 0.0 109.277 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.5 mt -128.34 118.72 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.852 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.17 -142.49 33.05 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 105.429 -3.068 . . . . 0.0 105.429 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -107.8 80.64 1.41 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 121.517 2.658 . . . . 0.0 108.182 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 77.5 tt0 -165.11 166.81 18.82 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 5' ' ' ILE . 41.0 t -126.61 142.12 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.244 -0.91 . . . . 0.0 110.037 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.452 ' CZ ' HD13 ' A' ' 5' ' ' ILE . 2.2 m-85 -124.19 130.85 53.24 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.038 0.447 . . . . 0.0 109.922 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.584 ' O ' HD12 ' A' ' 3' ' ' LEU . 91.2 mt-30 -132.32 118.08 18.97 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 109.35 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.664 ' C ' HD23 ' A' ' 125' ' ' LEU . 2.9 t -106.43 137.89 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.664 HD23 ' C ' ' A' ' 124' ' ' VAL . 0.1 OUTLIER -135.91 91.07 2.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.061 -1.025 . . . . 0.0 110.634 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 20.3 p -166.95 137.47 3.11 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.505 -1.372 . . . . 0.0 108.603 178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.509 ' O ' ' CD ' ' A' ' 127' ' ' GLU . 2.8 tm-20 -106.99 92.92 4.28 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 115.367 -2.533 . . . . 0.0 110.012 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.632 ' C ' ' H ' ' A' ' 130' ' ' ASP . 39.7 tttp -118.26 157.71 26.53 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.439 175.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -56.12 0.83 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.106 -1.621 . . . . 0.0 108.406 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.632 ' H ' ' C ' ' A' ' 128' ' ' LYS . 49.5 p-10 -66.84 131.36 45.75 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.157 0.979 . . . . 0.0 109.566 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.004 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -100.97 132.86 46.18 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.862 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 1.004 ' N ' HD12 ' A' ' 131' ' ' LEU . 8.2 tt -125.43 129.96 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.582 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.519 ' CB ' HG12 ' A' ' 103' ' ' VAL . 3.3 m -125.77 151.59 46.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.402 HG12 HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -107.48 149.59 39.01 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.41 151.52 75.91 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.569 2.179 . . . . 0.0 112.904 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.609 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -73.31 133.47 43.88 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.182 -0.949 . . . . 0.0 109.186 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.609 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.1 t-80 94.89 9.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.166 0.508 . . . . 0.0 109.705 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.09 126.96 30.26 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 108.579 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.84 132.1 31.37 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.57 1.513 . . . . 0.0 111.548 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -168.95 164.06 11.51 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.999 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.415 ' CG ' ' CB ' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -134.46 -148.8 0.33 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 109.348 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.693 ' CD1' ' NH1' ' A' ' 104' ' ' ARG . 83.5 t80 -176.03 126.38 0.21 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.052 -1.03 . . . . 0.0 109.048 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 31.9 p-10 -144.69 132.86 21.62 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.368 -0.833 . . . . 0.0 109.361 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.612 ' O ' ' C ' ' A' ' 145' ' ' GLY . 11.3 ptp -110.9 21.36 16.56 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.657 -0.652 . . . . 0.0 111.093 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.612 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 7.52 -86.21 0.0 OUTLIER Glycine 0 N--CA 1.499 2.893 0 CA-C-N 119.061 0.846 . . . . 0.0 111.94 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.479 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 51.2 m -88.07 116.74 26.47 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 117.688 -1.605 . . . . 0.0 108.75 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.486 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -118.28 115.11 36.28 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.671 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 59.1 Cg_endo -105.04 36.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.437 2.091 . . . . 0.0 111.395 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.671 ' ND2' ' O ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER 81.85 69.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 123.246 1.498 . . . . 0.0 108.682 -177.584 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.412 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 26.7 p90 -95.75 161.68 13.92 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.489 -1.382 . . . . 0.0 109.766 -177.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.625 HG23 ' OG ' ' A' ' 77' ' ' SER . 11.7 m -130.54 125.87 35.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.953 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.455 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -144.26 164.55 30.42 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.8 mt -109.73 128.77 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.954 -1.091 . . . . 0.0 109.342 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -134.51 163.18 30.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.583 HG21 ' CG ' ' A' ' 70' ' ' TYR . 36.2 mt -102.64 144.14 14.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.467 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.3 m-85 -96.46 118.55 33.22 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.415 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -135.73 161.56 35.21 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.04 158.61 33.84 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 120.699 -1.251 . . . . 0.0 109.483 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.584 ' O ' ' N ' ' A' ' 161' ' ' GLY . 46.4 Cg_endo -71.31 -53.86 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.326 2.017 . . . . 0.0 112.737 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 159' ' ' PRO . 83.7 tt0 -43.3 -16.7 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -69.38 -38.76 80.98 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.465 ' HB3' ' H ' ' A' ' 99' ' ' GLY . 4.3 p90 -119.14 175.74 5.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.695 -0.885 . . . . 0.0 111.03 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 76.2 mt -96.26 147.6 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.597 0.713 . . . . 0.0 109.315 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.92 -73.61 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.425 -0.797 . . . . 0.0 110.525 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -126.76 156.6 40.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.149 -0.969 . . . . 0.0 109.872 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.1 -40.6 7.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 0.0 109.754 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 86.1 m -101.54 -32.23 10.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.043 . . . . 0.0 108.976 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.24 -6.93 58.2 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.518 ' O ' ' OD1' ' A' ' 169' ' ' ASP . 44.4 p30 -80.92 148.35 29.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.568 -1.548 . . . . 0.0 108.545 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -112.17 88.68 2.87 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 117.737 -1.585 . . . . 0.0 110.368 175.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.41 HG23 ' H ' ' A' ' 171' ' ' ILE . 0.1 OUTLIER -82.27 -16.83 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.008 -1.682 . . . . 0.0 109.24 179.779 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.455 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -55.98 -37.96 69.78 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.568 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 7.3 m -56.09 -3.97 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.824 -0.547 . . . . 0.0 110.161 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.78 -37.87 29.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.022 -1.049 . . . . 0.0 111.755 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.627 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.5 m-85 -112.83 23.09 0.08 OUTLIER Pre-proline 0 N--CA 1.513 2.717 0 O-C-N 120.558 -1.339 . . . . 0.0 113.037 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 46.1 Cg_endo -63.31 -19.56 68.58 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 123.443 2.762 . . . . 0.0 114.262 -173.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -88.93 126.47 35.41 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.765 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.502 ' H ' ' HA3' ' A' ' 145' ' ' GLY . 5.7 tt -87.8 122.25 31.22 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.926 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.297 -1.691 0 O-C-N 121.138 -0.976 . . . . 0.0 109.367 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.81 ' O ' HG23 ' A' ' 19' ' ' THR . 5.1 p . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.11 169.03 9.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.004 -1.06 . . . . 0.0 109.08 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.454 HD13 HG22 ' A' ' 124' ' ' VAL . 4.8 tp -157.79 117.3 3.29 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.49 ' OG1' HD11 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -114.44 135.97 53.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.432 -0.792 . . . . 0.0 109.973 -178.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.679 HD12 ' HB3' ' A' ' 16' ' ' TRP . 25.7 mt -130.44 133.6 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -127.4 168.26 15.09 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.413 ' HB2' HD21 ' A' ' 13' ' ' ASN . 0.1 OUTLIER -89.39 174.81 7.6 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.216 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -87.73 -23.77 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.066 . . . . 0.0 109.575 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -75.1 -37.93 61.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.051 -1.031 . . . . 0.0 110.413 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -136.93 126.49 15.58 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.655 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 13' ' ' ASN . 56.2 Cg_endo -79.87 -39.16 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.002 1.801 . . . . 0.0 112.156 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 9.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.729 . . . . 0.0 110.041 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -114.69 119.1 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.176 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.9 p -102.29 122.9 45.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.249 -0.907 . . . . 0.0 109.493 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.446 HD13 HD21 ' A' ' 13' ' ' ASN . 3.6 mp -90.2 -3.86 57.59 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.671 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.679 ' HB3' HD12 ' A' ' 5' ' ' ILE . 35.4 t90 -156.04 104.25 2.26 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.667 -1.213 . . . . 0.0 110.256 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -118.8 110.36 17.14 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.736 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.464 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -162.58 163.62 27.16 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.079 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.81 HG23 ' O ' ' A' ' 1' ' ' SER . 54.6 m -130.93 89.46 2.75 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.15 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.773 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -128.16 148.46 50.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.429 -0.794 . . . . 0.0 110.401 177.099 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.38 -38.27 22.2 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.311 -1.493 . . . . 0.0 108.107 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -83.69 -48.8 9.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.472 -0.767 . . . . 0.0 109.855 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 27' ' ' GLN . 43.9 tt0 -60.99 -24.02 65.81 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.831 -1.168 . . . . 0.0 108.604 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.773 HD12 ' O ' ' A' ' 20' ' ' ASN . 10.4 mt -73.04 -62.75 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.174 -0.953 . . . . 0.0 109.497 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.514 ' CD ' ' N ' ' A' ' 26' ' ' GLN . 3.8 pp0? -61.41 -43.34 99.04 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.879 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 25' ' ' GLN . 11.0 tm0? -61.49 -43.99 97.88 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.129 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.588 ' OE1' ' CE2' ' A' ' 16' ' ' TRP . 5.3 tt0 -77.67 -47.23 19.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.977 . . . . 0.0 109.229 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 24' ' ' ILE . 23.9 tp -66.45 -54.41 24.47 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.999 -1.063 . . . . 0.0 109.149 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 25' ' ' GLN . 40.7 t-20 -57.9 -20.08 34.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.0 109.411 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 27' ' ' GLN . . . -65.25 -27.63 68.78 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.06 -1.025 . . . . 0.0 108.796 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.78 13.39 10.73 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.217 -0.927 . . . . 0.0 109.867 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.13 22.95 30.97 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.179 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.479 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 56.3 t -94.13 145.43 7.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.424 -1.044 . . . . 0.0 109.344 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.442 ' NE ' ' OG ' ' A' ' 133' ' ' SER . 2.4 ttm-85 -84.0 158.4 21.51 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.24 -0.912 . . . . 0.0 108.724 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.541 ' CE1' ' OD2' ' A' ' 130' ' ' ASP . 1.2 t80 -153.38 145.67 23.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.943 -1.098 . . . . 0.0 108.682 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.554 ' O ' ' OD1' ' A' ' 130' ' ' ASP . 43.8 mt-10 -165.81 168.64 15.78 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.188 -0.945 . . . . 0.0 109.961 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -148.53 113.91 5.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.587 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 22.1 m0 -109.98 153.81 24.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.273 -0.892 . . . . 0.0 109.308 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -142.79 159.09 42.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.902 . . . . 0.0 109.685 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.19 159.05 15.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.263 -0.898 . . . . 0.0 109.08 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -101.98 -13.64 17.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.152 -0.967 . . . . 0.0 108.535 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -93.05 161.55 14.39 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.234 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -95.08 118.94 32.74 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.734 -0.604 . . . . 0.0 109.666 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.0 mt -90.26 163.11 14.9 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.732 0.777 . . . . 0.0 109.292 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.08 -99.8 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.36 91.95 5.13 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.044 -1.269 . . . . 0.0 109.187 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.16 91.88 37.99 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.416 -0.802 . . . . 0.0 109.008 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -76.21 -26.41 9.07 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.316 2.011 . . . . 0.0 112.588 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.7 p -122.61 141.74 51.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.645 -0.66 . . . . 0.0 109.504 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.612 ' CB ' HG21 ' A' ' 151' ' ' THR . . . -80.69 -16.5 53.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.426 -0.796 . . . . 0.0 109.52 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -47.63 -38.96 15.77 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.796 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.1 m -79.43 -35.31 40.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.573 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.92 -48.78 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.887 . . . . 0.0 109.802 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 58' ' ' GLN . 17.7 mt -59.91 -36.77 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 108.796 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.51 -30.44 70.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.815 . . . . 0.0 109.527 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.59 -17.4 60.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.139 -0.975 . . . . 0.0 110.158 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -114.41 -8.59 12.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.393 -0.817 . . . . 0.0 109.507 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.511 ' OE1' HD11 ' A' ' 61' ' ' ILE . 3.6 tp-100 -48.95 -38.57 23.35 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 108.86 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.624 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 20.2 p80 -50.62 -46.81 58.32 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.54 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.624 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.39 -60.51 3.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.065 -1.022 . . . . 0.0 109.977 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.658 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -61.71 -30.16 47.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.85 -1.156 . . . . 0.0 109.024 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 58' ' ' GLN . 40.3 t0 -57.44 -26.43 61.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 0.0 109.645 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.75 -40.53 61.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.078 -1.013 . . . . 0.0 109.261 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -63.66 -34.65 78.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.064 -1.023 . . . . 0.0 109.653 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.649 HG22 ' CZ3' ' A' ' 73' ' ' TRP . 4.0 t -71.47 -33.95 51.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.245 -0.909 . . . . 0.0 109.442 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.37 -51.76 57.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.534 -1.354 . . . . 0.0 109.489 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -83.23 -50.07 8.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.013 -1.054 . . . . 0.0 110.472 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.605 ' O ' ' C ' ' A' ' 69' ' ' GLY . 15.7 mttm -86.65 15.79 5.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.608 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -12.01 85.52 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.866 ' CG ' HG21 ' A' ' 155' ' ' ILE . 53.9 m-85 -78.5 165.57 23.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.603 ' CD ' ' H ' ' A' ' 71' ' ' GLN . 25.4 mp0 -63.98 -83.99 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.372 -0.83 . . . . 0.0 109.401 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.23 157.3 17.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.597 -0.689 . . . . 0.0 109.566 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.649 ' CZ3' HG22 ' A' ' 65' ' ' VAL . 6.7 t-105 -136.15 139.36 42.83 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -167.38 -174.42 2.55 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.341 -0.849 . . . . 0.0 108.734 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 153' ' ' ILE . 3.2 m -118.92 146.76 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.0 109.45 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.24 116.53 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -174.42 108.84 0.13 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.828 -1.17 . . . . 0.0 109.563 177.464 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.427 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -100.39 -178.83 3.93 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 121.403 1.91 . . . . 0.0 109.331 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.452 ' HD2' ' ND2' ' A' ' 149' ' ' ASN . 7.8 tpt180 -88.88 143.81 26.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.856 -1.152 . . . . 0.0 109.207 -178.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.46 0.83 0.63 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.56 -0.712 . . . . 0.0 109.788 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 79' ' ' ARG . 57.5 t0 -94.08 -27.16 16.42 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.348 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -64.29 127.95 92.68 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.924 -1.11 . . . . 0.0 109.996 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.75 -1.79 11.96 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.323 2.015 . . . . 0.0 112.003 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -84.41 15.04 3.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.902 -1.124 . . . . 0.0 109.547 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -57.55 -58.54 7.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.305 -0.872 . . . . 0.0 108.809 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.01 -33.91 77.16 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.304 -0.873 . . . . 0.0 109.164 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.88 -58.2 8.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.0 110.023 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.0 tp -61.0 -43.98 98.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.639 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.483 ' HE ' ' H ' ' A' ' 145' ' ' GLY . 23.2 mtp-105 -60.71 -31.34 70.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.646 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -66.99 -58.28 5.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.454 -0.779 . . . . 0.0 110.322 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -53.98 -35.04 61.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 109.268 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -87.57 -18.21 30.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.274 -0.891 . . . . 0.0 109.629 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 89' ' ' ARG . 39.0 tp -56.9 -37.06 70.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.155 -0.966 . . . . 0.0 109.912 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -54.15 134.1 44.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.143 -0.973 . . . . 0.0 109.441 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.553 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 0.9 OUTLIER -64.77 164.7 11.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.418 -0.801 . . . . 0.0 109.537 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.562 ' O ' HG23 ' A' ' 97' ' ' THR . 42.8 p-80 -170.38 -171.44 1.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.066 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 96' ' ' HIS . 8.7 p -159.04 131.97 7.02 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.626 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -100.39 155.84 17.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.482 ' H ' ' HB3' ' A' ' 162' ' ' TRP . . . -79.53 -7.22 88.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.407 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 44.6 mt-10 -125.56 171.83 10.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.33 -1.1 . . . . 0.0 109.515 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -72.2 142.97 49.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.345 -0.847 . . . . 0.0 110.141 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.606 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 2.6 tt0 -101.7 93.33 5.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 103' ' ' VAL . 34.5 m -92.38 127.88 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.41 0.624 . . . . 0.0 109.786 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -127.41 126.64 42.79 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.632 -0.667 . . . . 0.0 109.318 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.629 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 18.7 t80 -108.51 133.23 52.93 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.785 0.802 . . . . 0.0 109.153 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.49 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.05 127.59 35.4 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.476 0.655 . . . . 0.0 110.022 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.8 t -108.83 -35.17 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.644 -0.66 . . . . 0.0 109.624 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -160.31 146.6 15.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 0.0 109.339 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.3 165.92 35.41 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.41 154.02 39.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.501 -0.999 . . . . 0.0 109.591 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.59 -132.08 2.65 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.1 tp -147.08 161.93 39.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.333 -1.098 . . . . 0.0 109.32 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -134.58 88.9 2.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.88 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.479 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -80.54 110.16 15.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.536 -0.727 . . . . 0.0 109.642 179.015 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 114' ' ' CYS . 8.4 mp -117.31 114.77 24.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.195 -0.94 . . . . 0.0 109.38 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -105.05 112.86 26.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.067 -1.021 . . . . 0.0 109.483 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.4 pt -129.57 115.51 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.238 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.99 -143.34 30.83 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 106.424 -2.671 . . . . 0.0 106.424 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -104.04 78.69 1.55 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 115.116 -2.634 . . . . 0.0 108.895 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -166.85 168.58 13.98 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 177.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.613 ' O ' HG23 ' A' ' 5' ' ' ILE . 38.6 t -128.84 151.46 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.257 -0.902 . . . . 0.0 109.949 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -129.12 131.99 47.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.612 . . . . 0.0 109.823 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -131.87 111.07 11.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 0.0 109.277 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.454 HG22 HD13 ' A' ' 3' ' ' LEU . 2.7 t -102.55 139.41 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.847 ' H ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.0 91.18 2.72 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.078 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 31.6 p -165.47 138.34 4.36 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.176 -1.577 . . . . 0.0 107.783 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -106.37 93.39 4.58 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 115.836 -2.345 . . . . 0.0 110.387 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.522 ' C ' ' H ' ' A' ' 130' ' ' ASP . 46.3 mtpt -114.7 154.57 28.22 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.917 176.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.629 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 89.7 m-20 -58.99 -3.03 0.29 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.479 -1.388 . . . . 0.0 107.778 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' A' ' 131' ' ' LEU . 7.3 t0 -70.58 148.57 48.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.066 -1.021 . . . . 0.0 109.314 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.885 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -111.08 149.83 30.24 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.512 0.672 . . . . 0.0 110.545 -179.681 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.885 ' N ' HD12 ' A' ' 131' ' ' LEU . 29.5 mm -115.31 138.59 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.502 ' HG ' HD11 ' A' ' 131' ' ' LEU . 5.0 m -121.25 145.64 47.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.486 -0.759 . . . . 0.0 110.193 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.5 t -116.12 135.47 22.8 Favored Pre-proline 0 N--CA 1.485 1.308 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.55 147.96 94.04 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.147 1.898 . . . . 0.0 113.126 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.617 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -72.31 134.61 45.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.136 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.617 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 8.8 t-80 92.28 11.13 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.1 126.51 30.85 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.015 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.21 130.3 28.33 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.959 1.773 . . . . 0.0 111.648 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.551 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.37 165.86 14.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.197 -0.94 . . . . 0.0 110.196 -179.189 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.59 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -137.03 -149.58 0.32 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -178.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.429 ' CZ ' ' HG2' ' A' ' 144' ' ' MET . 11.5 t80 -175.61 125.27 0.23 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.934 -1.104 . . . . 0.0 109.018 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -143.81 135.17 25.89 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.373 -0.829 . . . . 0.0 109.942 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.642 ' O ' ' C ' ' A' ' 145' ' ' GLY . 52.1 mmm -113.38 21.29 15.34 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.886 -0.509 . . . . 0.0 110.852 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.642 ' C ' ' O ' ' A' ' 144' ' ' MET . . . -1.32 -74.21 0.0 OUTLIER Glycine 0 N--CA 1.503 3.151 0 CA-C-N 119.279 0.945 . . . . 0.0 111.407 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 144' ' ' MET . 22.9 t -91.4 115.49 28.08 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 117.671 -1.612 . . . . 0.0 109.171 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -119.23 116.81 33.64 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.41 -0.806 . . . . 0.0 110.164 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.2 Cg_endo -100.18 33.37 0.09 OUTLIER 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 122.56 2.173 . . . . 0.0 111.628 176.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 11.9 t-20 79.8 68.39 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.521 -0.872 . . . . 0.0 108.721 -178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.522 ' O ' ' OG ' ' A' ' 77' ' ' SER . 14.2 p90 -96.41 -179.5 4.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.307 -0.871 . . . . 0.0 109.37 -177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.612 HG21 ' CB ' ' A' ' 50' ' ' ALA . 87.1 m -149.15 100.35 3.04 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.629 -0.669 . . . . 0.0 109.574 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 75' ' ' VAL . . . -110.69 163.77 13.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.918 -1.114 . . . . 0.0 109.19 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.679 ' HA ' HG12 ' A' ' 75' ' ' VAL . 94.7 mt -107.25 127.29 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.13 -0.981 . . . . 0.0 110.222 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.87 162.49 32.25 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.419 0.628 . . . . 0.0 109.427 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.866 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.0 mp -106.78 149.46 10.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.522 -0.736 . . . . 0.0 109.369 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -96.87 118.95 34.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.583 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -135.72 162.19 33.44 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.695 -0.628 . . . . 0.0 109.569 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -95.87 157.42 35.92 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.97 -1.081 . . . . 0.0 109.33 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 161' ' ' GLY . 47.4 Cg_endo -71.77 -52.58 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.614 2.209 . . . . 0.0 112.395 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 159' ' ' PRO . 95.1 mt-10 -43.83 -16.53 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.475 -0.765 . . . . 0.0 109.381 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -70.26 -39.88 70.91 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.482 ' HB3' ' H ' ' A' ' 99' ' ' GLY . 2.7 p90 -119.05 177.26 4.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.761 -0.847 . . . . 0.0 110.617 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.9 mm -95.37 152.05 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.417 -0.802 . . . . 0.0 109.219 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.34 -74.0 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 110.575 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -131.11 157.01 44.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -101.1 -41.54 6.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.707 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 60.0 p -105.86 -32.35 8.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.931 . . . . 0.0 109.235 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.29 -4.15 60.21 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.545 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -80.46 145.81 31.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.773 -1.428 . . . . 0.0 108.957 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -110.32 89.22 2.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.776 -1.569 . . . . 0.0 111.402 176.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.461 HG23 ' CH2' ' A' ' 141' ' ' TRP . 1.5 tt -78.63 -17.92 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.525 -1.359 . . . . 0.0 109.167 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.59 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -57.59 -42.7 83.7 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.637 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 45.8 m -54.17 -4.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.391 -0.818 . . . . 0.0 109.985 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.04 -40.5 31.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.958 -1.089 . . . . 0.0 111.549 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.618 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 9.3 m-85 -112.23 25.59 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.619 0 O-C-N 120.707 -1.246 . . . . 0.0 112.495 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.637 ' HD3' ' C ' ' A' ' 173' ' ' SER . 43.6 Cg_endo -62.42 -21.03 72.19 Favored 'Trans proline' 0 N--CA 1.503 2.088 0 C-N-CA 123.588 2.859 . . . . 0.0 113.168 -172.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -89.45 127.07 35.8 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.157 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' C ' ' A' ' 179' ' ' ALA . 0.7 OUTLIER -85.91 145.68 27.05 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.638 ' O ' HG23 ' A' ' 19' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.538 ' N ' ' SG ' ' A' ' 126' ' ' CYS . . . -99.2 172.04 7.62 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.147 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.891 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 25.2 tp -157.05 114.26 3.09 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.26 130.69 55.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 110.72 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.477 HD13 ' CE1' ' A' ' 122' ' ' PHE . 64.9 mt -124.76 134.0 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.2 168.93 14.75 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t -92.18 175.75 6.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.058 -1.026 . . . . 0.0 108.306 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.95 -26.7 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.728 -1.232 . . . . 0.0 109.396 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -72.35 -38.54 68.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.175 -0.953 . . . . 0.0 110.57 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.489 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 9.1 m-20 -139.41 123.38 11.02 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 109.766 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.3 -27.84 1.33 Allowed 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.021 1.814 . . . . 0.0 112.52 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -69.79 -0.49 7.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.455 -0.778 . . . . 0.0 111.178 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 6.7 p-10 -123.08 126.13 46.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.079 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 p -97.84 128.49 44.49 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 108.748 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pp -90.13 -9.93 46.47 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.801 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.891 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 31.1 t90 -158.01 108.79 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.052 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -122.37 124.58 44.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.334 -0.854 . . . . 0.0 110.241 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.61 168.62 21.47 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.053 -1.029 . . . . 0.0 110.594 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 19' ' ' THR . 1.0 OUTLIER -127.99 88.35 2.75 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 176.377 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.7 ' O ' HD12 ' A' ' 24' ' ' ILE . 82.1 m-20 -127.37 139.37 52.91 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.538 -0.726 . . . . 0.0 109.984 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.4 -36.13 24.52 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 119.676 -1.89 . . . . 0.0 108.675 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.35 -49.39 10.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.719 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.09 -22.94 67.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.875 -1.141 . . . . 0.0 108.128 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.74 HG12 HD22 ' A' ' 3' ' ' LEU . 1.7 mt -66.8 -50.32 66.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 29' ' ' ASN . 53.3 tt0 -56.2 -55.12 37.11 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.432 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.602 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 62.1 tt0 -56.66 -34.28 67.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 0.0 110.45 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.549 ' OE1' ' CE2' ' A' ' 16' ' ' TRP . 3.6 mm-40 -62.36 -65.13 0.73 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.912 -1.117 . . . . 0.0 109.656 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.429 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -70.27 -46.97 63.29 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.662 -1.274 . . . . 0.0 109.677 179.04 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.626 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 20.4 t-20 -57.0 -25.71 59.0 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.045 -1.035 . . . . 0.0 109.427 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -65.78 -28.08 68.76 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.76 -1.213 . . . . 0.0 107.762 177.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -87.58 14.6 8.03 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.975 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.91 23.38 35.63 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.434 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.626 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 56.7 t -94.53 144.73 9.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.226 -1.161 . . . . 0.0 109.89 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.7 ttt-85 -84.62 157.73 21.08 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.501 ' CZ ' ' OD2' ' A' ' 130' ' ' ASP . 1.3 t80 -155.22 153.68 31.04 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.3 pt-20 -175.81 176.45 1.84 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.042 -1.036 . . . . 0.0 110.102 177.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -154.31 121.8 5.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.394 -0.816 . . . . 0.0 109.065 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.611 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 33.2 m0 -111.28 154.98 23.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.405 -0.81 . . . . 0.0 109.033 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -142.23 155.13 45.24 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.284 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.31 159.68 14.77 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -98.38 -19.69 17.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.077 -1.014 . . . . 0.0 108.36 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -93.42 167.12 11.92 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -93.83 131.38 39.28 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.485 -0.759 . . . . 0.0 109.458 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -93.64 161.97 14.13 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.303 -0.873 . . . . 0.0 109.499 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.36 -96.3 0.11 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.78 107.09 8.84 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.344 -1.092 . . . . 0.0 108.15 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.97 90.02 46.56 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.638 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.57 46.3 1.71 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.819 2.346 . . . . 0.0 111.22 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.53 ' O ' ' OG1' ' A' ' 52' ' ' THR . 0.0 OUTLIER -169.27 139.9 2.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.556 -1.34 . . . . 0.0 108.978 178.061 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.09 -43.89 15.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.521 -1.362 . . . . 0.0 109.353 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -66.67 -4.32 8.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.59 -0.694 . . . . 0.0 110.335 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.53 ' OG1' ' O ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -77.77 -52.88 8.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.762 -1.211 . . . . 0.0 109.941 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.99 -44.67 84.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.112 -0.993 . . . . 0.0 110.253 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 58' ' ' GLN . 13.9 mm -60.3 -41.84 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.959 -1.088 . . . . 0.0 108.517 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.12 -22.87 66.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.445 -0.784 . . . . 0.0 109.89 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.1 -21.63 50.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.999 -1.063 . . . . 0.0 110.265 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 58' ' ' GLN . 59.2 m-85 -115.5 -10.16 11.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.493 -0.754 . . . . 0.0 109.206 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 62' ' ' ASP . 3.6 mm100 -46.89 -34.06 5.11 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.395 -0.922 . . . . 0.0 108.942 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.641 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 26.5 p80 -51.74 -50.48 60.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.891 -1.13 . . . . 0.0 109.573 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.641 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.2 -60.96 2.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.914 -1.116 . . . . 0.0 109.72 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.675 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -61.49 -27.58 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.393 -1.442 . . . . 0.0 109.55 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 58' ' ' GLN . 79.8 m-20 -59.24 -22.33 60.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.066 -1.021 . . . . 0.0 109.807 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 64' ' ' LEU . 3.3 pttp -83.0 -32.9 26.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.949 -1.094 . . . . 0.0 108.633 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.57 HD23 HG21 ' A' ' 103' ' ' VAL . 1.9 mp -65.53 -46.85 78.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.334 -0.854 . . . . 0.0 109.662 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.669 HG22 ' CZ3' ' A' ' 73' ' ' TRP . 0.9 OUTLIER -69.01 -27.74 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.549 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.32 -49.51 74.12 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.74 -1.225 . . . . 0.0 109.713 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.55 -51.74 7.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.028 -1.045 . . . . 0.0 110.54 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.629 ' O ' ' C ' ' A' ' 69' ' ' GLY . 2.1 mptp? -82.73 13.13 4.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.349 -0.844 . . . . 0.0 110.968 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -6.42 81.7 0.0 OUTLIER Glycine 0 N--CA 1.505 3.27 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.888 ' CG ' HG21 ' A' ' 155' ' ' ILE . 84.3 m-85 -75.16 159.95 31.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -1.071 . . . . 0.0 109.193 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.435 ' OE1' ' OD1' ' A' ' 158' ' ' ASN . 85.1 mt-30 -58.33 -41.83 85.46 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.456 -0.777 . . . . 0.0 109.861 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 t -147.21 155.41 42.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.938 -1.101 . . . . 0.0 110.847 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.669 ' CZ3' HG22 ' A' ' 65' ' ' VAL . 29.8 t-105 -129.5 133.34 47.21 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.472 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.4 OUTLIER -145.6 165.67 27.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.557 HG22 ' H ' ' A' ' 76' ' ' ILE . 3.1 p -97.98 174.8 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 121.308 -0.87 . . . . 0.0 109.084 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.557 ' H ' HG22 ' A' ' 75' ' ' VAL . 52.5 mt -109.51 118.11 56.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.4 p -92.58 160.33 15.08 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 123.11 1.433 . . . . 0.0 111.548 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.623 HD13 ' H ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -158.0 138.27 12.59 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.652 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.623 ' H ' HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -130.18 139.02 50.89 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.518 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 149' ' ' ASN . . . -76.94 0.4 21.2 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.898 -1.126 . . . . 0.0 110.743 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.488 ' H ' ' HD3' ' A' ' 79' ' ' ARG . 93.4 m-20 -111.11 -14.82 13.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 0.0 109.21 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.557 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 44.7 p-10 -63.36 117.91 38.55 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.285 -0.884 . . . . 0.0 110.414 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -88.14 -13.99 3.52 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.35 2.033 . . . . 0.0 113.039 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -92.38 -11.09 35.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.032 -1.043 . . . . 0.0 110.611 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.699 ' CG ' HH12 ' A' ' 89' ' ' ARG . 20.1 tptt -62.54 -38.77 91.3 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.956 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -59.69 -44.2 93.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.834 . . . . 0.0 109.57 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.59 -38.63 66.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.024 -1.048 . . . . 0.0 109.483 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 49.6 mt -60.58 -36.43 78.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 0.0 109.026 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.699 HH12 ' CG ' ' A' ' 85' ' ' LYS . 0.9 OUTLIER -60.09 -30.53 69.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 109.318 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 93' ' ' LEU . 15.1 tt0 -64.47 -60.39 3.21 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.044 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -58.73 -30.94 67.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.15 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -83.41 -18.74 37.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 90' ' ' GLU . 2.5 mt -63.82 -25.31 68.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.066 -1.022 . . . . 0.0 110.012 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -58.62 141.32 52.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 109.6 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -72.99 158.46 35.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 109.347 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -168.01 -168.96 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 110.788 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.9 133.64 6.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 109.11 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.683 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -106.43 154.32 20.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 0.0 109.738 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.21 -7.69 86.87 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -123.42 170.35 10.44 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.345 -1.091 . . . . 0.0 109.417 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -74.61 143.51 44.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.07 -1.019 . . . . 0.0 110.017 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.447 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 1.6 mt-10 -101.97 96.33 6.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.26 -0.9 . . . . 0.0 109.206 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.57 HG21 HD23 ' A' ' 64' ' ' LEU . 35.7 m -100.85 128.74 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.735 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.564 ' NE ' ' CZ ' ' A' ' 142' ' ' PHE . 6.6 mtm180 -128.9 134.58 48.31 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.611 ' CE2' ' CE3' ' A' ' 38' ' ' TRP . 66.0 t80 -112.99 131.53 55.72 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.77 0.795 . . . . 0.0 109.938 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.421 ' CG ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -87.18 125.8 34.4 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.359 0.599 . . . . 0.0 109.72 -179.555 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.89 -39.7 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.455 -0.778 . . . . 0.0 109.941 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -160.47 146.94 15.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.145 -0.972 . . . . 0.0 109.899 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.48 ' O ' ' OE1' ' A' ' 127' ' ' GLU . . . 87.89 164.18 39.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.72 160.59 26.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.513 -0.992 . . . . 0.0 109.664 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.22 -119.62 1.01 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.545 ' CD1' HD12 ' A' ' 125' ' ' LEU . 22.0 tp -148.31 163.33 37.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -1.106 . . . . 0.0 108.73 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.805 ' CD2' HG21 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -137.99 145.93 42.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.976 -1.078 . . . . 0.0 108.952 177.013 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.445 ' SG ' ' C ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -148.58 139.22 22.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.489 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.794 HD21 HG13 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -141.86 128.68 20.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.459 -0.776 . . . . 0.0 109.321 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.402 ' O ' HD13 ' A' ' 117' ' ' ILE . 2.2 t60 -103.3 111.56 24.02 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.178 -0.952 . . . . 0.0 109.18 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.459 HD11 HD12 ' A' ' 115' ' ' LEU . 51.9 mm -126.1 114.64 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.145 -0.972 . . . . 0.0 110.781 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.66 -142.42 29.93 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 104.422 -3.471 . . . . 0.0 104.422 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -109.92 82.95 1.67 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 115.296 -2.561 . . . . 0.0 107.675 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -165.46 168.33 16.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 83.4 t -131.13 150.03 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.123 -0.986 . . . . 0.0 109.418 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.477 ' CE1' HD13 ' A' ' 5' ' ' ILE . 7.1 m-85 -129.3 134.53 47.97 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.636 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -138.22 134.77 34.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.072 -1.018 . . . . 0.0 108.669 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.772 HG12 ' CD1' ' A' ' 113' ' ' PHE . 8.8 p -127.16 148.33 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.981 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.559 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 1.0 OUTLIER -123.72 75.16 1.32 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 118.193 -1.403 . . . . 0.0 110.732 179.541 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.559 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -162.29 119.7 2.1 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.48 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 8.7 tm-20 -115.37 106.24 13.77 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 117.526 -1.67 . . . . 0.0 110.653 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.605 ' C ' ' H ' ' A' ' 130' ' ' ASP . 86.6 mttt -110.92 -178.96 3.61 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 38' ' ' TRP . 71.4 m-80 -58.48 0.47 0.08 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.605 ' H ' ' C ' ' A' ' 128' ' ' LYS . 21.0 t0 -71.71 143.43 49.65 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.723 -1.236 . . . . 0.0 110.451 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.921 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.2 OUTLIER -110.85 149.36 30.69 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.657 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.921 ' N ' HD12 ' A' ' 131' ' ' LEU . 26.2 mm -114.45 131.93 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.646 ' OG ' HD11 ' A' ' 131' ' ' LEU . 4.4 m -120.31 144.57 47.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.869 . . . . 0.0 110.116 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.794 HG13 HD21 ' A' ' 115' ' ' LEU . 1.7 t -117.14 134.43 23.04 Favored Pre-proline 0 N--CA 1.488 1.436 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.17 151.87 76.65 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.954 1.769 . . . . 0.0 112.284 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.612 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.86 133.04 46.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 109.686 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.612 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 3.7 t-160 92.76 10.27 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 120.964 0.412 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.36 125.92 32.91 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.12 -0.987 . . . . 0.0 108.461 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.52 131.96 31.57 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.622 1.548 . . . . 0.0 111.575 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.504 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.16 163.15 15.55 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.479 -179.062 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.677 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 26.5 p90 -128.65 -153.9 0.6 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.533 -0.729 . . . . 0.0 109.67 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.631 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -172.92 124.0 0.43 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.505 -0.747 . . . . 0.0 109.214 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.472 ' OD1' HD11 ' A' ' 93' ' ' LEU . 29.9 t0 -147.96 131.91 17.16 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.147 -0.97 . . . . 0.0 109.453 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.606 ' O ' ' C ' ' A' ' 145' ' ' GLY . 7.4 mtm -111.76 20.02 17.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.273 -0.892 . . . . 0.0 110.815 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.606 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 11.02 -90.82 0.01 OUTLIER Glycine 0 N--CA 1.503 3.165 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.524 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 46.7 t -87.52 119.6 27.97 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.3 -1.36 . . . . 0.0 109.857 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.596 ' OE1' ' NE ' ' A' ' 89' ' ' ARG . 6.5 mp0 -114.08 120.11 39.31 Favored Pre-proline 0 N--CA 1.493 1.68 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.569 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.7 Cg_endo -100.32 28.88 0.12 Allowed 'Trans proline' 0 C--O 1.212 -0.806 0 C-N-CA 122.476 2.117 . . . . 0.0 112.753 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.621 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER 81.33 64.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.762 0.792 . . . . 0.0 110.16 -179.193 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.615 ' CZ ' HD23 ' A' ' 78' ' ' LEU . 15.2 p90 -101.6 171.06 7.78 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.577 0.703 . . . . 0.0 110.292 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 87.7 m -126.42 138.94 53.59 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.556 ' HB3' HD12 ' A' ' 76' ' ' ILE . . . -146.52 165.72 28.6 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.238 -0.914 . . . . 0.0 109.415 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 75.5 mt -118.09 136.66 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.386 -0.821 . . . . 0.0 109.746 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.518 ' HE ' HG12 ' A' ' 76' ' ' ILE . 2.7 mtm180 -140.15 168.01 20.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.021 -1.049 . . . . 0.0 109.653 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.888 HG21 ' CG ' ' A' ' 70' ' ' TYR . 3.9 mp -107.39 155.22 8.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.631 -0.668 . . . . 0.0 109.562 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.2 m-30 -103.06 121.09 41.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.204 -0.935 . . . . 0.0 110.319 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 3.9 t0 -133.27 163.06 30.15 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -93.41 161.9 29.43 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.102 -0.999 . . . . 0.0 109.285 -178.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.3 Cg_endo -62.73 -55.01 0.96 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.237 1.958 . . . . 0.0 112.293 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 55.2 mp0 -44.41 -13.28 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.401 -0.812 . . . . 0.0 109.247 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -78.75 -33.94 36.25 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.534 ' N ' ' O ' ' A' ' 159' ' ' PRO . 4.5 p90 -118.8 159.32 23.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.381 -1.07 . . . . 0.0 110.825 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 81.7 mt -100.2 147.91 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.549 -0.719 . . . . 0.0 109.453 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.65 -73.25 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.5 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -140.9 159.47 42.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.944 -1.097 . . . . 0.0 109.883 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -89.69 -41.87 11.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.393 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 52.7 m -116.06 -31.39 5.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.305 -0.872 . . . . 0.0 108.696 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.63 -5.4 51.3 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.807 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -80.77 149.51 29.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.659 -1.495 . . . . 0.0 107.952 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -105.38 89.97 3.28 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 117.337 -1.745 . . . . 0.0 110.762 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.435 HG22 ' H ' ' A' ' 171' ' ' ILE . 0.2 OUTLIER -71.76 -30.11 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.95 -1.094 . . . . 0.0 109.417 -179.689 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.677 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -63.45 -41.33 98.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.332 -0.855 . . . . 0.0 108.851 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.546 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 15.7 t -51.9 -4.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 110.173 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -83.19 -34.03 26.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.09 -1.007 . . . . 0.0 110.901 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.591 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.1 m-85 -110.03 27.32 0.07 OUTLIER Pre-proline 0 N--CA 1.515 2.81 0 O-C-N 120.81 -1.181 . . . . 0.0 112.764 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 40.5 Cg_endo -58.97 -24.02 71.11 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 123.559 2.839 . . . . 0.0 114.511 -172.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -88.92 125.7 35.07 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 118.375 -1.33 . . . . 0.0 108.133 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' C ' ' A' ' 179' ' ' ALA . 5.0 tt -87.06 128.95 35.09 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.596 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.596 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.36 170.76 8.63 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.047 -1.033 . . . . 0.0 109.412 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.725 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 29.3 tp -158.06 114.98 2.89 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 130.78 55.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.18 -0.95 . . . . 0.0 109.797 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 121' ' ' VAL . 71.5 mt -127.29 138.34 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 178.97 6.87 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.605 0.717 . . . . 0.0 109.444 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.1 t -96.05 174.62 6.83 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.38 -22.88 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.028 -1.045 . . . . 0.0 109.159 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -73.73 -37.76 65.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.148 -0.97 . . . . 0.0 110.512 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.458 ' OD2' ' N ' ' A' ' 10' ' ' ASP . 1.3 p30 -137.51 123.59 13.13 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.029 -1.045 . . . . 0.0 109.461 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -81.86 -38.4 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.944 1.763 . . . . 0.0 112.301 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.32 3.09 2.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 110.275 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -114.67 119.44 36.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.874 . . . . 0.0 109.089 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 p -100.21 122.77 43.55 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.192 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 pp -88.09 -8.97 54.7 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.054 -1.059 . . . . 0.0 108.991 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.725 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 38.7 t90 -157.7 107.69 2.17 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.315 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -120.4 121.86 39.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.409 -0.807 . . . . 0.0 110.026 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.405 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -163.15 164.45 25.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.439 -0.788 . . . . 0.0 109.999 -179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.866 HG23 ' O ' ' A' ' 19' ' ' THR . 10.7 t -130.86 88.83 2.66 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 118.955 -1.098 . . . . 0.0 108.16 175.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.749 ' O ' HD12 ' A' ' 24' ' ' ILE . 85.3 m-20 -125.9 143.68 50.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.098 -1.001 . . . . 0.0 110.684 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.15 -39.62 22.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.342 -1.474 . . . . 0.0 108.664 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.21 -50.89 8.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 109.566 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.7 -21.58 60.81 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.879 -1.138 . . . . 0.0 108.559 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 20' ' ' ASN . 2.0 mt -70.05 -57.34 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.256 -0.902 . . . . 0.0 108.943 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.517 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 8.7 pt20 -62.65 -44.94 94.99 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.941 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 25.9 mt-30 -59.88 -42.38 93.62 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.148 -0.97 . . . . 0.0 109.885 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.533 ' OE1' ' CZ2' ' A' ' 16' ' ' TRP . 39.8 tt0 -80.24 -47.03 15.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.912 -1.118 . . . . 0.0 109.399 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.49 ' CD1' HG21 ' A' ' 33' ' ' VAL . 20.2 tp -66.14 -55.4 16.58 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.986 -1.071 . . . . 0.0 109.022 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 33' ' ' VAL . 41.2 t-20 -59.63 -19.78 51.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.911 -1.118 . . . . 0.0 109.471 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -65.15 -27.58 68.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.859 -1.151 . . . . 0.0 108.601 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -86.5 12.78 9.6 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.737 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.72 23.23 31.26 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.042 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.49 HG21 ' CD1' ' A' ' 28' ' ' LEU . 70.6 t -94.33 145.44 7.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.469 -1.018 . . . . 0.0 109.176 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -84.45 158.5 21.02 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.345 -0.847 . . . . 0.0 108.737 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.475 ' CE2' HD11 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -152.77 152.31 31.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.881 -1.137 . . . . 0.0 108.006 177.749 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 130' ' ' ASP . 3.4 mm-40 -170.77 169.4 6.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.909 -1.119 . . . . 0.0 109.21 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -150.55 118.58 6.29 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.503 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 23.4 m0 -111.17 150.32 29.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.863 . . . . 0.0 108.996 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -139.68 157.51 45.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.149 -0.969 . . . . 0.0 109.629 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.31 159.53 15.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 108.968 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.47 ' OD2' ' N ' ' A' ' 42' ' ' ARG . 54.1 p30 -100.17 -9.94 21.96 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.47 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 15.8 ttm180 -93.48 150.69 20.25 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.3 117.88 30.03 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.536 -0.727 . . . . 0.0 109.261 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mt -93.28 165.63 12.71 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.32 -0.863 . . . . 0.0 109.383 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.39 -121.33 0.56 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.49 78.57 9.66 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.113 -1.228 . . . . 0.0 108.635 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.3 94.58 48.79 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.509 -0.744 . . . . 0.0 109.087 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.25 85.61 0.43 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.822 1.681 . . . . 0.0 111.646 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.28 109.02 0.64 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.265 -0.897 . . . . 0.0 109.276 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.25 -35.41 31.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.645 -1.284 . . . . 0.0 109.759 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 6.3 pt-20 -65.28 -20.78 66.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 110.155 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.9 m -79.83 -35.67 37.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.161 -0.962 . . . . 0.0 110.302 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.95 -46.51 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.957 . . . . 0.0 109.842 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -61.99 -42.18 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.935 . . . . 0.0 108.978 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.34 -29.75 70.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.399 -0.813 . . . . 0.0 109.702 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.12 -19.17 58.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 110.165 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -116.38 -9.0 11.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.794 . . . . 0.0 109.566 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 54' ' ' ILE . 4.2 mm100 -49.65 -39.04 34.79 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.145 -0.972 . . . . 0.0 108.857 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.598 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 21.5 p80 -52.68 -45.03 66.64 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.427 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.598 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.12 -59.65 4.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.906 -1.121 . . . . 0.0 110.015 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.699 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -63.42 -28.25 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.025 -1.047 . . . . 0.0 109.289 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.2 t70 -58.35 -24.73 60.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.382 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -84.6 -41.63 16.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 109.978 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.477 HD21 HG21 ' A' ' 103' ' ' VAL . 2.3 tt -66.49 -46.27 76.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.388 -0.82 . . . . 0.0 109.751 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.7 p -67.24 -30.11 48.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 109.283 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.41 -43.52 75.35 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.094 -1.004 . . . . 0.0 109.367 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -78.52 -52.21 8.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 0.0 109.832 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.64 ' O ' ' C ' ' A' ' 69' ' ' GLY . 45.0 mmtm -83.22 12.18 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.389 -0.82 . . . . 0.0 110.342 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.64 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -0.23 80.33 0.0 OUTLIER Glycine 0 N--CA 1.503 3.166 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.484 ' CG ' HG21 ' A' ' 155' ' ' ILE . 43.2 m-85 -77.27 166.36 23.29 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.375 -1.073 . . . . 0.0 108.461 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -57.24 -92.24 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.444 -0.785 . . . . 0.0 109.173 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.44 164.9 11.42 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.603 0.716 . . . . 0.0 110.177 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.506 ' CZ3' HD12 ' A' ' 155' ' ' ILE . 6.4 t-105 -136.2 140.61 43.67 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.427 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.8 OUTLIER -157.37 175.36 14.09 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.089 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -120.14 143.27 32.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 76' ' ' ILE . 4.3 tp -103.07 115.89 45.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 77' ' ' SER . 9.8 p -168.57 101.44 0.41 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.503 -0.748 . . . . 0.0 109.003 178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.662 HD23 ' CB ' ' A' ' 82' ' ' ASN . 9.9 tp -110.45 -179.49 3.78 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 119.564 -1.96 . . . . 0.0 107.751 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.56 ' C ' ' H ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -88.41 147.49 24.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.744 -1.223 . . . . 0.0 109.773 -178.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.423 ' H ' ' HD3' ' A' ' 79' ' ' ARG . . . -59.22 3.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.656 -0.652 . . . . 0.0 109.571 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 79' ' ' ARG . 84.6 m-20 -88.39 -25.52 22.65 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.624 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.662 ' CB ' HD23 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -63.61 128.08 92.24 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.991 -1.068 . . . . 0.0 109.639 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -75.95 -6.49 17.46 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.211 1.941 . . . . 0.0 112.392 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -89.33 10.69 21.43 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.9 -1.125 . . . . 0.0 109.41 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.509 ' CG ' ' H ' ' A' ' 86' ' ' GLU . 2.4 pttm -56.77 -57.28 13.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 108.798 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.509 ' H ' ' CG ' ' A' ' 85' ' ' LYS . 84.1 tt0 -66.15 -40.02 90.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.207 -0.933 . . . . 0.0 109.798 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.31 90.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.692 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.2 mt -61.3 -46.93 88.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 110.203 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.61 -26.41 67.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.947 -1.095 . . . . 0.0 109.721 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -67.21 -59.3 3.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.453 -0.779 . . . . 0.0 110.375 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -57.9 -38.65 76.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.97 . . . . 0.0 109.534 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -74.59 -24.21 58.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.719 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.439 HD21 ' N ' ' A' ' 173' ' ' SER . 1.5 tt -64.18 -33.98 77.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 109.997 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.473 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 44.0 p-10 -43.09 148.68 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 109.709 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.565 ' OE2' ' N ' ' A' ' 171' ' ' ILE . 77.5 mt-10 -85.24 157.44 20.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.334 -0.854 . . . . 0.0 109.626 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -174.38 -165.72 0.23 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.011 -1.056 . . . . 0.0 111.488 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.83 131.8 3.02 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.603 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -101.63 155.3 18.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 109.955 -178.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.86 -5.92 86.89 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' A' ' 101' ' ' ASP . 22.6 tp10 -126.57 169.26 13.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -1.07 . . . . 0.0 109.304 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.447 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 89.4 m-20 -70.06 143.42 52.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.245 -0.91 . . . . 0.0 110.06 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.603 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 2.7 tt0 -102.52 95.05 5.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 110.195 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.535 HG12 ' OG ' ' A' ' 133' ' ' SER . 18.0 m -94.64 125.52 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.31 126.03 38.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.503 ' CE2' ' CE3' ' A' ' 38' ' ' TRP . 42.3 t80 -101.92 126.89 48.93 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.492 ' CD1' ' HB2' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -89.61 134.24 34.23 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.618 -0.676 . . . . 0.0 110.39 -178.759 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.2 -25.9 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.814 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' A' ' 109' ' ' GLY . 74.3 tt0 -172.36 163.94 5.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.008 -1.057 . . . . 0.0 108.895 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.619 ' N ' ' OE1' ' A' ' 127' ' ' GLU . . . 43.78 104.61 0.01 OUTLIER Glycine 0 N--CA 1.495 2.569 0 O-C-N 121.104 -0.998 . . . . 0.0 110.792 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.492 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . . . -149.79 111.08 4.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.671 -1.488 . . . . 0.0 109.105 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.48 ' C ' HD12 ' A' ' 125' ' ' LEU . . . -78.51 -140.89 1.78 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -109.9 100.97 9.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.415 -1.05 . . . . 0.0 111.775 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.493 ' C ' ' OE1' ' A' ' 123' ' ' GLN . 30.8 p90 -79.82 128.62 33.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.61 -1.306 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.462 ' SG ' ' NE1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -78.91 143.71 35.58 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.318 0.58 . . . . 0.0 109.939 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.544 HD11 HG21 ' A' ' 134' ' ' VAL . 4.7 tp -131.38 124.73 30.95 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.2 t-160 -102.43 103.48 13.88 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.927 -1.108 . . . . 0.0 110.012 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.624 ' H ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -115.93 105.92 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.203 -0.936 . . . . 0.0 109.889 -179.152 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.54 -144.24 32.59 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 105.293 -3.123 . . . . 0.0 105.293 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.521 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 41.5 p30 -102.11 79.36 1.87 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 115.225 -2.59 . . . . 0.0 109.589 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.527 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 15.0 tp10 -165.76 170.68 13.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.666 ' O ' HG23 ' A' ' 5' ' ' ILE . 55.8 t -127.74 141.94 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.12 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.474 ' CE1' HD13 ' A' ' 5' ' ' ILE . 22.1 m-85 -128.49 132.32 48.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.808 -0.557 . . . . 0.0 109.788 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.493 ' OE1' ' C ' ' A' ' 113' ' ' PHE . 11.2 mm-40 -128.73 112.98 14.78 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 2.4 t -100.54 134.99 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.535 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 54.5 tp -126.54 86.05 2.46 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.543 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.535 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -168.2 137.51 2.45 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -104.67 99.42 9.09 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 116.119 -2.232 . . . . 0.0 109.792 -179.287 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.578 ' C ' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -119.38 159.53 24.01 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.988 176.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.478 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 13.0 p30 -60.68 2.67 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.578 ' H ' ' C ' ' A' ' 128' ' ' LYS . 9.6 t70 -66.45 135.3 54.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.86 -1.15 . . . . 0.0 110.353 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.777 HD13 ' N ' ' A' ' 132' ' ' ILE . 1.4 tm? -92.37 125.11 36.88 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.748 -177.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.777 ' N ' HD13 ' A' ' 131' ' ' LEU . 1.0 OUTLIER -108.33 127.62 64.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.535 ' OG ' HG12 ' A' ' 103' ' ' VAL . 5.2 t -120.69 144.15 48.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.451 -0.781 . . . . 0.0 109.673 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.544 HG21 HD11 ' A' ' 115' ' ' LEU . 1.1 t -119.13 142.18 31.72 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.39 147.16 70.92 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.343 2.029 . . . . 0.0 113.051 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.614 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.8 134.15 45.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 109.375 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.614 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 2.2 t-80 92.32 11.02 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.68 128.13 27.49 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.117 -0.99 . . . . 0.0 108.797 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.49 132.38 33.13 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.751 1.634 . . . . 0.0 111.53 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.55 164.72 10.39 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.199 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.48 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.4 OUTLIER -136.66 -149.14 0.31 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.195 -0.941 . . . . 0.0 109.597 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -173.61 124.1 0.37 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.997 -1.064 . . . . 0.0 109.018 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -137.66 129.99 29.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.55 -0.719 . . . . 0.0 109.525 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.612 ' SD ' ' CE2' ' A' ' 150' ' ' PHE . 60.5 mtm -100.61 16.97 23.04 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.764 -0.585 . . . . 0.0 111.312 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 32.64 -125.92 0.29 Allowed Glycine 0 N--CA 1.49 2.287 0 O-C-N 120.636 -1.29 . . . . 0.0 110.537 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.597 ' CB ' HD22 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -81.7 121.37 26.29 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.099 -1.441 . . . . 0.0 108.624 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.89 115.58 45.85 Favored Pre-proline 0 N--CA 1.492 1.636 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.355 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 60.3 Cg_endo -103.69 50.34 0.03 OUTLIER 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 122.957 2.438 . . . . 0.0 110.742 176.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 20.5 t-20 81.85 70.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.132 -177.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.612 ' CE2' ' SD ' ' A' ' 144' ' ' MET . 20.5 p90 -96.24 163.13 13.22 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.274 -0.891 . . . . 0.0 110.167 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.9 m -128.81 124.5 35.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.469 -0.769 . . . . 0.0 110.533 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.562 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . . . -141.97 160.75 39.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.501 -0.749 . . . . 0.0 109.012 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.505 HG23 ' HE1' ' A' ' 73' ' ' TRP . 79.6 mt -111.14 129.24 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.182 -0.949 . . . . 0.0 109.247 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.643 ' C ' HD13 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -135.29 165.09 26.24 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.643 HD13 ' C ' ' A' ' 154' ' ' ARG . 0.6 OUTLIER -107.59 152.66 9.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.49 -0.756 . . . . 0.0 109.381 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.427 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.8 m-30 -96.77 119.63 35.61 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.0 0.905 . . . . 0.0 109.892 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 53.5 p30 -134.99 163.84 28.95 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.03 161.54 29.48 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.982 -1.073 . . . . 0.0 109.075 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.63 ' O ' ' N ' ' A' ' 161' ' ' GLY . 40.7 Cg_endo -63.77 -55.45 0.67 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.013 1.809 . . . . 0.0 112.045 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 159' ' ' PRO . 94.4 mt-10 -43.77 -14.38 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.369 -0.832 . . . . 0.0 109.197 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -75.93 -40.52 30.29 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.507 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 4.1 p90 -108.83 159.56 16.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 79.2 mt -100.67 147.42 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.402 -0.811 . . . . 0.0 109.509 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -49.2 -74.11 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.263 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.29 161.47 38.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.111 -0.993 . . . . 0.0 109.804 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -88.19 -41.62 12.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.028 -1.045 . . . . 0.0 109.546 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 63.4 p -112.48 -31.89 6.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.293 -0.879 . . . . 0.0 108.877 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.91 -8.02 53.61 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -80.04 145.92 32.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.624 -1.515 . . . . 0.0 108.039 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -112.36 89.81 3.17 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.316 -1.354 . . . . 0.0 110.872 176.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.565 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -83.21 -20.12 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.049 -1.657 . . . . 0.0 109.284 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -56.77 -43.82 81.18 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.445 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 47.6 t -56.25 -1.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 109.648 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -87.93 -18.62 28.73 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.382 -0.824 . . . . 0.0 110.842 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.573 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 54.2 m-85 -108.45 27.41 0.07 OUTLIER Pre-proline 0 N--CA 1.518 2.952 0 O-C-N 121.187 -0.946 . . . . 0.0 112.83 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 42.1 Cg_endo -60.86 -5.57 4.86 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 123.916 3.077 . . . . 0.0 113.453 -173.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -84.62 148.94 26.18 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.3 -0.875 . . . . 0.0 109.149 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.747 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 15.9 tp -89.34 101.18 13.85 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.829 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.905 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.619 ' O ' ' OG1' ' A' ' 19' ' ' THR . 7.9 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.2 169.96 9.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.126 -0.983 . . . . 0.0 109.214 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 4' ' ' THR . 2.7 tp -157.24 118.96 3.74 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.534 ' N ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -109.79 133.88 52.66 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.179 -0.95 . . . . 0.0 109.795 -178.767 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.769 HG23 ' O ' ' A' ' 121' ' ' VAL . 52.9 mt -127.5 136.08 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.58 166.19 20.22 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.409 ' OG ' ' CD1' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -86.75 174.27 8.93 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 108.796 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.33 -28.31 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.03 -1.044 . . . . 0.0 109.117 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -73.54 -36.91 65.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.28 124.97 15.41 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 109.552 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.82 -37.82 0.31 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.935 1.757 . . . . 0.0 112.407 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -69.46 6.26 1.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.093 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -114.03 120.32 40.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.908 . . . . 0.0 109.055 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.5 p -100.29 122.01 42.4 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.365 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.409 ' CD1' ' OG ' ' A' ' 7' ' ' SER . 7.1 mt -88.9 -7.52 55.94 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.064 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.736 ' NE1' ' NE2' ' A' ' 27' ' ' GLN . 48.3 t90 -157.46 105.95 2.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.421 -1.312 . . . . 0.0 109.9 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -117.82 111.11 18.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.329 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.436 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -162.47 162.85 27.7 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.868 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.837 HG23 ' O ' ' A' ' 19' ' ' THR . 10.0 t -131.71 90.28 2.82 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 120.966 -1.084 . . . . 0.0 108.181 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.759 ' O ' HD12 ' A' ' 24' ' ' ILE . 1.7 m-80 -124.55 143.47 50.67 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.285 -0.884 . . . . 0.0 110.442 177.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.75 -40.88 22.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.012 -1.68 . . . . 0.0 108.536 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.28 -48.41 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 110.021 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -60.62 -23.95 65.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.969 -1.082 . . . . 0.0 108.698 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.759 HD12 ' O ' ' A' ' 20' ' ' ASN . 10.9 mt -72.63 -53.68 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.234 -0.916 . . . . 0.0 108.83 178.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 29' ' ' ASN . 52.0 tt0 -59.09 -52.87 63.85 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.141 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.656 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 1.0 OUTLIER -59.75 -40.14 87.16 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.28 -0.888 . . . . 0.0 109.64 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.736 ' NE2' ' NE1' ' A' ' 16' ' ' TRP . 54.8 tt0 -78.1 -50.21 12.46 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.933 -1.104 . . . . 0.0 109.579 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 24' ' ' ILE . 22.6 tp -69.03 -55.87 9.49 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.7 -1.25 . . . . 0.0 109.268 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 25' ' ' GLN . 26.2 t-20 -56.82 -20.89 25.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.876 -1.14 . . . . 0.0 109.448 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -66.54 -26.37 67.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.889 -1.132 . . . . 0.0 108.374 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 10.63 15.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.296 -0.877 . . . . 0.0 109.695 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.06 21.89 26.69 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.4 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 38.6 t -94.31 146.26 6.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.193 -1.18 . . . . 0.0 108.958 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.448 HH12 ' NZ ' ' A' ' 68' ' ' LYS . 13.4 ttm180 -84.12 157.24 21.78 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.438 ' C ' ' OE1' ' A' ' 36' ' ' GLU . 1.2 t80 -154.98 153.66 31.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.83 -1.169 . . . . 0.0 108.729 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.438 ' OE1' ' C ' ' A' ' 35' ' ' PHE . 1.5 pm0 -175.63 173.21 2.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.861 -1.149 . . . . 0.0 109.837 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -148.82 112.94 5.2 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.642 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 23.9 m0 -111.48 149.76 30.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 38' ' ' TRP . 84.0 mm-40 -138.09 157.87 45.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.776 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.22 158.79 15.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 108.937 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -101.34 -12.98 18.21 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -92.94 158.34 15.87 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.652 0.739 . . . . 0.0 109.051 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -93.0 119.29 32.1 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.615 -0.678 . . . . 0.0 109.507 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.34 164.0 14.01 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.381 -0.824 . . . . 0.0 109.278 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.72 -103.94 0.2 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.0 88.64 4.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.115 -1.226 . . . . 0.0 109.264 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.54 92.92 17.81 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.482 -0.761 . . . . 0.0 109.005 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.54 -28.2 10.26 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.151 1.901 . . . . 0.0 112.574 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 50.1 p -119.86 140.94 50.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.649 -0.657 . . . . 0.0 109.877 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.655 ' CB ' HG21 ' A' ' 151' ' ' THR . . . -81.0 -17.28 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 109.593 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -46.61 -37.53 8.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.33 -0.856 . . . . 0.0 109.119 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.5 p -78.81 -31.12 45.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 0.0 109.338 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 107' ' ' VAL . 25.1 t -69.11 -48.87 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.86 . . . . 0.0 109.818 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 58' ' ' GLN . 6.6 mt -59.65 -39.3 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 109.017 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.51 -31.0 71.69 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.434 -0.791 . . . . 0.0 109.657 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.22 -17.79 60.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 0.0 110.042 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -113.98 -6.8 13.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.448 -0.783 . . . . 0.0 109.307 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 62' ' ' ASP . 3.1 mm100 -48.64 -39.48 24.35 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.305 -0.958 . . . . 0.0 108.993 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 60' ' ' ALA . 35.6 p80 -52.08 -46.78 65.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.039 -1.038 . . . . 0.0 109.652 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.584 ' N ' ' ND1' ' A' ' 59' ' ' HIS . . . -62.49 -61.6 2.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.917 -1.114 . . . . 0.0 109.849 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.683 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -61.16 -29.45 45.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.749 -1.22 . . . . 0.0 109.187 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 58' ' ' GLN . 33.2 t0 -58.1 -26.12 62.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 109.521 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.33 -39.41 59.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.127 -0.983 . . . . 0.0 109.236 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.2 mp -63.75 -36.75 84.92 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.268 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 61' ' ' ILE . 2.8 t -70.41 -29.5 39.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.304 -0.872 . . . . 0.0 109.339 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.4 -53.82 51.43 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.488 -1.383 . . . . 0.0 109.392 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -82.64 -50.37 8.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.964 -1.085 . . . . 0.0 110.785 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.582 ' O ' ' C ' ' A' ' 69' ' ' GLY . 70.9 mttt -86.26 14.0 7.18 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.387 -0.821 . . . . 0.0 110.858 -177.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.582 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -15.34 88.97 0.01 OUTLIER Glycine 0 N--CA 1.502 3.068 0 CA-C-O 122.195 0.886 . . . . 0.0 111.731 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.785 ' CG ' HG21 ' A' ' 155' ' ' ILE . 84.0 m-85 -77.69 162.3 27.1 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -58.55 -81.7 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 108.742 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.1 m -103.26 157.52 16.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.466 -0.771 . . . . 0.0 109.599 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.672 ' CE2' HD13 ' A' ' 61' ' ' ILE . 11.0 t-105 -141.27 146.44 36.8 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.469 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.3 OUTLIER -177.44 -165.22 0.1 Allowed 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 153' ' ' ILE . 3.2 m -122.58 165.54 18.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.398 -0.814 . . . . 0.0 109.222 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -95.48 140.69 16.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.589 ' O ' HD22 ' A' ' 78' ' ' LEU . 58.8 p -91.68 162.38 14.51 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.049 1.404 . . . . 0.0 112.248 -176.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -158.85 118.48 3.1 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 113.49 -1.687 . . . . 0.0 112.41 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -131.7 139.54 49.05 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.39 -18.3 65.28 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.761 -1.212 . . . . 0.0 109.5 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -104.74 31.77 4.54 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.659 HD22 ' H ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -92.58 125.4 55.93 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.019 -1.05 . . . . 0.0 110.619 178.332 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -78.2 -7.6 16.19 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.997 1.798 . . . . 0.0 112.268 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -90.81 0.93 57.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.978 -1.076 . . . . 0.0 110.024 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.518 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 11.5 ptmm? -58.05 -51.29 70.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.183 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 49.7 tp10 -62.84 -56.61 15.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.093 -1.004 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.92 -44.6 78.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.404 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.4 -42.25 98.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.309 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.49 ' HG2' ' H ' ' A' ' 144' ' ' MET . 43.3 mtp180 -60.75 -40.69 93.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.725 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -66.7 -58.31 5.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.368 -0.833 . . . . 0.0 110.511 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -53.37 -34.41 57.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.611 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -88.14 -17.66 30.47 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 110.213 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 176' ' ' PRO . 6.0 tp -61.36 -38.23 86.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.866 -1.146 . . . . 0.0 109.97 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 40.2 p-10 -54.81 131.11 43.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 0.0 110.148 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.49 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 1.7 pp20? -71.55 165.55 23.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.389 -0.819 . . . . 0.0 109.339 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.49 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 38.3 p-80 -175.13 -165.22 0.17 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.294 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.84 135.66 4.83 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.67 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.37 154.98 21.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -0.835 . . . . 0.0 109.676 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.52 -6.98 85.19 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.515 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 84.9 tt0 -125.93 169.13 13.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.243 -1.151 . . . . 0.0 108.988 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.433 ' N ' ' HG2' ' A' ' 100' ' ' GLU . 90.3 m-20 -74.47 144.06 44.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.859 -1.151 . . . . 0.0 110.613 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.415 ' HG3' ' CE1' ' A' ' 98' ' ' HIS . 2.3 mt-10 -100.88 91.64 4.68 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.68 HG12 ' OG ' ' A' ' 133' ' ' SER . 6.4 m -84.63 131.31 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -130.62 112.74 13.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.758 -0.589 . . . . 0.0 109.513 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.65 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 17.3 t80 -101.25 135.87 42.02 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.606 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -92.17 133.66 35.58 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.465 -0.772 . . . . 0.0 110.118 -178.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -112.33 -36.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.268 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -156.56 143.24 18.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.939 -1.1 . . . . 0.0 109.919 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.43 170.67 40.08 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.56 -170.15 1.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.228 -1.16 . . . . 0.0 109.485 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.53 -138.22 2.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.7 tp -142.71 159.67 41.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.19 -1.182 . . . . 0.0 109.168 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -134.98 86.94 2.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 109.485 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.817 ' O ' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -80.94 120.24 24.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.875 . . . . 0.0 109.511 178.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.817 HD23 ' O ' ' A' ' 114' ' ' CYS . 2.2 mt -132.64 124.34 28.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.2 -0.937 . . . . 0.0 109.032 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 9.6 t-160 -108.3 114.54 28.48 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.943 -1.098 . . . . 0.0 108.985 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.3 mt -127.79 116.45 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.593 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.14 -143.5 33.29 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 105.916 -2.874 . . . . 0.0 105.916 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -105.57 79.11 1.42 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 115.578 -2.449 . . . . 0.0 108.474 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.5 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 31.5 tt0 -166.08 168.66 15.29 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 5' ' ' ILE . 41.9 t -126.37 140.91 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.997 -1.065 . . . . 0.0 110.227 177.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -120.48 130.38 54.26 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.191 0.519 . . . . 0.0 110.249 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.496 ' O ' HD12 ' A' ' 3' ' ' LEU . 19.0 mt-30 -131.08 112.58 13.01 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.496 -0.752 . . . . 0.0 109.107 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.79 137.81 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.6 mp -136.54 93.08 2.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.203 -0.936 . . . . 0.0 110.146 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 1' ' ' SER . 44.0 t -165.96 138.49 4.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.545 -1.347 . . . . 0.0 108.195 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.66 94.37 5.16 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 115.779 -2.368 . . . . 0.0 110.759 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.585 ' C ' ' H ' ' A' ' 130' ' ' ASP . 32.6 mtmt -116.18 150.38 37.56 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.585 176.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.65 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 1.4 m-20 -59.72 -1.95 0.32 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.414 -1.428 . . . . 0.0 107.695 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' A' ' 128' ' ' LYS . 57.0 p30 -68.47 146.13 53.44 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.069 0.937 . . . . 0.0 109.927 -176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.037 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -105.15 140.24 38.62 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.576 0.703 . . . . 0.0 109.962 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 1.037 ' N ' HD12 ' A' ' 131' ' ' LEU . 14.1 tt -128.8 120.6 52.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.68 ' OG ' HG12 ' A' ' 103' ' ' VAL . 8.1 t -118.59 142.99 47.09 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.57 HG11 HD22 ' A' ' 115' ' ' LEU . 12.4 m -99.19 148.57 34.81 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.751 ' O ' HG22 ' A' ' 138' ' ' THR . 38.6 Cg_endo -66.9 153.48 77.77 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.436 2.091 . . . . 0.0 113.355 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.613 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -74.81 136.64 41.62 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.173 -0.954 . . . . 0.0 109.188 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.613 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 13.2 t-80 94.14 10.94 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.751 HG22 ' O ' ' A' ' 135' ' ' PRO . 12.2 t -106.42 127.16 28.75 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.948 -1.095 . . . . 0.0 109.021 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.15 134.4 48.93 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.829 1.686 . . . . 0.0 111.752 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.515 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -171.78 162.15 6.12 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.972 -179.306 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.492 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -134.11 -148.67 0.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.222 -0.923 . . . . 0.0 109.446 -178.696 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -175.06 126.6 0.27 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.038 -1.039 . . . . 0.0 109.094 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.499 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 52.5 p-10 -146.88 138.05 24.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.328 -0.858 . . . . 0.0 109.75 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.613 ' O ' ' C ' ' A' ' 145' ' ' GLY . 6.6 mmt -107.06 19.43 20.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.339 -0.851 . . . . 0.0 111.791 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.613 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 2.22 -88.1 0.0 OUTLIER Glycine 0 N--CA 1.506 3.31 0 CA-C-N 119.5 1.046 . . . . 0.0 111.714 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.484 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 69.2 m -85.52 121.32 28.05 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.119 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.599 ' OE2' ' ND2' ' A' ' 82' ' ' ASN . 40.1 mt-10 -103.25 119.64 54.53 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.731 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 56.1 Cg_endo -104.22 0.89 0.28 Allowed 'Trans proline' 0 C--O 1.207 -1.072 0 C-N-CA 123.844 3.029 . . . . 0.0 110.964 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.731 ' ND2' ' O ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER 83.87 63.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 123.489 1.614 . . . . 0.0 110.424 -179.29 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.435 ' CE1' ' HG ' ' A' ' 78' ' ' LEU . 8.8 p90 -100.88 178.48 4.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.575 -1.328 . . . . 0.0 109.528 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.655 HG21 ' CB ' ' A' ' 50' ' ' ALA . 85.7 m -133.43 139.32 46.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.478 -0.764 . . . . 0.0 109.465 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 76' ' ' ILE . . . -141.23 161.69 37.28 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.853 -1.155 . . . . 0.0 109.721 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.76 ' HA ' HG12 ' A' ' 75' ' ' VAL . 64.4 mt -108.36 127.58 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.017 -1.052 . . . . 0.0 110.195 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -138.96 167.06 22.89 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.427 -0.796 . . . . 0.0 109.905 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.785 HG21 ' CG ' ' A' ' 70' ' ' TYR . 2.9 mt -101.76 147.24 8.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.449 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.6 m-85 -96.48 118.3 32.7 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.347 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.605 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 14.4 p30 -136.17 161.75 34.86 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.826 -0.546 . . . . 0.0 109.575 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -95.71 161.39 27.75 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 120.871 -1.143 . . . . 0.0 109.332 -179.333 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.615 ' O ' ' N ' ' A' ' 162' ' ' TRP . 42.0 Cg_endo -65.6 -53.91 0.68 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.372 2.048 . . . . 0.0 112.034 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 159' ' ' PRO . 49.7 tp10 -43.48 -16.25 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.328 -0.857 . . . . 0.0 109.177 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -86.0 -23.07 46.72 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.615 ' N ' ' O ' ' A' ' 159' ' ' PRO . 20.3 m95 -116.5 165.94 12.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.339 -1.095 . . . . 0.0 109.926 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 35.2 pt -102.46 153.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.212 -0.93 . . . . 0.0 109.284 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.94 -73.64 0.3 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.137 -0.977 . . . . 0.0 110.292 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -141.18 159.01 43.11 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.083 -1.011 . . . . 0.0 109.662 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -101.24 -41.07 6.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.11 -0.994 . . . . 0.0 109.589 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 58.4 p -101.47 -30.31 11.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.081 -1.012 . . . . 0.0 109.443 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.3 -4.03 62.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -79.41 147.64 32.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.829 -1.395 . . . . 0.0 108.361 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 37.5 p30 -110.65 87.64 2.58 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 117.949 -1.501 . . . . 0.0 111.021 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.46 ' H ' HG22 ' A' ' 171' ' ' ILE . 1.7 tt -76.26 -17.26 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.321 -1.487 . . . . 0.0 109.312 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.492 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -59.79 -41.86 92.09 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.799 -0.76 . . . . 0.0 108.952 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.63 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 24.1 t -52.7 -4.64 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.429 -0.794 . . . . 0.0 110.391 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.485 ' HB3' ' CE2' ' A' ' 175' ' ' TYR . . . -79.49 -40.37 29.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.783 -1.198 . . . . 0.0 111.514 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.632 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 6.1 m-85 -113.37 25.49 0.09 OUTLIER Pre-proline 0 N--CA 1.516 2.851 0 O-C-N 120.5 -1.375 . . . . 0.0 112.297 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.743 ' HB3' HD11 ' A' ' 93' ' ' LEU . 44.7 Cg_endo -60.91 -20.41 66.75 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.792 2.995 . . . . 0.0 114.06 -172.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -89.61 126.46 35.63 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.554 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 179' ' ' ALA . 5.3 tt -87.27 122.36 30.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.045 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.668 ' N ' HD23 ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.299 -1.598 0 O-C-N 121.01 -1.056 . . . . 0.0 109.503 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.558 ' O ' ' OG1' ' A' ' 19' ' ' THR . 85.0 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.39 172.51 7.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.262 -0.899 . . . . 0.0 109.203 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.817 ' CD1' HG22 ' A' ' 124' ' ' VAL . 34.8 tp -158.71 114.08 2.59 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 123' ' ' GLN . 0.1 OUTLIER -106.34 128.52 54.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.959 -1.088 . . . . 0.0 110.535 -178.379 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.523 HD12 ' CE3' ' A' ' 16' ' ' TRP . 58.1 mt -122.57 130.47 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.453 ' CD2' ' O ' ' A' ' 11' ' ' PRO . 78.0 m-85 -129.7 167.0 18.68 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.9 m -89.86 173.65 8.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.952 -1.093 . . . . 0.0 108.706 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 8' ' ' VAL . 2.0 m -89.3 -28.25 5.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.029 -1.044 . . . . 0.0 109.495 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -72.14 -39.57 68.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.488 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -138.48 124.6 12.67 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.89 -1.132 . . . . 0.0 109.563 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 55.9 Cg_endo -81.89 -31.52 1.02 Allowed 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.727 1.618 . . . . 0.0 112.193 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.84 1.07 4.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.415 -0.803 . . . . 0.0 110.444 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.37 118.78 32.09 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 p -96.82 127.13 42.5 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.055 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pp -89.93 -13.5 36.14 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.808 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.793 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 53.9 t90 -158.72 106.77 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.412 -1.315 . . . . 0.0 109.713 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -120.14 119.97 34.85 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.287 -0.883 . . . . 0.0 109.835 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.412 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -161.66 165.44 28.24 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.32 -0.863 . . . . 0.0 110.094 -179.737 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 19' ' ' THR . 7.9 t -130.11 89.6 2.82 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.182 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.766 ' O ' HD12 ' A' ' 24' ' ' ILE . 85.1 m-20 -125.12 137.37 54.17 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.707 -0.62 . . . . 0.0 110.181 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.8 -35.04 29.94 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.152 -1.593 . . . . 0.0 108.76 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.1 mp0 -82.92 -51.11 7.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.268 -0.895 . . . . 0.0 109.275 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.629 ' OE2' ' ND2' ' A' ' 20' ' ' ASN . 1.3 tt0 -61.17 -18.49 58.42 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.766 HD12 ' O ' ' A' ' 20' ' ' ASN . 1.9 mt -72.85 -58.4 5.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.144 -0.973 . . . . 0.0 108.514 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.514 ' N ' HG22 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -57.68 -45.59 85.39 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.455 -0.778 . . . . 0.0 109.324 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.671 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 7.9 tt0 -62.41 -44.18 97.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 110.144 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.546 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 27.2 mt-30 -79.02 -46.31 18.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.883 -1.136 . . . . 0.0 109.902 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.421 ' HG ' HG11 ' A' ' 33' ' ' VAL . 16.0 tp -65.82 -58.33 5.88 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.939 -1.1 . . . . 0.0 109.075 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.476 ' CG ' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -60.41 -18.95 54.22 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.735 -1.228 . . . . 0.0 109.715 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -64.67 -24.93 67.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.785 -1.197 . . . . 0.0 108.025 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -88.64 13.81 11.42 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.566 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.36 21.09 46.14 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.343 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.476 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 34.0 t -93.65 144.35 9.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.366 -1.079 . . . . 0.0 109.278 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -83.76 156.16 22.69 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -153.62 146.92 24.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.807 -1.183 . . . . 0.0 107.973 177.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.9 pt-20 -175.18 175.16 2.29 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.074 -1.016 . . . . 0.0 110.271 178.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -148.37 121.94 9.17 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.456 ' CZ2' HD23 ' A' ' 131' ' ' LEU . 34.5 m0 -112.25 153.61 26.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 108.836 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -139.25 146.58 40.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.689 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.597 ' HB2' ' CE1' ' A' ' 57' ' ' TYR . . . -101.85 159.95 14.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 108.708 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -96.23 -17.06 21.05 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.6 mtm-85 -93.09 147.95 22.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -91.91 137.17 32.59 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.582 -0.699 . . . . 0.0 109.273 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.445 ' N ' HD22 ' A' ' 44' ' ' LEU . 4.3 mm? -92.33 163.64 13.81 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.819 0.818 . . . . 0.0 109.378 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.15 -113.5 0.37 Allowed Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.92 -1.134 . . . . 0.0 110.639 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.61 89.01 4.51 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.126 -1.22 . . . . 0.0 109.392 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.49 92.42 19.59 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.1 -25.9 13.39 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.051 1.834 . . . . 0.0 112.285 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.4 p -119.61 141.29 49.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.696 -0.628 . . . . 0.0 109.571 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.63 -27.2 37.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.398 -0.813 . . . . 0.0 109.571 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' HA ' HD11 ' A' ' 54' ' ' ILE . 97.0 mt-10 -43.8 -38.97 3.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.23 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 p -79.82 -32.82 40.69 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.1 -1.0 . . . . 0.0 109.11 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' A' ' 50' ' ' ALA . 43.6 t -67.55 -52.22 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.438 -0.789 . . . . 0.0 109.942 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.618 ' O ' ' N ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -60.85 -30.89 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.044 -1.035 . . . . 0.0 108.795 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.29 -34.56 75.4 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.464 -0.772 . . . . 0.0 109.633 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.97 -18.04 56.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 0.0 110.306 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.597 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 82.5 m-85 -114.44 -10.29 12.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.361 -0.837 . . . . 0.0 109.962 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.618 ' N ' ' O ' ' A' ' 54' ' ' ILE . 2.8 tp-100 -50.74 -34.02 25.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.17 -0.956 . . . . 0.0 109.014 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.522 ' ND1' ' N ' ' A' ' 60' ' ' ALA . 29.0 p80 -54.67 -44.22 73.12 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.945 -1.097 . . . . 0.0 109.5 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.522 ' N ' ' ND1' ' A' ' 59' ' ' HIS . . . -64.2 -60.2 3.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 0.0 109.906 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -63.94 -22.2 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 109.961 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' GLN . 31.1 t0 -58.15 -65.25 0.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.53 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -51.61 -34.25 36.61 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.656 -1.278 . . . . 0.0 108.773 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.16 -55.18 17.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.086 -1.009 . . . . 0.0 109.672 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -67.37 -25.54 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.391 -0.818 . . . . 0.0 109.11 179.528 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.23 -41.89 72.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.963 -1.086 . . . . 0.0 109.495 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.49 -52.3 8.22 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.954 -1.091 . . . . 0.0 109.99 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.637 ' O ' ' C ' ' A' ' 69' ' ' GLY . 45.9 mttm -82.78 4.73 24.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.258 -0.901 . . . . 0.0 110.405 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.637 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . 8.07 80.33 0.01 OUTLIER Glycine 0 N--CA 1.503 3.126 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.832 ' CG ' HG21 ' A' ' 155' ' ' ILE . 30.5 m-85 -74.42 161.67 29.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.164 -1.198 . . . . 0.0 109.497 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.404 ' HG3' HD21 ' A' ' 158' ' ' ASN . 94.7 mm-40 -57.01 -46.27 82.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.428 -0.795 . . . . 0.0 109.716 -177.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 m -150.17 160.24 43.82 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.193 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.733 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 19.3 t-105 -125.77 128.14 47.25 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.483 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 2.5 t0 -136.85 157.63 46.31 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.935 -1.103 . . . . 0.0 108.479 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 76' ' ' ILE . 1.0 OUTLIER -97.86 174.13 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.64 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 35.2 mm -106.99 113.77 44.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.7 p -96.76 164.52 12.54 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 123.229 1.49 . . . . 0.0 111.817 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.016 HD22 ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -167.5 164.57 14.88 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.971 176.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 1.016 ' N ' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -137.45 140.42 41.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 174.611 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.65 -1.88 20.77 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.157 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -114.99 -14.13 11.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.205 -0.934 . . . . 0.0 109.384 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -66.16 123.68 85.89 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.445 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.66 -2.18 11.73 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.176 1.917 . . . . 0.0 111.212 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -87.01 -2.99 59.04 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.027 -1.046 . . . . 0.0 109.763 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.492 ' HB2' HD21 ' A' ' 82' ' ' ASN . 0.2 OUTLIER -54.52 -43.43 71.88 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.687 -1.258 . . . . 0.0 108.135 178.721 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.437 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 84.6 tt0 -60.73 -40.92 94.18 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.233 -0.917 . . . . 0.0 109.148 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.48 81.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.0 109.912 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 88' ' ' LEU . 4.5 mm? -61.59 -42.77 99.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.006 -1.059 . . . . 0.0 109.739 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.45 ' HG2' ' H ' ' A' ' 144' ' ' MET . 82.8 mtm180 -62.01 -27.54 68.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.844 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -65.63 -60.29 3.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.863 . . . . 0.0 109.862 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.427 ' HD3' HD13 ' A' ' 88' ' ' LEU . 12.8 ptmt -57.55 -36.76 72.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -0.913 . . . . 0.0 109.382 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -75.77 -24.26 56.01 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.54 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 94' ' ' ASN . 3.9 mt -74.46 -34.9 63.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 110.602 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 93' ' ' LEU . 16.5 m120 -45.8 127.13 7.77 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.906 -1.122 . . . . 0.0 109.156 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.472 ' HB3' HE22 ' A' ' 165' ' ' GLN . 3.2 tt0 -55.1 147.64 15.6 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -169.01 -172.55 1.58 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 117.612 -1.635 . . . . 0.0 112.628 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -165.03 135.28 3.79 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.645 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.19 157.04 18.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.942 . . . . 0.0 110.077 -179.052 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.485 ' H ' ' HA ' ' A' ' 162' ' ' TRP . . . -78.8 -6.82 88.5 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -122.93 169.78 10.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.454 -1.027 . . . . 0.0 109.3 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -74.94 142.82 43.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.136 -0.978 . . . . 0.0 110.013 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.634 ' CG ' HH22 ' A' ' 154' ' ' ARG . 17.0 tt0 -100.37 94.97 6.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.296 -0.878 . . . . 0.0 108.953 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.511 HG22 ' OG ' ' A' ' 133' ' ' SER . 47.5 t -88.19 128.59 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.501 -0.749 . . . . 0.0 109.173 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.402 ' NH1' ' HB1' ' A' ' 152' ' ' ALA . 5.9 tpt180 -129.39 122.55 29.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 52.2 t80 -109.37 127.06 54.06 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CG ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -87.34 125.68 34.39 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.432 0.634 . . . . 0.0 110.22 -178.494 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.95 -35.2 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.596 -0.69 . . . . 0.0 109.72 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -160.2 145.34 14.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.085 -1.009 . . . . 0.0 110.303 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.475 ' O ' ' OE2' ' A' ' 127' ' ' GLU . . . 97.11 162.85 32.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.21 163.82 28.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -1.154 . . . . 0.0 110.015 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.92 153.16 11.57 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.527 HD22 HD12 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -102.65 101.99 12.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.971 -1.311 . . . . 0.0 109.809 -179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -88.85 130.04 35.47 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.747 -1.22 . . . . 0.0 110.704 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.546 ' SG ' HG13 ' A' ' 121' ' ' VAL . 31.4 t -77.86 130.59 36.82 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.325 0.584 . . . . 0.0 109.714 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.417 HD11 HG13 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -115.82 124.57 51.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.431 ' CD2' ' HH2' ' A' ' 141' ' ' TRP . 2.2 t-80 -115.42 115.75 27.07 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.19 -0.944 . . . . 0.0 108.945 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.41 125.33 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.194 -0.941 . . . . 0.0 110.345 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.74 -143.94 41.04 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 104.167 -3.573 . . . . 0.0 104.167 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -109.28 81.43 1.44 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 122.212 3.006 . . . . 0.0 109.793 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -164.96 168.38 17.58 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.546 HG13 ' SG ' ' A' ' 114' ' ' CYS . 54.1 t -125.66 136.26 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.109 -0.994 . . . . 0.0 109.933 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -124.07 130.55 52.75 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.819 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 4' ' ' THR . 9.0 mt-30 -125.15 118.38 25.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.202 -0.936 . . . . 0.0 108.974 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.817 HG22 ' CD1' ' A' ' 3' ' ' LEU . 31.9 t -105.69 132.32 52.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 125' ' ' LEU . 7.5 tt -126.63 80.05 1.91 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.37 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 1' ' ' SER . 47.4 t -168.99 117.22 0.66 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 177.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.475 ' OE2' ' O ' ' A' ' 109' ' ' GLY . 10.5 tm-20 -113.5 105.7 13.67 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 116.086 -2.245 . . . . 0.0 112.34 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.547 ' C ' ' H ' ' A' ' 130' ' ' ASP . 12.2 mttm -109.31 177.08 4.86 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.16 -1.382 . . . . 0.0 108.68 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.518 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 54.5 m-80 -59.54 -2.0 0.29 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' A' ' 128' ' ' LYS . 31.2 p30 -72.39 154.37 40.94 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.943 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -120.52 155.71 33.06 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.99 0.9 . . . . 0.0 110.089 -179.171 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.943 ' N ' HD12 ' A' ' 131' ' ' LEU . 2.9 tp -122.37 128.33 75.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.511 ' OG ' HG22 ' A' ' 103' ' ' VAL . 4.9 t -109.04 134.39 51.73 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 108.985 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.417 HG13 HD11 ' A' ' 115' ' ' LEU . 2.3 t -103.63 133.86 20.05 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.01 151.41 73.36 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.893 1.729 . . . . 0.0 112.552 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.39 134.71 48.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.619 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 1.4 t-80 92.97 7.94 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 120.933 0.397 . . . . 0.0 110.262 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.87 125.91 33.3 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.89 -1.131 . . . . 0.0 109.228 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 166' ' ' PHE . 40.6 Cg_endo -64.02 131.55 31.16 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.636 1.557 . . . . 0.0 111.656 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.474 ' C ' ' CE3' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -169.71 160.56 8.83 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.096 -178.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.501 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -131.92 -146.6 0.29 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.295 -0.878 . . . . 0.0 109.414 -178.515 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.04 128.12 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.772 -1.205 . . . . 0.0 109.088 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.42 136.67 21.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.455 -0.778 . . . . 0.0 109.577 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.586 ' O ' ' C ' ' A' ' 145' ' ' GLY . 9.1 mmt -112.59 18.89 17.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.478 -0.764 . . . . 0.0 111.036 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 10.88 -94.38 0.01 OUTLIER Glycine 0 N--CA 1.506 3.339 0 CA-C-N 118.886 0.766 . . . . 0.0 112.349 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.488 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 18.5 p -85.38 120.89 27.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.351 -1.339 . . . . 0.0 109.02 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.743 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -113.4 118.17 44.06 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.873 -0.517 . . . . 0.0 109.783 178.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.6 Cg_endo -102.22 34.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.794 2.329 . . . . 0.0 110.742 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.681 ' HA ' HD11 ' A' ' 78' ' ' LEU . 13.4 t-20 82.66 64.61 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.446 0.641 . . . . 0.0 109.457 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.486 ' O ' HD12 ' A' ' 78' ' ' LEU . 24.8 p90 -99.85 153.24 19.3 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 122.212 1.006 . . . . 0.0 111.327 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.8 m -118.27 137.32 53.13 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.64 ' HB3' ' HB ' ' A' ' 76' ' ' ILE . . . -142.59 163.27 33.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.1 -1.0 . . . . 0.0 109.176 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.733 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 63.6 mt -119.17 136.96 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.219 -0.926 . . . . 0.0 109.874 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.634 HH22 ' CG ' ' A' ' 102' ' ' GLU . 2.6 ttt85 -140.11 167.75 21.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.901 -1.124 . . . . 0.0 110.472 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.832 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.1 mp -109.18 155.19 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.485 -0.759 . . . . 0.0 109.603 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.483 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 2.6 m-30 -106.97 125.42 50.98 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.975 0.893 . . . . 0.0 110.253 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 158' ' ' ASN . 1.1 t70 -131.07 162.03 30.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.439 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -93.85 161.83 28.91 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.105 -0.997 . . . . 0.0 108.464 -179.46 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 162' ' ' TRP . 41.4 Cg_endo -63.53 -55.97 0.61 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.009 1.806 . . . . 0.0 112.376 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 159' ' ' PRO . 48.9 tp10 -44.02 -19.22 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.072 -1.018 . . . . 0.0 108.309 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -90.0 -31.1 11.35 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.598 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -95.74 165.2 12.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.406 -1.055 . . . . 0.0 111.286 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.65 148.02 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.23 -74.87 0.29 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.932 -1.105 . . . . 0.0 110.644 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.472 HE22 ' HB3' ' A' ' 95' ' ' GLU . 14.3 mm100 -141.91 161.26 38.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.993 -1.067 . . . . 0.0 109.929 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.629 ' CD2' ' N ' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -101.95 -41.76 6.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.127 -0.983 . . . . 0.0 109.269 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 70.8 p -117.98 -30.42 5.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.346 -0.846 . . . . 0.0 108.887 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.06 -5.45 53.07 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 120.175 -1.012 . . . . 0.0 110.653 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -79.59 148.13 31.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.589 -1.536 . . . . 0.0 108.016 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -108.38 89.51 3.02 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 117.519 -1.672 . . . . 0.0 110.88 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.422 ' H ' HG22 ' A' ' 171' ' ' ILE . 1.3 tt -78.86 -23.57 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.489 -1.382 . . . . 0.0 109.737 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -56.74 -41.39 77.45 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 108.724 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.565 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 47.5 p -53.52 -3.38 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.348 -0.845 . . . . 0.0 109.973 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.83 -37.05 35.91 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.031 -1.043 . . . . 0.0 111.964 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.618 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.1 m-85 -111.9 25.18 0.08 OUTLIER Pre-proline 0 N--CA 1.517 2.895 0 O-C-N 120.449 -1.407 . . . . 0.0 113.077 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 38.0 Cg_endo -58.97 -24.0 71.04 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 123.902 3.068 . . . . 0.0 115.141 -172.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -89.05 126.25 35.35 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.487 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.734 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.8 OUTLIER -86.8 123.99 32.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.18 -0.95 . . . . 0.0 108.717 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.812 ' O ' HG23 ' A' ' 19' ' ' THR . 3.7 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.92 169.52 9.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.043 -1.036 . . . . 0.0 108.991 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.536 HD12 ' O ' ' A' ' 123' ' ' GLN . 5.5 tp -158.0 115.02 2.91 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.516 ' OG1' HD11 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -110.0 134.08 52.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.34 -0.85 . . . . 0.0 110.06 -178.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 121' ' ' VAL . 38.4 mt -129.74 132.12 66.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 96.6 m-85 -124.05 167.45 14.18 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -86.31 174.57 8.96 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.269 -0.895 . . . . 0.0 108.948 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.76 -31.32 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.898 -1.126 . . . . 0.0 109.492 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -73.03 -37.34 66.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.947 . . . . 0.0 110.303 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -136.52 124.71 14.96 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 109.519 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.427 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 56.3 Cg_endo -81.09 -35.53 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 122.068 1.845 . . . . 0.0 112.317 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.63 4.99 1.58 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.442 -0.787 . . . . 0.0 110.258 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -114.52 118.99 35.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.401 -0.812 . . . . 0.0 109.007 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.4 p -98.65 123.16 42.68 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.277 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 pp -91.0 -7.72 51.18 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.633 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.687 ' HB3' HD12 ' A' ' 5' ' ' ILE . 31.9 t90 -157.43 105.27 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.338 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -120.6 115.99 24.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.57 -0.706 . . . . 0.0 109.876 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.445 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -162.34 165.01 27.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.33 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 1' ' ' SER . 52.1 m -131.37 90.2 2.83 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.805 ' O ' HD12 ' A' ' 24' ' ' ILE . 84.0 m-20 -127.04 151.24 48.87 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.288 -0.882 . . . . 0.0 110.491 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.91 -45.02 13.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.037 -1.664 . . . . 0.0 108.279 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 23' ' ' GLU . 10.6 pt-20 -82.89 -46.12 13.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.704 . . . . 0.0 110.18 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.514 ' N ' ' CG ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -62.84 -23.69 67.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.52 -1.362 . . . . 0.0 108.705 -178.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.805 HD12 ' O ' ' A' ' 20' ' ' ASN . 4.6 mt -70.42 -58.68 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.522 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 6.6 pt20 -56.36 -44.17 79.88 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.303 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.551 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 74.5 mt-30 -57.73 -33.27 68.27 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.317 -0.865 . . . . 0.0 109.906 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.588 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 5.7 tt0 -70.34 -61.36 1.8 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.024 -1.048 . . . . 0.0 109.41 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -66.98 -55.36 14.8 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.776 -1.202 . . . . 0.0 109.794 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 18.1 t-20 -49.9 -31.95 13.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.886 -1.134 . . . . 0.0 109.333 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -63.59 -24.61 67.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.021 -1.049 . . . . 0.0 108.44 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.526 ' NZ ' ' OE1' ' A' ' 120' ' ' GLU . 30.0 mttt -92.48 14.12 17.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.54 24.44 26.01 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.714 -1.232 . . . . 0.0 110.089 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.599 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 39.6 t -96.36 146.3 7.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.386 -1.067 . . . . 0.0 109.704 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.448 ' HB3' ' H ' ' A' ' 133' ' ' SER . 18.2 ttt180 -85.83 155.85 20.81 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 120.927 -1.108 . . . . 0.0 109.136 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 25' ' ' GLN . 1.2 t80 -154.62 149.44 26.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.912 -1.117 . . . . 0.0 108.912 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 1.3 mt-10 -175.04 172.92 2.74 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.903 -1.123 . . . . 0.0 109.878 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -150.81 114.83 5.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 108.839 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -110.67 152.59 26.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.62 -0.675 . . . . 0.0 109.235 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -143.12 167.43 22.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 109.964 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.457 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . . . -93.52 158.66 15.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 108.86 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -102.97 -17.43 15.46 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.204 -0.935 . . . . 0.0 108.534 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -93.38 171.47 8.89 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.591 0.71 . . . . 0.0 109.185 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -94.34 116.88 29.33 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.556 -0.715 . . . . 0.0 109.501 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mt -91.17 163.68 14.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.429 -0.795 . . . . 0.0 109.137 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.62 -101.08 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.68 93.07 4.83 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.108 -1.23 . . . . 0.0 109.48 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.55 91.61 34.56 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -77.02 -26.94 7.32 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.412 2.074 . . . . 0.0 112.701 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.6 p -119.92 141.16 49.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 0.0 109.581 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.93 -20.85 41.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.405 -0.809 . . . . 0.0 109.475 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 50' ' ' ALA . 84.8 tt0 -44.83 -37.89 4.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.005 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.7 p -79.73 -31.95 41.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.275 -0.891 . . . . 0.0 109.42 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ALA . 79.7 t -67.74 -47.67 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 109.777 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 58' ' ' GLN . 9.9 mm -60.26 -37.26 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.957 . . . . 0.0 108.859 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.32 -29.87 70.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.418 -0.802 . . . . 0.0 109.45 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.23 -18.68 60.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 110.317 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.457 ' HE2' ' HB2' ' A' ' 40' ' ' ALA . 8.9 m-85 -118.42 -7.5 10.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.389 -0.82 . . . . 0.0 109.181 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.707 HE21 ' CG1' ' A' ' 61' ' ' ILE . 28.9 tp60 -50.53 -39.4 48.83 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.313 -0.867 . . . . 0.0 108.774 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.741 ' CD2' ' N ' ' A' ' 60' ' ' ALA . 10.7 p-80 -53.04 -42.99 66.27 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.853 -1.154 . . . . 0.0 109.24 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.741 ' N ' ' CD2' ' A' ' 59' ' ' HIS . . . -61.88 -58.69 6.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.075 -1.015 . . . . 0.0 109.464 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.711 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -64.24 -28.52 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.763 -1.211 . . . . 0.0 109.15 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 58' ' ' GLN . 27.0 t70 -55.29 -25.4 33.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.145 -0.972 . . . . 0.0 109.395 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HG2' ' N ' ' A' ' 64' ' ' LEU . 8.8 ptmt -83.71 -37.26 22.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.08 -1.012 . . . . 0.0 109.493 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.545 HD21 HG21 ' A' ' 103' ' ' VAL . 0.5 OUTLIER -68.86 -45.56 70.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.206 -0.934 . . . . 0.0 109.895 -179.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 69' ' ' GLY . 3.3 p -68.56 -32.64 56.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.431 -0.793 . . . . 0.0 109.479 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.1 67.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.209 -0.932 . . . . 0.0 109.538 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -79.44 -50.03 11.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.123 -0.985 . . . . 0.0 109.897 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.659 ' O ' ' C ' ' A' ' 69' ' ' GLY . 20.5 mmtt -85.83 14.12 6.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.464 -0.772 . . . . 0.0 110.14 -177.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.659 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -7.53 85.64 0.0 OUTLIER Glycine 0 N--CA 1.501 2.984 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.487 ' CG ' HG21 ' A' ' 155' ' ' ILE . 11.7 m-85 -75.96 166.84 22.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.463 -1.022 . . . . 0.0 108.977 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -57.53 -40.58 79.12 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.441 -0.787 . . . . 0.0 109.805 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.29 167.53 30.15 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.631 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.666 ' HE1' HG23 ' A' ' 153' ' ' ILE . 13.2 t-105 -134.24 137.64 44.48 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.269 -0.895 . . . . 0.0 109.126 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.69 179.02 8.9 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.061 -1.025 . . . . 0.0 108.343 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' A' ' 153' ' ' ILE . 3.8 m -124.17 149.38 28.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.422 -0.799 . . . . 0.0 109.438 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.4 mt -100.86 117.04 45.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 77' ' ' SER . 27.8 p -170.13 101.69 0.29 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.453 -0.78 . . . . 0.0 109.399 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -110.95 179.84 3.94 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.95 1.705 . . . . 0.0 107.864 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.648 ' H ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -89.71 144.75 25.72 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.688 -1.258 . . . . 0.0 109.062 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.66 2.21 0.11 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.749 -0.594 . . . . 0.0 109.593 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -85.63 -28.28 24.88 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.469 -1.292 . . . . 0.0 108.888 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -64.51 123.84 84.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.905 -1.122 . . . . 0.0 109.45 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -79.19 -8.97 15.32 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.134 1.889 . . . . 0.0 112.349 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -90.21 3.13 54.42 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.96 -1.087 . . . . 0.0 109.596 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.547 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 44.6 pttt -60.96 -47.4 86.6 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.211 -0.93 . . . . 0.0 108.96 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.547 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 96.5 mt-10 -64.56 -42.88 95.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.64 76.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.029 -1.044 . . . . 0.0 109.432 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.53 -50.17 72.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 0.0 110.129 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.585 HH12 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -65.06 -24.66 67.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.229 -0.92 . . . . 0.0 109.701 -179.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.585 ' CD ' HH12 ' A' ' 89' ' ' ARG . 58.0 mm-40 -65.41 -60.03 3.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.37 -0.831 . . . . 0.0 109.6 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -53.32 -27.81 25.23 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.072 -1.018 . . . . 0.0 109.038 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -18.4 33.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.017 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.9 -36.72 70.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.199 -0.938 . . . . 0.0 109.848 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -46.64 137.18 7.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.057 . . . . 0.0 109.337 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -70.93 164.6 25.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 0.0 109.555 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -175.9 -167.26 0.22 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.442 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.8 t -163.88 134.31 4.31 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.619 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -103.73 154.86 19.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 0.0 109.786 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.42 -6.58 86.66 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -123.97 170.06 11.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.443 -1.033 . . . . 0.0 109.38 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -73.84 143.19 46.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.217 -0.927 . . . . 0.0 109.778 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.559 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 4.6 tt0 -104.47 94.45 5.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.214 -0.929 . . . . 0.0 109.053 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.545 HG21 HD21 ' A' ' 64' ' ' LEU . 38.3 t -81.65 131.11 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.199 -0.938 . . . . 0.0 110.161 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.99 109.64 11.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.451 -0.78 . . . . 0.0 109.854 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.624 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 14.7 t80 -104.8 131.52 52.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.335 -0.853 . . . . 0.0 109.071 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.567 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -90.06 132.27 35.49 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.408 0.623 . . . . 0.0 109.861 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.408 ' HB ' HG22 ' A' ' 151' ' ' THR . 9.4 t -113.48 -31.01 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.743 -0.598 . . . . 0.0 109.784 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -167.65 156.02 9.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.1 -1.0 . . . . 0.0 109.358 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.29 155.76 8.42 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.62 ' HB2' ' CD ' ' A' ' 127' ' ' GLU . . . -114.69 148.75 37.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -1.072 . . . . 0.0 109.365 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.23 -136.69 3.47 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 26.5 tp -138.24 154.08 49.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.397 -1.06 . . . . 0.0 109.493 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -122.23 145.43 48.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.582 -0.699 . . . . 0.0 109.39 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.67 108.71 4.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.578 -0.701 . . . . 0.0 109.713 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.611 HD21 HG13 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -118.92 112.87 20.18 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.555 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.1 t-160 -105.25 113.22 26.68 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.204 -0.935 . . . . 0.0 109.601 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -131.68 119.24 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.25 -0.906 . . . . 0.0 110.203 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.37 -143.16 33.83 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 105.998 -2.841 . . . . 0.0 105.998 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 7.0 p-10 -105.36 79.26 1.45 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 115.185 -2.606 . . . . 0.0 109.61 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.555 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 78.8 tt0 -165.19 166.19 19.13 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.765 ' O ' HG23 ' A' ' 5' ' ' ILE . 45.7 t -129.91 152.19 36.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.038 -1.038 . . . . 0.0 109.683 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.28 131.32 46.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.63 -0.669 . . . . 0.0 109.286 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.536 ' O ' HD12 ' A' ' 3' ' ' LEU . 16.7 mt-30 -128.24 115.04 17.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 109.11 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.3 t -108.22 138.08 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -134.56 90.3 2.64 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.213 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 31.2 p -166.35 135.35 3.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.388 -1.445 . . . . 0.0 107.546 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.62 ' CD ' ' HB2' ' A' ' 110' ' ' ALA . 1.3 pt-20 -107.05 94.91 5.35 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 116.195 -2.202 . . . . 0.0 110.642 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 130' ' ' ASP . 29.8 mtmm -114.55 157.69 22.67 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.655 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.624 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 1.7 m120 -58.68 -4.0 0.38 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.421 -1.424 . . . . 0.0 108.096 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 128' ' ' LYS . 56.2 p30 -72.23 152.72 42.01 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.39 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.747 ' C ' HD12 ' A' ' 131' ' ' LEU . 2.3 pp -126.27 162.03 26.4 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.051 0.929 . . . . 0.0 110.944 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 131' ' ' LEU . 9.7 mt -129.95 130.8 66.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.448 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 5.6 t -106.81 136.92 45.81 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.477 -0.765 . . . . 0.0 109.011 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.611 HG13 HD21 ' A' ' 115' ' ' LEU . 2.3 t -101.98 133.63 20.58 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.743 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.09 151.33 81.81 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.835 1.69 . . . . 0.0 112.484 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.612 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.23 135.05 48.64 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.612 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.0 t-80 91.94 10.4 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.39 125.84 33.08 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.087 -1.008 . . . . 0.0 108.785 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.1 130.57 27.7 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.573 1.516 . . . . 0.0 111.573 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -166.94 165.42 15.97 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.229 -178.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.567 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -136.14 -149.76 0.34 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 109.646 -178.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.08 125.0 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 109.167 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.488 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 16.3 p-10 -141.6 132.12 25.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.627 ' O ' ' C ' ' A' ' 145' ' ' GLY . 49.7 mtt -112.73 17.77 18.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.597 -0.69 . . . . 0.0 110.692 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.67 ' N ' HD13 ' A' ' 178' ' ' LEU . . . 8.97 -90.08 0.0 OUTLIER Glycine 0 N--CA 1.502 3.098 0 CA-C-N 119.206 0.912 . . . . 0.0 111.685 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.517 ' H ' ' HB2' ' A' ' 178' ' ' LEU . 70.9 m -86.56 116.13 24.48 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 117.763 -1.575 . . . . 0.0 109.127 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.16 113.44 37.33 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.985 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.558 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.7 Cg_endo -103.36 40.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 122.935 2.423 . . . . 0.0 111.684 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 81.75 72.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.998 -177.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 5.5 p90 -94.53 138.23 32.68 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.215 -0.928 . . . . 0.0 110.476 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.408 HG22 ' HB ' ' A' ' 107' ' ' VAL . 15.9 m -103.57 118.73 37.4 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.723 -0.61 . . . . 0.0 109.625 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.8 163.34 33.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.454 -0.779 . . . . 0.0 109.283 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.741 ' HA ' HG12 ' A' ' 75' ' ' VAL . 61.4 mt -109.35 127.04 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.272 -0.893 . . . . 0.0 110.062 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.515 ' C ' HD13 ' A' ' 155' ' ' ILE . 9.0 tpt180 -129.9 157.28 42.7 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.55 0.69 . . . . 0.0 109.514 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.598 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -102.89 149.26 7.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -96.22 120.86 37.27 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 0.0 110.319 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -133.71 162.99 30.46 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -94.52 161.98 27.32 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.143 -0.973 . . . . 0.0 109.23 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.633 ' O ' ' N ' ' A' ' 161' ' ' GLY . 40.1 Cg_endo -65.21 -57.37 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.014 1.809 . . . . 0.0 111.54 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 159' ' ' PRO . 50.6 mt-10 -43.98 -13.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.793 . . . . 0.0 109.126 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -76.77 -33.05 47.94 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 177.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.52 ' N ' ' O ' ' A' ' 159' ' ' PRO . 4.3 p90 -118.3 159.12 23.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.274 -1.133 . . . . 0.0 110.279 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 26.6 mm -100.99 147.3 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.428 -0.795 . . . . 0.0 109.392 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.806 ' HB1' ' NE2' ' A' ' 165' ' ' GLN . . . -57.36 -72.67 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.806 ' NE2' ' HB1' ' A' ' 164' ' ' ALA . 11.7 mp0 -141.4 165.29 27.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.14 -0.975 . . . . 0.0 109.646 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -100.03 -41.45 7.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.467 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 59.4 m -105.3 -30.54 9.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.166 -0.958 . . . . 0.0 109.128 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.57 -6.35 52.45 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -81.88 149.33 28.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.78 -1.424 . . . . 0.0 108.522 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 44.2 p30 -107.82 87.54 2.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.116 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.1 tt -78.31 -26.92 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.59 -1.319 . . . . 0.0 109.313 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.567 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -58.22 -42.6 86.63 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.608 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 28.6 p -54.54 -2.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 109.924 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.03 -39.8 33.03 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.097 -1.002 . . . . 0.0 111.473 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.629 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.3 m-85 -111.38 23.92 0.08 OUTLIER Pre-proline 0 N--CA 1.512 2.64 0 O-C-N 120.603 -1.31 . . . . 0.0 113.039 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 49.9 Cg_endo -65.07 -20.1 63.51 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 123.466 2.777 . . . . 0.0 113.581 -173.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -89.31 126.71 35.63 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.217 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.67 HD13 ' N ' ' A' ' 145' ' ' GLY . 7.9 mp -86.08 147.75 26.03 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.837 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.587 ' O ' ' OG1' ' A' ' 19' ' ' THR . 89.6 p . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.39 173.39 7.22 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.102 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.904 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 18.0 tp -160.06 114.43 2.26 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.51 131.54 55.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.022 -1.049 . . . . 0.0 110.227 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.728 HD13 ' CE2' ' A' ' 122' ' ' PHE . 60.5 mt -126.76 133.64 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 11' ' ' PRO . 98.4 m-85 -128.37 165.5 20.47 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.46 0.648 . . . . 0.0 109.72 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.475 ' OG ' HD13 ' A' ' 15' ' ' LEU . 64.2 m -89.66 176.29 6.92 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.78 -25.82 5.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 120.732 -1.23 . . . . 0.0 109.428 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -72.56 -40.72 66.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.969 -1.082 . . . . 0.0 110.16 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -137.44 124.57 13.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.018 . . . . 0.0 109.324 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 56.4 Cg_endo -81.86 -29.92 1.54 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.876 1.717 . . . . 0.0 112.35 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -68.37 -27.36 66.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.505 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -94.56 120.87 35.47 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.798 -1.189 . . . . 0.0 108.985 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 p -95.31 132.86 39.86 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.391 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 15' ' ' LEU . 11.1 mp -89.34 -10.27 47.31 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.991 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.904 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 37.6 t90 -158.45 105.99 1.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.291 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -120.01 116.39 25.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 0.0 109.759 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.73 166.86 25.99 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.476 -0.765 . . . . 0.0 109.776 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.831 HG23 ' O ' ' A' ' 19' ' ' THR . 9.0 t -130.33 88.19 2.61 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.717 ' O ' HD12 ' A' ' 24' ' ' ILE . 15.0 m-20 -126.04 139.23 53.58 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.52 -35.58 27.18 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.095 -1.628 . . . . 0.0 108.919 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.534 ' CG ' ' N ' ' A' ' 23' ' ' GLU . 19.8 pt-20 -82.49 -49.92 9.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.12 -0.988 . . . . 0.0 108.981 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.534 ' N ' ' CG ' ' A' ' 22' ' ' GLU . 1.6 tm-20 -63.11 -18.97 64.0 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.893 -1.13 . . . . 0.0 108.57 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 20' ' ' ASN . 1.8 mt -71.32 -56.77 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.246 -0.909 . . . . 0.0 109.504 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.56 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 7.2 pt20 -53.25 -47.6 68.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 109.654 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.56 ' N ' ' CG ' ' A' ' 25' ' ' GLN . 49.3 tt0 -63.1 -26.77 68.98 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.444 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.516 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -69.74 -66.05 0.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.137 0.97 . . . . 0.0 110.871 -178.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.552 HD12 ' H ' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -71.35 -46.79 59.64 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.682 -1.261 . . . . 0.0 109.636 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.601 HD22 ' C ' ' A' ' 33' ' ' VAL . 10.8 m120 -54.8 -27.43 41.65 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.602 -1.311 . . . . 0.0 109.062 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -63.0 -25.75 68.54 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.7 ' HG3' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -92.6 8.67 37.99 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.367 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.06 25.47 11.26 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.742 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' HG3' ' A' ' 31' ' ' LYS . 69.5 t -94.08 145.46 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.633 -1.51 . . . . 0.0 109.084 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.608 HH12 ' NZ ' ' A' ' 68' ' ' LYS . 23.9 ttm180 -84.32 156.1 22.07 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.832 ' CE2' HD11 ' A' ' 132' ' ' ILE . 0.3 OUTLIER -153.43 147.09 25.12 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.1 tp10 -174.24 171.42 3.49 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.79 -1.194 . . . . 0.0 109.381 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -148.06 112.3 5.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.036 -1.04 . . . . 0.0 108.368 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.508 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 22.7 m0 -111.19 155.28 23.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.432 -0.793 . . . . 0.0 108.988 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.32 161.64 37.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.928 . . . . 0.0 109.969 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.86 158.14 16.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 108.931 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -102.64 -14.76 16.59 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.63 163.63 13.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.605 0.717 . . . . 0.0 109.155 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.504 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 46.3 p-10 -96.74 120.68 37.51 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.459 -0.775 . . . . 0.0 109.735 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.06 164.69 13.86 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.282 -0.886 . . . . 0.0 109.07 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.4 -105.8 0.22 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.73 90.97 5.24 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.052 -1.263 . . . . 0.0 109.104 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.44 92.17 42.9 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.93 -20.83 19.16 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.151 1.901 . . . . 0.0 112.501 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.8 p -124.27 141.67 51.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.563 -0.71 . . . . 0.0 109.622 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' GLU . . . -80.23 -20.58 44.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.538 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' ALA . 84.6 tt0 -43.12 -37.83 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.063 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.2 p -79.36 -36.35 39.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.149 -0.969 . . . . 0.0 109.144 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 50' ' ' ALA . 60.1 t -67.33 -46.34 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -0.846 . . . . 0.0 109.747 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.588 HG22 ' HG2' ' A' ' 58' ' ' GLN . 7.8 mm -60.92 -34.24 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 108.889 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.63 -29.27 70.49 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.449 -0.782 . . . . 0.0 109.627 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.56 -21.89 48.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.988 . . . . 0.0 110.136 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -110.56 -10.31 14.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.48 -0.762 . . . . 0.0 109.769 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.638 HE22 HD11 ' A' ' 61' ' ' ILE . 5.5 mm-40 -47.59 -36.75 11.19 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.054 -1.029 . . . . 0.0 109.128 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.677 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 5.4 p80 -53.22 -48.01 68.5 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.979 -1.088 . . . . 0.0 109.57 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.677 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.15 -58.1 9.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.941 -1.099 . . . . 0.0 110.054 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.638 HD11 HE22 ' A' ' 58' ' ' GLN . 0.9 OUTLIER -65.19 -26.25 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.924 -1.11 . . . . 0.0 109.462 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 58' ' ' GLN . 21.0 t70 -58.57 -25.19 62.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 109.32 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -83.99 -44.23 14.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.416 -0.803 . . . . 0.0 109.859 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.64 -46.46 79.12 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.422 -0.799 . . . . 0.0 109.761 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' GLY . 5.9 p -66.63 -29.61 47.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.85 -44.53 74.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.907 -1.121 . . . . 0.0 109.425 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -80.39 -51.46 8.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.934 -1.104 . . . . 0.0 110.182 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.608 ' NZ ' HH12 ' A' ' 34' ' ' ARG . 33.1 mttt -85.01 13.62 5.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 110.732 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.599 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -5.22 84.16 0.0 OUTLIER Glycine 0 N--CA 1.5 2.932 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.434 ' CG ' HG21 ' A' ' 155' ' ' ILE . 32.4 m-85 -77.5 165.08 24.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.663 -0.904 . . . . 0.0 108.703 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.418 HE21 ' HA ' ' A' ' 157' ' ' ASP . 58.5 mt-30 -57.21 -89.55 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.164 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.605 ' OG ' ' CG ' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -102.38 163.06 12.44 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.668 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.409 ' CE3' HG23 ' A' ' 155' ' ' ILE . 5.7 t-105 -136.98 141.23 42.58 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.46 -0.775 . . . . 0.0 109.187 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -174.7 -167.42 0.3 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 153' ' ' ILE . 4.7 m -124.21 168.21 17.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.492 -0.755 . . . . 0.0 109.488 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.664 HD11 ' HD2' ' A' ' 154' ' ' ARG . 75.9 mt -94.49 132.95 37.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.5 p -93.0 166.79 12.19 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.857 1.313 . . . . 0.0 112.135 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.607 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 1.0 OUTLIER -169.13 160.49 9.8 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.209 176.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.433 ' HG3' ' H ' ' A' ' 81' ' ' ASP . 1.3 tpt180 -132.4 141.52 48.91 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 174.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.47 -0.72 6.95 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.837 -1.164 . . . . 0.0 109.684 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.433 ' H ' ' HG3' ' A' ' 79' ' ' ARG . 91.2 m-20 -118.47 -12.44 9.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.086 -1.009 . . . . 0.0 109.196 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -62.72 123.9 81.17 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.938 . . . . 0.0 110.453 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.04 -1.6 11.5 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.758 2.306 . . . . 0.0 112.542 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.481 ' H ' ' ND2' ' A' ' 82' ' ' ASN . 72.9 mt-30 -83.25 16.19 2.58 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.76 -1.212 . . . . 0.0 109.161 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.456 ' HG2' ' H ' ' A' ' 85' ' ' LYS . 6.2 pttt -61.36 -59.88 4.59 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.5 -0.75 . . . . 0.0 109.507 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.405 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 20.1 pt-20 -64.56 -31.74 73.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.312 -0.868 . . . . 0.0 109.666 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.89 -59.27 5.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 110.077 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 72.4 mt -61.95 -42.81 99.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 110.185 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.451 ' HE ' ' C ' ' A' ' 85' ' ' LYS . 49.6 mtm180 -59.52 -28.98 67.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.886 . . . . 0.0 110.079 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.96 -59.58 4.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 0.0 109.497 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -51.22 -34.34 31.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.376 -0.827 . . . . 0.0 109.404 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -88.14 -17.74 30.31 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.043 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.711 HD21 ' OG ' ' A' ' 173' ' ' SER . 8.6 tp -55.79 -34.39 65.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 109.822 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.529 HD22 HE22 ' A' ' 165' ' ' GLN . 6.1 m120 -63.28 135.29 56.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.121 -0.987 . . . . 0.0 110.22 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -70.71 164.45 25.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.527 -0.733 . . . . 0.0 109.418 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -174.92 -165.6 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.82 -1.175 . . . . 0.0 111.272 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 163' ' ' ILE . 9.5 t -164.56 135.33 4.16 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.607 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -105.93 154.58 20.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.466 -0.771 . . . . 0.0 110.207 -178.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.39 -6.35 86.42 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.441 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 95.5 mt-10 -124.24 169.93 11.27 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.487 -1.008 . . . . 0.0 109.61 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -74.91 143.62 43.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 0.0 109.827 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.484 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 6.7 tt0 -107.54 93.25 4.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.261 -0.899 . . . . 0.0 108.592 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 103' ' ' VAL . 10.5 p -94.67 131.98 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.738 -1.226 . . . . 0.0 111.025 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.74 ' HE ' HH21 ' A' ' 154' ' ' ARG . 78.0 mtt180 -130.2 126.93 38.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.735 -0.603 . . . . 0.0 109.402 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.605 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 13.3 t80 -109.05 132.0 54.53 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.533 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -85.21 126.25 33.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.941 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.4 ' O ' ' CG ' ' A' ' 108' ' ' GLU . 5.0 t -107.15 -41.18 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.369 -0.832 . . . . 0.0 110.692 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 91.1 mt-10 -154.8 141.07 18.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.883 -1.136 . . . . 0.0 109.815 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.97 159.89 36.07 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.503 ' HB2' ' HG3' ' A' ' 127' ' ' GLU . . . -113.92 151.03 32.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -1.223 . . . . 0.0 109.737 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.57 -126.83 1.95 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.9 tp -147.95 163.22 37.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -1.015 . . . . 0.0 109.074 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -134.8 90.81 2.69 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.046 -1.034 . . . . 0.0 109.098 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.589 ' SG ' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -78.13 146.25 35.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.982 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mt -148.53 101.53 3.23 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -102.13 113.4 26.63 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.825 -1.172 . . . . 0.0 109.562 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.746 HD12 ' N ' ' A' ' 118' ' ' GLY . 0.1 OUTLIER -134.97 124.79 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.095 -1.003 . . . . 0.0 110.506 -178.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.746 ' N ' HD12 ' A' ' 117' ' ' ILE . . . 70.22 -142.67 36.24 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 105.636 -2.986 . . . . 0.0 105.636 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.32 79.11 1.18 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 115.157 -2.617 . . . . 0.0 108.303 176.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -165.07 166.62 19.05 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.682 ' O ' HG23 ' A' ' 5' ' ' ILE . 51.0 t -125.99 140.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.087 -1.008 . . . . 0.0 110.404 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.728 ' CE2' HD13 ' A' ' 5' ' ' ILE . 16.0 m-85 -123.83 131.02 53.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.442 0.639 . . . . 0.0 109.791 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -141.94 118.62 11.05 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.169 -0.957 . . . . 0.0 109.785 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -101.79 147.23 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.612 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tp -127.58 81.62 2.03 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.46 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.447 ' SG ' ' CB ' ' A' ' 1' ' ' SER . 35.9 t -166.56 122.65 1.22 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.703 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -109.3 105.82 15.38 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 116.705 -1.998 . . . . 0.0 112.338 -178.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.56 ' C ' ' H ' ' A' ' 130' ' ' ASP . 42.1 mmtt -113.77 171.04 7.82 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.02 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.605 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 12.5 m120 -58.76 -3.03 0.27 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.832 -1.168 . . . . 0.0 107.895 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 128' ' ' LYS . 40.2 p30 -73.43 153.99 40.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.793 0.806 . . . . 0.0 109.888 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.79 ' C ' HD12 ' A' ' 131' ' ' LEU . 2.3 pp -122.89 161.31 24.37 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.073 0.939 . . . . 0.0 110.366 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.832 HD11 ' CE2' ' A' ' 35' ' ' PHE . 1.3 mp -131.54 127.83 60.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.664 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.9 t -123.71 135.93 54.15 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.75 148.63 36.1 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.278 -0.889 . . . . 0.0 108.799 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.22 157.95 57.87 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.554 2.169 . . . . 0.0 113.052 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.621 ' O ' ' CD2' ' A' ' 137' ' ' HIS . . . -73.38 135.62 44.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.237 -0.914 . . . . 0.0 108.997 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.703 ' O ' ' ND1' ' A' ' 137' ' ' HIS . 0.1 OUTLIER 95.43 3.92 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.352 0.596 . . . . 0.0 109.732 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.78 125.47 42.19 Favored Pre-proline 0 N--CA 1.487 1.42 0 O-C-N 120.84 -1.162 . . . . 0.0 108.816 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.14 132.9 33.38 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.433 1.422 . . . . 0.0 111.6 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.512 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.42 164.28 15.05 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.189 -0.944 . . . . 0.0 110.161 -178.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.589 ' CD1' ' SG ' ' A' ' 114' ' ' CYS . 14.6 p90 -130.06 -153.78 0.59 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.469 -0.77 . . . . 0.0 109.752 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.616 ' CD1' ' NH1' ' A' ' 104' ' ' ARG . 2.8 t80 -170.78 125.01 0.68 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.303 -0.873 . . . . 0.0 108.999 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.501 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 49.0 p-10 -148.19 130.97 16.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.944 -1.097 . . . . 0.0 109.374 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.615 ' O ' ' C ' ' A' ' 145' ' ' GLY . 8.6 mmt -107.18 18.91 21.1 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 111.334 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 11.56 -99.39 0.01 OUTLIER Glycine 0 N--CA 1.501 3.008 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.507 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 31.6 t -84.16 120.56 26.33 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.897 -1.354 . . . . 0.0 109.351 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 147' ' ' GLU . 1.0 OUTLIER -115.51 117.6 40.32 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 57.2 Cg_endo -100.03 31.2 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.258 1.972 . . . . 0.0 112.209 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER 81.79 63.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.688 -179.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.559 ' CZ ' HD12 ' A' ' 78' ' ' LEU . 15.0 p90 -101.41 169.85 8.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.519 -0.738 . . . . 0.0 109.222 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 53.3 m -130.28 106.53 8.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.57 -0.706 . . . . 0.0 109.489 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' A' ' 75' ' ' VAL . . . -105.91 161.94 14.01 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.987 -1.07 . . . . 0.0 109.827 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.648 ' HA ' HG12 ' A' ' 75' ' ' VAL . 23.5 mt -105.45 123.26 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.869 -1.145 . . . . 0.0 110.291 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.74 HH21 ' HE ' ' A' ' 104' ' ' ARG . 1.9 mtt-85 -130.62 159.85 35.97 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.624 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.98 155.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.605 ' CG ' ' OG ' ' A' ' 72' ' ' SER . 5.8 m-85 -96.19 121.87 38.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 110.224 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.418 ' HA ' HE21 ' A' ' 71' ' ' GLN . 49.2 p30 -132.04 163.28 28.78 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -92.79 161.86 30.65 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.979 -1.076 . . . . 0.0 108.865 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.598 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.0 Cg_endo -62.52 -60.4 0.19 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.747 1.631 . . . . 0.0 112.288 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.7 tt0 -45.92 -13.53 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -72.7 -43.87 41.43 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.563 ' CE3' ' O ' ' A' ' 163' ' ' ILE . 9.9 p-90 -110.13 161.02 15.96 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.518 -0.989 . . . . 0.0 110.348 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.563 ' O ' ' CE3' ' A' ' 162' ' ' TRP . 4.0 tp -99.92 154.44 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.249 -0.907 . . . . 0.0 109.194 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.78 -75.54 0.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.97 . . . . 0.0 110.435 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.529 HE22 HD22 ' A' ' 94' ' ' ASN . 31.1 mt-30 -142.3 164.61 29.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.103 -0.998 . . . . 0.0 110.156 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -101.21 -40.18 7.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.89 . . . . 0.0 109.326 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 22.0 m -114.68 -32.36 5.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.937 . . . . 0.0 108.568 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.61 -1.34 58.38 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.505 ' OD2' ' O ' ' A' ' 169' ' ' ASP . 39.1 p30 -80.29 145.82 31.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.3 -1.706 . . . . 0.0 108.726 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.416 ' OD2' ' ND2' ' A' ' 94' ' ' ASN . 90.4 m-20 -113.21 89.7 3.15 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.113 -1.435 . . . . 0.0 110.263 175.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.455 HD11 ' HZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -78.71 -17.89 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.241 -1.537 . . . . 0.0 108.854 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -58.67 -41.59 86.51 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.362 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.711 ' OG ' HD21 ' A' ' 93' ' ' LEU . 1.2 m -52.46 -3.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.538 -0.726 . . . . 0.0 109.873 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.71 -39.57 26.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.909 -1.119 . . . . 0.0 111.371 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.639 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -114.57 25.58 0.09 OUTLIER Pre-proline 0 N--CA 1.516 2.842 0 O-C-N 120.668 -1.27 . . . . 0.0 112.089 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 39.1 Cg_endo -59.25 -18.18 43.44 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.333 2.689 . . . . 0.0 114.177 -171.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -89.44 125.57 35.22 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.619 -1.233 . . . . 0.0 108.107 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.507 ' HB3' ' H ' ' A' ' 146' ' ' SER . 3.9 tt -86.68 125.45 33.87 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.092 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.299 -1.593 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.623 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.776 ' O ' HG23 ' A' ' 19' ' ' THR . 2.8 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.49 169.32 9.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.066 . . . . 0.0 109.074 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.85 HD13 HG22 ' A' ' 124' ' ' VAL . 16.3 tp -157.65 114.99 3.01 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.7 OUTLIER -109.02 138.59 45.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.216 -0.928 . . . . 0.0 110.119 -179.16 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.708 HD12 ' HB3' ' A' ' 16' ' ' TRP . 52.9 mt -132.87 131.45 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -125.6 164.29 20.88 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m -85.91 175.0 8.87 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.144 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -26.87 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.023 -1.048 . . . . 0.0 109.677 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -74.11 -38.43 63.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.05 -1.031 . . . . 0.0 110.181 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.33 125.91 14.77 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 109.679 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 13' ' ' ASN . 56.1 Cg_endo -80.42 -36.9 0.43 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 121.974 1.783 . . . . 0.0 112.202 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 7.86 0.77 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.768 . . . . 0.0 110.113 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 11' ' ' PRO . 80.6 m-20 -116.96 119.77 36.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.196 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.419 ' C ' HD22 ' A' ' 15' ' ' LEU . 6.1 p -98.96 123.65 43.39 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.65 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.9 mm? -89.93 -9.84 47.36 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.585 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.708 ' HB3' HD12 ' A' ' 5' ' ' ILE . 33.1 t90 -157.48 106.87 2.15 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.629 -1.228 . . . . 0.0 110.133 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -121.87 119.92 33.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.512 -0.742 . . . . 0.0 109.729 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.409 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -162.85 164.56 25.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.218 -0.926 . . . . 0.0 110.132 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 1' ' ' SER . 76.1 m -130.14 89.11 2.75 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.017 -1.052 . . . . 0.0 108.188 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.754 ' O ' HD12 ' A' ' 24' ' ' ILE . 29.9 m120 -127.73 144.26 51.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.458 -0.776 . . . . 0.0 110.422 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.73 -38.74 21.0 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.235 -1.541 . . . . 0.0 108.312 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -82.9 -48.36 10.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.516 -0.74 . . . . 0.0 109.749 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.477 ' OE1' ' OD1' ' A' ' 20' ' ' ASN . 1.2 tt0 -62.83 -19.56 64.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.722 -1.236 . . . . 0.0 108.608 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.754 HD12 ' O ' ' A' ' 20' ' ' ASN . 4.0 mt -74.47 -56.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.871 . . . . 0.0 109.326 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.445 ' HB2' ' CG ' ' A' ' 35' ' ' PHE . 3.0 pp0? -55.41 -34.9 64.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.309 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.54 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 49.8 tt0 -68.09 -47.5 68.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.276 -0.89 . . . . 0.0 109.447 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.55 ' OE1' ' CD1' ' A' ' 5' ' ' ILE . 7.6 tt0 -68.16 -40.46 82.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.167 -0.958 . . . . 0.0 109.082 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.568 HD12 HG11 ' A' ' 33' ' ' VAL . 3.5 mm? -68.18 -62.42 1.41 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.172 -0.955 . . . . 0.0 109.286 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 15.1 t-20 -58.13 -17.98 22.21 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.298 -0.876 . . . . 0.0 109.907 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -67.1 -32.52 73.73 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.847 -1.158 . . . . 0.0 109.387 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -90.51 9.34 29.72 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.98 24.56 16.82 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.283 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.568 HG11 HD12 ' A' ' 28' ' ' LEU . 33.7 t -96.96 147.82 6.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.279 -1.13 . . . . 0.0 109.554 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' HB3' ' H ' ' A' ' 133' ' ' SER . 19.5 ttt180 -84.02 154.01 23.51 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 120.511 -1.368 . . . . 0.0 108.368 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.538 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 1.1 t80 -154.39 149.97 27.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.023 -1.048 . . . . 0.0 108.276 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 2.9 mt-10 -177.24 177.08 1.26 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.045 -1.034 . . . . 0.0 109.481 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -148.61 112.44 5.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.705 ' CH2' HD23 ' A' ' 131' ' ' LEU . 31.4 m0 -111.02 157.4 19.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.271 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -142.72 156.24 44.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 0.0 109.927 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.35 152.75 20.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.205 -0.934 . . . . 0.0 108.997 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -104.03 -6.39 21.22 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -93.34 159.15 15.39 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.781 0.801 . . . . 0.0 109.093 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -94.51 115.31 27.45 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.66 -0.65 . . . . 0.0 109.537 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.7 mt -94.86 164.96 12.7 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.43 -0.794 . . . . 0.0 109.505 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.29 -103.76 0.2 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.6 92.97 4.76 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.989 -1.301 . . . . 0.0 109.187 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.16 92.12 44.88 Favored Pre-proline 0 C--N 1.306 -1.293 0 C-N-CA 119.8 -0.76 . . . . 0.0 108.965 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.54 -21.91 14.41 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.297 1.998 . . . . 0.0 112.763 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 p -122.93 142.12 51.16 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.584 -0.698 . . . . 0.0 109.705 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.34 -16.91 53.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.43 -0.794 . . . . 0.0 109.419 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -46.92 -39.03 11.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.344 -0.847 . . . . 0.0 108.725 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.3 m -79.2 -39.68 32.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.617 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.71 -46.53 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.291 -0.881 . . . . 0.0 109.669 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 58' ' ' GLN . 15.6 mt -60.48 -36.02 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.073 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.06 -28.65 69.75 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.411 -0.806 . . . . 0.0 109.407 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.76 -20.29 50.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.038 -1.039 . . . . 0.0 110.331 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 58' ' ' GLN . 61.7 m-85 -112.02 -12.27 13.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.298 -0.876 . . . . 0.0 109.552 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.729 HE21 ' CG1' ' A' ' 61' ' ' ILE . 30.1 tp60 -45.52 -35.9 4.19 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.567 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.6 -47.64 63.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 109.546 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.567 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.34 -60.08 4.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 109.755 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.729 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.6 OUTLIER -63.17 -29.51 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 120.608 -1.308 . . . . 0.0 109.127 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 58' ' ' GLN . 21.3 t70 -55.9 -26.41 47.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.706 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -78.28 -36.1 47.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.985 -1.072 . . . . 0.0 109.543 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 64' ' ' LEU . 8.4 mp -63.19 -40.79 98.53 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.545 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -70.13 -29.01 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.173 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.53 -56.66 12.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.431 -1.418 . . . . 0.0 109.191 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -83.53 -48.81 9.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.035 -1.04 . . . . 0.0 110.608 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.627 ' O ' ' C ' ' A' ' 69' ' ' GLY . 7.5 mtpm? -87.79 14.7 8.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.878 . . . . 0.0 110.788 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.627 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -11.68 89.33 0.0 OUTLIER Glycine 0 N--CA 1.501 3.028 0 CA-C-O 121.959 0.755 . . . . 0.0 111.227 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.472 ' CG ' HG21 ' A' ' 155' ' ' ILE . 84.3 m-85 -76.86 164.42 25.83 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.586 ' NE2' ' OG ' ' A' ' 72' ' ' SER . 0.6 OUTLIER -63.2 -87.48 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.43 -0.794 . . . . 0.0 109.78 -178.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.586 ' OG ' ' NE2' ' A' ' 71' ' ' GLN . 14.7 m -102.74 160.24 14.76 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 109.595 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 74' ' ' ASP . 7.6 t-105 -140.79 145.75 36.74 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.454 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.2 OUTLIER -165.36 -176.6 4.1 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 152' ' ' ALA . 9.9 p -119.8 142.73 33.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 76' ' ' ILE . 2.5 tp -101.33 115.71 43.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 77' ' ' SER . 4.7 p -169.56 102.99 0.33 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.381 -0.825 . . . . 0.0 108.845 177.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.722 HD23 ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -117.98 179.77 3.99 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.094 1.77 . . . . 0.0 108.12 -179.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.722 ' H ' HD23 ' A' ' 78' ' ' LEU . 3.2 tpt180 -89.88 143.85 26.44 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.667 -1.27 . . . . 0.0 109.412 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.42 1.38 0.35 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.568 -0.707 . . . . 0.0 109.593 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 79' ' ' ARG . 84.6 m-20 -78.87 -29.09 44.28 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.213 -1.395 . . . . 0.0 108.872 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.75 HD21 ' CD ' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -64.27 124.85 86.9 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.044 -1.035 . . . . 0.0 109.085 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -78.55 -8.56 16.01 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.171 1.914 . . . . 0.0 112.401 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -89.59 4.14 50.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.006 -1.059 . . . . 0.0 109.482 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.75 ' CD ' HD21 ' A' ' 82' ' ' ASN . 3.5 tptp -60.0 -49.82 76.18 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.194 -0.941 . . . . 0.0 108.919 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -62.82 -41.99 99.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 109.57 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.16 -38.27 76.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.612 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 88' ' ' LEU . 2.7 mm? -60.3 -42.75 96.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.345 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.572 ' NH2' ' O ' ' A' ' 85' ' ' LYS . 1.0 OUTLIER -60.49 -30.65 69.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.845 . . . . 0.0 109.873 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.22 -60.22 3.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 109.671 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.403 ' O ' ' ND2' ' A' ' 94' ' ' ASN . 50.4 mttp -57.17 -32.18 66.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.504 -0.747 . . . . 0.0 109.278 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -85.6 -18.25 33.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.415 -0.803 . . . . 0.0 110.243 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -60.86 -40.17 91.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.125 -0.984 . . . . 0.0 109.85 -179.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 21.5 p30 -46.89 125.48 7.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.121 -0.987 . . . . 0.0 109.452 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.53 166.32 1.32 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.504 -0.748 . . . . 0.0 109.366 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -173.17 -169.26 0.52 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.899 -1.12 . . . . 0.0 111.433 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.2 t -164.1 135.58 4.6 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.676 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -107.55 156.2 19.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.443 -0.785 . . . . 0.0 109.735 -178.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.18 -6.94 86.7 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -123.51 170.67 10.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.316 -1.108 . . . . 0.0 109.288 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -76.26 142.99 41.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.972 -1.08 . . . . 0.0 110.161 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -100.24 94.6 6.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.194 -0.942 . . . . 0.0 109.058 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.627 HG22 HD11 ' A' ' 155' ' ' ILE . 1.0 OUTLIER -91.46 130.67 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.507 -0.745 . . . . 0.0 109.878 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.5 HH21 ' CB ' ' A' ' 152' ' ' ALA . 51.2 ttt180 -132.01 123.77 27.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.398 -0.814 . . . . 0.0 109.346 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.615 ' HB3' HD12 ' A' ' 153' ' ' ILE . 27.2 t80 -104.78 131.89 51.7 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.09 128.42 35.42 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.608 -0.682 . . . . 0.0 110.228 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.0 t -112.63 -29.67 2.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.683 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -169.04 158.04 8.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.027 . . . . 0.0 109.031 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.488 ' O ' ' OE1' ' A' ' 127' ' ' GLU . . . 78.49 150.0 4.69 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.9 156.05 31.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.421 -1.046 . . . . 0.0 109.512 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.483 ' C ' HD11 ' A' ' 178' ' ' LEU . . . -151.49 -125.99 1.24 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.88 HD12 HD12 ' A' ' 178' ' ' LEU . 1.6 mt -148.95 164.32 34.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -1.08 . . . . 0.0 109.659 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.518 ' CG ' HD11 ' A' ' 132' ' ' ILE . 0.2 OUTLIER -138.47 91.59 2.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.569 179.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.643 ' SG ' ' NE2' ' A' ' 123' ' ' GLN . 0.8 OUTLIER -77.97 117.04 18.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 109.476 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.582 HD11 HG22 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -118.34 106.16 12.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.116 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.5 t-160 -101.33 109.56 21.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.972 . . . . 0.0 109.462 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mm -125.57 111.82 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.005 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.99 -142.12 28.11 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 106.537 -2.625 . . . . 0.0 106.537 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.494 ' O ' ' CG ' ' A' ' 119' ' ' ASP . 48.2 p-10 -103.8 79.2 1.63 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 115.103 -2.639 . . . . 0.0 109.369 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.479 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 75.8 tt0 -165.92 167.34 16.78 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.64 ' O ' HG23 ' A' ' 5' ' ' ILE . 86.7 t -130.43 151.91 36.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.089 -1.007 . . . . 0.0 109.924 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.439 ' C ' ' OE1' ' A' ' 123' ' ' GLN . 32.7 m-85 -130.87 133.27 45.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.691 -0.631 . . . . 0.0 109.986 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.643 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 4.2 mp0 -122.35 110.07 15.2 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.412 -0.805 . . . . 0.0 109.088 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.85 HG22 HD13 ' A' ' 3' ' ' LEU . 21.2 t -104.84 133.9 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.948 ' H ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.55 90.54 2.62 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.341 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 30.1 p -166.36 128.8 1.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.393 -1.442 . . . . 0.0 107.329 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 7.0 tt0 -107.39 96.35 6.34 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 116.096 -2.242 . . . . 0.0 110.569 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.591 ' C ' ' H ' ' A' ' 130' ' ' ASP . 17.1 mtpp -112.73 159.78 18.6 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.66 176.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.586 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 14.6 m120 -57.12 -4.27 0.18 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.442 -1.411 . . . . 0.0 107.761 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.591 ' H ' ' C ' ' A' ' 128' ' ' LYS . 67.3 m-20 -66.73 143.14 57.12 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.705 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.101 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -110.79 142.67 42.45 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.614 0.721 . . . . 0.0 110.706 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 1.101 ' N ' HD12 ' A' ' 131' ' ' LEU . 47.6 pt -132.64 147.66 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.432 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 8.9 t -137.03 153.78 50.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.349 -0.844 . . . . 0.0 109.581 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.582 HG22 HD11 ' A' ' 115' ' ' LEU . 1.1 t -106.11 143.01 26.06 Favored Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.49 152.65 80.38 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.283 1.989 . . . . 0.0 112.274 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.609 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.59 134.61 47.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.275 -0.891 . . . . 0.0 109.223 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.609 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.1 t-80 91.31 11.21 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.121 0.486 . . . . 0.0 109.742 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 138' ' ' THR . 0.8 OUTLIER -104.13 126.5 31.48 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 0.0 108.739 179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.98 131.49 29.0 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.581 1.52 . . . . 0.0 111.474 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.488 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.9 163.79 9.62 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.223 -179.186 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.505 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -134.53 -146.94 0.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.239 -0.913 . . . . 0.0 109.713 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -177.9 126.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.926 -1.109 . . . . 0.0 109.037 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.496 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 10.9 p-10 -144.25 134.14 23.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.31 -0.869 . . . . 0.0 109.895 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.618 ' O ' ' C ' ' A' ' 145' ' ' GLY . 84.1 mmm -112.94 20.48 16.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.584 -0.697 . . . . 0.0 111.202 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.61 -92.68 0.01 OUTLIER Glycine 0 N--CA 1.506 3.363 0 CA-C-N 119.265 0.939 . . . . 0.0 111.534 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.486 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 74.5 m -85.85 117.51 24.76 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.92 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.653 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -117.3 113.18 39.12 Favored Pre-proline 0 C--N 1.299 -1.609 0 C-N-CA 119.764 -0.775 . . . . 0.0 109.804 178.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.3 Cg_endo -103.12 40.95 0.04 OUTLIER 'Trans proline' 0 C--O 1.213 -0.767 0 C-N-CA 122.717 2.278 . . . . 0.0 111.349 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 81.79 71.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.124 -177.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.536 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 8.9 p90 -95.53 144.31 26.11 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.388 -0.82 . . . . 0.0 109.895 -177.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.8 m -113.17 122.96 49.09 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.536 -0.728 . . . . 0.0 109.754 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.628 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -142.83 162.58 35.1 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.615 HD12 ' HB3' ' A' ' 105' ' ' PHE . 57.6 mt -107.49 126.92 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.076 -1.015 . . . . 0.0 109.374 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -136.51 164.13 28.9 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.113 -0.992 . . . . 0.0 109.803 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.627 HD11 HG22 ' A' ' 103' ' ' VAL . 4.7 mp -102.5 145.12 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.579 -0.701 . . . . 0.0 109.562 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.454 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.2 m-85 -95.54 118.81 32.94 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.291 -0.881 . . . . 0.0 109.361 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 0.9 OUTLIER -134.93 164.13 28.29 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.3 OUTLIER -93.65 160.26 33.16 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.167 -0.958 . . . . 0.0 109.052 -179.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.3 Cg_endo -61.76 -55.65 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.198 1.932 . . . . 0.0 112.199 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.4 tt0 -44.09 -15.49 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.336 -0.853 . . . . 0.0 108.986 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -72.72 -46.68 29.68 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 178.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.464 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 6.5 p90 -107.38 165.03 11.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.341 -1.094 . . . . 0.0 110.05 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 72.6 mt -100.59 149.58 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.35 -71.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.088 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.583 ' NE2' ' OD1' ' A' ' 170' ' ' ASP . 43.1 mt-30 -140.39 159.01 43.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 109.632 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -101.21 -41.12 6.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 109.564 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.7 p -102.44 -30.43 11.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.085 -1.009 . . . . 0.0 108.856 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.49 -6.49 52.81 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -82.13 148.55 28.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.704 -1.468 . . . . 0.0 108.688 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.583 ' OD1' ' NE2' ' A' ' 165' ' ' GLN . 88.5 m-20 -109.08 88.35 2.71 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 117.568 -1.653 . . . . 0.0 111.096 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.5 tt -77.75 -23.69 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.609 -1.307 . . . . 0.0 109.348 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.505 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -60.41 -41.44 93.92 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.632 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 93.4 p -54.62 -2.95 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.481 -0.762 . . . . 0.0 109.994 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.31 -39.84 31.83 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.942 -1.099 . . . . 0.0 111.298 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.627 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 9.9 m-85 -111.64 24.4 0.08 OUTLIER Pre-proline 0 N--CA 1.514 2.754 0 O-C-N 120.85 -1.156 . . . . 0.0 112.808 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.632 ' HD3' ' C ' ' A' ' 173' ' ' SER . 45.3 Cg_endo -63.59 -19.3 67.32 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.68 2.92 . . . . 0.0 113.348 -173.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.08 125.51 35.05 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.99 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.88 HD12 HD12 ' A' ' 112' ' ' LEU . 1.8 tp -88.03 120.41 29.34 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.525 -0.734 . . . . 0.0 109.135 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.295 -1.786 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.34 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.608 ' O ' ' OG1' ' A' ' 19' ' ' THR . 1.6 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.96 171.55 8.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 108.925 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.751 ' CD1' HG22 ' A' ' 124' ' ' VAL . 28.2 tp -158.85 113.1 2.44 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.74 130.32 54.96 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.166 -0.959 . . . . 0.0 110.365 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 121' ' ' VAL . 63.9 mt -124.59 133.61 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 97.2 m-85 -126.63 165.36 19.34 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -91.73 176.33 6.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 108.715 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -25.68 5.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.888 -1.133 . . . . 0.0 109.418 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -73.13 -40.68 64.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 110.086 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -136.81 124.01 14.16 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.093 -1.004 . . . . 0.0 109.437 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.565 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 56.4 Cg_endo -82.18 -33.13 0.6 Allowed 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.925 1.75 . . . . 0.0 112.319 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.482 ' OE1' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -68.43 -25.99 65.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 110.347 -178.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -95.41 120.79 36.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.959 -1.088 . . . . 0.0 108.977 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.38 131.99 40.91 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.297 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 pp -90.37 -8.96 49.38 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.209 -0.996 . . . . 0.0 108.822 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.66 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 45.1 t90 -157.54 106.79 2.13 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.506 -1.278 . . . . 0.0 109.943 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -120.77 119.82 33.85 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.535 -0.728 . . . . 0.0 109.801 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.47 161.84 30.24 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.198 -0.939 . . . . 0.0 109.82 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 19' ' ' THR . 8.9 t -131.36 89.08 2.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 118.773 -1.171 . . . . 0.0 108.507 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.752 ' O ' HD12 ' A' ' 24' ' ' ILE . 1.9 m-20 -126.27 142.37 51.55 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.372 -0.83 . . . . 0.0 110.24 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.85 -37.05 27.57 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.463 -1.398 . . . . 0.0 109.137 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.68 -50.15 9.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.167 -0.958 . . . . 0.0 109.862 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -63.32 -18.53 63.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.036 -1.04 . . . . 0.0 108.719 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.752 HD12 ' O ' ' A' ' 20' ' ' ASN . 3.1 mt -73.56 -56.07 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 108.912 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.427 ' N ' HG22 ' A' ' 24' ' ' ILE . 9.2 pt20 -57.61 -40.77 79.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.211 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.683 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 68.5 mt-30 -62.04 -43.03 99.7 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.142 -0.974 . . . . 0.0 109.114 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.488 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 7.5 tt0 -72.47 -44.85 61.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.204 -0.935 . . . . 0.0 108.899 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.597 HD12 HG11 ' A' ' 33' ' ' VAL . 2.8 mm? -64.19 -62.56 1.54 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.054 -1.029 . . . . 0.0 109.371 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.618 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -61.23 -17.56 53.93 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.165 -178.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -62.52 -28.82 70.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.529 -1.357 . . . . 0.0 108.439 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.679 ' HG3' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -94.19 6.81 47.46 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.855 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.81 25.64 12.92 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.046 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.679 HG23 ' HG3' ' A' ' 31' ' ' LYS . 61.8 t -95.29 145.98 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.149 -1.206 . . . . 0.0 109.191 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -83.59 153.47 24.3 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 121.058 -1.026 . . . . 0.0 108.555 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CB ' HD21 ' A' ' 29' ' ' ASN . 2.2 t80 -154.21 146.47 23.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.159 -0.963 . . . . 0.0 108.729 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.535 ' O ' ' OD2' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -177.9 178.07 1.0 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.006 -1.059 . . . . 0.0 110.251 178.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 119.3 6.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 108.886 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.428 ' CE3' ' HB1' ' A' ' 60' ' ' ALA . 23.1 m0 -111.99 156.83 21.51 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -143.05 160.98 39.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.867 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.44 158.17 16.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 108.946 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -101.45 -14.1 17.67 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -92.9 158.79 15.65 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.535 0.684 . . . . 0.0 109.161 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -93.71 123.63 37.16 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 109.46 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 mt -94.39 165.67 12.45 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 109.368 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.7 -105.14 0.22 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.01 93.06 5.04 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.999 -1.295 . . . . 0.0 109.327 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.9 91.65 43.37 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -75.88 -22.04 13.7 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.155 1.903 . . . . 0.0 112.421 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.1 p -120.58 141.19 50.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.618 -0.677 . . . . 0.0 109.679 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.681 ' HB1' HD13 ' A' ' 54' ' ' ILE . . . -80.86 -17.86 49.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.478 -0.764 . . . . 0.0 109.535 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.69 -39.22 16.86 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.223 -0.923 . . . . 0.0 108.862 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.8 m -78.92 -34.89 44.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 109.587 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.418 HG11 ' CG1' ' A' ' 107' ' ' VAL . 60.1 t -67.76 -57.12 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.342 -0.849 . . . . 0.0 110.33 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.681 HD13 ' HB1' ' A' ' 50' ' ' ALA . 1.7 mp -58.8 -34.99 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.968 -1.083 . . . . 0.0 108.9 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.68 -35.18 72.18 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.413 -0.804 . . . . 0.0 109.365 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.51 -13.7 60.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.21 -0.931 . . . . 0.0 109.632 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.4 m-85 -111.42 -8.39 14.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.489 -0.757 . . . . 0.0 109.762 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 62' ' ' ASP . 10.3 mm-40 -47.06 -36.05 7.63 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.159 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.713 ' CD2' ' N ' ' A' ' 60' ' ' ALA . 11.9 p-80 -53.36 -44.18 68.36 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.74 -1.225 . . . . 0.0 109.516 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.713 ' N ' ' CD2' ' A' ' 59' ' ' HIS . . . -63.6 -61.1 2.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.0 -1.063 . . . . 0.0 110.071 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.643 ' O ' HG23 ' A' ' 65' ' ' VAL . 1.3 pp -62.36 -27.72 43.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.75 -1.219 . . . . 0.0 108.983 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' A' ' 62' ' ' ASP . 36.8 t0 -58.41 -27.69 64.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.96 . . . . 0.0 109.567 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -74.19 -40.93 62.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.959 . . . . 0.0 109.121 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 64' ' ' LEU . 7.6 mp -64.42 -34.85 79.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 109.295 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 61' ' ' ILE . 11.5 t -68.13 -29.93 46.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.035 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.75 72.82 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.658 -1.276 . . . . 0.0 109.524 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -87.74 -53.86 4.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.083 -1.011 . . . . 0.0 110.5 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.604 ' O ' ' C ' ' A' ' 69' ' ' GLY . 8.2 mmtp -85.96 14.51 6.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.355 -0.84 . . . . 0.0 110.489 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -16.41 87.58 0.0 OUTLIER Glycine 0 N--CA 1.499 2.885 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 68' ' ' LYS . 81.1 m-85 -76.58 164.01 26.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.469 HE21 ' HA ' ' A' ' 157' ' ' ASP . 32.8 mt-30 -57.74 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.312 -0.868 . . . . 0.0 109.673 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.58 163.0 12.58 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.598 0.713 . . . . 0.0 110.058 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.775 ' HE1' HG23 ' A' ' 153' ' ' ILE . 5.6 t-105 -131.84 135.76 46.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HB2' ' CE2' ' A' ' 156' ' ' PHE . 0.7 OUTLIER -146.86 166.81 25.57 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.9 -1.125 . . . . 0.0 108.142 178.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 152' ' ' ALA . 8.8 p -119.55 141.28 40.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 76' ' ' ILE . 7.6 tp -102.7 115.01 43.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.235 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.0 t -167.63 100.06 0.49 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.34 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.657 HD23 ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -125.01 -179.26 4.48 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.34 -1.475 . . . . 0.0 107.658 -179.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.657 ' H ' HD23 ' A' ' 78' ' ' LEU . 23.2 tpt180 -88.91 153.07 21.34 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.671 -1.268 . . . . 0.0 109.075 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.97 0.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ARG . 83.8 m-20 -103.43 30.54 4.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.552 ' OD1' ' N ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -82.26 135.08 47.76 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.52 -0.737 . . . . 0.0 110.201 178.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.446 ' C ' ' OE1' ' A' ' 84' ' ' GLN . 55.7 Cg_endo -77.41 -25.75 7.97 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.173 1.915 . . . . 0.0 112.198 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.487 ' N ' ' OE1' ' A' ' 84' ' ' GLN . 0.9 OUTLIER -92.5 8.13 40.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.895 -1.128 . . . . 0.0 109.493 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.576 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 18.0 pttt -58.73 -51.7 68.86 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.214 -0.929 . . . . 0.0 108.774 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.576 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 84.2 tt0 -67.6 -54.24 21.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.146 -0.972 . . . . 0.0 109.504 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.83 -47.02 83.85 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.311 -0.955 . . . . 0.0 109.727 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 84' ' ' GLN . 13.3 tp -63.07 -46.13 88.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.768 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -60.83 -36.96 80.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 109.602 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.7 -58.84 4.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -0.878 . . . . 0.0 109.625 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -50.5 -37.89 41.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.278 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.03 -19.46 51.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.117 -0.99 . . . . 0.0 109.134 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 93' ' ' LEU . 8.0 tt -61.3 -34.86 75.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 109.758 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -64.26 150.44 45.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.107 -0.995 . . . . 0.0 110.188 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.726 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 7.7 pm0 -80.91 166.31 20.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 0.0 109.567 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -173.96 -169.24 0.47 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.044 -1.062 . . . . 0.0 111.195 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.2 t -163.48 132.97 4.09 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.635 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -104.3 156.74 17.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.516 -0.74 . . . . 0.0 110.125 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.446 ' N ' ' HB3' ' A' ' 162' ' ' TRP . . . -78.78 -6.56 88.49 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 95.7 mt-10 -124.36 171.15 10.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.395 -1.062 . . . . 0.0 109.429 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 102' ' ' GLU . 48.3 t0 -75.19 139.91 42.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.109 -0.994 . . . . 0.0 110.248 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.594 ' N ' ' OD2' ' A' ' 101' ' ' ASP . 14.9 tt0 -97.13 95.17 7.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.344 -0.848 . . . . 0.0 108.931 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.838 HG13 ' OG ' ' A' ' 133' ' ' SER . 29.5 t -95.29 123.17 47.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.65 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 34.0 ttm105 -127.28 126.3 42.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.46 -0.775 . . . . 0.0 109.018 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.622 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 15.2 t80 -102.36 131.18 49.15 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.825 0.822 . . . . 0.0 109.201 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.405 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -85.9 126.46 34.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.49 0.662 . . . . 0.0 110.154 -178.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.418 ' CG1' HG11 ' A' ' 53' ' ' VAL . 12.9 t -108.5 -30.24 2.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.73 -0.606 . . . . 0.0 109.476 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -165.94 153.8 10.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 109.27 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.76 157.09 32.8 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.46 ' HB2' ' CD ' ' A' ' 127' ' ' GLU . . . -134.17 162.38 32.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -1.171 . . . . 0.0 109.089 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.63 155.16 13.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.533 ' HB3' HD12 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -103.14 98.93 8.79 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.133 -1.216 . . . . 0.0 110.638 -178.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -80.5 126.41 31.18 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.66 -1.275 . . . . 0.0 110.054 -178.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.649 ' SG ' ' NE2' ' A' ' 123' ' ' GLN . 0.9 OUTLIER -78.5 125.84 29.93 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.312 0.577 . . . . 0.0 109.984 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.669 HD21 HG11 ' A' ' 134' ' ' VAL . 0.5 OUTLIER -113.62 125.53 54.27 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.48 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 8.2 t-160 -107.91 110.37 22.1 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.446 HG21 ' HD3' ' A' ' 31' ' ' LYS . 2.2 pt -124.64 114.25 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 O-C-N 121.45 -0.781 . . . . 0.0 110.513 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.63 -143.81 33.15 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 104.845 -3.302 . . . . 0.0 104.845 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -106.19 79.93 1.45 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 115.048 -2.661 . . . . 0.0 108.636 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.48 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 12.2 pt-20 -166.35 170.16 13.33 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.669 ' O ' HG23 ' A' ' 5' ' ' ILE . 88.9 t -125.27 137.56 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.006 -1.059 . . . . 0.0 109.853 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.556 ' CE2' HD13 ' A' ' 5' ' ' ILE . 7.2 m-85 -122.09 129.54 52.46 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.649 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.5 mt-30 -128.39 115.24 17.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 108.984 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.751 HG22 ' CD1' ' A' ' 3' ' ' LEU . 11.5 t -101.76 133.54 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.546 ' C ' HD23 ' A' ' 125' ' ' LEU . 5.7 tt -134.42 91.0 2.73 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.746 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.402 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 30.7 p -164.77 134.75 3.82 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.46 ' CD ' ' HB2' ' A' ' 110' ' ' ALA . 5.7 pt-20 -106.33 94.64 5.26 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 115.55 -2.46 . . . . 0.0 110.538 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.545 ' C ' ' H ' ' A' ' 130' ' ' ASP . 20.1 tptm -114.2 156.8 23.62 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.088 176.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.622 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 83.3 m-20 -58.35 -3.32 0.26 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.487 -1.383 . . . . 0.0 107.891 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.593 ' OD2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.89 153.03 43.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.199 -178.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.759 ' C ' HD12 ' A' ' 131' ' ' LEU . 2.1 pp -117.56 160.57 21.03 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.893 0.854 . . . . 0.0 110.095 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.645 ' N ' HD12 ' A' ' 131' ' ' LEU . 5.6 mm -131.65 128.77 60.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.805 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.838 ' OG ' HG13 ' A' ' 103' ' ' VAL . 14.5 m -123.0 142.09 51.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.401 -0.812 . . . . 0.0 109.373 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.669 HG11 HD21 ' A' ' 115' ' ' LEU . 8.3 m -109.31 148.96 39.08 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.407 -0.808 . . . . 0.0 108.98 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -66.81 154.76 73.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.378 2.052 . . . . 0.0 112.966 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.618 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -73.32 136.53 44.49 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.459 -0.776 . . . . 0.0 109.329 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.618 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 4.1 t-80 92.95 10.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.37 126.17 32.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 108.556 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.79 132.2 31.83 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.54 1.493 . . . . 0.0 111.534 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.45 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.86 162.83 9.54 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.219 -0.926 . . . . 0.0 110.18 -178.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.513 ' CD2' ' HB2' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -133.71 -147.16 0.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.65 ' CE1' ' NH1' ' A' ' 104' ' ' ARG . 0.2 OUTLIER -178.74 127.7 0.11 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.864 -1.148 . . . . 0.0 109.077 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 54.7 p-10 -147.23 139.55 24.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.808 . . . . 0.0 109.852 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.604 ' O ' ' C ' ' A' ' 145' ' ' GLY . 2.6 ptt? -113.7 22.9 13.6 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.579 -0.7 . . . . 0.0 110.72 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 7.11 -90.61 0.0 OUTLIER Glycine 0 N--CA 1.502 3.053 0 CA-C-N 119.517 1.053 . . . . 0.0 112.465 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.525 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 23.0 t -86.05 116.78 24.48 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 117.886 -1.525 . . . . 0.0 108.834 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.662 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -116.74 114.36 39.75 Favored Pre-proline 0 C--N 1.296 -1.719 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.748 178.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.0 Cg_endo -101.41 38.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.885 0 C-N-CA 122.873 2.382 . . . . 0.0 110.705 176.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER 82.56 70.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -176.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 20.2 p90 -95.25 163.35 13.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.747 -0.595 . . . . 0.0 109.635 -177.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.5 m -134.42 126.9 30.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 0.0 109.931 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.617 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . . . -143.65 163.48 33.13 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.539 -0.726 . . . . 0.0 109.14 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.775 HG23 ' HE1' ' A' ' 73' ' ' TRP . 24.8 mt -110.59 130.04 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.192 -0.943 . . . . 0.0 109.681 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.567 ' C ' HD13 ' A' ' 155' ' ' ILE . 6.5 ptm180 -131.26 159.02 39.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.42 -0.8 . . . . 0.0 110.494 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.581 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -108.12 149.63 11.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.501 0.667 . . . . 0.0 109.446 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 74' ' ' ASP . 4.0 m-30 -97.33 120.62 38.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.866 0.841 . . . . 0.0 110.77 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.614 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 52.0 t0 -133.93 158.93 42.23 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.594 ' O ' ' NE1' ' A' ' 162' ' ' TRP . 80.9 m-20 -96.96 150.8 37.26 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.901 -1.124 . . . . 0.0 109.513 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.625 ' O ' ' N ' ' A' ' 161' ' ' GLY . 45.9 Cg_endo -70.65 -53.23 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.363 2.042 . . . . 0.0 112.121 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.5 tt0 -42.4 -15.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.672 -0.643 . . . . 0.0 109.514 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.27 -41.4 13.74 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 177.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.614 ' HE1' ' CG ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -114.4 175.66 5.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.596 -0.944 . . . . 0.0 110.952 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 19.2 pt -96.32 155.44 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.535 -0.728 . . . . 0.0 109.339 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -93.56 -70.84 0.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 110.663 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -107.06 143.07 35.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.07 -1.019 . . . . 0.0 110.197 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -102.07 -40.48 6.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 109.619 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -116.92 -30.12 5.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.323 -0.861 . . . . 0.0 108.688 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.83 -7.41 53.02 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -80.9 149.2 29.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.661 -1.494 . . . . 0.0 108.176 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.484 ' OD2' ' OG ' ' A' ' 173' ' ' SER . 1.7 p30 -107.98 88.42 2.73 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 117.425 -1.71 . . . . 0.0 111.152 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.0 OUTLIER -75.83 -25.62 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.832 -1.168 . . . . 0.0 109.328 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.513 ' HB2' ' CD2' ' A' ' 141' ' ' TRP . . . -60.56 -40.37 91.41 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.61 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 52.8 p -55.45 -4.22 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.577 -0.702 . . . . 0.0 110.22 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.466 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -81.58 -37.84 27.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.04 -1.037 . . . . 0.0 111.281 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.624 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.3 m-85 -112.13 23.84 0.08 OUTLIER Pre-proline 0 N--CA 1.509 2.522 0 O-C-N 120.538 -1.351 . . . . 0.0 112.777 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 45.3 Cg_endo -64.0 -18.84 65.26 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 123.153 2.569 . . . . 0.0 113.911 -173.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -88.36 125.07 34.52 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.849 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.726 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.8 OUTLIER -87.97 120.84 29.71 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.367 -0.833 . . . . 0.0 109.194 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.432 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.57 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.35 171.93 8.1 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.097 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.837 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 18.3 tp -157.58 115.02 3.03 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.547 ' OG1' HD11 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -111.76 131.99 54.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.023 -1.048 . . . . 0.0 110.062 -178.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 121' ' ' VAL . 53.8 mt -127.11 131.55 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 71.4 m-85 -129.79 164.37 24.19 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.6 m -89.02 174.96 7.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.21 -0.931 . . . . 0.0 108.906 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -23.92 6.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 120.902 -1.124 . . . . 0.0 109.532 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -41.05 62.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.059 -1.026 . . . . 0.0 110.334 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.25 123.08 11.0 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.991 -1.068 . . . . 0.0 109.52 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.588 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 55.6 Cg_endo -82.58 -27.29 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.885 1.724 . . . . 0.0 112.214 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 12' ' ' GLN . 1.4 pp0? -70.45 0.55 6.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 110.546 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.578 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -123.12 118.63 28.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 108.923 179.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.32 129.41 41.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.03 -1.044 . . . . 0.0 109.095 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.578 ' CD1' HD21 ' A' ' 13' ' ' ASN . 9.4 mp -88.46 -12.25 43.59 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.046 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.837 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 40.8 t90 -158.44 107.33 1.98 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.747 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -120.03 117.69 28.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.367 -0.833 . . . . 0.0 109.76 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.71 163.43 29.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.532 -0.73 . . . . 0.0 109.753 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 19' ' ' THR . 8.9 t -130.63 89.25 2.74 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.039 -1.038 . . . . 0.0 108.297 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.713 ' O ' HD12 ' A' ' 24' ' ' ILE . 23.1 m120 -125.17 138.6 54.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.32 -0.862 . . . . 0.0 110.535 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.93 -34.08 30.03 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 119.874 -1.766 . . . . 0.0 108.555 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -82.65 -53.55 5.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.096 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -58.56 -20.22 44.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.134 -0.979 . . . . 0.0 108.666 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.713 HD12 ' O ' ' A' ' 20' ' ' ASN . 5.5 mt -75.85 -57.09 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.053 -1.03 . . . . 0.0 108.748 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.499 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 61.5 tt0 -53.47 -41.08 65.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.409 -0.807 . . . . 0.0 109.077 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -71.84 -49.08 41.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.124 -0.985 . . . . 0.0 110.652 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.564 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 27.0 mt-30 -72.23 -47.33 51.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.977 -1.077 . . . . 0.0 110.998 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 33' ' ' VAL . 14.7 tp -61.22 -54.66 41.36 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.017 -1.052 . . . . 0.0 109.467 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 15.0 m120 -62.78 -16.2 56.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.978 -1.076 . . . . 0.0 109.636 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 27' ' ' GLN . . . -62.86 -28.96 70.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.616 -1.302 . . . . 0.0 108.507 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 12.51 11.82 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.792 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.44 24.65 28.04 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.139 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.564 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 99.9 t -95.64 143.82 11.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.39 -1.065 . . . . 0.0 109.513 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -84.04 158.87 21.31 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.476 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -150.45 146.04 26.4 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 36.7 mt-10 -162.96 162.87 26.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.116 -0.99 . . . . 0.0 108.932 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.2 mtm-85 -148.41 111.59 4.91 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.615 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 18.0 m0 -112.71 155.99 23.57 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -142.65 162.32 35.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 0.0 109.846 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.23 159.59 15.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 108.905 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -100.59 -17.1 17.22 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -92.88 159.68 15.25 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.51 123.36 35.75 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.569 -0.707 . . . . 0.0 109.379 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.3 mt -90.53 166.15 13.38 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.299 -0.876 . . . . 0.0 109.342 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.69 -105.13 0.21 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.26 91.24 4.99 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.133 -1.216 . . . . 0.0 109.388 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.2 92.4 22.07 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.78 -27.43 8.81 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.206 1.937 . . . . 0.0 112.461 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 p -121.24 141.87 50.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.633 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.48 -21.2 42.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 109.532 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 50' ' ' ALA . 83.7 tt0 -43.54 -38.78 3.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -0.825 . . . . 0.0 109.096 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.7 p -78.52 -34.77 47.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 109.244 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 50' ' ' ALA . 59.1 t -68.28 -46.35 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.349 -0.844 . . . . 0.0 109.916 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.444 HD13 ' N ' ' A' ' 54' ' ' ILE . 6.5 mm -61.62 -35.62 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.957 . . . . 0.0 108.881 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.17 -30.34 71.51 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.52 -0.738 . . . . 0.0 109.653 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.55 -20.47 56.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 110.086 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.404 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.5 m-85 -110.74 -6.76 14.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.454 -0.779 . . . . 0.0 109.479 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.569 HE22 HD11 ' A' ' 61' ' ' ILE . 5.1 mm-40 -47.62 -37.9 13.57 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.068 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.702 ' CD2' ' N ' ' A' ' 60' ' ' ALA . 13.3 p-80 -52.59 -45.0 66.33 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.865 -1.147 . . . . 0.0 109.633 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.702 ' N ' ' CD2' ' A' ' 59' ' ' HIS . . . -63.66 -59.83 4.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.73 -1.232 . . . . 0.0 110.403 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.693 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.9 OUTLIER -61.83 -28.06 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.763 -1.211 . . . . 0.0 108.826 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 58' ' ' GLN . 25.9 t70 -57.62 -28.91 64.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.239 -0.913 . . . . 0.0 109.441 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.406 ' CD ' ' O ' ' A' ' 59' ' ' HIS . 4.7 mptp? -73.74 -41.31 62.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.108 -0.995 . . . . 0.0 109.185 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.4 mp -64.09 -35.27 80.21 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.387 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 61' ' ' ILE . 3.7 t -69.1 -28.9 41.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.227 -0.92 . . . . 0.0 109.321 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.77 -53.84 53.82 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.546 -1.346 . . . . 0.0 109.57 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -85.57 -53.69 5.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.024 -1.048 . . . . 0.0 110.704 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.583 ' O ' ' C ' ' A' ' 69' ' ' GLY . 11.2 mmtp -84.96 14.45 4.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.443 -0.786 . . . . 0.0 110.646 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -18.23 87.93 0.0 OUTLIER Glycine 0 N--CA 1.498 2.805 0 CA-C-O 122.041 0.8 . . . . 0.0 111.332 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 68' ' ' LYS . 58.7 m-85 -76.12 165.07 25.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.749 HE22 ' ND2' ' A' ' 158' ' ' ASN . 81.4 mt-30 -57.14 -88.83 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.431 -0.793 . . . . 0.0 109.522 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.404 ' CB ' ' HB2' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -103.76 163.1 12.56 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.641 0.734 . . . . 0.0 109.999 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.617 ' HE1' HG23 ' A' ' 153' ' ' ILE . 5.2 t-105 -135.23 139.24 44.31 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -155.48 173.5 16.6 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.98 141.39 39.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 76' ' ' ILE . 16.2 tt -102.78 117.09 47.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.517 ' O ' ' OG ' ' A' ' 77' ' ' SER . 8.8 p -168.24 101.78 0.44 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.585 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 9.6 tp -116.01 179.43 3.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 119.31 -2.119 . . . . 0.0 107.781 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.531 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -89.51 150.01 22.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.032 -1.042 . . . . 0.0 109.173 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.2 2.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -0.881 . . . . 0.0 109.675 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 79' ' ' ARG . 32.3 t0 -78.77 -28.1 44.7 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.566 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -63.69 123.66 82.13 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.872 -1.143 . . . . 0.0 109.91 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.59 -4.77 12.36 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.048 1.832 . . . . 0.0 111.97 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -87.98 6.26 36.8 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.044 -1.035 . . . . 0.0 109.761 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.532 ' HG3' ' H ' ' A' ' 86' ' ' GLU . 11.9 ptpt -57.27 -50.89 71.48 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.162 -0.961 . . . . 0.0 108.975 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.532 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 84.4 tt0 -66.33 -42.57 87.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.282 -0.886 . . . . 0.0 109.899 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.72 -59.42 4.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.13 -0.981 . . . . 0.0 110.136 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.537 ' H ' HD12 ' A' ' 88' ' ' LEU . 6.1 mp -62.8 -44.53 95.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.953 -1.092 . . . . 0.0 109.49 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 145' ' ' GLY . 47.7 ttp180 -59.54 -30.33 68.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.845 . . . . 0.0 109.627 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.82 -61.66 2.34 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.616 -0.833 . . . . 0.0 109.638 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -54.98 -32.66 61.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.462 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -63.69 -31.34 72.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.902 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.601 ' O ' ' HB3' ' A' ' 172' ' ' ALA . 73.6 mt -50.87 -41.37 58.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.001 -1.062 . . . . 0.0 110.014 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.716 HD22 ' H ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -49.22 141.01 8.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.762 -1.211 . . . . 0.0 109.583 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.716 ' H ' HD22 ' A' ' 94' ' ' ASN . 0.7 OUTLIER -81.63 171.65 14.37 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.5 p-80 -177.71 -165.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 110.537 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.1 t -163.32 137.74 6.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.625 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -109.33 155.57 21.04 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 109.87 -178.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.87 -7.03 87.49 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -123.51 170.64 10.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.54 -0.977 . . . . 0.0 109.356 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' A' ' 101' ' ' ASP . 48.3 p30 -75.98 143.9 41.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.056 -1.027 . . . . 0.0 110.07 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.434 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 1.8 mt-10 -104.11 94.28 5.3 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.06 -1.025 . . . . 0.0 108.446 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.781 HG13 ' OG ' ' A' ' 133' ' ' SER . 44.1 t -97.55 127.02 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.023 -1.048 . . . . 0.0 110.313 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 129.73 43.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.342 -0.849 . . . . 0.0 109.244 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.641 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 14.2 t80 -106.44 131.92 53.07 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.161 -0.962 . . . . 0.0 109.33 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.54 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -87.86 130.82 34.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 110.279 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.429 HG12 HG11 ' A' ' 53' ' ' VAL . 3.0 t -109.63 -34.17 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.66 -0.65 . . . . 0.0 110.065 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 109' ' ' GLY . 1.4 tm-20 -164.01 151.68 12.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.477 ' N ' ' OE1' ' A' ' 108' ' ' GLU . . . 87.42 148.76 14.63 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.71 155.39 27.83 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.32 -1.106 . . . . 0.0 108.933 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -150.87 -119.61 0.9 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.2 tp -146.71 162.23 38.95 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.368 -1.078 . . . . 0.0 109.097 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -131.31 90.43 2.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.282 -0.886 . . . . 0.0 109.234 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.719 ' O ' HD22 ' A' ' 115' ' ' LEU . 5.1 p -79.47 131.96 36.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 110.107 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.719 HD22 ' O ' ' A' ' 114' ' ' CYS . 0.6 OUTLIER -136.67 104.26 5.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.358 -0.839 . . . . 0.0 108.772 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.52 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 1.7 t-160 -98.41 108.93 21.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.928 -1.108 . . . . 0.0 109.582 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.443 ' H ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -126.12 113.19 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.004 -178.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.85 -141.47 27.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 104.968 -3.253 . . . . 0.0 104.968 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.495 ' O ' ' OD2' ' A' ' 119' ' ' ASP . 39.9 p30 -108.25 80.92 1.41 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 115.488 -2.485 . . . . 0.0 108.956 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.52 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 23.2 pt-20 -166.41 168.88 14.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.727 ' O ' HG23 ' A' ' 5' ' ' ILE . 55.5 t -129.19 150.8 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.984 . . . . 0.0 109.83 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.5 ' CZ ' HD13 ' A' ' 5' ' ' ILE . 1.5 m-85 -125.39 129.8 50.61 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.213 0.53 . . . . 0.0 109.575 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 4' ' ' THR . 28.6 mt-30 -129.23 110.74 12.22 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.664 HG22 ' CD1' ' A' ' 3' ' ' LEU . 3.1 t -102.2 138.2 27.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.551 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 5.6 mp -122.39 79.51 1.62 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 117.685 -1.606 . . . . 0.0 109.226 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.551 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -165.86 118.42 1.11 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 178.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 7.3 tm-20 -113.9 104.19 11.92 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 116.618 -2.033 . . . . 0.0 110.916 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 130' ' ' ASP . 44.6 mtmt -110.15 178.01 4.53 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.688 177.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.641 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.3 OUTLIER -59.42 -3.57 0.46 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.63 ' N ' HD22 ' A' ' 129' ' ' ASN . 26.7 p30 -72.28 151.88 42.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.835 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.76 ' C ' HD12 ' A' ' 131' ' ' LEU . 1.9 pp -114.9 160.77 19.13 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.023 0.916 . . . . 0.0 110.57 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.623 ' N ' HD12 ' A' ' 131' ' ' LEU . 6.2 mm -128.07 125.96 65.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.586 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.781 ' OG ' HG13 ' A' ' 103' ' ' VAL . 28.0 m -123.35 141.26 52.17 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.46 148.58 39.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.852 . . . . 0.0 108.716 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -70.24 156.68 61.55 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.269 1.979 . . . . 0.0 112.926 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.605 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.15 133.51 46.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.438 -0.789 . . . . 0.0 109.036 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.605 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 11.1 t60 92.24 11.75 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.168 0.509 . . . . 0.0 110.012 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.24 126.26 32.07 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.99 133.86 40.47 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.442 1.428 . . . . 0.0 111.699 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.511 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.41 163.49 8.59 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.084 -1.047 . . . . 0.0 110.313 -179.263 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.72 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 10.7 p90 -130.95 -153.49 0.57 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.365 -0.835 . . . . 0.0 110.031 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.534 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -168.41 125.06 1.03 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.476 -0.765 . . . . 0.0 109.169 179.112 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 46.2 p-10 -146.04 129.48 16.86 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.053 -1.029 . . . . 0.0 109.749 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.586 ' O ' ' C ' ' A' ' 145' ' ' GLY . 29.8 mtt -102.95 16.51 26.42 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.369 -0.832 . . . . 0.0 111.198 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 20.86 -113.85 0.01 OUTLIER Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.424 ' H ' ' HB2' ' A' ' 178' ' ' LEU . 67.2 m -81.3 120.77 25.35 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.064 -1.454 . . . . 0.0 109.159 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.04 114.46 46.21 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 120.181 -0.607 . . . . 0.0 109.386 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 59.6 Cg_endo -104.14 44.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 122.614 2.209 . . . . 0.0 111.485 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER 81.68 70.35 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.177 -177.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 23.8 p90 -96.44 159.06 15.14 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.414 -0.804 . . . . 0.0 110.225 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.3 m -125.37 125.39 43.37 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.582 0.706 . . . . 0.0 110.716 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.491 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . . . -143.22 162.76 34.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.37 -0.831 . . . . 0.0 109.295 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.617 HG23 ' HE1' ' A' ' 73' ' ' TRP . 94.9 mt -110.9 129.87 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.256 -0.902 . . . . 0.0 109.942 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.526 ' C ' HD13 ' A' ' 155' ' ' ILE . 95.5 mtt-85 -129.87 158.03 40.63 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.578 -0.701 . . . . 0.0 109.596 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.68 154.41 8.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.404 ' HB2' ' CB ' ' A' ' 72' ' ' SER . 4.2 m-30 -95.81 120.15 35.57 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.093 -1.004 . . . . 0.0 110.196 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.562 ' CG ' ' CE2' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -134.82 161.89 33.91 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.749 ' ND2' HE22 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -95.92 160.61 29.71 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 120.92 -1.113 . . . . 0.0 109.268 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 161' ' ' GLY . 43.0 Cg_endo -67.9 -54.83 0.3 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.367 2.044 . . . . 0.0 112.088 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 159' ' ' PRO . 16.5 pt-20 -43.98 -14.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.243 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -89.04 -36.7 7.54 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CE2' ' CG ' ' A' ' 157' ' ' ASP . 47.6 m0 -102.26 163.35 12.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.601 -0.941 . . . . 0.0 110.675 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -99.25 139.33 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.362 -0.836 . . . . 0.0 109.238 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.36 -73.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.5 -0.75 . . . . 0.0 110.736 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -142.25 159.69 41.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.941 -1.099 . . . . 0.0 110.062 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.6 -41.45 6.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.753 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.9 -31.74 5.0 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.26 -1.27 64.48 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.467 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 94.6 m-20 -80.71 149.51 29.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.761 -1.435 . . . . 0.0 108.291 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.462 ' OD2' ' OG ' ' A' ' 173' ' ' SER . 5.8 p-10 -109.5 88.07 2.65 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.624 -1.63 . . . . 0.0 110.682 176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.0 OUTLIER -76.16 -20.76 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.336 -1.477 . . . . 0.0 109.594 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.72 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -61.51 -39.82 92.4 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.972 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.583 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 38.2 p -52.9 -3.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.711 -0.618 . . . . 0.0 110.193 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.98 -39.66 29.6 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.957 -1.09 . . . . 0.0 111.491 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.636 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.7 m-85 -113.48 24.27 0.08 OUTLIER Pre-proline 0 N--CA 1.516 2.864 0 O-C-N 120.534 -1.353 . . . . 0.0 112.73 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 43.9 Cg_endo -61.56 -19.59 65.36 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.653 2.902 . . . . 0.0 114.486 -172.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -89.36 127.05 35.77 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.879 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.739 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 1.0 OUTLIER -85.5 118.81 25.25 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.085 -1.009 . . . . 0.0 108.698 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.624 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.492 ' O ' ' OG1' ' A' ' 19' ' ' THR . 1.3 p . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.77 171.08 8.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.237 -0.914 . . . . 0.0 109.437 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.775 HD13 HG22 ' A' ' 124' ' ' VAL . 30.9 tp -158.9 112.53 2.36 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.29 128.97 54.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.829 -1.169 . . . . 0.0 110.091 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 121' ' ' VAL . 60.4 mt -123.7 130.07 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -125.9 165.55 18.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.54 ' OG ' HD11 ' A' ' 15' ' ' LEU . 14.3 m -84.35 172.77 11.49 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.32 -0.863 . . . . 0.0 109.019 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -89.43 -30.45 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.121 . . . . 0.0 109.955 179.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -73.73 -38.33 64.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 0.0 110.043 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.71 123.93 13.12 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.34 -30.43 1.55 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.234 1.956 . . . . 0.0 112.312 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.745 HE21 ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -69.67 2.27 3.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.466 -0.771 . . . . 0.0 109.928 -179.102 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.745 ' ND2' HE21 ' A' ' 12' ' ' GLN . 0.9 OUTLIER -117.79 119.45 34.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.5 p -96.12 124.38 40.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.292 -0.88 . . . . 0.0 109.334 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.54 HD11 ' OG ' ' A' ' 7' ' ' SER . 72.0 mt -87.62 -15.4 37.42 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.715 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 46.2 t90 -158.93 108.59 1.96 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.649 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -120.5 122.08 39.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.136 -0.977 . . . . 0.0 109.275 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.07 164.02 20.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.969 -1.082 . . . . 0.0 109.961 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 19' ' ' THR . 10.3 t -131.47 89.89 2.78 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.566 175.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.779 ' O ' HD12 ' A' ' 24' ' ' ILE . 29.8 m120 -125.59 145.54 50.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.964 -1.085 . . . . 0.0 110.688 177.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.58 -41.67 19.27 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.34 -1.475 . . . . 0.0 109.072 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -82.77 -48.81 10.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.349 -0.844 . . . . 0.0 109.6 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.486 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.1 tt0 -61.31 -19.95 62.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.974 -1.079 . . . . 0.0 108.533 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.779 HD12 ' O ' ' A' ' 20' ' ' ASN . 2.3 mt -73.27 -58.59 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.183 -0.948 . . . . 0.0 109.316 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.516 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 6.2 pt20 -61.28 -42.22 98.27 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.035 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.516 ' N ' ' CG ' ' A' ' 25' ' ' GLN . 62.7 tt0 -61.77 -47.46 85.08 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.347 -0.846 . . . . 0.0 109.48 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.607 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 4.7 tt0 -76.06 -45.44 34.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.062 -1.024 . . . . 0.0 109.332 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.467 ' HA ' HD12 ' A' ' 28' ' ' LEU . 16.9 tp -64.54 -56.74 12.08 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.02 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.622 HD21 ' CB ' ' A' ' 35' ' ' PHE . 1.2 m-20 -57.26 -17.92 13.95 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.928 -1.108 . . . . 0.0 109.469 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 27' ' ' GLN . . . -63.93 -27.8 69.39 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.916 -1.115 . . . . 0.0 109.084 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -89.75 10.53 23.09 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.721 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.0 23.49 25.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.1 t -93.69 143.35 11.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.249 -1.148 . . . . 0.0 109.672 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 ttt85 -85.08 155.7 21.39 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.385 -0.822 . . . . 0.0 109.055 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.622 ' CB ' HD21 ' A' ' 29' ' ' ASN . 1.5 t80 -155.81 153.59 30.02 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.711 -1.243 . . . . 0.0 109.059 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' OE1' ' O ' ' A' ' 35' ' ' PHE . 13.1 tp10 -175.71 173.34 2.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.763 -1.211 . . . . 0.0 109.576 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.449 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 37.5 mtm180 -148.38 117.56 6.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.813 -1.18 . . . . 0.0 108.665 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.527 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 26.8 m0 -110.2 154.07 23.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 109.283 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.611 HE22 ' ND2' ' A' ' 129' ' ' ASN . 99.5 mm-40 -141.12 155.88 46.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.481 -0.762 . . . . 0.0 109.92 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.99 156.64 17.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.328 -0.857 . . . . 0.0 109.004 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.499 ' OD2' ' N ' ' A' ' 42' ' ' ARG . 53.2 p30 -101.11 -11.81 19.3 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.125 -0.985 . . . . 0.0 108.7 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.499 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -93.38 156.38 16.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -92.12 119.03 31.4 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.688 -0.632 . . . . 0.0 109.566 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.36 163.65 14.12 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.696 0.76 . . . . 0.0 109.3 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.37 -102.81 0.19 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.18 92.82 4.49 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.928 -1.336 . . . . 0.0 109.23 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.54 91.47 44.61 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -75.58 -22.67 13.6 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.461 2.107 . . . . 0.0 112.756 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 p -121.96 141.97 50.78 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.542 -0.723 . . . . 0.0 109.59 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 51' ' ' GLU . . . -80.29 -18.24 49.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.333 -0.854 . . . . 0.0 109.405 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 50' ' ' ALA . 79.8 mm-40 -45.34 -38.32 5.69 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.911 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.4 m -77.84 -33.3 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.41 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 50' ' ' ALA . 65.3 t -68.22 -47.0 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 109.961 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.513 ' O ' ' N ' ' A' ' 58' ' ' GLN . 14.4 mm -60.61 -39.16 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 109.261 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.26 70.62 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.571 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.34 -19.55 58.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 0.0 110.507 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -116.33 -8.53 11.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.435 -0.791 . . . . 0.0 109.267 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.694 HE21 ' CG1' ' A' ' 61' ' ' ILE . 33.5 tp60 -48.36 -38.03 18.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 108.737 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.599 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.22 -47.95 62.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.01 -1.056 . . . . 0.0 109.885 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.599 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.37 -58.93 6.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.968 -1.082 . . . . 0.0 109.819 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.702 HD12 ' C ' ' A' ' 61' ' ' ILE . 0.5 OUTLIER -62.72 -29.42 46.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.953 -1.092 . . . . 0.0 108.883 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 58' ' ' GLN . 47.4 t0 -57.31 -25.37 59.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.86 . . . . 0.0 109.713 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -78.47 -38.09 41.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 110.126 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -62.99 -39.52 94.97 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.266 -0.973 . . . . 0.0 109.695 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -69.25 -30.38 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.026 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.62 61.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.216 -1.552 . . . . 0.0 109.462 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -83.7 -52.48 6.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.022 -1.049 . . . . 0.0 110.799 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.629 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -86.7 14.88 6.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.544 -0.723 . . . . 0.0 110.666 -177.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -14.7 89.38 0.01 OUTLIER Glycine 0 N--CA 1.5 2.944 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.855 ' CG ' HG21 ' A' ' 155' ' ' ILE . 97.2 m-85 -76.03 160.07 30.19 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -58.93 -40.86 85.88 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.315 -0.866 . . . . 0.0 109.754 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.1 t -144.49 155.22 43.6 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.212 -0.93 . . . . 0.0 109.104 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.669 ' CE2' HD13 ' A' ' 61' ' ' ILE . 9.8 t-105 -141.68 146.3 35.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.303 -0.873 . . . . 0.0 108.658 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.537 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.3 OUTLIER -176.55 -165.87 0.15 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 153' ' ' ILE . 36.0 m -128.57 165.57 27.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.446 -0.784 . . . . 0.0 109.625 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.684 ' CD1' ' HE ' ' A' ' 154' ' ' ARG . 1.4 mp -95.52 136.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.0 p -91.95 165.6 13.14 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.423 1.106 . . . . 0.0 111.412 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.744 HD23 ' CZ ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -161.5 137.63 8.07 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.884 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.559 ' H ' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -123.64 137.78 54.66 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.601 ' HB2' ' HB3' ' A' ' 149' ' ' ASN . . . -70.56 -7.03 40.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 0.0 109.709 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.519 ' H ' ' HD2' ' A' ' 79' ' ' ARG . 45.8 t0 -110.64 -18.24 13.21 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.519 -0.738 . . . . 0.0 109.396 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.858 HD21 ' N ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -63.34 116.67 27.16 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.239 -178.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -90.07 -16.53 1.79 Allowed 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.964 2.443 . . . . 0.0 113.032 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.402 ' CG ' ' OD1' ' A' ' 82' ' ' ASN . 16.5 pt20 -80.26 1.18 29.56 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.008 -1.058 . . . . 0.0 109.165 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.858 ' N ' HD21 ' A' ' 82' ' ' ASN . 0.8 OUTLIER -65.84 -42.16 90.87 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.21 178.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -51.45 -47.04 63.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.013 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.87 -43.93 77.62 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.672 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.431 HD12 ' HE2' ' A' ' 85' ' ' LYS . 91.4 mt -61.75 -38.38 87.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.887 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.63 HH11 ' CA ' ' A' ' 89' ' ' ARG . 1.6 mmt-85 -58.78 -25.53 63.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.885 . . . . 0.0 108.865 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -58.57 3.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.465 -0.772 . . . . 0.0 110.248 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -54.81 -45.69 74.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.342 -0.849 . . . . 0.0 109.736 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -67.81 -18.67 64.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -62.48 -34.38 76.72 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 109.705 -179.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.495 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 45.9 p-10 -47.58 140.28 6.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 109.944 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' A' ' 96' ' ' HIS . 23.1 tt0 -77.79 163.08 26.43 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.293 -0.88 . . . . 0.0 109.476 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.523 ' N ' ' CG ' ' A' ' 95' ' ' GLU . 50.7 p-80 -174.64 -167.13 0.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.349 -1.341 . . . . 0.0 112.07 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.99 134.39 2.47 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -106.1 156.07 18.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.86 -178.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.6 -6.19 86.63 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -123.04 170.04 10.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.456 -1.026 . . . . 0.0 109.431 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -75.85 142.89 42.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 109.887 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.437 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 1.8 mt-10 -102.79 92.67 4.7 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.749 HG22 ' OG ' ' A' ' 133' ' ' SER . 35.1 t -89.65 128.15 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.484 -0.76 . . . . 0.0 109.636 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.459 ' NH1' HG22 ' A' ' 132' ' ' ILE . 9.2 tmm_? -130.27 122.6 28.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -0.784 . . . . 0.0 109.904 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.632 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 11.0 t80 -100.87 130.92 46.95 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.477 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -87.78 130.25 34.91 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.544 -0.722 . . . . 0.0 110.196 -178.507 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.8 -30.93 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.687 -0.633 . . . . 0.0 109.423 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -162.01 151.48 16.08 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.18 -0.95 . . . . 0.0 109.374 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.81 164.8 39.71 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' A' ' 127' ' ' GLU . . . -147.72 171.53 15.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.478 -1.013 . . . . 0.0 109.281 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.7 154.52 10.74 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.586 ' CB ' HD22 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -93.65 96.78 10.04 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.744 -1.445 . . . . 0.0 110.08 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.503 ' CE1' ' O ' ' A' ' 114' ' ' CYS . 3.5 t80 -87.75 127.95 35.31 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.767 -1.208 . . . . 0.0 109.332 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.664 ' SG ' ' NE2' ' A' ' 123' ' ' GLN . 1.8 m -78.93 129.96 35.07 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.711 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.751 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.0 tm? -114.62 129.47 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.623 ' N ' HD13 ' A' ' 115' ' ' LEU . 4.9 t-160 -114.68 112.84 23.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.417 -0.802 . . . . 0.0 109.558 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.3 112.2 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.441 -0.787 . . . . 0.0 109.597 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.42 -127.76 10.08 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 106.437 -2.665 . . . . 0.0 106.437 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.559 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 46.4 p30 -116.23 75.51 0.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 115.374 -2.53 . . . . 0.0 110.342 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.581 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 22.3 pt-20 -166.2 168.25 15.44 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 5' ' ' ILE . 55.7 t -125.4 138.96 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.46 -0.775 . . . . 0.0 109.986 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 115' ' ' LEU . 7.6 m-85 -127.61 131.25 49.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 0.0 109.353 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.664 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 11.7 mt-30 -126.45 118.54 25.16 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.031 -1.043 . . . . 0.0 108.983 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.909 ' C ' HD23 ' A' ' 125' ' ' LEU . 21.7 t -110.14 135.54 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.909 HD23 ' C ' ' A' ' 124' ' ' VAL . 0.1 OUTLIER -133.64 90.96 2.78 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.594 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 1.7 p -164.64 134.11 3.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 119.685 -1.884 . . . . 0.0 106.827 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 110' ' ' ALA . 2.5 pt-20 -106.34 93.72 4.75 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 115.71 -2.396 . . . . 0.0 110.185 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.558 ' C ' ' H ' ' A' ' 130' ' ' ASP . 51.7 mttm -115.52 158.95 21.85 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.108 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.632 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 23.1 m-80 -58.37 -3.02 0.23 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.345 -1.472 . . . . 0.0 107.622 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 128' ' ' LYS . 56.1 p30 -72.81 152.78 41.39 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.139 -0.976 . . . . 0.0 109.28 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.768 ' C ' HD12 ' A' ' 131' ' ' LEU . 3.0 pp -117.23 161.43 19.49 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.686 0.755 . . . . 0.0 110.052 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.58 ' N ' HD12 ' A' ' 131' ' ' LEU . 17.3 tt -133.11 126.36 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.281 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.749 ' OG ' HG22 ' A' ' 103' ' ' VAL . 19.1 t -122.1 138.53 54.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.452 -0.78 . . . . 0.0 109.605 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.16 147.87 35.02 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.387 -0.821 . . . . 0.0 109.145 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.723 ' O ' HG22 ' A' ' 138' ' ' THR . 39.1 Cg_endo -66.81 156.51 65.69 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.269 1.979 . . . . 0.0 112.795 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.644 ' O ' ' ND1' ' A' ' 137' ' ' HIS . . . -71.84 139.74 49.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.311 -0.868 . . . . 0.0 108.675 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.644 ' ND1' ' O ' ' A' ' 136' ' ' ALA . 7.4 m80 88.62 13.46 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.852 -0.53 . . . . 0.0 109.719 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.723 HG22 ' O ' ' A' ' 135' ' ' PRO . 14.9 t -106.7 126.4 30.4 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.288 -0.883 . . . . 0.0 108.864 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 116' ' ' HIS . 39.6 Cg_endo -63.66 134.06 42.39 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.597 1.531 . . . . 0.0 111.452 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.51 ' C ' ' CD2' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -172.29 162.08 5.45 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.959 -1.088 . . . . 0.0 109.982 -179.088 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.501 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -133.19 -149.01 0.35 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.159 -0.963 . . . . 0.0 109.413 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -176.38 127.99 0.2 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.925 -1.109 . . . . 0.0 108.938 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.76 138.68 18.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 109.143 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.623 ' SD ' ' CZ ' ' A' ' 89' ' ' ARG . 1.4 mpt? -113.17 21.69 15.06 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.395 -0.816 . . . . 0.0 110.574 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.599 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.67 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.501 2.971 0 CA-C-N 119.417 1.008 . . . . 0.0 111.835 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.477 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 74.9 m -86.74 117.24 25.36 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 117.94 -1.504 . . . . 0.0 109.562 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.45 ' N ' ' OE1' ' A' ' 147' ' ' GLU . 22.3 mp0 -115.2 116.92 41.81 Favored Pre-proline 0 C--N 1.294 -1.835 0 O-C-N 121.805 -0.56 . . . . 0.0 109.778 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.616 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 51.1 Cg_endo -103.39 31.96 0.07 OUTLIER 'Trans proline' 0 C--O 1.207 -1.064 0 C-N-CA 123.395 2.73 . . . . 0.0 111.791 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.721 ' CG ' ' O ' ' A' ' 149' ' ' ASN . 0.1 OUTLIER 82.54 63.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 123.102 1.43 . . . . 0.0 109.807 -178.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.744 ' CZ ' HD23 ' A' ' 78' ' ' LEU . 11.2 p90 -99.84 -178.86 3.99 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 119.805 -1.809 . . . . 0.0 110.16 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 59.7 m -135.69 131.7 36.0 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.701 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -134.98 153.94 51.91 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.065 -1.022 . . . . 0.0 108.972 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.459 HG12 HG12 ' A' ' 75' ' ' VAL . 10.9 mt -110.21 129.58 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.159 -0.963 . . . . 0.0 109.805 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.684 ' HE ' ' CD1' ' A' ' 76' ' ' ILE . 25.9 mtm-85 -143.97 170.08 16.6 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.192 -0.943 . . . . 0.0 109.481 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.855 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.6 mp -101.33 145.81 10.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.471 -0.768 . . . . 0.0 109.034 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.521 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 5.2 m-85 -96.38 118.73 33.52 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.489 -0.757 . . . . 0.0 109.408 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.575 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 55.3 p30 -134.89 161.57 34.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.848 -0.533 . . . . 0.0 109.607 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.605 ' O ' ' NE1' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -96.08 156.99 36.47 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.096 . . . . 0.0 108.981 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.5 Cg_endo -66.93 -54.06 0.45 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.667 2.245 . . . . 0.0 112.249 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.6 ' N ' ' OD1' ' A' ' 158' ' ' ASN . 95.5 mt-10 -44.4 -17.53 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.312 -0.867 . . . . 0.0 108.856 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.48 -50.84 5.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.605 ' NE1' ' O ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -104.07 169.33 8.56 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.474 -1.016 . . . . 0.0 109.95 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 74.9 mt -96.99 149.81 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 0.0 109.341 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 96' ' ' HIS . . . -83.31 -71.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 0.0 110.349 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -117.6 146.3 43.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.161 -0.962 . . . . 0.0 109.699 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -101.56 -41.71 6.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.436 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 69.4 p -106.44 -31.18 8.67 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.22 -0.925 . . . . 0.0 109.049 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.23 -9.1 56.01 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -82.78 145.98 29.23 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.253 -1.734 . . . . 0.0 108.722 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -112.33 90.6 3.38 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.527 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.07 -16.78 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.036 -1.665 . . . . 0.0 108.758 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -57.94 -38.05 75.22 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.672 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 22.7 t -51.61 -3.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.232 -0.917 . . . . 0.0 110.191 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.664 ' HB3' ' CE2' ' A' ' 175' ' ' TYR . . . -76.64 -42.05 43.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.784 -1.197 . . . . 0.0 111.701 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.664 ' CE2' ' HB3' ' A' ' 174' ' ' ALA . 0.1 OUTLIER -113.95 26.7 0.1 OUTLIER Pre-proline 0 N--CA 1.511 2.606 0 O-C-N 120.574 -1.328 . . . . 0.0 111.966 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.672 ' HD3' ' C ' ' A' ' 173' ' ' SER . 46.4 Cg_endo -60.95 -24.24 79.03 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 124.146 3.231 . . . . 0.0 113.038 -172.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.11 126.18 35.35 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.895 -1.122 . . . . 0.0 109.186 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.512 ' O ' ' C ' ' A' ' 179' ' ' ALA . 1.3 tp -87.59 122.69 31.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.633 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.633 ' O ' ' OG1' ' A' ' 19' ' ' THR . 11.3 p . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.68 170.76 8.78 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.301 -0.874 . . . . 0.0 109.325 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 4' ' ' THR . 3.8 tp -159.01 115.92 2.72 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.437 ' N ' HD12 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -108.83 140.78 41.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.746 HG23 ' O ' ' A' ' 121' ' ' VAL . 32.1 mt -134.18 134.65 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -126.65 166.89 16.51 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.9 m -86.04 173.92 9.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.051 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.3 -28.09 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.982 -1.074 . . . . 0.0 109.399 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -75.83 -36.59 59.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 110.381 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -137.89 123.75 12.81 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.476 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -81.69 -32.11 0.94 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.066 1.844 . . . . 0.0 112.353 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.577 ' NE2' ' O ' ' A' ' 12' ' ' GLN . 23.5 tp60 -69.81 2.78 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.448 -0.782 . . . . 0.0 110.011 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -114.73 120.11 38.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.912 . . . . 0.0 109.474 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.85 122.15 40.62 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.251 -0.906 . . . . 0.0 109.248 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 15' ' ' LEU . 10.8 mp -90.43 -6.18 55.21 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.022 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.707 ' HB3' HD12 ' A' ' 5' ' ' ILE . 39.1 t90 -156.22 105.13 2.29 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.43 -1.308 . . . . 0.0 110.276 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -119.13 110.97 17.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.642 -0.661 . . . . 0.0 109.544 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.448 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -163.01 163.45 26.03 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.002 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 19' ' ' THR . 11.7 t -131.47 90.77 2.91 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 120.786 -1.196 . . . . 0.0 108.416 176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.806 ' O ' HD12 ' A' ' 24' ' ' ILE . 29.9 m120 -124.66 152.29 43.84 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.851 -1.156 . . . . 0.0 110.613 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.32 -47.54 11.38 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.343 -1.473 . . . . 0.0 108.758 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -82.49 -43.35 17.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.347 -0.846 . . . . 0.0 110.242 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.498 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.2 tt0 -66.07 -24.73 66.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.749 -1.219 . . . . 0.0 108.908 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 20' ' ' ASN . 3.3 mt -68.26 -58.45 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.165 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 29' ' ' ASN . 14.2 pt20 -58.39 -43.77 88.69 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.127 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.586 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 50.4 tt0 -53.89 -35.11 61.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.463 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.703 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -66.97 -63.55 1.04 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.0 -1.062 . . . . 0.0 109.314 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.571 ' HB2' HG21 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -69.18 -54.94 12.24 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.822 -1.174 . . . . 0.0 109.834 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 17.1 t-20 -47.52 -33.06 5.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.681 -1.262 . . . . 0.0 109.068 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -63.68 -25.33 68.16 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.064 -1.022 . . . . 0.0 108.531 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 28' ' ' LEU . 29.0 mttm -91.39 10.53 27.17 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.273 -0.892 . . . . 0.0 110.498 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.92 25.88 12.4 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.048 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.6 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 48.4 t -96.36 146.2 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.449 -1.03 . . . . 0.0 109.347 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.458 ' CD ' HD11 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -84.77 155.24 21.93 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.135 -0.978 . . . . 0.0 109.243 -179.045 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.485 ' CD1' ' HB3' ' A' ' 25' ' ' GLN . 2.1 t80 -155.37 154.26 31.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.043 -1.036 . . . . 0.0 109.006 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 35' ' ' PHE . 11.5 tp10 -176.12 173.05 2.27 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.975 -1.078 . . . . 0.0 109.519 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.45 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 65.4 mtm-85 -148.54 118.45 7.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.039 -1.038 . . . . 0.0 108.603 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.44 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 30.2 m0 -110.93 148.37 32.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.324 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.695 HE21 ' ND2' ' A' ' 129' ' ' ASN . 49.6 mm-40 -137.08 159.98 40.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.437 -0.789 . . . . 0.0 109.664 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.27 160.45 14.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 109.044 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -98.45 -18.46 18.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.236 -0.915 . . . . 0.0 108.687 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -93.54 167.85 11.42 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -94.39 121.15 35.63 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.727 . . . . 0.0 109.386 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.33 167.14 11.52 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.05 -121.7 0.59 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.44 78.83 9.63 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.068 -1.254 . . . . 0.0 108.653 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.15 95.62 30.99 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 121.375 -0.828 . . . . 0.0 109.309 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.689 ' O ' HG23 ' A' ' 49' ' ' THR . 46.8 Cg_endo -70.61 79.17 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.22 1.947 . . . . 0.0 111.736 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.689 HG23 ' O ' ' A' ' 48' ' ' PRO . 6.0 p -162.99 118.03 1.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.061 -1.024 . . . . 0.0 109.364 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.81 -43.98 17.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.062 -1.024 . . . . 0.0 109.96 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -65.11 -17.17 64.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.392 -0.817 . . . . 0.0 109.728 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.6 m -77.05 -41.78 41.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.229 -0.919 . . . . 0.0 110.373 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.445 HG11 ' CG1' ' A' ' 107' ' ' VAL . 20.6 t -63.93 -47.87 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.051 -1.031 . . . . 0.0 109.537 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 58' ' ' GLN . 11.7 mm -61.21 -42.25 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 108.722 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.38 -30.3 71.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.332 -0.855 . . . . 0.0 109.83 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.77 -19.38 59.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 110.405 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.0 m-85 -113.75 -6.67 13.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.373 -0.829 . . . . 0.0 109.462 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.676 HE21 ' CG1' ' A' ' 61' ' ' ILE . 26.3 tp60 -47.74 -39.72 18.56 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -50.43 -44.22 55.25 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.619 -1.3 . . . . 0.0 109.369 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.87 -59.42 4.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.869 -1.144 . . . . 0.0 110.452 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.676 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.8 OUTLIER -61.41 -30.39 47.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 120.912 -1.117 . . . . 0.0 108.968 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -55.04 -28.85 55.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.01 -1.056 . . . . 0.0 109.68 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -74.94 -38.94 61.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.034 -1.041 . . . . 0.0 109.4 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.8 mp -65.28 -35.34 80.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.069 -1.019 . . . . 0.0 109.739 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 61' ' ' ILE . 2.6 t -70.11 -31.18 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.72 64.02 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.639 -1.288 . . . . 0.0 109.386 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -87.33 -52.52 5.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 110.612 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.581 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -85.81 14.85 5.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.843 . . . . 0.0 110.44 -177.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.581 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -19.54 89.08 0.01 OUTLIER Glycine 0 N--CA 1.495 2.572 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.518 ' CG ' HG21 ' A' ' 155' ' ' ILE . 48.8 m-85 -76.75 167.71 21.36 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -57.19 -88.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.431 -0.793 . . . . 0.0 109.452 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -104.74 166.13 10.59 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.399 0.619 . . . . 0.0 109.69 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.562 ' HE1' HG23 ' A' ' 153' ' ' ILE . 5.5 t-105 -137.58 141.61 41.31 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.448 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -158.47 176.64 12.17 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.4 p -122.89 144.58 31.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.1 mt -105.53 116.84 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.484 ' O ' ' OG ' ' A' ' 77' ' ' SER . 11.2 p -168.66 103.05 0.41 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.261 -0.9 . . . . 0.0 109.216 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 79' ' ' ARG . 1.0 OUTLIER -115.27 -177.22 3.09 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 120.7 1.591 . . . . 0.0 108.645 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' ASP . 2.3 ttt180 -92.82 152.61 19.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.375 -1.453 . . . . 0.0 109.129 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.15 -6.87 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.062 -1.024 . . . . 0.0 110.4 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ARG . 95.3 m-20 -92.52 33.78 1.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.651 ' ND2' ' N ' ' A' ' 85' ' ' LYS . 23.7 t30 -76.12 124.8 88.42 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.914 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.16 -27.86 3.42 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.645 2.23 . . . . 0.0 112.271 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -90.79 10.66 25.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.917 -1.115 . . . . 0.0 109.194 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.651 ' N ' ' ND2' ' A' ' 82' ' ' ASN . 0.4 OUTLIER -53.34 -58.52 6.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.146 -0.972 . . . . 0.0 108.815 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.38 -51.4 52.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.116 -0.99 . . . . 0.0 109.324 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.99 -42.06 72.0 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.343 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 5.7 tp -59.75 -42.92 94.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.179 -0.95 . . . . 0.0 109.199 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -56.77 -37.67 71.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.568 -1.332 . . . . 0.0 110.174 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -66.06 -22.35 66.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.538 ' CG ' ' N ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -65.64 -45.47 82.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.617 -0.677 . . . . 0.0 110.121 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.668 ' CD2' ' O ' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -88.14 -13.57 40.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 0.0 110.477 -178.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 92' ' ' PHE . 65.5 tp -42.18 -18.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.152 -0.967 . . . . 0.0 109.883 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 92' ' ' PHE . 9.4 p30 -99.8 114.61 27.89 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.055 -1.028 . . . . 0.0 109.235 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.504 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 3.0 pp20? -52.02 173.91 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.504 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 50.2 p-80 -176.5 -166.78 0.17 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.295 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.06 135.47 3.83 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.607 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -103.61 154.8 19.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 109.741 -178.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.73 -6.59 87.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -123.97 171.18 9.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.333 -1.099 . . . . 0.0 109.424 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -74.31 141.79 45.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.975 . . . . 0.0 110.068 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.607 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 3.7 tt0 -102.83 89.9 3.62 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 103' ' ' VAL . 13.8 p -88.43 130.43 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.082 -1.011 . . . . 0.0 110.521 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.544 ' NH1' ' HE ' ' A' ' 154' ' ' ARG . 52.5 mtt-85 -129.68 121.79 27.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.594 -0.691 . . . . 0.0 109.439 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.615 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 21.7 t80 -101.76 132.97 47.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 108.593 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.542 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.33 129.53 35.36 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.677 -0.639 . . . . 0.0 109.747 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.474 ' HB ' HG22 ' A' ' 151' ' ' THR . 19.3 t -112.42 -30.41 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.697 -0.627 . . . . 0.0 109.749 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -168.59 158.69 9.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.04 -1.038 . . . . 0.0 109.108 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.05 156.83 5.61 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.33 -168.79 1.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -1.126 . . . . 0.0 109.35 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.31 -135.75 3.5 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.708 HD12 HD12 ' A' ' 178' ' ' LEU . 3.9 mt -144.74 162.91 35.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -1.138 . . . . 0.0 109.602 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -136.83 89.6 2.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 109.455 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.49 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -79.48 108.68 13.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.428 -0.795 . . . . 0.0 109.904 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.49 HD12 ' C ' ' A' ' 114' ' ' CYS . 9.2 mp -115.71 114.13 24.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.289 -0.882 . . . . 0.0 109.118 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.442 ' NE2' ' O ' ' A' ' 118' ' ' GLY . 11.1 t-160 -102.89 109.9 21.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.046 -1.034 . . . . 0.0 109.476 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.2 mt -125.59 111.79 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.281 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.442 ' O ' ' NE2' ' A' ' 116' ' ' HIS . . . 75.45 -142.92 29.78 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 106.427 -2.669 . . . . 0.0 106.427 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.49 ' O ' ' CG ' ' A' ' 119' ' ' ASP . 48.2 p-10 -103.48 79.09 1.66 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 114.909 -2.716 . . . . 0.0 109.167 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.438 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 24.0 tp10 -166.29 167.28 16.13 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.474 -1.391 . . . . 0.0 107.781 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.746 ' O ' HG23 ' A' ' 5' ' ' ILE . 57.3 t -128.52 147.06 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.809 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -123.94 131.4 53.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.771 -0.581 . . . . 0.0 109.714 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.417 ' O ' HD12 ' A' ' 3' ' ' LEU . 38.6 mm-40 -126.65 106.66 9.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -0.949 . . . . 0.0 108.905 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.01 136.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.2 tt -136.53 91.57 2.67 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.937 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 20.0 p -166.16 136.37 3.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.598 -1.314 . . . . 0.0 108.468 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.507 ' O ' ' CD ' ' A' ' 127' ' ' GLU . 3.4 tm-20 -107.23 93.95 4.83 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 115.819 -2.352 . . . . 0.0 110.884 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.551 ' C ' ' H ' ' A' ' 130' ' ' ASP . 30.4 mttp -114.5 155.55 26.21 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.755 176.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.695 ' ND2' HE21 ' A' ' 39' ' ' GLN . 12.6 p30 -55.71 -5.15 0.13 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.229 -1.544 . . . . 0.0 107.928 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 128' ' ' LYS . 43.4 p-10 -72.21 150.3 43.82 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.881 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.783 ' C ' HD12 ' A' ' 131' ' ' LEU . 3.0 pp -119.03 161.58 20.0 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.753 0.787 . . . . 0.0 110.547 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 131' ' ' LEU . 17.0 tt -134.84 125.57 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.2 t -120.21 135.84 54.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 0.0 109.444 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.7 m -95.99 148.02 33.88 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.303 -0.873 . . . . 0.0 108.821 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.04 154.9 71.49 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.239 1.96 . . . . 0.0 112.621 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.613 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.93 136.34 46.82 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.613 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 5.7 t-80 91.67 11.12 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.92 126.61 30.67 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.32 131.63 30.82 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.621 1.547 . . . . 0.0 111.449 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.566 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.94 167.66 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.132 -0.98 . . . . 0.0 110.064 -179.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.536 ' CD2' ' HB2' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -138.41 -150.07 0.32 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.269 -0.895 . . . . 0.0 109.52 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.668 ' O ' ' CD2' ' A' ' 92' ' ' PHE . 76.9 t80 -174.95 122.93 0.24 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.893 -1.129 . . . . 0.0 109.034 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.594 ' OD2' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -139.29 134.06 32.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.321 -0.862 . . . . 0.0 110.186 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.622 ' O ' ' C ' ' A' ' 145' ' ' GLY . 4.0 mtp -113.42 20.65 15.9 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.667 -0.646 . . . . 0.0 110.569 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.622 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 5.17 -83.83 0.0 OUTLIER Glycine 0 N--CA 1.503 3.13 0 CA-C-N 119.155 0.889 . . . . 0.0 111.62 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.558 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 22.2 p -87.81 118.8 27.58 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.001 -1.48 . . . . 0.0 109.019 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -112.85 109.68 52.52 Favored Pre-proline 0 C--N 1.292 -1.911 0 C-N-CA 119.514 -0.875 . . . . 0.0 109.054 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.809 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 58.3 Cg_endo -100.06 20.44 0.27 Allowed 'Trans proline' 0 C--O 1.195 -1.629 0 C-N-CA 123.147 2.565 . . . . 0.0 112.129 176.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.888 ' ND2' ' O ' ' A' ' 149' ' ' ASN . 0.0 OUTLIER 90.39 69.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 123.533 1.635 . . . . 0.0 110.14 -176.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 14.2 p90 -89.21 167.44 13.09 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 118.986 -2.322 . . . . 0.0 110.278 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.474 HG22 ' HB ' ' A' ' 107' ' ' VAL . 13.6 m -131.41 118.69 20.61 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.734 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.75 163.71 33.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.505 -0.747 . . . . 0.0 109.041 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.562 HG23 ' HE1' ' A' ' 73' ' ' TRP . 36.8 mt -110.81 131.18 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.335 -0.853 . . . . 0.0 109.914 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.569 ' NH1' ' O ' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -133.51 161.1 35.5 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.118 -0.988 . . . . 0.0 108.885 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.569 ' O ' ' NH1' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -104.1 146.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.544 -0.722 . . . . 0.0 109.087 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.448 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.7 m-30 -95.97 119.67 34.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.025 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.44 ' HB3' ' CZ2' ' A' ' 162' ' ' TRP . 24.3 t70 -134.65 160.8 36.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.845 -0.535 . . . . 0.0 109.654 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.575 ' N ' ' ND2' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -96.21 161.0 28.56 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 109.172 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.4 Cg_endo -67.89 -54.03 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.564 2.176 . . . . 0.0 111.859 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 159' ' ' PRO . 98.1 mt-10 -42.91 -20.21 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.86 -36.64 7.68 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.558 ' N ' ' O ' ' A' ' 159' ' ' PRO . 45.9 m0 -97.06 165.28 12.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.36 -1.082 . . . . 0.0 110.266 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 21.0 mm -99.1 153.5 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.306 -0.871 . . . . 0.0 109.386 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.76 -72.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.163 -0.96 . . . . 0.0 110.404 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -141.07 153.43 45.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -0.919 . . . . 0.0 109.796 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.32 -41.65 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.249 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.61 -31.29 8.54 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.42 -8.17 62.15 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -80.79 148.24 30.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.686 -1.479 . . . . 0.0 108.591 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.53 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 47.4 p30 -111.02 87.82 2.63 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 117.536 -1.666 . . . . 0.0 111.514 175.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.6 tt -78.37 -17.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 119.968 -1.707 . . . . 0.0 109.352 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 141' ' ' TRP . . . -61.68 -40.45 95.03 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.71 -0.619 . . . . 0.0 109.338 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.638 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 53.9 p -53.43 -3.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.526 ' HB3' ' CE2' ' A' ' 175' ' ' TYR . . . -80.09 -39.9 28.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.947 -1.096 . . . . 0.0 111.362 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.622 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 7.0 m-85 -111.47 24.8 0.08 OUTLIER Pre-proline 0 N--CA 1.514 2.749 0 O-C-N 120.791 -1.193 . . . . 0.0 112.482 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.638 ' HD3' ' C ' ' A' ' 173' ' ' SER . 53.8 Cg_endo -65.26 -19.62 62.23 Favored 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 123.399 2.732 . . . . 0.0 113.129 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -89.03 125.54 35.04 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.043 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.727 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 1.5 tp -88.44 118.93 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.42 -0.8 . . . . 0.0 109.236 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.566 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.624 ' O ' ' OG1' ' A' ' 19' ' ' THR . 10.5 p . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.16 171.24 8.58 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.191 -0.943 . . . . 0.0 109.142 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 4' ' ' THR . 3.4 tp -158.97 115.84 2.72 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -109.14 139.23 44.32 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.151 -0.968 . . . . 0.0 110.149 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.757 HD12 ' HB3' ' A' ' 16' ' ' TRP . 45.0 mt -132.99 132.26 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.06 165.03 20.26 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 p -84.99 174.04 10.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.149 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.62 -31.23 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.096 -1.003 . . . . 0.0 109.362 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 tttp -74.13 -37.94 63.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.184 -0.948 . . . . 0.0 110.532 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.85 124.11 14.18 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.005 -1.059 . . . . 0.0 109.537 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.78 -30.06 1.52 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.922 1.748 . . . . 0.0 112.308 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.679 ' NE2' HD22 ' A' ' 13' ' ' ASN . 5.4 pp0? -69.85 4.69 1.86 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.461 -0.774 . . . . 0.0 110.358 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.679 HD22 ' NE2' ' A' ' 12' ' ' GLN . 0.5 OUTLIER -117.83 119.12 33.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.052 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -97.67 126.17 42.85 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.135 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 15' ' ' LEU . 4.0 mm? -91.83 -8.35 46.85 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.94 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.757 ' HB3' HD12 ' A' ' 5' ' ' ILE . 33.2 t90 -157.47 103.91 1.98 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.276 -1.37 . . . . 0.0 110.587 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -117.47 109.24 16.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.536 -0.727 . . . . 0.0 109.413 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.452 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -163.89 163.95 23.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.261 -0.9 . . . . 0.0 109.724 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 19' ' ' THR . 9.9 t -131.47 90.69 2.89 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.508 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.75 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -124.5 146.94 48.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.221 -0.925 . . . . 0.0 110.479 177.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.99 -39.49 23.53 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.266 -1.521 . . . . 0.0 108.423 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -82.86 -48.57 10.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.624 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -59.94 -25.07 64.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.086 -1.009 . . . . 0.0 108.42 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.75 HD12 ' O ' ' A' ' 20' ' ' ASN . 13.0 mt -72.38 -50.81 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.025 -1.047 . . . . 0.0 108.999 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 29' ' ' ASN . 23.1 tm0? -62.06 -51.92 66.02 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.287 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.706 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 14.9 mm100 -61.21 -40.3 93.47 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.235 -0.916 . . . . 0.0 109.732 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.715 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 5.2 tt0 -75.07 -50.8 15.27 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.062 -1.024 . . . . 0.0 109.478 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 28' ' ' LEU . 17.3 tp -70.45 -56.18 7.23 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.847 -1.158 . . . . 0.0 109.832 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 11.5 t-20 -57.1 -19.9 22.34 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.776 -1.202 . . . . 0.0 109.286 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -67.5 -27.99 67.46 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.796 -1.19 . . . . 0.0 108.637 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -86.42 12.54 10.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.141 -0.974 . . . . 0.0 109.604 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.24 21.58 32.16 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.185 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.55 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 47.9 t -92.71 146.54 6.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.384 -1.068 . . . . 0.0 109.348 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.1 ttt85 -82.49 156.87 23.82 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -155.21 155.46 33.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.815 -1.178 . . . . 0.0 108.354 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.476 ' OE2' ' N ' ' A' ' 37' ' ' ARG . 1.3 mm-40 -175.42 174.73 2.27 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.051 -1.031 . . . . 0.0 109.3 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.476 ' N ' ' OE2' ' A' ' 36' ' ' GLU . 74.4 mtm-85 -151.93 112.95 4.24 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.526 ' H ' HD22 ' A' ' 129' ' ' ASN . 34.2 m0 -110.73 151.52 27.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.124 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.574 ' NE2' ' OD1' ' A' ' 129' ' ' ASN . 82.0 mm-40 -138.49 154.35 48.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.908 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.93 158.34 16.06 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -101.28 -9.09 21.53 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.2 mtp85 -92.91 155.0 17.86 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.792 0.806 . . . . 0.0 109.216 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -93.25 118.98 31.89 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.569 -0.707 . . . . 0.0 109.524 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.12 161.89 14.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.774 0.797 . . . . 0.0 109.488 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.32 -99.26 0.15 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.98 92.63 4.97 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.134 -1.215 . . . . 0.0 109.483 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.27 92.02 30.33 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.434 -0.791 . . . . 0.0 109.008 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.42 -28.27 7.07 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.314 2.01 . . . . 0.0 112.613 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.6 p -119.57 141.86 48.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.619 -0.675 . . . . 0.0 109.594 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.34 -16.71 53.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.471 -0.768 . . . . 0.0 109.432 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -50.56 -37.49 39.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 109.06 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.5 m -78.64 -33.39 47.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 109.484 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.66 -52.41 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.352 -0.843 . . . . 0.0 110.273 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.505 HG22 ' HG2' ' A' ' 58' ' ' GLN . 6.4 mt -59.21 -40.01 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.046 -1.034 . . . . 0.0 108.836 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.34 -32.13 69.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.367 -0.833 . . . . 0.0 109.479 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.416 ' O ' ' CD2' ' A' ' 59' ' ' HIS . . . -74.67 -14.59 60.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.937 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -117.14 -9.4 11.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.0 109.588 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.505 ' HG2' HG22 ' A' ' 54' ' ' ILE . 5.8 mm-40 -50.86 -39.75 54.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.102 -0.998 . . . . 0.0 109.07 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.453 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 20.0 p80 -51.71 -46.1 63.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.453 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -60.39 -59.24 5.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.988 -1.07 . . . . 0.0 109.703 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.679 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -64.48 -28.54 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.717 -1.239 . . . . 0.0 109.364 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 58' ' ' GLN . 24.7 t70 -55.56 -25.09 36.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.372 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -84.36 -37.22 21.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 109.556 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -46.73 74.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.31 -0.869 . . . . 0.0 109.497 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 69' ' ' GLY . 1.1 p -70.03 -30.45 44.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.394 -0.816 . . . . 0.0 109.633 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.54 -46.29 66.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.152 -0.967 . . . . 0.0 109.484 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -77.6 -48.92 15.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.103 -0.998 . . . . 0.0 109.647 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.653 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -85.22 13.75 6.01 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.448 -0.782 . . . . 0.0 110.16 -177.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.653 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -1.46 84.08 0.0 OUTLIER Glycine 0 N--CA 1.502 3.053 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.91 ' CG ' HG21 ' A' ' 155' ' ' ILE . 20.3 m-85 -77.06 164.53 25.64 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.21 -1.171 . . . . 0.0 109.446 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -59.85 -43.11 94.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.57 -0.706 . . . . 0.0 110.222 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.27 165.65 36.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.991 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.736 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 6.6 t-105 -135.6 139.4 43.81 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.388 -0.82 . . . . 0.0 109.165 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.461 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -160.08 178.4 9.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 152' ' ' ALA . 1.3 t -117.91 141.69 35.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 pt -100.42 116.97 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.511 ' HB3' ' O ' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -174.59 106.7 0.11 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.113 -0.992 . . . . 0.0 109.69 177.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.547 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -101.38 179.99 4.2 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 120.9 1.682 . . . . 0.0 109.052 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.547 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 9.4 tpt180 -88.81 146.25 25.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.968 -1.083 . . . . 0.0 109.386 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.9 0.38 0.15 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 109.489 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 79' ' ' ARG . 23.9 t70 -91.58 -27.13 18.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.175 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.746 HD21 ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -63.52 122.14 74.43 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 120.911 -1.118 . . . . 0.0 109.437 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -83.78 -5.07 10.69 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.159 1.906 . . . . 0.0 112.385 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -86.39 3.02 45.46 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.653 -1.28 . . . . 0.0 109.428 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.746 ' N ' HD21 ' A' ' 82' ' ' ASN . 29.3 tptt -61.08 -46.61 89.94 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.176 -0.952 . . . . 0.0 109.134 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.601 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 15.9 mm-40 -59.85 -50.04 75.33 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.758 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.53 -41.49 88.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.889 . . . . 0.0 109.475 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.08 -55.09 32.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.96 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.601 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 7.4 ptt-85 -64.26 -20.14 65.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.97 -60.57 2.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.863 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -56.28 -37.44 69.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.107 -0.996 . . . . 0.0 109.538 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -72.45 -18.7 61.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 109.719 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 93' ' ' LEU . 0.4 OUTLIER -62.33 -26.3 68.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.666 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -48.74 145.9 3.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.918 . . . . 0.0 109.928 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.502 ' OE1' HG22 ' A' ' 171' ' ' ILE . 55.1 tt0 -76.54 157.27 32.2 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.5 -0.75 . . . . 0.0 110.095 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.423 ' N ' ' CG ' ' A' ' 95' ' ' GLU . 46.0 p-80 -172.17 -170.6 0.75 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.736 -1.185 . . . . 0.0 111.978 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.8 t -163.01 137.69 6.42 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.689 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.85 155.4 20.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.545 -178.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.66 -5.56 86.3 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.459 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 23.8 tp10 -124.52 168.49 13.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.378 -1.072 . . . . 0.0 109.221 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.415 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 88.5 m-20 -74.52 143.43 44.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.117 . . . . 0.0 110.106 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' A' ' 98' ' ' HIS . 2.2 mt-10 -101.08 90.37 4.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.12 -0.987 . . . . 0.0 108.491 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.674 HG12 ' OG ' ' A' ' 133' ' ' SER . 15.7 m -85.86 130.26 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.693 -0.629 . . . . 0.0 110.138 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.712 ' NE ' HH21 ' A' ' 154' ' ' ARG . 41.0 ttm105 -131.03 128.29 40.02 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.458 -0.777 . . . . 0.0 109.598 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.498 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 36.9 t80 -106.1 129.15 54.24 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.65 129.9 36.02 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.488 -0.757 . . . . 0.0 110.395 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.4 t -115.2 -27.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.651 -0.656 . . . . 0.0 109.672 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -166.29 153.06 9.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.395 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.96 154.25 25.64 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.695 ' HB2' ' HG2' ' A' ' 127' ' ' GLU . . . -137.45 165.83 25.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.191 -1.182 . . . . 0.0 108.944 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.34 152.97 10.09 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.628 HD23 HD12 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -99.72 98.61 9.43 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.047 -1.267 . . . . 0.0 110.256 -179.135 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 114' ' ' CYS . 2.3 t80 -84.4 135.02 34.44 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.873 -1.142 . . . . 0.0 109.715 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.568 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -77.77 117.68 19.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.431 0.634 . . . . 0.0 109.815 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 122' ' ' PHE . 2.2 mt -106.71 123.11 47.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 7.0 t-160 -105.53 106.97 17.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.156 -0.965 . . . . 0.0 109.602 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.424 HG23 HG21 ' A' ' 138' ' ' THR . 3.2 mt -119.95 109.34 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.956 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.34 -144.37 31.76 Favored Glycine 0 N--CA 1.502 3.092 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -100.5 78.27 2.0 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 114.891 -2.724 . . . . 0.0 109.521 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 1.6 mt-10 -167.04 171.94 10.6 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.724 ' O ' HG23 ' A' ' 5' ' ' ILE . 78.6 t -125.14 140.76 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.076 -1.015 . . . . 0.0 109.907 177.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 115' ' ' LEU . 26.4 m-85 -122.72 128.51 50.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.7 -0.625 . . . . 0.0 110.364 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' THR . 32.6 mm-40 -119.97 104.62 10.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -100.58 133.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.628 HD12 HD23 ' A' ' 112' ' ' LEU . 1.3 tt -133.34 87.57 2.4 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.107 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.616 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 16.8 p -167.88 122.42 0.97 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.695 ' HG2' ' HB2' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -105.47 100.0 9.58 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 116.384 -2.127 . . . . 0.0 110.352 -178.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.611 ' C ' ' H ' ' A' ' 130' ' ' ASP . 1.5 mmmt -117.24 166.02 12.76 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.19 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.574 ' OD1' ' NE2' ' A' ' 39' ' ' GLN . 0.7 OUTLIER -58.62 -0.31 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.611 ' H ' ' C ' ' A' ' 128' ' ' LYS . 53.6 p-10 -69.52 139.14 53.8 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.862 -1.149 . . . . 0.0 109.819 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.583 HD13 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -91.28 123.18 34.52 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.884 0.849 . . . . 0.0 109.586 -178.112 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.583 ' N ' HD13 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -115.11 112.18 38.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.111 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.674 ' OG ' HG12 ' A' ' 103' ' ' VAL . 9.4 t -120.74 151.68 39.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.391 -0.818 . . . . 0.0 109.168 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.72 137.79 20.88 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.564 ' O ' ' OG1' ' A' ' 138' ' ' THR . 36.6 Cg_endo -61.99 154.95 58.41 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.977 1.785 . . . . 0.0 113.46 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -74.85 136.35 41.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.347 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.619 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 24.4 t60 94.77 9.21 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.564 ' OG1' ' O ' ' A' ' 135' ' ' PRO . 0.2 OUTLIER -104.48 127.39 29.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.164 179.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.7 132.03 31.45 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.64 1.56 . . . . 0.0 111.678 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.529 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.0 163.9 9.43 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.142 -179.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.566 ' O ' ' CZ ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -135.3 -148.15 0.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.122 -0.986 . . . . 0.0 109.567 -178.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.68 ' CD1' ' NH2' ' A' ' 154' ' ' ARG . 90.1 t80 -176.42 127.54 0.2 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.962 -1.087 . . . . 0.0 109.281 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.499 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 43.3 p30 -148.2 137.52 22.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -0.871 . . . . 0.0 109.785 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.593 ' O ' ' C ' ' A' ' 145' ' ' GLY . 4.2 mmt -112.59 19.09 17.82 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.451 -0.781 . . . . 0.0 111.122 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.593 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 9.78 -88.12 0.0 OUTLIER Glycine 0 N--CA 1.507 3.395 0 CA-C-N 119.155 0.889 . . . . 0.0 111.922 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.489 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 22.9 p -89.0 119.62 29.68 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.253 -1.379 . . . . 0.0 109.6 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.559 ' O ' ' CG ' ' A' ' 147' ' ' GLU . 8.4 pt-20 -109.14 117.13 54.16 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.621 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 57.2 Cg_endo -102.42 25.48 0.12 Allowed 'Trans proline' 0 N--CA 1.48 0.731 0 C-N-CA 122.361 2.041 . . . . 0.0 111.363 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 80.73 69.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.96 -177.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.511 ' O ' ' HB3' ' A' ' 77' ' ' SER . 20.9 p90 -94.68 -178.21 4.46 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.488 -0.758 . . . . 0.0 109.084 -177.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 86.1 m -148.3 95.9 2.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.543 -0.723 . . . . 0.0 109.988 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -110.47 163.5 13.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.988 -1.07 . . . . 0.0 108.787 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.736 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 25.6 mt -111.57 129.7 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.712 HH21 ' NE ' ' A' ' 104' ' ' ARG . 63.0 mtt180 -138.91 168.32 20.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 110.063 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.91 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.2 mp -105.41 147.87 10.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.642 -0.661 . . . . 0.0 109.667 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.461 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.6 m-30 -95.79 117.75 31.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.545 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.602 ' OD2' ' NE1' ' A' ' 162' ' ' TRP . 17.9 t0 -136.46 160.75 37.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.842 -0.536 . . . . 0.0 109.771 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.52 160.65 29.06 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.176 -0.953 . . . . 0.0 109.106 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.4 Cg_endo -66.56 -50.86 1.14 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.883 2.388 . . . . 0.0 112.306 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 159' ' ' PRO . 96.1 mt-10 -43.34 -20.77 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.481 -0.762 . . . . 0.0 109.073 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -87.75 -42.15 6.15 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.602 ' NE1' ' OD2' ' A' ' 157' ' ' ASP . 45.8 m0 -96.17 166.49 11.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.293 -1.122 . . . . 0.0 109.888 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.3 mm -98.23 148.39 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 109.666 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 96' ' ' HIS . . . -79.09 -71.57 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.096 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -135.42 155.89 49.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.244 -0.91 . . . . 0.0 109.659 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -101.3 -41.1 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.635 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 60.2 p -108.09 -30.43 8.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.21 -0.931 . . . . 0.0 109.198 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.75 -8.28 56.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -80.65 148.04 30.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.887 -1.36 . . . . 0.0 108.451 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.503 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 34.6 p30 -111.03 87.55 2.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.966 -1.493 . . . . 0.0 111.122 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.502 HG22 ' OE1' ' A' ' 95' ' ' GLU . 1.7 tt -78.09 -17.39 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.261 -1.524 . . . . 0.0 109.486 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.504 ' HB2' ' CD2' ' A' ' 141' ' ' TRP . . . -60.2 -41.43 92.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.636 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 59.6 p -53.51 -3.72 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 110.283 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.518 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . . . -79.25 -40.21 31.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.004 . . . . 0.0 111.279 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.612 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 5.8 m-85 -112.63 24.96 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.623 0 O-C-N 120.575 -1.328 . . . . 0.0 112.471 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.636 ' HD3' ' C ' ' A' ' 173' ' ' SER . 44.3 Cg_endo -62.16 -18.82 64.14 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 123.71 2.94 . . . . 0.0 113.75 -172.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.0 ttm-85 -89.11 125.85 35.2 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.363 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.489 ' HB3' ' H ' ' A' ' 146' ' ' SER . 4.5 tt -88.38 123.44 32.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.213 -0.929 . . . . 0.0 109.194 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.298 -1.656 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.395 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.838 ' O ' HG23 ' A' ' 19' ' ' THR . 6.4 p . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.96 171.06 8.52 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.881 -1.137 . . . . 0.0 109.053 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 4' ' ' THR . 3.2 tp -158.99 116.94 2.85 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.674 ' OG1' HD11 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -109.83 133.47 53.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.64 -178.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.688 HD12 ' HB3' ' A' ' 16' ' ' TRP . 5.7 mt -128.16 134.83 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -126.59 168.02 14.86 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m -85.23 174.24 9.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.234 -0.916 . . . . 0.0 108.981 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -28.3 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.954 -1.091 . . . . 0.0 109.415 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -76.69 -34.7 58.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.55 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.39 124.08 14.69 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.202 -0.936 . . . . 0.0 109.429 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.55 -36.85 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.119 1.879 . . . . 0.0 112.347 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.53 3.99 2.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 110.235 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -111.9 119.05 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.418 -0.801 . . . . 0.0 109.211 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -99.41 120.97 40.46 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.379 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 15' ' ' LEU . 11.0 mp -91.32 -4.01 56.25 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.171 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.688 ' HB3' HD12 ' A' ' 5' ' ' ILE . 41.8 t90 -156.8 104.44 2.13 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 118.433 -1.307 . . . . 0.0 110.542 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -119.07 112.18 19.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.541 -0.725 . . . . 0.0 109.57 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.555 ' OG ' ' CH2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -161.45 163.7 30.26 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.262 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.838 HG23 ' O ' ' A' ' 1' ' ' SER . 45.4 m -131.38 89.56 2.74 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.938 -1.102 . . . . 0.0 108.35 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.762 ' O ' HD12 ' A' ' 24' ' ' ILE . 31.0 m120 -127.83 142.23 51.35 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.425 -0.797 . . . . 0.0 110.37 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.13 -37.86 23.17 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.303 -1.498 . . . . 0.0 108.337 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -83.67 -50.64 7.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.855 . . . . 0.0 109.751 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.46 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.2 tt0 -59.13 -21.73 59.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.107 -0.996 . . . . 0.0 108.754 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.762 HD12 ' O ' ' A' ' 20' ' ' ASN . 11.2 mt -76.09 -49.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.13 -0.981 . . . . 0.0 109.207 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.749 HE21 ' ND2' ' A' ' 29' ' ' ASN . 24.4 tm0? -59.68 -44.8 93.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.777 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -70.78 -38.58 73.42 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.243 -0.91 . . . . 0.0 109.344 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.657 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 6.5 tt0 -77.0 -49.81 14.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 110.252 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 33' ' ' VAL . 12.2 tp -62.07 -54.52 40.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.015 -1.053 . . . . 0.0 108.857 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.749 ' ND2' HE21 ' A' ' 25' ' ' GLN . 1.1 m-20 -61.95 -16.45 51.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.905 -1.122 . . . . 0.0 109.856 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 27' ' ' GLN . . . -62.77 -30.07 71.17 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.63 -1.294 . . . . 0.0 108.845 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.96 11.09 12.23 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.009 -1.076 . . . . 0.0 109.558 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.46 25.01 31.84 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.513 HG21 HD11 ' A' ' 28' ' ' LEU . 75.2 t -95.47 145.99 7.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 122.018 0.913 . . . . 0.0 109.471 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -84.32 156.87 21.7 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 121.346 -0.846 . . . . 0.0 108.855 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.594 ' CB ' HD21 ' A' ' 29' ' ' ASN . 1.8 t80 -154.12 149.63 27.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.913 -1.117 . . . . 0.0 109.041 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -169.79 167.78 9.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.006 -1.059 . . . . 0.0 109.866 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.474 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 18.8 ptt-85 -151.82 115.91 4.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.425 -0.797 . . . . 0.0 109.139 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.507 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 11.7 m0 -113.22 157.31 21.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.17 166.39 25.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.678 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.93 162.19 13.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.366 -0.834 . . . . 0.0 108.932 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -94.49 -26.02 16.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.123 -0.986 . . . . 0.0 108.695 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -94.85 172.98 7.83 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -89.86 131.59 35.71 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.368 -0.833 . . . . 0.0 108.993 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.4 mt -92.97 167.95 11.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.239 -0.913 . . . . 0.0 109.812 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.78 -94.28 0.11 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.45 107.47 7.6 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.33 -1.1 . . . . 0.0 108.166 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.4 90.44 45.31 Favored Pre-proline 0 C--N 1.302 -1.494 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.677 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -83.71 40.92 0.96 Allowed 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.795 2.33 . . . . 0.0 111.221 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 52' ' ' THR . 19.1 m -166.24 138.11 3.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.61 -1.306 . . . . 0.0 109.457 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 52' ' ' THR . . . -82.64 -51.78 7.42 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.905 -1.122 . . . . 0.0 110.262 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.15 -0.68 1.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.422 -0.799 . . . . 0.0 109.75 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -77.08 -56.82 4.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 109.806 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.486 ' N ' HG22 ' A' ' 52' ' ' THR . 49.0 t -64.19 -45.53 96.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 O-C-N 121.137 -0.977 . . . . 0.0 109.579 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.4 mt -59.82 -41.07 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.274 -0.97 . . . . 0.0 108.807 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.87 -24.16 67.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.351 -0.843 . . . . 0.0 109.788 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.04 -21.48 56.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.047 -1.033 . . . . 0.0 110.323 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 58' ' ' GLN . 57.0 m-85 -112.28 -6.54 14.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.384 -0.822 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.625 HE22 HD11 ' A' ' 61' ' ' ILE . 5.5 mm-40 -45.85 -39.05 8.02 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.743 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -50.81 -48.04 59.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.909 -1.116 . . . . 0.0 109.634 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.607 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.37 -60.77 3.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.01 -1.056 . . . . 0.0 110.309 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.654 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -62.6 -29.71 47.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 120.751 -1.218 . . . . 0.0 109.184 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 58' ' ' GLN . 45.5 t0 -54.85 -27.62 43.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.805 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -77.82 -37.41 48.68 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.018 -1.051 . . . . 0.0 109.812 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.6 mp -63.98 -39.22 93.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.126 -0.984 . . . . 0.0 109.865 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.51 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -69.24 -29.06 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 0.0 108.924 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.02 -54.12 47.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.474 -1.391 . . . . 0.0 109.297 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.42 -52.47 5.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.254 -0.904 . . . . 0.0 110.954 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.624 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -86.86 14.53 7.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 110.596 -177.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -15.54 89.31 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.525 ' CG ' HG21 ' A' ' 155' ' ' ILE . 87.4 m-85 -77.58 164.78 25.05 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -58.56 -88.01 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 109.949 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.52 ' OG ' ' CG ' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -101.26 159.72 15.01 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.568 -0.707 . . . . 0.0 109.618 -179.064 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.497 ' HE1' HG23 ' A' ' 153' ' ' ILE . 6.5 t-105 -136.29 140.04 43.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.496 -0.753 . . . . 0.0 109.139 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.1 -173.47 2.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 108.775 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.677 HG12 ' HA ' ' A' ' 153' ' ' ILE . 1.9 m -122.99 148.45 26.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.513 -0.742 . . . . 0.0 109.587 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.574 HG23 ' O ' ' A' ' 76' ' ' ILE . 2.8 tt -100.89 118.09 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 150' ' ' PHE . 91.8 p -171.83 103.79 0.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.604 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.556 ' CD1' ' H ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -105.39 -178.38 3.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 121.078 1.763 . . . . 0.0 108.209 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.556 ' H ' ' CD1' ' A' ' 78' ' ' LEU . 8.2 tpt180 -89.45 148.77 23.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.891 -1.131 . . . . 0.0 109.528 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.41 3.91 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.615 -0.678 . . . . 0.0 109.641 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 79' ' ' ARG . 80.5 m-20 -92.16 -24.11 19.19 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.922 -1.111 . . . . 0.0 109.34 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.672 HD21 ' NZ ' ' A' ' 85' ' ' LYS . 27.7 p-10 -60.63 118.07 31.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.83 -1.169 . . . . 0.0 109.586 -178.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -88.57 -23.77 0.98 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.241 1.96 . . . . 0.0 112.501 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -91.93 -14.8 28.97 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.919 -1.113 . . . . 0.0 109.945 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.672 ' NZ ' HD21 ' A' ' 82' ' ' ASN . 0.0 OUTLIER -60.89 -35.75 77.44 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.794 178.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 96.9 mt-10 -57.17 -40.57 77.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.133 -0.979 . . . . 0.0 108.491 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.41 -27.29 68.43 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.792 -1.193 . . . . 0.0 109.154 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.6 tp -60.67 -47.61 85.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -0.948 . . . . 0.0 109.989 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -64.58 -27.66 69.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.108 -0.995 . . . . 0.0 109.285 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.07 -60.74 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.394 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -58.33 -35.07 71.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.08 -1.013 . . . . 0.0 109.19 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -79.77 -18.35 51.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.414 -0.803 . . . . 0.0 109.956 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 94' ' ' ASN . 0.3 OUTLIER -60.75 -26.49 67.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.49 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.483 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 32.5 p-10 -46.27 135.22 8.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.293 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.68 159.33 13.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 0.0 109.871 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -171.9 -169.73 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.763 -1.175 . . . . 0.0 111.965 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.81 130.98 4.47 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.549 0.69 . . . . 0.0 109.364 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.621 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -100.67 154.37 18.65 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.625 -0.672 . . . . 0.0 109.716 -179.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.11 -7.98 87.52 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -123.4 170.98 9.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -1.112 . . . . 0.0 109.286 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -74.07 143.06 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.973 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.599 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 5.0 tt0 -103.49 90.02 3.55 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.947 HG22 ' OG ' ' A' ' 133' ' ' SER . 26.1 t -85.7 127.06 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.286 -0.884 . . . . 0.0 109.714 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 115.49 17.29 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.501 -0.749 . . . . 0.0 109.617 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.65 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 10.9 t80 -99.94 132.19 45.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 108.612 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.723 ' CD2' ' HB2' ' A' ' 110' ' ' ALA . 0.8 OUTLIER -91.08 135.47 33.74 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.364 0.602 . . . . 0.0 109.939 -179.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.0 t -116.84 -26.97 2.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.371 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 109' ' ' GLY . 73.7 tt0 -169.12 158.02 8.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.155 -0.965 . . . . 0.0 108.949 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 108' ' ' GLU . . . 48.37 107.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.723 ' HB2' ' CD2' ' A' ' 106' ' ' PHE . . . -151.8 112.33 4.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.649 -1.501 . . . . 0.0 109.574 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.93 -141.97 4.36 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.502 HD22 HD23 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -108.9 100.42 9.63 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.329 -1.101 . . . . 0.0 110.851 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.659 ' CD2' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.47 132.12 36.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.934 -1.104 . . . . 0.0 110.043 -178.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 9.8 m -78.46 154.7 30.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.554 -0.716 . . . . 0.0 110.148 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 122' ' ' PHE . 1.1 tp -145.28 121.0 10.51 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.5 t-160 -111.48 111.15 21.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.224 -0.923 . . . . 0.0 109.677 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.46 113.85 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.744 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.49 -145.14 35.3 Favored Glycine 0 N--CA 1.503 3.15 0 N-CA-C 106.146 -2.782 . . . . 0.0 106.146 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -100.73 77.74 1.91 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 114.581 -2.848 . . . . 0.0 109.688 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.59 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 1.5 mt-10 -166.6 170.0 13.09 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 120.949 -1.095 . . . . 0.0 108.064 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 5' ' ' ILE . 50.7 t -126.56 140.34 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.573 ' O ' ' N ' ' A' ' 115' ' ' LEU . 2.3 m-85 -126.95 130.71 50.61 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.601 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -131.23 110.14 10.91 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.444 -0.785 . . . . 0.0 109.134 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -98.52 138.22 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.727 ' H ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.8 88.13 2.68 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.425 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.522 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 5.2 p -167.89 136.11 2.37 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.291 -1.506 . . . . 0.0 107.216 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -104.42 96.8 6.86 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 115.292 -2.563 . . . . 0.0 110.05 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.586 ' C ' ' H ' ' A' ' 130' ' ' ASP . 24.5 mmtt -116.75 157.48 25.43 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.324 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.65 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 40.3 m-80 -58.38 -2.11 0.18 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.586 ' H ' ' C ' ' A' ' 128' ' ' LYS . 17.2 m-20 -70.47 147.32 49.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.108 -0.995 . . . . 0.0 109.303 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.754 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.8 OUTLIER -111.31 154.66 24.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.605 0.717 . . . . 0.0 110.448 -179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.754 ' N ' HD12 ' A' ' 131' ' ' LEU . 29.1 mm -116.65 118.73 59.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.947 ' OG ' HG22 ' A' ' 103' ' ' VAL . 0.3 OUTLIER -111.03 129.82 55.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.545 -0.722 . . . . 0.0 109.285 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.48 141.75 23.19 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.06 153.66 71.79 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.058 1.839 . . . . 0.0 112.347 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.623 ' O ' ' CG ' ' A' ' 137' ' ' HIS . . . -71.06 135.45 47.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -0.85 . . . . 0.0 108.895 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.623 ' CG ' ' O ' ' A' ' 136' ' ' ALA . 2.6 m170 89.83 14.95 0.05 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.094 0.473 . . . . 0.0 110.004 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.39 127.21 28.66 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.53 131.65 32.53 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.924 1.749 . . . . 0.0 111.513 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.08 163.09 9.19 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.245 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.516 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -134.52 -148.7 0.32 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.933 . . . . 0.0 109.542 -178.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.78 126.45 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.937 -1.102 . . . . 0.0 109.196 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.479 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 37.2 p-10 -144.58 134.28 23.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.429 -0.794 . . . . 0.0 109.686 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.671 ' SD ' ' N ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -112.96 19.13 17.55 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.614 -0.679 . . . . 0.0 110.44 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 13.18 -93.13 0.01 OUTLIER Glycine 0 N--CA 1.501 3.02 0 CA-C-N 119.216 0.916 . . . . 0.0 111.663 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.447 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 19.4 p -84.53 119.56 25.32 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.259 -1.376 . . . . 0.0 108.924 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -113.71 112.23 48.27 Favored Pre-proline 0 C--N 1.294 -1.847 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.093 178.447 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.8 Cg_endo -103.52 34.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 123.326 2.684 . . . . 0.0 111.542 176.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 81.56 69.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.529 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 9.0 p90 -95.67 135.89 36.78 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.064 -1.023 . . . . 0.0 109.944 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.7 m -97.73 119.72 36.82 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.779 -0.575 . . . . 0.0 109.686 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.45 159.96 41.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 109.266 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.677 ' HA ' HG12 ' A' ' 75' ' ' VAL . 96.1 mt -108.69 125.97 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.513 -0.742 . . . . 0.0 110.086 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.552 ' C ' HD13 ' A' ' 155' ' ' ILE . 62.9 mtp180 -132.5 160.72 35.69 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.575 -0.703 . . . . 0.0 109.713 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -108.39 156.91 8.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.416 0.627 . . . . 0.0 109.478 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.52 ' CG ' ' OG ' ' A' ' 72' ' ' SER . 4.5 m-85 -100.51 119.75 38.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.053 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 12.2 p30 -134.55 159.22 41.85 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -98.32 146.76 32.1 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.985 -1.072 . . . . 0.0 109.494 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.618 ' O ' ' N ' ' A' ' 161' ' ' GLY . 47.3 Cg_endo -71.37 -52.61 0.21 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.355 2.037 . . . . 0.0 112.048 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -43.54 -14.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.605 -0.685 . . . . 0.0 109.403 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.49 -32.17 38.87 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.634 ' N ' ' CD1' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -118.71 176.09 5.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.599 -0.942 . . . . 0.0 110.469 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 70.8 mt -94.2 145.75 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.306 -0.871 . . . . 0.0 109.277 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.27 -73.14 0.31 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.372 -0.83 . . . . 0.0 110.643 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -120.91 151.15 40.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.367 -0.833 . . . . 0.0 109.854 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.467 ' CD2' ' N ' ' A' ' 166' ' ' PHE . 2.7 p90 -101.54 -40.43 7.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.564 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 m -110.2 -31.15 7.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.315 -0.866 . . . . 0.0 108.977 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.68 -4.94 53.9 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.421 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -82.76 148.67 27.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.749 -1.442 . . . . 0.0 108.926 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.482 ' OD1' ' OG ' ' A' ' 173' ' ' SER . 60.9 t0 -109.83 89.13 2.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 117.925 -1.51 . . . . 0.0 111.058 176.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 171' ' ' ILE . 0.7 OUTLIER -76.09 -22.38 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.489 -1.382 . . . . 0.0 109.366 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -60.36 -40.55 91.19 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.662 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 24.1 m -51.17 -3.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 110.19 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.573 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . . . -77.4 -41.52 39.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.789 -1.194 . . . . 0.0 111.629 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.631 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 1.0 OUTLIER -112.83 25.24 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.607 0 O-C-N 120.772 -1.205 . . . . 0.0 112.27 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.662 ' HD3' ' C ' ' A' ' 173' ' ' SER . 49.6 Cg_endo -62.41 -22.66 74.36 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.722 2.948 . . . . 0.0 113.522 -172.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 177' ' ' ARG . 28.3 ptt85 -89.42 126.45 35.56 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.003 -1.079 . . . . 0.0 108.885 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.73 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.6 OUTLIER -87.78 118.68 27.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.262 -0.899 . . . . 0.0 109.022 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.534 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.849 ' O ' HG23 ' A' ' 19' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.119 0.485 . . . . 0.0 109.703 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 125' ' ' LEU . . . -95.89 171.09 8.85 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.959 -1.097 . . . . 0.0 109.288 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.95 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 18.7 tp -157.83 109.36 2.28 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.79 127.09 53.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.51 -0.744 . . . . 0.0 110.523 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.664 HD12 ' HB3' ' A' ' 16' ' ' TRP . 51.2 mt -120.87 135.62 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.27 169.75 15.02 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.8 p -87.47 173.05 9.34 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.0 -33.37 6.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.084 -1.01 . . . . 0.0 108.874 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -71.72 -37.47 70.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.53 -0.731 . . . . 0.0 110.384 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.14 125.25 14.58 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.98 -1.075 . . . . 0.0 109.634 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -82.26 -30.21 1.28 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.892 1.728 . . . . 0.0 112.266 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -70.22 0.74 5.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.41 -0.806 . . . . 0.0 110.662 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.769 HD21 HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.7 118.69 34.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.024 -1.047 . . . . 0.0 108.497 179.168 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -97.13 125.42 41.62 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.846 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.769 HD13 HD21 ' A' ' 13' ' ' ASN . 2.6 mp -90.46 -12.25 37.91 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.497 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.95 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 34.7 t90 -159.73 107.41 1.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.222 -1.391 . . . . 0.0 109.939 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -121.09 119.43 32.42 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.09 -1.006 . . . . 0.0 110.332 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.454 ' OG ' ' CZ2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -161.02 166.68 27.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.266 -0.897 . . . . 0.0 110.155 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.849 HG23 ' O ' ' A' ' 1' ' ' SER . 45.8 m -129.21 86.42 2.43 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.634 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -129.45 138.96 51.73 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.794 -0.566 . . . . 0.0 110.369 177.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.75 -28.59 30.31 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.592 -1.942 . . . . 0.0 108.905 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -82.95 -53.3 5.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -62.28 -18.76 62.16 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.66 -1.275 . . . . 0.0 107.984 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.728 HG12 HD22 ' A' ' 3' ' ' LEU . 3.0 mt -73.28 -59.14 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.344 -0.847 . . . . 0.0 109.375 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.486 ' N ' HG22 ' A' ' 24' ' ' ILE . 21.2 pt20 -58.34 -39.16 78.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.416 ' N ' ' HG3' ' A' ' 25' ' ' GLN . 44.1 tt0 -66.99 -42.64 84.69 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.332 -0.855 . . . . 0.0 109.47 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.687 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -67.2 -46.83 72.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.101 -1.0 . . . . 0.0 109.524 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 28' ' ' LEU . 3.7 mm? -65.95 -53.56 37.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.327 -0.858 . . . . 0.0 109.447 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 17.9 t-20 -64.16 -19.0 65.0 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.58 -0.7 . . . . 0.0 110.573 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.15 71.17 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.535 -1.353 . . . . 0.0 108.164 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -89.38 14.81 10.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.598 -0.689 . . . . 0.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.68 20.38 58.28 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.434 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 21.9 t -93.3 147.09 5.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.277 -1.131 . . . . 0.0 109.078 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.684 ' HE ' ' H ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -83.09 155.59 23.77 Favored 'General case' 0 C--N 1.281 -2.378 0 O-C-N 120.644 -1.285 . . . . 0.0 107.833 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.684 ' H ' ' HE ' ' A' ' 34' ' ' ARG . 2.3 t80 -152.87 147.09 25.59 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 17.0 tp10 -174.35 172.65 3.16 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.592 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.466 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 30.7 ptt-85 -151.95 121.86 7.06 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.115 -0.991 . . . . 0.0 108.732 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.465 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 33.7 m0 -112.75 156.43 22.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.512 -0.742 . . . . 0.0 109.141 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -142.64 157.64 44.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.293 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.71 159.06 15.34 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -98.66 -13.6 20.23 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -93.74 156.97 16.39 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.495 ' O ' ' OD2' ' A' ' 43' ' ' ASP . 46.4 p-10 -95.52 122.23 38.05 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.473 -0.767 . . . . 0.0 109.384 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.8 mt -91.8 165.83 13.07 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.176 -0.952 . . . . 0.0 108.95 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.95 -121.92 0.58 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.13 79.45 9.12 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.086 -1.244 . . . . 0.0 108.497 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.62 93.89 46.65 Favored Pre-proline 0 C--N 1.306 -1.317 0 O-C-N 121.462 -0.773 . . . . 0.0 109.56 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.745 ' O ' HG23 ' A' ' 49' ' ' THR . 46.9 Cg_endo -70.2 85.61 0.67 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.084 1.856 . . . . 0.0 111.505 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 48' ' ' PRO . 1.5 p -165.05 117.93 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -0.863 . . . . 0.0 109.019 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.43 -36.84 28.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.836 -1.165 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -69.3 -14.92 63.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.943 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 49' ' ' THR . 4.2 p -78.25 -43.67 27.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.051 -1.031 . . . . 0.0 110.89 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 t -67.13 -46.44 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.938 -1.101 . . . . 0.0 109.564 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 58' ' ' GLN . 55.7 mt -61.2 -39.58 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.282 -0.886 . . . . 0.0 108.888 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.22 70.66 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.678 -0.639 . . . . 0.0 109.905 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.85 -21.61 54.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.067 -1.021 . . . . 0.0 110.376 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -114.44 -7.09 12.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.489 -0.757 . . . . 0.0 109.13 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.655 HE21 ' CG1' ' A' ' 61' ' ' ILE . 38.1 tp60 -48.59 -36.93 16.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.242 -0.911 . . . . 0.0 108.546 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.685 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -53.25 -48.84 67.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.043 -1.035 . . . . 0.0 109.941 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.685 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.06 -55.43 32.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.728 -1.232 . . . . 0.0 109.669 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.655 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.5 OUTLIER -65.71 -26.91 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.083 -1.01 . . . . 0.0 109.543 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 58' ' ' GLN . 20.7 t70 -59.2 -25.2 63.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.461 -0.774 . . . . 0.0 109.224 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.7 -43.29 14.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 110.016 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 tt -65.6 -48.46 72.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.307 -0.87 . . . . 0.0 109.819 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' GLY . 3.4 p -66.91 -28.25 42.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.43 -44.21 76.06 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.791 -1.193 . . . . 0.0 109.279 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -80.02 -52.86 7.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.999 -1.063 . . . . 0.0 109.714 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.623 ' O ' ' C ' ' A' ' 69' ' ' GLY . 54.0 mttm -83.08 12.67 4.79 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.401 -0.812 . . . . 0.0 110.685 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -5.63 83.21 0.0 OUTLIER Glycine 0 N--CA 1.506 3.304 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.838 ' CG ' HG21 ' A' ' 155' ' ' ILE . 69.6 m-85 -75.66 156.6 34.66 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.433 -1.039 . . . . 0.0 109.88 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -64.82 -49.59 70.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.486 -0.759 . . . . 0.0 110.574 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.9 m -125.27 135.49 52.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.356 -0.84 . . . . 0.0 109.729 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.482 ' CZ2' HD13 ' A' ' 61' ' ' ILE . 7.4 t-105 -133.57 138.98 46.29 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.4 -168.87 0.56 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.155 -0.965 . . . . 0.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 152' ' ' ALA . 1.5 t -125.99 155.91 35.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.3 mt -93.88 131.82 39.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.5 p -93.55 167.77 11.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 122.769 1.271 . . . . 0.0 111.839 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.586 HD23 ' H ' ' A' ' 149' ' ' ASN . 10.1 tp -167.78 157.6 10.25 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.497 176.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HD3' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -128.99 142.18 51.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.412 ' H ' ' HD3' ' A' ' 79' ' ' ARG . . . -67.35 -4.79 11.9 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.216 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.426 ' OD2' ' C ' ' A' ' 81' ' ' ASP . 8.5 p-10 -116.64 -8.02 11.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.197 -0.939 . . . . 0.0 109.087 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.468 ' CG ' ' O ' ' A' ' 82' ' ' ASN . 1.6 p30 -62.88 124.72 84.56 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 109.801 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.36 -2.37 12.25 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.291 1.994 . . . . 0.0 111.954 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -90.19 3.75 52.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.976 . . . . 0.0 109.832 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 19.4 pttp -60.31 -51.25 70.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.159 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.579 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 46.1 tp10 -65.45 -43.16 91.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.882 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.99 -43.48 98.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.855 . . . . 0.0 109.981 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.2 tp -59.46 -45.61 91.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 109.171 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.579 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 17.1 ttp-105 -63.0 -28.59 70.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.555 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HA ' HD23 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -65.93 -60.55 2.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.806 . . . . 0.0 109.377 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -55.88 -31.57 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 109.461 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.06 -18.18 50.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.16 -0.963 . . . . 0.0 110.037 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -64.67 -27.54 68.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -1.0 . . . . 0.0 110.031 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -60.45 136.97 58.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.07 -1.019 . . . . 0.0 110.233 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 169' ' ' ASP . 20.7 pt-20 -73.95 164.07 27.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.394 -0.816 . . . . 0.0 109.186 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -172.54 -167.52 0.46 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.008 -1.058 . . . . 0.0 110.463 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.96 133.17 5.95 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.6 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -103.63 153.47 20.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 109.804 -179.181 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.22 -7.07 86.8 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -125.28 170.93 10.81 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.285 -1.126 . . . . 0.0 109.53 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -71.64 143.02 49.92 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.117 -0.989 . . . . 0.0 109.821 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.6 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 3.3 tt0 -104.16 97.91 7.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 110.034 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.719 HG22 ' OG ' ' A' ' 133' ' ' SER . 5.4 t -97.41 124.71 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.18 126.56 43.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.47 -0.769 . . . . 0.0 109.236 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 33.4 t80 -108.31 129.3 55.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.835 0.826 . . . . 0.0 109.008 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -80.85 117.05 21.16 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.566 -0.709 . . . . 0.0 110.353 -178.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.5 t -85.14 -47.54 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -0.822 . . . . 0.0 110.346 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -169.27 158.1 7.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.915 -1.116 . . . . 0.0 110.545 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.61 61.56 4.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.778 ' HB3' ' HB3' ' A' ' 127' ' ' GLU . . . -119.58 129.9 54.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.877 -1.367 . . . . 0.0 108.446 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -118.57 -29.92 1.79 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.004 HD12 ' N ' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -141.66 160.13 40.79 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.387 -1.066 . . . . 0.0 109.748 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 1.004 ' N ' HD12 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -139.35 95.51 2.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.715 ' O ' HD22 ' A' ' 115' ' ' LEU . 1.8 m -77.78 136.43 38.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.42 -0.8 . . . . 0.0 110.318 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.715 HD22 ' O ' ' A' ' 114' ' ' CYS . 0.3 OUTLIER -145.64 114.19 6.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.409 -0.807 . . . . 0.0 109.734 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 6.8 t-160 -106.73 110.55 22.76 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.901 -1.124 . . . . 0.0 109.342 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.3 mm -128.61 121.53 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.469 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.15 -143.82 36.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 103.682 -3.767 . . . . 0.0 103.682 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.492 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 44.7 p30 -111.0 82.67 1.63 Allowed 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 115.417 -2.513 . . . . 0.0 108.369 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.506 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 60.0 tt0 -164.76 167.69 18.67 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 5' ' ' ILE . 71.0 t -128.5 140.25 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.986 -1.071 . . . . 0.0 110.085 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -125.57 132.25 52.58 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.928 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -142.05 122.13 13.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.069 -1.02 . . . . 0.0 109.029 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -106.74 147.09 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.241 -0.912 . . . . 0.0 109.191 179.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 12.9 mt -118.44 78.33 1.25 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 117.848 -1.541 . . . . 0.0 111.586 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.446 ' SG ' ' N ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -166.79 163.65 16.46 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 103.3 -2.852 . . . . 0.0 103.3 177.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.778 ' HB3' ' HB3' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -117.78 110.74 18.18 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 122.59 2.45 . . . . 0.0 106.312 176.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.595 ' C ' ' H ' ' A' ' 130' ' ' ASP . 13.0 mmtt -113.61 148.51 36.08 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.603 -0.686 . . . . 0.0 111.114 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.579 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 93.5 m-20 -61.12 -0.19 0.31 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.595 ' H ' ' C ' ' A' ' 128' ' ' LYS . 49.2 p30 -70.28 153.06 43.48 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.222 1.011 . . . . 0.0 110.903 -176.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.771 ' C ' HD12 ' A' ' 131' ' ' LEU . 0.9 OUTLIER -125.76 161.87 26.37 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.856 0.836 . . . . 0.0 110.972 -178.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.77 ' N ' HD12 ' A' ' 131' ' ' LEU . 1.6 mp -128.43 145.41 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.669 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.719 ' OG ' HG22 ' A' ' 103' ' ' VAL . 2.6 t -119.12 138.08 53.15 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.308 -0.87 . . . . 0.0 109.789 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -112.14 140.06 23.13 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.33 150.83 59.33 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.099 1.866 . . . . 0.0 112.328 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -72.48 132.57 44.04 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.815 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 12.5 t60 94.53 9.86 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.39 126.94 30.12 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 108.46 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.41 132.59 31.82 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.541 1.494 . . . . 0.0 111.463 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.516 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -166.61 162.84 16.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.315 -0.866 . . . . 0.0 110.177 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.672 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 21.6 p90 -127.22 -154.37 0.63 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.505 -0.747 . . . . 0.0 109.818 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.672 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 47.4 t80 -169.71 119.79 0.65 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.491 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 34.3 p30 -139.52 119.64 13.63 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.28 -0.887 . . . . 0.0 108.692 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.566 ' SD ' ' CZ ' ' A' ' 150' ' ' PHE . 25.9 mtm -93.31 16.59 12.91 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 111.491 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.806 ' HA3' HD13 ' A' ' 178' ' ' LEU . . . 50.24 -144.3 10.93 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.587 ' H ' HD22 ' A' ' 178' ' ' LEU . 31.6 t -83.29 121.04 26.6 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.0 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -116.27 120.42 35.05 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.88 -0.512 . . . . 0.0 110.536 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 59.3 Cg_endo -102.87 59.41 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.807 0 C-N-CA 122.378 2.052 . . . . 0.0 110.65 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.586 ' H ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER 82.48 64.26 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.304 -0.873 . . . . 0.0 109.691 -177.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.566 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 1.0 OUTLIER -101.42 168.19 9.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.7 m -127.1 133.19 50.46 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.43 -0.794 . . . . 0.0 109.281 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -138.16 157.35 46.48 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.031 -1.043 . . . . 0.0 109.591 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.3 mt -108.32 124.91 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.062 -1.024 . . . . 0.0 108.985 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.16 164.49 27.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.414 -0.804 . . . . 0.0 109.346 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.838 HG21 ' CG ' ' A' ' 70' ' ' TYR . 2.9 mt -119.24 124.46 73.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.46 ' N ' ' CD1' ' A' ' 156' ' ' PHE . 26.5 m-85 -93.87 133.39 37.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.983 -1.073 . . . . 0.0 110.241 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.62 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -129.84 165.57 21.72 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.644 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -91.2 160.63 36.98 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.935 -1.103 . . . . 0.0 108.625 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 161' ' ' GLY . 36.1 Cg_endo -57.02 -54.28 3.88 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.678 2.252 . . . . 0.0 113.12 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 159' ' ' PRO . 11.8 pt-20 -42.27 -23.17 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.506 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.27 -56.07 2.1 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.644 ' CD1' ' O ' ' A' ' 158' ' ' ASN . 39.0 p-90 -98.86 155.97 17.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.121 -1.223 . . . . 0.0 110.633 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 14.8 tt -103.88 159.08 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.497 -0.752 . . . . 0.0 109.184 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.97 -71.73 0.24 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.37 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -139.82 158.63 43.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.014 -1.054 . . . . 0.0 110.242 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -101.09 -41.87 6.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.162 -0.961 . . . . 0.0 109.704 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.6 m -115.92 -34.21 4.84 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.93 -3.95 57.38 Favored Glycine 0 N--CA 1.484 1.863 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.812 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.422 ' O ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -81.7 148.11 29.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.08 -1.835 . . . . 0.0 107.957 178.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -112.35 91.16 3.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.089 -1.444 . . . . 0.0 111.104 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.419 HD11 ' HZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -75.3 -20.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.113 -1.617 . . . . 0.0 108.799 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.624 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -61.34 -39.91 92.3 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.549 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -51.4 -3.85 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.827 -0.546 . . . . 0.0 110.698 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.36 -36.34 34.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.915 -1.116 . . . . 0.0 111.053 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.612 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.5 OUTLIER -111.49 20.09 0.07 OUTLIER Pre-proline 0 N--CA 1.511 2.595 0 O-C-N 120.708 -1.245 . . . . 0.0 113.993 -178.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 51.8 Cg_endo -65.48 -23.62 57.6 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.961 2.441 . . . . 0.0 114.636 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -87.81 126.54 35.07 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.268 -1.373 . . . . 0.0 108.41 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.806 HD13 ' HA3' ' A' ' 145' ' ' GLY . 9.4 tp -85.41 145.2 27.58 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 108.779 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.168 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.584 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.29 168.22 10.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.071 -1.018 . . . . 0.0 109.313 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 4' ' ' THR . 2.6 tp -156.48 125.49 6.01 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.761 ' OG1' HD21 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -121.73 126.62 49.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.205 -0.935 . . . . 0.0 109.633 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.444 HG23 ' CD2' ' A' ' 122' ' ' PHE . 28.1 mt -117.43 140.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.794 ' CZ ' ' O ' ' A' ' 7' ' ' SER . 1.2 t80 -144.41 156.19 44.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.794 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 50.7 p -89.57 179.76 5.97 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.984 -1.073 . . . . 0.0 108.132 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 8' ' ' VAL . 18.7 m -88.19 3.21 5.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 119.975 -1.703 . . . . 0.0 110.149 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.406 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 1.4 mmmt -76.81 -49.57 15.53 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 120.509 -1.369 . . . . 0.0 114.13 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.787 ' O ' ' CE1' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -145.26 123.7 6.59 Favored Pre-proline 0 N--CA 1.507 2.404 0 O-C-N 119.96 -1.712 . . . . 0.0 109.546 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.71 -33.96 26.21 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.324 1.349 . . . . 0.0 113.413 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.616 ' C ' HD22 ' A' ' 13' ' ' ASN . 0.2 OUTLIER -70.43 6.15 1.5 Allowed 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.281 -0.887 . . . . 0.0 110.127 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.616 HD22 ' C ' ' A' ' 12' ' ' GLN . 4.2 m120 -125.74 124.64 41.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.152 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.477 ' C ' HD12 ' A' ' 15' ' ' LEU . 92.6 p -113.44 133.44 55.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.46 -0.775 . . . . 0.0 108.931 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.842 ' N ' HD12 ' A' ' 15' ' ' LEU . 6.3 mp -94.19 5.41 51.81 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.105 -0.997 . . . . 0.0 109.881 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.483 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 23.8 t90 -153.91 102.08 2.48 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.788 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -117.99 107.43 14.03 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.197 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.68 161.71 29.57 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.511 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.822 HG23 ' O ' ' A' ' 19' ' ' THR . 8.8 t -132.57 90.54 2.79 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 120.881 -1.137 . . . . 0.0 107.996 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.782 ' O ' HD12 ' A' ' 24' ' ' ILE . 12.6 t-20 -123.76 141.96 51.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.254 -0.904 . . . . 0.0 110.037 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.83 -35.53 29.31 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.035 -1.666 . . . . 0.0 108.779 176.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -83.13 -52.27 6.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.168 -0.957 . . . . 0.0 109.548 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 1.4 tm-20 -60.17 -20.48 58.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.96 . . . . 0.0 108.667 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.782 HD12 ' O ' ' A' ' 20' ' ' ASN . 4.6 mt -73.04 -54.76 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.198 -0.939 . . . . 0.0 108.766 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -58.72 -43.0 90.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.488 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.692 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 94.9 mt-30 -62.08 -40.72 96.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.207 -0.933 . . . . 0.0 108.967 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.483 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 8.9 tt0 -73.25 -45.74 54.16 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.79 HD12 HG11 ' A' ' 33' ' ' VAL . 3.3 mm? -67.01 -61.16 2.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.031 -1.043 . . . . 0.0 110.089 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.2 t-20 -59.48 -18.88 43.58 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.321 -0.862 . . . . 0.0 110.262 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.692 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -66.04 -31.25 72.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.81 -1.181 . . . . 0.0 108.966 177.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.644 ' NZ ' ' CE2' ' A' ' 122' ' ' PHE . 13.6 mtmt -91.47 12.3 21.17 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.296 -0.877 . . . . 0.0 109.963 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.25 24.76 30.58 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.159 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.79 HG11 HD12 ' A' ' 28' ' ' LEU . 28.8 t -95.3 147.41 5.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.385 -1.068 . . . . 0.0 109.194 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.457 ' HD3' HD11 ' A' ' 131' ' ' LEU . 18.9 ttt180 -82.82 153.23 25.29 Favored 'General case' 0 C--N 1.285 -2.208 0 O-C-N 120.82 -1.175 . . . . 0.0 108.097 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -154.81 149.45 26.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.063 -1.023 . . . . 0.0 108.564 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.533 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 5.5 pt-20 -178.78 179.54 0.7 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.019 -1.051 . . . . 0.0 110.561 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.8 ptt85 -152.97 122.35 6.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.319 -0.863 . . . . 0.0 109.353 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.612 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 33.4 m0 -111.78 153.38 26.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.49 -0.756 . . . . 0.0 109.108 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -140.01 155.01 47.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.901 . . . . 0.0 109.658 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.27 157.55 15.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 108.783 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -102.73 -8.75 20.6 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.61 162.16 14.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.683 0.754 . . . . 0.0 109.184 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 39.8 p-10 -96.41 123.72 40.16 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.425 0.631 . . . . 0.0 109.694 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.94 160.88 14.24 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.369 -0.832 . . . . 0.0 109.43 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.1 -105.3 0.22 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.87 88.62 4.68 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.057 -1.261 . . . . 0.0 109.078 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.99 91.89 40.77 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.145 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.91 -23.7 13.74 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.179 1.919 . . . . 0.0 112.477 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.0 p -119.65 141.93 48.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.782 -0.574 . . . . 0.0 109.494 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.42 -17.68 51.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.804 . . . . 0.0 109.428 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' ALA . 97.8 mt-10 -44.69 -38.2 4.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.476 -0.765 . . . . 0.0 109.094 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 m -76.36 -33.11 58.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.194 -0.941 . . . . 0.0 109.412 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.561 HG11 ' CG1' ' A' ' 107' ' ' VAL . 70.1 t -65.84 -45.07 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.385 -0.822 . . . . 0.0 110.042 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.935 HD13 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -61.47 -38.54 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.098 -1.001 . . . . 0.0 109.006 -179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.21 -31.28 70.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.425 -0.797 . . . . 0.0 109.686 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.86 -21.78 50.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.084 -1.01 . . . . 0.0 110.443 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -112.53 -10.22 13.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.332 -0.855 . . . . 0.0 109.526 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.697 HE21 ' CG1' ' A' ' 61' ' ' ILE . 28.2 tp60 -52.64 -43.05 65.2 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.421 -0.911 . . . . 0.0 108.86 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.547 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 6.3 p80 -49.71 -48.52 49.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.017 -1.052 . . . . 0.0 109.653 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.547 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.08 -60.76 3.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.948 -1.095 . . . . 0.0 109.853 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.697 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.6 OUTLIER -62.13 -30.01 47.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.773 -1.204 . . . . 0.0 109.304 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.4 t70 -55.22 -25.85 35.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.069 -1.019 . . . . 0.0 109.624 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -80.3 -35.23 36.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 109.298 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.97 -42.66 94.36 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.42 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.716 HG22 ' CZ3' ' A' ' 73' ' ' TRP . 0.6 OUTLIER -72.04 -28.97 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 109.532 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.66 -52.91 53.67 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.937 -1.102 . . . . 0.0 109.502 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.64 -46.27 17.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.023 -1.048 . . . . 0.0 109.988 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.626 ' O ' ' C ' ' A' ' 69' ' ' GLY . 23.2 mttm -83.59 13.36 4.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.835 . . . . 0.0 110.631 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.626 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -6.11 82.21 0.0 OUTLIER Glycine 0 N--CA 1.504 3.187 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.896 ' CG ' HG21 ' A' ' 155' ' ' ILE . 43.2 m-85 -76.36 161.82 28.39 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.709 -0.877 . . . . 0.0 109.138 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -58.93 -42.85 90.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 0.0 109.974 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.8 t -151.29 161.21 43.12 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.154 -0.967 . . . . 0.0 109.895 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.716 ' CZ3' HG22 ' A' ' 65' ' ' VAL . 12.3 t-105 -137.74 143.0 40.96 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.454 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -160.87 179.13 8.74 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.935 HG21 HD13 ' A' ' 54' ' ' ILE . 2.7 t -122.9 142.04 40.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.47 -0.769 . . . . 0.0 109.264 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.5 mm -100.0 116.25 42.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.515 ' O ' ' OG ' ' A' ' 77' ' ' SER . 5.8 p -168.71 102.07 0.4 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.512 -0.743 . . . . 0.0 109.047 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.677 HD23 ' HB2' ' A' ' 82' ' ' ASN . 10.3 tp -121.47 179.88 4.3 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 119.581 -1.95 . . . . 0.0 107.712 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.848 HH21 ' HB3' ' A' ' 80' ' ' ALA . 4.0 ttp85 -87.94 160.39 17.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.649 -1.282 . . . . 0.0 109.118 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.848 ' HB3' HH21 ' A' ' 79' ' ' ARG . . . -58.52 -2.74 0.23 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.895 0.855 . . . . 0.0 109.849 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.561 ' CG ' ' HE ' ' A' ' 79' ' ' ARG . 89.1 m-20 -97.95 31.98 2.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.677 ' HB2' HD23 ' A' ' 78' ' ' LEU . 1.5 t30 -80.19 125.13 82.12 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.7 -0.625 . . . . 0.0 110.771 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -78.73 -23.03 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.042 1.828 . . . . 0.0 112.405 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.491 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 88.8 mm-40 -91.9 10.73 27.52 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.917 -1.114 . . . . 0.0 109.365 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.618 ' CA ' ' ND2' ' A' ' 82' ' ' ASN . 47.1 pttt -57.98 -53.68 55.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.585 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 84.8 tt0 -68.7 -52.06 34.98 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.197 -0.94 . . . . 0.0 109.606 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.68 -45.92 84.99 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.71 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 84' ' ' GLN . 7.3 tt -62.3 -43.98 97.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.718 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -59.0 -36.41 74.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.1 -1.0 . . . . 0.0 109.696 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -66.97 -56.27 10.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 109.803 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -51.03 -36.21 38.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.479 -0.763 . . . . 0.0 109.232 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -87.88 -18.97 28.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.544 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.51 -36.09 81.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 109.889 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -61.36 133.41 55.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 110.017 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.74 151.5 38.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.444 -0.785 . . . . 0.0 109.376 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -163.39 -172.88 3.12 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.5 t -163.0 137.69 6.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.688 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -110.46 154.51 23.52 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.395 -0.815 . . . . 0.0 109.663 -178.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.26 -5.75 82.05 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 101' ' ' ASP . 79.9 tt0 -125.11 168.2 13.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.191 -1.181 . . . . 0.0 109.168 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.416 ' N ' ' HG2' ' A' ' 100' ' ' GLU . 92.4 m-20 -73.13 142.99 47.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.893 -1.129 . . . . 0.0 110.315 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.84 95.87 7.49 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.298 -0.876 . . . . 0.0 109.317 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.472 HG13 HD13 ' A' ' 131' ' ' LEU . 20.1 t -80.28 131.5 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.467 0.651 . . . . 0.0 109.302 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.672 ' NH2' ' CE2' ' A' ' 142' ' ' PHE . 20.0 mmm180 -129.26 114.23 16.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.654 -0.654 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.631 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 16.1 t80 -109.75 129.9 55.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.506 ' CD2' ' OE2' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -93.05 137.5 32.35 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 110.396 -179.086 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.561 ' CG1' HG11 ' A' ' 53' ' ' VAL . 38.5 t -111.92 -30.25 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.686 -0.634 . . . . 0.0 109.817 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -168.57 158.27 9.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.067 -1.021 . . . . 0.0 109.426 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.21 162.18 15.56 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.57 -176.62 2.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -1.137 . . . . 0.0 109.317 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.25 -144.36 5.12 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 113' ' ' PHE . 7.6 tt -142.37 160.06 41.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -1.168 . . . . 0.0 109.663 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.607 ' N ' HD23 ' A' ' 112' ' ' LEU . 6.1 m-85 -137.55 87.68 2.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 109.833 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.592 ' SG ' ' NE1' ' A' ' 141' ' ' TRP . 42.2 t -81.01 114.13 19.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.446 -0.784 . . . . 0.0 109.428 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 114' ' ' CYS . 7.8 mt -119.41 117.23 27.92 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.148 -0.97 . . . . 0.0 108.819 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.586 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 4.0 t-160 -106.85 113.56 27.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.053 -1.029 . . . . 0.0 109.635 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.79 117.68 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.678 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.74 -143.1 31.98 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 105.85 -2.9 . . . . 0.0 105.85 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -106.71 79.36 1.34 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 115.739 -2.385 . . . . 0.0 108.538 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.586 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 74.9 tt0 -165.61 167.94 16.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.401 ' N ' ' HG2' ' A' ' 120' ' ' GLU . 3.9 t -130.7 149.18 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.139 -0.976 . . . . 0.0 110.066 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.644 ' CE2' ' NZ ' ' A' ' 31' ' ' LYS . 51.1 m-85 -129.32 133.8 47.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.803 -0.561 . . . . 0.0 109.771 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.552 ' OE1' HD21 ' A' ' 112' ' ' LEU . 83.7 mm-40 -128.39 108.95 10.99 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.792 ' C ' HD13 ' A' ' 125' ' ' LEU . 3.3 t -103.74 138.11 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.978 HD22 ' N ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -130.98 83.17 2.09 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.452 178.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.538 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 25.9 p -170.19 116.89 0.53 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.506 ' OE2' ' CD2' ' A' ' 106' ' ' PHE . 79.3 mm-40 -114.82 103.44 10.95 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 116.126 -2.229 . . . . 0.0 111.245 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.58 ' C ' ' H ' ' A' ' 130' ' ' ASP . 93.6 mttt -109.34 177.26 4.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.333 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.631 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 22.5 p30 -55.7 -5.96 0.18 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.58 ' H ' ' C ' ' A' ' 128' ' ' LYS . 29.7 p30 -72.22 144.55 48.44 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.918 0.866 . . . . 0.0 109.362 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.922 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.2 OUTLIER -109.24 148.47 30.92 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.885 0.85 . . . . 0.0 109.974 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.922 ' N ' HD12 ' A' ' 131' ' ' LEU . 37.3 mm -122.35 121.11 62.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.4 t -111.74 142.4 44.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.67 143.55 26.92 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.0 108.894 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.17 150.19 85.12 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.317 2.011 . . . . 0.0 112.53 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.58 134.7 46.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.38 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.7 t60 92.71 10.17 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.65 125.46 34.71 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.075 -1.016 . . . . 0.0 108.685 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.57 132.05 31.77 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.482 1.455 . . . . 0.0 111.629 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.477 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.71 163.54 9.96 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.235 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.592 ' NE1' ' SG ' ' A' ' 114' ' ' CYS . 0.6 OUTLIER -133.36 -147.33 0.29 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.312 -0.868 . . . . 0.0 109.851 -178.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.672 ' CE2' ' NH2' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -178.71 126.26 0.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.887 -1.133 . . . . 0.0 109.289 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 176' ' ' PRO . 53.0 t0 -146.57 137.48 24.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.264 -0.898 . . . . 0.0 109.626 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.588 ' O ' ' C ' ' A' ' 145' ' ' GLY . 5.5 ptt? -109.81 21.1 17.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.515 -0.741 . . . . 0.0 111.295 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.588 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.12 -90.46 0.01 OUTLIER Glycine 0 N--CA 1.503 3.117 0 CA-C-N 119.336 0.971 . . . . 0.0 112.073 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.542 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 39.7 t -86.88 120.41 28.13 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.035 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.671 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -113.42 111.74 49.39 Favored Pre-proline 0 C--N 1.294 -1.805 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.742 178.335 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.584 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.4 Cg_endo -102.07 28.21 0.1 Allowed 'Trans proline' 0 C--O 1.212 -0.822 0 C-N-CA 123.068 2.512 . . . . 0.0 111.432 176.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.622 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER 84.06 71.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.747 0.784 . . . . 0.0 109.632 -177.229 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 25.6 p90 -94.89 159.55 14.99 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.64 -0.662 . . . . 0.0 109.528 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.468 HG22 ' HB ' ' A' ' 107' ' ' VAL . 29.7 m -130.26 125.52 35.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.223 -0.923 . . . . 0.0 110.012 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.505 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -144.62 164.16 31.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 109.44 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.538 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 29.1 mt -110.61 129.93 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.075 -1.016 . . . . 0.0 109.346 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.478 ' HE ' ' HD3' ' A' ' 104' ' ' ARG . 4.3 ttt180 -138.6 167.42 21.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.422 -0.799 . . . . 0.0 109.69 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.896 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.1 mp -104.36 146.68 11.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.501 -0.75 . . . . 0.0 109.444 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.454 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.3 m-30 -95.35 118.56 32.32 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.008 0.909 . . . . 0.0 109.732 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.63 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 11.8 p30 -135.89 161.92 34.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.891 -0.505 . . . . 0.0 109.829 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 2.3 m-20 -96.03 160.23 30.46 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.059 -1.025 . . . . 0.0 109.484 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.62 ' O ' ' N ' ' A' ' 162' ' ' TRP . 43.8 Cg_endo -69.02 -54.26 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.56 2.173 . . . . 0.0 112.042 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 159' ' ' PRO . 77.4 tt0 -43.45 -16.84 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 109.219 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.61 -25.67 29.55 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.63 ' HE1' ' CG ' ' A' ' 157' ' ' ASP . 32.6 m95 -107.27 169.08 8.78 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.387 -1.067 . . . . 0.0 109.964 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 77.3 mt -97.21 150.55 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.24 -0.912 . . . . 0.0 109.282 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -76.77 -71.63 0.39 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.31 -0.869 . . . . 0.0 110.449 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -133.95 158.71 42.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.215 -0.928 . . . . 0.0 109.819 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -101.08 -39.67 7.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.873 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.18 -30.26 5.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.328 -0.857 . . . . 0.0 108.957 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.66 -9.92 55.75 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.91 148.56 31.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.838 -1.389 . . . . 0.0 108.074 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -111.22 87.55 2.57 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 117.614 -1.635 . . . . 0.0 110.94 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.516 HG23 ' CH2' ' A' ' 141' ' ' TRP . 2.2 tt -77.79 -16.99 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.602 -1.311 . . . . 0.0 109.147 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -56.25 -38.91 71.75 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.632 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 68.0 m -52.82 -4.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.434 -0.791 . . . . 0.0 109.961 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.551 ' HB3' ' CE2' ' A' ' 175' ' ' TYR . . . -76.23 -41.37 49.42 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.68 -1.262 . . . . 0.0 111.894 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.629 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.6 m-85 -113.29 25.04 0.08 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 O-C-N 120.457 -1.402 . . . . 0.0 112.416 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.632 ' HD3' ' C ' ' A' ' 173' ' ' SER . 41.0 Cg_endo -60.66 -25.97 81.97 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 123.898 3.065 . . . . 0.0 113.892 -172.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -89.57 125.5 35.24 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 118.719 -1.192 . . . . 0.0 108.408 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.725 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.5 OUTLIER -87.34 120.9 29.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.2 -0.937 . . . . 0.0 109.084 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.491 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.641 ' O ' ' OG1' ' A' ' 19' ' ' THR . 6.0 p . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.31 170.48 9.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.208 -0.932 . . . . 0.0 108.699 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 123' ' ' GLN . 2.8 tp -156.93 119.23 3.91 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.505 ' N ' HD12 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -110.74 134.01 52.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.164 -0.96 . . . . 0.0 109.761 -178.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.71 HD12 ' HB3' ' A' ' 16' ' ' TRP . 6.2 mt -127.97 137.51 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.415 ' CE1' HG22 ' A' ' 4' ' ' THR . 96.8 m-85 -130.65 166.59 20.36 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.406 ' OG ' ' CD2' ' A' ' 15' ' ' LEU . 51.0 m -87.41 173.9 8.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.048 -1.033 . . . . 0.0 108.579 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.86 -29.53 5.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.913 -1.117 . . . . 0.0 109.413 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -73.02 -38.12 66.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.783 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -139.22 123.93 11.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.996 -1.065 . . . . 0.0 109.743 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -84.1 -21.91 3.65 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.754 1.636 . . . . 0.0 112.471 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.48 -1.87 12.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.484 -0.76 . . . . 0.0 111.579 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.544 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 47.4 p-10 -124.89 122.79 38.37 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.16 -0.962 . . . . 0.0 108.886 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.2 p -93.22 129.76 39.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.874 -1.141 . . . . 0.0 108.53 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 15' ' ' LEU . 11.0 mp -90.38 -7.28 53.62 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.166 -1.013 . . . . 0.0 109.068 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.71 ' HB3' HD12 ' A' ' 5' ' ' ILE . 39.0 t90 -157.58 105.63 2.05 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.253 -1.379 . . . . 0.0 110.055 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -119.0 111.13 17.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.378 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.425 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -161.37 162.71 30.83 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.369 -0.832 . . . . 0.0 109.872 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 19' ' ' THR . 10.2 t -131.72 89.18 2.66 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.005 -1.059 . . . . 0.0 108.153 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.773 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -125.52 151.45 46.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.014 -1.054 . . . . 0.0 110.06 177.423 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.26 -41.32 20.36 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.21 -1.557 . . . . 0.0 108.827 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -82.81 -47.35 12.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 110.737 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -64.52 -23.44 67.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.757 -1.215 . . . . 0.0 108.984 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.773 HD12 ' O ' ' A' ' 20' ' ' ASN . 7.2 mt -70.73 -51.36 37.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.228 -0.92 . . . . 0.0 108.537 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.429 ' NE2' ' CB ' ' A' ' 29' ' ' ASN . 13.2 tm0? -57.08 -50.1 73.83 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.525 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.604 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 44.6 tt0 -58.42 -35.03 71.46 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.525 -0.735 . . . . 0.0 110.229 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.703 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -64.3 -63.48 1.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.933 -1.105 . . . . 0.0 109.587 -179.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -55.09 14.15 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.114 -0.991 . . . . 0.0 109.76 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 19.8 t-20 -52.46 -27.63 16.91 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.972 -1.08 . . . . 0.0 109.73 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -64.5 -27.05 68.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.677 -1.264 . . . . 0.0 108.263 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -90.71 11.29 22.7 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.26 -0.9 . . . . 0.0 110.54 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.26 25.69 15.87 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.088 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.615 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 43.3 t -96.8 145.75 8.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.348 -1.089 . . . . 0.0 109.929 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -84.17 157.04 21.8 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -153.1 149.82 28.48 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.401 ' HG2' ' HE1' ' A' ' 38' ' ' TRP . 36.2 tp10 -174.89 166.41 3.61 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.95 -1.094 . . . . 0.0 108.619 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -153.77 131.06 11.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.401 ' HE1' ' HG2' ' A' ' 36' ' ' GLU . 11.0 m0 -117.38 151.58 36.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.583 -0.698 . . . . 0.0 109.945 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -135.96 158.75 43.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.372 -0.83 . . . . 0.0 109.439 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.38 160.46 14.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.917 . . . . 0.0 109.179 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -98.64 -17.64 18.5 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.222 -0.924 . . . . 0.0 108.544 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -93.61 164.83 13.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.687 0.756 . . . . 0.0 109.161 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.17 119.39 32.93 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.645 -0.659 . . . . 0.0 109.599 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.98 166.05 12.9 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.4 -121.87 0.59 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.46 79.4 8.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.069 -1.254 . . . . 0.0 108.98 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.92 94.93 26.76 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.448 -0.783 . . . . 0.0 109.205 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.706 ' O ' HG23 ' A' ' 49' ' ' THR . 50.6 Cg_endo -70.86 79.46 1.29 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.002 1.801 . . . . 0.0 111.854 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 48' ' ' PRO . 3.8 p -163.55 119.56 1.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.129 -0.982 . . . . 0.0 109.273 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.95 -43.54 17.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.858 -1.151 . . . . 0.0 110.044 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -66.61 -17.89 65.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.488 -0.757 . . . . 0.0 110.148 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 m -77.11 -40.77 44.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 110.228 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.402 HG11 ' CG1' ' A' ' 107' ' ' VAL . 43.9 t -66.87 -48.11 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.117 -0.989 . . . . 0.0 109.953 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 58' ' ' GLN . 8.5 mm -61.31 -41.94 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 108.619 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.81 -29.87 70.44 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.435 -0.79 . . . . 0.0 109.691 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.16 -17.85 59.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.98 . . . . 0.0 110.12 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 58' ' ' GLN . 57.4 m-85 -114.34 -7.47 12.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 109.121 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.481 HE21 HG12 ' A' ' 61' ' ' ILE . 5.1 mm-40 -46.52 -39.84 11.54 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.759 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.32 -46.6 62.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.54 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -63.67 -59.63 4.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.804 -1.185 . . . . 0.0 110.341 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.681 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -62.32 -31.85 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.996 -1.065 . . . . 0.0 109.352 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.7 t70 -59.04 -25.05 63.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.594 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.54 -39.08 47.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.949 . . . . 0.0 109.411 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.0 mp -64.19 -38.07 89.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.365 -0.834 . . . . 0.0 108.936 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.639 HG22 ' CZ3' ' A' ' 73' ' ' TRP . 2.8 t -71.02 -29.68 38.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.368 -0.832 . . . . 0.0 109.458 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.38 -52.36 63.8 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.514 -1.366 . . . . 0.0 109.597 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.05 -49.8 9.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.955 -1.091 . . . . 0.0 110.366 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.602 ' O ' ' C ' ' A' ' 69' ' ' GLY . 20.2 mmtt -83.99 13.0 5.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -0.868 . . . . 0.0 111.37 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.602 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -3.01 80.83 0.0 OUTLIER Glycine 0 N--CA 1.506 3.336 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.583 ' CG ' HG21 ' A' ' 155' ' ' ILE . 69.1 m-85 -77.35 158.94 29.86 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.658 -0.907 . . . . 0.0 108.791 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -57.65 -88.53 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.479 -0.763 . . . . 0.0 109.3 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -103.44 159.58 15.46 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.719 0.771 . . . . 0.0 110.161 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.639 ' CZ3' HG22 ' A' ' 65' ' ' VAL . 7.9 t-105 -139.51 144.7 38.03 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -163.05 -178.6 6.15 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 152' ' ' ALA . 7.3 p -121.13 143.87 32.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.729 HG23 ' O ' ' A' ' 76' ' ' ILE . 19.8 tt -101.72 115.45 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.625 ' OG ' HG23 ' A' ' 151' ' ' THR . 0.7 OUTLIER -167.94 101.06 0.46 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.816 -0.753 . . . . 0.0 109.194 177.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.535 ' HG ' ' H ' ' A' ' 79' ' ' ARG . 11.5 tp -106.59 178.34 4.59 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 121.08 1.764 . . . . 0.0 107.939 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.535 ' H ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -89.88 143.84 26.45 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.693 -1.254 . . . . 0.0 109.664 -178.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.03 0.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.594 -0.691 . . . . 0.0 109.588 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' A' ' 79' ' ' ARG . 58.5 t0 -83.57 -27.54 29.2 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.471 -1.292 . . . . 0.0 109.444 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.71 HD21 ' CB ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -67.41 122.42 83.03 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.054 -1.029 . . . . 0.0 109.507 179.481 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -85.83 -3.78 8.99 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.021 1.814 . . . . 0.0 112.234 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -88.39 -3.44 58.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.944 -1.097 . . . . 0.0 110.513 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.71 ' CB ' HD21 ' A' ' 82' ' ' ASN . 2.3 mmtt -62.8 -40.57 97.75 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.036 -1.04 . . . . 0.0 109.283 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -61.05 -54.49 44.1 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.322 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.04 -35.0 75.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.06 -1.025 . . . . 0.0 109.644 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.732 HD23 ' O ' ' A' ' 88' ' ' LEU . 4.3 tt -61.37 -43.51 98.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.73 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.6 ptt-85 -63.76 -25.78 68.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 109.934 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.72 -59.66 3.69 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.408 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -54.25 -29.39 46.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.962 . . . . 0.0 109.27 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.39 -18.37 36.3 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.306 -0.871 . . . . 0.0 109.661 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.666 ' C ' HD12 ' A' ' 93' ' ' LEU . 0.8 OUTLIER -58.44 -25.88 62.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 109.936 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -55.25 142.37 31.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.108 -0.995 . . . . 0.0 110.211 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.511 ' OE2' ' O ' ' A' ' 169' ' ' ASP . 19.8 pt-20 -72.59 164.24 26.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.395 -0.816 . . . . 0.0 109.663 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -174.24 -170.92 0.56 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.492 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.2 t -160.48 132.28 5.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.65 0.738 . . . . 0.0 109.36 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.665 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -103.4 154.64 19.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.712 -0.617 . . . . 0.0 110.01 -179.037 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' A' ' 162' ' ' TRP . . . -78.83 -6.05 88.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.426 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 96.6 mt-10 -124.77 170.11 11.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -1.027 . . . . 0.0 109.382 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -74.68 143.54 44.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.956 -1.09 . . . . 0.0 110.103 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.444 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 2.0 mt-10 -101.1 93.64 5.58 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.114 -0.992 . . . . 0.0 108.901 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.519 HG12 ' CB ' ' A' ' 133' ' ' SER . 9.1 m -89.11 130.65 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.767 -0.583 . . . . 0.0 109.495 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.693 ' NH1' ' CD1' ' A' ' 142' ' ' PHE . 21.4 mtp180 -129.59 116.94 19.63 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.561 -0.712 . . . . 0.0 109.437 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.457 ' CE2' ' O ' ' A' ' 106' ' ' PHE . 25.4 t80 -101.08 134.08 44.62 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.457 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.88 129.26 35.63 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.422 -0.799 . . . . 0.0 110.388 -178.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.402 ' CG1' HG11 ' A' ' 53' ' ' VAL . 17.9 t -107.96 -33.54 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.577 -0.702 . . . . 0.0 109.711 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -167.97 157.81 10.07 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.094 -1.004 . . . . 0.0 108.88 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.19 161.4 9.14 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.12 -177.51 3.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -1.061 . . . . 0.0 109.107 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.88 -142.51 4.09 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.8 tp -142.62 159.7 41.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.23 -1.159 . . . . 0.0 109.026 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -136.83 88.09 2.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.06 -1.025 . . . . 0.0 109.258 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.75 108.87 14.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.473 -0.767 . . . . 0.0 110.026 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.402 HD23 HG12 ' A' ' 134' ' ' VAL . 1.2 mp -116.43 121.18 41.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -0.924 . . . . 0.0 108.82 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 4.7 t-160 -107.29 113.37 26.72 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.097 -1.002 . . . . 0.0 109.277 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.5 mt -128.34 118.72 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.852 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.17 -142.49 33.05 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 105.429 -3.068 . . . . 0.0 105.429 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -107.8 80.64 1.41 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 121.517 2.658 . . . . 0.0 108.182 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 77.5 tt0 -165.11 166.81 18.82 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 5' ' ' ILE . 41.0 t -126.61 142.12 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.244 -0.91 . . . . 0.0 110.037 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.452 ' CZ ' HD13 ' A' ' 5' ' ' ILE . 2.2 m-85 -124.19 130.85 53.24 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.038 0.447 . . . . 0.0 109.922 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.584 ' O ' HD12 ' A' ' 3' ' ' LEU . 91.2 mt-30 -132.32 118.08 18.97 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 109.35 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.664 ' C ' HD23 ' A' ' 125' ' ' LEU . 2.9 t -106.43 137.89 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.664 HD23 ' C ' ' A' ' 124' ' ' VAL . 0.1 OUTLIER -135.91 91.07 2.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.061 -1.025 . . . . 0.0 110.634 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 20.3 p -166.95 137.47 3.11 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.505 -1.372 . . . . 0.0 108.603 178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.509 ' O ' ' CD ' ' A' ' 127' ' ' GLU . 2.8 tm-20 -106.99 92.92 4.28 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 115.367 -2.533 . . . . 0.0 110.012 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.632 ' C ' ' H ' ' A' ' 130' ' ' ASP . 39.7 tttp -118.26 157.71 26.53 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.439 175.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -56.12 0.83 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.106 -1.621 . . . . 0.0 108.406 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.632 ' H ' ' C ' ' A' ' 128' ' ' LYS . 49.5 p-10 -66.84 131.36 45.75 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.157 0.979 . . . . 0.0 109.566 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.004 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -100.97 132.86 46.18 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.862 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 1.004 ' N ' HD12 ' A' ' 131' ' ' LEU . 8.2 tt -125.43 129.96 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.582 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.519 ' CB ' HG12 ' A' ' 103' ' ' VAL . 3.3 m -125.77 151.59 46.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.402 HG12 HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -107.48 149.59 39.01 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.41 151.52 75.91 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.569 2.179 . . . . 0.0 112.904 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.609 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -73.31 133.47 43.88 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.182 -0.949 . . . . 0.0 109.186 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.609 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.1 t-80 94.89 9.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.166 0.508 . . . . 0.0 109.705 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.09 126.96 30.26 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 108.579 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.84 132.1 31.37 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.57 1.513 . . . . 0.0 111.548 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -168.95 164.06 11.51 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.999 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.415 ' CG ' ' CB ' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -134.46 -148.8 0.33 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 109.348 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.693 ' CD1' ' NH1' ' A' ' 104' ' ' ARG . 83.5 t80 -176.03 126.38 0.21 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.052 -1.03 . . . . 0.0 109.048 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 31.9 p-10 -144.69 132.86 21.62 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.368 -0.833 . . . . 0.0 109.361 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.612 ' O ' ' C ' ' A' ' 145' ' ' GLY . 11.3 ptp -110.9 21.36 16.56 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.657 -0.652 . . . . 0.0 111.093 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.612 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 7.52 -86.21 0.0 OUTLIER Glycine 0 N--CA 1.499 2.893 0 CA-C-N 119.061 0.846 . . . . 0.0 111.94 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.479 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 51.2 m -88.07 116.74 26.47 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 117.688 -1.605 . . . . 0.0 108.75 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.486 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -118.28 115.11 36.28 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.517 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 59.1 Cg_endo -105.04 36.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.437 2.091 . . . . 0.0 111.395 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.62 ' CG ' ' O ' ' A' ' 149' ' ' ASN . 0.0 OUTLIER 81.85 69.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 123.246 1.498 . . . . 0.0 108.682 -177.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.412 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 26.7 p90 -95.75 161.68 13.92 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.489 -1.382 . . . . 0.0 109.766 -177.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.625 HG23 ' OG ' ' A' ' 77' ' ' SER . 11.7 m -130.54 125.87 35.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.953 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.455 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -144.26 164.55 30.42 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.8 mt -109.73 128.77 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.954 -1.091 . . . . 0.0 109.342 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -134.51 163.18 30.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.583 HG21 ' CG ' ' A' ' 70' ' ' TYR . 36.2 mt -102.64 144.14 14.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.467 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.3 m-85 -96.46 118.55 33.22 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.415 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -135.73 161.56 35.21 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.04 158.61 33.84 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 120.699 -1.251 . . . . 0.0 109.483 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.584 ' O ' ' N ' ' A' ' 161' ' ' GLY . 46.4 Cg_endo -71.31 -53.86 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.326 2.017 . . . . 0.0 112.737 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 159' ' ' PRO . 83.7 tt0 -43.3 -16.7 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -69.38 -38.76 80.98 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.465 ' HB3' ' H ' ' A' ' 99' ' ' GLY . 4.3 p90 -119.14 175.74 5.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.695 -0.885 . . . . 0.0 111.03 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 76.2 mt -96.26 147.6 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.597 0.713 . . . . 0.0 109.315 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.92 -73.61 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.425 -0.797 . . . . 0.0 110.525 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -126.76 156.6 40.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.149 -0.969 . . . . 0.0 109.872 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.1 -40.6 7.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 0.0 109.754 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 86.1 m -101.54 -32.23 10.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.043 . . . . 0.0 108.976 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.24 -6.93 58.2 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.518 ' O ' ' OD1' ' A' ' 169' ' ' ASP . 44.4 p30 -80.92 148.35 29.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.568 -1.548 . . . . 0.0 108.545 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -112.17 88.68 2.87 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 117.737 -1.585 . . . . 0.0 110.368 175.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.41 HG23 ' H ' ' A' ' 171' ' ' ILE . 0.1 OUTLIER -82.27 -16.83 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.008 -1.682 . . . . 0.0 109.24 179.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.455 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -55.98 -37.96 69.78 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.568 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 7.3 m -56.09 -3.97 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.824 -0.547 . . . . 0.0 110.161 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.78 -37.87 29.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.022 -1.049 . . . . 0.0 111.755 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.627 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.5 m-85 -112.83 23.09 0.08 OUTLIER Pre-proline 0 N--CA 1.513 2.717 0 O-C-N 120.558 -1.339 . . . . 0.0 113.037 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 46.1 Cg_endo -63.31 -19.56 68.58 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 123.443 2.762 . . . . 0.0 114.262 -173.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -88.93 126.47 35.41 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.765 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.502 ' H ' ' HA3' ' A' ' 145' ' ' GLY . 5.7 tt -87.8 122.25 31.22 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.926 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.297 -1.691 0 O-C-N 121.138 -0.976 . . . . 0.0 109.367 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.81 ' O ' HG23 ' A' ' 19' ' ' THR . 5.1 p . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.11 169.03 9.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.004 -1.06 . . . . 0.0 109.08 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.454 HD13 HG22 ' A' ' 124' ' ' VAL . 4.8 tp -157.79 117.3 3.29 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.49 ' OG1' HD11 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -114.44 135.97 53.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.432 -0.792 . . . . 0.0 109.973 -178.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.679 HD12 ' HB3' ' A' ' 16' ' ' TRP . 25.7 mt -130.44 133.6 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -127.4 168.26 15.09 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.413 ' HB2' HD21 ' A' ' 13' ' ' ASN . 0.1 OUTLIER -89.39 174.81 7.6 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.216 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -87.73 -23.77 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.066 . . . . 0.0 109.575 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -75.1 -37.93 61.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.051 -1.031 . . . . 0.0 110.413 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -136.93 126.49 15.58 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.655 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 13' ' ' ASN . 56.2 Cg_endo -79.87 -39.16 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.002 1.801 . . . . 0.0 112.156 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 9.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.729 . . . . 0.0 110.041 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -114.69 119.1 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.176 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.9 p -102.29 122.9 45.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.249 -0.907 . . . . 0.0 109.493 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.446 HD13 HD21 ' A' ' 13' ' ' ASN . 3.6 mp -90.2 -3.86 57.59 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.671 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.734 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 35.4 t90 -156.04 104.25 2.26 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.667 -1.213 . . . . 0.0 110.256 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -118.8 110.36 17.14 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.736 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.464 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -162.58 163.62 27.16 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.079 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.81 HG23 ' O ' ' A' ' 1' ' ' SER . 54.6 m -130.93 89.46 2.75 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.15 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.773 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -128.16 148.46 50.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.429 -0.794 . . . . 0.0 110.401 177.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.38 -38.27 22.2 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.311 -1.493 . . . . 0.0 108.107 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -83.69 -48.8 9.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.472 -0.767 . . . . 0.0 109.855 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 27' ' ' GLN . 43.9 tt0 -60.99 -24.02 65.81 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.831 -1.168 . . . . 0.0 108.604 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.773 HD12 ' O ' ' A' ' 20' ' ' ASN . 10.4 mt -73.04 -62.75 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.174 -0.953 . . . . 0.0 109.497 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.514 ' CD ' ' N ' ' A' ' 26' ' ' GLN . 3.8 pp0? -61.41 -43.34 99.04 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.879 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 25' ' ' GLN . 11.0 tm0? -61.49 -43.99 97.88 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.129 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.734 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -77.67 -47.23 19.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.977 . . . . 0.0 109.229 179.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 24' ' ' ILE . 23.9 tp -66.45 -54.41 24.47 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.999 -1.063 . . . . 0.0 109.149 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 25' ' ' GLN . 40.7 t-20 -57.9 -20.08 34.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.0 109.411 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 27' ' ' GLN . . . -65.25 -27.63 68.78 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.06 -1.025 . . . . 0.0 108.796 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.78 13.39 10.73 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.217 -0.927 . . . . 0.0 109.867 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.13 22.95 30.97 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.179 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.479 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 56.3 t -94.13 145.43 7.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.424 -1.044 . . . . 0.0 109.344 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.442 ' NE ' ' OG ' ' A' ' 133' ' ' SER . 2.4 ttm-85 -84.0 158.4 21.51 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.24 -0.912 . . . . 0.0 108.724 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.541 ' CE1' ' OD2' ' A' ' 130' ' ' ASP . 1.2 t80 -153.38 145.67 23.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.943 -1.098 . . . . 0.0 108.682 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.554 ' O ' ' OD1' ' A' ' 130' ' ' ASP . 43.8 mt-10 -165.81 168.64 15.78 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.188 -0.945 . . . . 0.0 109.961 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -148.53 113.91 5.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.587 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 22.1 m0 -109.98 153.81 24.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.273 -0.892 . . . . 0.0 109.308 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -142.79 159.09 42.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.902 . . . . 0.0 109.685 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.19 159.05 15.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.263 -0.898 . . . . 0.0 109.08 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -101.98 -13.64 17.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.152 -0.967 . . . . 0.0 108.535 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -93.05 161.55 14.39 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.234 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -95.08 118.94 32.74 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.734 -0.604 . . . . 0.0 109.666 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.0 mt -90.26 163.11 14.9 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.732 0.777 . . . . 0.0 109.292 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.08 -99.8 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.36 91.95 5.13 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.044 -1.269 . . . . 0.0 109.187 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.16 91.88 37.99 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.416 -0.802 . . . . 0.0 109.008 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -76.21 -26.41 9.07 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.316 2.011 . . . . 0.0 112.588 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.7 p -122.61 141.74 51.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.645 -0.66 . . . . 0.0 109.504 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.612 ' CB ' HG21 ' A' ' 151' ' ' THR . . . -80.69 -16.5 53.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.426 -0.796 . . . . 0.0 109.52 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -47.63 -38.96 15.77 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.796 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.1 m -79.43 -35.31 40.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.573 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.92 -48.78 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.887 . . . . 0.0 109.802 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 58' ' ' GLN . 17.7 mt -59.91 -36.77 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 108.796 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.51 -30.44 70.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.815 . . . . 0.0 109.527 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.59 -17.4 60.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.139 -0.975 . . . . 0.0 110.158 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -114.41 -8.59 12.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.393 -0.817 . . . . 0.0 109.507 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.731 HE21 ' CG1' ' A' ' 61' ' ' ILE . 26.9 tp60 -48.95 -38.57 23.35 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 108.86 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.624 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 20.2 p80 -50.62 -46.81 58.32 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.54 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.624 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.39 -60.51 3.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.065 -1.022 . . . . 0.0 109.977 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.731 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.7 OUTLIER -61.71 -30.16 47.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.85 -1.156 . . . . 0.0 109.024 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 58' ' ' GLN . 40.3 t0 -57.44 -26.43 61.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 0.0 109.645 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.75 -40.53 61.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.078 -1.013 . . . . 0.0 109.261 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -63.66 -34.65 78.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.064 -1.023 . . . . 0.0 109.653 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.649 HG22 ' CZ3' ' A' ' 73' ' ' TRP . 4.0 t -71.47 -33.95 51.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.245 -0.909 . . . . 0.0 109.442 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.37 -51.76 57.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.534 -1.354 . . . . 0.0 109.489 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -83.23 -50.07 8.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.013 -1.054 . . . . 0.0 110.472 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.605 ' O ' ' C ' ' A' ' 69' ' ' GLY . 15.7 mttm -86.65 15.79 5.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.608 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -12.01 85.52 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.866 ' CG ' HG21 ' A' ' 155' ' ' ILE . 53.9 m-85 -78.5 165.57 23.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.603 ' CD ' ' H ' ' A' ' 71' ' ' GLN . 25.4 mp0 -63.98 -83.99 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.372 -0.83 . . . . 0.0 109.401 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.23 157.3 17.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.597 -0.689 . . . . 0.0 109.566 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.649 ' CZ3' HG22 ' A' ' 65' ' ' VAL . 6.7 t-105 -136.15 139.36 42.83 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -167.38 -174.42 2.55 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.341 -0.849 . . . . 0.0 108.734 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 153' ' ' ILE . 3.2 m -118.92 146.76 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.0 109.45 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.24 116.53 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -174.42 108.84 0.13 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.828 -1.17 . . . . 0.0 109.563 177.464 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.427 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -100.39 -178.83 3.93 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 121.403 1.91 . . . . 0.0 109.331 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.427 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 7.8 tpt180 -88.88 143.81 26.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.856 -1.152 . . . . 0.0 109.207 -178.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.46 0.83 0.63 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.56 -0.712 . . . . 0.0 109.788 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 79' ' ' ARG . 57.5 t0 -94.08 -27.16 16.42 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.348 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -64.29 127.95 92.68 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.924 -1.11 . . . . 0.0 109.996 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.75 -1.79 11.96 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.323 2.015 . . . . 0.0 112.003 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -84.41 15.04 3.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.902 -1.124 . . . . 0.0 109.547 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -57.55 -58.54 7.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.305 -0.872 . . . . 0.0 108.809 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.01 -33.91 77.16 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.304 -0.873 . . . . 0.0 109.164 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.88 -58.2 8.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.0 110.023 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.0 tp -61.0 -43.98 98.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.639 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.483 ' HE ' ' H ' ' A' ' 145' ' ' GLY . 23.2 mtp-105 -60.71 -31.34 70.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.646 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -66.99 -58.28 5.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.454 -0.779 . . . . 0.0 110.322 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -53.98 -35.04 61.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 109.268 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -87.57 -18.21 30.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.274 -0.891 . . . . 0.0 109.629 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 89' ' ' ARG . 39.0 tp -56.9 -37.06 70.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.155 -0.966 . . . . 0.0 109.912 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -54.15 134.1 44.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.143 -0.973 . . . . 0.0 109.441 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.553 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 0.9 OUTLIER -64.77 164.7 11.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.418 -0.801 . . . . 0.0 109.537 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.562 ' O ' HG23 ' A' ' 97' ' ' THR . 42.8 p-80 -170.38 -171.44 1.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.066 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 96' ' ' HIS . 8.7 p -159.04 131.97 7.02 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.626 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -100.39 155.84 17.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.482 ' H ' ' HB3' ' A' ' 162' ' ' TRP . . . -79.53 -7.22 88.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.407 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 44.6 mt-10 -125.56 171.83 10.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.33 -1.1 . . . . 0.0 109.515 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -72.2 142.97 49.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.345 -0.847 . . . . 0.0 110.141 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.606 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 2.6 tt0 -101.7 93.33 5.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 103' ' ' VAL . 34.5 m -92.38 127.88 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.41 0.624 . . . . 0.0 109.786 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -127.41 126.64 42.79 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.632 -0.667 . . . . 0.0 109.318 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.629 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 18.7 t80 -108.51 133.23 52.93 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.785 0.802 . . . . 0.0 109.153 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.49 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.05 127.59 35.4 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.476 0.655 . . . . 0.0 110.022 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.8 t -108.83 -35.17 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.644 -0.66 . . . . 0.0 109.624 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -160.31 146.6 15.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 0.0 109.339 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.3 165.92 35.41 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.41 154.02 39.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.501 -0.999 . . . . 0.0 109.591 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.59 -132.08 2.65 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.1 tp -147.08 161.93 39.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.333 -1.098 . . . . 0.0 109.32 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -134.58 88.9 2.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.88 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.479 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -80.54 110.16 15.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.536 -0.727 . . . . 0.0 109.642 179.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 114' ' ' CYS . 8.4 mp -117.31 114.77 24.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.195 -0.94 . . . . 0.0 109.38 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.6 t-160 -105.05 112.86 26.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.067 -1.021 . . . . 0.0 109.483 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.4 pt -129.57 115.51 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.238 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.99 -143.34 30.83 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 106.424 -2.671 . . . . 0.0 106.424 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -104.04 78.69 1.55 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 115.116 -2.634 . . . . 0.0 108.895 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.564 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 15.3 pt-20 -166.85 168.58 13.98 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.613 ' O ' HG23 ' A' ' 5' ' ' ILE . 38.6 t -128.84 151.46 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.257 -0.902 . . . . 0.0 109.949 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -129.12 131.99 47.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.612 . . . . 0.0 109.823 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -131.87 111.07 11.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 0.0 109.277 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.454 HG22 HD13 ' A' ' 3' ' ' LEU . 2.7 t -102.55 139.41 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.847 ' H ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.0 91.18 2.72 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.078 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 31.6 p -165.47 138.34 4.36 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.176 -1.577 . . . . 0.0 107.783 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -106.37 93.39 4.58 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 115.836 -2.345 . . . . 0.0 110.387 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.522 ' C ' ' H ' ' A' ' 130' ' ' ASP . 46.3 mtpt -114.7 154.57 28.22 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.917 176.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.629 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 89.7 m-20 -58.99 -3.03 0.29 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.479 -1.388 . . . . 0.0 107.778 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' A' ' 131' ' ' LEU . 7.3 t0 -70.58 148.57 48.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.066 -1.021 . . . . 0.0 109.314 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.885 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -111.08 149.83 30.24 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.512 0.672 . . . . 0.0 110.545 -179.681 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.885 ' N ' HD12 ' A' ' 131' ' ' LEU . 29.5 mm -115.31 138.59 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.502 ' HG ' HD11 ' A' ' 131' ' ' LEU . 5.0 m -121.25 145.64 47.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.486 -0.759 . . . . 0.0 110.193 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.5 t -116.12 135.47 22.8 Favored Pre-proline 0 N--CA 1.485 1.308 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.55 147.96 94.04 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.147 1.898 . . . . 0.0 113.126 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.617 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -72.31 134.61 45.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.136 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.617 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 8.8 t-80 92.28 11.13 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.1 126.51 30.85 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.015 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.21 130.3 28.33 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.959 1.773 . . . . 0.0 111.648 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.551 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.37 165.86 14.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.197 -0.94 . . . . 0.0 110.196 -179.189 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.59 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -137.03 -149.58 0.32 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -178.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.429 ' CZ ' ' HG2' ' A' ' 144' ' ' MET . 11.5 t80 -175.61 125.27 0.23 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.934 -1.104 . . . . 0.0 109.018 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -143.81 135.17 25.89 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.373 -0.829 . . . . 0.0 109.942 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.642 ' O ' ' C ' ' A' ' 145' ' ' GLY . 52.1 mmm -113.38 21.29 15.34 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.886 -0.509 . . . . 0.0 110.852 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.642 ' C ' ' O ' ' A' ' 144' ' ' MET . . . -1.32 -74.21 0.0 OUTLIER Glycine 0 N--CA 1.503 3.151 0 CA-C-N 119.279 0.945 . . . . 0.0 111.407 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 144' ' ' MET . 22.9 t -91.4 115.49 28.08 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 117.671 -1.612 . . . . 0.0 109.171 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -119.23 116.81 33.64 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.41 -0.806 . . . . 0.0 110.164 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.2 Cg_endo -100.18 33.37 0.09 OUTLIER 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 122.56 2.173 . . . . 0.0 111.628 176.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 79.8 68.39 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.521 -0.872 . . . . 0.0 108.721 -178.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.522 ' O ' ' OG ' ' A' ' 77' ' ' SER . 14.2 p90 -96.41 -179.5 4.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.307 -0.871 . . . . 0.0 109.37 -177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.612 HG21 ' CB ' ' A' ' 50' ' ' ALA . 87.1 m -149.15 100.35 3.04 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.629 -0.669 . . . . 0.0 109.574 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 75' ' ' VAL . . . -110.69 163.77 13.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.918 -1.114 . . . . 0.0 109.19 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.679 ' HA ' HG12 ' A' ' 75' ' ' VAL . 94.7 mt -107.25 127.29 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.13 -0.981 . . . . 0.0 110.222 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.87 162.49 32.25 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.419 0.628 . . . . 0.0 109.427 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.866 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.0 mp -106.78 149.46 10.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.522 -0.736 . . . . 0.0 109.369 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -96.87 118.95 34.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.583 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -135.72 162.19 33.44 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.695 -0.628 . . . . 0.0 109.569 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -95.87 157.42 35.92 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.97 -1.081 . . . . 0.0 109.33 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 161' ' ' GLY . 47.4 Cg_endo -71.77 -52.58 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.614 2.209 . . . . 0.0 112.395 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 159' ' ' PRO . 95.1 mt-10 -43.83 -16.53 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.475 -0.765 . . . . 0.0 109.381 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -70.26 -39.88 70.91 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.482 ' HB3' ' H ' ' A' ' 99' ' ' GLY . 2.7 p90 -119.05 177.26 4.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.761 -0.847 . . . . 0.0 110.617 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.9 mm -95.37 152.05 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.417 -0.802 . . . . 0.0 109.219 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.34 -74.0 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 110.575 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -131.11 157.01 44.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -101.1 -41.54 6.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.707 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 60.0 p -105.86 -32.35 8.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.931 . . . . 0.0 109.235 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.29 -4.15 60.21 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.545 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -80.46 145.81 31.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.773 -1.428 . . . . 0.0 108.957 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -110.32 89.22 2.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.776 -1.569 . . . . 0.0 111.402 176.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.461 HG23 ' CH2' ' A' ' 141' ' ' TRP . 1.5 tt -78.63 -17.92 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.525 -1.359 . . . . 0.0 109.167 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.59 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -57.59 -42.7 83.7 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.637 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 45.8 m -54.17 -4.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.391 -0.818 . . . . 0.0 109.985 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.04 -40.5 31.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.958 -1.089 . . . . 0.0 111.549 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.618 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 9.3 m-85 -112.23 25.59 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.619 0 O-C-N 120.707 -1.246 . . . . 0.0 112.495 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.637 ' HD3' ' C ' ' A' ' 173' ' ' SER . 43.6 Cg_endo -62.42 -21.03 72.19 Favored 'Trans proline' 0 N--CA 1.503 2.088 0 C-N-CA 123.588 2.859 . . . . 0.0 113.168 -172.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -89.45 127.07 35.8 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.157 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' C ' ' A' ' 179' ' ' ALA . 0.7 OUTLIER -85.91 145.68 27.05 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.638 ' O ' HG23 ' A' ' 19' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.538 ' N ' ' SG ' ' A' ' 126' ' ' CYS . . . -99.2 172.04 7.62 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.147 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.891 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 25.2 tp -157.05 114.26 3.09 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.26 130.69 55.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 110.72 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.477 HD13 ' CE1' ' A' ' 122' ' ' PHE . 64.9 mt -124.76 134.0 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.2 168.93 14.75 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t -92.18 175.75 6.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.058 -1.026 . . . . 0.0 108.306 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.95 -26.7 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.728 -1.232 . . . . 0.0 109.396 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -72.35 -38.54 68.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.175 -0.953 . . . . 0.0 110.57 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.489 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 9.1 m-20 -139.41 123.38 11.02 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 109.766 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.3 -27.84 1.33 Allowed 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.021 1.814 . . . . 0.0 112.52 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -69.79 -0.49 7.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.455 -0.778 . . . . 0.0 111.178 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 6.7 p-10 -123.08 126.13 46.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.079 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 p -97.84 128.49 44.49 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 108.748 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pp -90.13 -9.93 46.47 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.801 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.891 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 31.1 t90 -158.01 108.79 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.052 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -122.37 124.58 44.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.334 -0.854 . . . . 0.0 110.241 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.61 168.62 21.47 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.053 -1.029 . . . . 0.0 110.594 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 19' ' ' THR . 1.0 OUTLIER -127.99 88.35 2.75 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 176.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.7 ' O ' HD12 ' A' ' 24' ' ' ILE . 19.5 m120 -127.37 139.37 52.91 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.538 -0.726 . . . . 0.0 109.984 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.4 -36.13 24.52 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 119.676 -1.89 . . . . 0.0 108.675 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.35 -49.39 10.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.719 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.09 -22.94 67.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.875 -1.141 . . . . 0.0 108.128 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.74 HG12 HD22 ' A' ' 3' ' ' LEU . 1.7 mt -66.8 -50.32 66.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 29' ' ' ASN . 53.3 tt0 -56.2 -55.12 37.11 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.432 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.602 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 62.1 tt0 -56.66 -34.28 67.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 0.0 110.45 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.702 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -62.36 -65.13 0.73 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.912 -1.117 . . . . 0.0 109.656 -179.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.429 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -70.27 -46.97 63.29 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.662 -1.274 . . . . 0.0 109.677 179.04 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.626 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 20.4 t-20 -57.0 -25.71 59.0 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.045 -1.035 . . . . 0.0 109.427 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -65.78 -28.08 68.76 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.76 -1.213 . . . . 0.0 107.762 177.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -87.58 14.6 8.03 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.975 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.91 23.38 35.63 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.434 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.626 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 56.7 t -94.53 144.73 9.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.226 -1.161 . . . . 0.0 109.89 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.7 ttt-85 -84.62 157.73 21.08 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.501 ' CZ ' ' OD2' ' A' ' 130' ' ' ASP . 1.3 t80 -155.22 153.68 31.04 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.3 pt-20 -175.81 176.45 1.84 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.042 -1.036 . . . . 0.0 110.102 177.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -154.31 121.8 5.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.394 -0.816 . . . . 0.0 109.065 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.611 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 33.2 m0 -111.28 154.98 23.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.405 -0.81 . . . . 0.0 109.033 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -142.23 155.13 45.24 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.284 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.31 159.68 14.77 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -98.38 -19.69 17.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.077 -1.014 . . . . 0.0 108.36 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -93.42 167.12 11.92 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -93.83 131.38 39.28 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.485 -0.759 . . . . 0.0 109.458 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -93.64 161.97 14.13 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.303 -0.873 . . . . 0.0 109.499 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.36 -96.3 0.11 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.78 107.09 8.84 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.344 -1.092 . . . . 0.0 108.15 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.97 90.02 46.56 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.638 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.57 46.3 1.71 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.819 2.346 . . . . 0.0 111.22 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.53 ' O ' ' OG1' ' A' ' 52' ' ' THR . 0.0 OUTLIER -169.27 139.9 2.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.556 -1.34 . . . . 0.0 108.978 178.061 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.09 -43.89 15.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.521 -1.362 . . . . 0.0 109.353 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -66.67 -4.32 8.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.59 -0.694 . . . . 0.0 110.335 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.53 ' OG1' ' O ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -77.77 -52.88 8.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.762 -1.211 . . . . 0.0 109.941 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.99 -44.67 84.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.112 -0.993 . . . . 0.0 110.253 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 58' ' ' GLN . 13.9 mm -60.3 -41.84 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.959 -1.088 . . . . 0.0 108.517 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.12 -22.87 66.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.445 -0.784 . . . . 0.0 109.89 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.1 -21.63 50.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.999 -1.063 . . . . 0.0 110.265 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 58' ' ' GLN . 59.2 m-85 -115.5 -10.16 11.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.493 -0.754 . . . . 0.0 109.206 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.761 HE22 HD11 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -46.89 -34.06 5.11 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.395 -0.922 . . . . 0.0 108.942 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.641 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 26.5 p80 -51.74 -50.48 60.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.891 -1.13 . . . . 0.0 109.573 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.641 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.2 -60.96 2.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.914 -1.116 . . . . 0.0 109.72 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.761 HD11 HE22 ' A' ' 58' ' ' GLN . 0.5 OUTLIER -61.49 -27.58 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.393 -1.442 . . . . 0.0 109.55 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 58' ' ' GLN . 79.8 m-20 -59.24 -22.33 60.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.066 -1.021 . . . . 0.0 109.807 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 64' ' ' LEU . 3.3 pttp -83.0 -32.9 26.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.949 -1.094 . . . . 0.0 108.633 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.57 HD23 HG21 ' A' ' 103' ' ' VAL . 1.9 mp -65.53 -46.85 78.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.334 -0.854 . . . . 0.0 109.662 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.669 HG22 ' CZ3' ' A' ' 73' ' ' TRP . 0.9 OUTLIER -69.01 -27.74 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.549 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.32 -49.51 74.12 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.74 -1.225 . . . . 0.0 109.713 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.55 -51.74 7.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.028 -1.045 . . . . 0.0 110.54 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.629 ' O ' ' C ' ' A' ' 69' ' ' GLY . 2.1 mptp? -82.73 13.13 4.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.349 -0.844 . . . . 0.0 110.968 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -6.42 81.7 0.0 OUTLIER Glycine 0 N--CA 1.505 3.27 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.888 ' CG ' HG21 ' A' ' 155' ' ' ILE . 84.3 m-85 -75.16 159.95 31.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -1.071 . . . . 0.0 109.193 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.585 ' OE1' ' ND2' ' A' ' 158' ' ' ASN . 85.1 mt-30 -58.33 -41.83 85.46 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.456 -0.777 . . . . 0.0 109.861 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 t -147.21 155.41 42.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.938 -1.101 . . . . 0.0 110.847 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.669 ' CZ3' HG22 ' A' ' 65' ' ' VAL . 29.8 t-105 -129.5 133.34 47.21 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.472 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.4 OUTLIER -145.6 165.67 27.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.557 HG22 ' H ' ' A' ' 76' ' ' ILE . 3.1 p -97.98 174.8 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 121.308 -0.87 . . . . 0.0 109.084 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.557 ' H ' HG22 ' A' ' 75' ' ' VAL . 52.5 mt -109.51 118.11 56.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.4 p -92.58 160.33 15.08 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 123.11 1.433 . . . . 0.0 111.548 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.623 HD13 ' H ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -158.0 138.27 12.59 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.652 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.623 ' H ' HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -130.18 139.02 50.89 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 149' ' ' ASN . . . -76.94 0.4 21.2 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.898 -1.126 . . . . 0.0 110.743 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.488 ' H ' ' HD3' ' A' ' 79' ' ' ARG . 93.4 m-20 -111.11 -14.82 13.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 0.0 109.21 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.557 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 44.7 p-10 -63.36 117.91 38.55 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.285 -0.884 . . . . 0.0 110.414 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -88.14 -13.99 3.52 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.35 2.033 . . . . 0.0 113.039 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -92.38 -11.09 35.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.032 -1.043 . . . . 0.0 110.611 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.699 ' CG ' HH12 ' A' ' 89' ' ' ARG . 20.1 tptt -62.54 -38.77 91.3 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.956 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -59.69 -44.2 93.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.834 . . . . 0.0 109.57 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.59 -38.63 66.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.024 -1.048 . . . . 0.0 109.483 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 49.6 mt -60.58 -36.43 78.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 0.0 109.026 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.699 HH12 ' CG ' ' A' ' 85' ' ' LYS . 0.9 OUTLIER -60.09 -30.53 69.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 109.318 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 93' ' ' LEU . 15.1 tt0 -64.47 -60.39 3.21 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.044 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -58.73 -30.94 67.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.15 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -83.41 -18.74 37.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 90' ' ' GLU . 2.5 mt -63.82 -25.31 68.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.066 -1.022 . . . . 0.0 110.012 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.419 ' N ' HD22 ' A' ' 94' ' ' ASN . 2.8 m120 -58.62 141.32 52.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 109.6 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -72.99 158.46 35.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 109.347 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -168.01 -168.96 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 110.788 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.9 133.64 6.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 109.11 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.683 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -106.43 154.32 20.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 0.0 109.738 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.21 -7.69 86.87 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -123.42 170.35 10.44 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.345 -1.091 . . . . 0.0 109.417 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -74.61 143.51 44.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.07 -1.019 . . . . 0.0 110.017 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.447 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 1.6 mt-10 -101.97 96.33 6.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.26 -0.9 . . . . 0.0 109.206 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.57 HG21 HD23 ' A' ' 64' ' ' LEU . 35.7 m -100.85 128.74 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.735 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.564 ' NE ' ' CZ ' ' A' ' 142' ' ' PHE . 6.6 mtm180 -128.9 134.58 48.31 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.611 ' CE2' ' CE3' ' A' ' 38' ' ' TRP . 66.0 t80 -112.99 131.53 55.72 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.77 0.795 . . . . 0.0 109.938 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.421 ' CG ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -87.18 125.8 34.4 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.359 0.599 . . . . 0.0 109.72 -179.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.89 -39.7 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.455 -0.778 . . . . 0.0 109.941 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -160.47 146.94 15.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.145 -0.972 . . . . 0.0 109.899 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.48 ' O ' ' OE1' ' A' ' 127' ' ' GLU . . . 87.89 164.18 39.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.72 160.59 26.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.513 -0.992 . . . . 0.0 109.664 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.22 -119.62 1.01 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.545 ' CD1' HD12 ' A' ' 125' ' ' LEU . 22.0 tp -148.31 163.33 37.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -1.106 . . . . 0.0 108.73 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.805 ' CD2' HG21 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -137.99 145.93 42.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.976 -1.078 . . . . 0.0 108.952 177.013 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.445 ' SG ' ' C ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -148.58 139.22 22.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.489 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.794 HD21 HG13 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -141.86 128.68 20.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.459 -0.776 . . . . 0.0 109.321 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.402 ' O ' HD13 ' A' ' 117' ' ' ILE . 2.2 t60 -103.3 111.56 24.02 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.178 -0.952 . . . . 0.0 109.18 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.459 HD11 HD12 ' A' ' 115' ' ' LEU . 51.9 mm -126.1 114.64 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.145 -0.972 . . . . 0.0 110.781 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.66 -142.42 29.93 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 104.422 -3.471 . . . . 0.0 104.422 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -109.92 82.95 1.67 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 115.296 -2.561 . . . . 0.0 107.675 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -165.46 168.33 16.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 83.4 t -131.13 150.03 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.123 -0.986 . . . . 0.0 109.418 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.477 ' CE1' HD13 ' A' ' 5' ' ' ILE . 7.1 m-85 -129.3 134.53 47.97 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.636 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -138.22 134.77 34.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.072 -1.018 . . . . 0.0 108.669 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.772 HG12 ' CD1' ' A' ' 113' ' ' PHE . 8.8 p -127.16 148.33 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.981 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.559 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 1.0 OUTLIER -123.72 75.16 1.32 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 118.193 -1.403 . . . . 0.0 110.732 179.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.559 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -162.29 119.7 2.1 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.48 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 8.7 tm-20 -115.37 106.24 13.77 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 117.526 -1.67 . . . . 0.0 110.653 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.605 ' C ' ' H ' ' A' ' 130' ' ' ASP . 86.6 mttt -110.92 -178.96 3.61 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 38' ' ' TRP . 71.4 m-80 -58.48 0.47 0.08 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.605 ' H ' ' C ' ' A' ' 128' ' ' LYS . 21.0 t0 -71.71 143.43 49.65 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.723 -1.236 . . . . 0.0 110.451 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.921 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.2 OUTLIER -110.85 149.36 30.69 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.657 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.921 ' N ' HD12 ' A' ' 131' ' ' LEU . 26.2 mm -114.45 131.93 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.646 ' OG ' HD11 ' A' ' 131' ' ' LEU . 4.4 m -120.31 144.57 47.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.869 . . . . 0.0 110.116 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.794 HG13 HD21 ' A' ' 115' ' ' LEU . 1.7 t -117.14 134.43 23.04 Favored Pre-proline 0 N--CA 1.488 1.436 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.17 151.87 76.65 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.954 1.769 . . . . 0.0 112.284 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.612 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.86 133.04 46.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 109.686 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.612 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 3.7 t-160 92.76 10.27 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 120.964 0.412 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.36 125.92 32.91 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.12 -0.987 . . . . 0.0 108.461 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.52 131.96 31.57 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.622 1.548 . . . . 0.0 111.575 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.504 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.16 163.15 15.55 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.479 -179.062 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.677 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 26.5 p90 -128.65 -153.9 0.6 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.533 -0.729 . . . . 0.0 109.67 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.631 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -172.92 124.0 0.43 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.505 -0.747 . . . . 0.0 109.214 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.472 ' OD1' HD11 ' A' ' 93' ' ' LEU . 29.9 t0 -147.96 131.91 17.16 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.147 -0.97 . . . . 0.0 109.453 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.606 ' O ' ' C ' ' A' ' 145' ' ' GLY . 7.4 mtm -111.76 20.02 17.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.273 -0.892 . . . . 0.0 110.815 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.606 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 11.02 -90.82 0.01 OUTLIER Glycine 0 N--CA 1.503 3.165 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.524 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 46.7 t -87.52 119.6 27.97 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.3 -1.36 . . . . 0.0 109.857 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.596 ' OE1' ' NE ' ' A' ' 89' ' ' ARG . 6.5 mp0 -114.08 120.11 39.31 Favored Pre-proline 0 N--CA 1.493 1.68 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.569 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.7 Cg_endo -100.32 28.88 0.12 Allowed 'Trans proline' 0 C--O 1.212 -0.806 0 C-N-CA 122.476 2.117 . . . . 0.0 112.753 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.621 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER 81.33 64.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.762 0.792 . . . . 0.0 110.16 -179.193 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.615 ' CZ ' HD23 ' A' ' 78' ' ' LEU . 15.2 p90 -101.6 171.06 7.78 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.577 0.703 . . . . 0.0 110.292 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 87.7 m -126.42 138.94 53.59 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.556 ' HB3' HD12 ' A' ' 76' ' ' ILE . . . -146.52 165.72 28.6 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.238 -0.914 . . . . 0.0 109.415 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 75.5 mt -118.09 136.66 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.386 -0.821 . . . . 0.0 109.746 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.518 ' HE ' HG12 ' A' ' 76' ' ' ILE . 2.7 mtm180 -140.15 168.01 20.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.021 -1.049 . . . . 0.0 109.653 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.888 HG21 ' CG ' ' A' ' 70' ' ' TYR . 3.9 mp -107.39 155.22 8.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.631 -0.668 . . . . 0.0 109.562 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.2 m-30 -103.06 121.09 41.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.204 -0.935 . . . . 0.0 110.319 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 3.9 t0 -133.27 163.06 30.15 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.668 ' N ' ' ND2' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -93.41 161.9 29.43 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.102 -0.999 . . . . 0.0 109.285 -178.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.3 Cg_endo -62.73 -55.01 0.96 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.237 1.958 . . . . 0.0 112.293 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 55.2 mp0 -44.41 -13.28 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.401 -0.812 . . . . 0.0 109.247 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -78.75 -33.94 36.25 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.534 ' N ' ' O ' ' A' ' 159' ' ' PRO . 4.5 p90 -118.8 159.32 23.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.381 -1.07 . . . . 0.0 110.825 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 81.7 mt -100.2 147.91 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.549 -0.719 . . . . 0.0 109.453 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.65 -73.25 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.5 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -140.9 159.47 42.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.944 -1.097 . . . . 0.0 109.883 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -89.69 -41.87 11.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.393 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 52.7 m -116.06 -31.39 5.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.305 -0.872 . . . . 0.0 108.696 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.63 -5.4 51.3 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.807 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -80.77 149.51 29.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.659 -1.495 . . . . 0.0 107.952 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -105.38 89.97 3.28 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 117.337 -1.745 . . . . 0.0 110.762 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.435 HG22 ' H ' ' A' ' 171' ' ' ILE . 0.2 OUTLIER -71.76 -30.11 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.95 -1.094 . . . . 0.0 109.417 -179.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.677 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -63.45 -41.33 98.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.332 -0.855 . . . . 0.0 108.851 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.546 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 15.7 t -51.9 -4.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 110.173 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -83.19 -34.03 26.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.09 -1.007 . . . . 0.0 110.901 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.591 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.1 m-85 -110.03 27.32 0.07 OUTLIER Pre-proline 0 N--CA 1.515 2.81 0 O-C-N 120.81 -1.181 . . . . 0.0 112.764 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 40.5 Cg_endo -58.97 -24.02 71.11 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 123.559 2.839 . . . . 0.0 114.511 -172.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -88.92 125.7 35.07 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 118.375 -1.33 . . . . 0.0 108.133 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' C ' ' A' ' 179' ' ' ALA . 5.0 tt -87.06 128.95 35.09 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.596 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.596 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.36 170.76 8.63 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.047 -1.033 . . . . 0.0 109.412 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.725 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 29.3 tp -158.06 114.98 2.89 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 130.78 55.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.18 -0.95 . . . . 0.0 109.797 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 121' ' ' VAL . 71.5 mt -127.29 138.34 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 178.97 6.87 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.605 0.717 . . . . 0.0 109.444 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.1 t -96.05 174.62 6.83 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.38 -22.88 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.028 -1.045 . . . . 0.0 109.159 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -73.73 -37.76 65.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.148 -0.97 . . . . 0.0 110.512 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.458 ' OD2' ' N ' ' A' ' 10' ' ' ASP . 1.3 p30 -137.51 123.59 13.13 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.029 -1.045 . . . . 0.0 109.461 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -81.86 -38.4 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.944 1.763 . . . . 0.0 112.301 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.32 3.09 2.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 110.275 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -114.67 119.44 36.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.874 . . . . 0.0 109.089 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 p -100.21 122.77 43.55 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.192 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 pp -88.09 -8.97 54.7 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.054 -1.059 . . . . 0.0 108.991 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.725 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 38.7 t90 -157.7 107.69 2.17 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.315 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -120.4 121.86 39.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.409 -0.807 . . . . 0.0 110.026 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.405 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -163.15 164.45 25.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.439 -0.788 . . . . 0.0 109.999 -179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.866 HG23 ' O ' ' A' ' 19' ' ' THR . 10.7 t -130.86 88.83 2.66 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 118.955 -1.098 . . . . 0.0 108.16 175.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.749 ' O ' HD12 ' A' ' 24' ' ' ILE . 12.0 m120 -125.9 143.68 50.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.098 -1.001 . . . . 0.0 110.684 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.15 -39.62 22.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.342 -1.474 . . . . 0.0 108.664 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.21 -50.89 8.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 109.566 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.7 -21.58 60.81 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.879 -1.138 . . . . 0.0 108.559 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 20' ' ' ASN . 2.0 mt -70.05 -57.34 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.256 -0.902 . . . . 0.0 108.943 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.517 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 8.7 pt20 -62.65 -44.94 94.99 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.941 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 25.9 mt-30 -59.88 -42.38 93.62 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.148 -0.97 . . . . 0.0 109.885 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.676 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 5.3 tt0 -80.24 -47.03 15.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.912 -1.118 . . . . 0.0 109.399 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.49 ' CD1' HG21 ' A' ' 33' ' ' VAL . 20.2 tp -66.14 -55.4 16.58 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.986 -1.071 . . . . 0.0 109.022 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 33' ' ' VAL . 41.2 t-20 -59.63 -19.78 51.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.911 -1.118 . . . . 0.0 109.471 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -65.15 -27.58 68.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.859 -1.151 . . . . 0.0 108.601 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -86.5 12.78 9.6 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.737 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.72 23.23 31.26 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.042 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.49 HG21 ' CD1' ' A' ' 28' ' ' LEU . 70.6 t -94.33 145.44 7.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.469 -1.018 . . . . 0.0 109.176 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -84.45 158.5 21.02 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.345 -0.847 . . . . 0.0 108.737 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.475 ' CE2' HD11 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -152.77 152.31 31.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.881 -1.137 . . . . 0.0 108.006 177.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 130' ' ' ASP . 3.4 mm-40 -170.77 169.4 6.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.909 -1.119 . . . . 0.0 109.21 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -150.55 118.58 6.29 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.503 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 23.4 m0 -111.17 150.32 29.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.863 . . . . 0.0 108.996 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -139.68 157.51 45.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.149 -0.969 . . . . 0.0 109.629 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.31 159.53 15.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 108.968 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.47 ' OD2' ' N ' ' A' ' 42' ' ' ARG . 54.1 p30 -100.17 -9.94 21.96 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.47 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 15.8 ttm180 -93.48 150.69 20.25 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.3 117.88 30.03 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.536 -0.727 . . . . 0.0 109.261 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mt -93.28 165.63 12.71 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.32 -0.863 . . . . 0.0 109.383 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.39 -121.33 0.56 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.49 78.57 9.66 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.113 -1.228 . . . . 0.0 108.635 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.3 94.58 48.79 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.509 -0.744 . . . . 0.0 109.087 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.25 85.61 0.43 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.822 1.681 . . . . 0.0 111.646 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.28 109.02 0.64 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.265 -0.897 . . . . 0.0 109.276 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.25 -35.41 31.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.645 -1.284 . . . . 0.0 109.759 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 6.3 pt-20 -65.28 -20.78 66.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 110.155 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.9 m -79.83 -35.67 37.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.161 -0.962 . . . . 0.0 110.302 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.95 -46.51 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.957 . . . . 0.0 109.842 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -61.99 -42.18 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.935 . . . . 0.0 108.978 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.34 -29.75 70.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.399 -0.813 . . . . 0.0 109.702 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.12 -19.17 58.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 110.165 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -116.38 -9.0 11.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.794 . . . . 0.0 109.566 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 54' ' ' ILE . 4.8 mm-40 -49.65 -39.04 34.79 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.145 -0.972 . . . . 0.0 108.857 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.598 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 21.5 p80 -52.68 -45.03 66.64 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.427 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.598 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.12 -59.65 4.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.906 -1.121 . . . . 0.0 110.015 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.699 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -63.42 -28.25 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.025 -1.047 . . . . 0.0 109.289 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.2 t70 -58.35 -24.73 60.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.382 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -84.6 -41.63 16.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 109.978 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.477 HD21 HG21 ' A' ' 103' ' ' VAL . 2.3 tt -66.49 -46.27 76.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.388 -0.82 . . . . 0.0 109.751 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.7 p -67.24 -30.11 48.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 109.283 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.41 -43.52 75.35 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.094 -1.004 . . . . 0.0 109.367 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -78.52 -52.21 8.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 0.0 109.832 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.64 ' O ' ' C ' ' A' ' 69' ' ' GLY . 45.0 mmtm -83.22 12.18 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.389 -0.82 . . . . 0.0 110.342 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.64 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -0.23 80.33 0.0 OUTLIER Glycine 0 N--CA 1.503 3.166 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.484 ' CG ' HG21 ' A' ' 155' ' ' ILE . 43.2 m-85 -77.27 166.36 23.29 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.375 -1.073 . . . . 0.0 108.461 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -57.24 -92.24 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.444 -0.785 . . . . 0.0 109.173 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.44 164.9 11.42 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.603 0.716 . . . . 0.0 110.177 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.506 ' CZ3' HD12 ' A' ' 155' ' ' ILE . 6.4 t-105 -136.2 140.61 43.67 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.427 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.8 OUTLIER -157.37 175.36 14.09 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.089 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -120.14 143.27 32.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 76' ' ' ILE . 4.3 tp -103.07 115.89 45.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 77' ' ' SER . 9.8 p -168.57 101.44 0.41 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.503 -0.748 . . . . 0.0 109.003 178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.662 HD23 ' CB ' ' A' ' 82' ' ' ASN . 9.9 tp -110.45 -179.49 3.78 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 119.564 -1.96 . . . . 0.0 107.751 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.56 ' C ' ' H ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -88.41 147.49 24.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.744 -1.223 . . . . 0.0 109.773 -178.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.423 ' H ' ' HD3' ' A' ' 79' ' ' ARG . . . -59.22 3.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.656 -0.652 . . . . 0.0 109.571 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 79' ' ' ARG . 84.6 m-20 -88.39 -25.52 22.65 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.624 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.662 ' CB ' HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -63.61 128.08 92.24 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.991 -1.068 . . . . 0.0 109.639 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -75.95 -6.49 17.46 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.211 1.941 . . . . 0.0 112.392 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -89.33 10.69 21.43 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.9 -1.125 . . . . 0.0 109.41 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.509 ' CG ' ' H ' ' A' ' 86' ' ' GLU . 2.4 pttm -56.77 -57.28 13.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 108.798 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.509 ' H ' ' CG ' ' A' ' 85' ' ' LYS . 84.1 tt0 -66.15 -40.02 90.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.207 -0.933 . . . . 0.0 109.798 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.31 90.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.692 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.2 mt -61.3 -46.93 88.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 110.203 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.61 -26.41 67.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.947 -1.095 . . . . 0.0 109.721 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -67.21 -59.3 3.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.453 -0.779 . . . . 0.0 110.375 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -57.9 -38.65 76.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.97 . . . . 0.0 109.534 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -74.59 -24.21 58.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.719 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.439 HD21 ' N ' ' A' ' 173' ' ' SER . 1.5 tt -64.18 -33.98 77.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 109.997 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.473 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 44.0 p-10 -43.09 148.68 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 109.709 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.565 ' OE2' ' N ' ' A' ' 171' ' ' ILE . 77.5 mt-10 -85.24 157.44 20.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.334 -0.854 . . . . 0.0 109.626 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -174.38 -165.72 0.23 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.011 -1.056 . . . . 0.0 111.488 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.83 131.8 3.02 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.603 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -101.63 155.3 18.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 109.955 -178.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.86 -5.92 86.89 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' A' ' 101' ' ' ASP . 22.6 tp10 -126.57 169.26 13.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -1.07 . . . . 0.0 109.304 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.447 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 89.4 m-20 -70.06 143.42 52.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.245 -0.91 . . . . 0.0 110.06 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.603 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 2.7 tt0 -102.52 95.05 5.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 110.195 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.535 HG12 ' OG ' ' A' ' 133' ' ' SER . 18.0 m -94.64 125.52 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.31 126.03 38.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.503 ' CE2' ' CE3' ' A' ' 38' ' ' TRP . 42.3 t80 -101.92 126.89 48.93 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.492 ' CD1' ' HB2' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -89.61 134.24 34.23 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.618 -0.676 . . . . 0.0 110.39 -178.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.2 -25.9 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.814 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' A' ' 109' ' ' GLY . 74.3 tt0 -172.36 163.94 5.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.008 -1.057 . . . . 0.0 108.895 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.619 ' N ' ' OE1' ' A' ' 127' ' ' GLU . . . 43.78 104.61 0.01 OUTLIER Glycine 0 N--CA 1.495 2.569 0 O-C-N 121.104 -0.998 . . . . 0.0 110.792 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.492 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . . . -149.79 111.08 4.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.671 -1.488 . . . . 0.0 109.105 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.48 ' C ' HD12 ' A' ' 125' ' ' LEU . . . -78.51 -140.89 1.78 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -109.9 100.97 9.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.415 -1.05 . . . . 0.0 111.775 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.493 ' C ' ' OE1' ' A' ' 123' ' ' GLN . 30.8 p90 -79.82 128.62 33.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.61 -1.306 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.462 ' SG ' ' NE1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -78.91 143.71 35.58 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.318 0.58 . . . . 0.0 109.939 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.544 HD11 HG21 ' A' ' 134' ' ' VAL . 4.7 tp -131.38 124.73 30.95 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.2 t-160 -102.43 103.48 13.88 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.927 -1.108 . . . . 0.0 110.012 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.624 ' H ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -115.93 105.92 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.203 -0.936 . . . . 0.0 109.889 -179.152 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.54 -144.24 32.59 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 105.293 -3.123 . . . . 0.0 105.293 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.521 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 41.5 p30 -102.11 79.36 1.87 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 115.225 -2.59 . . . . 0.0 109.589 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.527 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 15.0 tp10 -165.76 170.68 13.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.666 ' O ' HG23 ' A' ' 5' ' ' ILE . 55.8 t -127.74 141.94 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.12 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.474 ' CE1' HD13 ' A' ' 5' ' ' ILE . 22.1 m-85 -128.49 132.32 48.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.808 -0.557 . . . . 0.0 109.788 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.493 ' OE1' ' C ' ' A' ' 113' ' ' PHE . 11.2 mm-40 -128.73 112.98 14.78 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 2.4 t -100.54 134.99 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.535 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 54.5 tp -126.54 86.05 2.46 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.543 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.535 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -168.2 137.51 2.45 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -104.67 99.42 9.09 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 116.119 -2.232 . . . . 0.0 109.792 -179.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.578 ' C ' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -119.38 159.53 24.01 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.988 176.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.491 HD22 ' C ' ' A' ' 129' ' ' ASN . 0.4 OUTLIER -60.68 2.67 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.002 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.578 ' H ' ' C ' ' A' ' 128' ' ' LYS . 9.6 t70 -66.45 135.3 54.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.86 -1.15 . . . . 0.0 110.353 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.777 HD13 ' N ' ' A' ' 132' ' ' ILE . 1.4 tm? -92.37 125.11 36.88 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.748 -177.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.777 ' N ' HD13 ' A' ' 131' ' ' LEU . 1.0 OUTLIER -108.33 127.62 64.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.535 ' OG ' HG12 ' A' ' 103' ' ' VAL . 5.2 t -120.69 144.15 48.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.451 -0.781 . . . . 0.0 109.673 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.544 HG21 HD11 ' A' ' 115' ' ' LEU . 1.1 t -119.13 142.18 31.72 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.39 147.16 70.92 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.343 2.029 . . . . 0.0 113.051 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.614 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.8 134.15 45.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 109.375 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.614 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 2.2 t-80 92.32 11.02 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.68 128.13 27.49 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.117 -0.99 . . . . 0.0 108.797 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.49 132.38 33.13 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.751 1.634 . . . . 0.0 111.53 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.55 164.72 10.39 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.199 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.48 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.4 OUTLIER -136.66 -149.14 0.31 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.195 -0.941 . . . . 0.0 109.597 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -173.61 124.1 0.37 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.997 -1.064 . . . . 0.0 109.018 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -137.66 129.99 29.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.55 -0.719 . . . . 0.0 109.525 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.612 ' SD ' ' CE2' ' A' ' 150' ' ' PHE . 60.5 mtm -100.61 16.97 23.04 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.764 -0.585 . . . . 0.0 111.312 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 32.64 -125.92 0.29 Allowed Glycine 0 N--CA 1.49 2.287 0 O-C-N 120.636 -1.29 . . . . 0.0 110.537 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.597 ' CB ' HD22 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -81.7 121.37 26.29 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.099 -1.441 . . . . 0.0 108.624 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.89 115.58 45.85 Favored Pre-proline 0 N--CA 1.492 1.636 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.355 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 60.3 Cg_endo -103.69 50.34 0.03 OUTLIER 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 122.957 2.438 . . . . 0.0 110.742 176.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.2 OUTLIER 81.85 70.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.132 -177.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.612 ' CE2' ' SD ' ' A' ' 144' ' ' MET . 20.5 p90 -96.24 163.13 13.22 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.274 -0.891 . . . . 0.0 110.167 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.9 m -128.81 124.5 35.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.469 -0.769 . . . . 0.0 110.533 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.562 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . . . -141.97 160.75 39.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.501 -0.749 . . . . 0.0 109.012 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.505 HG23 ' HE1' ' A' ' 73' ' ' TRP . 79.6 mt -111.14 129.24 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.182 -0.949 . . . . 0.0 109.247 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.643 ' C ' HD13 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -135.29 165.09 26.24 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.643 HD13 ' C ' ' A' ' 154' ' ' ARG . 0.6 OUTLIER -107.59 152.66 9.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.49 -0.756 . . . . 0.0 109.381 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.427 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.8 m-30 -96.77 119.63 35.61 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.0 0.905 . . . . 0.0 109.892 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 53.5 p30 -134.99 163.84 28.95 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.564 ' ND2' ' H ' ' A' ' 161' ' ' GLY . 0.0 OUTLIER -94.03 161.54 29.48 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.982 -1.073 . . . . 0.0 109.075 -179.259 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.63 ' O ' ' N ' ' A' ' 161' ' ' GLY . 40.7 Cg_endo -63.77 -55.45 0.67 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.013 1.809 . . . . 0.0 112.045 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 159' ' ' PRO . 94.4 mt-10 -43.77 -14.38 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.369 -0.832 . . . . 0.0 109.197 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -75.93 -40.52 30.29 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.507 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 4.1 p90 -108.83 159.56 16.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 79.2 mt -100.67 147.42 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.402 -0.811 . . . . 0.0 109.509 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -49.2 -74.11 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.263 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.29 161.47 38.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.111 -0.993 . . . . 0.0 109.804 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -88.19 -41.62 12.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.028 -1.045 . . . . 0.0 109.546 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 63.4 p -112.48 -31.89 6.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.293 -0.879 . . . . 0.0 108.877 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.91 -8.02 53.61 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -80.04 145.92 32.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.624 -1.515 . . . . 0.0 108.039 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -112.36 89.81 3.17 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.316 -1.354 . . . . 0.0 110.872 176.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.565 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -83.21 -20.12 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.049 -1.657 . . . . 0.0 109.284 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -56.77 -43.82 81.18 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.445 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 47.6 t -56.25 -1.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 109.648 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -87.93 -18.62 28.73 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.382 -0.824 . . . . 0.0 110.842 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.573 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 54.2 m-85 -108.45 27.41 0.07 OUTLIER Pre-proline 0 N--CA 1.518 2.952 0 O-C-N 121.187 -0.946 . . . . 0.0 112.83 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 42.1 Cg_endo -60.86 -5.57 4.86 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 123.916 3.077 . . . . 0.0 113.453 -173.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -84.62 148.94 26.18 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.3 -0.875 . . . . 0.0 109.149 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.747 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 15.9 tp -89.34 101.18 13.85 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.829 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.905 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.619 ' O ' ' OG1' ' A' ' 19' ' ' THR . 7.9 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.2 169.96 9.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.126 -0.983 . . . . 0.0 109.214 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 4' ' ' THR . 2.7 tp -157.24 118.96 3.74 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.534 ' N ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -109.79 133.88 52.66 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.179 -0.95 . . . . 0.0 109.795 -178.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.769 HG23 ' O ' ' A' ' 121' ' ' VAL . 52.9 mt -127.5 136.08 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.58 166.19 20.22 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.409 ' OG ' ' CD1' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -86.75 174.27 8.93 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 108.796 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.33 -28.31 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.03 -1.044 . . . . 0.0 109.117 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -73.54 -36.91 65.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.28 124.97 15.41 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 109.552 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.82 -37.82 0.31 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.935 1.757 . . . . 0.0 112.407 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.45 ' C ' HD22 ' A' ' 13' ' ' ASN . 1.6 tt0 -69.46 6.26 1.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.093 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.659 ' N ' HD22 ' A' ' 13' ' ' ASN . 0.9 OUTLIER -114.03 120.32 40.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.908 . . . . 0.0 109.055 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.5 p -100.29 122.01 42.4 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.365 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.409 ' CD1' ' OG ' ' A' ' 7' ' ' SER . 7.1 mt -88.9 -7.52 55.94 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.064 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.673 ' HB3' HD12 ' A' ' 5' ' ' ILE . 48.3 t90 -157.46 105.95 2.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.421 -1.312 . . . . 0.0 109.9 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -117.82 111.11 18.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.329 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.436 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -162.47 162.85 27.7 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.868 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.837 HG23 ' O ' ' A' ' 19' ' ' THR . 10.0 t -131.71 90.28 2.82 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 120.966 -1.084 . . . . 0.0 108.181 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.759 ' O ' HD12 ' A' ' 24' ' ' ILE . 1.7 m-80 -124.55 143.47 50.67 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.285 -0.884 . . . . 0.0 110.442 177.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.75 -40.88 22.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.012 -1.68 . . . . 0.0 108.536 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.28 -48.41 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 110.021 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -60.62 -23.95 65.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.969 -1.082 . . . . 0.0 108.698 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.759 HD12 ' O ' ' A' ' 20' ' ' ASN . 10.9 mt -72.63 -53.68 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.234 -0.916 . . . . 0.0 108.83 178.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 29' ' ' ASN . 52.0 tt0 -59.09 -52.87 63.85 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.141 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.656 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 1.0 OUTLIER -59.75 -40.14 87.16 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.28 -0.888 . . . . 0.0 109.64 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.644 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 7.0 tt0 -78.1 -50.21 12.46 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.933 -1.104 . . . . 0.0 109.579 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 24' ' ' ILE . 22.6 tp -69.03 -55.87 9.49 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.7 -1.25 . . . . 0.0 109.268 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 25' ' ' GLN . 26.2 t-20 -56.82 -20.89 25.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.876 -1.14 . . . . 0.0 109.448 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -66.54 -26.37 67.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.889 -1.132 . . . . 0.0 108.374 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 10.63 15.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.296 -0.877 . . . . 0.0 109.695 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.06 21.89 26.69 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.4 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 38.6 t -94.31 146.26 6.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.193 -1.18 . . . . 0.0 108.958 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.448 HH12 ' NZ ' ' A' ' 68' ' ' LYS . 13.4 ttm180 -84.12 157.24 21.78 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.438 ' C ' ' OE1' ' A' ' 36' ' ' GLU . 1.2 t80 -154.98 153.66 31.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.83 -1.169 . . . . 0.0 108.729 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.438 ' OE1' ' C ' ' A' ' 35' ' ' PHE . 1.5 pm0 -175.63 173.21 2.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.861 -1.149 . . . . 0.0 109.837 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -148.82 112.94 5.2 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.642 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 23.9 m0 -111.48 149.76 30.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 38' ' ' TRP . 84.0 mm-40 -138.09 157.87 45.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.776 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.22 158.79 15.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 108.937 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -101.34 -12.98 18.21 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -92.94 158.34 15.87 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.652 0.739 . . . . 0.0 109.051 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -93.0 119.29 32.1 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.615 -0.678 . . . . 0.0 109.507 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.34 164.0 14.01 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.381 -0.824 . . . . 0.0 109.278 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.72 -103.94 0.2 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.0 88.64 4.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.115 -1.226 . . . . 0.0 109.264 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.54 92.92 17.81 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.482 -0.761 . . . . 0.0 109.005 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.54 -28.2 10.26 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.151 1.901 . . . . 0.0 112.574 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 50.1 p -119.86 140.94 50.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.649 -0.657 . . . . 0.0 109.877 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.655 ' CB ' HG21 ' A' ' 151' ' ' THR . . . -81.0 -17.28 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 109.593 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -46.61 -37.53 8.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.33 -0.856 . . . . 0.0 109.119 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.5 p -78.81 -31.12 45.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 0.0 109.338 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 107' ' ' VAL . 25.1 t -69.11 -48.87 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.86 . . . . 0.0 109.818 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 58' ' ' GLN . 6.6 mt -59.65 -39.3 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 109.017 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.51 -31.0 71.69 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.434 -0.791 . . . . 0.0 109.657 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.22 -17.79 60.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 0.0 110.042 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -113.98 -6.8 13.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.448 -0.783 . . . . 0.0 109.307 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.661 HE22 HD11 ' A' ' 61' ' ' ILE . 1.1 mm-40 -48.64 -39.48 24.35 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.305 -0.958 . . . . 0.0 108.993 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 60' ' ' ALA . 35.6 p80 -52.08 -46.78 65.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.039 -1.038 . . . . 0.0 109.652 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.584 ' N ' ' ND1' ' A' ' 59' ' ' HIS . . . -62.49 -61.6 2.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.917 -1.114 . . . . 0.0 109.849 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.683 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -61.16 -29.45 45.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.749 -1.22 . . . . 0.0 109.187 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 58' ' ' GLN . 33.2 t0 -58.1 -26.12 62.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 109.521 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.33 -39.41 59.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.127 -0.983 . . . . 0.0 109.236 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.2 mp -63.75 -36.75 84.92 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.268 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 61' ' ' ILE . 2.8 t -70.41 -29.5 39.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.304 -0.872 . . . . 0.0 109.339 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.4 -53.82 51.43 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.488 -1.383 . . . . 0.0 109.392 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -82.64 -50.37 8.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.964 -1.085 . . . . 0.0 110.785 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.582 ' O ' ' C ' ' A' ' 69' ' ' GLY . 70.9 mttt -86.26 14.0 7.18 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.387 -0.821 . . . . 0.0 110.858 -177.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.582 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -15.34 88.97 0.01 OUTLIER Glycine 0 N--CA 1.502 3.068 0 CA-C-O 122.195 0.886 . . . . 0.0 111.731 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.785 ' CG ' HG21 ' A' ' 155' ' ' ILE . 84.0 m-85 -77.69 162.3 27.1 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -58.55 -81.7 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 108.742 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.1 m -103.26 157.52 16.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.466 -0.771 . . . . 0.0 109.599 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.672 ' CE2' HD13 ' A' ' 61' ' ' ILE . 11.0 t-105 -141.27 146.44 36.8 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.469 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.3 OUTLIER -177.44 -165.22 0.1 Allowed 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 153' ' ' ILE . 3.2 m -122.58 165.54 18.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.398 -0.814 . . . . 0.0 109.222 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -95.48 140.69 16.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.589 ' O ' HD22 ' A' ' 78' ' ' LEU . 58.8 p -91.68 162.38 14.51 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.049 1.404 . . . . 0.0 112.248 -176.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -158.85 118.48 3.1 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 113.49 -1.687 . . . . 0.0 112.41 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -131.7 139.54 49.05 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.39 -18.3 65.28 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.761 -1.212 . . . . 0.0 109.5 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -104.74 31.77 4.54 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.659 HD22 ' H ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -92.58 125.4 55.93 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.019 -1.05 . . . . 0.0 110.619 178.332 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -78.2 -7.6 16.19 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.997 1.798 . . . . 0.0 112.268 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -90.81 0.93 57.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.978 -1.076 . . . . 0.0 110.024 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.518 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 11.5 ptmm? -58.05 -51.29 70.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.183 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 49.7 tp10 -62.84 -56.61 15.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.093 -1.004 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.92 -44.6 78.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.404 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.4 -42.25 98.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.309 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.49 ' HG2' ' H ' ' A' ' 144' ' ' MET . 43.3 mtp180 -60.75 -40.69 93.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.725 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -66.7 -58.31 5.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.368 -0.833 . . . . 0.0 110.511 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -53.37 -34.41 57.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.611 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -88.14 -17.66 30.47 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 110.213 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 176' ' ' PRO . 6.0 tp -61.36 -38.23 86.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.866 -1.146 . . . . 0.0 109.97 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 40.2 p-10 -54.81 131.11 43.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 0.0 110.148 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.49 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 1.7 pp20? -71.55 165.55 23.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.389 -0.819 . . . . 0.0 109.339 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.49 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 38.3 p-80 -175.13 -165.22 0.17 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.294 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.84 135.66 4.83 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.67 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.37 154.98 21.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -0.835 . . . . 0.0 109.676 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.52 -6.98 85.19 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.515 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 84.9 tt0 -125.93 169.13 13.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.243 -1.151 . . . . 0.0 108.988 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.433 ' N ' ' HG2' ' A' ' 100' ' ' GLU . 90.3 m-20 -74.47 144.06 44.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.859 -1.151 . . . . 0.0 110.613 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.415 ' HG3' ' CE1' ' A' ' 98' ' ' HIS . 2.3 mt-10 -100.88 91.64 4.68 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.68 HG12 ' OG ' ' A' ' 133' ' ' SER . 6.4 m -84.63 131.31 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -130.62 112.74 13.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.758 -0.589 . . . . 0.0 109.513 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.65 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 17.3 t80 -101.25 135.87 42.02 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.606 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -92.17 133.66 35.58 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.465 -0.772 . . . . 0.0 110.118 -178.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -112.33 -36.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.268 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -156.56 143.24 18.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.939 -1.1 . . . . 0.0 109.919 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.43 170.67 40.08 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.56 -170.15 1.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.228 -1.16 . . . . 0.0 109.485 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.53 -138.22 2.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.7 tp -142.71 159.67 41.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.19 -1.182 . . . . 0.0 109.168 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -134.98 86.94 2.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 109.485 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.817 ' O ' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -80.94 120.24 24.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.875 . . . . 0.0 109.511 178.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.817 HD23 ' O ' ' A' ' 114' ' ' CYS . 2.2 mt -132.64 124.34 28.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.2 -0.937 . . . . 0.0 109.032 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 9.6 t-160 -108.3 114.54 28.48 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.943 -1.098 . . . . 0.0 108.985 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.3 mt -127.79 116.45 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.593 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.14 -143.5 33.29 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 105.916 -2.874 . . . . 0.0 105.916 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -105.57 79.11 1.42 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 115.578 -2.449 . . . . 0.0 108.474 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.5 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 31.5 tt0 -166.08 168.66 15.29 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 5' ' ' ILE . 41.9 t -126.37 140.91 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.997 -1.065 . . . . 0.0 110.227 177.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -120.48 130.38 54.26 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.191 0.519 . . . . 0.0 110.249 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.496 ' O ' HD12 ' A' ' 3' ' ' LEU . 19.0 mt-30 -131.08 112.58 13.01 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.496 -0.752 . . . . 0.0 109.107 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.79 137.81 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.6 mp -136.54 93.08 2.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.203 -0.936 . . . . 0.0 110.146 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 1' ' ' SER . 44.0 t -165.96 138.49 4.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.545 -1.347 . . . . 0.0 108.195 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.66 94.37 5.16 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 115.779 -2.368 . . . . 0.0 110.759 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.585 ' C ' ' H ' ' A' ' 130' ' ' ASP . 32.6 mtmt -116.18 150.38 37.56 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.585 176.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.712 ' N ' HD22 ' A' ' 129' ' ' ASN . 0.6 OUTLIER -59.72 -1.95 0.32 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.414 -1.428 . . . . 0.0 107.695 177.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' A' ' 128' ' ' LYS . 57.0 p30 -68.47 146.13 53.44 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.069 0.937 . . . . 0.0 109.927 -176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.037 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -105.15 140.24 38.62 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.576 0.703 . . . . 0.0 109.962 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 1.037 ' N ' HD12 ' A' ' 131' ' ' LEU . 14.1 tt -128.8 120.6 52.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.68 ' OG ' HG12 ' A' ' 103' ' ' VAL . 8.1 t -118.59 142.99 47.09 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.57 HG11 HD22 ' A' ' 115' ' ' LEU . 12.4 m -99.19 148.57 34.81 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.751 ' O ' HG22 ' A' ' 138' ' ' THR . 38.6 Cg_endo -66.9 153.48 77.77 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.436 2.091 . . . . 0.0 113.355 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.613 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -74.81 136.64 41.62 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.173 -0.954 . . . . 0.0 109.188 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.613 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 13.2 t-80 94.14 10.94 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.751 HG22 ' O ' ' A' ' 135' ' ' PRO . 12.2 t -106.42 127.16 28.75 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.948 -1.095 . . . . 0.0 109.021 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.15 134.4 48.93 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.829 1.686 . . . . 0.0 111.752 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.515 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -171.78 162.15 6.12 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.972 -179.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.492 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -134.11 -148.67 0.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.222 -0.923 . . . . 0.0 109.446 -178.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -175.06 126.6 0.27 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.038 -1.039 . . . . 0.0 109.094 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.499 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 52.5 p-10 -146.88 138.05 24.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.328 -0.858 . . . . 0.0 109.75 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.613 ' O ' ' C ' ' A' ' 145' ' ' GLY . 6.6 mmt -107.06 19.43 20.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.339 -0.851 . . . . 0.0 111.791 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.613 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 2.22 -88.1 0.0 OUTLIER Glycine 0 N--CA 1.506 3.31 0 CA-C-N 119.5 1.046 . . . . 0.0 111.714 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.484 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 69.2 m -85.52 121.32 28.05 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.119 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.599 ' OE2' ' ND2' ' A' ' 82' ' ' ASN . 40.1 mt-10 -103.25 119.64 54.53 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.589 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 56.1 Cg_endo -104.22 0.89 0.28 Allowed 'Trans proline' 0 C--O 1.207 -1.072 0 C-N-CA 123.844 3.029 . . . . 0.0 110.964 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.626 ' ND2' ' O ' ' A' ' 149' ' ' ASN . 0.1 OUTLIER 83.87 63.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 123.489 1.614 . . . . 0.0 110.424 -179.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.435 ' CE1' ' HG ' ' A' ' 78' ' ' LEU . 8.8 p90 -100.88 178.48 4.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.575 -1.328 . . . . 0.0 109.528 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.655 HG21 ' CB ' ' A' ' 50' ' ' ALA . 85.7 m -133.43 139.32 46.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.478 -0.764 . . . . 0.0 109.465 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 76' ' ' ILE . . . -141.23 161.69 37.28 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.853 -1.155 . . . . 0.0 109.721 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.76 ' HA ' HG12 ' A' ' 75' ' ' VAL . 64.4 mt -108.36 127.58 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.017 -1.052 . . . . 0.0 110.195 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -138.96 167.06 22.89 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.427 -0.796 . . . . 0.0 109.905 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.785 HG21 ' CG ' ' A' ' 70' ' ' TYR . 2.9 mt -101.76 147.24 8.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.449 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.6 m-85 -96.48 118.3 32.7 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.347 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.605 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 14.4 p30 -136.17 161.75 34.86 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.826 -0.546 . . . . 0.0 109.575 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -95.71 161.39 27.75 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 120.871 -1.143 . . . . 0.0 109.332 -179.333 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.615 ' O ' ' N ' ' A' ' 162' ' ' TRP . 42.0 Cg_endo -65.6 -53.91 0.68 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.372 2.048 . . . . 0.0 112.034 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 159' ' ' PRO . 49.7 tp10 -43.48 -16.25 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.328 -0.857 . . . . 0.0 109.177 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -86.0 -23.07 46.72 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.615 ' N ' ' O ' ' A' ' 159' ' ' PRO . 20.3 m95 -116.5 165.94 12.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.339 -1.095 . . . . 0.0 109.926 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 35.2 pt -102.46 153.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.212 -0.93 . . . . 0.0 109.284 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.94 -73.64 0.3 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.137 -0.977 . . . . 0.0 110.292 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -141.18 159.01 43.11 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.083 -1.011 . . . . 0.0 109.662 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -101.24 -41.07 6.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.11 -0.994 . . . . 0.0 109.589 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 58.4 p -101.47 -30.31 11.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.081 -1.012 . . . . 0.0 109.443 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.3 -4.03 62.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -79.41 147.64 32.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.829 -1.395 . . . . 0.0 108.361 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 37.5 p30 -110.65 87.64 2.58 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 117.949 -1.501 . . . . 0.0 111.021 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.46 ' H ' HG22 ' A' ' 171' ' ' ILE . 1.7 tt -76.26 -17.26 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.321 -1.487 . . . . 0.0 109.312 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.492 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -59.79 -41.86 92.09 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.799 -0.76 . . . . 0.0 108.952 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.63 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 24.1 t -52.7 -4.64 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.429 -0.794 . . . . 0.0 110.391 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.485 ' HB3' ' CE2' ' A' ' 175' ' ' TYR . . . -79.49 -40.37 29.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.783 -1.198 . . . . 0.0 111.514 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.632 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 6.1 m-85 -113.37 25.49 0.09 OUTLIER Pre-proline 0 N--CA 1.516 2.851 0 O-C-N 120.5 -1.375 . . . . 0.0 112.297 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.743 ' HB3' HD11 ' A' ' 93' ' ' LEU . 44.7 Cg_endo -60.91 -20.41 66.75 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.792 2.995 . . . . 0.0 114.06 -172.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -89.61 126.46 35.63 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.554 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 179' ' ' ALA . 5.3 tt -87.27 122.36 30.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.045 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.668 ' N ' HD23 ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.299 -1.598 0 O-C-N 121.01 -1.056 . . . . 0.0 109.503 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.558 ' O ' ' OG1' ' A' ' 19' ' ' THR . 85.0 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.39 172.51 7.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.262 -0.899 . . . . 0.0 109.203 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.817 ' CD1' HG22 ' A' ' 124' ' ' VAL . 34.8 tp -158.71 114.08 2.59 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 123' ' ' GLN . 0.1 OUTLIER -106.34 128.52 54.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.959 -1.088 . . . . 0.0 110.535 -178.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.523 HD12 ' CE3' ' A' ' 16' ' ' TRP . 58.1 mt -122.57 130.47 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.453 ' CD2' ' O ' ' A' ' 11' ' ' PRO . 78.0 m-85 -129.7 167.0 18.68 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.9 m -89.86 173.65 8.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.952 -1.093 . . . . 0.0 108.706 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 8' ' ' VAL . 2.0 m -89.3 -28.25 5.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.029 -1.044 . . . . 0.0 109.495 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -72.14 -39.57 68.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.488 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -138.48 124.6 12.67 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.89 -1.132 . . . . 0.0 109.563 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 55.9 Cg_endo -81.89 -31.52 1.02 Allowed 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.727 1.618 . . . . 0.0 112.193 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.84 1.07 4.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.415 -0.803 . . . . 0.0 110.444 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.37 118.78 32.09 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 p -96.82 127.13 42.5 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.055 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pp -89.93 -13.5 36.14 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.808 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.793 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 53.9 t90 -158.72 106.77 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.412 -1.315 . . . . 0.0 109.713 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -120.14 119.97 34.85 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.287 -0.883 . . . . 0.0 109.835 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.412 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -161.66 165.44 28.24 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.32 -0.863 . . . . 0.0 110.094 -179.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 19' ' ' THR . 7.9 t -130.11 89.6 2.82 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.182 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.766 ' O ' HD12 ' A' ' 24' ' ' ILE . 20.4 m120 -125.12 137.37 54.17 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.707 -0.62 . . . . 0.0 110.181 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.8 -35.04 29.94 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.152 -1.593 . . . . 0.0 108.76 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.1 mp0 -82.92 -51.11 7.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.268 -0.895 . . . . 0.0 109.275 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.483 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.3 tt0 -61.17 -18.49 58.42 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.766 HD12 ' O ' ' A' ' 20' ' ' ASN . 1.9 mt -72.85 -58.4 5.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.144 -0.973 . . . . 0.0 108.514 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.514 ' N ' HG22 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -57.68 -45.59 85.39 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.455 -0.778 . . . . 0.0 109.324 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.671 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 7.9 tt0 -62.41 -44.18 97.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 110.144 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.546 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 27.2 mt-30 -79.02 -46.31 18.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.883 -1.136 . . . . 0.0 109.902 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.421 ' HG ' HG11 ' A' ' 33' ' ' VAL . 16.0 tp -65.82 -58.33 5.88 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.939 -1.1 . . . . 0.0 109.075 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.476 ' CG ' ' O ' ' A' ' 33' ' ' VAL . 19.8 t-20 -60.41 -18.95 54.22 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.735 -1.228 . . . . 0.0 109.715 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -64.67 -24.93 67.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.785 -1.197 . . . . 0.0 108.025 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -88.64 13.81 11.42 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.566 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.36 21.09 46.14 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.343 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.476 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 34.0 t -93.65 144.35 9.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.366 -1.079 . . . . 0.0 109.278 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -83.76 156.16 22.69 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -153.62 146.92 24.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.807 -1.183 . . . . 0.0 107.973 177.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.9 pt-20 -175.18 175.16 2.29 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.074 -1.016 . . . . 0.0 110.271 178.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -148.37 121.94 9.17 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.456 ' CZ2' HD23 ' A' ' 131' ' ' LEU . 34.5 m0 -112.25 153.61 26.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 108.836 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -139.25 146.58 40.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.689 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.597 ' HB2' ' CE1' ' A' ' 57' ' ' TYR . . . -101.85 159.95 14.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 108.708 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -96.23 -17.06 21.05 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.6 mtm-85 -93.09 147.95 22.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -91.91 137.17 32.59 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.582 -0.699 . . . . 0.0 109.273 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.445 ' N ' HD22 ' A' ' 44' ' ' LEU . 4.3 mm? -92.33 163.64 13.81 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.819 0.818 . . . . 0.0 109.378 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.15 -113.5 0.37 Allowed Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.92 -1.134 . . . . 0.0 110.639 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.61 89.01 4.51 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.126 -1.22 . . . . 0.0 109.392 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.49 92.42 19.59 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.1 -25.9 13.39 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.051 1.834 . . . . 0.0 112.285 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.4 p -119.61 141.29 49.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.696 -0.628 . . . . 0.0 109.571 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.63 -27.2 37.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.398 -0.813 . . . . 0.0 109.571 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' HA ' HD11 ' A' ' 54' ' ' ILE . 97.0 mt-10 -43.8 -38.97 3.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.23 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 p -79.82 -32.82 40.69 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.1 -1.0 . . . . 0.0 109.11 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' A' ' 50' ' ' ALA . 43.6 t -67.55 -52.22 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.438 -0.789 . . . . 0.0 109.942 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.618 ' O ' ' N ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -60.85 -30.89 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.044 -1.035 . . . . 0.0 108.795 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.29 -34.56 75.4 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.464 -0.772 . . . . 0.0 109.633 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.97 -18.04 56.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 0.0 110.306 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.597 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 82.5 m-85 -114.44 -10.29 12.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.361 -0.837 . . . . 0.0 109.962 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.752 HE21 ' CG1' ' A' ' 61' ' ' ILE . 18.6 tp60 -50.74 -34.02 25.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.17 -0.956 . . . . 0.0 109.014 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.722 ' CD2' ' N ' ' A' ' 60' ' ' ALA . 12.0 p-80 -54.67 -44.22 73.12 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.945 -1.097 . . . . 0.0 109.5 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.722 ' N ' ' CD2' ' A' ' 59' ' ' HIS . . . -64.2 -60.2 3.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 0.0 109.906 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.752 ' CG1' HE21 ' A' ' 58' ' ' GLN . 1.0 OUTLIER -63.94 -22.2 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 109.961 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' GLN . 31.1 t0 -58.15 -65.25 0.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.53 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -51.61 -34.25 36.61 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.656 -1.278 . . . . 0.0 108.773 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.16 -55.18 17.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.086 -1.009 . . . . 0.0 109.672 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -67.37 -25.54 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.391 -0.818 . . . . 0.0 109.11 179.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.23 -41.89 72.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.963 -1.086 . . . . 0.0 109.495 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.49 -52.3 8.22 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.954 -1.091 . . . . 0.0 109.99 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.637 ' O ' ' C ' ' A' ' 69' ' ' GLY . 45.9 mttm -82.78 4.73 24.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.258 -0.901 . . . . 0.0 110.405 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.637 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . 8.07 80.33 0.01 OUTLIER Glycine 0 N--CA 1.503 3.126 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.832 ' CG ' HG21 ' A' ' 155' ' ' ILE . 30.5 m-85 -74.42 161.67 29.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.164 -1.198 . . . . 0.0 109.497 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.404 ' HG3' HD21 ' A' ' 158' ' ' ASN . 94.7 mm-40 -57.01 -46.27 82.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.428 -0.795 . . . . 0.0 109.716 -177.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 m -150.17 160.24 43.82 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.193 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.733 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 19.3 t-105 -125.77 128.14 47.25 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.483 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 2.5 t0 -136.85 157.63 46.31 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.935 -1.103 . . . . 0.0 108.479 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 76' ' ' ILE . 1.0 OUTLIER -97.86 174.13 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.64 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 35.2 mm -106.99 113.77 44.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.7 p -96.76 164.52 12.54 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 123.229 1.49 . . . . 0.0 111.817 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.016 HD22 ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -167.5 164.57 14.88 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.971 176.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 1.016 ' N ' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -137.45 140.42 41.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 174.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.65 -1.88 20.77 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.157 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -114.99 -14.13 11.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.205 -0.934 . . . . 0.0 109.384 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -66.16 123.68 85.89 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.445 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.66 -2.18 11.73 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.176 1.917 . . . . 0.0 111.212 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -87.01 -2.99 59.04 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.027 -1.046 . . . . 0.0 109.763 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.492 ' HB2' HD21 ' A' ' 82' ' ' ASN . 0.2 OUTLIER -54.52 -43.43 71.88 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.687 -1.258 . . . . 0.0 108.135 178.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.437 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 84.6 tt0 -60.73 -40.92 94.18 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.233 -0.917 . . . . 0.0 109.148 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.48 81.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.0 109.912 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 88' ' ' LEU . 4.5 mm? -61.59 -42.77 99.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.006 -1.059 . . . . 0.0 109.739 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.45 ' HG2' ' H ' ' A' ' 144' ' ' MET . 82.8 mtm180 -62.01 -27.54 68.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.844 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -65.63 -60.29 3.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.863 . . . . 0.0 109.862 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.427 ' HD3' HD13 ' A' ' 88' ' ' LEU . 12.8 ptmt -57.55 -36.76 72.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -0.913 . . . . 0.0 109.382 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -75.77 -24.26 56.01 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.54 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 94' ' ' ASN . 3.9 mt -74.46 -34.9 63.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 110.602 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 93' ' ' LEU . 16.5 m120 -45.8 127.13 7.77 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.906 -1.122 . . . . 0.0 109.156 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.472 ' HB3' HE22 ' A' ' 165' ' ' GLN . 3.2 tt0 -55.1 147.64 15.6 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -169.01 -172.55 1.58 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 117.612 -1.635 . . . . 0.0 112.628 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -165.03 135.28 3.79 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.645 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.19 157.04 18.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.942 . . . . 0.0 110.077 -179.052 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.485 ' H ' ' HA ' ' A' ' 162' ' ' TRP . . . -78.8 -6.82 88.5 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -122.93 169.78 10.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.454 -1.027 . . . . 0.0 109.3 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -74.94 142.82 43.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.136 -0.978 . . . . 0.0 110.013 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.634 ' CG ' HH22 ' A' ' 154' ' ' ARG . 17.0 tt0 -100.37 94.97 6.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.296 -0.878 . . . . 0.0 108.953 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.511 HG22 ' OG ' ' A' ' 133' ' ' SER . 47.5 t -88.19 128.59 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.501 -0.749 . . . . 0.0 109.173 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.402 ' NH1' ' HB1' ' A' ' 152' ' ' ALA . 5.9 tpt180 -129.39 122.55 29.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 52.2 t80 -109.37 127.06 54.06 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CG ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -87.34 125.68 34.39 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.432 0.634 . . . . 0.0 110.22 -178.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.95 -35.2 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.596 -0.69 . . . . 0.0 109.72 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -160.2 145.34 14.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.085 -1.009 . . . . 0.0 110.303 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.475 ' O ' ' OE2' ' A' ' 127' ' ' GLU . . . 97.11 162.85 32.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.21 163.82 28.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -1.154 . . . . 0.0 110.015 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.92 153.16 11.57 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.527 HD22 HD12 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -102.65 101.99 12.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.971 -1.311 . . . . 0.0 109.809 -179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -88.85 130.04 35.47 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.747 -1.22 . . . . 0.0 110.704 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.546 ' SG ' HG13 ' A' ' 121' ' ' VAL . 31.4 t -77.86 130.59 36.82 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.325 0.584 . . . . 0.0 109.714 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.417 HD11 HG13 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -115.82 124.57 51.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.503 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.5 t-160 -115.42 115.75 27.07 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.19 -0.944 . . . . 0.0 108.945 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.41 125.33 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.194 -0.941 . . . . 0.0 110.345 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.74 -143.94 41.04 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 104.167 -3.573 . . . . 0.0 104.167 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -109.28 81.43 1.44 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 122.212 3.006 . . . . 0.0 109.793 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.503 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 21.7 pt-20 -164.96 168.38 17.58 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.546 HG13 ' SG ' ' A' ' 114' ' ' CYS . 54.1 t -125.66 136.26 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.109 -0.994 . . . . 0.0 109.933 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -124.07 130.55 52.75 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.819 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.404 HE21 ' HB2' ' A' ' 114' ' ' CYS . 17.5 mt-30 -125.15 118.38 25.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.202 -0.936 . . . . 0.0 108.974 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.817 HG22 ' CD1' ' A' ' 3' ' ' LEU . 31.9 t -105.69 132.32 52.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 125' ' ' LEU . 7.5 tt -126.63 80.05 1.91 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.37 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 1' ' ' SER . 47.4 t -168.99 117.22 0.66 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 177.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.475 ' OE2' ' O ' ' A' ' 109' ' ' GLY . 10.5 tm-20 -113.5 105.7 13.67 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 116.086 -2.245 . . . . 0.0 112.34 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.547 ' C ' ' H ' ' A' ' 130' ' ' ASP . 12.2 mttm -109.31 177.08 4.86 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.16 -1.382 . . . . 0.0 108.68 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.518 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 54.5 m-80 -59.54 -2.0 0.29 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' A' ' 128' ' ' LYS . 31.2 p30 -72.39 154.37 40.94 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.943 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -120.52 155.71 33.06 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.99 0.9 . . . . 0.0 110.089 -179.171 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.943 ' N ' HD12 ' A' ' 131' ' ' LEU . 2.9 tp -122.37 128.33 75.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.511 ' OG ' HG22 ' A' ' 103' ' ' VAL . 4.9 t -109.04 134.39 51.73 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 108.985 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.417 HG13 HD11 ' A' ' 115' ' ' LEU . 2.3 t -103.63 133.86 20.05 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.01 151.41 73.36 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.893 1.729 . . . . 0.0 112.552 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.39 134.71 48.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.619 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 1.4 t-80 92.97 7.94 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 120.933 0.397 . . . . 0.0 110.262 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.87 125.91 33.3 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.89 -1.131 . . . . 0.0 109.228 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 166' ' ' PHE . 40.6 Cg_endo -64.02 131.55 31.16 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.636 1.557 . . . . 0.0 111.656 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.474 ' C ' ' CE3' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -169.71 160.56 8.83 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.096 -178.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.501 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -131.92 -146.6 0.29 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.295 -0.878 . . . . 0.0 109.414 -178.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.04 128.12 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.772 -1.205 . . . . 0.0 109.088 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.42 136.67 21.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.455 -0.778 . . . . 0.0 109.577 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.586 ' O ' ' C ' ' A' ' 145' ' ' GLY . 9.1 mmt -112.59 18.89 17.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.478 -0.764 . . . . 0.0 111.036 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 10.88 -94.38 0.01 OUTLIER Glycine 0 N--CA 1.506 3.339 0 CA-C-N 118.886 0.766 . . . . 0.0 112.349 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.488 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 18.5 p -85.38 120.89 27.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.351 -1.339 . . . . 0.0 109.02 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.743 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -113.4 118.17 44.06 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.873 -0.517 . . . . 0.0 109.783 178.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.6 Cg_endo -102.22 34.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.794 2.329 . . . . 0.0 110.742 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.737 HD22 HD11 ' A' ' 78' ' ' LEU . 0.3 OUTLIER 82.66 64.61 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.446 0.641 . . . . 0.0 109.457 -177.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.486 ' O ' HD12 ' A' ' 78' ' ' LEU . 24.8 p90 -99.85 153.24 19.3 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 122.212 1.006 . . . . 0.0 111.327 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.8 m -118.27 137.32 53.13 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.64 ' HB3' ' HB ' ' A' ' 76' ' ' ILE . . . -142.59 163.27 33.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.1 -1.0 . . . . 0.0 109.176 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.733 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 63.6 mt -119.17 136.96 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.219 -0.926 . . . . 0.0 109.874 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.634 HH22 ' CG ' ' A' ' 102' ' ' GLU . 2.6 ttt85 -140.11 167.75 21.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.901 -1.124 . . . . 0.0 110.472 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.832 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.1 mp -109.18 155.19 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.485 -0.759 . . . . 0.0 109.603 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.483 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 2.6 m-30 -106.97 125.42 50.98 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.975 0.893 . . . . 0.0 110.253 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 158' ' ' ASN . 1.1 t70 -131.07 162.03 30.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.439 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -93.85 161.83 28.91 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.105 -0.997 . . . . 0.0 108.464 -179.46 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 162' ' ' TRP . 41.4 Cg_endo -63.53 -55.97 0.61 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.009 1.806 . . . . 0.0 112.376 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 159' ' ' PRO . 48.9 tp10 -44.02 -19.22 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.072 -1.018 . . . . 0.0 108.309 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -90.0 -31.1 11.35 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.598 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -95.74 165.2 12.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.406 -1.055 . . . . 0.0 111.286 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.65 148.02 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.23 -74.87 0.29 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.932 -1.105 . . . . 0.0 110.644 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.472 HE22 ' HB3' ' A' ' 95' ' ' GLU . 14.3 mm100 -141.91 161.26 38.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.993 -1.067 . . . . 0.0 109.929 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.629 ' CD2' ' N ' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -101.95 -41.76 6.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.127 -0.983 . . . . 0.0 109.269 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 70.8 p -117.98 -30.42 5.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.346 -0.846 . . . . 0.0 108.887 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.06 -5.45 53.07 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 120.175 -1.012 . . . . 0.0 110.653 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -79.59 148.13 31.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.589 -1.536 . . . . 0.0 108.016 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -108.38 89.51 3.02 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 117.519 -1.672 . . . . 0.0 110.88 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.422 ' H ' HG22 ' A' ' 171' ' ' ILE . 1.3 tt -78.86 -23.57 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.489 -1.382 . . . . 0.0 109.737 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -56.74 -41.39 77.45 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 108.724 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.565 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 47.5 p -53.52 -3.38 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.348 -0.845 . . . . 0.0 109.973 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.83 -37.05 35.91 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.031 -1.043 . . . . 0.0 111.964 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.618 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.1 m-85 -111.9 25.18 0.08 OUTLIER Pre-proline 0 N--CA 1.517 2.895 0 O-C-N 120.449 -1.407 . . . . 0.0 113.077 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 38.0 Cg_endo -58.97 -24.0 71.04 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 123.902 3.068 . . . . 0.0 115.141 -172.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -89.05 126.25 35.35 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.487 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.734 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.8 OUTLIER -86.8 123.99 32.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.18 -0.95 . . . . 0.0 108.717 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.812 ' O ' HG23 ' A' ' 19' ' ' THR . 3.7 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.92 169.52 9.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.043 -1.036 . . . . 0.0 108.991 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.536 HD12 ' O ' ' A' ' 123' ' ' GLN . 5.5 tp -158.0 115.02 2.91 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.516 ' OG1' HD11 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -110.0 134.08 52.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.34 -0.85 . . . . 0.0 110.06 -178.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 121' ' ' VAL . 38.4 mt -129.74 132.12 66.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 96.6 m-85 -124.05 167.45 14.18 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -86.31 174.57 8.96 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.269 -0.895 . . . . 0.0 108.948 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.76 -31.32 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.898 -1.126 . . . . 0.0 109.492 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -73.03 -37.34 66.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.947 . . . . 0.0 110.303 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -136.52 124.71 14.96 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 109.519 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.427 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 56.3 Cg_endo -81.09 -35.53 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 122.068 1.845 . . . . 0.0 112.317 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.63 4.99 1.58 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.442 -0.787 . . . . 0.0 110.258 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -114.52 118.99 35.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.401 -0.812 . . . . 0.0 109.007 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.4 p -98.65 123.16 42.68 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.277 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 pp -91.0 -7.72 51.18 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.633 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.687 ' HB3' HD12 ' A' ' 5' ' ' ILE . 31.9 t90 -157.43 105.27 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.338 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -120.6 115.99 24.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.57 -0.706 . . . . 0.0 109.876 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.445 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -162.34 165.01 27.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.33 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 1' ' ' SER . 52.1 m -131.37 90.2 2.83 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.805 ' O ' HD12 ' A' ' 24' ' ' ILE . 84.0 m-20 -127.04 151.24 48.87 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.288 -0.882 . . . . 0.0 110.491 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.91 -45.02 13.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.037 -1.664 . . . . 0.0 108.279 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 23' ' ' GLU . 10.6 pt-20 -82.89 -46.12 13.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.704 . . . . 0.0 110.18 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.514 ' N ' ' CG ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -62.84 -23.69 67.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.52 -1.362 . . . . 0.0 108.705 -178.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.805 HD12 ' O ' ' A' ' 20' ' ' ASN . 4.6 mt -70.42 -58.68 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.522 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 6.6 pt20 -56.36 -44.17 79.88 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.303 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.551 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 74.5 mt-30 -57.73 -33.27 68.27 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.317 -0.865 . . . . 0.0 109.906 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.588 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 5.7 tt0 -70.34 -61.36 1.8 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.024 -1.048 . . . . 0.0 109.41 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -66.98 -55.36 14.8 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.776 -1.202 . . . . 0.0 109.794 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 18.1 t-20 -49.9 -31.95 13.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.886 -1.134 . . . . 0.0 109.333 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -63.59 -24.61 67.87 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.021 -1.049 . . . . 0.0 108.44 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.526 ' NZ ' ' OE1' ' A' ' 120' ' ' GLU . 30.0 mttt -92.48 14.12 17.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.54 24.44 26.01 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.714 -1.232 . . . . 0.0 110.089 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.599 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 39.6 t -96.36 146.3 7.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.386 -1.067 . . . . 0.0 109.704 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.448 ' HB3' ' H ' ' A' ' 133' ' ' SER . 18.2 ttt180 -85.83 155.85 20.81 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 120.927 -1.108 . . . . 0.0 109.136 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 25' ' ' GLN . 1.2 t80 -154.62 149.44 26.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.912 -1.117 . . . . 0.0 108.912 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 1.3 mt-10 -175.04 172.92 2.74 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.903 -1.123 . . . . 0.0 109.878 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -150.81 114.83 5.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 108.839 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -110.67 152.59 26.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.62 -0.675 . . . . 0.0 109.235 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -143.12 167.43 22.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 109.964 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.457 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . . . -93.52 158.66 15.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 108.86 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -102.97 -17.43 15.46 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.204 -0.935 . . . . 0.0 108.534 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -93.38 171.47 8.89 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.591 0.71 . . . . 0.0 109.185 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -94.34 116.88 29.33 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.556 -0.715 . . . . 0.0 109.501 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mt -91.17 163.68 14.18 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.429 -0.795 . . . . 0.0 109.137 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.62 -101.08 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.68 93.07 4.83 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.108 -1.23 . . . . 0.0 109.48 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.55 91.61 34.56 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -77.02 -26.94 7.32 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.412 2.074 . . . . 0.0 112.701 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.6 p -119.92 141.16 49.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 0.0 109.581 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.93 -20.85 41.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.405 -0.809 . . . . 0.0 109.475 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 50' ' ' ALA . 84.8 tt0 -44.83 -37.89 4.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.005 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.7 p -79.73 -31.95 41.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.275 -0.891 . . . . 0.0 109.42 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ALA . 79.7 t -67.74 -47.67 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 109.777 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 58' ' ' GLN . 9.9 mm -60.26 -37.26 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.957 . . . . 0.0 108.859 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.32 -29.87 70.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.418 -0.802 . . . . 0.0 109.45 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.23 -18.68 60.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 110.317 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.457 ' HE2' ' HB2' ' A' ' 40' ' ' ALA . 8.9 m-85 -118.42 -7.5 10.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.389 -0.82 . . . . 0.0 109.181 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.707 HE21 ' CG1' ' A' ' 61' ' ' ILE . 28.9 tp60 -50.53 -39.4 48.83 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.313 -0.867 . . . . 0.0 108.774 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.741 ' CD2' ' N ' ' A' ' 60' ' ' ALA . 10.7 p-80 -53.04 -42.99 66.27 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.853 -1.154 . . . . 0.0 109.24 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.741 ' N ' ' CD2' ' A' ' 59' ' ' HIS . . . -61.88 -58.69 6.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.075 -1.015 . . . . 0.0 109.464 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.711 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -64.24 -28.52 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.763 -1.211 . . . . 0.0 109.15 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 58' ' ' GLN . 27.0 t70 -55.29 -25.4 33.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.145 -0.972 . . . . 0.0 109.395 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HG2' ' N ' ' A' ' 64' ' ' LEU . 8.8 ptmt -83.71 -37.26 22.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.08 -1.012 . . . . 0.0 109.493 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.545 HD21 HG21 ' A' ' 103' ' ' VAL . 0.5 OUTLIER -68.86 -45.56 70.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.206 -0.934 . . . . 0.0 109.895 -179.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 69' ' ' GLY . 3.3 p -68.56 -32.64 56.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.431 -0.793 . . . . 0.0 109.479 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.1 67.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.209 -0.932 . . . . 0.0 109.538 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -79.44 -50.03 11.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.123 -0.985 . . . . 0.0 109.897 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.659 ' O ' ' C ' ' A' ' 69' ' ' GLY . 20.5 mmtt -85.83 14.12 6.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.464 -0.772 . . . . 0.0 110.14 -177.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.659 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -7.53 85.64 0.0 OUTLIER Glycine 0 N--CA 1.501 2.984 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.487 ' CG ' HG21 ' A' ' 155' ' ' ILE . 11.7 m-85 -75.96 166.84 22.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.463 -1.022 . . . . 0.0 108.977 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -57.53 -40.58 79.12 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.441 -0.787 . . . . 0.0 109.805 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.29 167.53 30.15 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.631 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.666 ' HE1' HG23 ' A' ' 153' ' ' ILE . 13.2 t-105 -134.24 137.64 44.48 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.269 -0.895 . . . . 0.0 109.126 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.69 179.02 8.9 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.061 -1.025 . . . . 0.0 108.343 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' A' ' 153' ' ' ILE . 3.8 m -124.17 149.38 28.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.422 -0.799 . . . . 0.0 109.438 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.4 mt -100.86 117.04 45.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 77' ' ' SER . 27.8 p -170.13 101.69 0.29 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.453 -0.78 . . . . 0.0 109.399 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -110.95 179.84 3.94 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.95 1.705 . . . . 0.0 107.864 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.648 ' H ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -89.71 144.75 25.72 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.688 -1.258 . . . . 0.0 109.062 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.66 2.21 0.11 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.749 -0.594 . . . . 0.0 109.593 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -85.63 -28.28 24.88 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.469 -1.292 . . . . 0.0 108.888 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -64.51 123.84 84.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.905 -1.122 . . . . 0.0 109.45 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -79.19 -8.97 15.32 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.134 1.889 . . . . 0.0 112.349 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -90.21 3.13 54.42 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.96 -1.087 . . . . 0.0 109.596 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.547 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 44.6 pttt -60.96 -47.4 86.6 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.211 -0.93 . . . . 0.0 108.96 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.547 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 96.5 mt-10 -64.56 -42.88 95.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.867 . . . . 0.0 109.39 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.9 -33.64 76.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.029 -1.044 . . . . 0.0 109.432 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.53 -50.17 72.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 0.0 110.129 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.585 HH12 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -65.06 -24.66 67.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.229 -0.92 . . . . 0.0 109.701 -179.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.585 ' CD ' HH12 ' A' ' 89' ' ' ARG . 58.0 mm-40 -65.41 -60.03 3.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.37 -0.831 . . . . 0.0 109.6 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -53.32 -27.81 25.23 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.072 -1.018 . . . . 0.0 109.038 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -18.4 33.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.017 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.9 -36.72 70.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.199 -0.938 . . . . 0.0 109.848 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -46.64 137.18 7.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.057 . . . . 0.0 109.337 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -70.93 164.6 25.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 0.0 109.555 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -175.9 -167.26 0.22 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.442 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.8 t -163.88 134.31 4.31 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.619 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -103.73 154.86 19.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 0.0 109.786 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.42 -6.58 86.66 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -123.97 170.06 11.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.443 -1.033 . . . . 0.0 109.38 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -73.84 143.19 46.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.217 -0.927 . . . . 0.0 109.778 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.559 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 4.6 tt0 -104.47 94.45 5.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.214 -0.929 . . . . 0.0 109.053 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.545 HG21 HD21 ' A' ' 64' ' ' LEU . 38.3 t -81.65 131.11 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.199 -0.938 . . . . 0.0 110.161 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.99 109.64 11.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.451 -0.78 . . . . 0.0 109.854 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.624 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 14.7 t80 -104.8 131.52 52.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.335 -0.853 . . . . 0.0 109.071 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.567 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -90.06 132.27 35.49 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.408 0.623 . . . . 0.0 109.861 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.408 ' HB ' HG22 ' A' ' 151' ' ' THR . 9.4 t -113.48 -31.01 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.743 -0.598 . . . . 0.0 109.784 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -167.65 156.02 9.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.1 -1.0 . . . . 0.0 109.358 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.29 155.76 8.42 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.62 ' HB2' ' CD ' ' A' ' 127' ' ' GLU . . . -114.69 148.75 37.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -1.072 . . . . 0.0 109.365 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.23 -136.69 3.47 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 26.5 tp -138.24 154.08 49.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.397 -1.06 . . . . 0.0 109.493 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -122.23 145.43 48.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.582 -0.699 . . . . 0.0 109.39 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.67 108.71 4.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.578 -0.701 . . . . 0.0 109.713 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.611 HD21 HG13 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -118.92 112.87 20.18 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.555 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.1 t-160 -105.25 113.22 26.68 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.204 -0.935 . . . . 0.0 109.601 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -131.68 119.24 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.25 -0.906 . . . . 0.0 110.203 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.37 -143.16 33.83 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 105.998 -2.841 . . . . 0.0 105.998 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 7.0 p-10 -105.36 79.26 1.45 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 115.185 -2.606 . . . . 0.0 109.61 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.555 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 78.8 tt0 -165.19 166.19 19.13 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.765 ' O ' HG23 ' A' ' 5' ' ' ILE . 45.7 t -129.91 152.19 36.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.038 -1.038 . . . . 0.0 109.683 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.28 131.32 46.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.63 -0.669 . . . . 0.0 109.286 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.536 ' O ' HD12 ' A' ' 3' ' ' LEU . 16.7 mt-30 -128.24 115.04 17.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 109.11 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.3 t -108.22 138.08 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -134.56 90.3 2.64 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.213 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 31.2 p -166.35 135.35 3.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.388 -1.445 . . . . 0.0 107.546 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.62 ' CD ' ' HB2' ' A' ' 110' ' ' ALA . 1.3 pt-20 -107.05 94.91 5.35 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 116.195 -2.202 . . . . 0.0 110.642 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 130' ' ' ASP . 29.8 mtmm -114.55 157.69 22.67 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.655 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.624 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 1.7 m120 -58.68 -4.0 0.38 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.421 -1.424 . . . . 0.0 108.096 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 128' ' ' LYS . 56.2 p30 -72.23 152.72 42.01 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.39 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.747 ' C ' HD12 ' A' ' 131' ' ' LEU . 2.3 pp -126.27 162.03 26.4 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.051 0.929 . . . . 0.0 110.944 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 131' ' ' LEU . 9.7 mt -129.95 130.8 66.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.448 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 5.6 t -106.81 136.92 45.81 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.477 -0.765 . . . . 0.0 109.011 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.611 HG13 HD21 ' A' ' 115' ' ' LEU . 2.3 t -101.98 133.63 20.58 Favored Pre-proline 0 C--N 1.301 -1.519 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.743 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.09 151.33 81.81 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.835 1.69 . . . . 0.0 112.484 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.612 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.23 135.05 48.64 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.612 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.0 t-80 91.94 10.4 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.39 125.84 33.08 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.087 -1.008 . . . . 0.0 108.785 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.1 130.57 27.7 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.573 1.516 . . . . 0.0 111.573 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -166.94 165.42 15.97 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.229 -178.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.567 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -136.14 -149.76 0.34 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 109.646 -178.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.08 125.0 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 109.167 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.488 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 16.3 p-10 -141.6 132.12 25.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.627 ' O ' ' C ' ' A' ' 145' ' ' GLY . 49.7 mtt -112.73 17.77 18.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.597 -0.69 . . . . 0.0 110.692 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.67 ' N ' HD13 ' A' ' 178' ' ' LEU . . . 8.97 -90.08 0.0 OUTLIER Glycine 0 N--CA 1.502 3.098 0 CA-C-N 119.206 0.912 . . . . 0.0 111.685 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.517 ' H ' ' HB2' ' A' ' 178' ' ' LEU . 70.9 m -86.56 116.13 24.48 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 117.763 -1.575 . . . . 0.0 109.127 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.16 113.44 37.33 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.985 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.558 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.7 Cg_endo -103.36 40.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 122.935 2.423 . . . . 0.0 111.684 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 81.75 72.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.998 -177.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.584 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 5.5 p90 -94.53 138.23 32.68 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.215 -0.928 . . . . 0.0 110.476 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.408 HG22 ' HB ' ' A' ' 107' ' ' VAL . 15.9 m -103.57 118.73 37.4 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.723 -0.61 . . . . 0.0 109.625 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.8 163.34 33.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.454 -0.779 . . . . 0.0 109.283 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.741 ' HA ' HG12 ' A' ' 75' ' ' VAL . 61.4 mt -109.35 127.04 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.272 -0.893 . . . . 0.0 110.062 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.515 ' C ' HD13 ' A' ' 155' ' ' ILE . 9.0 tpt180 -129.9 157.28 42.7 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.55 0.69 . . . . 0.0 109.514 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.598 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -102.89 149.26 7.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -96.22 120.86 37.27 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 0.0 110.319 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -133.71 162.99 30.46 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -94.52 161.98 27.32 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.143 -0.973 . . . . 0.0 109.23 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.633 ' O ' ' N ' ' A' ' 161' ' ' GLY . 40.1 Cg_endo -65.21 -57.37 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.014 1.809 . . . . 0.0 111.54 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 159' ' ' PRO . 50.6 mt-10 -43.98 -13.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.793 . . . . 0.0 109.126 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -76.77 -33.05 47.94 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 177.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.52 ' N ' ' O ' ' A' ' 159' ' ' PRO . 4.3 p90 -118.3 159.12 23.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.274 -1.133 . . . . 0.0 110.279 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 26.6 mm -100.99 147.3 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.428 -0.795 . . . . 0.0 109.392 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.806 ' HB1' ' NE2' ' A' ' 165' ' ' GLN . . . -57.36 -72.67 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.806 ' NE2' ' HB1' ' A' ' 164' ' ' ALA . 11.7 mp0 -141.4 165.29 27.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.14 -0.975 . . . . 0.0 109.646 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -100.03 -41.45 7.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.467 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 59.4 m -105.3 -30.54 9.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.166 -0.958 . . . . 0.0 109.128 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.57 -6.35 52.45 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -81.88 149.33 28.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.78 -1.424 . . . . 0.0 108.522 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 44.2 p30 -107.82 87.54 2.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.116 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.1 tt -78.31 -26.92 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.59 -1.319 . . . . 0.0 109.313 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.567 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -58.22 -42.6 86.63 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.608 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 28.6 p -54.54 -2.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 109.924 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.03 -39.8 33.03 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.097 -1.002 . . . . 0.0 111.473 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.629 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.3 m-85 -111.38 23.92 0.08 OUTLIER Pre-proline 0 N--CA 1.512 2.64 0 O-C-N 120.603 -1.31 . . . . 0.0 113.039 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 49.9 Cg_endo -65.07 -20.1 63.51 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 123.466 2.777 . . . . 0.0 113.581 -173.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -89.31 126.71 35.63 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.217 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.67 HD13 ' N ' ' A' ' 145' ' ' GLY . 7.9 mp -86.08 147.75 26.03 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.837 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.587 ' O ' ' OG1' ' A' ' 19' ' ' THR . 89.6 p . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.39 173.39 7.22 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.102 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.904 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 18.0 tp -160.06 114.43 2.26 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.51 131.54 55.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.022 -1.049 . . . . 0.0 110.227 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.728 HD13 ' CE2' ' A' ' 122' ' ' PHE . 60.5 mt -126.76 133.64 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 11' ' ' PRO . 98.4 m-85 -128.37 165.5 20.47 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.46 0.648 . . . . 0.0 109.72 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.475 ' OG ' HD13 ' A' ' 15' ' ' LEU . 64.2 m -89.66 176.29 6.92 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.78 -25.82 5.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 120.732 -1.23 . . . . 0.0 109.428 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -72.56 -40.72 66.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.969 -1.082 . . . . 0.0 110.16 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -137.44 124.57 13.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.071 -1.018 . . . . 0.0 109.324 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 56.4 Cg_endo -81.86 -29.92 1.54 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.876 1.717 . . . . 0.0 112.35 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -68.37 -27.36 66.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.505 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -94.56 120.87 35.47 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.798 -1.189 . . . . 0.0 108.985 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 p -95.31 132.86 39.86 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.391 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 15' ' ' LEU . 11.1 mp -89.34 -10.27 47.31 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.991 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.904 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 37.6 t90 -158.45 105.99 1.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.291 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -120.01 116.39 25.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 0.0 109.759 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.73 166.86 25.99 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.476 -0.765 . . . . 0.0 109.776 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.831 HG23 ' O ' ' A' ' 19' ' ' THR . 9.0 t -130.33 88.19 2.61 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.717 ' O ' HD12 ' A' ' 24' ' ' ILE . 15.0 m-20 -126.04 139.23 53.58 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.52 -35.58 27.18 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.095 -1.628 . . . . 0.0 108.919 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.534 ' CG ' ' N ' ' A' ' 23' ' ' GLU . 19.8 pt-20 -82.49 -49.92 9.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.12 -0.988 . . . . 0.0 108.981 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.534 ' N ' ' CG ' ' A' ' 22' ' ' GLU . 1.6 tm-20 -63.11 -18.97 64.0 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.893 -1.13 . . . . 0.0 108.57 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 20' ' ' ASN . 1.8 mt -71.32 -56.77 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.246 -0.909 . . . . 0.0 109.504 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.56 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 7.2 pt20 -53.25 -47.6 68.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 109.654 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.56 ' N ' ' CG ' ' A' ' 25' ' ' GLN . 49.3 tt0 -63.1 -26.77 68.98 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.444 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.516 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -69.74 -66.05 0.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.137 0.97 . . . . 0.0 110.871 -178.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.552 HD12 ' H ' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -71.35 -46.79 59.64 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.682 -1.261 . . . . 0.0 109.636 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.601 HD22 ' C ' ' A' ' 33' ' ' VAL . 10.8 m120 -54.8 -27.43 41.65 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.602 -1.311 . . . . 0.0 109.062 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -63.0 -25.75 68.54 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.7 ' HG3' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -92.6 8.67 37.99 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.367 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.06 25.47 11.26 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.742 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' HG3' ' A' ' 31' ' ' LYS . 69.5 t -94.08 145.46 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.633 -1.51 . . . . 0.0 109.084 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.608 HH12 ' NZ ' ' A' ' 68' ' ' LYS . 23.9 ttm180 -84.32 156.1 22.07 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.832 ' CE2' HD11 ' A' ' 132' ' ' ILE . 0.3 OUTLIER -153.43 147.09 25.12 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.1 tp10 -174.24 171.42 3.49 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.79 -1.194 . . . . 0.0 109.381 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -148.06 112.3 5.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.036 -1.04 . . . . 0.0 108.368 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.508 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 22.7 m0 -111.19 155.28 23.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.432 -0.793 . . . . 0.0 108.988 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.32 161.64 37.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.928 . . . . 0.0 109.969 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.86 158.14 16.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 108.931 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -102.64 -14.76 16.59 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.63 163.63 13.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.605 0.717 . . . . 0.0 109.155 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.504 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 46.3 p-10 -96.74 120.68 37.51 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.459 -0.775 . . . . 0.0 109.735 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.06 164.69 13.86 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.282 -0.886 . . . . 0.0 109.07 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.4 -105.8 0.22 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.73 90.97 5.24 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.052 -1.263 . . . . 0.0 109.104 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.44 92.17 42.9 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.93 -20.83 19.16 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.151 1.901 . . . . 0.0 112.501 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.8 p -124.27 141.67 51.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.563 -0.71 . . . . 0.0 109.622 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' GLU . . . -80.23 -20.58 44.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.538 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' ALA . 84.6 tt0 -43.12 -37.83 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.063 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.2 p -79.36 -36.35 39.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.149 -0.969 . . . . 0.0 109.144 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 50' ' ' ALA . 60.1 t -67.33 -46.34 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -0.846 . . . . 0.0 109.747 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.588 HG22 ' HG2' ' A' ' 58' ' ' GLN . 7.8 mm -60.92 -34.24 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 108.889 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.63 -29.27 70.49 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.449 -0.782 . . . . 0.0 109.627 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.56 -21.89 48.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.988 . . . . 0.0 110.136 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -110.56 -10.31 14.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.48 -0.762 . . . . 0.0 109.769 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.638 HE22 HD11 ' A' ' 61' ' ' ILE . 5.5 mm-40 -47.59 -36.75 11.19 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.054 -1.029 . . . . 0.0 109.128 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.677 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 5.4 p80 -53.22 -48.01 68.5 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.979 -1.088 . . . . 0.0 109.57 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.677 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.15 -58.1 9.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.941 -1.099 . . . . 0.0 110.054 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.638 HD11 HE22 ' A' ' 58' ' ' GLN . 0.9 OUTLIER -65.19 -26.25 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.924 -1.11 . . . . 0.0 109.462 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 58' ' ' GLN . 21.0 t70 -58.57 -25.19 62.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.905 . . . . 0.0 109.32 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -83.99 -44.23 14.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.416 -0.803 . . . . 0.0 109.859 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.64 -46.46 79.12 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.422 -0.799 . . . . 0.0 109.761 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' GLY . 5.9 p -66.63 -29.61 47.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.85 -44.53 74.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.907 -1.121 . . . . 0.0 109.425 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -80.39 -51.46 8.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.934 -1.104 . . . . 0.0 110.182 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.608 ' NZ ' HH12 ' A' ' 34' ' ' ARG . 33.1 mttt -85.01 13.62 5.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 110.732 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.599 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -5.22 84.16 0.0 OUTLIER Glycine 0 N--CA 1.5 2.932 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.434 ' CG ' HG21 ' A' ' 155' ' ' ILE . 32.4 m-85 -77.5 165.08 24.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.663 -0.904 . . . . 0.0 108.703 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.418 HE21 ' HA ' ' A' ' 157' ' ' ASP . 58.5 mt-30 -57.21 -89.55 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.164 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.605 ' OG ' ' CG ' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -102.38 163.06 12.44 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.668 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.409 ' CE3' HG23 ' A' ' 155' ' ' ILE . 5.7 t-105 -136.98 141.23 42.58 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.46 -0.775 . . . . 0.0 109.187 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -174.7 -167.42 0.3 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 153' ' ' ILE . 4.7 m -124.21 168.21 17.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.492 -0.755 . . . . 0.0 109.488 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.664 HD11 ' HD2' ' A' ' 154' ' ' ARG . 75.9 mt -94.49 132.95 37.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.5 p -93.0 166.79 12.19 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.857 1.313 . . . . 0.0 112.135 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.607 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 1.0 OUTLIER -169.13 160.49 9.8 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.209 176.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.433 ' HG3' ' H ' ' A' ' 81' ' ' ASP . 1.3 tpt180 -132.4 141.52 48.91 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 174.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.47 -0.72 6.95 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.837 -1.164 . . . . 0.0 109.684 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.433 ' H ' ' HG3' ' A' ' 79' ' ' ARG . 91.2 m-20 -118.47 -12.44 9.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.086 -1.009 . . . . 0.0 109.196 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 84' ' ' GLN . 0.2 OUTLIER -62.72 123.9 81.17 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.938 . . . . 0.0 110.453 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.04 -1.6 11.5 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.758 2.306 . . . . 0.0 112.542 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.481 ' H ' ' ND2' ' A' ' 82' ' ' ASN . 72.9 mt-30 -83.25 16.19 2.58 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.76 -1.212 . . . . 0.0 109.161 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.456 ' HG2' ' H ' ' A' ' 85' ' ' LYS . 6.2 pttt -61.36 -59.88 4.59 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.5 -0.75 . . . . 0.0 109.507 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.405 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 20.1 pt-20 -64.56 -31.74 73.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.312 -0.868 . . . . 0.0 109.666 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.89 -59.27 5.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 110.077 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 72.4 mt -61.95 -42.81 99.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 110.185 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.451 ' HE ' ' C ' ' A' ' 85' ' ' LYS . 49.6 mtm180 -59.52 -28.98 67.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.886 . . . . 0.0 110.079 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.96 -59.58 4.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.973 . . . . 0.0 109.497 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -51.22 -34.34 31.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.376 -0.827 . . . . 0.0 109.404 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -88.14 -17.74 30.31 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.043 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.711 HD21 ' OG ' ' A' ' 173' ' ' SER . 8.6 tp -55.79 -34.39 65.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 109.822 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.529 HD22 HE22 ' A' ' 165' ' ' GLN . 6.1 m120 -63.28 135.29 56.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.121 -0.987 . . . . 0.0 110.22 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -70.71 164.45 25.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.527 -0.733 . . . . 0.0 109.418 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -174.92 -165.6 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.82 -1.175 . . . . 0.0 111.272 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 163' ' ' ILE . 9.5 t -164.56 135.33 4.16 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.607 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -105.93 154.58 20.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.466 -0.771 . . . . 0.0 110.207 -178.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.39 -6.35 86.42 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.441 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 95.5 mt-10 -124.24 169.93 11.27 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.487 -1.008 . . . . 0.0 109.61 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -74.91 143.62 43.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 0.0 109.827 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.484 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 6.7 tt0 -107.54 93.25 4.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.261 -0.899 . . . . 0.0 108.592 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 103' ' ' VAL . 10.5 p -94.67 131.98 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.738 -1.226 . . . . 0.0 111.025 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.74 ' HE ' HH21 ' A' ' 154' ' ' ARG . 78.0 mtt180 -130.2 126.93 38.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.735 -0.603 . . . . 0.0 109.402 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.605 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 13.3 t80 -109.05 132.0 54.53 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.533 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -85.21 126.25 33.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.941 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.4 ' O ' ' CG ' ' A' ' 108' ' ' GLU . 5.0 t -107.15 -41.18 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.369 -0.832 . . . . 0.0 110.692 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 91.1 mt-10 -154.8 141.07 18.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.883 -1.136 . . . . 0.0 109.815 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.97 159.89 36.07 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.503 ' HB2' ' HG3' ' A' ' 127' ' ' GLU . . . -113.92 151.03 32.83 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -1.223 . . . . 0.0 109.737 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.57 -126.83 1.95 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.9 tp -147.95 163.22 37.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -1.015 . . . . 0.0 109.074 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -134.8 90.81 2.69 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.046 -1.034 . . . . 0.0 109.098 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.589 ' SG ' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -78.13 146.25 35.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.982 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mt -148.53 101.53 3.23 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -102.13 113.4 26.63 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.825 -1.172 . . . . 0.0 109.562 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.746 HD12 ' N ' ' A' ' 118' ' ' GLY . 0.1 OUTLIER -134.97 124.79 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.095 -1.003 . . . . 0.0 110.506 -178.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.746 ' N ' HD12 ' A' ' 117' ' ' ILE . . . 70.22 -142.67 36.24 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 105.636 -2.986 . . . . 0.0 105.636 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.32 79.11 1.18 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 115.157 -2.617 . . . . 0.0 108.303 176.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -165.07 166.62 19.05 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.682 ' O ' HG23 ' A' ' 5' ' ' ILE . 51.0 t -125.99 140.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.087 -1.008 . . . . 0.0 110.404 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.728 ' CE2' HD13 ' A' ' 5' ' ' ILE . 16.0 m-85 -123.83 131.02 53.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.442 0.639 . . . . 0.0 109.791 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -141.94 118.62 11.05 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.169 -0.957 . . . . 0.0 109.785 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -101.79 147.23 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.612 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tp -127.58 81.62 2.03 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.46 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.447 ' SG ' ' CB ' ' A' ' 1' ' ' SER . 35.9 t -166.56 122.65 1.22 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.703 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -109.3 105.82 15.38 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 116.705 -1.998 . . . . 0.0 112.338 -178.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.56 ' C ' ' H ' ' A' ' 130' ' ' ASP . 42.1 mmtt -113.77 171.04 7.82 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.02 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.605 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 12.5 m120 -58.76 -3.03 0.27 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.832 -1.168 . . . . 0.0 107.895 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 128' ' ' LYS . 40.2 p30 -73.43 153.99 40.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.793 0.806 . . . . 0.0 109.888 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.79 ' C ' HD12 ' A' ' 131' ' ' LEU . 2.3 pp -122.89 161.31 24.37 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.073 0.939 . . . . 0.0 110.366 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.832 HD11 ' CE2' ' A' ' 35' ' ' PHE . 1.3 mp -131.54 127.83 60.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.664 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.9 t -123.71 135.93 54.15 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.75 148.63 36.1 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.278 -0.889 . . . . 0.0 108.799 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.22 157.95 57.87 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.554 2.169 . . . . 0.0 113.052 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.621 ' O ' ' CD2' ' A' ' 137' ' ' HIS . . . -73.38 135.62 44.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.237 -0.914 . . . . 0.0 108.997 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.703 ' O ' ' ND1' ' A' ' 137' ' ' HIS . 0.1 OUTLIER 95.43 3.92 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.352 0.596 . . . . 0.0 109.732 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.78 125.47 42.19 Favored Pre-proline 0 N--CA 1.487 1.42 0 O-C-N 120.84 -1.162 . . . . 0.0 108.816 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.14 132.9 33.38 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.433 1.422 . . . . 0.0 111.6 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.512 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.42 164.28 15.05 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.189 -0.944 . . . . 0.0 110.161 -178.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.589 ' CD1' ' SG ' ' A' ' 114' ' ' CYS . 14.6 p90 -130.06 -153.78 0.59 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.469 -0.77 . . . . 0.0 109.752 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.616 ' CD1' ' NH1' ' A' ' 104' ' ' ARG . 2.8 t80 -170.78 125.01 0.68 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.303 -0.873 . . . . 0.0 108.999 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.501 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 49.0 p-10 -148.19 130.97 16.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.944 -1.097 . . . . 0.0 109.374 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.615 ' O ' ' C ' ' A' ' 145' ' ' GLY . 8.6 mmt -107.18 18.91 21.1 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 111.334 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 11.56 -99.39 0.01 OUTLIER Glycine 0 N--CA 1.501 3.008 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.507 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 31.6 t -84.16 120.56 26.33 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.897 -1.354 . . . . 0.0 109.351 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 147' ' ' GLU . 1.0 OUTLIER -115.51 117.6 40.32 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 57.2 Cg_endo -100.03 31.2 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.258 1.972 . . . . 0.0 112.209 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER 81.79 63.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.688 -179.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.559 ' CZ ' HD12 ' A' ' 78' ' ' LEU . 15.0 p90 -101.41 169.85 8.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.519 -0.738 . . . . 0.0 109.222 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 53.3 m -130.28 106.53 8.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.57 -0.706 . . . . 0.0 109.489 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' A' ' 75' ' ' VAL . . . -105.91 161.94 14.01 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.987 -1.07 . . . . 0.0 109.827 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.648 ' HA ' HG12 ' A' ' 75' ' ' VAL . 23.5 mt -105.45 123.26 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.869 -1.145 . . . . 0.0 110.291 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.74 HH21 ' HE ' ' A' ' 104' ' ' ARG . 1.9 mtt-85 -130.62 159.85 35.97 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.624 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.98 155.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.605 ' CG ' ' OG ' ' A' ' 72' ' ' SER . 5.8 m-85 -96.19 121.87 38.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 110.224 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.418 ' HA ' HE21 ' A' ' 71' ' ' GLN . 49.2 p30 -132.04 163.28 28.78 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -92.79 161.86 30.65 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.979 -1.076 . . . . 0.0 108.865 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.598 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.0 Cg_endo -62.52 -60.4 0.19 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.747 1.631 . . . . 0.0 112.288 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.7 tt0 -45.92 -13.53 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -72.7 -43.87 41.43 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.563 ' CE3' ' O ' ' A' ' 163' ' ' ILE . 9.9 p-90 -110.13 161.02 15.96 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.518 -0.989 . . . . 0.0 110.348 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.563 ' O ' ' CE3' ' A' ' 162' ' ' TRP . 4.0 tp -99.92 154.44 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.249 -0.907 . . . . 0.0 109.194 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.78 -75.54 0.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.97 . . . . 0.0 110.435 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.529 HE22 HD22 ' A' ' 94' ' ' ASN . 31.1 mt-30 -142.3 164.61 29.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.103 -0.998 . . . . 0.0 110.156 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -101.21 -40.18 7.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.89 . . . . 0.0 109.326 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 22.0 m -114.68 -32.36 5.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.937 . . . . 0.0 108.568 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.61 -1.34 58.38 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.505 ' OD2' ' O ' ' A' ' 169' ' ' ASP . 39.1 p30 -80.29 145.82 31.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.3 -1.706 . . . . 0.0 108.726 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.416 ' OD2' ' ND2' ' A' ' 94' ' ' ASN . 90.4 m-20 -113.21 89.7 3.15 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 118.113 -1.435 . . . . 0.0 110.263 175.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.455 HD11 ' HZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -78.71 -17.89 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.241 -1.537 . . . . 0.0 108.854 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -58.67 -41.59 86.51 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.362 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.711 ' OG ' HD21 ' A' ' 93' ' ' LEU . 1.2 m -52.46 -3.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.538 -0.726 . . . . 0.0 109.873 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.71 -39.57 26.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.909 -1.119 . . . . 0.0 111.371 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.639 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -114.57 25.58 0.09 OUTLIER Pre-proline 0 N--CA 1.516 2.842 0 O-C-N 120.668 -1.27 . . . . 0.0 112.089 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 39.1 Cg_endo -59.25 -18.18 43.44 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.333 2.689 . . . . 0.0 114.177 -171.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -89.44 125.57 35.22 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.619 -1.233 . . . . 0.0 108.107 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.507 ' HB3' ' H ' ' A' ' 146' ' ' SER . 3.9 tt -86.68 125.45 33.87 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.092 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.299 -1.593 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.623 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.776 ' O ' HG23 ' A' ' 19' ' ' THR . 2.8 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.49 169.32 9.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.066 . . . . 0.0 109.074 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.85 HD13 HG22 ' A' ' 124' ' ' VAL . 16.3 tp -157.65 114.99 3.01 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.7 OUTLIER -109.02 138.59 45.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.216 -0.928 . . . . 0.0 110.119 -179.16 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.708 HD12 ' HB3' ' A' ' 16' ' ' TRP . 52.9 mt -132.87 131.45 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -125.6 164.29 20.88 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m -85.91 175.0 8.87 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.144 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -26.87 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.023 -1.048 . . . . 0.0 109.677 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -74.11 -38.43 63.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.05 -1.031 . . . . 0.0 110.181 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.33 125.91 14.77 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 109.679 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 13' ' ' ASN . 56.1 Cg_endo -80.42 -36.9 0.43 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 121.974 1.783 . . . . 0.0 112.202 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 7.86 0.77 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.768 . . . . 0.0 110.113 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 11' ' ' PRO . 80.6 m-20 -116.96 119.77 36.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.196 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.419 ' C ' HD22 ' A' ' 15' ' ' LEU . 6.1 p -98.96 123.65 43.39 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.65 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.9 mm? -89.93 -9.84 47.36 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.585 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.708 ' HB3' HD12 ' A' ' 5' ' ' ILE . 33.1 t90 -157.48 106.87 2.15 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.629 -1.228 . . . . 0.0 110.133 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -121.87 119.92 33.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.512 -0.742 . . . . 0.0 109.729 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.409 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -162.85 164.56 25.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.218 -0.926 . . . . 0.0 110.132 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 1' ' ' SER . 76.1 m -130.14 89.11 2.75 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.017 -1.052 . . . . 0.0 108.188 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.754 ' O ' HD12 ' A' ' 24' ' ' ILE . 29.9 m120 -127.73 144.26 51.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.458 -0.776 . . . . 0.0 110.422 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.73 -38.74 21.0 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.235 -1.541 . . . . 0.0 108.312 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -82.9 -48.36 10.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.516 -0.74 . . . . 0.0 109.749 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' OE1' ' OD1' ' A' ' 20' ' ' ASN . 1.2 tt0 -62.83 -19.56 64.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.722 -1.236 . . . . 0.0 108.608 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.754 HD12 ' O ' ' A' ' 20' ' ' ASN . 4.0 mt -74.47 -56.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.871 . . . . 0.0 109.326 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.445 ' HB2' ' CG ' ' A' ' 35' ' ' PHE . 3.0 pp0? -55.41 -34.9 64.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.309 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.54 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 49.8 tt0 -68.09 -47.5 68.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.276 -0.89 . . . . 0.0 109.447 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.55 ' OE1' ' CD1' ' A' ' 5' ' ' ILE . 7.6 tt0 -68.16 -40.46 82.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.167 -0.958 . . . . 0.0 109.082 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.568 HD12 HG11 ' A' ' 33' ' ' VAL . 3.5 mm? -68.18 -62.42 1.41 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.172 -0.955 . . . . 0.0 109.286 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 15.1 t-20 -58.13 -17.98 22.21 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.298 -0.876 . . . . 0.0 109.907 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -67.1 -32.52 73.73 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.847 -1.158 . . . . 0.0 109.387 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -90.51 9.34 29.72 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.98 24.56 16.82 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.283 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.568 HG11 HD12 ' A' ' 28' ' ' LEU . 33.7 t -96.96 147.82 6.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.279 -1.13 . . . . 0.0 109.554 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' HB3' ' H ' ' A' ' 133' ' ' SER . 19.5 ttt180 -84.02 154.01 23.51 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 120.511 -1.368 . . . . 0.0 108.368 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.538 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 1.1 t80 -154.39 149.97 27.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.023 -1.048 . . . . 0.0 108.276 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 35' ' ' PHE . 2.9 mt-10 -177.24 177.08 1.26 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.045 -1.034 . . . . 0.0 109.481 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -148.61 112.44 5.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.705 ' CH2' HD23 ' A' ' 131' ' ' LEU . 31.4 m0 -111.02 157.4 19.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.271 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -142.72 156.24 44.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 0.0 109.927 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.35 152.75 20.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.205 -0.934 . . . . 0.0 108.997 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -104.03 -6.39 21.22 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -93.34 159.15 15.39 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.781 0.801 . . . . 0.0 109.093 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -94.51 115.31 27.45 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.66 -0.65 . . . . 0.0 109.537 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.7 mt -94.86 164.96 12.7 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.43 -0.794 . . . . 0.0 109.505 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.29 -103.76 0.2 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.6 92.97 4.76 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.989 -1.301 . . . . 0.0 109.187 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.16 92.12 44.88 Favored Pre-proline 0 C--N 1.306 -1.293 0 C-N-CA 119.8 -0.76 . . . . 0.0 108.965 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.54 -21.91 14.41 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.297 1.998 . . . . 0.0 112.763 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.2 p -122.93 142.12 51.16 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.584 -0.698 . . . . 0.0 109.705 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.34 -16.91 53.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.43 -0.794 . . . . 0.0 109.419 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -46.92 -39.03 11.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.344 -0.847 . . . . 0.0 108.725 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.3 m -79.2 -39.68 32.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.617 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.71 -46.53 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.291 -0.881 . . . . 0.0 109.669 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 58' ' ' GLN . 15.6 mt -60.48 -36.02 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.073 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.06 -28.65 69.75 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.411 -0.806 . . . . 0.0 109.407 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.76 -20.29 50.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.038 -1.039 . . . . 0.0 110.331 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 58' ' ' GLN . 61.7 m-85 -112.02 -12.27 13.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.298 -0.876 . . . . 0.0 109.552 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.729 HE21 ' CG1' ' A' ' 61' ' ' ILE . 30.1 tp60 -45.52 -35.9 4.19 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.567 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.6 -47.64 63.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 109.546 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.567 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.34 -60.08 4.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.927 -1.108 . . . . 0.0 109.755 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.729 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.6 OUTLIER -63.17 -29.51 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 120.608 -1.308 . . . . 0.0 109.127 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 58' ' ' GLN . 21.3 t70 -55.9 -26.41 47.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.706 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -78.28 -36.1 47.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.985 -1.072 . . . . 0.0 109.543 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 64' ' ' LEU . 8.4 mp -63.19 -40.79 98.53 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.545 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -70.13 -29.01 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.173 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.53 -56.66 12.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.431 -1.418 . . . . 0.0 109.191 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -83.53 -48.81 9.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.035 -1.04 . . . . 0.0 110.608 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.627 ' O ' ' C ' ' A' ' 69' ' ' GLY . 7.5 mtpm? -87.79 14.7 8.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.878 . . . . 0.0 110.788 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.627 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -11.68 89.33 0.0 OUTLIER Glycine 0 N--CA 1.501 3.028 0 CA-C-O 121.959 0.755 . . . . 0.0 111.227 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.472 ' CG ' HG21 ' A' ' 155' ' ' ILE . 84.3 m-85 -76.86 164.42 25.83 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.586 ' NE2' ' OG ' ' A' ' 72' ' ' SER . 0.6 OUTLIER -63.2 -87.48 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.43 -0.794 . . . . 0.0 109.78 -178.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.586 ' OG ' ' NE2' ' A' ' 71' ' ' GLN . 14.7 m -102.74 160.24 14.76 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 109.595 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 74' ' ' ASP . 7.6 t-105 -140.79 145.75 36.74 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.454 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.2 OUTLIER -165.36 -176.6 4.1 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 152' ' ' ALA . 9.9 p -119.8 142.73 33.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 76' ' ' ILE . 2.5 tp -101.33 115.71 43.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 77' ' ' SER . 4.7 p -169.56 102.99 0.33 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.381 -0.825 . . . . 0.0 108.845 177.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.722 HD23 ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -117.98 179.77 3.99 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.094 1.77 . . . . 0.0 108.12 -179.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.722 ' H ' HD23 ' A' ' 78' ' ' LEU . 3.2 tpt180 -89.88 143.85 26.44 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.667 -1.27 . . . . 0.0 109.412 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.42 1.38 0.35 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.568 -0.707 . . . . 0.0 109.593 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 79' ' ' ARG . 84.6 m-20 -78.87 -29.09 44.28 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.213 -1.395 . . . . 0.0 108.872 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.75 HD21 ' CD ' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -64.27 124.85 86.9 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.044 -1.035 . . . . 0.0 109.085 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -78.55 -8.56 16.01 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.171 1.914 . . . . 0.0 112.401 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -89.59 4.14 50.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.006 -1.059 . . . . 0.0 109.482 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.75 ' CD ' HD21 ' A' ' 82' ' ' ASN . 3.5 tptp -60.0 -49.82 76.18 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.194 -0.941 . . . . 0.0 108.919 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -62.82 -41.99 99.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 109.57 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.16 -38.27 76.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.612 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 88' ' ' LEU . 2.7 mm? -60.3 -42.75 96.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.345 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.572 ' NH2' ' O ' ' A' ' 85' ' ' LYS . 1.0 OUTLIER -60.49 -30.65 69.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.845 . . . . 0.0 109.873 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.22 -60.22 3.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 109.671 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.403 ' O ' ' ND2' ' A' ' 94' ' ' ASN . 50.4 mttp -57.17 -32.18 66.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.504 -0.747 . . . . 0.0 109.278 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -85.6 -18.25 33.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.415 -0.803 . . . . 0.0 110.243 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -60.86 -40.17 91.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.125 -0.984 . . . . 0.0 109.85 -179.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 21.5 p30 -46.89 125.48 7.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.121 -0.987 . . . . 0.0 109.452 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.53 166.32 1.32 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.504 -0.748 . . . . 0.0 109.366 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -173.17 -169.26 0.52 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.899 -1.12 . . . . 0.0 111.433 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.2 t -164.1 135.58 4.6 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.676 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -107.55 156.2 19.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.443 -0.785 . . . . 0.0 109.735 -178.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.18 -6.94 86.7 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -123.51 170.67 10.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.316 -1.108 . . . . 0.0 109.288 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -76.26 142.99 41.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.972 -1.08 . . . . 0.0 110.161 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -100.24 94.6 6.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.194 -0.942 . . . . 0.0 109.058 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.627 HG22 HD11 ' A' ' 155' ' ' ILE . 1.0 OUTLIER -91.46 130.67 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.507 -0.745 . . . . 0.0 109.878 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.5 HH21 ' CB ' ' A' ' 152' ' ' ALA . 51.2 ttt180 -132.01 123.77 27.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.398 -0.814 . . . . 0.0 109.346 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.615 ' HB3' HD12 ' A' ' 153' ' ' ILE . 27.2 t80 -104.78 131.89 51.7 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.09 128.42 35.42 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.608 -0.682 . . . . 0.0 110.228 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.0 t -112.63 -29.67 2.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.683 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -169.04 158.04 8.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.027 . . . . 0.0 109.031 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.488 ' O ' ' OE1' ' A' ' 127' ' ' GLU . . . 78.49 150.0 4.69 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.9 156.05 31.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.421 -1.046 . . . . 0.0 109.512 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.483 ' C ' HD11 ' A' ' 178' ' ' LEU . . . -151.49 -125.99 1.24 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.88 HD12 HD12 ' A' ' 178' ' ' LEU . 1.6 mt -148.95 164.32 34.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -1.08 . . . . 0.0 109.659 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.518 ' CG ' HD11 ' A' ' 132' ' ' ILE . 0.2 OUTLIER -138.47 91.59 2.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.569 179.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.643 ' SG ' ' NE2' ' A' ' 123' ' ' GLN . 0.8 OUTLIER -77.97 117.04 18.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 109.476 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.582 HD11 HG22 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -118.34 106.16 12.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.116 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.5 t-160 -101.33 109.56 21.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.972 . . . . 0.0 109.462 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mm -125.57 111.82 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.005 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.99 -142.12 28.11 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 106.537 -2.625 . . . . 0.0 106.537 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.494 ' O ' ' CG ' ' A' ' 119' ' ' ASP . 48.2 p-10 -103.8 79.2 1.63 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 115.103 -2.639 . . . . 0.0 109.369 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.479 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 75.8 tt0 -165.92 167.34 16.78 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.64 ' O ' HG23 ' A' ' 5' ' ' ILE . 86.7 t -130.43 151.91 36.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.089 -1.007 . . . . 0.0 109.924 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.439 ' C ' ' OE1' ' A' ' 123' ' ' GLN . 32.7 m-85 -130.87 133.27 45.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.691 -0.631 . . . . 0.0 109.986 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.643 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 4.2 mp0 -122.35 110.07 15.2 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.412 -0.805 . . . . 0.0 109.088 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.85 HG22 HD13 ' A' ' 3' ' ' LEU . 21.2 t -104.84 133.9 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.948 ' H ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.55 90.54 2.62 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.341 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.462 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 30.1 p -166.36 128.8 1.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.393 -1.442 . . . . 0.0 107.329 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 7.0 tt0 -107.39 96.35 6.34 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 116.096 -2.242 . . . . 0.0 110.569 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.591 ' C ' ' H ' ' A' ' 130' ' ' ASP . 17.1 mtpp -112.73 159.78 18.6 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.66 176.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.586 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 14.6 m120 -57.12 -4.27 0.18 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.442 -1.411 . . . . 0.0 107.761 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.591 ' H ' ' C ' ' A' ' 128' ' ' LYS . 67.3 m-20 -66.73 143.14 57.12 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.705 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.101 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -110.79 142.67 42.45 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.614 0.721 . . . . 0.0 110.706 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 1.101 ' N ' HD12 ' A' ' 131' ' ' LEU . 47.6 pt -132.64 147.66 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.432 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 8.9 t -137.03 153.78 50.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.349 -0.844 . . . . 0.0 109.581 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.582 HG22 HD11 ' A' ' 115' ' ' LEU . 1.1 t -106.11 143.01 26.06 Favored Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.49 152.65 80.38 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.283 1.989 . . . . 0.0 112.274 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.609 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.59 134.61 47.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.275 -0.891 . . . . 0.0 109.223 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.609 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.1 t-80 91.31 11.21 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.121 0.486 . . . . 0.0 109.742 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 138' ' ' THR . 0.8 OUTLIER -104.13 126.5 31.48 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 0.0 108.739 179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.98 131.49 29.0 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.581 1.52 . . . . 0.0 111.474 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.488 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.9 163.79 9.62 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.223 -179.186 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.505 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -134.53 -146.94 0.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.239 -0.913 . . . . 0.0 109.713 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -177.9 126.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.926 -1.109 . . . . 0.0 109.037 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.496 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 10.9 p-10 -144.25 134.14 23.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.31 -0.869 . . . . 0.0 109.895 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.618 ' O ' ' C ' ' A' ' 145' ' ' GLY . 84.1 mmm -112.94 20.48 16.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.584 -0.697 . . . . 0.0 111.202 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.61 -92.68 0.01 OUTLIER Glycine 0 N--CA 1.506 3.363 0 CA-C-N 119.265 0.939 . . . . 0.0 111.534 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.486 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 74.5 m -85.85 117.51 24.76 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.92 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.653 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -117.3 113.18 39.12 Favored Pre-proline 0 C--N 1.299 -1.609 0 C-N-CA 119.764 -0.775 . . . . 0.0 109.804 178.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.552 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.3 Cg_endo -103.12 40.95 0.04 OUTLIER 'Trans proline' 0 C--O 1.213 -0.767 0 C-N-CA 122.717 2.278 . . . . 0.0 111.349 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 81.79 71.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.124 -177.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.536 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 8.9 p90 -95.53 144.31 26.11 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.388 -0.82 . . . . 0.0 109.895 -177.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.8 m -113.17 122.96 49.09 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.536 -0.728 . . . . 0.0 109.754 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.628 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -142.83 162.58 35.1 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.615 HD12 ' HB3' ' A' ' 105' ' ' PHE . 57.6 mt -107.49 126.92 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.076 -1.015 . . . . 0.0 109.374 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -136.51 164.13 28.9 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.113 -0.992 . . . . 0.0 109.803 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.627 HD11 HG22 ' A' ' 103' ' ' VAL . 4.7 mp -102.5 145.12 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.579 -0.701 . . . . 0.0 109.562 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.454 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.2 m-85 -95.54 118.81 32.94 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.291 -0.881 . . . . 0.0 109.361 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 0.9 OUTLIER -134.93 164.13 28.29 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.3 OUTLIER -93.65 160.26 33.16 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.167 -0.958 . . . . 0.0 109.052 -179.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.3 Cg_endo -61.76 -55.65 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.198 1.932 . . . . 0.0 112.199 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.4 tt0 -44.09 -15.49 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.336 -0.853 . . . . 0.0 108.986 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -72.72 -46.68 29.68 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 178.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.464 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 6.5 p90 -107.38 165.03 11.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.341 -1.094 . . . . 0.0 110.05 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 72.6 mt -100.59 149.58 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.35 -71.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.088 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.583 ' NE2' ' OD1' ' A' ' 170' ' ' ASP . 43.1 mt-30 -140.39 159.01 43.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 109.632 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -101.21 -41.12 6.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 109.564 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.7 p -102.44 -30.43 11.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.085 -1.009 . . . . 0.0 108.856 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.49 -6.49 52.81 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -82.13 148.55 28.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.704 -1.468 . . . . 0.0 108.688 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.583 ' OD1' ' NE2' ' A' ' 165' ' ' GLN . 88.5 m-20 -109.08 88.35 2.71 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 117.568 -1.653 . . . . 0.0 111.096 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.5 tt -77.75 -23.69 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.609 -1.307 . . . . 0.0 109.348 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.505 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -60.41 -41.44 93.92 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.632 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 93.4 p -54.62 -2.95 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.481 -0.762 . . . . 0.0 109.994 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.31 -39.84 31.83 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.942 -1.099 . . . . 0.0 111.298 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.627 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 9.9 m-85 -111.64 24.4 0.08 OUTLIER Pre-proline 0 N--CA 1.514 2.754 0 O-C-N 120.85 -1.156 . . . . 0.0 112.808 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.632 ' HD3' ' C ' ' A' ' 173' ' ' SER . 45.3 Cg_endo -63.59 -19.3 67.32 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.68 2.92 . . . . 0.0 113.348 -173.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.08 125.51 35.05 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.99 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.88 HD12 HD12 ' A' ' 112' ' ' LEU . 1.8 tp -88.03 120.41 29.34 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.525 -0.734 . . . . 0.0 109.135 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.295 -1.786 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.34 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.608 ' O ' ' OG1' ' A' ' 19' ' ' THR . 1.6 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.96 171.55 8.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 108.925 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.751 ' CD1' HG22 ' A' ' 124' ' ' VAL . 28.2 tp -158.85 113.1 2.44 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.74 130.32 54.96 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.166 -0.959 . . . . 0.0 110.365 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 121' ' ' VAL . 63.9 mt -124.59 133.61 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 97.2 m-85 -126.63 165.36 19.34 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -91.73 176.33 6.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 108.715 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -25.68 5.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.888 -1.133 . . . . 0.0 109.418 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -73.13 -40.68 64.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 110.086 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -136.81 124.01 14.16 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.093 -1.004 . . . . 0.0 109.437 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.565 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 56.4 Cg_endo -82.18 -33.13 0.6 Allowed 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.925 1.75 . . . . 0.0 112.319 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.482 ' OE1' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -68.43 -25.99 65.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 110.347 -178.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -95.41 120.79 36.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.959 -1.088 . . . . 0.0 108.977 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.38 131.99 40.91 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.297 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 pp -90.37 -8.96 49.38 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.209 -0.996 . . . . 0.0 108.822 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.66 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 45.1 t90 -157.54 106.79 2.13 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.506 -1.278 . . . . 0.0 109.943 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -120.77 119.82 33.85 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.535 -0.728 . . . . 0.0 109.801 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.47 161.84 30.24 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.198 -0.939 . . . . 0.0 109.82 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 19' ' ' THR . 8.9 t -131.36 89.08 2.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 118.773 -1.171 . . . . 0.0 108.507 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.752 ' O ' HD12 ' A' ' 24' ' ' ILE . 1.9 m-20 -126.27 142.37 51.55 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.372 -0.83 . . . . 0.0 110.24 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.85 -37.05 27.57 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.463 -1.398 . . . . 0.0 109.137 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -82.68 -50.15 9.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.167 -0.958 . . . . 0.0 109.862 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -63.32 -18.53 63.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.036 -1.04 . . . . 0.0 108.719 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.752 HD12 ' O ' ' A' ' 20' ' ' ASN . 3.1 mt -73.56 -56.07 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.234 -0.916 . . . . 0.0 108.912 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.427 ' N ' HG22 ' A' ' 24' ' ' ILE . 9.2 pt20 -57.61 -40.77 79.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.211 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.683 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 68.5 mt-30 -62.04 -43.03 99.7 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.142 -0.974 . . . . 0.0 109.114 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.488 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 7.5 tt0 -72.47 -44.85 61.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.204 -0.935 . . . . 0.0 108.899 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.597 HD12 HG11 ' A' ' 33' ' ' VAL . 2.8 mm? -64.19 -62.56 1.54 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.054 -1.029 . . . . 0.0 109.371 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.618 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -61.23 -17.56 53.93 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.165 -178.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -62.52 -28.82 70.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.529 -1.357 . . . . 0.0 108.439 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.679 ' HG3' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -94.19 6.81 47.46 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.855 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.81 25.64 12.92 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.046 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.679 HG23 ' HG3' ' A' ' 31' ' ' LYS . 61.8 t -95.29 145.98 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.149 -1.206 . . . . 0.0 109.191 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -83.59 153.47 24.3 Favored 'General case' 0 C--N 1.287 -2.109 0 O-C-N 121.058 -1.026 . . . . 0.0 108.555 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CB ' HD21 ' A' ' 29' ' ' ASN . 2.2 t80 -154.21 146.47 23.83 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.159 -0.963 . . . . 0.0 108.729 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.535 ' O ' ' OD2' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -177.9 178.07 1.0 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.006 -1.059 . . . . 0.0 110.251 178.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 119.3 6.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 108.886 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.428 ' CE3' ' HB1' ' A' ' 60' ' ' ALA . 23.1 m0 -111.99 156.83 21.51 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -143.05 160.98 39.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.867 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.44 158.17 16.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 108.946 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -101.45 -14.1 17.67 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -92.9 158.79 15.65 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.535 0.684 . . . . 0.0 109.161 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -93.71 123.63 37.16 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 109.46 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 mt -94.39 165.67 12.45 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 109.368 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.7 -105.14 0.22 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.01 93.06 5.04 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.999 -1.295 . . . . 0.0 109.327 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.9 91.65 43.37 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -75.88 -22.04 13.7 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.155 1.903 . . . . 0.0 112.421 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.1 p -120.58 141.19 50.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.618 -0.677 . . . . 0.0 109.679 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.681 ' HB1' HD13 ' A' ' 54' ' ' ILE . . . -80.86 -17.86 49.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.478 -0.764 . . . . 0.0 109.535 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.69 -39.22 16.86 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.223 -0.923 . . . . 0.0 108.862 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.8 m -78.92 -34.89 44.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.212 -0.93 . . . . 0.0 109.587 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.418 HG11 ' CG1' ' A' ' 107' ' ' VAL . 60.1 t -67.76 -57.12 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.342 -0.849 . . . . 0.0 110.33 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.681 HD13 ' HB1' ' A' ' 50' ' ' ALA . 1.7 mp -58.8 -34.99 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.968 -1.083 . . . . 0.0 108.9 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.68 -35.18 72.18 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.413 -0.804 . . . . 0.0 109.365 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.51 -13.7 60.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.21 -0.931 . . . . 0.0 109.632 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.4 m-85 -111.42 -8.39 14.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.489 -0.757 . . . . 0.0 109.762 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 62' ' ' ASP . 10.3 mm-40 -47.06 -36.05 7.63 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.159 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.713 ' CD2' ' N ' ' A' ' 60' ' ' ALA . 11.9 p-80 -53.36 -44.18 68.36 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.74 -1.225 . . . . 0.0 109.516 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.713 ' N ' ' CD2' ' A' ' 59' ' ' HIS . . . -63.6 -61.1 2.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.0 -1.063 . . . . 0.0 110.071 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.643 ' O ' HG23 ' A' ' 65' ' ' VAL . 1.3 pp -62.36 -27.72 43.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.75 -1.219 . . . . 0.0 108.983 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' A' ' 62' ' ' ASP . 36.8 t0 -58.41 -27.69 64.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.96 . . . . 0.0 109.567 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -74.19 -40.93 62.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.959 . . . . 0.0 109.121 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 64' ' ' LEU . 7.6 mp -64.42 -34.85 79.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 109.295 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 61' ' ' ILE . 11.5 t -68.13 -29.93 46.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.035 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.75 72.82 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.658 -1.276 . . . . 0.0 109.524 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -87.74 -53.86 4.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.083 -1.011 . . . . 0.0 110.5 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.604 ' O ' ' C ' ' A' ' 69' ' ' GLY . 8.2 mmtp -85.96 14.51 6.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.355 -0.84 . . . . 0.0 110.489 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -16.41 87.58 0.0 OUTLIER Glycine 0 N--CA 1.499 2.885 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 68' ' ' LYS . 81.1 m-85 -76.58 164.01 26.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.469 HE21 ' HA ' ' A' ' 157' ' ' ASP . 32.8 mt-30 -57.74 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.312 -0.868 . . . . 0.0 109.673 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.58 163.0 12.58 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.598 0.713 . . . . 0.0 110.058 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.775 ' HE1' HG23 ' A' ' 153' ' ' ILE . 5.6 t-105 -131.84 135.76 46.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HB2' ' CE2' ' A' ' 156' ' ' PHE . 0.7 OUTLIER -146.86 166.81 25.57 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.9 -1.125 . . . . 0.0 108.142 178.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 152' ' ' ALA . 8.8 p -119.55 141.28 40.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 76' ' ' ILE . 7.6 tp -102.7 115.01 43.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.235 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.0 t -167.63 100.06 0.49 Allowed 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.481 -0.887 . . . . 0.0 109.34 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.657 HD23 ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -125.01 -179.26 4.48 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.34 -1.475 . . . . 0.0 107.658 -179.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.657 ' H ' HD23 ' A' ' 78' ' ' LEU . 23.2 tpt180 -88.91 153.07 21.34 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.671 -1.268 . . . . 0.0 109.075 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.97 0.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ARG . 83.8 m-20 -103.43 30.54 4.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.552 ' OD1' ' N ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -82.26 135.08 47.76 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.52 -0.737 . . . . 0.0 110.201 178.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.446 ' C ' ' OE1' ' A' ' 84' ' ' GLN . 55.7 Cg_endo -77.41 -25.75 7.97 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.173 1.915 . . . . 0.0 112.198 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.487 ' N ' ' OE1' ' A' ' 84' ' ' GLN . 0.9 OUTLIER -92.5 8.13 40.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.895 -1.128 . . . . 0.0 109.493 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.576 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 18.0 pttt -58.73 -51.7 68.86 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.214 -0.929 . . . . 0.0 108.774 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.576 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 84.2 tt0 -67.6 -54.24 21.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.146 -0.972 . . . . 0.0 109.504 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.83 -47.02 83.85 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.311 -0.955 . . . . 0.0 109.727 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 84' ' ' GLN . 13.3 tp -63.07 -46.13 88.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.768 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -60.83 -36.96 80.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 109.602 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.7 -58.84 4.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -0.878 . . . . 0.0 109.625 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -50.5 -37.89 41.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.278 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.03 -19.46 51.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.117 -0.99 . . . . 0.0 109.134 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 93' ' ' LEU . 8.0 tt -61.3 -34.86 75.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 109.758 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -64.26 150.44 45.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.107 -0.995 . . . . 0.0 110.188 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.726 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 7.7 pm0 -80.91 166.31 20.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 0.0 109.567 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -173.96 -169.24 0.47 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.044 -1.062 . . . . 0.0 111.195 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.2 t -163.48 132.97 4.09 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.635 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -104.3 156.74 17.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.516 -0.74 . . . . 0.0 110.125 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.446 ' N ' ' HB3' ' A' ' 162' ' ' TRP . . . -78.78 -6.56 88.49 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 95.7 mt-10 -124.36 171.15 10.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.395 -1.062 . . . . 0.0 109.429 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 102' ' ' GLU . 48.3 t0 -75.19 139.91 42.94 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.109 -0.994 . . . . 0.0 110.248 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.594 ' N ' ' OD2' ' A' ' 101' ' ' ASP . 14.9 tt0 -97.13 95.17 7.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.344 -0.848 . . . . 0.0 108.931 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.838 HG13 ' OG ' ' A' ' 133' ' ' SER . 29.5 t -95.29 123.17 47.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.65 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 34.0 ttm105 -127.28 126.3 42.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.46 -0.775 . . . . 0.0 109.018 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.622 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 15.2 t80 -102.36 131.18 49.15 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.825 0.822 . . . . 0.0 109.201 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.405 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -85.9 126.46 34.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.49 0.662 . . . . 0.0 110.154 -178.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.418 ' CG1' HG11 ' A' ' 53' ' ' VAL . 12.9 t -108.5 -30.24 2.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.73 -0.606 . . . . 0.0 109.476 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -165.94 153.8 10.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 109.27 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.76 157.09 32.8 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.46 ' HB2' ' CD ' ' A' ' 127' ' ' GLU . . . -134.17 162.38 32.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -1.171 . . . . 0.0 109.089 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.63 155.16 13.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.533 ' HB3' HD12 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -103.14 98.93 8.79 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.133 -1.216 . . . . 0.0 110.638 -178.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -80.5 126.41 31.18 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.66 -1.275 . . . . 0.0 110.054 -178.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.649 ' SG ' ' NE2' ' A' ' 123' ' ' GLN . 0.9 OUTLIER -78.5 125.84 29.93 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.312 0.577 . . . . 0.0 109.984 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.669 HD21 HG11 ' A' ' 134' ' ' VAL . 0.5 OUTLIER -113.62 125.53 54.27 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.48 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 8.2 t-160 -107.91 110.37 22.1 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.446 HG21 ' HD3' ' A' ' 31' ' ' LYS . 2.2 pt -124.64 114.25 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 O-C-N 121.45 -0.781 . . . . 0.0 110.513 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.63 -143.81 33.15 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 104.845 -3.302 . . . . 0.0 104.845 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -106.19 79.93 1.45 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 115.048 -2.661 . . . . 0.0 108.636 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.48 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 12.2 pt-20 -166.35 170.16 13.33 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.669 ' O ' HG23 ' A' ' 5' ' ' ILE . 88.9 t -125.27 137.56 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.006 -1.059 . . . . 0.0 109.853 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.556 ' CE2' HD13 ' A' ' 5' ' ' ILE . 7.2 m-85 -122.09 129.54 52.46 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.649 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.5 mt-30 -128.39 115.24 17.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 108.984 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.751 HG22 ' CD1' ' A' ' 3' ' ' LEU . 11.5 t -101.76 133.54 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.546 ' C ' HD23 ' A' ' 125' ' ' LEU . 5.7 tt -134.42 91.0 2.73 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.746 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.402 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 30.7 p -164.77 134.75 3.82 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.46 ' CD ' ' HB2' ' A' ' 110' ' ' ALA . 5.7 pt-20 -106.33 94.64 5.26 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 115.55 -2.46 . . . . 0.0 110.538 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.545 ' C ' ' H ' ' A' ' 130' ' ' ASP . 20.1 tptm -114.2 156.8 23.62 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.088 176.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.622 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 83.3 m-20 -58.35 -3.32 0.26 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.487 -1.383 . . . . 0.0 107.891 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.593 ' OD2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.89 153.03 43.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.199 -178.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.759 ' C ' HD12 ' A' ' 131' ' ' LEU . 2.1 pp -117.56 160.57 21.03 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.893 0.854 . . . . 0.0 110.095 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.645 ' N ' HD12 ' A' ' 131' ' ' LEU . 5.6 mm -131.65 128.77 60.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.805 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.838 ' OG ' HG13 ' A' ' 103' ' ' VAL . 14.5 m -123.0 142.09 51.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.401 -0.812 . . . . 0.0 109.373 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.669 HG11 HD21 ' A' ' 115' ' ' LEU . 8.3 m -109.31 148.96 39.08 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.407 -0.808 . . . . 0.0 108.98 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -66.81 154.76 73.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.378 2.052 . . . . 0.0 112.966 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.618 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -73.32 136.53 44.49 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.459 -0.776 . . . . 0.0 109.329 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.618 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 4.1 t-80 92.95 10.2 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.37 126.17 32.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 108.556 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.79 132.2 31.83 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.54 1.493 . . . . 0.0 111.534 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.45 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.86 162.83 9.54 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.219 -0.926 . . . . 0.0 110.18 -178.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.513 ' CD2' ' HB2' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -133.71 -147.16 0.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.65 ' CE1' ' NH1' ' A' ' 104' ' ' ARG . 0.2 OUTLIER -178.74 127.7 0.11 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.864 -1.148 . . . . 0.0 109.077 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 54.7 p-10 -147.23 139.55 24.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.808 . . . . 0.0 109.852 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.604 ' O ' ' C ' ' A' ' 145' ' ' GLY . 2.6 ptt? -113.7 22.9 13.6 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.579 -0.7 . . . . 0.0 110.72 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.604 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 7.11 -90.61 0.0 OUTLIER Glycine 0 N--CA 1.502 3.053 0 CA-C-N 119.517 1.053 . . . . 0.0 112.465 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.525 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 23.0 t -86.05 116.78 24.48 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 117.886 -1.525 . . . . 0.0 108.834 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.662 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -116.74 114.36 39.75 Favored Pre-proline 0 C--N 1.296 -1.719 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.748 178.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.0 Cg_endo -101.41 38.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.885 0 C-N-CA 122.873 2.382 . . . . 0.0 110.705 176.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER 82.56 70.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -176.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 20.2 p90 -95.25 163.35 13.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.747 -0.595 . . . . 0.0 109.635 -177.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.5 m -134.42 126.9 30.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 0.0 109.931 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.617 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . . . -143.65 163.48 33.13 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.539 -0.726 . . . . 0.0 109.14 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.775 HG23 ' HE1' ' A' ' 73' ' ' TRP . 24.8 mt -110.59 130.04 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.192 -0.943 . . . . 0.0 109.681 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.567 ' C ' HD13 ' A' ' 155' ' ' ILE . 6.5 ptm180 -131.26 159.02 39.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.42 -0.8 . . . . 0.0 110.494 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.581 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -108.12 149.63 11.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.501 0.667 . . . . 0.0 109.446 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 74' ' ' ASP . 4.0 m-30 -97.33 120.62 38.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.866 0.841 . . . . 0.0 110.77 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.614 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 52.0 t0 -133.93 158.93 42.23 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.594 ' O ' ' NE1' ' A' ' 162' ' ' TRP . 80.9 m-20 -96.96 150.8 37.26 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.901 -1.124 . . . . 0.0 109.513 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.625 ' O ' ' N ' ' A' ' 161' ' ' GLY . 45.9 Cg_endo -70.65 -53.23 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.363 2.042 . . . . 0.0 112.121 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 159' ' ' PRO . 85.5 tt0 -42.4 -15.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.672 -0.643 . . . . 0.0 109.514 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.27 -41.4 13.74 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 177.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.614 ' HE1' ' CG ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -114.4 175.66 5.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.596 -0.944 . . . . 0.0 110.952 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 19.2 pt -96.32 155.44 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.535 -0.728 . . . . 0.0 109.339 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -93.56 -70.84 0.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 110.663 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -107.06 143.07 35.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.07 -1.019 . . . . 0.0 110.197 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -102.07 -40.48 6.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 109.619 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -116.92 -30.12 5.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.323 -0.861 . . . . 0.0 108.688 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.83 -7.41 53.02 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -80.9 149.2 29.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.661 -1.494 . . . . 0.0 108.176 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.484 ' OD2' ' OG ' ' A' ' 173' ' ' SER . 1.7 p30 -107.98 88.42 2.73 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 117.425 -1.71 . . . . 0.0 111.152 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.0 OUTLIER -75.83 -25.62 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.832 -1.168 . . . . 0.0 109.328 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.513 ' HB2' ' CD2' ' A' ' 141' ' ' TRP . . . -60.56 -40.37 91.41 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.61 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 52.8 p -55.45 -4.22 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.577 -0.702 . . . . 0.0 110.22 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.466 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -81.58 -37.84 27.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.04 -1.037 . . . . 0.0 111.281 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.624 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.3 m-85 -112.13 23.84 0.08 OUTLIER Pre-proline 0 N--CA 1.509 2.522 0 O-C-N 120.538 -1.351 . . . . 0.0 112.777 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 45.3 Cg_endo -64.0 -18.84 65.26 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 123.153 2.569 . . . . 0.0 113.911 -173.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -88.36 125.07 34.52 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.849 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.726 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.8 OUTLIER -87.97 120.84 29.71 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.367 -0.833 . . . . 0.0 109.194 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.432 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.57 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.35 171.93 8.1 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.097 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.837 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 18.3 tp -157.58 115.02 3.03 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.547 ' OG1' HD11 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -111.76 131.99 54.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.023 -1.048 . . . . 0.0 110.062 -178.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 121' ' ' VAL . 53.8 mt -127.11 131.55 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 11' ' ' PRO . 71.4 m-85 -129.79 164.37 24.19 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.6 m -89.02 174.96 7.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.21 -0.931 . . . . 0.0 108.906 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -23.92 6.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 120.902 -1.124 . . . . 0.0 109.532 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -41.05 62.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.059 -1.026 . . . . 0.0 110.334 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.25 123.08 11.0 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.991 -1.068 . . . . 0.0 109.52 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.588 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 55.6 Cg_endo -82.58 -27.29 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.885 1.724 . . . . 0.0 112.214 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 12' ' ' GLN . 1.4 pp0? -70.45 0.55 6.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 110.546 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.578 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -123.12 118.63 28.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 108.923 179.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.32 129.41 41.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.03 -1.044 . . . . 0.0 109.095 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.578 ' CD1' HD21 ' A' ' 13' ' ' ASN . 9.4 mp -88.46 -12.25 43.59 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.046 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.837 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 40.8 t90 -158.44 107.33 1.98 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.747 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -120.03 117.69 28.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.367 -0.833 . . . . 0.0 109.76 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.71 163.43 29.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.532 -0.73 . . . . 0.0 109.753 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 19' ' ' THR . 8.9 t -130.63 89.25 2.74 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.039 -1.038 . . . . 0.0 108.297 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.713 ' O ' HD12 ' A' ' 24' ' ' ILE . 23.1 m120 -125.17 138.6 54.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.32 -0.862 . . . . 0.0 110.535 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.93 -34.08 30.03 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 119.874 -1.766 . . . . 0.0 108.555 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -82.65 -53.55 5.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.096 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -58.56 -20.22 44.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.134 -0.979 . . . . 0.0 108.666 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.713 HD12 ' O ' ' A' ' 20' ' ' ASN . 5.5 mt -75.85 -57.09 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.053 -1.03 . . . . 0.0 108.748 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.499 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 61.5 tt0 -53.47 -41.08 65.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.409 -0.807 . . . . 0.0 109.077 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -71.84 -49.08 41.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.124 -0.985 . . . . 0.0 110.652 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.564 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 27.0 mt-30 -72.23 -47.33 51.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.977 -1.077 . . . . 0.0 110.998 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 33' ' ' VAL . 14.7 tp -61.22 -54.66 41.36 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.017 -1.052 . . . . 0.0 109.467 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 15.0 m120 -62.78 -16.2 56.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.978 -1.076 . . . . 0.0 109.636 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 27' ' ' GLN . . . -62.86 -28.96 70.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.616 -1.302 . . . . 0.0 108.507 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 12.51 11.82 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.792 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.44 24.65 28.04 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.139 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.564 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 99.9 t -95.64 143.82 11.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.39 -1.065 . . . . 0.0 109.513 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -84.04 158.87 21.31 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.476 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -150.45 146.04 26.4 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 36.7 mt-10 -162.96 162.87 26.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.116 -0.99 . . . . 0.0 108.932 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.2 mtm-85 -148.41 111.59 4.91 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.615 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 18.0 m0 -112.71 155.99 23.57 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -142.65 162.32 35.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 0.0 109.846 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.23 159.59 15.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 108.905 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -100.59 -17.1 17.22 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -92.88 159.68 15.25 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.51 123.36 35.75 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.569 -0.707 . . . . 0.0 109.379 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.3 mt -90.53 166.15 13.38 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.299 -0.876 . . . . 0.0 109.342 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.69 -105.13 0.21 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.26 91.24 4.99 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.133 -1.216 . . . . 0.0 109.388 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.2 92.4 22.07 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.78 -27.43 8.81 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.206 1.937 . . . . 0.0 112.461 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 p -121.24 141.87 50.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.633 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.48 -21.2 42.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 109.532 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 50' ' ' ALA . 83.7 tt0 -43.54 -38.78 3.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -0.825 . . . . 0.0 109.096 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.7 p -78.52 -34.77 47.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 109.244 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 50' ' ' ALA . 59.1 t -68.28 -46.35 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.349 -0.844 . . . . 0.0 109.916 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.444 HD13 ' N ' ' A' ' 54' ' ' ILE . 6.5 mm -61.62 -35.62 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.957 . . . . 0.0 108.881 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.17 -30.34 71.51 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.52 -0.738 . . . . 0.0 109.653 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.55 -20.47 56.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 110.086 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.404 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.5 m-85 -110.74 -6.76 14.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.454 -0.779 . . . . 0.0 109.479 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.569 HE22 HD11 ' A' ' 61' ' ' ILE . 5.1 mm-40 -47.62 -37.9 13.57 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.068 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.702 ' CD2' ' N ' ' A' ' 60' ' ' ALA . 13.3 p-80 -52.59 -45.0 66.33 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.865 -1.147 . . . . 0.0 109.633 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.702 ' N ' ' CD2' ' A' ' 59' ' ' HIS . . . -63.66 -59.83 4.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.73 -1.232 . . . . 0.0 110.403 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.693 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.9 OUTLIER -61.83 -28.06 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.763 -1.211 . . . . 0.0 108.826 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 58' ' ' GLN . 25.9 t70 -57.62 -28.91 64.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.239 -0.913 . . . . 0.0 109.441 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' CD ' ' O ' ' A' ' 59' ' ' HIS . 4.7 mptp? -73.74 -41.31 62.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.108 -0.995 . . . . 0.0 109.185 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.4 mp -64.09 -35.27 80.21 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.387 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 61' ' ' ILE . 3.7 t -69.1 -28.9 41.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.227 -0.92 . . . . 0.0 109.321 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.77 -53.84 53.82 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.546 -1.346 . . . . 0.0 109.57 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -85.57 -53.69 5.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.024 -1.048 . . . . 0.0 110.704 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.583 ' O ' ' C ' ' A' ' 69' ' ' GLY . 11.2 mmtp -84.96 14.45 4.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.443 -0.786 . . . . 0.0 110.646 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -18.23 87.93 0.0 OUTLIER Glycine 0 N--CA 1.498 2.805 0 CA-C-O 122.041 0.8 . . . . 0.0 111.332 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 68' ' ' LYS . 58.7 m-85 -76.12 165.07 25.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.749 HE22 ' ND2' ' A' ' 158' ' ' ASN . 81.4 mt-30 -57.14 -88.83 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.431 -0.793 . . . . 0.0 109.522 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.404 ' CB ' ' HB2' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -103.76 163.1 12.56 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.641 0.734 . . . . 0.0 109.999 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.617 ' HE1' HG23 ' A' ' 153' ' ' ILE . 5.2 t-105 -135.23 139.24 44.31 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -155.48 173.5 16.6 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.98 141.39 39.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 76' ' ' ILE . 16.2 tt -102.78 117.09 47.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.517 ' O ' ' OG ' ' A' ' 77' ' ' SER . 8.8 p -168.24 101.78 0.44 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.585 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 9.6 tp -116.01 179.43 3.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 119.31 -2.119 . . . . 0.0 107.781 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.531 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -89.51 150.01 22.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.032 -1.042 . . . . 0.0 109.173 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.2 2.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -0.881 . . . . 0.0 109.675 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 79' ' ' ARG . 32.3 t0 -78.77 -28.1 44.7 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.566 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -63.69 123.66 82.13 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.872 -1.143 . . . . 0.0 109.91 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.59 -4.77 12.36 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.048 1.832 . . . . 0.0 111.97 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -87.98 6.26 36.8 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.044 -1.035 . . . . 0.0 109.761 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.532 ' HG3' ' H ' ' A' ' 86' ' ' GLU . 11.9 ptpt -57.27 -50.89 71.48 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.162 -0.961 . . . . 0.0 108.975 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.532 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 84.4 tt0 -66.33 -42.57 87.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.282 -0.886 . . . . 0.0 109.899 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.72 -59.42 4.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.13 -0.981 . . . . 0.0 110.136 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.537 ' H ' HD12 ' A' ' 88' ' ' LEU . 6.1 mp -62.8 -44.53 95.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.953 -1.092 . . . . 0.0 109.49 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 145' ' ' GLY . 47.7 ttp180 -59.54 -30.33 68.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.845 . . . . 0.0 109.627 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.82 -61.66 2.34 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.616 -0.833 . . . . 0.0 109.638 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -54.98 -32.66 61.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.462 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -63.69 -31.34 72.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.902 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.601 ' O ' ' HB3' ' A' ' 172' ' ' ALA . 73.6 mt -50.87 -41.37 58.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.001 -1.062 . . . . 0.0 110.014 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.716 HD22 ' H ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -49.22 141.01 8.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.762 -1.211 . . . . 0.0 109.583 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.716 ' H ' HD22 ' A' ' 94' ' ' ASN . 0.7 OUTLIER -81.63 171.65 14.37 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.5 p-80 -177.71 -165.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 110.537 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.1 t -163.32 137.74 6.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.625 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -109.33 155.57 21.04 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 109.87 -178.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.87 -7.03 87.49 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -123.51 170.64 10.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.54 -0.977 . . . . 0.0 109.356 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' A' ' 101' ' ' ASP . 48.3 p30 -75.98 143.9 41.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.056 -1.027 . . . . 0.0 110.07 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.434 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 1.8 mt-10 -104.11 94.28 5.3 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.06 -1.025 . . . . 0.0 108.446 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.781 HG13 ' OG ' ' A' ' 133' ' ' SER . 44.1 t -97.55 127.02 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.023 -1.048 . . . . 0.0 110.313 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 129.73 43.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.342 -0.849 . . . . 0.0 109.244 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.641 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 14.2 t80 -106.44 131.92 53.07 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.161 -0.962 . . . . 0.0 109.33 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.54 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -87.86 130.82 34.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 110.279 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.429 HG12 HG11 ' A' ' 53' ' ' VAL . 3.0 t -109.63 -34.17 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.66 -0.65 . . . . 0.0 110.065 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 109' ' ' GLY . 1.4 tm-20 -164.01 151.68 12.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.477 ' N ' ' OE1' ' A' ' 108' ' ' GLU . . . 87.42 148.76 14.63 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.71 155.39 27.83 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.32 -1.106 . . . . 0.0 108.933 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -150.87 -119.61 0.9 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.2 tp -146.71 162.23 38.95 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.368 -1.078 . . . . 0.0 109.097 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -131.31 90.43 2.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.282 -0.886 . . . . 0.0 109.234 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.719 ' O ' HD22 ' A' ' 115' ' ' LEU . 5.1 p -79.47 131.96 36.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 110.107 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.719 HD22 ' O ' ' A' ' 114' ' ' CYS . 0.6 OUTLIER -136.67 104.26 5.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.358 -0.839 . . . . 0.0 108.772 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.52 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 1.7 t-160 -98.41 108.93 21.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.928 -1.108 . . . . 0.0 109.582 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.443 ' H ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -126.12 113.19 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.004 -178.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.85 -141.47 27.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 104.968 -3.253 . . . . 0.0 104.968 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.495 ' O ' ' OD2' ' A' ' 119' ' ' ASP . 39.9 p30 -108.25 80.92 1.41 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 115.488 -2.485 . . . . 0.0 108.956 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.52 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 23.2 pt-20 -166.41 168.88 14.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.727 ' O ' HG23 ' A' ' 5' ' ' ILE . 55.5 t -129.19 150.8 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.984 . . . . 0.0 109.83 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.5 ' CZ ' HD13 ' A' ' 5' ' ' ILE . 1.5 m-85 -125.39 129.8 50.61 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.213 0.53 . . . . 0.0 109.575 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 4' ' ' THR . 28.6 mt-30 -129.23 110.74 12.22 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.664 HG22 ' CD1' ' A' ' 3' ' ' LEU . 3.1 t -102.2 138.2 27.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.551 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 5.6 mp -122.39 79.51 1.62 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 117.685 -1.606 . . . . 0.0 109.226 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.551 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -165.86 118.42 1.11 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 178.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 7.3 tm-20 -113.9 104.19 11.92 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 116.618 -2.033 . . . . 0.0 110.916 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 130' ' ' ASP . 44.6 mtmt -110.15 178.01 4.53 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.688 177.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.641 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.3 OUTLIER -59.42 -3.57 0.46 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.63 ' N ' HD22 ' A' ' 129' ' ' ASN . 26.7 p30 -72.28 151.88 42.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.835 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.76 ' C ' HD12 ' A' ' 131' ' ' LEU . 1.9 pp -114.9 160.77 19.13 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.023 0.916 . . . . 0.0 110.57 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.623 ' N ' HD12 ' A' ' 131' ' ' LEU . 6.2 mm -128.07 125.96 65.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.586 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.781 ' OG ' HG13 ' A' ' 103' ' ' VAL . 28.0 m -123.35 141.26 52.17 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.46 148.58 39.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.852 . . . . 0.0 108.716 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -70.24 156.68 61.55 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.269 1.979 . . . . 0.0 112.926 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.605 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.15 133.51 46.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.438 -0.789 . . . . 0.0 109.036 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.605 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 11.1 t60 92.24 11.75 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.168 0.509 . . . . 0.0 110.012 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.24 126.26 32.07 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.99 133.86 40.47 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.442 1.428 . . . . 0.0 111.699 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.511 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.41 163.49 8.59 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.084 -1.047 . . . . 0.0 110.313 -179.263 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.72 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 10.7 p90 -130.95 -153.49 0.57 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.365 -0.835 . . . . 0.0 110.031 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.534 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -168.41 125.06 1.03 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.476 -0.765 . . . . 0.0 109.169 179.112 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 46.2 p-10 -146.04 129.48 16.86 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.053 -1.029 . . . . 0.0 109.749 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.586 ' O ' ' C ' ' A' ' 145' ' ' GLY . 29.8 mtt -102.95 16.51 26.42 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.369 -0.832 . . . . 0.0 111.198 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 20.86 -113.85 0.01 OUTLIER Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.424 ' H ' ' HB2' ' A' ' 178' ' ' LEU . 67.2 m -81.3 120.77 25.35 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.064 -1.454 . . . . 0.0 109.159 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.04 114.46 46.21 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 120.181 -0.607 . . . . 0.0 109.386 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 59.6 Cg_endo -104.14 44.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 122.614 2.209 . . . . 0.0 111.485 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER 81.68 70.35 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.177 -177.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 23.8 p90 -96.44 159.06 15.14 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.414 -0.804 . . . . 0.0 110.225 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.3 m -125.37 125.39 43.37 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.582 0.706 . . . . 0.0 110.716 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.491 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . . . -143.22 162.76 34.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.37 -0.831 . . . . 0.0 109.295 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.617 HG23 ' HE1' ' A' ' 73' ' ' TRP . 94.9 mt -110.9 129.87 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.256 -0.902 . . . . 0.0 109.942 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.526 ' C ' HD13 ' A' ' 155' ' ' ILE . 95.5 mtt-85 -129.87 158.03 40.63 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.578 -0.701 . . . . 0.0 109.596 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.68 154.41 8.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.404 ' HB2' ' CB ' ' A' ' 72' ' ' SER . 4.2 m-30 -95.81 120.15 35.57 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.093 -1.004 . . . . 0.0 110.196 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.562 ' CG ' ' CE2' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -134.82 161.89 33.91 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.749 ' ND2' HE22 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -95.92 160.61 29.71 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 120.92 -1.113 . . . . 0.0 109.268 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 161' ' ' GLY . 43.0 Cg_endo -67.9 -54.83 0.3 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.367 2.044 . . . . 0.0 112.088 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 159' ' ' PRO . 16.5 pt-20 -43.98 -14.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.243 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -89.04 -36.7 7.54 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CE2' ' CG ' ' A' ' 157' ' ' ASP . 47.6 m0 -102.26 163.35 12.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.601 -0.941 . . . . 0.0 110.675 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -99.25 139.33 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.362 -0.836 . . . . 0.0 109.238 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -63.36 -73.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.5 -0.75 . . . . 0.0 110.736 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -142.25 159.69 41.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.941 -1.099 . . . . 0.0 110.062 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.6 -41.45 6.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.753 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.9 -31.74 5.0 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.26 -1.27 64.48 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.467 ' O ' ' CG ' ' A' ' 95' ' ' GLU . 94.6 m-20 -80.71 149.51 29.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.761 -1.435 . . . . 0.0 108.291 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.462 ' OD2' ' OG ' ' A' ' 173' ' ' SER . 5.8 p-10 -109.5 88.07 2.65 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.624 -1.63 . . . . 0.0 110.682 176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.0 OUTLIER -76.16 -20.76 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.336 -1.477 . . . . 0.0 109.594 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.72 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -61.51 -39.82 92.4 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.972 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.583 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 38.2 p -52.9 -3.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.711 -0.618 . . . . 0.0 110.193 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.98 -39.66 29.6 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.957 -1.09 . . . . 0.0 111.491 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.636 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.7 m-85 -113.48 24.27 0.08 OUTLIER Pre-proline 0 N--CA 1.516 2.864 0 O-C-N 120.534 -1.353 . . . . 0.0 112.73 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 43.9 Cg_endo -61.56 -19.59 65.36 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.653 2.902 . . . . 0.0 114.486 -172.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -89.36 127.05 35.77 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 119.005 -1.078 . . . . 0.0 108.879 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.739 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 1.0 OUTLIER -85.5 118.81 25.25 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.085 -1.009 . . . . 0.0 108.698 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.624 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.492 ' O ' ' OG1' ' A' ' 19' ' ' THR . 1.3 p . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.77 171.08 8.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.237 -0.914 . . . . 0.0 109.437 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.775 HD13 HG22 ' A' ' 124' ' ' VAL . 30.9 tp -158.9 112.53 2.36 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.29 128.97 54.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.829 -1.169 . . . . 0.0 110.091 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 121' ' ' VAL . 60.4 mt -123.7 130.07 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -125.9 165.55 18.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.54 ' OG ' HD11 ' A' ' 15' ' ' LEU . 14.3 m -84.35 172.77 11.49 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.32 -0.863 . . . . 0.0 109.019 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -89.43 -30.45 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.121 . . . . 0.0 109.955 179.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -73.73 -38.33 64.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 0.0 110.043 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.71 123.93 13.12 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.34 -30.43 1.55 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.234 1.956 . . . . 0.0 112.312 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.745 HE21 ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -69.67 2.27 3.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.466 -0.771 . . . . 0.0 109.928 -179.102 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.745 ' ND2' HE21 ' A' ' 12' ' ' GLN . 0.9 OUTLIER -117.79 119.45 34.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.5 p -96.12 124.38 40.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.292 -0.88 . . . . 0.0 109.334 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.54 HD11 ' OG ' ' A' ' 7' ' ' SER . 72.0 mt -87.62 -15.4 37.42 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.715 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 46.2 t90 -158.93 108.59 1.96 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.649 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -120.5 122.08 39.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.136 -0.977 . . . . 0.0 109.275 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.07 164.02 20.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.969 -1.082 . . . . 0.0 109.961 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 19' ' ' THR . 10.3 t -131.47 89.89 2.78 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.566 175.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.779 ' O ' HD12 ' A' ' 24' ' ' ILE . 29.8 m120 -125.59 145.54 50.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.964 -1.085 . . . . 0.0 110.688 177.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.58 -41.67 19.27 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.34 -1.475 . . . . 0.0 109.072 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -82.77 -48.81 10.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.349 -0.844 . . . . 0.0 109.6 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.486 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.1 tt0 -61.31 -19.95 62.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.974 -1.079 . . . . 0.0 108.533 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.779 HD12 ' O ' ' A' ' 20' ' ' ASN . 2.3 mt -73.27 -58.59 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.183 -0.948 . . . . 0.0 109.316 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.516 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 6.2 pt20 -61.28 -42.22 98.27 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.035 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.516 ' N ' ' CG ' ' A' ' 25' ' ' GLN . 62.7 tt0 -61.77 -47.46 85.08 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.347 -0.846 . . . . 0.0 109.48 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.607 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 4.7 tt0 -76.06 -45.44 34.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.062 -1.024 . . . . 0.0 109.332 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.467 ' HA ' HD12 ' A' ' 28' ' ' LEU . 16.9 tp -64.54 -56.74 12.08 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.02 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.622 HD21 ' CB ' ' A' ' 35' ' ' PHE . 1.2 m-20 -57.26 -17.92 13.95 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.928 -1.108 . . . . 0.0 109.469 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 27' ' ' GLN . . . -63.93 -27.8 69.39 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.916 -1.115 . . . . 0.0 109.084 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -89.75 10.53 23.09 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.721 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.0 23.49 25.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.1 t -93.69 143.35 11.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.249 -1.148 . . . . 0.0 109.672 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 ttt85 -85.08 155.7 21.39 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.385 -0.822 . . . . 0.0 109.055 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.622 ' CB ' HD21 ' A' ' 29' ' ' ASN . 1.5 t80 -155.81 153.59 30.02 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.711 -1.243 . . . . 0.0 109.059 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' OE1' ' O ' ' A' ' 35' ' ' PHE . 13.1 tp10 -175.71 173.34 2.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.763 -1.211 . . . . 0.0 109.576 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.449 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 37.5 mtm180 -148.38 117.56 6.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.813 -1.18 . . . . 0.0 108.665 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.527 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 26.8 m0 -110.2 154.07 23.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 109.283 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.611 HE22 ' ND2' ' A' ' 129' ' ' ASN . 99.5 mm-40 -141.12 155.88 46.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.481 -0.762 . . . . 0.0 109.92 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.99 156.64 17.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.328 -0.857 . . . . 0.0 109.004 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.499 ' OD2' ' N ' ' A' ' 42' ' ' ARG . 53.2 p30 -101.11 -11.81 19.3 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.125 -0.985 . . . . 0.0 108.7 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.499 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -93.38 156.38 16.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -92.12 119.03 31.4 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.688 -0.632 . . . . 0.0 109.566 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.36 163.65 14.12 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.696 0.76 . . . . 0.0 109.3 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.37 -102.81 0.19 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.18 92.82 4.49 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.928 -1.336 . . . . 0.0 109.23 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.54 91.47 44.61 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -75.58 -22.67 13.6 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.461 2.107 . . . . 0.0 112.756 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 p -121.96 141.97 50.78 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.542 -0.723 . . . . 0.0 109.59 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 51' ' ' GLU . . . -80.29 -18.24 49.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.333 -0.854 . . . . 0.0 109.405 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 50' ' ' ALA . 79.8 mm-40 -45.34 -38.32 5.69 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.911 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.4 m -77.84 -33.3 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.41 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' A' ' 50' ' ' ALA . 65.3 t -68.22 -47.0 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 109.961 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.513 ' O ' ' N ' ' A' ' 58' ' ' GLN . 14.4 mm -60.61 -39.16 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 109.261 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.26 70.62 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.571 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.34 -19.55 58.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 0.0 110.507 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -116.33 -8.53 11.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.435 -0.791 . . . . 0.0 109.267 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.694 HE21 ' CG1' ' A' ' 61' ' ' ILE . 33.5 tp60 -48.36 -38.03 18.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 108.737 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.599 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.22 -47.95 62.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.01 -1.056 . . . . 0.0 109.885 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.599 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.37 -58.93 6.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.968 -1.082 . . . . 0.0 109.819 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.702 HD12 ' C ' ' A' ' 61' ' ' ILE . 0.5 OUTLIER -62.72 -29.42 46.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.953 -1.092 . . . . 0.0 108.883 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 58' ' ' GLN . 47.4 t0 -57.31 -25.37 59.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.86 . . . . 0.0 109.713 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -78.47 -38.09 41.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 110.126 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -62.99 -39.52 94.97 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.266 -0.973 . . . . 0.0 109.695 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -69.25 -30.38 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.026 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.62 61.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.216 -1.552 . . . . 0.0 109.462 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -83.7 -52.48 6.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.022 -1.049 . . . . 0.0 110.799 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.629 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -86.7 14.88 6.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.544 -0.723 . . . . 0.0 110.666 -177.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -14.7 89.38 0.01 OUTLIER Glycine 0 N--CA 1.5 2.944 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.855 ' CG ' HG21 ' A' ' 155' ' ' ILE . 97.2 m-85 -76.03 160.07 30.19 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -58.93 -40.86 85.88 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.315 -0.866 . . . . 0.0 109.754 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.1 t -144.49 155.22 43.6 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.212 -0.93 . . . . 0.0 109.104 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.669 ' CE2' HD13 ' A' ' 61' ' ' ILE . 9.8 t-105 -141.68 146.3 35.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.303 -0.873 . . . . 0.0 108.658 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.537 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.3 OUTLIER -176.55 -165.87 0.15 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 153' ' ' ILE . 36.0 m -128.57 165.57 27.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.446 -0.784 . . . . 0.0 109.625 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.684 ' CD1' ' HE ' ' A' ' 154' ' ' ARG . 1.4 mp -95.52 136.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.0 p -91.95 165.6 13.14 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.423 1.106 . . . . 0.0 111.412 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.744 HD23 ' CZ ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -161.5 137.63 8.07 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.884 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.559 ' H ' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -123.64 137.78 54.66 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.601 ' HB2' ' HB3' ' A' ' 149' ' ' ASN . . . -70.56 -7.03 40.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 0.0 109.709 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.519 ' H ' ' HD2' ' A' ' 79' ' ' ARG . 45.8 t0 -110.64 -18.24 13.21 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.519 -0.738 . . . . 0.0 109.396 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.858 HD21 ' N ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -63.34 116.67 27.16 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.239 -178.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -90.07 -16.53 1.79 Allowed 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.964 2.443 . . . . 0.0 113.032 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.402 ' CG ' ' OD1' ' A' ' 82' ' ' ASN . 16.5 pt20 -80.26 1.18 29.56 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.008 -1.058 . . . . 0.0 109.165 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.858 ' N ' HD21 ' A' ' 82' ' ' ASN . 0.8 OUTLIER -65.84 -42.16 90.87 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.21 178.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -51.45 -47.04 63.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.013 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.87 -43.93 77.62 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.672 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.431 HD12 ' HE2' ' A' ' 85' ' ' LYS . 91.4 mt -61.75 -38.38 87.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.887 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.63 HH11 ' CA ' ' A' ' 89' ' ' ARG . 1.6 mmt-85 -58.78 -25.53 63.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.885 . . . . 0.0 108.865 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -58.57 3.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.465 -0.772 . . . . 0.0 110.248 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -54.81 -45.69 74.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.342 -0.849 . . . . 0.0 109.736 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -67.81 -18.67 64.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -62.48 -34.38 76.72 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 109.705 -179.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.495 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 45.9 p-10 -47.58 140.28 6.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 109.944 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' A' ' 96' ' ' HIS . 23.1 tt0 -77.79 163.08 26.43 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.293 -0.88 . . . . 0.0 109.476 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.523 ' N ' ' CG ' ' A' ' 95' ' ' GLU . 50.7 p-80 -174.64 -167.13 0.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.349 -1.341 . . . . 0.0 112.07 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.99 134.39 2.47 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -106.1 156.07 18.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.86 -178.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.6 -6.19 86.63 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -123.04 170.04 10.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.456 -1.026 . . . . 0.0 109.431 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -75.85 142.89 42.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 109.887 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.437 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 1.8 mt-10 -102.79 92.67 4.7 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.749 HG22 ' OG ' ' A' ' 133' ' ' SER . 35.1 t -89.65 128.15 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.484 -0.76 . . . . 0.0 109.636 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.459 ' NH1' HG22 ' A' ' 132' ' ' ILE . 9.2 tmm_? -130.27 122.6 28.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -0.784 . . . . 0.0 109.904 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.632 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 11.0 t80 -100.87 130.92 46.95 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.477 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -87.78 130.25 34.91 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.544 -0.722 . . . . 0.0 110.196 -178.507 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.8 -30.93 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.687 -0.633 . . . . 0.0 109.423 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -162.01 151.48 16.08 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.18 -0.95 . . . . 0.0 109.374 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.81 164.8 39.71 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' A' ' 127' ' ' GLU . . . -147.72 171.53 15.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.478 -1.013 . . . . 0.0 109.281 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.7 154.52 10.74 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.586 ' CB ' HD22 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -93.65 96.78 10.04 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.744 -1.445 . . . . 0.0 110.08 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.503 ' CE1' ' O ' ' A' ' 114' ' ' CYS . 3.5 t80 -87.75 127.95 35.31 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.767 -1.208 . . . . 0.0 109.332 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.664 ' SG ' ' NE2' ' A' ' 123' ' ' GLN . 1.8 m -78.93 129.96 35.07 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.711 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.751 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.0 tm? -114.62 129.47 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.623 ' N ' HD13 ' A' ' 115' ' ' LEU . 4.9 t-160 -114.68 112.84 23.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.417 -0.802 . . . . 0.0 109.558 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.3 112.2 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.441 -0.787 . . . . 0.0 109.597 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.42 -127.76 10.08 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 106.437 -2.665 . . . . 0.0 106.437 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.559 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 46.4 p30 -116.23 75.51 0.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 115.374 -2.53 . . . . 0.0 110.342 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.581 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 22.3 pt-20 -166.2 168.25 15.44 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 5' ' ' ILE . 55.7 t -125.4 138.96 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.46 -0.775 . . . . 0.0 109.986 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 115' ' ' LEU . 7.6 m-85 -127.61 131.25 49.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 0.0 109.353 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.664 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 11.7 mt-30 -126.45 118.54 25.16 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.031 -1.043 . . . . 0.0 108.983 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.909 ' C ' HD23 ' A' ' 125' ' ' LEU . 21.7 t -110.14 135.54 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.909 HD23 ' C ' ' A' ' 124' ' ' VAL . 0.1 OUTLIER -133.64 90.96 2.78 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.594 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 1.7 p -164.64 134.11 3.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 119.685 -1.884 . . . . 0.0 106.827 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 110' ' ' ALA . 2.5 pt-20 -106.34 93.72 4.75 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 115.71 -2.396 . . . . 0.0 110.185 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.558 ' C ' ' H ' ' A' ' 130' ' ' ASP . 51.7 mttm -115.52 158.95 21.85 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.108 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.632 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 23.1 m-80 -58.37 -3.02 0.23 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.345 -1.472 . . . . 0.0 107.622 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 128' ' ' LYS . 56.1 p30 -72.81 152.78 41.39 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.139 -0.976 . . . . 0.0 109.28 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.768 ' C ' HD12 ' A' ' 131' ' ' LEU . 3.0 pp -117.23 161.43 19.49 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.686 0.755 . . . . 0.0 110.052 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.58 ' N ' HD12 ' A' ' 131' ' ' LEU . 17.3 tt -133.11 126.36 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.281 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.749 ' OG ' HG22 ' A' ' 103' ' ' VAL . 19.1 t -122.1 138.53 54.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.452 -0.78 . . . . 0.0 109.605 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.16 147.87 35.02 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.387 -0.821 . . . . 0.0 109.145 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.723 ' O ' HG22 ' A' ' 138' ' ' THR . 39.1 Cg_endo -66.81 156.51 65.69 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.269 1.979 . . . . 0.0 112.795 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.644 ' O ' ' ND1' ' A' ' 137' ' ' HIS . . . -71.84 139.74 49.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.311 -0.868 . . . . 0.0 108.675 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.644 ' ND1' ' O ' ' A' ' 136' ' ' ALA . 7.4 m80 88.62 13.46 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.852 -0.53 . . . . 0.0 109.719 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.723 HG22 ' O ' ' A' ' 135' ' ' PRO . 14.9 t -106.7 126.4 30.4 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.288 -0.883 . . . . 0.0 108.864 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 116' ' ' HIS . 39.6 Cg_endo -63.66 134.06 42.39 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.597 1.531 . . . . 0.0 111.452 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.51 ' C ' ' CD2' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -172.29 162.08 5.45 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.959 -1.088 . . . . 0.0 109.982 -179.088 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.501 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -133.19 -149.01 0.35 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.159 -0.963 . . . . 0.0 109.413 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -176.38 127.99 0.2 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.925 -1.109 . . . . 0.0 108.938 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.76 138.68 18.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 109.143 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.623 ' SD ' ' CZ ' ' A' ' 89' ' ' ARG . 1.4 mpt? -113.17 21.69 15.06 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.395 -0.816 . . . . 0.0 110.574 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.599 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.67 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.501 2.971 0 CA-C-N 119.417 1.008 . . . . 0.0 111.835 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.477 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 74.9 m -86.74 117.24 25.36 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 117.94 -1.504 . . . . 0.0 109.562 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.45 ' N ' ' OE1' ' A' ' 147' ' ' GLU . 22.3 mp0 -115.2 116.92 41.81 Favored Pre-proline 0 C--N 1.294 -1.835 0 O-C-N 121.805 -0.56 . . . . 0.0 109.778 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.616 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 51.1 Cg_endo -103.39 31.96 0.07 OUTLIER 'Trans proline' 0 C--O 1.207 -1.064 0 C-N-CA 123.395 2.73 . . . . 0.0 111.791 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.721 ' CG ' ' O ' ' A' ' 149' ' ' ASN . 0.1 OUTLIER 82.54 63.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 123.102 1.43 . . . . 0.0 109.807 -178.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.744 ' CZ ' HD23 ' A' ' 78' ' ' LEU . 11.2 p90 -99.84 -178.86 3.99 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 119.805 -1.809 . . . . 0.0 110.16 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 59.7 m -135.69 131.7 36.0 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.701 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -134.98 153.94 51.91 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.065 -1.022 . . . . 0.0 108.972 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.459 HG12 HG12 ' A' ' 75' ' ' VAL . 10.9 mt -110.21 129.58 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.159 -0.963 . . . . 0.0 109.805 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.684 ' HE ' ' CD1' ' A' ' 76' ' ' ILE . 25.9 mtm-85 -143.97 170.08 16.6 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.192 -0.943 . . . . 0.0 109.481 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.855 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.6 mp -101.33 145.81 10.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.471 -0.768 . . . . 0.0 109.034 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.521 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 5.2 m-85 -96.38 118.73 33.52 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.489 -0.757 . . . . 0.0 109.408 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.575 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 55.3 p30 -134.89 161.57 34.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.848 -0.533 . . . . 0.0 109.607 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.605 ' O ' ' NE1' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -96.08 156.99 36.47 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.946 -1.096 . . . . 0.0 108.981 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.5 Cg_endo -66.93 -54.06 0.45 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.667 2.245 . . . . 0.0 112.249 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.6 ' N ' ' OD1' ' A' ' 158' ' ' ASN . 95.5 mt-10 -44.4 -17.53 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.312 -0.867 . . . . 0.0 108.856 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.48 -50.84 5.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.605 ' NE1' ' O ' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -104.07 169.33 8.56 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.474 -1.016 . . . . 0.0 109.95 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 74.9 mt -96.99 149.81 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 0.0 109.341 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 96' ' ' HIS . . . -83.31 -71.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 0.0 110.349 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -117.6 146.3 43.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.161 -0.962 . . . . 0.0 109.699 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -101.56 -41.71 6.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.436 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 69.4 p -106.44 -31.18 8.67 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.22 -0.925 . . . . 0.0 109.049 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.23 -9.1 56.01 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -82.78 145.98 29.23 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.253 -1.734 . . . . 0.0 108.722 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -112.33 90.6 3.38 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.527 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.07 -16.78 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.036 -1.665 . . . . 0.0 108.758 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -57.94 -38.05 75.22 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.672 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 22.7 t -51.61 -3.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.232 -0.917 . . . . 0.0 110.191 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.664 ' HB3' ' CE2' ' A' ' 175' ' ' TYR . . . -76.64 -42.05 43.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.784 -1.197 . . . . 0.0 111.701 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.664 ' CE2' ' HB3' ' A' ' 174' ' ' ALA . 0.1 OUTLIER -113.95 26.7 0.1 OUTLIER Pre-proline 0 N--CA 1.511 2.606 0 O-C-N 120.574 -1.328 . . . . 0.0 111.966 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.672 ' HD3' ' C ' ' A' ' 173' ' ' SER . 46.4 Cg_endo -60.95 -24.24 79.03 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 124.146 3.231 . . . . 0.0 113.038 -172.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.11 126.18 35.35 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.895 -1.122 . . . . 0.0 109.186 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.512 ' O ' ' C ' ' A' ' 179' ' ' ALA . 1.3 tp -87.59 122.69 31.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.633 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.633 ' O ' ' OG1' ' A' ' 19' ' ' THR . 11.3 p . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.68 170.76 8.78 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.301 -0.874 . . . . 0.0 109.325 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 4' ' ' THR . 3.8 tp -159.01 115.92 2.72 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.437 ' N ' HD12 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -108.83 140.78 41.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.746 HG23 ' O ' ' A' ' 121' ' ' VAL . 32.1 mt -134.18 134.65 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -126.65 166.89 16.51 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.9 m -86.04 173.92 9.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.051 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.3 -28.09 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.982 -1.074 . . . . 0.0 109.399 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -75.83 -36.59 59.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 110.381 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -137.89 123.75 12.81 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.476 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -81.69 -32.11 0.94 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.066 1.844 . . . . 0.0 112.353 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.577 ' NE2' ' O ' ' A' ' 12' ' ' GLN . 23.5 tp60 -69.81 2.78 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.448 -0.782 . . . . 0.0 110.011 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -114.73 120.11 38.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.912 . . . . 0.0 109.474 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.85 122.15 40.62 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.251 -0.906 . . . . 0.0 109.248 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 15' ' ' LEU . 10.8 mp -90.43 -6.18 55.21 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.022 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.707 ' HB3' HD12 ' A' ' 5' ' ' ILE . 39.1 t90 -156.22 105.13 2.29 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.43 -1.308 . . . . 0.0 110.276 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -119.13 110.97 17.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.642 -0.661 . . . . 0.0 109.544 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.448 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -163.01 163.45 26.03 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.002 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 19' ' ' THR . 11.7 t -131.47 90.77 2.91 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 120.786 -1.196 . . . . 0.0 108.416 176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.806 ' O ' HD12 ' A' ' 24' ' ' ILE . 29.9 m120 -124.66 152.29 43.84 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.851 -1.156 . . . . 0.0 110.613 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.32 -47.54 11.38 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.343 -1.473 . . . . 0.0 108.758 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -82.49 -43.35 17.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.347 -0.846 . . . . 0.0 110.242 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.498 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.2 tt0 -66.07 -24.73 66.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.749 -1.219 . . . . 0.0 108.908 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 20' ' ' ASN . 3.3 mt -68.26 -58.45 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.165 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 29' ' ' ASN . 14.2 pt20 -58.39 -43.77 88.69 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.127 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.586 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 50.4 tt0 -53.89 -35.11 61.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.463 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.703 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -66.97 -63.55 1.04 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.0 -1.062 . . . . 0.0 109.314 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.571 ' HB2' HG21 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -69.18 -54.94 12.24 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.822 -1.174 . . . . 0.0 109.834 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 17.1 t-20 -47.52 -33.06 5.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.681 -1.262 . . . . 0.0 109.068 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -63.68 -25.33 68.16 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.064 -1.022 . . . . 0.0 108.531 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 28' ' ' LEU . 29.0 mttm -91.39 10.53 27.17 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.273 -0.892 . . . . 0.0 110.498 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.92 25.88 12.4 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.048 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.6 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 48.4 t -96.36 146.2 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.449 -1.03 . . . . 0.0 109.347 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.458 ' CD ' HD11 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -84.77 155.24 21.93 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.135 -0.978 . . . . 0.0 109.243 -179.045 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.485 ' CD1' ' HB3' ' A' ' 25' ' ' GLN . 2.1 t80 -155.37 154.26 31.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.043 -1.036 . . . . 0.0 109.006 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 35' ' ' PHE . 11.5 tp10 -176.12 173.05 2.27 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.975 -1.078 . . . . 0.0 109.519 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.45 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 65.4 mtm-85 -148.54 118.45 7.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.039 -1.038 . . . . 0.0 108.603 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.44 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 30.2 m0 -110.93 148.37 32.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.324 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.695 HE21 ' ND2' ' A' ' 129' ' ' ASN . 49.6 mm-40 -137.08 159.98 40.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.437 -0.789 . . . . 0.0 109.664 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.27 160.45 14.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 109.044 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -98.45 -18.46 18.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.236 -0.915 . . . . 0.0 108.687 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -93.54 167.85 11.42 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -94.39 121.15 35.63 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.727 . . . . 0.0 109.386 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.33 167.14 11.52 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.05 -121.7 0.59 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.44 78.83 9.63 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.068 -1.254 . . . . 0.0 108.653 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.15 95.62 30.99 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 121.375 -0.828 . . . . 0.0 109.309 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.689 ' O ' HG23 ' A' ' 49' ' ' THR . 46.8 Cg_endo -70.61 79.17 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.22 1.947 . . . . 0.0 111.736 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.689 HG23 ' O ' ' A' ' 48' ' ' PRO . 6.0 p -162.99 118.03 1.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.061 -1.024 . . . . 0.0 109.364 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.81 -43.98 17.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.062 -1.024 . . . . 0.0 109.96 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -65.11 -17.17 64.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.392 -0.817 . . . . 0.0 109.728 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.6 m -77.05 -41.78 41.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.229 -0.919 . . . . 0.0 110.373 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.445 HG11 ' CG1' ' A' ' 107' ' ' VAL . 20.6 t -63.93 -47.87 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.051 -1.031 . . . . 0.0 109.537 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 58' ' ' GLN . 11.7 mm -61.21 -42.25 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 108.722 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.38 -30.3 71.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.332 -0.855 . . . . 0.0 109.83 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.77 -19.38 59.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 110.405 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' GLN . 55.0 m-85 -113.75 -6.67 13.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.373 -0.829 . . . . 0.0 109.462 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.676 HE21 ' CG1' ' A' ' 61' ' ' ILE . 26.3 tp60 -47.74 -39.72 18.56 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -50.43 -44.22 55.25 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.619 -1.3 . . . . 0.0 109.369 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.87 -59.42 4.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.869 -1.144 . . . . 0.0 110.452 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.676 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.8 OUTLIER -61.41 -30.39 47.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 120.912 -1.117 . . . . 0.0 108.968 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -55.04 -28.85 55.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.01 -1.056 . . . . 0.0 109.68 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -74.94 -38.94 61.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.034 -1.041 . . . . 0.0 109.4 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.8 mp -65.28 -35.34 80.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.069 -1.019 . . . . 0.0 109.739 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 61' ' ' ILE . 2.6 t -70.11 -31.18 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.72 64.02 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.639 -1.288 . . . . 0.0 109.386 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -87.33 -52.52 5.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 110.612 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.581 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -85.81 14.85 5.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.843 . . . . 0.0 110.44 -177.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.581 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -19.54 89.08 0.01 OUTLIER Glycine 0 N--CA 1.495 2.572 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.518 ' CG ' HG21 ' A' ' 155' ' ' ILE . 48.8 m-85 -76.75 167.71 21.36 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -57.19 -88.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.431 -0.793 . . . . 0.0 109.452 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -104.74 166.13 10.59 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.399 0.619 . . . . 0.0 109.69 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.562 ' HE1' HG23 ' A' ' 153' ' ' ILE . 5.5 t-105 -137.58 141.61 41.31 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.448 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -158.47 176.64 12.17 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.4 p -122.89 144.58 31.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.1 mt -105.53 116.84 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.484 ' O ' ' OG ' ' A' ' 77' ' ' SER . 11.2 p -168.66 103.05 0.41 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.261 -0.9 . . . . 0.0 109.216 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 79' ' ' ARG . 1.0 OUTLIER -115.27 -177.22 3.09 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 120.7 1.591 . . . . 0.0 108.645 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' ASP . 2.3 ttt180 -92.82 152.61 19.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.375 -1.453 . . . . 0.0 109.129 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.15 -6.87 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.062 -1.024 . . . . 0.0 110.4 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ARG . 95.3 m-20 -92.52 33.78 1.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.651 ' ND2' ' N ' ' A' ' 85' ' ' LYS . 23.7 t30 -76.12 124.8 88.42 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.914 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.16 -27.86 3.42 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.645 2.23 . . . . 0.0 112.271 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -90.79 10.66 25.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.917 -1.115 . . . . 0.0 109.194 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.651 ' N ' ' ND2' ' A' ' 82' ' ' ASN . 0.4 OUTLIER -53.34 -58.52 6.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.146 -0.972 . . . . 0.0 108.815 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.38 -51.4 52.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.116 -0.99 . . . . 0.0 109.324 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.99 -42.06 72.0 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.343 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 5.7 tp -59.75 -42.92 94.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.179 -0.95 . . . . 0.0 109.199 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -56.77 -37.67 71.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.568 -1.332 . . . . 0.0 110.174 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -66.06 -22.35 66.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.29 -0.881 . . . . 0.0 109.763 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.538 ' CG ' ' N ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -65.64 -45.47 82.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.617 -0.677 . . . . 0.0 110.121 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.668 ' CD2' ' O ' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -88.14 -13.57 40.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 0.0 110.477 -178.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 92' ' ' PHE . 65.5 tp -42.18 -18.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.152 -0.967 . . . . 0.0 109.883 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 92' ' ' PHE . 9.4 p30 -99.8 114.61 27.89 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.055 -1.028 . . . . 0.0 109.235 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.504 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 3.0 pp20? -52.02 173.91 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.504 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 50.2 p-80 -176.5 -166.78 0.17 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.295 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.06 135.47 3.83 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.607 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -103.61 154.8 19.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 109.741 -178.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.73 -6.59 87.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -123.97 171.18 9.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.333 -1.099 . . . . 0.0 109.424 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -74.31 141.79 45.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.975 . . . . 0.0 110.068 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.607 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 3.7 tt0 -102.83 89.9 3.62 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 103' ' ' VAL . 13.8 p -88.43 130.43 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.082 -1.011 . . . . 0.0 110.521 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.544 ' NH1' ' HE ' ' A' ' 154' ' ' ARG . 52.5 mtt-85 -129.68 121.79 27.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.594 -0.691 . . . . 0.0 109.439 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.615 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 21.7 t80 -101.76 132.97 47.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 108.593 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.542 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.33 129.53 35.36 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.677 -0.639 . . . . 0.0 109.747 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.474 ' HB ' HG22 ' A' ' 151' ' ' THR . 19.3 t -112.42 -30.41 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.697 -0.627 . . . . 0.0 109.749 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -168.59 158.69 9.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.04 -1.038 . . . . 0.0 109.108 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.05 156.83 5.61 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.33 -168.79 1.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -1.126 . . . . 0.0 109.35 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.31 -135.75 3.5 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.708 HD12 HD12 ' A' ' 178' ' ' LEU . 3.9 mt -144.74 162.91 35.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -1.138 . . . . 0.0 109.602 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -136.83 89.6 2.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 109.455 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.49 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -79.48 108.68 13.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.428 -0.795 . . . . 0.0 109.904 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.49 HD12 ' C ' ' A' ' 114' ' ' CYS . 9.2 mp -115.71 114.13 24.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.289 -0.882 . . . . 0.0 109.118 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.442 ' NE2' ' O ' ' A' ' 118' ' ' GLY . 11.1 t-160 -102.89 109.9 21.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.046 -1.034 . . . . 0.0 109.476 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.2 mt -125.59 111.79 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.281 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.442 ' O ' ' NE2' ' A' ' 116' ' ' HIS . . . 75.45 -142.92 29.78 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 106.427 -2.669 . . . . 0.0 106.427 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.49 ' O ' ' CG ' ' A' ' 119' ' ' ASP . 48.2 p-10 -103.48 79.09 1.66 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 114.909 -2.716 . . . . 0.0 109.167 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.438 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 24.0 tp10 -166.29 167.28 16.13 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.474 -1.391 . . . . 0.0 107.781 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.746 ' O ' HG23 ' A' ' 5' ' ' ILE . 57.3 t -128.52 147.06 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.809 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -123.94 131.4 53.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.771 -0.581 . . . . 0.0 109.714 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.417 ' O ' HD12 ' A' ' 3' ' ' LEU . 38.6 mm-40 -126.65 106.66 9.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -0.949 . . . . 0.0 108.905 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.01 136.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.2 tt -136.53 91.57 2.67 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.937 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 20.0 p -166.16 136.37 3.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.598 -1.314 . . . . 0.0 108.468 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.507 ' O ' ' CD ' ' A' ' 127' ' ' GLU . 3.4 tm-20 -107.23 93.95 4.83 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 115.819 -2.352 . . . . 0.0 110.884 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.551 ' C ' ' H ' ' A' ' 130' ' ' ASP . 30.4 mttp -114.5 155.55 26.21 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.755 176.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.695 ' ND2' HE21 ' A' ' 39' ' ' GLN . 12.6 p30 -55.71 -5.15 0.13 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.229 -1.544 . . . . 0.0 107.928 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 128' ' ' LYS . 43.4 p-10 -72.21 150.3 43.82 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.881 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.783 ' C ' HD12 ' A' ' 131' ' ' LEU . 3.0 pp -119.03 161.58 20.0 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.753 0.787 . . . . 0.0 110.547 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 131' ' ' LEU . 17.0 tt -134.84 125.57 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.2 t -120.21 135.84 54.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 0.0 109.444 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.7 m -95.99 148.02 33.88 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.303 -0.873 . . . . 0.0 108.821 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.04 154.9 71.49 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.239 1.96 . . . . 0.0 112.621 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.613 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.93 136.34 46.82 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.613 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 5.7 t-80 91.67 11.12 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.92 126.61 30.67 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.32 131.63 30.82 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.621 1.547 . . . . 0.0 111.449 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.566 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.94 167.66 12.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.132 -0.98 . . . . 0.0 110.064 -179.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.536 ' CD2' ' HB2' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -138.41 -150.07 0.32 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.269 -0.895 . . . . 0.0 109.52 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.668 ' O ' ' CD2' ' A' ' 92' ' ' PHE . 76.9 t80 -174.95 122.93 0.24 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.893 -1.129 . . . . 0.0 109.034 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.594 ' OD2' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -139.29 134.06 32.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.321 -0.862 . . . . 0.0 110.186 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.622 ' O ' ' C ' ' A' ' 145' ' ' GLY . 4.0 mtp -113.42 20.65 15.9 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.667 -0.646 . . . . 0.0 110.569 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.622 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 5.17 -83.83 0.0 OUTLIER Glycine 0 N--CA 1.503 3.13 0 CA-C-N 119.155 0.889 . . . . 0.0 111.62 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.558 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 22.2 p -87.81 118.8 27.58 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.001 -1.48 . . . . 0.0 109.019 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -112.85 109.68 52.52 Favored Pre-proline 0 C--N 1.292 -1.911 0 C-N-CA 119.514 -0.875 . . . . 0.0 109.054 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.809 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 58.3 Cg_endo -100.06 20.44 0.27 Allowed 'Trans proline' 0 C--O 1.195 -1.629 0 C-N-CA 123.147 2.565 . . . . 0.0 112.129 176.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.888 ' ND2' ' O ' ' A' ' 149' ' ' ASN . 0.0 OUTLIER 90.39 69.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 123.533 1.635 . . . . 0.0 110.14 -176.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 14.2 p90 -89.21 167.44 13.09 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 118.986 -2.322 . . . . 0.0 110.278 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.474 HG22 ' HB ' ' A' ' 107' ' ' VAL . 13.6 m -131.41 118.69 20.61 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.734 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.75 163.71 33.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.505 -0.747 . . . . 0.0 109.041 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.562 HG23 ' HE1' ' A' ' 73' ' ' TRP . 36.8 mt -110.81 131.18 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.335 -0.853 . . . . 0.0 109.914 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.569 ' NH1' ' O ' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -133.51 161.1 35.5 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.118 -0.988 . . . . 0.0 108.885 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.569 ' O ' ' NH1' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -104.1 146.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.544 -0.722 . . . . 0.0 109.087 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.448 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.7 m-30 -95.97 119.67 34.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.025 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.44 ' HB3' ' CZ2' ' A' ' 162' ' ' TRP . 24.3 t70 -134.65 160.8 36.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.845 -0.535 . . . . 0.0 109.654 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.575 ' N ' ' ND2' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -96.21 161.0 28.56 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 109.172 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.4 Cg_endo -67.89 -54.03 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.564 2.176 . . . . 0.0 111.859 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 159' ' ' PRO . 98.1 mt-10 -42.91 -20.21 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.86 -36.64 7.68 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.558 ' N ' ' O ' ' A' ' 159' ' ' PRO . 45.9 m0 -97.06 165.28 12.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.36 -1.082 . . . . 0.0 110.266 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 21.0 mm -99.1 153.5 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.306 -0.871 . . . . 0.0 109.386 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.76 -72.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.163 -0.96 . . . . 0.0 110.404 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -141.07 153.43 45.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -0.919 . . . . 0.0 109.796 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.32 -41.65 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.249 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.61 -31.29 8.54 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.42 -8.17 62.15 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -80.79 148.24 30.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.686 -1.479 . . . . 0.0 108.591 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.53 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 47.4 p30 -111.02 87.82 2.63 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 117.536 -1.666 . . . . 0.0 111.514 175.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 171' ' ' ILE . 1.6 tt -78.37 -17.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 119.968 -1.707 . . . . 0.0 109.352 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 141' ' ' TRP . . . -61.68 -40.45 95.03 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.71 -0.619 . . . . 0.0 109.338 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.638 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 53.9 p -53.43 -3.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.526 ' HB3' ' CE2' ' A' ' 175' ' ' TYR . . . -80.09 -39.9 28.65 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.947 -1.096 . . . . 0.0 111.362 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.622 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 7.0 m-85 -111.47 24.8 0.08 OUTLIER Pre-proline 0 N--CA 1.514 2.749 0 O-C-N 120.791 -1.193 . . . . 0.0 112.482 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.638 ' HD3' ' C ' ' A' ' 173' ' ' SER . 53.8 Cg_endo -65.26 -19.62 62.23 Favored 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 123.399 2.732 . . . . 0.0 113.129 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -89.03 125.54 35.04 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.043 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.727 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 1.5 tp -88.44 118.93 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.42 -0.8 . . . . 0.0 109.236 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.566 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.624 ' O ' ' OG1' ' A' ' 19' ' ' THR . 10.5 p . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.16 171.24 8.58 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.191 -0.943 . . . . 0.0 109.142 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 4' ' ' THR . 3.4 tp -158.97 115.84 2.72 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -109.14 139.23 44.32 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.151 -0.968 . . . . 0.0 110.149 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.757 HD12 ' HB3' ' A' ' 16' ' ' TRP . 45.0 mt -132.99 132.26 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.06 165.03 20.26 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 p -84.99 174.04 10.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.988 . . . . 0.0 109.149 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.62 -31.23 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.096 -1.003 . . . . 0.0 109.362 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 tttp -74.13 -37.94 63.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.184 -0.948 . . . . 0.0 110.532 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.85 124.11 14.18 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.005 -1.059 . . . . 0.0 109.537 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.78 -30.06 1.52 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.922 1.748 . . . . 0.0 112.308 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.679 ' NE2' HD22 ' A' ' 13' ' ' ASN . 5.4 pp0? -69.85 4.69 1.86 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.461 -0.774 . . . . 0.0 110.358 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.679 HD22 ' NE2' ' A' ' 12' ' ' GLN . 0.5 OUTLIER -117.83 119.12 33.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.052 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -97.67 126.17 42.85 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.135 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 15' ' ' LEU . 4.0 mm? -91.83 -8.35 46.85 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.94 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.757 ' HB3' HD12 ' A' ' 5' ' ' ILE . 33.2 t90 -157.47 103.91 1.98 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.276 -1.37 . . . . 0.0 110.587 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -117.47 109.24 16.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.536 -0.727 . . . . 0.0 109.413 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.452 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -163.89 163.95 23.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.261 -0.9 . . . . 0.0 109.724 179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 19' ' ' THR . 9.9 t -131.47 90.69 2.89 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.508 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.75 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -124.5 146.94 48.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.221 -0.925 . . . . 0.0 110.479 177.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.99 -39.49 23.53 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.266 -1.521 . . . . 0.0 108.423 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -82.86 -48.57 10.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.624 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -59.94 -25.07 64.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.086 -1.009 . . . . 0.0 108.42 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.75 HD12 ' O ' ' A' ' 20' ' ' ASN . 13.0 mt -72.38 -50.81 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.025 -1.047 . . . . 0.0 108.999 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 29' ' ' ASN . 23.1 tm0? -62.06 -51.92 66.02 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.287 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.706 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 14.9 mm100 -61.21 -40.3 93.47 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.235 -0.916 . . . . 0.0 109.732 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.715 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 5.2 tt0 -75.07 -50.8 15.27 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.062 -1.024 . . . . 0.0 109.478 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 28' ' ' LEU . 17.3 tp -70.45 -56.18 7.23 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.847 -1.158 . . . . 0.0 109.832 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 11.5 t-20 -57.1 -19.9 22.34 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.776 -1.202 . . . . 0.0 109.286 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -67.5 -27.99 67.46 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.796 -1.19 . . . . 0.0 108.637 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -86.42 12.54 10.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.141 -0.974 . . . . 0.0 109.604 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.24 21.58 32.16 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.185 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.55 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 47.9 t -92.71 146.54 6.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.384 -1.068 . . . . 0.0 109.348 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.1 ttt85 -82.49 156.87 23.82 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -155.21 155.46 33.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.815 -1.178 . . . . 0.0 108.354 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.476 ' OE2' ' N ' ' A' ' 37' ' ' ARG . 1.3 mm-40 -175.42 174.73 2.27 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.051 -1.031 . . . . 0.0 109.3 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.476 ' N ' ' OE2' ' A' ' 36' ' ' GLU . 74.4 mtm-85 -151.93 112.95 4.24 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.526 ' H ' HD22 ' A' ' 129' ' ' ASN . 34.2 m0 -110.73 151.52 27.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.124 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.574 ' NE2' ' OD1' ' A' ' 129' ' ' ASN . 82.0 mm-40 -138.49 154.35 48.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.908 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.93 158.34 16.06 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -101.28 -9.09 21.53 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.2 mtp85 -92.91 155.0 17.86 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.792 0.806 . . . . 0.0 109.216 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -93.25 118.98 31.89 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.569 -0.707 . . . . 0.0 109.524 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.12 161.89 14.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.774 0.797 . . . . 0.0 109.488 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.32 -99.26 0.15 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.98 92.63 4.97 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.134 -1.215 . . . . 0.0 109.483 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.27 92.02 30.33 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.434 -0.791 . . . . 0.0 109.008 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.42 -28.27 7.07 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.314 2.01 . . . . 0.0 112.613 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.6 p -119.57 141.86 48.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.619 -0.675 . . . . 0.0 109.594 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.34 -16.71 53.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.471 -0.768 . . . . 0.0 109.432 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -50.56 -37.49 39.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 109.06 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.5 m -78.64 -33.39 47.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.0 109.484 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.66 -52.41 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.352 -0.843 . . . . 0.0 110.273 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.505 HG22 ' HG2' ' A' ' 58' ' ' GLN . 6.4 mt -59.21 -40.01 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.046 -1.034 . . . . 0.0 108.836 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.34 -32.13 69.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.367 -0.833 . . . . 0.0 109.479 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.416 ' O ' ' CD2' ' A' ' 59' ' ' HIS . . . -74.67 -14.59 60.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.937 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -117.14 -9.4 11.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.0 109.588 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.505 ' HG2' HG22 ' A' ' 54' ' ' ILE . 5.8 mm-40 -50.86 -39.75 54.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.102 -0.998 . . . . 0.0 109.07 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.453 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 20.0 p80 -51.71 -46.1 63.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.453 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -60.39 -59.24 5.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.988 -1.07 . . . . 0.0 109.703 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.679 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -64.48 -28.54 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.717 -1.239 . . . . 0.0 109.364 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 58' ' ' GLN . 24.7 t70 -55.56 -25.09 36.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.372 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -84.36 -37.22 21.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 109.556 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -46.73 74.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.31 -0.869 . . . . 0.0 109.497 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 69' ' ' GLY . 1.1 p -70.03 -30.45 44.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.394 -0.816 . . . . 0.0 109.633 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.54 -46.29 66.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.152 -0.967 . . . . 0.0 109.484 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -77.6 -48.92 15.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.103 -0.998 . . . . 0.0 109.647 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.653 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -85.22 13.75 6.01 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.448 -0.782 . . . . 0.0 110.16 -177.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.653 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -1.46 84.08 0.0 OUTLIER Glycine 0 N--CA 1.502 3.053 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.91 ' CG ' HG21 ' A' ' 155' ' ' ILE . 20.3 m-85 -77.06 164.53 25.64 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.21 -1.171 . . . . 0.0 109.446 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -59.85 -43.11 94.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.57 -0.706 . . . . 0.0 110.222 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.27 165.65 36.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.991 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.736 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 6.6 t-105 -135.6 139.4 43.81 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.388 -0.82 . . . . 0.0 109.165 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.461 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -160.08 178.4 9.73 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 152' ' ' ALA . 1.3 t -117.91 141.69 35.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 pt -100.42 116.97 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.511 ' HB3' ' O ' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -174.59 106.7 0.11 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.113 -0.992 . . . . 0.0 109.69 177.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.547 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -101.38 179.99 4.2 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 120.9 1.682 . . . . 0.0 109.052 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.547 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 9.4 tpt180 -88.81 146.25 25.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.968 -1.083 . . . . 0.0 109.386 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.9 0.38 0.15 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 109.489 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 79' ' ' ARG . 23.9 t70 -91.58 -27.13 18.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.175 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.746 HD21 ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -63.52 122.14 74.43 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 120.911 -1.118 . . . . 0.0 109.437 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -83.78 -5.07 10.69 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.159 1.906 . . . . 0.0 112.385 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -86.39 3.02 45.46 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.653 -1.28 . . . . 0.0 109.428 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.746 ' N ' HD21 ' A' ' 82' ' ' ASN . 29.3 tptt -61.08 -46.61 89.94 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.176 -0.952 . . . . 0.0 109.134 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.601 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 15.9 mm-40 -59.85 -50.04 75.33 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.758 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.53 -41.49 88.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.889 . . . . 0.0 109.475 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.08 -55.09 32.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.96 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.601 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 7.4 ptt-85 -64.26 -20.14 65.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -66.97 -60.57 2.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.863 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -56.28 -37.44 69.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.107 -0.996 . . . . 0.0 109.538 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -72.45 -18.7 61.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 109.719 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 93' ' ' LEU . 0.4 OUTLIER -62.33 -26.3 68.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.666 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -48.74 145.9 3.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.918 . . . . 0.0 109.928 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.502 ' OE1' HG22 ' A' ' 171' ' ' ILE . 55.1 tt0 -76.54 157.27 32.2 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.5 -0.75 . . . . 0.0 110.095 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.423 ' N ' ' CG ' ' A' ' 95' ' ' GLU . 46.0 p-80 -172.17 -170.6 0.75 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.736 -1.185 . . . . 0.0 111.978 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.8 t -163.01 137.69 6.42 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.689 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.85 155.4 20.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.545 -178.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.66 -5.56 86.3 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.459 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 23.8 tp10 -124.52 168.49 13.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.378 -1.072 . . . . 0.0 109.221 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.415 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 88.5 m-20 -74.52 143.43 44.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.117 . . . . 0.0 110.106 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' A' ' 98' ' ' HIS . 2.2 mt-10 -101.08 90.37 4.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.12 -0.987 . . . . 0.0 108.491 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.674 HG12 ' OG ' ' A' ' 133' ' ' SER . 15.7 m -85.86 130.26 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.693 -0.629 . . . . 0.0 110.138 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.712 ' NE ' HH21 ' A' ' 154' ' ' ARG . 41.0 ttm105 -131.03 128.29 40.02 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.458 -0.777 . . . . 0.0 109.598 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.498 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 36.9 t80 -106.1 129.15 54.24 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.65 129.9 36.02 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.488 -0.757 . . . . 0.0 110.395 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.4 t -115.2 -27.34 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.651 -0.656 . . . . 0.0 109.672 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -166.29 153.06 9.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.395 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.96 154.25 25.64 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.695 ' HB2' ' HG2' ' A' ' 127' ' ' GLU . . . -137.45 165.83 25.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.191 -1.182 . . . . 0.0 108.944 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.34 152.97 10.09 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.628 HD23 HD12 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -99.72 98.61 9.43 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.047 -1.267 . . . . 0.0 110.256 -179.135 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 114' ' ' CYS . 2.3 t80 -84.4 135.02 34.44 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.873 -1.142 . . . . 0.0 109.715 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.568 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -77.77 117.68 19.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.431 0.634 . . . . 0.0 109.815 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 122' ' ' PHE . 2.2 mt -106.71 123.11 47.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 7.0 t-160 -105.53 106.97 17.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.156 -0.965 . . . . 0.0 109.602 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.424 HG23 HG21 ' A' ' 138' ' ' THR . 3.2 mt -119.95 109.34 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.956 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.34 -144.37 31.76 Favored Glycine 0 N--CA 1.502 3.092 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -100.5 78.27 2.0 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 114.891 -2.724 . . . . 0.0 109.521 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 1.6 mt-10 -167.04 171.94 10.6 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.724 ' O ' HG23 ' A' ' 5' ' ' ILE . 78.6 t -125.14 140.76 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.076 -1.015 . . . . 0.0 109.907 177.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 115' ' ' LEU . 26.4 m-85 -122.72 128.51 50.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.7 -0.625 . . . . 0.0 110.364 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 4' ' ' THR . 32.6 mm-40 -119.97 104.62 10.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -100.58 133.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.628 HD12 HD23 ' A' ' 112' ' ' LEU . 1.3 tt -133.34 87.57 2.4 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.107 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.616 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 16.8 p -167.88 122.42 0.97 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.695 ' HG2' ' HB2' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -105.47 100.0 9.58 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 116.384 -2.127 . . . . 0.0 110.352 -178.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.611 ' C ' ' H ' ' A' ' 130' ' ' ASP . 1.5 mmmt -117.24 166.02 12.76 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.19 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.574 ' OD1' ' NE2' ' A' ' 39' ' ' GLN . 0.7 OUTLIER -58.62 -0.31 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.611 ' H ' ' C ' ' A' ' 128' ' ' LYS . 53.6 p-10 -69.52 139.14 53.8 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.862 -1.149 . . . . 0.0 109.819 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.583 HD13 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -91.28 123.18 34.52 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.884 0.849 . . . . 0.0 109.586 -178.112 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.583 ' N ' HD13 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -115.11 112.18 38.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.111 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.674 ' OG ' HG12 ' A' ' 103' ' ' VAL . 9.4 t -120.74 151.68 39.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.391 -0.818 . . . . 0.0 109.168 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.72 137.79 20.88 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.564 ' O ' ' OG1' ' A' ' 138' ' ' THR . 36.6 Cg_endo -61.99 154.95 58.41 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.977 1.785 . . . . 0.0 113.46 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -74.85 136.35 41.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.347 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.619 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 24.4 t60 94.77 9.21 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.564 ' OG1' ' O ' ' A' ' 135' ' ' PRO . 0.2 OUTLIER -104.48 127.39 29.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.164 179.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.7 132.03 31.45 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.64 1.56 . . . . 0.0 111.678 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.529 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.0 163.9 9.43 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.142 -179.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.566 ' O ' ' CZ ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -135.3 -148.15 0.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.122 -0.986 . . . . 0.0 109.567 -178.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.68 ' CD1' ' NH2' ' A' ' 154' ' ' ARG . 90.1 t80 -176.42 127.54 0.2 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.962 -1.087 . . . . 0.0 109.281 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.499 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 43.3 p30 -148.2 137.52 22.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -0.871 . . . . 0.0 109.785 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.593 ' O ' ' C ' ' A' ' 145' ' ' GLY . 4.2 mmt -112.59 19.09 17.82 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.451 -0.781 . . . . 0.0 111.122 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.593 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 9.78 -88.12 0.0 OUTLIER Glycine 0 N--CA 1.507 3.395 0 CA-C-N 119.155 0.889 . . . . 0.0 111.922 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.489 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 22.9 p -89.0 119.62 29.68 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.253 -1.379 . . . . 0.0 109.6 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.559 ' O ' ' CG ' ' A' ' 147' ' ' GLU . 8.4 pt-20 -109.14 117.13 54.16 Favored Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.621 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 57.2 Cg_endo -102.42 25.48 0.12 Allowed 'Trans proline' 0 N--CA 1.48 0.731 0 C-N-CA 122.361 2.041 . . . . 0.0 111.363 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 80.73 69.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.96 -177.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.511 ' O ' ' HB3' ' A' ' 77' ' ' SER . 20.9 p90 -94.68 -178.21 4.46 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.488 -0.758 . . . . 0.0 109.084 -177.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 86.1 m -148.3 95.9 2.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.543 -0.723 . . . . 0.0 109.988 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -110.47 163.5 13.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.988 -1.07 . . . . 0.0 108.787 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.736 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 25.6 mt -111.57 129.7 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.712 HH21 ' NE ' ' A' ' 104' ' ' ARG . 63.0 mtt180 -138.91 168.32 20.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 110.063 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.91 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.2 mp -105.41 147.87 10.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.642 -0.661 . . . . 0.0 109.667 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.461 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.6 m-30 -95.79 117.75 31.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.545 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.602 ' OD2' ' NE1' ' A' ' 162' ' ' TRP . 17.9 t0 -136.46 160.75 37.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.842 -0.536 . . . . 0.0 109.771 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.52 160.65 29.06 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.176 -0.953 . . . . 0.0 109.106 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . 42.4 Cg_endo -66.56 -50.86 1.14 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.883 2.388 . . . . 0.0 112.306 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 159' ' ' PRO . 96.1 mt-10 -43.34 -20.77 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.481 -0.762 . . . . 0.0 109.073 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -87.75 -42.15 6.15 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.602 ' NE1' ' OD2' ' A' ' 157' ' ' ASP . 45.8 m0 -96.17 166.49 11.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.293 -1.122 . . . . 0.0 109.888 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.3 mm -98.23 148.39 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 109.666 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 96' ' ' HIS . . . -79.09 -71.57 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.096 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -135.42 155.89 49.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.244 -0.91 . . . . 0.0 109.659 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -101.3 -41.1 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.635 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 60.2 p -108.09 -30.43 8.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.21 -0.931 . . . . 0.0 109.198 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.75 -8.28 56.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -80.65 148.04 30.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.887 -1.36 . . . . 0.0 108.451 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.503 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 34.6 p30 -111.03 87.55 2.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.966 -1.493 . . . . 0.0 111.122 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.502 HG22 ' OE1' ' A' ' 95' ' ' GLU . 1.7 tt -78.09 -17.39 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.261 -1.524 . . . . 0.0 109.486 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.504 ' HB2' ' CD2' ' A' ' 141' ' ' TRP . . . -60.2 -41.43 92.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.636 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 59.6 p -53.51 -3.72 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 110.283 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.518 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . . . -79.25 -40.21 31.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.004 . . . . 0.0 111.279 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.612 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 5.8 m-85 -112.63 24.96 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.623 0 O-C-N 120.575 -1.328 . . . . 0.0 112.471 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.636 ' HD3' ' C ' ' A' ' 173' ' ' SER . 44.3 Cg_endo -62.16 -18.82 64.14 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 123.71 2.94 . . . . 0.0 113.75 -172.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.0 ttm-85 -89.11 125.85 35.2 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.363 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.489 ' HB3' ' H ' ' A' ' 146' ' ' SER . 4.5 tt -88.38 123.44 32.94 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.213 -0.929 . . . . 0.0 109.194 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.298 -1.656 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.395 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.838 ' O ' HG23 ' A' ' 19' ' ' THR . 6.4 p . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.96 171.06 8.52 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.881 -1.137 . . . . 0.0 109.053 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 4' ' ' THR . 3.2 tp -158.99 116.94 2.85 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.674 ' OG1' HD11 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -109.83 133.47 53.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.64 -178.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.688 HD12 ' HB3' ' A' ' 16' ' ' TRP . 5.7 mt -128.16 134.83 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -126.59 168.02 14.86 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m -85.23 174.24 9.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.234 -0.916 . . . . 0.0 108.981 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -28.3 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.954 -1.091 . . . . 0.0 109.415 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -76.69 -34.7 58.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.55 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.39 124.08 14.69 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.202 -0.936 . . . . 0.0 109.429 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.55 -36.85 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.119 1.879 . . . . 0.0 112.347 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.53 3.99 2.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 110.235 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -111.9 119.05 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.418 -0.801 . . . . 0.0 109.211 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -99.41 120.97 40.46 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.379 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 15' ' ' LEU . 11.0 mp -91.32 -4.01 56.25 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.171 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.688 ' HB3' HD12 ' A' ' 5' ' ' ILE . 41.8 t90 -156.8 104.44 2.13 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 118.433 -1.307 . . . . 0.0 110.542 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -119.07 112.18 19.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.541 -0.725 . . . . 0.0 109.57 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.555 ' OG ' ' CH2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -161.45 163.7 30.26 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.262 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.838 HG23 ' O ' ' A' ' 1' ' ' SER . 45.4 m -131.38 89.56 2.74 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.938 -1.102 . . . . 0.0 108.35 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.762 ' O ' HD12 ' A' ' 24' ' ' ILE . 31.0 m120 -127.83 142.23 51.35 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.425 -0.797 . . . . 0.0 110.37 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.13 -37.86 23.17 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.303 -1.498 . . . . 0.0 108.337 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -83.67 -50.64 7.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.855 . . . . 0.0 109.751 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.46 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.2 tt0 -59.13 -21.73 59.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.107 -0.996 . . . . 0.0 108.754 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.762 HD12 ' O ' ' A' ' 20' ' ' ASN . 11.2 mt -76.09 -49.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.13 -0.981 . . . . 0.0 109.207 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.749 HE21 ' ND2' ' A' ' 29' ' ' ASN . 24.4 tm0? -59.68 -44.8 93.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.777 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -70.78 -38.58 73.42 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.243 -0.91 . . . . 0.0 109.344 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.657 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 6.5 tt0 -77.0 -49.81 14.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 110.252 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 33' ' ' VAL . 12.2 tp -62.07 -54.52 40.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.015 -1.053 . . . . 0.0 108.857 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.749 ' ND2' HE21 ' A' ' 25' ' ' GLN . 1.1 m-20 -61.95 -16.45 51.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.905 -1.122 . . . . 0.0 109.856 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 27' ' ' GLN . . . -62.77 -30.07 71.17 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.63 -1.294 . . . . 0.0 108.845 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.96 11.09 12.23 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.009 -1.076 . . . . 0.0 109.558 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.46 25.01 31.84 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.513 HG21 HD11 ' A' ' 28' ' ' LEU . 75.2 t -95.47 145.99 7.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 122.018 0.913 . . . . 0.0 109.471 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -84.32 156.87 21.7 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 121.346 -0.846 . . . . 0.0 108.855 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.594 ' CB ' HD21 ' A' ' 29' ' ' ASN . 1.8 t80 -154.12 149.63 27.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.913 -1.117 . . . . 0.0 109.041 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -169.79 167.78 9.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.006 -1.059 . . . . 0.0 109.866 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.474 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 18.8 ptt-85 -151.82 115.91 4.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.425 -0.797 . . . . 0.0 109.139 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.507 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 11.7 m0 -113.22 157.31 21.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -144.17 166.39 25.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.678 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.93 162.19 13.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.366 -0.834 . . . . 0.0 108.932 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -94.49 -26.02 16.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.123 -0.986 . . . . 0.0 108.695 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -94.85 172.98 7.83 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -89.86 131.59 35.71 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.368 -0.833 . . . . 0.0 108.993 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.4 mt -92.97 167.95 11.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.239 -0.913 . . . . 0.0 109.812 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.78 -94.28 0.11 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.45 107.47 7.6 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.33 -1.1 . . . . 0.0 108.166 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.4 90.44 45.31 Favored Pre-proline 0 C--N 1.302 -1.494 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.677 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -83.71 40.92 0.96 Allowed 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.795 2.33 . . . . 0.0 111.221 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 52' ' ' THR . 19.1 m -166.24 138.11 3.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.61 -1.306 . . . . 0.0 109.457 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 52' ' ' THR . . . -82.64 -51.78 7.42 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.905 -1.122 . . . . 0.0 110.262 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.15 -0.68 1.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.422 -0.799 . . . . 0.0 109.75 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -77.08 -56.82 4.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 109.806 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.486 ' N ' HG22 ' A' ' 52' ' ' THR . 49.0 t -64.19 -45.53 96.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 O-C-N 121.137 -0.977 . . . . 0.0 109.579 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.4 mt -59.82 -41.07 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.274 -0.97 . . . . 0.0 108.807 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.87 -24.16 67.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.351 -0.843 . . . . 0.0 109.788 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.04 -21.48 56.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.047 -1.033 . . . . 0.0 110.323 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 58' ' ' GLN . 57.0 m-85 -112.28 -6.54 14.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.384 -0.822 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.625 HE22 HD11 ' A' ' 61' ' ' ILE . 5.5 mm-40 -45.85 -39.05 8.02 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.743 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -50.81 -48.04 59.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.909 -1.116 . . . . 0.0 109.634 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.607 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.37 -60.77 3.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.01 -1.056 . . . . 0.0 110.309 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.654 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -62.6 -29.71 47.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 120.751 -1.218 . . . . 0.0 109.184 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 58' ' ' GLN . 45.5 t0 -54.85 -27.62 43.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.805 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -77.82 -37.41 48.68 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.018 -1.051 . . . . 0.0 109.812 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.6 mp -63.98 -39.22 93.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.126 -0.984 . . . . 0.0 109.865 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.51 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -69.24 -29.06 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 0.0 108.924 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.02 -54.12 47.03 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.474 -1.391 . . . . 0.0 109.297 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.42 -52.47 5.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.254 -0.904 . . . . 0.0 110.954 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.624 ' O ' ' C ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -86.86 14.53 7.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 110.596 -177.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -15.54 89.31 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.525 ' CG ' HG21 ' A' ' 155' ' ' ILE . 87.4 m-85 -77.58 164.78 25.05 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -58.56 -88.01 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 109.949 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.52 ' OG ' ' CG ' ' A' ' 156' ' ' PHE . 0.0 OUTLIER -101.26 159.72 15.01 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.568 -0.707 . . . . 0.0 109.618 -179.064 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.497 ' HE1' HG23 ' A' ' 153' ' ' ILE . 6.5 t-105 -136.29 140.04 43.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.496 -0.753 . . . . 0.0 109.139 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.1 -173.47 2.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 108.775 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.677 HG12 ' HA ' ' A' ' 153' ' ' ILE . 1.9 m -122.99 148.45 26.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.513 -0.742 . . . . 0.0 109.587 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.574 HG23 ' O ' ' A' ' 76' ' ' ILE . 2.8 tt -100.89 118.09 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 150' ' ' PHE . 91.8 p -171.83 103.79 0.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.604 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.556 ' CD1' ' H ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -105.39 -178.38 3.64 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 121.078 1.763 . . . . 0.0 108.209 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.556 ' H ' ' CD1' ' A' ' 78' ' ' LEU . 8.2 tpt180 -89.45 148.77 23.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.891 -1.131 . . . . 0.0 109.528 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.41 3.91 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.615 -0.678 . . . . 0.0 109.641 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 79' ' ' ARG . 80.5 m-20 -92.16 -24.11 19.19 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.922 -1.111 . . . . 0.0 109.34 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.672 HD21 ' NZ ' ' A' ' 85' ' ' LYS . 27.7 p-10 -60.63 118.07 31.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.83 -1.169 . . . . 0.0 109.586 -178.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -88.57 -23.77 0.98 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.241 1.96 . . . . 0.0 112.501 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -91.93 -14.8 28.97 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.919 -1.113 . . . . 0.0 109.945 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.672 ' NZ ' HD21 ' A' ' 82' ' ' ASN . 0.0 OUTLIER -60.89 -35.75 77.44 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.794 178.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 96.9 mt-10 -57.17 -40.57 77.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.133 -0.979 . . . . 0.0 108.491 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.41 -27.29 68.43 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.792 -1.193 . . . . 0.0 109.154 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.6 tp -60.67 -47.61 85.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -0.948 . . . . 0.0 109.989 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -64.58 -27.66 69.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.108 -0.995 . . . . 0.0 109.285 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.07 -60.74 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.394 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -58.33 -35.07 71.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.08 -1.013 . . . . 0.0 109.19 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -79.77 -18.35 51.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.414 -0.803 . . . . 0.0 109.956 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 94' ' ' ASN . 0.3 OUTLIER -60.75 -26.49 67.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.49 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.483 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 32.5 p-10 -46.27 135.22 8.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.293 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.68 159.33 13.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 0.0 109.871 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -171.9 -169.73 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.763 -1.175 . . . . 0.0 111.965 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.81 130.98 4.47 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.549 0.69 . . . . 0.0 109.364 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.621 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -100.67 154.37 18.65 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.625 -0.672 . . . . 0.0 109.716 -179.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.11 -7.98 87.52 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -123.4 170.98 9.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -1.112 . . . . 0.0 109.286 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -74.07 143.06 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.973 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.599 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 5.0 tt0 -103.49 90.02 3.55 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.947 HG22 ' OG ' ' A' ' 133' ' ' SER . 26.1 t -85.7 127.06 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.286 -0.884 . . . . 0.0 109.714 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 115.49 17.29 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.501 -0.749 . . . . 0.0 109.617 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.65 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 10.9 t80 -99.94 132.19 45.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.968 . . . . 0.0 108.612 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.723 ' CD2' ' HB2' ' A' ' 110' ' ' ALA . 0.8 OUTLIER -91.08 135.47 33.74 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.364 0.602 . . . . 0.0 109.939 -179.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.0 t -116.84 -26.97 2.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.371 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 109' ' ' GLY . 73.7 tt0 -169.12 158.02 8.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.155 -0.965 . . . . 0.0 108.949 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 108' ' ' GLU . . . 48.37 107.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.723 ' HB2' ' CD2' ' A' ' 106' ' ' PHE . . . -151.8 112.33 4.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.649 -1.501 . . . . 0.0 109.574 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.93 -141.97 4.36 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.502 HD22 HD23 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -108.9 100.42 9.63 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.329 -1.101 . . . . 0.0 110.851 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.659 ' CD2' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -79.47 132.12 36.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.934 -1.104 . . . . 0.0 110.043 -178.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 9.8 m -78.46 154.7 30.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.554 -0.716 . . . . 0.0 110.148 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 122' ' ' PHE . 1.1 tp -145.28 121.0 10.51 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.5 t-160 -111.48 111.15 21.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.224 -0.923 . . . . 0.0 109.677 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.46 113.85 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.744 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.49 -145.14 35.3 Favored Glycine 0 N--CA 1.503 3.15 0 N-CA-C 106.146 -2.782 . . . . 0.0 106.146 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -100.73 77.74 1.91 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 114.581 -2.848 . . . . 0.0 109.688 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.59 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 1.5 mt-10 -166.6 170.0 13.09 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 120.949 -1.095 . . . . 0.0 108.064 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 5' ' ' ILE . 50.7 t -126.56 140.34 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.573 ' O ' ' N ' ' A' ' 115' ' ' LEU . 2.3 m-85 -126.95 130.71 50.61 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.601 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -131.23 110.14 10.91 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.444 -0.785 . . . . 0.0 109.134 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -98.52 138.22 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.727 ' H ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.8 88.13 2.68 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.425 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.522 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 5.2 p -167.89 136.11 2.37 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.291 -1.506 . . . . 0.0 107.216 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -104.42 96.8 6.86 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 115.292 -2.563 . . . . 0.0 110.05 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.586 ' C ' ' H ' ' A' ' 130' ' ' ASP . 24.5 mmtt -116.75 157.48 25.43 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.324 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.65 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 40.3 m-80 -58.38 -2.11 0.18 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.586 ' H ' ' C ' ' A' ' 128' ' ' LYS . 17.2 m-20 -70.47 147.32 49.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.108 -0.995 . . . . 0.0 109.303 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.754 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.8 OUTLIER -111.31 154.66 24.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.605 0.717 . . . . 0.0 110.448 -179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.754 ' N ' HD12 ' A' ' 131' ' ' LEU . 29.1 mm -116.65 118.73 59.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.947 ' OG ' HG22 ' A' ' 103' ' ' VAL . 0.3 OUTLIER -111.03 129.82 55.79 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.545 -0.722 . . . . 0.0 109.285 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.48 141.75 23.19 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.06 153.66 71.79 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.058 1.839 . . . . 0.0 112.347 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.623 ' O ' ' CG ' ' A' ' 137' ' ' HIS . . . -71.06 135.45 47.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -0.85 . . . . 0.0 108.895 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.623 ' CG ' ' O ' ' A' ' 136' ' ' ALA . 2.6 m170 89.83 14.95 0.05 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.094 0.473 . . . . 0.0 110.004 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.39 127.21 28.66 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.53 131.65 32.53 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.924 1.749 . . . . 0.0 111.513 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -170.08 163.09 9.19 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.245 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.516 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -134.52 -148.7 0.32 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.933 . . . . 0.0 109.542 -178.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.78 126.45 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.937 -1.102 . . . . 0.0 109.196 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.479 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 37.2 p-10 -144.58 134.28 23.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.429 -0.794 . . . . 0.0 109.686 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.671 ' SD ' ' N ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -112.96 19.13 17.55 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.614 -0.679 . . . . 0.0 110.44 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 13.18 -93.13 0.01 OUTLIER Glycine 0 N--CA 1.501 3.02 0 CA-C-N 119.216 0.916 . . . . 0.0 111.663 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.447 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 19.4 p -84.53 119.56 25.32 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.259 -1.376 . . . . 0.0 108.924 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -113.71 112.23 48.27 Favored Pre-proline 0 C--N 1.294 -1.847 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.093 178.447 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.8 Cg_endo -103.52 34.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 123.326 2.684 . . . . 0.0 111.542 176.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 81.56 69.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.529 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 9.0 p90 -95.67 135.89 36.78 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.064 -1.023 . . . . 0.0 109.944 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.7 m -97.73 119.72 36.82 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.779 -0.575 . . . . 0.0 109.686 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.45 159.96 41.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 109.266 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.677 ' HA ' HG12 ' A' ' 75' ' ' VAL . 96.1 mt -108.69 125.97 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.513 -0.742 . . . . 0.0 110.086 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.552 ' C ' HD13 ' A' ' 155' ' ' ILE . 62.9 mtp180 -132.5 160.72 35.69 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.575 -0.703 . . . . 0.0 109.713 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -108.39 156.91 8.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.416 0.627 . . . . 0.0 109.478 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.52 ' CG ' ' OG ' ' A' ' 72' ' ' SER . 4.5 m-85 -100.51 119.75 38.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.053 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 12.2 p30 -134.55 159.22 41.85 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -98.32 146.76 32.1 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.985 -1.072 . . . . 0.0 109.494 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.618 ' O ' ' N ' ' A' ' 161' ' ' GLY . 47.3 Cg_endo -71.37 -52.61 0.21 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.355 2.037 . . . . 0.0 112.048 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -43.54 -14.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.605 -0.685 . . . . 0.0 109.403 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -79.49 -32.17 38.87 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.634 ' N ' ' CD1' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -118.71 176.09 5.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.599 -0.942 . . . . 0.0 110.469 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 70.8 mt -94.2 145.75 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.306 -0.871 . . . . 0.0 109.277 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.27 -73.14 0.31 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.372 -0.83 . . . . 0.0 110.643 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -120.91 151.15 40.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.367 -0.833 . . . . 0.0 109.854 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.467 ' CD2' ' N ' ' A' ' 166' ' ' PHE . 2.7 p90 -101.54 -40.43 7.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.564 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 m -110.2 -31.15 7.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.315 -0.866 . . . . 0.0 108.977 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.68 -4.94 53.9 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.421 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -82.76 148.67 27.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.749 -1.442 . . . . 0.0 108.926 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.482 ' OD1' ' OG ' ' A' ' 173' ' ' SER . 60.9 t0 -109.83 89.13 2.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 117.925 -1.51 . . . . 0.0 111.058 176.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 171' ' ' ILE . 0.7 OUTLIER -76.09 -22.38 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.489 -1.382 . . . . 0.0 109.366 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -60.36 -40.55 91.19 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.662 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 24.1 m -51.17 -3.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 110.19 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.573 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . . . -77.4 -41.52 39.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.789 -1.194 . . . . 0.0 111.629 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.631 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 1.0 OUTLIER -112.83 25.24 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.607 0 O-C-N 120.772 -1.205 . . . . 0.0 112.27 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.662 ' HD3' ' C ' ' A' ' 173' ' ' SER . 49.6 Cg_endo -62.41 -22.66 74.36 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.722 2.948 . . . . 0.0 113.522 -172.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 177' ' ' ARG . 28.3 ptt85 -89.42 126.45 35.56 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.003 -1.079 . . . . 0.0 108.885 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.73 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.6 OUTLIER -87.78 118.68 27.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.262 -0.899 . . . . 0.0 109.022 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.534 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.849 ' O ' HG23 ' A' ' 19' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.119 0.485 . . . . 0.0 109.703 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 125' ' ' LEU . . . -95.89 171.09 8.85 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.959 -1.097 . . . . 0.0 109.288 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.95 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 18.7 tp -157.83 109.36 2.28 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.79 127.09 53.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.51 -0.744 . . . . 0.0 110.523 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.664 HD12 ' HB3' ' A' ' 16' ' ' TRP . 51.2 mt -120.87 135.62 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.27 169.75 15.02 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.8 p -87.47 173.05 9.34 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.0 -33.37 6.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.084 -1.01 . . . . 0.0 108.874 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -71.72 -37.47 70.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.53 -0.731 . . . . 0.0 110.384 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.14 125.25 14.58 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.98 -1.075 . . . . 0.0 109.634 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -82.26 -30.21 1.28 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.892 1.728 . . . . 0.0 112.266 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -70.22 0.74 5.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.41 -0.806 . . . . 0.0 110.662 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.769 HD21 HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.7 118.69 34.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.024 -1.047 . . . . 0.0 108.497 179.168 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -97.13 125.42 41.62 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.846 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.769 HD13 HD21 ' A' ' 13' ' ' ASN . 2.6 mp -90.46 -12.25 37.91 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.497 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.95 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 34.7 t90 -159.73 107.41 1.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.222 -1.391 . . . . 0.0 109.939 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -121.09 119.43 32.42 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.09 -1.006 . . . . 0.0 110.332 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.454 ' OG ' ' CZ2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -161.02 166.68 27.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.266 -0.897 . . . . 0.0 110.155 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.849 HG23 ' O ' ' A' ' 1' ' ' SER . 45.8 m -129.21 86.42 2.43 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.634 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -129.45 138.96 51.73 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.794 -0.566 . . . . 0.0 110.369 177.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.75 -28.59 30.31 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.592 -1.942 . . . . 0.0 108.905 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -82.95 -53.3 5.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -62.28 -18.76 62.16 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.66 -1.275 . . . . 0.0 107.984 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.728 HG12 HD22 ' A' ' 3' ' ' LEU . 3.0 mt -73.28 -59.14 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.344 -0.847 . . . . 0.0 109.375 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.486 ' N ' HG22 ' A' ' 24' ' ' ILE . 21.2 pt20 -58.34 -39.16 78.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.17 -0.956 . . . . 0.0 108.848 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.416 ' N ' ' HG3' ' A' ' 25' ' ' GLN . 44.1 tt0 -66.99 -42.64 84.69 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.332 -0.855 . . . . 0.0 109.47 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.687 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -67.2 -46.83 72.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.101 -1.0 . . . . 0.0 109.524 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 28' ' ' LEU . 3.7 mm? -65.95 -53.56 37.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.327 -0.858 . . . . 0.0 109.447 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 17.9 t-20 -64.16 -19.0 65.0 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.58 -0.7 . . . . 0.0 110.573 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.15 71.17 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.535 -1.353 . . . . 0.0 108.164 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -89.38 14.81 10.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.598 -0.689 . . . . 0.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.68 20.38 58.28 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.434 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 21.9 t -93.3 147.09 5.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.277 -1.131 . . . . 0.0 109.078 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.684 ' HE ' ' H ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -83.09 155.59 23.77 Favored 'General case' 0 C--N 1.281 -2.378 0 O-C-N 120.644 -1.285 . . . . 0.0 107.833 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.684 ' H ' ' HE ' ' A' ' 34' ' ' ARG . 2.3 t80 -152.87 147.09 25.59 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 17.0 tp10 -174.35 172.65 3.16 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.592 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.466 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 30.7 ptt-85 -151.95 121.86 7.06 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.115 -0.991 . . . . 0.0 108.732 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.465 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 33.7 m0 -112.75 156.43 22.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.512 -0.742 . . . . 0.0 109.141 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -142.64 157.64 44.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.293 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.71 159.06 15.34 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -98.66 -13.6 20.23 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -93.74 156.97 16.39 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.495 ' O ' ' OD2' ' A' ' 43' ' ' ASP . 46.4 p-10 -95.52 122.23 38.05 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.473 -0.767 . . . . 0.0 109.384 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.8 mt -91.8 165.83 13.07 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.176 -0.952 . . . . 0.0 108.95 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.95 -121.92 0.58 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.13 79.45 9.12 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.086 -1.244 . . . . 0.0 108.497 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.62 93.89 46.65 Favored Pre-proline 0 C--N 1.306 -1.317 0 O-C-N 121.462 -0.773 . . . . 0.0 109.56 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.745 ' O ' HG23 ' A' ' 49' ' ' THR . 46.9 Cg_endo -70.2 85.61 0.67 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.084 1.856 . . . . 0.0 111.505 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 48' ' ' PRO . 1.5 p -165.05 117.93 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -0.863 . . . . 0.0 109.019 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.43 -36.84 28.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.836 -1.165 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -69.3 -14.92 63.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.943 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 49' ' ' THR . 4.2 p -78.25 -43.67 27.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.051 -1.031 . . . . 0.0 110.89 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 t -67.13 -46.44 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.938 -1.101 . . . . 0.0 109.564 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 58' ' ' GLN . 55.7 mt -61.2 -39.58 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.282 -0.886 . . . . 0.0 108.888 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.22 70.66 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.678 -0.639 . . . . 0.0 109.905 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.85 -21.61 54.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.067 -1.021 . . . . 0.0 110.376 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -114.44 -7.09 12.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.489 -0.757 . . . . 0.0 109.13 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.655 HE21 ' CG1' ' A' ' 61' ' ' ILE . 38.1 tp60 -48.59 -36.93 16.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.242 -0.911 . . . . 0.0 108.546 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.685 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -53.25 -48.84 67.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.043 -1.035 . . . . 0.0 109.941 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.685 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.06 -55.43 32.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.728 -1.232 . . . . 0.0 109.669 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.655 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.5 OUTLIER -65.71 -26.91 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.083 -1.01 . . . . 0.0 109.543 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 58' ' ' GLN . 20.7 t70 -59.2 -25.2 63.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.461 -0.774 . . . . 0.0 109.224 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.7 -43.29 14.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 110.016 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 tt -65.6 -48.46 72.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.307 -0.87 . . . . 0.0 109.819 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' GLY . 3.4 p -66.91 -28.25 42.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.43 -44.21 76.06 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.791 -1.193 . . . . 0.0 109.279 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -80.02 -52.86 7.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.999 -1.063 . . . . 0.0 109.714 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.623 ' O ' ' C ' ' A' ' 69' ' ' GLY . 54.0 mttm -83.08 12.67 4.79 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.401 -0.812 . . . . 0.0 110.685 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -5.63 83.21 0.0 OUTLIER Glycine 0 N--CA 1.506 3.304 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.838 ' CG ' HG21 ' A' ' 155' ' ' ILE . 69.6 m-85 -75.66 156.6 34.66 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.433 -1.039 . . . . 0.0 109.88 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -64.82 -49.59 70.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.486 -0.759 . . . . 0.0 110.574 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.9 m -125.27 135.49 52.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.356 -0.84 . . . . 0.0 109.729 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.482 ' CZ2' HD13 ' A' ' 61' ' ' ILE . 7.4 t-105 -133.57 138.98 46.29 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.4 -168.87 0.56 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.155 -0.965 . . . . 0.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 152' ' ' ALA . 1.5 t -125.99 155.91 35.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.3 mt -93.88 131.82 39.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.5 p -93.55 167.77 11.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 122.769 1.271 . . . . 0.0 111.839 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.586 HD23 ' H ' ' A' ' 149' ' ' ASN . 10.1 tp -167.78 157.6 10.25 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.497 176.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HD3' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -128.99 142.18 51.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.412 ' H ' ' HD3' ' A' ' 79' ' ' ARG . . . -67.35 -4.79 11.9 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.216 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.426 ' OD2' ' C ' ' A' ' 81' ' ' ASP . 8.5 p-10 -116.64 -8.02 11.51 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.197 -0.939 . . . . 0.0 109.087 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.468 ' CG ' ' O ' ' A' ' 82' ' ' ASN . 1.6 p30 -62.88 124.72 84.56 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.325 -0.859 . . . . 0.0 109.801 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.36 -2.37 12.25 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.291 1.994 . . . . 0.0 111.954 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -90.19 3.75 52.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.976 . . . . 0.0 109.832 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 19.4 pttp -60.31 -51.25 70.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.159 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.579 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 46.1 tp10 -65.45 -43.16 91.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.882 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.99 -43.48 98.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.855 . . . . 0.0 109.981 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.2 tp -59.46 -45.61 91.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 109.171 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.579 ' NH2' ' OE2' ' A' ' 86' ' ' GLU . 17.1 ttp-105 -63.0 -28.59 70.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.555 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HA ' HD23 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -65.93 -60.55 2.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.806 . . . . 0.0 109.377 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -55.88 -31.57 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 109.461 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.06 -18.18 50.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.16 -0.963 . . . . 0.0 110.037 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -64.67 -27.54 68.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -1.0 . . . . 0.0 110.031 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -60.45 136.97 58.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.07 -1.019 . . . . 0.0 110.233 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 169' ' ' ASP . 20.7 pt-20 -73.95 164.07 27.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.394 -0.816 . . . . 0.0 109.186 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -172.54 -167.52 0.46 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.008 -1.058 . . . . 0.0 110.463 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.96 133.17 5.95 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.6 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -103.63 153.47 20.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 109.804 -179.181 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.22 -7.07 86.8 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -125.28 170.93 10.81 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.285 -1.126 . . . . 0.0 109.53 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -71.64 143.02 49.92 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.117 -0.989 . . . . 0.0 109.821 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.6 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 3.3 tt0 -104.16 97.91 7.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 110.034 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.719 HG22 ' OG ' ' A' ' 133' ' ' SER . 5.4 t -97.41 124.71 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.18 126.56 43.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.47 -0.769 . . . . 0.0 109.236 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 33.4 t80 -108.31 129.3 55.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.835 0.826 . . . . 0.0 109.008 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -80.85 117.05 21.16 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.566 -0.709 . . . . 0.0 110.353 -178.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.5 t -85.14 -47.54 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -0.822 . . . . 0.0 110.346 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -169.27 158.1 7.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.915 -1.116 . . . . 0.0 110.545 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.61 61.56 4.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.778 ' HB3' ' HB3' ' A' ' 127' ' ' GLU . . . -119.58 129.9 54.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.877 -1.367 . . . . 0.0 108.446 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -118.57 -29.92 1.79 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.004 HD12 ' N ' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -141.66 160.13 40.79 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.387 -1.066 . . . . 0.0 109.748 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 1.004 ' N ' HD12 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -139.35 95.51 2.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.715 ' O ' HD22 ' A' ' 115' ' ' LEU . 1.8 m -77.78 136.43 38.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.42 -0.8 . . . . 0.0 110.318 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.715 HD22 ' O ' ' A' ' 114' ' ' CYS . 0.3 OUTLIER -145.64 114.19 6.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.409 -0.807 . . . . 0.0 109.734 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 6.8 t-160 -106.73 110.55 22.76 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.901 -1.124 . . . . 0.0 109.342 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.3 mm -128.61 121.53 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.63 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.469 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.15 -143.82 36.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 103.682 -3.767 . . . . 0.0 103.682 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.492 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 44.7 p30 -111.0 82.67 1.63 Allowed 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 115.417 -2.513 . . . . 0.0 108.369 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.506 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 60.0 tt0 -164.76 167.69 18.67 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 5' ' ' ILE . 71.0 t -128.5 140.25 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.986 -1.071 . . . . 0.0 110.085 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -125.57 132.25 52.58 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.928 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -142.05 122.13 13.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.069 -1.02 . . . . 0.0 109.029 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -106.74 147.09 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.241 -0.912 . . . . 0.0 109.191 179.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 2' ' ' ALA . 12.9 mt -118.44 78.33 1.25 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 117.848 -1.541 . . . . 0.0 111.586 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.446 ' SG ' ' N ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -166.79 163.65 16.46 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 103.3 -2.852 . . . . 0.0 103.3 177.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.778 ' HB3' ' HB3' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -117.78 110.74 18.18 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 122.59 2.45 . . . . 0.0 106.312 176.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.595 ' C ' ' H ' ' A' ' 130' ' ' ASP . 13.0 mmtt -113.61 148.51 36.08 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.603 -0.686 . . . . 0.0 111.114 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.579 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 93.5 m-20 -61.12 -0.19 0.31 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.595 ' H ' ' C ' ' A' ' 128' ' ' LYS . 49.2 p30 -70.28 153.06 43.48 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.222 1.011 . . . . 0.0 110.903 -176.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.771 ' C ' HD12 ' A' ' 131' ' ' LEU . 0.9 OUTLIER -125.76 161.87 26.37 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.856 0.836 . . . . 0.0 110.972 -178.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.77 ' N ' HD12 ' A' ' 131' ' ' LEU . 1.6 mp -128.43 145.41 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.669 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.719 ' OG ' HG22 ' A' ' 103' ' ' VAL . 2.6 t -119.12 138.08 53.15 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.308 -0.87 . . . . 0.0 109.789 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -112.14 140.06 23.13 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.33 150.83 59.33 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.099 1.866 . . . . 0.0 112.328 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -72.48 132.57 44.04 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.815 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 12.5 t60 94.53 9.86 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.39 126.94 30.12 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 108.46 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.41 132.59 31.82 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.541 1.494 . . . . 0.0 111.463 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.516 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -166.61 162.84 16.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.315 -0.866 . . . . 0.0 110.177 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.672 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 21.6 p90 -127.22 -154.37 0.63 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.505 -0.747 . . . . 0.0 109.818 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.672 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 47.4 t80 -169.71 119.79 0.65 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.491 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 34.3 p30 -139.52 119.64 13.63 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.28 -0.887 . . . . 0.0 108.692 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.566 ' SD ' ' CZ ' ' A' ' 150' ' ' PHE . 25.9 mtm -93.31 16.59 12.91 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 111.491 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.806 ' HA3' HD13 ' A' ' 178' ' ' LEU . . . 50.24 -144.3 10.93 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.587 ' H ' HD22 ' A' ' 178' ' ' LEU . 31.6 t -83.29 121.04 26.6 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.0 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -116.27 120.42 35.05 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.88 -0.512 . . . . 0.0 110.536 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 59.3 Cg_endo -102.87 59.41 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.807 0 C-N-CA 122.378 2.052 . . . . 0.0 110.65 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.586 ' H ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER 82.48 64.26 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.304 -0.873 . . . . 0.0 109.691 -177.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.566 ' CZ ' ' SD ' ' A' ' 144' ' ' MET . 1.0 OUTLIER -101.42 168.19 9.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.7 m -127.1 133.19 50.46 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.43 -0.794 . . . . 0.0 109.281 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -138.16 157.35 46.48 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.031 -1.043 . . . . 0.0 109.591 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.3 mt -108.32 124.91 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.062 -1.024 . . . . 0.0 108.985 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.16 164.49 27.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.414 -0.804 . . . . 0.0 109.346 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.838 HG21 ' CG ' ' A' ' 70' ' ' TYR . 2.9 mt -119.24 124.46 73.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.46 ' N ' ' CD1' ' A' ' 156' ' ' PHE . 26.5 m-85 -93.87 133.39 37.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.983 -1.073 . . . . 0.0 110.241 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.62 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 0.2 OUTLIER -129.84 165.57 21.72 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.644 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -91.2 160.63 36.98 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.935 -1.103 . . . . 0.0 108.625 -178.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 161' ' ' GLY . 36.1 Cg_endo -57.02 -54.28 3.88 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.678 2.252 . . . . 0.0 113.12 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 159' ' ' PRO . 11.8 pt-20 -42.27 -23.17 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.506 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.27 -56.07 2.1 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.644 ' CD1' ' O ' ' A' ' 158' ' ' ASN . 39.0 p-90 -98.86 155.97 17.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.121 -1.223 . . . . 0.0 110.633 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 14.8 tt -103.88 159.08 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.497 -0.752 . . . . 0.0 109.184 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.97 -71.73 0.24 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 110.37 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -139.82 158.63 43.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.014 -1.054 . . . . 0.0 110.242 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -101.09 -41.87 6.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.162 -0.961 . . . . 0.0 109.704 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 30.6 m -115.92 -34.21 4.84 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.93 -3.95 57.38 Favored Glycine 0 N--CA 1.484 1.863 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.812 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.422 ' O ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -81.7 148.11 29.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.08 -1.835 . . . . 0.0 107.957 178.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -112.35 91.16 3.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.089 -1.444 . . . . 0.0 111.104 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.419 HD11 ' HZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -75.3 -20.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.113 -1.617 . . . . 0.0 108.799 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.624 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -61.34 -39.91 92.3 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.549 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -51.4 -3.85 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.827 -0.546 . . . . 0.0 110.698 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.36 -36.34 34.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.915 -1.116 . . . . 0.0 111.053 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.612 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.5 OUTLIER -111.49 20.09 0.07 OUTLIER Pre-proline 0 N--CA 1.511 2.595 0 O-C-N 120.708 -1.245 . . . . 0.0 113.993 -178.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 51.8 Cg_endo -65.48 -23.62 57.6 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.961 2.441 . . . . 0.0 114.636 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -87.81 126.54 35.07 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.268 -1.373 . . . . 0.0 108.41 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.806 HD13 ' HA3' ' A' ' 145' ' ' GLY . 9.4 tp -85.41 145.2 27.58 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 108.779 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.168 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.584 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.29 168.22 10.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.071 -1.018 . . . . 0.0 109.313 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 4' ' ' THR . 2.6 tp -156.48 125.49 6.01 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.761 ' OG1' HD21 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -121.73 126.62 49.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.205 -0.935 . . . . 0.0 109.633 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.444 HG23 ' CD2' ' A' ' 122' ' ' PHE . 28.1 mt -117.43 140.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.794 ' CZ ' ' O ' ' A' ' 7' ' ' SER . 1.2 t80 -144.41 156.19 44.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.794 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 50.7 p -89.57 179.76 5.97 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.984 -1.073 . . . . 0.0 108.132 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 8' ' ' VAL . 18.7 m -88.19 3.21 5.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 119.975 -1.703 . . . . 0.0 110.149 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.406 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 1.4 mmmt -76.81 -49.57 15.53 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 120.509 -1.369 . . . . 0.0 114.13 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.787 ' O ' ' CE1' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -145.26 123.7 6.59 Favored Pre-proline 0 N--CA 1.507 2.404 0 O-C-N 119.96 -1.712 . . . . 0.0 109.546 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.71 -33.96 26.21 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.324 1.349 . . . . 0.0 113.413 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.616 ' C ' HD22 ' A' ' 13' ' ' ASN . 0.2 OUTLIER -70.43 6.15 1.5 Allowed 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.281 -0.887 . . . . 0.0 110.127 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.616 HD22 ' C ' ' A' ' 12' ' ' GLN . 4.2 m120 -125.74 124.64 41.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.152 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.477 ' C ' HD12 ' A' ' 15' ' ' LEU . 92.6 p -113.44 133.44 55.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.46 -0.775 . . . . 0.0 108.931 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.842 ' N ' HD12 ' A' ' 15' ' ' LEU . 6.3 mp -94.19 5.41 51.81 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.105 -0.997 . . . . 0.0 109.881 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.483 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 23.8 t90 -153.91 102.08 2.48 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.788 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -117.99 107.43 14.03 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.197 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.68 161.71 29.57 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.511 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.822 HG23 ' O ' ' A' ' 19' ' ' THR . 8.8 t -132.57 90.54 2.79 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 120.881 -1.137 . . . . 0.0 107.996 176.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.782 ' O ' HD12 ' A' ' 24' ' ' ILE . 12.6 t-20 -123.76 141.96 51.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.254 -0.904 . . . . 0.0 110.037 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.83 -35.53 29.31 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.035 -1.666 . . . . 0.0 108.779 176.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -83.13 -52.27 6.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.168 -0.957 . . . . 0.0 109.548 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 1.4 tm-20 -60.17 -20.48 58.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.96 . . . . 0.0 108.667 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.782 HD12 ' O ' ' A' ' 20' ' ' ASN . 4.6 mt -73.04 -54.76 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.198 -0.939 . . . . 0.0 108.766 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -58.72 -43.0 90.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.488 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.692 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 94.9 mt-30 -62.08 -40.72 96.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.207 -0.933 . . . . 0.0 108.967 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.483 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 8.9 tt0 -73.25 -45.74 54.16 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.79 HD12 HG11 ' A' ' 33' ' ' VAL . 3.3 mm? -67.01 -61.16 2.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.031 -1.043 . . . . 0.0 110.089 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.2 t-20 -59.48 -18.88 43.58 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.321 -0.862 . . . . 0.0 110.262 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.692 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -66.04 -31.25 72.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.81 -1.181 . . . . 0.0 108.966 177.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.644 ' NZ ' ' CE2' ' A' ' 122' ' ' PHE . 13.6 mtmt -91.47 12.3 21.17 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.296 -0.877 . . . . 0.0 109.963 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.25 24.76 30.58 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.159 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.79 HG11 HD12 ' A' ' 28' ' ' LEU . 28.8 t -95.3 147.41 5.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.385 -1.068 . . . . 0.0 109.194 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.457 ' HD3' HD11 ' A' ' 131' ' ' LEU . 18.9 ttt180 -82.82 153.23 25.29 Favored 'General case' 0 C--N 1.285 -2.208 0 O-C-N 120.82 -1.175 . . . . 0.0 108.097 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -154.81 149.45 26.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.063 -1.023 . . . . 0.0 108.564 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.533 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 5.5 pt-20 -178.78 179.54 0.7 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.019 -1.051 . . . . 0.0 110.561 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.8 ptt85 -152.97 122.35 6.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.319 -0.863 . . . . 0.0 109.353 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.612 ' CE3' ' CE1' ' A' ' 105' ' ' PHE . 33.4 m0 -111.78 153.38 26.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.49 -0.756 . . . . 0.0 109.108 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -140.01 155.01 47.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.901 . . . . 0.0 109.658 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.27 157.55 15.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 108.783 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -102.73 -8.75 20.6 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -93.61 162.16 14.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.683 0.754 . . . . 0.0 109.184 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 39.8 p-10 -96.41 123.72 40.16 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.425 0.631 . . . . 0.0 109.694 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.94 160.88 14.24 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.369 -0.832 . . . . 0.0 109.43 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.1 -105.3 0.22 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.87 88.62 4.68 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.057 -1.261 . . . . 0.0 109.078 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.99 91.89 40.77 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.145 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.91 -23.7 13.74 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.179 1.919 . . . . 0.0 112.477 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.0 p -119.65 141.93 48.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.782 -0.574 . . . . 0.0 109.494 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.42 -17.68 51.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.804 . . . . 0.0 109.428 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' ALA . 97.8 mt-10 -44.69 -38.2 4.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.476 -0.765 . . . . 0.0 109.094 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 m -76.36 -33.11 58.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.194 -0.941 . . . . 0.0 109.412 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.561 HG11 ' CG1' ' A' ' 107' ' ' VAL . 70.1 t -65.84 -45.07 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.385 -0.822 . . . . 0.0 110.042 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.935 HD13 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -61.47 -38.54 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.098 -1.001 . . . . 0.0 109.006 -179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.21 -31.28 70.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.425 -0.797 . . . . 0.0 109.686 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.86 -21.78 50.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.084 -1.01 . . . . 0.0 110.443 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -112.53 -10.22 13.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.332 -0.855 . . . . 0.0 109.526 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.697 HE21 ' CG1' ' A' ' 61' ' ' ILE . 28.2 tp60 -52.64 -43.05 65.2 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.421 -0.911 . . . . 0.0 108.86 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.547 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 6.3 p80 -49.71 -48.52 49.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.017 -1.052 . . . . 0.0 109.653 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.547 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.08 -60.76 3.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.948 -1.095 . . . . 0.0 109.853 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.697 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.6 OUTLIER -62.13 -30.01 47.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.773 -1.204 . . . . 0.0 109.304 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.4 t70 -55.22 -25.85 35.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.069 -1.019 . . . . 0.0 109.624 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -80.3 -35.23 36.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 109.298 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.97 -42.66 94.36 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.42 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.716 HG22 ' CZ3' ' A' ' 73' ' ' TRP . 0.6 OUTLIER -72.04 -28.97 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 109.532 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.66 -52.91 53.67 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.937 -1.102 . . . . 0.0 109.502 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.64 -46.27 17.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.023 -1.048 . . . . 0.0 109.988 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.626 ' O ' ' C ' ' A' ' 69' ' ' GLY . 23.2 mttm -83.59 13.36 4.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.835 . . . . 0.0 110.631 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.626 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -6.11 82.21 0.0 OUTLIER Glycine 0 N--CA 1.504 3.187 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.896 ' CG ' HG21 ' A' ' 155' ' ' ILE . 43.2 m-85 -76.36 161.82 28.39 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.709 -0.877 . . . . 0.0 109.138 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -58.93 -42.85 90.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 0.0 109.974 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.8 t -151.29 161.21 43.12 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.154 -0.967 . . . . 0.0 109.895 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.716 ' CZ3' HG22 ' A' ' 65' ' ' VAL . 12.3 t-105 -137.74 143.0 40.96 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.454 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -160.87 179.13 8.74 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.935 HG21 HD13 ' A' ' 54' ' ' ILE . 2.7 t -122.9 142.04 40.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.47 -0.769 . . . . 0.0 109.264 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.5 mm -100.0 116.25 42.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.515 ' O ' ' OG ' ' A' ' 77' ' ' SER . 5.8 p -168.71 102.07 0.4 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.512 -0.743 . . . . 0.0 109.047 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.677 HD23 ' HB2' ' A' ' 82' ' ' ASN . 10.3 tp -121.47 179.88 4.3 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 119.581 -1.95 . . . . 0.0 107.712 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.848 HH21 ' HB3' ' A' ' 80' ' ' ALA . 4.0 ttp85 -87.94 160.39 17.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.649 -1.282 . . . . 0.0 109.118 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.848 ' HB3' HH21 ' A' ' 79' ' ' ARG . . . -58.52 -2.74 0.23 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.895 0.855 . . . . 0.0 109.849 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.561 ' CG ' ' HE ' ' A' ' 79' ' ' ARG . 89.1 m-20 -97.95 31.98 2.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.677 ' HB2' HD23 ' A' ' 78' ' ' LEU . 1.5 t30 -80.19 125.13 82.12 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.7 -0.625 . . . . 0.0 110.771 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -78.73 -23.03 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.042 1.828 . . . . 0.0 112.405 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.491 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 88.8 mm-40 -91.9 10.73 27.52 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.917 -1.114 . . . . 0.0 109.365 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.618 ' CA ' ' ND2' ' A' ' 82' ' ' ASN . 47.1 pttt -57.98 -53.68 55.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.585 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 84.8 tt0 -68.7 -52.06 34.98 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.197 -0.94 . . . . 0.0 109.606 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.68 -45.92 84.99 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.71 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 84' ' ' GLN . 7.3 tt -62.3 -43.98 97.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.718 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -59.0 -36.41 74.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.1 -1.0 . . . . 0.0 109.696 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -66.97 -56.27 10.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 109.803 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -51.03 -36.21 38.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.479 -0.763 . . . . 0.0 109.232 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -87.88 -18.97 28.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.544 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.51 -36.09 81.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 109.889 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -61.36 133.41 55.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 110.017 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.74 151.5 38.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.444 -0.785 . . . . 0.0 109.376 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -163.39 -172.88 3.12 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.5 t -163.0 137.69 6.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.688 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -110.46 154.51 23.52 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.395 -0.815 . . . . 0.0 109.663 -178.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.26 -5.75 82.05 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 101' ' ' ASP . 79.9 tt0 -125.11 168.2 13.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.191 -1.181 . . . . 0.0 109.168 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.416 ' N ' ' HG2' ' A' ' 100' ' ' GLU . 92.4 m-20 -73.13 142.99 47.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.893 -1.129 . . . . 0.0 110.315 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.84 95.87 7.49 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.298 -0.876 . . . . 0.0 109.317 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.472 HG13 HD13 ' A' ' 131' ' ' LEU . 20.1 t -80.28 131.5 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.467 0.651 . . . . 0.0 109.302 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.672 ' NH2' ' CE2' ' A' ' 142' ' ' PHE . 20.0 mmm180 -129.26 114.23 16.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.654 -0.654 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.631 ' CE1' ' O ' ' A' ' 129' ' ' ASN . 16.1 t80 -109.75 129.9 55.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.506 ' CD2' ' OE2' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -93.05 137.5 32.35 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 110.396 -179.086 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.561 ' CG1' HG11 ' A' ' 53' ' ' VAL . 38.5 t -111.92 -30.25 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.686 -0.634 . . . . 0.0 109.817 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -168.57 158.27 9.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.067 -1.021 . . . . 0.0 109.426 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.21 162.18 15.56 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.57 -176.62 2.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -1.137 . . . . 0.0 109.317 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.25 -144.36 5.12 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 113' ' ' PHE . 7.6 tt -142.37 160.06 41.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -1.168 . . . . 0.0 109.663 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.607 ' N ' HD23 ' A' ' 112' ' ' LEU . 6.1 m-85 -137.55 87.68 2.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 109.833 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.592 ' SG ' ' NE1' ' A' ' 141' ' ' TRP . 42.2 t -81.01 114.13 19.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.446 -0.784 . . . . 0.0 109.428 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 114' ' ' CYS . 7.8 mt -119.41 117.23 27.92 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.148 -0.97 . . . . 0.0 108.819 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.586 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 4.0 t-160 -106.85 113.56 27.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.053 -1.029 . . . . 0.0 109.635 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.79 117.68 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.678 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.74 -143.1 31.98 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 105.85 -2.9 . . . . 0.0 105.85 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -106.71 79.36 1.34 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 115.739 -2.385 . . . . 0.0 108.538 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.586 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 74.9 tt0 -165.61 167.94 16.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.401 ' N ' ' HG2' ' A' ' 120' ' ' GLU . 3.9 t -130.7 149.18 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.139 -0.976 . . . . 0.0 110.066 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.644 ' CE2' ' NZ ' ' A' ' 31' ' ' LYS . 51.1 m-85 -129.32 133.8 47.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.803 -0.561 . . . . 0.0 109.771 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.552 ' OE1' HD21 ' A' ' 112' ' ' LEU . 83.7 mm-40 -128.39 108.95 10.99 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.792 ' C ' HD13 ' A' ' 125' ' ' LEU . 3.3 t -103.74 138.11 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.978 HD22 ' N ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -130.98 83.17 2.09 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.452 178.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.538 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 25.9 p -170.19 116.89 0.53 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.506 ' OE2' ' CD2' ' A' ' 106' ' ' PHE . 79.3 mm-40 -114.82 103.44 10.95 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 116.126 -2.229 . . . . 0.0 111.245 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.58 ' C ' ' H ' ' A' ' 130' ' ' ASP . 93.6 mttt -109.34 177.26 4.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.333 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.631 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 22.5 p30 -55.7 -5.96 0.18 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.58 ' H ' ' C ' ' A' ' 128' ' ' LYS . 29.7 p30 -72.22 144.55 48.44 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.918 0.866 . . . . 0.0 109.362 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.922 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.2 OUTLIER -109.24 148.47 30.92 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.885 0.85 . . . . 0.0 109.974 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.922 ' N ' HD12 ' A' ' 131' ' ' LEU . 37.3 mm -122.35 121.11 62.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.4 t -111.74 142.4 44.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.67 143.55 26.92 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.0 108.894 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.17 150.19 85.12 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.317 2.011 . . . . 0.0 112.53 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.615 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.58 134.7 46.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.38 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.615 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.7 t60 92.71 10.17 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.65 125.46 34.71 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.075 -1.016 . . . . 0.0 108.685 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.57 132.05 31.77 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.482 1.455 . . . . 0.0 111.629 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.477 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.71 163.54 9.96 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.235 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.592 ' NE1' ' SG ' ' A' ' 114' ' ' CYS . 0.6 OUTLIER -133.36 -147.33 0.29 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.312 -0.868 . . . . 0.0 109.851 -178.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.672 ' CE2' ' NH2' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -178.71 126.26 0.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.887 -1.133 . . . . 0.0 109.289 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 176' ' ' PRO . 53.0 t0 -146.57 137.48 24.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.264 -0.898 . . . . 0.0 109.626 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.588 ' O ' ' C ' ' A' ' 145' ' ' GLY . 5.5 ptt? -109.81 21.1 17.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.515 -0.741 . . . . 0.0 111.295 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.588 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 12.12 -90.46 0.01 OUTLIER Glycine 0 N--CA 1.503 3.117 0 CA-C-N 119.336 0.971 . . . . 0.0 112.073 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.542 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 39.7 t -86.88 120.41 28.13 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.035 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.671 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -113.42 111.74 49.39 Favored Pre-proline 0 C--N 1.294 -1.805 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.742 178.335 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.584 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.4 Cg_endo -102.07 28.21 0.1 Allowed 'Trans proline' 0 C--O 1.212 -0.822 0 C-N-CA 123.068 2.512 . . . . 0.0 111.432 176.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.622 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER 84.06 71.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.747 0.784 . . . . 0.0 109.632 -177.229 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 150' ' ' PHE . 25.6 p90 -94.89 159.55 14.99 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.64 -0.662 . . . . 0.0 109.528 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.468 HG22 ' HB ' ' A' ' 107' ' ' VAL . 29.7 m -130.26 125.52 35.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.223 -0.923 . . . . 0.0 110.012 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.505 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -144.62 164.16 31.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 109.44 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.538 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 29.1 mt -110.61 129.93 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.075 -1.016 . . . . 0.0 109.346 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.478 ' HE ' ' HD3' ' A' ' 104' ' ' ARG . 4.3 ttt180 -138.6 167.42 21.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.422 -0.799 . . . . 0.0 109.69 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.896 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.1 mp -104.36 146.68 11.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.501 -0.75 . . . . 0.0 109.444 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.454 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.3 m-30 -95.35 118.56 32.32 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.008 0.909 . . . . 0.0 109.732 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.63 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 11.8 p30 -135.89 161.92 34.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.891 -0.505 . . . . 0.0 109.829 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 2.3 m-20 -96.03 160.23 30.46 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.059 -1.025 . . . . 0.0 109.484 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.62 ' O ' ' N ' ' A' ' 162' ' ' TRP . 43.8 Cg_endo -69.02 -54.26 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.56 2.173 . . . . 0.0 112.042 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 159' ' ' PRO . 77.4 tt0 -43.45 -16.84 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 109.219 -178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -88.61 -25.67 29.55 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.63 ' HE1' ' CG ' ' A' ' 157' ' ' ASP . 32.6 m95 -107.27 169.08 8.78 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.387 -1.067 . . . . 0.0 109.964 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 77.3 mt -97.21 150.55 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.24 -0.912 . . . . 0.0 109.282 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -76.77 -71.63 0.39 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.31 -0.869 . . . . 0.0 110.449 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -133.95 158.71 42.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.215 -0.928 . . . . 0.0 109.819 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -101.08 -39.67 7.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.873 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.18 -30.26 5.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.328 -0.857 . . . . 0.0 108.957 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.66 -9.92 55.75 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.91 148.56 31.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.838 -1.389 . . . . 0.0 108.074 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -111.22 87.55 2.57 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 117.614 -1.635 . . . . 0.0 110.94 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.516 HG23 ' CH2' ' A' ' 141' ' ' TRP . 2.2 tt -77.79 -16.99 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.602 -1.311 . . . . 0.0 109.147 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -56.25 -38.91 71.75 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.632 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 68.0 m -52.82 -4.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.434 -0.791 . . . . 0.0 109.961 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.551 ' HB3' ' CE2' ' A' ' 175' ' ' TYR . . . -76.23 -41.37 49.42 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.68 -1.262 . . . . 0.0 111.894 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.629 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.6 m-85 -113.29 25.04 0.08 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 O-C-N 120.457 -1.402 . . . . 0.0 112.416 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.632 ' HD3' ' C ' ' A' ' 173' ' ' SER . 41.0 Cg_endo -60.66 -25.97 81.97 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 123.898 3.065 . . . . 0.0 113.892 -172.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -89.57 125.5 35.24 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 118.719 -1.192 . . . . 0.0 108.408 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.725 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.5 OUTLIER -87.34 120.9 29.1 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.2 -0.937 . . . . 0.0 109.084 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.491 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.641 ' O ' ' OG1' ' A' ' 19' ' ' THR . 6.0 p . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.31 170.48 9.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.208 -0.932 . . . . 0.0 108.699 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 123' ' ' GLN . 2.8 tp -156.93 119.23 3.91 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.505 ' N ' HD12 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -110.74 134.01 52.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.164 -0.96 . . . . 0.0 109.761 -178.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.71 HD12 ' HB3' ' A' ' 16' ' ' TRP . 6.2 mt -127.97 137.51 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.415 ' CE1' HG22 ' A' ' 4' ' ' THR . 96.8 m-85 -130.65 166.59 20.36 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.406 ' OG ' ' CD2' ' A' ' 15' ' ' LEU . 51.0 m -87.41 173.9 8.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.048 -1.033 . . . . 0.0 108.579 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.86 -29.53 5.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.913 -1.117 . . . . 0.0 109.413 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -73.02 -38.12 66.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.783 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -139.22 123.93 11.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.996 -1.065 . . . . 0.0 109.743 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -84.1 -21.91 3.65 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.754 1.636 . . . . 0.0 112.471 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.48 -1.87 12.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.484 -0.76 . . . . 0.0 111.579 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.544 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 47.4 p-10 -124.89 122.79 38.37 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.16 -0.962 . . . . 0.0 108.886 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.2 p -93.22 129.76 39.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.874 -1.141 . . . . 0.0 108.53 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 15' ' ' LEU . 11.0 mp -90.38 -7.28 53.62 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.166 -1.013 . . . . 0.0 109.068 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.71 ' HB3' HD12 ' A' ' 5' ' ' ILE . 39.0 t90 -157.58 105.63 2.05 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.253 -1.379 . . . . 0.0 110.055 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -119.0 111.13 17.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.378 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.425 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -161.37 162.71 30.83 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.369 -0.832 . . . . 0.0 109.872 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 19' ' ' THR . 10.2 t -131.72 89.18 2.66 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.005 -1.059 . . . . 0.0 108.153 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.773 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -125.52 151.45 46.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.014 -1.054 . . . . 0.0 110.06 177.423 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.26 -41.32 20.36 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.21 -1.557 . . . . 0.0 108.827 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -82.81 -47.35 12.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 110.737 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -64.52 -23.44 67.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.757 -1.215 . . . . 0.0 108.984 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.773 HD12 ' O ' ' A' ' 20' ' ' ASN . 7.2 mt -70.73 -51.36 37.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.228 -0.92 . . . . 0.0 108.537 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.429 ' NE2' ' CB ' ' A' ' 29' ' ' ASN . 13.2 tm0? -57.08 -50.1 73.83 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.525 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.604 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 44.6 tt0 -58.42 -35.03 71.46 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.525 -0.735 . . . . 0.0 110.229 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.703 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -64.3 -63.48 1.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.933 -1.105 . . . . 0.0 109.587 -179.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -55.09 14.15 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.114 -0.991 . . . . 0.0 109.76 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 19.8 t-20 -52.46 -27.63 16.91 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.972 -1.08 . . . . 0.0 109.73 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -64.5 -27.05 68.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.677 -1.264 . . . . 0.0 108.263 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -90.71 11.29 22.7 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.26 -0.9 . . . . 0.0 110.54 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.26 25.69 15.87 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.088 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.615 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 43.3 t -96.8 145.75 8.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.348 -1.089 . . . . 0.0 109.929 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -84.17 157.04 21.8 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -153.1 149.82 28.48 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.401 ' HG2' ' HE1' ' A' ' 38' ' ' TRP . 36.2 tp10 -174.89 166.41 3.61 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.95 -1.094 . . . . 0.0 108.619 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -153.77 131.06 11.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.401 ' HE1' ' HG2' ' A' ' 36' ' ' GLU . 11.0 m0 -117.38 151.58 36.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.583 -0.698 . . . . 0.0 109.945 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -135.96 158.75 43.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.372 -0.83 . . . . 0.0 109.439 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.38 160.46 14.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.917 . . . . 0.0 109.179 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -98.64 -17.64 18.5 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.222 -0.924 . . . . 0.0 108.544 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -93.61 164.83 13.01 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.687 0.756 . . . . 0.0 109.161 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.17 119.39 32.93 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.645 -0.659 . . . . 0.0 109.599 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.98 166.05 12.9 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.4 -121.87 0.59 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.46 79.4 8.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.069 -1.254 . . . . 0.0 108.98 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.92 94.93 26.76 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.448 -0.783 . . . . 0.0 109.205 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.706 ' O ' HG23 ' A' ' 49' ' ' THR . 50.6 Cg_endo -70.86 79.46 1.29 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.002 1.801 . . . . 0.0 111.854 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 48' ' ' PRO . 3.8 p -163.55 119.56 1.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.129 -0.982 . . . . 0.0 109.273 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.95 -43.54 17.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.858 -1.151 . . . . 0.0 110.044 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -66.61 -17.89 65.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.488 -0.757 . . . . 0.0 110.148 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 m -77.11 -40.77 44.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 110.228 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.402 HG11 ' CG1' ' A' ' 107' ' ' VAL . 43.9 t -66.87 -48.11 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.117 -0.989 . . . . 0.0 109.953 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 58' ' ' GLN . 8.5 mm -61.31 -41.94 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 108.619 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.81 -29.87 70.44 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.435 -0.79 . . . . 0.0 109.691 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.16 -17.85 59.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.98 . . . . 0.0 110.12 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 58' ' ' GLN . 57.4 m-85 -114.34 -7.47 12.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 109.121 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.481 HE21 HG12 ' A' ' 61' ' ' ILE . 5.1 mm-40 -46.52 -39.84 11.54 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.759 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -51.32 -46.6 62.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.54 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -63.67 -59.63 4.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.804 -1.185 . . . . 0.0 110.341 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.681 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -62.32 -31.85 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.996 -1.065 . . . . 0.0 109.352 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.7 t70 -59.04 -25.05 63.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.594 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.54 -39.08 47.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.949 . . . . 0.0 109.411 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.0 mp -64.19 -38.07 89.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.365 -0.834 . . . . 0.0 108.936 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.639 HG22 ' CZ3' ' A' ' 73' ' ' TRP . 2.8 t -71.02 -29.68 38.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.368 -0.832 . . . . 0.0 109.458 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.38 -52.36 63.8 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.514 -1.366 . . . . 0.0 109.597 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.05 -49.8 9.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.955 -1.091 . . . . 0.0 110.366 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.602 ' O ' ' C ' ' A' ' 69' ' ' GLY . 20.2 mmtt -83.99 13.0 5.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -0.868 . . . . 0.0 111.37 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.602 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -3.01 80.83 0.0 OUTLIER Glycine 0 N--CA 1.506 3.336 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.583 ' CG ' HG21 ' A' ' 155' ' ' ILE . 69.1 m-85 -77.35 158.94 29.86 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.658 -0.907 . . . . 0.0 108.791 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -57.65 -88.53 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.479 -0.763 . . . . 0.0 109.3 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -103.44 159.58 15.46 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.719 0.771 . . . . 0.0 110.161 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.639 ' CZ3' HG22 ' A' ' 65' ' ' VAL . 7.9 t-105 -139.51 144.7 38.03 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -163.05 -178.6 6.15 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 152' ' ' ALA . 7.3 p -121.13 143.87 32.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.729 HG23 ' O ' ' A' ' 76' ' ' ILE . 19.8 tt -101.72 115.45 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.625 ' OG ' HG23 ' A' ' 151' ' ' THR . 0.7 OUTLIER -167.94 101.06 0.46 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.816 -0.753 . . . . 0.0 109.194 177.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.535 ' HG ' ' H ' ' A' ' 79' ' ' ARG . 11.5 tp -106.59 178.34 4.59 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 121.08 1.764 . . . . 0.0 107.939 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.535 ' H ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -89.88 143.84 26.45 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.693 -1.254 . . . . 0.0 109.664 -178.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.03 0.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.594 -0.691 . . . . 0.0 109.588 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' A' ' 79' ' ' ARG . 58.5 t0 -83.57 -27.54 29.2 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.471 -1.292 . . . . 0.0 109.444 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.71 HD21 ' CB ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -67.41 122.42 83.03 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.054 -1.029 . . . . 0.0 109.507 179.481 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -85.83 -3.78 8.99 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.021 1.814 . . . . 0.0 112.234 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -88.39 -3.44 58.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.944 -1.097 . . . . 0.0 110.513 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.71 ' CB ' HD21 ' A' ' 82' ' ' ASN . 2.3 mmtt -62.8 -40.57 97.75 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.036 -1.04 . . . . 0.0 109.283 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -61.05 -54.49 44.1 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.322 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.04 -35.0 75.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.06 -1.025 . . . . 0.0 109.644 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.732 HD23 ' O ' ' A' ' 88' ' ' LEU . 4.3 tt -61.37 -43.51 98.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.73 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.6 ptt-85 -63.76 -25.78 68.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 109.934 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.72 -59.66 3.69 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.408 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -54.25 -29.39 46.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.962 . . . . 0.0 109.27 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.39 -18.37 36.3 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.306 -0.871 . . . . 0.0 109.661 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.666 ' C ' HD12 ' A' ' 93' ' ' LEU . 0.8 OUTLIER -58.44 -25.88 62.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 109.936 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -55.25 142.37 31.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.108 -0.995 . . . . 0.0 110.211 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.511 ' OE2' ' O ' ' A' ' 169' ' ' ASP . 19.8 pt-20 -72.59 164.24 26.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.395 -0.816 . . . . 0.0 109.663 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -174.24 -170.92 0.56 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.492 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.2 t -160.48 132.28 5.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.65 0.738 . . . . 0.0 109.36 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.665 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -103.4 154.64 19.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.712 -0.617 . . . . 0.0 110.01 -179.037 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' A' ' 162' ' ' TRP . . . -78.83 -6.05 88.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 96.6 mt-10 -124.77 170.11 11.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -1.027 . . . . 0.0 109.382 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -74.68 143.54 44.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.956 -1.09 . . . . 0.0 110.103 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.444 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 2.0 mt-10 -101.1 93.64 5.58 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.114 -0.992 . . . . 0.0 108.901 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.519 HG12 ' CB ' ' A' ' 133' ' ' SER . 9.1 m -89.11 130.65 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.767 -0.583 . . . . 0.0 109.495 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.693 ' NH1' ' CD1' ' A' ' 142' ' ' PHE . 21.4 mtp180 -129.59 116.94 19.63 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.561 -0.712 . . . . 0.0 109.437 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.457 ' CE2' ' O ' ' A' ' 106' ' ' PHE . 25.4 t80 -101.08 134.08 44.62 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.457 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.88 129.26 35.63 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.422 -0.799 . . . . 0.0 110.388 -178.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.402 ' CG1' HG11 ' A' ' 53' ' ' VAL . 17.9 t -107.96 -33.54 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.577 -0.702 . . . . 0.0 109.711 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -167.97 157.81 10.07 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.094 -1.004 . . . . 0.0 108.88 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.19 161.4 9.14 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.12 -177.51 3.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.396 -1.061 . . . . 0.0 109.107 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.88 -142.51 4.09 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.8 tp -142.62 159.7 41.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.23 -1.159 . . . . 0.0 109.026 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -136.83 88.09 2.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.06 -1.025 . . . . 0.0 109.258 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.75 108.87 14.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.473 -0.767 . . . . 0.0 110.026 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.402 HD23 HG12 ' A' ' 134' ' ' VAL . 1.2 mp -116.43 121.18 41.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -0.924 . . . . 0.0 108.82 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 4.7 t-160 -107.29 113.37 26.72 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.097 -1.002 . . . . 0.0 109.277 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 52.5 mt -128.34 118.72 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.852 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.17 -142.49 33.05 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 105.429 -3.068 . . . . 0.0 105.429 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -107.8 80.64 1.41 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 121.517 2.658 . . . . 0.0 108.182 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 77.5 tt0 -165.11 166.81 18.82 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 5' ' ' ILE . 41.0 t -126.61 142.12 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.244 -0.91 . . . . 0.0 110.037 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.452 ' CZ ' HD13 ' A' ' 5' ' ' ILE . 2.2 m-85 -124.19 130.85 53.24 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.038 0.447 . . . . 0.0 109.922 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.584 ' O ' HD12 ' A' ' 3' ' ' LEU . 91.2 mt-30 -132.32 118.08 18.97 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 109.35 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.664 ' C ' HD23 ' A' ' 125' ' ' LEU . 2.9 t -106.43 137.89 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.664 HD23 ' C ' ' A' ' 124' ' ' VAL . 0.1 OUTLIER -135.91 91.07 2.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.061 -1.025 . . . . 0.0 110.634 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 126' ' ' CYS . 20.3 p -166.95 137.47 3.11 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.505 -1.372 . . . . 0.0 108.603 178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.509 ' O ' ' CD ' ' A' ' 127' ' ' GLU . 2.8 tm-20 -106.99 92.92 4.28 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 115.367 -2.533 . . . . 0.0 110.012 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.632 ' C ' ' H ' ' A' ' 130' ' ' ASP . 39.7 tttp -118.26 157.71 26.53 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.439 175.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -56.12 0.83 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.106 -1.621 . . . . 0.0 108.406 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.632 ' H ' ' C ' ' A' ' 128' ' ' LYS . 49.5 p-10 -66.84 131.36 45.75 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.157 0.979 . . . . 0.0 109.566 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.004 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -100.97 132.86 46.18 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.862 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 1.004 ' N ' HD12 ' A' ' 131' ' ' LEU . 8.2 tt -125.43 129.96 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.582 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.519 ' CB ' HG12 ' A' ' 103' ' ' VAL . 3.3 m -125.77 151.59 46.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.402 HG12 HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -107.48 149.59 39.01 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.41 151.52 75.91 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.569 2.179 . . . . 0.0 112.904 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.609 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -73.31 133.47 43.88 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.182 -0.949 . . . . 0.0 109.186 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.609 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 10.1 t-80 94.89 9.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.166 0.508 . . . . 0.0 109.705 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.09 126.96 30.26 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 108.579 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.84 132.1 31.37 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.57 1.513 . . . . 0.0 111.548 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -168.95 164.06 11.51 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.999 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.415 ' CG ' ' CB ' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -134.46 -148.8 0.33 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 109.348 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.693 ' CD1' ' NH1' ' A' ' 104' ' ' ARG . 83.5 t80 -176.03 126.38 0.21 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.052 -1.03 . . . . 0.0 109.048 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 143' ' ' ASP . 31.9 p-10 -144.69 132.86 21.62 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.368 -0.833 . . . . 0.0 109.361 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.612 ' O ' ' C ' ' A' ' 145' ' ' GLY . 11.3 ptp -110.9 21.36 16.56 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.657 -0.652 . . . . 0.0 111.093 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.612 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 7.52 -86.21 0.0 OUTLIER Glycine 0 N--CA 1.499 2.893 0 CA-C-N 119.061 0.846 . . . . 0.0 111.94 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.479 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 51.2 m -88.07 116.74 26.47 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 117.688 -1.605 . . . . 0.0 108.75 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.486 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -118.28 115.11 36.28 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.517 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 59.1 Cg_endo -105.04 36.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.437 2.091 . . . . 0.0 111.395 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.62 ' CG ' ' O ' ' A' ' 149' ' ' ASN . 0.0 OUTLIER 81.85 69.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 123.246 1.498 . . . . 0.0 108.682 -177.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.412 ' CD2' ' N ' ' A' ' 150' ' ' PHE . 26.7 p90 -95.75 161.68 13.92 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.489 -1.382 . . . . 0.0 109.766 -177.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.625 HG23 ' OG ' ' A' ' 77' ' ' SER . 11.7 m -130.54 125.87 35.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.953 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.455 ' O ' HG23 ' A' ' 75' ' ' VAL . . . -144.26 164.55 30.42 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.8 mt -109.73 128.77 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.954 -1.091 . . . . 0.0 109.342 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -134.51 163.18 30.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.583 HG21 ' CG ' ' A' ' 70' ' ' TYR . 36.2 mt -102.64 144.14 14.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.467 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.3 m-85 -96.46 118.55 33.22 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.415 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 157' ' ' ASP . 0.5 OUTLIER -135.73 161.56 35.21 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.04 158.61 33.84 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 120.699 -1.251 . . . . 0.0 109.483 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.584 ' O ' ' N ' ' A' ' 161' ' ' GLY . 46.4 Cg_endo -71.31 -53.86 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.326 2.017 . . . . 0.0 112.737 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 159' ' ' PRO . 83.7 tt0 -43.3 -16.7 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -69.38 -38.76 80.98 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.465 ' HB3' ' H ' ' A' ' 99' ' ' GLY . 4.3 p90 -119.14 175.74 5.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.695 -0.885 . . . . 0.0 111.03 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 76.2 mt -96.26 147.6 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.597 0.713 . . . . 0.0 109.315 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.92 -73.61 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.425 -0.797 . . . . 0.0 110.525 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -126.76 156.6 40.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.149 -0.969 . . . . 0.0 109.872 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.1 -40.6 7.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 0.0 109.754 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 86.1 m -101.54 -32.23 10.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.043 . . . . 0.0 108.976 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.24 -6.93 58.2 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.518 ' O ' ' OD1' ' A' ' 169' ' ' ASP . 44.4 p30 -80.92 148.35 29.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.568 -1.548 . . . . 0.0 108.545 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -112.17 88.68 2.87 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 117.737 -1.585 . . . . 0.0 110.368 175.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.41 HG23 ' H ' ' A' ' 171' ' ' ILE . 0.1 OUTLIER -82.27 -16.83 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.008 -1.682 . . . . 0.0 109.24 179.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.455 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -55.98 -37.96 69.78 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.568 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 7.3 m -56.09 -3.97 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.824 -0.547 . . . . 0.0 110.161 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -80.78 -37.87 29.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.022 -1.049 . . . . 0.0 111.755 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.627 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.5 m-85 -112.83 23.09 0.08 OUTLIER Pre-proline 0 N--CA 1.513 2.717 0 O-C-N 120.558 -1.339 . . . . 0.0 113.037 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 46.1 Cg_endo -63.31 -19.56 68.58 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 123.443 2.762 . . . . 0.0 114.262 -173.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -88.93 126.47 35.41 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.765 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.502 ' H ' ' HA3' ' A' ' 145' ' ' GLY . 5.7 tt -87.8 122.25 31.22 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.926 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.297 -1.691 0 O-C-N 121.138 -0.976 . . . . 0.0 109.367 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.81 ' O ' HG23 ' A' ' 19' ' ' THR . 5.1 p . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.11 169.03 9.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.004 -1.06 . . . . 0.0 109.08 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.454 HD13 HG22 ' A' ' 124' ' ' VAL . 4.8 tp -157.79 117.3 3.29 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.49 ' OG1' HD11 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -114.44 135.97 53.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.432 -0.792 . . . . 0.0 109.973 -178.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.679 HD12 ' HB3' ' A' ' 16' ' ' TRP . 25.7 mt -130.44 133.6 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -127.4 168.26 15.09 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.413 ' HB2' HD21 ' A' ' 13' ' ' ASN . 0.1 OUTLIER -89.39 174.81 7.6 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.216 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -87.73 -23.77 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.995 -1.066 . . . . 0.0 109.575 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -75.1 -37.93 61.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.051 -1.031 . . . . 0.0 110.413 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -136.93 126.49 15.58 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 109.655 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 13' ' ' ASN . 56.2 Cg_endo -79.87 -39.16 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.002 1.801 . . . . 0.0 112.156 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 9.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.729 . . . . 0.0 110.041 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -114.69 119.1 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.176 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.9 p -102.29 122.9 45.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.249 -0.907 . . . . 0.0 109.493 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.446 HD13 HD21 ' A' ' 13' ' ' ASN . 3.6 mp -90.2 -3.86 57.59 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.671 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.734 ' CE2' ' NE2' ' A' ' 27' ' ' GLN . 35.4 t90 -156.04 104.25 2.26 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.667 -1.213 . . . . 0.0 110.256 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -118.8 110.36 17.14 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.736 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.464 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -162.58 163.62 27.16 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.079 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.81 HG23 ' O ' ' A' ' 1' ' ' SER . 54.6 m -130.93 89.46 2.75 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.15 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.773 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -128.16 148.46 50.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.429 -0.794 . . . . 0.0 110.401 177.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.38 -38.27 22.2 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.311 -1.493 . . . . 0.0 108.107 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -83.69 -48.8 9.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.472 -0.767 . . . . 0.0 109.855 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 27' ' ' GLN . 43.9 tt0 -60.99 -24.02 65.81 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.831 -1.168 . . . . 0.0 108.604 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.773 HD12 ' O ' ' A' ' 20' ' ' ASN . 10.4 mt -73.04 -62.75 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.174 -0.953 . . . . 0.0 109.497 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.514 ' CD ' ' N ' ' A' ' 26' ' ' GLN . 3.8 pp0? -61.41 -43.34 99.04 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.879 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 25' ' ' GLN . 11.0 tm0? -61.49 -43.99 97.88 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.129 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.734 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -77.67 -47.23 19.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.977 . . . . 0.0 109.229 179.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 24' ' ' ILE . 23.9 tp -66.45 -54.41 24.47 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.999 -1.063 . . . . 0.0 109.149 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 25' ' ' GLN . 40.7 t-20 -57.9 -20.08 34.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.0 109.411 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 27' ' ' GLN . . . -65.25 -27.63 68.78 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.06 -1.025 . . . . 0.0 108.796 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.78 13.39 10.73 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.217 -0.927 . . . . 0.0 109.867 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.13 22.95 30.97 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.179 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.479 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 56.3 t -94.13 145.43 7.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.424 -1.044 . . . . 0.0 109.344 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.442 ' NE ' ' OG ' ' A' ' 133' ' ' SER . 2.4 ttm-85 -84.0 158.4 21.51 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.24 -0.912 . . . . 0.0 108.724 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.541 ' CE1' ' OD2' ' A' ' 130' ' ' ASP . 1.2 t80 -153.38 145.67 23.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.943 -1.098 . . . . 0.0 108.682 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.554 ' O ' ' OD1' ' A' ' 130' ' ' ASP . 43.8 mt-10 -165.81 168.64 15.78 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.188 -0.945 . . . . 0.0 109.961 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -148.53 113.91 5.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.587 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 22.1 m0 -109.98 153.81 24.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.273 -0.892 . . . . 0.0 109.308 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -142.79 159.09 42.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.902 . . . . 0.0 109.685 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.19 159.05 15.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.263 -0.898 . . . . 0.0 109.08 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -101.98 -13.64 17.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.152 -0.967 . . . . 0.0 108.535 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -93.05 161.55 14.39 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.234 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -95.08 118.94 32.74 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.734 -0.604 . . . . 0.0 109.666 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.0 mt -90.26 163.11 14.9 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.732 0.777 . . . . 0.0 109.292 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.08 -99.8 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.36 91.95 5.13 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.044 -1.269 . . . . 0.0 109.187 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.16 91.88 37.99 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.416 -0.802 . . . . 0.0 109.008 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -76.21 -26.41 9.07 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.316 2.011 . . . . 0.0 112.588 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.7 p -122.61 141.74 51.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.645 -0.66 . . . . 0.0 109.504 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.612 ' CB ' HG21 ' A' ' 151' ' ' THR . . . -80.69 -16.5 53.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.426 -0.796 . . . . 0.0 109.52 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -47.63 -38.96 15.77 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.796 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.1 m -79.43 -35.31 40.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.573 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.92 -48.78 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.887 . . . . 0.0 109.802 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 58' ' ' GLN . 17.7 mt -59.91 -36.77 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 108.796 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.51 -30.44 70.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.815 . . . . 0.0 109.527 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.59 -17.4 60.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.139 -0.975 . . . . 0.0 110.158 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -114.41 -8.59 12.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.393 -0.817 . . . . 0.0 109.507 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.731 HE21 ' CG1' ' A' ' 61' ' ' ILE . 26.9 tp60 -48.95 -38.57 23.35 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 108.86 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.624 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 20.2 p80 -50.62 -46.81 58.32 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.54 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.624 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.39 -60.51 3.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.065 -1.022 . . . . 0.0 109.977 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.731 ' CG1' HE21 ' A' ' 58' ' ' GLN . 0.7 OUTLIER -61.71 -30.16 47.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.85 -1.156 . . . . 0.0 109.024 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 58' ' ' GLN . 40.3 t0 -57.44 -26.43 61.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 0.0 109.645 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.75 -40.53 61.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.078 -1.013 . . . . 0.0 109.261 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -63.66 -34.65 78.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.064 -1.023 . . . . 0.0 109.653 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.649 HG22 ' CZ3' ' A' ' 73' ' ' TRP . 4.0 t -71.47 -33.95 51.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.245 -0.909 . . . . 0.0 109.442 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.37 -51.76 57.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.534 -1.354 . . . . 0.0 109.489 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -83.23 -50.07 8.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.013 -1.054 . . . . 0.0 110.472 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.605 ' O ' ' C ' ' A' ' 69' ' ' GLY . 15.7 mttm -86.65 15.79 5.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.608 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -12.01 85.52 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.866 ' CG ' HG21 ' A' ' 155' ' ' ILE . 53.9 m-85 -78.5 165.57 23.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.603 ' CD ' ' H ' ' A' ' 71' ' ' GLN . 25.4 mp0 -63.98 -83.99 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.372 -0.83 . . . . 0.0 109.401 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.23 157.3 17.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.597 -0.689 . . . . 0.0 109.566 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.649 ' CZ3' HG22 ' A' ' 65' ' ' VAL . 6.7 t-105 -136.15 139.36 42.83 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -167.38 -174.42 2.55 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.341 -0.849 . . . . 0.0 108.734 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 153' ' ' ILE . 3.2 m -118.92 146.76 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.0 109.45 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.24 116.53 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -174.42 108.84 0.13 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.828 -1.17 . . . . 0.0 109.563 177.464 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.427 ' CD2' ' H ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -100.39 -178.83 3.93 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 121.403 1.91 . . . . 0.0 109.331 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.427 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 7.8 tpt180 -88.88 143.81 26.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.856 -1.152 . . . . 0.0 109.207 -178.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.46 0.83 0.63 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.56 -0.712 . . . . 0.0 109.788 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 79' ' ' ARG . 57.5 t0 -94.08 -27.16 16.42 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.348 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -64.29 127.95 92.68 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.924 -1.11 . . . . 0.0 109.996 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.75 -1.79 11.96 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.323 2.015 . . . . 0.0 112.003 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -84.41 15.04 3.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.902 -1.124 . . . . 0.0 109.547 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -57.55 -58.54 7.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.305 -0.872 . . . . 0.0 108.809 179.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.01 -33.91 77.16 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.304 -0.873 . . . . 0.0 109.164 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.88 -58.2 8.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.0 110.023 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.0 tp -61.0 -43.98 98.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.639 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.483 ' HE ' ' H ' ' A' ' 145' ' ' GLY . 23.2 mtp-105 -60.71 -31.34 70.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.646 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -66.99 -58.28 5.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.454 -0.779 . . . . 0.0 110.322 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -53.98 -35.04 61.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 109.268 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -87.57 -18.21 30.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.274 -0.891 . . . . 0.0 109.629 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 89' ' ' ARG . 39.0 tp -56.9 -37.06 70.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.155 -0.966 . . . . 0.0 109.912 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -54.15 134.1 44.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.143 -0.973 . . . . 0.0 109.441 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.553 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 0.9 OUTLIER -64.77 164.7 11.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.418 -0.801 . . . . 0.0 109.537 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.562 ' O ' HG23 ' A' ' 97' ' ' THR . 42.8 p-80 -170.38 -171.44 1.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.066 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 96' ' ' HIS . 8.7 p -159.04 131.97 7.02 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.626 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -100.39 155.84 17.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.482 ' H ' ' HB3' ' A' ' 162' ' ' TRP . . . -79.53 -7.22 88.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.407 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 44.6 mt-10 -125.56 171.83 10.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.33 -1.1 . . . . 0.0 109.515 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -72.2 142.97 49.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.345 -0.847 . . . . 0.0 110.141 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.606 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 2.6 tt0 -101.7 93.33 5.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 103' ' ' VAL . 34.5 m -92.38 127.88 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.41 0.624 . . . . 0.0 109.786 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -127.41 126.64 42.79 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.632 -0.667 . . . . 0.0 109.318 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.629 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 18.7 t80 -108.51 133.23 52.93 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.785 0.802 . . . . 0.0 109.153 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.49 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -88.05 127.59 35.4 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.476 0.655 . . . . 0.0 110.022 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.8 t -108.83 -35.17 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.644 -0.66 . . . . 0.0 109.624 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -160.31 146.6 15.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 0.0 109.339 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.3 165.92 35.41 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.41 154.02 39.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.501 -0.999 . . . . 0.0 109.591 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.59 -132.08 2.65 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.1 tp -147.08 161.93 39.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.333 -1.098 . . . . 0.0 109.32 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -134.58 88.9 2.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.88 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.479 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -80.54 110.16 15.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.536 -0.727 . . . . 0.0 109.642 179.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 114' ' ' CYS . 8.4 mp -117.31 114.77 24.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.195 -0.94 . . . . 0.0 109.38 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.6 t-160 -105.05 112.86 26.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.067 -1.021 . . . . 0.0 109.483 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.4 pt -129.57 115.51 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.238 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.99 -143.34 30.83 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 106.424 -2.671 . . . . 0.0 106.424 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -104.04 78.69 1.55 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 115.116 -2.634 . . . . 0.0 108.895 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.564 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 15.3 pt-20 -166.85 168.58 13.98 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.613 ' O ' HG23 ' A' ' 5' ' ' ILE . 38.6 t -128.84 151.46 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.257 -0.902 . . . . 0.0 109.949 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -129.12 131.99 47.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.612 . . . . 0.0 109.823 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -131.87 111.07 11.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 0.0 109.277 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.454 HG22 HD13 ' A' ' 3' ' ' LEU . 2.7 t -102.55 139.41 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.847 ' H ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.0 91.18 2.72 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.078 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 31.6 p -165.47 138.34 4.36 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.176 -1.577 . . . . 0.0 107.783 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -106.37 93.39 4.58 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 115.836 -2.345 . . . . 0.0 110.387 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.522 ' C ' ' H ' ' A' ' 130' ' ' ASP . 46.3 mtpt -114.7 154.57 28.22 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.917 176.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.629 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 89.7 m-20 -58.99 -3.03 0.29 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.479 -1.388 . . . . 0.0 107.778 177.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' A' ' 131' ' ' LEU . 7.3 t0 -70.58 148.57 48.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.066 -1.021 . . . . 0.0 109.314 -178.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.885 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -111.08 149.83 30.24 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.512 0.672 . . . . 0.0 110.545 -179.681 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.885 ' N ' HD12 ' A' ' 131' ' ' LEU . 29.5 mm -115.31 138.59 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.502 ' HG ' HD11 ' A' ' 131' ' ' LEU . 5.0 m -121.25 145.64 47.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.486 -0.759 . . . . 0.0 110.193 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.5 t -116.12 135.47 22.8 Favored Pre-proline 0 N--CA 1.485 1.308 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.55 147.96 94.04 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.147 1.898 . . . . 0.0 113.126 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.617 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -72.31 134.61 45.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.136 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.617 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 8.8 t-80 92.28 11.13 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.1 126.51 30.85 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.015 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.21 130.3 28.33 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.959 1.773 . . . . 0.0 111.648 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.551 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.37 165.86 14.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.197 -0.94 . . . . 0.0 110.196 -179.189 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.59 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -137.03 -149.58 0.32 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -178.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.429 ' CZ ' ' HG2' ' A' ' 144' ' ' MET . 11.5 t80 -175.61 125.27 0.23 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.934 -1.104 . . . . 0.0 109.018 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -143.81 135.17 25.89 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.373 -0.829 . . . . 0.0 109.942 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.642 ' O ' ' C ' ' A' ' 145' ' ' GLY . 52.1 mmm -113.38 21.29 15.34 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.886 -0.509 . . . . 0.0 110.852 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.642 ' C ' ' O ' ' A' ' 144' ' ' MET . . . -1.32 -74.21 0.0 OUTLIER Glycine 0 N--CA 1.503 3.151 0 CA-C-N 119.279 0.945 . . . . 0.0 111.407 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 144' ' ' MET . 22.9 t -91.4 115.49 28.08 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 117.671 -1.612 . . . . 0.0 109.171 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -119.23 116.81 33.64 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.41 -0.806 . . . . 0.0 110.164 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.2 Cg_endo -100.18 33.37 0.09 OUTLIER 'Trans proline' 0 C--O 1.213 -0.75 0 C-N-CA 122.56 2.173 . . . . 0.0 111.628 176.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.3 OUTLIER 79.8 68.39 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.521 -0.872 . . . . 0.0 108.721 -178.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.522 ' O ' ' OG ' ' A' ' 77' ' ' SER . 14.2 p90 -96.41 -179.5 4.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.307 -0.871 . . . . 0.0 109.37 -177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.612 HG21 ' CB ' ' A' ' 50' ' ' ALA . 87.1 m -149.15 100.35 3.04 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.629 -0.669 . . . . 0.0 109.574 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 75' ' ' VAL . . . -110.69 163.77 13.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.918 -1.114 . . . . 0.0 109.19 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.679 ' HA ' HG12 ' A' ' 75' ' ' VAL . 94.7 mt -107.25 127.29 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.13 -0.981 . . . . 0.0 110.222 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.87 162.49 32.25 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.419 0.628 . . . . 0.0 109.427 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.866 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.0 mp -106.78 149.46 10.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.522 -0.736 . . . . 0.0 109.369 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -96.87 118.95 34.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.583 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -135.72 162.19 33.44 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.695 -0.628 . . . . 0.0 109.569 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -95.87 157.42 35.92 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.97 -1.081 . . . . 0.0 109.33 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 161' ' ' GLY . 47.4 Cg_endo -71.77 -52.58 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.614 2.209 . . . . 0.0 112.395 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 159' ' ' PRO . 95.1 mt-10 -43.83 -16.53 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.475 -0.765 . . . . 0.0 109.381 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -70.26 -39.88 70.91 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.482 ' HB3' ' H ' ' A' ' 99' ' ' GLY . 2.7 p90 -119.05 177.26 4.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.761 -0.847 . . . . 0.0 110.617 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.9 mm -95.37 152.05 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.417 -0.802 . . . . 0.0 109.219 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.34 -74.0 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 110.575 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -131.11 157.01 44.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -101.1 -41.54 6.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.707 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 60.0 p -105.86 -32.35 8.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.931 . . . . 0.0 109.235 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.29 -4.15 60.21 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.545 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -80.46 145.81 31.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.773 -1.428 . . . . 0.0 108.957 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -110.32 89.22 2.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.776 -1.569 . . . . 0.0 111.402 176.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.461 HG23 ' CH2' ' A' ' 141' ' ' TRP . 1.5 tt -78.63 -17.92 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.525 -1.359 . . . . 0.0 109.167 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.59 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -57.59 -42.7 83.7 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.637 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 45.8 m -54.17 -4.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.391 -0.818 . . . . 0.0 109.985 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.04 -40.5 31.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.958 -1.089 . . . . 0.0 111.549 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.618 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 9.3 m-85 -112.23 25.59 0.08 OUTLIER Pre-proline 0 N--CA 1.511 2.619 0 O-C-N 120.707 -1.246 . . . . 0.0 112.495 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.637 ' HD3' ' C ' ' A' ' 173' ' ' SER . 43.6 Cg_endo -62.42 -21.03 72.19 Favored 'Trans proline' 0 N--CA 1.503 2.088 0 C-N-CA 123.588 2.859 . . . . 0.0 113.168 -172.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -89.45 127.07 35.8 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.157 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' C ' ' A' ' 179' ' ' ALA . 0.7 OUTLIER -85.91 145.68 27.05 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.638 ' O ' HG23 ' A' ' 19' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.538 ' N ' ' SG ' ' A' ' 126' ' ' CYS . . . -99.2 172.04 7.62 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.088 -1.045 . . . . 0.0 109.147 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.891 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 25.2 tp -157.05 114.26 3.09 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.26 130.69 55.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 110.72 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.477 HD13 ' CE1' ' A' ' 122' ' ' PHE . 64.9 mt -124.76 134.0 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.2 168.93 14.75 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t -92.18 175.75 6.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.058 -1.026 . . . . 0.0 108.306 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.95 -26.7 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.728 -1.232 . . . . 0.0 109.396 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -72.35 -38.54 68.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.175 -0.953 . . . . 0.0 110.57 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.489 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 9.1 m-20 -139.41 123.38 11.02 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 109.766 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.3 -27.84 1.33 Allowed 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.021 1.814 . . . . 0.0 112.52 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -69.79 -0.49 7.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.455 -0.778 . . . . 0.0 111.178 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 6.7 p-10 -123.08 126.13 46.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.079 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 p -97.84 128.49 44.49 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 108.748 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pp -90.13 -9.93 46.47 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.801 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.891 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 31.1 t90 -158.01 108.79 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.052 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -122.37 124.58 44.0 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.334 -0.854 . . . . 0.0 110.241 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.61 168.62 21.47 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.053 -1.029 . . . . 0.0 110.594 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 19' ' ' THR . 1.0 OUTLIER -127.99 88.35 2.75 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 176.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.7 ' O ' HD12 ' A' ' 24' ' ' ILE . 19.5 m120 -127.37 139.37 52.91 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.538 -0.726 . . . . 0.0 109.984 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.4 -36.13 24.52 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 119.676 -1.89 . . . . 0.0 108.675 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.35 -49.39 10.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.719 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.09 -22.94 67.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.875 -1.141 . . . . 0.0 108.128 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.74 HG12 HD22 ' A' ' 3' ' ' LEU . 1.7 mt -66.8 -50.32 66.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.444 ' O ' ' CB ' ' A' ' 29' ' ' ASN . 53.3 tt0 -56.2 -55.12 37.11 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.432 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.602 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 62.1 tt0 -56.66 -34.28 67.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.474 -0.766 . . . . 0.0 110.45 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.702 ' NE2' ' CE2' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -62.36 -65.13 0.73 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.912 -1.117 . . . . 0.0 109.656 -179.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.429 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -70.27 -46.97 63.29 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.662 -1.274 . . . . 0.0 109.677 179.04 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.626 ' ND2' ' O ' ' A' ' 33' ' ' VAL . 20.4 t-20 -57.0 -25.71 59.0 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.045 -1.035 . . . . 0.0 109.427 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -65.78 -28.08 68.76 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.76 -1.213 . . . . 0.0 107.762 177.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -87.58 14.6 8.03 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.975 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.91 23.38 35.63 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.434 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.626 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 56.7 t -94.53 144.73 9.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.226 -1.161 . . . . 0.0 109.89 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.7 ttt-85 -84.62 157.73 21.08 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.501 ' CZ ' ' OD2' ' A' ' 130' ' ' ASP . 1.3 t80 -155.22 153.68 31.04 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.3 pt-20 -175.81 176.45 1.84 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.042 -1.036 . . . . 0.0 110.102 177.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -154.31 121.8 5.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.394 -0.816 . . . . 0.0 109.065 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.611 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 33.2 m0 -111.28 154.98 23.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.405 -0.81 . . . . 0.0 109.033 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -142.23 155.13 45.24 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.284 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.31 159.68 14.77 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -98.38 -19.69 17.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.077 -1.014 . . . . 0.0 108.36 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -93.42 167.12 11.92 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -93.83 131.38 39.28 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.485 -0.759 . . . . 0.0 109.458 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mt -93.64 161.97 14.13 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.303 -0.873 . . . . 0.0 109.499 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.36 -96.3 0.11 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.78 107.09 8.84 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.344 -1.092 . . . . 0.0 108.15 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.97 90.02 46.56 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.638 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.57 46.3 1.71 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.819 2.346 . . . . 0.0 111.22 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.53 ' O ' ' OG1' ' A' ' 52' ' ' THR . 0.0 OUTLIER -169.27 139.9 2.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.556 -1.34 . . . . 0.0 108.978 178.061 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.09 -43.89 15.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.521 -1.362 . . . . 0.0 109.353 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -66.67 -4.32 8.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.59 -0.694 . . . . 0.0 110.335 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.53 ' OG1' ' O ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -77.77 -52.88 8.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.762 -1.211 . . . . 0.0 109.941 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.99 -44.67 84.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.112 -0.993 . . . . 0.0 110.253 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 58' ' ' GLN . 13.9 mm -60.3 -41.84 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.959 -1.088 . . . . 0.0 108.517 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.12 -22.87 66.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.445 -0.784 . . . . 0.0 109.89 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.1 -21.63 50.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.999 -1.063 . . . . 0.0 110.265 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.417 ' O ' ' C ' ' A' ' 58' ' ' GLN . 59.2 m-85 -115.5 -10.16 11.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.493 -0.754 . . . . 0.0 109.206 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.761 HE22 HD11 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -46.89 -34.06 5.11 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.395 -0.922 . . . . 0.0 108.942 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.641 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 26.5 p80 -51.74 -50.48 60.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.891 -1.13 . . . . 0.0 109.573 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.641 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -61.2 -60.96 2.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.914 -1.116 . . . . 0.0 109.72 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.761 HD11 HE22 ' A' ' 58' ' ' GLN . 0.5 OUTLIER -61.49 -27.58 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.393 -1.442 . . . . 0.0 109.55 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 58' ' ' GLN . 79.8 m-20 -59.24 -22.33 60.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.066 -1.021 . . . . 0.0 109.807 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 64' ' ' LEU . 3.3 pttp -83.0 -32.9 26.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.949 -1.094 . . . . 0.0 108.633 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.57 HD23 HG21 ' A' ' 103' ' ' VAL . 1.9 mp -65.53 -46.85 78.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.334 -0.854 . . . . 0.0 109.662 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.669 HG22 ' CZ3' ' A' ' 73' ' ' TRP . 0.9 OUTLIER -69.01 -27.74 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.549 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.32 -49.51 74.12 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.74 -1.225 . . . . 0.0 109.713 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.55 -51.74 7.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.028 -1.045 . . . . 0.0 110.54 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.629 ' O ' ' C ' ' A' ' 69' ' ' GLY . 2.1 mptp? -82.73 13.13 4.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.349 -0.844 . . . . 0.0 110.968 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -6.42 81.7 0.0 OUTLIER Glycine 0 N--CA 1.505 3.27 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.888 ' CG ' HG21 ' A' ' 155' ' ' ILE . 84.3 m-85 -75.16 159.95 31.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -1.071 . . . . 0.0 109.193 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.585 ' OE1' ' ND2' ' A' ' 158' ' ' ASN . 85.1 mt-30 -58.33 -41.83 85.46 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.456 -0.777 . . . . 0.0 109.861 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 t -147.21 155.41 42.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.938 -1.101 . . . . 0.0 110.847 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.669 ' CZ3' HG22 ' A' ' 65' ' ' VAL . 29.8 t-105 -129.5 133.34 47.21 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.472 ' CB ' ' CE1' ' A' ' 156' ' ' PHE . 0.4 OUTLIER -145.6 165.67 27.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.557 HG22 ' H ' ' A' ' 76' ' ' ILE . 3.1 p -97.98 174.8 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 O-C-N 121.308 -0.87 . . . . 0.0 109.084 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.557 ' H ' HG22 ' A' ' 75' ' ' VAL . 52.5 mt -109.51 118.11 56.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.4 p -92.58 160.33 15.08 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 123.11 1.433 . . . . 0.0 111.548 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.623 HD13 ' H ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -158.0 138.27 12.59 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.652 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.623 ' H ' HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -130.18 139.02 50.89 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 149' ' ' ASN . . . -76.94 0.4 21.2 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.898 -1.126 . . . . 0.0 110.743 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.488 ' H ' ' HD3' ' A' ' 79' ' ' ARG . 93.4 m-20 -111.11 -14.82 13.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 0.0 109.21 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.557 ' O ' ' OD1' ' A' ' 82' ' ' ASN . 44.7 p-10 -63.36 117.91 38.55 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.285 -0.884 . . . . 0.0 110.414 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -88.14 -13.99 3.52 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.35 2.033 . . . . 0.0 113.039 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -92.38 -11.09 35.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.032 -1.043 . . . . 0.0 110.611 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.699 ' CG ' HH12 ' A' ' 89' ' ' ARG . 20.1 tptt -62.54 -38.77 91.3 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.956 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -59.69 -44.2 93.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.834 . . . . 0.0 109.57 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.59 -38.63 66.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.024 -1.048 . . . . 0.0 109.483 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 49.6 mt -60.58 -36.43 78.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 0.0 109.026 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.699 HH12 ' CG ' ' A' ' 85' ' ' LYS . 0.9 OUTLIER -60.09 -30.53 69.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 109.318 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 93' ' ' LEU . 15.1 tt0 -64.47 -60.39 3.21 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.044 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -58.73 -30.94 67.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.15 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -83.41 -18.74 37.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 90' ' ' GLU . 2.5 mt -63.82 -25.31 68.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.066 -1.022 . . . . 0.0 110.012 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.419 ' N ' HD22 ' A' ' 94' ' ' ASN . 2.8 m120 -58.62 141.32 52.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 109.6 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -72.99 158.46 35.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 109.347 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -168.01 -168.96 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 110.788 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.9 133.64 6.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 109.11 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.683 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -106.43 154.32 20.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 0.0 109.738 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.21 -7.69 86.87 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -123.42 170.35 10.44 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.345 -1.091 . . . . 0.0 109.417 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -74.61 143.51 44.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.07 -1.019 . . . . 0.0 110.017 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.447 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 1.6 mt-10 -101.97 96.33 6.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.26 -0.9 . . . . 0.0 109.206 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.57 HG21 HD23 ' A' ' 64' ' ' LEU . 35.7 m -100.85 128.74 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.735 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.564 ' NE ' ' CZ ' ' A' ' 142' ' ' PHE . 6.6 mtm180 -128.9 134.58 48.31 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.611 ' CE2' ' CE3' ' A' ' 38' ' ' TRP . 66.0 t80 -112.99 131.53 55.72 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.77 0.795 . . . . 0.0 109.938 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.421 ' CG ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -87.18 125.8 34.4 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.359 0.599 . . . . 0.0 109.72 -179.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.89 -39.7 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.455 -0.778 . . . . 0.0 109.941 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -160.47 146.94 15.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.145 -0.972 . . . . 0.0 109.899 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.48 ' O ' ' OE1' ' A' ' 127' ' ' GLU . . . 87.89 164.18 39.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.72 160.59 26.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.513 -0.992 . . . . 0.0 109.664 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.22 -119.62 1.01 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.545 ' CD1' HD12 ' A' ' 125' ' ' LEU . 22.0 tp -148.31 163.33 37.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -1.106 . . . . 0.0 108.73 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.805 ' CD2' HG21 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -137.99 145.93 42.51 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.976 -1.078 . . . . 0.0 108.952 177.013 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.445 ' SG ' ' C ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -148.58 139.22 22.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.489 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.794 HD21 HG13 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -141.86 128.68 20.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.459 -0.776 . . . . 0.0 109.321 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.402 ' O ' HD13 ' A' ' 117' ' ' ILE . 2.2 t60 -103.3 111.56 24.02 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.178 -0.952 . . . . 0.0 109.18 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.459 HD11 HD12 ' A' ' 115' ' ' LEU . 51.9 mm -126.1 114.64 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.145 -0.972 . . . . 0.0 110.781 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.66 -142.42 29.93 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 104.422 -3.471 . . . . 0.0 104.422 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -109.92 82.95 1.67 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 115.296 -2.561 . . . . 0.0 107.675 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -165.46 168.33 16.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 83.4 t -131.13 150.03 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.123 -0.986 . . . . 0.0 109.418 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.477 ' CE1' HD13 ' A' ' 5' ' ' ILE . 7.1 m-85 -129.3 134.53 47.97 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.636 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -138.22 134.77 34.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.072 -1.018 . . . . 0.0 108.669 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.772 HG12 ' CD1' ' A' ' 113' ' ' PHE . 8.8 p -127.16 148.33 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.981 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.559 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 1.0 OUTLIER -123.72 75.16 1.32 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 118.193 -1.403 . . . . 0.0 110.732 179.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.559 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -162.29 119.7 2.1 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.48 ' OE1' ' O ' ' A' ' 109' ' ' GLY . 8.7 tm-20 -115.37 106.24 13.77 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 117.526 -1.67 . . . . 0.0 110.653 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.605 ' C ' ' H ' ' A' ' 130' ' ' ASP . 86.6 mttt -110.92 -178.96 3.61 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 38' ' ' TRP . 71.4 m-80 -58.48 0.47 0.08 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.605 ' H ' ' C ' ' A' ' 128' ' ' LYS . 21.0 t0 -71.71 143.43 49.65 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.723 -1.236 . . . . 0.0 110.451 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.921 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.2 OUTLIER -110.85 149.36 30.69 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.657 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.921 ' N ' HD12 ' A' ' 131' ' ' LEU . 26.2 mm -114.45 131.93 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.646 ' OG ' HD11 ' A' ' 131' ' ' LEU . 4.4 m -120.31 144.57 47.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.869 . . . . 0.0 110.116 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.794 HG13 HD21 ' A' ' 115' ' ' LEU . 1.7 t -117.14 134.43 23.04 Favored Pre-proline 0 N--CA 1.488 1.436 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.17 151.87 76.65 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.954 1.769 . . . . 0.0 112.284 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.612 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.86 133.04 46.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 109.686 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.612 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 3.7 t-160 92.76 10.27 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 120.964 0.412 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.36 125.92 32.91 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.12 -0.987 . . . . 0.0 108.461 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.52 131.96 31.57 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.622 1.548 . . . . 0.0 111.575 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.504 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -167.16 163.15 15.55 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.479 -179.062 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.677 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 26.5 p90 -128.65 -153.9 0.6 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.533 -0.729 . . . . 0.0 109.67 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.631 ' N ' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -172.92 124.0 0.43 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.505 -0.747 . . . . 0.0 109.214 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.472 ' OD1' HD11 ' A' ' 93' ' ' LEU . 29.9 t0 -147.96 131.91 17.16 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.147 -0.97 . . . . 0.0 109.453 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.606 ' O ' ' C ' ' A' ' 145' ' ' GLY . 7.4 mtm -111.76 20.02 17.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.273 -0.892 . . . . 0.0 110.815 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.606 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 11.02 -90.82 0.01 OUTLIER Glycine 0 N--CA 1.503 3.165 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.524 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 46.7 t -87.52 119.6 27.97 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.3 -1.36 . . . . 0.0 109.857 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.596 ' OE1' ' NE ' ' A' ' 89' ' ' ARG . 6.5 mp0 -114.08 120.11 39.31 Favored Pre-proline 0 N--CA 1.493 1.68 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.569 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 56.7 Cg_endo -100.32 28.88 0.12 Allowed 'Trans proline' 0 C--O 1.212 -0.806 0 C-N-CA 122.476 2.117 . . . . 0.0 112.753 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.621 ' ND2' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER 81.33 64.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.762 0.792 . . . . 0.0 110.16 -179.193 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.615 ' CZ ' HD23 ' A' ' 78' ' ' LEU . 15.2 p90 -101.6 171.06 7.78 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.577 0.703 . . . . 0.0 110.292 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 87.7 m -126.42 138.94 53.59 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.556 ' HB3' HD12 ' A' ' 76' ' ' ILE . . . -146.52 165.72 28.6 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.238 -0.914 . . . . 0.0 109.415 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 75.5 mt -118.09 136.66 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.386 -0.821 . . . . 0.0 109.746 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.518 ' HE ' HG12 ' A' ' 76' ' ' ILE . 2.7 mtm180 -140.15 168.01 20.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.021 -1.049 . . . . 0.0 109.653 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.888 HG21 ' CG ' ' A' ' 70' ' ' TYR . 3.9 mp -107.39 155.22 8.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.631 -0.668 . . . . 0.0 109.562 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 74' ' ' ASP . 3.2 m-30 -103.06 121.09 41.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.204 -0.935 . . . . 0.0 110.319 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 3.9 t0 -133.27 163.06 30.15 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.668 ' N ' ' ND2' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -93.41 161.9 29.43 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.102 -0.999 . . . . 0.0 109.285 -178.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 161' ' ' GLY . 38.3 Cg_endo -62.73 -55.01 0.96 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.237 1.958 . . . . 0.0 112.293 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 55.2 mp0 -44.41 -13.28 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.401 -0.812 . . . . 0.0 109.247 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -78.75 -33.94 36.25 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.534 ' N ' ' O ' ' A' ' 159' ' ' PRO . 4.5 p90 -118.8 159.32 23.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.381 -1.07 . . . . 0.0 110.825 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 81.7 mt -100.2 147.91 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.549 -0.719 . . . . 0.0 109.453 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.65 -73.25 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.5 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -140.9 159.47 42.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.944 -1.097 . . . . 0.0 109.883 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -89.69 -41.87 11.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 109.393 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 52.7 m -116.06 -31.39 5.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.305 -0.872 . . . . 0.0 108.696 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.63 -5.4 51.3 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.807 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -80.77 149.51 29.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.659 -1.495 . . . . 0.0 107.952 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -105.38 89.97 3.28 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 117.337 -1.745 . . . . 0.0 110.762 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.435 HG22 ' H ' ' A' ' 171' ' ' ILE . 0.2 OUTLIER -71.76 -30.11 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.95 -1.094 . . . . 0.0 109.417 -179.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.677 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -63.45 -41.33 98.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.332 -0.855 . . . . 0.0 108.851 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.546 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 15.7 t -51.9 -4.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 110.173 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -83.19 -34.03 26.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.09 -1.007 . . . . 0.0 110.901 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.591 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.1 m-85 -110.03 27.32 0.07 OUTLIER Pre-proline 0 N--CA 1.515 2.81 0 O-C-N 120.81 -1.181 . . . . 0.0 112.764 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 40.5 Cg_endo -58.97 -24.02 71.11 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 123.559 2.839 . . . . 0.0 114.511 -172.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -88.92 125.7 35.07 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 118.375 -1.33 . . . . 0.0 108.133 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' C ' ' A' ' 179' ' ' ALA . 5.0 tt -87.06 128.95 35.09 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.596 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.596 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.36 170.76 8.63 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.047 -1.033 . . . . 0.0 109.412 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.725 HD23 ' CZ3' ' A' ' 16' ' ' TRP . 29.3 tp -158.06 114.98 2.89 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 130.78 55.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.18 -0.95 . . . . 0.0 109.797 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 121' ' ' VAL . 71.5 mt -127.29 138.34 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 178.97 6.87 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.605 0.717 . . . . 0.0 109.444 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.1 t -96.05 174.62 6.83 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.38 -22.88 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.028 -1.045 . . . . 0.0 109.159 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -73.73 -37.76 65.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.148 -0.97 . . . . 0.0 110.512 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.458 ' OD2' ' N ' ' A' ' 10' ' ' ASP . 1.3 p30 -137.51 123.59 13.13 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.029 -1.045 . . . . 0.0 109.461 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -81.86 -38.4 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.944 1.763 . . . . 0.0 112.301 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.32 3.09 2.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 110.275 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -114.67 119.44 36.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.874 . . . . 0.0 109.089 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 p -100.21 122.77 43.55 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.192 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 pp -88.09 -8.97 54.7 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.054 -1.059 . . . . 0.0 108.991 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.725 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 38.7 t90 -157.7 107.69 2.17 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.315 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -120.4 121.86 39.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.409 -0.807 . . . . 0.0 110.026 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.405 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -163.15 164.45 25.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.439 -0.788 . . . . 0.0 109.999 -179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.866 HG23 ' O ' ' A' ' 19' ' ' THR . 10.7 t -130.86 88.83 2.66 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 118.955 -1.098 . . . . 0.0 108.16 175.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.749 ' O ' HD12 ' A' ' 24' ' ' ILE . 12.0 m120 -125.9 143.68 50.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.098 -1.001 . . . . 0.0 110.684 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.15 -39.62 22.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.342 -1.474 . . . . 0.0 108.664 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.21 -50.89 8.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 109.566 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.7 -21.58 60.81 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.879 -1.138 . . . . 0.0 108.559 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 20' ' ' ASN . 2.0 mt -70.05 -57.34 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.256 -0.902 . . . . 0.0 108.943 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.517 ' CG ' ' N ' ' A' ' 26' ' ' GLN . 8.7 pt20 -62.65 -44.94 94.99 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.941 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 25.9 mt-30 -59.88 -42.38 93.62 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.148 -0.97 . . . . 0.0 109.885 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.676 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 5.3 tt0 -80.24 -47.03 15.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.912 -1.118 . . . . 0.0 109.399 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.49 ' CD1' HG21 ' A' ' 33' ' ' VAL . 20.2 tp -66.14 -55.4 16.58 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.986 -1.071 . . . . 0.0 109.022 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 33' ' ' VAL . 41.2 t-20 -59.63 -19.78 51.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.911 -1.118 . . . . 0.0 109.471 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -65.15 -27.58 68.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.859 -1.151 . . . . 0.0 108.601 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -86.5 12.78 9.6 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.737 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.72 23.23 31.26 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.042 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.49 HG21 ' CD1' ' A' ' 28' ' ' LEU . 70.6 t -94.33 145.44 7.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.469 -1.018 . . . . 0.0 109.176 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -84.45 158.5 21.02 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.345 -0.847 . . . . 0.0 108.737 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.475 ' CE2' HD11 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -152.77 152.31 31.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.881 -1.137 . . . . 0.0 108.006 177.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 130' ' ' ASP . 3.4 mm-40 -170.77 169.4 6.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.909 -1.119 . . . . 0.0 109.21 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -150.55 118.58 6.29 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.503 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 23.4 m0 -111.17 150.32 29.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.863 . . . . 0.0 108.996 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -139.68 157.51 45.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.149 -0.969 . . . . 0.0 109.629 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.31 159.53 15.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.881 . . . . 0.0 108.968 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.47 ' OD2' ' N ' ' A' ' 42' ' ' ARG . 54.1 p30 -100.17 -9.94 21.96 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.47 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 15.8 ttm180 -93.48 150.69 20.25 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.3 117.88 30.03 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.536 -0.727 . . . . 0.0 109.261 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mt -93.28 165.63 12.71 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.32 -0.863 . . . . 0.0 109.383 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.39 -121.33 0.56 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.49 78.57 9.66 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.113 -1.228 . . . . 0.0 108.635 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.3 94.58 48.79 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.509 -0.744 . . . . 0.0 109.087 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.25 85.61 0.43 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.822 1.681 . . . . 0.0 111.646 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.28 109.02 0.64 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.265 -0.897 . . . . 0.0 109.276 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.25 -35.41 31.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.645 -1.284 . . . . 0.0 109.759 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 6.3 pt-20 -65.28 -20.78 66.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 110.155 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.9 m -79.83 -35.67 37.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.161 -0.962 . . . . 0.0 110.302 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.95 -46.51 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.957 . . . . 0.0 109.842 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -61.99 -42.18 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.935 . . . . 0.0 108.978 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.34 -29.75 70.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.399 -0.813 . . . . 0.0 109.702 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.12 -19.17 58.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 110.165 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -116.38 -9.0 11.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.794 . . . . 0.0 109.566 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 54' ' ' ILE . 4.8 mm-40 -49.65 -39.04 34.79 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.145 -0.972 . . . . 0.0 108.857 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.598 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 21.5 p80 -52.68 -45.03 66.64 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.427 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.598 ' N ' ' CG ' ' A' ' 59' ' ' HIS . . . -62.12 -59.65 4.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.906 -1.121 . . . . 0.0 110.015 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.699 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -63.42 -28.25 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.025 -1.047 . . . . 0.0 109.289 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 58' ' ' GLN . 23.2 t70 -58.35 -24.73 60.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.382 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -84.6 -41.63 16.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 109.978 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.477 HD21 HG21 ' A' ' 103' ' ' VAL . 2.3 tt -66.49 -46.27 76.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.388 -0.82 . . . . 0.0 109.751 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' GLY . 4.7 p -67.24 -30.11 48.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 109.283 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.41 -43.52 75.35 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.094 -1.004 . . . . 0.0 109.367 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -78.52 -52.21 8.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 0.0 109.832 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.64 ' O ' ' C ' ' A' ' 69' ' ' GLY . 45.0 mmtm -83.22 12.18 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.389 -0.82 . . . . 0.0 110.342 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.64 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -0.23 80.33 0.0 OUTLIER Glycine 0 N--CA 1.503 3.166 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.484 ' CG ' HG21 ' A' ' 155' ' ' ILE . 43.2 m-85 -77.27 166.36 23.29 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.375 -1.073 . . . . 0.0 108.461 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -57.24 -92.24 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.444 -0.785 . . . . 0.0 109.173 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.44 164.9 11.42 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.603 0.716 . . . . 0.0 110.177 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.506 ' CZ3' HD12 ' A' ' 155' ' ' ILE . 6.4 t-105 -136.2 140.61 43.67 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.427 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 0.8 OUTLIER -157.37 175.36 14.09 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.089 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -120.14 143.27 32.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 76' ' ' ILE . 4.3 tp -103.07 115.89 45.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 77' ' ' SER . 9.8 p -168.57 101.44 0.41 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.503 -0.748 . . . . 0.0 109.003 178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.662 HD23 ' CB ' ' A' ' 82' ' ' ASN . 9.9 tp -110.45 -179.49 3.78 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 119.564 -1.96 . . . . 0.0 107.751 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.56 ' C ' ' H ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -88.41 147.49 24.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.744 -1.223 . . . . 0.0 109.773 -178.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.423 ' H ' ' HD3' ' A' ' 79' ' ' ARG . . . -59.22 3.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.656 -0.652 . . . . 0.0 109.571 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 79' ' ' ARG . 84.6 m-20 -88.39 -25.52 22.65 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.624 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.662 ' CB ' HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -63.61 128.08 92.24 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 120.991 -1.068 . . . . 0.0 109.639 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -75.95 -6.49 17.46 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.211 1.941 . . . . 0.0 112.392 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -89.33 10.69 21.43 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.9 -1.125 . . . . 0.0 109.41 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.509 ' CG ' ' H ' ' A' ' 86' ' ' GLU . 2.4 pttm -56.77 -57.28 13.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 108.798 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.509 ' H ' ' CG ' ' A' ' 85' ' ' LYS . 84.1 tt0 -66.15 -40.02 90.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.207 -0.933 . . . . 0.0 109.798 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.31 90.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.692 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.2 mt -61.3 -46.93 88.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 110.203 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.61 -26.41 67.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.947 -1.095 . . . . 0.0 109.721 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -67.21 -59.3 3.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.453 -0.779 . . . . 0.0 110.375 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -57.9 -38.65 76.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.97 . . . . 0.0 109.534 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -74.59 -24.21 58.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.719 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.439 HD21 ' N ' ' A' ' 173' ' ' SER . 1.5 tt -64.18 -33.98 77.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 109.997 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.473 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 44.0 p-10 -43.09 148.68 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 109.709 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.565 ' OE2' ' N ' ' A' ' 171' ' ' ILE . 77.5 mt-10 -85.24 157.44 20.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.334 -0.854 . . . . 0.0 109.626 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -174.38 -165.72 0.23 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.011 -1.056 . . . . 0.0 111.488 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.83 131.8 3.02 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.603 ' CD2' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -101.63 155.3 18.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 109.955 -178.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.86 -5.92 86.89 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' A' ' 101' ' ' ASP . 22.6 tp10 -126.57 169.26 13.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -1.07 . . . . 0.0 109.304 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.447 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 89.4 m-20 -70.06 143.42 52.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.245 -0.91 . . . . 0.0 110.06 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.603 ' OE2' ' CD2' ' A' ' 98' ' ' HIS . 2.7 tt0 -102.52 95.05 5.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 110.195 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.535 HG12 ' OG ' ' A' ' 133' ' ' SER . 18.0 m -94.64 125.52 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.31 126.03 38.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.503 ' CE2' ' CE3' ' A' ' 38' ' ' TRP . 42.3 t80 -101.92 126.89 48.93 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.492 ' CD1' ' HB2' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -89.61 134.24 34.23 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.618 -0.676 . . . . 0.0 110.39 -178.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.2 -25.9 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.814 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' A' ' 109' ' ' GLY . 74.3 tt0 -172.36 163.94 5.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.008 -1.057 . . . . 0.0 108.895 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.619 ' N ' ' OE1' ' A' ' 127' ' ' GLU . . . 43.78 104.61 0.01 OUTLIER Glycine 0 N--CA 1.495 2.569 0 O-C-N 121.104 -0.998 . . . . 0.0 110.792 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.492 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . . . -149.79 111.08 4.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.671 -1.488 . . . . 0.0 109.105 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.48 ' C ' HD12 ' A' ' 125' ' ' LEU . . . -78.51 -140.89 1.78 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -109.9 100.97 9.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.415 -1.05 . . . . 0.0 111.775 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.493 ' C ' ' OE1' ' A' ' 123' ' ' GLN . 30.8 p90 -79.82 128.62 33.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.61 -1.306 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.462 ' SG ' ' NE1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -78.91 143.71 35.58 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.318 0.58 . . . . 0.0 109.939 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.544 HD11 HG21 ' A' ' 134' ' ' VAL . 4.7 tp -131.38 124.73 30.95 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.2 t-160 -102.43 103.48 13.88 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.927 -1.108 . . . . 0.0 110.012 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.624 ' H ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -115.93 105.92 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.203 -0.936 . . . . 0.0 109.889 -179.152 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.54 -144.24 32.59 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 105.293 -3.123 . . . . 0.0 105.293 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.521 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 41.5 p30 -102.11 79.36 1.87 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 115.225 -2.59 . . . . 0.0 109.589 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.527 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 15.0 tp10 -165.76 170.68 13.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.666 ' O ' HG23 ' A' ' 5' ' ' ILE . 55.8 t -127.74 141.94 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.12 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.474 ' CE1' HD13 ' A' ' 5' ' ' ILE . 22.1 m-85 -128.49 132.32 48.36 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.808 -0.557 . . . . 0.0 109.788 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.493 ' OE1' ' C ' ' A' ' 113' ' ' PHE . 11.2 mm-40 -128.73 112.98 14.78 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 2.4 t -100.54 134.99 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.535 ' C ' ' SG ' ' A' ' 126' ' ' CYS . 54.5 tp -126.54 86.05 2.46 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.543 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.535 ' SG ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -168.2 137.51 2.45 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.619 ' OE1' ' N ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -104.67 99.42 9.09 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 116.119 -2.232 . . . . 0.0 109.792 -179.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.578 ' C ' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -119.38 159.53 24.01 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.988 176.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.491 HD22 ' C ' ' A' ' 129' ' ' ASN . 0.4 OUTLIER -60.68 2.67 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.002 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.578 ' H ' ' C ' ' A' ' 128' ' ' LYS . 9.6 t70 -66.45 135.3 54.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.86 -1.15 . . . . 0.0 110.353 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.777 HD13 ' N ' ' A' ' 132' ' ' ILE . 1.4 tm? -92.37 125.11 36.88 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.748 -177.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.777 ' N ' HD13 ' A' ' 131' ' ' LEU . 1.0 OUTLIER -108.33 127.62 64.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.535 ' OG ' HG12 ' A' ' 103' ' ' VAL . 5.2 t -120.69 144.15 48.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.451 -0.781 . . . . 0.0 109.673 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.544 HG21 HD11 ' A' ' 115' ' ' LEU . 1.1 t -119.13 142.18 31.72 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.39 147.16 70.92 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.343 2.029 . . . . 0.0 113.051 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.614 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -71.8 134.15 45.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 109.375 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.614 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 2.2 t-80 92.32 11.02 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.68 128.13 27.49 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.117 -0.99 . . . . 0.0 108.797 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.49 132.38 33.13 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.751 1.634 . . . . 0.0 111.53 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -169.55 164.72 10.39 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.199 -179.182 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.48 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.4 OUTLIER -136.66 -149.14 0.31 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.195 -0.941 . . . . 0.0 109.597 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -173.61 124.1 0.37 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.997 -1.064 . . . . 0.0 109.018 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -137.66 129.99 29.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.55 -0.719 . . . . 0.0 109.525 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.612 ' SD ' ' CE2' ' A' ' 150' ' ' PHE . 60.5 mtm -100.61 16.97 23.04 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.764 -0.585 . . . . 0.0 111.312 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 32.64 -125.92 0.29 Allowed Glycine 0 N--CA 1.49 2.287 0 O-C-N 120.636 -1.29 . . . . 0.0 110.537 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.597 ' CB ' HD22 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -81.7 121.37 26.29 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.099 -1.441 . . . . 0.0 108.624 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.89 115.58 45.85 Favored Pre-proline 0 N--CA 1.492 1.636 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.355 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 60.3 Cg_endo -103.69 50.34 0.03 OUTLIER 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 122.957 2.438 . . . . 0.0 110.742 176.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 148' ' ' PRO . 0.2 OUTLIER 81.85 70.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.132 -177.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.612 ' CE2' ' SD ' ' A' ' 144' ' ' MET . 20.5 p90 -96.24 163.13 13.22 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.274 -0.891 . . . . 0.0 110.167 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 21.9 m -128.81 124.5 35.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.469 -0.769 . . . . 0.0 110.533 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.562 ' HB3' ' CG2' ' A' ' 76' ' ' ILE . . . -141.97 160.75 39.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.501 -0.749 . . . . 0.0 109.012 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.505 HG23 ' HE1' ' A' ' 73' ' ' TRP . 79.6 mt -111.14 129.24 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.182 -0.949 . . . . 0.0 109.247 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.643 ' C ' HD13 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -135.29 165.09 26.24 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.643 HD13 ' C ' ' A' ' 154' ' ' ARG . 0.6 OUTLIER -107.59 152.66 9.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.49 -0.756 . . . . 0.0 109.381 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.427 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.8 m-30 -96.77 119.63 35.61 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.0 0.905 . . . . 0.0 109.892 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 53.5 p30 -134.99 163.84 28.95 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.564 ' ND2' ' H ' ' A' ' 161' ' ' GLY . 0.0 OUTLIER -94.03 161.54 29.48 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.982 -1.073 . . . . 0.0 109.075 -179.259 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.63 ' O ' ' N ' ' A' ' 161' ' ' GLY . 40.7 Cg_endo -63.77 -55.45 0.67 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.013 1.809 . . . . 0.0 112.045 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 159' ' ' PRO . 94.4 mt-10 -43.77 -14.38 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.369 -0.832 . . . . 0.0 109.197 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -75.93 -40.52 30.29 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.507 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 4.1 p90 -108.83 159.56 16.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 79.2 mt -100.67 147.42 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.402 -0.811 . . . . 0.0 109.509 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -49.2 -74.11 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.263 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.29 161.47 38.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.111 -0.993 . . . . 0.0 109.804 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -88.19 -41.62 12.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.028 -1.045 . . . . 0.0 109.546 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 63.4 p -112.48 -31.89 6.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.293 -0.879 . . . . 0.0 108.877 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.91 -8.02 53.61 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -80.04 145.92 32.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.624 -1.515 . . . . 0.0 108.039 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -112.36 89.81 3.17 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.316 -1.354 . . . . 0.0 110.872 176.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.565 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -83.21 -20.12 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.049 -1.657 . . . . 0.0 109.284 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -56.77 -43.82 81.18 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.445 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 47.6 t -56.25 -1.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 109.648 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -87.93 -18.62 28.73 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.382 -0.824 . . . . 0.0 110.842 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.573 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 54.2 m-85 -108.45 27.41 0.07 OUTLIER Pre-proline 0 N--CA 1.518 2.952 0 O-C-N 121.187 -0.946 . . . . 0.0 112.83 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 42.1 Cg_endo -60.86 -5.57 4.86 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 123.916 3.077 . . . . 0.0 113.453 -173.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -84.62 148.94 26.18 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.3 -0.875 . . . . 0.0 109.149 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.747 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 15.9 tp -89.34 101.18 13.85 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.829 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.905 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.619 ' O ' ' OG1' ' A' ' 19' ' ' THR . 7.9 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.2 169.96 9.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.126 -0.983 . . . . 0.0 109.214 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 4' ' ' THR . 2.7 tp -157.24 118.96 3.74 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.534 ' N ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -109.79 133.88 52.66 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.179 -0.95 . . . . 0.0 109.795 -178.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.769 HG23 ' O ' ' A' ' 121' ' ' VAL . 52.9 mt -127.5 136.08 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.58 166.19 20.22 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.409 ' OG ' ' CD1' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -86.75 174.27 8.93 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 108.796 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.33 -28.31 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.03 -1.044 . . . . 0.0 109.117 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -73.54 -36.91 65.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.28 124.97 15.41 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 109.552 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.82 -37.82 0.31 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.935 1.757 . . . . 0.0 112.407 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.45 ' C ' HD22 ' A' ' 13' ' ' ASN . 1.6 tt0 -69.46 6.26 1.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.093 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.659 ' N ' HD22 ' A' ' 13' ' ' ASN . 0.9 OUTLIER -114.03 120.32 40.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.908 . . . . 0.0 109.055 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.5 p -100.29 122.01 42.4 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.365 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.409 ' CD1' ' OG ' ' A' ' 7' ' ' SER . 7.1 mt -88.9 -7.52 55.94 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.064 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.673 ' HB3' HD12 ' A' ' 5' ' ' ILE . 48.3 t90 -157.46 105.95 2.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.421 -1.312 . . . . 0.0 109.9 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -117.82 111.11 18.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.329 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.436 ' CB ' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -162.47 162.85 27.7 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.868 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.837 HG23 ' O ' ' A' ' 19' ' ' THR . 10.0 t -131.71 90.28 2.82 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 120.966 -1.084 . . . . 0.0 108.181 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.759 ' O ' HD12 ' A' ' 24' ' ' ILE . 1.7 m-80 -124.55 143.47 50.67 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.285 -0.884 . . . . 0.0 110.442 177.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.75 -40.88 22.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.012 -1.68 . . . . 0.0 108.536 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.28 -48.41 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 110.021 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -60.62 -23.95 65.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.969 -1.082 . . . . 0.0 108.698 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.759 HD12 ' O ' ' A' ' 20' ' ' ASN . 10.9 mt -72.63 -53.68 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.234 -0.916 . . . . 0.0 108.83 178.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 29' ' ' ASN . 52.0 tt0 -59.09 -52.87 63.85 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.141 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.656 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 1.0 OUTLIER -59.75 -40.14 87.16 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.28 -0.888 . . . . 0.0 109.64 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.644 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 7.0 tt0 -78.1 -50.21 12.46 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.933 -1.104 . . . . 0.0 109.579 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 24' ' ' ILE . 22.6 tp -69.03 -55.87 9.49 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.7 -1.25 . . . . 0.0 109.268 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 25' ' ' GLN . 26.2 t-20 -56.82 -20.89 25.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.876 -1.14 . . . . 0.0 109.448 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -66.54 -26.37 67.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.889 -1.132 . . . . 0.0 108.374 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 10.63 15.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.296 -0.877 . . . . 0.0 109.695 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.06 21.89 26.69 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.4 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 38.6 t -94.31 146.26 6.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.193 -1.18 . . . . 0.0 108.958 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.448 HH12 ' NZ ' ' A' ' 68' ' ' LYS . 13.4 ttm180 -84.12 157.24 21.78 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.438 ' C ' ' OE1' ' A' ' 36' ' ' GLU . 1.2 t80 -154.98 153.66 31.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.83 -1.169 . . . . 0.0 108.729 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.438 ' OE1' ' C ' ' A' ' 35' ' ' PHE . 1.5 pm0 -175.63 173.21 2.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.861 -1.149 . . . . 0.0 109.837 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -148.82 112.94 5.2 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.642 ' CE3' ' CE2' ' A' ' 105' ' ' PHE . 23.9 m0 -111.48 149.76 30.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 38' ' ' TRP . 84.0 mm-40 -138.09 157.87 45.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.776 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.22 158.79 15.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 108.937 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -101.34 -12.98 18.21 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -92.94 158.34 15.87 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.652 0.739 . . . . 0.0 109.051 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -93.0 119.29 32.1 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.615 -0.678 . . . . 0.0 109.507 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.34 164.0 14.01 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.381 -0.824 . . . . 0.0 109.278 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.72 -103.94 0.2 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.0 88.64 4.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.115 -1.226 . . . . 0.0 109.264 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.54 92.92 17.81 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.482 -0.761 . . . . 0.0 109.005 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.54 -28.2 10.26 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.151 1.901 . . . . 0.0 112.574 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 50.1 p -119.86 140.94 50.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.649 -0.657 . . . . 0.0 109.877 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.655 ' CB ' HG21 ' A' ' 151' ' ' THR . . . -81.0 -17.28 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 109.593 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -46.61 -37.53 8.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.33 -0.856 . . . . 0.0 109.119 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.5 p -78.81 -31.12 45.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 0.0 109.338 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 107' ' ' VAL . 25.1 t -69.11 -48.87 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.86 . . . . 0.0 109.818 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 58' ' ' GLN . 6.6 mt -59.65 -39.3 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 109.017 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.51 -31.0 71.69 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.434 -0.791 . . . . 0.0 109.657 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.22 -17.79 60.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 0.0 110.042 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -113.98 -6.8 13.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.448 -0.783 . . . . 0.0 109.307 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.661 HE22 HD11 ' A' ' 61' ' ' ILE . 1.1 mm-40 -48.64 -39.48 24.35 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.305 -0.958 . . . . 0.0 108.993 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 60' ' ' ALA . 35.6 p80 -52.08 -46.78 65.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.039 -1.038 . . . . 0.0 109.652 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.584 ' N ' ' ND1' ' A' ' 59' ' ' HIS . . . -62.49 -61.6 2.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.917 -1.114 . . . . 0.0 109.849 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.683 ' C ' HD12 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -61.16 -29.45 45.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.749 -1.22 . . . . 0.0 109.187 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 58' ' ' GLN . 33.2 t0 -58.1 -26.12 62.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 109.521 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.33 -39.41 59.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.127 -0.983 . . . . 0.0 109.236 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.2 mp -63.75 -36.75 84.92 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.268 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 61' ' ' ILE . 2.8 t -70.41 -29.5 39.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.304 -0.872 . . . . 0.0 109.339 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.4 -53.82 51.43 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.488 -1.383 . . . . 0.0 109.392 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -82.64 -50.37 8.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.964 -1.085 . . . . 0.0 110.785 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.582 ' O ' ' C ' ' A' ' 69' ' ' GLY . 70.9 mttt -86.26 14.0 7.18 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.387 -0.821 . . . . 0.0 110.858 -177.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.582 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . -15.34 88.97 0.01 OUTLIER Glycine 0 N--CA 1.502 3.068 0 CA-C-O 122.195 0.886 . . . . 0.0 111.731 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.785 ' CG ' HG21 ' A' ' 155' ' ' ILE . 84.0 m-85 -77.69 162.3 27.1 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -58.55 -81.7 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 108.742 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.1 m -103.26 157.52 16.96 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.466 -0.771 . . . . 0.0 109.599 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.672 ' CE2' HD13 ' A' ' 61' ' ' ILE . 11.0 t-105 -141.27 146.44 36.8 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.469 ' N ' ' CD1' ' A' ' 73' ' ' TRP . 0.3 OUTLIER -177.44 -165.22 0.1 Allowed 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 153' ' ' ILE . 3.2 m -122.58 165.54 18.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.398 -0.814 . . . . 0.0 109.222 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -95.48 140.69 16.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.589 ' O ' HD22 ' A' ' 78' ' ' LEU . 58.8 p -91.68 162.38 14.51 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.049 1.404 . . . . 0.0 112.248 -176.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -158.85 118.48 3.1 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 113.49 -1.687 . . . . 0.0 112.41 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -131.7 139.54 49.05 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.39 -18.3 65.28 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.761 -1.212 . . . . 0.0 109.5 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -104.74 31.77 4.54 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.659 HD22 ' H ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -92.58 125.4 55.93 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.019 -1.05 . . . . 0.0 110.619 178.332 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -78.2 -7.6 16.19 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.997 1.798 . . . . 0.0 112.268 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -90.81 0.93 57.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.978 -1.076 . . . . 0.0 110.024 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.518 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 11.5 ptmm? -58.05 -51.29 70.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.183 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.518 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 49.7 tp10 -62.84 -56.61 15.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.093 -1.004 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.92 -44.6 78.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.404 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.4 -42.25 98.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.309 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.49 ' HG2' ' H ' ' A' ' 144' ' ' MET . 43.3 mtp180 -60.75 -40.69 93.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.725 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -66.7 -58.31 5.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.368 -0.833 . . . . 0.0 110.511 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -53.37 -34.41 57.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.611 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -88.14 -17.66 30.47 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 110.213 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 176' ' ' PRO . 6.0 tp -61.36 -38.23 86.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.866 -1.146 . . . . 0.0 109.97 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 94' ' ' ASN . 40.2 p-10 -54.81 131.11 43.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 0.0 110.148 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.49 ' OE2' ' N ' ' A' ' 96' ' ' HIS . 1.7 pp20? -71.55 165.55 23.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.389 -0.819 . . . . 0.0 109.339 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.49 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 38.3 p-80 -175.13 -165.22 0.17 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.294 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.84 135.66 4.83 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.67 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.37 154.98 21.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -0.835 . . . . 0.0 109.676 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.52 -6.98 85.19 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.515 ' C ' ' HB2' ' A' ' 136' ' ' ALA . 84.9 tt0 -125.93 169.13 13.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.243 -1.151 . . . . 0.0 108.988 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.433 ' N ' ' HG2' ' A' ' 100' ' ' GLU . 90.3 m-20 -74.47 144.06 44.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.859 -1.151 . . . . 0.0 110.613 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.415 ' HG3' ' CE1' ' A' ' 98' ' ' HIS . 2.3 mt-10 -100.88 91.64 4.68 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.68 HG12 ' OG ' ' A' ' 133' ' ' SER . 6.4 m -84.63 131.31 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -130.62 112.74 13.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.758 -0.589 . . . . 0.0 109.513 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.65 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 17.3 t80 -101.25 135.87 42.02 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.606 ' O ' ' CE1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -92.17 133.66 35.58 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.465 -0.772 . . . . 0.0 110.118 -178.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -112.33 -36.72 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.268 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -156.56 143.24 18.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.939 -1.1 . . . . 0.0 109.919 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.43 170.67 40.08 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.56 -170.15 1.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.228 -1.16 . . . . 0.0 109.485 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.53 -138.22 2.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.7 tp -142.71 159.67 41.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.19 -1.182 . . . . 0.0 109.168 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -134.98 86.94 2.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 109.485 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.817 ' O ' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -80.94 120.24 24.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.875 . . . . 0.0 109.511 178.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.817 HD23 ' O ' ' A' ' 114' ' ' CYS . 2.2 mt -132.64 124.34 28.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.2 -0.937 . . . . 0.0 109.032 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 9.6 t-160 -108.3 114.54 28.48 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.943 -1.098 . . . . 0.0 108.985 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.3 mt -127.79 116.45 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.593 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.14 -143.5 33.29 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 105.916 -2.874 . . . . 0.0 105.916 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -105.57 79.11 1.42 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 115.578 -2.449 . . . . 0.0 108.474 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.5 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 31.5 tt0 -166.08 168.66 15.29 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 5' ' ' ILE . 41.9 t -126.37 140.91 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.997 -1.065 . . . . 0.0 110.227 177.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -120.48 130.38 54.26 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.191 0.519 . . . . 0.0 110.249 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.496 ' O ' HD12 ' A' ' 3' ' ' LEU . 19.0 mt-30 -131.08 112.58 13.01 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.496 -0.752 . . . . 0.0 109.107 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.79 137.81 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 125' ' ' LEU . 1.6 mp -136.54 93.08 2.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.203 -0.936 . . . . 0.0 110.146 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 1' ' ' SER . 44.0 t -165.96 138.49 4.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.545 -1.347 . . . . 0.0 108.195 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.66 94.37 5.16 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 115.779 -2.368 . . . . 0.0 110.759 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.585 ' C ' ' H ' ' A' ' 130' ' ' ASP . 32.6 mtmt -116.18 150.38 37.56 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.585 176.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.712 ' N ' HD22 ' A' ' 129' ' ' ASN . 0.6 OUTLIER -59.72 -1.95 0.32 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.414 -1.428 . . . . 0.0 107.695 177.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' A' ' 128' ' ' LYS . 57.0 p30 -68.47 146.13 53.44 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.069 0.937 . . . . 0.0 109.927 -176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.037 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -105.15 140.24 38.62 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.576 0.703 . . . . 0.0 109.962 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 1.037 ' N ' HD12 ' A' ' 131' ' ' LEU . 14.1 tt -128.8 120.6 52.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.68 ' OG ' HG12 ' A' ' 103' ' ' VAL . 8.1 t -118.59 142.99 47.09 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.57 HG11 HD22 ' A' ' 115' ' ' LEU . 12.4 m -99.19 148.57 34.81 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.751 ' O ' HG22 ' A' ' 138' ' ' THR . 38.6 Cg_endo -66.9 153.48 77.77 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.436 2.091 . . . . 0.0 113.355 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.613 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -74.81 136.64 41.62 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.173 -0.954 . . . . 0.0 109.188 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.613 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 13.2 t-80 94.14 10.94 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.751 HG22 ' O ' ' A' ' 135' ' ' PRO . 12.2 t -106.42 127.16 28.75 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.948 -1.095 . . . . 0.0 109.021 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.15 134.4 48.93 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.829 1.686 . . . . 0.0 111.752 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.515 ' CD2' ' C ' ' A' ' 140' ' ' HIS . 0.0 OUTLIER -171.78 162.15 6.12 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.972 -179.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.492 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -134.11 -148.67 0.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.222 -0.923 . . . . 0.0 109.446 -178.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -175.06 126.6 0.27 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.038 -1.039 . . . . 0.0 109.094 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.499 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 52.5 p-10 -146.88 138.05 24.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.328 -0.858 . . . . 0.0 109.75 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.613 ' O ' ' C ' ' A' ' 145' ' ' GLY . 6.6 mmt -107.06 19.43 20.44 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.339 -0.851 . . . . 0.0 111.791 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.613 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 2.22 -88.1 0.0 OUTLIER Glycine 0 N--CA 1.506 3.31 0 CA-C-N 119.5 1.046 . . . . 0.0 111.714 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.484 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 69.2 m -85.52 121.32 28.05 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.119 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.599 ' OE2' ' ND2' ' A' ' 82' ' ' ASN . 40.1 mt-10 -103.25 119.64 54.53 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.589 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 56.1 Cg_endo -104.22 0.89 0.28 Allowed 'Trans proline' 0 C--O 1.207 -1.072 0 C-N-CA 123.844 3.029 . . . . 0.0 110.964 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.626 ' ND2' ' O ' ' A' ' 149' ' ' ASN . 0.1 OUTLIER 83.87 63.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 123.489 1.614 . . . . 0.0 110.424 -179.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.435 ' CE1' ' HG ' ' A' ' 78' ' ' LEU . 8.8 p90 -100.88 178.48 4.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.575 -1.328 . . . . 0.0 109.528 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.655 HG21 ' CB ' ' A' ' 50' ' ' ALA . 85.7 m -133.43 139.32 46.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.478 -0.764 . . . . 0.0 109.465 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 76' ' ' ILE . . . -141.23 161.69 37.28 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.853 -1.155 . . . . 0.0 109.721 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.76 ' HA ' HG12 ' A' ' 75' ' ' VAL . 64.4 mt -108.36 127.58 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.017 -1.052 . . . . 0.0 110.195 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -138.96 167.06 22.89 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.427 -0.796 . . . . 0.0 109.905 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.785 HG21 ' CG ' ' A' ' 70' ' ' TYR . 2.9 mt -101.76 147.24 8.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.449 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 3.6 m-85 -96.48 118.3 32.7 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.347 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.605 ' CG ' ' HE1' ' A' ' 162' ' ' TRP . 14.4 p30 -136.17 161.75 34.86 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.826 -0.546 . . . . 0.0 109.575 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -95.71 161.39 27.75 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 120.871 -1.143 . . . . 0.0 109.332 -179.333 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.615 ' O ' ' N ' ' A' ' 162' ' ' TRP . 42.0 Cg_endo -65.6 -53.91 0.68 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.372 2.048 . . . . 0.0 112.034 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 159' ' ' PRO . 49.7 tp10 -43.48 -16.25 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.328 -0.857 . . . . 0.0 109.177 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -86.0 -23.07 46.72 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.615 ' N ' ' O ' ' A' ' 159' ' ' PRO . 20.3 m95 -116.5 165.94 12.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.339 -1.095 . . . . 0.0 109.926 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 35.2 pt -102.46 153.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.212 -0.93 . . . . 0.0 109.284 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.94 -73.64 0.3 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.137 -0.977 . . . . 0.0 110.292 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -141.18 159.01 43.11 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.083 -1.011 . . . . 0.0 109.662 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -101.24 -41.07 6.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.11 -0.994 . . . . 0.0 109.589 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 58.4 p -101.47 -30.31 11.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.081 -1.012 . . . . 0.0 109.443 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.3 -4.03 62.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -79.41 147.64 32.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.829 -1.395 . . . . 0.0 108.361 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 170' ' ' ASP . 37.5 p30 -110.65 87.64 2.58 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 117.949 -1.501 . . . . 0.0 111.021 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.46 ' H ' HG22 ' A' ' 171' ' ' ILE . 1.7 tt -76.26 -17.26 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.321 -1.487 . . . . 0.0 109.312 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.492 ' HB2' ' CG ' ' A' ' 141' ' ' TRP . . . -59.79 -41.86 92.09 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.799 -0.76 . . . . 0.0 108.952 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.63 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 24.1 t -52.7 -4.64 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.429 -0.794 . . . . 0.0 110.391 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.485 ' HB3' ' CE2' ' A' ' 175' ' ' TYR . . . -79.49 -40.37 29.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.783 -1.198 . . . . 0.0 111.514 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.632 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 6.1 m-85 -113.37 25.49 0.09 OUTLIER Pre-proline 0 N--CA 1.516 2.851 0 O-C-N 120.5 -1.375 . . . . 0.0 112.297 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.743 ' HB3' HD11 ' A' ' 93' ' ' LEU . 44.7 Cg_endo -60.91 -20.41 66.75 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 123.792 2.995 . . . . 0.0 114.06 -172.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -89.61 126.46 35.63 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.554 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 179' ' ' ALA . 5.3 tt -87.27 122.36 30.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.045 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.668 ' N ' HD23 ' A' ' 178' ' ' LEU . . . . . . . . 0 C--N 1.299 -1.598 0 O-C-N 121.01 -1.056 . . . . 0.0 109.503 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.558 ' O ' ' OG1' ' A' ' 19' ' ' THR . 85.0 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.39 172.51 7.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.262 -0.899 . . . . 0.0 109.203 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.817 ' CD1' HG22 ' A' ' 124' ' ' VAL . 34.8 tp -158.71 114.08 2.59 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 123' ' ' GLN . 0.1 OUTLIER -106.34 128.52 54.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.959 -1.088 . . . . 0.0 110.535 -178.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.523 HD12 ' CE3' ' A' ' 16' ' ' TRP . 58.1 mt -122.57 130.47 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.453 ' CD2' ' O ' ' A' ' 11' ' ' PRO . 78.0 m-85 -129.7 167.0 18.68 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.9 m -89.86 173.65 8.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.952 -1.093 . . . . 0.0 108.706 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 8' ' ' VAL . 2.0 m -89.3 -28.25 5.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.029 -1.044 . . . . 0.0 109.495 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -72.14 -39.57 68.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 110.488 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -138.48 124.6 12.67 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.89 -1.132 . . . . 0.0 109.563 179.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 55.9 Cg_endo -81.89 -31.52 1.02 Allowed 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.727 1.618 . . . . 0.0 112.193 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.84 1.07 4.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.415 -0.803 . . . . 0.0 110.444 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.37 118.78 32.09 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 p -96.82 127.13 42.5 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.055 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pp -89.93 -13.5 36.14 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.808 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.793 ' CZ3' HD23 ' A' ' 3' ' ' LEU . 53.9 t90 -158.72 106.77 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.412 -1.315 . . . . 0.0 109.713 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -120.14 119.97 34.85 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.287 -0.883 . . . . 0.0 109.835 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.412 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -161.66 165.44 28.24 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.32 -0.863 . . . . 0.0 110.094 -179.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 19' ' ' THR . 7.9 t -130.11 89.6 2.82 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.182 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.766 ' O ' HD12 ' A' ' 24' ' ' ILE . 20.4 m120 -125.12 137.37 54.17 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.707 -0.62 . . . . 0.0 110.181 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.8 -35.04 29.94 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.152 -1.593 . . . . 0.0 108.76 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.1 mp0 -82.92 -51.11 7.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.268 -0.895 . . . . 0.0 109.275 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.483 ' OE2' ' OD1' ' A' ' 20' ' ' ASN . 1.3 tt0 -61.17 -18.49 58.42 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.766 HD12 ' O ' ' A' ' 20' ' ' ASN . 1.9 mt -72.85 -58.4 5.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.144 -0.973 . . . . 0.0 108.514 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.514 ' N ' HG22 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -57.68 -45.59 85.39 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.455 -0.778 . . . . 0.0 109.324 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.671 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 7.9 tt0 -62.41 -44.18 97.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 110.144 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.546 ' NE2' ' CZ2' ' A' ' 16' ' ' TRP . 27.2 mt-30 -79.02 -46.31 18.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.883 -1.136 . . . . 0.0 109.902 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.421 ' HG ' HG11 ' A' ' 33' ' ' VAL . 16.0 tp -65.82 -58.33 5.88 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.939 -1.1 . . . . 0.0 109.075 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.476 ' CG ' ' O ' ' A' ' 33' ' ' VAL . 19.8 t-20 -60.41 -18.95 54.22 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.735 -1.228 . . . . 0.0 109.715 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 26' ' ' GLN . . . -64.67 -24.93 67.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.785 -1.197 . . . . 0.0 108.025 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -88.64 13.81 11.42 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.566 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.36 21.09 46.14 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.343 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.476 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 34.0 t -93.65 144.35 9.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.366 -1.079 . . . . 0.0 109.278 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -83.76 156.16 22.69 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -153.62 146.92 24.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.807 -1.183 . . . . 0.0 107.973 177.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 2.9 pt-20 -175.18 175.16 2.29 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.074 -1.016 . . . . 0.0 110.271 178.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -148.37 121.94 9.17 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.456 ' CZ2' HD23 ' A' ' 131' ' ' LEU . 34.5 m0 -112.25 153.61 26.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 108.836 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -139.25 146.58 40.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.689 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.597 ' HB2' ' CE1' ' A' ' 57' ' ' TYR . . . -101.85 159.95 14.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 108.708 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -96.23 -17.06 21.05 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.6 mtm-85 -93.09 147.95 22.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -91.91 137.17 32.59 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.582 -0.699 . . . . 0.0 109.273 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.445 ' N ' HD22 ' A' ' 44' ' ' LEU . 4.3 mm? -92.33 163.64 13.81 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.819 0.818 . . . . 0.0 109.378 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.15 -113.5 0.37 Allowed Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.92 -1.134 . . . . 0.0 110.639 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.61 89.01 4.51 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.126 -1.22 . . . . 0.0 109.392 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.49 92.42 19.59 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.1 -25.9 13.39 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.051 1.834 . . . . 0.0 112.285 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.4 p -119.61 141.29 49.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.696 -0.628 . . . . 0.0 109.571 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -80.63 -27.2 37.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.398 -0.813 . . . . 0.0 109.571 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' HA ' HD11 ' A' ' 54' ' ' ILE . 97.0 mt-10 -43.8 -38.97 3.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.23 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 p -79.82 -32.82 40.69 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.1 -1.0 . . . . 0.0 109.11 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' A' ' 50' ' ' ALA . 43.6 t -67.55 -52.22 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.438 -0.789 . . . . 0.0 109.942 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.618 ' O ' ' N ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -60.85 -30.89 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.044 -1.035 . . . . 0.0 108.795 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.29 -34.56 75.4 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.464 -0.772 . . . . 0.0 109.633 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.97 -18.04 56.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 0.0 110.306 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.597 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 82.5 m-85 -114.44 -10.29 12.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.361 -0.837 . . . . 0.0 109.962 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.752 HE21 ' CG1' ' A' ' 61' ' ' ILE . 18.6 tp60 -50.74 -34.02 25.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.17 -0.956 . . . . 0.0 109.014 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.722 ' CD2' ' N ' ' A' ' 60' ' ' ALA . 12.0 p-80 -54.67 -44.22 73.12 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.945 -1.097 . . . . 0.0 109.5 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.722 ' N ' ' CD2' ' A' ' 59' ' ' HIS . . . -64.2 -60.2 3.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 0.0 109.906 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.752 ' CG1' HE21 ' A' ' 58' ' ' GLN . 1.0 OUTLIER -63.94 -22.2 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 109.961 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 58' ' ' GLN . 31.1 t0 -58.15 -65.25 0.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.009 -1.077 . . . . 0.0 108.53 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -51.61 -34.25 36.61 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.656 -1.278 . . . . 0.0 108.773 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.16 -55.18 17.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.086 -1.009 . . . . 0.0 109.672 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -67.37 -25.54 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.391 -0.818 . . . . 0.0 109.11 179.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.23 -41.89 72.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.963 -1.086 . . . . 0.0 109.495 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.49 -52.3 8.22 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.954 -1.091 . . . . 0.0 109.99 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.637 ' O ' ' C ' ' A' ' 69' ' ' GLY . 45.9 mttm -82.78 4.73 24.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.258 -0.901 . . . . 0.0 110.405 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.637 ' C ' ' O ' ' A' ' 68' ' ' LYS . . . 8.07 80.33 0.01 OUTLIER Glycine 0 N--CA 1.503 3.126 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.832 ' CG ' HG21 ' A' ' 155' ' ' ILE . 30.5 m-85 -74.42 161.67 29.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.164 -1.198 . . . . 0.0 109.497 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.404 ' HG3' HD21 ' A' ' 158' ' ' ASN . 94.7 mm-40 -57.01 -46.27 82.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.428 -0.795 . . . . 0.0 109.716 -177.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 m -150.17 160.24 43.82 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.193 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.733 ' HE1' ' CG2' ' A' ' 153' ' ' ILE . 19.3 t-105 -125.77 128.14 47.25 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.483 ' CB ' ' CE2' ' A' ' 156' ' ' PHE . 2.5 t0 -136.85 157.63 46.31 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.935 -1.103 . . . . 0.0 108.479 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 76' ' ' ILE . 1.0 OUTLIER -97.86 174.13 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.64 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 35.2 mm -106.99 113.77 44.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.7 p -96.76 164.52 12.54 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 123.229 1.49 . . . . 0.0 111.817 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.016 HD22 ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -167.5 164.57 14.88 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.971 176.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 1.016 ' N ' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -137.45 140.42 41.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 174.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.65 -1.88 20.77 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.157 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -114.99 -14.13 11.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.205 -0.934 . . . . 0.0 109.384 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -66.16 123.68 85.89 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.445 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.66 -2.18 11.73 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.176 1.917 . . . . 0.0 111.212 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -87.01 -2.99 59.04 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.027 -1.046 . . . . 0.0 109.763 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.492 ' HB2' HD21 ' A' ' 82' ' ' ASN . 0.2 OUTLIER -54.52 -43.43 71.88 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.687 -1.258 . . . . 0.0 108.135 178.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.437 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 84.6 tt0 -60.73 -40.92 94.18 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.233 -0.917 . . . . 0.0 109.148 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.48 81.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.0 109.912 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 88' ' ' LEU . 4.5 mm? -61.59 -42.77 99.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.006 -1.059 . . . . 0.0 109.739 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.45 ' HG2' ' H ' ' A' ' 144' ' ' MET . 82.8 mtm180 -62.01 -27.54 68.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.844 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -65.63 -60.29 3.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.863 . . . . 0.0 109.862 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.427 ' HD3' HD13 ' A' ' 88' ' ' LEU . 12.8 ptmt -57.55 -36.76 72.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -0.913 . . . . 0.0 109.382 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -75.77 -24.26 56.01 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.54 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 94' ' ' ASN . 3.9 mt -74.46 -34.9 63.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 110.602 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 93' ' ' LEU . 16.5 m120 -45.8 127.13 7.77 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.906 -1.122 . . . . 0.0 109.156 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.472 ' HB3' HE22 ' A' ' 165' ' ' GLN . 3.2 tt0 -55.1 147.64 15.6 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -169.01 -172.55 1.58 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 117.612 -1.635 . . . . 0.0 112.628 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -165.03 135.28 3.79 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.645 ' ND1' ' N ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -108.19 157.04 18.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.942 . . . . 0.0 110.077 -179.052 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.485 ' H ' ' HA ' ' A' ' 162' ' ' TRP . . . -78.8 -6.82 88.5 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -122.93 169.78 10.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.454 -1.027 . . . . 0.0 109.3 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -74.94 142.82 43.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.136 -0.978 . . . . 0.0 110.013 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.634 ' CG ' HH22 ' A' ' 154' ' ' ARG . 17.0 tt0 -100.37 94.97 6.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.296 -0.878 . . . . 0.0 108.953 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.511 HG22 ' OG ' ' A' ' 133' ' ' SER . 47.5 t -88.19 128.59 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.501 -0.749 . . . . 0.0 109.173 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.402 ' NH1' ' HB1' ' A' ' 152' ' ' ALA . 5.9 tpt180 -129.39 122.55 29.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 129' ' ' ASN . 52.2 t80 -109.37 127.06 54.06 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CG ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -87.34 125.68 34.39 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.432 0.634 . . . . 0.0 110.22 -178.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.95 -35.2 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.596 -0.69 . . . . 0.0 109.72 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -160.2 145.34 14.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.085 -1.009 . . . . 0.0 110.303 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.475 ' O ' ' OE2' ' A' ' 127' ' ' GLU . . . 97.11 162.85 32.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.21 163.82 28.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -1.154 . . . . 0.0 110.015 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.92 153.16 11.57 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.527 HD22 HD12 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -102.65 101.99 12.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.971 -1.311 . . . . 0.0 109.809 -179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -88.85 130.04 35.47 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.747 -1.22 . . . . 0.0 110.704 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.546 ' SG ' HG13 ' A' ' 121' ' ' VAL . 31.4 t -77.86 130.59 36.82 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.325 0.584 . . . . 0.0 109.714 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.417 HD11 HG13 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -115.82 124.57 51.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.503 ' CD2' ' O ' ' A' ' 120' ' ' GLU . 3.5 t-160 -115.42 115.75 27.07 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.19 -0.944 . . . . 0.0 108.945 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.41 125.33 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.194 -0.941 . . . . 0.0 110.345 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.74 -143.94 41.04 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 104.167 -3.573 . . . . 0.0 104.167 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -109.28 81.43 1.44 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 122.212 3.006 . . . . 0.0 109.793 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.503 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 21.7 pt-20 -164.96 168.38 17.58 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.546 HG13 ' SG ' ' A' ' 114' ' ' CYS . 54.1 t -125.66 136.26 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.109 -0.994 . . . . 0.0 109.933 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -124.07 130.55 52.75 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.819 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.404 HE21 ' HB2' ' A' ' 114' ' ' CYS . 17.5 mt-30 -125.15 118.38 25.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.202 -0.936 . . . . 0.0 108.974 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.817 HG22 ' CD1' ' A' ' 3' ' ' LEU . 31.9 t -105.69 132.32 52.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 125' ' ' LEU . 7.5 tt -126.63 80.05 1.91 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.37 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' A' ' 1' ' ' SER . 47.4 t -168.99 117.22 0.66 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 177.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.475 ' OE2' ' O ' ' A' ' 109' ' ' GLY . 10.5 tm-20 -113.5 105.7 13.67 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 116.086 -2.245 . . . . 0.0 112.34 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.547 ' C ' ' H ' ' A' ' 130' ' ' ASP . 12.2 mttm -109.31 177.08 4.86 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.16 -1.382 . . . . 0.0 108.68 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.518 ' O ' ' CE2' ' A' ' 105' ' ' PHE . 54.5 m-80 -59.54 -2.0 0.29 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' A' ' 128' ' ' LYS . 31.2 p30 -72.39 154.37 40.94 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.943 HD12 ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -120.52 155.71 33.06 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.99 0.9 . . . . 0.0 110.089 -179.171 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.943 ' N ' HD12 ' A' ' 131' ' ' LEU . 2.9 tp -122.37 128.33 75.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.511 ' OG ' HG22 ' A' ' 103' ' ' VAL . 4.9 t -109.04 134.39 51.73 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 108.985 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.417 HG13 HD11 ' A' ' 115' ' ' LEU . 2.3 t -103.63 133.86 20.05 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.01 151.41 73.36 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.893 1.729 . . . . 0.0 112.552 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 137' ' ' HIS . . . -70.39 134.71 48.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.619 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 1.4 t-80 92.97 7.94 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 120.933 0.397 . . . . 0.0 110.262 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.87 125.91 33.3 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.89 -1.131 . . . . 0.0 109.228 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 166' ' ' PHE . 40.6 Cg_endo -64.02 131.55 31.16 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.636 1.557 . . . . 0.0 111.656 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.474 ' C ' ' CE3' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -169.71 160.56 8.83 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.096 -178.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.501 ' CG ' ' HB2' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -131.92 -146.6 0.29 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.295 -0.878 . . . . 0.0 109.414 -178.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.04 128.12 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.772 -1.205 . . . . 0.0 109.088 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.42 136.67 21.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.455 -0.778 . . . . 0.0 109.577 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.586 ' O ' ' C ' ' A' ' 145' ' ' GLY . 9.1 mmt -112.59 18.89 17.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.478 -0.764 . . . . 0.0 111.036 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 144' ' ' MET . . . 10.88 -94.38 0.01 OUTLIER Glycine 0 N--CA 1.506 3.339 0 CA-C-N 118.886 0.766 . . . . 0.0 112.349 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.488 ' H ' ' HB3' ' A' ' 178' ' ' LEU . 18.5 p -85.38 120.89 27.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.351 -1.339 . . . . 0.0 109.02 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.743 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -113.4 118.17 44.06 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.873 -0.517 . . . . 0.0 109.783 178.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 149' ' ' ASN . 58.6 Cg_endo -102.22 34.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.794 2.329 . . . . 0.0 110.742 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.737 HD22 HD11 ' A' ' 78' ' ' LEU . 0.3 OUTLIER 82.66 64.61 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.446 0.641 . . . . 0.0 109.457 -177.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.486 ' O ' HD12 ' A' ' 78' ' ' LEU . 24.8 p90 -99.85 153.24 19.3 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 122.212 1.006 . . . . 0.0 111.327 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.8 m -118.27 137.32 53.13 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.64 ' HB3' ' HB ' ' A' ' 76' ' ' ILE . . . -142.59 163.27 33.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.1 -1.0 . . . . 0.0 109.176 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.733 ' CG2' ' HE1' ' A' ' 73' ' ' TRP . 63.6 mt -119.17 136.96 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.219 -0.926 . . . . 0.0 109.874 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.634 HH22 ' CG ' ' A' ' 102' ' ' GLU . 2.6 ttt85 -140.11 167.75 21.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.901 -1.124 . . . . 0.0 110.472 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.832 HG21 ' CG ' ' A' ' 70' ' ' TYR . 4.1 mp -109.18 155.19 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.485 -0.759 . . . . 0.0 109.603 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.483 ' CE2' ' CB ' ' A' ' 74' ' ' ASP . 2.6 m-30 -106.97 125.42 50.98 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.975 0.893 . . . . 0.0 110.253 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 158' ' ' ASN . 1.1 t70 -131.07 162.03 30.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.439 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -93.85 161.83 28.91 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.105 -0.997 . . . . 0.0 108.464 -179.46 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 162' ' ' TRP . 41.4 Cg_endo -63.53 -55.97 0.61 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.009 1.806 . . . . 0.0 112.376 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 159' ' ' PRO . 48.9 tp10 -44.02 -19.22 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.072 -1.018 . . . . 0.0 108.309 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 159' ' ' PRO . . . -90.0 -31.1 11.35 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.598 ' CD1' ' C ' ' A' ' 162' ' ' TRP . 0.0 OUTLIER -95.74 165.2 12.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.406 -1.055 . . . . 0.0 111.286 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.65 148.02 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.23 -74.87 0.29 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.932 -1.105 . . . . 0.0 110.644 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.472 HE22 ' HB3' ' A' ' 95' ' ' GLU . 14.3 mm100 -141.91 161.26 38.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.993 -1.067 . . . . 0.0 109.929 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.629 ' CD2' ' N ' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -101.95 -41.76 6.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.127 -0.983 . . . . 0.0 109.269 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 70.8 p -117.98 -30.42 5.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.346 -0.846 . . . . 0.0 108.887 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.06 -5.45 53.07 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 120.175 -1.012 . . . . 0.0 110.653 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -79.59 148.13 31.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.589 -1.536 . . . . 0.0 108.016 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -108.38 89.51 3.02 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 117.519 -1.672 . . . . 0.0 110.88 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.422 ' H ' HG22 ' A' ' 171' ' ' ILE . 1.3 tt -78.86 -23.57 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.489 -1.382 . . . . 0.0 109.737 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 174' ' ' ALA . . . -56.74 -41.39 77.45 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 108.724 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.565 ' C ' ' HD3' ' A' ' 176' ' ' PRO . 47.5 p -53.52 -3.38 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.348 -0.845 . . . . 0.0 109.973 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 172' ' ' ALA . . . -79.83 -37.05 35.91 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.031 -1.043 . . . . 0.0 111.964 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.618 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 10.1 m-85 -111.9 25.18 0.08 OUTLIER Pre-proline 0 N--CA 1.517 2.895 0 O-C-N 120.449 -1.407 . . . . 0.0 113.077 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 175' ' ' TYR . 38.0 Cg_endo -58.97 -24.0 71.04 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 123.902 3.068 . . . . 0.0 115.141 -172.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -89.05 126.25 35.35 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.487 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.734 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.8 OUTLIER -86.8 123.99 32.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.18 -0.95 . . . . 0.0 108.717 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 178' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_